FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hahn, JY
AF Hahn, Joo-Yong
TI Effects of Ticagrelor on Myocardial Infarct Size
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CLOPIDOGREL; ANTAGONIST; INHIBITION; AZD6140
C1 [Hahn, Joo-Yong] Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
RP Hahn, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM jyhahn@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X
CR Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323
   Armstrong PW, 2012, CIRCULATION, V125, P514, DOI 10.1161/CIRCULATIONAHA.111.047530
   Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754
   Khan JN, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003403
   Kim EK, 2017, J AM COLL CARDIOL, V69, P2098, DOI 10.1016/j.jacc.2017.02.034
   Nanhwan MK, 2014, ARTERIOSCL THROM VAS, V34, P2078, DOI 10.1161/ATVBAHA.114.304002
   Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Ye YM, 2015, ARTERIOSCL THROM VAS, V35, P1805, DOI 10.1161/ATVBAHA.115.305655
   Yun KH, 2017, KOREAN CIRC J, V47, P705, DOI 10.4070/kcj.2017.0044
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 689
EP 691
DI 10.4070/kcj.2017.0161
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200007
PM 28955386
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
AF Kim, Jang Young
TI Renal Dysfunction in Korean Acute Heart Failure Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Jang Young] Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Kim, JY (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM kimjy@yonsei.ac.kr
OI Kim, Jang Young/0000-0002-0813-7082
CR Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Park CS, 2017, KOREAN CIRC J, V47, P727, DOI 10.4070/kcj.2017.0050
   Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 692
EP 693
DI 10.4070/kcj.2017.0201
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200008
PM 28955387
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, SJ
   Ahn, CM
   Shin, DH
   Kim, JS
   Kim, BK
   Ko, YG
   Choi, D
   Her, AY
   Kim, YH
   Jang, Y
   Hong, MK
AF Hong, Sung-Jin
   Ahn, Chul-Min
   Shin, Dong-Ho
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Ko, Young-Guk
   Choi, Donghoon
   Her, Ae-Young
   Kim, Yong Hoon
   Jang, Yangsoo
   Hong, Myeong-Ki
TI Effect of Adjunct Balloon Dilation after Long Everolimus-eluting Stent
   Deployment on Major Adverse Cardiac Events
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Drug-eluting stents; Treatment outcome
ID PERCUTANEOUS CORONARY INTERVENTION; INTRAVASCULAR ULTRASOUND;
   MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; POST-DILATION; IMPLANTATION;
   TRIAL; ANGIOGRAPHY; RESTENOSIS; POSTDILATATION
AB Background and Objectives: The effectiveness of adjunct balloon dilation after drug-eluting stent (DES) deployment has not been sufficiently evaluated. We evaluated whether adjunct balloon dilation was associated with a reduction in major adverse cardiac events (MACEs) after long everolimus-eluting stents (EESs) implantation.
   Subjects and Methods: Drawing from 2 randomized trials, a total of 1,672 patients treated with long EES were analyzed. Of 1,672 patients, 1,061 patients (64%) received post-stent adjunct balloon dilation. MACE, defined as a composite of cardiac death, myocardial infarction, and target-lesion revascularization (TLR), was compared between patients who received post-stent adjunct balloon dilation and patients who did not in 595 propensity score-matched pairs.
   Results: For the matched population, MACE occurred in 29 patients (4.9%) who received adjunct balloon dilation and in 29 patients (4.9%) who did not (hazard ratio [HR], 1.01; 95% confidence interval [CI], 0.60-1.69; p=0.972). However, significant interactions were observed among the subgroups for clinical presentation and vessel size. Adjunct balloon dilation was more favored within the subset of patients with stable angina vs. the subset of patients with acute coronary syndrome (p for interaction=0.037), and within the subset of lesions with small vessel diameter (reference vessel diameter [RVD] <3 mm) vs. the subset of lesions with larger vessel diameter (RVD >= 3 mm; p for interaction=0.027).
   Conclusion: Adjunct balloon dilation was not associated with MACE reduction at 1 year among patients requiring long EES implantation. However, post-stent adjunct balloon dilation may be necessary for patients requiring long EES implantation who present with stable angina or for lesions with small vessel diameters.
C1 [Hong, Sung-Jin; Ahn, Chul-Min; Shin, Dong-Ho; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Her, Ae-Young; Kim, Yong Hoon] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea.
   [Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
   [Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Kim, Jung-Sun/0000-0003-2263-3274; Hong, Myeong-Ki/0000-0002-2090-2031;
   Hong, Sung-Jin/0000-0003-4893-039X; Choi, Donghoon/0000-0002-2009-9760;
   Ahn, Chul-Min/0000-0002-7071-4370; Ko, Young-Guk/0000-0001-7748-5788;
   Kim, Byeong-Keuk/0000-0003-2493-066X; Jang, Yangsoo/0000-0002-2169-3112;
   Shin, Dong-Ho/0000-0002-7874-5542
FU Ministry of Health and Welfare, KoreaMinistry of Health & Welfare,
   Republic of Korea [A085136, HI15C1277]; National Research Foundation of
   Korea (NRF) - Ministry of Education, Science and Technology (MEST),
   Korea [2015R1A2A2A01002731]; Cardiovascular Research Center, Seoul,
   Korea
FX This study was supported by a grant from the Korea Healthcare Technology
   Research and Development Project, Ministry of Health and Welfare, Korea
   (No. A085136 and HI15C1277), the Mid-career Researcher Program through
   National Research Foundation of Korea (NRF) grant funded by the Ministry
   of Education, Science and Technology (MEST), Korea (No.
   2015R1A2A2A01002731), and the Cardiovascular Research Center, Seoul,
   Korea.
CR Brodie BR, 2003, CATHETER CARDIO INTE, V59, P184, DOI 10.1002/ccd.10474
   Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P1209, DOI 10.1016/j.jcin.2011.07.016
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005
   Frobert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056348
   Hoffmann R, 2005, CATHETER CARDIO INTE, V66, P499, DOI 10.1002/ccd.20542
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020
   Hur SH, 2001, AM J CARDIOL, V88, P1114, DOI 10.1016/S0002-9149(01)02044-6
   Iakovou I, 2003, J AM COLL CARDIOL, V42, P1900, DOI 10.1016/j.jacc.2003.06.012
   Kastrati A, 2006, CIRCULATION, V113, P2293, DOI 10.1161/CIRCULATIONAHA.105.601823
   Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043
   Kim JS, 2015, CAN J CARDIOL, V31, P723, DOI 10.1016/j.cjca.2015.01.002
   Kim JS, 2013, JACC-CARDIOVASC INTE, V6, P369, DOI 10.1016/j.jcin.2012.11.009
   Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872
   Naidu SS, 2012, JACC-CARDIOVASC INTE, V5, P626, DOI 10.1016/j.jcin.2012.02.014
   Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9
   Pasceri V, 2014, CATHETER CARDIO INTE, V83, P898, DOI 10.1002/ccd.24999
   Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005
   Russo RJ, 2009, CIRC-CARDIOVASC INTE, V2, P113, DOI 10.1161/CIRCINTERVENTIONS.108.778647
   Srour JF, 2014, CATHETER CARDIO INTE, V83, P905, DOI 10.1002/ccd.25481
   Steg PG, 2016, EUR HEART J, V37, P335, DOI 10.1093/eurheartj/ehv708
   Stone GW, 2015, JACC-CARDIOVASC INTE, V8, P927, DOI 10.1016/j.jcin.2015.01.032
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Zhang ZJ, 2010, AM HEART J, V160, P979, DOI 10.1016/j.ahj.2010.07.007
NR 27
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 694
EP 704
DI 10.4070/kcj.2017.0016
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200009
PM 28955388
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
   Park, JJ
   Oh, IY
   Yoon, CH
   Choi, DJ
   Park, HA
   Kang, SM
   Yoo, BS
   Jeon, ES
   Kim, JJ
   Cho, MC
   Chae, SC
   Ryu, KH
   Oh, BH
AF Park, Chan Soon
   Park, Jin Joo
   Oh, Il-Young
   Yoon, Chang-Hwan
   Choi, Dong-Ju
   Park, Hyun-Ah
   Kang, Seok-Min
   Yoo, Byung-Su
   Jeon, Eun-Seok
   Kim, Jae-Joong
   Cho, Myeong-Chan
   Chae, Shung Chull
   Ryu, Kyu-Hyung
   Oh, Byung-Hee
CA KorHF Investigators
TI Relation of Renal Function with Left Ventricular Systolic Function and
   NT-proBNP Level and Its Prognostic Implication in Heart Failure with
   Preserved versus Reduced Ejection Fraction: an analysis from the Korean
   Heart Failure (KorHF) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Renal dysfunction; Ejection fraction; Pro-brain natriuretic peptide
   (1-76); Prognosis; Heart failure
ID BRAIN NATRIURETIC PEPTIDE; EMERGENCY-DEPARTMENT PRIDE; CARDIORENAL
   SYNDROME; DYSFUNCTION; DISEASE; BNP; INFLAMMATION; MORTALITY; DIAGNOSIS;
   SURVIVAL
AB Background and Objectives: The relationship between ejection fraction (EF), N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and renal function is unknown as stratified by heart failure (HF) type. We investigated their relation and the prognostic value of renal function in heart failure with preserved ejection fraction (HFpEF) vs. reduced ejection fraction (HFrEF).
   Materials and Methods: NT-proBNP, glomerular filtration rate (GFR), and EF were obtained in 1,932 acute heart failure (AHF) patients. HFrEF was defined as EF < 50%, and renal dysfunction as GFR < 60 mL/min/1.73 m(2) (mild renal dysfunction: 30 <= GFR < 60 mL/min/1.73 m(2); severe renal dysfunction: GFR < 30 mL/min/1.73 m(2)). The primary outcome was 12-month all-cause death.
   Results: There was an inverse correlation between GFR and log NT-proBNP level (r=-0.298, p < 0.001), and between EF and log NT-proBNP (r=-0.238, p < 0.001), but no correlation between EF and GFR (r=0.017, p=0.458). Interestingly, the prevalence of renal dysfunction did not differ between HFpEF and HFrEF (49% vs. 52%, p=0.210). Patients with renal dysfunction had higher 12-month mortality in both HFpEF (7.9% vs. 15.2%, log-rank p=0.008) and HFrEF (8.6% vs. 16.8%, log-rank p < 0.001). Multivariate analysis showed severe renal dysfunction was an independent predictor of 12-month mortality (hazard ratio [HR], 2.08; 95% confidence interval [CI], 1.40-3.11). When stratified according to EF: the prognostic value of severe renal dysfunction was attenuated in HFpEF patients (HR, 1.46; 95% CI, 0.66-3.21) contrary to HFrEF patients (HR, 2.43; 95% CI, 1.52-3.89).
   Conclusion: In AHF patients, the prevalence of renal dysfunction did not differ between HFpEF and HFrEF patients. However, the prognostic value of renal dysfunction was attenuated in HFpEF patients.
C1 [Park, Chan Soon; Park, Jin Joo; Oh, Il-Young; Yoon, Chang-Hwan; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea.
   [Park, Hyun-Ah] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Family Med, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Severance Hosp, Div Cardiol, Seoul, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Severance Christian Hosp, Div Cardiol, Wonju, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea.
   [Ryu, Kyu-Hyung] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Internal Med, Hwaseong, South Korea.
   [Oh, Byung-Hee] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Cardiovasc Ctr, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM djchoi@snubh.org
RI Oh, Byung-Hee/G-9875-2011
OI Oh, Byung-Hee/0000-0002-9945-4306; Yoon, Chang-Hwan/0000-0001-6305-4442;
   Kang, Seok-Min/0000-0001-9856-9227
FU Korean Society of Heart Failure; Korean Society of Cardiology
FX This work was supported by the Korean Society of Heart Failure and the
   Korean Society of Cardiology. The KorHFRegistry was conducted at 24
   medical centers: The Catholic University of Korea, St. Mary's Hospital;
   Chungnam National University Hospital; Chungbuk National University
   Hospital; Chonnam National University Hospital; Ewha Woman's University
   Hospital; Eulji University Daejeon Hospital; Gacheon University Gil
   Hospital; Hallym University Sacred Heart Hospital; Hanyang University
   Guri Hospital; Jeju National University Hospital; Konkuk University
   Medical Centre; Keimyung University Hospital; Korea University Guro
   Hospital; Kyungpook National University Hospital; Sungkyunkwan
   University Samsung Medical Centre; Seoul National University Bundang
   Hospital; Seoul National University Hospital; Ulsan University Asan
   Medical Centre; Wonkwang University Hospital; Yonsei University Wonju
   Christian Hospital; Yeungnam University Hospital; Yonsei University
   Severance Hospital; Dongguk University Ilsan Hospital; Soonchunhyang
   University Cheonan Hospital; and Inje University Busan Paik Hospital.
CR Ahmed A, 2007, AM J CARDIOL, V99, P393, DOI 10.1016/j.amjcard.2006.08.042
   Anwaruddin S, 2006, J AM COLL CARDIOL, V47, P91, DOI 10.1016/j.jacc.2005.08.051
   Bidani AK, 2013, CURR OPIN NEPHROL HY, V22, P1, DOI 10.1097/MNH.0b013e32835b36c1
   Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426
   Brown WV, 2008, AM J CARDIOL, V102, p10L, DOI 10.1016/j.amjcard.2008.09.068
   Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386
   de Silva R, 2006, EUR HEART J, V27, P569, DOI 10.1093/eurheartj/ehi696
   Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7
   Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506
   HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107
   Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631
   Kang SH, 2015, HEART, V101, P1881, DOI 10.1136/heartjnl-2015-307782
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Luchner A, 2005, HYPERTENSION, V46, P118, DOI 10.1161/01.HYP.0000170140.36633.8f
   NAKAGAWA O, 1995, J CLIN INVEST, V96, P1280, DOI 10.1172/JCI118162
   O'Donoghue M, 2005, J CARD FAIL, V11, pS9, DOI 10.1016/j.cardfail.2005.04.011
   Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256
   Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092
   Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051
   Rusinaru D, 2011, INT J CARDIOL, V147, P278, DOI 10.1016/j.ijcard.2009.09.529
   Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067
   Seino Y, 2004, EUR J HEART FAIL, V6, P295, DOI 10.1016/j.ejheart.2003.12.009
   Tang WHW, 2010, HEART, V96, P255, DOI 10.1136/hrt.2009.166256
   ter Maaten JM, 2016, EUR J HEART FAIL, V18, P588, DOI 10.1002/ejhf.497
   van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
NR 30
TC 3
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 727
EP 741
DI 10.4070/kcj.2017.0050
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200012
PM 28955391
OA Green Published
DA 2021-04-22
ER

PT J
AU Jia, ZZ
   Tu, JF
   Jiang, GM
AF Jia, Zhongzhi
   Tu, Jianfei
   Jiang, Guomin
TI The Classification and Management Strategy of Spontaneous Isolated
   Superior Mesenteric Artery Dissection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Superior mesenteric artery; Dissection; Classification; Treatment
ID PERCUTANEOUS STENT PLACEMENT; TOMOGRAPHY IMAGING FEATURES; CONSERVATIVE
   MANAGEMENT; THERAPY; ISCHEMIA
AB Spontaneous isolated superior mesenteric artery dissection (SISMAD) is an uncommon but potentially catastrophic pathology. Multiple classification schemes have been proposed for this occurrence. Although no consensus has emerged regarding which classification should be used, Li's classification scheme is more precise and complete compared to other classification systems and can be used to guide the treatment of SISMAD. Initial conservative treatment is promising, with favorable early and long- term outcomes for most patients; endovascular treatment is recommended for patients with persistent/recurrent symptoms after conservative treatment; surgical treatment should be performed without delay for patients with arterial rupture, intestinal necrosis, or failed endovascular treatment.
C1 [Jia, Zhongzhi; Jiang, Guomin] Nanjing Med Univ, Peoples Hosp Changzhou 2, Dept Intervent Radiog, Changzhou, Peoples R China.
   [Tu, Jianfei] Lishui Cent Hosp, Dept Radiol & Intervent Radiol, Lishui, Peoples R China.
RP Jiang, GM (corresponding author), Nanjing Med Univ, Peoples Hosp Changzhou 2, Dept Vasc & Intervent Radiol, 29 Xing Long Rd, Changzhou 213003, Peoples R China.
EM 747094035@qq.com
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [81401498]; Jiangsu Provincial Medical Youth Talent
   [QNRC2016270]; High-Level Medical Talents Training Project [2016CZBJ009]
FX This study was supported by the Natural Science Foundation of China (NO.
   81401498), Jiangsu Provincial Medical Youth Talent (QNRC2016270) and by
   the High-Level Medical Talents Training Project (NO. 2016CZBJ009). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BAUERSFELD SR, 1947, ANN INTERN MED, V26, P873, DOI 10.7326/0003-4819-26-6-873
   Chu SY, 2012, CLIN RADIOL, V67, P32, DOI 10.1016/j.crad.2011.04.007
   Garrett HE, 2014, J VASC SURG, V59, P1433, DOI 10.1016/j.jvs.2014.01.040
   Han Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003480
   Jia ZZ, 2013, EUR J VASC ENDOVASC, V45, P502, DOI 10.1016/j.ejvs.2013.01.039
   Jia ZZ, 2014, J VASC SURG, V59, P876, DOI 10.1016/j.jvs.2013.11.069
   Kim HK, 2014, J VASC SURG, V59, P465, DOI 10.1016/j.jvs.2013.07.112
   Kim Young-Wook, 2016, Vasc Specialist Int, V32, P37, DOI 10.5758/vsi.2016.32.2.37
   Lee JH, 2012, KOREAN CIRC J, V42, P140, DOI 10.4070/kcj.2012.42.2.140
   Leung DA, 2000, EUR RADIOL, V10, P1916, DOI 10.1007/s003300000520
   Li DL, 2014, J VASC SURG, V59, P165, DOI 10.1016/j.jvs.2013.07.014
   Li N, 2014, ANN VASC SURG, V28, P445, DOI 10.1016/j.avsg.2013.01.028
   Luan JY, 2014, EUR J VASC ENDOVASC, V47, P108, DOI 10.1016/j.ejvs.2013.10.023
   Luan JY, 2013, EUR J VASC ENDOVASC, V46, P232, DOI 10.1016/j.ejvs.2013.04.035
   Luan JY, 2016, J VASC SURG, V63, P530, DOI 10.1016/j.jvs.2015.09.047
   Luan JY, 2013, J VASC SURG, V57, P1612, DOI 10.1016/j.jvs.2012.11.121
   Min SI, 2011, J VASC SURG, V54, P461, DOI 10.1016/j.jvs.2011.03.001
   Nomura Y, 2011, J VASC SURG, V54, P1808, DOI 10.1016/j.jvs.2011.05.006
   Ogino H, 2016, CIRC J, V80, P1323, DOI 10.1253/circj.CJ-16-0406
   Okamura K, 2014, ANN VASC SURG, V28, P1939, DOI 10.1016/j.avsg.2014.06.062
   Park UJ, 2014, SURG TODAY, V44, P2092, DOI 10.1007/s00595-014-0849-9
   Sakamoto I, 2007, EUR J RADIOL, V64, P103, DOI 10.1016/j.ejrad.2007.05.027
   SISTERON A, 1975, CHIRURG ARTERIOPATHI, P197
   Sparks SR, 2000, ANN VASC SURG, V14, P105, DOI 10.1007/s100169910019
   Tomita K, 2016, CIRC J, V80, P1452, DOI 10.1253/circj.CJ-15-1369
   Wagenhauser MU, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-47
   Yang HJ, 2011, YONSEI MED J, V52, P859, DOI 10.3349/ymj.2011.52.5.859
   Yun WS, 2009, EUR J VASC ENDOVASC, V37, P572, DOI 10.1016/j.ejvs.2008.12.010
   Zerbib P, 2010, LANGENBECK ARCH SURG, V395, P437, DOI 10.1007/s00423-009-0537-1
   Zhao Y, 2016, VASC ENDOVASC SURG, V50, P183, DOI 10.1177/1538574416639151
NR 30
TC 13
Z9 15
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 425
EP 431
DI 10.4070/kcj.2016.0237
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500001
PM 28765730
OA Green Published
DA 2021-04-22
ER

PT J
AU Koh, KK
   Sakuma, I
   Shimada, K
   Hayashi, T
   Quon, MJ
AF Koh, Kwang Kon
   Sakuma, Ichiro
   Shimada, Kazunori
   Hayashi, Toshio
   Quon, Michael J.
TI Combining Potent Statin Therapy with Other Drugs to Optimize
   Simultaneous Cardiovascular and Metabolic Benefits while Minimizing
   Adverse Events
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypercholesterolemia; Hypertension; Statins; Renin-angiotensin system
   inhibitors; Cardiovascular disease
ID BALANCE CARDIORENOMETABOLIC BENEFITS; ANGIOTENSIN SYSTEM INHIBITOR;
   REDUCES ADIPONECTIN LEVELS; LOW-DENSITY-LIPOPROTEIN; FLOW-MEDIATED
   DILATION; CORONARY-HEART-DISEASE; HYPERCHOLESTEROLEMIC PATIENTS;
   BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; INSULIN SENSITIVITY
AB Hypercholesterolemia and hypertension are among the most important risk factors for cardiovascular (CV) disease. They are also important contributors to metabolic diseases including diabetes that further increase CV risk. Updated guidelines emphasize targeted reduction of overall CV risks but do not explicitly incorporate potential adverse metabolic outcomes that also influence CV health. Hypercholesterolemia and hypertension have synergistic deleterious effects on interrelated insulin resistance and endothelial dysfunction. Dysregulation of the renin-angiotensin system is an important pathophysiological mechanism linking insulin resistance and endothelial dysfunction to atherogenesis. Statins are the reference standard treatment to prevent CV disease in patients with hypercholesterolemia. Statins work best for secondary CV prevention. Unfortunately, most statin therapies dose-dependently cause insulin resistance, increase new onset diabetes risk and exacerbate existing type 2 diabetes mellitus. Pravastatin is often too weak to achieve target low-density lipoprotein cholesterol levels despite having beneficial metabolic actions. Renin-angiotensin system inhibitors improve both endothelial dysfunction and insulin resistance in addition to controlling blood pressure. In this regard, combined statin-based and renin-angiotensin system (RAS) inhibitor therapies demonstrate additive/synergistic beneficial effects on endothelial dysfunction, insulin resistance, and other metabolic parameters in addition to lowering both cholesterol levels and blood pressure. This combined therapy simultaneously reduces CV events when compared to either drug type used as monotherapy. This is mediated by both separate and interrelated mechanisms. Therefore, statin-based therapy combined with RAS inhibitors is important for developing optimal management strategies in patients with hypertension, hypercholesterolemia, diabetes, metabolic syndrome, or obesity. This combined therapy can help prevent or treat CV disease while minimizing adverse metabolic consequences.
C1 [Koh, Kwang Kon] Gachon Univ, Gil Med Ctr, Dept Cardiol, Incheon, South Korea.
   [Koh, Kwang Kon] Gachon Cardiovasc Res Inst, Incheon, South Korea.
   [Sakuma, Ichiro] Hlth Sci Univ Hokkaido, Hokko Mem Clin, Cardiovasc Med, Sapporo, Hokkaido, Japan.
   [Shimada, Kazunori] Juntendo Univ, Grad Sch Med, Cardiovasc Med, Tokyo, Japan.
   [Hayashi, Toshio] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi, Japan.
   [Quon, Michael J.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.
RP Koh, KK (corresponding author), Gachon Univ, Gil Hosp, Div Cardiol, 774 Beongil 21 Namdongdaero, Incheon 21565, South Korea.
EM kwangk@gilhospital.com
RI Hayashi, Toshio/I-7346-2014
OI Hayashi, Toshio/0000-0002-7711-2700
CR Athyros VG, 2014, CURR PHARM DESIGN, V20, P6299, DOI 10.2174/1381612820666140620115756
   Athyros VG, 2004, J HUM HYPERTENS, V18, P781, DOI 10.1038/sj.jhh.1001748
   Bavishi C, 2016, PROG CARDIOVASC DIS, V59, P253, DOI 10.1016/j.pcad.2016.10.002
   Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5
   Egan BM, 2013, CIRCULATION, V128, P29, DOI 10.1161/CIRCULATIONAHA.112.000500
   Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304
   Go AS, 2014, J AM COLL CARDIOL, V63, P1230, DOI 10.1016/j.jacc.2013.11.007
   Han SH, 2016, KOREAN CIRC J, V46, P135, DOI 10.4070/kcj.2016.46.2.135
   Jang JY, 2015, KOREAN CIRC J, V45, P225, DOI 10.4070/kcj.2015.45.3.225
   Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76
   Koh KK, 2005, HYPERTENSION, V45, P1088, DOI 10.1161/01.HYP.0000166722.91714.ba
   Koh KK, 2005, DIABETES CARE, V28, P1419, DOI 10.2337/diacare.28.6.1419
   Koh KK, 2003, J AM COLL CARDIOL, V42, P905, DOI 10.1016/S0735-1097(03)00846-5
   Koh KK, 2005, J AM COLL CARDIOL, V45, P1649, DOI 10.1016/j.jacc.2005.02.052
   Koh KK, 2004, CIRCULATION, V110, P3687, DOI 10.1161/01.CIR.0000143085.86697.13
   Koh KK, 2000, CARDIOVASC RES, V47, P648, DOI 10.1016/S0008-6363(00)00146-2
   Koh KK, 2008, DIABETES CARE, V31, P776, DOI 10.2337/dc07-2199
   Koh KK, 2017, J AM COLL CARDIOL, V69, P600, DOI 10.1016/j.jacc.2016.11.035
   Koh KK, 2016, INT J CARDIOL, V223, P488, DOI 10.1016/j.ijcard.2016.08.051
   Koh KK, 2016, CIRCULATION, V134, pE294, DOI 10.1161/CIRCULATIONAHA.116.023680
   Koh KK, 2016, INT J CARDIOL, V221, P572, DOI 10.1016/j.ijcard.2016.06.121
   Koh KK, 2015, J AM COLL CARDIOL, V66, P2808, DOI 10.1016/j.jacc.2015.08.1130
   Koh KK, 2015, J AM COLL CARDIOL, V66, P1848, DOI 10.1016/j.jacc.2015.07.072
   Koh KK, 2015, INT J CARDIOL, V199, P126, DOI 10.1016/j.ijcard.2015.07.016
   Koh KK, 2015, EXPERT OPIN PHARMACO, V16, P949, DOI 10.1517/14656566.2015.1019464
   Koh KK, 2014, J AM COLL CARDIOL, V63, P2880, DOI 10.1016/j.jacc.2014.01.080
   Koh KK, 2013, DIABETES, V62, P3547, DOI 10.2337/db13-0566
   Koh KK, 2013, INT J CARDIOL, V166, P509, DOI 10.1016/j.ijcard.2011.11.028
   Koh KK, 2012, INT J CARDIOL, V154, P97, DOI 10.1016/j.ijcard.2011.09.002
   Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036
   Koh KK, 2010, ATHEROSCLEROSIS, V209, P307, DOI 10.1016/j.atherosclerosis.2009.09.007
   Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053
   Koh KK, 2010, INT J CARDIOL, V140, P73, DOI 10.1016/j.ijcard.2008.11.017
   Lee BS, 2012, KOREAN CIRC J, V42, P543, DOI 10.4070/kcj.2012.42.8.543
   Lee DSH, 2014, JAMA INTERN MED, V174, P1263, DOI 10.1001/jamainternmed.2014.2266
   Lee HY, 2014, CIRC J, V78, P281, DOI 10.1253/circj.CJ-13-1494
   Lim S, 2014, ATHEROSCLEROSIS, V235, P644, DOI 10.1016/j.atherosclerosis.2014.06.001
   Lim S, 2014, ANTIOXID REDOX SIGN, V20, P1286, DOI 10.1089/ars.2013.5531
   Lim S, 2013, INT J CARDIOL, V167, P1696, DOI 10.1016/j.ijcard.2012.10.037
   Lotta LA, 2016, JAMA-J AM MED ASSOC, V316, P1383, DOI 10.1001/jama.2016.14568
   Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074
   Nickenig G, 1997, CIRCULATION, V95, P473
   Nickenig G, 1999, CIRCULATION, V100, P2131, DOI 10.1161/01.CIR.100.21.2131
   Oh PC, 2016, KOREAN J INTERN MED, V31, P237, DOI 10.3904/kjim.2016.026
   Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8
   Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985
   Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a
   Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177
NR 48
TC 9
Z9 9
U1 1
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 432
EP 439
DI 10.4070/kcj.2016.0406
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500002
PM 28765731
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, H
   Hong, YJ
   Cho, JY
   Sim, DS
   Yoon, HJ
   Kim, KH
   Kim, JH
   Ahn, Y
   Jeong, MH
   Cho, JG
   Park, JC
AF Park, Hyukjin
   Hong, Young Joon
   Cho, Jae Yeong
   Sim, Doo Sun
   Yoon, Hyun Ju
   Kim, Kye Hun
   Kim, Ju Han
   Ahn, Youngkeun
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
CA Korean Acute Myocardial Infarction
TI Blood Pressure Targets and Clinical Outcomes in Patients with Acute
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Myocardial infarction; Prognosis
ID CORONARY SYNDROMES; MORTALITY; DISEASE; EVENTS; HYPERTENSION; RISK
AB Background and Objectives: The optimal blood pressure (BP) target in patients with a history of acute myocardial infarction (MI) remains as a subject of debate. The 'J curve phenomenon' has been suggested as a target for BP control, however, it is unclear whether this phenomenon can be applied to MI patients. We analyzed patients with acute MI and investigated whether the 'J curve phenomenon' exists in this population.
   Subjects and Methods: Data were obtained from a nationwide prospective Korea Acute Myocardial Infarction Registry, which included 10337 patients with acute MI who underwent percutaneous coronary intervention (PCI) between 2011 and 2014. The patients were divided into quintiles according to systolic blood pressure (SBP) and diastolic blood pressure (DBP), which were measured during a two-year clinical follow up. Two-year cumulative incidence of major adverse cardiac events (MACE) was analyzed among the groups.
   Results: MACE was defined as a composite of cardiac death, need for recurrent revascularization (repeated PCI or coronary arterial bypass graft due to recurrent anginal symptoms or reoccurrence of MI), ischemic cerebrovascular accident, and need for hospitalization due to heart failure. During the two-year follow up, the total cumulative incidence of MACE was 9.7% (n=1005). BP-MACE analysis showed a U-shaped curve for both SBP and DBP, with the lowest MACE rate in quintiles with an average SBP of 112.2 mmHg and DBP of 73.3 mmHg. On Cox regression analysis, the U-shaped relation was statistically significant.
   Conclusion: In patients with acute MI, a 'U curve phenomenon' was observed when assessing patient BP control versus MACE rate.
C1 [Park, Hyukjin; Hong, Young Joon; Cho, Jae Yeong; Sim, Doo Sun; Yoon, Hyun Ju; Kim, Kye Hun; Kim, Ju Han; Ahn, Youngkeun; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun; Korean Acute Myocardial Infarction] Chonnam Natl Univ Hosp, Cardiovasc Convergence Res Ctr Nominated Korea, Minist Hlth & Welf, Div Cardiol, 671 Jaebongro, Gwangju 61469, South Korea.
RP Hong, YJ (corresponding author), Chonnam Natl Univ Hosp, Cardiovasc Convergence Res Ctr Nominated Korea, Minist Hlth & Welf, Div Cardiol, 671 Jaebongro, Gwangju 61469, South Korea.
EM hyj200@hanmail.net
CR Chang WC, 2004, AM HEART J, V148, P62, DOI 10.1016/j.ahj.2003.05.004
   Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004
   Denardo SJ, 2010, AM J CARDIOL, V106, P498, DOI 10.1016/j.amjcard.2010.03.056
   Denardo SJ, 2010, AM J MED, V123, P719, DOI 10.1016/j.amjmed.2010.02.014
   Dorresteijn JAN, 2012, HYPERTENSION, V59, P14, DOI 10.1161/HYPERTENSIONAHA.111.179143
   Frazier CG, 2005, AM HEART J, V150, P1260, DOI 10.1016/j.ahj.2005.08.004
   Kim JH, 2016, CIRC J, V80, P1427, DOI 10.1253/circj.CJ-16-0061
   Kong DG, 2009, J KOREAN MED SCI, V24, P800, DOI 10.3346/jkms.2009.24.5.800
   Lewington S, 2002, LANCET, V360, P1903
   Neal B, 2000, LANCET, V356, P1955
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217
   Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183
   Rosendorff C, 2015, J AM COLL CARDIOL, V65, P1998, DOI 10.1016/j.jacc.2015.02.038
   STRAUER BE, 1992, J CARDIOVASC PHARM, V19, pS67
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417
   WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
NR 18
TC 5
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 446
EP 454
DI 10.4070/kcj.2017.0008
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500006
PM 28765735
OA Green Published
DA 2021-04-22
ER

PT J
AU Lu, J
   Liu, LJ
   Zhu, JL
   Guo, XY
AF Lu, Jing
   Liu, Lijun
   Zhu, Jianliang
   Guo, Xinying
TI Factors Influencing the Quality of Standardized Treatment for Patients
   with Post-Cardiac Arrest Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart arrest; Therapeutics, treatment outcome; Prognosis, quality of
   health care
ID THERAPEUTIC HYPOTHERMIA; RESUSCITATION; GUIDELINES; IMPROVE; CARE
AB Background and Objectives: For the present study, we investigated the factors that influence the quality of standardized treatment for patients with post-cardiac arrest syndrome (PCAS) to improve the quality of PCAS treatment.
   Subjects and Methods: We collected data on patients with cardiac arrest (CA) who were admitted to the intensive care units (ICUs) of 11 hospitals-Class II Grade A or above-in Suzhou from January to October 2013. Indexes of standardized treatment were observed within 72 hrs of CA. We analyzed monitoring techniques, monitoring frequency, ICU human and material resources, and intensivists' knowledge of PCAS treatment to explore how those factors affected the management of patients with PCAS.
   Results: The bed/nurse ratio and the frequency with which core temperature was recorded correlated closely with the implementation of therapeutic hypothermia (TH) within 6 hrs of CA. The bed/doctor ratio and intensivists' knowledge about PCAS correlated closely with high-quality blood glucose control within 6 hrs of CA. Furthermore, the frequency with which core temperature was recorded was an independent factor influencing the quality of TH implementation, and the number times blood gas was analyzed was an independent factor influencing how well partial pressure of carbon dioxide was kept within the normal range in the 6 hrs after CA.
   Conclusion: The frequency of core temperature measurements and the number of times blood gas is analyzed are the most important factors influencing the quality of standardized treatment for patients with PCAS.
C1 [Lu, Jing] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
   [Lu, Jing; Guo, Xinying] Nanjing Univ Chinese Med, Dept Intens Care Unit, Tradit Chinese Med Kunshan, Suzhou, Peoples R China.
   [Liu, Lijun; Zhu, Jianliang] Soochow Univ, Affiliated Hosp 2, Dept Emergency & Intens Care Unit, Suzhou 215004, Peoples R China.
RP Liu, LJ (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Emergency & Intens Care Unit, Suzhou 215004, Peoples R China.
EM lijunliusz@126.com
FU First Affiliated Hospital of Soochow University; Suzhou Municipal
   Hospital; Suzhou Hospital of Traditional Chinese Medicine; Changshu No.
   1 People's Hospital; Changshu No. 2 People's Hospital; First People's
   Hospital of Kunshan; Taicang First People's Hospital; Wujiang First
   People's Hospital; Zhangjiagang First People's Hospital; Suzhou Social
   Development Foundation [SYS201063]
FX We would like to thank the 9 hospitals of this research group for their
   support and help: First Affiliated Hospital of Soochow University,
   Suzhou Municipal Hospital, Suzhou Hospital of Traditional Chinese
   Medicine, Changshu No. 1 People's Hospital, Changshu No. 2 People's
   Hospital, First People's Hospital of Kunshan, Taicang First People's
   Hospital, Wujiang First People's Hospital, and Zhangjiagang First
   People's Hospital. This work was supported by the Suzhou Social
   Development Foundation (SYS201063).
CR Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014
   Aufderheide TP, 2006, CURR OPIN CRIT CARE, V12, P207, DOI 10.1097/01.ccx.0000224863.55711.56
   Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1
   Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289
   Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88
   Cueni-Villoz N, 2011, CRIT CARE MED, V39, P2225, DOI 10.1097/CCM.0b013e31822572c9
   Holzer M, 2002, NEW ENGL J MED, V346, P549
   Jena AB, 2012, J HOSP MED, V7, P684, DOI 10.1002/jhm.1974
   Karanjia N, 2011, CURR TREAT OPTION NE, V13, P191, DOI 10.1007/s11940-011-0112-2
   Liu LJ, 2014, CHINESE MED J-PEKING, V127, P3024, DOI 10.3760/cma.j.issn.0366-6999.20140694
   Losert H, 2008, RESUSCITATION, V76, P214, DOI 10.1016/j.resuscitation.2007.08.003
   Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49
   Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002
   Soar J, 2007, BRIT MED J, V335, P459, DOI 10.1136/bmj.39315.519201.BE
   Tran Bau P, 2010, JAAPA, V23, P43
NR 15
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 455
EP 461
DI 10.4070/kcj.2016.0437
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500007
PM 28765736
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, DK
   Im, HJ
   Seo, JS
   Jin, HY
   Jang, JS
   Yang, TH
   Kim, DS
   Jeong, SY
   Song, YS
   Kim, DK
   Song, PS
   Seol, SH
   Kim, DI
AF Kim, Ki-Hun
   Kim, Dae-Kyeong
   Im, Hyun-Ji
   Seo, Jeong-Sook
   Jin, Han-Young
   Jang, Jae-Sik
   Yang, Tae-Hyun
   Kim, Dong-Soo
   Jeong, So-Young
   Song, Yun Seok
   Kim, Dong-Kie
   Song, Pil-Sang
   Seol, Sang-Hoon
   Kim, Doo-Il
TI Local Atrial/Ventricular Ratio as an Adjuvant Marker for Catheter
   Ablation of Atrioventricular Accessory Pathways
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Accessory pathway; Catheter ablation; Supraventricular tachycardia;
   Electrophysiologic technique, cardiac
ID 2015 ACC/AHA/HRS GUIDELINE; SUPRAVENTRICULAR TACHYCARDIA; ADULT
   PATIENTS; MANAGEMENT; STATE; WAVE; ART
AB Background and Objectives: The earliest atrial (A)/ventricular (V) activation potential, or accessory pathway (AP) potential are commonly used as ablation targets for atrioventricular (AV) APs. However, these targets are sometimes ambiguous.
   Subjects and Methods: We reviewed 119 catheter ablation cases in 112 patients diagnosed with orthodromic atrioventricular reentrant tachycardia (AVRT) or Wolff-Parkinson-White (WPW) syndrome. Local A/V amplitude potentials with the earliest activation or AP potential were measured shortly before achieving antegrade AP conduction block, ventriculoatrial block during right ventricle (RV) pacing, or AVRT termination with no AP conduction.
   Results: APs were located in the left lateral (55.5%), left posterior (17.6%), left posteroseptal (10.1%), midseptal (1.7%), right posteroseptal (7.6%), right posterior (1.7%), and right lateral (5.9%) regions. The mean earliest activation time was 16.7 +/- 15.5 ms, mean A/V potential was 1.1 +/- 0.9/1.0 +/- 0.9 mV, and mean A/V ratio was 1.7 +/- 2.0. There was no statistically significant difference between the activation methods (antegrade vs. RV pacing vs. orthodromic AVRT) or AP locations (left vs. right atrium). However, when the local A/V ratio was divided into 3 groups (<= 0.6, 1.0 +/- 0.3, and >= 1.4), the antegrade approach resulted in an A/V ratio greater than 1.0 +/- 0.3 (86.7%, p=0.007), and the orthodromic AVRT state resulted in a ratio of less than 1.0 +/- 0.3 (87.5%, p<0.001).
   Conclusion: The mean local A/V potential and ratio did not differ by activation method or AP location. However, a different A/V ratio based on activation method (>= 1.0 +/- 0.3, antegrade approach; and <= 1.0 +/- 0.3, orthodromic AVRT state) could be a good adjuvant marker for targeting AV APs.
C1 [Kim, Ki-Hun; Jeong, So-Young; Song, Yun Seok; Kim, Dong-Kie; Song, Pil-Sang; Kim, Doo-Il] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med, Busan, South Korea.
   [Kim, Dae-Kyeong; Im, Hyun-Ji; Seo, Jeong-Sook; Jin, Han-Young; Jang, Jae-Sik; Yang, Tae-Hyun; Kim, Dong-Soo; Seol, Sang-Hoon] Inje Univ, Busan Paik Hosp, Paik Hosp, Coll Med,Dept Internal Med, Busan, South Korea.
RP Kim, DK (corresponding author), Inje Univ, Busan Paik Hosp, Coll Med, Dept Internal Med, 75 Bokji Ro, Busan 47392, South Korea.
EM epkimdk@paik.ac.kr
CR CAPPATO R, 1994, CIRCULATION, V90, P884, DOI 10.1161/01.CIR.90.2.884
   Chen SA, 2001, PACE, V24, P1795, DOI 10.1046/j.1460-9592.2001.01795.x
   Dagres N, 1999, EUR HEART J, V20, P1826, DOI 10.1053/euhj.1999.1749
   Guo XG, 2015, J CARDIOVASC ELECTR, V26, P404, DOI 10.1111/jce.12607
   HAISSAGUERRE M, 1991, CIRCULATION, V84, P188, DOI 10.1161/01.CIR.84.1.188
   HAISSAGUERRE M, 1992, PACE, V15, P2138, DOI 10.1111/j.1540-8159.1992.tb03037.x
   Han S, 2012, HEART RHYTHM, V9, P1321, DOI 10.1016/j.hrthm.2012.03.009
   Issa ZF, 2012, CLIN ARRHYTHMOLOGY E, P411
   Iturralde P, 2002, EUROPACE, V4, P273, DOI 10.1053/eupc.2002.0236
   Liu EZ, 2012, CIRC-ARRHYTHMIA ELEC, V5, pE63, DOI 10.1161/CIRCEP.112.971135
   Long DY, 2013, J CARDIOVASC ELECTR, V24, P788, DOI 10.1111/jce.12122
   Mont L, 1993, Rev Esp Cardiol, V46, P745
   Morady F, 2004, J CARDIOVASC ELECTR, V15, P124, DOI 10.1046/j.1540-8167.2004.03516.x
   Otomo K, 2001, CIRCULATION, V104, P550, DOI 10.1161/hc3001.093499
   Page RL, 2016, HEART RHYTHM, V13, pE136, DOI 10.1016/j.hrthm.2015.09.019
   Page RL, 2016, HEART RHYTHM, V13, pE92, DOI 10.1016/j.hrthm.2015.09.018
   Scheinman M, 2003, PACE, V26, P789, DOI 10.1046/j.1460-9592.2003.00139.x
   Wang LX, 2003, ARCH MED RES, V34, P394, DOI 10.1016/j.arcmed.2003.06.001
NR 18
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 462
EP 468
DI 10.4070/kcj.2016.0371
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500008
PM 28765737
OA Green Published
DA 2021-04-22
ER

PT J
AU Upala, S
   Yong, WC
   Sanguankeo, A
AF Upala, Sikarin
   Yong, Wai Chung
   Sanguankeo, Anawin
TI Increased Arterial Stiffness in Behcet's Disease: a Systematic Review
   and Meta-Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Meta-analysis; Vascular stiffness; Pulse wave analysis; Behcet's disease
ID INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; CAROTID-ARTERY;
   BLOOD-PRESSURE; ATHEROSCLEROSIS; DISTENSIBILITY; INVOLVEMENT
AB Background and Objectives: Behcet's disease (BD) is a systemic vasculitis that is characterized by genital, oral, or skin lesions, uveitis, and vascular complications. Studies have shown that increased arterial stiffness is common in systemic immune and inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus. However, current research has not yet determined whether patients with BD have increased arterial stiffness. This meta-analysis compares arterial stiffness parameters in subjects with a BD diagnosis to normal subjects.
   Subjects and Methods: A comprehensive search of the MEDLINE and EMBASE databases was performed from the database beginning through May 2016. Observation studies were included in this analysis if they assessed the association between BD and arterial stiffness in adult subjects. BD patients met the International Study Group criteria for a diagnosis of Behcet's disease. Aortic stiffness was assessed using carotid-femoral pulse wave velocity (PWV) measurements as an indicator. Pooled mean difference (MD) of PWV and 95% confidence intervals (CI) were calculated using a random-effect, generic inverse variance meta-analysis. The between-study heterogeneity of effect-size was quantified using the Q statistic and I-2.
   Results: Data were extracted from four observational studies that included 303 subjects. PWV is significantly higher in patients with Behcet's disease compared with controls (MD=0.74; 95%, CI: 0.28-1.20, p=0.002, I-2=63%).
   Conclusion: In this meta-analysis, we observed that PWV, an ideal indicator of arterial stiffness, is increased in patients with Behcet's disease compared with the controls. Prospective studies in a large population should be done to determine the pathophysiological and prognostic implications of increased arterial stiffness in BD.
C1 [Upala, Sikarin; Yong, Wai Chung; Sanguankeo, Anawin] Bassett Med Ctr, Dept Internal Med, 1 Atwell, Cooperstown, NY 13326 USA.
   [Upala, Sikarin; Yong, Wai Chung; Sanguankeo, Anawin] Columbia Univ, Coll Phys & Surg, Cooperstown, NY USA.
   [Upala, Sikarin; Sanguankeo, Anawin] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand.
RP Yong, WC (corresponding author), Bassett Med Ctr, Dept Internal Med, 1 Atwell, Cooperstown, NY 13326 USA.
EM waichung.yong@outlook.com
OI Yong, Wai Chung/0000-0002-8395-6897
CR Alan S, 2004, ANGIOLOGY, V55, P413, DOI 10.1177/000331970405500408
   Balta I, 2014, J EUR ACAD DERMATOL, V28, P1388, DOI 10.1111/jdv.12297
   Butta NV, 2015, SEMIN THROMB HEMOST, V41, P621, DOI 10.1055/s-0035-1556727
   Caldas CAM, 2013, J EUR ACAD DERMATOL, V27, P454, DOI 10.1111/j.1468-3083.2012.04458.x
   Celik G, 2015, HYPERTENS RES, V38, P856, DOI 10.1038/hr.2015.86
   Chang HK, 2006, ANN RHEUM DIS, V65, P415, DOI 10.1136/ard.2005.043430
   Davatchi F., 2012, PATHOLOG RES INT, V2012, DOI DOI 10.1155/2012/607921
   Davies JI, 2003, J HYPERTENS, V21, P463, DOI 10.1097/00004872-200303000-00004
   Haznedaroglu S, 2000, ANN RHEUM DIS, V59, P61, DOI 10.1136/ard.59.1.61
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994
   Hong Seo Na, 2008, Korean Journal of Internal Medicine, V23, P87, DOI 10.3904/kjim.2008.23.2.87
   IMURA T, 1986, CARDIOVASC RES, V20, P208, DOI 10.1093/cvr/20.3.208
   Izzo JL, 2004, CURR OPIN CARDIOL, V19, P341, DOI 10.1097/01.hco.0000126581.89648.10
   Kayikcioglu M, 2006, RHEUMATOL INT, V26, P304, DOI 10.1007/s00296-005-0590-1
   Kiraz S, 2002, THROMB RES, V105, P125, DOI 10.1016/S0049-3848(02)00006-3
   Klocke R, 2003, ANN RHEUM DIS, V62, P414, DOI 10.1136/ard.62.5.414
   Kurum T, 2005, CLIN RHEUMATOL, V24, P134, DOI 10.1007/s10067-004-0990-8
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Ozturk MA, 2006, RHEUMATOL INT, V26, P867, DOI 10.1007/s00296-005-0098-8
   Ozturk MA, 2008, CLIN RHEUMATOL, V27, P961, DOI 10.1007/s10067-007-0825-5
   Patel RS, 2011, ATHEROSCLEROSIS, V218, P90, DOI 10.1016/j.atherosclerosis.2011.04.033
   Rhee MY, 2007, J KOREAN MED SCI, V22, P387, DOI 10.3346/jkms.2007.22.3.387
   Seyahi E, 2008, SEMIN ARTHRITIS RHEU, V38, P1, DOI 10.1016/j.semarthrit.2007.09.009
   Seyahi E, 2016, BEST PRACT RES CL RH, V30, P279, DOI 10.1016/j.berh.2016.08.002
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Uyar B, 2015, ANN DERMATOL, V27, P702, DOI 10.5021/ad.2015.27.6.702
   Yilmaz S, 2014, SCAND J RHEUMATOL, V43, P63, DOI 10.3109/03009742.2013.809787
NR 30
TC 4
Z9 4
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 477
EP 482
DI 10.4070/kcj.2017.0004
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500010
PM 28765739
OA Green Published
DA 2021-04-22
ER

PT J
AU Karaman, K
   Arisoy, A
   Altunkas, A
   Erken, E
   Demirtas, A
   Ozturk, M
   Karayakali, M
   Sahin, S
   Celik, A
AF Karaman, Kayihan
   Arisoy, Arif
   Altunkas, Aysegul
   Erken, Ertugrul
   Demirtas, Ahmet
   Ozturk, Mustafa
   Karayakali, Metin
   Sahin, Safak
   Celik, Atac
TI Aortic Flow Propagation Velocity in Patients with Familial Mediterranean
   Fever: an Observational Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Familial Mediterranean fever; Aortic flow propagation velocity; Arterial
   stiffness; Carotid intima-media thickness
ID CORONARY-ARTERY-DISEASE; PULSE-WAVE VELOCITY; ECHOCARDIOGRAPHIC METHOD;
   RHEUMATOID-ARTHRITIS; STIFFNESS; ATHEROSCLEROSIS; ELASTICITY; PSORIASIS;
   DIAGNOSIS; MARKER
AB Background and Objectives: Systemic inflammation has an important role in the initiation of atherosclerosis, which is associated with arterial stiffness (AS). Aortic flow propagation velocity (APV) is a new echocardiographic parameter of aortic stiffness. The relationship between systemic inflammation and AS has not yet been described in patients with familial Mediterranean fever (FMF). We aimed to investigate the early markers of AS in patients with FMF by measuring APV and carotid intima-media thickness (CIMT).
   Subjects and Methods: Sixty-one FMF patients (43 women; mean age 27.3 +/- 6.7 years) in an attack-free period and 57 healthy individuals (36 women; mean age 28.8 +/- 7.1 years) were included in this study. The individuals with atherosclerotic risk factors were excluded from the study. The flow propagation velocity of the descending aorta and CIMT were measured to assess AS.
   Results: APV was significantly lower (60.2 +/- 16.5 vs. 89.5 +/- 11.6 cm/sec, p<0.001) and CIMT was significantly higher (0.49 +/- 0.09 vs. 0.40 +/- 0.10 mm, p<0.001) in the FMF group compared to the control group. There were significant correlations between APV and mean CIMT (r=-0.424, p<0.001), erythrocyte sedimentation rate (ESR) (r=-0.198, p=0.032), and left ventricle ejection fraction (r=0.201, p=0.029). APV and the ESR were independent predictors of FMF in logistic regression analysis (OR=-0.900, 95% CI=0.865-0.936, p<0.001 and OR=-1.078, 95% CI=1.024-1.135, p=0.004, respectively). Mean CIMT and LVEF were independent factors associated with APV in linear regression analysis (beta=-0.423, p<0.001 and beta=0.199, p=0.017, respectively)
   Conclusion: We demonstrated that APV was lower in FMF patients and is related to CIMT. According to our results, APV may be an independent predictor of FMF.
C1 [Karaman, Kayihan; Arisoy, Arif; Karayakali, Metin; Celik, Atac] Gaziosmanpasa Univ, Dept Cardiol, Sch Med, Tokat, Turkey.
   [Altunkas, Aysegul] Gaziosmanpasa Univ, Dept Radiol, Sch Med, Tokat, Turkey.
   [Erken, Ertugrul; Demirtas, Ahmet; Sahin, Safak] Gaziosmanpasa Univ, Dept Internal Med, Sch Med, Tokat, Turkey.
   [Ozturk, Mustafa] Erzurum Terr Training & Res Hosp, Dept Cardiol, Erzurum, Turkey.
RP Karaman, K (corresponding author), Gaziosmanpasa Univ, Sch Med, Dept Cardiol, Training & Res Hosp, TR-60100 Tokat, Turkey.
EM drkkaraman55@gmail.com
RI karayakali, metin/AAD-4838-2019; Erken, Ertugrul/P-4517-2015
OI karayakali, metin/0000-0002-9040-7992; Erken,
   Ertugrul/0000-0002-7054-1203
CR Akcay A, 2009, MOD RHEUMATOL, V19, P550, DOI 10.1007/s10165-009-0196-7
   Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7
   Berkun Y, 2007, SEMIN ARTHRITIS RHEU, V37, P182, DOI 10.1016/j.semarthrit.2007.03.005
   Bicer A, 2009, ACTA CARDIOL, V64, P597, DOI 10.2143/AC.64.5.2042688
   Caliskan M, 2007, ATHEROSCLEROSIS, V195, pE161, DOI 10.1016/j.atherosclerosis.2007.06.014
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4
   Demiralp E, 2004, ACTA CARDIOL, V59, P630, DOI 10.2143/AC.59.6.2005246
   Duprez Daniel A, 2007, Curr Atheroscler Rep, V9, P139, DOI 10.1007/s11883-007-0010-y
   FAZIO GP, 1993, J AM COLL CARDIOL, V21, P144, DOI 10.1016/0735-1097(93)90729-K
   Gunes A, 2012, ANATOL J CARDIOL, V12, P568, DOI 10.5152/akd.2012.186
   Gunes Y, 2008, MED SCI MONITOR, V14, pMT42
   Kaya EB, 2009, TEX HEART I J, V36, P282
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   LEVY M, 1980, J RHEUMATOL, V7, P886
   Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023
   Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641
   Ossareh S, 2011, IRAN J KIDNEY DIS, V5, P169
   Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471
   Rozenbaum M, 2002, J RHEUMATOL, V29, P987
   Sen T, 2013, J CARDIOL, V62, P236, DOI 10.1016/j.jjcc.2013.04.006
   Simsek H, 2013, ECHOCARDIOGR-J CARD, V30, P644, DOI 10.1111/echo.12125
   Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446
   Thenappan T, 2008, ECHOCARDIOGR-J CARD, V25, P198, DOI 10.1111/j.1540-8175.2007.00568.x
   Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658
   Turesson C, 2004, ANN RHEUM DIS, V63, P952, DOI 10.1136/ard.2003.018101
   Ugurlu S, 2009, RHEUMATOLOGY, V48, P911, DOI 10.1093/rheumatology/kep131
   Wright CI, 2007, PHYSIOL MEAS, V28, P573, DOI 10.1088/0967-3334/28/5/010
   Yildirim K, 2012, BIOCHEM MEDICA, V22, P109
   Yildiz M, 2006, CAN J CARDIOL, V22, P1127, DOI 10.1016/S0828-282X(06)70949-7
   Yiu KH, 2011, BRIT J DERMATOL, V164, P514, DOI 10.1111/j.1365-2133.2010.10107.x
NR 30
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 483
EP 489
DI 10.4070/kcj.2016.0400
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500011
PM 28765740
OA Green Published
DA 2021-04-22
ER

PT J
AU Kong, YH
   Song, J
   Huh, J
   Kang, IS
AF Kong, Young Hwa
   Song, Jinyoung
   Huh, Jun
   Kang, I-Seok
TI Outcomes Associated with the Off-label Use of Medical Devices in
   Congenital Heart Disease at a Single Institute
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Off-label; Medical device; Transcatheter therapy; Congenital heart
   defects
ID PATENT DUCTUS-ARTERIOSUS; VASCULAR PLUG II; TRANSCATHETER CLOSURE;
   CARDIAC-CATHETERIZATION; INTERVENTIONS; OCCLUDER; STENTS
AB Background and Objectives: While the off-label use of implantable medical devices for treating congenital heart disease is not uncommon, the present conditions and outcomes of their off-label use have rarely been described. Therefore, this study evaluated the prevalence and results of using implantable devices off-label to treat congenital heart disease at a single institute.
   Subjects and Methods: This was a retrospective study based on the medical records of catheter-based interventions for congenital heart disease performed from July 1, 1995 to June 1, 2015. The inclusion criterion was the off-label use of an implantable device. Patient demographic data, procedural success, and follow-up status regarding late complications were investigated, and the results of the off-label use of each device were compared.
   Results: Off-label use occurred in 144 of 1730 interventions with device implantation, accounting for 8.3% of the interventions. The median patient age and mean body weight were 51.0 months and 16.3 kg, respectively. Immediate and late failures were found in 9 cases, and 3 cases of mortality were not directly related to the devices used. The overall success rate was 93.8%. There were no long-term complications of the off-label use of occlusion devices. No procedural failures resulted from stent implantation, but one case of stent malposition and two cases of stent fracture were identified after procedure completion.
   Conclusion: In general, the off-label use of implantable devices for treating congenital heart disease is safe and effective.
C1 [Kong, Young Hwa; Song, Jinyoung; Huh, Jun; Kang, I-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwon Ro, Seoul 06351, South Korea.
RP Song, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwon Ro, Seoul 06351, South Korea.
EM amyjys@naver.com
OI Huh, June/0000-0003-4523-9632
CR Baspinar O, 2013, ACTA CARDIOL, V68, P31, DOI 10.1080/AC.68.1.2959629
   Breinholt JP, 2008, CATHETER CARDIO INTE, V72, P977, DOI 10.1002/ccd.21742
   Cho Eun Hyun, 2013, Korean J Pediatr, V56, P396, DOI 10.3345/kjp.2013.56.9.396
   Cho YK, 2009, PEDIATR CARDIOL, V30, P540, DOI 10.1007/s00246-009-9397-2
   David Y, 2007, P ANN INT IEEE EMBS, P3556, DOI 10.1109/IEMBS.2007.4353099
   Delaney JW, 2013, CATHETER CARDIO INTE, V81, P820, DOI 10.1002/ccd.24707
   Hascoet S, 2014, ARCH CARDIOVASC DIS, V107, P462, DOI 10.1016/j.acvd.2014.06.005
   Holzer R, 2008, CATHETER CARDIO INTE, V72, P848, DOI 10.1002/ccd.21708
   Holzer RJ, 2008, CATHETER CARDIO INTE, V72, P93, DOI 10.1002/ccd.21545
   Kim Soo Jin, 2013, Korean J Pediatr, V56, P176, DOI 10.3345/kjp.2013.56.4.176
   Lee KE, 2016, KOREAN CIRC J, V46, P246, DOI 10.4070/kcj.2016.46.2.246
   Lee SM, 2013, CATHETER CARDIO INTE, V82, P1141, DOI 10.1002/ccd.24810
   McElhinney DB, 2012, CIRC-CARDIOVASC INTE, V5, P739, DOI 10.1161/CIRCINTERVENTIONS.112.976043
   Moore John W., 2001, Curr Interv Cardiol Rep, V3, P80
   Ng B, 2011, CONGENIT HEART DIS, V6, P64, DOI 10.1111/j.1747-0803.2010.00466.x
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   Peng LF, 2006, CIRCULATION, V113, P2598, DOI 10.1161/CIRCULATIONAHA.105.607127
   POWELL AJ, 1995, CIRCULATION, V92, P3282, DOI 10.1161/01.CIR.92.11.3282
   Sutherell JS, 2010, CONGENIT HEART DIS, V5, P2, DOI 10.1111/j.1747-0803.2009.00364.x
   Walsh KP, 1999, HEART, V81, P257, DOI 10.1136/hrt.81.3.257
   Zellers TM, 2000, CATHETER CARDIO INTE, V49, P307, DOI 10.1002/(SICI)1522-726X(200003)49:3<307::AID-CCD17>3.3.CO;2-D
NR 21
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 509
EP 515
DI 10.4070/kcj.2016.0311
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500014
PM 28765743
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeon, DS
   Park, JS
AF Jeon, Dong Sub
   Park, Jong Sung
TI Rapid and Potent Antiarrhythmic Effect of Cardiac Resynchronization
   Therapy in a Patient with Advanced Dilated Cardiomyopathy and a Large
   Ventricular Arrhythmia Burden
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac resynchronization therapy; Cardiomyopathy, dilated
ID HEART-FAILURE; DEFIBRILLATOR; FREQUENCY; IMPACT
AB We report a case demonstrating a rapid and potent antiarrhythmic effect of biventricular pacing. A 67-year-old male patient with dilated cardiomyopathy was admitted for heart failure. The initial surface electrocardiogram revealed a left bundle branch block with a QRS complex duration of 200 ms. Echocardiographic examination revealed a left ventricular ejection fraction of 16%, a left ventricular end-diastolic dimension of 91 mm, and marked interventricular dyssynchrony. Continuous rhythm monitoring revealed frequently-recurring non-sustained monomorphic ventricular tachycardia (VT). Polymorphic VT, which persisted for 27 seconds, occurred on the third day after admission, and the R on T phenomenon recurred every two to three days thereafter. Optimal medical therapy for four weeks failed to suppress the recurrence of ventricular arrhythmias or ameliorate heart failure. Cardiac resynchronization therapy was initiated for an anticipated antiarrhythmic effect of biventricular pacing. Three days after the initiation of biventricular pacing, the ventricular arrhythmias disappeared almost completely.
C1 [Jeon, Dong Sub; Park, Jong Sung] Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, Busan, South Korea.
RP Park, JS (corresponding author), Dong A Univ, Coll Med, Dept Cardiol, Div Internal Med, 32 Daesingongwon Ro, Busan 49202, South Korea.
EM thinkmed@dau.ac.kr
CR Cha YM, 2011, CIRC-HEART FAIL, V4, P339, DOI 10.1161/CIRCHEARTFAILURE.110.959858
   DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589
   Di Biase L, 2008, J AM COLL CARDIOL, V52, P1442, DOI 10.1016/j.jacc.2008.07.043
   Ermis C, 2005, J AM COLL CARDIOL, V46, P2258, DOI 10.1016/j.jacc.2005.04.067
   Fish JM, 2005, J AM COLL CARDIOL, V46, P2340, DOI 10.1016/j.jacc.2005.08.035
   Goldenberg I, 2006, CIRCULATION, V113, P2810, DOI 10.1161/CIRCULATIONAHA.105.577262
   Hamdan MH, 2000, CIRCULATION, V102, P1027, DOI 10.1161/01.CIR.102.9.1027
   Kies P, 2005, AM J CARDIOL, V95, P1111, DOI 10.1016/j.amjcard.2005.01.029
   Kies P, 2004, AM J CARDIOL, V94, P130, DOI 10.1016/j.amjcard.2004.03.045
   McSwain RL, 2005, J CARDIOVASC ELECTR, V16, P1168, DOI 10.1111/j.1540-8167.2005.40719.x
   MEINERTZ T, 1984, AM J CARDIOL, V53, P902, DOI 10.1016/0002-9149(84)90522-8
   PINSKI SL, 1995, CIRCULATION, V92, P1651, DOI 10.1161/01.CIR.92.6.1651
   Ponikowski P, 2016, EUR J HEART FAIL, V18, P891, DOI 10.1002/ejhf.592
   Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098
   Runsio M, 1997, AM J CARDIOL, V79, P1241, DOI 10.1016/S0002-9149(97)00090-8
   Russo AM, 2013, HEART RHYTHM, V10, pE11, DOI 10.1016/j.hrthm.2013.01.008
NR 16
TC 1
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 523
EP 527
DI 10.4070/kcj.2016.0361
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500016
PM 28765745
OA Green Published
DA 2021-04-22
ER

PT J
AU Gwon, HC
   Jeon, DW
   Kang, HJ
   Jang, JS
   Park, DW
   Shin, DH
   Moon, KW
   Kim, JS
   Kim, J
   Bae, JW
   Hur, SH
   Kim, BO
   Choi, D
   Han, KR
   Kim, HS
AF Gwon, Hyeon-Cheol
   Jeon, Dong Woon
   Kang, Hyun-Jae
   Jang, Jae-Sik
   Park, Duk-Woo
   Shin, Dong-Ho
   Moon, Keon-Woong
   Kim, Jung-Sun
   Kim, Juhan
   Bae, Jang-Whan
   Hur, Seung-Ho
   Kim, Byung Ok
   Choi, Donghoon
   Han, Kyoo-Rok
   Kim, Hyo-Soo
TI The Practice Pattern of Percutaneous Coronary Intervention in Korea -
   Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention
   (K-PCI) Registry (vol 47, pg 320, 2017)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Heart Vasc & Stroke Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea.
   [Jeon, Dong Woon] Ilsan Hosp, Div Cardiol, Natl Hlth Insurance Serv, Goyang, South Korea.
   [Kang, Hyun-Jae; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Jang, Jae-Sik] Univ Inje, Coll Med, Div Cardiol, Busan Paik Hosp, Busan, South Korea.
   [Park, Duk-Woo] Univ Ulsan, Div Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Shin, Dong-Ho; Kim, Jung-Sun; Choi, Donghoon] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, St Vincents Hosp, Div Cardiol, Coll Med, Suwon, South Korea.
   [Kim, Juhan] Chonnam Natl Univ Hosp, Heart Ctr, Div Cardiol, Gwangju, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea.
   [Hur, Seung-Ho] Keimyung Univ, Div Cardiol, Dongsan Med Ctr, Daegu, South Korea.
   [Kim, Byung Ok] Univ Inje, Sanggye Paik Hosp, Div Cardiol, Coll Med, Seoul, South Korea.
   [Han, Kyoo-Rok] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Med Ctr, Seoul, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Heart Vasc & Stroke Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea.
CR Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 541
EP 541
DI 10.4070/kcj.2016.0446
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500023
PM 28765752
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
AF Lee, Hae-Young
TI The J Curve Phenomenon is Still Valid in the Era of Primary
   Revascularization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CORONARY-ARTERY-DISEASE; AMERICAN-HEART-ASSOCIATION; BLOOD-PRESSURE
   TARGETS; CLINICAL CHARACTERISTICS; SCIENTIFIC STATEMENT; FAILURE
   REGISTRY; HYPERTENSION; CARDIOLOGY; OUTCOMES
C1 [Lee, Hae-Young] Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM hylee612@snu.ac.kr
CR Bangalore S, 2013, HEART, V99, P601, DOI 10.1136/heartjnl-2012-301968
   Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SH, 2015, KOREAN CIRC J, V45, P275, DOI 10.4070/kcj.2015.45.4.275
   Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175
   Lu W, 2016, EUR REV MED PHARMACO, V20, P1350
   Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005
   Moon Shin-Hang, 2015, Clin Hypertens, V21, P5, DOI 10.1186/s40885-015-0016-7
   Park H, 2017, KOREAN CIRC J, V47, P446, DOI 10.4070/kcj.2017.0008
   Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885
   Rosendorff C, 2015, HYPERTENSION, V65, P1372, DOI 10.1161/HYP.0000000000000018
   Sattar N, 2017, CIRCULATION, V135, P2369, DOI 10.1161/CIRCULATIONAHA.117.028307
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Shin Jinho, 2015, Clin Hypertens, V21, P3, DOI 10.1186/s40885-014-0014-1
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Youn JC, 2017, KOREAN CIRC J, V47, P316, DOI 10.4070/kcj.2017.0075
NR 16
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 440
EP 441
DI 10.4070/kcj.2017.0139
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500003
PM 28765732
OA Green Published
DA 2021-04-22
ER

PT J
AU Joung, B
AF Joung, Boyoung
TI Markers for Catheter Ablation of Atrioventricular Accessory Pathways
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SUPRAVENTRICULAR TACHYCARDIA; RADIOFREQUENCY ABLATION; RECURRENCE;
   TARGET
C1 [Joung, Boyoung] Yonsei Univ, Coll Med, Div Cardiol, 50 Yonseiro, Seoul 03722, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, 50 Yonseiro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
OI Joung, Boyoung/0000-0001-9036-7225
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2017R1A2B 3003303]; Korean Healthcare technology R&D project -
   Ministry of Health Welfare [HI16C0058, HI15C1200]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Science, ICT & Future Planning (NRF-2017R1A2B 3003303) and grants
   from the Korean Healthcare technology R&D project funded by the Ministry
   of Health & Welfare (HI16C0058, HI15C1200).
CR BASHIR Y, 1993, BRIT HEART J, V69, P315
   Chen SA, 2001, PACE, V24, P1795, DOI 10.1046/j.1460-9592.2001.01795.x
   Guo XG, 2015, J CARDIOVASC ELECTR, V26, P404, DOI 10.1111/jce.12607
   HAISSAGUERRE M, 1991, CIRCULATION, V84, P188, DOI 10.1161/01.CIR.84.1.188
   Iturralde P, 2002, EUROPACE, V4, P273, DOI 10.1053/eupc.2002.0236
   Jang Sung-Won, 2009, Korean Circ J, V39, P389, DOI 10.4070/kcj.2009.39.9.389
   Joung B, 2006, CIRC J, V70, P278, DOI 10.1253/circj.70.278
   Kim KH, 2017, KOREAN CIRC J, V47, P462, DOI 10.4070/kcj.2016.0371
   Page RL, 2016, HEART RHYTHM, V13, pE92, DOI 10.1016/j.hrthm.2015.09.018
   Van Hare GF, 2004, HEART RHYTHM, V1, P188, DOI 10.1016/j.hrthm.2004.03.067
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 442
EP 443
DI 10.4070/kcj.2017.0113
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500004
PM 28765733
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, JW
AF Jung, Jo Won
TI Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary
   Aneurysm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jung, Jo Won] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Pediat Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Jung, JW (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Pediat Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jwjung@yuhs.ac
CR Abrams JY, 2017, J PEDIATR-US, V188, P64, DOI 10.1016/j.jpeds.2017.05.034
   Bang JS, 2017, KOREAN CIRC J, V47, P516, DOI 10.4070/kcj.2016.0163
   Golshevsky D, 2013, AUST FAM PHYSICIAN, V42, P473
   Jang GY, 2015, PEDIATR INT, V57, P367, DOI 10.1111/ped.12536
   Kato H., 2004, PROG PEDIATR CARDIOL, V19, P137, DOI [DOI 10.1016/J.PPEDCARD.2004.08.007, rg/10.1016/j.ppedcard.2004.08.007]
   Kawasaki T, 1967, Arerugi, V16, P178
   Kim Gi Beom, 2017, Pediatr Infect Dis J, V36, P482, DOI [10.1097/inf.0000000000001474, 10.1097/INF.0000000000001474]
   Lim YJ, 2014, YONSEI MED J, V55, P1260, DOI 10.3349/ymj.2014.55.5.1260
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Suda K, 2011, CIRCULATION, V123, P1836, DOI 10.1161/CIRCULATIONAHA.110.978213
NR 10
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 444
EP 445
DI 10.4070/kcj.2017.0135
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500005
PM 28765734
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, YG
   Ahn, CM
   Min, PK
   Lee, JH
   Yoon, CH
   Yu, CW
   Lee, SW
   Lee, SR
   Choi, SH
   Koh, YS
   Chae, IH
   Choi, D
AF Ko, Young-Guk
   Ahn, Chul-Min
   Min, Pil-Ki
   Lee, Jae-Hwan
   Yoon, Chang-Hwan
   Yu, Cheol Woong
   Lee, Seung Whan
   Lee, Sang-Rok
   Choi, Seung Hyuk
   Koh, Yoon Seok
   Chae, In-Ho
   Choi, Donghoon
CA K-VIS Investigators
TI Baseline Characteristics of a Retrospective Patient Cohort in the Korean
   Vascular Intervention Society Endovascular Therapy in Lower Limb Artery
   Diseases (K-VIS ELLA) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral artery disease; Lower extremity; Endovascular therapy; Risk
   factors
ID LOWER-EXTREMITY; CARDIOVASCULAR RISK; BYPASS-SURGERY; TASK-FORCE;
   ISCHEMIA; TRENDS; ASSOCIATION; GUIDELINES; MORTALITY
AB Background and Objectives: The Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry is a multicenter observational study with retrospective and prospective cohorts of patients with lower extremity peripheral artery disease (PAD) undergoing endovascular treatment. In this study, we report the baseline characteristics of this retrospective cohort.
   Subjects and Methods: In the present study we analyzed datasets of 3073 patients with 3972 target limbs from a retrospective cohort treated with endovascular therapy in 31 Korean hospitals. Data regarding patient baseline clinical and lesion characteristics and post-intervention medications were collected from electronic medical records.
   Results: The mean patient age was 68.3 +/- 9.4 years. The majority were male (82.1%) with comorbidities such as diabetes mellitus (58.0%), hypertension (73.4%), and coronary artery disease (CAD; 55.3%). Patients more commonly presented with intermittent claudication (66.3%) than with critical limb ischemia (CLI; 33.7%). Femoropopliteal artery (41.2%) was the most common target vessel for endovascular treatment, followed by the aortoiliac (35.6%) and infrapopliteal arteries (23.2%). TransAtlantic Inter-Society Consensus for the Management of Peripheral Artery Disease (TASC II) type C/D aortoiliac (48.0%) or femoropopliteal lesions (60.2%) were frequent targets of endovascular treatment. At hospital discharge, only 73.1% of patients received dual antiplatelet therapy and 69.2% received a statin.
   Conclusion: The majority of Korean patients with PAD exhibited conventional risk factors, such as male sex, older age, diabetes, and hypertension with coexisting CAD. Complex lesions were frequently treated with endovascular therapy. However, the rate of adherence to guidelines regarding post-procedural medical treatment requires improvement.
C1 [Ko, Young-Guk; Ahn, Chul-Min; Choi, Donghoon] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.
   [Min, Pil-Ki] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.
   [Lee, Jae-Hwan] Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daejeon, South Korea.
   [Yoon, Chang-Hwan; Chae, In-Ho] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea.
   [Yu, Cheol Woong] Korea Univ, Anam Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Seung Whan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea.
   [Lee, Sang-Rok] Chonbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jeonju, South Korea.
   [Choi, Seung Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul, South Korea.
   [Koh, Yoon Seok] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cdhlyj@yuhs.ac
RI Koh, Yoon-Seok/AAE-1749-2019
OI Min, Pil-Ki/0000-0001-7033-7651; Ahn, Chul-Min/0000-0002-7071-4370; Ko,
   Young-Guk/0000-0001-7748-5788; Choi, Donghoon/0000-0002-2009-9760; Lee,
   Jae-Hwan/0000-0002-6561-7760
CR Agarwal S, 2016, J AM COLL CARDIOL, V67, P1901, DOI 10.1016/j.jacc.2016.02.040
   Antoniou GA, 2014, VASC PHARMACOL, V63, P79, DOI 10.1016/j.vph.2014.09.001
   Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180
   Bisdas T, 2016, JACC-CARDIOVASC INTE, V9, P2557, DOI 10.1016/j.jcin.2016.09.039
   Blanc B, 1968, WHO TECH REP SER, V405, P5
   Farber A, 2016, JAMA SURG, V151, P1070, DOI 10.1001/jamasurg.2016.2018
   Harris SK, 2016, J VASC SURG, V64, P1881, DOI 10.1016/j.jvs.2016.08.094
   Heald CL, 2006, ATHEROSCLEROSIS, V189, P61, DOI 10.1016/j.atherosclerosis.2006.03.011
   Heart Protection Study Collaborati, 2007, J VASC SURG, V45, P645, DOI 10.1016/j.jvs.2006.12.054
   Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526
   Howard DPJ, 2015, CIRCULATION, V132, P1805, DOI 10.1161/CIRCULATIONAHA.115.016424
   Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318
   Kim MH, 2016, ANN SURG TREAT RES, V90, P218, DOI 10.4174/astr.2016.90.4.218
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI [10.1016/j.ejvs.2006.09.024, 10.1016/j.jvs.2006.12.037]
   Park YY, 2015, ANN SURG TREAT RES, V89, P319, DOI 10.4174/astr.2015.89.6.319
   Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4
   Sigvant B, 2016, J VASC SURG, V64, P1009, DOI 10.1016/j.jvs.2016.03.429
   Soga Y, 2014, J ENDOVASC THER, V21, P243, DOI 10.1583/13-4510MR.1
   Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211
   Westin GG, 2014, J AM COLL CARDIOL, V63, P682, DOI 10.1016/j.jacc.2013.09.073
NR 20
TC 16
Z9 16
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 469
EP 476
DI 10.4070/kcj.2017.0020
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500009
PM 28765738
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JB
   Kwak, JG
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
AF Park, Jung Bin
   Kwak, Jae Gun
   Lim, Hong-Gook
   Kim, Woong-Han
   Lee, Jeong Ryul
   Kim, Yong Jin
TI Experience with Mechanical Circulatory Support for Medically Intractable
   Low Cardiac Output in a Pediatric Intensive Care Unit
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Resuscitation; Low cardiac output; Extracorporeal membrane oxygenation;
   Ventricular assist device
ID EXTRACORPOREAL MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; LIFE-SUPPORT;
   RISK-FACTORS; CHILDREN; SURVIVAL; SURGERY; RESUSCITATION; DYSFUNCTION;
   MORTALITY
AB Background and Objectives: Mechanical circulatory support with extracorporeal membrane oxygenation (ECMO) and ventricular assist device has always been the optimal choice for treating the majority of medically intractable low cardiac output case. We retrospectively investigated our institution's outcomes and variables associated with a high risk of mortality.
   Subjects and Methods: From 1999 to 2014, 86 patients who were of pediatric age or had grown-up congenital heart disease underwent mechanical circulatory support for medically intractable low cardiac output in our pediatric intensive care unit. Of these, 9 grown-up congenital heart disease patients were over 18 years of age, and the median age of the subject group was 5.82 years (range: 1 day to 41.6 years). A review of all demographic, clinical, and surgical data and survival analysis were performed.
   Results: A total of 45 (52.3%) patients were successfully weaned from the mechanical assist device, and 25 (29.1%) survivors were able to be discharged. There was no significant difference in results between patients over 18 years and under 18 years of age. Risk factors for mortality were younger age (<30 days), functional single ventricle anatomy, support after cardiac operations, longer support duration, and deteriorated pre-ECMO status (severe metabolic acidosis and increased levels of lactate, creatinine, bilirubin, or liver enzyme). The survival rate has improved since 2010 (from 25% before 2010 to 35% after 2010), when we introduced an upgraded oxygenator, activated heart transplantation, and also began to apply ECMO before the end-stage of cardiac dysfunction, even though we could not reveal significant correlations between survival rate and changed strategies associated with ECMO.
   Conclusion: Mechanical circulatory support has played a critical role and has had a dramatic effect on survival in patients with medically intractable heart failure, particularly in recent years. Meticulous monitoring of acid-base status, laboratory findings, and early and liberal applications are recommended to improve outcomes without critical complication rates, particularly in neonates with single ventricle physiology.
C1 [Park, Jung Bin] Seoul Natl Univ, Seoul, South Korea.
   [Kwak, Jae Gun; Lim, Hong-Gook; Kim, Woong-Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 101 Daehak Ro, Seoul 03080, South Korea.
RP Lim, HG (corresponding author), Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 101 Daehak Ro, Seoul 03080, South Korea.
EM hongklim@hanmail.net
OI Park, Jung-Bin/0000-0002-8816-5605
CR Aharon AS, 2001, ANN THORAC SURG, V72, P2095, DOI 10.1016/S0003-4975(01)03209-X
   Alsoufi B, 2009, EUR J CARDIO-THORAC, V35, P1004, DOI 10.1016/j.ejcts.2009.02.015
   Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007
   Cengiz P, 2005, CRIT CARE MED, V33, P2817, DOI 10.1097/01.CCM.0000189940.70617.C3
   Chow G, 2004, EUR J CARDIO-THORAC, V26, P38, DOI 10.1016/j.ejcts.2004.04.010
   del Nido PJ, 1999, ANN THORAC SURG, V67, P169, DOI 10.1016/S0003-4975(98)01309-5
   DELNIDO PJ, 1992, CIRCULATION, V86, P300
   Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8
   Duncan BW, 1998, J THORAC CARDIOV SUR, V116, P305, DOI 10.1016/S0022-5223(98)70131-X
   Fuchs A, 2001, Images Paediatr Cardiol, V3, P24
   Fuhrman BP, 1999, ARTIF ORGANS, V23, P966, DOI 10.1046/j.1525-1594.1999.06484.x
   GREASON KL, 1995, ANN THORAC SURG, V60, P209
   Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6
   Kolovos NS, 2003, ANN THORAC SURG, V76, P1435, DOI 10.1016/S0003-4975(03)00898-1
   Kumar TKS, 2010, J THORAC CARDIOV SUR, V140, P330, DOI 10.1016/j.jtcvs.2010.02.034
   Lee J, 2014, KOREAN CIRC J, V44, P320, DOI 10.4070/kcj.2014.44.5.320
   Montgomery VL, 2000, CRIT CARE MED, V28, P526, DOI 10.1097/00003246-200002000-00040
   Morris MC, 2004, CRIT CARE MED, V32, P1061, DOI 10.1097/01.CCM.0000119425.04364.CF
   Osaki S, 2008, EUR J CARDIO-THORAC, V34, P281, DOI 10.1016/j.ejcts.2008.04.023
   Polimenakos AC, 2011, EUR J CARDIO-THORAC, V40, P1396, DOI 10.1016/j.ejcts.2011.01.087
   Rossano JW, 2015, KOREAN CIRC J, V45, P1, DOI 10.4070/kcj.2015.45.1.1
NR 21
TC 1
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 490
EP 500
DI 10.4070/kcj.2016.0320
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500012
PM 28765741
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kwon, BS
   Kim, GB
   Bae, EJ
   Noh, CI
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
AF Lee, Sun Hyang
   Kwon, Bo Sang
   Kim, Gi Beom
   Bae, Eun Jung
   Noh, Chung Il
   Lim, Hong Gook
   Kim, Woong Han
   Lee, Jeong Ryul
   Kim, Yong Jin
TI Clinical Characteristics and Independent Factors Related to Long-Term
   Outcomes in Patients with Left Isomerism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heterotaxy syndrome; Left atrial isomerism; Arteriovenous fistula;
   Cardiac dysrhythmia
ID ATRIAL ISOMERISM; HETEROTAXY; APPENDAGES; HEARTS
AB Background and Objectives: We studied the results of patient management for left isomerism (LI) and sought to determine factors that may influence survival and prognosis.
   Subjects and Methods: We reviewed the medical records of 76 patients who were compatible with LI criteria between 1982 and 2014.
   Results: Of the total study population, 29 patients (38.1%) had functional univentricular heart disease, 43 patients (56.5%) had cardiac anomalies suitable for biventricular hearts, and four patients (5.2%) had normal heart structure. Extracardiac anomalies were noted in 38.1% of the study population, including biliary atresia in 7.8% of all patients. Of the 25 patients who underwent Kawashima procedures, 24.0% developed pulmonary arteriovenous fistulas (PAVFs). During the median follow-up period of 11.4 years (range: 1 day to 32 years), 14 patients died. The 10-year, 20-year, and 30-year survival rates were 87%, 84%, and 76%, respectively. Preoperative dysrhythmia and uncorrected atrioventricular valve regurgitation were significantly associated with late death. There was no significant difference in the number of surgical procedures and in survival expectancy between patients in the functional single-ventricle group and in the biventricular group. However, late mortality was higher in functional single-ventricle patients after 18 years of age.
   Conclusion: Patients with LI need to be carefully followed, not only for late cardiovascular problems such as dysrhythmia, valve regurgitation, and the development of PAVFs, but also for noncardiac systemic manifestations.
C1 [Lee, Sun Hyang; Kwon, Bo Sang; Kim, Gi Beom; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Dept Pediat, Childrens Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
   [Lim, Hong Gook; Kim, Woong Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ, Dept Thorac & Cardiovasc Surg, Childrens Hosp, Seoul, South Korea.
   [Lee, Sun Hyang] Soonchunhyang Univ, Dept Pediat, Bucheon Hosp, Bucheon, South Korea.
RP Bae, EJ (corresponding author), Seoul Natl Univ, Dept Pediat, Childrens Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM eunjbaek@snu.ac.kr
CR Frogoudaki A, 2003, EUROPACE, V5, P189, DOI 10.1053/eupc.2002.0291
   Hashmi A, 1998, J AM COLL CARDIOL, V31, P1120, DOI 10.1016/S0735-1097(98)00062-X
   HO SY, 1995, BRIT HEART J, V74, P437
   Kim SJ, 2011, KOREAN CIRC J, V41, P227, DOI 10.4070/kcj.2011.41.5.227
   Kim SJ, 2009, ANN THORAC SURG, V87, P548, DOI 10.1016/j.athoracsur.2008.10.024
   MOMMA K, 1990, AM J CARDIOL, V65, P231, DOI 10.1016/0002-9149(90)90090-N
   Smith A, 2004, PRACT ATL CONG, P41
   Stamm C, 2002, ANN THORAC SURG, V74, P1967, DOI 10.1016/S0003-4975(02)04124-3
   Takeuchi Koh, 2006, Asian Cardiovasc Thorac Ann, V14, P489
   UEMURA H, 1995, ANN THORAC SURG, V60, P561, DOI 10.1016/0003-4975(95)00538-V
   WREN C, 1987, AM J CARDIOL, V59, P1156, DOI 10.1016/0002-9149(87)90866-6
   Youn JK, 2014, PEDIATR TRANSPLANT, V18, pE274, DOI 10.1111/petr.12364
NR 12
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 501
EP 508
DI 10.4070/kcj.2016.0293
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500013
PM 28765742
OA Green Published
DA 2021-04-22
ER

PT J
AU Bang, JS
   Kim, GB
   Kwon, BS
   Song, MK
   An, HS
   Song, YW
   Bae, EJ
   Noh, CI
AF Bang, Ji Seok
   Kim, Gi Beom
   Kwon, Bo Sang
   Song, Mi Kyung
   An, Hyo Soon
   Song, Young Whan
   Bae, Eun Jung
   Noh, Chung Il
TI Long-Term Prognosis for Patients with Kawasaki Disease Complicated by
   Large Coronary Aneurysm (diameter >= 6 mm)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Coronary aneurysm; Myocardial
   infarction; Prognosis
ID ARTERY ANEURYSMS; FOLLOW-UP; YOUNG-CHILDREN; EXPERIENCE; LESIONS
AB Background and Objectives: Some patients with Kawasaki disease (KD) develop large coronary aneurysms and subsequent coronary stenosis or obstruction, leading to ischemic heart disease. This study examined the long-term outcomes of patients with KD complicated by large coronary aneurysms.
   Subjects and Methods: The medical records of 71 patients (53 men and 18 women) diagnosed with large coronary aneurysms (diameter >= 6 mm) between December 1986 and December 2013 were retrospectively reviewed from our institutional database.
   Results: The mean age at onset was 4.6 +/- 3.3 years, and the mean follow-up duration was 12.5 +/- 6.9 years. Maximum coronary artery internal diameter ranged from 6.1 to 25 mm. Giant coronary aneurysms occurred in 48 patients and coronary aneurysms 6-8 mm in diameter developed in 23 patients. Coronary stenosis and/or complete occlusion occurred in 30 patients (42.3%). Catheter and/or surgical interventions (mean: 1.5 interventions, range: 1-5 interventions) were performed in 20 patients (28.2%), 9 months to 18 years after KD onset, resulting in 33.7% cumulative coronary intervention rates at 20 years after onset. There were no differences in cumulative coronary intervention rates between two coronary aneurysm groups (6-8 mm vs. >= 8 mm). Myocardial infarction occurred in 7 patients with a giant aneurysm and there was one death.
   Conclusions: Long-term survival of patients with KD complicated by large coronary aneurysm was good even though 28.2% of patients underwent multiple catheter or surgical interventions. Careful follow-up is also necessary in KD patients with coronary aneurysms 6-8 mm in diameter, such as those with giant aneurysms.
C1 [Bang, Ji Seok; Kim, Gi Beom; Kwon, Bo Sang; Song, Mi Kyung; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
   [Bang, Ji Seok] Sejong Gen Hosp, Dept Pediat, Bucheon, South Korea.
   [An, Hyo Soon] Seoul Natl Univ, Boramae Hosp, Dept Pediat, Seoul, South Korea.
   [Song, Young Whan] Bundang Seoul Natl Univ Hosp, Dept Pediat, Seongnam, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM ped9526@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; An, Hyo Soon/0000-0001-6513-0592
CR AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3
   AlHuzaimi A, 2013, J AM SOC ECHOCARDIOG, V26, P1084, DOI 10.1016/j.echo.2013.05.015
   Gong FQ, 2002, CHINESE MED J-PEKING, V115, P681
   Gu CH, 2009, HEART SURG FORUM, V12, pE241, DOI 10.1532/HSF98.20091055
   Harada M, 2013, PEDIATR INT, V55, P690, DOI 10.1111/ped.12187
   Jang GY, 2015, PEDIATR INT, V57, P367, DOI 10.1111/ped.12536
   KATO H, 1986, J PEDIATR-US, V108, P923, DOI 10.1016/S0022-3476(86)80928-3
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4
   KITAMURA S, 1994, J THORAC CARDIOV SUR, V107, P663
   Lee J, 2014, KOREAN CIRC J, V44, P54, DOI 10.4070/kcj.2014.44.1.54
   Muta H, 2010, J PEDIATR-US, V157, P120, DOI 10.1016/j.jpeds.2010.01.032
   Muta H, 2010, J PEDIATR-US, V156, P439, DOI 10.1016/j.jpeds.2009.09.041
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Ohmoto-Sekine Y, 2013, INTERNAL MED, V52, P977, DOI 10.2169/internalmedicine.52.9463
   Onouchi Z, 2005, CIRC J, V69, P265, DOI 10.1253/circj.69.265
   Peng Y, 2009, EUR J RADIOL, V69, P500, DOI 10.1016/j.ejrad.2007.11.024
   Sohn S, 2004, PEDIATR CARDIOL, V25, P35, DOI 10.1007/s00246-003-0559-3
   Suda K, 2011, CIRCULATION, V123, P1836, DOI 10.1161/CIRCULATIONAHA.110.978213
   Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131
   Waki K, 2013, CATHETER CARDIO INTE, V81, P713, DOI 10.1002/ccd.24486
   Yanagawa H, 2006, PEDIATR INT, V48, P356, DOI 10.1111/j.1442-200X.2006.02221.x
NR 22
TC 6
Z9 7
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 516
EP 522
DI 10.4070/kcj.2016.0163
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500015
PM 28765744
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YA
   Seo, J
   Pak, HN
AF Park, Young-Ah
   Seo, Jiwon
   Pak, Hui-Nam
TI Controlled Atrial Fibrillation after Pulmonary Vein Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Balloon angioplasty
ID RADIOFREQUENCY CATHETER ABLATION; PERSISTENT
AB When there is no pulmonary vein reconnection after catheter ablation for atrial fibrillation, patients can experience recurrence of atrial fibrillation without clear evidence of non-pulmonary vein foci. We describe a patient with significant pulmonary vein stenosis and recurrent atrial fibrillation after four ablation procedures. After successful pulmonary vein stenting, the symptoms were resolved, and sinus rhythm was maintained for 2 years without treatment with antiarrhythmic medication. We believe pulmonary vein stenting potentially controlled atrial fibrillation by providing pulmonary vein pressure relief or by compressing the epicardial triggers occurring at the pulmonary vein ostium.
C1 [Park, Young-Ah; Seo, Jiwon; Pak, Hui-Nam] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Pak, HN (corresponding author), 50 Yonsei Ro, Seoul 03722, South Korea.
EM hnpak@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
FU Korea Health 21 R&D Project, Ministry of Health [A085136]
FX This work was supported by a grant (A085136) from the Korea Health 21
   R&D Project, Ministry of Health.
CR Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Chang SL, 2007, HEART, V93, P82, DOI 10.1136/hrt.2006.089359
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Hsieh MH, 2006, J CARDIOVASC ELECTR, V17, P231, DOI 10.1111/j.1540-8167.2005.00323.x
   Hwang ES, 2010, CIRC J, V74, P644, DOI 10.1253/circj.CJ-09-0703
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Montserrat S, 2011, AM J CARDIOL, V108, P1741, DOI 10.1016/j.amjcard.2011.07.041
   Pak HN, 2007, J CARDIOVASC ELECTR, V18, P917, DOI 10.1111/j.1540-8167.2007.00882.x
   Verheule S, 2014, PROG BIOPHYS MOL BIO, V115, P173, DOI 10.1016/j.pbiomolbio.2014.07.007
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 528
EP 531
DI 10.4070/kcj.2016.0382
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500017
PM 28765746
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, BS
   Park, JH
   Sun, BJ
   Lee, JH
   Lee, JW
AF Seo, Bong Seok
   Park, Jae-Hyeong
   Sun, Byung Joo
   Lee, Jae-Hwan
   Lee, Jae Won
TI Severe Leakage Presenting Mitral Regurgitation Caused by a
   Pseudoaneurysm Connecting the Left Ventricle and the Left Atrium Through
   Fistulae as a Rare Complication of Cardiac Trauma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VALVE-PROLAPSE; PREVALENCE
C1 [Seo, Bong Seok; Park, Jae-Hyeong; Sun, Byung Joo; Lee, Jae-Hwan] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Lee, Jae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Lee, Jae-Hwan/0000-0002-6561-7760; Sun, Byung Joo/0000-0001-6019-4343;
   Park, Jae-Hyeong/0000-0001-7035-286X
CR Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101
   GRENADIER E, 1983, AM HEART J, V105, P603, DOI 10.1016/0002-8703(83)90484-2
   KAUTZNER J, 1990, AM HEART J, V120, P1233, DOI 10.1016/0002-8703(90)90146-O
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 532
EP 533
DI 10.4070/kcj.2017.0035
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500018
PM 28765747
OA Green Published
DA 2021-04-22
ER

PT J
AU Te, ALD
   Chung, FP
   Lin, CY
   Prabhu, A
   Lee, PC
   Chen, SA
AF Te, Abigail Louise D.
   Chung, Fa-Po
   Lin, Chin Yu
   Prabhu, Atul
   Lee, Pi-Chang
   Chen, Shih-Ann
TI Catheter Ablation of Peri-Conduit Ventricular Tachycardia in a Patient
   with Rastelli Procedure for Double Outlet Right Ventricle with
   Malposition of Great Arteries
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CONGENITAL HEART-DISEASE; REPAIR; TETRALOGY; FALLOT
C1 [Te, Abigail Louise D.; Chung, Fa-Po; Lin, Chin Yu; Prabhu, Atul; Lee, Pi-Chang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.
   [Chung, Fa-Po; Chen, Shih-Ann] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei, Taiwan.
RP Chung, FP (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, 201 Sec 2,Shih Pai Rd, Taipei, Taiwan.
EM marxtaiji@gmail.com
OI Te, Abigail Louise/0000-0002-7461-2793; Lin, Chin-Yu/0000-0003-3282-7523
FU Center for Dynamical Biomarkers and Translational Medicine, Ministry of
   Science and Technology [MOST104-2314-B-075-089-MY3,
   MOST103-2911-I-008-001, MOST103-2314-B-075-089-MY3, NSC
   102-2314-B-010-056-MY2]; Research Foundation of Cardiovascular Medicine
   [RFCM 104-01-012, RFCM 105-02-028, RFCM 105-02-008]; TVGH-NTUH Joint
   Research Program [VGHUST105-G7-4-1, VN103-04]; Szu-Yuan Research
   Foundation of Internal Medicine [106003]; Taipei Veterans General
   HospitalTaipei Veterans General Hospital [V103C-042, V104B-018,
   V104E7-001, V104C-109, V105B-014, V105C-122, V105C-116, V106C-158,
   V106B-010]
FX This work was supported by the Center for Dynamical Biomarkers and
   Translational Medicine, Ministry of Science and Technology (Grant No.
   MOST104-2314-B-075-089-MY3, MOST103-2911-I-008-001, MOST103-2314-B-075
   -089 -MY3, NSC 102-2314-B-010-056-MY2), Research Foundation of
   Cardiovascular Medicine (Grant No. RFCM 104-01-012, RFCM 105-02-028,
   RFCM 105-02-008, and RFCM 105-02-028), TVGH-NTUH Joint Research Program
   (Grant No. VGHUST105-G7-4-1), Szu-Yuan Research Foundation of Internal
   Medicine (Grant No. 106003), TVGH-NTUH Joint Research Program (Grant No.
   VN103-04) and Taipei Veterans General Hospital (Grant No. V103C-042,
   V104B-018, V104E7-001, V104C-109, V105B-014, V105C-122, V105C-116,
   V106C-158 and V106B-010).
CR Khairy P, 2016, HEART, V102, P1703, DOI 10.1136/heartjnl-2015-309069
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   Zeppenfeld K, 2007, CIRCULATION, V116, P2241, DOI 10.1161/CIRCULATIONAHA.107.723551
   Zeppenfeld Katja, 2016, Herzschrittmacherther Elektrophysiol, V27, P131, DOI 10.1007/s00399-016-0428-4
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 534
EP 535
DI 10.4070/kcj.2017.0012
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500019
PM 28765748
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Sung, SH
   Chang, TY
   Tsai, IL
   Hsu, CP
   Shih, CC
AF Lee, Ching-Wei
   Sung, Shih-Hsien
   Chang, Ting-Yung
   Tsai, I-Lin
   Hsu, Chih-Po
   Shih, Chun-Che
TI Grasping the Pseudo-Cleft in the Case of a Small, Severely Tethered
   Posterior Mitral Leaflet
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ching-Wei; Sung, Shih-Hsien; Chang, Ting-Yung; Tsai, I-Lin] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
   [Lee, Ching-Wei; Sung, Shih-Hsien; Chang, Ting-Yung; Tsai, I-Lin; Hsu, Chih-Po; Shih, Chun-Che] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.
   [Hsu, Chih-Po; Shih, Chun-Che] Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.
RP Sung, SH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM mr.sungsh@gmail.com
CR Patzelt J, 2016, JACC-CARDIOVASC INTE, V9, P151, DOI 10.1016/j.jcin.2015.09.038
NR 1
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 536
EP 537
DI 10.4070/kcj.2016.0433
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500020
PM 28765749
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Oh, J
   Lee, CJ
   Kim, JY
   Youn, YN
   Kang, SM
AF Kim, In-Cheol
   Oh, Jaewon
   Lee, Chan-Joo
   Kim, Jin-Young
   Youn, Young-Nam
   Kang, Seok-Min
TI Bioptome Perforation at Superior Vena Cava Anastomosis Site in
   Transplanted Heart
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ENDOMYOCARDIAL BIOPSY
C1 [Kim, In-Cheol; Oh, Jaewon; Lee, Chan-Joo; Kang, Seok-Min] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Jin-Young] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea.
   [Youn, Young-Nam] Yonsei Univ, Severance Cardiovasc Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.
RP Kang, SM (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM smkang@yuhs.ac
OI Oh, Jaewon/0000-0002-4585-1488; Kang, Seok-Min/0000-0001-9856-9227
CR Awad M, 2014, TRANSPL P, V46, P3580, DOI 10.1016/j.transproceed.2014.05.084
   Holzmann M, 2008, CIRCULATION, V118, P1722, DOI 10.1161/CIRCULATIONAHA.107.743427
   Lee SR, 2016, KOREAN CIRC J, V46, P197, DOI 10.4070/kcj.2016.46.2.197
   Saraiva F, 2011, TRANSPL P, V43, P1908, DOI 10.1016/j.transproceed.2011.03.010
NR 4
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 538
EP 539
DI 10.4070/kcj.2017.0015
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500021
PM 28765750
OA Green Published
DA 2021-04-22
ER

PT J
AU Sohn, DW
   Kim, HK
   Kim, YJ
   Oh, S
   Seong, MW
   Park, SS
AF Sohn, Dae-Won
   Kim, Hyung-Kwan
   Kim, Yong-Jin
   Oh, Seil
   Seong, Moon-Woo
   Park, Sung-Sup
TI Cardiomyopathies with Mixed and Inapparent Morphological Features in
   Cardiac Troponin I3 Mutation (vol 47, pg 413, 2017)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Sohn, Dae-Won; Kim, Hyung-Kwan; Kim, Yong-Jin; Oh, Seil] Seoul Natl Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.
   [Seong, Moon-Woo; Park, Sung-Sup] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.
RP Sohn, DW (corresponding author), Seoul Natl Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.
CR Sohn DW, 2017, KOREAN CIRC J, V47, P413, DOI 10.4070/kcj.2016.0302
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2017
VL 47
IS 4
BP 540
EP 540
DI 10.4070/kcj.2016.0445
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FE4VN
UT WOS:000408211500022
PM 28765751
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, HY
AF Park, Hyun-Young
TI Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic
   Diagnostics
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiomyopathy; dilated; Hereditary; Genetic testing
ID HYPERTROPHIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; BARTH SYNDROME;
   MUTATIONS; DISEASE; DYSFUNCTION; COMPLEXITY
AB Dilated cardiomyopathy (DCM) is the most common cause of heart failure in young adults and up to 500/o of idiopathic DCM is thought to be caused by genetic mutations in candidate genes. Although a genetic diagnosis can confirm a clinical diagnosis of hereditary DCM, genetic testing has not been easily accessible due to genetic heterogeneity and complexity. Next-generation sequencing (NGS) technologies have recently been introduced, and genetic testing for multiple genes is currently available and more than 40 different genes have been associated with DCM. In Korea, the government has supported genetic diagnosis for patients with idiopathic DCM. When a targeted gene panel with NGS technology was used, the detection rate was about 400/0. MYBPC3, LMNA, and MYH7 were the most frequently identified genes, and the pattern of causative genes was different from previous reports. In the analysis, a significant number of subjects (42.00/0) had rare or novel unspecified variants in DCM candidate genes, which should be assessed as potential causative mutations. Developing a more comprehensive test panel with additional DCM genes and whole exome sequencing will improve the detection rate, and allow genetic testing to be an option for patients with idiopathic DCM. However, all genetic variations are not pathogenic mutations, and the majority of reported mutations in DCM are unique to a single family, which makes genetic data interpretation more difficult. Therefore, clinical features and familial history integration are needed to improve clinical decision making.
C1 [Park, Hyun-Young] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Cheongju, South Korea.
RP Park, HY (corresponding author), Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, South Korea.
EM hypark65@nih.go.kr
FU Korea National Institute of Health Intramural Research Grant
   [4800-4861-303, 2011-NG63002-00]
FX This work was supported by the Korea National Institute of Health
   Intramural Research Grant, 4800-4861-303 (2011-NG63002-00).
CR Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI 10.1016/j.hrthm.2011.05.020
   Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038
   Brodt C, 2013, J CARD FAIL, V19, P233, DOI 10.1016/j.cardfail.2013.03.001
   Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055
   Chauveau C, 2014, HUM MUTAT, V35, P1046, DOI 10.1002/humu.22611
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Garcia-Pavia P, 2013, BIOMARK MED, V7, P517, DOI 10.2217/bmm.13.77
   Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9
   Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693
   Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64
   Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186
   Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105
   Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006
   Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250
   Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013
   Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009
   McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862
   Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084
   Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761
   Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016
   Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339
   Remme CA, 2008, EUROPACE, V10, P1253, DOI 10.1093/europace/eun267
   Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Takai E, 1999, AM J MED GENET, V86, P325, DOI 10.1002/(SICI)1096-8628(19991008)86:4<325::AID-AJMG5>3.0.CO;2-U
   Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6
   WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603
   Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6
NR 28
TC 9
Z9 11
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 291
EP 298
DI 10.4070/kcj.2016.0017
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400001
PM 28567076
OA Green Published
DA 2021-04-22
ER

PT J
AU Viskin, S
AF Viskin, Sami
TI Idiopathic Polymorphic Ventricular Tachycardia: a "Benign Disease" with
   a Touch of Bad Luck?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ventricular tachycardia; Sudden cardiac death
ID TERM-FOLLOW-UP; RADIOFREQUENCY CATHETER ABLATION; OUTFLOW TRACT
   TACHYCARDIA; FIBRILLATION; ARRHYTHMIAS; COMPLEXES
AB Ventricular extrasystole originating from the right ventricular outflow tract or the left ventricular outflow tract are the most commonly encountered ventricular arrhythmias recorded in ostensibly healthy individuals with no evidence of heart disease. These ventricular arrhythmias have a distinctive electrocardiographic morphology. The morphology is so distinctive that it is common practice to accept the diagnosis of "idiopathic benign ventricular arrhythmias from the outflow tract" based on this unique morphology when the electrocardiogram during sinus rhythm and the echocardiogram are normal, sometimes removing the need to perform invasive tests in patients. Even if the outflow ventricular extrasystole ultimately triggers sustained ventricular arrhythmia, the resulting ventricular tachycardia (VT) will be a monomorphic VT originating from the outflow tract, which is known to be hemodynamically well tolerated. Thus, idiopathic ventricular arrhythmias originating from outflow tracts are universally considered benign. In 2005, we described a rare form of malignant polymorphic VT resulting in syncope or cardiac arrest. Here, we review the literature on this topic since the emergence of initial descriptions of this intriguing phenomenon.
C1 [Viskin, Sami] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel.
   [Viskin, Sami] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
RP Viskin, S (corresponding author), Tel Aviv Med Ctr & Sch Med, Dept Cardiol, Weizman 6, IL-64239 Tel Aviv, Israel.
EM samiviskin@gmail.com
CR Ashida K, 1997, INT J CARDIOL, V59, P171, DOI 10.1016/S0167-5273(97)02938-0
   BELHASSEN B, 1993, J CARDIOVASC ELECTR, V4, P356, DOI 10.1111/j.1540-8167.1993.tb01236.x
   Biffi A, 2002, J AM COLL CARDIOL, V40, P446, DOI 10.1016/S0735-1097(02)01977-0
   Bradfield JS, 2014, J AM COLL CARDIOL, V63, P2151, DOI 10.1016/j.jacc.2014.02.551
   BUXTON AE, 1983, CIRCULATION, V68, P917, DOI 10.1161/01.CIR.68.5.917
   Gaita F, 2001, J AM COLL CARDIOL, V38, P364, DOI 10.1016/S0735-1097(01)01403-6
   Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1
   Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968
   HAN J, 1966, CIRC RES, V18, P18, DOI 10.1161/01.RES.18.1.18
   Igarashi M, 2012, J CARDIOVASC ELECTR, V23, P521, DOI 10.1111/j.1540-8167.2011.02232.x
   Kataoka M, 2008, NAT CLIN PRACT CARD, V5, P111, DOI 10.1038/ncpcardio1082
   Knecht S, 2009, J AM COLL CARDIOL, V54, P522, DOI 10.1016/j.jacc.2009.03.065
   Kurosaki K, 2013, CIRC J, V77, P968, DOI 10.1253/circj.CJ-12-0864
   Kusano KF, 2000, J CARDIOVASC ELECTR, V11, P682, DOI 10.1111/j.1540-8167.2000.tb00031.x
   LEMERY R, 1989, CIRCULATION, V79, P990, DOI 10.1161/01.CIR.79.5.990
   Lerman BB, 1998, J CLIN INVEST, V101, P2862, DOI 10.1172/JCI1582
   LERMAN BB, 1986, CIRCULATION, V74, P270, DOI 10.1161/01.CIR.74.2.270
   Michowitz Yoav, 2016, Card Electrophysiol Clin, V8, P593, DOI 10.1016/j.ccep.2016.04.008
   MORADY F, 1990, CIRCULATION, V82, P2093, DOI 10.1161/01.CIR.82.6.2093
   Noda T, 2005, J AM COLL CARDIOL, V46, P1288, DOI 10.1016/j.jacc.2005.05.077
   Ramirez AH, 2011, HEART RHYTHM, V8, P271, DOI 10.1016/j.hrthm.2010.10.034
   ROBLESDEMEDINA EO, 1989, AM J CARDIOL, V63, P1326, DOI 10.1016/0002-9149(89)91043-6
   Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010
   Shimizu W, 2009, HEART RHYTHM, V6, P1507, DOI 10.1016/j.hrthm.2009.06.017
   SUGIMOTO T, 1967, CIRC RES, V21, P601, DOI 10.1161/01.RES.21.5.601
   Takatsuki S, 2001, Heart, V86, pE3, DOI 10.1136/heart.86.1.e3
   Takemoto M, 2005, J AM COLL CARDIOL, V45, P1259, DOI 10.1016/j.jacc.2004.12.073
   Uemura T, 2008, INTERNAL MED, V47, P1799, DOI 10.2169/internalmedicine.47.1211
   Valk SDA, 2013, INT J CARDIOL, V165, P385, DOI 10.1016/j.ijcard.2012.08.021
   Viskin S, 2005, J AM COLL CARDIOL, V46, P1295, DOI 10.1016/j.jacc.2005.07.010
   Viskin S, 2005, J CARDIOVASC ELECTR, V16, P912, DOI 10.1111/j.1540-8167.2005.50040.x
   Viskin S, 1997, J CARDIOVASC ELECTR, V8, P1115, DOI 10.1111/j.1540-8167.1997.tb00997.x
   Viskin S, 2004, HEART RHYTHM, V1, P587, DOI 10.1016/j.hrthm.2004.07.010
   VISKIN S, 1990, AM HEART J, V120, P661, DOI 10.1016/0002-8703(90)90025-S
   Viskin S, 2007, EUROPACE, V9, P707, DOI 10.1093/europace/eum174
NR 35
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 299
EP 306
DI 10.4070/kcj.2016.0303
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400002
PM 28567077
OA Green Published
DA 2021-04-22
ER

PT J
AU Alfonso, F
AF Alfonso, Fernando
CA Editors Network European Soc Cardi
TI Data Sharing: a New Editorial Initiative from the International
   Committee of Medical Journal Editors. Implications for the Editors'
   Network
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Editorial ethics; Scientific process; Data sharing; Clinical trial;
   Trial registration; Authorship; Conflict of interest; Big-data;
   Scientific Journals
ID OPEN ACCESS PLATFORMS; CLINICAL-TRIAL DATA; EUROPEAN-SOCIETY;
   CARDIOVASCULAR JOURNALS; LEVEL DATA; DISCLOSURE; STATEMENT
AB The International Committee of Medical Journal Editors (ICMJE) provides recommendations to improve the editorial standards and scientific quality of biomedical journals. These recommendations range from uniform technical requirements to more complex and elusive. editorial issues including ethical aspects of the scientific process. Recently, registration of clinical trials, conflicts of interest disclosure, and new criteria for authorship -emphasizing the importance of responsibility and accountability-, have been proposed. This year a new editorial initiative to foster sharing of clinical trial data has been launched. This review discusses this novel initiative with the aim of increasing awareness among readers, investigators, authors and Editors of the Editors' Network of the European Society of Cardiology.
C1 [Alfonso, Fernando; Editors Network European Soc Cardi] Univ Autonoma Madrid, Hosp Univ La Princesa, IIS IP, Chairman Editors Network, Madrid, Spain.
RP Alfonso, F (corresponding author), Univ Autonoma Madrid, Hosp Univ La Princesa, IIS IP, Dept Cardiol,Chairman Editors Network, C Diego Leon 62, Madrid 28006, Spain.
EM falf@hotmail.com
CR Alfonso F, 2008, REV ESP CARDIOL, V61, P644, DOI 10.1157/13123071
   Alfonso F, 2006, REV ESP CARDIOL, V59, P1206
   Alfonso F, 2012, EUR HEART J, V33, P587, DOI 10.1093/eurheartj/ehr464
   Alfonso F, 2011, EUR HEART J, V32, P919
   Alfonso F, 2010, EUR HEART J, V31, P26, DOI 10.1093/eurheartj/ehp462
   Coady SA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-201
   Committee On Publication Ethics. COPE, COD COND BEST PRACT
   Council of Science Editors, WHIT PAP PUBL ETH CS
   Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093
   De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127
   Devereaux PJ, 2016, NEW ENGL J MED, V375, P405, DOI 10.1056/NEJMp1605654
   Drazen JM, 2016, NEW ENGL J MED, V374, pE24, DOI 10.1056/NEJMe1601087
   Drazen JM, 2009, NEW ENGL J MED, V361, P1896, DOI 10.1056/NEJMe0909052
   Fletcher C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0168-5
   Geifman N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0525-y
   Goncalves LM, 2012, REV PORT CARDIOL, V31, P763, DOI 10.1016/j.repc.2012.10.001
   Hayes R, 2016, LANCET, V387, P2287, DOI 10.1016/S0140-6736(16)30682-1
   Hopkins C, 2016, J CLIN EPIDEMIOL, V70, P17, DOI 10.1016/j.jclinepi.2015.07.002
   Horton R, 2016, LANCET, V388, P1143, DOI 10.1016/S0140-6736(16)31638-5
   Institute of Medicine, 2015, SHAR CLIN TRIAL DAT
   International Committee of Medical Journal Editors, REC COND REP ED PUBL
   Kavsak PA, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.10
   Krumholz HM, 2016, NEW ENGL J MED, V375, P403, DOI 10.1056/NEJMp1607342
   Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292
   Loder E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2373
   Manamley N, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0172-9
   Merson L, 2016, NEW ENGL J MED, V374, P2414, DOI 10.1056/NEJMp1605148
   Mills P, 2009, HEART, V95, DOI 10.1136/hrt.2009.186338
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Navar AM, 2016, JAMA-J AM MED ASSOC, V315, P1283, DOI 10.1001/jama.2016.2374
   Patel MR, 2016, NEW ENGL J MED, V375, P407, DOI 10.1056/NEJMp1605260
   Ross JS, 2016, JAMA-J AM MED ASSOC, V316, P666, DOI 10.1001/jama.2016.8794
   Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794
   Sudlow R, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0171-x
   Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172
   Tucker K, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0169-4
   Vallance P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001936
   Van Tuyl S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147942
   World Association of Medical Editors, WAME PROF COD COND N
NR 39
TC 0
Z9 0
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 307
EP 313
DI 10.4070/kcj.2016.0444
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400003
PM 28567078
OA Green Published
DA 2021-04-22
ER

PT J
AU Gwon, HC
   Jeon, DW
   Kang, HJ
   Jang, JS
   Park, DW
   Shin, DH
   Moon, KW
   Kim, JS
   Kim, J
   Bae, JW
   Hur, SH
   Kim, BO
   Choi, D
   Han, KR
   Kim, HS
AF Gwon, Hyeon-Cheol
   Jeon, Dong Woon
   Kang, Hyun-Jae
   Jang, Jae-Sik
   Park, Duk-Woo
   Shin, Dong-Ho
   Moon, Keon-Woong
   Kim, Jung-Sun
   Kim, Juhan
   Bae, Jang-Whan
   Hur, Seung-Ho
   Kim, Byung Ok
   Choi, Donghoon
   Han, Kyoo-Rok
   Kim, Hyo-Soo
TI The Practice Pattern of Percutaneous Coronary Intervention in Korea
   -Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention
   (K-PCI) Registry-
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Appropriateness criteria; Clinical
   practice
ID APPROPRIATE USE CRITERIA; REVASCULARIZATION; PATIENT; TRENDS
AB Background and Objectives: Appropriate use criteria (AUC) was developed to improve the quality of percutaneous coronary intervention (PCI). However, these criteria should consider the current practice pattern in the country where they are being applied.
   Materials and Methods: The algorithm for the Korean PCI practice pattern (KP3) was developed by modifying the United States-derived AUC in expert consensus meetings. KP3 class A was defined as any strategy with evidence from randomized trials that was more conservative for PCI than medical therapy or coronary artery bypass graft (CABG). Class C was defined as any strategy with less evidence from randomized trials and more aggressive for PCI than medical therapy or CABG. Class B was defined as a strategy that was partly class A and partly class C. We applied the KP3 classification system to the Korean PCI registry.
   Results: The KP3 class A was noted in 67.7% of patients, class B in 28.8%, and class C in 3.50%. The median proportion of class C cases per center was 2.0%. The distribution of KP3 classes varied significantly depending on clinical and angiographic characteristics. The proportion of KP3 class C cases per center was not significantly dependent on PCI volume, but rather on the percentage of ACS cases in each center.
   Conclusion: We report the current PCI practice pattern by applying the new KP3 classification in a nationwide PCI registry. The results should be interpreted carefully with due regard for the complex relationships between the determining variables and the healthcare system in Korea.
C1 [Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Heart Vasc & Stroke Inst, Seoul, South Korea.
   [Jeon, Dong Woon] Ilsan Hosp, Div Cardiol, Natl Hlth Insurance Serv, 100 Ilsan Ro, Goyang 10444, South Korea.
   [Kang, Hyun-Jae; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Jang, Jae-Sik] Univ Inje, Busan Paik Hosp, Coll Med, Div Cardiol, Busan, South Korea.
   [Park, Duk-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Busan, South Korea.
   [Shin, Dong-Ho; Kim, Jung-Sun; Choi, Donghoon] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiovasc, Seoul, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Cardiol, Suwon, South Korea.
   [Kim, Juhan] Chonnam Natl Univ Hosp, Heart Ctr, Div Cardiol, Gwangju, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Daegu, South Korea.
   [Kim, Byung Ok] Univ Inje, Sanggye Paik Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
   [Han, Kyoo-Rok] Hallym Univ, Kangdong Sacred Heart Hosp, Med Ctr, Dept Internal Med, Seoul, South Korea.
RP Jeon, DW (corresponding author), Ilsan Hosp, Div Cardiol, Natl Hlth Insurance Serv, 100 Ilsan Ro, Goyang 10444, South Korea.
EM jdw121620@naver.com
FU Korean Society of Cardiology; Korean Society of Interventional
   Cardiology
FX This study was co-sponsored by the Korean Society of Cardiology and the
   Korean Society of Interventional Cardiology.
CR Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9
   Chan PS, 2013, J AM COLL CARDIOL, V62, P2274, DOI 10.1016/j.jacc.2013.07.086
   Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916
   Committee for the Korean guidelines for the management of dyslipidemia, 2015, KOREAN CIRC J, V46, P275
   Desai NR, 2015, JAMA-J AM MED ASSOC, V314, P2045, DOI 10.1001/jama.2015.13764
   Feldman DN, 2014, J INVASIVE CARDIOL, V26, P559
   del Blanco BG, 2014, REV ESP CARDIOL, V67, P1013, DOI 10.1016/j.rec.2014.08.005
   Inohara T, 2014, JACC-CARDIOVASC INTE, V7, P1000, DOI 10.1016/j.jcin.2014.06.006
   Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804
   Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9
   Patel MR, 2017, J AM COLL CARDIOL, V69, P570, DOI 10.1016/j.jacc.2016.10.034
   Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001
   Patel MR, 2009, J AM COLL CARDIOL, V53, P530, DOI 10.1016/j.jacc.2008.10.005
   Wayangankar SA, 2016, JACC-CARDIOVASC INTE, V9, P341, DOI 10.1016/j.jcin.2015.10.039
NR 14
TC 10
Z9 10
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 320
EP 327
DI 10.4070/kcj.2017.0070
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400007
PM 28567082
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, SH
   Lee, CW
   Yun, SC
   Lee, PH
   Ahn, JM
   Park, DW
   Kang, SJ
   Lee, SW
   Kim, YH
   Park, SW
   Park, SJ
AF Kang, Se Hun
   Lee, Cheol Whan
   Yun, Sung-Cheol
   Lee, Pil Hyung
   Ahn, Jung-Min
   Park, Duk-Woo
   Kang, Soo-Jin
   Lee, Seung-Whan
   Kim, Young-Hak
   Park, Seong-Wook
   Park, Seung-Jung
TI Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for
   Multivessel Disease in Patients with Chronic Kidney Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery bypass; Coronary disease; Percutaneous coronary
   intervention; Renal insufficiency
ID LONG-TERM MORTALITY; RENAL-INSUFFICIENCY; 5-YEAR OUTCOMES;
   REVASCULARIZATION; SURGERY; IMPACT; INTERVENTIONS
AB Background and Objectives: There is currently a limited amount of data that demonstrate the optimal revascularization strategy for chronic kidney disease (CKD) patients with multivessel coronary artery disease (CAD). We compared the long-term outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass graft surgery (CABG) for multivessel CAD in patients with CKD.
   Subjects and Methods: We analyzed 2108 CKD patients (estimated glomerular filtration rate <60 mL/imin/1.73 m(2)) with multivessel CAD that were treated with PCI with DES (n=1165) or CABG (n=943). The primary outcome was a composite of all causes of mortality, myocardial infarction, or stroke. The mean age was 66.9 +/- 9.1 years.
   Results: Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 (32.2%) patients in the CABG group (adjusted hazard ratio [HR], 0.941; 95% confidence interval [Cl], 0.79-1.12; p=0.493). The two groups exhibited similar rates of all-cause mortality (adjusted HR, 0.91; 95% CI, 0.77-1.09; p=0.295), myocardial infarction (adjusted HR, 1.86; 95% CI, 0.85-4.07; p=0.120) and stroke (3.2% vs. 4.8%; HR, 0.93; 95% CI, 0.57-1.61; p=0.758). However, PCI was associated with significantly increased rates of repeat revascularization (adjusted HR, 4.72; 95% CI, 3.20-6.96; p<0.001).
   Conclusion: Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed.
C1 [Kang, Se Hun] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Lee, Cheol Whan; Lee, Pil Hyung; Ahn, Jung-Min; Park, Duk-Woo; Kang, Soo-Jin; Lee, Seung-Whan; Kim, Young-Hak; Park, Seong-Wook; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea.
   [Yun, Sung-Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea.
RP Lee, CW (corresponding author), Univ Ulsan, Asan Med Ctr, Heart Ctr, Div Cardiol, 88 Olympic Ro, Seoul 05505, South Korea.
EM cheolwlee@amc.seoul.kr
OI Kang, Se Hun/0000-0001-5876-1791
CR Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761
   Anderson RJ, 1999, KIDNEY INT, V55, P1057, DOI 10.1046/j.1523-1755.1999.0550031057.x
   Ashrith G, 2010, AM J CARDIOL, V106, P348, DOI 10.1016/j.amjcard.2010.03.037
   Bangalore S, 2015, J AM COLL CARDIOL, V66, P1209, DOI 10.1016/j.jacc.2015.06.1334
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   Blackman DJ, 2006, AM HEART J, V151, P146, DOI 10.1016/j.ahj.2005.03.018
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Chang M, 2016, J AM COLL CARDIOL, V68, P29, DOI 10.1016/j.jacc.2016.04.034
   Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084
   Deb S, 2013, JAMA-J AM MED ASSOC, V310, P2086, DOI 10.1001/jama.2013.281718
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585
   Gruberg L, 2002, CATHETER CARDIO INTE, V55, P66, DOI 10.1002/ccd.10103
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hillis GS, 2006, CIRCULATION, V113, P1056, DOI 10.1161/CIRCULATIONAHA.105.591990
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718
   Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416
   Lee SH, 2008, CIRC J, V72, P1410, DOI 10.1253/circj.CJ-08-0088
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2011, J AM COLL CARDIOL, V57, P128, DOI 10.1016/j.jacc.2010.09.022
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4
   Wang ZJ, 2009, CIRC J, V73, P1228, DOI 10.1253/circj.CJ-08-1091
NR 30
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 354
EP 360
DI 10.4070/kcj.2016.0439
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400010
PM 28567085
OA Green Published
DA 2021-04-22
ER

PT J
AU Karaca, M
   Aytekin, D
AF Karaca, Mustafa
   Aytekin, Deniz
TI Predicting Intermittent Atrial Fibrillation in Outpatient Clinics
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; inter-atrial conduction time; Echocardiography
ID INTERATRIAL CONDUCTION TIME; APPENDAGE EJECTION FLOW; P-WAVE; STROKE;
   INITIATION; RISK; PALPITATIONS; PREVALENCE; INTERVAL; START
AB Background and Objectives: Palpitations are the most common complaint in cardiology-outpatient clinics. These palpitations may be derived from paroxysmal atrial fibrillation (AF) and can be easily overlooked. It is unclear whether inter-atrial conduction time (ICT) may predict the paroxysmal AF in out-patients that present with palpitations. We evaluated the ability of the ICT to predict paroxysmal AF in these patients. Subjects and
   Methods: The study group consisted of 199 patients (110 female). All patients underwent 24-hour Holter electrocardiogram (ECG) monitoring (total of 327 Holter ECG monitorings, mean: 1.64 times per patient). Brief episodes of AF were documented in 35 patients (20 female, Group 1). The remaining patients without AF were designated as Group 2 (90 female). All patients underwent routine transthoracic echocardiographic examination. ICT was also measured by echocardiography.
   Results: The mean age in Group 1 was greater than in Group 2 (63.02 +/- 14 vs. 51.27 +/- 16 years, p<0.001). The left atrium was larger in Group 1 than in Group 2 (39.7 +/- 3.4 vs. 37.29 +/- 4.3 mm, p<0.001). The other echocardiographic variables were comparable between the two groups. The mean ICT was significantly higher in Group 1 than in Group 2 (138 +/- 14 vs. 114 +/- 12 msn, p<0.001). The ICT of 127 ms was predictive for AF with a sensitivity of 86% and specificity of 87% (p<0.001).
   Conclusion: Our findings show that ICT was prolonged in patients with palpitations who developed a brief episode of AF in Holter ECG monitoring. ICT prolongation may be used to identify patients with palpitation that are at risk of an AF episode. Holter ECG monitoring should be repeated to detect AF episodes in patients with prolonged ICT.
C1 [Karaca, Mustafa] Katip Celebi Univ IAEH, Dept Cardiol, TR-35160 Izmir, Turkey.
   [Aytekin, Deniz] Medikalp Heart Dis Clin, Dept Cardiol, Izmir, Turkey.
RP Karaca, M (corresponding author), Katip Celebi Univ IAEH, Dept Cardiol, TR-35160 Izmir, Turkey.
EM mustafakaraca99@hotmail.com
CR BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835
   Chei CL, 2015, CHINESE MED J-PEKING, V128, P2426, DOI 10.4103/0366-6999.164918
   Cozma Dragos, 2006, Kardiol Pol, V64, P143
   de Asmundis C, 2014, EUROPACE, V16, P1231, DOI 10.1093/europace/eut411
   Fuenmayor Abdel J, 2002, Arch. Cardiol. Méx., V72, P125
   Gladstone DJ, 2015, STROKE, V46, P936, DOI 10.1161/STROKEAHA.115.008714
   Healey JS, 2013, CAN J CARDIOL, V29, P224, DOI 10.1016/j.cjca.2012.08.019
   Karaca M, 2012, CARDIOVASC J AFR, V23, P34, DOI 10.5830/CVJA-2011-010
   Karaca M, 2007, ECHOCARDIOGR-J CARD, V24, P810, DOI 10.1111/j.1540-8175.2007.00483.x
   Karaca M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1756-x
   Kinay O, 2002, J AM SOC ECHOCARDIOG, V15, P1479, DOI 10.1067/mje.2002.127515
   Lee DH, 2015, KOREAN CIRC J, V45, P479, DOI 10.4070/kcj.2015.45.6.479
   Lima CEB, 2016, ANN NONINVAS ELECTRO, V21, P246, DOI 10.1111/anec.12294
   Malnick SDH, 2014, NEW ENGL J MED, V371, P1259, DOI 10.1056/NEJMc1409495
   Papageorgiou P, 1996, CIRCULATION, V94, P384, DOI 10.1161/01.CIR.94.3.384
   SPACH MS, 1988, CIRC RES, V62, P811, DOI 10.1161/01.RES.62.4.811
   Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
NR 18
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 361
EP 365
DI 10.4070/kcj.2016.0340
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400011
PM 28567086
OA Green Published
DA 2021-04-22
ER

PT J
AU Wang, JL
   Zhou, N
   Wu, SZ
   Zhang, XY
   Su, DC
AF Wang, Juanli
   Zhou, Nan
   Wu, Shouzhen
   Zhang, Xiaoyan
   Su, Decheng
TI Changes in 11 beta-Hydroxysteroid Dehydrogenase and Glucocorticoid
   Receptor Expression in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; 11 beta-hydroxysteroid dehydrogenase; Receptor,
   glucocorticoid
ID CORONARY-ARTERY ABNORMALITIES; INTRAVENOUS IMMUNE GLOBULIN; BINDING
   PROTEIN-BETA; CARDIOVASCULAR-DISEASE; IMMUNOGLOBULIN; TYPE-1;
   METHYLPREDNISOLONE; INFLAMMATION; METABOLISM; SECRETION
AB Background and Objectives: This study aims to investigate the significance of changes in the expression 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) and gluCocorticoid receptor (OR) for the development of Kawasaki disease (KD).
   Subjects and Methods: Real-time polymerase chain reaction was performed to determine the mRNA expression levels of GR and 11 beta-HSD in peripheral blood monocytes, both in the acute phase of the disease and after treatment. Western blotting was performed to determine the protein expression levels of OR and 11 beta-1-ISD.
   Results: The expression levels of GR beta, GRP, and 11 beta-HSD1 mRNA in the acute phase were significantly higher than levels at baseline (p<0.01) and after treatment (p<0.05). The 1 beta-HSD2 mRNA levels were lower in the acute phase than in the normal group (p<0.01), and they were significantly higher after treatment than before (p<0.01). Western blot results were consistent with the real-time PCR results. The coronary artery lesion group exhibited significantly different 11 beta-HSD2 expression levels from that of the group with normal coronary arteries (p<0.01).
   Conclusion: GR and 11 beta-HSD expression changes in the acute phase of KD are important factors for regulating inflammatory responses in KD.
C1 [Wang, Juanli; Zhou, Nan] Xian Childrens Hosp, Dept Cardiol, Xian 710003, Peoples R China.
   [Wu, Shouzhen; Su, Decheng] Xian Childrens Hosp, Dept Cent Lab, Xian, Peoples R China.
   [Zhang, Xiaoyan] Shanxi Povince Hosp, Dept Pediat, Taiyuan, Peoples R China.
RP Wang, JL (corresponding author), Xian Childrens Hosp, Dept Cardiol, Xian 710003, Peoples R China.
EM juanliwangcn@163.com
CR Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x
   Chapman KE, 2006, MOL CELL ENDOCRINOL, V248, P3, DOI 10.1016/j.mce.2005.11.036
   Chen SJ, 2013, HEART, V99, P76, DOI 10.1136/heartjnl-2012-302126
   Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005
   D'Attilio L, 2013, TUBERCULOSIS, V93, P635, DOI 10.1016/j.tube.2013.07.008
   Furukawa T, 2008, ARCH DIS CHILD, V93, P142, DOI 10.1136/adc.2007.126144
   Garbrecht MR, 2006, AM J PHYSIOL-ENDOC M, V290, pE653, DOI 10.1152/ajpendo.00396.2005
   Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x
   Holmes MC, 2006, NEUROSCIENCE, V137, P865, DOI 10.1016/j.neuroscience.2005.09.037
   Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008
   Jibiki T, 2011, PEDIATR INT, V53, P729, DOI 10.1111/j.1442-200X.2011.03338.x
   Kino T, 2009, CELL MOL LIFE SCI, V66, P3435, DOI 10.1007/s00018-009-0098-z
   Kobayashi Tohru, 2014, Nihon Rinsho, V72, P1623
   Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2
   Lim YJ, 2014, YONSEI MED J, V55, P1260, DOI 10.3349/ymj.2014.55.5.1260
   Meduri GU, 2002, AM J RESP CRIT CARE, V165, P983, DOI 10.1164/ajrccm.165.7.2106014
   Ogata S, 2012, PEDIATRICS, V129, pE17, DOI 10.1542/peds.2011-0148
   Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489
   Sano S, 2010, STEROIDS, V75, P848, DOI 10.1016/j.steroids.2010.06.006
   Shirley DA, 2010, PEDIATR INFECT DIS J, V29, P978, DOI 10.1097/INF.0b013e3181e05564
   Subspecialty Group of Cardiology the Society of Pediatrics Chinese Medical Association., 2012, CHIN J PEDIAT, V50, P746
   Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455
   Weng KP, 2011, J CHIN MED ASSOC, V74, P481, DOI 10.1016/j.jcma.2011.09.001
NR 23
TC 2
Z9 2
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 377
EP 382
DI 10.4070/kcj.2016.0257
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400013
PM 28567088
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, HC
   Jang, JS
   Jin, HY
   Seo, JS
   Yang, TH
   Kim, DK
   Kim, DS
AF Shin, Ho-Cheol
   Jang, Jae-Sik
   Jin, Han-Young
   Seo, Jeong-Sook
   Yang, Tae-Hyun
   Kim, Dae-Kyeong
   Kim, Dong-Soo
TI Combined Use of Neutrophil to Lymphocyte Ratio and C-Reactive Protein
   Level to Predict Clinical Outcomes in Acute Myocardial Infarction
   Patients Undergoing Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Neutrophils; Lymphocytes; Myocardial Infarction; Prognosis
ID ARTERY-DISEASE; TO-LYMPHOCYTE; MORTALITY; ATHEROSCLEROSIS; INFLAMMATION;
   ASSOCIATION; SEVERITY; PLATELET; COLLEGE
AB Background and Objectives: Both neutrophil to lymphocyte ratio (NLR) and C-reactive protein (CRP) are biomarkers associated with poor prognosis of patients with acute myocardial infarction (AMI). However, the combined usefulness of NLR and CRP in predicting adverse outcomes has not been investigated.
   Subjects and Methods: We analyzed 381 consecutive AMI patients who underwent percutaneous coronary intervention (PCI) from January 2012 to January 2014. The endpoints were all-cause mortality, recurrent myocardial infarction (MI), stent thrombosis, repeat revascularization, stroke, and major adverse cardiac and cerebrovascular events (MACCE) at 2-year follow-up. Included patients were divided into 4 groups according to the optimal cut-off values for NLR and CRP on receiver operating characteristic analysis predicting mortality.
   Results: Patients with both high NLR (>6.30) and high CRP (>0.76) had significantly greater risk of all-cause death and MACCE at 24 months, with no significant increase in the risk of recurrent MI, stent thrombosis, or stroke compared with patients with either low NLR or low CRP, as well as those with low NLR and low CRP. Kaplan-Meier analysis revealed significantly lower survival in patients with high NLR-CRP. On Cox multivariate analysis, high NLR-CRP (hazard ratio 23.172, 95% confidence interval 6.575 to 81.671, p<0.001) was an independent predictor of all-cause death.
   Conclusion: Elevated levels of both NLR and CRP are associated with increased risk of long-term mortality in AMI patients who have undergone PCI.
C1 [Shin, Ho-Cheol; Jang, Jae-Sik; Jin, Han-Young; Seo, Jeong-Sook; Yang, Tae-Hyun; Kim, Dae-Kyeong; Kim, Dong-Soo] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med, 75 Bokji Ro, Busan 47392, South Korea.
RP Jang, JS (corresponding author), Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med, 75 Bokji Ro, Busan 47392, South Korea.
EM jsjang71@gmail.com
CR Agrawal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/319215
   Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   Aune E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-97
   Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062
   Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   De Servi S, 2005, J AM COLL CARDIOL, V46, P1496, DOI 10.1016/j.jacc.2005.05.083
   Deftereos S, 2015, CIRCULATION, V132, P1395, DOI 10.1161/CIRCULATIONAHA.115.017611
   FORMAN MB, 1989, J AM COLL CARDIOL, V13, P450, DOI 10.1016/0735-1097(89)90526-3
   Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008
   Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043
   Gibson PH, 2010, AM J CARDIOL, V105, P186, DOI 10.1016/j.amjcard.2009.09.007
   Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93
   Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406
   Helmers C, 1973, Acta Med Scand Suppl, V555, P7
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   KELLY TL, 1985, AM HEART J, V110, P535
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009
   Misumida N, 2015, CORONARY ARTERY DIS, V26, P381, DOI 10.1097/MCA.0000000000000237
   Nakamura T, 2013, J SURG ONCOL, V108, P481, DOI 10.1002/jso.23424
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Ogita M, 2015, AM J CARDIOL, V116, P999, DOI 10.1016/j.amjcard.2015.06.036
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sari I, 2015, KARDIOL POL, V73, P1310, DOI 10.5603/KP.a2015.0098
   SPARROW D, 1978, J CHRON DIS, V31, P425, DOI 10.1016/0021-9681(78)90006-1
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   Temiz A, 2014, MED SCI MONITOR, V20, P660, DOI 10.12659/MSM.890152
   Ugur M, 2014, BLOOD COAGUL FIBRIN, V25, P806, DOI 10.1097/MBC.0000000000000150
   WEINBLATT E, 1968, AM J PUBLIC HEALTH N, V58, P1329, DOI 10.2105/AJPH.58.8.1329
NR 30
TC 10
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 383
EP 391
DI 10.4070/kcj.2016.0327
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400014
PM 28567089
OA Green Published
DA 2021-04-22
ER

PT J
AU Kee, HJ
   Kim, GR
   Lin, MQ
   Choi, SY
   Ryu, Y
   Jin, L
   Piao, ZH
   Jeong, MH
AF Kee, Hae Jin
   Kim, Gwi Ran
   Lin, Ming Quan
   Choi, Sin Young
   Ryu, Yuhee
   Jin, Li
   Piao, Zhe Hao
   Jeong, Myung Ho
TI Expression of Class I and Class II a/b Histone Deacetylase is
   Dysregulated in Hypertensive Animal Models
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Spontaneously hypertensive rats; L-NAME; Angiotensin II;
   Class II histone deacetylases
ID NITRIC-OXIDE SYNTHESIS; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; NEOINTIMAL
   HYPERPLASIA; INHIBITION; HYPERTROPHY; HDAC3; RATS; ACTIVATION; FIBROSIS
AB Background and Objectives: Dysregulation of histone deacetylase expression and enzymatic activity is associated with a number of diseases. It has been reported that protein levels of histone deacetylase (HDAC)1 and HDAC5 increase during human pulmonary hypertension, and that the enzymatic activity of HDAC6 is induced in a chronic hypertensive animal model. This study investigated the protein expression profiles of class I and II a/b HDACs in three systemic hypertension models.
   Materials and Methods: We used three different hypertensive animal models: (i) Wistar-Kyoto rats (n=8) and spontaneously hypertensive rats (SHR; n=8), (ii) mice infused with saline or angiotensin II to induce hypertension, via osmotic mini-pump for 2 weeks, and (iii) mice that were allowed to drink L-N-G-nitro-L-arginine methyl ester (L-NAME) to induce hypertension.
   Results: SHR showed high systolic, diastolic, and mean blood pressures. Similar increases in systolic blood pressure were observed in angiotensin II or L-NAME-induced hypertensive mice. In SHR, class Ila HDAC (HDAC4, 5, and 7) and class Ilb HDAC (HDAC6 and 10) protein expression were significantly increased. In addition, a HDAC3 protein expression was induced in SHR. However, in L-NAME mice, class Ila HDAC protein levels (HDAC4, 5, 7, and 9) were significantly reduced. HDAC8 protein levels were significantly reduced both in angiotensin II mice and in SHR.
   Conclusion: These results indicate that dysregulation of class I and class II HDAC protein is closely associated with chronic hypertension.
C1 [Kee, Hae Jin; Kim, Gwi Ran; Lin, Ming Quan; Choi, Sin Young; Ryu, Yuhee; Jin, Li; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea.
   [Lin, Ming Quan] Yanbian Univ Hosp, Yanbian, Jilin, Peoples R China.
   [Jin, Li] Jilin Univ, Jilin Hosp, Jilin, Jilin, Peoples R China.
   [Piao, Zhe Hao] Jilin Univ, Hosp 2, Changchun, Peoples R China.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
FU Korean Society of Cardiology
FX This work was supported by a research grant from the Korean Society of
   Cardiology in 201403-01.
CR Bartunek J, 2000, CIRCULATION, V101, P423, DOI 10.1161/01.CIR.101.4.423
   BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849
   Brand S, 2013, J HYPERTENS, V31, P333, DOI 10.1097/HJH.0b013e32835ba77e
   Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426
   Choi SY, 2015, VASC PHARMACOL, V72, P130, DOI 10.1016/j.vph.2015.04.006
   Kameshima S, 2016, BIOCHEM BIOPH RES CO, V469, P654, DOI 10.1016/j.bbrc.2015.12.048
   Kee HJ, 2013, KIDNEY BLOOD PRESS R, V37, P229, DOI 10.1159/000350148
   Kee HJ, 2011, VASC PHARMACOL, V55, P127, DOI 10.1016/j.vph.2011.07.001
   Kim GR, 2016, J HYPERTENS, V34, P2206, DOI 10.1097/HJH.0000000000001081
   Koumangoye RB, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0284-y
   Lee HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136801
   Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071
   Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005
   Ler SY, 2015, ONCOL REP, V34, P2238, DOI 10.3892/or.2015.4263
   Li S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-18
   Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243
   Pang JJ, 2008, ARTERIOSCL THROM VAS, V28, P892, DOI 10.1161/ATVBAHA.107.161349
   RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298
   Usui T, 2014, HYPERTENSION, V63, P397, DOI 10.1161/HYPERTENSIONAHA.113.01843
   Usui T, 2012, AM J PHYSIOL-HEART C, V302, pH1894, DOI 10.1152/ajpheart.01039.2011
   Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200
   Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704
NR 22
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 392
EP 400
DI 10.4070/kcj.2016.0266
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400015
PM 28567090
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kim, DH
   Youn, YN
   Lee, S
   Joo, HC
   Chang, BC
   Yoo, KJ
AF Lee, Seung Hyun
   Kim, Dae-Hyun
   Youn, Young-Nam
   Lee, Sak
   Joo, Hyun Chel
   Chang, Byung Chul
   Yoo, Kyung-Jong
TI Effect of Rosuvastatin on Bovine Pericardial Aortic Tissue Valve
   Calcification in a Rat Subdermal Implantation Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart valve; Hypercholesterolemia; Statins (HMG-CoA reductase
   inhibitor); Aortic valve, calcification
ID BONE-FORMATION; PROGRESSION; PREVENTION; STENOSIS; STATINS;
   HYPERCHOLESTEROLEMIA; ATORVASTATIN; ASSOCIATION; CHOLESTEROL; CALCIUM
AB Background and Objectives: There are pathophysiologic similarities between calcification and atherosclerosis because both are the product of an active inflammatory process. The aim of this study was to examine the effects of statin treatment on calcification in bovine pericardial tissue valves.
   Materials and Methods: Forty Sprague-Dawley rats were randomly divided into 4 groups according to hypercholesterolemia induction and statin intake (Group 1, n=10: normal diet without statin treatment, Group 2, n=10: normal diet with statin treatment, Group 3, n=10: high fat diet without statin treatment, Group 4, n=10: high fat diet with statin treatment). Serum lipid levels were measured just before the experiment and after 4 and 12 weeks. Bovine pericardial tissue valve cusps were surgically implanted in rat dorsal subcutis at 4 weeks. After the surgery, statin was administered daily to Groups 2 and 4. Serum interleukin-6 (IL-6) level was measured at 5 weeks. Cusps were explanted at 12 weeks and calcium levels were determined by atomic absorption spectroscopy.
   Results: Mean IL-6 was significantly higher in Group 3 at 5 weeks (7.14, 2.03, 31.70, and 6.90 pg/dL for each group, respectively). Mean calcium level in Group 3 was significantly higher among groups but Group 4 was significantly lower compared to Group 3 and was similar to Group 1, 2 (1.86, 1.92, 2.55, and 1.80 mg/g for each group, respectively, p<0.01).
   Conclusion: Hypercholesterolemia may be a significant risk factor for bovine pericardial valve calcification. Statin treatment significantly attenuated calcification of bovine pericardial valve tissue in a rat subdermal implantation model and might prolong the durability of bioprostheses.
C1 [Lee, Seung Hyun; Kim, Dae-Hyun; Youn, Young-Nam; Lee, Sak; Joo, Hyun Chel; Chang, Byung Chul; Yoo, Kyung-Jong] Yonsei Univ, Severance Cardiovasc Hosp, Yonsei Cardiovasc Res Inst, Div Thorac & Cardiovasc Surg,Coll Med, Seoul, South Korea.
RP Lee, S (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Yonsei Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM SAK911@yuhs.ac
RI Chang, Byung/AAP-9674-2020
OI lee, seung hyun/0000-0002-0311-6565; Lee, Sak/0000-0001-6130-2342;
   Chang, Byung Chul/0000-0001-5005-8217; Joo,
   hyun-chel/0000-0002-6842-2942
FU Korean Society of Cardiology
FX This study was supported by a research grant from Korean Society of
   Cardiology for 201403-04 and the authors report no relationships that
   could be construed as a conflict of interest.
CR Achenbach S, 2002, CIRCULATION, V106, P1077, DOI 10.1161/01.CIR.0000027567.49283.FF
   Aronow WS, 2001, AM J CARDIOL, V88, P693, DOI 10.1016/S0002-9149(01)01821-5
   Bellamy MF, 2002, J AM COLL CARDIOL, V40, P1723, DOI 10.1016/S0735-1097(02)02496-8
   Black AE, 1998, DRUG METAB DISPOS, V26, P755
   Cohn LH, 1998, ANN THORAC SURG, V66, pS30, DOI 10.1016/S0003-4975(98)01105-9
   Colli A, 2007, INT J CARDIOL, V116, P144, DOI 10.1016/j.ijcard.2006.03.047
   Demer LL, 2001, CIRCULATION, V104, P1881, DOI 10.1161/circ.104.16.1881
   Farivar RS, 2003, J THORAC CARDIOV SUR, V126, P969, DOI 10.1016/S0022-5223(03)00708-6
   Jamieson WRE, 1998, ANN THORAC SURG, V66, pS40, DOI 10.1016/S0003-4975(98)01124-2
   Lorusso R, 2010, INT J CARDIOL, V141, P68, DOI 10.1016/j.ijcard.2008.11.174
   Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Novaro GM, 2001, CIRCULATION, V104, P2205, DOI 10.1161/hc4301.098249
   Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218
   Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115
   Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497
   Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72
   Schmermund A, 2002, AM J CARDIOL, V90, p12L, DOI 10.1016/S0002-9149(02)02955-7
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHOEN FJ, 1987, J BIOMED MATER RES-A, V21, P91
   Shavelle DM, 2002, LANCET, V359, P1125, DOI 10.1016/S0140-6736(02)08161-8
   Vyavahare NR, 2000, J HEART VALVE DIS, V9, P561
   Yildirir Aylin, 2004, Current Vascular Pharmacology, V2, P309, DOI 10.2174/1570161043385475
NR 23
TC 2
Z9 5
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 401
EP 408
DI 10.4070/kcj.2016.0214
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400016
PM 28567091
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
AF Park, Chul Soo
TI Inflammation in Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ACUTE MYOCARDIAL-INFARCTION; RISK
C1 [Park, Chul Soo] Catholic Univ Korea, Yoido St Marys Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.
RP Park, CS (corresponding author), Catholic Univ Korea, Yoido St Marys Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea.
EM Charlie@catholic.ac.kr
CR Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934
   Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219
   Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054
   Kim Bong-Joon, 2016, J Cardiovasc Ultrasound, V24, P115, DOI 10.4250/jcu.2016.24.2.115
   Nam SH, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1989417
   Nidorf SM, 2013, J AM COLL CARDIOL, V61, P404, DOI 10.1016/j.jacc.2012.10.027
   O'Donoghue ML, 2016, JAMA-J AM MED ASSOC, V315, P1591, DOI 10.1001/jama.2016.3609
   Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052
   Shin HC, 2017, KOREAN CIRC J, V47, P383, DOI 10.4070/kcj.2016.0327
NR 9
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 314
EP 315
DI 10.4070/kcj.2017.0076
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400004
PM 28567079
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, JC
   Han, S
   Ryu, KH
AF Youn, Jong-Chan
   Han, Seongwoo
   Ryu, Kyu-Hyung
TI Toward a New Heart Failure Registry in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Youn, Jong-Chan; Han, Seongwoo; Ryu, Kyu-Hyung] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
RP Ryu, KH (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
EM khryu@hallym.or.kr
RI Youn, Jong-Chan/AAS-1405-2020
OI Youn, Jong-Chan/0000-0003-0998-503X
CR Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
NR 5
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 316
EP 317
DI 10.4070/kcj.2017.0075
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400005
PM 28567080
OA Green Published
DA 2021-04-22
ER

PT J
AU Woo, JS
   Kim, W
AF Woo, Jong Shin
   Kim, Weon
TI PCI or CABG, That is the Question!
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; ELUTING
   STENTS; ARTERY-DISEASE; REVASCULARIZATION; CLOPIDOGREL; TICAGRELOR
C1 [Woo, Jong Shin; Kim, Weon] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Cardiovasc, Seoul, South Korea.
RP Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Internal Med,Cardiovasc Div, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM mylovekw@hanmail.net
CR Ashrith G, 2010, AM J CARDIOL, V106, P348, DOI 10.1016/j.amjcard.2010.03.037
   Bangalore S, 2015, J AM COLL CARDIOL, V66, P1209, DOI 10.1016/j.jacc.2015.06.1334
   Charytan DM, 2016, KIDNEY INT, V90, P411, DOI 10.1016/j.kint.2016.03.033
   James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796
   Jeong KH, 2015, AM J KIDNEY DIS, V65, P916, DOI 10.1053/j.ajkd.2014.11.023
   Kang SH, 2017, KOREAN CIRC J, V47, P354, DOI 10.4070/kcj.2016.0439
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Palmer S. C., 2013, COCHRANE DATABASE SY
   Wang ZJ, 2009, CIRC J, V73, P1228, DOI 10.1253/circj.CJ-08-1091
NR 9
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 318
EP 319
DI 10.4070/kcj.2017.0066
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400006
PM 28567081
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JS
   Han, KR
   Moon, KW
   Jeon, DW
   Shin, DH
   Kim, JS
   Park, DW
   Kang, HJ
   Kim, J
   Bae, JW
   Hur, SH
   Kim, BO
   Choi, D
   Gwon, HC
   Kim, HS
AF Jang, Jae-Sik
   Han, Kyoo-Rok
   Moon, Keon-Woong
   Jeon, Dong Woon
   Shin, Dong-Ho
   Kim, Jung-Sun
   Park, Duk-Woo
   Kang, Hyun-Jae
   Kim, Juhan
   Bae, Jang-Whan
   Hur, Seung-Ho
   Kim, Byung Ok
   Choi, Donghoon
   Gwon, Hyeon-Cheol
   Kim, Hyo-Soo
TI The Current Status of Percutaneous Coronary Intervention in Korea -Based
   on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI)
   Registry-
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Registry
ID ASSOCIATION TASK-FORCE; FRACTIONAL FLOW RESERVE; DRUG-ELUTING STENTS;
   ELEVATION MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; CARDIOVASCULAR
   ANGIOGRAPHY; CARDIAC-CATHETERIZATION; ST-ELEVATION;
   PERFORMANCE-MEASURES; SOCIETY
AB Background and Objectives: Although several multicenter registries have evaluated percutaneous coronary intervention (PCI) procedures in Korea, those databases have been limited by non-standardized data collection and lack of uniform reporting methods. We aimed to collect and report data from a standardized database to analyze PCI procedures throughout the country.
   Materials and Methods: Both clinical and procedural data, as well as clinical outcomes data during hospital stay, were collected based on case report forms that used a standard set of 54 data elements. This report is based on 2014 Korean PCI registry cohort data.
   Results: A total of 92 hospitals offered data on 44967 PCI procedures. The median age was 66.0 interquartile range 57.0-74.0 years, and 70.3% were men. Thirty-eight percent of patients presented with acute myocardial infarction and one-third of all PCI procedures were performed in an urgent or emergency setting. Non-invasive stress tests were performed in 13.9% of cases, while coronary computed tomography angiography was used in 13.7% of cases prior to PCI. Radial artery access was used in 56.1% of all PCI procedures. Devices that used PCI included drug-eluting stent, plain old balloon angioplasty, drug-eluting balloon, and bare-metal stent (around 91%, 19%, 6%, and 1% of all procedures, respectively). The incidences of in-hospital death, non-fatal myocardial infarction, and stroke were 2.3%, 1.6% and 0.2%, respectively.
   Conclusion: These data may provide an overview of the current PCI practices and in-hospital outcomes in Korea and could be used as a foundation for developing treatment guidelines and nationwide clinical research.
C1 [Jang, Jae-Sik] Univ Inje, Busan Paik Hosp, Coll Med, Div Cardiol, Busan, South Korea.
   [Han, Kyoo-Rok] Hallym Univ, Kangdong Sacred Heart Hosp, Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, St Vincents Hosp, Div Cardiol, Suwon, South Korea.
   [Jeon, Dong Woon] Ilsan Hosp, Natl Hlth Insurance Serv, Div Cardiol, Goyang, South Korea.
   [Shin, Dong-Ho; Kim, Jung-Sun; Choi, Donghoon] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
   [Park, Duk-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea.
   [Kang, Hyun-Jae; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Kim, Juhan] Chonnam Natl Univ Hosp, Heart Ctr, Div Cardiol, Gwangju, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Daegu, South Korea.
   [Kim, Byung Ok] Univ Inje, Sanggye Paik Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
   [Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Heart Vasc & Stroke Inst, Seoul, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM hyosoo@snu.ac.kr
FU Korean Society of Cardiology (KSC); Koran Society of Interventional
   Cardiology (KSIC)
FX This study was co-sponsored by the Korean Society of Cardiology (KSC)
   and Koran Society of Interventional Cardiology (KSIC). Authors
   acknowledge the contribution of Dr. Byung-Hee Oh (Chairman, Board of
   Directors, KSC in 2015-2016) and Dr. Tae-Noon Ahn (Chairman, Board of
   Directors, KSIC in 2015-2016) who initiated the KPCI registry project in
   2015.
CR Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133
   Anderson HV, 2002, J AM COLL CARDIOL, V39, P1096, DOI 10.1016/S0735-1097(02)01733-3
   Bangalore S, 2014, INT J CARDIOL, V175, P108, DOI 10.1016/j.ijcard.2014.04.269
   Banning AP, 2015, HEART, V101, P1, DOI 10.1136/heartjnl-2015-307821
   Bashore TM, 2012, J AM COLL CARDIOL, V59, P2221, DOI 10.1016/j.jacc.2012.02.010
   Dattilo PB, 2012, J AM COLL CARDIOL, V60, P2337, DOI 10.1016/j.jacc.2012.08.990
   De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
   Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966
   del Blanco BG, 2014, REV ESP CARDIOL, V67, P1013, DOI 10.1016/j.rec.2014.08.005
   Grech ED, 2003, BRIT MED J, V326, P1080, DOI 10.1136/bmj.326.7398.1080
   Hahn JY, 2013, J AM COLL CARDIOL, V62, P1654, DOI 10.1016/j.jacc.2013.07.041
   Harnek J, 2013, SCAND CARDIOVASC J, V47, P1, DOI 10.3109/14017431.2013.780389
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013
   Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804
   Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036
   Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275
   Kim KH, 2016, KOREAN CIRC J, V46, P324, DOI 10.4070/kcj.2016.46.3.324
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099
   Lee PH, 2016, JACC-CARDIOVASC INTE, V9, P530, DOI 10.1016/j.jcin.2015.11.016
   Lee SH, 2016, AM J CARDIOL, V117, P1582, DOI 10.1016/j.amjcard.2016.02.030
   Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622
   Nallamothu BK, 2014, CIRCULATION, V129, P926, DOI 10.1161/01.cir.0000441966.31451.3f
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005
   Pothineni NV, 2016, J AM COLL CARDIOL, V67, P732, DOI 10.1016/j.jacc.2015.11.042
   Sim DS, 2010, J CARDIOL, V56, P1, DOI 10.1016/j.jjcc.2010.04.002
   Yan BP, 2009, HEART LUNG CIRC, V18, P184, DOI 10.1016/j.hlc.2008.10.005
   Zeymer U, 2005, Z KARDIOL, V94, P392, DOI 10.1007/s00392-005-0233-2
NR 30
TC 18
Z9 18
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 328
EP 340
DI 10.4070/kcj.2017.0071
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400008
PM 28567083
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SE
   Lee, HY
   Cho, HJ
   Choe, WS
   Kim, H
   Choi, JO
   Jeon, ES
   Kim, MS
   Kim, JJ
   Hwang, KK
   Chae, SC
   Baek, SH
   Kang, SM
   Choi, DJ
   Yoo, BS
   Kim, KH
   Park, HY
   Cho, MC
   Oh, BH
AF Lee, Sang Eun
   Lee, Hae-Young
   Cho, Hyun-Jai
   Choe, Won-Seok
   Kim, Hokon
   Choi, Jin Oh
   Jeon, Eun-Seok
   Kim, Min-Seok
   Kim, Jae-Joong
   Hwang, Kyung-Kuk
   Chae, Shung Chull
   Baek, Sang Hong
   Kang, Seok-Min
   Choi, Dong-Ju
   Yoo, Byung-Su
   Kim, Kye Hun
   Park, Hyun-Young
   Cho, Myeong-Chan
   Oh, Byung-Hee
TI Clinical Characteristics and Outcome of Acute Heart Failure in Korea:
   Results from the Korean Acute Heart Failure Registry (KorAHF)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; acute heart failure; Mortality; Guideline adherence;
   Quality of health care; Treatment outcome
ID ACUTE MYOCARDIAL-INFARCTION; MULTICENTER COHORT; EUROPEAN-SOCIETY;
   RATIONALE; MORTALITY; DESIGN; HOSPITALIZATIONS; EPIDEMIOLOGY;
   ASSOCIATION; PREDICTORS
AB Background and Objectives: The burden of heart failure has increased in Korea. This registry aims to evaluate demographics, clinical characteristics, management, and long-term outcomes in patients hospitalized for acute heart failure (AHF).
   Subjects and Methods: We prospectively enrolled a total of 5625 consecutive subjects hospitalized for AHF in one of 10 tertiary university hospitals from March 2011 to February 2014. Descriptive statistics were used to determine the baseline characteristics of the study population and to compare them with those from other registries.
   Results: The mean age was 68.5 +/- 14.5 years, 53.2% were male, and 52.2% had de novo heart failure. The mean systolic and diastolic blood pressures were 131.2 +/- 30.3 mmHg and 78.6 +/- 18.8 mmHg at admission, respectively. The left ventricular ejection fraction was <= 40% in 60.5% of patients. lschemia was the most frequent etiology (37.6%) and aggravating factor (26.3%). Angiotensin converting enzyme inhibitors/ angiotensin receptor blockers, beta-blockers, and aldosterone antagonists were prescribed in 68.8%, 52.2%, and 46.6% of the patients at discharge, respectively. Compared with the previous registry performed in Korea a decade ago, extracorporeal membrane oxygenation (ECMO) and heart transplantation have been performed more frequently (ECMO 0.8% vs. 2.8%, heart transplantation 0.3% vs. 1.2%), and in-hospital mortality decreased from 7.6% to 4.8%. However, the total cost of hospital care increased by 40%, and one-year follow-up mortality remained high.
   Conclusion: While the quality of acute clinical care and AHF-related outcomes have improved over the last decade, the long-term prognosis of heart failure is still poor in Korea. Therefore, additional research is needed to improve long-term outcomes and implement cost-effective care.
C1 [Lee, Sang Eun; Lee, Hae-Young; Cho, Hyun-Jai; Choe, Won-Seok; Kim, Hokon; Oh, Byung-Hee] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Choi, Jin Oh; Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Min-Seok; Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Hwang, Kyung-Kuk; Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea.
   [Baek, Sang Hong] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnm, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea.
   [Kim, Kye Hun] Chonnam Natl Univ, Heart Res Ctr, Dept Internal Med, Gwangju, South Korea.
   [Park, Hyun-Young] Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, Cheongju, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM hylee612@snu.ac.kr
RI Oh, Byung-Hee/G-9875-2011; choi, jo/O-5940-2014
OI Oh, Byung-Hee/0000-0002-9945-4306; Kang, Seok-Min/0000-0001-9856-9227
FU Research of Korea Centers for Disease Control and Prevention
   [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00,
   2013-E63003-01, 2013-E63003-02, 2016-ER6303-00]
FX This work was supported by the Research of Korea Centers for Disease
   Control and Prevention [2010-E63003-00, 2011-E63002-00, 2012-E63005-00,
   2013-E63003-00, 2013-E63003-01, 2013-E63003-02, and 2016-ER6303-00].
CR Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028
   Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053
   Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165
   한성우, 2005, Korean Circulation Journal, V35, P357
   Chioncel O, 2011, AM HEART J, V162, P142, DOI 10.1016/j.ahj.2011.03.033
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80
   Farwell D, 2000, EUR HEART J, V21, P1246, DOI 10.1053/euhj.1999.1985
   Fonarow GC, 2007, AM HEART J, V154, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]
   Francis GS, 2014, J AM COLL CARDIOL, V64, P1775, DOI 10.1016/j.jacc.2014.07.978
   Ha KH, 2015, ENDOCRINOL METAB, V30, P142, DOI 10.3803/EnM.2015.30.2.142
   Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Jhun HJ, 2011, J KOREAN MED SCI, V26, P637, DOI 10.3346/jkms.2011.26.5.637
   Kook HY, 2014, AM J CARDIOL, V114, P1817, DOI 10.1016/j.amjcard.2014.09.019
   Lee HY, 2016, KOREAN J INTERN MED, V31, P277, DOI 10.3904/kjim.2015.043
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Maggioni AP, 2013, EUR J HEART FAIL, V15, P1173, DOI 10.1093/eurjhf/hft134
   McCullough PA, 2005, INT J CARDIOL, V102, P303, DOI 10.1016/j.ijcard.2004.10.008
   Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193
   Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489
   Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019
   West R, 2011, EUR J HEART FAIL, V13, P945, DOI 10.1093/eurjhf/hfr064
NR 27
TC 56
Z9 56
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 341
EP 353
DI 10.4070/kcj.2016.0419
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400009
PM 28567084
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, Y
   Kim, KH
   Kang, MG
   Ahn, JH
   Jang, JY
   Park, HW
   Koh, JS
   Park, JR
   Hwang, SJ
   Jeong, YH
   Hwang, JY
   Lee, HR
   Kwak, CH
AF Park, Yongwhi
   Kim, Kye Hwan
   Kang, Min Gyu
   Ahn, Jong-Hwa
   Jang, Jeong Yoon
   Park, Hyun Woong
   Koh, Jin-Sin
   Park, Jeong-Rang
   Hwang, Seok-Jae
   Jeong, Young-Hoon
   Hwang, Jin-Yong
   Lee, Hye Ryun
   Kwak, Choong Hwan
TI Antiplatelet Therapy Combinations and Thrombogenicity in Patients with
   Non-Valvular Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Platelet aggregation inhibitors; Blood platelets;
   Biomarker
ID SECONDARY PREVENTION; ORAL ANTICOAGULANTS; JAPANESE PATIENTS; ASPIRIN;
   WARFARIN; CLOPIDOGREL; STROKE; RISK; RIVAROXABAN; MECHANISMS
AB Background and objectives: Combination antiplatelet therapy reduces the risk of ischemic stroke compared with aspirin monotherapy in non-valvular atrial fibrillation (NVAF) patients. The underlying mechanism, however, remains unclear. In addition, the association between platelet inhibition and thrombogenicity in NVAF has not been evaluated.
   Subjects and methods: We randomized 60 patients with NVAF that were taking 100 mg of aspirin daily (>1 month) to adding 75 mg of clopidogrel daily (CLPD group), 100 mg of cilostazol twice daily (CILO group), or 1000 mg of omega-3 polyunsaturated fatty acid twice daily (PUFA group). Biomarkers (von Willebrand factor antigen [vWF:Ag], fibrinogen, D-dimper, and high-sensitivity C-reactive protein [hs-CRP]) and platelet reactivity (PR), which were the levels stimulated by adenosine diphosphate (ADP), thrombin-receptor agonist peptide, collagen, and arachidonic acid, were measured at baseline and 30-day follow-up.
   Results: Combination antiplatelet therapy significantly reduced vWF:Ag and fibrinogen levels (7.7 IU/dL, p=0.015 and 15.7 mg/dL, p=0.005, respectively), but no changes were found in D-dimer and hs-CRP levels. The CLPD and CILO groups showed fibrinogen and vWF:Ag level reductions (24.9 mg/dL, p=0.015 and 9.3 IU/dL, p=0.044, respectively), whereas the PUFA group did not show any differences in biomarkers. Irrespective of regimen, the changes in fibrinogen and vWF:Ag levels were mainly associated with the change in ADP-mediated PR (r=0.339, p=0.008 and r=0.322, p=0.012, respeCtively).
   Conclusion: In patients with NVAF, combination antiplatelet therapy showed reductions for vWF:Ag and fibrinogen levels, which may be associated with the inhibitory levels of ADP-mediated PR. The clinical implications of these findings need to be evaluated in future trials.
C1 [Park, Yongwhi; Ahn, Jong-Hwa; Jang, Jeong Yoon; Jeong, Young-Hoon; Kwak, Choong Hwan] Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, Dept Internal Med,Sch Med, Chang Won, South Korea.
   [Kim, Kye Hwan; Kang, Min Gyu; Park, Hyun Woong; Koh, Jin-Sin; Park, Jeong-Rang; Hwang, Seok-Jae; Hwang, Jin-Yong] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Internal Med, Jinju, South Korea.
   [Lee, Hye Ryun] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Lab Med, Jinju, South Korea.
RP Kwak, CH (corresponding author), Gyeongsang Natl Univ, Changwon Hosp, Sch Med, Dept Internal Med, 11 Samjeongja Ro, Chang Won 51472, South Korea.
EM cwakch@naver.com
RI Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
FU Kunil Pharmacy and the Institute of Health Sciences; Gyeongsang National
   University
FX This study was supported by a grant from Kunil Pharmacy and the
   Institute of Health Sciences, Gyeongsang National University. Kunil
   Pharmacy and Otsuka Korea provided the omega-3 polyunsaturated fatty
   acid (Omacor<SUP>(R)</SUP>) and cilostazol (Pletaal<SUP>(R)</SUP>),
   respectively.
CR Bassand JP, 2016, EUR HEART J, V37, P2882, DOI 10.1093/eurheartj/ehw233
   Choi JH, 2014, J STROKE CEREBROVASC, V23, pE215, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.011
   Chowdhury R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6698
   Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4
   Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301
   Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1
   Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082
   Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990
   Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   Jaremo P, 2013, PLATELETS, V24, P407, DOI 10.3109/09537104.2012.712168
   Kim D, 2013, EUR HEART J, V34, P2760, DOI 10.1093/eurheartj/eht185
   Kim IS, 2010, J THROMB THROMBOLYS, V30, P486, DOI 10.1007/s11239-010-0484-2
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Larson MK, 2008, THROMB HAEMOSTASIS, V100, P634, DOI 10.1160/TH08-02-0084
   Lee JH, 2010, EUR J NEUROL, V17, P434, DOI 10.1111/j.1468-1331.2009.02837.x
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   McFadyen JD, 2013, THROMB HAEMOSTASIS, V110, P859, DOI 10.1160/TH13-05-0379
   Moshfegh K, 2000, J AM COLL CARDIOL, V36, P699, DOI 10.1016/S0735-1097(00)00817-2
   Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236
   Park Y, 2016, TRENDS CARDIOVAS MED, V26, P321, DOI 10.1016/j.tcm.2015.08.002
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Sabir I, 2014, NAT REV CARDIOL, V11, P290, DOI 10.1038/nrcardio.2014.22
   Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8
   Siegbahn A, 2016, THROMB HAEMOSTASIS, V115, P921, DOI 10.1160/TH15-07-0529
   Son MK, 2016, KOREAN CIRC J, V46, P515, DOI 10.4070/kcj.2016.46.4.515
   Suzuki S, 2007, CIRC J, V71, P761, DOI 10.1253/circj.71.761
   Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4
   Wu N, 2015, CAN J CARDIOL, V31, P278, DOI 10.1016/j.cjca.2014.12.002
NR 30
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 366
EP 376
DI 10.4070/kcj.2016.0384
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400012
PM 28567087
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MJ
   Yoon, YE
   Park, JJ
   Kim, YK
   Chun, EJ
   Choi, SI
   Cho, GY
AF Kim, Min Jeong
   Yoon, Yeonyee E.
   Park, Jin Joo
   Kim, Yeo Koon
   Chun, Eun Ju
   Choi, Sang Il
   Cho, Goo-Young
TI Additive Role of Coronary Magnetic Resonance Angiography for the
   Evaluation of Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Magnetic resonance angiography
ID COMPUTED-TOMOGRAPHY; LIMITATIONS
AB Coronary magnetic resonance angiography (CMRA) allows a noninvasive assessment of the coronary anatomy without exposing the patients to radiation. It is also superior to coronary computed tomography angiography (CCTA) for the evaluation of luminal narrowing in heavily calcified coronary segments. We report a case with triple-vessel disease, but it could not be accurately assessed by CCTA because of calcification and lack of a significant perfusion defect or myocardial scarring on cardiac magnetic resonance imaging (MRI). However, whole-heart CMRA performed as part of the cardiac MRI protocol demonstrated significant triple-vessel disease with left main involvement, confirmed by subsequent invasive angiography with a fractional flow reserve measurement.
C1 [Kim, Min Jeong; Yoon, Yeonyee E.; Park, Jin Joo; Cho, Goo-Young] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Cardiol, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
   [Kim, Yeo Koon; Chun, Eun Ju; Choi, Sang Il] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Radiol, Seongnam, South Korea.
RP Yoon, YE (corresponding author), Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Cardiol, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM yeonyeeyoon@snubh.org
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2014R1A1A3051343]
FX This case report was supported by a Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT & Future Planning (NRF-2014R1A1A3051343).
CR Chung SY, 2010, AM J ROENTGENOL, V195, P356, DOI 10.2214/AJR.08.1839
   Kato S, 2010, J AM COLL CARDIOL, V56, P983, DOI 10.1016/j.jacc.2010.01.071
   Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116
   Schroeder S, 2008, EUR HEART J, V29, P531, DOI 10.1093/eurheartj/ehm544
   Schuijf JD, 2011, HEART, V97, P330, DOI 10.1136/hrt.2010.199224
   Yoon YE, 2014, KOREAN CIRC J, V44, P359, DOI 10.4070/kcj.2014.44.6.359
NR 6
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 409
EP 412
DI 10.4070/kcj.2016.0288
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400017
PM 28567092
OA Green Published
DA 2021-04-22
ER

PT J
AU Sohn, DW
   Kim, HK
   Kim, YJ
   Oh, S
   Seong, MW
   Park, SS
AF Sohn, Dae-Won
   Kim, Hyung-Kwan
   Kim, Yong-Jin
   Oh, Seil
   Seong, Moon-Woo
   Park, Sung-Sup
TI Cardiomyopathies with Mixed and Inapparent Morphological Features in
   Cardiac Troponin I3 Mutation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertrophic cardiomyopathy; Left ventricular non-compaction;
   Restrictive cardiomyopathy; TNNI3
ID FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; PROTEIN-C GENE; CLINICAL
   EXPRESSION; ALPHA-TROPOMYOSIN; DISEASE GENE; ACTIN
AB The fact that different types of cardiomyopathies can be manifested by the same sarcomere protein gene mutation in a single family is well known. However, mixed features of different types of cardiomyopathies in a single patient have not been well appreciated. We identified a novel mutation in cardiac troponin 13 (Arg186Gly) in the present case, and two of the family members showed mixed morphologic features of hypertrophic cardiomyopathy and left ventricular non-compaction. Moreover, both the features of cardiomyopathies were not apparent for each type of cardiomyopathy. In the patient's family, four other members had unexpected deaths before the age of 30.
C1 [Sohn, Dae-Won; Kim, Hyung-Kwan; Kim, Yong-Jin; Oh, Seil] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Seong, Moon-Woo; Park, Sung-Sup] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.
RP Sohn, DW (corresponding author), Seoul Natl Univ, Cardiovasc Ctr, Dept Internal Med, Div Cardiol,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM dwsohn@snu.ac.kr
RI Oh, Seil/J-5539-2012; Kim, Hyung-Kwan/R-8375-2019
OI Oh, Seil/0000-0002-2504-9615; Park, Sung Sup/0000-0003-3754-4848; Seong,
   Moon-Woo/0000-0003-2954-3677
CR BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438
   GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I
   Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379
   Kokado H, 2000, CIRCULATION, V102, P663, DOI 10.1161/01.CIR.102.6.663
   Menon SC, 2008, CLIN GENET, V74, P445, DOI 10.1111/j.1399-0004.2008.01062.x
   Mogensen J, 2004, J AM COLL CARDIOL, V44, P2315, DOI 10.1016/j.jacc.2004.05.088
   Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336
   Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460
   Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750
   Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221
   THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X
   WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603
   WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434
   Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031
NR 14
TC 5
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 413
EP 417
DI 10.4070/kcj.2016.0302
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400018
PM 28567093
OA Green Published
DA 2021-04-22
ER

PT J
AU Gunay, N
   Ocal, L
   Aksoy, S
   Baktir, AO
   Keser, N
AF Gunay, Nuran
   Ocal, Lutfi
   Aksoy, Sukru
   Baktir, Ahmet Oguz
   Keser, Nurgul
TI A Giant Isolated Cardiac Hydatid Cyst in the Interventricular Septum
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Gunay, Nuran; Ocal, Lutfi; Aksoy, Sukru; Keser, Nurgul] Istanbul Hlth Sci Univ, Umraniye Res & Training Hosp, Dept Cardiol, Istanbul, Turkey.
   [Baktir, Ahmet Oguz] Kayseri Res & Training Hosp, Kayseri, Turkey.
   [Keser, Nurgul] Univ Sakarya, Fac Med, Dept Cardiol, Sakarya, Turkey.
RP Gunay, N (corresponding author), Sokak Cumba Home Club Sitesi 8 B Blok Daire 10, TR-34775 Istanbul, Turkey.
EM drnurankara2000@yahoo.com
OI baktir, ahmet oguz/0000-0003-3359-1487
CR Abhishek Vijayakumar, 2012, Asian Cardiovasc Thorac Ann, V20, P747, DOI 10.1177/0218492312460774
   CACOUB P, 1991, ARCH MAL COEUR VAISS, V84, P1857
   Kahlfuss S, 2016, HEART, V102, P1348, DOI 10.1136/heartjnl-2016-309350
   Zobel C, 2006, CLIN RES CARDIOL, V95, P600, DOI 10.1007/s00392-006-0428-1
NR 4
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 418
EP 419
DI 10.4070/kcj.2016.0248
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400019
PM 28567094
OA Green Published
DA 2021-04-22
ER

PT J
AU Woo, JS
   Chung, H
   Kim, WS
   Kim, W
AF Woo, Jong Shin
   Chung, Hyemoon
   Kim, Woo Shik
   Kim, Weon
TI Embolic Myocardial Infarction in a Patient with Massive Pulmonary
   Thromboembolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Woo, Jong Shin; Chung, Hyemoon; Kim, Woo Shik; Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM mylovekw@hanmail.net
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 420
EP 421
DI 10.4070/kcj.2016.0260
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400020
PM 28567095
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Han, JH
   Park, JH
   Song, IC
AF Lee, Jae-Hwan
   Han, Ji Hye
   Park, Jae-Hyeong
   Song, Ik-Chan
TI Invasive Aspergillosis of the Abdominal Aorta with Multiple Peripheral
   Embolic Lesions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Jae-Hwan; Han, Ji Hye; Park, Jae-Hyeong; Song, Ik-Chan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med, Daejeon, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Lee, Jae-Hwan/0000-0002-6561-7760; Park, Jae-Hyeong/0000-0001-7035-286X
CR Silva ME, 2000, CLIN INFECT DIS, V31, P1144, DOI 10.1086/317467
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2017
VL 47
IS 3
BP 422
EP 423
DI 10.4070/kcj.2016.0358
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZX
UT WOS:000402950400021
PM 28567096
OA Green Published
DA 2021-04-22
ER

PT J
AU Fukui, H
   Chiba, A
   Miyazaki, T
   Takano, H
   Ishikawa, H
   Omori, T
   Mochiuzki, N
AF Fukui, Hajime
   Chiba, Ayano
   Miyazaki, Takahiro
   Takano, Haruko
   Ishikawa, Hiroyuki
   Omori, Toyonori
   Mochiuzki, Naoki
TI Spatial Allocation and Specification of Cardiomyocytes during Zebrafish
   Embryogenesis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Embryo development; Cardiac differentiation; Cardiomyocyte; Cardiac
   progenitor cell; Cilia.
ID LEFT-RIGHT ASYMMETRY; CONGENITAL HEART-DISEASE; PRIMARY CILIARY
   DYSKINESIA; RIGHT AXIS DETERMINATION; KUPFFERS VESICLE; ENDODERM
   FORMATION; CARDIAC DEVELOPMENT; CELL-MIGRATION; RETINOIC ACID; FIELD
AB Incomplete development and severe malformation of the heart result in miscarriage of embryos because of its malfunction as a pump for circulation. During cardiogenesis, development of the heart is precisely coordinated by the genetically-primed program that is revealed by the sequential expression of transcription factors. It is important to investigate how spatial allocation of the heart containing cardiomyocytes and other mesoderm-derived cells is determined. In addition, the molecular mechanism underlying cardiomyocyte differentiation still remains elusive. The location of ectoderm-, mesoderm-, and endoderm-derived organs is determined by their initial allocation and subsequent mutual cell-cell interactions or paracrine-based regulation. In the present work, we provide an overview of cardiac development controlled by the germ layers and discuss the points that should be uncovered in future for understanding cardiogenesis.
C1 [Fukui, Hajime; Chiba, Ayano; Miyazaki, Takahiro; Takano, Haruko; Ishikawa, Hiroyuki; Mochiuzki, Naoki] Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
   [Omori, Toyonori] Natl Ctr Child Hlth & Dev, Management Off, Tokyo, Japan.
   [Mochiuzki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst, AMED CREST, Osaka, Japan.
RP Mochiuzki, N (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cell Biol, Res Inst, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM nmochizu@ri.ncvc.go.jp
RI Fukui, Hajime/AAG-2004-2020
OI Fukui, Hajime/0000-0002-7652-2222
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [15H01221] Funding Source: KAKEN
CR Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002
   Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027
   Begemann G, 2001, DEVELOPMENT, V128, P3081
   Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8
   Clay H, 2016, DEV BIOL, V418, P157, DOI 10.1016/j.ydbio.2016.06.024
   D'Amico LA, 1997, BIOCHEM CELL BIOL, V75, P563, DOI 10.1139/bcb-75-5-563
   Damerla RR, 2014, BIRTH DEFECTS RES C, V102, P115, DOI 10.1002/bdrc.21067
   Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426
   Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901
   Driever W, 1996, J CLIN INVEST, V97, P1788, DOI 10.1172/JCI118608
   Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663
   Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014
   Guner-Ataman B, 2013, DEVELOPMENT, V140, P1353, DOI 10.1242/dev.088351
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449
   Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573
   Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185
   Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038
   Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301
   Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI
   Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772
   Kupperman E, 2000, NATURE, V406, P192
   Lahvic JL, 2013, DEV BIOL, V384, P166, DOI 10.1016/j.ydbio.2013.10.009
   Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028
   Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504
   Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436
   Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033
   Marques SR, 2009, DEV BIOL, V328, P472, DOI 10.1016/j.ydbio.2009.02.010
   Matsui T, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00027
   Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108
   McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7
   McGrath J, 2003, CURR OPIN GENET DEV, V13, P385, DOI 10.1016/S0959-437X(03)00091-1
   Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805
   Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107
   MOLLER JH, 1994, CIRCULATION, V89, P923, DOI 10.1161/01.CIR.89.2.923
   Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753
   Okabe N, 2008, DEV DYNAM, V237, P3602, DOI 10.1002/dvdy.21730
   Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061
   Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567
   Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2
   Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038
   Regan L, 2000, BEST PRACT RES CL OB, V14, P839, DOI 10.1053/beog.2000.0123
   Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983
   Reiter JF, 2001, DEV BIOL, V234, P330, DOI 10.1006/dbio.2001.0259
   Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe
   Roxo-Rosa M, 2015, BIOL OPEN, V4, P1356, DOI 10.1242/bio.014076
   Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581
   Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434
   Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002
   Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752
   STAINIER DYR, 1993, DEVELOPMENT, V119, P31
   Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018
   Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494
   Tong YF, 2016, GENE, V588, P86, DOI 10.1016/j.gene.2016.04.061
   Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
   Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004
   Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243
   Yuan SL, 2015, CURR BIOL, V25, P556, DOI 10.1016/j.cub.2014.12.051
   Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011
   Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094
NR 61
TC 1
Z9 1
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 160
EP 167
DI 10.4070/kcj.2016.0280
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100002
PM 28382067
OA Green Published
DA 2021-04-22
ER

PT J
AU Li, YW
   Li, YM
   Hon, Y
   Wan, QL
   He, RL
   Wang, ZZ
   Zhao, CH
AF Li, Yun-Wei
   Li, Yan-Ming
   Hon, Yan
   Wan, Qi-Lin
   He, Rui-Li
   Wang, Zhi-Zhong
   Zhao, Cui-Hua
TI AT1 Receptor Modulator Attenuates the Hypercholesterolemia-Induced
   Impairment of the Myocardial lschemic Post-Conditioning Benefits
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE AT1 receptor blocker; lschemia-reperfusion injury; Azilsartan;
   myocardial infarction
ID ANGIOTENSIN-II; RAT-HEART; REPERFUSION INJURY; PRESSURE-OVERLOAD;
   AZILSARTAN; BLOCKER; ACTIVATION; RESTORES; KINASE; CARDIOPROTECTION
AB Background and Objectives: lschemic post-conditioning (PostC) has been demonstrated as a novel strategy to harness nature's protection against myocardial ischemia-reperfusion (I/R). Hypercholesterolemia (HC) has been reported to block the effect of PostC on the heart. Angiotensin II type-1 (AT1) modulators have shown benefits in myocardial ischemia. The present study investigates the effect of a novel inhibitor of AT1, azilsartan in PostC of the heart of normocholesterolemic (NC) and HC rats.
   Materials and Methods: HC was induced by the administration of high-fat diet to the animals for eight weeks. Isolated Langendorff's perfused NC and HC rat hearts were exposed to global ischemia for 30 min and reperfusion for 120 min. I/R-injury had been assessed by cardiac hemodynamic parameters, myocardial infarct size, release of tumor necrosis factor-alpha troponin I, lactate dehydrogenase, creatine kinase, nitrite in coronary effluent, thiobarbituric acid reactive species, a reduced form of glutathione, superoxide anion, and left ventricle collagen content in normal and HC rat hearts.
   Results: Azilsartan post-treatment and six episodes of PostC (10 sec each) afforded cardioprotection against I/R-injury in normal rat hearts. PostC protection against I/R-injury was abolished in HC rat hearts. Azilsartan prevented the HC-mediated impairment of the beneficial effects of PostC in I/R-induced myocardial injury, which was inhibited by L-N5-(1-Iminoethyl)pornithinehydrochloride, a potent inhibitor of endothelial nitric oxide synthase (eNOS).
   Conclusion: Azilsartan treatment has attenuated the HC-induced impairment of beneficial effects of PostC in I/R-injury of rat hearts, by specifically modulating eNOS. Azilsartan may be explored further in I/R-myocardial injury, both in NC and HC conditions, with or without PostC.
C1 [Li, Yun-Wei; Li, Yan-Ming; Hon, Yan; Wan, Qi-Lin; He, Rui-Li; Wang, Zhi-Zhong; Zhao, Cui-Hua] Henan Univ Huaihe Hosp, Dept Cardiol, 8 Bao Gong Hu North Rd, Kaifeng 450000, Henan, Peoples R China.
RP Li, YM (corresponding author), Henan Univ Huaihe Hosp, Dept Cardiol, 8 Bao Gong Hu North Rd, Kaifeng 450000, Henan, Peoples R China.
EM drliyanming86@hotmail.com
CR [Anonymous], 2012, SUMM BAS DEC SBD EDA
   Badalzadeh R, 2014, J PHYSIOL SCI, V64, P393, DOI 10.1007/s12576-014-0333-8
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bopassa JC, 2006, CARDIOVASC RES, V69, P178, DOI 10.1016/j.cardiores.2005.07.014
   Carroll MA, 2015, AM J HYPERTENS, V28, P664, DOI 10.1093/ajh/hpu201
   Ferrario CM, 2002, AM J MED SCI, V323, P17, DOI 10.1097/00000441-200201000-00004
   Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024
   Huisamen B, 2011, MOL CELL BIOCHEM, V349, P21, DOI 10.1007/s11010-010-0656-6
   Iwai M, 2007, AM J HYPERTENS, V20, P579, DOI 10.1016/j.amjhyper.2006.12.010
   Iwanami J, 2015, J AM SOC HYPERTENS, V9, P250, DOI 10.1016/j.jash.2015.01.010
   JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X
   Jivraj N, 2015, ANAESTHESIA, V70, P598, DOI 10.1111/anae.12974
   Kansal SK, 2015, N-S ARCH PHARMACOL, V388, P635, DOI 10.1007/s00210-015-1105-6
   Khan MAH, 2014, CARDIOVASC DRUG THER, V28, P313, DOI 10.1007/s10557-014-6530-0
   Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019
   Li KY, 2015, ACTA CARDIOL, V70, P67, DOI 10.1080/AC.70.1.3064595
   Matsumoto S, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-30
   Miura S, 2014, J RENIN-ANGIO-ALDO S, V15, P7, DOI 10.1177/1470320313482170
   Nakamura Y, 2013, BIOL PHARM BULL, V36, P1326, DOI 10.1248/bpb.b13-00194
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Parikh V, 1999, MOL CELL BIOCHEM, V199, P1, DOI 10.1023/A:1006930011622
   Sato T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/536510
   Sgarra L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088542
   Skorska A, 2015, J CELL MOL MED, V19, P1975, DOI 10.1111/jcmm.12574
   Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832
   Wu N, 2015, BIOCHEM BIOPH RES CO, V458, P148, DOI 10.1016/j.bbrc.2015.01.084
   Wu N, 2014, MOL MED REP, V10, P2517, DOI 10.3892/mmr.2014.2566
   Xu TY, 2015, INT J CLIN EXP PATHO, V8, P530
   Yang JT, 2015, J CARDIOVASC PHARM, V65, P349, DOI 10.1097/FJC.0000000000000202
   Zaman AKMT, 2013, J CARDIOVASC PHARM, V62, P381, DOI 10.1097/FJC.0b013e31829f0c1b
NR 30
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 182
EP 192
DI 10.4070/kcj.2015.0295
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100008
PM 28382073
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, ZY
   Duan, ZX
   Yu, T
   Xu, JM
   Liu, L
AF Yang, Zhaoyun
   Duan, Zhongxin
   Yu, Tian
   Xu, Junmei
   Liu, Lei
TI Inhibiting Cytochrome C Oxidase Leads to Alleviated Ischemia Reperfusion
   Injury
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE lschemia-reperfusion injury; Cytochrome C oxidase; Mitochondria;
   Myocardial infarction
ID HYDROGEN-SULFIDE; COMPLEX IV; ISCHEMIA/REPERFUSION; HEART;
   CARDIOMYOCYTES; DECREASES; MUTATIONS; PROTECTS; GENE
AB Background and Objectives: The overall purpose of this study was to investigate the role of cytochrome C oxidase (CcO) in preventing ischemia reperfusion-induced cardiac injury through gaseous signaling molecule pathways.
   Materials and Methods: We used CcO inhibitor, potassium cyanide (KCN) to mimic the pre-treatment of gaseous signaling molecules in a global ischemia/reperfusion (IR) injury model in rats. Intracellular reactive oxygen species (ROS) was determined by measuring mitochondrial H2O2 and mitochondrial complex activity.
   Results: KCN pre-treatment led to decreased infarction area after IR injury and improved cardiac function. KCN pre-treated group challenged with IR injury was associated with reduced ROS production through inhibition of activity and not downregulation of CcO expression. In addition, KCN pre-treatment was associated with enhanced expression and activity of mitochondrial antioxidase, suggesting the role of CcO in regulating IR injury through oxidative stress.
   Conclusion: KCN pre-treatment reduced the severity of IR injury. The potential mechanism could be increased endogenous anti-oxidase activity and consequently, the enhanced clearance of ROS.
C1 [Yang, Zhaoyun; Xu, Junmei; Liu, Lei] Cent S Univ, Xiang Ya Hosp 2, Dept Anesthesia, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.
   [Duan, Zhongxin] Univ South China, Dept Anesthesiol, Affiliated Hosp 2, Hengyang, Peoples R China.
   [Yu, Tian] Zunyi Med Coll, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China.
RP Liu, L (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Dept Anesthesia, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.
EM lei_liull@sina.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81370254]; Research Foundation of the Health
   and Family Planning Commision of Hunna Province [132015-028]
FX This study was supported by National Natural Science Foundation of China
   (grant no. 81370254) and Research Foundation of the Health and Family
   Planning Commision of Hunna Province (grant no. 132015-028).
CR Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Booth EA, 2008, J CARDIOVASC PHARM, V52, P228, DOI 10.1097/FJC.0b013e3181824d59
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Burkard N, 2010, CIRCULATION, V122, P1588, DOI 10.1161/CIRCULATIONAHA.109.933630
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013
   Groening P, 2011, JPEN-PARENTER ENTER, V35, P249, DOI 10.1177/0148607110383040
   Guo W, 2013, ACTA PHARMACOL SIN, V34, P1284, DOI 10.1038/aps.2013.127
   Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001
   Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200
   Sun WH, 2012, BIOCHEM BIOPH RES CO, V421, P164, DOI 10.1016/j.bbrc.2012.03.121
   Tanaka-Esposito C, 2012, TRANSL RES, V160, P207, DOI 10.1016/j.trsl.2012.01.024
   TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554
   Vogt S, 2013, SHOCK, V40, P407, DOI 10.1097/SHK.0b013e3182a51a06
   Whittington HJ, 2013, CARDIOVASC DRUG THER, V27, P5, DOI 10.1007/s10557-012-6425-x
   Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com
NR 21
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 193
EP 200
DI 10.4070/kcj.2016.0137
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100009
PM 28382074
OA Green Published
DA 2021-04-22
ER

PT J
AU Shim, MS
   Jun, TG
   Yang, JH
   Park, PW
   Cho, YH
   Kang, S
   Huh, J
   Song, JY
AF Shim, Man-shik
   Jun, Tae-Gook
   Yang, Ji-Hyuk
   Park, Pyo Won
   Cho, Yang Hyun
   Kang, Seok
   Huh, June
   Song, Jin Young
TI Clinical Outcomes after Anatomic Repair Including Hemi-Mustard Operation
   in Patients with Congenitally Corrected Transposition of the Great
   Arteries
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Anatomic repair; Congenitally corrected TGA; Congenital heart defect
ID DOUBLE-SWITCH OPERATION; BIVENTRICULAR REPAIR; ATRIOVENTRICULAR
   DISCORDANCE; RIGHT VENTRICLE; ANASTOMOSIS; ANOMALIES; DEFECTS; RISK;
   SIZE
AB Background and Objectives: The aims of this study were to determine the early and late outcomes of anatomic repair of congenitally corrected transposition of the great arteries (ccTGA) and to evaluate effectiveness of the hemi-Mustard procedure.
   Subjects and Methods: We conducted a retrospective, single-center study of patients who underwent anatomic repair for ccTGA between July 1996 and December 2013. Sixteen patients were included in the study. The median age at the time of the operation was 3.5 years (range: 0.5-29.7), and the median body weight was 13.3 kg (range: 5.8-54). The median follow-up duration was 7.7 years (range: 0.2-17.4).
   Results: Atrial switch was achieved using the Mustard procedure in 12 patients (hemi-Mustard procedure in 11) or the Senning procedure in four patients. The ventriculoarterial procedure was performed using the Rastelli procedure in 11 patients and arterial switch in five patients. Six patients underwent tricuspid valvuloplasty. The survival rate was 93.8 +/- 6.10/0. The rate of freedom from reoperation at 5 years was 92.3 +/- 7.40/0 in the Rastelli group. All patients except one were New York Heart Association class I. All patients except one had mild tricuspid regurgitation.
   Conclusion: Anatomic repair can be performed with a low risk of in-hospital mortality. The hemi-Mustard strategy for selected patients is one solution for reducing early mortality and morbidity, and long-term complications such as venous pathway stenosis or sinus node dysfunction.
C1 [Shim, Man-shik; Jun, Tae-Gook; Yang, Ji-Hyuk; Park, Pyo Won; Cho, Yang Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 81 Irwon Ro, Seoul 06351, South Korea.
   [Kang, Seok; Huh, June; Song, Jin Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.
RP Jun, TG (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 81 Irwon Ro, Seoul 06351, South Korea.
EM tgjunsmc@gmail.com
OI Huh, June/0000-0003-4523-9632
CR Barron David J, 2011, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V14, P109, DOI 10.1053/j.pcsu.2011.01.005
   Biliciler-Denktas G, 2001, J THORAC CARDIOV SUR, V122, P234, DOI 10.1067/mtc.2001.115241
   DiBardino DJ, 2004, CARDIOL YOUNG, V14, P330, DOI 10.1017/S1047951104003154
   Gales MG, 2009, ANN THORAC SURG, V88, P1952
   Hanley FL, 1996, J THORAC CARDIOV SUR, V112, P1148
   Hiramatsu T, 2012, EUR J CARDIO-THORAC, V42, P1004, DOI 10.1093/ejcts/ezs118
   Hoashi T, 2013, ANN THORAC SURG, V96, P611, DOI 10.1016/j.athoracsur.2013.03.095
   Horer J, 2008, THORAC CARDIOV SURG, V56, P391, DOI 10.1055/s-2008-1038665
   Hosseinpour AR, 2004, ANN THORAC SURG, V77, P2163, DOI 10.1016/j.athoracsur.2003.11.046
   Hraska V, 2005, J THORAC CARDIOV SUR, V129, P182, DOI 10.1016/j.jtcvs.2004.02.046
   Khairy P, 2004, CARDIOL YOUNG, V14, P284, DOI 10.1017/S1047951104003063
   Malhotra SP, 2011, J THORAC CARDIOV SUR, V141, P162, DOI 10.1016/j.jtcvs.2010.08.063
   Murtuza B, 2011, J THORAC CARDIOV SUR, V142, P1348, DOI 10.1016/j.jtcvs.2011.08.016
   Myers PO, 2014, J THORAC CARDIOV SUR, V147, P576, DOI 10.1016/j.jtcvs.2013.10.014
   Myers PO, 2013, ANN THORAC SURG, V96, P603, DOI 10.1016/j.athoracsur.2013.03.096
   Quinn DW, 2008, J THORAC CARDIOV SUR, V135, P1137, DOI 10.1016/j.jtcvs.2008.02.017
   Raisky O, 2012, EUR J CARDIO-THORAC, V42, P685, DOI 10.1093/ejcts/ezs209
   Reddy VM, 1998, J THORAC CARDIOV SUR, V116, P21, DOI 10.1016/S0022-5223(98)70238-7
   Sharma R, 2009, J THORAC CARDIOV SUR, V137, P404, DOI 10.1016/j.jtcvs.2008.09.048
   Shin'oka T, 2007, J THORAC CARDIOV SUR, V133, P1318, DOI 10.1016/j.jtcvs.2006.11.063
   Sojak V, 2012, EUR J CARDIO-THORAC, V42, P680, DOI 10.1093/ejcts/ezs055
   VanArsdell GS, 1996, J THORAC CARDIOV SUR, V112, P1143, DOI 10.1016/S0022-5223(96)70127-7
   Wallis GA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-22
   Winlaw DS, 2005, CIRCULATION, V111, P405, DOI 10.1161/01.CIR.0000153355.92687.FA
   YAGIHARA T, 1994, J THORAC CARDIOV SUR, V107, P351, DOI 10.1016/S0022-5223(94)70079-6
   Yang JH, 2010, ANN THORAC SURG, V89, P1821, DOI 10.1016/j.athoracsur.2010.03.009
   Yeh T, 1999, J THORAC CARDIOV SUR, V117, P1190, DOI 10.1016/S0022-5223(99)70259-X
NR 27
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 201
EP 208
DI 10.4070/kcj.2016.0194
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100010
PM 28382075
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, KL
   Lee, HY
   Yu, JJ
   Lee, JY
   Han, MY
   Kim, KY
   Huh, J
AF Yoon, Kyung Lim
   Lee, Hae Yong
   Yu, Jeong Jin
   Lee, Jae Young
   Han, Mi Young
   Kim, Ki Yong
   Huh, June
TI Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and
   High-Dose "IVIG-SN" Therapy for Pediatric Patients with Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Pediatric; Immunoglobulins; intravenous; Coronary
   artery disease
ID NATIONWIDE SURVEY; FEATURES; HEART
AB Background and Objectives: Intravenous immunoglobulin-SN (IVIG-SN) is a new human immunoglobulin product. Its safety is ensured by pathogen-elimination steps comprising solvent/detergent treatment and a nanofiltration process. This multicenter clinical study was designed to evaluate the efficacy and safety of combined aspirin and high-dose IVIG-SN therapy in pediatric patients with Kawasaki disease(KD).
   Subjects and Methods: We evaluated coronary artery lesions (CALs) at 2 and 7 weeks after administering IVIG-SN; total fever duration; and variations in erythrocyte sedimentation rate, N-terminal pro B-type natriuretic peptide or B-type natriuretic peptide, and creatine kinase-myocardial band level before and after treatment with IVIG-SN (2 g/kg). Adverse events were monitored.
   Results: Forty-five patients were enrolled, three of whom were excluded according to the exclusion criteria; the other 42 completed the study. The male:female ratio was 0.91:1, and the mean age was 29.11 +/- 17.23 months. The mean fever duration before IVIG-SN treatment was 6.45 +/- 1.30 days. Although most patients had complete KD (40 patients, 90.91%), four had atypical KD (9.09%). After IVIG-SN treatment, one patient (2.38%) had CALs, which was significantly lower than the incidence reported previously (15%) (p=0.022), but not significantly different from recent data (5%). There were no serious adverse events, though 28 patients (63.64%) had mild adverse events. Three adverse drug reactions occurred in 2 patients (eczema, anemia, and increased eosinophil count), all of which were transient.
   Conclusion: IVIG-SN treatment in patients with KD was safe and effective.
C1 [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Lee, Hae Yong] Yonsei Univ, Wonju Severance Christian Hosp, Dept Pediat, Wonju, South Korea.
   [Yu, Jeong Jin] Univ Ulsan, Div Pediat Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Lee, Jae Young] Catholic Univ Korea, Dept Pediat, Coll Med, Div Cardiol,Seoul St Marys Hosp, Seoul, South Korea.
   [Han, Mi Young] Kyung Hee Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Kim, Ki Yong] Green Cross Co, Seoul, South Korea.
   [Huh, June] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Pediat,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Huh, J (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Pediat,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM herzhuh@gmail.com
OI Huh, June/0000-0003-4523-9632
FU Green Cross Corporation
FX This study was sponsored by Green Cross Corporation.
CR Ahn SY, 1990, J KOREAN PEDIAT SOC, V33, P1380
   Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328
   FUJIWARA H, 1978, PEDIATRICS, V61, P100
   FUKUSHIGE J, 1994, ACTA PAEDIATR, V83, P1057, DOI 10.1111/j.1651-2227.1994.tb12985.x
   KATO H, 1982, AM J CARDIOL, V49, P1758, DOI 10.1016/0002-9149(82)90256-9
   Kawasaki T, 1967, Arerugi, V16, P178
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   KURIBAYASHI S, 1989, RADIOLOGY, V172, P629, DOI 10.1148/radiology.172.3.2772168
   Lee DB, 1985, J CATH COLL, V38, P8
   Melish M E, 1996, Pediatr Rev, V17, P153, DOI 10.1542/pir.17-5-153
   Mori Masaaki, 2004, Mod Rheumatol, V14, P361, DOI 10.1007/s10165-004-0324-3
   NAGASHIMA M, 1987, J PEDIATR-US, V110, P710, DOI 10.1016/S0022-3476(87)80007-0
   NAKASHIMA L, 1990, CLIN PHARMACY, V9, P755
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   박민지, 2009, Clinical and Experimental Pediatrics, V52, P1161
   Shim SY, 2002, J KOREAN PEDIAT SOC, V45, P1273
   Stiehm ER, 2006, J PEDIATR-US, V148, P6, DOI 10.1016/j.jpeds.2005.09.019
   Taubert KA, 1997, PROG PEDIATR CARDIOL, V6, P181, DOI 10.1016/S1058-9813(97)00188-4
   Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10
   YANAGAWA H, 1987, PEDIATRICS, V80, P58
NR 20
TC 1
Z9 1
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 209
EP 214
DI 10.4070/kcj.2016.0139
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100011
PM 28382076
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Lee, HC
   Choe, JC
   Kim, SP
   Park, TS
   Ahn, J
   Park, JS
   Lee, HW
   Oh, JH
   Choi, JH
   Cha, KS
AF Park, Jong Ha
   Lee, Han Cheol
   Choe, Jeong Cheon
   Kim, Sang-Pil
   Park, Tae Sik
   Ahn, Jinhee
   Park, Jin Sup
   Lee, Hye Won
   Oh, Jun-Hyok
   Choi, Jung Hyun
   Cha, Kwang Soo
TI Safety and Efficacy of an Aortic Arch Stent Graft with Window-Shaped
   Fenestration for Supra-Aortic Arch Vessels: an Experimental Study in
   Swine
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Aneurysm; thoracic aortic; Aortic diseases; Animal
   experimentation
ID THORACIC ENDOVASCULAR REPAIR; OPEN SURGICAL REPAIR; ANEURYSMS;
   PLACEMENT; INTERVENTIONS; DISSECTION; SURGERY
AB Background and Objectives: Thoracic endovascular aortic repair exhibits limitations in cases where the aortic pathology involves the aortic arch. We had already developed a fenestrated aortic stent graft (FASG) with a preloaded catheter for aortic pathology involving the aortic arch. FASG was suitable for elective cases.
   Materials and Methods: An aortic arch stent graft with a window-shaped fenestration (FASG-W) for supra-aortic arch vessels is suitable for emergent cases. This study aims to test a FASG-W for supra-aortic arch vessels and to perform a preclinical study in swine to evaluate the safety and efficacy of this device. Six FASG-Ws with 1 preloaded catheter were advanced through the iliac artery in 6 swine. The presence of endoleak and the patency and deformity of the grafts were examined with computed tomography (CT) at 4 weeks postoperatively. A postmortem examination was performed at 8 weeks. The mean procedure time for FASG-W was 27.15 +/- 4.02 minutes. The mean time for the selection of the right carotid artery was 5.72 +/- 0.72 minutes.
   Results: Major adverse events were not observed in any of the 6 pigs who survived for 8 weeks. For the FASG-W, no endoleaks, no disconnection, and no occlusion of the stent grafts were observed in the CT findings or the postmortem gross findings.
   Conclusion: The procedure with the FASG-W was able to be performed safely in a relatively short procedure time and involved an easy technique. The FASG-W was found to be safe and convenient for use in this preclinical study of swine.
C1 [Park, Jong Ha; Lee, Han Cheol; Choe, Jeong Cheon; Park, Tae Sik; Ahn, Jinhee; Park, Jin Sup; Lee, Hye Won; Oh, Jun-Hyok; Choi, Jung Hyun; Cha, Kwang Soo] Pusan Natl Univ, Coll Med, Pusan Natl Univ Hosp, Div Cardiol,Dept Internal Med,Med Res Inst, Busan, South Korea.
   [Kim, Sang-Pil] Pusan Natl Univ, Coll Med, Pusan Natl Univ Hosp, Dept Thorac Surg,Med Res Inst, Busan, South Korea.
RP Lee, HC (corresponding author), Pusan Natl Univ Hosp, Div Cardiol, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea.
EM glaraone@hanmail.net
CR Ahanchi SS, 2012, J ENDOVASC THER, V19, P226, DOI 10.1583/11-3770MR.1
   Al-Nouri O, 2011, ANN VASC SURG, V25, p982e1
   Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004
   DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601
   Grabenwoger M, 2012, EUR J CARDIO-THORAC, V42, P17, DOI 10.1093/ejcts/ezs107
   Greenberg R, 2000, J VASC SURG, V31, P147, DOI 10.1016/S0741-5214(00)70076-0
   Inoue K, 1999, CIRCULATION, V100, P316
   Kim SP, 2015, J KOREAN MED SCI, V30, P426, DOI 10.3346/jkms.2015.30.4.426
   Lee CJ, 2013, J VASC SURG, V57, P1269, DOI 10.1016/j.jvs.2012.10.124
   Lee KN, 2012, KOREAN CIRC J, V42, P360, DOI 10.4070/kcj.2012.42.5.360
   Lee SH, 2012, KOREAN J RADIOL, V13, P476, DOI 10.3348/kjr.2012.13.4.476
   Makaroun MS, 2008, J VASC SURG, V47, P912, DOI 10.1016/j.jvs.2007.12.006
   Narayan P, 2011, EUR J CARDIO-THORAC, V40, P869, DOI 10.1016/j.ejcts.2011.01.010
   Nienaber CA, 2012, EUR HEART J, V33, P26, DOI 10.1093/eurheartj/ehr186
   Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408
   Schneider DB, 2003, J VASC SURG, V38, P855, DOI 10.1016/S0741-5214(03)01024-3
   Shah AA, 2012, ANN THORAC SURG, V94, P1394, DOI 10.1016/j.athoracsur.2012.05.072
   Sun ZH, 2009, KOREAN J RADIOL, V10, P285, DOI 10.3348/kjr.2009.10.3.285
   Ullery BW, 2012, J VASC SURG, V56, P1510, DOI 10.1016/j.jvs.2012.05.086
   Wei G, 2009, EUR J VASC ENDOVASC, V37, P560, DOI 10.1016/j.ejvs.2009.01.017
   Zhang H, 2012, ANN VASC SURG, V26, P454, DOI 10.1016/j.avsg.2011.09.004
NR 21
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 215
EP 221
DI 10.4070/kcj.2016.0286
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100012
PM 28382077
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SM
   Tripathy, DR
   Park, SW
   Park, B
   Son, JW
   Lee, JW
   Youn, YJ
   Ahn, SG
   Ahn, MS
   Kim, JY
   Yoo, BS
   Lee, SH
   Yoon, J
AF Kim, Su-Min
   Tripathy, Dipti Ranjan
   Park, Sang Wook
   Park, Bonil
   Son, Jung-Woo
   Lee, Jun-Won
   Youn, Young Jin
   Ahn, Sung-Gyun
   Ahn, Min Soo
   Kim, Jang-Young
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Yoon, Junghan
TI Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic
   Patients Undergoing Percutaneous Coronary Intervention in the Era of
   Newer-Generation Drug-Eluting Stents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Chronic kidney disease; Diabetes mellitus; Drug-eluting stent;
   Percutaneous coronary intervention; Prognosis
ID MELLITUS; TRIALS
AB Background and Objectives: Chronic kidney disease (CKD) is known to be a major adverse predictor in diabetes mellitus (DM) patients undergoing percutaneous coronary intervention (PCI). It is expected that the use of newer-generation drug-eluting stents (DES) would improve clinical outcomes in these patients. We evaluated the impact of CKD on clinical outcomes in diabetic patients undergoing PCI using newer-generation DES in a real-world setting.
   Subjects and Methods: A total of 887 patients who underwent PCI with newer-generation DES and who had a history of DM or HbA1c > 6.5% at the time of hospitalization were analyzed. These patients were divided into groups without CKD (n=549) and with CKD (n=338). Among survivors at discharge, a patient-oriented composite outcome (POCO) including all-cause mortality, myocardial infarction (MI), and revascularization was evaluated, together with a device-oriented composite outcome (DOCO) including cardiac death, target vessel-related MI, and target lesion revascularization at a follow-up period of one year.
   Results: The incidence of POCO (5.4% vs. 14.0%, log-rank p < 0.001) and DOCO (1.1% vs. 4.1%, log-rank p < 0.001) was higher in patients with CKD. According to multivariate analysis, which was adjusted for baseline differences in demographic, clinical, and angiographic factors, the presence of CKD was an independent predictor of POCO (hazard ratio [HR]: 1.82, 95% confidence interval [CI]: 1.07 to 3.12), but not of DOCO (HR 2.08, 95% CI: 0.69-6.28).
   Conclusion: In DM patients, CKD is an independent and powerful predictor of patient-related outcomes, but not of device-related outcomes in the era of newer-generation DES.
C1 [Kim, Su-Min; Tripathy, Dipti Ranjan; Park, Sang Wook; Park, Bonil; Son, Jung-Woo; Lee, Jun-Won; Youn, Young Jin; Ahn, Sung-Gyun; Ahn, Min Soo; Kim, Jang-Young; Yoo, Byung-Su; Lee, Seung-Hwan; Yoon, Junghan] Yonsei Univ, Div Cardiol, Dept Internal Med, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Youn, YJ (corresponding author), Yonsei Univ, Div Cardiol, Dept Internal Med, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM younyj@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704;
   Son, Jung-Woo/0000-0002-1790-3228
CR Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108
   Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132
   Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436
   Gruberg L, 2002, CATHETER CARDIO INTE, V55, P66, DOI 10.1002/ccd.10103
   Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
   Latif F, 2009, JACC-CARDIOVASC INTE, V2, P37, DOI 10.1016/j.jcin.2008.06.012
   Lepor NE, 2006, REV CARDIOVASC MED, V7, pS38
   Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20
   Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
   Nikolsky E, 2004, AM J CARDIOL, V94, P300, DOI 10.1016/j.amjcard.2004.04.023
   Piccolo R, 2015, JACC-CARDIOVASC INTE, V8, P1657, DOI 10.1016/j.jcin.2015.08.013
   Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wilson SR, 2004, DIABETES CARE, V27, P1137, DOI 10.2337/diacare.27.5.1137
NR 18
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 222
EP 230
DI 10.4070/kcj.2016.0312
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100013
PM 28382078
OA Green Published
DA 2021-04-22
ER

PT J
AU Cagirci, G
   Kucukseymen, S
   Yuksel, IO
   Bayar, N
   Koklu, E
   Guven, R
   Arslan, S
AF Cagirci, Goksel
   Kucukseymen, Selcuk
   Yuksel, Isa Oner
   Bayar, Nermin
   Koklu, Erkan
   Guven, Ramazan
   Arslan, Sakir
TI The Relationship between Vitamin D and Coronary Artery Ectasia in
   Subjects with a Normal C-Reactive Protein Level
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Vitamin D; Vitamin D deficiency; Coronary artery ectasia; Inflammation
ID CELL DISTRIBUTION WIDTH; CLINICAL-SIGNIFICANCE; OXIDATIVE STRESS;
   AORTIC-ANEURYSM; ASSOCIATION; SEVERITY; EXERCISE; MARKERS
AB Background and Objectives: Vitamin D is generally known to be closely related to inflammation. The effects of vitamin D on coronary artery disease (CAD) are not fully explained. Nowadays, coronary artery ectasia (CAE) cases are common and are regarded as being a kind of CAD. We aimed to investigate, in a case-control study, the relationship between vitamin D and CAE without an associated inflammatory process.
   Subject and Methods: This study population included 201 patients (CAE group, 121 males; mean age, 61.2 +/- 6.4 years) with isolated CAE; and 197 healthy individuals (control group, 119 males; mean age, 62.4 +/- 5.8 years), comprising the control group, who had normal coronary arteries. These participants concurrently underwent routine biochemical tests, tests for inflammatory markers, and tests for 25-OH vitamin D in whole-blood draws. These parameters were compared.
   Results:There are no statistical significance differences among the groups for basic clinical characteristics (p > 0.05). Inflammatory markers were recorded and compared to exclude any inflammatory process. All of them were similar, and no statistical significance difference was found. The average parathyroid hormone (PTH) level of patients was higher than the average PTH level in controls (41.8 +/- 15.1 pg/mL vs. 19.1 +/- 5.81 pg/mL; p < 0.001). Also, the average 25-OH vitamin D level of patients was lower than the average 25-OH vitamin D level of controls (14.5 +/- 6.3 ng/mL vs. 24.6 +/- 9.3 ng/mL; p < 0.001). In receiver operating characteristic curve analysis, the observed cut-off value for vitamin D between the control group and patients was 10.8 and 85.6% sensitivity and 75.2% specificity (area under the curve: 0.854, 95% confidence interval: 0.678-0.863).
   Conclusion: We found that there is an association between vitamin D and CAE in patients who had no inflammatory processes. Our study may provide evidence for the role of vitamin D as a non-inflammatory factor in the pathophysiology of CAE.
C1 [Cagirci, Goksel; Kucukseymen, Selcuk; Yuksel, Isa Oner; Bayar, Nermin; Koklu, Erkan; Arslan, Sakir] Antalya Educ & Res Hosp, Dept Cardiol, TR-07100 Antalya, Turkey.
   [Guven, Ramazan] Antalya Educ & Res Hosp, Dept Emergency Med, Antalya, Turkey.
RP Kucukseymen, S (corresponding author), Antalya Educ & Res Hosp, Dept Cardiol, TR-07100 Antalya, Turkey.
EM skucukseymen@gmail.com
RI koklu, erkan/AAE-8595-2020; arslan, sakir/A-3933-2017; koklu,
   erkan/AAD-1697-2019; Kucukseymen, Selcuk/Q-4135-2018
OI Kucukseymen, Selcuk/0000-0002-9757-3088
CR Bilik MZ, 2015, KOREAN CIRC J, V45, P386, DOI 10.4070/kcj.2015.45.5.386
   Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999
   Demir M, 2014, POSTEP KARDIOL INTER, V10, P238, DOI 10.5114/pwki.2014.46764
   Dogan A, 2008, CORONARY ARTERY DIS, V19, P559, DOI 10.1097/MCA.0b013e3283109079
   FALSETTI HL, 1976, CHEST, V69, P630, DOI 10.1378/chest.69.5.630
   Finkelstein A, 2005, ATHEROSCLEROSIS, V179, P353, DOI 10.1016/j.atherosclerosis.2004.10.020
   Giovannucci E, 2008, THERAPY, V6, P655
   Guo YL, 2014, CLIN LAB, V60, P199, DOI 10.7754/Clin.Lab.2013.130130
   HARTNELL GG, 1985, BRIT HEART J, V54, P392
   HOLICK MF, 1971, BIOCHEMISTRY-US, V10, P2799
   Isik T, 2012, CLIN APPL THROMB-HEM, V18, P441, DOI 10.1177/1076029612447678
   Izadpanah M, 2013, IMMUNOTHERAPY-UK, V5, P843, DOI [10.2217/IMT.13.84, 10.2217/imt.13.84]
   Ke CY, 2016, INT J MED SCI, V13, P147, DOI 10.7150/ijms.13746
   Koc F, 2011, CORONARY ARTERY DIS, V22, P306, DOI 10.1097/MCA.0b013e328346b864
   Koc F, 2010, CORONARY ARTERY DIS, V21, P445, DOI 10.1097/MCA.0b013e32833fd22b
   Kocaman SA, 2008, CORONARY ARTERY DIS, V19, P307, DOI 10.1097/MCA.0b013e328300427e
   Koli K, 2000, CELL GROWTH DIFFER, V11, P221
   Kota Sunil Kumar, 2011, Indian J Endocrinol Metab, V15 Suppl 4, pS395, DOI 10.4103/2230-8210.86985
   Kruger D, 1999, J AM COLL CARDIOL, V34, P1461, DOI 10.1016/S0735-1097(99)00375-7
   Lin CT, 2008, EURASIP J ADV SIG PR, V20, P2008
   Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012
   MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5
   Michos ED, 2009, FUTUR CARDIOL, V5, P15, DOI 10.2217/14796678.5.1.15
   Sata M, 2011, INFLAMM REGEN, V31, P245
   Tohari AM, 2016, CELL BIOCHEM FUNCT, V34, P82, DOI 10.1002/cbf.3167
   Turhan H, 2005, CORONARY ARTERY DIS, V16, P45, DOI 10.1097/00019501-200502000-00009
   Yalcin AA, 2015, CLIN APPL THROMB-HEM, V21, P229, DOI 10.1177/1076029613520488
   Yasar AS, 2007, CORONARY ARTERY DIS, V18, P451, DOI 10.1097/MCA.0b013e3282a30665
   Zittermann A, 2011, FUTUR CARDIOL, V7, P725, DOI [10.2217/fca.11.65, 10.2217/FCA.11.65]
NR 29
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 231
EP 237
DI 10.4070/kcj.2016.0198
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100014
PM 28382079
OA Green Published
DA 2021-04-22
ER

PT J
AU Ozbicer, S
   Ulucam, ZM
AF Ozbicer, Suleyman
   Ulucam, Zekiye Melek
TI Association Between Interleukin-18 Level and Left Ventricular Mass Index
   in Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Interleukin-18; Inflammation; Hypertension; Left ventricular hypertrophy
ID AMBULATORY BLOOD-PRESSURE; C-REACTIVE PROTEIN; SMOOTH-MUSCLE-CELLS;
   MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; EXPRESSION; HEALTHY; HEART;
   IL-18; PHARMACOKINETICS
AB Background and Objectives: In clinical trials, hypertensive patients tend to have higher interleukin-18 (IL-18) concentrations than normotensive groups, but the relationship between IL-18 and left ventricular hypertrophy (LVH), which is a marker of end-organ damage, is not well studied. We aimed to investigate the relationship between IL-18 and LVH in apparently healthy subjects free of clinically significant atherosclerotic disease.
   Subjects and Methods: We enrolled 198 subjects (102 women and 96 men) between May 2006 and March 2007, who were free of cardiovascular or immune diseases, but were suspected to have hypertension. Twenty-four-hour ambulatory blood pressure monitoring and two-dimensional echocardiography were performed. Lipid profiles, high-sensitivity CRP (hs-CRP), IL-18, and whole blood cell counts were measured for all subjects.
   Results: White blood cell count, hs-CRP, left ventricular mass, left ventricular mass index (LVMI), and IL-18 were higher in the hypertensive group than in the normotensive group (p=0.045, p=0.004, p < 0.0001, p=0.001, and p=0.017 respectively). Twenty-four hour day and night systolic and diastolic blood pressure averages were positively correlated with IL-18 level in the entire study population. In multivariate regression analysis, left ventricular mass index and hs-CRP level were independently associated with IL-18 level in both the hypertensive group and the entire study population (beta=0.154, beta=0.149 p=0.033, p=0.040 and beta=0.151, beta=0.155 p=0.036, p=0.032 respectively)
   Conclusion: We found that IL-18 level independently predicted LVMI in both the general population and in newly diagnosed hypertensive patients.
C1 [Ozbicer, Suleyman] Adana Numune Training & Res Hosp, Dept Cardiol, TR-01170 Adana, Turkey.
   [Ulucam, Zekiye Melek] Bakent Univ Hosp, Dept Cardiol, Ankara, Turkey.
RP Ozbicer, S (corresponding author), Adana Numune Training & Res Hosp, Dept Cardiol, TR-01170 Adana, Turkey.
EM suleymanozbicer@gmail.com
OI ozbicer, suleyman/0000-0002-2016-0672
CR Aso Y, 2003, DIABETES CARE, V26, P2622, DOI 10.2337/diacare.26.9.2622
   Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785
   Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004
   Blacher J, 2010, J HUM HYPERTENS, V24, P19, DOI 10.1038/jhh.2009.34
   Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2
   Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4
   Borekci A, 2016, KOREAN CIRC J, V46, P15, DOI 10.4070/kcj.2016.46.1.15
   Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185
   Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033
   Colston JT, 2007, BIOCHEM BIOPH RES CO, V354, P552, DOI 10.1016/j.bbrc.2007.01.030
   Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854
   Dehghani MR, 2016, KOREAN CIRC J, V46, P229, DOI 10.4070/kcj.2016.46.2.229
   Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350
   Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008
   Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727
   Gaborieau V, 2008, J HYPERTENS, V26, P1919, DOI 10.1097/HJH.0b013e32830c4368
   Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022
   Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013
   Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003
   Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d
   Mistry P, 2014, INT J CLIN PHARM TH, V52, P867, DOI 10.5414/CP202087
   O'Brien LC, 2014, MOL MED, V20, P221, DOI 10.2119/molmed.2014.00034
   Pickering TG, 2008, J AM SOC HYPERTENS, V2, P119, DOI 10.1016/j.jash.2008.04.002
   Rabkin SW, 2009, NAT CLIN PRACT CARD, V6, P192, DOI 10.1038/ncpcardio1453
   Rumantir MS, 2000, J HYPERTENS, V18, P717, DOI 10.1097/00004872-200018060-00009
   Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4
   Tak PP, 2006, EUR J DRUG METAB PH, V31, P109
   Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932
   Vilarrasa N, 2006, HORM METAB RES, V38, P507, DOI 10.1055/s-2006-949122
   Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004
NR 30
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 238
EP 244
DI 10.4070/kcj.2016.0351
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100015
PM 28382080
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Yun, BS
   Lee, S
   Jung, SY
   Choi, JY
   Kim, NK
AF Kim, Jung Yoon
   Yun, Bong-Sic
   Lee, Sunho
   Jung, Se Yong
   Choi, Jae Young
   Kim, Nam Kyun
TI Changes in Strain Pattern and Exercise Capacity after Transcatheter
   Closure of Atrial Septal Defects
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiopulmonary exercise tests; Atrial septal defect; Strain; Brain
   natriuretic peptide
ID LEFT-VENTRICULAR HYPERTROPHY; BRAIN NATRIURETIC PEPTIDE;
   PULMONARY-HYPERTENSION; ADULTS; IMPROVEMENT; DOPPLER; DISEASE; HEART
AB Background and Objectives: Assessment of left ventricle (LV) function by using strain and strain rate is popular in the clinical setting. However, the use of these echocardiographic tools in assessing right ventricle (RV) failure, and the manner in which they both reflect the functional capacity of the patient, remains poorly understood. This study aimed to investigate the change in exercise capacity and strain between before and (1 month) after the transcatheter closure of atrial septal defects (ASDs.).
   Subjects and Methods: Thirty patients who underwent transcatheter closure of ASD between May 2014 and June 2015 at the Division of Pediatric Cardiology, Severance Cardiovascular Hospital, were enrolled. We compared and analyzed the results of the following examinations, before and (1 month) after the procedure: echocardiography, cardiopulmonary exercise test (CPET), and N-terminal pro brain natriuretic peptide level.
   Results: There were no mortalities, and the male-to-female ratio was 1:2. The mean defect size was 22.3 +/- 4.9 mm; the mean ratio of pulmonary to systemic flow, 2.1+0.5; and the mean device size, 22.3 +/- 4.9 mm. Changes in global RV longitudinal (GRVL) strain and LV torsion were measured echocardiographically. Exercise capacity improved from 7.7 +/- 1.2 to 8.7 +/- 1.8 metabolic equivalents (p=0.001). These findings correlated to the change in GRVL strain (p=0.03).
   Conclusion: The average exercise capacity increased after device closure of ASD. The change in strain was evident on echocardiography, especially for GRVL strain and LV torsion. Further studies comparing CPET and strain in various patients may show increased exercise capacity in patients with improved RV function.
C1 [Kim, Jung Yoon; Lee, Sunho; Jung, Se Yong; Choi, Jae Young; Kim, Nam Kyun] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Pediat Cardiol,Dept Pediat,Congenital Heart D, Seoul, South Korea.
   [Yun, Bong-Sic] Natl Hlth Insurance Serv Ilsan Hosp, Dept Pediat, Goyang, South Korea.
RP Kim, NK (corresponding author), Severance Cardiovasc Hosp, Div Pediat Cardiol, Congenital Heart Dis Ctr, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM pednk@yuhs.ac
RI Jung, Yong/AAR-3286-2020
OI Jung, Yong/0000-0003-1337-563X
FU research fund of the Korean Society of Cardiology [201203-1]
FX This work was supported by the research fund of the Korean Society of
   Cardiology (201203-1).
CR Baur LHB, 2008, INT J CARDIOVAS IMAG, V24, P493, DOI 10.1007/s10554-008-9301-9
   Brochu MC, 2002, CIRCULATION, V106, P1821, DOI 10.1161/01.CIR.0000029924.90823.E0
   Buechel ERV, 2012, EUR HEART J, V33, P949, DOI 10.1093/eurheartj/ehr490
   Bussadori C, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-8
   Chen JH, 2007, CAN J CARDIOL, V23, P957, DOI 10.1016/S0828-282X(07)70857-7
   D'hooge J, 2003, CIRCULATION, V107, pE49, DOI 10.1161/01.CIR.0000055725.51783.4A
   Dong LL, 2009, INT J CARDIOVAS IMAG, V25, P479, DOI 10.1007/s10554-009-9458-x
   Elsheikh RG, 2013, J SAUDI HEART ASSOC, V25, P3, DOI 10.1016/j.jsha.2012.08.003
   Friedberg MK, 2009, EUR J ECHOCARDIOGR, V10, P585, DOI 10.1093/ejechocard/jep045
   Giardini A, 2004, J AM COLL CARDIOL, V43, P1886, DOI 10.1016/j.jacc.2003.10.067
   Gorcsan J, 2008, EUROPACE, V10, P80, DOI 10.1093/europace/eun222
   Kaminsky L A, 1998, J Cardiopulm Rehabil, V18, P438, DOI 10.1097/00008483-199811000-00006
   Kaya MG, 2014, ACTA CARDIOL, V69, P161, DOI 10.1080/AC.69.2.3017297
   Li XP, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-67
   Mertens LL, 2010, NAT REV CARDIOL, V7, P551, DOI 10.1038/nrcardio.2010.118
   Mooman-Smook J C, 2007, Cardiovasc J Afr, V18, P387
   Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X
   Nagaya N, 1998, AM HEART J, V136, P297, DOI 10.1053/hj.1998.v136.89729
   Pislaru C, 2005, EXPERT REV CARDIOVAS, V3, P1, DOI 10.1586/14779072.3.1.1
   Su CT, 2013, CHINESE J PHYSIOL, V56, P110, DOI 10.4077/CJP.2013.BAA086
   Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440
   Vitarelli A, 2006, EUR RESPIR J, V27, P268, DOI 10.1183/09031936.06.00072005
   Weber M, 2004, Z KARDIOL, V93, P209, DOI 10.1007/s00392-004-0042-z
   Wu ET, 2007, CATHETER CARDIO INTE, V69, P866, DOI 10.1002/ccd.21075
NR 24
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 245
EP 253
DI 10.4070/kcj.2016.0205
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100016
PM 28382081
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, TW
   Kim, SO
   Kim, MS
   Jang, SI
   Kim, SH
   Lee, SY
   Choi, EY
   Park, SJ
   Kwon, HW
   Lim, HB
AF Hwang, Tae Woong
   Kim, Sung Ook
   Kim, Moon Sun
   Jang, So Ick
   Kim, Seong Ho
   Lee, Sang Yun
   Choi, Eun Young
   Park, Su Jin
   Kwon, Hye Won
   Lim, Hyo Bin
TI Short-Term Change of Exercise Capacity in Patients with Pulmonary Valve
   Replacement after Tetralogy of Fallot Repair
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiopulmonary exercise test; Pulmonary valve replacement; Tetralogy of
   Fallot
ID CARDIOVASCULAR MAGNETIC-RESONANCE; CHRONIC HEART-FAILURE; ANAEROBIC
   THRESHOLD; SURGICAL REPAIR; RIGHT VENTRICLE; FOLLOW-UP; REGURGITATION;
   OUTCOMES; INSUFFICIENCY; IMPLANTATION
AB Background and Objectives: The aim of this study was to investigate the effect of pulmonary valve replacement (PVR) on exercise capacity and determine cardiopulmonary exercise (CPEX) parameters associated with improvement in right ventricle (RV) function.
   Subjects and Methods: We retrospectively analyzed CPEX and magnetic resonance imaging parameters in a total of 245 patients who underwent PVR from January 1998 to October 2015. In addition, we analyzed the characteristics of the patients who showed improved exercise capacity after PVR.
   Results: Twenty-eight patients met the inclusion criteria for the study. CPEX parameters after PVR showed no significant changes in all patients. However, baseline predicted peak oxygen uptake (VO2(peak)) (0/0) value was significantly lower in patients with significant improvement in exercise capacity after PVR, as compared to patients who showed decreased exercise capacity after PVR (60.83 +/- 10.28 vs. 75.81 +/- 13.83) (p=0.003). In addition, patients with improved exercise capacity showed a positive correlation between the change of right ventricular ejection fraction (RVEF) (0/0) and the change of anaerobic threshold (r=0.733, p=0.007); whereas, patients with decreased exercise capacity showed a negative correlation between the change of RVEF (0/0) and the change of predicted VO2(peak) (0/0) (r=-0.575, p=0.020).
   Conclusion: The importance of predicted VO2(peak) (0/0) (in evaluating exercise capacity differentiated from other CPEX variables. The change of anaerobic threshold and predicted VO2(peak) (0/0) might be a useful predictor of the change in RV function after PVR.
C1 [Hwang, Tae Woong; Kim, Sung Ook; Kim, Moon Sun; Jang, So Ick; Kim, Seong Ho; Lee, Sang Yun; Choi, Eun Young; Park, Su Jin; Kwon, Hye Won; Lim, Hyo Bin] Sejong Gen Hosp, Dept Pediat, 28 Hohyeon Ro 489 Beon Gil, Bucheon 14754, South Korea.
RP Jang, SI (corresponding author), Sejong Gen Hosp, Dept Pediat, 28 Hohyeon Ro 489 Beon Gil, Bucheon 14754, South Korea.
EM prelud15@korea.com
RI 권, 혜원/Q-1141-2019
CR Babu-Narayan SV, 2014, CIRCULATION, V129, P18, DOI 10.1161/CIRCULATIONAHA.113.001485
   Batra AS, 2012, AM HEART J, V163, P280, DOI 10.1016/j.ahj.2011.10.017
   Bouzas B, 2005, EUR HEART J, V26, P433, DOI 10.1093/eurheartj/ehi091
   BOVE EL, 1983, J THORAC CARDIOV SUR, V85, P691
   Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581
   DAVIS JA, 1985, MED SCI SPORT EXER, V17, P6
   Fredriksen PM, 2002, CARDIOL YOUNG, V12, P554, DOI 10.1017/S1047951102001002
   Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GAULTIER C, 1986, CHEST, V89, P561, DOI 10.1378/chest.89.4.561
   Gengsakul A, 2007, EUR J CARDIO-THORAC, V32, P462, DOI 10.1016/j.ejcts.2007.06.009
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Ghez O, 2007, EUR J CARDIO-THORAC, V31, P654, DOI 10.1016/j.ejcts.2006.12.031
   Guazzi M, 2012, CIRCULATION, V126, P2261, DOI 10.1161/CIR.0b013e31826fb946
   ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36
   IVY JL, 1980, J APPL PHYSIOL, V48, P523
   KATZ NM, 1982, CIRCULATION, V65, P403, DOI 10.1161/01.CIR.65.2.403
   Lee C, 2012, J AM COLL CARDIOL, V60, P1005, DOI 10.1016/j.jacc.2012.03.077
   Lee Jun-Sook, 2013, Korean J Pediatr, V56, P242, DOI 10.3345/kjp.2013.56.6.242
   Lurz P, 2010, AM J CARDIOL, V105, P721, DOI 10.1016/j.amjcard.2009.10.054
   LW S., 1996, EXERCISE GAS EXCHANG, P271
   MATSUMURA N, 1983, CIRCULATION, V68, P360, DOI 10.1161/01.CIR.68.2.360
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Oosterhof T, 2006, AM HEART J, V151, P265, DOI 10.1016/j.ahj.2005.03.058
   Sterrett LE, 2014, PEDIATR CARDIOL, V35, P1395, DOI 10.1007/s00246-014-0942-2
   SULLIVAN MJ, 1989, CIRCULATION, V79, P324, DOI 10.1161/01.CIR.79.2.324
   Therrien Judith, 2002, Cardiology Clinics, V20, P395
   Wasserman K, 1994, PRINCIPLES EXERCISE, P64
NR 30
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 254
EP 262
DI 10.4070/kcj.2016.0226
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100017
PM 28382082
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Kim, GH
   Park, HS
   Choi, JA
   Bae, JM
   Cho, U
AF Kim, Ji-Hoon
   Kim, Gee-Hee
   Park, Hoon-Suk
   Choi, Jin-A
   Bae, Jung-Min
   Cho, Uiju
TI Identification of a Novel GLA Mutation (L206 P) in a Patient with Fabry
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Galactosidase alpha mutation; Fabry disease; Hypertrophy cardiomyopathy
ID PREVALENCE; INVOLVEMENT; REGISTRY
AB We report a new alpha-Galactosidase A (alpha Gal-A) mutation in a 39-year-old Korean born, male Fabry disease patient. Fabry disease is a devastating, progressive inborn error of metabolism caused by X-linked genetic mutations. In this case, the first clinical symptom to occur was in childhood consisting of a burning pain originating in the extremities then radiating inwards to the limbs. This patient also stated to have ringing in his ears, angiokeratomas on his trunk, and cornea verticillata. He visited an outpatient cardiologist due to intermittent and atypical chest discomfort at the age of 39. Electrocardiographic and echocardiographic examination showed left ventricular hypertrophy. A physical examination revealed proteinuria without hematuria. The patient's plasma alpha Gal-A activity was markedly lower than the mean value of the controls. After genetic counseling and obtaining written informed consent, we identified one hemizygous mutation in exon 4 of galactosidase alpha, c.617T>C (p.Leu206 Pro). He was eventually diagnosed as having Fabry disease.
C1 [Kim, Ji-Hoon; Kim, Gee-Hee] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Cardiol,Dept Internal Med, 93 Jungbu Daero, Seoul 16247, South Korea.
   [Park, Hoon-Suk] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Nephrol,Dept Internal Med, Seoul, South Korea.
   [Choi, Jin-A] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.
   [Bae, Jung-Min] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Dermatol, Seoul, South Korea.
   [Cho, Uiju] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Pathol, Seoul, South Korea.
RP Kim, GH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Cardiol,Dept Internal Med, 93 Jungbu Daero, Seoul 16247, South Korea.
EM jiheekim@catholic.ac.kr
FU Sanofi Genzyme Korea's Rare Disease Diagnostic Support Program; Sanofi
   Genzyme Korea
FX We thank Sanofi Genzyme Korea for their scientific support. Enzyme assay
   and gene test were supported by Sanofi Genzyme Korea's Rare Disease
   Diagnostic Support Program.
CR Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105
   Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003
   DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375
   Eng CM, 2006, GENET MED, V8, P539, DOI 10.1097/01.gim.0000237866.70357.c6
   Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30
   Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132
   Inoue T, 2013, J HUM GENET, V58, P548, DOI 10.1038/jhg.2013.48
   Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034
   Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x
   Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249
   Naleschinski D, 2009, PAIN, V145, P10, DOI 10.1016/j.pain.2009.07.025
   Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031
   Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601
   Umeda Toshiko, 2015, Hum Genome Var, V2, P15044, DOI 10.1038/hgv.2015.44
   Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013
NR 15
TC 0
Z9 0
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 278
EP 281
DI 10.4070/kcj.2016.0321
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100020
PM 28382085
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, FP
   Lin, YJ
   Kuo, L
   Chen, SA
AF Chung, Fa-Po
   Lin, Yenn-Jiang
   Kuo, Ling
   Chen, Shih-Ann
TI Catheter Ablation of Ventricular Tachycardia/Fibrillation in a Patient
   with Right Ventricular Amyloidosis with Initial Manifestations Mimicking
   Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Amyloidosis; Arrhythmogenic right ventricular cardiomyopathy-dysplasia;
   Catheter ablation; Biopsy; Ventricular tachycardia
ID TACHYCARDIA
AB Differentiating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from other cardiomyopathies is clinically important but challenging. Although the modified Task Force Criteria can facilitate diagnosis of ARVD/C according to clinical manifestations, histopathological examination plays a pivotal role in excluding other diseases that can mimic ARVD/C. Here, we report a patient with amyloidosis that initially presented similarly to ARVD/C. The diagnosis was confirmed by endomyocardial biopsy, and catheter ablation eliminated the ventricular tachyarrhythmias through an epicardial approach.
C1 [Chung, Fa-Po; Lin, Yenn-Jiang; Kuo, Ling; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.
   [Chung, Fa-Po; Lin, Yenn-Jiang; Kuo, Ling; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.
   [Chung, Fa-Po; Lin, Yenn-Jiang; Kuo, Ling; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.
RP Chen, SA (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM epsachen@ms41.hinet.net
CR Chung FP, 2015, J CARDIOL, V65, P441, DOI 10.1016/j.jjcc.2014.12.023
   Chung FP, 2015, ACTA CARDIOL SIN, V31, P8, DOI 10.6515/ACS20140721A
   Frankel DS, 2012, J AM COLL CARDIOL, V59, P1529, DOI 10.1016/j.jacc.2012.01.026
   Marcus FI, 2010, EUR HEART J, V31, P806, DOI 10.1093/eurheartj/ehq025
   Mori Minako, 2014, Rinsho Ketsueki, V55, P450
   Sacher F, 2015, J CARDIOVASC ELECTR, V26, P464, DOI 10.1111/jce.12565
NR 6
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 282
EP 285
DI 10.4070/kcj.2016.0328
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100021
PM 28382086
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, HJ
   Kim, JH
   Hong, SJ
AF Joo, Hyung Joon
   Kim, Jong-Ho
   Hong, Soon Jun
TI Adipose Tissue-Derived Stem Cells for Myocardial Regeneration
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Adipose tissue; Stem cell; Myocardium; Regeneration
ID MESENCHYMAL STROMAL CELLS; LEFT-VENTRICULAR FUNCTION; UMBILICAL-CORD
   BLOOD; BONE-MARROW; IN-VITRO; INTERNATIONAL-SOCIETY; RAT MODEL;
   DIFFERENTIATION; HEART; TRANSPLANTATION
AB Over the past decade, stem cell therapy has been extensively studied for clinical application for heart diseases. Among various stem cells, adipose tissue-derived stem cell (ADSC) is still an attractive stem cell resource due to its abundance and easy accessibility. In vitro studies showed the multipotent differentiation potentials of ADSC, even differentiation into cardiomyocytes. Many pre-clinical animal studies have also demonstrated promising therapeutic results of ADSC. Furthermore, there were several clinical trials showing the positive results in acute myocardial infarction using ADSC. The present article covers the brief introduction, the suggested therapeutic mechanisms, application methods including cell dose and delivery, and human clinical trials of ADSC for myocardial regeneration.
C1 [Joo, Hyung Joon; Kim, Jong-Ho; Hong, Soon Jun] Korea Univ, Anam Hosp, Dept Cardiol, Ctr Cardiovasc, 73 Inchon Ro, Seoul 02841, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Ctr Cardiovasc, 73 Inchon Ro, Seoul 02841, South Korea.
EM psyche94@hanmail.net
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI14C0209]; Basic Science Research Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning, Republic of Korea [NRF-2014R1A2A1A11051998]
FX This research was supported by a grant of the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health & Welfare (Grant number:
   HI14C0209), and by a grant of the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Science, ICT & Future Planning (No. NRF-2014R1A2A1A11051998),
   Republic of Korea.
CR Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632
   Alt E, 2010, INT J CARDIOL, V144, P26, DOI 10.1016/j.ijcard.2009.03.124
   Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568
   Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006
   Chang Jui-Chih, 2011, J Stem Cells, V6, P21
   Chen LN, 2014, J CARDIOVASC TRANSL, V7, P651, DOI 10.1007/s12265-014-9585-1
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   D'Andrea F, 2008, TISSUE ENG PART C-ME, V14, P233, DOI 10.1089/ten.tec.2008.0108
   De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537
   De Siena R, 2010, EXP CELL RES, V316, P1804, DOI 10.1016/j.yexcr.2010.02.009
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253
   Follin B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-219
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Hao CN, 2014, AM J PHYSIOL-HEART C, V307, pH869, DOI 10.1152/ajpheart.00310.2014
   Henry TD, 2017, CATHETER CARDIO INTE, V89, P169, DOI 10.1002/ccd.26601
   Hong SJ, 2015, CATHETER CARDIO INTE, V86, pE38, DOI 10.1002/ccd.25566
   Hong SJ, 2014, CATHETER CARDIO INTE, V83, pE17, DOI 10.1002/ccd.24659
   Hong SJ, 2013, INT J CARDIOL, V164, P205, DOI 10.1016/j.ijcard.2011.06.128
   Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074
   Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065
   Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1
   Ishida O, 2015, TRANSL RES, V165, P631, DOI 10.1016/j.trsl.2014.12.005
   Ishii M, 2014, INT J CARDIOL, V175, P545, DOI 10.1016/j.ijcard.2014.06.034
   Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986
   Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim JH, 2015, BIOCHEM BIOPH RES CO, V468, P372, DOI 10.1016/j.bbrc.2015.10.083
   Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496
   Kroeze RJ, 2011, METHODS MOL BIOL, V702, P233, DOI 10.1007/978-1-61737-960-4_17
   Li CY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0066-5
   Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179
   Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269
   Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017
   Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847
   Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042
   Naaijkens BA, 2014, STEM CELL REV REP, V10, P389, DOI 10.1007/s12015-014-9502-7
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   Nicoletti GF, 2015, J CELL PHYSIOL, V230, P489, DOI 10.1002/jcp.24837
   Paul A, 2013, CELL BIOCHEM BIOPHYS, V67, P263, DOI 10.1007/s12013-011-9323-0
   Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016
   Perin EC, 2014, AM HEART J, V168, P88, DOI 10.1016/j.ahj.2014.03.022
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47
   Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Qayyum AA, 2012, REGEN MED, V7, P421, DOI [10.2217/RME.12.17, 10.2217/rme.12.17]
   Rasmussen JG, 2014, CELL TRANSPLANT, V23, P195, DOI 10.3727/096368912X659871
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006
   RODBELL M, 1964, J BIOL CHEM, V239, P753
   Sun CK, 2014, INT J CARDIOL, V173, P410, DOI 10.1016/j.ijcard.2014.03.015
   Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025
   Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426
   van Dijk A, 2011, STEM CELL RES, V7, P219, DOI 10.1016/j.scr.2011.06.003
   Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008
   Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495]
   Yang JJ, 2012, TOHOKU J EXP MED, V226, P231, DOI 10.1620/tjem.226.231
   Yeh TS, 2014, BIOMATERIALS, V35, P174, DOI 10.1016/j.biomaterials.2013.09.080
   Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14
   Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 70
TC 16
Z9 17
U1 0
U2 16
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 151
EP 159
DI 10.4070/kcj.2016.0207
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100001
PM 28382066
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SR
   Han, J
AF Lee, Sung Ryul
   Han, Jin
TI Mitochondria! Metabolic Inhibition and Cardioprotection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CYTOCHROME-C-OXIDASE; INJURY
C1 [Lee, Sung Ryul] Inje Univ Coll Med, Dept Integrated Biomed Sci, Cardiovasc & Metab Dis Ctr, Busan, South Korea.
   [Han, Jin] Inje Univ Coll Med, Dept Physiol, Cardiovasc & Metab Dis Ctr, Bokji Ro 75, Busan 47392, South Korea.
RP Han, J (corresponding author), Inje Univ Coll Med, Dept Physiol, Cardiovasc & Metab Dis Ctr, Bokji Ro 75, Busan 47392, South Korea.
EM phyhanj@inje.ac.kr
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) - Ministry of Education, Science, and
   Technology [2010-0020224]; Basic Science Research Program through the
   National Research Foundation of Korea (NRF) - Ministry of Education,
   Science, and Technology [2015R1A2A1A13001900, 2015R1D1A3A01015596]
FX This work was supported by the Priority Research Centers Program
   (2010-0020224) and by the Basic Science Research Program
   (2015R1A2A1A13001900 and 2015R1D1A3A01015596) through the National
   Research Foundation of Korea (NRF), funded by the Ministry of Education,
   Science, and Technology.
CR Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026
   Cebova M, 2016, PHYSIOL RES, V65, pS291, DOI 10.33549/physiolres.933441
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006
   Hausenloy DJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0588-8
   Heusch G, 2016, CIRC RES, V119, P676, DOI 10.1161/CIRCRESAHA.116.308736
   Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001
   Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021
   Yang ZY, 2017, KOREAN CIRC J, V47, P193, DOI 10.4070/kcj.2016.0137
NR 8
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 168
EP 170
DI 10.4070/kcj.2016.0401
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100003
PM 28382068
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, D
AF Choi, Donghoon
TI A Great Start, but the Long-Term Durability Remains to be Demonstrated
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID STENT-GRAFT; ANEURYSM
C1 [Choi, Donghoon] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp,Yonsei Univ Hlth Syst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp,Yonsei Univ Hlth Syst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cdhlyj@yuhs.ac
OI Choi, Donghoon/0000-0002-2009-9760
CR Inoue K, 1996, J THORAC CARDIOV SUR, V112, P1111, DOI 10.1016/S0022-5223(96)70115-0
   Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408
   Nishimura M, 2002, ANN THORAC SURG, V74, P1264, DOI 10.1016/S0003-4975(02)03763-3
   Park JH, 2017, KOREAN CIRC J, V47, P215, DOI 10.4070/kcj.2016.0286
   Saito N, 2005, J VASC SURG, V41, P206, DOI 10.1016/j.jvs.2004.11.030
   Starnes BW, 2012, J VASC SURG, V56, P601, DOI 10.1016/j.jvs.2012.02.011
   Wei G, 2009, EUR J VASC ENDOVASC, V37, P560, DOI 10.1016/j.ejvs.2009.01.017
   Yokoi Y, 2013, J THORAC CARDIOV SUR, V145, pS103, DOI 10.1016/j.jtcvs.2012.11.058
NR 8
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 171
EP 172
DI 10.4070/kcj.2017.0002
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100004
PM 28382069
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CH
   Choi, ES
   Cho, S
   Park, SJ
AF Lee, Chang-Ha
   Choi, Eun Seok
   Cho, Sungkyu
   Park, Su-Jin
TI Anatomic Repair Including Henri-Mustard in Congenitally Corrected
   Transposition of the Great Arteries: What We know and Still Need to Know
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VENTRICULAR SEPTAL-DEFECT; PULMONARY STENOSIS; SURGICAL-MANAGEMENT;
   EXPERIENCE; TRANSLOCATION
C1 [Lee, Chang-Ha; Choi, Eun Seok; Cho, Sungkyu] Sejong Gen Hosp, Dept Thorac & Cardiovasc Surg, 28 Hohyeon Ro,489 Beon Gil, Bucheon 14754, South Korea.
   [Park, Su-Jin] Sejong Gen Hosp, Dept Pediat, Bucheon, South Korea.
RP Lee, CH (corresponding author), Sejong Gen Hosp, Dept Thorac & Cardiovasc Surg, 28 Hohyeon Ro,489 Beon Gil, Bucheon 14754, South Korea.
EM leechha@gmail.com
CR Biliciler-Denktas G, 2001, J THORAC CARDIOV SUR, V122, P234, DOI 10.1067/mtc.2001.115241
   Gewillig M, 2014, HEART FAIL CLIN, V10, P105, DOI 10.1016/j.hfc.2013.09.010
   Hoashi T, 2013, ANN THORAC SURG, V96, P611, DOI 10.1016/j.athoracsur.2013.03.095
   Hraska V, 2005, J THORAC CARDIOV SUR, V129, P182, DOI 10.1016/j.jtcvs.2004.02.046
   Hraska V, 2011, EUR J CARDIO-THORAC, V40, P1227, DOI 10.1016/j.ejcts.2011.01.077
   Hsu KH, 2016, EUR J CARDIO-THORAC, V49, P522, DOI 10.1093/ejcts/ezv148
   ILBAWI MN, 1990, J THORAC CARDIOV SUR, V100, P410
   Kreutzer C, 2000, J THORAC CARDIOV SUR, V120, P211, DOI 10.1067/mtc.2000.108163
   Kwak JG, 2010, J THORAC CARDIOV SUR, V139, P1652, DOI 10.1016/j.jtcvs.2009.09.041
   Mainwaring RD, 2013, OPER TECH CARDIOTHOR, V18, P171
   Metton O, 2010, EUR J CARDIO-THORAC, V38, P728, DOI 10.1016/j.ejcts.2010.03.065
   Morell VO, 2005, ANN THORAC SURG, V79, P2089, DOI 10.1016/j.athoracsur.2004.11.059
   Murtuza B, 2011, J THORAC CARDIOV SUR, V142, P1348, DOI 10.1016/j.jtcvs.2011.08.016
   Raisky O, 2012, EUR J CARDIO-THORAC, V42, P685, DOI 10.1093/ejcts/ezs209
   Shim MS, 2017, KOREAN CIRC J, V47, P201, DOI 10.4070/kcj.2016.0194
NR 15
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 173
EP 175
DI 10.4070/kcj.2017.0001
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100005
PM 28382070
OA Green Published
DA 2021-04-22
ER

PT J
AU Ryu, JK
   Lee, IH
AF Ryu, Jae Kean
   Lee, In Hee
TI Impact of Chronic Kidney Disease in Patients Undergoing Percutaneous
   Coronary Intervention: Improved but Not Solved
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARDIOVASCULAR-DISEASE; NEPHROPATHY; CANDIDATES
C1 [Ryu, Jae Kean] Catholic Univ Daegu, Dept Internal Med, Div Cardiol, Sch Med, 33 Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
   [Lee, In Hee] Catholic Univ Daegu, Dept Internal Med, Div Nephrol, Sch Med, Daegu, South Korea.
RP Ryu, JK (corresponding author), Catholic Univ Daegu, Dept Internal Med, Div Cardiol, Sch Med, 33 Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
EM jkryu@cu.ac.kr
CR Abe M, 2014, AM J CARDIOL, V114, P362, DOI 10.1016/j.amjcard.2014.05.009
   Kim SM, 2017, KOREAN CIRC J, V47, P222, DOI 10.4070/kcj.2016.0312
   Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209
   Muntner P, 2002, J AM SOC NEPHROL, V13
   Peng JR, 2017, KOREAN CIRC J, V47, P50, DOI 10.4070/kcj.2016.0093
   Reinecke H, 2005, CARDIOLOGY, V104, P24, DOI 10.1159/000086050
   Rubenstein MH, 2000, CIRCULATION, V102, P2966
   Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c
   Weiner DE, 2007, J MANAGE CARE PHARM, V13, pS1
   Zhu Zheng Bin, 2009, Cardiology, V112, P191, DOI 10.1159/000149571
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 176
EP 178
DI 10.4070/kcj.2017.0013
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100006
PM 28382071
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, JW
AF Han, Ji Whan
TI The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the
   Treatment of Kawasaki Disease: How Can We Predict Resistance to
   Intravenous Immunoglobulin Treatment of Kawasaki Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GAMMA-GLOBULIN; THERAPY; MODULATE; SYSTEM
C1 [Han, Ji Whan] Catholic Univ Korea, Dept Pediat, Yeouido St Marys Hosp, Coll Med, 10,63-Ro, Seoul 07345, South Korea.
RP Han, JW (corresponding author), Catholic Univ Korea, Dept Pediat, Yeouido St Marys Hosp, Coll Med, 10,63-Ro, Seoul 07345, South Korea.
EM hanji59@gmail.com
OI Han, Ji Whan/0000-0002-3024-0609
CR Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61
   Bonilla FA, 2016, ALLERGY ASTHMA PROC, V37, P426, DOI 10.2500/aap.2016.37.3987
   Burns JC, 2015, EXPERT REV CLIN IMMU, V11, P819, DOI 10.1586/1744666X.2015.1044980
   Chang LS, 2017, ONCOTARGET, V8, P2044, DOI 10.18632/oncotarget.13489
   Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034
   Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2
   Durongpisitkul K, 2003, PEDIATR CARDIOL, V24, P145, DOI 10.1007/s00246-002-0216-2
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   ElAdawy M, 2011, PEDIATR INFECT DIS J, V30, P141, DOI 10.1097/INF.0b013e3181f6fe2a
   Franco A, 2014, AUTOIMMUNITY, V47, P95, DOI 10.3109/08916934.2013.860524
   FURUSHO K, 1983, LANCET, V2, P1359
   Hamrock DJ, 2006, INT IMMUNOPHARMACOL, V6, P535, DOI 10.1016/j.intimp.2005.11.015
   Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805
   HSU CH, 1993, PEDIATR INFECT DIS J, V12, P509, DOI 10.1097/00006454-199306000-00010
   IMBACH P, 1981, LANCET, V1, P1228
   Katz U, 2007, AUTOIMMUN REV, V6, P257, DOI 10.1016/j.autrev.2006.08.011
   Kim BY, 2016, KOREAN CIRC J, V46, P542, DOI 10.4070/kcj.2016.46.4.542
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Lim Goh-Woon, 2010, Korean Circ J, V40, P507, DOI 10.4070/kcj.2010.40.10.507
   Marie I, 2017, REV MED INTERNE, V38, P312, DOI 10.1016/j.revmed.2016.10.390
   Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   Okuma Y, 2016, CIRC J, V80, P2376, DOI 10.1253/circj.CJ-16-0563
   ONCLEY JL, 1949, J AM CHEM SOC, V71, P541, DOI 10.1021/ja01170a048
   Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401
   Stein MR, 2015, LYMPHOSIGN J, V2, P21
   Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167434
   Yeo Y, 2009, EUR J PEDIATR, V168, P157, DOI 10.1007/s00431-008-0722-1
   Yoon KL, 2017, KOREAN CIRC J, V47, P209, DOI 10.4070/kcj.2016.0139
NR 33
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 179
EP 181
DI 10.4070/kcj.2017.0011
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100007
PM 28382072
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
   Cha, MJ
   Choi, EK
   Oh, S
AF Park, Chan Soon
   Cha, Myung-jin
   Choi, Eue-Keun
   Oh, Seil
TI Prognostic Implication of the QRS Axis and its Association with
   Myocardial Scarring in Patients with Left Bundle Branch Block
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bundle branch block; Electrocardiography; Electrophysiology; Prognosis
ID CARDIOVASCULAR MAGNETIC-RESONANCE; DEVIATION; CONDUCTION;
   QUANTIFICATION; CARDIOMYOPATHY
AB Background and Objectives: Left bundle branch block (LBBB) with left axis deviation (LAD) has a worse prognosis than LBBB with a normal axis, and myocardial dysfunction has been suggested as a cause of left axis deviation. This study investigated the prognostic significance of the QRS axis in patients with LBBB and analyzed its relationship with the amount of myocardial scarring.
   Subjects and Methods: A total of 829 patients were diagnosed with LBBB at Seoul National University Hospital from October 2004 to June 2014. Of these, 314 who were asymptomatic and had no previous history of cardiac disease were included in the present study. Myocardial scarring was calculated using the Selvester QRS scoring system, and LAD was defined as a QRS axis between -180 degrees and -30 degrees.
   Results: Of the total patients, 91 (29%) had LAD, and patients were followed for a median of 30 months. During follow-up, two patients were hospitalized for de novo heart failure, four had pacemaker implants, and 10 died. There was a significant inverse correlation between myocardial scar score and the QRS axis (r=-0.356, p<0.001). Patients with concomitant LAD had a higher rate of major cardiac adverse events compared with patients with a normal axis (5.50/0 vs. 1.30/0, log-rank p=0.010); the prognostic value was attenuated in multivariable analysis (hazard ratio 4.117; 95% confidence interval 0.955-17.743; p=0.058).
   Conclusion: Concomitant LAD is an indicator of poor prognosis for patients with LBBB and may be associated with greater myocardial scarring.
C1 [Park, Chan Soon; Cha, Myung-jin; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM seil@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014; Choi,
   Eue-Keun/K-3752-2019
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; 
CR BEACH TB, 1969, ANN INTERN MED, V70, P269, DOI 10.7326/0003-4819-70-2-269
   Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328
   DAVIS JA, 1985, MED SCI SPORT EXER, V17, P6
   DHINGRA RC, 1978, AM J CARDIOL, V42, P551, DOI 10.1016/0002-9149(78)90622-7
   GAULTIER C, 1986, CHEST, V89, P561, DOI 10.1378/chest.89.4.561
   HAFT JI, 1971, CIRCULATION, V43, P279, DOI 10.1161/01.CIR.43.2.279
   Lee SA, 2016, HEART VESSELS, V31, P1131, DOI 10.1007/s00380-015-0707-8
   LICHSTEIN E, 1979, AM J CARDIOL, V44, P239, DOI 10.1016/0002-9149(79)90311-4
   Loring Z, 2011, J ELECTROCARDIOL, V44, P544, DOI 10.1016/j.jelectrocard.2011.06.008
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   Miller WL, 2008, AM J CARDIOL, V101, P102, DOI 10.1016/j.amjcard.2007.07.056
   Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X
   Parharidis G, 1997, ACTA CARDIOL, V52, P295
   Patel PJ, 2013, AM J CARDIOL, V112, P390, DOI 10.1016/j.amjcard.2013.03.045
   PRYOR R, 1966, AM HEART J, V72, P391, DOI 10.1016/S0002-8703(66)80014-5
   Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010
   Strauss DG, 2011, HEART, V97, P357, DOI 10.1136/hrt.2010.210047
   Strauss DG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P327, DOI 10.1161/CIRCEP.108.798660
   Strauss DG, 2009, J ELECTROCARDIOL, V42, P85, DOI 10.1016/j.jelectrocard.2008.07.011
   WAGNER GS, 1982, CIRCULATION, V65, P342, DOI 10.1161/01.CIR.65.2.342
   YANO K, 1975, AM J CARDIOL, V35, P809, DOI 10.1016/0002-9149(75)90116-2
NR 21
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 263
EP 269
DI 10.4070/kcj.2016.0359
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100018
PM 28382083
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, JW
   Jang, MA
   Jang, SY
   Seo, SH
   Seong, MW
   Park, SS
   Ki, CS
   Kim, DK
AF Hwang, Ji-won
   Jang, Mi-Ae
   Jang, Shin Yi
   Seo, Soo Hyun
   Seong, Moon-Woo
   Park, Sung Sup
   Ki, Chang-Seok
   Kim, Duk-Kyung
TI Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3
   p.Arg145Trp Mutation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathies; TNNI3 mutation; Cardiomyopathy; hypertrophic;
   Cardiomyopathy; restrictive; Korean
ID CARDIAC TROPONIN-I; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE
   CARDIOMYOPATHY
AB Genetic diagnosis of cardiomyopathies (CMPs) is challenging, due to the marked genetic and allelic heterogeneity and the lack of knowledge of the mutations that lead to clinical phenotypes. Here, we present the case of a large family, in which a single troponin I type 3 (TNNI3) mutation caused variable phenotypic expression, ranging from restrictive cardiomyopathy (RCMP) to hypertrophic cardiomyopathy (HCMP) to near-normal phenotype. The proband was a 57-year-old female with HCMP. Examining the family history revealed that her elder sister had expired due to severe RCMP. Using a next-generation sequencing-based gene panel to analyze the proband, we identified a known TNNI3 gene mutation, c.433C>T, which is predicted to cause an amino acid substitution (p.Arg145Trp) in the highly conserved inhibitory region of the cardiac troponin I protein. Sanger sequencing confirmed that six relatives with RCMP or near-normal phenotypes also carried this mutation. To our knowledge, this is the first genetically confirmed family with diverse phenotypic expression of CMPs in Korea. Our findings demonstrate familial implications, where a single mutation in a sarcomere protein can cause diverse phenotypic expression of cardiomyopathies.
C1 [Hwang, Ji-won; Jang, Shin Yi; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 lrwon Ro, Seoul 06351, South Korea.
   [Jang, Mi-Ae] Korea Univ, Dept Lab Med, Coll Med, Seoul, South Korea.
   [Seo, Soo Hyun; Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea.
   [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 lrwon Ro, Seoul 06351, South Korea.
EM dukkyung.kim@gmail.com
RI Ki, Chang-Seok/G-7559-2014; Jang, Mi-Ae/P-1228-2019; ki, cs/O-5931-2014;
   Kim, Duk Kyung/F-4613-2014
OI Ki, Chang-Seok/0000-0001-7679-8731; Seong, Moon-Woo/0000-0003-2954-3677;
   Park, Sung Sup/0000-0003-3754-4848
FU National Supporting Program for Genetic Diagnosis of Rare Diseases of
   the Korea Centers for Disease Control Prevention
FX This work was supported by the National Supporting Program for Genetic
   Diagnosis of Rare Diseases of the Korea Centers for Disease Control &
   Prevention.
CR Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317
   Callis TE, 2010, EXPERT REV MOL DIAGN, V10, P329, DOI [10.1586/erm.10.13, 10.1586/ERM.10.13]
   Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274
   Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502
   Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200
   Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200
   Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200
   Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009
   Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336
   Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715
   Roma-Rodrigues C, 2014, APPL CLIN GENET, V7, P195, DOI 10.2147/TACG.S49126
   Tariq M, 2014, WORLD J CARDIOL, V6, P1156, DOI 10.4330/wjc.v6.i11.1156
   VALLINS WJ, 1990, FEBS LETT, V270, P57, DOI 10.1016/0014-5793(90)81234-F
   Webber SA, 2012, CIRCULATION, V126, P1237, DOI 10.1161/CIRCULATIONAHA.112.104638
   Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031
   Zou YB, 2013, MOL BIOL REP, V40, P3969, DOI 10.1007/s11033-012-2474-2
NR 16
TC 4
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 270
EP 277
DI 10.4070/kcj.2016.0213
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100019
PM 28382084
OA Green Published
DA 2021-04-22
ER

PT J
AU Demirel, M
   Acar, E
   Toprak, C
   Izci, S
   Ocal, L
AF Demirel, Muhittin
   Acar, Emrah
   Toprak, Cuneyt
   Izci, Servet
   Ocal, Lutfi
TI Papillary Fibroelastoma of the Mitral Valve: an Unusual Cause of Mitral
   Valve Obstruction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Demirel, Muhittin; Acar, Emrah; Toprak, Cuneyt; Izci, Servet] Kartal Kosuyolu Cardiovasc Res & Training Hosp, Dept Cardiol, Istanbul 34786, Turkey.
   [Ocal, Lutfi] Umraniye Res & Training Hosp, Dept Cardiol, Istanbul, Turkey.
RP Demirel, M (corresponding author), Kartal Kosuyolu Cardiovasc Res & Training Hosp, Dept Cardiol, Istanbul 34786, Turkey.
EM muhi7343@gmail.com
CR Karaeren H, 2000, ECHOCARDIOGR-J CARD, V17, P165, DOI 10.1111/j.1540-8175.2000.tb01118.x
   Thomas M R, 1993, J Am Soc Echocardiogr, V6, P83
NR 2
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 286
EP 287
DI 10.4070/kcj.2016.0223
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100022
PM 28382087
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, D
   Jung, MH
   Youn, HJ
   Choi, Y
   Byeon, JH
   Jung, HO
AF Lee, Dongjae
   Jung, Mi-Hyang
   Youn, Ho-Joong
   Choi, Young
   Byeon, Jae Ho
   Jung, Hae Ok
TI Giant Right Coronary Artery with Coronary Artery Fistula Complicated by
   Infective Endocarditis: Multimodality Imaging Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Dongjae; Jung, Mi-Hyang; Youn, Ho-Joong; Choi, Young; Byeon, Jae Ho; Jung, Hae Ok] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Ctr Cardiovasc, 222 Banpo Daero, Seoul 06591, South Korea.
RP Jung, MH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Ctr Cardiovasc, 222 Banpo Daero, Seoul 06591, South Korea.
EM floria0515@gmail.com
RI Jung, Mi-Hyang/AAV-2013-2020; BYEON, JAEHO/W-7828-2019
OI Jung, Mi-Hyang/0000-0003-0224-5178; BYEON, JAEHO/0000-0002-6981-6732
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2017
VL 47
IS 2
BP 288
EP 289
DI 10.4070/kcj.2016.0268
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EQ7EI
UT WOS:000398246100023
PM 28382088
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, H
   Kim, TH
   Baek, YS
   Uhm, JS
   Pak, HN
   Lee, MH
   Joung, B
AF Lee, Hancheol
   Kim, Tae-Hoon
   Baek, Yong-Soo
   Uhm, Jae-Sun
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Joung, Boyoung
TI The Trends of Atrial Fibrillation-Related Hospital Visit and Cost,
   Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample
   Cohort Data
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Hospital costs; National health programs
ID UNITED-STATES; RISK-FACTORS; STROKE PREVENTION; HEART-FAILURE; LIFETIME
   RISK; PREVALENCE; ANTICOAGULATION; POPULATION; WARFARIN; BURDEN
AB Background and Objectives: The change of in-hospital and out-hospital treatments, and hospital costs for atrial fibrillation (AF) were not well known in rapidly aging Asian countries. This study is to examine the trends of AF management and outcomes in Korea.
   Subjects and Methods: In the sample cohort from Korean National Health Insurance Data Sample Cohort (K-NHID-Sample Cohort) from 2004 through 2013, we identified patients with AF and hospital visit records using Korean Classification of Diseases, 6th Revision (KCD-6). Hospital cost, prescribed medications, radiofrequency catheter ablation (RFCA), morbidity and mortality were identified.
   Results: AF-related hospitalization and outpatient clinic visits increased by 2.19 and 3.06-fold, respectively. While the total cost increased from 3.6 to 11.3 billion won (p<0.001), the mean cost per patient increased from 0.68 to 0.83 million won (p<0.001). Although the mean CHA2DS2-VASc score increased from 3.5 to 4.4 in the total AF population, the proportion of patients who receive anticoagulation therapy with warfarin showed no significant change for the decade. The proportion of hospitalization for RFCA was increased (0.4% to 1.10/o, p<0.001). All-cause mortality (6.7% to 5.0%), cardiovascular mortality (1.4% to 1.1%) and stroke-related death (1.3% to 0.8%) showed a modest decrease from 2004 to 2013.
   Conclusion: During the last decade, AF-related hospitalization and outpatient clinic visits have increased with the increase of many other comorbidities, whereas the rate of anticoagulation did not improved. Although mortality in patients with AF showed a modest decrease from 2004 to 2013, proper anticoagulation therapy is warranted for the improvement of public health.
C1 [Lee, Hancheol] Ilsan Hosp, Natl Hlth Insurance Serv, Div Cardiol, Goyang, South Korea.
   [Kim, Tae-Hoon; Baek, Yong-Soo; Uhm, Jae-Sun; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
RP Joung, B (corresponding author), Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
RI ; Pak, Hui-Nam/C-4266-2015
OI Joung, Boyoung/0000-0001-9036-7225; Uhm, Jae-Sun/0000-0002-1611-8172;
   Kim, Tae-Hoon/0000-0003-4200-3456; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Pak, Hui-Nam/0000-0002-3256-3620
FU Korean Circulation Society [201505-02]
FX This study was supported by research grants from Korean Circulation
   Society (201505-02).
CR Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   Chao TF, 2015, CIRCULATION, V132, P1604, DOI 10.1161/CIRCULATIONAHA.114.013709
   Chen SJ, 2013, INT J CARDIOL, V168, P2300, DOI 10.1016/j.ijcard.2013.01.192
   Cherubini A, 2012, DRUG AGING, V29, P463, DOI 10.2165/11631750-000000000-00000
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004
   Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9
   Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165
   Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425
   Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025
   Patel NJ, 2014, CIRCULATION, V129, P2371, DOI 10.1161/CIRCULATIONAHA.114.008201
   Son MK, 2016, KOREAN CIRC J, V46, P515, DOI 10.4070/kcj.2016.46.4.515
   Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748
   Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060
   Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E
   Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A
   Williams KA, 2016, J AM COLL CARDIOL, V67, pE27, DOI 10.1016/j.jacc.2015.08.856
   Wong CX, 2012, ARCH INTERN MED, V172, P739, DOI 10.1001/archinternmed.2012.878
   이광수, 2008, Korean Circulation Journal, V38, P601
NR 26
TC 45
Z9 45
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 56
EP 64
DI 10.4070/kcj.2016.0045
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200011
PM 28154592
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, J
   Kim, DH
   Roh, SY
   Lee, KN
   Lee, DI
   Shim, J
   Choi, JI
   Kim, YH
AF Ahn, Jinhee
   Kim, Dong-Hyeok
   Roh, Seung-Young
   Lee, Kwang No
   Lee, Dae-In
   Shim, Jaemin
   Choi, Jong-Il
   Kim, Young-Hoon
TI The Role of Intravenous Dopamine on Hemodynamic Support during
   Radiofrequency Catheter Ablation of Poorly Tolerated Idiopathic
   Ventricular Tachycardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tachycardia; ventricular; Idiopathic; Catheter ablation; Dopamine
AB Background and Objectives: Hemodynamically unstable idiopathic ventricular tachycardias (VTs) are a challenge for activation or entrainment mapping technique. Mechanical circulatory support is an option, but is not always readily available. In this study, we investigated the safety and efficacy of hemodynamic support using intravenous (IV) dopamine solely during radiofrequency catheter ablation (RFCA) of hemodynamically unstable VT.
   Subjects and Methods: Seven out of 86 patients with hemodynamically unstable idiopathic VT underwent de novo RFCA using dopamine in our single center. They were included in the study and reviewed retrospectively to investigate the procedural characteristics and outcomes.
   Results: All patients were male, and the mean age was 50.7 +/- 5.3 years. One patient had implantable cardioverter-defibrillator for the secondary prevention. No evidence of myocardial ischemia was found in all patients. During the procedure, the mean blood pressure during VT without dopamine was 52.3 +/-.1 mmHg and increased to 82.6 +/- 3.8 mmHg after administering dopamine (Delta 28.8 +/- 3.2 mmHg; total average dopamine dosage was 1266.1 +/- 389.6 mcgikg). In all patients, activation mapping was safely applied, and VTs were terminated during energy delivery. Non-inducibility of clinical VT was achieved in all cases. There was no evidence of deterioration due to hypoperfusion during the peri-procedural period. No recurrence of ventricular tachyarrhythmias was observed in any of the patients, during a median follow-up of 23.0 +/- 6.1 months.
   Conclusion: Hemodynamic support using IV dopamine during RFCA of hemodynamically unstable idiopathic VT facilitated detailed mapping to guide successful ablation.
C1 [Ahn, Jinhee; Kim, Dong-Hyeok; Roh, Seung-Young; Lee, Kwang No; Lee, Dae-In; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
EM yhkmd@unitel.co.kr
RI Kim, Dong-Hyeok/N-7559-2018
CR Aryana A, 2014, HEART RHYTHM, V11, P1122, DOI 10.1016/j.hrthm.2014.04.018
   Bunch TJ, 2012, EUROPACE, V14, P709, DOI 10.1093/europace/eur347
   Della Bella P, 2013, CIRCULATION, V127, P1359, DOI 10.1161/CIRCULATIONAHA.112.000872
   Della Bella P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1056, DOI 10.1161/CIRCEP.112.979013
   Issa ZF, 2012, CLIN ARRHYTHMOLOGY E, P573
   Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216
   Letsas KP, 2011, HELL J CARDIOL, V52, P427
   Lu F, 2013, INT J CARDIOL, V168, P3859, DOI 10.1016/j.ijcard.2013.06.035
   Marchlinski FE, 2000, CIRCULATION, V101, P1288, DOI 10.1161/01.CIR.101.11.1288
   Miller MA, 2014, CIRC-ARRHYTHMIA ELEC, V7, P192, DOI 10.1161/CIRCEP.114.001590
   Miller MA, 2013, CIRC-ARRHYTHMIA ELEC, V6, P151, DOI 10.1161/CIRCEP.112.975888
   Miller MA, 2011, J AM COLL CARDIOL, V58, P1363, DOI 10.1016/j.jacc.2011.06.022
   Nazer B, 2014, KOREAN CIRC J, V44, P210, DOI 10.4070/kcj.2014.44.4.210
   Pedersen CT, 2014, EUROPACE, V16, P1257, DOI 10.1093/europace/euu194
   Reddy YM, 2014, CIRC-ARRHYTHMIA ELEC, V7, P244, DOI 10.1161/CIRCEP.113.000548
   Rizkallah J, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2013.08.015
   Stevenson WG, 2007, CIRCULATION, V115, P2750, DOI 10.1161/CIRCULATIONAHA.106.655720
   Tabatabaei N, 2009, CIRC-ARRHYTHMIA ELEC, V2, P316, DOI 10.1161/CIRCEP.108.847962
   TISDALE JE, 1995, PROG CARDIOVASC DIS, V38, P167, DOI 10.1016/S0033-0620(05)80005-2
   Vergara P, 2012, J CARDIOVASC ELECTR, V23, P621, DOI 10.1111/j.1540-8167.2011.02246.x
NR 20
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 65
EP 71
DI 10.4070/kcj.2016.0039
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200012
PM 28154593
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, S
   Jeong, MH
   Lim, KS
   Bae, IH
   Park, JK
   Park, DS
   Shim, JW
   Kim, JH
   Kim, HK
   Sim, DS
   Hong, YJ
   Ahn, Y
   Kang, JC
AF Jang, Suyoung
   Jeong, Myung Ho
   Lim, Kyung Seob
   Bae, In Ho
   Park, Jun-Kyu
   Park, Dae Sung
   Shim, Jae Won
   Kim, Jung Ha
   Kim, Hyun Kuk
   Sim, Doo Sun
   Hong, Young Joon
   Ahn, Youngkeun
   Kang, Jung Chaee
TI Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a
   Porcine Coronary Restenosis Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Coronary restenosis; Inflammation
ID BARE-METAL STENTS; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; BALLOON
   ANGIOPLASTY; ELUTING STENTS; ARTERY-DISEASE; SIROLIMUS; PROLIFERATION;
   METAANALYSIS; MIGRATION
AB Background and objectives: Artemisinin and dihydroartemisinin are drugs used to treat malaria. These drugs suppress inflammatory reactions. The aim of this study was to examine the anti-intima hyperplasia effect of a novel drug-eluting stent with artemisinin or dihydroartemisinin in a porcine coronary restenosis model.
   Materials and Methods: Pigs were randomized into four groups; in the first, the coronary arteries (20 pigs, a total of 40 coronary arteries, with 10 coronary arteries in each group) was implanted with bare metal stents (BMS, n=10); the second group was given polymer-coated stents (PCS, n=10); the third group was treated with artemisinin-eluting stents (AES, n=10); and the fourth group was given dihydroartemisinin-eluting stents (DAES, n=10). Histopathologic analysis was performed 28 days after stenting.
   Results: The injury and fibrin scores among the four groups were not significantly different. However, the internal elastic lamina, lumen area, and neointima area were significantly different. Moreover, the percent area of stenosis (46.2 +/- 18.66% in BMS vs. 89.4 +/- 10.92% in PCS vs. 83.3 +/- 17.07% in AES vs. 36.7 +/- 11.20% in DAES, p<0.0001) and inflammation score (1.0 [range: 1.0-1.0] vs. 3.0 [range: 2.25-3.0] vs. 3.0 [range: 1.0-3.0] vs. 2.0 [range: 1.75-3.0] in BMS, PCS, AES, and DAES, respectively; p<0.001) were markedly decreased in the DAES group compared to the PCS group.
   Conclusion: DES, which uses a natural substance, dihydroartemisinin, showed a neointima and inflammatory suppressive effect in a porcine coronary restenosis model.
C1 [Jang, Suyoung; Jeong, Myung Ho; Bae, In Ho] Korea Cardiovasc Stent Res Inst, Jangsung, South Korea.
   [Jang, Suyoung; Jeong, Myung Ho; Lim, Kyung Seob; Bae, In Ho; Park, Jun-Kyu; Park, Dae Sung; Shim, Jae Won; Kim, Jung Ha; Kim, Hyun Kuk; Sim, Doo Sun; Hong, Young Joon; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Gwangju, South Korea.
   [Jang, Suyoung; Jeong, Myung Ho; Lim, Kyung Seob; Park, Jun-Kyu; Park, Dae Sung; Shim, Jae Won; Kim, Jung Ha; Sim, Doo Sun; Hong, Young Joon; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Cardiovasc Res Ctr, Gwangju, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ, Regener Res Ctr, Gwangju, South Korea.
RP Jeong, MH (corresponding author), Korea Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Korea Cardiovasc Stent Res Inst, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
FU Korean Society of Cardiology [201303-07]
FX This study was supported by a grant from the Korean Society of
   Cardiology in 2013 (201303-07).
CR Bae IH, 2015, J IND ENG CHEM, V21, P1295, DOI 10.1016/j.jiec.2014.05.045
   Cao Q, 2015, CLIN EXP PHARMACOL P, V42, P502, DOI 10.1111/1440-1681.12375
   Cao Q, 2015, J SURG RES, V194, P667, DOI 10.1016/j.jss.2014.12.013
   Che HL, 2012, BIOMATERIALS, V33, P8548, DOI 10.1016/j.biomaterials.2012.07.045
   Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4
   De Luca G, 2015, J THROMB THROMBOLYS, V39, P101, DOI 10.1007/s11239-014-1091-4
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Kang SN, 2015, BIOMATERIALS, V44, P1, DOI 10.1016/j.biomaterials.2014.12.015
   Lee KP, 2014, NUTR RES PRACT, V8, P521, DOI 10.4162/nrp.2014.8.5.521
   Lim K.S., 2014, CLIN EXP THROMB HEMO, V1, P59
   Lim KS, 2014, MACROMOL RES, V22, P639, DOI 10.1007/s13233-014-2095-9
   Lim Kyung Seob, 2013, Chonnam Med J, V49, P7, DOI 10.4068/cmj.2013.49.1.7
   Ma XD, 2011, J PHARMACEUT BIOMED, V54, P807, DOI 10.1016/j.jpba.2010.10.027
   Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872
   Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SOLLOTT SJ, 1995, J CLIN INVEST, V95, P1869, DOI 10.1172/JCI117867
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   Yang DX, 2015, INT J CLIN EXP PATHO, V8, P1270
   Yu Wan-ying, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2618
NR 24
TC 3
Z9 4
U1 1
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 115
EP 122
DI 10.4070/kcj.2016.0278
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200018
PM 28154599
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kwon, BS
   Kim, GB
   Bae, EJ
   Noh, CI
   Kim, WH
AF Lee, Sun Hyang
   Kwon, Bo Sang
   Kim, Gi Beom
   Bae, Eun Jung
   Noh, Chung Il
   Kim, Woong Han
TI Prophylactic Pulmonary Artery Reduction in a Young Female with Severe
   Pulmonary Hypertension from Complete Atrioventricular Septal Defect
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary arterial hypertension; Congenital heart defects; Pulmonary
   surgical procedure
ID MAIN CORONARY-ARTERY; EXTRINSIC COMPRESSION; DILATATION; ANEURYSM
AB Management of severely dilated pulmonary artery (PA) associated with severe pulmonary hypertension from congenital heart disease remains controversial, primarily due to its rare nature and concern for perioperative unpredictable complications. Herein, we report a 25 year-old female with a severely dilated PA (up to 73 mm), who was successfully treated by a PA graft replacement by creating a Y-shaped conduit using a 28 mm hemashield tube in the main PA and a 20 mm hemashield tube in both proximal parts of the branch PA.
C1 [Lee, Sun Hyang; Kwon, Bo Sang; Kim, Gi Beom; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea.
   [Kim, Woong Han] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Lee, Sun Hyang] Hallym Univ, Coll Med, Dept Pediat, Dongtan Sacred Heart Hosp, Chunchon, Gangwon Do, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Sch Med, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM ped9526@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
CR Boerrigter B, 2010, CHEST, V138, P1395, DOI 10.1378/chest.10-0363
   Choi YJ, 2013, J KOREAN MED SCI, V28, P1543, DOI 10.3346/jkms.2013.28.10.1543
   Degano B, 2009, EUR RESPIR REV, V18, P181, DOI 10.1183/09059180.00002909
   Duijnhouwer AL, 2016, CONGENIT HEART DIS, V11, P102, DOI 10.1111/chd.12316
   Mesquita SMF, 2004, AM J MED, V116, P369, DOI 10.1016/j.amjmed.2003.11.015
   Sahay S, 2013, HEART, V99, P895, DOI 10.1136/heartjnl-2012-303408
   Sakuma M, 2007, INTERNAL MED, V46, P1789, DOI 10.2169/internalmedicine.46.0187
   WILLIAMS TE, 1971, J THORAC CARDIOV SUR, V62, P63, DOI 10.1016/S0022-5223(19)42106-5
   Zylkowska J, 2012, CHEST, V142, P1406, DOI 10.1378/chest.11-2794
NR 9
TC 0
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 136
EP 140
DI 10.4070/kcj.2016.0123
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200021
PM 28154602
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, GH
   Youn, HJ
AF Kim, Gee-Hee
   Youn, Ho-Joong
TI Is Carotid Artery Ultrasound Still Useful Method for Evaluation of
   Atherosclerosis?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Carotid artery; Carotid atherosclerosis; Carotid artery plaque
ID INTIMA-MEDIA THICKNESS; HEART-DISEASE RISK; END-DIASTOLIC VELOCITY;
   CARDIOVASCULAR-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; AMERICAN SOCIETY;
   ISCHEMIC-STROKE; PLAQUE BURDEN; BLOOD-FLOW; PREDICTION
AB Carotid ultrasound is an imaging modality that allows non-invasive assessment of vascular anatomy and function. Carotid intima-media thickness (IMT) has been shown to predict cardiovascular (CV) risk in multiple large studies. However, in 2013, American College of Cardiology/American Heart Association guidelines designated that the carotid IMT as class III evidence level was not recommended for use in clinical practice as a routine measurement of risk assessment for a first atherosclerotic CV event. Following the announcement of this guideline, combined common carotid IMT and plaque, including plaque tissue characterization and plaque burden, using 3D ultrasound was reported to be better than either measurement alone in a variety of studies. Moreover, changes in the intima thickness were related to aging and early atherosclerosis, and remodeling of the media thickness was associated with hypertension. Separate measurement is useful for evaluating the effects of different atherosclerotic risk factors on the arterial wall; however, a more detailed and elaborate technique needs to be developed. If so, separate measurement will play an important role in the assessment of atherosclerosis and arterial wall change according to a variety of risk factors, such as metabolic syndrome. In addition, although carotid blood flow velocity is a useful tool for risk classification and prediction in clinical practice, further clinical research is needed. The value of carotid IMT by ultrasound examination for risk stratification remains controversial, and groups developing future guidelines should consider the roles of plaque presence and burden and hemodynamic parameters in additional risk stratification beyond carotid IMT in clinical practice.
C1 [Kim, Gee-Hee] St Vincents Hosp, Div Cardiol, Dept Internal Med, Suwon, South Korea.
   [Youn, Ho-Joong] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp,Coll Med, Seoul, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Div Cardiol, Dept Internal Med, Sch Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM younhj@catholic.ac.kr
CR Azarpazhooh MR, 2014, INT J PREVENTIVE MED, V5, P1412
   Bae JH, 2006, ARTERIOSCL THROM VAS, V26, P2380, DOI 10.1161/01.ATV.0000240420.36229.f9
   Bai CH, 2007, J CLIN ULTRASOUND, V35, P322, DOI 10.1002/jcu.20351
   Choi YS, 2011, J NUCL CARDIOL, V18, P267, DOI 10.1007/s12350-011-9338-3
   Choi YS, 2009, ULTRASOUND MED BIOL, V35, P962, DOI 10.1016/j.ultrasmedbio.2008.12.004
   Chuang SY, 2016, EUR J PREV CARDIOL, V23, P116, DOI 10.1177/2047487315571888
   Chuang SY, 2011, STROKE, V42, P1338, DOI 10.1161/STROKEAHA.110.605477
   Chung H, 2016, KOREAN CIRC J, V46, P72, DOI 10.4070/kcj.2016.46.1.72
   Cohen GI, 2013, JACC-CARDIOVASC IMAG, V6, P1160, DOI 10.1016/j.jcmg.2013.06.007
   del Sol AI, 2001, STROKE, V32, P1532, DOI 10.1161/01.STR.32.7.1532
   Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   GUSSENHOVEN EJ, 1991, AM J CARDIOL, V68, P1625, DOI 10.1016/0002-9149(91)90320-K
   Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
   HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297
   Ikeda N, 2013, CIRC J, V77, P712, DOI 10.1253/circj.CJ-12-1087
   Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044
   Kanters SDJM, 1997, STROKE, V28, P665, DOI 10.1161/01.STR.28.3.665
   Khalil A, 2013, INT J CARDIOL, V167, P1322, DOI 10.1016/j.ijcard.2012.03.180
   Kim GH, 2015, INT J CLIN EXP MED, V8, P18591
   Kim G, 2015, CLIN INTERV AGING, V10, P1111, DOI 10.2147/CIA.S85216
   Kim Ji-Hoon, 2016, J Cardiovasc Ultrasound, V24, P48, DOI 10.4250/jcu.2016.24.1.48
   Lal BK, 2002, J VASC SURG, V35, P1210, DOI 10.1067/mva.2002.122888
   Lee S, 2014, CAN J CARDIOL, V30, P1620, DOI 10.1016/j.cjca.2014.06.026
   Liang YH, 2015, EXP THER MED, V10, P275, DOI 10.3892/etm.2015.2486
   Nakashima Y, 2002, VIRCHOWS ARCH, V441, P279, DOI 10.1007/s00428-002-0605-1
   Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192
   Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075
   Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014
   Naqvi TZ, 2010, J AM SOC ECHOCARDIOG, V23, P809, DOI 10.1016/j.echo.2010.05.005
   OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752
   Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747
   Peters SAE, 2011, J ATHEROSCLER THROMB, V18, P784, DOI 10.5551/jat.8169
   PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399
   Plichart M, 2011, ATHEROSCLEROSIS, V219, P917, DOI 10.1016/j.atherosclerosis.2011.09.024
   Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592
   Prabhakaran Shyam, 2007, Atherosclerosis, V195, pe197, DOI 10.1016/j.atherosclerosis.2007.03.044
   Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020
   SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245
   Schmidt-Trucksass A, 1999, ARTERIOSCL THROM VAS, V19, P1091, DOI 10.1161/01.ATV.19.4.1091
   SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17
   Sillesen H, 2012, JACC-CARDIOVASC IMAG, V5, P681, DOI 10.1016/j.jcmg.2012.03.013
   Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011
   Thompson T, 2015, J HYPERTENS, V33, P810, DOI 10.1097/HJH.0000000000000488
   van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B
   Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570
   Wahlgren CM, 2009, CEREBROVASC DIS, V27, P193, DOI 10.1159/000189204
   Wasserman BA, 2008, STROKE, V39, P329, DOI 10.1161/STROKEAHA.107.498634
   Wikstrand J, 2007, CLIN PHYSIOL FUNCT I, V27, P341, DOI 10.1111/j.1475-097X.2007.00757.x
   Won Hee Kwan, 2008, [The Korean Journal of Medicine, 대한내과학회지], V75, P179
   김지훈, 2005, Korean Circulation Journal, V35, P467
   Yu Jin-Sok, 2015, Clin Hypertens, V21, P15, DOI 10.1186/s40885-015-0021-x
NR 52
TC 11
Z9 12
U1 1
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 1
EP 8
DI 10.4070/kcj.2016.0232
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200001
PM 28154582
OA Green Published
DA 2021-04-22
ER

PT J
AU Bohm, M
   Ewen, S
   Mahfoud, F
AF Boehm, Michael
   Ewen, Sebastian
   Mahfoud, Felix
TI Renal Denervation for Chronic Heart Failure: Background and
   Pathophysiological Rationale
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Congestive heart failure; Sympathetic nervous system; Neuroendocrine
   activation; Denervation
ID SYMPATHETIC-NERVOUS-SYSTEM; ARTERIAL-BLOOD PRESSURE; RESISTANT
   HYPERTENSION; ATRIAL-FIBRILLATION; SLEEP-APNEA; PLASMA NOREPINEPHRINE;
   ACTIVATION; TRIAL; INNERVATION; DESIGN
AB The activation of the sympathetic nervous system is associated with cardiovascular hospitalizations and death in heart failure. Renal denervation has been shown to effectively reduce sympathetic overdrive in certain patients with uncontrolled hypertension. Pilot trials investigating renal denervation as a potential treatment approach for heart failure were initiated. Heart failure comorbidities like obstructive sleep apnea, metabolic syndrome and arrhythmias could also be targets for renal denervation, because these occurrences are also mediated by the activation of the sympathetic nervous system. Therefore, renal denervation in heart failure is worthy of further investigation, although its effectiveness still has to be proven. Herein, we describe the pathophysiological rationale and the effect of renal denervation on surrogates of the heart failure syndrome.
C1 [Boehm, Michael; Ewen, Sebastian; Mahfoud, Felix] Saarland Univ Hosp, Dept Internal Med 3, Cardiol Angiol & Intens Care, Kirrberger Str,Geb 40, D-66421 Homburg, Germany.
RP Bohm, M (corresponding author), Saarland Univ Hosp, Dept Internal Med 3, Cardiol Angiol & Intens Care, Kirrberger Str,Geb 40, D-66421 Homburg, Germany.
EM michael.boehm@uks.eu
RI Mahfoud, Felix/D-7707-2011; Bohm, Michael/C-3638-2011
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); German
   Cardiac Society; Hochdruckliga
FX MB received scientific support and speakers honoraria from Bayer,
   Boehringer Ingelheim, Medtronic and Servier. MB is supported by the
   Deutsche Forschungsgemeinschaft and FM by the Hochdruckliga and the
   German Cardiac Society. FM received scientific support and speaker
   honoraria from Medtronic and SJM.
CR Ahmed H, 2013, J CARDIOVASC ELECTR, V24, P503, DOI 10.1111/jce.12095
   Bohm M, 2014, CIRC RES, V115, P400, DOI 10.1161/CIRCRESAHA.115.302522
   BOHM M, 1990, CIRCULATION, V82, P1249, DOI 10.1161/01.CIR.82.4.1249
   BOHM M, 1995, J AM COLL CARDIOL, V25, P146, DOI 10.1016/0735-1097(94)00353-R
   BOHM M, 1988, EUR HEART J, V9, P844
   Brandt MC, 2012, J AM COLL CARDIOL, V60, P1956, DOI 10.1016/j.jacc.2012.08.959
   Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034
   Campese VM, 1997, J NEPHROL, V10, P184
   COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303
   Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019
   DIBONA GF, 1991, AM J PHYSIOL, V260, pR298
   Donazzan L, 2016, CLIN RES CARDIOL, V105, P364, DOI 10.1007/s00392-015-0930-4
   Dunlap ME, 2013, J AM COLL CARDIOL, V62, P165, DOI 10.1016/j.jacc.2013.02.081
   ESLER M, 1989, CLIN EXP HYPERTENS A, V11, P75, DOI 10.3109/10641968909045414
   Esler M, 2010, J APPL PHYSIOL, V108, P227, DOI 10.1152/japplphysiol.00832.2009
   Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880
   Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9
   Fallick C, 2011, CIRC-HEART FAIL, V4, P669, DOI 10.1161/CIRCHEARTFAILURE.111.961789
   Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061
   FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724
   GOLDSTEIN DS, 1988, CIRCULATION, V78, P41, DOI 10.1161/01.CIR.78.1.41
   HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615
   Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96
   Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983
   Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062
   Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y
   HOLMER S, 1994, AM J PHYSIOL, V266, pF738
   Huggett RJ, 2003, CIRCULATION, V108, P3097, DOI 10.1161/01.CIR.0000103123.66264.FE
   Kandzari DE, 2016, AM HEART J, V171, P82, DOI 10.1016/j.ahj.2015.08.021
   Katholi R E, 1984, J Hypertens, V2, P349
   Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3
   Linz D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P466, DOI 10.1161/CIRCEP.114.002453
   Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015
   Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728
   Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965
   Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053
   LJUNGQVIST A, 1970, NEPHRON, V7, P218, DOI 10.1159/000179824
   Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022
   Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192
   Mahfoud F, 2014, EUR HEART J, V35, P2224, DOI 10.1093/eurheartj/ehu093
   Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870
   Mahfoud F, 2011, CIRCULATION, V123, P1940, DOI 10.1161/CIRCULATIONAHA.110.991869
   Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Page IH, 1935, J CLIN INVEST, V14, P27, DOI 10.1172/JCI100652
   Page IH, 1934, J CLIN INVEST, V13, P909, DOI 10.1172/JCI100635
   Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901
   Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184
   RECTOR TS, 1987, AM HEART J, V114, P148, DOI 10.1016/0002-8703(87)90318-8
   Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014
   Schirmer SH, 2015, JACC-CARDIOVASC INTE, V8, P972, DOI 10.1016/j.jcin.2015.02.014
   Schirmer SH, 2014, J AM COLL CARDIOL, V63, P1916, DOI 10.1016/j.jacc.2013.10.073
   Schlaich MP, 2013, INT J CARDIOL, V168, P2214, DOI 10.1016/j.ijcard.2013.01.218
   SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001
   Sobotka PA, 2012, CURR CARDIOL REP, V14, P285, DOI 10.1007/s11886-012-0258-x
   STELLA A, 1991, PHYSIOL REV, V71, P659
   SWEDBERG K, 1984, AM J CARDIOL, V54, P783, DOI 10.1016/S0002-9149(84)80208-8
   Tzafriri AR, 2014, J AM COLL CARDIOL, V64, P1079, DOI 10.1016/j.jacc.2014.07.937
   Ukena C, 2016, CLIN RES CARDIOL, V105, P873, DOI 10.1007/s00392-016-1012-y
   Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5
   Ukena C, 2011, J AM COLL CARDIOL, V58, P1176, DOI 10.1016/j.jacc.2011.05.036
NR 61
TC 9
Z9 9
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 9
EP 15
DI 10.4070/kcj.2016.0231
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200002
PM 28154583
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, JC
   Han, S
   Ryu, KH
AF Youn, Jong-Chan
   Han, Seongwoo
   Ryu, Kyu-Hyung
TI Temporal Trends of Hospitalized Patients with Heart Failure in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Hospitalization; Trends; Korea
ID PROGNOSTIC VALUE; CLINICAL-IMPLICATION; QRS PROLONGATION; UNITED-STATES;
   OUTCOMES; EPIDEMIOLOGY; HYPONATREMIA; MARKER; PREDICTION; SURVIVAL
AB Heart failure (HF) is an important cardiovascular disease because of its increasing prevalence, significant morbidity, high mortality and rapidly expanding health care costs. The number of HF patients is increasing worldwide and Korea is no exception. Temporal trends of four representative Korean hospitalized HF registries-the Hallym HF study, the Korean Multicenter HF study, the Korean Heart Failure (KorHF) registry and the Korean Acute Heart Failure (KorAHF) registry showed mild survival improvement reflecting overall HF patient care development in Korea despite the increased severity of enrolled patients with higher incidence of multiple comorbidities. Moreover, device therapies such as implantable cardioverter defibrillator and cardiac resynchronization therapy and definitive treatment such as heart transplantation have been increasing in Korea as well. To prevent HF burden increase, it is essential to set up long term effective prevention strategies for better control of ischemic heart disease, hypertension and diabetes, which might be risk factors for HF development. Moreover, proper HF guidelines, performance measures, and performance improvement programs might be necessary to limit HF burden as well.
C1 [Youn, Jong-Chan; Han, Seongwoo; Ryu, Kyu-Hyung] Hallym Univ, Div Cardiol, Dongtan Sacred Heart Hosp, Coll Med, Keunjaebong Gil 7, Hwaseong 18450, South Korea.
RP Han, S (corresponding author), Hallym Univ, Div Cardiol, Dongtan Sacred Heart Hosp, Coll Med, Keunjaebong Gil 7, Hwaseong 18450, South Korea.
EM hansw29@hallym.or.kr
RI Youn, Jong-Chan/AAS-1405-2020
OI Youn, Jong-Chan/0000-0003-0998-503X
FU Korean Society of Cardiology [201403-03]; Basic Science Research Program
   through the National Research Foundation of Korea (NRF) - Ministry of
   Science, ICT & Future Planning [NRF-2015R1C1A1A02036645]
FX This study was supported by the fund from the Korean Society of
   Cardiology (201403-03) and by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT & Future Planning (NRF-2015R1C1A1A02036645). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The authors have declared
   that no competing interests exist.
CR Agarwal SK, 2016, AM J EPIDEMIOL, V183, P462, DOI 10.1093/aje/kwv455
   Askoxylakis V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-105
   Bae MH, 2015, KOREAN J INTERN MED, V30, P450, DOI 10.3904/kjim.2015.30.4.450
   한성우, 2005, Korean Circulation Journal, V35, P357
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061
   Filippatos D., 2014, EUR HEART J-ACUTE CA, DOI [10.1177/2048872614527012, DOI 10.1177/2048872614527012]
   Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a
   Hong SJ, 2012, INT J CARDIOL, V157, P416, DOI 10.1016/j.ijcard.2012.03.155
   Kang SM, 2015, HEART FAIL CLIN, V11, P543, DOI 10.1016/j.hfc.2015.07.006
   Kang SH, 2015, HEART, V101, P1881, DOI 10.1136/heartjnl-2015-307782
   Krittayaphong R, 2015, HEART FAIL CLIN, V11, P563, DOI 10.1016/j.hfc.2015.07.008
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334
   Lee Y., 1998, KOREAN J MED, V55, P446
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Oh J, 2015, AM HEART J, V169, P713, DOI 10.1016/j.ahj.2015.01.014
   Oh J, 2013, INT J CARDIOL, V168, P4739, DOI 10.1016/j.ijcard.2013.07.241
   Oh J, 2013, INT J CARDIOL, V167, P1084, DOI 10.1016/j.ijcard.2012.10.054
   Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489
   Park HS, 2013, CARDIOLOGY, V125, P96, DOI 10.1159/000348334
   Park JJ, 2016, KOREAN CIRC J, V46, P610, DOI 10.4070/kcj.2016.46.5.610
   Park JJ, 2015, EUR J HEART FAIL, V17, P601, DOI 10.1002/ejhf.276
   Park JJ, 2014, AM J CARDIOL, V113, P511, DOI 10.1016/j.amjcard.2013.10.022
   Park SJ, 2013, AM HEART J, V165, P57, DOI 10.1016/j.ahj.2012.10.009
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Ryu KH, 2002, J KOREAN SOC HYPERTE, V8, P38
   Sato N, 2015, HEART FAIL CLIN, V11, P573, DOI 10.1016/j.hfc.2015.07.009
   Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339
   Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0
   Teng THK, 2010, CIRC-HEART FAIL, V3, P236, DOI 10.1161/CIRCHEARTFAILURE.109.879239
   Yoo BS, 2015, KOREAN J INTERN MED, V30, P460, DOI 10.3904/kjim.2015.30.4.460
   Yoon CH, 2012, J CARD FAIL, V18, P194, DOI 10.1016/j.cardfail.2011.12.006
   Youn JC, 2014, J KOREAN MED SCI, V29, P544, DOI 10.3346/jkms.2014.29.4.544
   Youn YJ, 2012, CIRC J, V76, P1151, DOI 10.1253/circj.CJ-11-1093
   Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25
NR 37
TC 23
Z9 23
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 16
EP 24
DI 10.4070/kcj.2016.0429
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200003
PM 28154584
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, T
   Suh, SY
   Lee, K
   Kang, WC
   Han, SH
   Ahn, Y
   Jeong, MH
AF Ahn, Taehoon
   Suh, Soon Yong
   Lee, Kyounghoon
   Kang, Woong Chol
   Han, Seung Hwan
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Clinical Outcomes according to the Achievement of Target Low Density
   Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Low density lipoprotein-cholesterol; Treatment
   outcome
ID ACUTE CORONARY SYNDROMES; STATIN THERAPY; CARDIOVASCULAR-DISEASE;
   SERUM-CHOLESTEROL; JAPANESE PATIENTS; METAANALYSIS; RISK; ATORVASTATIN;
   PREVENTION; REDUCTION
AB Background and Objectives:The clinical outcome of patient with an acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI), with or without achievement of target low density lipoprotein-cholesterol (LDL-C), has little known information. This study investigated if target LDL-C level (below 70 mg/dL) achievements in patients with AMI showed better clinical outcomes or not.
   Subjects and Methods: Between May 2008 and September 2012, this study enrolled 13473 AMI patients in a large-scale, prospective, multicenter Korean Myocardial Infarction (KorMI) registry. 12720 patients survived and 6746 patients completed a 1-year clinical follow up. Among them 3315 patients received serial lipid profile follow-ups. Propensity score matching was applied to adjust for differences in clinical baseline and angiographic characteristics, producing a total of 1292 patients (646 target LDL-C achievers vs. 646 non-achievers). The primary end point was the composite of a 1-year major adverse cardiac event (MACE) including cardiac death, recurrent myocardial infarction (MI), target lesion revascularization (TLR) and coronary artery bypass grafting.
   Results: After propensity score matching, baseline clinical and angiographic characteristics were similar between the two groups. Clinical outcomes of the propensity score matched patients who showed no significant differences in cardiac death (0.5% vs. 0.5%, p=1.000), recurrent MI (1.1% vs. 0.8%, p=0.562),.TLR (5.00% vs. 4.5%, p=0.649), MACEs (6.5% vs. 5.9%, p=0.644) and stent thrombosis (2.5% vs. 1.9%, p=0.560).
   Conclusion: In this propensity-matched comparison, AMI patients undergoing PCI with a target LDL-C (below 70 mg/dL) achievement did not show better clinical outcomes.
C1 [Ahn, Taehoon; Suh, Soon Yong; Lee, Kyounghoon; Kang, Woong Chol; Han, Seung Hwan] Gachon Univ, Gil Hosp, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
   [Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Gwangju, South Korea.
RP Suh, SY (corresponding author), Gachon Univ, Gil Hosp, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
EM mrsue74@gmail.com
CR Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]
   Baessler A, 2005, INT J CARDIOL, V101, P293, DOI 10.1016/j.ijcard.2004.03.053
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046
   Brown BG, 2006, CURR OPIN LIPIDOL, V17, P631, DOI 10.1097/MOL.0b013e32800ff750
   Bybee KA, 2001, AM J CARDIOL, V87, P771, DOI 10.1016/S0002-9149(00)01501-0
   Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028
   Davidson MH, 2005, AM J CARDIOL, V96, P556, DOI 10.1016/j.amjcard.2005.04.019
   Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
   Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010
   Itakura H, 2008, CIRC J, V72, P1218, DOI 10.1253/circj.72.1218
   Karlson BW, 2013, ATHEROSCLEROSIS, V228, P265, DOI 10.1016/j.atherosclerosis.2013.02.027
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340
   LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367
   Lee JH, 2012, CLIN CARDIOL, V35, P211, DOI 10.1002/clc.20984
   Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009
   Lenderink T, 2006, EUR HEART J, V27, P1799, DOI 10.1093/eurheartj/ehl125
   Martin SS, 2013, AM HEART J, V165, P26, DOI 10.1016/j.ahj.2012.10.005
   Melloni C, 2010, AM HEART J, V160, P1121, DOI 10.1016/j.ahj.2010.09.008
   Morrissey RP, 2009, J AM COLL CARDIOL, V54, P1425, DOI 10.1016/j.jacc.2009.04.093
   Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356
   Santos RD, 2009, AM HEART J, V158, P860, DOI 10.1016/j.ahj.2009.08.009
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430
   Teramoto T, 2010, J ATHEROSCLER THROMB, V17, P879, DOI 10.5551/jat.4176
   Walter DH, 2002, AM J CARDIOL, V89, P1, DOI 10.1016/S0002-9149(01)02153-1
   Wiviott SD, 2005, J AM COLL CARDIOL, V46, P1411, DOI 10.1016/j.jacc.2005.04.064
NR 28
TC 5
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 31
EP 35
DI 10.4070/kcj.2015.0266
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200007
PM 28154588
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, I
   Kim, MC
   Jeong, HC
   Park, KH
   Sim, DS
   Hong, YJ
   Kim, JH
   Jeong, MH
   Cho, JG
   Park, JC
   Seung, KB
   Chang, K
   Ahn, Y
AF Kim, Inna
   Kim, Min Chul
   Jeong, Hae Chang
   Park, Keun Ho
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
   Seung, Ki-Bae
   Chang, Kiyuk
   Ahn, Youngkeun
TI Optimal Timing of Percutaneous Coronary Intervention for Nonculprit
   Vessel in Patients with ST-Segment Elevation Myocardial Infarction and
   Multivessel Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Percutaneous coronary intervention
ID ARTERY-DISEASE; PROGNOSTIC IMPACT; CULPRIT VESSEL; REVASCULARIZATION;
   TRIAL; SURVIVAL; OUTCOMES; SHOCK
AB Background and Objectives: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), the optimal timing of staged percutaneous coronary intervention (PCI) remains unclear.
   Subjects and Methods: This study was a retrospective analysis of 753 STEMI patients with MVD who were treated by multivessel PCI in the Convergent Registry of Catholic and Chonnam University for Acute myocardial infarction (MI). Patients were divided into 3 groups according to the time from initial to staged PCI: group 1 (n=316, multivessel PCI performed during the index procedure), group 2 (n=360, staged PCI within 1 week), and group 3 (n=77, staged PCI after 1 week). The endpoint was major adverse cardiac events (MACEs), including all-cause mortality, non-fatal MI, and repeat PCI during 3.4 years follow-up.
   Results: The incidence of composite MACEs was higher in group 3 than in group 1 (odds ratio [OR]: 1.83, 95% confidence interval [CI]: 1.06 to 3.18, p=0.031). However, the risk of MACEs in groups 1 and 2 was comparable (OR: 1.01, 95% CI: 0.70 to 1.46, p=0.950). In multivariate logistic regression, independent predictors of 3-year MACEs were high Killip class (OR: 2.72, 95% CI: 1.38 to 5.37, p=0.004), left ventricular ejection fraction <45% (OR: 1.57, 95% CI: 1.06 to 2.32, p=0.024), and group 3 (OR: 1.83, 95% CI: 1.06 to 3.18, p=0.009).
   Conclusion: Deferred staged PCI after one week index PCI was associated with the highest MACE, as compared to both simultaneous multivessel PCI and early staged PCI <1 week.
C1 [Kim, Inna; Kim, Min Chul; Jeong, Hae Chang; Park, Keun Ho; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiovasc, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Seung, Ki-Bae; Chang, Kiyuk] Catholic Univ Korea, Dept Cardiol, Ctr Cardiovasc, Seoul St Marys Hosp, Seoul, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiovasc, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
FU National Research Foundation of Korea - Korean Government (MEST),
   Republic of Korea [2010-0020261]; Korea Healthcare Technology R&D
   Project, Ministry for Health & Welfare, Republic of Korea [HI12C0199,
   HI13C1527]
FX This work was supported by a grant of the National Research Foundation
   of Korea funded by the Korean Government (MEST), Republic of Korea
   (2010-0020261), and by a grant of the Korea Healthcare Technology R&D
   Project, Ministry for Health & Welfare, Republic of Korea (HI12C0199,
   HI13C1527).
CR Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016
   Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B
   Claessen BE, 2012, EUR HEART J, V33, P768, DOI 10.1093/eurheartj/ehr471
   Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Dangas GD, 2010, JACC-CARDIOVASC INTE, V3, P1096, DOI 10.1016/j.jcin.2010.09.005
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Jensen LO, 2012, EUROINTERVENTION, V8, P456, DOI 10.4244/EIJV8I4A72
   Kirschbaum SW, 2010, JACC-CARDIOVASC INTE, V3, P392, DOI 10.1016/j.jcin.2010.01.011
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184
   Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220
   Vieira RD, 2012, CIRCULATION, V126, pS158, DOI 10.1161/CIRCULATIONAHA.111.084236
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
NR 21
TC 7
Z9 8
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 36
EP 43
DI 10.4070/kcj.2015.0358
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200008
PM 28154589
OA Green Published
DA 2021-04-22
ER

PT J
AU Efe, TH
   Acar, B
   Ertem, AG
   Yayla, KG
   Algul, E
   Yayla, C
   Unal, S
   Bilgin, M
   Cimen, T
   Kirbas, O
   Yeter, E
AF Efe, Tolga Han
   Acar, Burak
   Ertem, Ahmet Goktug
   Yayla, Kadriye Gayretli
   Algul, Engin
   Yayla, Cagri
   Unal, Sefa
   Bilgin, Murat
   Cimen, Tolga
   Kirbas, Ozgur
   Yeter, Ekrem
TI Serum Irisin Level Can Predict the Severity of Coronary Artery Disease
   in Patients with Stable Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Atherosclerosis; Irisin
ID CIRCULATING IRISIN; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION;
   MESSENGER-RNA; SYNTAX SCORE; WEIGHT-LOSS; EXERCISE; ASSOCIATION;
   OBESITY; ATHEROSCLEROSIS
AB Background and Objectives: The recently discovered myokine irisin has a proposed role in adipose tissue metabolism. The aim of this study was to evaluate the relationship between serum irisin level and the coronary artery severity in patients with stable coronary artery disease (CAD).
   Subjects and Methods: Sixty-three patients who underwent coronary angiography (CA) diagnosed with stable CAD and twenty-six patients with normal coronary artery (NCA) were enrolled in the study. Stable CAD patients were divided into two groups as high synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score (>= 23) and lower SYNTAX score (<23). Serum irisin level measurement was carried out using human irisin colorimetric enzyme-linked immunosorbent assay (ELISA) commercial kit (AG-45A-0046EK-KI01, Adipogen, San Diego, CA, USA) as recommended by the manufacturer's protocol.
   Results: The patients with stable CAD with a higher SYNTAX score (score >= 23) had significantly lower serum irisin levels (127.91 +/- 55.38 ng/mL), as compared the patients with a low SYNTAX score (score <23) (224.69 +/- 92.99 ng/mL) and control group (299.54 +/- 123.20 ng/mL). Irisin levels showed significant differences between all groups (p<0.001).
   Conclusion: Serum irisin level is an independent predictor of coronary artery severity in patients with stable CAD.
C1 [Efe, Tolga Han; Yayla, Kadriye Gayretli; Algul, Engin; Bilgin, Murat; Cimen, Tolga; Yeter, Ekrem] Diskapi Yildinm Beyazit Training & Res Hosp, Cardiol Clin, Ankara, Turkey.
   [Acar, Burak; Ertem, Ahmet Goktug; Yayla, Cagri; Unal, Sefa; Kirbas, Ozgur] Turkiye Yuksek Ihtisas Training & Res Hosp, Cardiol Clin, Ankara, Turkey.
RP Yayla, C (corresponding author), Turkiye Yuksek Ihtisas Training & Res Hosp, TR-06500 Ankara, Turkey.
EM cagriyayla@gmail.com
RI Yayla, Kadriye Gayretli/AAL-3096-2021; Yayla, Cagri/B-9270-2019
OI Yayla, Kadriye Gayretli/0000-0002-0664-9164; Yayla,
   Cagri/0000-0002-5302-4052; Acar, Burak/0000-0003-3217-5000
CR Aronis KN, 2015, INT J OBESITY, V39, P156, DOI 10.1038/ijo.2014.101
   Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007
   Crujeiras AB, 2014, AM J HUM BIOL, V26, P198, DOI 10.1002/ajhb.22493
   Emanuele E, 2014, AM J MED, V127, P888, DOI 10.1016/j.amjmed.2014.04.025
   Farooq V, 2012, EUR HEART J, V33, P3098, DOI 10.1093/eurheartj/ehs295
   Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017
   Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002
   Kuloglu T, 2014, PEPTIDES, V55, P85, DOI 10.1016/j.peptides.2014.02.008
   Liu JJ, 2014, J DIABETES COMPLICAT, V28, P208, DOI 10.1016/j.jdiacomp.2013.09.011
   Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002
   Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932
   Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020
   Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Moreno M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124100
   Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373
   Park SE, 2015, CRIT REV CL LAB SCI, V52, P180, DOI 10.3109/10408363.2015.1023429
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007
   Polyzos SA, 2015, ENDOCRINE, V49, P560, DOI 10.1007/s12020-014-0473-x
   Sesti G, 2014, ACTA DIABETOL, V51, P705, DOI 10.1007/s00592-014-0576-0
   Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014
   Vamvini MT, 2013, EUR J ENDOCRINOL, V169, P829, DOI 10.1530/EJE-13-0276
NR 25
TC 22
Z9 27
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 44
EP 49
DI 10.4070/kcj.2016.0079
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200009
PM 28154590
OA Green Published
DA 2021-04-22
ER

PT J
AU Peng, JR
   Chang, CJ
   Wang, CL
   Tung, YC
   Lee, HF
AF Peng, Jian-Rong
   Chang, Chi-Jen
   Wang, Chun-Li
   Tung, Ying-Chang
   Lee, Hsin-Fu
TI Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass
   Candidates Treated with Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Coronary angioplasty; bypass surgery; Chronic
   kidney disease
ID 5-YEAR FOLLOW-UP; REVASCULARIZATION; SURGERY; STENTS; HEART
AB Background and Objectives: The aim of this study was to identify clinical, lesional, and procedural predictors for adverse outcomes of coronary angioplasty and stenting in coronary bypass candidates.
   Subjects and Methods: This cohort study included 107 consecutive candidates for coronary artery bypass surgery who underwent percutaneous coronary intervention with multiple coronary stents between Jan 2004 and Dec 2011. The study endpoint was major adverse cardiovascular events (MACEs) including all-cause mortality, nonfatal myocardial infarction, repeat revascularization, and stent thrombosis. Follow up was from the date of index percutaneous coronary intervention to the date of the first MACE, date of death, or December 31, 2015, whichever came first.
   Results: In this study (age 62.3 +/- 11.2 years, 86% male), 38 patients (360/0) had MACE. Among baseline, angiographic, and procedural parameters, there were significant differences in lower left ventricular ejection fraction (LVEF) and worse renal function. In a Cox regression model, LVEF and chronic kidney disease (CKD) were significant predictors for MACE. After a multivariate adjustment, CKD remained a significant predictor of MACEs (hazard ratio: 2.97, 95% confidence interval: 1.50-5.90).
   Conclusions: For coronary bypass candidates who were treated with coronary angioplasty and stenting, CKD seems to be the strongest predictor for adverse outcomes compared with other traditional factors.
C1 [Peng, Jian-Rong; Chang, Chi-Jen; Wang, Chun-Li; Tung, Ying-Chang; Lee, Hsin-Fu] Chang Gung Univ, Div Cardiovasc, Dept Internal Med, Taoyuan, Taiwan.
   [Chang, Chi-Jen; Lee, Hsin-Fu] Chang Gung Mem Hosp, Cardiovasc Intervent Ctr, Taoyuan, Taiwan.
   [Chang, Chi-Jen; Wang, Chun-Li] Chang Gung Univ, Coll Med, Taoyuan, Taiwan.
RP Lee, HF (corresponding author), Chang Gung Mem Hosp, Div Cardiovasc, Dept Internal Med, Taoyuan, Taiwan.
EM hsinfu.lee@gmail.com
RI Lee, Hsin-Fu/AAC-1560-2019
CR Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Holper EM, 2006, AM HEART J, V151, P69, DOI 10.1016/j.ahj.2005.03.053
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5
   Navab KD, 2011, CURR PHARM DESIGN, V17, P17
   Onuma Y, 2011, JACC-CARDIOVASC INTE, V4, P317, DOI 10.1016/j.jcin.2010.12.004
   Panichi V, 2001, RENAL FAILURE, V23, P551, DOI 10.1081/JDI-100104737
   Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447
   Polonsky TS, 2012, LANCET, V380, P783, DOI 10.1016/S0140-6736(12)60772-7
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Samak MJ, 2002, CLIN NEPHROL, V57, P327
   Serruys Patrick W, 2005, EuroIntervention, V1, P147
   Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Tomai F, 2014, CIRCULATION, V129, P1104, DOI 10.1161/CIRCULATIONAHA.113.005186
NR 19
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 50
EP 55
DI 10.4070/kcj.2016.0093
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200010
PM 28154591
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KH
   Lee, CH
   Jung, BC
   Cho, Y
   Bae, MH
   Kim, YN
   Park, HS
   Han, S
   Lee, YS
   Hyun, DW
   Kim, J
   Kim, DK
   Cha, TJ
   Shin, DG
AF Park, Kyu-Hwan
   Lee, Chan-Hee
   Jung, Byung Chun
   Cho, Yongkeun
   Bae, Myung Hwan
   Kim, Yoon-Nyun
   Park, Hyoung-Seob
   Han, Seongwook
   Lee, Young Soo
   Hyun, Dae-Woo
   Kim, Jun
   Kim, Dae Kyeong
   Cha, Tae-Jun
   Shin, Dong-Gu
TI Effectiveness of Implantable Cardioverter-Defibrillator Therapy for
   Heart Failure Patients according to Ischemic or Non-Ischemic Etiology in
   Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter-defibrillator; Left ventricular dysfunction;
   Mortality; Heart failure
ID PRIMARY PREVENTION; DILATED CARDIOMYOPATHY; HIGH-RISK; INAPPROPRIATE;
   TRIAL; PREDICTORS; SHOCKS; AMIODARONE; MORTALITY
AB Background and Objectives: This study was performed to describe clinical characteristics of patients with left ventriculars (LV) dysfunction and implantable cardioverter-defibrillator (ICD), and to evaluate the effect of ICD.therapy on survival in Yeongnam province of Korea. Subjects and
   Methods: From a community-based device registry (9 centers, Yeongnam province, from November 1999 to September 2012), 146 patients with LV dysfunction and an ICD implanted for primary or secondary prophylaxis, were analyzed. The patients were divided into two groups, based on the etiology (73 with ischemic cardiomyopathy and 73 with non-ischemic cardiomyopathy), and indication for the device implantation (36 for primary prevention and 110 for secondary prevention). The cumulative first shock rate, all cause death, and type and mode of death, were determined according to the etiology and indication.
   Results: Over a mean follow-up of 3.5 years, the overall ICD shock rate was about 39.00/o. ICD shock therapy was significantly more frequent in the secondary prevention group (46.4% vs. 16.7%, p=0.002). The cumulative probability of a first appropriate shock was higher in the secondary prevention group (p=0.015). There was no significant difference in the all-cause death, cardiac death, and mode of death between the groups according to the etiology and indication.
   Conclusion: Studies from this multicenter regional registry data shows that in both ischemic and non-ischemic cardiomyopathy patients, the ICD shock therapy rate was higher in the secondary prevention group than primary prevention group.
C1 [Park, Kyu-Hwan; Lee, Chan-Hee; Shin, Dong-Gu] Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
   [Jung, Byung Chun] Daegu Fatima Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Cho, Yongkeun; Bae, Myung Hwan] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kim, Yoon-Nyun; Park, Hyoung-Seob; Han, Seongwook] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Lee, Young Soo] Catholic Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Hyun, Dae-Woo] Andong Med Grp, Cardiovasc Ctr, Andong, South Korea.
   [Kim, Jun] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, Yangsan, South Korea.
   [Kim, Dae Kyeong] Inje Univ, Busan Paik Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Cha, Tae-Jun] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
RP Shin, DG (corresponding author), Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
EM dgshin@med.yu.ac.kr
CR Auricchio A, 2015, HEART RHYTHM, V12, P926, DOI 10.1016/j.hrthm.2015.01.017
   Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201
   Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297
   Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073
   Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007
   Gracieux J, 2014, INT J CARDIOL, V177, P990, DOI 10.1016/j.ijcard.2014.09.170
   Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088
   Kim J, 2012, KOREAN CIRC J, V42, P173, DOI 10.4070/kcj.2012.42.3.173
   Klein Richard C, 2003, J Cardiovasc Electrophysiol, V14, P940, DOI 10.1046/j.1540-8167.2003.01554.x
   Koneru JN, 2011, CIRC-ARRHYTHMIA ELEC, V4, P778, DOI 10.1161/CIRCEP.110.961243
   Kutyifa V, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.114.001965
   Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
   Mann DL, 2015, BRAUNWALDS HEART DIS, P724
   McAnulty J, 1997, NEW ENGL J MED, V337, P1576
   Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107
   Sedlacek K, 2015, J CARDIOVASC ELECTR, V26, P424, DOI 10.1111/jce.12605
   Verma A, 2010, PACE, V33, P320, DOI 10.1111/j.1540-8159.2009.02566.x
   Yang JH, 2012, J KOREAN MED SCI, V27, P619, DOI 10.3346/jkms.2012.27.6.619
NR 22
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 72
EP 81
DI 10.4070/kcj.2016.0242
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200013
PM 28154594
OA Green Published
DA 2021-04-22
ER

PT J
AU Abudiab, MM
   Pandit, A
   Chaliki, HP
AF Abudiab, Muaz M.
   Pandit, Anil
   Chaliki, Hari P.
TI Role of Transesophageal Echocardiography in the Diagnosis of Paradoxical
   Low Flow, Low Gradient Severe Aortic Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Transthoracic echocardiography; Transesophageal echocardiography; Aortic
   valve stenosis; Ventricular ejection fraction
ID VENTRICULAR OUTFLOW TRACT; VALVE STENOSIS; EJECTION FRACTION; AREA;
   TOMOGRAPHY; ACCURACY; INDEX
AB Background and Objectives: Prior studies indicate that up to 35% of cases of severe aortic stenosis (AS) have paradoxical low flow, low gradient despite preserved left ventricular ejection fraction (LVEF). However, error in left ventricular outflow tract (LVOT) diameter may lead to misclassification. Herein, we determined whether measurement of LVOT diameter by transesophageal echocardiography (TEE) results in reclassification of cases to non-severe AS. Subjects and
   Methods: Patients with severe AS with aortic valve area (AVA) <1 cm(2) by transthoracic echocardiography (TTE) within 6 months were studied. Paradoxical low flow, low gradient was defined as mean Doppler gradient (MG) <40 mm Hg and stroke volume index (SVI) <= 35 mL/m(2). Preserved LVEF was defined as >= 0.50.
   Results: Among 108 patients, 12 (15%) had paradoxical low flow, low gradient severe AS despite preserved LVEF based on TTE measurement. When LVOT diameter by TEE in 2D was used, only 5 (6.3%) patients had low flow, low gradient severe AS (p<0.001). Coefficients of variability for intraobserver and interobserver measurement of LVOT were <10%. However, the limits of agreement between TTE and TEE measurement of LVOT ranged from 0.43 cm (950/o confidence interval [CI]: 0.36 to 0.5) to-0.31 cm (95% CI:-0.38 to -0.23).
   Conclusion: TEE measured LVOT diameter may result in reclassification to moderate AS in some patients due to low prevalence of true paradoxical low flow, low gradient (PLFLG) severe AS.
C1 [Abudiab, Muaz M.; Pandit, Anil; Chaliki, Hari P.] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.
RP Chaliki, HP (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.
EM Chaliki.Hari@mayo.edu
FU A.J. and Sigismunda Palumbo Charitable Trust
FX This work was supported by grant support from the A.J. and Sigismunda
   Palumbo Charitable Trust.
CR Altiok E, 2011, HEART, V97, P1578, DOI 10.1136/hrt.2011.223974
   Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029
   Clavel MA, 2011, JACC-CARDIOVASC IMAG, V4, P1053, DOI 10.1016/j.jcmg.2011.06.021
   Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765
   Hachicha Z, 2007, CIRCULATION, V115, P2856, DOI 10.1161/CIRCULATIONAHA.106.668681
   Hachicha Z, 2009, J AM COLL CARDIOL, V54, P1003, DOI 10.1016/j.jacc.2009.04.079
   Jander N, 2011, CIRCULATION, V123, P887, DOI 10.1161/CIRCULATIONAHA.110.983510
   Kempfert J, 2012, EUR J CARDIO-THORAC, V42, P627, DOI 10.1093/ejcts/ezs064
   Khaw AV, 2009, INT J CARDIOL, V136, P64, DOI 10.1016/j.ijcard.2008.04.070
   Kim KS, 1997, AM J CARDIOL, V79, P436, DOI 10.1016/S0002-9149(96)00782-5
   Malyar NM, 2008, CARDIOLOGY, V109, P126, DOI 10.1159/000105554
   Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063
   Ng ACT, 2010, CIRC-CARDIOVASC IMAG, V3, P94, DOI 10.1161/CIRCIMAGING.109.885152
   Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Pibarot P, 2013, CIRCULATION, V127, P1101, DOI 10.1161/CIRCULATIONAHA.113.001130
   Pibarot P, 2012, J AM COLL CARDIOL, V60, P1845, DOI 10.1016/j.jacc.2012.06.051
   Pibarot P, 2010, HEART, V96, P1431, DOI 10.1136/hrt.2010.195149
   Reant P, 2006, EUR J RADIOL, V59, P276, DOI 10.1016/j.ejrad.2006.02.011
   Shiran A, 2009, EUR J ECHOCARDIOGR, V10, P319, DOI 10.1093/ejechocard/jen254
   Tribouilloy C, 2015, J AM COLL CARDIOL, V65, P55, DOI 10.1016/j.jacc.2014.09.080
   Utsunomiya H, 2012, INT J CARDIOL, V157, P347, DOI 10.1016/j.ijcard.2010.12.071
   ZOGHBI WA, 1986, CIRCULATION, V73, P452, DOI 10.1161/01.CIR.73.3.452
NR 23
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 82
EP 88
DI 10.4070/kcj.2016.0126
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200014
PM 28154595
OA Green Published
DA 2021-04-22
ER

PT J
AU Vuruskan, E
   Saracoglu, E
AF Vuruskan, Ertan
   Saracoglu, Erhan
TI Procedural and Early Outcomes of Two Re-entry Devices for Subintimal
   Recanalization of Aortoiliac and Femoropopliteal Chronic Total
   Occlusions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral arterial disease; Angioplasty
ID PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SUPERFICIAL FEMORAL-ARTERY;
   DISEASE
AB Background and Objectives: Subintimal angioplasty is a common treatment choice for chronic total occlusions (CTO) in the iliac and femoropopliteal arteries. This article describes the technical aspects and early outcomes of two different re-entry devices and comparison with manual re-entry technique.
   Subjects and Methods: A retrospective review of 61 patients (re-entry group) treated with Outback or Pioneer Plus catheters was carried out. A matched cohort of patients (n=62) who underwent lower extremity interventions without the use of re-entry devices (manual reentry group) were also analyzed (overall 123 patients were analyzed). Procedural success, procedural durations, patency estimates, ankle brachial indices, and complications were analyzed.
   Results: Sixty-one patients underwent Outback or Pioneer Plus guided subintimal recanalization. After the procedure, ankle-brachial indices significantly increased in all patients during follow-up. Primary patency for the entire cohort was 83% in the first month. When the re-entry device group was compared with manual re-entry group, no difference was found with respect to success, complication, and patencies between the two groups during follow-up. However, procedure duration and the amount of contrast agent used was significantly decreased in re-entry groups (p<0.001). Also, re-entry time was significantly decreased in Pioneer plus group according to Outback group (p<0.001)
   Conclusion: Recanalization of CTO using re-entry devices for aortoiliac or femoropopliteal arteries is safe and effective. These devices shorten the procedure time, the re-entry time, reduce radiation risk, and reduce the amount of contrast agent employed. (Korean
C1 [Vuruskan, Ertan; Saracoglu, Erhan] Gaziantep Dr Ersin Arslan Educ & Res Hosp, Dept Cardiol, Gaziantep, Turkey.
RP Vuruskan, E (corresponding author), Gaziantep Dr Ersin Arslan Educ & Res Hosp, TR-27100 Gaziantep, Turkey.
EM ertanvuruskan@hotmail.com
RI Vuruskan, Ertan/AAH-4425-2020
OI Vuruskan, Ertan/0000-0001-6820-3582
CR Al-Ameri H, 2009, J INVASIVE CARDIOL, V21, P468
   Araki M, 2014, CARDIOVASC INTERV TH, V29, P40, DOI 10.1007/s12928-013-0210-z
   Arslan S, 2015, POSTEP KARDIOL INTER, V11, P114, DOI 10.5114/pwki.2015.52284
   BOLIA A, 1990, CARDIOVASC INTER RAD, V13, P357, DOI 10.1007/BF02578675
   CAPEK P, 1991, CIRCULATION, V83, P70
   Hamur H, 2016, ANGIOLOGY
   Jacobs Donald L, 2006, Perspect Vasc Surg Endovasc Ther, V18, P31, DOI 10.1177/153100350601800114
   Jacobs DL, 2006, J VASC SURG, V43, P1291, DOI 10.1016/j.jvs.2006.02.051
   Jaff Michael R, 2015, Ann Vasc Dis, V8, P343, DOI 10.3400/avd.tasc.15-01000
   Kjellgren O, 1995, CATHETER CARDIO DIAG, V36, P360, DOI 10.1002/ccd.1810360418
   Landis Gregg S, 2007, Perspect Vasc Surg Endovasc Ther, V19, P285, DOI 10.1177/1531003507304452
   Laxdal E, 2003, EUR J VASC ENDOVASC, V25, P578, DOI 10.1053/ejvs.2002.1899
   LONDON NJM, 1994, EUR J VASCULAR SURG, V8, P148, DOI 10.1016/S0950-821X(05)80450-5
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI [10.1016/j.ejvs.2006.09.024, 10.1016/j.jvs.2006.12.037]
   Patel MR, 2015, J AM COLL CARDIOL, V65, P931, DOI 10.1016/j.jacc.2014.12.036
   Patel SD, 2016, BR J SURG
   Spanos K, 2016, J CARDIOVASC SURG TO
   Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211
   TONNESEN KH, 1988, CARDIOVASC INTER RAD, V11, P127, DOI 10.1007/BF02577101
   Villas PA, 1999, J VASC INTERV RADIOL, V10, P325, DOI 10.1016/S1051-0443(99)70038-2
   Yilmaz S, 2002, EUR RADIOL, V12, P911, DOI 10.1007/s003300101043
NR 21
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 89
EP 96
DI 10.4070/kcj.2016.0310
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200015
PM 28154596
OA Green Published
DA 2021-04-22
ER

PT J
AU Bassiri, HA
   Abdi, S
   Shafe, O
   Sarpooshi, J
AF Bassiri, Hossein Ali
   Abdi, Seifollah
   Shafe, Omid
   Sarpooshi, Javad
TI Early and Midterm Results Following Interventional Coarctoplasty:
   Evaluation of Variables That Can Affect the Results
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic coarctation; Stents; Aorta; thoracic
ID BALLOON ANGIOPLASTY; STENT IMPLANTATION; NATIVE COARCTATION; AORTIC
   COARCTATION; BLOOD-PRESSURE; INTERMEDIATE; ADULT; ADOLESCENT;
   CONSORTIUM; CCISC
AB Background and Objectives: Stent coarctoplasty has been approved as the treatment of choice for adult patients with coarctation of the aorta. We have evaluated the early and midterm clinical and procedural results after interventional coarctoplasty. Also, variables that can affect these results were evaluated.
   Subjects and Methods: Gathering clinical, angiographic and procedural data, we evaluated the pre-specified outcomes, including procedural success, complications, the incidence of hypertension after coarctoplasty etc., after the procedure. The effect of pre-specified variables including aortic arch shape, coarctation type and etc. on the procedural result was evaluated.
   Results: Between February 2005 through March 2014, 133 stent coarctoplasty procedures were performed. Median age was 23.5 years old (interquartile range [IQR]:19-28), and 105 (71.9%) were male. Nearly all of the patients were undergone stent coarctoplasty, mostly with cheatham platinum (CP) stents. There was no association between aortic arch morphology and acute procedural complications. Balloon length more than 40 mm (p=0.028), aorta diameter at the site of Coarctation larger than 2.35 mm (p=0.008) was associated with higher rate of restenosis during follow-up. Comparison between the prevalence of hypertension (HTN) before and after coarctoplasty showed a significant reduction in the prevalence of HTN (117 [91.4%] vs. 95 [74.20/o] p<0.001).
   Conclusion: Stent coarctoplasty is a low-risk procedure with favorable early and delayed outcomes. Most mortality is related to the patient's comorbid conditions and not to the procedure.
C1 [Bassiri, Hossein Ali; Abdi, Seifollah; Shafe, Omid; Sarpooshi, Javad] Iran Univ Med Sci, Cardiovasc Intervent Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
RP Abdi, S (corresponding author), Iran Univ Med Sci, Cardiovasc Intervent Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
EM safeabdi@gmail.com
RI Bassiri, Hamid/B-9840-2014
OI Bassiri, Hamid/0000-0001-6532-8478
CR Baykan A, 2009, TURKISH J PEDIATR, V51, P116
   Chen SSM, 2008, HEART, V94, P919, DOI 10.1136/hrt.2006.109389
   Feltes TF, 2011, CIRCULATION, V123, P2607, DOI 10.1161/CIR.0b013e31821b1f10
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P569, DOI 10.1002/ccd.21191
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P276, DOI 10.1002/ccd.21164
   Forbes TJ, 2011, J AM COLL CARDIOL, V58, P2664, DOI 10.1016/j.jacc.2011.08.053
   Godart F, 2011, ARCH CARDIOVASC DIS, V104, P627, DOI 10.1016/j.acvd.2011.08.005
   Harrison DA, 2001, HEART, V85, P561, DOI 10.1136/heart.85.5.561
   Holzer R, 2010, CATHETER CARDIO INTE, V76, P553, DOI 10.1002/ccd.22587
   Marshall AC, 2000, AM HEART J, V139, P1054, DOI 10.1067/mhj.2000.106616
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810, DOI 10.1016/S0735-1097(96)00379-8
   Mullen MJ, 2003, HEART, V89, P3, DOI 10.1136/heart.89.1.3
   Ou P, 2006, J THORAC CARDIOV SUR, V132, P1105, DOI 10.1016/j.jtcvs.2006.05.061
   Peters B, 2009, ANN PEDIAT CARDIOL, V2, P3, DOI 10.4103/0974-2069.52802
   Ringel RE, 2012, AM HEART J, V164, P7, DOI 10.1016/j.ahj.2012.04.008
   Turner D R, 2007, Semin Intervent Radiol, V24, P153, DOI 10.1055/s-2007-980052
NR 16
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 97
EP 106
DI 10.4070/kcj.2016.0211
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200016
PM 28154597
OA Green Published
DA 2021-04-22
ER

PT J
AU Jun, WY
   Ann, YK
   Kim, JY
   Son, JS
   Kim, SJ
   Yang, HS
   Bae, SH
   Chung, S
   Kim, KS
AF Jun, Woo Young
   Ann, Yu Kyung
   Kim, Ja Yeong
   Son, Jae Sung
   Kim, Soo-Jin
   Yang, Hyun Suk
   Bae, Sun Hwan
   Chung, Sochung
   Kim, Kyo Sun
TI Kawasaki Disease with Fever and Cervical Lymphadenopathy as the Sole
   Initial Presentation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lymphadenopathy; Neck; Coronary arteries; Kawasaki disease
ID INTRAVENOUS IMMUNOGLOBULIN TREATMENT; PREDICTION; LYMPHADENITIS;
   DIAGNOSIS
AB Background and Objectives: Some patients with Kawasaki disease (KD) present with fever and cervical lymphadenopathy alone. The purpose of this study was to characterize the clinical features of these unusual KD patients and determine whether this is a severe form of KD associated with increased risks of intravenous immunoglobulin (IVIG) resistance and coronary artery lesions (CALs).
   Subjects and Methods: A total of 146 children with KD were reviewed retrospectively, and classified into two groups according to initial clinical features. Those presenting with only fever and cervical lymphadenopathy (LKD) were classified as LKD patients. Other-KD patients included all except the LKD patients.
   Results: Among 146 KD patients, 13 (8.90/o) were classified as LKD patients. The LKD patients were significantly older and admitted earlier. The duration between fever onset and KD diagnosis was significantly longer in the LKD patients (5.9 days vs. 4.9 days, p=0.023). The frequency of IVIG resistance was not different between the two groups., In the LKD patients, the incidence of CALs was significantly higher in the acute phase, and without significant difference in the convalescent phase. The percentage of neutrophils and C-reactive protein, albumin, and total bilirubin levels were significantly higher in LKD patients.
   Conclusion: Even though LKD patients were older, admitted earlier, and had higher inflammatory marker levels, they did not have a greater risk of CALs or IVIG resistance. However, echocardiography may be helpful in the acute stage if patients have only fever and cervical lymphadenopathy and are unresponsive to empirical antibiotics.
C1 [Jun, Woo Young; Ann, Yu Kyung; Kim, Ja Yeong; Son, Jae Sung; Kim, Soo-Jin; Bae, Sun Hwan; Chung, Sochung; Kim, Kyo Sun] Konkuk Univ, Sch Med, Med Ctr, Dept Pediat, 120-1 Neungdong Ro, Seoul 05030, South Korea.
   [Yang, Hyun Suk] Konkuk Univ, Sch Med, Med Ctr, Dept Cardiovasc Med, Seoul, South Korea.
RP Son, JS (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Pediat, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM drsonped@kuh.ac.kr
RI Yang, Hyun Suk/X-6266-2019; Chung, Sochung/AAU-7950-2020; Kim,
   Soo-Jin/P-2677-2014
OI Yang, Hyun Suk/0000-0002-7056-3648; Chung, Sochung/0000-0002-7655-2691;
   Son, Jae Sung/0000-0002-1970-9461; Kim, Soo-Jin/0000-0001-9671-6019
CR Anderson MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1824
   APRIL MM, 1989, ARCH OTOLARYNGOL, V115, P512
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   ElAdawy M, 2011, PEDIATR INFECT DIS J, V30, P141, DOI 10.1097/INF.0b013e3181f6fe2a
   Eleftheriou D, 2014, ARCH DIS CHILD, V99, P74, DOI 10.1136/archdischild-2012-302841
   Kanegaye JT, 2013, J PEDIATR-US, V162, P1259, DOI 10.1016/j.jpeds.2012.11.064
   Kao HT, 2001, OTOLARYNG HEAD NECK, V124, P468, DOI 10.1067/mhn.2001.114796
   Kawasaki T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2
   Kubota M, 2008, J PAEDIATR CHILD H, V44, P359, DOI 10.1111/j.1440-1754.2008.01310.x
   Muta H, 2012, PEDIATRICS, V129, pE291, DOI 10.1542/peds.2011-1704
   Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182
   Nomura Y, 2010, J PEDIATR-US, V156, P786, DOI 10.1016/j.jpeds.2009.11.042
   Park AH, 1997, INT J PEDIATR OTORHI, V40, P41, DOI 10.1016/S0165-5876(97)01494-8
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN, P56
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   STAMOS JK, 1994, PEDIATRICS, V93, P525
   Tashiro N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e77
   Yanagi S, 2008, PEDIATR INT, V50, P179, DOI 10.1111/j.1442-200X.2008.02547.x
NR 20
TC 6
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 107
EP 114
DI 10.4070/kcj.2016.0160
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200017
PM 28154598
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, IH
   Jeong, MH
   Kim, JH
   Park, YH
   Lim, KS
   Park, DS
   Shim, JW
   Kim, JH
   Ahn, Y
   Hong, YJ
   Sim, DS
AF Bae, In-Ho
   Jeong, Myung Ho
   Kim, Ju Han
   Park, Yong Hwan
   Lim, Kyung Seob
   Park, Dae Sung
   Shim, Jae Won
   Kim, Jung Ha
   Ahn, Youngkeun
   Hong, Young Joon
   Sim, Doo Sun
TI The Control of Drug Release and Vascular Endothelialization after
   Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation
   in Porcine Coronary Restenosis Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Hyaluronic acid; Paclitaxel; Preclinical drug evaluation;
   Coronary restenosis
ID BARE METAL STENTS; ELUTING-STENTS; LATE THROMBOSIS; IN-VIVO; EFFICACY;
   ACTIVATION; DELIVERY; SAFETY; METAANALYSIS; ANGIOPLASTY
AB Background and Objectives: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel (PTX)-eluting stent via simple ionic interactions and to evaluate its effects in vitro and in vivo.
   Materials and Methods: HA and catechol were conjugated by means of an activation agent, and then the stent was immersed in this solution (resulting in a HA-coated stent). After that, PTX was immobilized on the HA-coated stent (resulting in a hyaluronic acid-coated paclitaxel-eluting stent [H-PTX stent]). Study groups were divided into 4 groups: bare metal stent (BMS), HA, H-PTX, and poly (L-lactide)coated paclitaxel-eluting stent (P-PTX). Stents were randomly implanted in a porcine coronary artery. After 4 weeks, vessels surrounding the stents were isolated and subjected to various analyses.
   Results: Smoothness of the surface was maintained after expansion of the stent. In contrast to a previous study on a PTX-eluting stent, in this study, the PTX was effectively released up to 14 days (a half amount of PTX in 4 days). The proliferation of smooth muscle cells was successfully inhibited (by 80.5+12.110/o at 7 days of culture as compared to the control) by PTX released from the stent. Animal experiments showed that the H-PTX stent does not induce an obvious inflammatory response. Nevertheless, restenosis was clearly decreased in the H-PTX stent group (9.8+3.25%) compared to the bare-metal stent group (29.7+8.11%).
   Conclusion: A stent was stably coated with P-D( via simple ionic interactions with HA. Restenosis was decreased in the H-PTX group. These results suggest that HA, a natural polymer, is suitable for fabrication of drug-eluting stents (without inflammation) as an alternative to a synthetic polymer.
C1 [Bae, In-Ho; Jeong, Myung Ho; Lim, Kyung Seob; Park, Dae Sung; Shim, Jae Won; Kim, Jung Ha] Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Gwangju, South Korea.
   [Bae, In-Ho; Jeong, Myung Ho; Kim, Ju Han; Park, Yong Hwan; Lim, Kyung Seob; Park, Dae Sung; Shim, Jae Won; Kim, Jung Ha; Ahn, Youngkeun; Hong, Young Joon; Sim, Doo Sun] Korea Cardiovasc Stent Res Inst, Jangsung, South Korea.
   [Jeong, Myung Ho; Kim, Ju Han; Ahn, Youngkeun; Hong, Young Joon; Sim, Doo Sun] Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Park, Yong Hwan] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Internal Med, Chang Won, South Korea.
RP Kim, JH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM kim@zuhan.com
FU Korean Society of Cardiology [201203-04]
FX This study was supported by a research grant from the Korean Society of
   Cardiology (201203-04).
CR Albrecht T, 2007, INVEST RADIOL, V42, P579, DOI 10.1097/RLI.0b013e31804f5a60
   Bae IH, 2015, J IND ENG CHEM, V21, P1295, DOI 10.1016/j.jiec.2014.05.045
   Baek S, 1998, CIRC RES, V82, P295, DOI 10.1161/01.RES.82.3.295
   Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625
   Barbucci R, 1998, J THROMB THROMBOLYS, V6, P109, DOI 10.1023/A:1008841303634
   Buszman P, 2007, KARDIOL POL, V65, P1041
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Che HL, 2016, KOREAN CIRC J, V46, P23, DOI 10.4070/kcj.2016.46.1.23
   CLOWES AW, 1985, LAB INVEST, V52, P611
   Commandeur Suzan, 2006, J Interv Cardiol, V19, P500, DOI 10.1111/j.1540-8183.2006.00198.x
   Ding DW, 2014, AAPS PHARMSCITECH, V15, P213, DOI 10.1208/s12249-013-0041-3
   Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017
   Herdeg C, 2000, J AM COLL CARDIOL, V35, P1969, DOI 10.1016/S0735-1097(00)00614-8
   Jabara R, 2008, JACC-CARDIOVASC INTE, V1, P81, DOI 10.1016/j.jcin.2007.11.009
   Kamath KR, 2006, ADV DRUG DELIVER REV, V58, P412, DOI 10.1016/j.addr.2006.01.023
   Kee WJ, 2011, KOREAN CIRC J, V41, P754, DOI 10.4070/kcj.2011.41.12.754
   Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479
   Kolodgie FD, 2002, CIRCULATION, V106, P1195, DOI 10.1161/01.CIR.0000032141.31476.15
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011
   Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071
   Otsuka Yoritaka, 2007, J Invasive Cardiol, V19, P71
   Park S, 2012, BIOMATERIALS, V33, P5468, DOI 10.1016/j.biomaterials.2012.04.005
   POPMA JJ, 1991, CIRCULATION, V84, P1426, DOI 10.1161/01.CIR.84.3.1426
   Qian Z, 2006, MOL THER, V13, P694, DOI 10.1016/j.ymthe.2005.11.016
   Regar E, 2001, BRIT MED BULL, V59, P227, DOI 10.1093/bmb/59.1.227
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974
   Seidel CL, 1997, ARTERIOSCL THROM VAS, V17, P1868, DOI 10.1161/01.ATV.17.10.1868
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Waugh John, 2004, Am J Cardiovasc Drugs, V4, P257, DOI 10.2165/00129784-200404040-00006
NR 32
TC 3
Z9 3
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 123
EP 131
DI 10.4070/kcj.2016.0203
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200019
PM 28154600
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, K
   Choi, JO
   Yang, JH
   Park, SJ
   Kim, SH
   Kang, J
   Joh, HS
   Shin, SH
AF Lim, Kyunghee
   Choi, Jin-Oh
   Yang, Jeong Hoon
   Park, Seung-Jung
   Kim, Sun Hwa
   Kang, Jiseok
   Joh, Hyun Sung
   Shin, Sun Hye
TI Cardiac Resynchronization Therapy Device Implantation in a Patient with
   Cardiogenic Shock under Percutaneous Mechanical Circulatory Support
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac resynchronization therapy; Extracorporeal membrane oxygenation;
   Shock; cardiogenic
ID RESYNCHRONISATION THERAPY
AB A 65-year-old woman was admitted to our hospital with acute decompensated heart failure with reduced left ventricular ejection fraction and severe mitral regurgitation. Electrocardiography revealed a typical left bundle branch block and atrial fibrillation. Her condition deteriorated despite administering high-doses of inotropes and vasopressors. Pending a decision to therapy, venoarterial extracorporeal membrane oxygenation (ECMO) was performed when the patient underwent a cardiogenic shock. Although the hemodynamic status stabilized with ECMO support, weaning the patient from ECMO was not possible. Thus, we decided to perform cardiac resynchronization with defibrillator implantation as a "rescue" therapy. Five days post-implantation, the patient was successfully weaned from ECMO.
C1 [Lim, Kyunghee; Choi, Jin-Oh; Yang, Jeong Hoon; Park, Seung-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol, Seoul, South Korea.
   [Kim, Sun Hwa; Kang, Jiseok; Joh, Hyun Sung; Shin, Sun Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM choijean5@gmail.com
RI choi, jo/O-5940-2014
CR Bang Ji Hyun, 2015, Korean J Thorac Cardiovasc Surg, V48, P55, DOI 10.5090/kjtcs.2015.48.1.55
   Bhattacharya S, 2010, J CARD FAIL, V16, P931, DOI 10.1016/j.cardfail.2010.07.253
   Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206
   Cowburn PJ, 2005, EUR J HEART FAIL, V7, P215, DOI 10.1016/j.ejheart.2004.11.005
   Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6
   Mantziari L, 2013, INT J CARDIOL, V163, P141, DOI 10.1016/j.ijcard.2011.05.034
   Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431
   National Institute for Health and Care Excellence, 2014, IMPL CARD DEF CARD R
   Pecha S, 2012, INTERACT CARDIOV TH, V15, P922, DOI 10.1093/icvts/ivs338
   Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555
   Serri K, 2007, CAN J CARDIOL, V23, P303, DOI 10.1016/S0828-282X(07)70760-2
   Sokal A, 2014, KARDIOL POL, V72, P777, DOI 10.5603/KP.a2014.0090
   Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1
   Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043
   Zaeem F, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/319205
NR 15
TC 2
Z9 2
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 132
EP 135
DI 10.4070/kcj.2016.0176
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200020
PM 28154601
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, IG
   Kim, SH
   Oh, YS
   Rho, TH
AF Song, In Geol
   Kim, Sung-Hwan
   Oh, Yong-Seog
   Rho, Tai-Ho
TI Underdevelopment of Left Atrial Appendage
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Atrial appendage
ID CONGENITAL ABSENCE; HEART
AB A patient was admitted for catheter ablation of atrial fibrillation. Cardiac computed tomography and transesophageal echocardiography revealed the absence of the left atrial appendage. However, the right atrial appendage looked normal and the level of pro B-natriuretic peptide was within normal limits. Successful catheter ablation was performed without any procedural complications and the sinus rhythm was appropriately maintained for 10 months with an antiarrhythmic drug.
C1 [Song, In Geol] Konyang Univ Hosp, Div Cardiol, Ctr Heart, Daejeon, South Korea.
   [Kim, Sung-Hwan; Oh, Yong-Seog; Rho, Tai-Ho] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM oys@catholic.ac.kr
CR CHAPEAU C, 1985, J HISTOCHEM CYTOCHEM, V33, P541, DOI 10.1177/33.6.3158698
   Collier P, 2012, CIRC-CARDIOVASC IMAG, V5, P549, DOI 10.1161/CIRCIMAGING.112.975516
   deBold AJ, 1996, CARDIOVASC RES, V31, P7, DOI 10.1016/0008-6363(95)00121-2
   Donal E, 2005, CHEST, V128, P1853, DOI 10.1378/chest.128.3.1853
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Rosso R, 2014, J CARDIOVASC ELECTR, V25, P795, DOI 10.1111/jce.12383
   Saleh M, 2015, ECHOCARDIOGR-J CARD, V32, P1206, DOI 10.1111/echo.12882
   Tabata T, 1998, AM J CARDIOL, V81, P327, DOI 10.1016/S0002-9149(97)00903-X
   Yoshihara F, 1998, J THORAC CARDIOV SUR, V116, P213, DOI 10.1016/S0022-5223(98)70119-9
   Zhang ZJ, 2013, ACTA CARDIOL, V68, P325, DOI 10.1080/AC.68.3.2983429
NR 10
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 141
EP 143
DI 10.4070/kcj.2016.0181
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200022
PM 28154603
OA Green Published
DA 2021-04-22
ER

PT J
AU Al-Dairy, A
   Rezaei, Y
   Pouraliakbar, H
   Mahdavi, M
   Bayati, P
   Gholampour-Dehaki, M
AF Al-Dairy, Alwaleed
   Rezaei, Yousef
   Pouraliakbar, Hamidreza
   Mahdavi, Mohammad
   Bayati, Parvin
   Gholampour-Dehaki, Maziar
TI Surgical Repair for Anomalous Origin of the Right Coronary Artery from
   the Pulmonary Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital abnormalities; Coronary vessel anomalies; Cardiac surgical
   procedures; Electrocardiography
AB Anomalous origin of the right coronary artery from the pulmonary artery (ARCAPA) is a very rare congenital heart defect. Herein, we describe three cases of ARCAPA in an 8 months old, 18 months old, and 4 year old child. Two cases were incidentally diagnosed using a computed tomographic angiograph, and the other was incidentally diagnosed using a coronary angiograph. These cases underwent a reimplantation technique on diagnosis and resulting in positive clinical outcomes during the follow-up period which was a mean of 1.5 years.
C1 [Al-Dairy, Alwaleed; Gholampour-Dehaki, Maziar] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Div Congenital Cardiac Surg, Dept Cardiovasc Surg, Tehran, Iran.
   [Rezaei, Yousef] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Heart Valve Dis Res Ctr, Tehran, Iran.
   [Pouraliakbar, Hamidreza] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Dept Radiol, Tehran, Iran.
   [Mahdavi, Mohammad; Bayati, Parvin] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Dept Pediat Cardiol, Tehran, Iran.
RP Gholampour-Dehaki, M (corresponding author), Rajaie Cardiovasc Med & Res Ctr, Div Congenital Cardiac Surg, Dept Cardiovasc Surg, Tehran 1996911151, Iran.
EM drgholampour@yahoo.com
RI Al-Dairy, Alwaleed/P-6286-2019; Dehaki, Maziar Gholampour/AAY-6866-2020
OI Rezaei, Yousef/0000-0002-6804-4232; Al-Dairy,
   Alwaleed/0000-0002-2239-646X
CR Brooks H S, 1885, J Anat Physiol, V20, P26
   Gupta R, 2012, ANN PEDIAT CARDIOL, V5, P95, DOI 10.4103/0974-2069.93727
   Hauser M, 2005, HEART, V91, P1240, DOI 10.1136/hrt.2004.057299
   최에스터, 2002, The Korean Journal of Thoracic and Cardiovascular Surgery, V35, P894
   Kuba Paresh Kumar, 2013, Sultan Qaboos Univ Med J, V13, P169
   Li RJ, 2010, TEX HEART I J, V37, P376
   Maroules CD, 2013, TEX HEART I J, V40, P106
   Williams IA, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.023
   Winner MW, 2011, CASE REP MED, V2011, DOI 10.1155/2011/642126
   박정수, 2008, Korean Circulation Journal, V38, P627
NR 10
TC 6
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 144
EP 147
DI 10.4070/kcj.2016.0174
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200023
PM 28154604
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MJ
AF Kim, Mi-Jeong
TI Paradoxical Low-Flow, Low-Gradient Aortic Stenosis-a Tough Nut to Crack
   in Echocardiographic Diagnosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Mi-Jeong] Incheon St Marys Hosp, Dept Cardiovasc Med, Inchon, South Korea.
   [Kim, Mi-Jeong] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Kim, MJ (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Cardiovasc Med, Coll Med, 56 Dongsu Ro, Inchon 21431, South Korea.
EM mjkim@catholic.ac.kr
CR Abudiab MM, 2017, KOREAN CIRC J, V47, P82, DOI 10.4070/kcj.2016.0126
   Clavel MA, 2016, EUR HEART J, V37, P2645, DOI 10.1093/eurheartj/ehw096
   Clavel MA, 2015, JACC-CARDIOVASC IMAG, V8, P248, DOI 10.1016/j.jcmg.2015.01.009
   Clavel MA, 2013, JACC-CARDIOVASC IMAG, V6, P175, DOI 10.1016/j.jcmg.2012.10.015
   Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063
   Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029
NR 6
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 25
EP 26
DI 10.4070/kcj.2016.0413
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200004
PM 28154585
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, J
AF Song, Jinyoung
TI Progress toward Approval of Stents in Coarctation of the Aorta
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BALLOON ANGIOPLASTY; TRIAL COAST; MULTICENTER; SURGERY
C1 [Song, Jinyoung] Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Song, J (corresponding author), Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM amyjys@naver.com
CR Bassiri HA, 2017, KOREAN CIRC J, V47, P97, DOI 10.4070/kcj.2016.0211
   Cowley CG, 2005, CIRCULATION, V111, P3453, DOI 10.1161/CIRCULATIONAHA.104.510198
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P569, DOI 10.1002/ccd.21191
   Harris KC, 2014, CATHETER CARDIO INTE, V83, P1116, DOI 10.1002/ccd.25284
   Kvitting JPE, 2009, ANN THORAC SURG, V87, P342, DOI 10.1016/j.athoracsur.2008.08.072
   LOCK JE, 1983, CIRCULATION, V68, P109, DOI 10.1161/01.CIR.68.1.109
   Meadows J, 2015, CIRCULATION, V131, P1656, DOI 10.1161/CIRCULATIONAHA.114.013937
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   Ringel RE, 2012, AM HEART J, V164, P7, DOI 10.1016/j.ahj.2012.04.008
   Padua LMS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008204.pub2
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 27
EP 28
DI 10.4070/kcj.2016.0407
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200005
PM 28154586
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, JH
AF Oh, Jin-Hee
TI Understanding Kawasaki Disease on the Ground of Pediatric Growth and
   Lymphoid Tissue Maturation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID NATIONWIDE SURVEY; SOUTH-KOREA; LYMPHADENOPATHY
C1 [Oh, Jin-Hee] Catholic Univ Korea, St Vincents Hosp, Dept Pediat, Coll Med, 93 Jungbu Daero, Suwon 16247, South Korea.
RP Oh, JH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Dept Pediat, Coll Med, 93 Jungbu Daero, Suwon 16247, South Korea.
EM jeany@catholic.ac.kr
CR Buckley RH., 2016, NELSON TXB PEDIAT, P1006
   Jun WY, 2017, KOREAN CIRC J, V47, P107, DOI 10.4070/kcj.2016.0160
   Kim GB, 2014, KOREAN CIRC J, V44, P250, DOI 10.4070/kcj.2014.44.4.250
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kubota M, 2008, J PAEDIATR CHILD H, V44, P359, DOI 10.1111/j.1440-1754.2008.01310.x
   Makino N, 2015, J EPIDEMIOL, V25, P239, DOI 10.2188/jea.JE20140089
   Nomura Y, 2010, J PEDIATR-US, V156, P786, DOI 10.1016/j.jpeds.2009.11.042
   Yanagi S, 2008, PEDIATR INT, V50, P179, DOI 10.1111/j.1442-200X.2008.02547.x
NR 8
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 29
EP 30
DI 10.4070/kcj.2016.0408
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200006
PM 28154587
OA Green Published
DA 2021-04-22
ER

PT J
AU Virk, HU
   Inayat, F
   Athar, MW
   Mirrani, GA
   Ghani, AR
   Sardar, MR
AF Virk, Hafeez Ul Hassan
   Inayat, Faisal
   Athar, Muhammed Waqas
   Mirrani, Ghazi A.
   Ghani, Ali Raza
   Sardar, Muhammad Rizwan
TI Prolonged Systole in a Patient with Hypothermia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Virk, Hafeez Ul Hassan] Icahn Sch Med Mt Sinai, St Lukes Roosevelt Hosp, Dept Med, New York, NY 10029 USA.
   [Inayat, Faisal] Weill Cornell Med Coll, New York Presbyterian Hosp, Dept Med, 525 East 68th St, New York, NY 10065 USA.
   [Athar, Muhammed Waqas] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA.
   [Mirrani, Ghazi A.] Lehigh Valley Hosp, Allentown, PA USA.
   [Ghani, Ali Raza] Abington Jefferson Hosp, Dept Med, Abington, PA USA.
   [Sardar, Muhammad Rizwan] Brown Univ, Rhode Isl Hosp, Intervent Cardiol & Struct Heart Dis, Warren Alpert Sch Med, Providence, RI 02903 USA.
RP Inayat, F (corresponding author), Weill Cornell Med Coll, New York Presbyterian Hosp, Dept Med, 525 East 68th St, New York, NY 10065 USA.
EM faisalinayat@hotmail.com
RI Inayat, Faisal/S-4533-2019
CR Steendijk P, 2011, CRIT CARE, V15, DOI 10.1186/cc9989
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2017
VL 47
IS 1
BP 148
EP 149
DI 10.4070/kcj.2016.0069
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI5TR
UT WOS:000392558200024
PM 28154605
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, Y
AF Cho, Yongkeun
TI Management of Patients with Long QT Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Long QT syndrome; Adrenergic beta-blocker; Sympathectomy;
   Defibrillators; implantable
ID CARDIAC SYMPATHETIC DENERVATION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;
   BETA-BLOCKER THERAPY; RISK-FACTORS; EVENTS; RECOMMENDATIONS;
   ASSOCIATION; EXERCISE; TRIGGER; ASTHMA
AB Long QT syndrome (LQTS) is a rare cardiac channelopathy associated with syncope and sudden death due to torsades de pointes and ventricular fibrillation. Syncope and sudden death are frequently associated with physical and emotional stress. Management of patients with LQTS consists of life-style modification, beta-blockers, left cardiac sympathetic denervation (LCSD), and implantable cardioverter-defibrillator (ICD) implantation. Prohibition of competitive exercise and avoidance of QT-prolonging drugs are important issues in life-style modification. Although beta-blockers are the primary treatment modality for patients with LQTS, these drugs are not completely effective in some patients. Lifelong ICD implantation in young and active patients is associated with significant complications. LCSD is a relatively simple and highly effective surgical procedure. However, LCSD is rarely used.
C1 [Cho, Yongkeun] Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea.
RP Cho, Y (corresponding author), Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea.
EM choyk@knu.ac.kr
CR Abu-Zeitone A, 2014, J AM COLL CARDIOL, V64, P1352, DOI 10.1016/j.jacc.2014.05.068
   Abu-Zeitone A, 2014, HEART RHYTHM, V11, P1170, DOI 10.1016/j.hrthm.2014.04.016
   Ackerman MJ, 2015, J AM COLL CARDIOL, V66, P2424, DOI 10.1016/j.jacc.2015.09.042
   Ackerman Michael J, 2015, Trends Cardiovasc Med, V25, P67, DOI 10.1016/j.tcm.2014.07.007
   Antiel RM, 2016, HEART RHYTHM, V13, P62, DOI 10.1016/j.hrthm.2015.09.001
   Bos JM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P705, DOI 10.1161/CIRCEP.113.000102
   Chockalingam P, 2012, J AM COLL CARDIOL, V60, P2092, DOI 10.1016/j.jacc.2012.07.046
   Choi G, 2004, CIRCULATION, V110, P2119, DOI 10.1161/01.CIR.0000144471.98080.CA
   Christian S, 2016, CARDIOL YOUNG, V26, P1123, DOI 10.1017/S1047951115001894
   Collins S, 2012, PAEDIATR RESPIR REV, V13, P100, DOI 10.1016/j.prrv.2011.02.003
   Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018
   Crean AM, 2009, CAN J CARDIOL, V25, pE357, DOI 10.1016/S0828-282X(09)70723-8
   Etheridge SP, 2003, J AM COLL CARDIOL, V42, P1777, DOI 10.1016/j.jacc.2003.07.006
   Gaba P, 2016, HEART RHYTHM, V13, P879, DOI 10.1016/j.hrthm.2015.12.008
   Goldenberg I, 2012, HEART RHYTHM, V9, P49, DOI 10.1016/j.hrthm.2011.08.020
   Hocini M, 2014, EUROPACE, V16, P600, DOI 10.1093/europace/euu074
   Horner JM, 2010, HEART RHYTHM, V7, P1616, DOI 10.1016/j.hrthm.2010.08.023
   Johnson JN, 2013, BRIT J SPORT MED, V47, P28, DOI 10.1136/bjsports-2012-091751
   Kim JA, 2010, HEART RHYTHM, V7, P1797, DOI 10.1016/j.hrthm.2010.09.011
   Koponen M, 2015, CIRC-ARRHYTHMIA ELEC, V8, P815, DOI 10.1161/CIRCEP.114.002654
   Lampert R, 2013, CIRCULATION, V127, P2021, DOI 10.1161/CIRCULATIONAHA.112.000447
   Lee YS, 2013, J KOREAN MED SCI, V28, P1454, DOI 10.3346/jkms.2013.28.10.1454
   Lin CR, 2008, CARDIOLOGY, V110, P145, DOI 10.1159/000111923
   Loar RW, 2015, J CARDIOVASC ELECTR, V26, P300, DOI 10.1111/jce.12600
   Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060
   Monnig G, 2012, EUROPACE, V14, P396, DOI 10.1093/europace/eur316
   MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136
   Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616
   Nordkamp LRAO, 2016, HEART RHYTHM, V13, P443, DOI 10.1016/j.hrthm.2015.09.010
   Nordkamp LRO, 2013, CIRC-ARRHYTHMIA ELEC, V6, P91, DOI 10.1161/CIRCEP.112.975268
   Park YM, 2013, KOREAN CIRC J, V43, P830, DOI 10.4070/kcj.2013.43.12.830
   Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325
   Poterucha JT, 2015, HEART RHYTHM, V12, P1815, DOI 10.1016/j.hrthm.2015.04.034
   Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341
   Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014
   Rosero SZ, 1999, AM J CARDIOL, V84, P1406, DOI 10.1016/S0002-9149(99)00586-X
   Schwartz PJ, 2015, TRENDS CARDIOVAS MED, V25, P376, DOI 10.1016/j.tcm.2014.09.017
   Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089
   Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044
   Schwartz PJ, 2010, CIRCULATION, V122, P1272, DOI 10.1161/CIRCULATIONAHA.110.950147
   Schwartz PJ, 2009, HEART RHYTHM, V6, P760, DOI 10.1016/j.hrthm.2009.04.009
   Schwartz PJ, 2001, CIRCULATION, V103, P89
   SCHWARTZ PJ, 1976, AM J CARDIOL, V37, P1034, DOI 10.1016/0002-9149(76)90420-3
   Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E
   SCHWARTZ PJ, 1979, CIRC RES, V44, P637, DOI 10.1161/01.RES.44.5.637
   Seth R, 2007, J AM COLL CARDIOL, V49, P1092, DOI 10.1016/j.jacc.2006.09.054
   Thottathil P, 2008, AM J CARDIOL, V102, P871, DOI 10.1016/j.amjcard.2008.05.029
   Vincent GM, 2009, CIRCULATION, V119, P215, DOI 10.1161/CIRCULATIONAHA.108.772533
   Viskin S, 2009, CIRCULATION, V119, P204, DOI 10.1161/CIRCULATIONAHA.108.826198
   Wilde AAM, 1999, J AM COLL CARDIOL, V33, P327, DOI 10.1016/S0735-1097(98)00578-6
   Zhang C, 2015, J CARDIOVASC ELECTR, V26, P1039, DOI 10.1111/jce.12739
   Zipes DP, 2005, J AM COLL CARDIOL, V45, P1354, DOI 10.1016/j.jacc.2005.02.014
NR 52
TC 8
Z9 9
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 747
EP 752
DI 10.4070/kcj.2016.46.6.747
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700001
PM 27826330
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, IH
   Oh, GT
AF Jung, In-Hyuk
   Oh, Goo Taeg
TI The Roles of CD137 Signaling in Atherosclerosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE CD137; Atherosclerosis; T cell; Plaque stability
ID REGULATORY T-CELLS; DENDRITIC CELLS; CATHEPSIN-K; REDUCES
   ATHEROSCLEROSIS; CLINICAL-IMPLICATIONS; INTERFERON-GAMMA; POTENTIAL
   ROLE; GROWTH-FACTOR; RECEPTOR; 4-1BB
AB The tumor necrosis factor receptor superfamily (TNFRSF), which includes CD40, LIGHT, and OX40, plays important roles in the initiation and progression of cardiovascular diseases, involving atherosclerosis. CD137, a member of TNFRSF, is a well-known activation-induced T cell co-stimulatory molecule and has been reported to be expressed in human atherosclerotic plaque lesions, and plays pivotal roles in mediating disease processes. In this review, we focus on and summarize recent advances in mouse studies on the involvement of CD137 signaling in the pathogenesis and plaque stability of atherosclerosis, thereby highlighting a valuable therapeutic target in atherosclerosis.
C1 [Jung, In-Hyuk; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
   [Jung, In-Hyuk] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63110 USA.
RP Oh, GT (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
EM gootaeg@ewha.ac.kr
FU National Research Foundation (NRF) of Korea grants (MESA)
   [2012R1A3A2026454, 2010-0020878]; Bio & Medical Technology Development
   Program of the NRF (MSIP) by the Korea government [2015M3A9B6029138]
FX We thank the members of the GTO laboratory for their participation in
   our valuable discussions. This work was supported by National Research
   Foundation (NRF) of Korea grants (MESA, No. 2012R1A3A2026454 and No.
   2010-0020878) and the Bio & Medical Technology Development Program of
   the NRF (MSIP, No. 2015M3A9B6029138) by the Korea government.
CR Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343
   Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753
   Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218
   Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479
   Bjorkbacka H, 2013, ATHEROSCLEROSIS, V227, P9, DOI 10.1016/j.atherosclerosis.2012.10.074
   Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8
   Broll K, 2001, AM J CLIN PATHOL, V115, P543, DOI 10.1309/E343-KMYX-W3Y2-10KY
   Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784
   Chen Yi, 2008, Tokai J Exp Clin Med, V33, P28
   Chistiakov DA, 2016, J CELL MOL MED, V20, P17, DOI 10.1111/jcmm.12689
   Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459
   Choi ET, 2005, ARTERIOSCL THROM VAS, V25, P1020, DOI 10.1161/01.ATV.0000161275.82687.f6
   Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014
   Clarke M, 2006, AM J NEPHROL, V26, P531, DOI 10.1159/000097815
   Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148
   Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003
   Dongming L, 2010, CLIN CHIM ACTA, V411, P406, DOI 10.1016/j.cca.2009.12.011
   Foks AC, 2015, ARTERIOSCL THROM VAS, V35, P280, DOI 10.1161/ATVBAHA.114.303568
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428
   Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263
   Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074
   Guo J, 2009, CARDIOVASC RES, V81, P278, DOI 10.1093/cvr/cvn311
   Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10
   Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882
   Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100
   Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001
   Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019
   Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340
   Jeon HJ, 2010, CIRCULATION, V121, P1124, DOI 10.1161/CIRCULATIONAHA.109.882704
   Jung IH, 2014, FASEB J, V28, P4779, DOI 10.1096/fj.14-253732
   Kim SH, 2001, JPN CIRC J, V65, P136, DOI 10.1253/jcj.65.136
   Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523
   Kuang YL, 2012, ONCOL LETT, V3, P477, DOI 10.3892/ol.2011.506
   Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0
   Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2
   Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483
   Lee SW, 2006, J IMMUNOL, V177, P4464, DOI 10.4049/jimmunol.177.7.4464
   Lee SW, 2012, J IMMUNOL, V189, P2697, DOI 10.4049/jimmunol.1201248
   Lee SW, 2005, J IMMUNOL, V174, P6803, DOI 10.4049/jimmunol.174.11.6803
   Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945
   Levick S, 2014, HEART FAIL REV, V19, P227, DOI 10.1007/s10741-013-9393-8
   Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707
   Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863
   Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497
   Liu DM, 2008, CLIN CHIM ACTA, V397, P22, DOI 10.1016/j.cca.2008.07.003
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293
   Maganto-Garcia E, 2011, J IMMUNOL, V187, P3521, DOI 10.4049/jimmunol.1003947
   Makkouk A, 2016, EUR J CANCER, V54, P112, DOI 10.1016/j.ejca.2015.09.026
   Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415
   Michallet MC, 2013, CURR OPIN MICROBIOL, V16, P296, DOI 10.1016/j.mib.2013.04.003
   Mittal B, 2014, ADV CLIN CHEM, V64, P1, DOI 10.1016/B978-0-12-800263-6.00001-X
   Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89
   Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001
   Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173
   Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35
   Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003
   Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84
   Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009
   Samokhin AO, 2008, ATHEROSCLEROSIS, V200, P58, DOI 10.1016/j.atherosclerosis.2007.12.047
   Scott RA, 2014, BIOMACROMOLECULES, V15, P2090, DOI 10.1021/bm500224f
   Seda V, 2015, EUR J HAEMATOL, V94, P193, DOI 10.1111/ejh.12427
   Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355
   Smeets E, 2013, CURR OPIN LIPIDOL, V24, P518, DOI 10.1097/MOL.0000000000000025
   Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886
   Smith MA, 2007, AM J PHYSIOL-CELL PH, V293, pC1947, DOI 10.1152/ajpcell.00269.2007
   Stancel N, 2016, CLIN CHEM, V62, P320, DOI 10.1373/clinchem.2015.243923
   Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211
   Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915
   Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488
   Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545
   Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   van Wanrooij EJA, 2007, ARTERIOSCL THROM VAS, V27, P204, DOI 10.1161/01.ATV.0000251007.07648.81
   Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343
   Vinay DS, 2014, BMB REP, V47, P122, DOI 10.5483/BMBRep.2014.47.3.283
   Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677
   Vinay DS, 2004, J IMMUNOL, V173, P4218, DOI 10.4049/jimmunol.173.6.4218
   Wan YL, 2004, WORLD J GASTROENTERO, V10, P195
   Wang ZX, 2014, J CARDIOVASC MED, V15, P273, DOI 10.2459/JCM.0b013e3283641b9c
   Wei DH, 2013, INT J MOL MED, V31, P400, DOI 10.3892/ijmm.2012.1201
   Yan JC, 2013, CHEM-BIOL INTERACT, V206, P256, DOI 10.1016/j.cbi.2013.09.014
   Yan JC, 2013, CLINICS, V68, P193, DOI [10.6061/CLINICS/2013(02)OA12, 10.6061/clinics/2013(02)OA12]
   Yan JC, 2011, CLIN CHIM ACTA, V412, P993, DOI 10.1016/j.cca.2011.02.038
   Yan JC, 2009, J CARDIOVASC PHARM, V54, P451, DOI 10.1097/FJC.0b013e3181be7578
   Yu Y, 2014, EUR REV MED PHARMACO, V18, P1525
   Zhang GB, 2007, TISSUE ANTIGENS, V70, P470, DOI 10.1111/j.1399-0039.2007.00943.x
   Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455
NR 90
TC 6
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 753
EP 761
DI 10.4070/kcj.2016.46.6.753
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700002
PM 27826331
OA Green Published
DA 2021-04-22
ER

PT J
AU Ertem, AG
   Ozcelik, F
   Kasapkara, HA
   Koseoglu, C
   Bastug, S
   Ayhan, H
   Sari, C
   Bayram, NA
   Bilen, E
   Durmaz, T
   Keles, T
   Bozkurt, E
AF Ertem, Ahmet Goktug
   Ozcelik, Filiz
   Kasapkara, Haci Ahmet
   Koseoglu, Cemal
   Bastug, Serdal
   Ayhan, Huseyin
   Sari, Cenk
   Bayram, Nihal Akar
   Bilen, Emine
   Durmaz, Tahir
   Keles, Telat
   Bozkurt, Engin
TI Neutrophil Lymphocyte Ratio as a Predictor of Left Ventricular Apical
   Thrombus in Patients with Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Inflammation; Thrombus; Myocardial infarction
ID BLOOD-CELL SUBTYPES; HEART-FAILURE; ECHOCARDIOGRAPHY; MORTALITY;
   DISEASE; RISK
AB Background and Objectives: In this study, we examined the role of inflammatory parameters in an apical mural thrombus with a reduced ejection fraction due to large anterior myocardial infarction (MI).
   Subjects and Methods: A total of 103 patients who had suffered from heart failure, 45 of whom had left ventricular apical thrombus (AT) after a large anterior MI, were enrolled in the study. A detailed clinical history was taken of each participant, biochemical inflammatory markers, which were obtained during admission, were analyzed and an echocardiographical and angiographical evaluation of specific parameters were performed.
   Results:There were no statistically significant differences in terms of age, gender, and history of hypertension, diabetes mellitus, and atrial fibrillation between both groups (p>0.05). Similarly there were no statistically significant differences in terms of biochemical and echocardiographic parameters (p>0.05). However, there were significant differences in terms of neutrophil lymphocyte ratio (p=0.032). After a multivariate regression analysis, neutrophil lymphocyte ratio (NLR) was an independent predictor of thrombus formation (beta: 0.296, p=0.024). The NLR >2.74 had a 78% sensivity and 61% specifity in predicting thrombus in patients with a low left ventricular ejection fraction.
   Conclusion: In this study, neutrophil lymphocyte ratios were significantly higher in patients with apical thrombus.
C1 [Ertem, Ahmet Goktug; Ozcelik, Filiz; Koseoglu, Cemal; Bastug, Serdal; Sari, Cenk; Bilen, Emine] Ataturk Training & Res Hosp, Dept Cardiol, Ankara, Turkey.
   [Kasapkara, Haci Ahmet; Ayhan, Huseyin; Bayram, Nihal Akar; Durmaz, Tahir; Keles, Telat; Bozkurt, Engin] Yildirim Beyazit Univ, Dept Cardiol, Ankara, Turkey.
RP Ertem, AG (corresponding author), Ataturk Training & Res Hosp, Univ St 1, Ankara, Turkey.
EM agertem@hotmail.com
RI sari, cenk/AAB-7359-2019
OI sari, Cenk/0000-0003-1115-493X
CR Arruda-Olson AM, 2009, CIRC-CARDIOVASC QUAL, V2, P656, DOI 10.1161/CIRCOUTCOMES.108.831024
   ASINGER RW, 1981, NEW ENGL J MED, V305, P297, DOI 10.1056/NEJM198108063050601
   Bakalli A, 2013, J CLIN ULTRASOUND, V41, P38, DOI 10.1002/jcu.21953
   Delewi R, 2012, HEART, V98, P1743, DOI 10.1136/heartjnl-2012-301962
   Dogan M, 2015, CLIN APPL THROMB-HEM, V21, P25, DOI 10.1177/1076029613488935
   Dogdu O, 2012, TURK KARDIYOL DERN A, V40, P706, DOI 10.5543/tkda.2012.82429
   Gazi E, 2015, CLIN APPL THROMB-HEM, V21, P155, DOI 10.1177/1076029613492011
   Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93
   Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054
   Jala VR, 2004, TRENDS IMMUNOL, V25, P315, DOI 10.1016/j.it.2004.04.003
   JOHANNESSEN KA, 1987, CIRCULATION, V75, P151, DOI 10.1161/01.CIR.75.1.151
   Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Momiyama Y, 2009, ATHEROSCLEROSIS, V207, P272, DOI 10.1016/j.atherosclerosis.2009.04.015
   Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19
   Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019
   RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7
   ROBERTS WC, 1987, AM J CARDIOL, V60, P1340, DOI 10.1016/0002-9149(87)90618-7
   Rudiger A, 2006, AM J EMERG MED, V24, P451, DOI 10.1016/j.ajem.2005.10.010
   Schneider C, 2003, CIRCULATION, V107, pE114, DOI 10.1161/01.CIR.0000061023.00510.BF
   Sharma ND, 2000, CHEST, V117, P314, DOI 10.1378/chest.117.2.314
   THOMSON SP, 1995, ANN INTERN MED, V122, P335, DOI 10.7326/0003-4819-122-5-199503010-00003
   Tokgoz S, 2013, J STROKE CEREBROVASC, V22, P1169, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.011
   VISSER CA, 1983, EUR HEART J, V4, P333, DOI 10.1093/oxfordjournals.eurheartj.a061470
   Yayla C, 2016, ANGIOLOGY, V67, P133, DOI 10.1177/0003319715578258
   Yilmaz M, 2015, CLIN APPL THROMB-HEM, V21, P446, DOI 10.1177/1076029613507337
NR 26
TC 4
Z9 6
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 768
EP 773
DI 10.4070/kcj.2016.46.6.768
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700005
PM 27826334
OA Green Published
DA 2021-04-22
ER

PT J
AU Yu, XF
   Li, Y
   Wang, QC
   Liang, M
   Xu, K
   Han, YL
AF Yu, Xiaofan
   Li, Yi
   Wang, Qiancheng
   Liang, Ming
   Xu, Kai
   Han, Yaling
TI "One-Time" versus Staged Multivessel Intervention in Intermediate to
   Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary
   Syndromes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndromes; Coronary artery disease; Percutaneous coronary
   intervention
ID ARTERY-DISEASE; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA;
   REVASCULARIZATION; STRATEGY
AB Background and Objectives: To compare clinical outcomes of staged versus "one-time" percutaneous coronary intervention (PCI) in intermediate to very high-risk patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and multivessel coronary disease (MVD).
   Subjects and Methods: 1531 NSTE-ACS patients with multivessel PCI and meeting the criteria of intermediate to very high risk were screened from a prospectively registered database obtained from General Hospital of Shenyang Military Region between 2008 and 2012. They were categorized into "one-time" PCI (n=859) and staged PCI (n=672) according to intervention strategy. The primary outcomes included a 3-year major adverse cardiac event (MACE), a composite of cardiac death, myocardial infarction (MI), and target vessel revascularization.
   Results: At 3 years, no significant differences in MACE (20.8% vs. 19.7%, p=0.608) and cardiac death/MI (7.1% vs. 9.1%, p=0.129) were observed between the two groups. After propensity score matching, there was no statistical significance in MACE (18.9% vs. 21.8%, p=0.249); whereas cardiac death/MI was significantly lower in the staged PCI group (7.0% vs. 11.1%, p=0.033). Ninety-day landmark analysis showed that the staged PCI group had a lower 90-day incidence of MACE (1.2% vs. 3.3%, p=0.037) and cardiac death/MI (0.7% vs. 2.6%, p=0.031). For the 90-day to 3-year follow-up period, the incidences of MACE (17.9% vs. 19.1%, p=0.641) and cardiac death/MI (6.3% vs. 8.7%, p=0.191) were similar in both groups.
   Conclusion: In intermediate-to very high-risk NSTE-ACS patients with MVD, staged PCI is superior to "one-time" PCI in terms of cardiac death/MI.
C1 [Yu, Xiaofan; Wang, Qiancheng] Dalian Med Univ, Hosp 2, Dept Cardiol, Dalian, Liao Ning, Peoples R China.
   [Yu, Xiaofan; Li, Yi; Liang, Ming; Xu, Kai; Han, Yaling] Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Liao Ning, Peoples R China.
   [Yu, Xiaofan] Anhui Prov Hosp, Dept Cardiol, Hefei, Anhui, Peoples R China.
RP Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, 83 Wenhua Rd, Shenyang, Liaoning Provin, Peoples R China.
EM hanyaling@263.net
CR Abu-Assi E, 2010, AM HEART J, V160, P826, DOI 10.1016/j.ahj.2010.06.053
   AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3
   Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   [Anonymous], 2013, DIAGNOSTICS
   Brener SJ, 2008, AM HEART J, V155, P140, DOI 10.1016/j.ahj.2007.09.007
   Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104
   Chan MY, 2008, CIRCULATION, V118, P2286, DOI 10.1161/CIRCULATIONAHA.108.778837
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Dangas GD, 2010, JACC-CARDIOVASC INTE, V3, P1096, DOI 10.1016/j.jcin.2010.09.005
   Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128
   Elbarouni B, 2011, AM HEART J, V162, P347, DOI 10.1016/j.ahj.2011.05.020
   Gasior P, 2013, POSTEP KARDIOL INTER, V9, P136, DOI 10.5114/pwki.2013.35448
   Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303
   Hannan EL, 2013, CIRC-CARDIOVASC INTE, V6, P12, DOI 10.1161/CIRCINTERVENTIONS.112.974485
   Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505
   Kereiakes DJ, 2008, JACC-CARDIOVASC INTE, V1, P111, DOI 10.1016/j.jcin.2008.01.005
   Kerensky RA, 2002, J AM COLL CARDIOL, V39, P1456, DOI 10.1016/S0735-1097(02)01770-9
   Kim MC, 2011, INT J CARDIOL, V153, P148, DOI 10.1016/j.ijcard.2010.08.044
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Loscalzo J, 2013, HARRISON CARDIOVASCU, P407
   Luczak D, 2015, KARDIOL POL, V73, P159, DOI 10.5603/KP.a2014.0169
   Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368
   Marso SP, 2014, J AM COLL CARDIOL, V64, P1198, DOI 10.1016/j.jacc.2014.07.022
   Ohashi Y, 2006, INT J CARDIOL, V112, P52, DOI 10.1016/j.ijcard.2005.09.051
   Reuter PG, 2015, INT J CARDIOL, V182, P414, DOI 10.1016/j.ijcard.2014.12.089
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Shishehbor MH, 2007, J AM COLL CARDIOL, V49, P849, DOI 10.1016/j.jacc.2006.10.054
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Zapata GO, 2009, J INTERV CARDIOL, V22, P329, DOI 10.1111/j.1540-8183.2009.00477.x
   Zimarino M, 2013, INT J CARDIOL, V168, P1748, DOI 10.1016/j.ijcard.2013.05.004
NR 30
TC 2
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 774
EP 783
DI 10.4070/kcj.2016.46.6.774
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700006
PM 27826335
OA Green Published
DA 2021-04-22
ER

PT J
AU Cetin, MS
   Cetin, EHO
   Balci, KG
   Aydin, S
   Ediboglu, E
   Bayraktar, MF
   Balci, MM
   Maden, O
   Temizhan, A
   Aydogdu, S
AF Cetin, Mehmet Serkan
   Cetin, Elif Hande Ozcan
   Balci, Keyser Gulcihan
   Aydin, Selahattin
   Ediboglu, Emek
   Bayraktar, Muhammed Fatih
   Balci, Mustafa Mucahit
   Maden, Orhan
   Temizhan, Ahmet
   Aydogdu, Sinan
TI The Association between Whole Blood Viscosity and Coronary Collateral
   Circulation in Patients with Chronic Total Occlusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary collateral circulation; Whole blood viscosity; SYNTAX score
ID STROMA-FREE HEMOGLOBIN; ARTERY OCCLUSION; CELL DEFORMABILITY; PLASMA
   VISCOSITY; SYNTAX SCORE; DISEASE; RISK; ATHEROSCLEROSIS; HEMODILUTION;
   DETERMINANTS
AB Background and Objectives: Coronary collateral circulation (CCC) has been attributed as inborn bypass mechanisms supporting ischemic myocardium. Various factors have been postulated in CCC. Whole blood viscosity (WBV) has been an underappreciated entity despite close relationships between multiple cardiovascular diseases. WBV can be calculated with a validated equation from hematocrit and total plasma protein levels for a low and high shear rate. On the grounds, we aimed to evaluate the association between WBV and CCC in. patients with chronic total occlusion.
   Subjects and Methods: A total of 371 patients diagnosed as having at least one major, chronic total occluded coronary artery were included. 197 patients with good CCC (Rentrop 2 and 3) composed the patient group. The poor collateral group consisted of 174 patients (Rentrop grade 0 and 1).
   Results: Patients with poor CCC had higher WBV values for a low-shear rate (LSR) (69.5 +/- 8.7 vs. 60.1 +/- 9.8, p<0.0.01) and high-shear rate (HSR) (17.0 +/- 2.0 vs. 16.4 +/- 1.8, p<0.001) than the good collateral group. Correlation analysis demonstrated a significant negative correlation between the grade of CCC and WBV for LSR (beta=0.597, p<0.001) and HSR (beta=0.494, p<0.001). WBV for LSR (beta=0.476, p<0.001) and HSR (beta=0.407, p<0.001) had a significant correlation with the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score. A multivariate analysis showed that the WBV for both shear rates were independent risk factors of poor CCC (WBV at LSR, OR: 1.362 CI 95%: 1.095-1.741 p<0.001 and WBV at HSR, 1.251 CI 95%: 1.180-1.347 p<0.001).
   Conclusion: WBV has been demonstrated as the overlooked predictor of poor coronary collateralization. WBV seemed to be associated with microvascular perfusion and angiogenesis process impairing CCC development.
C1 [Cetin, Mehmet Serkan; Cetin, Elif Hande Ozcan; Balci, Keyser Gulcihan; Aydin, Selahattin; Ediboglu, Emek; Bayraktar, Muhammed Fatih; Balci, Mustafa Mucahit; Maden, Orhan; Temizhan, Ahmet; Aydogdu, Sinan] Turkiye Yuksek Ihtisas Training & Res Hosp, Dept Cardiol, Kizilay St, TR-06100 Ankara, Turkey.
RP Cetin, MS (corresponding author), Turkiye Yuksek Ihtisas Training & Res Hosp, Dept Cardiol, Kizilay St, TR-06100 Ankara, Turkey.
EM mehmetserkancetin@gmail.com
RI Cetin, Elif Hande Ozcan/ABG-1478-2020
OI Ozcan cetin, Elif hande/0000-0001-5969-2345
CR ARNTZ HR, 1992, EUR HEART J, V13, P275, DOI 10.1093/oxfordjournals.eurheartj.a060159
   BIRO GP, 1980, AM HEART J, V99, P64, DOI 10.1016/0002-8703(80)90315-4
   BIRO GP, 1982, AM HEART J, V103, P870, DOI 10.1016/0002-8703(82)90402-1
   Blann A, 1998, ATHEROSCLEROSIS, V139, P317, DOI 10.1016/S0021-9150(98)00090-2
   Borekci A, 2015, PERFUSION-UK, V30, P457, DOI 10.1177/0267659114558287
   Cho YI, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0404-6
   COHEN M, 1986, CIRCULATION, V74, P469, DOI 10.1161/01.CIR.74.3.469
   DESIMONE G, 1990, CIRCULATION, V81, P107, DOI 10.1161/01.CIR.81.1.107
   Doi H, 2000, JPN J PHARMACOL, V83, P73, DOI 10.1254/jjp.83.73
   Empen K, 2003, NUTR METAB CARDIOVAS, V13, P87, DOI 10.1016/S0939-4753(03)80023-6
   HANSEN JF, 1989, AM HEART J, V117, P290, DOI 10.1016/0002-8703(89)90771-0
   Junker R, 1998, ARTERIOSCL THROM VAS, V18, P870, DOI 10.1161/01.ATV.18.6.870
   Kilian JG, 2002, CORONARY ARTERY DIS, V13, P155, DOI 10.1097/00019501-200205000-00004
   KYRIAKIDES ZS, 1991, AM J CARDIOL, V67, P687, DOI 10.1016/0002-9149(91)90522-M
   Mellwig KP, 2003, Z KARDIOL, V92, P11130
   MOHANDAS N, 1983, SEMIN HEMATOL, V20, P225
   MUGGEO M, 1983, RES CLIN LAB, V13, P165
   Nacar AB, 2015, MED PRIN PRACT, V24, P65, DOI 10.1159/000365734
   Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9
   RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587
   Shah PB, 2011, CIRCULATION, V123, P1780, DOI 10.1161/CIRCULATIONAHA.110.972802
   Sloop GD, 1997, CLIN SCI, V92, P473, DOI 10.1042/cs0920473
   Sloop Gregory, 2015, Ther Adv Cardiovasc Dis, V9, P19, DOI 10.1177/1753944714553226
   Soulis JV, 2006, ANGIOLOGY, V57, P33, DOI 10.1177/000331970605700105
   van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033
   van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6
   Wasilewski J, 2007, KARDIOL POL, V65, P778
   Yaylali YT, 2013, CORONARY ARTERY DIS, V24, P11, DOI 10.1097/MCA.0b013e32835b0bdf
NR 28
TC 13
Z9 13
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 784
EP 790
DI 10.4070/kcj.2016.46.6.784
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700007
PM 27826336
OA Green Published
DA 2021-04-22
ER

PT J
AU Ozturk, O
   Ozturk, U
   Nergiz, S
   Karahan, MZ
AF Ozturk, Onder
   Ozturk, Unal
   Nergiz, Sebnem
   Karahan, M. Zulkif
TI The Relationship between Angiotensin-II Type 1 Receptor Gene
   Polymorphism and Repolarization Parameters after a First Anterior Acute
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Genetic; Polymorphism; Myocardial infarction; Electrocardiography
ID LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY-DISEASE; T-WAVE PEAK; QT
   DISPERSION; CONVERTING ENZYME; HEART-FAILURE; D-ALLELE; ACE
   POLYMORPHISM; ARRHYTHMIAS; HYPERTENSION
AB Background and Objectives: Genetic influence on T-wave peak to End (Tpe) time in patients with a first anterior acute myocardial infarction (AMI) is uncertain. A polymorphism in the angiotensin-II type 1 receptor (AT1R) gene was discovered recently. The polymorphism consists of an A or C variant, given three different possible genotypes: AA, AC, CC. The purpose of this study was to determine the effects of polymorphism of the AT1R gene polymorphism on Tpe after a first anterior AMI.
   Subjects and Methods: The subjects were 142 patients (110 men, 32 women, 58 13 years) with a first anterior AMI; ten patients were excluded from this study. Based on the polymorphism of the AT1R gene, they were classified into two groups: Group 1 (AA genotype) of 91 patients and group 2 (AC and CC genotype) of 41 patients. A 12-lead resting ECG was recorded at admission to the coronary care unit in patients with anterior AMI and were manually measured with a ruler. QTc, QTd, QTcd, Tpe, Tpe/QT parameters were measured.
   Results: There was no significant difference in the baseline characteristics of patients (p>0.05). We found significant reduction in QTc, QTd, QTcd, Tpe, Tpe/QT indices Group 1 (AA genotype) (mean 66 +/- 28 ms) than group 2 (AC and CC genotype) (mean 95 34 ms) (p<0.05).
   Conclusion: In patients with a first anterior AMI, AT1R gene polymorphisms may influence on repolarization parameters. Although further studies are required.
C1 [Ozturk, Onder; Karahan, M. Zulkif] Diyarbakir Gazi Yasargil Educ & Res Hosp, Dept Cardiol, TR-21070 Diyarbakir, Turkey.
   [Ozturk, Unal] Dicle Univ, Fac Med, Dept Publ Hlth & Neurol, Diyarbakir, Turkey.
   [Nergiz, Sebnem] Dicle Univ, Fac Med, Dept Microbiol, Diyarbakir, Turkey.
RP Ozturk, O (corresponding author), Diyarbakir Gazi Yasargil Educ & Res Hosp, Dept Cardiol, TR-21070 Diyarbakir, Turkey.
EM droozturk21@hotmail.com
RI OZTURK, ONDER/U-5392-2018
OI OZTURK, UNAL/0000-0002-8341-5070; Ozturk, Onder/0000-0003-4204-0599
CR Anvari A, 1999, CARDIOVASC RES, V43, P879, DOI 10.1016/S0008-6363(99)00143-1
   Aoki S, 2001, JPN CIRC J, V65, P621, DOI 10.1253/jcj.65.621
   Araujo Messias Antonio de, 2004, Arq Bras Cardiol, V83, P409
   Blanco RR, 2012, J CARD FAIL, V18, P717, DOI 10.1016/j.cardfail.2012.06.531
   DAY CP, 1990, BRIT HEART J, V63, P342
   de Gasparo M, 2000, PHARMACOL REV, V52, P415
   De Sutter J, 1999, HEART, V81, P533, DOI 10.1136/hrt.81.5.533
   Endoh Y, 1999, JPN CIRC J, V63, P467, DOI 10.1253/jcj.63.467
   Eslami V, 2013, J INVASIVE CARDIOL, V25, P232
   Fujimoto S, 1999, JPN CIRC J, V63, P577, DOI 10.1253/jcj.63.577
   Gubaev K I, 2006, Genetika, V42, P1712
   Hamon M, 1997, HEART, V77, P502, DOI 10.1136/hrt.77.6.502
   Jeron A, 2001, EUR HEART J, V22, P663, DOI 10.1053/euhj.2000.2297
   Jeunemaitre X, 1997, HUM GENET, V99, P66
   Jin Y, 2012, AM J HYPERTENS, V25, P472, DOI 10.1038/ajh.2011.244
   Karpanou EA, 1998, AM HEART J, V136, P765, DOI 10.1016/S0002-8703(98)70119-X
   LARAGH JH, 1995, J HUM HYPERTENS, V9, P385
   Lin TH, 2007, CIRC J, V71, P39, DOI 10.1253/circj.71.39
   Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1
   Miller JA, 1999, KIDNEY INT, V56, P2173, DOI 10.1046/j.1523-1755.1999.00770.x
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Oikarinen L, 2001, J HYPERTENS, V19, P1883, DOI 10.1097/00004872-200110000-00025
   Ozturk O, 2006, ECHOCARDIOGR-J CARD, V23, P536, DOI 10.1111/j.1540-8175.2006.00258.x
   Porthan K, 2010, HEART RHYTHM, V7, P898, DOI 10.1016/j.hrthm.2010.03.002
   Spargias KS, 1999, AM J CARDIOL, V83, P969, DOI 10.1016/S0002-9149(98)01049-2
   Takezako T, 2001, JPN CIRC J, V65, P603, DOI 10.1253/jcj.65.603
NR 26
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 791
EP 797
DI 10.4070/kcj.2016.46.6.791
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700008
PM 27826337
OA Green Published
DA 2021-04-22
ER

PT J
AU Cerit, L
   Duygu, H
   Gulsen, K
   Kemal, HS
   Ozcem, B
   Balcioglu, O
   Gunsel, A
   Tosun, O
   Emren, V
AF Cerit, Levent
   Duygu, Hamza
   Gulsen, Kamil
   Kemal, Hatice S.
   Ozcem, Barcin
   Balcioglu, Ozlem
   Gunsel, Aziz
   Tosun, Ozgur
   Emren, Volkan
TI Is SYNTAX Score Predictive of Atrial Fibrillation after On-Pump Coronary
   Artery Bypass Graft Surgery?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Coronary artery bypass surgery; Coronary artery
   disease
ID TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; COMPLEXITY; DISEASE; COHORT;
   IMPACT
AB Background and Objectives: The relationship of synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score and development of atrial fibrillation (AF) after coronary artery bypass surgery (CABG) has not been studied. Therefore, we assessed the relationship between the SYNTAX score and development of AF after CABG (POAF).
   Subjects and Methods:The medical records of consecutive patients, who underwent CABG surgery from January 2013 to September 2015, were retrospectively reviewed for the development of AF in the postoperative period. SYNTAX score, clinical and echocardiographic parameters were evaluated. The independent variables for the development of POAF were defined and their predictive values were measured.
   Results: The study group consisted of 106 patients, of which 36 (34%) developed POAF. Age, hypertension, stroke, chronic obstructive pulmonary disease (COPD), heart failure (HF), diabetes mellitus (DM), left atrial diameter, neutrophil/lymphocyte ratio, platelet large cell ratio, creatinine, blood urea nitrogen and SYNTAX score were identified as important variables for the development of POAF. However, in logistic regression analysis COPD (OR=19.313, 95% C1=2.416-154.407, p=0.005), HF (OR=28.362, 95% C1=2.034-395.515, p=0.013), SYNTAX score (OR=0.863, 95% CI=0.757-0.983, p=0.026), and DM (OR=20.770, 95% Cl=3.791-113.799, p<0.001) appeared as independent variables predicting the development of POAF. In receiver operation characteristic analysis, SYNTAX score (>= 22.25) (AUC=0.777, 95% CI=0.676-0.877, p<0.001) was one of the strongest predictors for the development of POAF.
   Conclusion: The SYNTAX score level was independently associated with the development of AF after CABO.
C1 [Cerit, Levent; Duygu, Hamza; Gulsen, Kamil; Kemal, Hatice S.; Gunsel, Aziz] Near East Univ, Dept Cardiol, Nicosia, Cyprus.
   [Ozcem, Barcin; Balcioglu, Ozlem] Near East Univ, Dept Cardiovasc Surg, Nicosia, Cyprus.
   [Tosun, Ozgur] Near East Univ, Dept Biostat, Nicosia, Cyprus.
   [Emren, Volkan] Afyon State Hosp, Dept Cardiol, Afyon, Turkey.
RP Cerit, L (corresponding author), Univ Hosp, Near East Hosp, CY-07100 Nicosia, Cyprus.
EM drcerit@hotmail.com
RI Gulsen, Kamil/R-2710-2019; balcioglu, ozlem/AAL-8578-2020; Tosun,
   Ozgur/O-7316-2019
OI Tosun, Ozgur/0000-0003-1995-9425; cerit, levent/0000-0002-2222-3681;
   Gulsen, Kamil/0000-0003-1103-0013
CR Aksakal E, 2013, ANGIOLOGY, V64, P304, DOI 10.1177/0003319712464815
   *AM HEART ASS STAT, 2007, CIRCULATION, V115, P69
   Amar D, 2004, J AM COLL CARDIOL, V44, P1248, DOI 10.1016/j.jacc.2004.05.078
   Banach M, 2006, CIRC J, V70, P438, DOI 10.1253/circj.70.438
   Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Blommaert D, 2000, J AM COLL CARDIOL, V35, P1411, DOI 10.1016/S0735-1097(00)00608-2
   Caglar IM, 2012, CLIN RES CARDIOL, V101, P599, DOI 10.1007/s00392-012-0431-7
   CRIJNS HJ, 1991, AM J CARDIOL, V68, P335, DOI 10.1016/0002-9149(91)90828-9
   Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875
   Fukui T, 2015, EUR J CARDIO-THORAC, V47, P66, DOI 10.1093/ejcts/ezu045
   Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004
   Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024964
   Kwon CH, 2015, KOREAN CIRC J, V45, P473, DOI 10.4070/kcj.2015.45.6.473
   LIP GYH, 1995, BRIT MED J, V311, P1361, DOI 10.1136/bmj.311.7016.1361
   MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40
   Moller CH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007224.pub2
   Rechcinski T, 2013, CARDIOL J, V20, P491, DOI 10.5603/CJ.2013.0134
   Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030
   Shao QM, 2015, ARCH MED RES, V46, P199, DOI 10.1016/j.arcmed.2015.03.011
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068
   Ucar H, 2015, ANATOL J CARDIOL, V15, P789, DOI 10.5152/akd.2014.5747
   Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
NR 25
TC 10
Z9 12
U1 0
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 798
EP 803
DI 10.4070/kcj.2016.46.6.798
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700009
PM 27826338
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, YM
   Kim, J
   Lee, JH
   Kim, M
   Nam, GB
   Choi, KJ
   Kim, YH
AF Hwang, You Mi
   Kim, Jun
   Lee, Ji Hyun
   Kim, Minsu
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Cardiac Implantable Electronic Device Safety during Magnetic Resonance
   Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Magnetic resonance imaging; Pacemaker; artificial; Defibrillators;
   implantable
ID 1.5 TESLA; CARDIOVERTER-DEFIBRILLATORS; ABANDONED PACEMAKER; CLINICAL
   SAFETY; MRI; PERFORMANCE; LEADS; SYSTEM; HEART; PATIENT
AB Background and Objectives: Although magnetic resonance imaging (MRI) conditional cardiac implantable electronic devices (CIEDs) have become recently available, non-MRI conditional devices and the presence of epicardial and abandoned leads remain a contraindication for MRIs.
   Subjects and Methods: This was a single center retrospective study, evaluating the clinical outcomes and device parameter changes in patients with CIEDs who underwent an MRI from June 1992 to March 2015. Clinical and device related information was acquired by a thorough chart review.
   Results: A total of 40 patients, 38 with a pacemaker (including epicardially located pacemaker leads) and 2 with implantable cardioverter defibrillators, underwent 50 MRI examinations. Among the patients, 11 had MRI conditional CIEDs, while the remaining had non-MRI conditional devices. Among these patients, 23 patients had traditional contraindications for an MRI: (1) nonfunctional leads (n=1, 2.5%), (2) epicardially located leads (n=9, 22.5%), (3) scanning area in proximity to a device (n=9, 22.5%), (4) devices implanted within 6 weeks (n=2, 5%), and (5) MRI field strength at 3.0 Tesla (n=6, 15%). All patients underwent a satisfactory MRI examination with no adverse events during or after the procedure. There were no significant changes in parameters or malfunctioning devices in any patients with CIEDs.
   Conclusion: Under careful monitoring, MRI is safe to perform on patients with non-MRI conditional CIEDs, remnant leads, and epicardially located leads, as well as MRI-conditional devices.
C1 [Hwang, You Mi; Kim, Jun; Lee, Ji Hyun; Kim, Minsu; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Dept Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Div Cardiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
CR Bailey WM, 2015, HEART RHYTHM, V12, P1183, DOI 10.1016/j.hrthm.2015.02.010
   Beinart R, 2013, CIRCULATION, V128, P2799, DOI 10.1161/CIRCULATIONAHA.113.005697
   ERLEBACHER JA, 1986, AM J CARDIOL, V57, P437, DOI 10.1016/0002-9149(86)90768-X
   FETTER J, 1984, PACE, V7, P720, DOI 10.1111/j.1540-8159.1984.tb05602.x
   Gimbel JR, 2013, HEART RHYTHM, V10, P685, DOI 10.1016/j.hrthm.2013.01.022
   Gimbel JR, 2010, EUROPACE, V12, P915, DOI 10.1093/europace/euq174
   Gimbel JR, 1996, PACE, V19, P913, DOI 10.1111/j.1540-8159.1996.tb03387.x
   Higgins JV, 2014, PACE, V37, P1284, DOI 10.1111/pace.12419
   Keller J, 2015, EUROPACE, V17, P761, DOI 10.1093/europace/euu377
   Kypta A, 2016, J MAGN RESON IMAGING, V43, P574, DOI 10.1002/jmri.25037
   Langman DA, 2011, PACE, V34, P1051, DOI 10.1111/j.1540-8159.2011.03176.x
   Langman DA, 2011, J MAGN RESON IMAGING, V33, P426, DOI 10.1002/jmri.22463
   Misiri J, 2012, CLIN CARDIOL, V35, P276, DOI 10.1002/clc.21998
   Mitka M, 2011, JAMA-J AM MED ASSOC, V305, P985, DOI 10.1001/jama.2011.273
   Mollerus M, 2010, EUROPACE, V12, P947, DOI 10.1093/europace/euq092
   Nazarian S, 2006, CIRCULATION, V114, P1277, DOI 10.1161/CIRCULATIONAHA.105.607655
   Pohost G M, 1992, Heart Dis Stroke, V1, P348
   Pulver AF, 2009, PACE, V32, P450, DOI 10.1111/j.1540-8159.2009.02304.x
   Rickard J, 2014, HEART RHYTHM, V11, P222, DOI 10.1016/j.hrthm.2013.10.056
   Roguin A, 2009, J AM COLL CARDIOL, V54, P556, DOI 10.1016/j.jacc.2009.04.047
   Sheldon SH, 2015, HEART RHYTHM, V12, P345, DOI 10.1016/j.hrthm.2014.11.037
   Shellock FG, 2004, RADIOLOGY, V232, P635, DOI 10.1148/radiol.2323030830
   Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013
   Verma A, 2014, CAN ASSOC RADIOL J, V65, P290, DOI 10.1016/j.carj.2014.08.001
   Wollmann C, 2005, PACE, V28, P339, DOI 10.1111/j.1540-8159.2005.09535.x
   Wollmann CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-30
NR 26
TC 8
Z9 8
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 804
EP 810
DI 10.4070/kcj.2016.46.6.804
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700010
PM 27826339
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, GY
   Choi, JO
   Ju, ES
   Lee, YJ
   Jeon, ES
AF Lee, Ga Yeon
   Choi, Jin-Oh
   Ju, Eun-Seon
   Lee, Yoo-Jung
   Jeon, Eun-Seok
TI Role of Soluble ST2 as a Marker for Rejection after Heart Transplant
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Biomarkers; ST2 protein; Heart transplantation; Graft rejection
ID C-REACTIVE PROTEIN; CARDIAC TRANSPLANTATION; INTERNATIONAL SOCIETY;
   NATRIURETIC PEPTIDE; ALLOGRAFT-REJECTION; TROPONIN-I; MORTALITY;
   REGURGITATION; BIOMARKERS; RECIPIENTS
AB Background and Objectives: Endomyocardial biopsy is obligatory during the first year after heart transplant (HTx) for the surveillance of acute rejection. Previous attempts using cardiac biomarkers for the detection of rejection failed to show enough evidence to substitute endomyocardial biopsy. Therefore, this study sought the possibility of using soluble ST2 (sST2), a novel cardiovascular marker, as a surrogate marker for acute allograft rejection after HTx.
   Subjects and Methods: A total of 494 blood samples acquired at the time of endomyocardial biopsy were analyzed in 67 HTx cases from September 2006 to August 2014. Significant rejection was defined as International Society of Heart and Lung Transplant (ISHLT) score and humoral rejection accompanied by hemodynamic instability.
   Results: Twenty cases of HTx with 22 blood samples showed significant rejection in endomyocardial biopsy at 4.0 (2.0-9.0) months after HTx. The level of sST2 showed positive correlation with cardiac troponin I, and N-terminal pro-B-type natriuretic peptide (all p<0.001), and negative correlation with post-HTx months (p<0.001). The levels of sST2 according to the ISHLT scores were 36 (19-98), 28 (18-62), 15 (16-37), and 191 (85-343) ng/mL, consecutively OR, 1R, 2R, and 3R+ (3R plus hemodynamically-unstable humoral rejection) (p=0.003). However, when we studied within-subject effects of sST2 using a mixed model, the sST2 level according to the predefined time point was not different according to the presence of significant rejection (p for interaction=0.94).
   Conclusion: Although sST2 is known as a promising predictor for cardiovascular events, its role in HTx patients to predict acute allograft rejection seems to be limited.
C1 [Lee, Ga Yeon; Choi, Jin-Oh; Ju, Eun-Seon; Lee, Yoo-Jung; Jeon, Eun-Seok] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Cardiac & Vasc Ctr,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Cardiac & Vasc Ctr,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM choijean5@gmail.com
RI lee, ga yeon/I-9382-2017; choi, jo/O-5940-2014
FU Korean Society of Cardiology [201402-02]
FX This study was supported by the fund from the Korean Society of
   Cardiology (201402-02).
CR Ahn KT, 2015, TRANSPL P, V47, P504, DOI 10.1016/j.transproceed.2014.10.049
   Arora S, 2007, TRANSPLANTATION, V83, P1308, DOI 10.1097/01.tp.0000263338.39555.21
   Battes LC, 2015, TRANSPLANTATION, V99, P580, DOI 10.1097/TP.0000000000000378
   Ciccone MM, 2013, MOLECULES, V18, P15314, DOI 10.3390/molecules181215314
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Januzzi JL, 2013, J CARDIOVASC TRANSL, V6, P493, DOI 10.1007/s12265-013-9459-y
   Januzzi JL, 2010, CLIN CHEM, V56, P1814, DOI 10.1373/clinchem.2010.146506
   Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660
   Kim BS, 2014, KOREAN CIRC J, V322
   Marelli D, 2009, J THORAC CARDIOV SUR, V137, P1557, DOI 10.1016/j.jtcvs.2008.09.012
   Mathews LR, 2016, AM J TRANSPLANT, V16, P938, DOI 10.1111/ajt.13542
   Nguyen V, 2005, J HEART LUNG TRANSPL, V24, pS227, DOI 10.1016/j.healun.2004.07.007
   Pascual-Figal DA, 2011, ANN THORAC SURG, V92, P2118, DOI 10.1016/j.athoracsur.2011.07.048
   Patel PC, 2014, CIRC-HEART FAIL, V7, P463, DOI 10.1161/CIRCHEARTFAILURE.113.000697
   Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A
   Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002
   Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019
   Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437
   Wong RCC, 2008, J HEART LUNG TRANSPL, V27, P247, DOI 10.1016/j.healun.2007.12.011
NR 19
TC 3
Z9 4
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 811
EP 820
DI 10.4070/kcj.2016.46.6.811
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700011
PM 27826340
OA Green Published
DA 2021-04-22
ER

PT J
AU Ucar, FM
   Acar, B
   Gul, M
   Ozeke, O
   Aydogdu, S
AF Ucar, Fatih Mehmet
   Acar, Burak
   Gul, Murat
   Ozeke, Ozcan
   Aydogdu, Sinan
TI The Association between Platelet/Lymphocyte Ratio and Coronary Artery
   Disease Severity in Asymptomatic Low Ejection Fraction Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Low ejection fraction; Asymptomatic disease; Coronary artery disease;
   Gensini score; Platelet-lymphocyte ratio
ID PLATELET-LYMPHOCYTE RATIO; HEART-FAILURE; NEUTROPHIL; MORTALITY; COUNT;
   MECHANISMS; OUTCOMES; DEATH
AB Background and Objectives: Coronary angiography (CAG) is generally needed in the setting of systolic heart failure (HF) with an unidentified etiology as a part of diagnostic strategy. On the other hand, the clinical value of this invasive strategy is largely unknown. Platelet-lymphocyte ratio (PLR) has recently emerged as a novel inflammatory index that may serve as an important predictor of inflammatory state and overall mortality. The present study aimed to search the predictive value of PLR in determining the extent of coronary atherosclerosis in asymptomatic low ejection fraction (EF) patients.
   Subjects and Methods: 156 asymptomatic heart failure (HF) subjects (without angina or HF symptoms, mean age: 58 years; to male: 71.2% were enrolled, and thereafter a CAG was performed. Gensini Score was used to determine the severity of coronary artery disease (CAD) on CAG. According to this scoring system, the overall study group was categorized into three distinct subgroups: control group with the score 0, mild atherosclerosis group with the score 0 to 20 and severe atherosclerosis group with the score of >20. Thereafter, a comparison was made among groups with regard to mean values of PLR.
   Results:The severe atherosclerosis group had a substantially higher level of mean PLR in comparison to other groups (p<0.001). Pre-CAG PLR levels as well as a variety of clinical variables including age, low density lipoprotein (LDL)-cholesterol demonstrated an independent correlation with Gensini score through a multivariate analysis.
   Conclusion: These findings suggest the potential association of high PLR levels with severe atherosclerosis in the setting of asymptomatic systolic HF. A simple measurement of PLR helps to identify the severity of coronary atherosclerosis prior to conducting coronary angiography.
C1 [Ucar, Fatih Mehmet] Trakya Univ Hosp, Dept Cardiol, TR-22001 Edirne, Turkey.
   [Acar, Burak; Gul, Murat; Ozeke, Ozcan; Aydogdu, Sinan] Turkiye Yuksek Ihtisas Training & Res Hosp, Ankara, Turkey.
RP Ucar, FM (corresponding author), Trakya Univ Hosp, Dept Cardiol, TR-22001 Edirne, Turkey.
EM dr_fmucar@hotmail.com
RI Ozeke, Ozcan/AAS-8730-2020; GUL, Murat/AAH-7852-2021; Ozeke,
   Ozcan/N-1871-2015; GUL, Murat/L-5770-2015
OI Ozeke, Ozcan/0000-0002-4770-8159; Ozeke, Ozcan/0000-0002-4770-8159;
   Acar, Burak/0000-0003-3217-5000
CR Acar G, 2015, CLIN APPL THROMB-HEM, V21, P462, DOI 10.1177/1076029613508599
   Azab B, 2012, J THROMB THROMBOLYS, V34, P326, DOI 10.1007/s11239-012-0718-6
   Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0
   Cetin EHO, 2016, ANGIOLOGY, V67, P336, DOI 10.1177/0003319715591751
   Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014
   Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008
   Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.034
   Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067688
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Iijima R, 2007, THROMB HAEMOSTASIS, V98, P852, DOI 10.1160/TH07-04-0285
   McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105
   Nikolsky E, 2007, AM J CARDIOL, V99, P1055, DOI 10.1016/j.amjcard.2006.11.066
   Sari I, 2015, KARDIOL POL, V73, P1310, DOI 10.5603/KP.a2015.0098
   Stancel N, 2016, CLIN CHEM, V62, P320, DOI 10.1373/clinchem.2015.243923
   STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   ten Kate GJR, 2013, EUR J HEART FAIL, V15, P1028, DOI 10.1093/eurjhf/hft090
   THAULOW E, 1991, CIRCULATION, V84, P613, DOI 10.1161/01.CIR.84.2.613
   de Melo RMV, 2012, ARQ BRAS CARDIOL, V98, P437, DOI 10.1590/S0066-782X2012005000035
   Yildiz A, 2015, CLIN APPL THROMB-HEM, V21, P223, DOI 10.1177/1076029613519851
   Yuksel M, 2015, ANATOL J CARDIOL, V15, P640, DOI 10.5152/akd.2014.5565
   Zouridakis EG, 2000, AM J CARDIOL, V86, P449, DOI 10.1016/S0002-9149(00)00963-2
NR 23
TC 11
Z9 11
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 821
EP 826
DI 10.4070/kcj.2016.46.6.821
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700012
PM 27826341
OA Green Published
DA 2021-04-22
ER

PT J
AU Cimen, T
   Bilgin, M
   Akyel, A
   Felekoglu, MA
   Nallbani, A
   Ozdemir, S
   Erden, G
   Orturk, A
   Dogan, M
   Yeter, E
AF Cimen, Tolga
   Bilgin, Murat
   Akyel, Ahmet
   Felekoglu, Mehmet Ali
   Nallbani, Ali
   Ozdemir, Seyda
   Erden, Gonul
   Orturk, Alpaslan
   Dogan, Mehmet
   Yeter, Ekrem
TI Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure monitoring; ambulatory; Hypertension; Dipping pattern;
   Endocan
ID CELL-SPECIFIC MOLECULE-1; BLOOD-PRESSURE; INDIVIDUALS; EXPRESSION;
   DIPPERS; MARKER; ESM-1; LUNG
AB Background and Objectives: Non-dipper hypertension is frequently accompanied by endothelial dysfunction and activation. Previous studies suggested that endocan may be a novel endothelial dysfunction marker. This study aims to investigate the association between circadian blood pressure (BP) pattern and plasma endocan levels together with high-sensitivity C-reactive protein (hsCRP) in patients with newly diagnosed untreated hypertension.
   Subjects and Methods: Twenty-four hour ambulatory blood pressure monitoring was recorded in 35 dipper, 35 non-dipper hypertensives and 35 healthy controls. Endocan levels were measured by enzyme-linked immunosorbent assay. Serum levels of hsCRP were also recorded.
   Results: Despite similar daytime and 24-hour average BP values between dippers and non-dippers, statistically significant high nocturnal BP was accompanied by a non-dipping pattern (Systolic BP: 132 +/- 9 vs. 147 +/- 11 mmHg; Distolic BP: 80 +/- 7 vs. 91 +/- 9 mmHg, respectively, p<0.001 for both). Non-dipper patients demonstrated higher endocan levels compared to dippers and normotensives (367 (193-844) pg/mL, 254 (182-512) pg/mL and 237 (141-314) pg/mL, respectively, p<0.001). HsCRP levels were significantly higher in non-dippers than the other groups (p=0.013). In a multivariate logistic regression analysis, endocan (p=0.021) and hsCRP (p=0.044) were independently associated with a non-dipping pattern.
   Conclusion: Elevated endocan levels were found in non-dipper groups. Endocan and hsCRP were found to be independently associated with a non-dipping pattern. We suggest that elevated levels of endocan in non-dipper hypertensive patients might be associated with a longer duration of exposure to high BP. These results point to the possible future role of endocan in selection of hypertensive patients at higher risk or target organ damage.
C1 [Cimen, Tolga; Bilgin, Murat; Akyel, Ahmet; Felekoglu, Mehmet Ali; Nallbani, Ali; Dogan, Mehmet; Yeter, Ekrem] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Cardiol, Ankara, Turkey.
   [Ozdemir, Seyda; Erden, Gonul; Orturk, Alpaslan] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Clin Biochem, Ankara, Turkey.
RP Cimen, T (corresponding author), Diskapi Yildirim Beyazit Training & Res Hosp, Dept Cardiol, Ankara, Turkey.
EM drtolgacim@hotmail.com
CR Abid MR, 2006, MICROVASC RES, V72, P136, DOI 10.1016/j.mvr.2006.05.010
   Amiya E, 2014, ANN VASC DIS, V7, P169
   Balta S, 2014, ANGIOLOGY, V65, P773, DOI 10.1177/0003319713513492
   Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758
   Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099
   Celik T, 2015, BLOOD PRESSURE, V24, P55, DOI 10.3109/08037051.2014.972816
   de la Sierra A, 2009, HYPERTENSION, V53, P466, DOI 10.1161/HYPERTENSIONAHA.108.124008
   Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe
   Grigoriu BD, 2006, CLIN CANCER RES, V12, P4575, DOI 10.1158/1078-0432.CCR-06-0185
   Higashi Y, 2002, J AM COLL CARDIOL, V40, P2039, DOI 10.1016/S0735-1097(02)02535-4
   Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571
   Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003
   Larochelle Pierre, 2002, J Clin Hypertens (Greenwich), V4, P3, DOI 10.1111/j.1524-6175.2002.01033.x
   Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458
   Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410
   Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151
   Mauno V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/619704
   MILLARCRAIG MW, 1978, LANCET, V1, P795
   Ozdemir E, 2014, ECHOCARDIOGR-J CARD, V31, P663, DOI 10.1111/echo.12444
   PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105
   Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004
   Tadzic R, 2013, KIDNEY BLOOD PRESS R, V37, P103, DOI 10.1159/000350064
   Tosu AR, 2014, POSTEP KARDIOL INTER, V10, P98, DOI 10.5114/pwki.2014.43514
   VERDECCHIA P, 1991, J HYPERTENS, V9, pS42
   VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528
   Verdecchia P, 1997, BLOOD PRESS MONIT, V2, P347
   von Kanel Roland, 2004, Journal of Hypertension, V22, P2087, DOI 10.1097/00004872-200411000-00009
   Wang XS, 2015, GENET TEST MOL BIOMA, V19, P124, DOI 10.1089/gtmb.2014.0274
   WATSON RDS, 1979, HYPERTENSION, V1, P341, DOI 10.1161/01.HYP.1.4.341
   Yan B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000604
NR 30
TC 7
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 827
EP 833
DI 10.4070/kcj.2016.46.6.827
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700013
PM 27826342
OA Green Published
DA 2021-04-22
ER

PT J
AU Logan, JG
   Kim, SS
AF Logan, Jeongok G.
   Kim, Suk-Sun
TI Resting Heart Rate and Aortic Stiffness in Normotensive Adults
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart rate; Arterial stiffness; Cardiovascular diseases; Pulse wave
   velocity; Hypertension
ID PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; HYPERTENSION; ASSOCIATION;
   PROGRESSION; PRESSURE; STRESS; AMPLIFICATION; POPULATION; PREDICTOR
AB Background and Objective: Large-artery stiffness is an independent predictor of cardiovascular disease (CVD), and carotid-femoral pulse wave velocity (cfPWV) is considered the gold standard measure of arterial stiffness. A resting heart rate is an easily measured vital sign that is also associated with CVD morbidity and mortality. Previous studies have reported the significant relationship of a resting heart rate with arterial stiffness as measured by cfPWV only in hypertensive subjects; their relationship in nonhypertensive subjects remains unknown. The present study, therefore, examined their relationship in normotensive subjects.
   Subjects and Methods: In 102 healthy Korean Americans between ages 20 and 60 years, their resting heart rate was measured by an automated blood pressure measuring device after a 10 minute rest in the supine position. Arterial stiffness was measured by cfPWV using the SphygmoCor device.
   Results: The mean resting heart rate of participants (mean age, 39.64 years; 59% women) was 61.91 bpm (standard deviation [SD], 9.62 bpm) and mean the cfPWV was 6.99 (SD, 1.14) m/s. A multiple regression analysis showed that a resting heart rate is a significant predictor of cfPWV after controlling for age, body mass index, and mean arterial pressure. For one bpm increase of resting heart rate, cfPWV increased approximately 0.02 m/s.
   Conclusion: Our results suggest that a higher resting heart rate is independently associated with increased arterial stiffness as measured by cfPWV in normotensive adults. Arterial stiffness may explain the prognostic role of an individual's heart rate in cardiovascular morbidity and mortality.
C1 [Logan, Jeongok G.] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA.
   [Kim, Suk-Sun] Ewha Womans Univ, Coll Nursing, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
RP Kim, SS (corresponding author), Ewha Womans Univ, Coll Nursing, 52 Ewhayeodae Gil, Seoul 03760, South Korea.
EM suksunkim@ewha.ac.kr
FU NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Nursing Research (NINR) [F31NR011377, F31NR011377] Funding
   Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Nursing Research (NINR) [F31 NR011377] Funding Source:
   Medline
CR Albaladejo P, 2003, J HYPERTENS, V21, P555, DOI 10.1097/00004872-200303000-00021
   Albaladejo P, 2001, HYPERTENSION, V38, P949, DOI 10.1161/hy1001.096210
   Albaladejo P, 2000, J HUM HYPERTENS, V14, P137, DOI 10.1038/sj.jhh.1000961
   Amiya E, 2013, J BIOL CHEM, V288, P14497, DOI 10.1074/jbc.M112.448522
   Avolio A, 2013, HYPERTENSION, V62, pE46, DOI 10.1161/HYPERTENSIONAHA.113.02260
   Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135
   BONAA KH, 1992, CIRCULATION, V86, P394
   Chen W, 2016, AM J EPIDEMIOL, V183, P599, DOI 10.1093/aje/kwv274
   Chung CM, 2012, AM J MED SCI, V344, P190, DOI 10.1097/MAJ.0b013e318242a354
   Cunha RS, 1997, J HYPERTENS, V15, P1423, DOI 10.1097/00004872-199715120-00009
   Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93
   Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281
   Hornig B, 1997, CIRCULATION, V95, P1115
   Hozawa A, 2004, AM J HYPERTENS, V17, P1005, DOI 10.1016/j.amjhyper.2004.06.019
   Hu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076922
   Kawahara H, 2000, EUR J PHARMACOL, V387, P279, DOI 10.1016/S0014-2999(99)00793-1
   Kwon O, 2016, CLIN PHYSIOL FUNCT I, V36, P286, DOI 10.1111/cpf.12226
   Lantelme P, 2002, HYPERTENSION, V39, P1083, DOI 10.1161/01.HYP.0000019132.41066.95
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   Palatini P, 2002, ARCH INTERN MED, V162, P2313, DOI 10.1001/archinte.162.20.2313
   Palatini P, 2000, AM J HYPERTENS, V13, P92, DOI 10.1016/S0895-7061(99)00170-3
   Palatini P, 2006, J HYPERTENS, V24, P1873, DOI 10.1097/01.hjh.0000242413.96277.5b
   Palatini P, 2010, J HYPERTENS, V28, P653, DOI 10.1097/HJH.0b013e3283389e3d
   Tan J, 2007, HYPERTENS RES, V30, P959, DOI 10.1291/hypres.30.959
   Tomiyama H, 2010, J HYPERTENS, V28, P687, DOI 10.1097/HJH.0b013e3283369fe8
   Whelton SP, 2013, HYPERTENSION, V62, P477, DOI 10.1161/HYPERTENSIONAHA.113.01605
   Wilkinson IB, 2002, AM J HYPERTENS, V15, P24, DOI 10.1016/S0895-7061(01)02252-X
   Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9
   Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41
NR 29
TC 10
Z9 11
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 834
EP 840
DI 10.4070/kcj.2016.46.6.834
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700014
PM 27826343
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, AY
   Song, JS
   Kim, EK
   Jang, SY
   Chung, TY
   Choi, SH
   Sung, K
   Huh, J
   Kang, IS
   Choe, YH
   Ki, CS
   Kim, DK
AF Lim, A. Young
   Song, Ju Sun
   Kim, Eun Kyoung
   Jang, Shin Yi
   Chung, Tae-Young
   Choi, Seung-Hyuk
   Sung, Kiick
   Huh, June
   Kang, I-Seok
   Choe, Yeon Hyeon
   Ki, Chang-Seok
   Kim, Duk-Kyung
TI Clinical Characteristics of Marfan Syndrome in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Marfan syndrome; Demographics; Koreans
ID GHENT; DIAGNOSIS
AB Background and Objectives: Marfan syndrome (MFS) is a connective tissue disorder with autosomal dominant inheritance and a highly variable clinical spectrum. However, there are limited data available on the clinical features of Korean patients with MFS. The aim of the present study was to describe the clinical characteristics and outcomes of Korean patients with MFS.
   Subjects and Methods: We included all patients who were diagnosed with MFS between January 1995 and May 2015 at a single tertiary medical center. Patients with an MFS-related disorder including MASS phenotype (myopia, mitral valve prolapse, borderline and non progressive aortic root dilatation, skeletal findings, and striae), mitral valve prolapse syndrome, and ectopia lentis syndrome were excluded. A total of 343 Korean patients aged years who satisfied the revised Ghent nosology were included.
   Results: The mean patient age at diagnosis was 35.9 +/- 12.6 years and 172 (50.1%) patients were male. Median follow-up duration was 52.8 months. A total of 303 patients (88.6%) had aortic root dilatation with Z score >= 2 or aortic root dissection. Ectopia lentis was relatively less common (163 patients, 55.1%) and systemic score >= 7 was found in 217 patients (73.8%). Among 219 probands, a family history of MFS was present in 97 patients (44.5%) and sporadic cases in 121 patients (55.5%). Among the 157 probands who underwent genetic analysis, 141 (89.8%) had an FBN1 mutation associated with aortic root aneurysm/dissection. Aortic dissection (AD) or intramural hematoma (IMH) was identified in 110 patients (32.1%). Among the 221 patients without AD or IMH, descending aortic aneurysms were identified in 19 patients (8.6%). Two hundred thirteen patients (62%) underwent cardiovascular surgery of any type. Eight patients died during follow-up.
   Conclusion: We described the clinical characteristics and outcomes of Korean MFS patients. Cardiovascular manifestations were commonly detected and FBN1 mutation was present in approximately 90% of patients. In contrast, ectopia lentis was identified in approximately half of patients. Our findings will be informative for the evaluation of patients with MFS.
C1 [Lim, A. Young; Kim, Eun Kyoung; Jang, Shin Yi; Choi, Seung-Hyuk; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
   [Song, Ju Sun; Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.
   [Chung, Tae-Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.
   [Sung, Kiick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg,Heart Vasc Stroke I, Seoul, South Korea.
   [Huh, June; Kang, I-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Heart Vasc Stroke Inst, Seoul, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol,HVSI Imaging Ctr,Heart Vasc Stroke In, Seoul, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
EM dukyung.kim@gmail.com
RI Ki, Chang-Seok/G-7559-2014; ki, cs/O-5931-2014; Choe, Yeon
   Hyeon/F-1422-2010; Kim, Duk Kyung/F-4613-2014
OI Ki, Chang-Seok/0000-0001-7679-8731; Choe, Yeon
   Hyeon/0000-0002-9983-048X; Huh, June/0000-0003-4523-9632
CR Akutsu K, 2009, AM J CARDIOL, V103, P1146, DOI 10.1016/j.amjcard.2008.12.037
   Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063
   Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125
   Franken R, 2013, CIRC J, V77, P2793, DOI 10.1253/circj.CJ-13-0584
   Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6
   Kim EK, 2014, J THORAC CARDIOV SUR, V147, P1505, DOI 10.1016/j.jtcvs.2013.05.025
   Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003
   Lin Fay Y, 2008, J Cardiovasc Comput Tomogr, V2, P298, DOI 10.1016/j.jcct.2008.08.002
   Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785
   PYERITZ RE, 1990, NEW ENGL J MED, V323, P987, DOI 10.1056/NEJM199010043231409
   Sohn GH, 2011, INT J CARDIOVAS IMAG, V27, P679, DOI 10.1007/s10554-011-9867-5
   Von Kodolitsch Y, 2015, APPL CLIN GENET, V8, P137, DOI 10.2147/TACG.S60472
   Williams A, 2008, HEART, V94, P414, DOI 10.1136/hrt.2006.109454
   Yang JH, 2012, AM J MED GENET A, V158A, P989, DOI 10.1002/ajmg.a.34392
   Yoo EH, 2010, CLIN GENET, V77, P177, DOI 10.1111/j.1399-0004.2009.01287.x
NR 15
TC 7
Z9 7
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 841
EP 845
DI 10.4070/kcj.2016.46.6.841
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700015
PM 27826344
OA Green Published
DA 2021-04-22
ER

PT J
AU Saritas, T
   Yucel, IK
   Demir, IH
   Demir, F
   Erdem, A
   Celebi, A
AF Saritas, Turkay
   Yucel, Ilker Kemal
   Demir, Ibrahim Halil
   Demir, Fadli
   Erdem, Abdullah
   Celebi, Ahmet
TI Comparison of Transcatheter Atrial Septal Defect Closure in Children,
   Adolescents and Adults: Differences, Challenges and Short-, Mid- and
   Long-Term Results
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Septal occluder; Children; Adult
ID DEVICE CLOSURE; OCCLUDER DEVICES; FOLLOW-UP; INFANTS; KG
AB Background and Objectives: This study aims to compare the characteristics, effectiveness and results of transcatheter closure of atrial septal defect between children, adolescents, and adults.
   Subjects and Methods: In this study, 683 patients who underwent atrial septal defect closure in the last 10 years were divided into three groups: children (age <12), adolescents (age 12 to 16), and adults (age >16) as group 1, group 2 and group 3, respectively.
   Results: The average defect size and incidence of complex atrial septal defect were higher in group 3 (p=0.0001 and 0.03 respectively). While the average size of the devic was higher in adults (22.6 +/- 6.4 mm vs. 18.5 +/- 4.9 mm; p=0.0001), the ratio of the device size/total septum was higher in both children and adolescents (Group 1 and 2). In the child and adolescent groups and patients with only complex atrial septal defect, the use of techniques, other than standard deployment, was similar in all three groups (p=0.86 and 0.41, respectively). The ratio of the residual shunt was similar in all three groups. Major complications were seen in 5 cases (4 cases with migration, and 1 case with dislocation) in group 3 and 1 case (migration) in group 1.
   Conclusion: Depending on the complexity of the defect and age of the patient, transcatheter closure of atrial septal defect might have certain difficulties and complications. Patients must be evaluated in detail to avoid major complications and possible problems during the procedure.
C1 [Saritas, Turkay; Erdem, Abdullah] Istanbul Medipol Univ, Fac Med, Dept Pediat Cardiol, Istanbul, Turkey.
   [Yucel, Ilker Kemal; Demir, Ibrahim Halil; Demir, Fadli; Celebi, Ahmet] Dr Siyami Ersek Thorac & Cardiovasc Surg Ctr & Re, Dept Pediat Cardiol, Istanbul, Turkey.
RP Saritas, T (corresponding author), Goztepe Mh Dr Rifat Pasa Sk 21-33, TR-34730 Istanbul, Turkey.
EM turkaysaritas@yahoo.com
RI Demir, Fadli/J-7606-2018
CR Amoozgar H, 2014, PEDIATR CARDIOL, V35, P1301, DOI 10.1007/s00246-014-0986-3
   Awad SM, 2007, CATHETER CARDIO INTE, V70, P265, DOI 10.1002/ccd.21145
   Beitzke A, 2009, ACTA PAEDIATR, V98, P582, DOI 10.1111/j.1651-2227.2008.01149.x
   Bishnoi RN, 2014, PEDIATR CARDIOL, V35, P1124, DOI 10.1007/s00246-014-0905-7
   Butera G, 2010, CATHETER CARDIO INTE, V76, P121, DOI 10.1002/ccd.22435
   Cardenas L, 2007, CATHETER CARDIO INTE, V69, P447, DOI 10.1002/ccd.21030
   Cooke JC, 1999, J AM SOC ECHOCARDIOG, V12, P601, DOI 10.1016/S0894-7317(99)70009-X
   Dalvi B, 2008, CATHETER CARDIO INTE, V71, P679, DOI 10.1002/ccd.21450
   Dhaliwal RS, 2009, THORAC CARDIOV SURG, V57, P233, DOI 10.1055/s-2008-1038727
   Diab KA, 2007, J THORAC CARDIOV SUR, V134, P960, DOI 10.1016/j.jtcvs.2007.06.018
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI DOI 10.1016/S0735-1097(02)01862-4
   El-Said H, 2015, CATHETER CARDIO INTE, V85, P227, DOI 10.1002/ccd.25684
   Erdem A, 2013, INT J CARDIOVAS IMAG, V29, P53, DOI 10.1007/s10554-011-9933-z
   Gabriels C, 2014, INT J CARDIOL, V176, P833, DOI 10.1016/j.ijcard.2014.08.009
   Geva T, 2014, LANCET, V383, P1921, DOI 10.1016/S0140-6736(13)62145-5
   Goel PK, 2012, TEX HEART I J, V39, P653
   Kawamura A, 2014, CARDIOVASC INTERV TH, V29, P296, DOI 10.1007/s12928-013-0238-0
   Kim NK, 2011, KOREAN CIRC J, V41, P633, DOI 10.4070/kcj.2011.41.11.633
   Knirsch W, 2005, PEDIATR CARDIOL, V26, P147, DOI 10.1007/s00246-004-0958-0
   Lairakdomrong Khanittha, 2013, Journal of the Medical Association of Thailand, V96, P1127
   Lakhdhar R, 2013, Tunis Med, V91, P243
   Mahadevan VS, 2009, INT J CARDIOL, V133, P359, DOI 10.1016/j.ijcard.2008.01.027
   Mashman WE, 2005, CATHETER CARDIO INTE, V65, P588, DOI 10.1002/ccd.20429
   Masseli J, 2013, CATHETER CARDIO INTE, V81, P825, DOI 10.1002/ccd.24329
   Nehgme RA, 2009, PEDIATR CARDIOL, V30, P367, DOI 10.1007/s00246-008-9322-0
   Park Su-Jin, 2010, Korean Circ J, V40, P191, DOI 10.4070/kcj.2010.40.4.191
   Rohit Manoj Kumar, 2014, Indian Heart J, V66, P366, DOI 10.1016/j.ihj.2014.03.013
   Szkutnik Malgorzata, 2008, Cardiol J, V15, P510
   Turkay Saritas, 2010, J Cardiovasc Dis Res, V1, P181, DOI 10.4103/0975-3583.74261
   Zhang H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-123
NR 30
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 851
EP 861
DI 10.4070/kcj.2016.46.6.851
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700017
PM 27826346
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, J
   Chun, KJ
   Lee, DS
   Lee, SY
   Chon, MK
   Lee, SH
   Hwang, KW
   Kim, JH
AF Hwang, Jongmin
   Chun, Kook-Jin
   Lee, Dae Sung
   Lee, Soo Yong
   Chon, Min Ku
   Lee, Sang Hyun
   Hwang, Ki Won
   Kim, June Hong
TI Extraction of a Fully Deployed Coronary Stent during Retrieval of
   Another Dislodged Stent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Stent; Complication
AB Coronary stent dislodgement is a rare and serious complication of percutaneous coronary intervention and is associated with major adverse cardiac events. Successful retrieval of the stent is recommended in this situation because it is important for the prognosis. Recently, a patient was referred to our hospital with a dislodged coronary stent. When attempting to percutaneously extract the dislodged stent, a challenging situation was encountered, as the stent was entrapped and tightly entangled with another fully deployed coronary stent. Extraction of a fully deployed stent is generally prohibited as it may result in severe complications. Nevertheless, we extracted both the dislodged stent and the fully deployed stent, as a last resort. Herein, we report about this case. Our case highlights if the operator had a thorough understanding of the surrounding circumstances regarding the fully deployed coronary stent, successful extraction of the fully deployed coronary stent without any complications could be possible.
C1 [Hwang, Jongmin; Chun, Kook-Jin; Lee, Dae Sung; Lee, Soo Yong; Chon, Min Ku; Lee, Sang Hyun; Hwang, Ki Won; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol,Sch Med,Ctr Cardiovasc, 20 Geumo Ro, Yangsan 50612, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol,Sch Med,Ctr Cardiovasc, 20 Geumo Ro, Yangsan 50612, South Korea.
EM ptca82@gmail.com
CR Alomar ME, 2013, J INVASIVE CARDIOL, V25, P637
   Bolte J, 2001, AM J CARDIOL, V88, P565, DOI 10.1016/S0002-9149(01)01742-8
   Brilakis ES, 2005, CATHETER CARDIO INTE, V66, P333, DOI 10.1002/ccd.20449
   Collins Nicholas, 2007, J Invasive Cardiol, V19, pE230
   Jang JH, 2013, KOREAN J INTERN MED, V28, P481, DOI 10.3904/kjim.2013.28.4.481
   Kang JH, 2012, KOREAN CIRC J, V42, P201, DOI 10.4070/kcj.2012.42.3.201
   Kim JH, 2012, KOREAN CIRC J, V42, P492, DOI 10.4070/kcj.2012.42.7.492
   Kim JY, 2005, YONSEI MED J, V46, P166, DOI 10.3349/ymj.2005.46.1.166
NR 8
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 862
EP 865
DI 10.4070/kcj.2016.46.6.862
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700018
PM 27826347
OA Green Published
DA 2021-04-22
ER

PT J
AU Virk, HU
   Inayat, F
   Rahman, ZU
AF Virk, Hafeez Ul Hassan
   Inayat, Faisal
   Rahman, Zia Ur
TI Complete Heart Block in Association with Dengue Hemorrhagic Fever
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dengue hemorrhagic fever; Heart block
ID SPECTRUM
AB Dengue virus infection affects the heart structurally and functionally. Clinical manifestations of cardiac complications secondary to dengue virus infection vary from self-limiting arrhythmias to severe myocardial infarction, leading to hypotension, pulmonary edema, and cardiogenic shock. However, we report a case of dengue hemorrhagic fever (DHF) complicated by a complete heart block. A female with DHF due to dengue virus serotype 2, presented to the emergency department with fever, headache, rash, and fatigue followed by an episode of syncope. She was found to have a third-degree atrioventricular block, with pulseless polymorphic ventricular tachycardia. Patient was resuscitated and a temporary trans-venous pacemaker was placed. She reverted back to normal sinus rhythm after 4 days of syncope and was subsequently discharged from the hospital after complete resolution of symptoms, without the need for a permanent pacemaker. Physicians are warranted to have high index of suspicion for dengue virus infection as an etiology in patients with acute cardiovascular compromise, especially in tropical areas.
C1 [Virk, Hafeez Ul Hassan] Mt Sinai St Lukes Hosp, Dept Med, Icahn Sch Med, New York, NY USA.
   [Virk, Hafeez Ul Hassan] Mt Sinai Roosevelt Hosp, Dept Med, Icahn Sch Med, New York, NY USA.
   [Inayat, Faisal] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Med, 525 East 68th St, New York, NY 10065 USA.
   [Rahman, Zia Ur] Quillen Coll Med, Johnson City Med Ctr, Dept Med, Johnson City, TN USA.
RP Inayat, F (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Med, 525 East 68th St, New York, NY 10065 USA.
EM faisalinayat@hotmail.com
RI Inayat, Faisal/S-4533-2019
CR Agarwal R., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P735
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHUAH S K, 1987, SMJ Singapore Medical Journal, V28, P569
   Veloso Henrique Horta, 2003, Braz J Infect Dis, V7, P418, DOI 10.1590/S1413-86702003000600010
   Kayal AK, 2013, ANN INDIAN ACAD NEUR, V16, P211, DOI 10.4103/0972-2327.112469
   Khongphafthanayothin A, 2007, PEDIATR CRIT CARE ME, V8, P524, DOI 10.1097/01.PCC.0000288672.77782.D4
   Khongphatthallayothin A, 2000, Southeast Asian J Trop Med Public Health, V31, P642
   Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021
   La-Orkhun V, 2011, ANN TROP PAEDIATR, V31, P123, DOI 10.1179/1465328111Y.0000000008
   Lateef A, 2007, EMERG INFECT DIS, V13, P650, DOI 10.3201/eid1304.061212
   Lee CH, 2009, INT J CARDIOL, V136, pE69, DOI 10.1016/j.ijcard.2008.05.023
   Lim SMS, 2014, RAWAL MED J, V39, P104
   Martha JW, 2009, J CARDIOVASC ELECTR, V20, pS59
   Mekmullica Jutarat, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P197
   MOUALLEM M, 1991, CLIN CARDIOL, V14, P165, DOI 10.1002/clc.4960140214
   Nijjer S, 2010, BMJ CASE REP, V2010
   Satarasinghe RL, 2007, BRIT J CARDIOL, V14, P171
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Wali JP, 1998, INT J CARDIOL, V64, P31, DOI 10.1016/S0167-5273(98)00008-4
NR 20
TC 8
Z9 8
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 866
EP 869
DI 10.4070/kcj.2016.46.6.866
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700019
PM 27826348
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, IS
   Pyun, WB
AF Kang, In Sook
   Pyun, Wook Bum
TI Life Threatening Complication of Self-Made Remedy for Controlling High
   Blood Pressure-Coronary Artery Vasospasm Associated with latrogenic
   Thyrotoxicosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Complementary medicine; Kelp; Thyrotoxicosis; Angina pectoris; variant;
   Adherence
ID HYPERTENSION; MEDICATION; ADHERENCE; MEDICINE; SPASM
AB We report the case of a middle aged woman who was previously diagnosed with hypertension. She had been drinking a kelp concentrate solution daily for her hypertension instead of taking the prescribed medicine due to her personal beliefs about the kelp solution. As a consequence, she experienced vasospastic angina complicated by myocardial infarction and cardiogenic syncope resulting from iatrogenic thyrotoxicosis.
   Complementary medicine is widely used by the general population. However, there is still a lack of evidence regarding their efficacy and safety. This case shows that inadequate use of complementary medicine could have no effect and may even be harmful. In patients with chronic diseases such as hypertension, self-care in the form of life style modification, home blood pressure monitoring and medial adherence are important for disease management
C1 [Kang, In Sook] Green Hosp, Dept Internal Med, Seoul, South Korea.
   [Kang, In Sook] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
   [Pyun, Wook Bum] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Div Cardiol, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM pwb423@ewha.ac.kr
CR Bell RA, 2008, PATIENT EDUC COUNS, V72, P115, DOI 10.1016/j.pec.2008.01.021
   BERGERON GA, 1988, ARCH INTERN MED, V148, P1450, DOI 10.1001/archinte.148.6.1450
   Chao MT, 2006, J ALTERN COMPLEM MED, V12, P719, DOI 10.1089/acm.2006.12.719
   Choi YH, 2005, CORONARY ARTERY DIS, V16, P135, DOI 10.1097/00019501-200505000-00001
   De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323
   Eliason B C, 1998, J Am Board Fam Pract, V11, P478
   Ernst E, 2005, WIEN MED WOCHENSCHR, V155, P386, DOI 10.1007/s10354-005-0205-1
   Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31
   FEATHERSTONE HJ, 1983, ARCH INTERN MED, V143, P554, DOI 10.1001/archinte.143.3.554
   Finset A, 2008, PATIENT EDUC COUNS, V72, P1, DOI 10.1016/j.pec.2008.05.008
   Fukuyama K, 2003, HYPERTENSION, V41, P598, DOI 10.1161/01.HYP.0000056524.35294.80
   Gohar F, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-4
   Hermenegildo C, 2002, J CLIN ENDOCR METAB, V87, P5636, DOI 10.1210/jc.2002-020905
   Jaber JA, 2010, ANGIOLOGY, V61, P807, DOI 10.1177/0003319710365146
   Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251
   Mussig K, 2006, J GEN INTERN MED, V21, pC11, DOI 10.1111/j.1525-1497.2006.00416.x
   Napoli R, 2001, CIRCULATION, V104, P3076, DOI 10.1161/hc5001.100621
   Napoli R, 2007, J CLIN ENDOCR METAB, V92, P250, DOI 10.1210/jc.2006-1552
   WEI JY, 1979, AM J CARDIOL, V43, P335, DOI 10.1016/S0002-9149(79)80023-5
   Zava TT, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-14
NR 20
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 870
EP 874
DI 10.4070/kcj.2016.46.6.870
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700020
PM 27826349
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, H
   Jo, S
   Cho, YK
   Kim, J
   Cho, S
   Kim, JH
   Jeong, YJ
   Song, JK
AF Park, Hanbit
   Jo, Seokjung
   Cho, Yun Kyung
   Kim, Jongkwan
   Cho, Sangcheol
   Kim, Ju Hyeon
   Jeong, Yeong Jin
   Song, Jae-Kwan
TI Differential Diagnosis of a Left Atrial Mass after Surgical Excision of
   Myxoma: a Remnant or a Thrombus?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myxoma; Thrombosis; Echocardiography
ID SEPTAL-DEFECT; EXPERIENCE
AB Echocardiographic diagnosis of atrial myxoma may not always be straightforward, and the distinction between myxoma and thrombi is not easy, especially when we observe a mass after successful surgery. Our report describes a 72-year-old woman who presented with right upper limb hemiparesis and was subsequently diagnosed as having transient ischemic attack due to a left atrial myxoma. One month after successful surgical resection of the tumor, the patient developed left-sided weakness. Echocardiography revealed a left atrial mass attached to the interatrial septum. Intravenous heparin was administered as a therapeutic trial for postoperative thrombi, which resulted in a decrease in mass size within a week. Anticoagulation with warfarin was continued, and complete resolution was demonstrated on a 4-month follow-up transesophageal echocardiography. This case highlights the fact that thrombus formation at the surgical site should be considered an unusual but potential complication after surgical resection of left atrial myxomas.
C1 [Park, Hanbit; Kim, Ju Hyeon; Jeong, Yeong Jin; Song, Jae-Kwan] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Internal Med,Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Jo, Seokjung; Cho, Yun Kyung; Kim, Jongkwan; Cho, Sangcheol] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Internal Med, Seoul, South Korea.
RP Song, JK (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Internal Med,Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM jksong@amc.seoul.kr
CR Bjessmo S, 1997, ANN THORAC SURG, V63, P697, DOI 10.1016/S0003-4975(96)01368-9
   Dinckal MH, 2003, ECHOCARDIOGR-J CARD, V20, P535, DOI 10.1046/j.1540-8175.2003.03091.x
   Feinglass NG, 1998, J AM SOC ECHOCARDIOG, V11, P677, DOI 10.1016/S0894-7317(98)70046-X
   Garatti A, 2012, ANN THORAC SURG, V93, P825, DOI 10.1016/j.athoracsur.2011.11.009
   Hammami R, 2012, CASE REP MED, V2012, DOI 10.1155/2012/518539
   Heitner JF, 2005, J CARDIOV MAGN RESON, V7, P841, DOI 10.1080/10976640500288156
   Hesse B, 2006, CIRCULATION, V113, pE456, DOI 10.1161/CIRCULATIONAHA.105.565903
   Hill M, 2010, AORN J, V92, P407
   Hill Marites, 2010, AORN J, V92, P393, DOI 10.1016/j.aorn.2010.06.012
   Jang Kyeong-Hee, 2010, J Cardiovasc Ultrasound, V18, P154, DOI 10.4250/jcu.2010.18.4.154
   Perek B, 2011, KARDIOL POL, V69, P558
   REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407
   Rodriguez CJ, 2001, J AM SOC ECHOCARDIOG, V14, P63, DOI 10.1067/mje.2001.108539
   Samanidis G, 2011, INTERACT CARDIOV TH, V13, P597, DOI 10.1510/icvts.2011.278705
   Sheikh AY, 2007, ANN THORAC SURG, V84, P1742, DOI 10.1016/j.athoracsur.2007.05.065
   THOMAS KE, 1967, J THORAC CARDIOV SUR, V53, P535, DOI 10.1016/S0022-5223(19)43181-4
   Yu SH, 2006, YONSEI MED J, V47, P367, DOI 10.3349/ymj.2006.47.3.367
NR 17
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 875
EP 878
DI 10.4070/kcj.2016.46.6.875
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700021
PM 27826350
OA Green Published
DA 2021-04-22
ER

PT J
AU Liebenberg, J
   van der Biji, P
AF Liebenberg, Jacques
   van der Biji, Pieter
TI A "Vanishing", Tuberculous, Pericardial Effusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pericardial effusion; Tuberculosis; Echocardiography; Pleural cavity
ID MAYO-CLINIC EXPERIENCE; GUIDED PERICARDIOCENTESIS; OUTCOMES; MANAGEMENT
AB We present an iatrogenic, pleuro-pericardial connection resulting from pericardiocentesis of a large, tuberculous, pericardial effusion. Recognition of this situation is paramount when one is unable to aspirate pericardial fluid after a successful, initial puncture. Such knowledge will help prevent myocardial or coronary artery injury with further attempts at aspiration.
C1 [Liebenberg, Jacques] Kimberley Hosp, Kimberley Prov Hosp, Dept Internal Med, Du Toitspan Rd, Kimberley, South Africa.
   [van der Biji, Pieter] Kuils River Hosp, SA Endovasc, Kuils River, South Africa.
RP van der Biji, P (corresponding author), Kuils River Hosp, Endovasc, 33 Van Riebeeck Rd, ZA-7580 Kuils River, South Africa.
EM pieter.vanderbijl@gmail.com
CR Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3
   El Haddad D, 2015, J AM COLL CARDIOL, V66, P1119, DOI 10.1016/j.jacc.2015.06.1332
   Klein SV, 2005, EMERG RADIOL, V11, P353, DOI 10.1007/s10140-004-0389-5
   Maggiolini S, 2001, J AM SOC ECHOCARDIOG, V14, P821, DOI 10.1067/mje.2001.114009
   Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002
   PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9
   Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123
   Tsang TSM, 1999, CHEST, V116, P322, DOI 10.1378/chest.116.2.322
   Tsang TSM, 2002, MAYO CLIN PROC, V77, P429
   Tsang TSM, 1998, J AM COLL CARDIOL, V32, P1345, DOI 10.1016/S0735-1097(98)00390-8
   Winter M, 2009, J AM SOC ECHOCARDIOG, V22, DOI 10.1016/j.echo.2009.03.029
   ZISKIND AA, 1993, J AM COLL CARDIOL, V21, P1, DOI 10.1016/0735-1097(93)90710-I
NR 12
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 879
EP 881
DI 10.4070/kcj.2016.46.6.879
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700022
PM 27826351
OA Green Published
DA 2021-04-22
ER

PT J
AU Beck, KS
   Jeong, SY
   Lee, KY
   Chang, K
   Jung, JI
AF Beck, Kyongmin Sarah
   Jeong, Soh Yong
   Lee, Kyo Young
   Chang, Kiyuk
   Jung, Jung Im
TI Native T1 Mapping Demonstrating Apical Thrombi in Eosinophilic
   Myocarditis Associated with Churg-Strauss Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocarditis; Necrosis; Thrombosis; Churg-Strauss syndrome; Magnetic
   resonance imaging
ID RESTRICTIVE CARDIOMYOPATHY; MRI
AB Eosinophilic myocarditis is a disease characterized by eosinophilic infiltration of the myocardium, consisting of acute necrotic stage, thrombotic stage, and fibrotic stage. Although T1 mapping has been increasingly used in various cardiac pathologies, there has been no report of T1 mapping in eosinophilic myocarditis. We report a case of 75-year-old female with eosinophilic myocarditis, whose cardiac magnetic resonance imaging included native T1 mapping, in which apical thrombi were distinctly seen as areas with decreased T1 values, next to areas of inflammation seen as increased T1 value in subendocardium.
C1 [Beck, Kyongmin Sarah; Jung, Jung Im] Catholic Univ, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea.
   [Jeong, Soh Yong] Catholic Univ, Yeouido St Marys Hosp, Dept Radiol, Seoul, South Korea.
   [Lee, Kyo Young] Catholic Univ, Seoul St Marys Hosp, Dept Pathol, Seoul, South Korea.
   [Chang, Kiyuk] Catholic Univ, Seoul St Marys Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
RP Jung, JI (corresponding author), Catholic Univ, Seoul St Marys Hosp, Dept Radiol, Coll Med, 222 Banpodaero, Seoul 06591, South Korea.
EM jijung@catholic.ac.kr
OI Jung, Jung Im/0000-0001-8264-9388
CR Chang SA, 2009, CIRCULATION, V120, P82, DOI 10.1161/CIRCULATIONAHA.108.833566
   Deb K, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-21
   Gupta A, 2012, CLIN RADIOL, V67, P95, DOI 10.1016/j.crad.2011.05.020
   Hamlin SA, 2014, RADIOGRAPHICS, V34, P1594, DOI 10.1148/rg.346140030
   Karamitsos TD, 2013, JACC-CARDIOVASC IMAG, V6, P488, DOI 10.1016/j.jcmg.2012.11.013
   MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806
   OLSEN EGJ, 1986, POSTGRAD MED J, V62, P607, DOI 10.1136/pgmj.62.728.607
   Salanitri GC, 2005, AM J ROENTGENOL, V184, P1432, DOI 10.2214/ajr.184.5.01841432
   Tani H, 2012, JPN J RADIOL, V30, P824, DOI 10.1007/s11604-012-0130-3
   Thambidorai SK, 2009, TEX HEART I J, V36, P355
   Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481
   Yoon YE, 2014, KOREAN CIRC J, V44, P359, DOI 10.4070/kcj.2014.44.6.359
NR 12
TC 1
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 882
EP 885
DI 10.4070/kcj.2016.46.6.882
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700023
PM 27826352
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YG
   Hong, SJ
AF Kim, Yun Gi
   Hong, Soon Jun
TI Staged versus One-Time Percutaneous Coronary Intervention Strategy for
   Multivessel Non-ST Segment Elevation Acute Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MYOCARDIAL-INFARCTION; ARTERY-DISEASE; CULPRIT VESSEL; REVASCULARIZATION
C1 [Kim, Yun Gi; Hong, Soon Jun] Korea Univ, Dept Cardiol, Ctr Cardiovasc, Anam Hosp, 73 Inchon Ro, Seoul 02841, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Dept Cardiol, Ctr Cardiovasc, Anam Hosp, 73 Inchon Ro, Seoul 02841, South Korea.
EM psyche94@gmail.com
CR Blankenship JC, 2012, CATHETER CARDIO INTE, V79, P1138, DOI 10.1002/ccd.23353
   Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074
   Hannan EL, 2013, CIRC-CARDIOVASC INTE, V6, P12, DOI 10.1161/CIRCINTERVENTIONS.112.974485
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Kim MC, 2011, INT J CARDIOL, V153, P148, DOI 10.1016/j.ijcard.2010.08.044
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Shishehbor MH, 2007, J AM COLL CARDIOL, V49, P849, DOI 10.1016/j.jacc.2006.10.054
   TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Yu XF, 2016, KOREAN CIRC J, V46, P774, DOI 10.4070/kcj.2016.46.6.774
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 762
EP 764
DI 10.4070/kcj.2016.46.6.762
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700003
PM 27826332
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, JI
AF Jung, Jung Im
TI Magnetic Resonance Imaging for Patients with Cardiac Implantable
   Electronic Devices: Reduced Concerns Regarding Safety, but Scrutiny
   Remains Critical
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DEFIBRILLATOR PATIENTS; PACEMAKER; MRI; LEADS
C1 [Jung, Jung Im] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, 222 Bandpo Daero, Seoul 06591, South Korea.
RP Jung, JI (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, 222 Bandpo Daero, Seoul 06591, South Korea.
EM jijung@catholic.ac.kr
OI Jung, Jung Im/0000-0001-8264-9388
CR Bartsch Ch IW, 2003, 19 C INT AC LEG MED, p114A
   Beinart R, 2013, CIRCULATION, V128, P2799, DOI 10.1161/CIRCULATIONAHA.113.005697
   Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206
   Eyal A, 2015, CIRCULATION, V132, pE176, DOI 10.1161/CIRCULATIONAHA.114.014640
   Gimbel JR, 2008, PACE, V31, P795, DOI 10.1111/j.1540-8159.2008.01117.x
   Hsu CJ, 2012, HEART LUNG CIRC, V21, P358, DOI 10.1016/j.hlc.2012.04.004
   Hwang YM, 2016, KOREAN CIRC J, V46, P804, DOI 10.4070/kcj.2016.46.6.804
   Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x
   Langman DA, 2011, J MAGN RESON IMAGING, V33, P426, DOI 10.1002/jmri.22463
   Naehle CP, 2008, RADIOLOGY, V249, P991, DOI 10.1148/radiol.2493072195
   Nazarian S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P419, DOI 10.1161/CIRCEP.113.000116
   Nordbeck P, 2015, EUR HEART J, V36, P1505, DOI 10.1093/eurheartj/ehv086
   Nordbeck P, 2011, MAGN RESON MED, V65, P44, DOI 10.1002/mrm.22592
   Sabzevari K, 2016, EUROPACE
   이철민, 2015, [Journal of the Korean Society of Radiology (JKSR), 대한영상의학회지], V73, P424, DOI 10.3348/jksr.2015.73.6.424
   Tsai LL, 2015, RADIOGRAPHICS, V35, P1722, DOI 10.1148/rg.2015150108
   Verma A, 2014, CAN ASSOC RADIOL J, V65, P290, DOI 10.1016/j.carj.2014.08.001
NR 17
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 765
EP 767
DI 10.4070/kcj.2016.46.6.765
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700004
PM 27826333
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, DH
   Lee, S
   Kim, YJ
   Kim, SH
   Kim, DH
   Yun, SC
   Song, JM
   Chung, CH
   Song, JK
   Lee, JW
AF Kang, Duk-Hyun
   Lee, Sahmin
   Kim, Yong-Jin
   Kim, Sung-Han
   Kim, Dae-Hee
   Yun, Sung-Cheol
   Song, Jong-Min
   Chung, Cheol-Hyun
   Song, Jae-Kwan
   Lee, Jae-Won
TI Long Term Results of Early Surgery versus Conventional Treatment for
   Infective Endocarditis Trial
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Infective endocarditis; Echocardiography; Embolism; Valvular heart
   disease; Cardiac surgery
ID MANAGEMENT; DIAGNOSIS; GUIDELINES; MORTALITY; DISEASE
AB Background and Objectives: Compared with conventional treatment, early surgery significantly reduced the composite end point of all cause death and embolic events during hospitalization, but long-term data in this area are lacking. This study sought to compare longterm outcomes of early surgery with a conventional treatment strategy in patients with infective endocarditis (15) and large vegetations.
   Subjects and Methods: The Early Surgery versus Conventional Treatment in Infective Endocarditis (EASE) trial randomly assigned patients with left-sided IE, severe valve disease and large vegetation to early surgery (37 patients) or conventional treatment groups (39 patients). The pre-specified end points were all-cause death, embolic events, recurrence of IE and repeat hospitalizations due to the development of congestive heart failure occurring during follow-up.
   Results: There were no significant differences between the early surgery and the conventional treatment group in all-cause mortality at 4 years (8.1% and 7.7%, respectively; hazard ratio [HR] 1.04; 95% CI, 0.21 to 5.15; p=0.96). The rate of the composite end point of death from any cause, embolic events or recurrence of IE at 4 years was 8.1% in the early surgery group and 30.8% in the conventional treatment group (HR, 0.22; 95% CI, 0.06-0.78; p=0.02). The estimated actuarial rate of end points at 7 years was significantly lower in the early surgery group than in the conventional treatment group (log-rank p=0.007).
   Conclusion: There was a substantial benefit in having early surgery for patients with IE and large vegetations whose health was sustained up to 7 years, and late clinical outcome after surgery was excellent in survivors of IE.
C1 [Kang, Duk-Hyun; Lee, Sahmin; Kim, Sung-Han; Kim, Dae-Hee; Yun, Sung-Cheol; Song, Jong-Min; Chung, Cheol-Hyun; Song, Jae-Kwan; Lee, Jae-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Cardiac Surg,Infect Dis,Biostat, Seoul, South Korea.
   [Kim, Yong-Jin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Ctr Cardiovasc, Seoul, South Korea.
RP Kang, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88 Olymp Ro 43 gil, Seoul 05505, South Korea.
EM dhkang@amc.seoul.kr
OI Kim, Dae-Hee/0000-0002-8275-4871
CR Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
   Bannay A, 2011, EUR HEART J, V32, P2003, DOI 10.1093/eurheartj/ehp008
   Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857
   FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304
   Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285
   Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536
   Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782
   Kang DH, 2015, HEART, V101, P1786, DOI 10.1136/heartjnl-2015-307878
   Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843
   Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753
   Mokhles MM, 2011, ANN THORAC SURG, V91, P1407, DOI 10.1016/j.athoracsur.2011.02.007
   Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603
   Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082
   Shih CJ, 2014, CIRCULATION, V130, P1684, DOI 10.1161/CIRCULATIONAHA.114.012717
   Ternhag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067519
   Thuny F, 2012, AM HEART J, V164, P94, DOI 10.1016/j.ahj.2012.04.003
NR 16
TC 13
Z9 14
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2016
VL 46
IS 6
BP 846
EP 850
DI 10.4070/kcj.2016.46.6.846
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB9SP
UT WOS:000387737700016
PM 27826345
OA Green Published
DA 2021-04-22
ER

PT J
AU Calhoun, DA
AF Calhoun, David A.
TI Refractory and Resistant Hypertension: Antihypertensive Treatment
   Failure versus Treatment Resistance
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Resistant hypertension; Refractory hypertension; Sympathetic nervous
   system; Spironolactone
ID BLOOD-PRESSURE; UNITED-STATES; PREVALENCE; MANAGEMENT; DISEASE;
   ALDOSTERONE; ASSOCIATION; POPULATION; DIAGNOSIS; THERAPY
AB Resistant hypertension has for many decades been defined as difficult-to-treat hypertension in order to identify patients who may benefit from special diagnostic and/or therapeutic considerations. Recently, the term "refractory hypertension" has been proposed as a novel phenotype of antihypertensive failure, that is, patients whose blood pressure cannot be controlled with maximal treatment. Early studies of this phenotype indicate that it is uncommon, affecting less than 5% of patients with resistant hypertension. Risk factors for refractory hypertension include obesity, diabetes, chronic kidney disease, and especially, being of African origin. Patients with refractory are at high cardiovascular risk based on increased rates of known heart disease, prior stroke, and prior episodes of congestive heart failure. Mechanisms of refractory hypertension need exploration, but early studies suggest a possible role of heightened sympathetic tone as evidenced by increased office and ambulatory heart rates and higher urinary excretion of norepinephrine compared to patients with controlled resistant hypertension. Important negative findings argue against refractory hypertension being fluid dependent as is typical of resistant hypertension, including aldosterone levels, dietary sodium intake, and brain natriuretic peptide levels being similar or even less than patients with resistant hypertension and the failure to control blood pressure with use of intensive diuretic therapy, including both a long-acting thiazide diuretic and a mineralocorticoid receptor antagonist. Further studies, especially longitudinal assessments, are needed to better characterize this extreme phenotype in terms of risk factors and outcomes and hopefully to identify effective treatment strategies.
C1 [Calhoun, David A.] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, 430 BMR2 1530 3rd Ave South, Birmingham, AL 35294 USA.
RP Calhoun, DA (corresponding author), Univ Alabama Birmingham, Vasc Biol & Hypertens Program, 430 BMR2 1530 3rd Ave South, Birmingham, AL 35294 USA.
EM dcalhoun@uab.edu
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30 DK079626] Funding Source:
   Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626, P30DK079626, P30DK079626, P30DK079626,
   P30DK079626, P30DK079626] Funding Source: NIH RePORTER
CR Bangalore S, 2014, AM J MED, V127, P71, DOI 10.1016/j.amjmed.2013.07.038
   Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6
   Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141
   Calhoun DA, 2014, HYPERTENSION, V63, P451, DOI 10.1161/HYPERTENSIONAHA.113.02026
   Acelajado MC, 2012, J CLIN HYPERTENS, V14, P7, DOI 10.1111/j.1751-7176.2011.00556.x
   Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064
   de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948
   Dudenbostel T, 2015, HYPERTENSION, V66, P126, DOI 10.1161/HYPERTENSIONAHA.115.05449
   Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448
   Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189
   Eide IK, 2004, J HYPERTENS, V22, P2217, DOI 10.1097/00004872-200411000-00026
   Gaddam KK, 2008, ARCH INTERN MED, V168, P1159, DOI 10.1001/archinte.168.11.1159
   Gifford Jr RW, 1988, HYPERTENSION 2, V11, pII65
   GIFFORD RW, 1978, ANN INTERN MED, V88, P661, DOI 10.7326/0003-4819-88-5-661
   Grigoryan L, 2013, J CLIN HYPERTENS, V15, P107, DOI 10.1111/jch.12030
   Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678
   Irvin MR, 2014, J AM SOC HYPERTENS, V8, P405, DOI 10.1016/j.jash.2014.03.003
   Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286
   Kumbhani DJ, 2013, EUR HEART J, V34, P1204, DOI 10.1093/eurheartj/ehs368
   LEE RE, 1958, ANN INTERN MED, V49, P1129, DOI 10.7326/0003-4819-49-5-1129
   LESLIE CH, 1962, J AM GERIATR SOC, V10, P85, DOI 10.1111/j.1532-5415.1962.tb00246.x
   Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003
   Modolo R, 2015, J AM SOC HYPERTENS, V9, P397, DOI 10.1016/j.jash.2015.03.005
   Muntner P, 2014, HYPERTENSION, V64, P1012, DOI 10.1161/HYPERTENSIONAHA.114.03850
   Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308
   Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235
   Roberie DR, 2012, CURR OPIN CARDIOL, V27, P386, DOI 10.1097/HCO.0b013e328353ad6e
   Sartori M, 2006, AM J HYPERTENS, V19, P373, DOI 10.1016/j.amjhyper.2005.06.031
   Sim JJ, 2013, MAYO CLIN PROC, V88, P1099, DOI 10.1016/j.mayocp.2013.06.017
   Taler SJ, 2002, HYPERTENSION, V39, P982, DOI 10.1161/01.HYP.0000016176.16042.2F
NR 30
TC 8
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 593
EP 600
DI 10.4070/kcj.2016.46.5.593
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100001
PM 27721847
OA Green Published
DA 2021-04-22
ER

PT J
AU Yayla, C
   Okyay, K
   Yilmaz, A
   Sahinarslan, A
   Saglam, ASY
   Eyiol, A
   Bolayir, HA
   Sezenoz, B
   Menevse, S
   Cengel, A
AF Yayla, Cagri
   Okyay, Kaan
   Yilmaz, Akin
   Sahinarslan, Asife
   Saglam, Atiye Seda Yar
   Eyiol, Azmi
   Bolayir, Hasan Ata
   Sezenoz, Burak
   Menevse, Sevda
   Cengel, Atiye
TI Association of rs10757274 and rs2383206 Polymorphisms on 9p21 locus with
   Coronary Artery Disease in Turkish Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Genetics; Atherosclerosis; Polymorphism
ID MYOCARDIAL-INFARCTION; COMMON VARIANT; ATHEROSCLEROSIS; RISK;
   REPLICATION; SEVERITY; ANRIL; GENE
AB Background and Objectives: Genetic predisposition is an important risk factor for coronary artery disease (CAD). In this study, we aimed to evaluate the impact of rs10757274 and rs2383206 polymorphisms in chromosome 9p21 on presence and severity of CAD in a Turkish population.
   Subjects and Methods: A total of 646 patients who underwent coronary angiography were included in this study. Coronary vessel score and Gensini score were calculated to assess the angiographic severity of CAD. Alleles of AA, AG, and GG were determined for rs10757274 (polymorphism-1) and rs2383206 (polymorphism-2) polymorphisms located in chromosome 9p21 from the blood samples.
   Results: There was a significant difference between the alleles in polymorphism-1 in the presence of coronary artery disease (38.9% in AA, 48.0% in GG and 56.4% in AG, p=0.017). However, there was no difference between the alleles in polymorphism-2. According to vessel scores, there was a significant difference between the alleles in polymorphism-1 (AA 0.71 +/- 1.04, GG 0.88 +/- 1.07, AG 1.06 +/- 1.12, p=0.018). In polymorphism-2, vessel scores did not show a difference between the alleles. In polymorphism-1, there was a significant difference in Gensini score (p=0.041). Gensini scores did not differ between the alleles in polymorphism-2 (p>0.05 for all). In multivariate analyses, none of the alleles was an independent factor for presence of CAD.
   Conclusion: The presence of rs10757274 polymorphism including AG allele in chromosome 9p21 was related to CAD. However, this relationship was not independent of other cardiovascular risk factors.
C1 [Yayla, Cagri; Sahinarslan, Asife; Eyiol, Azmi; Bolayir, Hasan Ata; Sezenoz, Burak; Cengel, Atiye] Gazi Univ, Dept Cardiol, Sch Med, Ankara, Turkey.
   [Okyay, Kaan] Baskent Univ, Dept Cardiol, Sch Med, Ankara, Turkey.
   [Yilmaz, Akin; Saglam, Atiye Seda Yar; Menevse, Sevda] Gazi Univ, Dept Med Biol & Genet, Sch Med, Ankara, Turkey.
RP Yayla, C (corresponding author), Gazi Univ, Dept Cardiol, Sch Med, Bestepeler Mah Merhale Sok 28-6, TR-06500 Yenimahalle Ankara, Turkey.
EM cagriyayla@gmail.com
RI Yayla, Cagri/B-9270-2019; Sezenoz, Burak/S-5141-2019; Bolayir, Hasan
   Ata/AAF-4988-2021; Okyay, Kaan/AAK-7355-2020; YILMAZ, AKIN/G-1451-2011
OI Yayla, Cagri/0000-0002-5302-4052; Sezenoz, Burak/0000-0002-6386-7045;
   Okyay, Kaan/0000-0001-6134-8826; YILMAZ, AKIN/0000-0002-4368-0777
CR Ahn SG, 2013, KOREAN CIRC J, V43, P541, DOI 10.4070/kcj.2013.43.8.541
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   Cakmak HA, 2015, ANADOLU KARDIYOL DER, V15, P196, DOI 10.5152/akd.2014.5285
   Chan L, 1994, CARDIOL REV, V2, P130, DOI DOI 10.1097/00045415-199405000-00003
   Chen HH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0502-7
   Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017
   Dandona S, 2010, J AM COLL CARDIOL, V56, P479, DOI 10.1016/j.jacc.2009.10.092
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   Di Chiara A, 2009, EUR HEART J, V30, P1027, DOI 10.1093/eurheartj/ehp025
   Ding H, 2009, CIRC-CARDIOVASC GENE, V2, P338, DOI 10.1161/CIRCGENETICS.108.810226
   Emanuele E, 2011, NEUROBIOL AGING, V32, P1231, DOI 10.1016/j.neurobiolaging.2009.07.003
   Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72
   Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842
   Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4
   Kral BG, 2011, J HUM GENET, V56, P224, DOI 10.1038/jhg.2010.171
   Kumar J, 2011, CLIN GENET, V79, P588, DOI 10.1111/j.1399-0004.2010.01509.x
   McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447
   Munir MS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-66
   Okrainec K, 2004, AM HEART J, V148, P7, DOI 10.1016/j.ahj.2003.11.027
   Onat A, 2010, TURK KARDIYOL DERN A, V38, P159
   Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118
   Roberts R, 2012, J AM COLL CARDIOL, V60, P1715, DOI 10.1016/j.jacc.2011.12.062
   Saleheen D, 2010, ARTERIOSCL THROM VAS, V30, P1467, DOI 10.1161/ATVBAHA.109.197210
   Shin DJ, 2013, KOREAN CIRC J, V43, P13, DOI 10.4070/kcj.2013.43.1.13
   Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472
   Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021
   Yoo SY, 2012, KOREAN CIRC J, V42, P406, DOI 10.4070/kcj.2012.42.6.406
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 30
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 615
EP 621
DI 10.4070/kcj.2016.46.5.615
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100005
PM 27721851
OA Green Published
DA 2021-04-22
ER

PT J
AU Avci, A
   Fidan, S
   Tabakci, MM
   Toprak, C
   Alizade, E
   Acar, E
   Bayam, E
   Tellice, M
   Naser, A
   Kargin, R
AF Avci, Anil
   Fidan, Serdar
   Tabakci, Mehmet Mustafa
   Toprak, Cuneyt
   Alizade, Elnur
   Acar, Emrah
   Bayam, Emrah
   Tellice, Muhammet
   Naser, Abdurrahman
   Kargin, Ramazan
TI Association between the Gensini Score and Carotid Artery Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary atherosclerosis; Carotid artery disease; Doppler
   ultrasonography
ID RISK-FACTORS; CORONARY; DISEASE; BYPASS; SYNTAX; PREVALENCE; PREDICTION;
   MANAGEMENT; SURGERY
AB Background and Objectives: The aim of this study was to evaluate the association between the extent of coronary artery disease assessed by the Gensini score and/or the SYNTAX score and the significant carotid stenosis in patients undergoing coronary artery bypass grafting (CABG).
   Subjects and Methods: A total of 225 patients who had carotid doppler ultrasonography prior to CABG were included retrospectively. Significant coronary artery disease was assumed as a lumen diameter stenosis of >= 50% in any of the major epicardial coronary arteries. The severity of carotid stenosis was determined by B-mode and duplex ultrasonography. Clinically significant carotid stenosis was defined as peak systolic velocity greater than 125 cm/s.
   Results: The mean value of SYNTAX score and Gensini score was highest in patients allocated to significant carotid stenosis (22.98 +/- 7.32, p<0.001 and 77.40 +/- 32.35, p<0.001, respectively). The other risk factors for significant carotid stenosis were found to be male gender (p=0.029), carotid bruit (p<0.001), diabetes (p=0.021), left main disease (p=0.002), 3-vessel disease (p=0.008), chronic total coronary occlusion (p=0.001), and coronary artery calcification (p=0.001) in univariate analysis. However, only the Gensini score (odds ratio[OR]=1.030, p=0.004), carotid bruit (OR=0.068, p<0.001), and male gender (OR=0.190, p=0.003) were the independent predictors. The Gensini score cut off value predicting significant carotid stenosis was 50.5 with 77% sensitivity (p<0.001).
   Conclusion: The Gensini score may be used to identify patients at high risk for significant carotid stenosis prior to CABG.
C1 [Avci, Anil; Fidan, Serdar; Tabakci, Mehmet Mustafa; Toprak, Cuneyt; Alizade, Elnur; Acar, Emrah; Bayam, Emrah; Tellice, Muhammet; Naser, Abdurrahman; Kargin, Ramazan] 1 Kartal Kosuyolu Cardiovasc Res & Training Hosp, Deparment Cardiol, Istanbul, Turkey.
RP Avci, A (corresponding author), Kartal Kosuyolu Cardiovasc Res & Training Hosp, Deparment Cardiol, TR-34846 Istanbul, Turkey.
EM dr_kouyolu@yahoo.com
CR Costanzo L, 2014, CATHETER CARDIO INTE, V83, P1169, DOI 10.1002/ccd.25320
   Drohomirecka A, 2010, KARDIOL POL, V68, P789
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athoracsur.2004.02.024
   FAGGIOLI GL, 1990, J VASC SURG, V12, P724, DOI 10.1067/mva.1990.24458
   Goyal Brij Mohan, 2014, Indian Heart J, V66, P183, DOI 10.1016/j.ihj.2013.12.015
   Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516
   Kolh PH, 2006, EUR HEART J, V27, P49, DOI 10.1093/eurheartj/ehi494
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Paciaroni M, 2005, J NEUROL NEUROSUR PS, V76, P1332, DOI 10.1136/jnnp.2005.066936
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Sinning C, 2013, CLIN RES CARDIOL, V102, P495, DOI 10.1007/s00392-013-0555-4
   Stamou SC, 2001, STROKE, V32, P1508, DOI 10.1161/01.STR.32.7.1508
   Steinvil A, 2011, J AM COLL CARDIOL, V57, P779, DOI 10.1016/j.jacc.2010.09.047
   Tanimoto S, 2005, STROKE, V36, P2094, DOI 10.1161/01.STR.0000185337.82019.9e
   Venkatachalam S, 2011, CURR OPIN CARDIOL, V26, P480, DOI 10.1097/HCO.0b013e32834a7035
   Wanamaker KM, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-78
   Yadav M, 2013, J AM COLL CARDIOL, V62, P1219, DOI 10.1016/j.jacc.2013.06.047
NR 17
TC 18
Z9 19
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 639
EP 645
DI 10.4070/kcj.2016.46.5.639
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100008
PM 27721854
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SW
   Rho, RW
   Kim, TS
   Kim, SH
   Shin, WS
   Kim, JH
   Oh, YS
   Lee, MY
   Zen, E
   Rho, TH
AF Jang, Sung-Won
   Rho, Robert W.
   Kim, Tae-Seok
   Kim, Sung-Hwan
   Shin, Woo-Seung
   Kim, Ji-Hoon
   Oh, Yong-Seog
   Lee, Man Young
   Zen, Eiwa
   Rho, Tai-Ho
TI Differences between Korea and Japan in Physician Decision Making
   Regarding Permanent Pacemaker Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pacemaker, artificial; Sick sinus syndrome; Atrioventricular block;
   Physicians; Guidelines
ID CARDIOVERTER-DEFIBRILLATORS; RACIAL DISPARITY
AB Background and Objectives: The number of permanent pacemakers (PPMs) implanted in patients in Japan and Korea differs significantly. We aimed to investigate the differences in decision making processes of implanting a PPM.
   Materials and Methods: Our survey included 15 clinical case scenarios based on the 2008 AHA/ACC/HRS guidelines for device-basd therapy of cardiac rhythm abnormalities (class unspecified). Members of the Korean and Japanese Societies of Cardiology were asked to rate each scenario according to a 5-point scale and to indicate their decisions for or against implantation.
   Results: Eighty-nine Korean physicians and 192 Japanese physicians replied to the questionnaire. For the case scenarios in which there was a class I indication for PPM implantation, the decision to implant a PPM did not differ significantly between the two physician groups. However, the Japanese physicians were significantly more likely than the Korean physicians to choose implantation in class IIa scenarios (48% vs. 37%, p<0.001), class IIb scenarios (40% vs. 19%, p<0.001), and class III scenarios (36% vs. 18%, p<0.001). These results did not change when the cases were categorized based on disease entity, such as sinus node dysfunction and conduction abnormality.
   Conclusion: Korean physicians are less likely than Japanese physicians to favor a PPM implantation when considering a variety of clinical case scenarios, which probably contributes to the relatively small number of PPMs implanted in patients in Korea as compared with those in Japan.
C1 [Jang, Sung-Won; Kim, Tae-Seok; Kim, Sung-Hwan; Kim, Ji-Hoon; Oh, Yong-Seog; Lee, Man Young; Rho, Tai-Ho] Catholic Univ Korea, Seoul, South Korea.
   [Rho, Robert W.] Virginia Mason Med Ctr, Seattle, WA 98101 USA.
   [Shin, Woo-Seung] Gimhae Jungang Hosp, Busan, South Korea.
   [Zen, Eiwa] Takeda Hosp, Kyoto, Japan.
RP Rho, TH (corresponding author), Catholic Univ Korea, St Pauls Hosp, 180 Wangsan Ro, Seoul 02559, South Korea.
EM Tairho@catholic.ac.kr
CR Barnhart JM, 2003, ARCH INTERN MED, V163, P461, DOI 10.1001/archinte.163.4.461
   Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014
   Groeneveld PW, 2006, J GEN INTERN MED, V21, P559, DOI 10.1111/j.1525-1497.2006.00453.x
   Groeneveld PW, 2005, J AM COLL CARDIOL, V45, P72, DOI 10.1016/j.jacc.2004.07.061
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Okumura K, 2013, CIRC J, V77, P249, DOI 10.1253/circj.CJ-66-0054
   Thomas KL, 2007, AM J CARDIOL, V100, P924, DOI 10.1016/j.amjcard.2007.04.024
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 654
EP 657
DI 10.4070/kcj.2016.46.5.654
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100010
PM 27721856
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Lim, NK
   Cho, MC
   Park, HY
AF Lee, Jung Hoon
   Lim, Nam-Kyoo
   Cho, Myeong-Chan
   Park, Hyun-Young
TI Epidemiology of Heart Failure in Korea: Present and Future
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Prevalence; Risk factor; Comorbidity; Projection
ID HOSPITALIZED-PATIENTS; UNITED-STATES; RISK-FACTORS; OUTCOMES;
   POPULATION; CARDIOLOGY; RATIONALE; REGISTRY; DESIGN; JAPAN
AB Background and Objectives: Heart failure (HF) is an important healthcare issue because of its high mortality, morbidity, and healthcare costs. The number of HF patients is increasing worldwide as a consequence of aging of the population. However, there are limited studies on the prevalence of HF in Korea. This study aimed to estimate the prevalence of HF, its comorbidities, and the projected population with HF in the future.
   Materials and Methods: The prevalence and comorbidity estimates of HF were determined using data from the 2002-2013 National Sample Cohort based on the National Health Information Database. We calculated the projected prevalence of HF by multiplying the estimated prevalence in 2013 by the projected population counts for 2015-2040.
   Results: The prevalence of HF in Korea was estimated to be 1.53% in 2013. The prevalence of HF in Korea is expected to increase by 2-fold, from 1.60% in 2015 to 3.35% in 2040. By 2040, more than 1.7 million Koreans are expected to have HF. In terms of comorbid diseases of HF, ischemic heart disease, hypertension, and diabetes mellitus were common (45.4%, 43.6%, and 49.1% in 2013, respectively). The prevalence rates of arrhythmia, valvular disease, and cardiomyopathy in HF patients were approximately 22.6%, 5.6%, and 3.1% in 2013, respectively.
   Conclusion: This is the first nationwide report in Korea to demonstrate the prevalence and comorbidities of HF. These data may be used for the prevention and management of HF in Korea.
C1 [Lee, Jung Hoon; Lim, Nam-Kyoo; Park, Hyun-Young] Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, 776 Sunhwan 1 Ro, Cheongju 28644, South Korea.
RP Park, HY (corresponding author), Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, South Korea.; Cho, MC (corresponding author), Chungbuk Natl Univ, Dept Internal Med, Coll Med, 776 Sunhwan 1 Ro, Cheongju 28644, South Korea.
EM mccho@cbnu.ac.kr; mdhypark@gmail.com
FU Korea National Institute of Health [4800-4845-302-210 (2011-NG63002-00)]
FX This work was supported by funding from the Korea National Institute of
   Health [4800-4845-302-210 (2011-NG63002-00)]. This study used NHIS-NSC
   data (NHIS-2014-2-010) made by NHIS. The authors declare no conflict of
   interest with NHIS. The authors alone are responsible for the contents
   and writing of the paper.
CR Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028
   Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Chong AY, 2003, EUR J HEART FAIL, V5, P569, DOI 10.1016/S1388-9842(03)00013-8
   Guo YT, 2013, CURR CARDIOL REV, V9, P112, DOI 10.2174/1573403X11309020004
   Hamaguchi S, 2012, CIRC J, V76, P1920, DOI 10.1253/circj.CJ-11-1196
   He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996
   Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a
   Kajimoto K, 2013, INT J CARDIOL, V168, P554, DOI 10.1016/j.ijcard.2013.01.187
   KANNEL WB, 1994, BRIT HEART J, V72, P3
   Khatibzadeh S, 2013, INT J CARDIOL, V168, P1186, DOI 10.1016/j.ijcard.2012.11.065
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193
   Okamoto Hiroshi, 2003, Nihon Rinsho, V61, P709
   Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489
   Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256
   Pillai HS, 2013, CURR CARDIOL REV, V9, P102, DOI 10.2174/1573403X11309020003
   Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971
   Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965
   Shiba N, 2008, VASC HEALTH RISK MAN, V4, P103, DOI 10.2147/vhrm.2008.04.01.103
   Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135
   Statistics Korea, 2011, POP PROJ KOR 2010 20
   Yang Yi-ning, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P460
NR 26
TC 50
Z9 50
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 658
EP 664
DI 10.4070/kcj.2016.46.5.658
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100011
PM 27721857
OA Green Published
DA 2021-04-22
ER

PT J
AU Noh, J
   Kim, HC
   Shin, A
   Yeom, H
   Jang, SY
   Lee, JH
   Kim, C
   Suh, I
AF Noh, Juhwan
   Kim, Hyeon Chang
   Shin, Anna
   Yeom, Hyungseon
   Jang, Suk-Yong
   Lee, Jung Hyun
   Kim, Changsoo
   Suh, Il
TI Prevalence of Comorbidity among People with Hypertension: The Korea
   National Health and Nutrition Examination Survey 2007-2013
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Chronic disease; Epidemiology; Prevalence; Korea
ID BLOOD-PRESSURE; RISK-FACTORS; MULTIMORBIDITY; AGE; POPULATION; PATTERNS;
   DISEASE; EQUITY; TRENDS; LIFE
AB Background and Objectives: Joint National Committee guidelines attempt to vary treatment recommendations for patients based on considerations of their comorbidities. The aim of the present study is to estimate the age-standardized prevalence of common comorbidities among Korean hypertension patients.
   Subjects and Methods: We analyzed the Korea National Health and Nutrition Examination Survey from 2007 to 2013. Among the 58423 participants, 30092 adults, aged >= 30 yrs who completed a health examination and interview survey, were selected. The survey procedures were used to estimate weighted prevalence and odds ratios for 8 comorbidities, including obesity, diabetes mellitus, dyslipidemia, cardiovascular disease, chronic kidney disease, and thyroid disease.
   Results: Most chronic conditions were more prevalent in adults with hypertension than in those without hypertension. Common comorbidities were obesity (60.1%), dyslipidemia (57.6%), and impaired fasting glucose (45.1%). Hypertensive patients with two or more comorbid diseases were 42.2% and those with three or more diseases were 17.7%. The age- and sex-specific prevalence of three or more comorbid diseases among male hypertension patients was significantly higher than those patients in the 30-59 (p<0.05) age group.
   Conclusion: Comorbidity is highly prevalent in Korean patients with hypertension.
C1 [Noh, Juhwan; Kim, Hyeon Chang; Yeom, Hyungseon; Jang, Suk-Yong; Kim, Changsoo; Suh, Il] Yonsei Univ, Coll Med, Dept Prevent Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.
   [Shin, Anna] Yonsei Univ, Coll Med, Dept Publ Hlth, Seoul, South Korea.
   [Lee, Jung Hyun] Grad Sch Publ Hlth, Dept Prevent Med, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM HCKIM@yuhs.ac
RI Noh, Juhwan/Q-9902-2019; Kim, Hyeon Chang/F-8796-2019
OI Noh, Juhwan/0000-0003-0657-0082; Jang, Suk-Yong/0000-0003-0558-1505; a,
   gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649; Kim, Hyeon
   Chang/0000-0001-7867-1240; Suh, Il/0000-0002-9689-7849
FU Korean Health Technology R&D Project, Ministry of Health and Welfar,
   Republic of Korea [HI13C0715]
FX This work was supported by the Korean Health Technology R&D Project,
   Ministry of Health and Welfare (HI13C0715), Republic of Korea.
CR Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bassett J, 2000, AS PAC PERSP RED OB
   Benoist Bd, 2008, WORLDWIDE PREVALENCE
   Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680
   Davila EP, ANN EPIDEMIOL, V17, P726
   Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337
   Fryar Cheryl D, 2010, NCHS Data Brief, P1
   Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141
   Giampaoli S, 2015, EUR J PREV CARDIOL, V22, P9, DOI 10.1177/2047487315589011
   Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x
   Jung Y.H., 2013, STUDY EFFECTIVE CHRO
   Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163
   Lewis SA, 2002, AM J RESP CRIT CARE, V165, P961, DOI 10.1164/ajrccm.165.7.2103044
   Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003
   Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2013 K
   Perelman J, 2010, SOC SCI MED, V71, P25, DOI 10.1016/j.socscimed.2010.03.026
   성예나, 2009, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V19, P167
   Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x
   Strandberg AY, 2014, J HYPERTENS, V32, P1797, DOI 10.1097/HJH.0000000000000265
   Tocci G, 2016, J CLIN HYPERTENS, V18, P551, DOI 10.1111/jch.12711
   Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530
   Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251
NR 24
TC 17
Z9 18
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 672
EP 680
DI 10.4070/kcj.2016.46.5.672
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100013
PM 27721859
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, MY
   Kim, SW
   Choi, EH
   Kim, JH
   Nah, DY
   Shin, SJ
   Gu, N
AF Rhee, Moo-Yong
   Kim, Sun-Woong
   Choi, Eun-Hee
   Kim, Ji-Hyun
   Nah, Deuk-Young
   Shin, Sung-Joon
   Gu, Namyi
TI Prevalence of Masked Hypertension: a Population-Based Survey in a Large
   City by Using 24-Hour Ambulatory Blood Pressure Monitoring
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Masked hypertension; Ambulatory blood pressure monitoring; Prevalence
ID WHITE-COAT HYPERTENSION; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS;
   RISK-FACTORS; FOLLOW-UP; ADULTS; METAANALYSIS; PROGNOSIS; MORTALITY;
   CHINESE
AB Background and Objectives: We estimated the prevalence of hypertension and hypertension subtypes in a large semi-urban city in Korea, using 24-hour ambulatory blood pressure monitoring (ABPM) in a randomly selected sample population.
   Subjects and Methods: A random sample (aged 20-65 years) from a city with an adult population of approximately 600000 was selected by using a list-assisted random digit dialing method. The 24-hour ABPM and conventional blood pressure measurement (CBPM) of these individuals were obtained.
   Results: Among the 496 participants, valid 24-hour ABPM and CBPM were obtained from 462 (93%) individuals. The estimated prevalence of hypertension in Goyang was 17.54% by CBPM and 32.70% by 24-hour ABPM (p<0.01). In the age stratified analysis, both CBPM and 24-hour ABPM showed increased prevalence of hypertension with age. The estimated prevalence of masked hypertension was 16.22% and that of white-coat hypertension was 1.08%. Men had a higher prevalence of masked hypertension than women (20.79% vs. 11.86%, p=0.0295). The estimated prevalence of masked hypertension was 17.5%, 20.58%, 24.34% and 13.29% in the age categories of 30s, 40s, 50s, and 60s, respectively. The estimated prevalence of masked uncontrolled hypertension was 26.79% in patients with hypertension who were taking antihypertensive medications.
   Conclusion: The estimated prevalence of hypertension by 24-hour ABPM was higher than that by CBPM, revealing high prevalence of masked hypertension. The high prevalence of masked hypertension supports the adoption of ABPM in the national population survey and clinical practice to improve public health and reduce health care costs.
C1 [Rhee, Moo-Yong; Kim, Ji-Hyun] Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, 27 Dongguk Ro, Goyang 10326, South Korea.
   [Kim, Sun-Woong; Choi, Eun-Hee] Dongguk Univ, Dept Stat, Survey & Hlth Policy Res Ctr, Seoul, South Korea.
   [Nah, Deuk-Young] Dongguk Univ, Div Cardiol, Dept Internal Med, Coll Med, Gyeongju, South Korea.
   [Shin, Sung-Joon] Dongguk Univ, Ilsan Hosp, Div Nephrol, Goyang, South Korea.
   [Gu, Namyi] Dongguk Univ, Ilsan Hosp, Dept Clin Pharmacol & Therapeut, Goyang, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, 27 Dongguk Ro, Goyang 10326, South Korea.
EM mooyong_rhee@dumc.or.kr
FU Korea Food and Drug Administration [11162KFDA162]
FX This research was supported by a grant (11162KFDA162) from the Korea
   Food and Drug Administration in 2011.
CR Angeli F, 2010, AM J HYPERTENS, V23, P941, DOI 10.1038/ajh.2010.112
   Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854
   Conen D, 2014, HYPERTENSION, V64, P1073, DOI 10.1161/HYPERTENSIONAHA.114.03957
   Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a
   Dolan E, 2004, BLOOD PRESS MONIT, V9, P307, DOI 10.1097/00126097-200412000-00007
   Fang L, 2014, J HUM HYPERTENS, V28, P649, DOI 10.1038/jhh.2014.5
   Franklin SS, 2013, HYPERTENSION, V62, P982, DOI 10.1161/HYPERTENSIONAHA.113.01275
   Gorostidi M, 2015, HYPERTENS RES, V38, P1, DOI 10.1038/hr.2014.149
   Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423
   Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163
   Kim SW, 2012, INT J PUBLIC OPIN R, V24, P79, DOI 10.1093/ijpor/edr022
   Krakoff LR, 2006, HYPERTENSION, V47, P29, DOI 10.1161/01.HYP.0000197195.84725.66
   Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8
   Lewington S, 2002, LANCET, V360, P1903
   Li Y, 2005, BLOOD PRESS MONIT, V10, P125, DOI 10.1097/00126097-200506000-00003
   Lim YH, 2014, AM J HYPERTENS, V27, P537, DOI 10.1093/ajh/hpt100
   Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   National Institute for Health and Clinical Excellence, 2011, HYP AD DIAGN MAN
   O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001
   Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070
   Rhee MY, 2013, EUR J CLIN NUTR, V67, P875, DOI 10.1038/ejcn.2013.87
   Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B
   Trudel X, 2009, J HYPERTENS, V27, P1560, DOI 10.1097/HJH.0b013e32832cb036
   Turnbull F, 2003, LANCET, V362, P1527
   Weiss W, 2010, BLOOD PRESS MONIT, V15, P225, DOI 10.1097/MBP.0b013e328338892f
NR 26
TC 8
Z9 8
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 681
EP 687
DI 10.4070/kcj.2016.46.5.681
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100014
PM 27721860
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, H
   Shim, JS
   Lee, MH
   Yoon, YM
   Choi, DP
   Kim, HC
AF Choi, Hansol
   Shim, Jee-Seon
   Lee, Myung Ha
   Yoon, Young Mi
   Choi, Dong Phil
   Kim, Hyeon Chang
TI Comparison of Formulas for Calculating Low-Density Lipoprotein
   Cholesterol in General Population and High-Risk Patients with
   Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Low-density lipoprotein cholesterol; Cholesterol; Triglyceride;
   Friedewald formula
ID DIRECT HOMOGENEOUS ASSAY; LDL-CHOLESTEROL; FRIEDEWALD FORMULA;
   DIABETES-MELLITUS; MANAGEMENT; REGRESSION; EQUATIONS; VALUES
AB Background and Objectives: Low-density lipoprotein cholesterol (LDL-C), an established cardiovascular risk factor, can be generally determined by calculation from total cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations. The aim of this study was to compare LDL-C estimations using various formulas with directly measured LDL-C in a community-based group and hospital-based group among the Korean population.
   Subjects and Methods: A total of 1498 participants were classified into four groups according to triglyceride concentrations as follows: <100, 100-199, 200-299, and >= 300 mg/dL. LDL-C was calculated using the Friedewald, Chen, Vujovic, Hattori, de Cordova, and Anandaraja formulas and directly measured using a homogenous enzymatic method. Pearson's correlation coefficients, intraclass correlation coefficients (ICC), Passing & Bablok regression, and Bland-Altman plots were used to evaluate the performance of six formulas.
   Results: The Friedewald formula had the highest accuracy (ICC=0.977; 95% confidence interval 0.974-0.979) of all the triglyceride ranges, while the Vujovic formula had the highest accuracy (ICC=0.876; 98.75% confidence interval 0.668-0.951) in people with triglycerides >= 300 mg/dL. The mean difference was the lowest for the Friedewald formula (0.5 mg/dL) and the percentage error was the lowest for the Vujovic formula (30.2%). However, underestimation of the LDL-C formulas increased with triglyceride concentrations.
   Conclusion: The accuracy of the LDL-C formulas varied considerably with differences in triglyceride concentrations. The Friedewald formula outperformed other formulas for estimating LDL-C against a direct measurement and the Vujovic formula was suitable for hypertriglyceridemic samples; it could be used as an alternative cost-effective tool to measure LDL-C when the direct measurement cannot be afforded.
C1 [Choi, Hansol] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.
   [Lee, Myung Ha; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Choi, Hansol; Shim, Jee-Seon; Lee, Myung Ha; Yoon, Young Mi; Choi, Dong Phil; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI ; Kim, Hyeon Chang/F-8796-2019
OI Shim, Jee-Seon/0000-0002-8671-3153; Kim, Hyeon Chang/0000-0001-7867-1240
FU Research Program - Korean Health Technology R&D Project, Ministry of
   Health Welfare [HI13C0715]
FX This work was supported by the Research Program funded by the Korean
   Health Technology R&D Project, Ministry of Health & Welfare (HI13C0715).
CR Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009
   Anwar M, 2014, JCPSP-J COLL PHYSICI, V24, P8, DOI 01.2014/JCPSP.0812
   BACHORIK PS, 1995, CLIN CHEM, V41, P1414
   Bilic-Zulle L, 2011, BIOCHEM MEDICA, V21, P49
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Chen YQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-52
   Choi SY, 2012, J CLIN LIPIDOL, V6, P114, DOI 10.1016/j.jacl.2011.12.007
   CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3
   Hattori Y, 1998, ATHEROSCLEROSIS, V138, P289, DOI 10.1016/S0021-9150(98)00034-3
   Hwang YC, 2012, J KOREAN MED SCI, V27, P1530, DOI 10.3346/jkms.2012.27.12.1530
   Kapoor Reema, 2015, J Lab Physicians, V7, P11, DOI 10.4103/0974-2727.154780
   Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532
   Martins J, 2015, CLIN CHIM ACTA, V444, P137, DOI 10.1016/j.cca.2015.01.037
   de Cordova CMM, 2013, ANN CLIN BIOCHEM, V50, P13, DOI 10.1258/acb.2012.011259
   Miller WG, 2002, CLIN CHEM, V48, P489
   Oliveira MJA, 2013, CLIN CHIM ACTA, V423, P135, DOI 10.1016/j.cca.2013.04.009
   Onyenekwu CP, 2014, ANN CLIN BIOCHEM, V51, P672, DOI 10.1177/0004563214520750
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   RUBIESPRAT J, 1993, DIABETES CARE, V16, P1081, DOI 10.2337/diacare.16.8.1081
   Scharnagl H, 2001, CLIN CHEM LAB MED, V39, P426, DOI 10.1515/CCLM.2001.068
   Tanno K, 2010, CLIN CHIM ACTA, V411, P1774, DOI 10.1016/j.cca.2010.07.034
   Vujovic A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-27
   Woo J., 2012, J LIPID ATHEROSCLER, V1, P45, DOI DOI 10.12997/JLA.2012.1.2.45
NR 27
TC 9
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 688
EP 698
DI 10.4070/kcj.2016.46.5.688
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100015
PM 27721861
OA Green Published
DA 2021-04-22
ER

PT J
AU Yuksel, IO
   Koklu, E
   Arslan, S
   Cagirci, G
   Goksu, EO
   Koc, P
   Cay, S
   Kizilirmak, F
AF Yuksel, Isa Oner
   Koklu, Erkan
   Arslan, Sakir
   Cagirci, Goksel
   Goksu, Eylem Ozaydin
   Koc, Pinar
   Cay, Serkan
   Kizilirmak, Filiz
TI Association of Neutrophil/Lymphocyte Ratio with Plaque Morphology in
   Patients with Asymptomatic Intermediate Carotid Artery Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Carotid artery stenosis; Neutrophil, lymphocyte, ratio;
   Atherosclerotic plaque; Stroke
ID PROGNOSTIC VALUE; NEUTROPHIL; DISEASE; ANGIOGRAPHY; EXPRESSION;
   SUBTYPES; OUTCOMES; LESIONS
AB Background and Objectives: Non-calcified carotid plaques are more unstable than calcified plaques; and they are associated with a higher risk of rupture, thromboembolism, and consequently, stroke. The purpose of the present study is to compare calcified and non-calcified plaques that cause intermediate carotid artery stenosis with respect to neutrophil/lymphocyte ratio (NLR).
   Subjects and Methods: A total number of 139 asymptomatic patients with 50-70% stenosis of the carotid artery were included in this study. Carotid Doppler ultrasound imaging and computed tomography angiography were performed to divide the carotid artery plaques into two groups as calcified and non-calcified. Patients included in the calcified (n=73)and non-calcified (n=66) plaque groups were compared with respect to total neutrophil count, lymphocyte count and NLR.
   Results: Total lymphocyte count was statistically significantly lower in the non-calcified plaque group compared to the calcified plaque group (total lymphocyte count in non-calcified/calcified plaque groups [10(3)/mm(3)]: 2.1/2.3, respectively) (p=0.002). NLR was statistically significantly higher in the non-calcified plaque group compared to the calcified plaque group (NLR in non-calcified/calcified plaque groups: 2.6/2.1, respectively) (p<0.001). The cut-off value for NLR was found to be >2.54. Multivariate regression analysis showed that NLR was independently associated with non-calcified carotid artery plaques (odds ratio 5.686, 95% CI 2.498-12.944, p<0.001).
   Conclusions: NLR is increased in the presence of non-calcified carotid artery plaques that cause asymptomatic intermediate stenosis. Increased NLR can be used as a marker to assess the risk of rupture of non-calcified carotid artery plaques.
C1 [Yuksel, Isa Oner; Koklu, Erkan; Arslan, Sakir; Cagirci, Goksel] Antalya Educ & Res Hosp, Clin Cardiol, Antalya, Turkey.
   [Goksu, Eylem Ozaydin] Antalya Educ & Res Hosp, Neurol Clin, Antalya, Turkey.
   [Koc, Pinar] Antalya Educ & Res Hosp, Clin Radiol, Antalya, Turkey.
   [Cay, Serkan] Turkiye Yuksek Ihtisas Educ & Res Hosp, Clin Cardiol, Ankara, Turkey.
   [Kizilirmak, Filiz] Medipol Univ, Dept Cardiol, Fac Med, Istanbul, Turkey.
RP Yuksel, IO (corresponding author), Antalya Egitim & Arastirma Hastanesi, Varlik Mah Kazim Karabekir Cad Soguksu, TR-07100 Antalya, Turkey.
EM drisayuksel2@hotmail.com
RI koklu, erkan/AAD-1697-2019; koklu, erkan/AAE-8595-2020; arslan,
   sakir/A-3933-2017
CR Ahmadi N, 2011, AM J CARDIOL, V107, P10, DOI 10.1016/j.amjcard.2010.08.034
   Bozzao A, 2001, Radiol Med, V101, P48
   Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005
   CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440
   Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022
   Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714
   Gibson PH, 2010, AM J CARDIOL, V105, P186, DOI 10.1016/j.amjcard.2009.09.007
   Gokhan S, 2013, EUR REV MED PHARMACO, V17, P653
   Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776
   Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015
   Hingwala D, 2013, INDIAN J RADIOL IMAG, V23, P24
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Hunt JL, 2002, STROKE, V33, P1214, DOI 10.1161/01.STR.0000013741.41309.67
   Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296
   Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006
   Larionov S, 2007, ACTA NEUROPATHOL, V113, P33, DOI 10.1007/s00401-006-0134-0
   Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671
   Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006
   Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705
   Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028
   Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20
   Nasr N, 2009, ATHEROSCLEROSIS, V207, P519, DOI 10.1016/j.atherosclerosis.2009.05.003
   ONSRUD M, 1981, SCAND J IMMUNOL, V13, P573, DOI 10.1111/j.1365-3083.1981.tb00171.x
   Pellizzon GG, 2003, AM J CARDIOL, V91, P729, DOI 10.1016/S0002-9149(02)03416-1
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   Tavora FR, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-27
   THOMSON SP, 1995, ANN INTERN MED, V122, P335, DOI 10.7326/0003-4819-122-5-199503010-00003
   van Lammeren GW, 2012, EUR J VASC ENDOVASC, V43, P632, DOI 10.1016/j.ejvs.2012.03.011
   van Werkhoven JM, 2009, EUR HEART J, V30, P2622, DOI 10.1093/eurheartj/ehp272
   Wang PQ, 2015, EUR REV MED PHARMACO, V19, P3480
NR 30
TC 5
Z9 5
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 699
EP 705
DI 10.4070/kcj.2016.46.5.699
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100016
PM 27721862
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, M
   Kim, MG
   Kang, WC
   Oh, PC
   Lee, JY
   Kang, JM
   Chung, WJ
   Shin, EK
AF Kim, Minsu
   Kim, Myeong Gun
   Kang, Woong Chol
   Oh, Pyung Chun
   Lee, Ji Yeon
   Kang, Jin Mo
   Chung, Wook-Jin
   Shin, Eak Kyun
TI Thrombotic Occlusion of Stent Graft Limbs due to Severe Angulation of
   Aortic Neck in Endovascular Repair of Abdominal Aortic Aneurysm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Abdominal aortic aneurysm; Endovascular aneurysm repair; Graft occlusion
ID PREDICTIVE FACTORS; COMPLICATIONS; OUTCOMES; ANATOMY; HOSTILE
AB Endovascular aneurysm repair (EVAR) is a safe alternative to open surgical repair for an abdominal aortic aneurysm. However, unfavorable aortic anatomy of the aneurysm has restricted the widespread use of EVAR. Anatomic limitation is most often related to characteristics of the proximal neck anatomy. In this report, we described a patient with a severely angulated proximal neck who underwent EVAR, but required repeat intervention because of thrombotic occlusion of stent graft limbs.
C1 [Kim, Minsu; Kim, Myeong Gun; Kang, Woong Chol; Oh, Pyung Chun; Chung, Wook-Jin; Shin, Eak Kyun] Gachon Univ, Gil Med Ctr, Dept Cardiovasc Med, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
   [Kim, Minsu; Kim, Myeong Gun; Kang, Woong Chol; Oh, Pyung Chun; Lee, Ji Yeon; Kang, Jin Mo; Chung, Wook-Jin; Shin, Eak Kyun] Gachon Univ, Gachon Cardiovasc Res Inst, Inchon, South Korea.
   [Lee, Ji Yeon] Gachon Univ, Gil Med Ctr, Dept Anesthesiol, Inchon, South Korea.
   [Kang, Jin Mo] Gachon Univ, Gil Med Ctr, Dept Vasc Surg, Inchon, South Korea.
RP Kang, WC (corresponding author), Gachon Univ, Gil Med Ctr, Dept Cardiovasc Med, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
EM kangwch@gilhospital.com
RI Chung, Wook-Jin/AAJ-5613-2021
OI Chung, Wook-Jin/0000-0002-9767-7098
CR AbuRahma AF, 2011, J VASC SURG, V54, P13, DOI 10.1016/j.jvs.2010.12.010
   AbuRahma AF, 2009, J VASC SURG, V50, P738, DOI 10.1016/j.jvs.2009.04.061
   Choke E, 2006, CARDIOVASC INTER RAD, V29, P975, DOI 10.1007/s00270-006-0011-1
   Faure EM, 2015, J VASC SURG, V61, P1138, DOI 10.1016/j.jvs.2014.11.084
   Goncalves FB, 2015, EUR J VASC ENDOVASC, V49, P156, DOI 10.1016/j.ejvs.2014.10.003
   Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1
   Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305
   Hobo R, 2007, J ENDOVASC THER, V14, P1, DOI 10.1583/06-1914.1
   Leurs LJ, 2006, J ENDOVASC THER, V13, P640, DOI 10.1583/06-1882.1
   Sampaio SM, 2004, ANN VASC SURG, V18, P621, DOI 10.1007/s10016-004-0100-z
NR 10
TC 3
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 727
EP 729
DI 10.4070/kcj.2016.46.5.727
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100020
PM 27721866
OA Green Published
DA 2021-04-22
ER

PT J
AU Baek, WK
   Lee, M
   Kim, YS
   Yoon, YH
   Kim, JT
   Kim, DH
AF Baek, Wan Ki
   Lee, Mina
   Kim, Young Sam
   Yoon, Yong Han
   Kim, Joung Taek
   Kim, Dae Hyeock
TI Spontaneous Resolution of the Left Subclavian Artery Obstruction in
   Takayasu's Arteritis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arteritis; Takayasu
AB Spontaneous resolution of the arterial obstruction in Takayasu's arteritis is rarely reported. We reported a case of spontaneous resolution of an obstruction of the left subclavian artery in a young female. The patient underwent a bilateral coronary patch ostioplasty for both coronary ostial lesions complicated by Takayasu's arteritis at the age of 28. Concomitant left subclavian obstruction was seen at that time but left untreated. Surprisingly, the 10-year follow-up angiogram revealed complete resolution of the left subclavian artery obstruction. Meanwhile, no specific medical treatment was administered.
C1 [Baek, Wan Ki; Lee, Mina; Kim, Young Sam; Yoon, Yong Han; Kim, Joung Taek] Inha Univ, Dept Thorac & Cardiovasc Surg, Coll Med, Inchon, South Korea.
   [Kim, Dae Hyeock] Inha Univ, Div Cardiol, Internal Med, Coll Med, Inchon, South Korea.
RP Baek, WK (corresponding author), Inha Univ Hosp, Dept Thorac & Cardiovasc Surg, 27 Inhang Ro, Inchon 22332, South Korea.
EM wkbaek@inha.ac.kr
OI Kim, Joung Taek/0000-0003-3792-519X
FU INHA University Hospital Research Grant
FX This work was supported by INHA University Hospital Research Grant.
CR Chatterjee S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0499-y
   Lee ES, 2001, KOREAN J THORAC CARD, V34, P944
   Maksimowicz-McKinnon K, 2007, RHEUM DIS CLIN N AM, V33, P777, DOI 10.1016/j.rdc.2007.07.014
   Schmidt J, 2013, MAYO CLIN PROC, V88, P822, DOI 10.1016/j.mayocp.2013.04.025
   Solvit D, 1990, J Radiol, V71, P221
   WIGGELINKHUIZEN J, 1980, S AFR MED J, V57, P96
NR 6
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 730
EP 733
DI 10.4070/kcj.2016.46.5.730
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100021
PM 27721867
OA Green Published
DA 2021-04-22
ER

PT J
AU Mateescu, AD
   Coman, IM
   Beladan, CC
   Radulescu, B
   Ginghina, C
   Popescu, BA
AF Mateescu, Anca D.
   Coman, Ioan M.
   Beladan, Carmen C.
   Radulescu, Bogdan
   Ginghina, Carmen
   Popescu, Bogdan A.
TI A Congenital Gerbode Defect associated with a Rare Structural
   Abnormality of the Mitral Valve Diagnosed in an Adult Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defect; Mitral valve; Mitral regurgitation;
   Echocardiography; Echocardiography; transesophageal
ID RIGHT ATRIAL SHUNT; ECHOCARDIOGRAPHY; HYPERTENSION
AB We report the case of a rare association of a congenital Gerbode defect with severe mitral regurgitation due to abnormal linear structure of mitral valve, diagnosed in an adult patient. The case highlights the importance of a thorough examination interpreting the echocardiographic findings on a pathophysiological basis. It also underlines the complementary role of different imaging techniques with transesophageal echocardiography, allowing the precise assessment of both structural and functional abnormalities in such a complex case. The patient underwent mitral valve replacement with a bileaflet mechanical prosthesis and repair of the Gerbode defect. The imaging findings were confirmed during the surgical procedure, leading to a good outcome.
C1 [Mateescu, Anca D.; Coman, Ioan M.; Beladan, Carmen C.; Radulescu, Bogdan; Ginghina, Carmen; Popescu, Bogdan A.] Univ Med & Pharm Carol Davila, Sos Fundeni 258,Sect 2, Bucharest 022328, Romania.
   [Mateescu, Anca D.; Coman, Ioan M.; Beladan, Carmen C.; Radulescu, Bogdan; Ginghina, Carmen; Popescu, Bogdan A.] Emergency Inst Cardiovasc Dis, Dept Cardiol, Bucharest, Romania.
RP Coman, IM (corresponding author), Univ Med & Pharm Carol Davila, Sos Fundeni 258,Sect 2, Bucharest 022328, Romania.
EM euroecolab@gmail.com
RI Popescu, Bogdan A/A-4528-2011
OI Popescu, Bogdan A/0000-0001-6122-8533
CR Acar P, 2011, ECHOCARDIOGR-J CARD, V28, pE140, DOI 10.1111/j.1540-8175.2011.01396.x
   GERBODE F, 1958, ANN SURG, V148, P433, DOI 10.1097/00000658-195809000-00012
   Hansalia S, 2009, ECHOCARDIOGR-J CARD, V26, P224, DOI 10.1111/j.1540-8175.2008.00861.x
   Kelle AM, 2009, CARDIOL YOUNG, V19, P96, DOI 10.1017/S1047951109991685
   LAURICHESSE J, 1964, Arch Mal Coeur Vaiss, V57, P703
   Taskesen T, 2015, INT J CARDIOVAS IMAG, V31, P753, DOI 10.1007/s10554-015-0620-3
   Tehrani F, 2007, EUR J ECHOCARDIOGR, V8, P494, DOI 10.1016/j.euje.2006.07.014
   Thurnam J, 1838, Med Chir Trans, V21, P187
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 739
EP 742
DI 10.4070/kcj.2016.46.5.739
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100023
PM 27721869
OA Green Published
DA 2021-04-22
ER

PT J
AU Liu, T
   Zheng, JF
   Yan, GX
AF Liu, Tong
   Zheng, Jifeng
   Yan, Gan-Xin
TI J Wave Syndromes: History and Current Controversies
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Brugada syndrome; Sudden cardiac death; Ventricular fibrillation
ID ST-SEGMENT ELEVATION; IDIOPATHIC VENTRICULAR-FIBRILLATION; EARLY
   REPOLARIZATION SYNDROME; BRUGADA-SYNDROME; CELLULAR BASIS; CLINICAL
   CHARACTERISTICS; ELECTROCARDIOGRAM; DEATH; PREVENTION; PATTERN
AB The concept of J wave syndromes was first proposed in 2004 by Yan et al.(1)) for a spectrum of electrocardiographic (ECG) manifestations of prominent J waves that are associated with a potential to predispose affected individuals to ventricular fibrillation (VF). Although the concept of J wave syndromes is widely used and accepted, there has been tremendous debate over the definition of J wave, its ionic and cellular basis and arrhythmogenic mechanism. In this review article, we attempted to discuss the history from which the concept of J wave syndromes (JWS) is evolved and current controversies in JWS.
C1 [Liu, Tong] Tianjin Med Univ, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Dept Cardiol, Tianjin Inst Cardiol,Hosp 2, Tianjin, Peoples R China.
   [Zheng, Jifeng] Second Hosp Jiaxing, Dept Cardiol, Jiaxing, Zhejiang, Peoples R China.
   [Yan, Gan-Xin] Lankenau Inst Med Res, 100 Lancaster Ave, Wynnewood, PA 19096 USA.
   [Yan, Gan-Xin] Lankenau Med Ctr, 100 Lancaster Ave, Wynnewood, PA 19096 USA.
   [Yan, Gan-Xin] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian, Peoples R China.
RP Yan, GX (corresponding author), Lankenau Inst Med Res, 100 Lancaster Ave, Wynnewood, PA 19096 USA.; Yan, GX (corresponding author), Lankenau Med Ctr, 100 Lancaster Ave, Wynnewood, PA 19096 USA.
EM YanG@mlhs.org
CR AIZAWA Y, 1993, AM HEART J, V126, P1473, DOI 10.1016/0002-8703(93)90550-S
   Aizawa Y, 2015, HEART RHYTHM, V12, P376, DOI 10.1016/j.hrthm.2014.11.010
   Antzelevitch C, 2015, HEART RHYTHM, V12, P1852, DOI 10.1016/j.hrthm.2015.04.014
   Antzelevitch C, 2011, J ELECTROCARDIOL, V44, P656, DOI 10.1016/j.jelectrocard.2011.07.026
   Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006
   Badri M, 2015, TRENDS CARDIOVAS MED, V25, P12, DOI 10.1016/j.tcm.2014.09.003
   Bastiaenen R, 2012, EUROPACE, V14, P5, DOI 10.1093/europace/eur326
   Belhassen B, 2009, PACE, V32, P294, DOI 10.1111/j.1540-8159.2008.02235.x
   BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J
   CALDINI P, 1959, Postgrad Med J, V35, P538
   Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106
   GUSSAK I, 1995, J ELECTROCARDIOL, V28, P49, DOI 10.1016/S0022-0736(05)80007-X
   Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968
   Hlaing T, 2005, ANN NONINVAS ELECTRO, V10, P211, DOI 10.1111/j.1542-474X.2005.05588.x
   HUSFELDT E., 1956, THORAX, V11, P67, DOI 10.1136/thx.11.2.67
   JOHNSON P, 1960, ANN SURG, V151, P490
   Kalla H, 2000, J CARDIOVASC ELECTR, V11, P95, DOI 10.1111/j.1540-8167.2000.tb00743.x
   Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3
   Li GL, 2015, CHINESE MED J-PEKING, V128, P969, DOI 10.4103/0366-6999.154320
   Macfarlane PW, 2015, J AM COLL CARDIOL, V66, P470, DOI 10.1016/j.jacc.2015.05.033
   Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862
   Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612
   OSBORN JJ, 1953, AM J PHYSIOL, V175, P389
   OTTO CM, 1984, ANN INTERN MED, V101, P45, DOI 10.7326/0003-4819-101-1-45
   Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014
   Shipley RA, 1936, AM HEART J, V11, P325, DOI 10.1016/S0002-8703(36)90417-9
   Shu J, 2005, J ELECTROCARDIOL, V38, P26, DOI 10.1016/j.jelectrocard.2005.06.006
   Sinner MF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000314
   Surawicz B, 2011, J AM COLL CARDIOL, V57, P1584, DOI 10.1016/j.jacc.2010.11.040
   Szel T, 2014, J AM COLL CARDIOL, V63, P2037, DOI 10.1016/j.jacc.2014.01.067
   Takagi M, 2000, J CARDIOVASC ELECTR, V11, P844, DOI 10.1111/j.1540-8167.2000.tb00062.x
   Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068
   Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589
   WASSERBURGER R, 1961, AM J CARDIOL, V8, P184, DOI 10.1016/0002-9149(61)90204-1
   Wu SH, 2013, J AM COLL CARDIOL, V61, P645, DOI 10.1016/j.jacc.2012.11.023
   Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660
   Yan GX, 2003, J AM COLL CARDIOL, V42, P401, DOI 10.1016/S0735-1097(03)00713-7
   Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372
   Yan GX, 2004, CHIN J CARDIAC ARRHY, V8, P360
   齐欣, 2004, [中华心血管病杂志, Chinese Journal of Cardiology], V32, P272
NR 40
TC 6
Z9 6
U1 1
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 601
EP 609
DI 10.4070/kcj.2016.46.5.601
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100002
PM 27721848
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JJ
   Choi, DJ
AF Park, Jin Joo
   Choi, Dong-Ju
TI Heart Failure Epidemic: an Expected Phenomenon
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ASSOCIATION
C1 [Park, Jin Joo; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Div Cardiol, Songnam, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, 166 Gumi Ro, Songnam 13620, South Korea.
EM djchoi@snubh.org
CR Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F
   Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366
   Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
NR 6
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 610
EP 612
DI 10.4070/kcj.2016.46.5.610
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100003
PM 27721849
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
AF Kim, Jang Young
TI Risk Factor Clustering in Korean Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID NUTRITION EXAMINATION SURVEY; METABOLIC SYNDROME; NATIONAL-HEALTH;
   PREVALENCE
C1 [Kim, Jang Young] Yonsei Univ, Div Cardiol, Dept Internal Med, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Kim, JY (corresponding author), Yonsei Univ, Div Cardiol, Dept Internal Med, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM kimjy@yonsei.ac.kr
CR Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lloyd-Jones DM, 1999, ARCH INTERN MED, V159, P2206, DOI 10.1001/archinte.159.18.2206
   Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151
   Noh J, 2016, KOREAN CIRC J, V46, P672, DOI 10.4070/kcj.2016.46.5.672
   Shin Jinho, 2015, Clin Hypertens, V21, P2, DOI 10.1186/s40885-014-0013-2
   Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 613
EP 614
DI 10.4070/kcj.2016.46.5.613
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100004
PM 27721850
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JS
   Shin, HC
   Bae, JS
   Jin, HY
   Seo, JS
   Yang, TH
   Kim, DK
   Cho, KI
   Kim, BH
   Park, YH
   Je, HG
   Kim, DS
AF Jang, Jae-Sik
   Shin, Ho-Cheol
   Bae, Jong Seok
   Jin, Han-Young
   Seo, Jeong-Sook
   Yang, Tae-Hyun
   Kim, Dae-Kyeong
   Cho, Kyoung-Im
   Kim, Bo-Hyun
   Park, Yong Hyun
   Je, Hyung-Gon
   Kim, Dong-Soo
TI Diagnostic Performance of Intravascular Ultrasound-Derived Minimal Lumen
   Area to Predict Functionally Significant Non-Left Main Coronary Artery
   Disease: a Meta-Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Intravascular ultrasonography; Fractional flow reserve; Percutaneous
   coronary intervention
ID FRACTIONAL FLOW RESERVE; ANTERIOR DESCENDING ARTERY; DE-NOVO LESIONS;
   SYSTEMATIC REVIEWS; TEST ACCURACY; STENOSIS; CRITERIA; PARAMETERS;
   INTERVENTION; MULTICENTER
AB Background and Objectives: Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention frequently results in unnecessary stenting due to the low positive predictive value of IVUS-derived minimal lumen area (MLA) for identification of functionally significant coronary stenosis. We appraised the diagnostic accuracy of IVUS-derived MLA compared with the fractional flow reserve (FFR) to assess intermediate coronary stenosis.
   Subjects and Methods: We searched MEDLINE and Cochrane databases for studies using IVUS and FFR methods to establish the best MLA cutoff values to predict significant non -left main coronary artery stenosis. Summary estimates were obtained using a random-effects model.
   Results: The 17 studies used in our analysis enrolled 3920 patients with 4267 lesions. The weighted overall mean MLA cut-off value was 2.58 mm(2). The pooled MLA sensitivity that predicted functionally significant coronary stenosis was 0.75 (confidence interval [Cl]: 0.72 to 0.77) and the specificity was 0.66 (Cl: 0.64 to 0.68). The positive likelihood ratio (LR) was 2.33 (Cl: 2.06 to 2.63) and LR (-) was 0.33 (Cl: 0.26 to 0.42). The pooled diagnostic odds ratio (DOR) was 7.53 (Cl: 5.26 to 10.76) and the area under the summary receiver operating characteristic curve for all the trials was 0.782 with a Q point of 0.720. Meta-regression analysis demonstrated that an FFR cut-off point of 0.75 was associated with a four times higher diagnostic accuracy compared to that of 0.80 (relative DOR: 3.92; 95% Cl: 1.25 to 12.34).
   Conclusion: IVUS-derived MLA has limited diagnostic accuracy and needs careful interpretation to correlate with functionally significant non-left main coronary artery stenosis.
C1 [Jang, Jae-Sik; Shin, Ho-Cheol; Jin, Han-Young; Seo, Jeong-Sook; Yang, Tae-Hyun; Kim, Dae-Kyeong; Kim, Dong-Soo] Univ Inje, Coll Med, Div Cardiol, Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea.
   [Bae, Jong Seok] Hallym Univ, Coll Med, Dept Neurol, Kangdong Sacred Heart Hosp, Seoul, South Korea.
   [Cho, Kyoung-Im] Kosin Univ, Med Ctr, Div Cardiol, Busan, South Korea.
   [Kim, Bo-Hyun] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.
   [Park, Yong Hyun] Pusan Natl Univ, Yangsan Hosp, Div Cardiol, Yangsan, South Korea.
   [Je, Hyung-Gon] Busan Natl Univ, Yangsan Hosp, Dept Cardiovasc Surg, Yangsan, South Korea.
RP Jang, JS (corresponding author), Univ Inje, Coll Med, Div Cardiol, Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea.
EM jsjang71@gmail.com
OI Bae, Jong Seok/0000-0002-4313-1786
FU Inje University Busan Paik Hospital research grant
FX This work was supported by 2015 Inje University Busan Paik Hospital
   research grant.
CR Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928
   Ben-Dor I, 2012, CARDIOVASC REVASCULA, V13, P177, DOI 10.1016/j.carrev.2011.12.003
   Ben-Dor I, 2011, EUROINTERVENTION, V7, P225, DOI 10.4244/EIJV7I2A37
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   Chen SL, 2013, INT J CARDIOL, V168, P1364, DOI 10.1016/j.ijcard.2012.12.010
   Cui M, 2013, CHINESE MED J-PEKING, V126, P1606, DOI 10.3760/cma.j.issn.0366-6999.20123358
   Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168
   Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120
   Doh JH, 2014, EUR HEART J-CARD IMG, V15, P870, DOI 10.1093/ehjci/jeu009
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Gonzalo N, 2012, J AM COLL CARDIOL, V59, P1080, DOI 10.1016/j.jacc.2011.09.078
   Han JK, 2014, CARDIOLOGY, V127, P256, DOI 10.1159/000356480
   Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013
   Jasti V, 2004, CIRCULATION, V110, P2831, DOI 10.1161/01.CIR.0000146338.62813.E7
   Kang SJ, 2012, AM J CARDIOL, V109, P947, DOI 10.1016/j.amjcard.2011.11.024
   Kang SJ, 2011, JACC-CARDIOVASC INTE, V4, P1168, DOI 10.1016/j.jcin.2011.08.009
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013
   Kwan TW, 2012, CHINESE MED J-PEKING, V125, P4249, DOI 10.3760/cma.j.issn.0366-6999.2012.23.016
   Lee CH, 2010, AM J CARDIOL, V105, P1378, DOI 10.1016/j.amjcard.2010.01.002
   Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008
   MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121403
   Naganuma T, 2014, CARDIOVASC REVASCULA, V15, P3, DOI 10.1016/j.carrev.2013.11.002
   Nascimento BR, 2014, CATHETER CARDIO INTE, V84, P377, DOI 10.1002/ccd.25047
   Park SJ, 2014, JACC-CARDIOVASC INTE, V7, P868, DOI 10.1016/j.jcin.2014.02.015
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Takagi A, 1999, CIRCULATION, V100, P250, DOI 10.1161/01.CIR.100.3.250
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Waksman R, 2013, J AM COLL CARDIOL, V61, P917, DOI 10.1016/j.jacc.2012.12.012
   Yang HM, 2014, CATHETER CARDIO INTE, V83, P386, DOI 10.1002/ccd.25088
NR 30
TC 10
Z9 10
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 622
EP 631
DI 10.4070/kcj.2016.46.5.622
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100006
PM 27721852
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, BG
   Rha, SW
   Park, T
   Choi, SY
   Byun, JK
   Shim, MS
   Xu, S
   Li, H
   Park, SH
   Park, JY
   Choi, WG
   Cho, YH
   Lee, S
   Na, JO
   Choi, CU
   Lim, HE
   Kim, JW
   Kim, EJ
   Park, CG
   Seo, HS
   Oh, DJ
AF Choi, Byoung Geol
   Rha, Seung-Woon
   Park, Taeshik
   Choi, Se Yeon
   Byun, Jae Kyeong
   Shim, Min Suk
   Xu, Shaopeng
   Li, Hu
   Park, Sang-Ho
   Park, Ji Young
   Choi, Woong Gil
   Cho, Yun-Hyeong
   Lee, Sunki
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Kim, Jin Won
   Kim, Eung Ju
   Park, Chang Gyu
   Seo, Hong Seog
   Oh, Dong Joo
TI Impact of Cigarette Smoking: a 3-Year Clinical Outcome of Vasospastic
   Angina Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery spasm; Cigarette smoking; Clinical outcome
ID CORONARY-ARTERY SPASM; RISK-FACTORS; DISEASE; ACETYLCHOLINE;
   ASSOCIATION; CESSATION; JAPANESE
AB Background and Objectives: Cigarette smoking is a risk significant factor in coronary artery disease (CAD) and vasospastic angina (VSA). However, it is largely unknown whether smoking adds to any long-term clinical risk in VSA patients.
   Subjects and Methods: A total of 2797 patients without significant CAD underwent acetylcholine (Ach) provocation test between November 2004 and October 2010. Patients were divided into three groups, based on the presence of coronary artery spasm (CAS) and smoking habits (non-CAS group: n=1188, non-smoking CAS group: n=1214, smoking CAS group: n=395). All CAS patients were prescribed with anti-anginal medications for at least 6 months. The incidence of major clinical outcomes and recurrent angina of these groups were compared up to 3 years.
   Results: There were considerable differences in the baseline clinical and angiographic characteristics among the three groups, but there was no difference in the endpoints among the three groups (including individual and composite hard endpoints) such as death, myocardial infarction, de novo percutaneous coronary intervention, cerebrovascular accident, and major adverse cardiac events. However, there was a higher incidence of recurrent angina in both the non-smoking CAS group and smoking CAS group, as compared to the non CAS group. In multivariable adjusted Cox-proportional hazards regression analysis, smoking CAS group exhibited a higher incidence of recurrent angina compared with the non-CAS group (hazard ratio [HR]; 2.46, 95% confidence interval [Cl]; 1.46-4.14, p=0.001) and nonsmoking CAS group (HR; 1.76, 95% Cl; 1.08-2.87, p=0.021).
   Conclusion: Cigarette smoking CAS group exhibited higher incidence of recurrent angina during the 3-year clinical follow-up compared with both the non-CAS group and non-smoking CAS group. Quitting of smoking, paired with intensive medical therapy and close clinical follow-up, can help to prevent recurrent angina.
C1 [Choi, Byoung Geol; Choi, Se Yeon; Byun, Jae Kyeong] Korea Univ, Grad Sch, Dept Med, Seoul, South Korea.
   [Rha, Seung-Woon; Shim, Min Suk; Xu, Shaopeng; Li, Hu; Lee, Sunki; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo] Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
   [Park, Taeshik] Weiss Mem Hosp, Dept Gen Internal Med, Chicago, IL USA.
   [Park, Sang-Ho] Soonchunhyang Univ, Cheonan Hosp, Dept Cardiol, Cheonan, South Korea.
   [Park, Ji Young] Eulji Univ, Cardiovasc Ctr, Eulji Gen Hosp, Seoul, South Korea.
   [Choi, Woong Gil] Chungju Kunkuk Univ, Cardiovasc Ctr, Chungju, South Korea.
   [Cho, Yun-Hyeong] Seonam Univ, Cardiovasc Ctr, Myongji Hosp, Goyang, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
EM swrha617@yahoo.co.kr
OI Choi, Byoung Geol/0000-0002-6090-869X
CR Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160
   Beltrame JF, 1999, J AM COLL CARDIOL, V33, P1442, DOI 10.1016/S0735-1097(99)00073-X
   BORNEMISZA P, 1981, REV ROUM MED-MED INT, V19, P251
   Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001
   Choi BG, 2015, INT J CARDIOL, V184, P533, DOI 10.1016/j.ijcard.2015.02.021
   deMaat MPM, 1996, ATHEROSCLEROSIS, V121, P185, DOI 10.1016/0021-9150(95)05716-1
   Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007
   Figueras J, 2012, AM J CARDIOL, V110, P1249, DOI 10.1016/j.amjcard.2012.06.026
   Haustein KO, 2004, INT J CLIN PHARM TH, V42, P83
   Kugiyama K, 1995, INT J CARDIOL, V52, P223, DOI 10.1016/0167-5273(95)02478-6
   Kugiyama K, 1997, J AM COLL CARDIOL, V30, P920, DOI 10.1016/S0735-1097(97)00236-2
   Kugiyama K, 1996, CIRCULATION, V94, P266, DOI 10.1161/01.CIR.94.3.266
   Park JY, 2013, YONSEI MED J, V54, P1299, DOI 10.3349/ymj.2013.54.6.1299
   전병원, 2006, Korean Circulation Journal, V36, P661
   SUGIISHI M, 1993, CIRCULATION, V87, P76, DOI 10.1161/01.CIR.87.1.76
   Takaoka K, 2000, INT J CARDIOL, V72, P121, DOI 10.1016/S0167-5273(99)00172-2
   WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025
NR 17
TC 10
Z9 10
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 632
EP 638
DI 10.4070/kcj.2016.46.5.632
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100007
PM 27721853
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, MJ
   Jo, SJ
   Cho, Y
   Choi, EK
   Oh, S
AF Cha, Myung-Jin
   Jo, Seong Jin
   Cho, Youngjin
   Choi, Eue-Keun
   Oh, Seil
TI Patient Characteristics and the Incidence of Radiation-Induced
   Dermatitis Following Radiofrequency Catheter Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catheter ablation; Fluoroscopy; Radiation; Dermatitis; Body mass index
ID FLUOROSCOPICALLY GUIDED PROCEDURES; INDUCED SKIN INJURIES; TACHYCARDIA;
   PROTECTION; EXPOSURE
AB Background and Objectives: Radiofrequency catheter ablation (RFCA) exposes patients to fixed angle radiation for extended periods of time. We investigated the incidence and characteristics of radiation-induced dermatitis (RID) associated with RFCA.
   Subjects and Methods: We screened 1347 consecutive patients from 2000 to 2011 who underwent RFCA for any indication and reviewed patients with dermatologic issues at the 1-month follow-up. Skin lesions were classified into three groups: most likely RID, probable RID, and possible RID.
   Results: Of the 1347 enrolled patients, 12 (0.89%) experienced dermatologic issues within 1 month after RFCA, including six patients (0.45%) clinically classified as 'most likely RID' and four patients (0.30%) with 'probable RID'. Ten patients, including most likely RID or probable RID patients, developed skin lesions on the right back and upper arm. Skin lesions did not improve without meticulous treatment, and three cases required surgical intervention. We compared the RID group to the remaining 1335 patients (normal group). The mean body mass indices (BMIs) of the RID and normal groups were 29.3 and 23.9 kg/m(2), respectively (p<0.001). Radiation exposure times were longer in the RID group (180 +/- 31.0 vs. 47 +/- 49.9 minutes, p<0.001). We further analyzed 44 patients (6 RID cases and 38 normal patients) that had BMIs >26 kg/m(2) and exposure times >115 minutes based on receiver operator characteristic curve analyses. Among the 35 patients without RID, 29 patients (82.9%) did not use biplane fluoroscopy.
   Conclusions: Patients with high BMIs have a higher risk of developing severe RID with increasing fluoroscopy times using biplane fluoroscopy.
C1 [Cha, Myung-Jin; Cho, Youngjin; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Jo, Seong Jin] Seoul Natl Univ Hosp, Dept Dermatol, Seoul, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Oh, S (corresponding author), Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM seil@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014; Choi,
   Eue-Keun/K-3752-2019
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; 
CR Glazier JJ, 2012, QJM-INT J MED, V105, P571, DOI 10.1093/qjmed/hcr089
   Heidbuchel H, 2014, EUROPACE, V16, P946, DOI 10.1093/europace/eut409
   Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003
   Koenig TR, 2001, AM J ROENTGENOL, V177, P13, DOI 10.2214/ajr.177.1.1770013
   LINDSAY BD, 1992, AM J CARDIOL, V70, P218, DOI 10.1016/0002-9149(92)91278-C
   Mettler FA, 2002, SEMIN ULTRASOUND CT, V23, P428, DOI 10.1016/S0887-2171(02)90014-4
   Nahass GT, 1997, J AM ACAD DERMATOL, V36, P881, DOI 10.1016/S0190-9622(97)70047-1
   Park TH, 1996, PACE, V19, P1363, DOI 10.1111/j.1540-8159.1996.tb04216.x
   Rosenthal LS, 1998, AM J CARDIOL, V82, P451, DOI 10.1016/S0002-9149(98)00356-7
   Rosenthal LS, 1997, PACE, V20, P1834, DOI 10.1111/j.1540-8159.1997.tb03574.x
   Shope TB, 1996, RADIOGRAPHICS, V16, P1195, DOI 10.1148/radiographics.16.5.8888398
   Vano E, 1998, BRIT J RADIOL, V71, P510, DOI 10.1259/bjr.71.845.9691896
   Vlietstra Ronald E, 2004, J Interv Cardiol, V17, P131, DOI 10.1111/j.1540-8183.2004.09885.x
   WAGNER LK, 1994, J VASC INTERV RADIOL, V5, P71, DOI 10.1016/S1051-0443(94)71456-1
   Wagner Lk, 2007, Biomed Imaging Interv J, V3, pe22, DOI 10.2349/biij.3.2.e22
   Weiss EM, 2007, HEART RHYTHM, V4, P1583, DOI 10.1016/j.hrthm.2007.08.006
NR 16
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 646
EP 653
DI 10.4070/kcj.2016.46.5.646
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100009
PM 27721855
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Kim, HS
   Park, JH
   Kim, MS
   Sun, BJ
   Ryu, S
   Kim, SS
   Jin, SA
   Kim, JH
   Choi, SW
   Jeong, JO
   Kwon, IS
   Seong, IW
AF Lee, Jae-Hwan
   Kim, Hyun-Sook
   Park, Jae-Hyeong
   Kim, Min Su
   Sun, Byung Joo
   Ryu, Seung
   Kim, Song Soo
   Jin, Seon Ah
   Kim, Jun Hyung
   Choi, Si Wan
   Jeong, Jin-Ok
   Kwon, In-Sun
   Seong, In-Whan
TI Incidence and Clinical Course of Left Ventricular Systolic Dysfunction
   in Patients with Carbon Monoxide Poisoning
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carbon monoxide; Poisoning; Left ventricular dysfunction
ID NATRIURETIC PEPTIDE; MYOCARDIAL INJURY; TERM MORTALITY; EXPOSURE;
   TOXICITY; MODERATE
AB Background and Objectives: Carbon monoxide (CO) poisoning can cause tissue hypoxia and left ventricular systolic dysfunction (LVSD) requiring intensive medical management. Our objectives were to find incidence and clinical course of LVSD CO intoxicated patients and make a clinical scoring to predict LVSD.
   Subjects and Methods: We included all consecutive patients with CO exposure in the emergency room. LVSD was defined by LVEF <50% assessed by echocardiography. We compared their clinical, chemical, radiological and electrocardiographic patterns according to the presence of LVSD.
   Results: From May 2009 to June 2015, we included a total of 81 patients (48 men, 47 +/- 19 years old) with CO exposure in this cohort. LVSD was found in about 25 patients (31%). Nine had regional wall motion abnormality. Follow up echocardiographic examinations were available in 21 patients. Of them, 18 patients showed complete recovery in about 3 days (mean 2.8 +/- 1.7 days). Of 3 patients without recovery, 2 had significant coronary artery stenosis. LVSD was significantly associated with initial heart rate (>100/min), pulmonary edema on chest X-ray, serum NT pro-BNP (>100 pg/mL), troponin-I (>0.1 ng/mL) and lactic acid (>4.0 mg/dL) after a univariate analysis. Combining these into a clinical score, according to their beta score after a multivariate analysis (rage=0-16), allowed prediction of LVSD with a sensitivity of 84% and specificity of 91% (reference >= 8, area under the curve=0.952, p<0.001)
   Conclusion: About 31% showed LVSD in patients with CO poisoning, and most of them (86%, 18 of 21 patients) recovered within 3 days. Patients with a higher clinical score (>= 8) might have LVSD.
C1 [Lee, Jae-Hwan; Park, Jae-Hyeong; Kim, Min Su; Sun, Byung Joo; Jin, Seon Ah; Kim, Jun Hyung; Choi, Si Wan; Jeong, Jin-Ok; Seong, In-Whan] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Daejeon, South Korea.
   [Kim, Hyun-Sook] Hallym Univ, Sacred Heart Hosp, Ctr Cardiovasc, Anyang, South Korea.
   [Ryu, Seung] Chungnam Natl Univ, Sch Med, Dept Emergency Med, Chungnam Natl Univ Hosp, Daejeon, South Korea.
   [Kim, Song Soo] Chungnam Natl Univ, Sch Med, Dept Diagnost Imaging, Chungnam Natl Univ Hosp, Daejeon, South Korea.
   [Kwon, In-Sun] Chungnam Natl Univ Hosp, Clin Trial Ctr, Daejeon, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Cardiol, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Seong, In-Whan/0000-0003-4628-0258; Sun, Byung Joo/0000-0001-6019-4343;
   gim, junhyeong/0000-0002-1185-1543; Kim, Song Soo/0000-0002-3078-2184;
   jin, seon-ah/0000-0001-6895-9101; Lee, Jae-Hwan/0000-0002-6561-7760;
   Jeong, Jin-Ok/0000-0003-0763-4754; Choi, Si Wan/0000-0002-1035-1512;
   Park, Jae-Hyeong/0000-0001-7035-286X
CR Ahn KT, 2011, INT J CARDIOL, V153, P108, DOI 10.1016/j.ijcard.2011.09.024
   ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102
   ANDERSON RF, 1967, ANN INTERN MED, V67, P1172, DOI 10.7326/0003-4819-67-6-1172
   Cha YS, 2014, EMERG MED J, V31, P210, DOI 10.1136/emermed-2012-202152
   Davutoglu V, 2006, INHAL TOXICOL, V18, P155, DOI 10.1080/08958370500305885
   Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878
   Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398
   Jang Won Il, 2010, J Cardiovasc Ultrasound, V18, P12, DOI 10.4250/jcu.2010.18.1.12
   Kalay N, 2007, AM J CARDIOL, V99, P322, DOI 10.1016/j.amjcard.2006.08.030
   Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233
   MARIUSNUNEZ AL, 1990, CHEST, V97, P491, DOI 10.1378/chest.97.2.491
   Mark DB, 2004, NEW ENGL J MED, V350, P718, DOI 10.1056/NEJMe038233
   MCMEEKIN J D, 1987, Canadian Journal of Cardiology, V3, P118
   Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681
   Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6
   Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6
   Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044
   THOMPSON N, 1983, HUM TOXICOL, V2, P335, DOI 10.1177/096032718300200226
NR 22
TC 6
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 665
EP 671
DI 10.4070/kcj.2016.46.5.665
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100012
PM 27721858
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MS
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
AF Kim, Min-Seok
   Lim, Hong-Gook
   Kim, Woong Han
   Lee, Jeong Ryul
   Kim, Yong Jin
TI Long-Term Results after Surgical Treatment of Ebstein's Anomaly: a
   30-Year Experience
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defects, congenital; Cyanosis; Outcomes
ID TRICUSPID-VALVE; MALFORMATION; ARRHYTHMIA; MANAGEMENT; CHILDREN; REPAIR;
   ADULT; FETUS
AB Background and Objectives: The aim of the study is to evaluate the long-term results after a surgical repair of Ebstein's anomaly.
   Subjects and Methods: Forty-eight patients with Ebstein's anomaly who underwent open heart surgery between 1982 and 2013 were included. Median age at operation was 5.6 years (1 day-42.1 years). Forty-five patients (93.7%) demonstrated tricuspid valve (TV) regurgitation of less than moderate degree. When. the patients were divided according to Carpentier's classification, types A, B, C, and D were 11, 21, 12, and 4 patients, respectively. Regarding the type of surgical treatment, bi-ventricular repair (n=38), one-and-a half ventricular repair (n=5), and single ventricle palliation (n=5) were performed. Of 38 patients who underwent a bi-ventricular repair, TV repairs were performed by Danielson's technique (n=20), Carpentier's technique (n=11), Cone repair (n=4), and TV annuloplasty (n=1). Two patients underwent TV replacement. Surgical treatment strategies were different according to Carpentier's types (p<0.001) and patient's age (p=0.022).
   Results: There were 2 in-hospital mortalities (4.2%; 1 neonate and 1 infant) and 2 late mortalities during follow-up. Freedom from recurrent TV regurgitation rates at 5, 10, and 15 years were 88.6%, 66.3%, 52.7%, respectively. TV regurgitation recurrence did not differ according to surgical method (p=0.800). Survival rates at 5, 10, and 20 years were 95.8%, 95.8%, and 85.6%, respectively, and freedom from reoperation rates at 5, 10, and 15 years were 85.9%, 68.0%, and 55.8%, respectively.
   Conclusion: Surgical treatment strategies were decided according to Carpentier's type and patient's age. Overall survival and freedom from reoperation rates at 10 years were 95.8% and 68.0%, respectively. Approximately 25% of patients required a second operation for TV during the follow-up.
C1 [Kim, Min-Seok; Lim, Hong-Gook; Kim, Woong Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
RP Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 101 Daehak Ro, Seoul 03080, South Korea.
EM kyj@plaza.snu.ac.kr
CR Boston US, 2006, ANN THORAC SURG, V81, P690, DOI 10.1016/j.athoracsur.2005.08.011
   Brown ML, 2008, J THORAC CARDIOV SUR, V135, P1120, DOI 10.1016/j.jtcvs.2008.02.034
   CARPENTIER A, 1988, J THORAC CARDIOV SUR, V96, P92
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170, DOI 10.1016/0735-1097(94)90516-9
   Chauvaud SM, 2001, ANN THORAC SURG, V71, P1547, DOI 10.1016/S0003-4975(01)02464-X
   Cheung YF, 2014, KOREAN CIRC J, V44, P59, DOI 10.4070/kcj.2014.44.2.59
   DANIELSON GK, 1992, J THORAC CARDIOV SUR, V104, P1195
   Davies RR, 2013, ANN THORAC SURG, V96, P1703, DOI 10.1016/j.athoracsur.2013.05.005
   Fost CHA, 2005, SWISS MED WKLY, V135, P269
   HARDY KL, 1964, J THORAC CARDIOV SUR, V48, P927, DOI 10.1016/S0022-5223(19)33337-9
   Huang CJ, 2000, THORAC CARDIOV SURG, V48, P347, DOI 10.1055/s-2000-8348
   HUNTER SW, 1958, DIS CHEST, V33, P297, DOI 10.1378/chest.33.3.297
   Iturralde P, 2006, J CARDIOVASC ELECTR, V17, P1332, DOI 10.1111/j.1540-8167.2006.00617.x
   Jaquiss RDB, 2007, SEMIN THORAC CARDIOV, V19, P258, DOI 10.1053/j.semtcvs.2007.07.004
   Jost CHA, 2007, CIRCULATION, V115, P277, DOI 10.1161/CIRCULATIONAHA.106.619338
   Kapusta L, 2007, EUR HEART J, V28, P2661, DOI 10.1093/eurheartj/ehm398
   Khositseth A, 2004, J THORAC CARDIOV SUR, V128, P826, DOI 10.1016/j.jtcvs.2004.02.012
   Krieger Eric V, 2012, Curr Treat Options Cardiovasc Med, V14, P594, DOI 10.1007/s11936-012-0209-2
   McKenzie E, 2014, ANN THORAC SURG, V98, P173, DOI 10.1016/j.jvsv.2013.10.056
   Muraru D, 2016, KOREAN CIRC J, V46, P443, DOI 10.4070/kcj.2016.46.4.443
   Oxenius A, 2013, CARDIOL YOUNG, V23, P27, DOI 10.1017/S1047951112000224
   Paranon S, 2008, HEART, V94, P237, DOI 10.1136/hrt.2006.105262
   Raju V, 2014, ANN THORAC SURG, V98, P167, DOI 10.1016/j.athoracsur.2014.03.009
   Silva José Pedro da, 2004, Arq. Bras. Cardiol., V82, P212, DOI 10.1590/S0066-782X2004000300002
   Stulak John M, 2007, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P105, DOI 10.1053/j.pcsu.2007.01.007
NR 25
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 706
EP 713
DI 10.4070/kcj.2016.46.5.706
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100017
PM 27721863
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, ES
   Cho, S
   Jang, WS
   Kim, WH
AF Choi, Eun Seok
   Cho, Sungkyu
   Jang, Woo Sung
   Kim, Woong-Han
TI Cardiopulmonary Bypass Priming Using Autologous Cord Blood in Neonatal
   Congenital Cardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fetal blood; Cardiopulmonary bypass; Cardiac surgery
ID PLACENTAL BLOOD; SPARING APPROACH; 1ST HOURS; TRANSFUSION
AB Background and Objectives: A blood transfusion is almost inevitable in neonatal cardiac surgery. This study aimed to assess the feasibility of using autologous cord blood for a cardiopulmonary bypass (CPB) priming as an alternative to an allo-transfusion in neonatal cardiac surgery.
   Subjects and Methods: From January 2012 to December 2014, cord blood had been collected during delivery after informed consent and. was stored immediately into a blood bank. Eight neonatal patients had their own cord blood used for CPB priming during cardiac surgery.
   Results: All patients underwent surgery for their complex congenital heart disease. The median age and body weight at surgery was 11 days (from 0 to 21 days) and 3.2 kg (from 2.2 to 3.7 kg). The median amount and hematocrit of collected cord blood was 72.5 mL (from 43 to 105 mL) and 48.7% (from 32.0 to 51.2%). The median preoperative hematocrit of neonates was 36.5% (from 31.0 to 45.0%); the median volume of CPB priming was 130 mL (From 120 to 140 mL). Seven out of eight patients did not need an allo-transfusion in CPB priming and only one neonate used 20 mL of packed red blood cells in CPB priming to obtain the target hematocrit.
   Conclusion: Autologous cord blood can be used for CPB priming as alternative to packed red blood cells in neonatal congenital cardiac surgery in order to reduce allo-transfusion.
C1 [Choi, Eun Seok] Sejong Gen Hosp, Dept Thorac & Cardiovasc Surg, Bucheon, South Korea.
   [Cho, Sungkyu; Kim, Woong-Han] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Childrens Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
   [Jang, Woo Sung] Kyungpook Natl Univ, Coll Med, Kyungpook Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Daegu, South Korea.
RP Kim, WH (corresponding author), Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Childrens Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM woonghan@snu.ac.kr
FU Korean Society of Cardiology [201203-3]
FX This research is financially supported by 'The Korean Society of
   Cardiology' (201203-3).
CR Beattie R, 1996, ARCH DIS CHILD-FETAL, V74, pF221, DOI 10.1136/fn.74.3.F221
   Bhattacharya N, 2005, J AM COLL SURGEONS, V200, P557, DOI 10.1016/j.jamcollsurg.2004.12.007
   BIFANO EM, 1994, PEDIATR RES, V36, P90, DOI 10.1203/00006450-199407001-00016
   Brune T, 2002, BIOL NEONATE, V81, P236, DOI 10.1159/000056754
   Brune T, 2007, TRANSFUSION, V47, P2271, DOI 10.1111/j.1537-2995.2007.01456.x
   Chang HW, 2014, ARTIF ORGANS, V38, P78, DOI 10.1111/aor.12241
   Chasovskyi K, 2012, ANN THORAC SURG, V93, P1571, DOI 10.1016/j.athoracsur.2012.01.104
   Choi J, 2010, KOREAN J THORAC CARD, V43, P721
   Durandy Y, 2015, ARTIF ORGANS, V39, P21, DOI 10.1111/aor.12447
   Fedevych O, 2011, EUR J CARDIO-THORAC, V40, P985, DOI 10.1016/j.ejcts.2011.01.011
   Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099
   Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078
   Hassall O, 2003, LANCET, V361, P678, DOI 10.1016/S0140-6736(03)12565-2
   Imura K, 2001, J PEDIATR SURG, V36, P851, DOI 10.1053/jpsu.2001.23952
   Redlin M, 2013, J THORAC CARDIOV SUR, V146, P537, DOI 10.1016/j.jtcvs.2012.09.101
   Redlin M, 2012, J THORAC CARDIOV SUR, V144, P493, DOI 10.1016/j.jtcvs.2012.01.008
   Taguchi T, 2003, J PEDIATR SURG, V38, P604, DOI 10.1053/jpsu.2003.50131
   Widing L, 2007, TRANSFUSION, V47, P1481, DOI 10.1111/j.1537-2995.2007.01287.x
NR 18
TC 4
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 714
EP 718
DI 10.4070/kcj.2016.46.5.714
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100018
PM 27721864
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, AY
   Jung, SY
   Choi, JY
   Kim, GB
   Kim, YH
   Shim, WS
   Kang, IS
   Jung, JW
AF Kim, Ah Young
   Jung, Se Yong
   Choi, Jae Young
   Kim, Gi Beom
   Kim, Young-Hwue
   Shim, Woo Sup
   Kang, I-Seok
   Jung, Jo Won
TI Retrospective Multicenter Study of Respiratory Syncytial Virus
   Prophylaxis in Korean Children with Congenital Heart Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Respiratory syncytial virus; Congenital heart disease; Pediatrics;
   Palivizumab; Prophylaxis
ID PALIVIZUMAB PROPHYLAXIS; YOUNG-CHILDREN; RISK-FACTORS; PREVENTION;
   INFECTIONS; INFANTS; IMMUNOPROPHYLAXIS; HOSPITALIZATION; EPIDEMIOLOGY;
   IMPACT
AB Background and Objectives: We conducted a review of current data on respiratory syncytial virus (RSV) prophylaxis with palivizumab, in Korean children with congenital heart diseases (CHD). In 2009, the Korean guideline for RSV prophylaxis had established up to five shots monthly per RSV season, only for children <1 year of age with hemodynamic significance CHD (HS-CHD).
   Subjects and Methods: During the RSV seasons in 2009-2015, we performed a retrospective review of data for 466 infants with CHD, examined at six centers in Korea
   Results: Infants received an average of 3.7 +/- 1.9 (range, 1-10) injections during the RSV season. Fifty-seven HS-CHD patients (12.2%) were hospitalized with breakthrough RSV bronchiolitis, with a recurrence in three patients, one year after the initial check-up. Among patients with simple CHD, only five (1.1%) patients received one additional dose postoperatively, as per the limitations set by the Korean guideline. Among the 30 deaths (6.4%), five (1.1%) were attributed to RSV infection; three to simple CHD, one to Tetralogy of Fallot, and one to hypertrophic cardiomyopathy (HCM). Of the three HCM patients that exceeded guidelines for RSV prophylaxis, two (66.6%) were hospitalized, and one died of RSV infection (33.3%).
   Conclusion: In accordance to the Korean guideline, minimal injections of palivizumab were administered to patients having HS-CHD <one year of age during the RSV season; the risk of RSV infection remains significant among children with simple CHD, cardiomyopathy, and children above the age of one year with HS-CHD.
C1 [Kim, Ah Young; Jung, Se Yong; Choi, Jae Young; Jung, Jo Won] Yonsei Univ, Severance Cardiovasc, Seoul, South Korea.
   [Kim, Gi Beom] Seoul Natl Univ, Childrens Hosp, Seoul, South Korea.
   [Kim, Young-Hwue] Univ Ulsan, Asan Med Ctr, Seoul, South Korea.
   [Shim, Woo Sup] Gangwon Natl Univ, Chunchon, South Korea.
   [Kang, I-Seok] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea.
RP Jung, JW (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Pediat Cardiol,Dept Pediat, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jwjung@yuhs.ac
RI Kim, Gi Beom/AAK-3377-2021; Jung, Yong/AAR-3286-2020
OI Kim, Gi Beom/0000-0002-7880-280X; Jung, Yong/0000-0003-1337-563X; Choi,
   Jae Young/0000-0002-1247-6669; Kim, Ah Young/0000-0002-0713-4461
FU Korean Pediatric Cardiology Society
FX This study was supported by Korean Pediatric Cardiology Society in 2011.
CR Abramson JS, 2003, PEDIATRICS, V112, P1447, DOI 10.1542/peds.112.6.1447
   Alexander PMA, 2012, J PAEDIATR CHILD H, V48, P395, DOI 10.1111/j.1440-1754.2011.02219.x
   Altman CA, 2000, PEDIATR CARDIOL, V21, P433, DOI 10.1007/s002460010103
   Andabaka T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006602.pub4
   Brady MT, 2014, PEDIATRICS, V134, P415, DOI 10.1542/peds.2014-1665
   Butt M, 2014, CARDIOL YOUNG, V24, P337, DOI 10.1017/S1047951113000401
   Cabalka AK, 2004, PEDIATR INFECT DIS J, V23, pS41, DOI 10.1097/01.inf.0000108220.94201.1a
   Chang RKR, 2010, PEDIATR CARDIOL, V31, P90, DOI 10.1007/s00246-009-9577-0
   Chantepie A, 2004, ARCH PEDIATRIE, V11, P1402, DOI 10.1016/j.arcped.2004.06.007
   Cohen SA, 2008, PEDIATR CARDIOL, V29, P382, DOI 10.1007/s00246-007-9039-5
   Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2
   Feltes TF, 2007, EXPERT OPIN BIOL TH, V7, P1471, DOI 10.1517/14712598.7.9.1471
   Feltes TF, 2011, PEDIATR RES, V70, P186, DOI 10.1203/PDR.0b013e318220a553
   Golombek SG, 2004, PEDIATR INFECT DIS J, V23, P318, DOI 10.1097/00006454-200404000-00008
   Granbom E, 2014, ACTA PAEDIATR, V103, P840, DOI 10.1111/apa.12658
   Jung Jo Won, 2011, Korean J Pediatr, V54, P192, DOI 10.3345/kjp.2011.54.5.192
   Khongphatthanayothin A, 1999, CRIT CARE MED, V27, P1974, DOI 10.1097/00003246-199909000-00042
   Kristensen K, 2009, ARCH DIS CHILD, V94, P785, DOI 10.1136/adc.2008.143057
   Lopez CM, 2010, PEDIATR INFECT DIS J, V29, P1077, DOI 10.1097/INF.0b013e3181efdac5
   Mitchell I, 2011, PEDIATR INFECT DIS J, V30, P651, DOI 10.1097/INF.0b013e31821146f7
   MOLER FW, 1992, CRIT CARE MED, V20, P1406, DOI 10.1097/00003246-199210000-00008
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Parnes C, 2003, PEDIATR PULM, V35, P484, DOI 10.1002/ppul.10288
   Rackham OJ, 2005, CARDIOL YOUNG, V15, P251, DOI 10.1017/S1047951105000533
   Resch B, 2013, CURR OPIN CARDIOL, V28, P85, DOI 10.1097/HCO.0b013e32835dce2f
   Saji T, 2008, PEDIATR INFECT DIS J, V27, P1108, DOI 10.1097/INF.0b013e3181801d76
   Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c
   Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0
   심우섭, 2010, Clinical and Experimental Pediatrics, V53, P380
   Yount LE, 2004, PEDIATRICS, V114, P1606, DOI 10.1542/peds.2004-0224
NR 30
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 719
EP 726
DI 10.4070/kcj.2016.46.5.719
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100019
PM 27721865
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DJ
   Uhm, JS
   Park, JW
   Youn, JC
   Lee, DW
   Koo, BN
   Lee, MH
AF Kim, Dong-Jun
   Uhm, Jae-Sun
   Park, Je Wook
   Youn, Jong-Chan
   Lee, Dong Won
   Koo, Bon-Nyeo
   Lee, Moon-Hyoung
TI Combined Subpectoral Implantation of Implantable
   Cardioverter-Defibrillator and Augmentation Mammoplasty in a Young
   Female Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter-defibrillator; Young adult; Female;
   Mammoplasty; Pectoralis muscles
ID WOMEN
AB Subcutaneous implantation of a cardiac implantable electronic device is the standard method. Occasionally, subpectoral cardiac implantable electronic device (CIED) implantation via axillary incisions is performed in young female patients for cosmetic purposes. Because subpectoral CIED implantation and augmentation mammoplasty involve the same layer, it is feasible to perform both procedures simultaneously. We report a case of combined subpectoral implantation of an implantable cardioverter-defibrillator and augmentation mammoplasty via the axillary approach in a young female patient with dilated cardiomyopathy and small breasts.
C1 [Kim, Dong-Jun; Uhm, Jae-Sun; Park, Je Wook; Youn, Jong-Chan; Lee, Moon-Hyoung] Yonsei Univ, Coll Med, Severance Hosp, Dept Cardiol, Seoul, South Korea.
   [Lee, Dong Won] Yonsei Univ, Coll Med, Severance Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea.
   [Koo, Bon-Nyeo] Yonsei Univ, Coll Med, Severance Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.
RP Uhm, JS (corresponding author), Severance Cardiovasc Hosp, Dept Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jason@yuhs.ac
RI Youn, Jong-Chan/AAS-1405-2020
OI Lee, Dongwon/0000-0003-0046-3139; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Koo, Bon-Nyeo/0000-0002-3189-1673; Uhm, Jae-Sun/0000-0002-1611-8172;
   Youn, Jong-Chan/0000-0003-0998-503X
CR Al-Bataineh M, 2010, J INTERV CARD ELECTR, V27, P137, DOI 10.1007/s10840-009-9444-1
   Burns KM, 2011, HEART RHYTHM, V8, P23, DOI 10.1016/j.hrthm.2010.09.073
   Giudici MC, 2010, PACE, V33, P1373, DOI 10.1111/j.1540-8159.2010.02871.x
   Gold MR, 1996, J AM COLL CARDIOL, V28, P1278, DOI 10.1016/S0735-1097(96)00314-2
   Goldberger Z, 2006, JAMA-J AM MED ASSOC, V295, P809, DOI 10.1001/jama.295.7.809
   Kistler PM, 2004, PACE, V27, P361, DOI 10.1111/j.1540-8159.2004.00442.x
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Obeyesekere MN, 2010, EUROPACE, V12, P1239, DOI 10.1093/europace/euq152
   Reiffel JA, 2002, CIRCULATION, V105, P1022, DOI 10.1161/hc0902.105131
   Starrenburg A, 2014, PACE, V37, P843, DOI 10.1111/pace.12357
   Thomas DE, 2015, FUTUR CARDIOL, V11, P293, DOI [10.2217/fca.15.17, 10.2217/FCA.15.17]
   Vazquez LD, 2008, PACE, V31, P1528, DOI 10.1111/j.1540-8159.2008.01223.x
NR 13
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 734
EP 738
DI 10.4070/kcj.2016.46.5.734
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100022
PM 27721868
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
   Kim, JJ
   Park, JJ
AF Park, Chan Soon
   Kim, Jeong Jae
   Park, Jin Joo
TI Congenital Absence of Superior Vena Cava with No Manifestation of
   Superior Vena Cava Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Vena cava; superior; Congenital abnormalities; Computed tomography;
   Echocardiography
AB Total absence of superior vena cava (SVC) is a very rare anomaly, and the patient usually suffers from SVC syndrome or conduction disturbances. We report an asymptomatic 27 year-old male, with complete absence of SVC. Transthoracic echocardiography and computed tomography demonstrated the absence of SVC and other congenital cardiac anomalies, but the presence of prominent collateral vessels that allow a sufficient venous return.
C1 [Park, Chan Soon; Park, Jin Joo] Seoul Natl Univ, Ctr Cardiovasc, Bundang Hosp, Songnam, South Korea.
   [Park, Chan Soon] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul, South Korea.
   [Kim, Jeong Jae] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Songnam, South Korea.
RP Park, JJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Songnam 13620, South Korea.; Park, JJ (corresponding author), Seoul Natl Univ, Ctr Cardiovasc, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Songnam 13620, South Korea.
EM jinjooparkmd@gmail.com
CR Bartram U, 1997, AM J CARDIOL, V80, P175, DOI 10.1016/S0002-9149(97)00314-7
   Lee CY, 2005, ACTA PAEDIATR, V94, P1840, DOI 10.1080/08035250510035184
   LENOX CC, 1980, AM J CARDIOL, V45, P117, DOI 10.1016/0002-9149(80)90228-3
   Romer S, 2006, ULTRASOUND OBST GYN, V28, P842, DOI 10.1002/uog.3867
   Saunders RN, 2001, ANN THORAC SURG, V71, P2041, DOI 10.1016/S0003-4975(00)02562-5
   Wan JF, 2010, HEMATOL ONCOL CLIN N, V24, P501, DOI 10.1016/j.hoc.2010.03.003
   Wilson LD, 2007, NEW ENGL J MED, V356, P1862, DOI 10.1056/NEJMcp067190
   Wudel L J Jr, 2001, Curr Treat Options Oncol, V2, P77, DOI 10.1007/s11864-001-0019-3
   Ylanen K, 2012, CASE REP CARDIOL, V2012, DOI 10.1155/2012/461040
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2016
VL 46
IS 5
BP 743
EP 745
DI 10.4070/kcj.2016.46.5.743
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9IF
UT WOS:000384706100024
PM 27721870
OA Green Published
DA 2021-04-22
ER

PT J
AU Muraru, D
   Surkova, E
   Badano, LP
AF Muraru, Denisa
   Surkova, Elena
   Badano, Luigi Paolo
TI Revisit of Functional Tricuspid Regurgitation; Current Trends in the
   Diagnosis and Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Tricuspid valve; Echocardiography; Functional tricuspid regurgitation;
   Tricuspid annulus; Pathophysiology
ID VALVE REPAIR; REAL-TIME; DIAMETER MEASUREMENT; DETERMINANTS;
   ANNULOPLASTY; ANNULUS; ECHOCARDIOGRAPHY; DISEASE; QUANTIFICATION;
   INTERVENTIONS
AB Current knowledge of functional tricuspid regurgitation(FTR) as a progressive entity, worsening the prognosis of patients irrespective of its aetiology, has led to renewed interest in the pathophysiology and assessment of FTR. For the proper management of FTR, not only its severity, but also the mechanisms, the mode of leaflet coaptation, the degree of tricuspid annulus enlargement and leaflet tenting, and the haemodynamic consequences for right atrial and right ventricular morphology and function have to be taken into account. A better assessment of the anatomy and function of tricuspid apparatus and tricuspid regurgitation severity should help with the appropriate selection of patients who will benefit from either surgical tricuspid valve repair/replacement or a percutaneous procedure, especially among patients who are to undergo or have undergone primary left-sided valvular surgery. In this article, we review the anatomy, pathophysiology and the use of imaging techniques to assess patients with FTR, as well as the various treatment options for FTR, including emerging transcatheter procedures. The limitations affecting the current approach to FTR patients and the unmet clinical needs for their management have also been discussed.
C1 [Muraru, Denisa; Surkova, Elena; Badano, Luigi Paolo] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.
RP Badano, LP (corresponding author), Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.
EM lpbadano@gmail.com
RI Muraru, Denisa/S-9628-2019; Surkova, Elena/AAN-3515-2020; Badano, Luigi
   Paolo/H-9755-2019; Surkova, Elena/N-5067-2014
OI Muraru, Denisa/0000-0003-2514-3668; Badano, Luigi
   Paolo/0000-0002-0379-3283; Surkova, Elena/0000-0001-5334-8551
FU European Association of Cardiovascular Imaging
FX Dr. Eena Surkova has received a research grant from the European
   Association of Cardiovascular Imaging.
CR de Agustin JA, 2013, J AM SOC ECHOCARDIOG, V26, P1063, DOI 10.1016/j.echo.2013.06.006
   Anwar AM, 2007, INT J CARDIOVAS IMAG, V23, P701, DOI 10.1007/s10554-006-9206-4
   Arsalan M, 2015, EUR HEART J
   Badano LP, 2013, EUR HEART J, V34, P1875, DOI 10.1093/eurheartj/ehs474
   Badano LP, 2009, EUR J ECHOCARDIOGR, V10, P477, DOI 10.1093/ejechocard/jep044
   Basso C, 2013, CARDIAC VALVULAR MED, P211
   Benedetto U, 2012, J THORAC CARDIOV SUR, V143, P632, DOI 10.1016/j.jtcvs.2011.12.006
   BRAUNWALD NS, 1967, CIRCULATION, V35, pI63
   Chen TE, 2013, J AM SOC ECHOCARDIOG, V26, P1143, DOI 10.1016/j.echo.2013.07.020
   De Bonis M, 2008, EUR J CARDIO-THORAC, V33, P600, DOI 10.1016/j.ejcts.2008.01.011
   Di Mauro M, 2013, INT J CARDIOL, V168, P707, DOI 10.1016/j.ijcard.2013.04.043
   Di Mauro M, 2009, EUR J CARDIO-THORAC, V35, P635, DOI 10.1016/j.ejcts.2008.12.040
   Dreyfus GD, 2005, ANN THORAC SURG, V79, P127, DOI 10.1016/j.athoracsur.2004.06.057
   Dreyfus GD, 2015, J AM COLL CARDIOL, V65, P2331, DOI 10.1016/j.jacc.2015.04.011
   Fukuda S, 2006, CIRCULATION, V114, pI492, DOI 10.1161/CIRCULATIONAHA.105.000257
   Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536
   Jeong DS, 2013, ANN THORAC SURG, V95, P2007, DOI 10.1016/j.athoracsur.2013.03.007
   Kim HK, 2006, AM J CARDIOL, V98, P236, DOI 10.1016/j.amjcard.2006.01.082
   Kim HK, 2010, EUR HEART J, V31, P1520, DOI 10.1093/eurheartj/ehq063
   Kim JB, 2012, HEART, V98, P24, DOI 10.1136/heartjnl-2011-300403
   Kim YJ, 2009, CIRCULATION, V120, P1672, DOI 10.1161/CIRCULATIONAHA.109.849448
   Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031
   Lauten A, 2015, EUROINTERVENTION, V11, pW133, DOI 10.4244/EIJV11SWA37
   Maffessanti F, 2013, EUR HEART J-CARD IMG, V14, P986, DOI 10.1093/ehjci/jet004
   Mascherbauer J, 2010, EUR HEART J, V31, P2841, DOI 10.1093/eurheartj/ehq303
   McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019
   Miglioranza MH, 2015, JACC-CARDIOVASC IMAG, V8, P864, DOI 10.1016/j.jcmg.2014.09.010
   Miglioranza MH, 2015, J AM SOC ECHOCARDIOG, V28, P226, DOI 10.1016/j.echo.2014.09.017
   Muraru D, 2011, TEXTBOOK OF REAL-TIME THREE DIMENSIONAL ECHOCARDIOGRAPHY, P173, DOI 10.1007/978-1-84996-495-1_17
   Nasis A, 2013, RADIOLOGY, V267, P11, DOI 10.1148/radiol.13111196
   Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036
   Navia JL, 2012, ANN THORAC SURG, V93, P59, DOI 10.1016/j.athoracsur.2011.08.037
   Porter A, 1999, J HEART VALVE DIS, V8, P57
   RIVERA R, 1985, J THORAC CARDIOV SUR, V89, P196
   Rogers JH, 2009, CIRCULATION, V119, P2718, DOI 10.1161/CIRCULATIONAHA.108.842773
   Ruel M, 2004, EUR J CARDIO-THORAC, V25, P364, DOI 10.1016/j.ejcts.2003.12.013
   SADE RM, 1975, SURGERY, V77, P624
   Shiran A, 2009, J AM COLL CARDIOL, V53, P401, DOI 10.1016/j.jacc.2008.09.048
   Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9
   Song JM, 2011, J AM SOC ECHOCARDIOG, V24, P663, DOI 10.1016/j.echo.2011.01.005
   Starck CT, 2015, EUROINTERVENTION, V11, pW128, DOI 10.4244/EIJV11SWA36
   Sutton J P 3rd, 1995, J Heart Valve Dis, V4, P571
   Tang GHL, 2006, CIRCULATION, V114, pI577, DOI 10.1161/CIRCULATIONAHA.105.001263
   Taramasso M, 2016, EUR HEART J
   Taramasso M, 2016, J CARDIAC SURG, V31, P9, DOI 10.1111/jocs.12656
   Ton-Nu TT, 2006, CIRCULATION, V114, P143, DOI 10.1161/CIRCULATIONAHA.106.611889
   Topilsky Y, 2010, CIRCULATION, V122, P1505, DOI 10.1161/CIRCULATIONAHA.110.941310
   Tops LF, 2008, JACC-CARDIOVASC IMAG, V1, P94, DOI 10.1016/j.jcmg.2007.10.011
   Mas PT, 2015, HEART, V101, P1840, DOI 10.1136/heartjnl-2014-307252
   Tribouilloy CM, 2000, J AM COLL CARDIOL, V36, P472, DOI 10.1016/S0735-1097(00)00762-2
   Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455
   van Rosendael PJ, 2016, EUR HEART J-CARD IMG, V17, P96, DOI 10.1093/ehjci/jev140
   Vassileva CM, 2012, J THORAC CARDIOV SUR, V143, P1043, DOI 10.1016/j.jtcvs.2011.07.004
   Victor S, 1994, J Heart Valve Dis, V3, P27
   Zhu TY, 2015, INTERACT CARDIOV TH, V20, P114, DOI 10.1093/icvts/ivu326
NR 55
TC 14
Z9 18
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 443
EP 455
DI 10.4070/kcj.2016.46.4.443
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500002
PM 27482252
OA Green Published
DA 2021-04-22
ER

PT J
AU Kario, K
AF Kario, Kazuomi
TI Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis
   of Blood Pressure Variability: Triggering Cardiovascular Events
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; Masked hypertension; Blood pressure; Remote sensing
   technology
ID VISIT-TO-VISIT; OBSTRUCTIVE SLEEP-APNEA; BY-DAY VARIABILITY; RENAL
   DENERVATION; MORNING SURGE; ORTHOSTATIC HYPERTENSION; RESISTANT
   HYPERTENSION; CEREBROVASCULAR-DISEASE; ORGAN DAMAGE; ANTIHYPERTENSIVE
   THERAPY
AB Blood pressure (BP) exhibits different variabilities and surges with different time phases, from the shortest beat-by-beat to longest yearly changes. We hypothesized that the synergistic resonance of these BP variabilites generates an extraordinarily large dynamic surge in BP and triggers cardiovascular events (the resonance hypothesis). The power of pulses is transmitted to the peripheral sites without attenuation by the large arteries, in individuals with stiffened arteries. Thus, the effect of a BP surge on cardiovascular risk would be especially exaggerated in high-risk patients with vascular disease. Based on this concept, our group recently proposed a new theory of systemic hemodynamic atherothromboltic syndrome (SHATS), a vicious cycle of hemodynamic stress and vascular disease that advances organ damage and triggers cardiovascular disease. Clinical phenotypes of SHATS are large-artery atherothombotic diseases such as stroke, coronary artery disease, and aortic and pheripheral artery disease; small-artery diseases, and microcirculation-related disease such as vascular cognitive dysfunction, heart failure, and chronic kidney disease. The careful consideration of BP variability and vascular diseases such as SHATS, and the early detection and management of SHATS, will achieve more effective individualized cardiovascular protection. In the near future, information and communication technology-based 'anticipation medicine' predicted by the changes of individual BP values could be a promising approach to achieving zero cardiovascular events.
C1 [Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
   [Kario, Kazuomi] Jichi Med Univ, Ctr Excellence Cardiovasc Res & Dev JCARD, Shimotsuke, Tochigi, Japan.
   [Kario, Kazuomi] Hypertens Cardiovasc Outcome Prevent & Evidence A, Shimotsuke, Tochigi, Japan.
RP Kario, K (corresponding author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
EM kkario@jichi.ac.jp
CR Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670
   Bombelli M, 2014, HYPERTENSION, V64, P943, DOI 10.1161/HYPERTENSIONAHA.114.03675
   Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273
   Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75
   Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007
   Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880
   Fukui M, 2013, HYPERTENS RES, V36, P219, DOI 10.1038/hr.2012.177
   Hering D, 2013, HYPERTENSION, V61, P457, DOI 10.1161/HYPERTENSIONAHA.111.00194
   Hoshide S, 2016, CURR HYPERTENS REV, V12, P164, DOI 10.2174/1573402111666150812143155
   Hoshide S, 2015, HYPERTENSION, V66, P750, DOI 10.1161/HYPERTENSIONAHA.115.05958
   Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290
   Imai Y, 1996, BLOOD PRESS MONIT, V1, P251
   Ito S, 2009, HYPERTENS RES, V32, P115, DOI 10.1038/hr.2008.27
   Kagitani H, 2015, AM J HYPERTENS, V28, P586, DOI 10.1093/ajh/hpu210
   Kandzari DE, 2016, AM HEART J, V171, P82, DOI 10.1016/j.ahj.2015.08.021
   Kario K, 2006, HYPERTENSION, V47, P139, DOI 10.1161/01.HYP.0000199162.89857.7a
   Kario K, 2000, LANCET, V355, P1645, DOI 10.1016/S0140-6736(05)72549-6
   Kario K, 2004, AM J HYPERTENS, V17, P668, DOI 10.1016/j.amjhyper.2004.04.001
   Kario K, 1998, HYPERTENSION, V31, P77, DOI 10.1161/01.HYP.31.1.77
   Kario K, 2002, J AM COLL CARDIOL, V40, P133, DOI 10.1016/S0735-1097(02)01923-X
   Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA
   Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0
   Kario K, 2015, J CLIN HYPE IN PRESS
   Kario K, 2004, CLIN MANUAL EARLY MO, P1
   Kario K, 2015, ESSENTIAL MANUAL 24, P1
   Kario K, 2008, J HYPERTENS, V26, P1257, DOI 10.1097/HJH.0b013e3282fd173c
   Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581
   Kario K, 2016, ANN GLOB HEALTH, V82, P254, DOI 10.1016/j.aogh.2016.02.004
   Kario K, 2016, CURR HYPERTENS REV, V12, P156, DOI 10.2174/1573402112666160302102841
   Kario K, 2016, CIRC J, V80, P1404, DOI 10.1253/circj.CJ-16-0035
   Kario K, 2016, J AM COLL CARDIOL, V67, P1519, DOI 10.1016/j.jacc.2016.01.037
   Kario K, 2016, NAT REV CARDIOL, V13, P125, DOI 10.1038/nrcardio.2016.13
   Kario K, 2016, AM J HYPERTENS, V29, P14, DOI 10.1093/ajh/hpv114
   Kario K, 2015, HYPERTENSION, V66, P1130, DOI 10.1161/HYPERTENSIONAHA.115.06260
   Kario K, 2015, J CLIN HYPERTENS, V17, P682, DOI 10.1111/jch.12576
   Kario K, 2015, CIRC J, V79, P1222, DOI 10.1253/circj.CJ-15-0150
   Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800
   Kario K, 2015, J CLIN HYPERTENS, V17, P328, DOI 10.1111/jch.12505
   Kario K, 2015, AM J HYPERTENS, V28, P7, DOI 10.1093/ajh/hpu179
   Kario K, 2014, HYPERTENSION, V64, P989, DOI 10.1161/HYPERTENSIONAHA.114.04262
   Kario K, 2014, J CLIN HYPERTENS, V16, P459, DOI 10.1111/jch.12327
   Kario K, 2013, NAT REV NEPHROL, V9, P726, DOI 10.1038/nrneph.2013.224
   Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19
   Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149
   Kario K, 2009, HYPERTENS RES, V32, P428, DOI 10.1038/hr.2009.56
   Kario K, 2009, CIRC J, V73, P1002, DOI 10.1253/circj.CJ-09-0286
   Kawai T, 2013, J HYPERTENS, V31, P1387, DOI 10.1097/HJH.0b013e328360f796
   Kawai T, 2013, HYPERTENS RES, V36, P232, DOI 10.1038/hr.2012.162
   Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620
   Kim BK, 2016, J HUM HYPERTENS, V30, P315, DOI 10.1038/jhh.2015.77
   Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3
   Kuwabara M, 2016, CURR HYPERTENS REV, V12, P27, DOI 10.2174/1573402112666160114093500
   Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B
   Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273
   Liu ZD, 2016, HYPERTENS RES, V39, P245, DOI 10.1038/hr.2015.135
   Luo Y, 2013, CHINESE MED J-PEKING, V126, P510, DOI 10.3760/cma.j.issn.0366-6999.20122110
   Manfredini Roberto, 2003, Circulation, V108, pe72
   Matsui Y, 2012, HYPERTENSION, V59, P1132, DOI 10.1161/HYPERTENSIONAHA.111.189217
   Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645
   Matsui Y, 2010, J HYPERTENS, V28, P1752, DOI 10.1097/HJH.0b013e32833a3981
   Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f
   Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255
   Murakami S, 2004, AM J HYPERTENS, V17, P1179, DOI 10.1016/j.amjhyper.2004.07.016
   Nagai M, 2014, ATHEROSCLEROSIS, V233, P19, DOI 10.1016/j.atherosclerosis.2013.11.071
   Nagai M, 2013, AM J HYPERTENS, V26, P1369, DOI 10.1093/ajh/hpt167
   Nagai M, 2013, AM J HYPERTENS, V26, P981, DOI 10.1093/ajh/hpt070
   Nagai M, 2012, J HYPERTENS, V30, P1556, DOI 10.1097/HJH.0b013e3283552735
   Nakase T, 2013, J STROKE CEREBROVASC, V22, P406, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.005
   O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964
   Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070
   Palatini P, 2014, HYPERTENSION, V64, P487, DOI 10.1161/HYPERTENSIONAHA.114.03694
   PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402
   Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1
   Park JB, 2015, HYPERTENS RES, V38, P227, DOI 10.1038/hr.2014.169
   Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433
   Rakugi H, 2015, J HYPERTENS, V33, P2165, DOI 10.1097/HJH.0000000000000668
   Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X
   Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179
   Shibasaki S, 2015, AM J HYPERTENS, V28, P1098, DOI 10.1093/ajh/hpu295
   Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]
   Shirasaki O, 2011, HYPERTENS RES, V34, P922, DOI 10.1038/hr.2011.52
   Tanaka E, 2014, STROKE, V45, P2275, DOI 10.1161/STROKEAHA.114.005420
   Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048
   Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858
   Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681
   Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145
   Yoshida T, 2016, J AM SOC HYPERTENS, V10, P201, DOI 10.1016/j.jash.2016.01.013
NR 87
TC 8
Z9 8
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 456
EP 467
DI 10.4070/kcj.2016.46.4.456
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500003
PM 27482253
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, J
   Park, SK
   Park, TS
   Kim, JH
   Yun, E
   Kim, SP
   Lee, HW
   Oh, JH
   Choi, JH
   Cha, KS
   Hong, TJ
   Lee, SY
   Lee, HC
AF Ahn, Jinhee
   Park, Seo Kwang
   Park, Tae Sik
   Kim, Jin Hee
   Yun, Eunyoung
   Kim, Sang-Pil
   Lee, Hye Won
   Oh, Jun-Hyok
   Choi, Jung Hyun
   Cha, Kwang Soo
   Hong, Taek Jong
   Lee, Sang Yeoup
   Lee, Han Cheol
TI Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary
   Atherosclerosis in Statin Treated Patients Undergoing Percutaneous
   Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE n-3 polyunsaturated fatty acids; Atherosclerosis; Coronary artery
   disease; Statin
ID CARDIOVASCULAR OUTCOMES; FISH CONSUMPTION; DOUBLE-BLIND;
   OMEGA-3-FATTY-ACIDS; RISK; METAANALYSIS; PROGRESSION; PREVENTION;
   THERAPY; DISEASE
AB Background and Objectives: Statins remain the mainstay of secondary coronary artery disease (CAD) prevention, but n-3 polyunsaturated fatty acids (omega-3 PUFA) display biological effects that may also reduce the risk of atherosclerosis and CAD. However, data on the possible antiatherosclerotic benefits of adding omega-3 PUFA to statin therapy are limited. This study aimed to investigate the potential additive effects of omega-3 PUFA on regression of atherosclerosis in CAD patients receiving statin therapy and stent implantation.
   Subjects and Methods: Seventy-four CAD patients undergoing percutaneous coronary intervention (PCI) with stent implantation were enrolled, prescribed statins, and randomly assigned to two groups: n-3 group (omega-3 PUFA 3 g/day, n=38) or placebo group (placebo, n=36). All patients completed the study follow-up consisting of an intravascular ultrasound at baseline and at 12 months.
   Results: There was no difference in the baseline characteristics and distribution of other medications. No significant differences were observed in primary endpoints, including changes in atheroma volume index (-12.65% vs. -8.51%, p=0.768) and percent atheroma volume (-4.36% vs. -9.98%, p=0.526), and in secondary endpoints including a change in neointimal volume index (7.84 vs. 4.94 mm(3)/mm, p=0.087).
   Conclusion: omega-3 PUFA had no definite additional effect on the regression of coronary atherosclerosis when added to statin in CAD patients undergoing PCI.
C1 [Ahn, Jinhee; Park, Seo Kwang; Park, Tae Sik; Lee, Hye Won; Oh, Jun-Hyok; Choi, Jung Hyun; Cha, Kwang Soo; Hong, Taek Jong; Lee, Han Cheol] Pusan Natl Univ Hosp, Dept Internal Med, Div Cardiol, 179 Gudeok Ro, Busan 49241, South Korea.
   [Kim, Jin Hee] Pusan Natl Univ Hosp, Busan Med Ctr, Dept Internal Med, Busan, South Korea.
   [Yun, Eunyoung] Pusan Natl Univ Hosp, Dept Biostat, Busan, South Korea.
   [Kim, Sang-Pil] Pusan Natl Univ Hosp, Dept Cardiovasc Surg, Busan, South Korea.
   [Lee, Sang Yeoup] Pusan Natl Univ, Yangsan Hosp, Family Med Clin, Yangsan, South Korea.
   [Lee, Sang Yeoup] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.
   [Lee, Sang Yeoup] Pusan Natl Univ, Sch Med, Med Educ Unit, Yangsan, South Korea.
   [Lee, Sang Yeoup] Pusan Natl Univ, Sch Med, Med Res Inst, Yangsan, South Korea.
RP Lee, HC (corresponding author), Pusan Natl Univ Hosp, Dept Internal Med, Div Cardiol, 179 Gudeok Ro, Busan 49241, South Korea.
EM glaraone@hanmail.net
RI Lee, Sang Yeoup/AAV-2125-2020
FU Pusan National University HospitalPusan National University
FX This work was supported by clinical research grant from Pusan National
   University Hospital in 2016.
CR Amano T, 2011, ATHEROSCLEROSIS, V218, P110, DOI 10.1016/j.atherosclerosis.2011.05.030
   Arnesen H, 2001, LIPIDS, V36, pS103, DOI 10.1007/s11745-001-0690-z
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859
   Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539
   Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119
   Casula M, 2013, ATHEROSCLEROSIS SUPP, V14, P243, DOI 10.1016/S1567-5688(13)70005-9
   Cawood AL, 2010, ATHEROSCLEROSIS, V212, P252, DOI 10.1016/j.atherosclerosis.2010.05.022
   Chang CL, 2010, ARTERIOSCL THROM VAS, V30, P2510, DOI 10.1161/ATVBAHA.110.215848
   CHARNOCK JS, 1992, MOL CELL BIOCHEM, V116, P19, DOI 10.1007/BF01270564
   Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603
   Lee E, 2008, BRIT J NUTR, V100, P609, DOI 10.1017/S0007114508925435
   Leon H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2931
   Longo D. L., 2012, HARRISONS PRINCIPLES, P1983
   Maki KC, 2013, CLIN THER, V35, P1400, DOI 10.1016/j.clinthera.2013.07.420
   Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604
   Massaro M, 2010, CARDIOVASC THER, V28, pe13, DOI 10.1111/j.1755-5922.2010.00211.x
   Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063
   Nakajima K, 2011, ARTERIOSCL THROM VAS, V31, P1963, DOI 10.1161/ATVBAHA.111.229443
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   Nozue T, 2013, AM J CARDIOVASC DIS, V3, P255
   O'Keefe JH, 2006, AM J CARDIOL, V97, P1127, DOI 10.1016/j.amjcard.2005.11.025
   Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562
   Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3
   Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8
   Valagussa F, 1999, LANCET, V354, P447
   Wu JHY, 2014, HEART, V100, P530, DOI 10.1136/heartjnl-2013-305257
NR 29
TC 6
Z9 6
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 481
EP 489
DI 10.4070/kcj.2016.46.4.481
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500006
PM 27482256
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, JE
   Lee, WS
   Mintz, GS
   Hong, YJ
   Lee, SY
   Kim, KS
   Hahn, JY
   Kumar, KS
   Won, H
   Hyeon, SH
   Shin, SY
   Lee, KJ
   Kim, TH
   Kim, CJ
   Kim, SW
AF Kwon, Jee Eun
   Lee, Wang Soo
   Mintz, Gary S.
   Hong, Young Joon
   Lee, Sung Yun
   Kim, Ki Seok
   Hahn, Joo-Yong
   Kumar, Kaup Sharath
   Won, Hoyoun
   Hyeon, Seong Hyeop
   Shin, Seung Yong
   Lee, Kwang Je
   Kim, Tae Ho
   Kim, Chee Jeong
   Kim, Sang Wook
TI Multimodality Intravascular Imaging Assessment of Plaque Erosion versus
   Plaque Rupture in Patients with Acute Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Optical coherence tomography; Atherosclerotic plaque; Acute coronary
   syndrome
ID OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; CULPRIT
   LESION MORPHOLOGY; THIN-CAP FIBROATHEROMA; SPATIAL-DISTRIBUTION;
   ULTRASOUND; ACQUISITION; THROMBOSIS; DEATH; VALIDATION
AB Background and Objectives: We assessed plaque erosion of culprit lesions in patients with acute coronary syndrome in real world practice.
   Subjects and Methods: Culprit lesion plaque rupture or plaque erosion was diagnosed with optical coherence tomography (OCT). Intravascular ultrasound (IVUS) was used to determine arterial remodeling. Positive remodeling was defined as a remodeling index (lesion/reference EEM [external elastic membrane area) > 1.05.
   Results: A total of 90 patients who had plaque rupture showing fibrous-cap discontinuity and ruptured cavity were enrolled. 36 patients showed definite OCT-plaque erosion, while 7 patients had probable OCT-plaque erosion. Overall, 26% (11/43) of definite/probable plaque erosion had non-ST elevation myocardial infarction (NSTEMI) while 35% (15/43) had ST elevation myocardial infarction (STEMI). Conversely, 14.5% (13/90) of plaque rupture had NSTEMI while 71% (64/90) had STEMI (p<0.0001). Among plaque erosion, white thrombus was seen in 55.8% (24/43) of patients and red thrombus in 27.9% (12/43) of patients. Compared to plaque erosion, plaque rupture more often showed positive remodeling (p=0.003) with a larger necrotic core area examined by virtual histology (VH)-IVUS, while negative remodeling was prominent in plaque erosion. Overall, 65% 28/43 of plaque erosions were located in the proximal 30 mm of a culprit vessel-similar to plaque ruptures (72%, 65/90, p=0.29).
   Conclusion: Although most of plaque erosions show nearly normal coronary angiogram, modest plaque burden with negative remodeling and an uncommon fibroatheroma might be the nature of plaque erosion. Multimodality intravascular imaging with OCT and VH-IVUS showed fundamentally different pathoanatomic substrates underlying plaque rupture and erosion.
C1 [Kwon, Jee Eun; Lee, Wang Soo; Kumar, Kaup Sharath; Won, Hoyoun; Hyeon, Seong Hyeop; Shin, Seung Yong; Lee, Kwang Je; Kim, Tae Ho; Kim, Chee Jeong; Kim, Sang Wook] Chung Ang Univ Hosp, Coll Med, Cardiovasc Arrhythmia Ctr, Heart Res Inst, 102 Heukseok Ro, Seoul 06973, South Korea.
   [Mintz, Gary S.] Cardiovasc Res Fdn, New York, NY USA.
   [Hong, Young Joon] Chonnam Natl Univ Hosp, Gwangju, South Korea.
   [Lee, Sung Yun] Inje Univ, Ilsan Paik Hosp, Koyang, South Korea.
   [Kim, Ki Seok] Jeju Natl Univ Hosp, Jeju, South Korea.
   [Hahn, Joo-Yong] Samsung Med Ctr, Seoul, South Korea.
RP Lee, WS (corresponding author), Chung Ang Univ Hosp, Coll Med, Cardiovasc Arrhythmia Ctr, Heart Res Inst, 102 Heukseok Ro, Seoul 06973, South Korea.
EM wslee1227@cau.ac.kr
RI Hahn, Joo-Yong/AAU-7250-2020; Shin, Seung Yong/AAF-7226-2019
OI Hahn, Joo-Yong/0000-0002-4412-377X; Shin, Seung
   Yong/0000-0002-3408-6899; Kim, Sang-Wook/0000-0002-7208-8596
CR Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110
   Cho YK, 2015, KOREAN CIRC J, V45, P87, DOI 10.4070/kcj.2015.45.2.87
   Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354
   Fujii K, 2008, J AM COLL CARDIOL, V52, P787, DOI 10.1016/j.jacc.2008.05.030
   Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29
   Hang YJ, 2015, KOREAN CIRC J, V45, P259, DOI 10.4070/kcj.2015.45.4.259
   Hayashi T, 2005, AM HEART J, V149, P284, DOI 10.1016/j.ahj.2004.06.020
   Hong MK, 2005, J AM COLL CARDIOL, V46, P261, DOI 10.1016/j.jacc.2005.03.067
   Inaba S, 2014, JACC-CARDIOVASC IMAG, V7, P70, DOI 10.1016/j.jcmg.2013.10.007
   Ino Y, 2011, JACC-CARDIOVASC INTE, V4, P76, DOI 10.1016/j.jcin.2010.09.022
   Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69
   Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071
   Kim SW, 2012, AM J CARDIOL, V109, P794, DOI 10.1016/j.amjcard.2011.10.042
   Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007
   Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
   Kume T, 2009, CIRC J, V73, P1086, DOI 10.1253/circj.CJ-08-0733
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Rathore S, 2012, ATHEROSCLEROSIS, V221, P405, DOI 10.1016/j.atherosclerosis.2011.10.018
   Sanidas EA, 2011, AM J CARDIOL, V107, P1285, DOI 10.1016/j.amjcard.2010.12.037
   Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598
   Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079
   Toutouzas K, 2012, EUROINTERVENTION, V8, P477, DOI 10.4244/EIJV8I4A75
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
   Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6
NR 24
TC 18
Z9 18
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 499
EP 506
DI 10.4070/kcj.2016.46.4.499
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500008
PM 27482258
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SW
   Kim, HC
   Lee, HS
   Suh, I
AF Lee, Seung Won
   Kim, Hyeon Chang
   Lee, Hye Sun
   Suh, Il
TI Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cerebrovascular disorders; Stroke; Mortality; Trends; Korea
ID STROKE MORTALITY; SECULAR TRENDS; RISK-FACTORS; METAANALYSIS; DECLINE;
   COUNTRIES; BURDEN; ADULTS
AB Background and Objectives: Cerebrovascular disease is a leading cause of mortality and morbidity in Korea. Understanding of cerebrovascular disease mortality trends is important to reduce the health burden from cerebrovascular diseases. We examined the changing pattern of mortality related to cerebrovascular disease in Korea over 30 years from 1983 to 2012.
   Subjects and Methods: Numbers of deaths from cerebrovascular disease, hemorrhagic stroke, and cerebral infarction were obtained from the national Cause of Death Statistics. Crude and age-adjusted mortality rates were calculated for men and women for each year. Penalized B-spline methods, which reduce bias and variability in curve fitting, were used to identify the trends of 30-year mortality and identify the year of highest mortality.
   Results: During the 30 years, cerebrovascular disease mortality has markedly declined. The age-adjusted cerebrovascular disease mortality rate has decreased by 78% in men and by 68% in women. In the case of hemorrhagic stroke, crude mortality peaked in 2001 but age-adjusted mortality peaked in 1994. Between 1994 and 2012, age-adjusted mortality from hemorrhagic stroke has decreased by 68% in men and 59% in women. In the case of cerebral infarction, crude and age-adjusted mortality rates steeply increased until 2004 and 2003, respectively, and both rates decreased rapidly thereafter.
   Conclusion: Cerebrovascular disease mortality rate has significantly decreased over the last 30 years in Korea, but remains a health burden. The prevalence of major cardiovascular risk factors are still highly prevalent in Korea.
C1 [Lee, Seung Won] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.
   [Lee, Seung Won; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.
   [Kim, Hyeon Chang; Suh, Il] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019; Lee, Hye Sun/J-2154-2015
OI Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Hye Sun/0000-0001-6328-6948;
   Suh, Il/0000-0002-9689-7849
FU Korean Health Technology R&D Project, Ministry of Health Welfare, Korea
   [HI13C0715]
FX This work was supported by the Korean Health Technology R&D Project,
   Ministry of Health & Welfare, Korea (HI13C0715).
CR BONITA R, 1989, Hypertension (Dallas), V13, pI69
   Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054
   Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277
   Costa M. S., 2008, THESIS
   Deaton C, 2011, EUR J CARDIOVASC NUR, V10, pS5, DOI 10.1016/S1474-5151(11)00111-3
   GARRAWAY WM, 1983, MAYO CLIN PROC, V58, P520
   HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410
   Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2
   Jung KH, 2012, CIRC-CARDIOVASC QUAL, V5, P327, DOI 10.1161/CIRCOUTCOMES.111.963736
   Kannel W B, 1995, Hypertens Res, V18, P181, DOI 10.1291/hypres.18.181
   Kim Hyeon Chang, 2013, J Prev Med Public Health, V46, P165, DOI 10.3961/jpmph.2013.46.4.165
   Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163
   KLAG MJ, 1989, STROKE, V20, P14, DOI 10.1161/01.STR.20.1.14
   Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692
   Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf
   Lee KS, 2014, J PUBLIC HEALTH-UK, V36, P225, DOI 10.1093/pubmed/fdt056
   Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
   LEVER AF, 1995, J HYPERTENS, V13, P571, DOI 10.1097/00004872-199506000-00001
   Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d
   Lewington S, 2002, LANCET, V360, P1903
   Mirzaei M, 2012, J NEUROL NEUROSUR PS, V83, P138, DOI 10.1136/jnnp-2011-300408
   Neaton J D, 1993, Ann Epidemiol, V3, P493
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   Park Tai-Hwan, 2008, [Korean Journal of Stroke, 대한뇌졸중학회지], V10, P125
   Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588
   Suh I, 2001, ACTA CARDIOL, V56, P75, DOI 10.2143/AC.56.2.2005621
   THIJS L, 1992, J HYPERTENS, V10, P1103, DOI 10.1097/00004872-199210000-00001
   THOM TJ, 1994, CIRCULATION, V90, P574, DOI 10.1161/01.CIR.90.1.574
   Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904
   원태영, 2007, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V18, P256
NR 30
TC 22
Z9 23
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 507
EP +
DI 10.4070/kcj.2016.46.4.507
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500009
PM 27482259
OA Green Published
DA 2021-04-22
ER

PT J
AU Sahin, BD
   Yildirim, E
   Ipek, E
   Cengiz, M
   Aslan, K
   Poyraz, E
   Demirelli, S
   Bayantemur, M
   Ermis, E
   Ciftci, C
AF Sahin, Bingul Dilekci
   Yildirim, Erkan
   Ipek, Emrah
   Cengiz, Mahir
   Aslan, Kursat
   Poyraz, Esra
   Demirelli, Selami
   Bayantemur, Murat
   Ermis, Emrah
   Ciftci, Cavlan
TI The Relationship between P & QT Dispersions and Presence & Severity of
   Stable Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; P wave & QT interval; Electrocardiography
ID MYOCARDIAL-INFARCTION; INTERVAL DISPERSION; CARDIAC DEATH; CORRECTED QT;
   SUDDEN-DEATH; ISCHEMIA; RISK; MORTALITY; SURVIVAL
AB Background and Objectives: The study aimed to evaluate the correlation between electrocardiographic (ECG) parameters and presence and extent of coronary artery disease (CAD) to indicate the usefulness of these parameters as predictors of severity in patients with stable CAD.
   Subjects and Methods: Two hundred fifty patients, without a history of any cardiovascular event were included in the study. The ECG parameters were measured manually by a cardiologist before coronary angiography. The patients were allocated into five groups: those with normal coronary arteries (Group 1), non-critical coronary lesions (Group 2), one, two and three vessel disease (Group 3, Group 4 and Group 5, respectively.
   Results: Group 1 had the lowest P wave dispersion (PWD) and P wave (Pmax), QT interval (QTmax), QT dispersion (QTd), corrected QT dispersion (QTcd) and QT dispersion ratio (QTdR), while the patients in group 5 had the highest values of these parameters. Gensini score and QTmax, QTd, QTcmax, QTcd, QTdR, Pmax, and PWD were positively correlated. QTdR was the best ECG parameter to differentiate group 1 and 2 from groups with significant stenosis (groups 3, 4, and 5) (area under curve [AUC] 0.846). QTdR was the best ECG parameter to detect coronary arterial narrowing lesser than 50% and greater than 50%, respectively (AUC 0.858).
   Conclusion: Presence and severity of CAD can be determined by using ECG in patients with stable CAD and normal left ventricular function.
C1 [Sahin, Bingul Dilekci; Yildirim, Erkan; Ipek, Emrah; Aslan, Kursat; Demirelli, Selami; Bayantemur, Murat; Ermis, Emrah] Erzurum Reg Training & Res Hosp, Dept Cardiol, TR-25100 Erzurum, Turkey.
   [Cengiz, Mahir] Istanbul Univ, Cerrahpasa Fac Med, Dept Internal Med, Istanbul, Turkey.
   [Poyraz, Esra] Istanbul Siyami Ersek Training & Res Hosp, Dept Cardiol, Istanbul, Turkey.
   [Ciftci, Cavlan] Istanbul Bilim Univ, Dept Cardiol, Istanbul, Turkey.
RP Sahin, BD (corresponding author), Erzurum Reg Training & Res Hosp, Dept Cardiol, TR-25100 Erzurum, Turkey.
EM bng_dlkc@hotmail.com
RI Cengiz, Mahir/A-6417-2019; IPEK, EMRAH/V-6806-2019; Yildirim,
   Erkan/Q-9702-2019; Ermis, Emrah/ABB-7141-2020; Cengiz, Mahir/C-4995-2015
OI Cengiz, Mahir/0000-0003-3343-8650; IPEK, EMRAH/0000-0002-5439-1970;
   Cengiz, Mahir/0000-0003-3343-8650
CR Akyuz A, 2013, KOREAN CIRC J, V43, P655, DOI 10.4070/kcj.2013.43.10.655
   Batur MK, 1999, CLIN CARDIOL, V22, P103
   Beaubien ER, 2002, AM J KIDNEY DIS, V39, P834, DOI 10.1053/ajkd.2002.32005
   DAY CP, 1990, BRIT HEART J, V63, P342
   DAY CP, 1992, BRIT HEART J, V67, P39
   Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4
   Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094
   Elsasser A, 1997, CIRCULATION, V96, P2920, DOI 10.1161/01.CIR.96.9.2920
   EMOND M, 1994, CIRCULATION, V90, P2645, DOI 10.1161/01.CIR.90.6.2645
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Glancy JM, 1996, INT J CARDIOL, V57, P55, DOI 10.1016/S0167-5273(96)02732-5
   HIGHAM PD, 1995, BRIT HEART J, V73, P32
   HULL SS, 1990, J AM COLL CARDIOL, V16, P978, DOI 10.1016/S0735-1097(10)80351-1
   KANNEL WB, 1975, CIRCULATION, V51, P606, DOI 10.1161/01.CIR.51.4.606
   Kautzner J, 1997, PACE, V20, P2625, DOI 10.1111/j.1540-8159.1997.tb06112.x
   Lowe MD, 1997, LANCET, V349, P1175, DOI 10.1016/S0140-6736(05)63054-1
   Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602
   Naas AAO, 1998, BRIT MED J, V316, P745, DOI 10.1136/bmj.316.7133.745
   Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5
   SANZ G, 1982, NEW ENGL J MED, V306, P1065, DOI 10.1056/NEJM198205063061801
   Savelieva I, 1999, PACE, V22, P885
   Sporton SC, 1997, LANCET, V349, P306, DOI 10.1016/S0140-6736(96)06143-0
   TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583
   ZAREBA W, 1994, AM J CARDIOL, V74, P550, DOI 10.1016/0002-9149(94)90742-0
NR 26
TC 3
Z9 3
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 522
EP 529
DI 10.4070/kcj.2016.46.4.522
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500011
PM 27482261
OA Green Published
DA 2021-04-22
ER

PT J
AU Yaman, M
   Arslan, U
   Beton, O
   Asarcikli, LD
   Aksakal, A
   Dogdu, O
AF Yaman, Mehmet
   Arslan, Ugur
   Beton, Osman
   Asarcikli, Lale Dinc
   Aksakal, Aytekin
   Dogdu, Orhan
TI Atrial Electromechanical Coupling in Patients with Lichen Planus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lichen planus; Echocardiography; Electrocardiography
ID TISSUE DOPPLER-ECHOCARDIOGRAPHY; P-WAVE DISPERSION;
   EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; DELAY; FIBRILLATION; PSORIASIS;
   GUIDELINES; CARDIOLOGY; BRANCH
AB Background and objectives: A chronic inflammatory disease, lichen planus may cause disturbance of atrial electromechanical coupling and increase the risk of atrial fibrillation. The aim of this study was to evaluate atrial electromechanical delay with both electrocardiography (ECG) and echocardiography in patients with lichen planus (LP).
   Subjects and Methods: Seventy-two LP patients (43 males [59.7%], mean age: 44.0 +/- 16.7 years) were enrolled in this cross-sectional case-control study. The control group was selected in a 1: 1 ratio from 70 patients in an age and sex matched manner. P wave dispersion was measured by ECG to show atrial electromechanical delay. All of the patients underwent transthoracic echocardiography for measuring inter-and intra-atrial electromechanical delays.
   Results: The baseline characteristics of the patients and the control group were similar except for the presence of LP. P-wave dispersion measured by ECG was significantly higher in patients with LP (p<0.001). Patients with LP had significantly prolonged intra- and interatrial electromechanical delays when compared to the control group (p<0.001). In addition, all of these variables were significantly correlated with high sensitive C-reactive protein (hsCRP) levels.
   Conclusion: Atrial electromechanical coupling, which is significantly correlated with increased hsCRP levels, is impaired in patients with LP.
C1 [Yaman, Mehmet; Arslan, Ugur; Aksakal, Aytekin] Samsun Educ & Res Hosp, Dept Cardiol, Samsun, Turkey.
   [Beton, Osman; Asarcikli, Lale Dinc] Diskapi Educ & Res Hosp, Dept Cardiol, Ankara, Turkey.
   [Dogdu, Orhan] Firat Univ, Dept Cardiol, Fac Med, Elazig, Turkey.
RP Arslan, U (corresponding author), Samsun Educ & Res Hosp, Dept Cardiol, Baris Bulvari 199, Ilkadim Samsun, Turkey.
EM ugurarslan5@yahoo.com
RI Arslan, Ugur/F-4993-2014
OI Arslan, Ugur/0000-0001-8572-3571
CR Acar G, 2009, TURK KARDIYOL DERN A, V37, P447
   Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285
   Ari H, 2013, CARDIOL J, V20, P639, DOI 10.5603/CJ.2013.0164
   Arias-Santiago S, 2011, J EUR ACAD DERMATOL, V25, P1398, DOI 10.1111/j.1468-3083.2011.03983.x
   Arias-Santiago S, 2011, AM J MED, V124, P543, DOI 10.1016/j.amjmed.2010.12.025
   Bacaksiz A, 2013, UPSALA J MED SCI, V118, P35, DOI 10.3109/03009734.2012.744372
   Calik AN, 2014, CARDIOL J, V21, P138, DOI 10.5603/CJ.a2013.0106
   Deniz A, 2014, HERZ, V39, P137, DOI 10.1007/s00059-013-3795-1
   Deniz A, 2009, ECHOCARDIOGR-J CARD, V26, P779, DOI 10.1111/j.1540-8175.2008.00881.x
   Flammer AJ, 2012, EUR HEART J, V33, P1989, DOI 10.1093/eurheartj/ehr425
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Michelucci Antonio, 2002, Card Electrophysiol Rev, V6, P215, DOI 10.1023/A:1016368723033
   Middel P, 2000, PATHOBIOLOGY, V68, P291, DOI 10.1159/000055940
   Nar G, 2015, ECHOCARDIOGR-J CARD, V32, P1359, DOI 10.1111/echo.12855
   Ozer N, 2005, J AM SOC ECHOCARDIOG, V18, P945, DOI 10.1016/j.echo.2005.01.015
   Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010
   Sahin M, 2014, HERZ, V39, P749, DOI 10.1007/s00059-013-3898-8
   Sahin M, 2013, CLINICS, V68, P846, DOI 10.6061/clinics/2013(06)20
   Simsek H, 2010, CLINICS, V65, P1067, DOI 10.1590/S1807-59322010001100001
NR 19
TC 0
Z9 0
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 530
EP 535
DI 10.4070/kcj.2016.46.4.530
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500012
PM 27482262
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SY
   Kim, S
   Lee, CK
   Cho, EJ
   Cho, SJ
   Lee, SC
AF Jang, Shin Yi
   Kim, Sujin
   Lee, Chang Kwan
   Cho, Eun Jeong
   Cho, Soo Jin
   Lee, Sang-Chol
TI Prehypertension and Left Ventricular Diastolic Dysfunction in
   Middle-Aged Koreans
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prehypertension; Ventricular dysfunction, left; Echocardiography;
   Middle-aged
ID AORTIC ELASTIC PROPERTIES; BLOOD-PRESSURE; EARLY HYPERTENSION; OBESITY;
   COHORT; ECHOCARDIOGRAPHY; RECOMMENDATIONS; ASSOCIATION; COMMITTEE;
   DISEASE
AB Background and Objectives: Left ventricular diastolic dysfunction is known to be a marker of myocardial damage, in particular myocardial fibrosis resulting from hypertension (HT). However, few studies have shown an association between the grade of diastolic dysfunction and blood pressure classification. We investigated the association between diastolic dysfunction and prehypertension (preHT) in apparently healthy adults who underwent routine health examinations.
   Subjects and Methods: The study sample included 4261 Koreans, 45 to 64 years of age with no previous history of HT, diabetes mellitus, malignancy, proven coronary artery disease, or valvular heart disease based on echocardiography, who underwent routine health examinations including echocardiography. The subjects were classified into three groups based on resting blood pressure: prehypertensive, hypertensive, and normotensive.
   Results: The prevalence of preHT in our study was 42.1%. After adjusting for age, gender, smoking status, alcohol consumption, fasting blood sugar, serum lipid profile, and body mass index, left ventricular diastolic dysfunction grades 1 and 2 were significantly more frequent in subjects with preHT (odds ratio [OR] 1.66 [95% confidence interval {CI} 1.40-1.96] and 1.37 [95% CI 0.95-1.97], respectively). When analyzed according to gender, the increased OR was especially notable in males.
   Conclusion: Left ventricular diastolic dysfunction appears to be significantly associated with preHT in Korean middle-aged males.
C1 [Jang, Shin Yi; Kim, Sujin; Lee, Sang-Chol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea.
   [Lee, Chang Kwan] KC Univ, Dept Nursing, Seoul, South Korea.
   [Cho, Eun Jeong] Natl Canc Ctr, Div Cardiol, Dept Internal Med, Cardiol Clin, Goyang, South Korea.
   [Cho, Soo Jin] Sungkyunkwan Univ, Hlth Promot Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea.
RP Lee, SC (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Med,Sch Med, Imaging Ctr,Heart Vasc Stroke Inst,Samsung Med Ct, 81 Irwon Ro, Seoul 06351, South Korea.
EM sc.lea@samsung.com
FU Samsung Medical Center grant [SM0113-15-01]
FX This study was supported by Samsung Medical Center grant [#
   SM0113-15-01].
CR Ahn HS, 2006, KOREAN CIRC J, V36, P437
   Almuntaser I, 2007, AM J CARDIOL, V100, P1771, DOI 10.1016/j.amjcard.2007.07.029
   Almuntaser I, 2009, AM J HYPERTENS, V22, P1227, DOI 10.1038/ajh.2009.173
   Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388
   Celentano A., 1996, Blood Pressure, V5, P29
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Eisenmann JC, 2006, PREV MED, V42, P329, DOI 10.1016/j.ypmed.2006.02.002
   Erdogan D, 2007, BLOOD PRESSURE, V16, P114, DOI 10.1080/08037050701395910
   Erdogan D, 2006, BLOOD PRESS MONIT, V11, P191, DOI 10.1097/01.mbp.0000209079.17246.7d
   Fenk S, 2015, INT HEART J, V56, P196, DOI 10.1536/ihj.14-261
   Jang SY, 2014, J KOREAN MED SCI, V29, P798, DOI 10.3346/jkms.2014.29.6.798
   Jang SY, 2012, J PUBLIC HEALTH-UK, V34, P562, DOI 10.1093/pubmed/fds033
   Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8
   Li Xi, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P469
   Mainous AG, 2004, AM J CARDIOL, V94, P1496, DOI 10.1016/j.amjcard.2004.08.026
   MILLER TR, 1986, AM J CARDIOL, V58, P531, DOI 10.1016/0002-9149(86)90028-7
   Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007
   Regenauer A, 2008, Versicherungsmedizin, V60, P32
   Russo C, 2012, HYPERTENSION, V60, P362, DOI 10.1161/HYPERTENSIONAHA.112.191148
   Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042
   Schulz R, 2010, GESUNDHEITSWESEN, V72, P88, DOI 10.1055/s-0029-1214402
   Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1
   Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x
   Zabalgoitia N, 1997, J HYPERTENS, V15, P1175, DOI 10.1097/00004872-199715100-00016
NR 27
TC 5
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 536
EP +
DI 10.4070/kcj.2016.46.4.536
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500013
PM 27482263
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, BY
   Kim, D
   Kim, YH
   Ryoo, E
   Sun, YH
   Jeon, IS
   Jung, MJ
   Cho, HK
   Tchah, H
   Choi, DY
   Kim, NY
AF Kim, Bo Young
   Kim, Dongwan
   Kim, Yong Hyun
   Ryoo, Eell
   Sun, Yong Han
   Jeon, In-sang
   Jung, Mi-Jin
   Cho, Hye Kyung
   Tchah, Hann
   Choi, Deok Young
   Kim, Na Yeon
TI Non-Responders to Intravenous Immunoglobulin and Coronary Artery
   Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Intravenous immunoglobulins; Coronary arteries;
   Children
ID GAMMA-GLOBULIN TREATMENT; RISK-FACTORS; THERAPY; RESISTANCE; ANEURYSMS;
   RETREATMENT; FAILURE
AB Background and Objectives: In Kawasaki disease (KD), high dose intravenous immunoglobulin (IVIG) significantly lowers the coronary complications. However, some patients either do not respond to initial therapy or develop coronary complications. We aimed to identify the predictive factors for unresponsiveness to initial IVIG therapy and coronary artery dilatation (CAD; defined by Z-score >= 2.5) in the acute phase and convalescent phase.
   Subjects and Methods: A retrospective review was conducted of 703 patients with KD, admitted to Gachon University Gil Medical Center between January 2005 and June 2013. The patients were divided into two groups-IVIG responders vs. non-responders-based on the IVIG treatments, and presence of fever after treatment. Further, these groups were divided into two subgroups based on their CAD.
   Results: Among the 703 patients with KD, the rate of non-responders to initial IVIG was 16.8%. Serum total bilirubin, platelet count, and neutrophil proportion were independent predictive parameters of unresponsiveness (p<0.05). CAD was found in 234 patients (33.3%) in the acute phase, and in 32 patients (4.6%) in the convalescent phase. Male gender, fever duration, serum C-reactive protein, and white blood cell count were related to CAD (p<0.05). CAD was detected more frequently in non-responders than in the responders (47.5% vs. 31.5%, p=0.001). Kobayashi, Egami, and Sano scoring systems applied to our study population reflected low sensitivities (28.0-33.9%).
   Conclusion: Several independent parameters were related to unresponsiveness to the initial IVIG or CAD. These parameters might be helpful in establishing more focused and careful monitoring of high-risk KD patients in Korea.
C1 [Kim, Bo Young; Kim, Dongwan; Kim, Yong Hyun; Ryoo, Eell; Sun, Yong Han; Jeon, In-sang; Jung, Mi-Jin; Cho, Hye Kyung; Tchah, Hann; Choi, Deok Young; Kim, Na Yeon] Gachon Univ, Dept Pediat, Gil Med Ctr, Inchon, South Korea.
   [Kim, Na Yeon] Bundang Cheil Womans Hosp, Dept Pediat, 27 Seohyeon Ro 180 Beon Gil, Songnam 13590, South Korea.
RP Kim, NY (corresponding author), Bundang Cheil Womans Hosp, Dept Pediat, 27 Seohyeon Ro 180 Beon Gil, Songnam 13590, South Korea.
EM nakim2016.5@gmail.com
CR Ashouri N, 2008, J PEDIATR-US, V153, P365, DOI 10.1016/j.jpeds.2008.03.014
   Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Cha S, 2008, J KOREAN MED SCI, V23, P718, DOI 10.3346/jkms.2008.23.4.718
   Chen SJ, 2013, HEART, V99, P76, DOI 10.1136/heartjnl-2012-302126
   Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328
   Dallaire F, 2011, J AM SOC ECHOCARDIOG, V24, P60, DOI 10.1016/j.echo.2010.10.004
   Do Young-Sun, 2010, Korean Circ J, V40, P239, DOI 10.4070/kcj.2010.40.5.239
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   Fu PP, 2013, PEDIATR INFECT DIS J, V32, pE319, DOI 10.1097/INF.0b013e31828e887f
   Gersony WM, 1998, AM J CARDIOL, V81, P1162, DOI 10.1016/S0002-9149(98)00115-5
   Honkanen VEA, 2003, PEDIATR CARDIOL, V24, P122, DOI 10.1007/s00246-002-0063-1
   Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x
   Kawai H, 2015, HEART VESSELS, V30, P549, DOI 10.1007/s00380-014-0541-4
   Kawasaki T, 1967, Arerugi, V16, P178
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   KOREN G, 1986, J PEDIATR-US, V108, P388, DOI 10.1016/S0022-3476(86)80878-2
   Manlhiot C, 2010, PEDIATR CARDIOL, V31, P242, DOI 10.1007/s00246-009-9599-7
   Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x
   Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182
   Ogata S, 2012, PEDIATRICS, V129, pE17, DOI 10.1542/peds.2011-0148
   Park Hyo Min, 2013, Korean J Pediatr, V56, P75, DOI 10.3345/kjp.2013.56.2.75
   박민지, 2009, Clinical and Experimental Pediatrics, V52, P1161
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Singh S, 2014, INDIAN J PEDIATR, V81, P328, DOI 10.1007/s12098-013-1229-y
   Sleeper LA, 2011, J PEDIAT, V269
   Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021
   Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78
   최명현, 2014, Pediatric Infection and Vaccine, V21, P29
NR 30
TC 16
Z9 17
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 542
EP 549
DI 10.4070/kcj.2016.46.4.542
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500014
PM 27482264
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, YM
   Yun, HW
   Kim, SH
AF Yoon, You Min
   Yun, Hye Won
   Kim, Sung Hye
TI Clinical Characteristics of Kawasaki Disease in Infants Younger than Six
   Months: A Single-Center Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Complications; Coronary arteries; Infant
ID NATIONWIDE SURVEY; PREDICTORS; DIAGNOSIS; AGE
AB Background and Objectives: Kawasaki disease (KD) is the leading cause of acquired heart disease, which predominantly occurs in children under the age of 5 years. However, there are fewer cases of KD in infants younger than 6 months, which makes it difficult to diagnose. We investigated the clinical manifestations of KD in this age group and compared them with those in the older age group.
   Subjects and Methods: We retrospectively reviewed the medical records of 239 patients with KD admitted to the Hallym Sacred Heart Hospital from January 2013 to June 2015. The data were categorized into 2 groups by age: Group A (<= 6 months, n=26) and Group B (>6 months, n=213).
   Results: Group A had a longer hospitalization period than Group B (6.69 vs. 5.19 days, p=0.002). Group A had fewer clinical manifestations upon admission, due to which there was a higher incidence of incomplete KD (1.88 vs. 3.54 of the diagnostic criteria, p<0.05; and 19.2% vs. 4.2% incomplete KD incidence, p=0.002). The rate of cardiac complications was higher in Group A (30.8% vs. 11.7%, p=0.011).
   Conclusion: The rate of cardiac complications of the patients younger than 6 months was significantly higher than that of the older patients. Therefore, infants younger than 6 months with unexplained fever for more than 5 days should be suspected as having KD, even if the principal clinical features are not fully presented. Echocardiography must be appropriately used for diagnosis of KD in suspected patients.
C1 [Yoon, You Min; Yun, Hye Won; Kim, Sung Hye] Hallym Univ, Dept Pediat, Sacred Heart Hosp, 22 Gwanpyeong Ro 170 Beon Gil, Anyang, South Korea.
RP Kim, SH (corresponding author), Hallym Univ, Dept Pediat, Sacred Heart Hosp, 22 Gwanpyeong Ro 170 Beon Gil, Anyang, South Korea.
EM rohetkim@yahoo.co.kr
CR Bayers S, 2013, J AM ACAD DERMATOL, V69, DOI DOI 10.1016/J.JAAD.2013.06.040
   Bayers S, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.07.002
   BURNS JC, 1986, J PEDIATR-US, V109, P759, DOI 10.1016/S0022-3476(86)80689-8
   Chang FY, 2006, PEDIATR INFECT DIS J, V25, P241, DOI 10.1097/01.inf.0000202067.50975.90
   Chuang Chih-Hsien, 2006, Journal of Microbiology Immunology and Infection, V39, P387
   Freeman AF, 2006, AM FAM PHYSICIAN, V74, P1141
   Hangai M, 2014, EUR J PEDIATR, V173, P1533, DOI 10.1007/s00431-014-2347-x
   박용원, 2008, Clinical and Experimental Pediatrics, V51, P1320
   Jamieson N, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/645391
   JOFFE A, 1995, WESTERN J MED, V162, P322
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kim JJ, 2012, PEDIATR CARDIOL, V33, P513, DOI 10.1007/s00246-011-0143-1
   Krishna MR, 2014, CLIN PEDIATR, V53, P561, DOI 10.1177/0009922814530802
   Lee Eun Jung, 2012, Korean J Pediatr, V55, P202, DOI 10.3345/kjp.2012.55.6.202
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   No SJ, 2013, PEDIATR CARDIOL, V34, P286, DOI 10.1007/s00246-012-0440-3
   ROSENFELD EA, 1995, J PEDIATR-US, V126, P524, DOI 10.1016/S0022-3476(95)70344-6
   Sanchez-Manubens J, 2014, J AUTOIMMUN, V48-49, P113, DOI 10.1016/j.jaut.2014.01.010
   Uysal F, 2015, CLIN PEDIATR, V54, P579, DOI 10.1177/0009922814561594
   Verma P, 2015, INDIAN PEDIATR, V52, P152
   Yeo Y, 2009, EUR J PEDIATR, V168, P157, DOI 10.1007/s00431-008-0722-1
   Yeom Jung Sook, 2013, Korean J Pediatr, V56, P377, DOI 10.3345/kjp.2013.56.9.377
   Yu Jeong Jin, 2012, Korean J Pediatr, V55, P83, DOI 10.3345/kjp.2012.55.3.83
NR 23
TC 17
Z9 17
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 550
EP 555
DI 10.4070/kcj.2016.46.4.550
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500015
PM 27482265
OA Green Published
DA 2021-04-22
ER

PT J
AU Duvan, I
   Ates, MS
   Onuk, BE
   Bakkaloglu, B
   Sungur, UP
   Kurtoglu, M
   Karagoz, YH
AF Duvan, Ibrahim
   Ates, Mehmet Sanser
   Onuk, Burak Emre
   Bakkaloglu, Beyhan
   Sungur, Umit Pinar
   Kurtoglu, Murat
   Karagoz, Yahya Halidun
TI Single Stage Repair for Aortic Coarctation associated with Intracardiac
   Defects Using Extra-Anatomic Bypass Graft in Adults
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic coarctation; Associated disease; Median sternotomy; Bypass, graft
ID ASCENDING-DESCENDING BYPASS; VALVE-REPLACEMENT; MEDIAN STERNOTOMY;
   RECURRENT; LESIONS
AB Background and Objectives: Coarctation of the aorta in adulthood is generally associated with other cardiovascular disorders requiring surgical management. An extra anatomic bypass grafting from the ascending to descending aorta by posterior pericardial approach via median sternotomy could be a reasonable single stage surgical strategy for these patients.
   Subjects and Methods: Seven male patients aged between 14-41 years underwent an extra anatomic bypass grafting for coarctation repair concomitantly with the surgical management of the associated cardiovascular disorders via median sternotomy. Preoperative mean systolic arterial blood pressure was 161.8 +/- 24.5 mmHg, although the patients were under treatment of different combinations of antihypertensive agents. Additional surgical procedures were: aortic valve replacement (n=4), ventricular septal defect (VSD) closure (n=2), ascending aortic replacement (n=3) and Bentall procedure (n=1). None of our patients have been previously diagnosed or operated on for coarctation. Data were evaluated during their hospital stay and in post-operative follow-up.
   Results: The post-operative course was uneventful in all but one patient was re-operated on due to bleeding. There was neither mortality nor significant morbidity during the in-hospital period and all patients were discharged within 5-9 (mean: 6.3 +/- 1.5) days. The mean follow up period was 71.83 +/- 23 months (range: 23-95 months). Unfortunately one of our patients could not be contacted for a follow up period because of invalid personal data.
   Conclusion: Coarctation of the aorta in adulthood associated with other cardiovascular disorders can be operated on simultaneously via an extra anatomic bypass grafting technique with low morbidity and mortality.
C1 [Duvan, Ibrahim; Ates, Mehmet Sanser; Onuk, Burak Emre; Sungur, Umit Pinar; Kurtoglu, Murat; Karagoz, Yahya Halidun] Guven Hosp, Dept Cardiovasc Surg, Ankara, Turkey.
   [Bakkaloglu, Beyhan] Guven Hosp, Dept Cardiovasc Anaesthesiol, Ankara, Turkey.
RP Duvan, I (corresponding author), Guven Hosp, Dept Cardiovasc Surg, Simsek Sok 29, TR-06540 Kavaklidere, Turkey.
EM ibrahimduvan@hotmail.com
RI Ates, M. Sanser/J-9893-2017
OI Ates, Mehmet Sanser/0000-0002-4502-9670
CR Bigdeli AK, 2010, ANN THORAC SURG, V89, pE22, DOI 10.1016/j.athoracsur.2009.12.075
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   de Oliveira SA, 2003, ANN THORAC SURG, V76, P1962, DOI 10.1016/S0003-4975(03)01140-8
   EDIE RN, 1975, ANN THORAC SURG, V20, P558, DOI 10.1016/S0003-4975(10)64255-5
   Fedoruk L, 2004, J CARDIAC SURG, V19, P343, DOI 10.1111/j.0886-0440.2004.4093_11.x
   Izhar U, 2000, ANN THORAC SURG, V70, P31, DOI 10.1016/S0003-4975(00)01481-8
   Kanter KR, 2000, J THORAC CARDIOV SUR, V120, P885, DOI 10.1067/mtc.2000.110462
   Kenny D, 2011, CARDIOL J, V18, P487, DOI 10.5603/CJ.2011.0003
   Mulay AV, 1997, ANN THORAC SURG, V64, P1309, DOI 10.1016/S0003-4975(97)00814-X
   Park JH, 2012, KOREAN CIRC J, V42, P62, DOI 10.4070/kcj.2012.42.1.62
   Patel Y, 1998, THORAC CARDIOV SURG, V46, P158, DOI 10.1055/s-2007-1010216
   Pethig K, 1996, ANN THORAC SURG, V61, P1724, DOI 10.1016/0003-4975(96)00140-3
   POWELL WR, 1983, TEX HEART I J, V10, P409
   ROBICSEK F, 1992, EUR J CARDIO-THORAC, V6, P536, DOI 10.1016/1010-7940(92)90004-H
   Sun Li Zhong, 2003, Asian Cardiovasc Thorac Ann, V11, P208
   SWEENEY MS, 1985, ANN THORAC SURG, V40, P46, DOI 10.1016/S0003-4975(10)61168-X
   VIJAYANAGAR R, 1980, J THORAC CARDIOV SUR, V79, P266
   Wang R, 2010, J VASC SURG, V51, P1203, DOI 10.1016/j.jvs.2009.12.027
NR 18
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 556
EP 561
DI 10.4070/kcj.2016.46.4.556
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500016
PM 27482266
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, D
   Lee, MY
AF Kim, Dongmin
   Lee, Myung-Yong
TI Spontaneous Transition of Double Tachycardias with Atrial Fusion in a
   Patient with Wolff-Parkinson-White Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tachycardia, atrioventricular nodal reentry; Tachycardia, reciprocating;
   Tachycardia, paroxysmal; Tachycardia, supraventricular;
   Wolff-Parkinson-White syndrome
ID ACCESSORY PATHWAY; RECIPROCATING TACHYCARDIA; ABLATION; MECHANISM
AB Among patients with Wolff-Parkinson-White syndrome, atrioventricular reciprocating tachycardia (AVRT) and atrioventricular nodal reentrant tachycardia (AVNRT) can coexist in a single patient. Direct transition of both tachycardias is rare; however, it can occur after premature atrial or ventricular activity if the cycle lengths of the two tachycardias are similar. Furthermore, persistent atrial activation by an accessory pathway (AP) located outside of the AV node during ongoing AVNRT is also rare. This article describes a case of uncommon atrial activation by an AP during AVNRT and gradual transition of the two supraventricular tachycardias without any preceding atrial or ventricular activity in a patient with preexcitation syndrome.
C1 [Kim, Dongmin; Lee, Myung-Yong] Dankook Univ, Sch Med, Div Cardiol, Dept Internal Med, 119 Dandae Ro, Cheonan 31116, South Korea.
RP Lee, MY (corresponding author), Dankook Univ, Sch Med, Div Cardiol, Dept Internal Med, 119 Dandae Ro, Cheonan 31116, South Korea.
EM mel_lee@dankook.ac.kr
OI Lee, Myung Yong/0000-0003-2147-7134
CR Crawford TC, 2007, J CARDIOVASC ELECTR, V18, P698, DOI 10.1111/j.1540-8167.2007.00860.x
   Delacretaz E, 2000, J CARDIOVASC ELECTR, V11, P121, DOI 10.1111/j.1540-8167.2000.tb00748.x
   GALLAGHER JJ, 1978, PROG CARDIOVASC DIS, V20, P285, DOI 10.1016/0033-0620(78)90015-4
   Hwang C, 1997, J AM COLL CARDIOL, V30, P218, DOI 10.1016/S0735-1097(97)00114-9
   Kuo JY, 2001, J CARDIOVASC ELECTR, V12, P1339, DOI 10.1046/j.1540-8167.2001.01339.x
   Luria DM, 2001, J CARDIOVASC ELECTR, V12, P744, DOI 10.1046/j.1540-8167.2001.00744.x
   Rakovec P, 2009, EUROPACE, V11, P1563, DOI 10.1093/europace/eup256
   Tada H, 2003, J CARDIOVASC ELECTR, V14, P204, DOI 10.1046/j.1540-8167.2003.02370.x
NR 8
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 574
EP 579
DI 10.4070/kcj.2016.46.4.574
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500019
PM 27482269
OA Green Published
DA 2021-04-22
ER

PT J
AU Moradi, B
   Oraii, S
   Roshanali, F
   Ghorbanisharif, A
   Mikaeili, J
   Tahraei, M
AF Moradi, Bahieh
   Oraii, Saeed
   Roshanali, Farideh
   Ghorbanisharif, Alireza
   Mikaeili, Javad
   Tahraei, Mahmood
TI Conservative Management of Left Atrial Intramural Hematoma after
   Catheter Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart atria; Radiofrequency; Ablation; Hematoma; Complications
ID FIBRILLATION
AB Left atrial intramural hematoma is a very rare complication of radiofrequency ablation procedures. A patient with tachyarrhythmia underwent radiofrequency catheter ablation. Echocardiography performed the following morning showed a large mass in the left atrium, suggestive of intramural hematoma formation. The patient was in a stable condition; therefore, it was decided that follow-up should be conservative and her anticoagulation therapy was continued. The size of the hematoma decreased significantly over the following 50 days. This case highlights a rare complication of a complex catheter ablation procedure in the left atrium that was managed via a noninvasive approach, with which all interventionists should be familiar.
C1 [Moradi, Bahieh; Roshanali, Farideh] Day Gen Hosp, Dept Echocardiog, Vali Asr Ave,Abbaspour St, Tehran 1434873111, Iran.
   [Oraii, Saeed; Ghorbanisharif, Alireza; Mikaeili, Javad] Day Gen Hosp, Dept Electrophysiol, Tehran, Iran.
   [Tahraei, Mahmood] Day Gen Hosp, Dept Radiol, Tehran, Iran.
RP Moradi, B (corresponding author), Day Gen Hosp, Dept Echocardiog, Vali Asr Ave,Abbaspour St, Tehran 1434873111, Iran.
EM faraviolet@yahoo.com
CR Fukuhara S, 2015, INTERACT CARDIOV TH, V20, P96, DOI 10.1093/icvts/ivu317
   Gual-Capllonch F, 2010, EUR J ECHOCARDIOGR, V11, DOI 10.1093/ejechocard/jep210
   Kelly S, 2006, AM J ROENTGENOL, V186, P1317, DOI 10.2214/AJR.05.0102
   Kurek C, 2009, EUROPACE, V11, P667, DOI 10.1093/europace/eup052
   Lanfranchi Antonio, 2009, Interact Cardiovasc Thorac Surg, V9, P363, DOI 10.1510/icvts.2009.205443
   Sah R, 2007, CIRCULATION, V115, pE446, DOI 10.1161/CIRCULATIONAHA.106.684449
   Shaikh N, 1999, J AM SOC ECHOCARDIOG, V12, P1101, DOI 10.1016/S0894-7317(99)70108-2
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 580
EP 583
DI 10.4070/kcj.2016.46.4.580
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500020
PM 27482270
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, TK
   Yang, JH
   Choi, SH
AF Park, Taek Kyu
   Yang, Jeong Hoon
   Choi, Seung-Hyuk
TI Endovascular Repair Using Suture-Mediated Closure Devices and Balloon
   Tamponade following Inadvertent Subclavian Artery Catheterization with
   Large-Caliber Hemodialysis Catheter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Central venous catheterization; Hemodialysis; Complications; Vascular
   closure device
ID MANAGEMENT; PLACEMENT; INJURIES
AB Accidental subclavian artery cannulation is an uncommon but potentially serious complication of central venous catheterization. Removal of a catheter inadvertently placed in the subclavian artery can lead to substantial bleeding, as achieving hemostasis in this area through manual compression presents considerable difficulty. Additionally, surgical treatment might be unsuitable for high-risk patients due to comorbidities. Here, we report a case of an inadvertently-inserted 11.5-French hemodialysis catheter in the subclavian artery during internal jugular venous catheterization. We performed percutaneous closure of the subclavian artery using three 6-French Perclose Proglide (R) devices with a balloon tamponade in the proximal part of the subclavian artery. Closure was completed without embolic neurological complications.
C1 [Park, Taek Kyu; Yang, Jeong Hoon; Choi, Seung-Hyuk] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
RP Choi, SH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
EM cardiochoi@skku.edu
CR Abbott Vascular, 2015, PERCL PROGLIDE SUT M
   Berlet MH, 2001, CARDIOVASC INTER RAD, V24, P122, DOI 10.1007/s002700002542
   du Toit DF, 2008, J VASC SURG, V47, P739, DOI 10.1016/j.jvs.2007.11.009
   Eisen Lewis A, 2006, J Intensive Care Med, V21, P40, DOI 10.1177/0885066605280884
   Fraizer MC, 2003, CATHETER CARDIO INTE, V59, P369, DOI 10.1002/ccd.10545
   Guilbert MC, 2008, J VASC SURG, V48, P918, DOI 10.1016/j.jvs.2008.04.046
   Jahromi BS, 2009, CATHETER CARDIO INTE, V73, P706, DOI 10.1002/ccd.21884
   Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345
   Pikwer A, 2009, EUR J VASC ENDOVASC, V38, P707, DOI 10.1016/j.ejvs.2009.08.009
   Rabindranath KS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005279.pub4
   Schoder M, 2003, J ENDOVASC THER, V10, P58, DOI 10.1583/1545-1550(2003)010<0058:EAEETO>2.0.CO;2
   Wallace MJ, 2001, J VASC INTERV RADIOL, V12, P1227, DOI 10.1016/S1051-0443(07)61685-6
NR 12
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 584
EP 587
DI 10.4070/kcj.2016.46.4.584
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500021
PM 27482271
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Chun, KJ
   Lee, DS
   Lee, SY
   Hwang, J
   Chon, MK
   Hwang, KW
   Kim, JS
   Park, YH
   Kim, JH
AF Lee, Sang Hyun
   Chun, Kook Jin
   Lee, Dae Sung
   Lee, Soo Yong
   Hwang, Jongmin
   Chon, Min Ku
   Hwang, Ki Won
   Kim, Jeong Su
   Park, Yong Hyun
   Kim, June Hong
TI Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean
   Patients (vol 46, pg 207, 2016)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Lee, Sang Hyun; Chun, Kook Jin; Lee, Dae Sung; Lee, Soo Yong; Hwang, Jongmin; Chon, Min Ku; Hwang, Ki Won; Kim, Jeong Su; Park, Yong Hyun; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, Yangsan, South Korea.
RP Lee, SH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, Yangsan, South Korea.
CR Lee SH, 2016, KOREAN CIRC J, V46, P207, DOI 10.4070/kcj.2016.46.2.207
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 590
EP 590
DI 10.4070/kcj.2016.46.4.590
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500023
PM 27482273
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, MG
   Kang, S
   Kim, BR
   Baek, MY
   Park, YM
   Shin, MS
AF Kim, JinShil
   Kim, Myeong Gun
   Kang, Sewon
   Kim, Bong Roung
   Baek, Min Young
   Park, Yae Min
   Shin, Mi-Seung
TI Obesity and Hypertension in Association with Diastolic Dysfunction Could
   Reduce Exercise Capacity (vol 46, pg 394, 2016)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Kim, JinShil] Gachon Univ, Coll Nursing, Inchon, South Korea.
   [Kim, Myeong Gun; Baek, Min Young; Park, Yae Min; Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon, South Korea.
   [Kang, Sewon] Dongseo Univ, Dept Nursing, Pusan, South Korea.
   [Kim, Bong Roung] Seoul Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Park, Yae Min; Shin, Mi-Seung] Gachon Univ, Coll Med, Inchon, South Korea.
RP Kim, J (corresponding author), Gachon Univ, Coll Nursing, Inchon, South Korea.
CR Kim J, 2016, KOREAN CIRC J, V46, P394, DOI 10.4070/kcj.2016.46.3.394
NR 1
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 591
EP 591
DI 10.4070/kcj.2016.46.4.591
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500024
PM 27482274
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, SM
   Merz, CNB
AF Park, Seong-Mi
   Merz, C. Noel Bairey
TI Women and Ischemic Heart Disease: Recognition, Diagnosis and Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Women; Coronary artery disease; Myocardial ischemia; Microvascular
   angina; Guideline
ID CORONARY-ARTERY-DISEASE; SYNDROME EVALUATION WISE; MYOCARDIAL-PERFUSION;
   CHEST-PAIN; RISK STRATIFICATION; GENDER-DIFFERENCES; SEX-DIFFERENCES;
   NATIONAL-HEART; MICROVASCULAR REACTIVITY; CARDIOVASCULAR EVENTS
AB Cardiovascular disease is one of the most frequent causes of death in both males and females throughout the world. However, women exhibit a greater symptom burden, more functional disability, and a higher prevalence of nonobstructive coronary artery disease (CAD) compared to men when evaluated for signs and symptoms of myocardial ischemia. This paradoxical sex difference appears to be linked to a sex-specific pathophysiology of myocardial ischemia including coronary microvascular dysfunction, a component of the 'Yentl Syndrome'. Accordingly, the term ischemic heart disease (IHD) is more appropriate for a discussion specific to women rather than CAD or coronary heart disease. Following the National Heart, Lung, and Blood Institute Heart Truth/American Heart Association, Women's Ischemia Syndrome Evaluation and guideline campaigns, the cardiovascular mortality in women has been decreased, although significant gender gaps in clinical outcomes still exist. Women less likely undergo testing, yet guidelines indicate that symptomatic women at intermediate to high IHD risk should have further test (e.g. exercise treadmill test or stress imaging) for myocardial ischemia and prognosis. Further, women have suboptimal use of evidence-based guideline therapies compared with men with and without obstructive CAD. Anti-anginal and anti-atherosclerotic strategies are effective for symptom and ischemia management in women with evidence of ischemia and nonobstructive CAD, although more female-specific study is needed. IHD guidelines are not "cardiac catheterization" based but related to evidence of "myocardial ischemia and angina". A simplified approach to IHD management with ABCs (aspirin, angiotensin-converting enzyme inhibitors/angiotensin-renin blockers, beta blockers, cholesterol management and statin) should be used and can help to increases adherence to guidelines.
C1 [Park, Seong-Mi] Korea Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA.
RP Merz, CNB (corresponding author), Cedars Sinai Heart Ctr, Los Angeles, CA 90048 USA.
EM merz@cshs.org
FU National Heart, Lung and Blood InstitutesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [N01-HV-68161,
   N01-HV-68162, N01-HV-68163, N01-HV-68164, R01-HL-073412-01, U0164829,
   U01 HL649141, U01 HL649241]; Gustavus and Louis Pfeiffer Research
   Foundation, Danville, New Jersey; The Women's Guild of Cedars-Sinai
   Medical Center, Los Angeles, California; Ladies Hospital Aid Society of
   Western Pennsylvania, Pittsburgh, Pennsylvania,; QMED, Inc.; Laurence
   Harbor, New Jersey; Edythe L. Broad Endowment; Barbra Streisand Women's
   Cardiovascular Research and Education Program; Linda Joy Pollin Women's
   Heart Health Program; Constance Austin Fellowship Endowment,
   Cedars-Sinai Medical Center, Los Angeles; Erika Glazer Women's Heart
   Health Project, Cedars-Sinai Medical Center, Los Angeles, California;
   DIVISION OF HEART AND VASCULAR DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [N01HV068161, N01HV068161,
   N01HV068164, N01HV068164, N01HV068164, N01HV068161, N01HV068164,
   N01HV068161, N01HV068164, N01HV068164, N01HV068161] Funding Source: NIH
   RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073412,
   R01HL068162, R01HL068162, R01HL068162, R01HL073412, R01HL073412,
   R01HL073412, R01HL073412, R01HL073412] Funding Source: NIH RePORTER
FX This work was supported by contracts from the National Heart, Lung and
   Blood Institutes, nos. N01-HV-68161, N01-HV-68162, N01-HV-68163,
   N01-HV-68164, R01-HL-073412-01, grants U0164829, U01 HL649141, U01
   HL649241, and grants from the Gustavus and Louis Pfeiffer Research
   Foundation, Danville, New Jersey, The Women's Guild of Cedars-Sinai
   Medical Center, Los Angeles, California, The Ladies Hospital Aid Society
   of Western Pennsylvania, Pittsburgh, Pennsylvania, and QMED, Inc.,
   Laurence Harbor, New Jersey, and the Edythe L. Broad Endowment, the
   Barbra Streisand Women's Cardiovascular Research and Education Program,
   the Linda Joy Pollin Women's Heart Health Program, and the Constance
   Austin Fellowship Endowment, Cedars-Sinai Medical Center, Los Angeles
   and the Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical
   Center, Los Angeles, California.
CR Alexander KP, 2006, CIRCULATION, V114, P1380, DOI 10.1161/CIRCULATIONAHA.106.620815
   Alexander KP, 1998, J AM COLL CARDIOL, V32, P1657, DOI 10.1016/S0735-1097(98)00451-3
   Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305
   AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203
   Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Arruda-Olson AM, 2002, J AM COLL CARDIOL, V39, P625, DOI 10.1016/S0735-1097(01)01801-0
   AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401
   Bateman TM, 2006, J NUCL CARDIOL, V13, P24, DOI 10.1016/j.nuclcard.2005.12.004
   Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790
   Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477
   Burke Allen P., 2003, Journal of the American College of Cardiology, V41, P1874, DOI 10.1016/S0735-1097(03)00359-0
   Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110
   Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045
   Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309
   Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981
   Chen JW, 2002, AM J CARDIOL, V90, P974, DOI 10.1016/S0002-9149(02)02664-4
   Cho L, 2008, J WOMENS HEALTH, V17, P515, DOI 10.1089/jwh.2007.0443
   Chou AF, 2007, WOMEN HEALTH ISS, V17, P120, DOI 10.1016/j.whi.2007.03.002
   DeVon HA, 2008, AM J CRIT CARE, V17, P14
   DIVER DJ, 1994, AM J CARDIOL, V74, P531, DOI 10.1016/0002-9149(94)90739-0
   Dreyer RP, 2015, CIRCULATION, V131, P1971, DOI 10.1161/CIRCULATIONAHA.114.014503
   Eriksson BE, 2000, J AM COLL CARDIOL, V36, P1619, DOI 10.1016/S0735-1097(00)00931-1
   Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013
   Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056
   Gargiulo P, 2011, EUR J NUCL MED MOL I, V38, P2040, DOI 10.1007/s00259-011-1891-0
   Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124
   Glaser R, 2006, AM J CARDIOL, V98, P1446, DOI 10.1016/j.amjcard.2006.06.044
   Gluckman TJ, 2005, JAMA-J AM MED ASSOC, V293, P349, DOI 10.1001/jama.293.3.349
   Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50
   HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408
   Hendrix Katharine H, 2005, Ethn Dis, V15, P11
   HJALMARSON A, 1981, LANCET, V2, P823
   Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402
   Johnson BD, 2006, EUR HEART J, V27, P1408, DOI 10.1093/eurheartj/ehl040
   Johnson BD, 2004, CONTEMP CARDIOL, P129
   Johnston N, 2011, EUR HEART J, V32, P1331, DOI 10.1093/eurheartj/ehr009
   Kay J, 2013, J AM COLL CARDIOL, V62, P1866, DOI 10.1016/j.jacc.2013.06.017
   Kayikcioglu M, 2003, EUR HEART J, V24, P1999, DOI 10.1016/S0195-668X(03)00478-0
   KEMP HG, 1986, J AM COLL CARDIOL, V7, P479, DOI 10.1016/S0735-1097(86)80456-9
   Kothawade K, 2011, CURR PROB CARDIOLOGY, V36, P291, DOI 10.1016/j.cpcardiol.2011.05.002
   LaBresh KA, 2003, CIRCULATION, V108, P722
   Lanza GA, 1999, AM J CARDIOL, V84, P854, DOI 10.1016/S0002-9149(99)00450-6
   Lee DH, 2012, KOREAN CIRC J, V42, P692, DOI 10.4070/kcj.2012.42.10.692
   Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078
   Manfrini O, 2004, AM J CARDIOL, V93, P1391, DOI 10.1016/j.amjcard.2004.02.037
   McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C
   Merz CNB, 2011, EUR HEART J, V32, P1313, DOI 10.1093/eurheartj/ehr083
   Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453
   Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084
   Mieres JH, 2014, CIRCULATION, V130, P350, DOI 10.1161/CIR.0000000000000061
   Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60
   Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074
   MORIEL M, 1995, AM J CARDIOL, V76, P1030, DOI 10.1016/S0002-9149(99)80290-2
   Nohria Anju, 1998, Cardiology Clinics, V16, P45, DOI 10.1016/S0733-8651(05)70383-0
   Novack V, 2008, AM J MED, V121, P597, DOI 10.1016/j.amjmed.2008.01.041
   O'Meara JG, 2004, ARCH INTERN MED, V164, P1313, DOI 10.1001/archinte.164.12.1313
   Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054
   Pizzi C, 2004, CIRCULATION, V109, P53, DOI 10.1161/01.CIR.0000100722.34034.E4
   PROUDFIT WL, 1966, CIRCULATION, V33, P901, DOI 10.1161/01.CIR.33.6.901
   Reis SE, 1999, J AM COLL CARDIOL, V33, P1469, DOI 10.1016/S0735-1097(99)00072-8
   Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198
   Scott Lisa Benz, 2004, J Cardiopulm Rehabil, V24, P387, DOI 10.1097/00008483-200411000-00005
   Sharaf B, 2013, AM HEART J, V166, P134, DOI 10.1016/j.ahj.2013.04.002
   Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2
   Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562
   Shaw LJ, 2012, J NUCL CARDIOL, V19, P1026, DOI 10.1007/s12350-012-9593-y
   Shaw LJ, 2011, CIRCULATION, V124, P1239, DOI 10.1161/CIRCULATIONAHA.111.029660
   Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072
   Shaw LJ, 2005, EUR HEART J, V26, P447, DOI 10.1093/eurheartj/ehi102
   Smilowitz NR, 2011, AM HEART J, V161, P681, DOI 10.1016/j.ahj.2010.12.022
   STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402
   Timmis AD, 2006, EUR HEART J, V27, P42, DOI 10.1093/eurheartj/ehi495
   von Mering GO, 2004, CIRCULATION, V109, P722, DOI 10.1161/01.CIR.0000115525.92645.16
   Wessel TR, 2007, CLIN CARDIOL, V30, P69, DOI 10.1002/clc.19
   Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153
NR 75
TC 8
Z9 9
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 433
EP 442
DI 10.4070/kcj.2016.46.4.433
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500001
PM 27482251
OA Green Published
DA 2021-04-22
ER

PT J
AU Habon, T
   Toth, K
AF Habon, Tamas
   Toth, Kalman
TI Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of
   Statins or Effect of LDL-cholesterol Reduction?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ATORVASTATIN; THERAPY; IMPACT; DAMAGE; TRIAL
C1 [Habon, Tamas; Toth, Kalman] Univ Pecs, Div Cardiol, Dept Med 1, Med Ctr, Pecs, Hungary.
RP Toth, K (corresponding author), Univ Pecs, Med Ctr, Ifjusag Ut 13, Pecs, Hungary.
EM toth.kalman@pte.hu
RI Habon, Tamas/S-9289-2019
OI Habon, Tamas/0000-0002-4816-857X
CR Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Eagle KA, 2010, J AM COLL CARDIOL, V56, P1110, DOI 10.1016/j.jacc.2010.04.022
   Eisen A, 2015, CARDIOVASC DRUG THER, V29, P129, DOI 10.1007/s10557-015-6575-8
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Fujii K, 2011, JACC-CARDIOVASC INTE, V4, P513, DOI 10.1016/j.jcin.2011.02.005
   Jarcho JA, 2015, NEW ENGL J MED, V372, P2448, DOI 10.1056/NEJMe1507041
   Lee BK, 2016, KOREAN CIRC J, V46, P472, DOI 10.4070/kcj.2016.46.4.472
   Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87
   Rosenson RS, 2003, EUR HEART J, V24, P1993, DOI 10.1016/j.ehj.2003.08.005
   Szapary L, 2004, CNS DRUGS, V18, P165, DOI 10.2165/00023210-200418030-00003
   Tamai O, 1997, CIRCULATION, V95, P76, DOI 10.1161/01.CIR.95.1.76
   Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004
NR 12
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 468
EP 471
DI 10.4070/kcj.2016.46.4.468
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500004
PM 27482254
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, BK
   Koo, BK
   Nam, CW
   Doh, JH
   Chung, WY
   Cho, BR
   Fearon, WF
AF Lee, Bong-Ki
   Koo, Bon-Kwon
   Nam, Chang-Wook
   Doh, Joon-Hyung
   Chung, Woo-Young
   Cho, Byung-Ryul
   Fearon, William F.
TI Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular
   Dysfunction after Percutaneous Coronary Intervention in Patients with
   Acute Coronary Syndrome?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Angioplasty; Statins; IMR; Microcirculation
ID PERIPROCEDURAL MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN;
   MICROCIRCULATORY RESISTANCE; RANDOMIZED-TRIAL; PROGNOSTIC VALUE;
   TROPONIN-I; INDEX; ELEVATION; HEART; PERFUSION
AB Background and Objectives: There is controversy surrounding whether or not high dose statin administration before percutaneous coronary intervention (PCI) decreases peri-procedural microvascular injury. We performed a prospective randomized study to investigate the mechanisms and effects of pre-treatment high dose atorvastatin on myocardial damage in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing PCI.
   Subjects and Methods: Seventy seven patients with NSTE-ACS were randomly assigned to either the high dose group (atorvastatin 80 mg loading 12 to 24 h before PCI with a further 40 mg loading 2 h before PCI, n=39) or low dose group (atorvastatin 10 mg administration 12 to 24 h before PCI, n=38). Index of microcirculatory resistance (IMR) was measured after stent implantation. Creatine kinase-myocardial band (CK-MB) and high sensitivity C-reactive protein (CRP) levels were measured before and after PCI.
   Results: The baseline characteristics were not different between the two patient groups. Compared to the low dose group, the high dose group had lower post PCI IMR (14.1 +/- 5.0 vs. 19.2 +/- 9.3 U, p=0.003). Post PCI CK-MB was also lower in the high dose group (median: 1.40 ng/mL (interquartile range [IQR: 0.75 to 3.45] vs. 4.00 [IQR:1.70 to 7.37], p=0.002) as was the post-PCI CRP level (0.09 mg/dL [IQR: 0.04 to 0.16] vs. 0.22 [IQR: 0.08 to 0.60], p=0.001).
   Conclusion: Pre-treatment with high dose atorvastatin reduces peri-PCI microvascular dysfunction verified by post-PCI IMR and exerts an immediate anti-inflammatory effect in patients with NSTE-ACS.
C1 [Lee, Bong-Ki; Cho, Byung-Ryul] Kangwon Natl Univ, Sch Med, Div Cardiol, Chunchon, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Div Cardiol, Seoul, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Daegu, South Korea.
   [Doh, Joon-Hyung] Inje Univ, Ilsan Paik Hosp, Div Cardiol, Goyang, South Korea.
   [Chung, Woo-Young] Seoul Natl Univ, Boramae Med Ctr, Div Cardiol, Seoul, South Korea.
   [Fearon, William F.] Stanford Univ, Med Ctr, Dept Cardiovasc Med, Stanford, CA 94305 USA.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Ctr Cardiovasc, 101 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
OI Lee, Bong-Ki/0000-0002-4289-2284
FU Korean Society of Cardiology; St. Jude MedicalSt. Jude Medical;
   Medtronics
FX This study was supported by a grant from the Korean Society of
   Cardiology (2009).; Dr. Bon-Kwon Koo received institutional research
   grant from St. Jude Medical. Dr. Fearon received grants from St. Jude
   Medical, grants and personal fees from Medtronics, other from Heart
   Flow, outside the submitted work.
CR Aarnoudse W, 2004, CIRCULATION, V110, P2137, DOI 10.1161/01.CIR.0000143893.18451.0E
   Ahmed K, 2012, KOREAN CIRC J, V42, P164, DOI 10.4070/kcj.2012.42.3.164
   Bolognese L, 2004, CIRCULATION, V110, P1592, DOI 10.1161/01.CIR.0000142856.56565.56
   Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Correia LCL, 2003, AM J CARDIOL, V92, P298, DOI 10.1016/S0002-9149(03)00630-1
   Fearon WF, 2003, CIRCULATION, V108, P1605, DOI 10.1161/01.CIR.0000091116.84926.6F
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062
   Fearon WF, 2013, CIRCULATION, V127, P2436, DOI 10.1161/CIRCULATIONAHA.112.000298
   Fuchs S, 2000, AM J CARDIOL, V85, P1077, DOI 10.1016/S0002-9149(00)00699-8
   Gibson CM, 2002, AM HEART J, V143, P106, DOI 10.1067/mhj.2002.119618
   Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455
   Jang Y, 2014, J CARDIOL, V63, P335, DOI 10.1016/j.jjcc.2013.09.012
   Joshi MS, 2012, CARDIOVASC PATHOL, V21, P428, DOI 10.1016/j.carpath.2011.12.003
   Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF
   Lee BK, 2015, CIRCULATION, V131, P1054, DOI 10.1161/CIRCULATIONAHA.114.012636
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Melikian N, 2010, EUROINTERVENTION, V5, P939, DOI 10.4244/
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Patti G, 2013, AM J CARDIOL, V111, P1739, DOI 10.1016/j.amjcard.2013.02.028
   Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054
   Prasad A, 2006, J AM COLL CARDIOL, V48, P1765, DOI 10.1016/j.jacc.2006.04.102
   Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486
   Veselka J, 2011, AM J CARDIOL, V107, P1295, DOI 10.1016/j.amjcard.2010.12.040
   Zemanek D, 2013, INT J CARDIOL, V168, P2494, DOI 10.1016/j.ijcard.2013.03.002
NR 30
TC 9
Z9 12
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 472
EP 480
DI 10.4070/kcj.2016.46.4.472
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500005
PM 27482255
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MC
   Cho, JY
   Jeong, HC
   Lee, KH
   Park, KH
   Sim, DS
   Yoon, NS
   Youn, HJ
   Kim, KH
   Hong, YJ
   Park, HW
   Kim, JH
   Jeong, MH
   Cho, JG
   Park, JC
   Seung, KB
   Chang, K
   Ahn, Y
AF Kim, Min Chul
   Cho, Jae Yeong
   Jeong, Hae Chang
   Lee, Ki Hong
   Park, Keun Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Youn, Hyun Joo
   Kim, Kye Hun
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
   Seung, Ki-Bae
   Chang, Kiyuk
   Ahn, Youngkeun
TI Long-Term Clinical Outcomes of Transient and Persistent No Reflow
   Phenomena following Percutaneous Coronary Intervention in Patients with
   Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; No-reflow phenomenon; Percutaneous coronary
   interventions
ID INTRAVASCULAR ULTRASOUND; PRIMARY ANGIOPLASTY; PROGNOSTIC VALUE; ELUTING
   STENTS; IMPACT; REPERFUSION; PREDICTORS; TRIALS
AB Background and Objectives: There is limited information on the transient or persistent no reflow phenomenon in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).
   Subjects and Methods: The study analyzed 4329 patients with AMI from a Korean multicenter registry who underwent PCI using coronary stents (2668 ST-elevation and 1661 non-ST-elevation myocardial infarction [MI] patients): 4071 patients without any no reflow, 213 with transient no reflow (no reflow with final thrombolysis in myocardial infarction [TIMI] flow grade 3), and 45 with persistent no reflow (no reflow with final TIMI flow grade <= 2). The primary endpoint was all-cause mortality during 3-year follow-up. We also analyzed the incidence of cardiac mortality, non-fatal MI, re-hospitalization due to heart failure, target vessel revascularization, and stent thrombosis.
   Results: The persistent no reflow group was associated with higher all-cause mortality (hazard ratio [HR] 1.98, 95% confidence interval [CI] 1.08-3.65, p=0.028) and cardiac mortality (HR 3.28, 95% CI 1.54-6.95, p=0.002) compared with the normal reflow group. Transient no reflow increased all-cause mortality only when compared with normal reflow group (HR 1.58, 95% CI 1.11-2.24, p=0.010). When comparing transient and persistent no reflow, persistent no reflow was associated with increased all-cause mortality (46.7 vs. 24.4%, log rank p=0.033).
   Conclusion: The persistent no reflow phenomenon was associated with a poor in-hospital outcome and increased long-term mortality mainly driven by increased cardiac mortality compared to the transient no reflow phenomenon or normal reflow.
C1 [Kim, Min Chul; Cho, Jae Yeong; Jeong, Hae Chang; Lee, Ki Hong; Park, Keun Ho; Sim, Doo Sun; Yoon, Nam Sik; Youn, Hyun Joo; Kim, Kye Hun; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun; Ahn, Youngkeun] Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea.
   [Seung, Ki-Bae; Chang, Kiyuk] Catholic Univ, Sch Med, Seoul St Marys Hosp, Dept Cardiol, Seoul, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiovasc, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
FU National Research Foundation of Korea - Korean Government (MEST), Korea
   [2010-0020261]; Korea Healthcare Technology R&D Project, Ministry for
   Health Welfare, Korea [HI12C0199, HI13C1527]
FX This work was supported by a grant of the National Research Foundation
   of Korea funded by the Korean Government (MEST), Korea (2010-0020261),
   and by a grant of the Korea Healthcare Technology R&D Project, Ministry
   for Health & Welfare, Korea (HI12C0199, HI13C1527).
CR ABBO KM, 1995, AM J CARDIOL, V75, P778, DOI 10.1016/S0002-9149(99)80410-X
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Alhadramy O, 2010, AM HEART J, V159, P899, DOI 10.1016/j.ahj.2010.02.028
   Brener SJ, 2008, EUR HEART J, V29, P1127, DOI 10.1093/eurheartj/ehn125
   Brener SJ, 2012, CIRC-CARDIOVASC INTE, V5, P563, DOI 10.1161/CIRCINTERVENTIONS.112.969022
   Brodie B, 2012, JACC-CARDIOVASC INTE, V5, P1043, DOI 10.1016/j.jcin.2012.06.013
   Brosh D, 2007, AM J CARDIOL, V99, P442, DOI 10.1016/j.amjcard.2006.08.054
   Chan W, 2012, AM J CARDIOL, V109, P478, DOI 10.1016/j.amjcard.2011.09.037
   Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P1209, DOI 10.1016/j.jcin.2011.07.016
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   Hong SN, 2007, AM J CARDIOL, V100, P631, DOI 10.1016/j.amjcard.2007.03.075
   Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034
   Iijima R, 2006, AM J CARDIOL, V97, P29, DOI 10.1016/j.amjcard.2005.07.104
   Jaffe R, 2008, CIRCULATION, V117, P3152, DOI 10.1161/CIRCULATIONAHA.107.742312
   Jeong YH, 2010, INT J CARDIOL, V141, P175, DOI 10.1016/j.ijcard.2008.11.189
   Jinnouchi H, 2014, HEART VESSELS, V29, P429, DOI 10.1007/s00380-013-0379-1
   Khattab AA, 2008, AM J CARDIOL, V101, P477, DOI 10.1016/j.amjcard.2007.09.094
   Lee Chi Hang, 2005, J Interv Cardiol, V18, P261, DOI 10.1111/j.1540-8183.2005.00041.x
   Magro M, 2012, AM J CARDIOL, V109, P601, DOI 10.1016/j.amjcard.2011.10.013
   Mehta RH, 2003, AM J CARDIOL, V92, P1031, DOI 10.1016/j.amjcard.2003.06.001
   Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2
   Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054
   Ndrepepa G, 2010, CIRC-CARDIOVASC INTE, V3, P27, DOI 10.1161/CIRCINTERVENTIONS.109.896225
   Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
   Wu XF, 2011, JACC-CARDIOVASC INTE, V4, P495, DOI 10.1016/j.jcin.2010.12.012
NR 29
TC 12
Z9 13
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 490
EP 498
DI 10.4070/kcj.2016.46.4.490
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500007
PM 27482257
OA Green Published
DA 2021-04-22
ER

PT J
AU Son, MK
   Lim, NK
   Cho, MC
   Park, HY
AF Son, Mi Kyoung
   Lim, Nam-Kyoo
   Cho, Myeong-Chan
   Park, Hyun-Young
TI Incidence and Risk Factors for Atrial Fibrillation in Korea: the
   National Health Insurance Service Database (2002-2010)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Incidence; Comorbidity
ID STROKE PREVENTION; LIFETIME RISK; PREVALENCE; OLDER; PROJECTIONS;
   MORTALITY; OBESITY; DISEASE; ADULTS; WOMEN
AB Background and Objectives: Atrial fibrillation (AF) is a common arrhythmia that is known as an important independent risk factor for stroke. However, limited information is available on AF in Korea. This study evaluated the incidence of AF, its associated co-morbidities and risk factors for AF in Korea.
   Subjects and Methods: The National Health Insurance Service database between 2002 and 2010 was used in the study. Individuals<30 years old and those diagnosed with AF between 2002 and 2004 were excluded. Hazard ratios (HRs) according to co-morbidities and risk factors for AF were determined using a Cox proportional hazard model. Population attributable fractions (PAFs) of AF risk factors were determined.
   Results: During a 6-year follow-up period, 3517 (1.7%) developed AF. The incidence rates in men and women aged 30-39 years were 0.82 and 0.55 per 1000 person-years, respectively; the incidence rates further increased with age to 13.09 and 11.54 per 1000 person-years in men and women aged >= 80 years, respectively. The risk factors for incident AF were age, sex, body mass index (BMI), hypertension, ischemic heart disease (IHD) and heart failure. After adjusting for variables related to AF, the risk of AF was significantly associated with hypertension (HR 1.667), IHD (HR 1.639), heart failure (HR 1.521), and the PAFs for age, sex, BMI, hypertension, IHD, heart failure and diabetes mellitus were 30.6%, 10.1%, 3.4%, 16.6%, 8.2%, 5.3% and 0.8%, respectively.
   Conclusion: Incidence of AF increased with age and was higher in men than in women. A larger proportion of AF events was attributable to hypertension than to other co-morbidities.
C1 [Son, Mi Kyoung; Lim, Nam-Kyoo; Park, Hyun-Young] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, 187 Osongsaengmyeong 2 Ro, Chongju 28159, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Chongju, South Korea.
RP Park, HY (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, 187 Osongsaengmyeong 2 Ro, Chongju 28159, South Korea.
EM mdhypark@gmail.com
FU Korea National Institute of Health intramural research grant
   [4800-4845-302 (2011-NG63002-00)]
FX This work was supported by the Korea National Institute of Health
   intramural research grant, 4800-4845-302 (2011-NG63002-00).
CR Allessie MA, 2001, CIRCULATION, V103, P769
   Aronow WS, 2002, J GERONTOL A-BIOL, V57, pM45, DOI 10.1093/gerona/57.1.M45
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Djousse L, 2004, AM J CARDIOL, V93, P710, DOI 10.1016/j.amjcard.2003.12.004
   Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023
   Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825
   Jeong JH, 2005, J KOREAN MED SCI, V20, P26, DOI 10.3346/jkms.2005.20.1.26
   KANNEL WB, 1983, AM HEART J, V106, P389, DOI 10.1016/0002-8703(83)90208-9
   Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9
   Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280
   LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
   Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888
   Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688
   Psaty BM, 1997, CIRCULATION, V96, P2455
   Rodriguez CJ, 2015, ANN EPIDEMIOL, V25, P71, DOI 10.1016/j.annepidem.2014.11.024
   Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8
   Suh HS, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0570-9
   Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017
   Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471
   Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   이광수, 2008, Korean Circulation Journal, V38, P601
NR 26
TC 38
Z9 38
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 515
EP +
DI 10.4070/kcj.2016.46.4.515
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500010
PM 27482260
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, IS
   Cho, HJ
   Cho, JG
   Kim, SH
   Na, KJ
   Kim, JK
AF Jeong, In Seok
   Cho, Hwa Jin
   Cho, Jeong Gwan
   Kim, Sang Hyung
   Na, Kook Joo
   Kim, Jong-Keun
TI Influence of Thromboxane A(2) on the Regulation of Adenosine
   Triphosphate-Sensitive Potassium Channels in Mouse Ventricular Myocytes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE KATP channels; Thromboxane A(2); Myocytes; Cardiac
ID VASCULAR SMOOTH-MUSCLE; K+ CHANNELS; MYOCARDIAL-ISCHEMIA;
   CORONARY-ARTERY; ATP; MEMBRANE; CELLS; HEART; PATCHES; I-2
AB Background and Objectives: Adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels play an important role in myocardial protection. We examined the effects of thromboxane A(2) on the regulation of K-ATP channel activity in single ventricular myocytes.
   Materials and Methods: Single ventricular myocytes were isolated from the hearts of adult Institute of Cancer Research (ICR) mice by enzymatic digestion. Single channel activity was recorded by excised inside-out and cell-attached patch clamp configurations at -60 mV holding potential during the perfusion of an ATP-free K-5 solution.
   Results: In the excised inside-out patches, the thromboxane A(2) analog, U46619, decreased the K-ATP channel activity in a dose-dependent manner; however, the thromboxane A(2) receptor antagonist, SQ29548, did not significantly attenuate the inhibitory effect of U46619. In the cell-attached patches, U46619 inhibited dinitrophenol (DNP)-induced K-ATP channel activity in a dose-dependent manner, and SQ29548 attenuated the inhibitory effects of U46619 on DNP-induced K-ATP channel activity.
   Conclusion: Thromboxane A(2) may inhibit K-ATP channel activity, and may have a harmful effect on ischemic myocardium.
C1 [Jeong, In Seok; Kim, Sang Hyung; Na, Kook Joo] Chonnam Natl Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Gwangju, South Korea.
   [Cho, Hwa Jin] Chonnam Natl Univ, Sch Med, Dept Pediat, Gwangju, South Korea.
   [Cho, Jeong Gwan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.
   [Kim, Jong-Keun] Chonnam Natl Univ, Sch Med, Dept Pharmacol, 160 Baekseo Ro, Gwangju 61469, South Korea.
RP Kim, JK (corresponding author), Chonnam Natl Univ, Sch Med, Dept Pharmacol, 160 Baekseo Ro, Gwangju 61469, South Korea.
EM jkkim57@jnu.ac.kr
RI /AAN-8442-2020
CR Ackerman MJ, 1997, NEW ENGL J MED, V336, P1575, DOI 10.1056/NEJM199705293362207
   ANTZELEVITCH C, 1992, CIRCULATION, V85, P1627, DOI 10.1161/01.CIR.85.4.1627
   BOUCHARD JF, 1994, CARDIOVASC RES, V28, P901, DOI 10.1093/cvr/28.6.901
   COETZEE WA, 1992, CARDIOVASC DRUG THER, V6, P201, DOI 10.1007/BF00051140
   Cogolludo A, 2003, CIRC RES, V93, P656, DOI 10.1161/01.RES.0000095245.97945.FE
   FURUKAWA K, 1981, J PHARMACOL EXP THER, V218, P248
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   HILL JL, 1980, CIRCULATION, V61, P768, DOI 10.1161/01.CIR.61.4.768
   JACKSON WF, 1993, AM J PHYSIOL, V264, pH238
   Ju Jeong-Min, 1999, Korean Journal of Physiology and Pharmacology, V3, P507
   Ju JM, 2003, KOREAN CIRC J, V33, P420
   KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820
   KLEBER AG, 1984, J MOL CELL CARDIOL, V16, P389, DOI 10.1016/S0022-2828(84)80610-0
   KUBO M, 1994, CIRC RES, V74, P471, DOI 10.1161/01.RES.74.3.471
   Li QJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1358, DOI 10.1152/ajplung.00421.2001
   NEHER E, 1992, SCI AM, V266, P44, DOI 10.1038/scientificamerican0392-44
   NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0
   QUAST U, 1992, FUND CLIN PHARMACOL, V6, P279, DOI 10.1111/j.1472-8206.1992.tb00122.x
   QUAYLE JM, 1994, CARDIOVASC RES, V28, P797, DOI 10.1093/cvr/28.6.797
   SCHMIDANTOMARCHI H, 1987, J BIOL CHEM, V262, P15840
   SCORNIK FS, 1992, AM J PHYSIOL, V262, pC708
   TRUBE G, 1984, PFLUG ARCH EUR J PHY, V401, P178, DOI 10.1007/BF00583879
   Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058
NR 23
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 562
EP 568
DI 10.4070/kcj.2016.46.4.562
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500017
PM 27482267
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, D
   Baek, YS
   Lee, M
   Uhm, JS
   Pak, HN
   Lee, MH
   Joung, B
AF Kim, Daehoon
   Baek, Yong-Soo
   Lee, Misol
   Uhm, Jae-Sun
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Joung, Boyoung
TI Remnant Pacemaker Lead Tips after Lead Extractions in Pacemaker
   Infections
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac pacemaker, artificial; Infection; Device removal
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CARDIAC DEVICES; UNITED-STATES;
   MANAGEMENT; INDICATE
AB Complete hardware removal is recommended in the case of patients with cardiovascular implantable electronic device (CIED) infections. However, the complete extraction of chronically implanted leads is not always achieved. The outcomes and optimal management of CIED infections with retained material after lead extractions have not been elucidated. In this case report, we present five patients with CIED infections with remnant lead tips even after lead extractions. Two patients had localized pocket infections, and were managed with antibiotics for a period of more than two weeks. The other three patients had infective endocarditis, and were managed with antibiotics for a period of more than four weeks. In one patient, the lead tip migrated to the right pulmonary artery, but did not produce any symptoms or complications. Only one of five patients experienced a resurgence of an infection.
C1 [Kim, Daehoon; Baek, Yong-Soo; Lee, Misol; Uhm, Jae-Sun; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
RI Kim, Daehoon/AAK-7921-2021; Pak, Hui-Nam/C-4266-2015
OI Kim, Daehoon/0000-0002-9736-450X; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Pak, Hui-Nam/0000-0002-3256-3620; Uhm, Jae-Sun/0000-0002-1611-8172;
   Joung, Boyoung/0000-0001-9036-7225
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science and Technology [2012-0007604,
   2012-045367]; Korean Healthcare technology R&D project - Ministry of
   Health Welfare [A121668]
FX This study was supported in part by research grants from the Basic
   Science Research Program through the National Research Foundation of
   Korea funded by the Ministry of Education, Science and Technology
   (2012-0007604, 2012-045367), and a grant from the Korean Healthcare
   technology R&D project funded by Ministry of Health & Welfare (A121668).
CR Athan E, 2012, JAMA-J AM MED ASSOC, V307, P1727, DOI 10.1001/jama.2012.497
   Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665
   Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47
   Byrd CL, 2002, PACE, V25, P804, DOI 10.1046/j.1460-9592.2002.t01-1-00804.x
   Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033
   Klug D, 2005, AM HEART J, V149, P322, DOI 10.1016/j.ahj.2004.07.032
   Klug D, 2004, HEART, V90, P882, DOI 10.1136/hrt.2003.010595
   Love CJ, 2000, PACE, V23, P544
   Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099
   Robinson T, 2010, EUROPACE, V12, P754, DOI 10.1093/europace/euq001
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
   Turkisher V, 1997, PACE, V20, P2268, DOI 10.1111/j.1540-8159.1997.tb04247.x
   Victor F, 1999, HEART, V81, P82, DOI 10.1136/hrt.81.1.82
   Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020
NR 16
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 569
EP 573
DI 10.4070/kcj.2016.46.4.569
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500018
PM 27482268
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, JI
   Koh, YS
   Chang, K
AF Jung, Jung Im
   Koh, Yoon-Seog
   Chang, Kiyuk
TI 3D Printing Model before and after Transcatheter Aortic Valve
   Implantation for a Better Understanding of the Anatomy of Aortic Root
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID REPLACEMENT
C1 [Jung, Jung Im] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, 222 Banpodae Ro, Seoul 06591, South Korea.
   [Koh, Yoon-Seog; Chang, Kiyuk] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Ctr Cardiovasc, Seoul, South Korea.
   [Koh, Yoon-Seog; Chang, Kiyuk] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
RP Jung, JI (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, 222 Banpodae Ro, Seoul 06591, South Korea.
EM jijung@catholic.ac.kr
OI Jung, Jung Im/0000-0001-8264-9388
CR Cao C, 2013, ANN CARDIOTHORAC SUR, V2, P10, DOI 10.3978/j.issn.2225-319X.2012.11.09
   Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
   Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277
   Nguyen G, 2013, CURR OPIN CARDIOL, V28, P497, DOI 10.1097/HCO.0b013e32836245c1
   Valverde I, 2015, CATHETER CARDIO INTE, V85, P1006, DOI 10.1002/ccd.25810
NR 5
TC 9
Z9 10
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2016
VL 46
IS 4
BP 588
EP 589
DI 10.4070/kcj.2016.46.4.588
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW8HS
UT WOS:000383896500022
PM 27482272
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, DS
   Yun, KH
   Park, HY
   Rhee, SJ
   Kim, NH
   Oh, SK
   Jeong, JW
AF Park, Do-Sim
   Yun, Kyeong Ho
   Park, Hyun Young
   Rhee, Sang Jae
   Kim, Nam-Ho
   Oh, Seok Kyu
   Jeong, Jin-Won
TI Antioxidative Activity after Rosuvastatin Treatment in Patients with
   Stable Ischemic Heart Disease and Decreased High Density Lipoprotein
   Cholesterol
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hydroxymethylglutaryl-CoA; Reductase inhibitors; High-density
   lipoproteins; Paraoxonase
ID POTENT STATIN THERAPY; HDL-CHOLESTEROL; MYOCARDIAL-INFARCTION; RISK;
   PARAOXONASE; ELEVATION; EVENTS; TRIAL; SIZE
AB Background and Objectives: The clinical significance of statin-induced high-density lipoprotein cholesterol (HDL-C) changes is not well known. We investigated whether rosuvastatin-induced HDL-C changes can influence the anti-oxidative action of high-density lipoprotein particle.
   Subjects and Methods: A total of 240 patients with stable ischemic heart disease were studied. Anti-oxidative property was assessed by paraoxonase 1 (PON1) activity. We compared the lipid profile and PON1 activity at baseline and at 8 weeks after rosuvastatin 10 mg treatment.
   Results: Rosuvastatin treatment increased the mean HDL-C concentration by 1.9 +/- 9.2 mg/dL (6.4 +/- 21.4%). HDL-C increased in 138 patients (57.5%), but decreased in 102 patients (42.5%) after statin treatment. PON1 activity increased to 19.1% in all patients. In both, the patients with increased HDL-C and with decreased HDL-C, PON1 activity significantly increased after rosuvastatin treatment (+19.3% in increased HDL-C responder; p=0.018, +18.8% in decreased HDL-C responder; p=0.045 by paired t-test). Baseline PON1 activity modestly correlated with HDL-C levels (r=0.248, p=0.009); however, the PON1 activity evaluated during the course of the treatment did not correlate with HDL-C levels (r=0.153, p=0.075).
   Conclusion: Rosuvastatin treatment improved the anti-oxidative properties as assessed by PON1 activity, regardless of on-treatment HDL-C levels, in patients with stable ischemic heart disease.
C1 [Park, Do-Sim] Wonkwang Univ Hosp, Dept Lab Med, Iksan, South Korea.
   [Park, Do-Sim] Sch Med, Iksan, South Korea.
   [Yun, Kyeong Ho; Rhee, Sang Jae; Kim, Nam-Ho; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
   [Yun, Kyeong Ho; Park, Hyun Young] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
EM dryunkh@gmail.com
RI Park, Do-Sim/B-6594-2013
OI Park, Do-Sim/0000-0002-6001-4223
FU Korean Society of Cardiology [2012-08]; Basic Science Research Program
   through the NRF of Korea - Ministry of education [2012R1A1A2041914]
FX This study was supported by grants from The Korean Society of Cardiology
   (2012-08) and Basic Science Research Program through the NRF of Korea
   funded by the Ministry of education (2012R1A1A2041914).
CR Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649
   Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628
   BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x
   Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
   Cebeci Egemen, 2011, Acta Biomed, V82, P214
   Harangi M, 2009, CARDIOVASC DRUG THER, V23, P501, DOI 10.1007/s10557-009-6205-4
   홍영준, 2003, Korean Circulation Journal, V33, P891
   MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U
   Mazer NA, 2013, CLIN CHEM, V59, P949, DOI 10.1373/clinchem.2012.196949
   MCELVEEN J, 1986, CLIN CHEM, V32, P671
   Miyamoto-Sasaki M, 2013, J ATHEROSCLER THROMB, V20, P708
   Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671
   Nagila A, 2009, PHARMACOL REP, V61, P892, DOI 10.1016/S1734-1140(09)70146-X
   PEDERSEN TR, 1994, LANCET, V344, P1383
   Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735
   Ridker PM, 2010, LANCET, V376, P333, DOI 10.1016/S0140-6736(10)60713-1
   Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Sim DS, 2013, KOREAN CIRC J, V43, P100, DOI 10.4070/kcj.2013.43.2.100
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Yamashita S, 2010, J ATHEROSCLER THROMB, V17, P436, DOI 10.5551/jat.5405
   Yun KH, 2012, J CARDIOL, V60, P383, DOI 10.1016/j.jjcc.2012.07.008
NR 22
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 309
EP 314
DI 10.4070/kcj.2016.46.3.309
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100003
PM 27275167
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Jeong, MH
   Ahn, Y
   Kim, YJ
   Cho, MC
   Kim, W
AF Kim, Kyung Hwan
   Jeong, Myung Ho
   Ahn, Youngkeun
   Kim, Young Jo
   Cho, Myeong Chan
   Kim, Wan
CA Korea Acute Myocardial Infarction
TI Differential Clinical Implications of High-Degree Atrioventricular Block
   Complicating ST-Segment Elevation Myocardial Infarction according to the
   Location of Infarction in the Era of Primary Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrioventricular block; Myocardial infarction; Primary percutaneous
   coronary intervention; In-hospital mortality
ID BUNDLE-BRANCH BLOCK; HEART-BLOCK; TERM
AB Background and Objectives: The clinical implication of high-degree (second- and third-degree) atrioventricular block (HAVB) complicating ST-segment elevation myocardial infarction (STEMI) is ripe for investigation in this era of primary percutaneous coronary intervention (PCI). We sought to address the incidence, predictors and prognosis of HAVB according to the location of infarct in STEMI patients treated with primary PCI.
   Subjects and Methods: A total of 16536 STEMI patients (anterior infarction: n=9354, inferior infarction: n=7692) treated with primary PCI were enrolled from a multicenter registry. We compared in-hospital mortality between patients with HAVB and those without HAVB with anterior or inferior infarction, separately. Multivariate analyses were performed to unearth predictors of HAVB and to identify whether HAVB is independently associated with in-hospital mortality.
   Results: STEMI patients with HAVB showed higher in-hospital mortality than those without HAVB in both anterior (hazard ratio [HR]=9.821, 95% confidence interval [CI]: 4.946-19.503, p<0.001) and inferior infarction (HR=2.819, 95% CI: 2.076-3.827, p<0.001). In multivariate analyses, HAVB was associated with increased in-hospital mortality in anterior myocardial infarction (HR=19.264, 95% CI: 5.804-63.936, p<0.001). However, HAVB in inferior infarction was not an independent predictor of increased in-hospital mortality (HR=1.014, 95% CI: 0.547-1.985, p=0.901).
   Conclusion: In this era of primary PCI, the prognostic impact of HAVB is different according to the location of infarction. Because of recent improvements in reperfusion strategy, the negative prognostic impact of HAVB in inferior STEMI is no longer prominent.
C1 [Kim, Kyung Hwan; Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, Cheongju, South Korea.
   [Kim, Wan] Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, Korea Minist Hlth & Welf, 42 Jaebong Ro, Gwangju 61469, South Korea.
EM mhjeong@chonnam.ac.kr
OI Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754
FU Korean Society of Cardiology; Korean Centers for Disease Control and
   Prevention [2013-E63005-01]; Korean Health Technology RH Project,
   Ministry of Health & Welfare, Republic of Korea [HI13C1527]
FX This study was supported by grants from The Korean Society of
   Cardiology, The Korean Centers for Disease Control and Prevention
   (2013-E63005-01), and The Korean Health Technology RH Project
   (HI13C1527), Ministry of Health & Welfare, Republic of Korea.
CR Abidov A, 2004, AM J CARDIOL, V93, P76, DOI 10.1016/j.amjcard.2003.09.016
   Aplin M, 2003, AM J CARDIOL, V92, P853, DOI 10.1016/S0002-9149(03)00900-7
   BEHAR S, 1993, AM HEART J, V125, P1622, DOI 10.1016/0002-8703(93)90750-4
   BERGER PB, 1992, J AM COLL CARDIOL, V20, P533, DOI 10.1016/0735-1097(92)90004-7
   BERGER PB, 1990, CIRCULATION, V81, P401, DOI 10.1161/01.CIR.81.2.401
   CLEMMENSEN P, 1991, AM J CARDIOL, V67, P225, DOI 10.1016/0002-9149(91)90550-5
   FEIGL D, 1984, J AM COLL CARDIOL, V4, P35, DOI 10.1016/S0735-1097(84)80315-0
   Gang UJO, 2012, EUROPACE, V14, P1639, DOI 10.1093/europace/eus161
   GOLDBERG RJ, 1992, AM J CARDIOL, V69, P1135, DOI 10.1016/0002-9149(92)90925-O
   Harpaz D, 1999, J AM COLL CARDIOL, V34, P1721, DOI 10.1016/S0735-1097(99)00431-3
   HINDMAN MC, 1978, CIRCULATION, V58, P679, DOI 10.1161/01.CIR.58.4.679
   Meine TJ, 2005, AM HEART J, V149, P670, DOI 10.1016/j.ahj.2004.07.035
   NICOD P, 1988, J AM COLL CARDIOL, V12, P589, DOI 10.1016/S0735-1097(88)80042-1
   O'Gara PT, 2013, CATHETER CARDIO INTE, V82, pE1, DOI 10.1002/ccd.24776
   Rathore SS, 2001, AM HEART J, V141, P47, DOI 10.1067/mhj.2001.111259
   Sgarbossa EB, 1998, J AM COLL CARDIOL, V31, P105, DOI 10.1016/S0735-1097(97)00446-4
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001
NR 18
TC 8
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 315
EP 323
DI 10.4070/kcj.2016.46.3.315
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100004
PM 27275168
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, CH
   Jeong, MH
   Ahn, Y
   Kim, YJ
   Cho, MC
   Kim, W
   Kim, JJ
AF Kim, Kyung Hwan
   Kim, Cheol Hwan
   Jeong, Myung Ho
   Ahn, Youngkeun
   Kim, Young Jo
   Cho, Myeong Chan
   Kim, Wan
   Kim, Jong Jin
CA Korea Acute Myocardial Infarction
TI Differential Benefit of Statin in Secondary Prevention of Acute
   Myocardial Infarction according to the Level of Triglyceride and High
   Density Lipoprotein Cholesterol
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Statin; Acute myocardial infarction; Triglyceride; High-density
   lipoprotein cholesterol; Prognosis
ID RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS; ACUTE CORONARY
   SYNDROMES; LIPID-LOWERING THERAPY; HEART-DISEASE; EVENTS; SIMVASTATIN;
   COMBINATION; PRAVASTATIN; PROTEIN
AB Background and Objectives: The differential benefit of statin according to the state of dyslipidemia has been sparsely investigated. We sought to address the efficacy of statin in secondary prevention of myocardial infarction (MI) according to the level of triglyceride and high density lipoprotein cholesterol (HDL-C) on admission.
   Subjects and Methods: Acute MI patients (24653) were enrolled and the total patients were divided according to level of triglyceride and HDL-C on admission: group A (HDL-C >= 40 mg/dL and triglyceride<150 mg/dL; n=11819), group B (HDL-C >= 40 mg/dL and triglyceride >= 150 mg/dL; n=3329), group C (HDL-C<40 mg/dL and triglyceride<150 mg/dL; n=6062), and group D (HDL-C<40 mg/dL & triglyceride >= 150 mg/dL; n=3443). We evaluated the differential efficacy of statin according to the presence or absence of component of dyslipidemia. The primary end points were major adverse cardiac events (MACE) for 2 years.
   Results: Statin therapy significantly reduced the risk of MACE in group A (hazard ratio =0.676; 95% confidence interval: 0.582-0.785; p<0.001). However, the efficacy of statin was not prominent in groups B, C, or D. In a propensity-matched population, the result was similar. In particular, the benefit of statin in group A was different compared with group D (interaction p=0.042)
   Conclusion: The benefit of statin in patients with MI was different according to the presence or absence of dyslipidemia. In particular, because of the insufficient benefit of statin in patients with MI and dyslipidemia, a different lipid-lowering strategy is necessary in these patients.
C1 [Kim, Kyung Hwan; Kim, Cheol Hwan; Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Gwangju 61469, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Busan, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Cheongju, South Korea.
   [Kim, Wan] Gwangju Vet Hosp, Gwangju, South Korea.
   [Kim, Jong Jin] Kyung Hee Univ, Coll Med, Seoul, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Heart Res Ctr, 42 Jaebongro, Gwangju 61469, South Korea.
EM mhjeong@chonnam.ac.kr
OI Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754
FU Korean Society of Cardiology; Korean Centers for Disease Control and
   Prevention [2013-E63005-00]; Korean Health Technology R&D Project,
   Ministry of Health & Welfare, Republic of Korea [HI13C1527]
FX This study was supported by grants of The Korean Society of Cardiology,
   The Korean Centers for Disease Control and Prevention (2013-E63005-00),
   and The Korean Health Technology R&D Project, Ministry of Health &
   Welfare (HI13C1527), Republic of Korea.
CR Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624
   Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090
   BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Collins R, 2002, LANCET, V360, P7, DOI 10.1016/s0140-6736(02)09327-3
   Colquhoun D, 2004, EUR HEART J, V25, P771, DOI 10.1016/j.ehj.2004.03.013
   Daskalopoulou SS, 2008, EUR HEART J, V29, P2083, DOI 10.1093/eurheartj/ehn346
   Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Giraldez RR, 2008, J AM COLL CARDIOL, V52, P914, DOI 10.1016/j.jacc.2008.05.046
   Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057
   Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649
   Niesor EJ, 2010, J LIPID RES, V51, P3443, DOI 10.1194/jlr.M008706
   O'Gara PT, 2013, CATHETER CARDIO INTE, V82, pE1, DOI 10.1002/ccd.24776
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V286, P533
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Whitney EJ, 2005, ANN INTERN MED, V142, P95, DOI 10.7326/0003-4819-142-2-200501180-00008
NR 22
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 324
EP 334
DI 10.4070/kcj.2016.46.3.324
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100005
PM 27275169
OA Green Published
DA 2021-04-22
ER

PT J
AU Yaman, M
   Arslan, U
   Gumrukcuoglu, HA
   Sahin, M
   Simsek, H
   Akdag, S
AF Yaman, Mehmet
   Arslan, Ugur
   Gumrukcuoglu, Hasan Ali
   Sahin, Musa
   Simsek, Hakki
   Akdag, Serkan
TI Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ischemic heart disease; Trimetazidine; Electrocardiography;
   Echocardiography
ID TYPE-2 DIABETIC-PATIENTS; DYSFUNCTION; RISK
AB Background and Objectives: Studies reveal that the microvolt T wave alternans (MTWA) test has a high negative predictive value for arrhythmic mortality among patients with ischemic or non-ischemic cardiomyopathy. In this study, we investigate the effects of trimetazidine treatment on MTWA and several echocardiographic parameters in patients with stable coronary artery disease.
   Subjects and Methods: One hundred patients (23 females, mean age 55.6 +/- 9.2 years) with stable ischemic heart disease were included in the study group. Twenty-five age- and sex-matched patients with stable coronary artery disease formed the control group. All patients were stable with medical treatment, and had no active complaints. Trimetazidine, 60 mg/day, was added to their current treatment for a minimum three months in the study group and the control group received no additional treatment. Pre- and post-treatment MTWA values were measured by 24 hour Holter testing. Left ventricular systolic and diastolic functions were assessed by echocardiography.
   Results: After trimetazidine treatment, several echocardiographic parameters related with diastolic dysfunction significantly improved. MTWA has been found to be significantly improved after trimethazidine treatment (63 +/- 8 mu V vs. 53 +/- 7 mu V, p<0.001). Abnormal MTWA was present in 29 and 11 patients pre- and post-treatment, respectively (p< 0.001).
   Conclusion: Trimetazidine improves MTWA, a non-invasive determinant of electrical instability. Moreover, several echocardiographic parameters related with left ventricular functions also improved. Thus, we can conclude that trimetazidine may be an effective agent to prevent arrhythmic complications and improve myocardial functions in patients with stable coronary artery disease.
C1 [Yaman, Mehmet; Arslan, Ugur] Samsun Educ & Res Hosp, Dept Cardiol, Samsun, Turkey.
   [Gumrukcuoglu, Hasan Ali; Sahin, Musa; Simsek, Hakki; Akdag, Serkan] Van 100 Yil Univ, Dept Cardiol, Van, Turkey.
RP Arslan, U (corresponding author), Samsun Educ & Res Hosp, Dept Cardiol, Baris Bulvari 199, TR-55400 Ilkadim Samsun, Turkey.
EM ugurarslan5@yahoo.com
RI Arslan, Ugur/F-4993-2014
OI Arslan, Ugur/0000-0001-8572-3571
CR Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011
   Armoundas AA, 2002, J AM COLL CARDIOL, V40, P207, DOI 10.1016/S0735-1097(02)01960-5
   Baykan M, 2003, J AM SOC ECHOCARDIOG, V16, P1024, DOI 10.1016/S0894-7317(03)00552-2
   Belardinelli R, 2008, J CARDIOVASC PHARM, V51, P611, DOI 10.1097/FJC.0b013e31817bdd66
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Cosson S, 2007, DIABETES METAB, V33, P61, DOI 10.1016/j.diabet.2006.11.003
   Di Napoli P, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.06.033
   Duzenli MA, 2008, TURK KARDIYOL DERN A, V36, P143
   Fedorova T A, 2004, Klin Med (Mosk), V82, P15
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Maeda S, 2009, CIRC J, V73, P2223, DOI 10.1253/circj.CJ-09-0420
   Merchant FM, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0398-7
   Mornos C, 2009, INT J CARDIOL, V136, P120, DOI 10.1016/j.ijcard.2008.04.029
   Multicentral Collaborative Group on Trimetazidine (Phase IV), 2005, Zhonghua Xin Xue Guan Bing Za Zhi, V33, P793
   Nearing BD, 2002, J APPL PHYSIOL, V92, P541, DOI 10.1152/japplphysiol.00592.2001
   Sakaki K, 2009, HEART RHYTHM, V6, P332, DOI 10.1016/j.hrthm.2008.12.011
   Shimada H, 2012, AM J CARDIOL, V110, P1446, DOI 10.1016/j.amjcard.2012.06.054
   Soliman OII, 2009, J DIABETES COMPLICAT, V23, P365, DOI 10.1016/j.jdiacomp.2008.04.003
   Spector KS, 1998, CLIN CARDIOL, V21, P885, DOI 10.1002/clc.4960211205
   Verrier RL, 2013, J ELECTROCARDIOL, V46, P585, DOI 10.1016/j.jelectrocard.2013.06.006
   Vitale C, 2004, EUR HEART J, V25, P1814, DOI 10.1016/j.ehj.2004.06.034
NR 21
TC 1
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 343
EP 349
DI 10.4070/kcj.2016.46.3.343
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100007
PM 27275171
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, MG
   Kang, S
   Kim, BR
   Baek, MY
   Park, YM
   Shin, MS
AF Kim, JinShil
   Kim, Myeong Gun
   Kang, Sewon
   Kim, Bong Roung
   Baek, Min Young
   Park, Yae Min
   Shin, Mi-Seung
TI Obesity and Hypertension in Association with Diastolic Dysfunction Could
   Reduce Exercise Capacity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Obesity; Hypertension; Echocardiography; Diastolic function; Exercise
   capacity
ID METABOLIC SYNDROME; PREVALENCE; PROGRAM; UPDATE; RISK
AB Background and Objectives: Empirical evidence is lacking on the cumulative disease burden of obesity and hypertension and its impact on cardiac function and exercise capacity. The purpose of this study was to determine whether the presence of obesity and hypertension together was associated with cardiac dysfunction and exercise capacity.
   Subjects and Methods: Using a retrospective study design, medical records were reviewed for echocardiographic and treadmill exercise stress test data. Subjects were grouped according to four categories: normal control, obese, hypertensive, or obese and hypertensive.
   Results: Obese, hypertensive persons showed significantly lower Ea and E/A ratio and greater E/Ea ratio, deceleration time, left ventricular (LV) mass, and LV mass index compared to their counter parts (normal control, obese and/or hypertensive) (all p<0.05), after controlling for age and sex. After controlling for age and sex, significant differences in exercise capacity indices were found, with the obese group having shorter exercise time, lower metabolic equivalents, and lower maximal oxygen uptake than the normal control, hypertensive, or both groups (all p<0.05). The hypertensive or obese and hypertensive group had greater maximal blood pressure compared with the normal control group (all p<0.001). Obese and hypertensive persons were approximately three times more likely to have diastolic dysfunction (odd ratio=2.96, p=0.001), when compared to the reference group (normotensive, non-obese, or hypertensive only persons).
   Conclusion: Diastolic dysfunction was associated with obesity and/or hypertension. The cumulative risk of obesity and hypertension and their impact on diastolic dysfunction which could be modifiable could reduce exercise capacity.
C1 [Kim, JinShil] Gachon Univ, Coll Nursing, Inchon, South Korea.
   [Kim, Myeong Gun; Baek, Min Young; Park, Yae Min; Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Inchon, South Korea.
   [Kang, Sewon] Dongseoi Univ, Coll Nursing, Pusan, South Korea.
   [Kim, Bong Roung] Seoul Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Park, Yae Min; Shin, Mi-Seung] Gachon Univ, Coll Med, Inchon, South Korea.
RP Shin, MS (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, 21 Namdong Daero 774Beon Gil, Inchon 21565, South Korea.
EM msshin@gilhospital.com
FU Korean Society of Cardiology [2011-10]
FX This study was supported by a grant from the Korean Society of
   Cardiology (#2011-10).
CR Arkin JM, 2008, AM J CARDIOL, V101, P98, DOI 10.1016/j.amjcard.2007.07.055
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Baynard T, 2008, OBESITY, V16, P1277, DOI 10.1038/oby.2008.212
   Bradshaw PT, 2013, OBESITY, V21, P203, DOI 10.1002/oby.20248
   Canepa M, 2013, AM J CARDIOL, V112, P1182, DOI 10.1016/j.amjcard.2013.05.070
   Centers for Disease Control and Prevention, 2011, FACT SHEET HLTH DISP
   Chockalingam A, 2010, ANGIOLOGY, V61, P192, DOI 10.1177/0003319709336418
   de Simone G, 2005, EUR HEART J, V26, P1039, DOI 10.1093/eurheartj/ehi019
   Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003
   Fenk S, 2015, INT HEART J, V56, P196, DOI 10.1536/ihj.14-261
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022
   Hess Dean R, 2004, Respir Care, V49, P1171
   Hwang LC, 2012, ASIA PAC J CLIN NUTR, V21, P227
   Kim HK, 2004, CLIN CARDIOL, V27, P624, DOI 10.1002/clc.4960271109
   Korean National Health and Nutrition Examination Survey (KNHANES V-3). Ministry of Health & Welfare/Korea Centers for Disease Control & Prevention, 2012, 11758 MIN HLTH WELF
   Melis RJF, 2008, J GERONTOL A-BIOL, V63, P283, DOI 10.1093/gerona/63.3.283
   Mendis S., 2011, GLOBAL ATLAS CARDIOV
   MESSERLI FH, 1983, ANN INTERN MED, V99, P757, DOI 10.7326/0003-4819-99-6-757
   Ministry of Health and Welfare Statistics Portal, 2012, PREV CHRON DIS
   Ministry of Health & Welfare, 2012, HIGH SALT INT KOR
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623
   Rhee SY, 2013, KOREAN J INTERN MED, V28, P29, DOI 10.3904/kjim.2013.28.1.29
   Seto S, 1998, HYPERTENS RES-CLIN E, V21, P245, DOI 10.1291/hypres.21.245
   So AY, 2008, J KOREAN ACAD NURS, V38, P822, DOI 10.4040/jkan.2008.38.6.822
   Stuart-Shor EM, 2012, CIRCULATION, V125, P171, DOI 10.1161/CIRCULATIONAHA.110.968495
   Tobe SW, 2014, J HUM HYPERTENS, V28, P44, DOI 10.1038/jhh.2013.48
   유승기, 2008, Korean Circulation Journal, V38, P270
NR 29
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 394
EP 401
DI 10.4070/kcj.2016.46.3.394
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100012
PM 27275176
OA Green Published
DA 2021-04-22
ER

PT J
AU Feng, JB
   Liu, HY
   Chen, JY
   Wang, JY
   Liu, Z
   Ge, SL
AF Feng, Junbo
   Liu, Haiyuan
   Chen, Jiayi
   Wang, Jiyuan
   Liu, Zhuang
   Ge, Shenglin
TI Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary
   Bypass
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Levosimendan; Cardiopulmonary bypass; Canine; protective effect
ID CONTROLLED OXYGEN REPERFUSION; PULMONARY-FUNCTION
AB Background and Objectives: To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine model by determining the wet/dry weight (W/D) ratio of lung tissue, malonaldehyde (MDA) and superoxide dismutase (SOD) concentrations, and performing a histological evaluation.
   Materials and Methods: Thirty-two canines were divided randomly into four groups and underwent a routine aortic cross-clamping cardiopulmonary bypass procedure for 1 h, followed by recovery for 2 h. Animals were handled as follows: group C (means control group), no special treatment after aortic cross clamping; group P (means pulmonary artery perfusion group), pulmonary artery perfusion with cold oxygenated blood after aortic cross clamping; group LSIV (means intravenous injection of LS group), intravenous injection of LS (65 mu g/kg) before thoracotomy, and the rest of the procedure was identical to the control group; group LPS (means pulmonary perfusion with LS group), pulmonary perfusion with cold oxygenated blood combined with LS (65 mu g/kg) after aortic cross clamping. Lung tissues were removed and subjected to evaluation of pathological alterations, W/D ratio and MDA and SOD concentrations.
   Results: In group C, the W/D ratio and MDA concentration were higher, while the SOD concentrations were lower (p<0.05). Compared with groups P and LSIV, the MDA concentration was lower in group LPS, while that of SOD was higher (p<0.05); Light and electron microscopy indicated that LS intervention reduced impairment of lung tissues.
   Conclusion: Our findings suggest that LS plays an important role in protecting lung tissues.
C1 [Feng, Junbo; Chen, Jiayi; Wang, Jiyuan; Liu, Zhuang; Ge, Shenglin] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Ward 1, 218 Jixi Rd, Hefei 230000, Anhui, Peoples R China.
   [Liu, Haiyuan] Hefei Second Peoples Hosp, Dept Oncol, Hefei, Peoples R China.
RP Ge, SL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Ward 1, 218 Jixi Rd, Hefei 230000, Anhui, Peoples R China.
EM aydgsl@sina.com
FU Natural Science Research Project of Anhui Province for Colleges and
   Universities [KJ2013Z108]
FX The Natural Science Research Project of Anhui Province for Colleges and
   Universities, KJ2013Z108.
CR Caimmi PP, 2011, EUR J CARDIO-THORAC, V39, pE59, DOI 10.1016/j.ejcts.2010.11.044
   Gecit I, 2014, TOXICOL IND HEALTH, V30, P47, DOI 10.1177/0748233712451773
   Honisch A, 2010, BASIC RES CARDIOL, V105, P155, DOI 10.1007/s00395-009-0064-9
   Kim JC, 2012, CHEST, V142, P467, DOI 10.1378/chest.11-2246
   Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033
   Markou T, 2011, EUR J PHARMACOL, V667, P298, DOI 10.1016/j.ejphar.2011.05.078
   Ozturk T, 2010, J CARDIOTHOR VASC AN, V24, P624, DOI 10.1053/j.jvca.2009.08.003
   Paraskevaidis Ioannis A., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P243, DOI 10.2174/1568016054368232
   Qi DN, 2013, ARTIF ORGANS, V37, P142, DOI 10.1111/j.1525-1594.2012.01542.x
   Qiu WS, 2008, J THORAC CARDIOV SUR, V136, P352, DOI 10.1016/j.jtcvs.2008.01.014
   Radovits T, 2012, EUR J CARDIO-THORAC, V41, P391, DOI 10.1016/j.ejcts.2011.05.056
   Rong J, 2013, ASAIO J, V59, P302, DOI 10.1097/MAT.0b013e318290504e
   Rong J, 2012, EXP LUNG RES, V38, P183, DOI 10.3109/01902148.2012.662667
   Wang CT, 2012, LAB INVEST, V92, P910, DOI 10.1038/labinvest.2012.50
NR 14
TC 3
Z9 7
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 402
EP 407
DI 10.4070/kcj.2016.46.3.402
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100013
PM 27275177
OA Green Published
DA 2021-04-22
ER

PT J
AU Moon, IT
   Shin, JH
   Sohn, YS
   Lee, JY
   Park, HC
   Choi, SI
   Kim, SG
   Oh, JY
AF Moon, In Tae
   Shin, Jeong Hun
   Sohn, Young Seok
   Lee, Ji Young
   Park, Hwan Cheol
   Choi, Sung Ii
   Kim, Soon Gil
   Oh, Ji Young
TI Abdominal Wall Hematoma as a Rare Complication following Percutaneous
   Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Hematoma; Femoral artery
ID ARTERY; ACCESS; RISK
AB Abdominal wall hematoma is a rare but potentially serious vascular complication that may develop after coronary angiographic procedures. In particular, an oblique muscle hematoma caused by an injury of the circumflex iliac artery is very rare, yet can be managed by conservative treatment including hydration and transfusion. However, when active bleeding continues, angiographic embolization or surgery might be needed. In this study, we report an uncommon case of injury to the circumflex iliac artery by an inappropriate introduction of the hydrophilic guidewire during the performance of a percutaneous coronary intervention.
C1 Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med,Div Cardiol, Guri 11923, South Korea.
   [Oh, Ji Young] Hanyang Univ, Coll Med, Guri Hosp, Dept Radiol, Guri 11923, South Korea.
RP Shin, JH (corresponding author), Hanyang Univ, Guri Hosp, Dept Internal Med, Div Cardiol, 153 Gyeongchun Ro, Guri 11923, South Korea.
EM cardio.hyapex@gmail.com
RI Shin, Jeong Hun/O-1273-2019
OI Shin, Jeong Hun/0000-0002-6718-9763; Choi, Seongil/0000-0001-5927-8574
CR Bangalore S, 2011, CIRCULATION, V124, pE147, DOI 10.1161/CIRCULATIONAHA.111.032235
   Dutta Sumanta, 2009, Cases J, V2, P9358, DOI 10.1186/1757-1626-2-9358
   Fitts J, 2008, J INTERV CARDIOL, V21, P273, DOI 10.1111/j.1540-8183.2008.00351.x
   Fukunaga Naoto, 2009, World J Emerg Surg, V4, P39, DOI 10.1186/1749-7922-4-39
   Hamel WJ, 2009, CRIT CARE NURSE, V29, P39, DOI 10.4037/ccn2009157
   Jabr Fadi I, 2011, J Med Liban, V59, P160
   Luhmann A, 2006, WORLD J SURG, V30, P2050, DOI 10.1007/s00268-005-0702-9
   Merriweather N, 2012, CRIT CARE NURSE, V32, P16, DOI 10.4037/ccn2012123
   Ranieri P, 2009, J AM GERIATR SOC, V57, P2375, DOI 10.1111/j.1532-5415.2009.02581.x
   Shimizu T, 2003, SURG TODAY, V33, P475, DOI 10.1007/s10595-002-2512-1
   Shimodaira Masanori, 2013, BMC Res Notes, V6, P18, DOI 10.1186/1756-0500-6-18
NR 11
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 408
EP 411
DI 10.4070/kcj.2016.46.3.408
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100014
PM 27275178
OA Green Published
DA 2021-04-22
ER

PT J
AU Zha, BS
   Zhu, HG
   Liu, B
   Ye, YS
   Li, J
AF Zha, Binshan
   Zhu, Huagang
   Liu, Bin
   Ye, Yusheng
   Li, Jun
TI Preservation of Internal Iliac Artery after Endovascular Repair of
   Common Iliac Artery Dissection Using Modified Fenestrated Stent Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dissection; Iliac artery; Fenestrated stent-graft
ID ANEURYSM REPAIR; AORTIC-ANEURYSMS; SECONDARY
AB Standard endovascular repair of iliaciaortoiliac pathologies can lead to complications, such as buttock claudication, colon ischemia and erectile dysfunction. Branch grafts have been developed but require at least 6 weeks for customization and are not currently available in China; they are also quite expensive. To our knowledge, modified fenestrated stent grafts (MFSGs) are a safe and effective alternative for treating patients with juxtarenal aneurysms. Most MFSGs are used for the preservation of renal and left subclavian arteries. Few cases of MFSGs have been reported in the treatment of iliac pathologies. The use of an MFSG is decided on a case-by-case basis. This report presents our first clinical use of an MFSG for preservation of the internal iliac artery.
C1 [Zha, Binshan; Zhu, Huagang; Liu, Bin; Ye, Yusheng; Li, Jun] Anhui Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 218 Jixi Rd, Hefei 230022, Peoples R China.
RP Zhu, HG (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 218 Jixi Rd, Hefei 230022, Peoples R China.
EM huagzhu@yeah.net
CR COOK PS, 1995, J VASC SURG, V22, P173, DOI 10.1016/S0741-5214(95)70113-3
   Farahmand P, 2008, EUR J VASC ENDOVASC, V35, P429, DOI 10.1016/j.ejvs.2007.12.001
   Honjo O, 2004, J VASC SURG, V40, P1032, DOI 10.1016/j.jvs.2004.08.020
   Kwak HS, 2006, CARDIOVASC INTER RAD, V29, P883, DOI 10.1007/s00270-005-0087-z
   Kwon SH, 2006, J VASC INTERV RADIOL, V17, P717, DOI 10.1097/01.RVI.0000203919.91135.BD
   Lee CW, 2000, J VASC INTERV RADIOL, V11, P567, DOI 10.1016/S1051-0443(07)61607-8
   Lobato AC, 2013, J VASC SURG, V57, p26S, DOI 10.1016/j.jvs.2012.09.081
   Naughton PA, 2012, J VASC SURG, V55, P956, DOI 10.1016/j.jvs.2011.10.121
   Oderich Gustavo S, 2009, Perspect Vasc Surg Endovasc Ther, V21, P157, DOI 10.1177/1531003509351594
   Oderich GS, 2010, ANN VASC SURG, V24, P278, DOI 10.1016/j.avsg.2009.10.007
   Parlani G, 2012, EUR J VASC ENDOVASC, V43, P287, DOI 10.1016/j.ejvs.2011.12.011
   Redlinger RE, 2013, J VASC SURG, V58, P1171, DOI 10.1016/j.jvs.2013.04.045
   Ricotta JJ, 2012, J VASC SURG, V56, P1535, DOI 10.1016/j.jvs.2012.05.096
   Starnes BW, 2012, J VASC SURG, V56, P601, DOI 10.1016/j.jvs.2012.02.011
   Stone PA, 2011, VASC ENDOVASC SURG, V45, P174, DOI 10.1177/1538574410377240
NR 15
TC 7
Z9 7
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 412
EP 416
DI 10.4070/kcj.2016.46.3.412
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100015
PM 27275179
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Ko, YG
   Choi, D
AF Lee, Jung-Hee
   Ko, Young-Guk
   Choi, Donghoon
TI Endovascular Treatment of Multilevel Chronic Total Occlusion Using a
   Stent Puncture Technique in Buerger's Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Punctures; Endovascular procedures; Peripheral artery disease;
   Thromboangiitis obliterans
ID SUPERFICIAL FEMORAL-ARTERY; THROMBOANGIITIS-OBLITERANS; RECANALIZATION
AB We reported a patient with Buerger's disease who presented with critical limb ischemiawith prior recurrent occlusions after multiple surgical and endovascular treatments. Total occlusion of the whole native femoropopliteal and infrapopliteal arteries was observed. The femoropopliteal bypass graft, as well as a stent that was implanted in the mid-popliteal artery, were also occluded. Because of the lack of distal targets for bypass, surgical revascularization was not feasible; therefore, we decided to perform endovascular treatment. To overcome the limitation of vascular access, the previously implanted popliteal stent was directly punctured, and a guide wire was passed through the bypass graft. After the organized thrombus in the bypass graft was aspirated, further recanalization below the popliteal stent down to the plantar arteries was performed successfully. In conclusion, the stent puncture technique is a feasible and safe option for overcoming the limitations of vascular access in patients with multilevel occlusions.
C1 [Lee, Jung-Hee; Ko, Young-Guk; Choi, Donghoon] Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp,Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp,Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cdhlyj@yuhs.ac
OI Ko, Young-Guk/0000-0001-7748-5788; Choi, Donghoon/0000-0002-2009-9760
CR Cooper LT, 2004, J AM COLL CARDIOL, V44, P2410, DOI 10.1016/j.jacc.2004.09.029
   Del Conde I, 2014, TECH VASC INTERV RAD, V17, P234, DOI 10.1053/j.tvir.2014.11.003
   Gandini R, 2012, J ENDOVASC THER, V19, P30, DOI 10.1583/11-3660.1
   Graziani L, 2012, ANN VASC SURG, V26, P387, DOI 10.1016/j.avsg.2011.08.014
   Graziani L, 2010, CATHETER CARDIO INTE, V75, P433, DOI 10.1002/ccd.22287
   Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468
   Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207
   Palena LM, 2013, CARDIOVASC REVASCULA, V14, P203, DOI 10.1016/j.carrev.2013.05.001
   Puechal X, 2007, RHEUMATOLOGY, V46, P192, DOI 10.1093/rheumatology/kel388
   Sasaki S, 2000, SURG TODAY, V30, P600, DOI 10.1007/s005950070099
   Schlager O, 2005, J ENDOVASC THER, V12, P676, DOI 10.1583/05-1672.1
NR 11
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 417
EP 420
DI 10.4070/kcj.2016.46.3.417
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100016
PM 27275180
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, JH
   Kim, JY
   Kim, SH
   Oh, YS
AF Yang, Ji Hyun
   Kim, Ju Youn
   Kim, Sung-Hwan
   Oh, Yong-Seog
TI Reversal of Pacing-Induced Cardiomyopathy by Normal QRS Axis Pacing
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pacemaker; Heart failure; Cardiac pacing; Cardiomyopathy
ID LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; ATRIAL-FIBRILLATION;
   EJECTION FRACTION; STIMULATION; OUTFLOW
AB Right ventricular apical pacing has been a commonly used method for placement of permanent pacemaker, but it is known to be associated with ventricular dyssynchrony and may lead to heart failure. Septal pacing could be an alternative method to improve this complication but the results have been conflicting; hence, other strategies are needed. This case is about a patient with pacing-induced cardiomyopathy who showed much improvement after repositioning the leads to a site different from that of normally paced QRS axis.
C1 [Yang, Ji Hyun; Kim, Ju Youn; Kim, Sung-Hwan; Oh, Yong-Seog] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM oys@catholic.ac.kr
CR Cano O, 2010, AM J CARDIOL, V105, P1426, DOI 10.1016/j.amjcard.2010.01.004
   Dreger H, 2012, EUROPACE, V14, P238, DOI 10.1093/europace/eur258
   Fung JWH, 2009, INT J CARDIOL, V134, P117, DOI 10.1016/j.ijcard.2007.12.018
   Kim SH, 2014, J INTERV CARD ELECTR, V41, P223, DOI 10.1007/s10840-014-9950-7
   Lieberman R, 2006, J AM COLL CARDIOL, V48, P1634, DOI 10.1016/j.jacc.2006.04.099
   Ouali Sana, 2011, J Med Case Rep, V5, P524, DOI 10.1186/1752-1947-5-524
   Stambler BS, 2003, J CARDIOVASC ELECTR, V14, P1180, DOI 10.1046/j.1540-8167.2003.03216.x
   Sweeney MO, 2006, CIRCULATION, V113, P2082, DOI 10.1161/CIRCULATIONAHA.105.608356
   Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1
   Te CC, 2013, J CARDIOVASC ELECTR, V24, P224, DOI 10.1111/j.1540-8167.2012.02396.x
   Thackray SDR, 2003, EUR HEART J, V24, P1143, DOI 10.1016/S0195-668X(03)00199-4
   Tse HF, 2002, J AM COLL CARDIOL, V40, P1451, DOI 10.1016/S0735-1097(02)02169-1
   Vanagt WY, 2007, NEW ENGL J MED, V357, P2637, DOI 10.1056/NEJMc072317
   Victor F, 1999, J AM COLL CARDIOL, V33, P311, DOI 10.1016/S0735-1097(98)00589-0
   Yu CM, 2009, NEW ENGL J MED, V361, P2123, DOI 10.1056/NEJMoa0907555
NR 15
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 421
EP 424
DI 10.4070/kcj.2016.46.3.421
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100017
PM 27275181
OA Green Published
DA 2021-04-22
ER

PT J
AU Dogan, M
   Arslan, Z
   Un, H
AF Dogan, Mehmet
   Arslan, Zekeriya
   Un, Haluk
TI Sympathetic Activity Index Should Be Kept in Mind When Assessing
   Autonomic Tonus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Dogan, Mehmet] Mevki Mil Hosp, Dept Cardiol, Ankara, Turkey.
   [Arslan, Zekeriya; Un, Haluk] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Cardiol, Istanbul, Turkey.
RP Dogan, M (corresponding author), Irfan Bastug St, Altindag Ankara, Turkey.
EM mehmetdoganmd@yahoo.com
CR Aparci M, 2016, BLOOD PRESS MONIT, V21, P21, DOI 10.1097/MBP.0000000000000152
   Hayashi H, 1997, PACE, V20, P2371, DOI 10.1111/j.1540-8159.1997.tb06073.x
   He WB, 2013, CLIN RES CARDIOL, V102, P361, DOI 10.1007/s00392-013-0545-6
   Hwang JK, 2015, KOREAN CIRC J, V45, P391, DOI 10.4070/kcj.2015.45.5.391
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 429
EP 429
DI 10.4070/kcj.2016.46.3.429
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100019
PM 27275183
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, JK
   Park, SJ
   On, YK
   Kim, JS
   Park, KM
AF Hwang, Jin Kyung
   Park, Seung-Jung
   On, Young Keun
   Kim, June Soo
   Park, Kyoung-Min
TI Sympathetic Activity Index Should Be Kept in Mind When Assessing
   Autonomic Tonus Reply
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Hwang, Jin Kyung; Park, Seung-Jung; On, Young Keun; Kim, June Soo; Park, Kyoung-Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.
RP Hwang, JK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.
CR Aparci M, 2016, BLOOD PRESS MONIT, V21, P21, DOI 10.1097/MBP.0000000000000152
   Hayashi H, 1997, PACE, V20, P2371, DOI 10.1111/j.1540-8159.1997.tb06073.x
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 430
EP 430
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100020
DA 2021-04-22
ER

PT J
AU Balta, S
   Ozturk, C
   Demir, M
   Yildirim, AO
AF Balta, Sevket
   Ozturk, Cengiz
   Demir, Mustafa
   Yildirim, Ali Osman
TI Apelin Levels in Patients with Coronary Artery Ectasia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Balta, Sevket; Ozturk, Cengiz; Demir, Mustafa; Yildirim, Ali Osman] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey.
RP Balta, S (corresponding author), Gulhane Mil Med Acad, Dept Cardiol, Tevfik Saglam St, TR-06018 Etlik, Turkey.
EM drsevketb@gmail.com
CR Bilik MZ, 2015, KOREAN CIRC J, V45, P386, DOI 10.4070/kcj.2015.45.5.386
   Demirkol S, 2013, ANGIOLOGY
   MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5
NR 3
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 431
EP 431
DI 10.4070/kcj.2016.46.3.431
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100021
PM 27275184
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JG
   Choi, JH
   Kim, SY
   Kim, KS
   Joo, SJ
AF Lee, Jae-Geun
   Choi, Joon Hyouk
   Kim, Song-Yi
   Kim, Ki-Seok
   Joo, Seung-Jae
TI Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain
   (vol 46, pg 169, 2016)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Lee, Jae-Geun; Choi, Joon Hyouk; Kim, Song-Yi; Kim, Ki-Seok; Joo, Seung-Jae] Jeju Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jeju, South Korea.
RP Lee, JG (corresponding author), Jeju Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Jeju, South Korea.
CR Lee JG, 2016, KOREAN CIRC J, V46, P169, DOI 10.4070/kcj.2016.46.2.169
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 432
EP 432
DI 10.4070/kcj.2016.46.3.432
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100022
PM 27275185
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KI
   Kim, MA
   Kim, MK
   Kim, SH
   Kim, HS
   Moon, MK
   Park, KS
   Park, YB
   Lim, S
   Choi, SH
   Lee, HY
   Jang, HC
   Lee, SH
   Choi, D
   Lee, HC
   Kim, HC
   Jee, SH
   Cheong, HT
   Park, JY
   Jung, CH
   Lee, MK
   Rhee, EJ
   Do Kyung, K
   Kim, EM
   Hong, SJ
   Hong, SC
   Kim, YS
   Kim, WS
   Hwang, YC
   Ahn, KJ
   Kim, Y
   Chae, SC
   Yun, YM
   Kim, Y
   Park, J
   Kim, YJ
   Han, J
   Kim, J
   Kim, YJ
   Kim, SR
   Baek, SH
   Kwon, HS
   Song, YJ
   Kim, H
   Nam, MS
   Shin, SH
   Lee, JE
   Kim, J
   Kim, CJ
   Kim, DJ
   Kim, OY
   Kim, JR
   Cho, KH
   Park, Y
   Song, GH
   Shin, HH
   Ahn, Y
   Hong, YJ
   Lee, M
   Jae, SY
   Jo, SH
   Choi, S
   Md, YJC
   Park, HY
   Oh, K
   Ahn, KM
AF Kim, Kwang-il
   Kim, Myung-A
   Kim, Min Kyung
   Kim, Sang-Hyun
   Kim, Hyo Soo
   Moon, Min Kyong
   Park, Kyong Soo
   Park, Young-Bae
   Lim, Soo
   Choi, Sung Hee
   Lee, Hae-Young
   Jang, Hak Chul
   Lee, Sang-Hak
   Choi, Donghoon
   Lee, Hyun Cheol
   Kim, Hyeon Chang
   Jee, Sun Ha
   Cheong, Hyun Taek
   Park, Joong-Yeol
   Jung, Chang Hee
   Lee, Mun Kyu
   Rhee, Eun-Jung
   Do Kyung, Kim
   Kim, Eun Mi
   Hong, Soon Jun
   Hong, Soon-Cheol
   Kim, Young Seol
   Kim, Woo-Sik
   Hwang, You-Cheol
   Ahn, Kyu Jeong
   Kim, Youngmi
   Chae, Seong-Cheol
   Yun, Yeo-Min
   Kim, Yangha
   Park, Jung
   Kim, Yong Jae
   Han, Jin
   Kim, Jongwoo
   Kim, Young-Joo
   Kim, Sung-Rae
   Baek, Sang Hong
   Kwon, Hyuk-Sang
   Song, Yoon Ju
   Kim, Hyunwook
   Nam, Moon Suk
   Shin, Sung Hee
   Lee, Ji-Eun
   Kim, Jaetaek
   Kim, Chee Jeong
   Kim, Dae Jung
   Kim, Oh Yoen
   Kim, Jae-Ryong
   Cho, Kyung-Hyun
   Park, Yongsoon
   Song, Gi Ho
   Shin, Hyun Ho
   Ahn, Youngkeun
   Hong, Young Joon
   Lee, Myoungsook
   Jae, Sae Young
   Jo, Sang-Ho
   Choi, Seonghoon
   Choi, Young Jin
   Park, Hyun-Young
   Oh, Kyungwon
   Ahn, Ki Man
CA Comm Korean Guidelines Manage
TI 2015 Korean Guidelines for the Management of Dyslipidemia: Executive
   Summary (English Translation)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
ID CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; ACUTE
   MYOCARDIAL-INFARCTION; ABDOMINAL AORTIC-ANEURYSM; LOWERING LDL
   CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; FAMILIAL
   HYPERCHOLESTEROLEMIA; SCIENTIFIC STATEMENT; PRIMARY PREVENTION
C1 [Kim, Kwang-il; Kim, Myung-A; Kim, Min Kyung; Kim, Sang-Hyun; Kim, Hyo Soo; Moon, Min Kyong; Park, Kyong Soo; Park, Young-Bae; Lim, Soo; Choi, Sung Hee; Lee, Hae-Young; Jang, Hak Chul; Comm Korean Guidelines Manage] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   [Lee, Sang-Hak; Choi, Donghoon; Lee, Hyun Cheol] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea.
   [Jee, Sun Ha] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul 120749, South Korea.
   [Cheong, Hyun Taek; Park, Joong-Yeol; Jung, Chang Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Lee, Mun Kyu; Rhee, Eun-Jung] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
   [Do Kyung, Kim] Samsung Med Ctr, Dept Sport Med, Seoul, South Korea.
   [Kim, Eun Mi] Kangbuk Samsung Hosp, Dietet Dept, Seoul, South Korea.
   [Hong, Soon Jun] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea.
   [Hong, Soon-Cheol] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea.
   [Kim, Young Seol; Kim, Woo-Sik; Hwang, You-Cheol; Ahn, Kyu Jeong] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Youngmi] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea.
   [Chae, Seong-Cheol] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea.
   [Yun, Yeo-Min] Konkuk Univ, Med Ctr, Dept Clin Lab Med, Seoul, South Korea.
   [Kim, Yangha; Park, Jung] Ewha Womans Univ, Coll Med, Dept Nutr Sci & Food Management, Seoul, South Korea.
   [Kim, Yong Jae] Ewha Womans Univ, Coll Med, Dept Neurol, Seoul, South Korea.
   [Han, Jin] Inje Univ, Coll Med, Dept Physiol, Busan, South Korea.
   [Kim, Jongwoo] Inje Univ, Coll Med, Dept Family Med, Seoul, South Korea.
   [Kim, Young-Joo] Inje Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea.
   [Kim, Sung-Rae; Baek, Sang Hong; Kwon, Hyuk-Sang] Catholic Univ, Sch Human Ecol, Dept Internal Med, Seoul, South Korea.
   [Song, Yoon Ju] Catholic Univ, Sch Human Ecol, Dept Food Sci & Nutr, Seoul, South Korea.
   [Kim, Hyunwook] Wonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea.
   [Nam, Moon Suk; Shin, Sung Hee; Lee, Ji-Eun] Inha Univ, Sch Med, Dept Internal Med, Inchon, South Korea.
   [Kim, Jaetaek; Kim, Chee Jeong] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea.
   [Kim, Dae Jung] Ajou Univ, Sch Med, Dept Internal Med, Suwon 441749, South Korea.
   [Kim, Oh Yoen] Dong A Univ, Dept Food Sci & Nutr, Busan, South Korea.
   [Kim, Jae-Ryong] Yeungnam Univ, Dept Biochem & Mol Biol, Kyungsan, South Korea.
   [Cho, Kyung-Hyun] Yeungnam Univ, Dept Med Biotechnol, Kyungsan, South Korea.
   [Park, Yongsoon] Hanyang Univ, Dept Food & Nutr, Seoul 133791, South Korea.
   [Song, Gi Ho] Konkuk Univ, Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Shin, Hyun Ho] Dankook Univ, Cheil Gen Hosp, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Ahn, Youngkeun; Hong, Young Joon] Chonnam Natl Univ, Coll Med, Dept Internal Med, Kwangju, South Korea.
   [Lee, Myoungsook] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea.
   [Jae, Sae Young] Univ Seoul, Dept Sport Sci, Seoul, South Korea.
   [Jo, Sang-Ho; Choi, Seonghoon] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea.
   [Choi, Young Jin] Sejong Gen Hosp, Dept Internal Med, Bucheon, South Korea.
   [Park, Hyun-Young; Oh, Kyungwon] Ctr Dis Control & Prevent, Osong, South Korea.
   [Ahn, Ki Man] Humanworkers, Seoul, South Korea.
RP Kim, CJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, 84 Heukseok Ro, Seoul 06974, South Korea.
EM cjkim@cau.ac.kr
RI Kim, Kwang-il/D-8024-2012; Park, Yoon Jung/AAW-2712-2020; Moon, Min
   Kyong/AAE-7663-2020; Rhim, Sonny H./W-9532-2019; Park,
   Yongsoon/E-6968-2017; Jung, Chang Hee/AAU-7897-2020; Lim,
   Soo/AAU-8107-2020; Kim, Hack-Lyoung/AAL-5038-2020; Lee,
   Ji-Eun/I-4784-2013; Kim, Dae Jung/AAJ-7518-2021; Kim,
   Jaetaek/AAE-7147-2020; Rhee, Eun-Jung/M-9294-2015; Park, Kyong
   Soo/C-2265-2008; Kim, Hyeon Chang/F-8796-2019
OI Kim, Kwang-il/0000-0002-6658-047X; Moon, Min Kyong/0000-0002-5460-2846;
   Park, Yongsoon/0000-0001-5110-5716; Lim, Soo/0000-0002-4137-1671; Kim,
   Hack-Lyoung/0000-0002-6703-1472; Lee, Ji-Eun/0000-0002-7386-0015; Kim,
   Dae Jung/0000-0003-1025-2044; Kim, Jaetaek/0000-0001-5247-0408; Rhee,
   Eun-Jung/0000-0002-6108-7758; Ahn, Kyu Jeung/0000-0002-4648-3605; Park,
   Kyong Soo/0000-0003-3597-342X; Yun, Yeo-Min/0000-0002-5485-8331; Song,
   YoonJu/0000-0002-4764-5864; Hwang, You-Cheol/0000-0003-4033-7874; Lee,
   Myoungsook/0000-0003-1344-6979; Choi, Donghoon/0000-0002-2009-9760; Kim,
   Sang-Hyun/0000-0001-8026-1582; Kim, Hyeon Chang/0000-0001-7867-1240;
   Jee, Sun Ha/0000-0001-9519-3068
CR Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4
   Amarenco P, 2006, NEW ENGL J MED, V355, P549
   Arai H, 2014, J ATHEROSCLER THROMB, V21, P79
   BACHORIK PS, 1995, CLIN CHEM, V41, P1414
   Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3
   Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012
   Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213
   Blair SN, 2006, JAMA-J AM MED ASSOC, V296, P216, DOI 10.1001/jama.296.2.216
   Broeders N, 2000, NEPHROL DIAL TRANSPL, V15, P1993, DOI 10.1093/ndt/15.12.1993
   Brown L, 1999, AM J CLIN NUTR, V69, P30
   Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023
   Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7
   Cannon CP, 2014, CIRCULATION, V130, P2109
   Chrysohoou Christina, 2003, Eur J Cardiovasc Prev Rehabil, V10, P355, DOI 10.1097/01.hjr.0000065928.57001.4d
   Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5
   Collins R, 2002, LANCET, V360, P7, DOI 10.1016/s0140-6736(02)09327-3
   Collins R, 2003, LANCET, V361, P2005
   de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307
   Defesche Joep C, 2004, Semin Vasc Med, V4, P59
   Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004
   Elisaf M, 2002, CURR MED RES OPIN, V18, P269, DOI 10.1185/030079902125000516
   Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d
   Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C
   Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a
   Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177
   Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44
   FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679
   Germano G, 2012, EUR HEART J, V33, P137
   Gidding Samuel S, 2005, Circulation, V112, P2061, DOI 10.1161/CIRCULATIONAHA.105.169251
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Gotto Jr AM, 2013, DRUGS FOR THE HEART, P398
   GRUNDY SM, 1981, J LIPID RES, V22, P24
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S
   Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1249/mss.0b013e3180616b27
   HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575, DOI 10.1016/0002-9378(88)90193-7
   HERTZER NR, 1980, ANN SURG, V192, P667
   Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0
   Hong S, 2012, METABOLISM, V61, P883, DOI 10.1016/j.metabol.2011.10.018
   Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356
   Hyre AD, 2007, AM J KIDNEY DIS, V49, P37, DOI 10.1053/j.ajkd.2006.09.017
   Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025
   JONAS MA, 1992, CIRCULATION, V86, P1664, DOI 10.1161/01.CIR.86.5.1664
   Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7
   Jun KR, 2008, CLIN CHEM LAB MED, V46, P371, DOI 10.1515/CCLM.2008.064
   Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kelley GA, 2009, PREV MED, V49, P473, DOI 10.1016/j.ypmed.2009.09.018
   Kelley GA, 2009, PREV MED, V48, P9, DOI 10.1016/j.ypmed.2008.10.010
   Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
   Kim Hyeon Chang, 2013, J Prev Med Public Health, V46, P165, DOI 10.3961/jpmph.2013.46.4.165
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194
   KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1
   Kwon JE, 2014, J LIPID ATHEROSCLER, V3, P21, DOI DOI 10.12997/jla.2014.3.1.21
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057
   Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014
   McCrindle BW, 2007, CIRCULATION, V115, P1948, DOI 10.1161/CIRCULATIONAHA.107.181946
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146
   Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5
   Miller WG, 2010, CLIN CHEM, V56, P977, DOI 10.1373/clinchem.2009.142810
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2013, KOR HLTH STAT 2012 O
   MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5
   Nicholls SJ, 2010, AM J CARDIOL, V105, P69, DOI 10.1016/j.amjcard.2009.08.651
   Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273
   NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485
   Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x
   Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   RISSANEN AM, 1977, BRIT HEART J, V39, P875, DOI 10.1136/hrt.39.8.875
   Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374
   Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6
   Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207
   SELMER R, 1992, AM J EPIDEMIOL, V136, P428, DOI 10.1093/oxfordjournals.aje.a116516
   Sharp Collaborative G, 2010, AM HEART J, V160
   Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
   Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a
   Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725
   Sukhija R, 2006, AM J CARDIOL, V97, P279, DOI 10.1016/j.amjcard.2005.08.033
   Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112
   Tonelli M, 2005, J AM SOC NEPHROL, V16, P3748, DOI 10.1681/ASN.2005070779
   Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453
   TOSKES PP, 1990, GASTROENTEROL CLIN N, V19, P783
   US Food and Drug Administration, 2012, FDA DRUG SAF COMM IM
   Vaucher J, 2014, EUR HEART J, V35, P958, DOI 10.1093/eurheartj/ehu064
   Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA
   Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545
   Welfare MoH, 2012, KOR HLTH STAT 2011 K
   Wenger NK, 2007, ANN INTERN MED, V147, P1, DOI 10.7326/0003-4819-147-1-200707030-00002
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   World Health Organization (CH), 2012, GLOB HLTH OBS GHO DA
   World Health Organization Human Genetics Programme (CH), 1998, WHOHGNHCONS992
   Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]
NR 102
TC 62
Z9 62
U1 0
U2 13
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 275
EP 306
DI 10.4070/kcj.2016.46.3.275
PG 32
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100001
PM 27275165
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, EK
AF Choi, Eue-Keun
TI Angiotensin Receptor Blocker for Stroke Prevention in Atrial
   Fibrillation: beyond Blood Pressure Lowering?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PLATELET-AGGREGATION; INHIBITION; SYSTEM
C1 [Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul 110744, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019
OI Choi, Eue-Keun/0000-0002-0411-6372; 
CR Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Choi JI, 2016, KOREAN CIRC J, V46, P335, DOI 10.4070/kcj.2016.46.3.335
   Murad JP, 2012, J CARDIOVASC PHARM T, V17, P308, DOI 10.1177/1074248411425491
   Remkova A, 2010, PHYSIOL RES, V59, P13, DOI 10.33549/physiolres.931525
   Sakamoto T, 2014, HYPERTENS RES, V37, P513, DOI 10.1038/hr.2014.22
   Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043
   TOUYZ RM, 1993, HYPERTENSION, V22, P853, DOI 10.1161/01.HYP.22.6.853
NR 7
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 307
EP 308
DI 10.4070/kcj.2016.46.3.307
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100002
PM 27275166
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JI
   Jung, JS
   Kim, MK
   Sim, J
   Kim, JS
   Lim, HE
   Park, SW
   Kim, YH
AF Choi, Jong-Ii
   Jung, Jae Seung
   Kim, Min Kyung
   Sim, Jaemin
   Kim, Jin Seok
   Lim, Hong Euy
   Park, Sang Wean
   Kim, Young-Hoon
TI Effects of Angiotensin-II Receptor Blocker on Inhibition of
   Thrombogenicity in a Canine Atrial Fibrillation Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Angiotensin II; Fibrosis; Biological markers;
   Thromboembolism
ID HEART-FAILURE; MECHANISMS; FIBROSIS
AB Background and Objectives: Angiotensin-II receptor blockers (ARBs) are known to reduce the development of atrial fibrillation (AF) through reverse-remodeling. However, the effect of ARBs on thrombogenicity in AF remains unknown.
   Materials and Methods: Twelve dogs were assigned to control (n=4), ARB (candesartan cilexitil 10 mg/kg/day p.o., 12 weeks; n=4), or sham (n=4) groups. Sustained AF was induced by rapid atrial pacing. Both arterial and venous serum levels of tissue inhibitor of matrix metalloproteinase-1, von Willebrand factor, P-selectin, and vascular cell adhesion molecule-1 (VCAM-1) were measured at baseline and during AF (0, 4, and 12 weeks) with enzyme-linked immunosorbent assay. Biopsies from both atria including the appendages were performed to semi-quantitatively assess endocardial and myocardial fibrosis after 12 weeks.
   Results: The serum levels of bio-markers were not significantly different at baseline or during AF between the control and the candesartan groups. The levels were not significantly different over time, but there was a trend toward a decrease in arterial VCAM-1 from 4 to 12 weeks in the candesartan group compared to the control group. The grades of endocardial fibrosis after 12 weeks but not those of myocardial fibrosis were slightly reduced in the candesartan group compared to the control group.
   Conclusion: This study did not show that the ARB candesartan significantly reverses thrombogenicity or fibrosis during AF. Future studies using a larger number of subjects are warranted to determine the therapeutic effect of renin-angiotensin-aldosterone system blockade on prothrombogenic processes in AF.
C1 [Choi, Jong-Ii; Sim, Jaemin; Kim, Jin Seok; Lim, Hong Euy; Park, Sang Wean; Kim, Young-Hoon] Korea Univ, Coll Med, Med Ctr, Dept Internal Med,Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
   [Jung, Jae Seung] Korea Univ, Coll Med, Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 02841, South Korea.
   [Kim, Min Kyung] Kim Min Kyungs Pathol Clin, Seoul, South Korea.
RP Choi, JI (corresponding author), Korea Univ, Coll Med, Med Ctr, Dept Internal Med,Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
EM jongilchoi@korea.ac.kr
RI Kim, Jin-Seok/AAK-5424-2020
OI Kim, Jin-Seok/0000-0002-1854-9312; Jung, Jae Seung/0000-0002-8848-4112
FU Korean Society of Cardiology [2011-20]; Korea University Grant
   [K1220361]; Basic Science Research Program through the National Research
   Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning
   [2012R1A1A1013260]
FX This study was supported by a grant from the Korean Society of
   Cardiology (2011-20) and by a Korea University Grant (K1220361).; This
   research was supported in part by the Basic Science Research Program
   through the National Research Foundation (NRF) of Korea funded by the
   Ministry of Science, ICT & Future Planning (2012R1A1A1013260).
CR Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4
   Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064
   Das UN, 2005, MED SCI MONITOR, V11, pRA155
   Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040
   Freestone B, 2004, J HUM HYPERTENS, V18, P461, DOI 10.1038/sj.jhh.1001694
   Goette A, 2008, CIRCULATION, V117, P732, DOI 10.1161/CIRCULATIONAHA.107.730101
   He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369
   Kim HS, 2013, J KOREAN MED SCI, V28, P700, DOI 10.3346/jkms.2013.28.5.700
   Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9
   Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402
   Lin CS, 2008, CELL MOL LIFE SCI, V65, P1489, DOI 10.1007/s00018-008-7408-8
   Nakashima H, 2007, CIRC J, V71, P1977, DOI 10.1253/circj.71.1977
   Nattel S, 2004, CIRC RES, V94, P1403, DOI 10.1161/01.RES.0000133229.19586.bb
   Park JH, 2014, KOREAN CIRC J, V44, P233, DOI 10.4070/kcj.2014.44.4.233
   Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009
   Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748
   TAKAGISHI T, 1995, BIOCHEM MOL BIOL INT, V35, P265
   Vasiljevic JD, 2001, HISTOPATHOLOGY, V38, P338, DOI 10.1046/j.1365-2559.2001.01101.x
   Wachtell K, 2005, J AM COLL CARDIOL, V45, P705, DOI 10.1016/j.jacc.2004.06.080
   Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4
NR 20
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 335
EP 342
DI 10.4070/kcj.2016.46.3.335
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100006
PM 27275170
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, S
   Shin, JH
   Park, WC
   Kim, SG
   Shin, J
   Lim, YH
   Lee, Y
AF Choi, Seongll
   Shin, Jeung-Hun
   Park, Whan-Cheol
   Kim, Soon-Gil
   Shin, Jinho
   Lim, Young-Hyo
   Lee, Yonggu
TI Two Distinct Responses of Left Ventricular End-Diastolic Pressure to
   Leg-Raise Exercise in Euvolemic Patients with Exertional Dyspnea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Left ventricular function; Exercise; Heart failure; diastolic
ID PRESERVED EJECTION FRACTION; HEART-FAILURE; DYNAMIC EXERCISE; DIAGNOSIS;
   RELAXATION; RESERVE
AB Background and Objectives: Few studies have invasively assessed diastolic functional reserve and serial changes in left ventricular hemodynamics in euvolemic patients with exertional dyspnea. In this study, sequential changes in left ventricular end-diastolic pressure (LVEDP) to leg-raise exercise were measured invasively in patients with early heart failure with preserved ejection fraction (HFpEF) to determine the association between these serial changes and echocardiographic results or clinical features.
   Subjects and Methods: During their hospital stay, 181 patients with early HFpEF underwent left cardiac catheterization, coronary angiography, and transthoracic echocardiography (TTE). Leg-raise exercise was performed in two stages: during cardiac catheterization and again during TTE.
   Results: Compared with the initial values, all the invasively measured LVEDP values increased significantly during the leg-raise exercise, whereas the septal e/e' ratio remained unchanged. Active leg-raise led to increased LVEDP, which caused dyspnea. The severity of symptoms correlated with the level and extent of changes in LVEDP. At the end of active leg-raise, LVEDP decreased in 40 patients (22.1%), who were younger and had significantly lower e/e' ratios. On multivariate analysis to predict the response of LVEDP to active leg-raise, age and the septal e/e' ratio remained significant predictors.
   Conclusion: Despite having similar LVEDP values at rest, patients may respond to exercise with different LVEDP levels and clinical manifestations, depending on their diastolic capacity. The leg-raise exercise in early HFpEF can elucidate individual diastolic profiles, and the LVEDP response to the leg-raise test may serve as a useful criterion in stratifying patients with early HFpEF with respect to functional reserve.
C1 [Choi, Seongll; Shin, Jeung-Hun; Park, Whan-Cheol; Kim, Soon-Gil] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med,Dept Cardiol, 153 Gyeongchun Ro, Guri 11923, South Korea.
   [Shin, Jinho; Lim, Young-Hyo] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.
   [Lee, Yonggu] Seoul SeungAe Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Choi, S (corresponding author), Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med,Dept Cardiol, 153 Gyeongchun Ro, Guri 11923, South Korea.
EM saint536@hanmail.net
RI Lee, Yonggu/Q-3832-2018
OI Lee, Yonggu/0000-0002-3757-3692; Choi, Seongil/0000-0001-5927-8574;
   Shin, Jinho/0000-0001-6706-6504
CR Borlaug BA, 2011, HEART, V97, P964, DOI 10.1136/hrt.2010.212787
   Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426
   Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701
   Chattopadhyay S, 2010, CIRC-HEART FAIL, V3, P35, DOI 10.1161/CIRCHEARTFAILURE.108.824888
   Choi EY, 2010, J AM SOC ECHOCARDIOG, V23, P523
   Dorfs S, 2014, EUR HEART J, V35, P3103, DOI 10.1093/eurheartj/ehu315
   Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054
   Erdei T, 2015, HEART, V101, P1355, DOI 10.1136/heartjnl-2014-307040
   Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
   Ha JW, 2009, HEART, V95, P399, DOI 10.1136/hrt.2008.145441
   HITTINGER L, 1994, CIRCULATION, V89, P2219, DOI 10.1161/01.CIR.89.5.2219
   Ingle L, 2008, HEART, V94, P748, DOI 10.1136/hrt.2007.131144
   Ishizu T, 2008, EUR J HEART FAIL, V10, P1094, DOI 10.1016/j.ejheart.2008.07.011
   Kerner W, 2014, EXP CLIN ENDOCR DIAB, V122, P384, DOI 10.1055/s-0034-1366278
   Lam CSP, 2010, J AM COLL CARDIOL, V55, P1710, DOI 10.1016/j.jacc.2009.12.034
   Maier LS, 2013, JACC-HEART FAIL, V1, P115, DOI 10.1016/j.jchf.2012.12.002
   Obokata M, 2013, JACC-CARDIOVASC IMAG, V6, P749, DOI 10.1016/j.jcmg.2013.04.006
   Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037
   Penicka M, 2010, J AM COLL CARDIOL, V55, P1700, DOI 10.1016/j.jacc.2009.11.076
   Previtali M, 2012, EUR HEART J-CARD IMG, V13, P588, DOI 10.1093/ejechocard/jer286
   Takeichi Y, 2001, J AM COLL CARDIOL, V38, P335, DOI 10.1016/S0735-1097(01)01384-5
NR 21
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 350
EP 364
DI 10.4070/kcj.2016.46.3.350
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100008
PM 27275172
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, IS
   Pyun, WB
   Shin, J
   Ihm, SH
   Kim, JH
   Park, S
   Kim, KI
   Kim, WS
   Kim, SG
   Shin, GJ
AF Kang, In Sook
   Pyun, Wook Bum
   Shin, Jinho
   Ihm, Sang-Hyun
   Kim, Ju Han
   Park, Sungha
   Kim, Kwang-Il
   Kim, Woo-Shik
   Kim, Soon Gil
   Shin, Gil Ja
TI Higher Blood Pressure Variability in White Coat Hypertension; from the
   Korean Ambulatory Blood Pressure Monitoring Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure monitoring; Ambulatory; Blood pressure variability; White
   coat hypertension
ID VISIT-TO-VISIT; PROGNOSTIC-SIGNIFICANCE; SUSTAINED HYPERTENSION; MASKED
   HYPERTENSION; SHORT-TERM; FOLLOW-UP; STROKE; NORMOTENSION; DEFINITIONS;
   IMPACT
AB Background and Objectives: Blood pressure variability (BPV) was recently shown to be a risk factor of stroke. White coat hypertension (WCH) used to be regarded as innocuous, but one long-term follow-up study reported that WCH increased stroke rate compared to normotension (NT). In this study, we aimed to evaluate the relationship between WCH and BPV.
   Subjects and Methods: We analyzed 1398 subjects from the Korean Ambulatory Blood Pressure Registry, who were divided into NT (n=364), masked hypertension (n=122), white coat hypertension (n=254), and sustained hypertension (n=658) groups.
   Results: Baseline characteristics were similar among groups. The average real variability (ARV), a highly sensitive BPV parameter, was highest in the WCH group, followed by the sustained hypertension, masked hypertension, and NT groups. The results persisted after being adjusted for covariates. The WCH vs. sustained hypertension results (adjusted mean standard error) were as follows: 24-h systolic ARV, 22.9 +/- 0.8 vs. 19.4 +/- 0.6; 24-h diastolic ARV, 16.8 +/- 0.6 vs. 14.3 +/- 0.5; daytime systolic ARV, 21.8 +/- 0.8 vs. 16.8 +/- 0.6; and daytime diastolic ARV, 16.2 +/- 0.6 vs. 13.4 +/- 0.5 (p<0.001 for all comparisons).
   Conclusion: From the registry data, we found that subjects with WCH or masked hypertension had higher BPV than NT. However, long-term follow-up data assessing the clinical influences of WCH on stroke are needed.
C1 [Kang, In Sook; Pyun, Wook Bum; Shin, Gil Ja] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
   [Shin, Jinho; Kim, Soon Gil] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.
   [Ihm, Sang-Hyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Ju Han] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.
   [Park, Sungha] Yonsei Univ, Sch Med, Dept Internal Med, Seoul 120749, South Korea.
   [Kim, Kwang-Il] Seoul Natl Univ, Sch Med, Dept Internal Med, Songnam, South Korea.
   [Kim, Woo-Shik] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Div Cardiol, Anyangcheon Ro 1071, Seoul 07985, South Korea.
EM pwb423@ewha.ac.kr
RI Kim, Kwang-il/D-8024-2012
OI Kim, Kwang-il/0000-0002-6658-047X; Shin, Jinho/0000-0001-6706-6504
FU Korean Society of Hypertension; Working Group on Blood Pressure
   Monitoring in the Korean Society of Hypertension
FX This study was supported and organized by the Korean Society of
   Hypertension and the Working Group on Blood Pressure Monitoring in the
   Korean Society of Hypertension.
CR Bjorklund K, 2002, CIRCULATION, V106, P63, DOI 10.1161/01.CIR.0000019737.87850.5A
   Bonow RO, 2012, BRAUNWALDS HEART DIS, P218
   Cacciolati C, 2013, AM J HYPERTENS, V26, P367, DOI 10.1093/ajh/hps054
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135
   Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007
   Fagard RH, 2007, J HYPERTENS, V25, P2193, DOI 10.1097/HJH.0b013e3282ef6185
   Franks PW, 2005, HYPERTENSION, V45, P183, DOI 10.1161/01.HYP.0000151621.03913.f3
   Glen SK, 1996, LANCET, V348, P654, DOI 10.1016/S0140-6736(96)02303-3
   Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2
   JULIUS S, 1990, HYPERTENSION, V16, P617, DOI 10.1161/01.HYP.16.6.617
   Kang IS, 2013, J KOREAN MED SCI, V28, P1461, DOI 10.3346/jkms.2013.28.10.1461
   Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb
   Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151
   Mancia G, 2013, HYPERTENSION, V62, P168, DOI 10.1161/HYPERTENSIONAHA.111.00690
   Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Myers MG, 2012, HYPERTENSION, V59, P532, DOI 10.1161/HYPERTENSIONAHA.111.189472
   Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070
   Parati G, 1996, ANN NY ACAD SCI, V783, P47, DOI 10.1111/j.1749-6632.1996.tb26706.x
   Pickering T. G., 1998, BLOOD PRESS MONIT, V3, P141
   Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103
   Poortvliet RKE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052438
   Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1
   Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X
   Schillaci G, 2012, HYPERTENSION, V60, P369, DOI 10.1161/HYPERTENSIONAHA.112.197491
   Sorof JM, 2001, AM J HYPERTENS, V14, P855, DOI 10.1016/S0895-7061(01)02180-X
   VERDECCHIA P, 1992, HYPERTENSION, V20, P555, DOI 10.1161/01.HYP.20.4.555
   Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89
   Zakopoulos NA, 2006, J HYPERTENS, V24, P2071, DOI 10.1097/01.hjh.0000244957.47114.88
NR 30
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 365
EP 373
DI 10.4070/kcj.2016.46.3.365
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100009
PM 27275173
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, BM
   Kim, HC
   Shim, JS
   Lee, MH
   Choi, DP
AF Song, Bo Mi
   Kim, Hyeon Chang
   Shim, Jee-Seon
   Lee, Myung Ha
   Choi, Dong Phil
TI Inter-Arm Difference in Brachial Blood Pressure in the General
   Population of Koreans0
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Korean; General population
ID VASCULAR-DISEASE; PRIMARY-CARE; HYPERTENSION; ASSOCIATION; MORTALITY;
   READINGS; PATIENT
AB Background and Objectives: We investigated the inter-arm difference in blood pressure of the general Korean population to identify associated factors.
   Subjects and Methods: A total of 806 participants aged 30 to 64 years without history of major cardiovascular disease were analyzed in this cross-sectional study. They participated in the Cardiovascular and Metabolic Disease Etiology Research Center cohort study that began in 2013. Brachial blood pressure was measured simultaneously for both arms using an automated oscillometric device equipped with two cuffs in seated position. After five minutes of rest, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured three times. The average of the three measurements was used for analysis. Multivariate logistic regression models were used to identify factors associated with inter-arm differences in blood pressure.
   Results: The mean inter-arm difference was 3.3 mmHg for SBP and 2.0 mmHg for DBP. Large inter-arm differences (>= 10 mmHg) in SBP and in DBP were found in 3.7% and 0.9% of subjects, respectively. A large inter-arm difference in SBP was associated with mean SBP (p=0.002) and C-reactive protein (p=0.014) while a large inter-arm different in DBP was only associated with body mass index (p=0.015). Sex, age, and anti-hypertensive medication use were not associated with differences in inter-arm blood pressure.
   Conclusion: Large inter-arm difference in blood pressure is only present in a small portion of healthy Korean adults. Our findings suggest that high SBP, chronic inflammation, and obesity may be associated with larger difference in inter-arm blood pressure.
C1 [Song, Bo Mi] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea.
   [Song, Bo Mi; Kim, Hyeon Chang; Shim, Jee-Seon; Lee, Myung Ha; Choi, Dong Phil] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Choi, Dong Phil] Rural Dev Adm, Natl Acad Agr Sci, Jeonju, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240; Shim, Jee-Seon/0000-0002-8671-3153
FU Korean Health Technology R&D Project - Ministry of Health Welfare, Korea
   [HI13C0715]
FX The study was supported by a grant (HI13C0715) of the Korean Health
   Technology R&D Project funded by the Ministry of Health & Welfare,
   Korea.
CR Agarwal NK, 2013, DRUG DISCOV, V7, P9
   AMSTERDAM B, 1943, NY STATE J MED, V43, P2294
   Arnett DK, 2005, J HYPERTENS, V23, P1141, DOI 10.1097/01.hjh.0000170376.23461.f7
   Cassidy P, 2001, J HUM HYPERTENS, V15, P519, DOI 10.1038/sj.jhh.1001224
   Cho HM, 2015, YONSEI MED J, V56, P921, DOI 10.3349/ymj.2015.56.4.921
   Clark CE, 2007, J HUM HYPERTENS, V21, P633, DOI 10.1038/sj.jhh.1002209
   Clark CE, 2006, J HUM HYPERTENS, V20, P923, DOI 10.1038/sj.jhh.1002093
   Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035
   Clark CE, 2014, DIABETES CARE, V37, P1613, DOI 10.2337/dc13-1576
   Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327
   Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8
   Eguchi K, 2007, ARCH INTERN MED, V167, P388, DOI 10.1001/archinte.167.4.388
   Fonseca-Reyes S, 2012, BLOOD PRESS MONIT, V17, P149, DOI 10.1097/MBP.0b013e32835681e2
   HARRISON EG, 1960, CIRCULATION, V22, P419, DOI 10.1161/01.CIR.22.3.419
   Jin Tak Young, 2013, Clinical Hypertension, V19, P71
   Johansson JK, 2014, J HYPERTENS, V32, P260, DOI 10.1097/HJH.0000000000000040
   Kim J, 2013, NEUROLOGY, V80, P1457, DOI 10.1212/WNL.0b013e31828cf87c
   Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009
   Maeda S, 2013, BLOOD PRESS MONIT, V18, P133, DOI 10.1097/MBP.0b013e32836175e3
   Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
   PEPYS MB, 1981, LANCET, V1, P653
   PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611
   Pickering TG, 2005, CIRCULATION, V111, P697, DOI [10.1161/01.CIR.0000154900.76284.F6, 10.1161/01.HYP.0000150859.47929.8e]
   PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399
   REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.273.15.1211
   Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173
   Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125
   Weinberg I, 2014, AM J MED, V127, P209, DOI 10.1016/j.amjmed.2013.10.027
   Wingfield D, 2002, QJM-INT J MED, V95, P571, DOI 10.1093/qjmed/95.9.571
NR 29
TC 11
Z9 12
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 374
EP 383
DI 10.4070/kcj.2016.46.3.374
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100010
PM 27275174
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HJ
   Yoon, SJ
   Oh, IH
   Lim, JH
   Kim, YA
AF Kim, Hyun-Jin
   Yoon, Seok-Jun
   Oh, In-Hwan
   Lim, Jae Hee
   Kim, Young Ae
TI Medication Adherence and the Occurrence of Complications in Patients
   with Newly Diagnosed Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Medication adherence; Anti-hypertensive medications;
   Cerebrovascular disease
ID CARE EXPENDITURES; ECONOMIC BURDEN; POPULATION; IMPACT; KOREA; RISK;
   METAANALYSIS; OUTCOMES; THERAPY; DISEASE
AB Background and Objectives: In this retrospective cohort study, we sought to elucidate the relationship between medication adherence (MA) and the incidence of complications in patients with newly diagnosed hypertension.
   Subjects and Methods: Using claims data from the National Health Insurance Service, we measured health outcomes based on levels of MA, analyzed the incidence of complications in patients with a good MA, and clarified factors that may affect or predict MA.
   Results: In 2008, a total of 4294773 patients were diagnosed with hypertension and were subsequently prescribed anti-hypertensive medications. In the present study, we enrolled 564782 patients who met our inclusion/exclusion criteria. The 40-59% medication possession ratio (MPR) group had a 1.36 times higher risk of developing complications (95% confidehce interval [CI]: 1.27-1.45) than did the MPR >= 80% group, as revealed through Cox's proportional hazards analysis. Similarly, the <20% MPR group was 2.01 times more likely to develop complications than the good MA group (95% CI: 1.82-2.23). Overall, patients who had a lower level of MA had a higher risk of developing complications.
   Conclusion: Our results demonstrate that MA is tightly correlated with hypertension health outcomes. Improving MA could be one strategy for reducing the risk of cerebrovascular disease complications and the loss of productivity in these patients.
C1 [Kim, Hyun-Jin] Korea Natl Rehabil Res Inst, Dept Rehabil Stand & Policy, Seoul, South Korea.
   [Yoon, Seok-Jun] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.
   [Oh, In-Hwan; Lim, Jae Hee] Kyung Hee Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Kim, Young Ae] Natl Canc Ctr, Natl Canc Control Inst, Canc Policy Branch, Goyang, South Korea.
RP Yoon, SJ (corresponding author), Seoul Korea Univ, Korea Univ, Coll Med, Dept Prevent Med, 145 Anam Ro, Seoul 02841, South Korea.
EM yoonsj02@korea.ac.kr
RI Oh, In Hwan/AAI-9070-2020
OI Oh, In Hwan/0000-0002-5450-9887
FU Korean Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [HI13C0729]
FX This study was supported by a grant from the Korean Health Technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea
   (HI13C0729).
CR Ademi Z, 2013, CARDIOVASC THER, V31, P370, DOI 10.1111/1755-5922.12034
   Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x
   Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575
   Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008
   Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd
   Dreiher J, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-21
   Friedman O, 2010, AM J MED, V123, P173, DOI 10.1016/j.amjmed.2009.08.008
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Hodgson TA, 2001, MED CARE, V39, P599, DOI 10.1097/00005650-200106000-00008
   Jin Jing, 2008, Ther Clin Risk Manag, V4, P269
   Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230
   Kang JH, 2011, J KOREAN MED SCI, V26, P1533, DOI 10.3346/jkms.2011.26.12.1533
   Kim HJ, 2012, J KOREAN MED ASSOC, V55, P1226, DOI 10.5124/jkma.2012.55.12.1226
   Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681
   Lee CY, 2013, EUR J PREV CARDIOL, V20, P930, DOI 10.1177/2047487312451252
   Lee DH, 2003, KOREAN J PREV MED, V36, P289
   Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x
   Oh IH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-157
   Patel RP, 2002, ANN PHARMACOTHER, V36, P40, DOI 10.1345/aph.1A046
   Ren XS, 2002, J CLIN PHARM THER, V27, P47, DOI 10.1046/j.1365-2710.2002.00387.x
   Roger JP, 2007, AM J PUBLIC HEALTH, V97, P804, DOI 10.2105/AJPH.2005.080184
   Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591
   SKAER TL, 1993, CLIN THER, V15, P905
   Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af
   Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X
   Vlasnik Jon J, 2005, Case Manager, V16, P47
   Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038
   Washington DL, 2002, MIL MED, V167, P235
NR 28
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 384
EP 393
DI 10.4070/kcj.2016.46.3.384
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100011
PM 27275175
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JH
   Park, JE
   Kim, JY
   Kang, T
AF Choi, Jung-Hye
   Park, Jeong-Eun
   Kim, Jang-Young
   Kang, Taeyoung
TI Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid
   Arthritis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endocarditis; non-infective; Arthritis; rheumatoid; Mitral valve
ID CARDIOVASCULAR MORTALITY; CANCER-PATIENTS; DISEASE; METAANALYSIS;
   COHORT; HEART; RISK
AB Rheumatoid arthritis (RA) is frequently associated with various extra-joint complications. Although rare, thromboembolic complications are associated with high morbidity and mortality. We experienced a very rare case of nonbacterial thrombotic endocarditis (NBTE) and subsequent embolic stroke in a patient with RA. A 72-year-old male with a 15-year history of RA suddenly developed neurologic symptoms of vomiting and dizziness. Brain magnetic resonance imaging revealed recently developed multiple cerebellar and cerebral lacunar infarctions. Echocardiography showed a pulsating mitral valve vegetation involving the posterior cusp of the mitral valve leaflet, which was confirmed as NBTE. Immediate anti-coagulation therapy was started. The NBTE lesion disappeared in follow-up echocardiography after 4 weeks of anti-coagulation treatment.
C1 [Choi, Jung-Hye; Park, Jeong-Eun; Kang, Taeyoung] Yonsei Univ, Wonju Coll Med, Dept Rheumatol, Wonju, South Korea.
   [Kim, Jang-Young] Yonsei Univ, Wonju Coll Med, Dept Cardiol, Wonju, South Korea.
RP Kang, T (corresponding author), Yonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Dept Rheumatol, 20 Ilsan Ro, Wonju 16233, South Korea.
EM taeyoung@yonsei.ac.kr
RI Choi, Jung-Hye/AAI-9922-2020
CR Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092
   Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322
   Baghdadi LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117952
   Chatzis A, 1999, CARDIOVASC SURG, V7, P659, DOI 10.1016/S0967-2109(99)00013-7
   Choi HK, 2013, ANN RHEUM DIS, V72, P1182, DOI 10.1136/annrheumdis-2012-201669
   Eiken PW, 2001, MAYO CLIN PROC, V76, P1204, DOI 10.4065/76.12.1204
   el-Shami K, 2007, ONCOLOGIST, V12, P518, DOI 10.1634/theoncologist.12-5-518
   Kang H, 2004, J RHEUMATOL, V31, P1001
   Kim SC, 2014, AM J MED, V128
   Mazokopakis Elias E., 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P84
   Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252
   Mounet F, 1997, ARCH MAL COEUR VAISS, V90, P987
   ONG ML, 1992, INT J CARDIOL, V34, P69, DOI 10.1016/0167-5273(92)90084-G
   Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2
   Turiel M, 2010, AUTOIMMUN REV, V9, P414, DOI 10.1016/j.autrev.2009.11.002
   VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302
   Wislowska M, 1998, CLIN RHEUMATOL, V17, P369, DOI 10.1007/BF01450894
NR 17
TC 6
Z9 6
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2016
VL 46
IS 3
BP 425
EP 428
DI 10.4070/kcj.2016.46.3.425
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DN3GJ
UT WOS:000376950100018
PM 27275182
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, SH
   Nicholls, SJ
   Sakuma, I
   Zhao, D
   Koh, KK
AF Han, Seung Hwan
   Nicholls, Stephen J.
   Sakuma, Ichiro
   Zhao, Dong
   Koh, Kwang Kon
TI Hypertriglyceridemia and Cardiovascular Diseases: Revisited
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Residual cardiovascular risk; Hypertriglyceridemia; Treatment;
   Cardiovascular disease
ID TRIGLYCERIDE-RICH LIPOPROTEINS; CORONARY-ARTERY-DISEASE;
   APOLIPOPROTEIN-C-III; BLOOD CHOLESTEROL PROFILE; ISCHEMIC-HEART-DISEASE;
   ESTER TRANSFER PROTEIN; HIGH-RISK; NONFASTING TRIGLYCERIDES;
   OMEGA-3-FATTY-ACID SUPPLEMENTS; SECONDARY PREVENTION
AB Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting hypertriglyceridemia. Hypertriglyceridemia, triglyceride-rich lipoproteins, and remnant cholesterol have demonstrated to be important risk factors for cardiovascular disease; this has been demonstrated in experimental, genetic, and epidemiological studies. Fibrates can reduce cardiovascular event rates with or without statins. High dose omega-3 fatty acids continue to be evaluated and new specialized targeting treatment modulating triglyceride pathways, such as inhibition of apolipoprotein C-III and angiopoietin-like proteins, are being tested with regard to their effects on lipid profiles and cardiovascular outcomes. In this review, we will discuss the role of hypertriglyceridemia, triglyceride-rich lipoproteins and remnant cholesterol on cardiovascular disease, and the potential implications for treatment stargeting hypertriglyceridemia.
C1 [Han, Seung Hwan; Koh, Kwang Kon] Gachon Univ, Gil Med Ctr, Dept Cardiol, Inchon, South Korea.
   [Nicholls, Stephen J.] Univ Adelaide, Dept Cardiol, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Sakuma, Ichiro] Hokko Mem Clin, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan.
   [Zhao, Dong] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China.
RP Koh, KK (corresponding author), Gachon Univ, Gil Hosp, Dept Cardiol, 21,Namdong Daero 774beon Gil, Inchon 21565, South Korea.
EM kwangk@gilhospital.com
OI Nicholls, Stephen/0000-0002-9668-4368; Sakuma,
   Ichiro/0000-0002-3863-0492
CR Abe Y, 2010, ARTERIOSCL THROM VAS, V30, P2242, DOI 10.1161/ATVBAHA.110.210427
   Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715
   Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749
   [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
   Avanzini F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-68
   Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309
   Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628
   CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5
   Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112
   Chapman MJ, 2010, PHARMACOL THERAPEUT, V126, P314, DOI 10.1016/j.pharmthera.2010.01.008
   Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399
   Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095
   CROUSE JR, 1987, AM J MED, V83, P243, DOI 10.1016/0002-9343(87)90692-9
   Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
   Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603
   Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917
   Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795
   Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100
   Han SH, 2013, INT J CARDIOL, V167, P2404, DOI 10.1016/j.ijcard.2013.01.223
   Han SH, 2005, HYPERTENSION, V46, P1086, DOI 10.1161/01.HYP.0000187900.36455.4c
   Hatsuda S, 2007, J VASC RES, V44, P61, DOI 10.1159/000098153
   Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8
   Henderson HE, 1999, J LIPID RES, V40, P735
   Humphries SE, 1998, ARTERIOSCL THROM VAS, V18, P526, DOI 10.1161/01.ATV.18.4.526
   Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012
   Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628
   Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027
   Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431
   Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3
   Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424
   Kawakami A, 2008, CIRCULATION, V118, P731, DOI 10.1161/CIRCULATIONAHA.108.784785
   Khetarpal SA, 2015, ARTERIOSCL THROM VAS, V35, pE3, DOI 10.1161/ATVBAHA.114.305172
   Kim KI, 2015, KOREAN CIRC J, V45, P108, DOI 10.4070/kcj.2015.45.2.108
   Koh KK, 2004, ATHEROSCLEROSIS, V174, P379, DOI 10.1016/j.atherosclerosis.2004.01.033
   Koh KK, 2005, DIABETES CARE, V28, P1419, DOI 10.2337/diacare.28.6.1419
   Koh KK, 2005, J AM COLL CARDIOL, V45, P1649, DOI 10.1016/j.jacc.2005.02.052
   Koh KK, 2015, J AM COLL CARDIOL, V66, P1848, DOI 10.1016/j.jacc.2015.07.072
   Koh KK, 2012, ATHEROSCLEROSIS, V220, P537, DOI 10.1016/j.atherosclerosis.2011.11.018
   Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406
   Korstanje R, 2004, ATHEROSCLEROSIS, V177, P443, DOI 10.1016/j.atherosclerosis.2004.08.006
   Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603
   Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262
   Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955
   Langsted A, 2011, J INTERN MED, V270, P65, DOI 10.1111/j.1365-2796.2010.02333.x
   Lee MH, 2012, DIABETES METAB J, V36, P43, DOI 10.4093/dmj.2012.36.1.43
   Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300
   Lim S, 2013, INT J CARDIOL, V166, P8, DOI 10.1016/j.ijcard.2012.03.127
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009
   Mora S, 2015, CIRCULATION, V132, P2220, DOI 10.1161/CIRCULATIONAHA.115.016857
   Mora S, 2012, CIRCULATION, V125, P1979, DOI 10.1161/CIRCULATIONAHA.111.088591
   Moyer MP, 1998, ARTERIOSCL THROM VAS, V18, P458, DOI 10.1161/01.ATV.18.3.458
   Nicholls SJ, 2015, AM HEART J, V170, P1061, DOI 10.1016/j.ahj.2015.09.007
   NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534
   Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299
   Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6
   Oh PC, 2014, INT J CARDIOL, V176, P696, DOI 10.1016/j.ijcard.2014.07.075
   Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308
   Park JH, 2015, KOREAN CIRC J, V45, P141, DOI 10.4070/kcj.2015.45.2.141
   Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83
   Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852
   Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001
   Qamar A, 2015, ARTERIOSCL THROM VAS, V35, P1880, DOI 10.1161/ATVBAHA.115.305415
   RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767
   Ren J, 2010, ATHEROSCLEROSIS, V211, P327, DOI 10.1016/j.atherosclerosis.2010.02.020
   Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43
   Rosenson RS, 2014, J AM COLL CARDIOL, V64, P2525, DOI 10.1016/j.jacc.2014.09.042
   Sacks FM, 2014, JAMA INTERN MED, V174, P443, DOI 10.1001/jamainternmed.2013.13309
   Sacks FM, 2010, NEW ENGL J MED, V363, P692, DOI 10.1056/NEJMc1006407
   Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793
   Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4
   Schwartz GG, 2015, J AM COLL CARDIOL, V65, P2267, DOI 10.1016/j.jacc.2015.03.544
   Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797
   Soufi M, 2012, J INVEST MED, V60, P1015, DOI 10.2310/JIM.0b013e3182686918
   Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002
   Taher TH, 2002, AM J CARDIOL, V89, P390, DOI 10.1016/S0002-9149(01)02258-5
   Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917
   Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026
   Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200
   Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020
   Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901
   Zheng XY, 2007, J LIPID RES, V48, P1673, DOI 10.1194/jlr.R700001-JLR200
NR 86
TC 22
Z9 26
U1 0
U2 11
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 135
EP 144
DI 10.4070/kcj.2016.46.2.135
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300002
PM 27014342
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, LY
   Lee, SR
   Jung, JM
   Kim, YS
   Lee, SH
   Rhee, KS
   Chae, JK
   Lee, DH
   Kim, DS
   Kim, WH
   Ko, JK
AF Jung, Lae-Young
   Lee, Sang-Rok
   Jung, Jin-Mu
   Kim, Yi-Shik
   Lee, Sun-Hwa
   Rhee, Kyoung-Suk
   Chae, Jei-Keon
   Lee, Dong-Hwan
   Kim, Dal-Sik
   Kim, Won-Ho
   Ko, Jae-Ki
TI Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood viscosity; Rheology; Acute coronary syndrome; Rosuvastatin
ID DENSITY-LIPOPROTEIN CHOLESTEROL; FAMILIAL HYPERCHOLESTEROLEMIA;
   RHEOLOGY; STATINS; HEMATOCRIT; PARAMETERS; FIBRINOGEN; APHERESIS
AB Background and Objectives: Wall shear stress contributes to atherosclerosis progression and plaque rupture. There are limited studies for statin as a major contributing factor on whole blood viscosity (WBV) in patients with acute coronary syndrome (ACS). This study investigates the effect of statin on WBV in ACS patients.
   Subjects and Methods: We prospectively enrolled 189 consecutive patients (mean age, 61.3 +/- 10.9 years; 132 males; ST-segment elevation myocardial infarction, n=52; non-ST-segment elevation myocardial infarction, n=84; unstable angina n=53). Patients were divided into two groups (group I: previous use of statins for at least 3 months, n=51; group II: statin-naive patients, n=138). Blood viscosities at shear rates of 1 s-1 (diastolic blood viscosity; DBV) and 300 s-1 (systolic blood viscosity; SBV) were measured at baseline and one month after statin treatment. Rosuvastatin was administered to patients after enrollment (mean daily dose, 16.2 +/- 4.9 mg).
   Results: Baseline WBV was significantly higher in group II ([SBV: group I vs group II, 40.8 +/- 5.9 mP vs. 44.2 +/- 7.4 mP, p=0.003], [DBV: 262.2 +/- 67.8 mP vs. 296.9 +/- 76.0 mP, p=0.002]). WBV in group II was significantly lower one month after statin treatment ([SBV: 42.0 +/- 4.7 mP, p=0.012, DBV: 281.4 +/- 52.6 mP, p=0.044]). However, low-density lipoprotein cholesterol level was not associated with WBV in both baseline (SBV: R-2=0.074, p=0.326; DBV: R-2=0.073, p=0.337) and after one month follow up (SBV: R-2=0.104, p=0.265; DBV: R-2=0.112, p=0.232).
   Conclusion: Previous statin medication is an important determinant in lowering WBV in patients with ACS. However, one month of rosuvastatin decreased WBV in statin-naive ACS patients.
C1 [Jung, Lae-Young; Lee, Sang-Rok; Kim, Yi-Shik; Lee, Sun-Hwa; Rhee, Kyoung-Suk; Chae, Jei-Keon; Kim, Won-Ho; Ko, Jae-Ki] Chonbuk Natl Univ Hosp, Div Cardiol, Jeonju, South Korea.
   [Jung, Lae-Young; Lee, Sang-Rok; Kim, Yi-Shik; Lee, Sun-Hwa; Rhee, Kyoung-Suk; Chae, Jei-Keon; Kim, Dal-Sik; Kim, Won-Ho; Ko, Jae-Ki] Chonbuk Natl Univ, Sch Med, 20 Geonji Ro, Jeonju 54907, South Korea.
   [Jung, Jin-Mu; Lee, Dong-Hwan] Chonbuk Natl Univ, Div Mech Design Engn, Jeonju 561756, South Korea.
   [Kim, Dal-Sik] Chonbuk Natl Univ Hosp, Dept Lab Med, Jeonju, South Korea.
RP Lee, SR (corresponding author), Chonbuk Natl Univ, Sch Med, 20 Geonji Ro, Jeonju 54907, South Korea.
EM medorche@jbnu.ac.kr
RI lee, sun hwa/R-1431-2019
OI Lee, Sun Hwa/0000-0001-9752-9717
FU Korea Healthcare Technology R&D Project, Ministry of Health Welfare,
   Korea [HI12C1525-A121641]; Chonbuk National University; CardioVascular
   Research Foundation, Korea (CVRF); Korean Society of Cardiology
   [2011-0315]
FX This study was supported by a grant from the Korea Healthcare Technology
   R&D Project, Ministry of Health & Welfare, Korea (HI12C1525-A121641).
   This paper was supported by research funds from Chonbuk National
   University in 2014. This work was supported by the CardioVascular
   Research Foundation, Korea (CVRF). This work was supported by the
   research fund of the Korean Society of Cardiology (2011-0315).
CR Arbab-Zadeh A, 2012, CIRCULATION, V125, P1147, DOI 10.1161/CIRCULATIONAHA.111.047431
   Banyai S, 2001, ATHEROSCLEROSIS, V159, P513, DOI 10.1016/S0021-9150(01)00532-9
   BEIGEL Y, 1991, J CLIN PHARMACOL, V31, P512, DOI 10.1002/j.1552-4604.1991.tb03729.x
   BO M, 1991, ANGIOLOGY, V42, P106, DOI 10.1177/000331979104200204
   CHO YI, 1991, BIORHEOLOGY, V28, P241
   Cho YI, 2011, KOREAN CIRC J, V41, P287, DOI 10.4070/kcj.2011.41.6.287
   DITZEL J, 1971, ACTA PHYSIOL SCAND, V81, P264
   Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739
   Froom P, 2000, EUR HEART J, V21, P513, DOI 10.1053/euhj.1999.1923
   FUCHS J, 1990, EUR HEART J, V11, P1029, DOI 10.1093/oxfordjournals.eurheartj.a059630
   Holsworth RE, 2014, PERFUSION-UK, V29, P102, DOI 10.1177/0267659113505637
   JAY RH, 1990, ATHEROSCLEROSIS, V85, P249, DOI 10.1016/0021-9150(90)90117-2
   Jung JM, 2014, CLIN BIOCHEM, V47, P489, DOI 10.1016/j.clinbiochem.2014.01.021
   Kensey KR, 2003, CURR MED RES OPIN, V19, P587, DOI 10.1185/030079903125002289
   Kim H, 2013, CLIN BIOCHEM, V46, P139, DOI 10.1016/j.clinbiochem.2012.10.015
   Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423
   Lee AJ, 1998, CIRCULATION, V97, P1467
   Lee SR, 2013, CLIN HEMORHEOL MICRO, V55, P85, DOI 10.3233/CH-131692
   Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966
   Marton Z, 2003, CLIN HEMORHEOL MICRO, V29, P81
   Moriarty PM, 2004, AM J CARDIOL, V93, P1044, DOI 10.1016/j.amjcard.2003.12.059
   Rosenson R S, 2004, J Thromb Haemost, V2, P340, DOI 10.1111/j.1538-79333.2004.0615f.x
   Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643
   Sezer M, 2007, NEW ENGL J MED, V356, P1823, DOI 10.1056/NEJMoa054374
   Shin S, 2007, CLIN HEMORHEOL MICRO, V37, P319
   Vaughan CJ, 1996, LANCET, V348, P1079, DOI 10.1016/S0140-6736(96)05190-2
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
NR 27
TC 5
Z9 5
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 147
EP 153
DI 10.4070/kcj.2016.46.2.147
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300004
PM 27014344
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, SW
   Kim, JY
   Suh, YJ
   Lee, DH
   Yoon, YW
   Lee, BK
   Jung, YH
   Choi, EY
   Hong, BK
   Rim, SJ
   Kwon, HM
AF Kwon, Sung Woo
   Kim, Jong-Youn
   Suh, Young Ju
   Lee, Dae Hyung
   Yoon, Young Won
   Lee, Byoung Kwon
   Jung, Young-Hak
   Choi, Eui-Young
   Hong, Bum-Kee
   Rim, Se-Joong
   Kwon, Hyuck Moon
TI Prognostic Value of Elevated Homocysteine Levels in Korean Patients with
   Coronary Artery Disease: A Propensity Score Matched Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Homocysteine; Coronary artery disease; Prognosis
ID C-REACTIVE PROTEIN; PLASMA HOMOCYSTEINE; FOLIC-ACID;
   CARDIOVASCULAR-DISEASE; LIPOPROTEIN(A); EVENTS; RISK; MORTALITY; IMPACT
AB Background and Objectives: We sought to determine whether an elevated homocysteine (Hcy) level is associated with a worse prognosis in Korean patients with coronary artery disease (CAD).
   Subjects and Methods: A total of 5839 patients (60.40/o male, mean age 61.3 +/- 11.2 years) with CAD were enrolled from 2000 to 2010 at Gangnam Severance Hospital. CAD was diagnosed by invasive coronary angiography. Laboratory values including Hcy level were obtained on the day of coronary angiography and analyses were performed shortly after sampling. Patients were divided into two groups according to their Hcy levels. Baseline risk factors, coronary angiographic findings, length of follow-up, and composite endpoints including cardiac death (CD) and non-fatal myocardial infarction (NFMI) were recorded. 1:1 propensity score matched analysis was also performed.
   Results: Over a mean follow-up period of 4.4 +/- 2.5 years, there were 132 composite endpoints (75 CD and 57 NFMI) with an event rate of 2.3%. Mean Hcy level was 9.9 +/- 4.3 mu mol/L (normal Hcy 7.9 +/- 1.5 mu mol/L and elevated Hcy 13.9 +/- 5.1 mu mol/L). Kaplan-Meier survival analysis showed an association of elevated Hcy level with worse prognosis (p<0.0001). In addition, a multivariate Cox regression analysis showed an association of elevated Hcy level with worse prognosis for both the entire cohort (hazard ratio [HR] 2.077, 95% confidence interval [Cl] 1.467-2.941, p<0.0001) and the propensity score matched cohort (HR 1.982, 95% CI 1.305-3.009, p=0.001).
   Conclusion: Elevated Hcy level is associated with worse outcomes in Korean patients with CAD.
C1 [Kwon, Sung Woo] Inha Univ Hosp, Dept Cardiol, Inchon, South Korea.
   [Kwon, Sung Woo] Yonsei Univ, Grad Sch, Dept Med, Seoul 120749, South Korea.
   [Kim, Jong-Youn; Yoon, Young Won; Lee, Byoung Kwon; Jung, Young-Hak; Choi, Eui-Young; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Cardiol, 211 Eonju Ro, Seoul 06273, South Korea.
   [Kim, Jong-Youn; Yoon, Young Won; Lee, Byoung Kwon; Jung, Young-Hak; Choi, Eui-Young; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiovasc Ctr, 211 Eonju Ro, Seoul 06273, South Korea.
RP Kwon, HM (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Cardiol, 211 Eonju Ro, Seoul 06273, South Korea.; Kwon, HM (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiovasc Ctr, 211 Eonju Ro, Seoul 06273, South Korea.
EM kwonhm@yuhs.ac
RI Suh, Young Ju/AAD-5737-2021
OI Lee, Byoung Kwon/0000-0001-9259-2776; Kwon, Hyuck
   Moon/0000-0001-9901-5015; Hong, Bum Kee/0000-0002-6456-0184; Kim,
   Jong-Youn/0000-0001-7040-8771; Rim, Se Joong/0000-0002-7631-5581
FU Inha University Hospital Research Grant
FX This work was supported by an Inha University Hospital Research Grant.
CR Banos-Gonzalez MA, 2012, CIRC J, V76, P1953, DOI 10.1253/circj.CJ-12-0039
   Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840
   Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227
   Cappuccio FP, 2002, ATHEROSCLEROSIS, V164, P95, DOI 10.1016/S0021-9150(02)00024-2
   Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015
   Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180
   Ebbing M, 2010, J INTERN MED, V268, P367, DOI 10.1111/j.1365-2796.2010.02259.x
   Ferretti G, 2006, ATHEROSCLEROSIS, V184, P1, DOI 10.1016/j.atherosclerosis.2005.08.008
   Ghassibe-Sabbagh M, 2012, ATHEROSCLEROSIS, V222, P180, DOI 10.1016/j.atherosclerosis.2012.02.035
   Kumakura H, 2015, J ATHEROSCLER THROMB, V22, P344, DOI 10.5551/jat.25478
   Kwon SW, 2013, INT J CARDIOL, V167, P1990, DOI 10.1016/j.ijcard.2012.05.007
   Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900
   Marcucci R, 2006, HEART, V92, P377, DOI 10.1136/hrt.2005.061895
   Marti-Carvajal AJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub4
   Miller ER, 2010, AM J CARDIOL, V106, P517, DOI 10.1016/j.amjcard.2010.03.064
   Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403
   Schaffer A, 2014, THROMB RES, V134, P288, DOI 10.1016/j.thromres.2014.05.025
   Sun Y, 2009, CIRC J, V73, P1423, DOI 10.1253/circj.CJ-08-1077
   Tanriverdi H, 2007, CARDIOLOGY, V107, P313, DOI 10.1159/000099068
   Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005
   van Oijen MGH, 2008, AM J CARDIOL, V102, P135, DOI 10.1016/j.amjcard.2008.03.022
   Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028
   Weiss N, 2003, CLIN CHEM LAB MED, V41, P1455, DOI 10.1515/CCLM.2003.223
   Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507
   Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619
   Zairis MN, 2002, J AM COLL CARDIOL, V40, P1375, DOI 10.1016/S0735-1097(02)02267-2
NR 26
TC 5
Z9 5
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 154
EP 160
DI 10.4070/kcj.2016.46.2.154
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300005
PM 27014345
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, HJ
   Kim, JY
   Han, JD
   Lee, HJ
   Kim, JS
   Park, JS
   Choi, RK
   Choi, YJ
   Shim, WH
   Kwon, SW
   Kim, TH
AF Jang, Ho-Jun
   Kim, Ji-Young
   Han, Jae Deok
   Lee, Hyun Jong
   Kim, Je Sang
   Park, Jin Sik
   Choi, Rak Kyeong
   Choi, Young Jin
   Shim, Won-Heum
   Kwon, Sung Woo
   Kim, Tae-Hoon
TI Numbness after Transradial Cardiac Catheterization: the Results from a
   Nerve Conduction Study of the Superficial Radial Nerve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac catheterization; Numbness; Superficial radial nerve lesion;
   Radial neuropathy
ID PERCUTANEOUS CORONARY INTERVENTION; VASCULAR COMPLICATIONS; ARTERIAL
   ACCESS; ANGIOPLASTY; ANGIOGRAPHY; DIAMETER; IMPACT; HAND; SITE; SIZE
AB Background and Objectives: Numbness on the hand occurs infrequently after a transradial cardiac catheterization (TRC). The symptom resembles that of neuropathy. We, therefore, investigated the prevalence, the predicting factors and the presence of neurological abnormalities of numbness, using a nerve conduction study (NCS).
   Subjects and Methods: From April to December 2013, all patients who underwent a TRC were prospectively enrolled. From among these, the patients who experienced numbness on the ipsilateral hand were instructed to describe their symptoms using a visual analogue scale; subsequently, NCSs were performed on these patients.
   Results: Of the total 479 patients in the study sample, numbness occurred in nine (1.8%) following the procedure. The NCS was performed for eight out of the nine patients, four (50%) of which had an abnormal NCS result at the superficial radial nerve. A larger sheath and history of myocardial infarction (p=0.14 and 0.08 respectively) tended towards the occurrence of numbness; however, only the use of size 7 French sheaths was an independent predictor for the occurrence of numbness (odds ratio: 5.50, 95% confidence interval: 1.06-28.58, p=0.042). The symptoms disappeared for all patients but one, within four months.
   Conclusion: A transient injury of the superficial radial nerve could be one reason for numbness after a TRC. A large sheath size was an independent predictor of numbness; therefore, large sized sheaths should be used with caution when performing a TRC.
C1 [Jang, Ho-Jun; Lee, Hyun Jong; Kim, Je Sang; Park, Jin Sik; Choi, Rak Kyeong; Choi, Young Jin; Shim, Won-Heum; Kim, Tae-Hoon] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, 28 Hohyeon Ro,489 Beon Gil, Bucheon 14754, South Korea.
   [Kim, Ji-Young] Inje Univ, Seoul Paik Hosp, Dept Neurol, Seoul, South Korea.
   [Han, Jae Deok] Sejong Gen Hosp, Dept Rehabil, Bucheon, South Korea.
   [Kwon, Sung Woo] Inha Univ Hosp, Dept Internal Med, Div Cardiol, Inchon, South Korea.
RP Kim, TH (corresponding author), Sejong Gen Hosp, Dept Internal Med, Div Cardiol, 28 Hohyeon Ro,489 Beon Gil, Bucheon 14754, South Korea.
EM sch.kimtaehoon@gmail.com
RI Kim, Tae-Hoon/AAG-3292-2021
OI Kim, Tae-Hoon/0000-0002-4032-1285
CR Ahmed B, 2013, J THROMB THROMBOLYS, V36, P84, DOI 10.1007/s11239-012-0847-y
   BRAIDWOOD AS, 1975, J BONE JOINT SURG BR, V57, P380
   CAMPEAU L, 1989, CATHETER CARDIO DIAG, V16, P3, DOI 10.1002/ccd.1810160103
   Cappellari AM, 2013, MUSCLE NERVE, V47, P105, DOI 10.1002/mus.23483
   Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052
   Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390
   Cho EJ, 2013, CATHETER CARDIO INTE, V82, pE465, DOI 10.1002/ccd.24853
   From AM, 2010, CATHETER CARDIO INTE, V76, P911, DOI 10.1002/ccd.22742
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Kanei Y, 2011, CATHETER CARDIO INTE, V78, P840, DOI 10.1002/ccd.22978
   Kiemeneij Ferdinand, 2006, J Invasive Cardiol, V18, P159
   Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x
   Pancholy SB, 2012, CATHETER CARDIO INTE, V80, P288, DOI 10.1002/ccd.23445
   Papadimos TJ, 2002, CATHETER CARDIO INTE, V57, P537, DOI 10.1002/ccd.10367
   Park BK, 2010, CLIN NEUROPHYSIOL, V121, P228, DOI 10.1016/j.clinph.2009.10.011
   Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039
   Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4
   Sasano Nobuko, 2004, J Anesth, V18, P310, DOI 10.1007/s00540-004-0266-0
   SPINDLER HA, 1986, ARCH PHYS MED REHAB, V67, P821
   Stella PR, 1997, CATHETER CARDIO DIAG, V40, P156, DOI 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.3.CO;2-E
   Uhlemann M, 2012, JACC-CARDIOVASC INTE, V5, P36, DOI 10.1016/j.jcin.2011.08.011
   Velasco A, 2012, J INVASIVE CARDIOL, V24, P339
NR 22
TC 10
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 161
EP 168
DI 10.4070/kcj.2016.46.2.161
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300006
PM 27014346
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JG
   Choi, JH
   Kim, SY
   Kim, KS
   Joo, SJ
AF Lee, Jea-Geun
   Choi, Joon Hyouk
   Kim, Song-Yi
   Kim, Ki-Seok
   Joo, Seung-Jae
TI Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Chest pain; Coronary disease; Psychology
ID NORMAL CORONARY-ARTERIES; PSYCHOLOGICAL-FACTORS; DISEASE; THERAPY;
   ANXIETY; ASSOCIATION; DEPRESSION; MORBIDITY; SYMPTOMS; DISORDER
AB Background and Objective: A cardiologist's evaluation of psychiatric symptoms in patients with chest pain is rare. This study aimed to determine the psychiatric characteristics of patients with and without coronary artery disease (CAD) and explore their relationship with the intensity of chest pain.
   Subjects and Methods: Out of 139 consecutive patients referred to the cardiology outpatient department, 31 with atypical chest pain (heartburn, acid regurgitation, dyspnea, and palpitation) were excluded and 108 were enrolled for the present study. The enrolled patients underwent complete numerical rating scale of chest pain and the symptom checklist for minor psychiatric disorders at the time of first outpatient visit. The non-CAD group consisted of patients with a normal stress test, coronary computed tomography angiogram, or coronary angiogram, and the CAD group included those with an abnormal coronary angiogram.
   Results: Nineteen patients (17.6%) were diagnosed with CAD. No differences in the psychiatric characteristics were observed between the groups. "Feeling tense", "self-reproach", and "trouble falling asleep" were more frequently observed in the non-CAD (p=0.007; p=0.046; p=0.044) group. In a multiple linear regression analysis with a stepwise selection, somatization without chest pain in the non-CAD group and hypochondriasis in the CAD group were linearly associated with the intensity of chest pain (beta=0.108, R-2=0.092, p=0.004; beta= -0.525, R-2=0.290, p=0.010).
   Conclusion: No differences in psychiatric characteristics were observed between the groups. The intensity of chest pain was linearly associated with somatization without chest pain in the non-CAD group and inversely 'linearly associated with hypochondriasis in the CAD group.
C1 [Lee, Jea-Geun; Choi, Joon Hyouk; Kim, Song-Yi; Kim, Ki-Seok; Joo, Seung-Jae] Jeju Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Aran 13 Gil 15, Jeju 63241, South Korea.
RP Choi, JH (corresponding author), Jeju Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Aran 13 Gil 15, Jeju 63241, South Korea.
EM valgom@hanmail.net
OI Lee, Jae-Geun/0000-0003-4915-9584
FU Jeju National University Hospital [2012-21]
FX This study was supported by a research grant from the Jeju National
   University Hospital (2012-21).
CR Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011
   BASS C, 1984, PSYCHOL MED, V14, P51, DOI 10.1017/S003329170000307X
   CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003
   CHANNER KS, 1985, LANCET, V2, P820
   CHEN ACN, 1989, PAIN, V37, P143, DOI 10.1016/0304-3959(89)90126-7
   CORMIER LE, 1988, J NERV MENT DIS, V176, P351, DOI 10.1097/00005053-198806000-00004
   D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579
   Dammen T, 2004, GEN HOSP PSYCHIAT, V26, P463, DOI 10.1016/j.genhosppsych.2004.08.004
   Dempe C, 2013, J PSYCHOSOM RES, V74, P122, DOI 10.1016/j.jpsychores.2012.12.003
   GOLD PW, 1986, NEW ENGL J MED, V314, P1329, DOI 10.1056/NEJM198605223142101
   Hoffmann U, 2006, CIRCULATION, V114, P2251, DOI 10.1161/CIRCULATIONAHA.106.634808
   Jeong W, 1987, J KOREAN NEUROPSYCHI, V26, P15
   Kim JY, 2013, J NEUROGASTROENTEROL, V19, P344, DOI 10.5056/jnm.2013.19.3.344
   Kisely SR, 1998, AUST NZ J PSYCHIAT, V32, P172, DOI 10.3109/00048679809062726
   KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3
   Ladwig KH, 1998, PSYCHOTHER PSYCH MED, V48, P46
   LOWN B, 1973, SCIENCE, V182, P834, DOI 10.1126/science.182.4114.834
   MAYOU R, 1994, BRIT HEART J, V72, P548
   Mayou RA, 1997, PSYCHOL MED, V27, P1021, DOI 10.1017/S0033291797005254
   Mayou RA, 1999, HEART, V81, P387, DOI 10.1136/hrt.81.4.387
   Meyer T, 2015, EUR J PREV CARDIOL, V22, P75, DOI 10.1177/2047487313505244
   PAPANICOLAOU MN, 1986, AM J CARDIOL, V58, P1181, DOI 10.1016/0002-9149(86)90378-4
   Ramasubbu R, 2002, MED HYPOTHESES, V59, P537, DOI 10.1016/S0306-9877(02)00244-X
   Reynolds K, 2015, WORLD PSYCHIATRY, V14, P74, DOI 10.1002/wps.20193
   Rohani Atoosheh, 2011, Heart Views, V12, P161, DOI 10.4103/1995-705X.90903
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   TENNANT C, 1994, J PSYCHOSOM RES, V38, P365, DOI 10.1016/0022-3999(94)90041-8
   Varia I, 2000, AM HEART J, V140, P367, DOI 10.1067/mhj.2000.108514
   Watkins LL, 1998, PSYCHOSOM MED, V60, P498, DOI 10.1097/00006842-199807000-00018
   Zachariae R, 2001, AM HEART J, V142, P63, DOI 10.1067/mhj.2001.115794
NR 30
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 169
EP 178
DI 10.4070/kcj.2016.46.2.169
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300007
PM 27014347
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, WS
   Kim, J
   Kwon, CH
   Choi, JH
   Jo, U
   Kim, YR
   Nam, GB
   Choi, KJ
   Kim, YH
AF Lee, Woo Seok
   Kim, Jun
   Kwon, Chang-Hee
   Choi, Jin Hee
   Jo, Uk
   Kim, Yoo Ri
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Tachyarrhythmia Cycle Length in Appropriate versus Inappropriate
   Defibrillator Shocks in Brugada Syndrome, Early Repolarization Syndrome,
   or Idiopathic Ventricular Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardioverter defibrillator, implantable; Brugada syndrome; Ventricular
   fibrillation
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; QUALITY-OF-LIFE; ST-SEGMENT
   ELEVATION; BUNDLE-BRANCH BLOCK; TERM-FOLLOW-UP; THERAPY; ARRHYTHMIAS;
   DELIVERY; ADULTS; TRIAL
AB Background and Objectives: Implantable cardioverter-defibrillators (ICDs) are indicated in patients with Brugada syndrome (BS), early repolarization syndrome (ERS), or idiopathic ventricular fibrillation (IVF) who are at high risk for sudden cardiac death. The optimal ICD programming for reducing inappropriate shocks in these patients remains to be determined. We investigated the difference in the mean cycle length of tachyarrhythmias that activated either appropriate or inappropriate ICD shocks in these three patient groups to determine the optimal ventricular fibrillation (VF) zone for minimizing inappropriate ICD shocks.
   Subjects and Methods: We selected 41 patients (35 men) (mean age standard deviation=42.6 +/- 13.0 year) who received ICD shocks between April 1996 and April 2014 to treat BS (n=24), ERS (n=9), or IVF (n=8). Clinical and ICD interrogation data were retrospectively collected and analyzed for all events with ICD shocks.
   Results: Of the 244 episodes, 180 (73.8%) shocks were appropriate and 64 (26.2%) were inappropriate. The mean cycle lengths of the tachyarrhythmias that activated appropriate and inappropriate shocks were 178.9 +/- 28.7 ms and 284.8 +/- 24.4 ms, respectively (p<0.001). The cutoff value with the highest sensitivity and specificity for discriminating between appropriate and inappropriate shocks was 235 ms (sensitivity, 98.4%; specificity, 95.6%). When we programmed a single VF zone of <= 270 ms, inappropriate ICD shocks were reduced by 70.5% and appropriate shocks were missed in 1.7% of these patients.
   Conclusion: Programming of a single VF zone of <= 270 ms in patients with BS, ERS, or IVF could reduce inappropriate ICD shocks, with a low risk of missing appropriate shocks.
C1 [Lee, Woo Seok; Kim, Jun; Kwon, Chang-Hee; Choi, Jin Hee; Jo, Uk; Kim, Yoo Ri; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
CR Bordachar P, 2004, EUR HEART J, V25, P879, DOI 10.1016/j.ehj.2004.01.004
   Brugada J, 2002, CIRCULATION, V105, P73, DOI 10.1161/hc0102.101354
   BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J
   Cook SC, 2013, HEART RHYTHM, V10, P805, DOI 10.1016/j.hrthm.2013.02.016
   de Vries JW, 1998, ANESTH ANALG, V87, P16, DOI 10.1097/00000539-199807000-00005
   Delaney JT, 2012, EUROPACE, V14, P1428, DOI 10.1093/europace/eus150
   Dubin AM, 1996, PACE, V19, P1555, DOI 10.1111/j.1540-8159.1996.tb03180.x
   Gasparini M, 2013, JAMA-J AM MED ASSOC, V309, P1903, DOI 10.1001/jama.2013.4598
   Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968
   Haissaguerre M, 2009, J AM COLL CARDIOL, V53, P612, DOI 10.1016/j.jacc.2008.10.044
   Kamphuis HCM, 2003, EUROPACE, V5, P381, DOI 10.1016/S1099-5129(03)00078-3
   Kawabata M, 2008, EUROPACE, V10, P282, DOI 10.1093/europace/eun012
   Klein Richard C, 2003, J Cardiovasc Electrophysiol, V14, P940, DOI 10.1046/j.1540-8167.2003.01554.x
   Lever NA, 2007, EUROPACE, V9, P1054, DOI 10.1093/europace/eum194
   Li HG, 1998, PACE, V21, P1789, DOI 10.1111/j.1540-8159.1998.tb00280.x
   Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107
   Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182
   Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014
   RAITT MH, 1995, CIRCULATION, V91, P1996, DOI 10.1161/01.CIR.91.7.1996
   Sacher F, 2013, CIRCULATION, V128, P1739, DOI 10.1161/CIRCULATIONAHA.113.001941
   Sarkozy A, 2007, EUR HEART J, V28, P334, DOI 10.1093/eurheartj/ehl450
   Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330
   Turitto G, 2009, PACE, V32, P82, DOI 10.1111/j.1540-8159.2009.02180.x
   Veltmann C, 2010, CLIN RES CARDIOL, V99, P37, DOI 10.1007/s00392-009-0075-4
   Watanabe H, 2005, J CARDIOVASC ELECTR, V16, P262, DOI 10.1046/j.1540-8167.2005.40579.x
   Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4
   Xie JL, 1997, CIRCULATION, V96, P683
   Yokoshiki H, 2003, J ELECTROCARDIOL, V36, P137, DOI 10.1054/jelc.2003.50018
NR 28
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 179
EP 185
DI 10.4070/kcj.2016.46.2.179
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300008
PM 27014348
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, U
   Kim, J
   Hwang, YM
   Lee, JH
   Kim, MS
   Choi, HO
   Lee, WS
   Kwon, CH
   Ko, GY
   Yoon, HK
   Nam, GB
   Choi, KJ
   Kim, YH
AF Jo, Uk
   Kim, Jun
   Hwang, You-Mi
   Lee, Ji-Hyun
   Kim, Min-Su
   Choi, Hyung-Oh
   Lee, Woo-Seok
   Kwon, Chang-Hee
   Ko, Gi-Young
   Yoon, Hyun-Ki
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Transvenous Lead Extraction via the Inferior Approach Using a Gooseneck
   Snare versus Simple Manual Traction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pacemaker, artificial; Defibrillators, implantable; Device removal
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; SINGLE-CENTER EXPERIENCE;
   DUAL-COIL; PACEMAKER; FAILURE; REMOVAL; PREDICTORS; STANDARD; SHEATHS;
   PATIENT
AB Background and Objectives: The number of patients with cardiac implantable electronic devices needing lead extraction is increasing for various reasons, including infections, vascular obstruction, and lead failure. We report our experience with transvenous extraction of pacemaker and defibrillator leads via the inferior approach of using a gooseneck snare as a first-line therapy and compare extraction using a gooseneck snare with extraction using simple manual traction.
   Subjects and Methods: The study included 23 consecutive patients (43 leads) who underwent transvenous lead extraction using a gooseneck snare (group A) and 10 consecutive patients (17 leads) who underwent lead extraction using simple manual traction (group B). Patient characteristics, indications, and outcomes were analyzed and compared between the groups.
   Results: The dwelling time of the leads was longer in group A (median, 121) than in group B (median, 56; p=0.000). No differences were noted in the overall procedural success rate (69.6% vs. 70%), clinical procedural success rate (82.6% vs. 90%), and lead clinical success rate (86% vs: 94.1%) between the groups. The procedural success rates according to lead type were 89.2% and 100% for pacing leads and 66.7% and 83.3% for defibrillator leads in groups A and B, respectively. Major complications were noted in 3 (mortality in 1) patients in group A and 2 patients in group B.
   Conclusion: Transvenous extraction of pacemaker leads via an inferior approach using a gooseneck snare was both safe and effective. However, stand-alone transvenous extraction of defibrillator leads using the inferior approach was suboptimal.
C1 [Jo, Uk; Kim, Jun; Hwang, You-Mi; Lee, Ji-Hyun; Kim, Min-Su; Lee, Woo-Seok; Kwon, Chang-Hee; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Heart, Seoul, South Korea.
   [Choi, Hyung-Oh] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Div Cardiol,Dept Internal Med, Bucheon, South Korea.
   [Ko, Gi-Young; Yoon, Hyun-Ki] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
CR Aoukar PS, 2013, HEART RHYTHM, V10, P970, DOI 10.1016/j.hrthm.2013.03.046
   Belott PH, 2007, HEART RHYTHM, V4, P1102, DOI 10.1016/j.hrthm.2007.06.010
   Bongiorni MG, 2008, EUR HEART J, V29, P2886, DOI 10.1093/eurheartj/ehn461
   Bordachar P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P319, DOI 10.1161/CIRCEP.109.933051
   Brunner MP, 2014, HEART RHYTHM, V11, P799, DOI 10.1016/j.hrthm.2014.01.016
   BYRD CL, 1990, PACE, V13, P1871, DOI 10.1111/j.1540-8159.1990.tb06906.x
   Choi K, 2013, KOREAN CIRC J, V43, P336, DOI 10.4070/kcj.2013.43.5.336
   de Bie MK, 2012, EUROPACE, V14, P112, DOI 10.1093/europace/eur269
   DOTTER CT, 1971, AMER J ROENTGENOL RA, V111, P467, DOI 10.2214/ajr.111.3.467
   Epstein AE, 1998, CIRCULATION, V98, P1517, DOI 10.1161/01.CIR.98.15.1517
   Epstein LM, 2013, J AM COLL CARDIOL, V61, P987, DOI 10.1016/j.jacc.2012.12.014
   Gomes S, 2014, EUROPACE, V16, P1350, DOI 10.1093/europace/eut424
   Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033
   Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041
   Hauser RG, 2012, HEART RHYTHM, V9, P742, DOI 10.1016/j.hrthm.2011.12.019
   Jarwe M, 1999, PACE, V22, P1202, DOI 10.1111/j.1540-8159.1999.tb00601.x
   Kennergren C, 2009, EUROPACE, V11, P612, DOI 10.1093/europace/eup054
   Klug D, 2002, PACE, V25, P1023, DOI 10.1046/j.1460-9592.2002.01023.x
   Kutyifa V, 2013, J CARDIOVASC ELECTR, V24, P1246, DOI 10.1111/jce.12219
   Maytin M, 2010, J AM COLL CARDIOL, V56, P646, DOI 10.1016/j.jacc.2010.03.058
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Neuzil P, 2007, EUROPACE, V9, P98, DOI 10.1093/europace/eul171
   Segreti L, 2014, HEART RHYTHM, V11, P2196, DOI 10.1016/j.hrthm.2014.08.011
   SMITH HJ, 1994, PACE, V17, P2016, DOI 10.1111/j.1540-8159.1994.tb03792.x
   Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070
   Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020
   YEDLICKA JW, 1991, RADIOLOGY, V178, P691, DOI 10.1148/radiology.178.3.1994404
   Zhou XH, 2013, EUROPACE, V15, P1629, DOI 10.1093/europace/eut077
NR 28
TC 7
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 186
EP 196
DI 10.4070/kcj.2016.46.2.186
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300009
PM 27014349
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SR
   Kang, DY
   Cho, Y
   Cho, HJ
   Lee, HY
   Choi, EK
   Oh, S
AF Lee, So-Ryoung
   Kang, Do-Yoon
   Cho, Youngjin
   Cho, Hyun-Jai
   Lee, Hae-Young
   Choi, Eue-Keun
   Oh, Seil
TI Early Parasympathetic Reinnervation Is Not Related to Reconnection of
   Major Branches of the Vagus Nerve after Heart Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart transplantation; Reinnervation; Vagus nerve; Parasympathetic
ID SYMPATHETIC REINNERVATION; RATE-VARIABILITY; RE-INNERVATION
AB Background and Objectives: Bicaval heart transplantation (HTx) may promote parasympathetic reinnervation. However, the prevalence and timing of reinnervation have not been fully. investigated. Heart rate variability (HRV) and direct vagal stimulation were used to evaluate the presence of parasympathetic reinnervation after bicaval HTx.
   Subjects and Methods: A total of 21 patients (time after HTx 0.52-4.41 years, mean 1.8 +/- 1.2 years) who received a bicaval HTx was enrolled. Reinnervation was evaluated using HRV values from 24-hour Holter recordings. A cross-sectional analysis of the HRV at 0.5-1, 1-2, and >2 years after HTx was performed. We also applied high-frequency electrical stimulation (16.7 Hz, 1 msec pulse width, <= 10 V) to the cardiac branches of the vagus nerve at the level of the superior vena cava in eight patients at 6 and 12 months after HTx.
   Results: The degree of parasympathetic reinnervation corresponded to the time after HTx. The HRV analysis revealed that the root mean square of the successive differences between consecutive RR-intervals (RMSSD) and high-frequency power were significantly higher during the late period (>2 years) compared with the early period (0.5-1 year) after HTx. None of the eight patients who underwent direct vagal stimulation responded during the stimulation at 6 and 12 months, whereas incremental trends in HRV parameters were observed, which indicated that parasympathetic reinnervation began within 1 year after HTx.
   Conclusion: Parasympathetic reinnervation seemed to begin in the early period (<1year) after bicaval HTx. Reconnection of major branches of the vagus nerve may not be related to early reinnervation.
C1 [Lee, So-Ryoung; Kang, Do-Yoon; Cho, Youngjin; Cho, Hyun-Jai; Lee, Hae-Young; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM seil@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019; Oh,
   Seil/J-5539-2012
OI Choi, Eue-Keun/0000-0002-0411-6372; Oh, Seil/0000-0002-2504-9615
CR AKSELROD S, 1985, AM J PHYSIOL, V249, pH867
   [Anonymous], 2000, JAMA, V284, P3043
   Bannister R., 1992, AUTONOMIC FAILURE TX, P312
   Bengel FM, 2001, NEW ENGL J MED, V345, P731, DOI 10.1056/NEJMoa010519
   Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866
   Bernardi L, 1998, CIRCULATION, V97, P1368, DOI 10.1161/01.CIR.97.14.1368
   Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x
   BREUER HWM, 1993, BRIT HEART J, V70, P144
   Buendia-Fuentes F, 2011, TRANSPL P, V43, P2247, DOI 10.1016/j.transproceed.2011.05.020
   Cornelissen VA, 2012, J CARDIOL, V59, P220, DOI 10.1016/j.jjcc.2011.12.002
   Gallego-Page JC, 2004, J HEART LUNG TRANSPL, V23, P674, DOI 10.1016/j.healun.2003.07.011
   Halpert I, 1996, AM J CARDIOL, V77, P180, DOI 10.1016/S0002-9149(96)90592-5
   Imamura T, 2015, INT HEART J, V56, P180, DOI 10.1536/ihj.14-292
   Keeley EC, 2000, J HEART LUNG TRANSPL, V19, P310, DOI 10.1016/S1053-2498(99)00125-4
   Keith LM, 1992, CLIN ORIENTED ANATOM, P137
   KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8
   KONDO Y, 1972, ANN SURG, V176, P42, DOI 10.1097/00000658-197207000-00009
   MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482
   Murphy DA, 2000, ANN THORAC SURG, V69, P1769, DOI 10.1016/S0003-4975(00)01240-6
   Raczak G, 1999, J HEART LUNG TRANSPL, V18, P399, DOI 10.1016/S1053-2498(98)00071-0
   ROPER S, 1982, J PHYSIOL-LONDON, V326, P155, DOI 10.1113/jphysiol.1982.sp014183
   ROWAN RA, 1988, J HEART TRANSPLANT, V7, P448
   SCHWAIGER M, 1991, J CLIN INVEST, V87, P1681, DOI 10.1172/JCI115185
   Tio RA, 1997, J AUTONOM NERV SYST, V67, P176, DOI 10.1016/S0165-1838(97)00104-5
   Uberfuhr P, 1997, EUR J CARDIO-THORAC, V12, P907, DOI 10.1016/S1010-7940(97)00271-6
   WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210
NR 26
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 197
EP 206
DI 10.4070/kcj.2016.46.2.197
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300010
PM 27014350
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Chun, KJ
   Lee, DS
   Lee, SY
   Hwang, J
   Chon, MK
   Hwang, KW
   Kim, JS
   Park, YH
   Kim, JH
AF Lee, Sang Hyun
   Chun, Kook Jin
   Lee, Dae Sung
   Lee, Soo Yong
   Hwang, Jongmin
   Chon, Min Ku
   Hwang, Ki Won
   Kim, Jeong Su
   Park, Yong Huyn
   Kim, June Hong
TI Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean
   Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac catheterization; Cephalic vein; Basilic vein
ID RIGHT HEART CATHETERIZATION; ACCESS; SAFETY
AB Background and Objectives: Right heart catheterization is traditionally performed using a femoral vein approach that involves admission, bed rest, and risks of bleeding and hematoma. Recent studies have confirmed safety of the use of forearm vein for right cardiac catheterization. In the present study, we evaluated the feasibility of right cardiac catheterization via the antecubital fossa vein in Korean patients.
   Subjects and Methods: The medical records of all patients who underwent right heart catheterization at our hospital between January 2003 and December 2014 were reviewed retrospectively. Right cardiac catheterizations via the antecubital fossa vein and the femoral vein were compared in terms of demographic data (age, sex, weight, height, and body mass index), indications for right cardiac catheterization, and procedural and outcome data (initial success rate, procedure time, compression to ambulation time, and complications).
   Results: We reviewed 132 cases (antecubital fossa vein approach, n=37; femoral vein approach, n=95). The demographic data, initial success rate (100% vs. 100%) and procedure time (21.6 +/- 16.8 min vs. 25.6 +/- 12.6 min, p=0.14) were similar in both groups. The antecubital fossa vein group had a shorter mean compression to ambulation time than the femoral vein group (0.0 min vs. 201.2 +/- 48.1 min, p<0.01). No complications were observed in either group.
   Conclusion: Our study indicated the ease of performance of right cardiac catheterization via the antecubital fossa vein. Thus, the antecubital fossa vein can be an alternative access site for right cardiac catheterization in Korean patients.
C1 [Lee, Sang Hyun; Chun, Kook Jin; Lee, Dae Sung; Lee, Soo Yong; Hwang, Jongmin; Chon, Min Ku; Hwang, Ki Won; Kim, Jeong Su; Park, Yong Huyn; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, 20 Geumo Ro, Yangsan 50612, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, 20 Geumo Ro, Yangsan 50612, South Korea.
EM ptca82@gmail.com
FU Pusan National UniversityPusan National University
FX This work was supported for 2 years by a Pusan National University
   Research Grant.
CR Cheng NJ, 2003, ACTA CARDIOL SIN, V19, P159
   Cooper CJ, 1999, AM HEART J, V138, P430, DOI 10.1016/S0002-8703(99)70143-2
   Forssmann W., 1929, KLIN WOCHENSCHR, V8, P2085, DOI [DOI 10.1007/BF01875120, 10.1007/BF01875120]
   Gilchrist IC, 2006, CATHETER CARDIO INTE, V67, P585, DOI 10.1002/ccd.20678
   Gilchrist IC, 2002, CATHETER CARDIO INTE, V55, P20, DOI 10.1002/ccd.10069
   Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269, DOI 10.1016/S0735-1097(97)00064-8
   Lo Ted S N, 2006, J Interv Cardiol, V19, P258, DOI 10.1111/j.1540-8183.2006.00139.x
   Rogers T, 2014, CATHETER CARDIO INTE, V84, P75, DOI 10.1002/ccd.25531
   Shah S, 2014, CATHETER CARDIO INTE, V84, P70, DOI 10.1002/ccd.25249
   Yang CH, 2006, INT HEART J, V47, P21, DOI 10.1536/ihj.47.21
NR 10
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 207
EP 212
DI 10.4070/kcj.2016.46.2.207
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300011
PM 27014351
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, EJ
   Park, SJ
   Yun, HR
   Jeong, DS
   Lee, SC
   Park, SW
   Park, PW
AF Cho, Eun Jeong
   Park, Sung-Ji
   Yun, Hye Rim
   Jeong, Dong Seop
   Lee, Sang-Chol
   Park, Seung Woo
   Park, Pyo Won
TI Predicting Left Ventricular Dysfunction after Surgery in Patients with
   Chronic Mitral Regurgitation: Assessment of Myocardial Deformation by
   2-Dimensional Multilayer Speckle Tracking Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mitral valve regurgitation; Mitral valve insufficiency; Mitral valve
   annuloplasty; Mitral valve annulus repair; Echocardiography
ID GLOBAL LONGITUDINAL STRAIN; CONTRACTILE FUNCTION; VALVE REPAIR;
   POPULATION; RECOMMENDATIONS; QUANTIFICATION; DETERMINANTS; STRESS
AB Background and Objectives: The development of postoperative left ventricular (LV) dysfunction is a frequent complication in patients with chronic severe mitral valve regurgitation (MR) and portends a poor prognosis. Assessment of myocardial deformation enables myocardial contractility to be accurately estimated. The aim of the present study was to evaluate the predictive value of preoperative regional LV contractile function assessment using two-dimensional multilayer speckle-tracking echocardiography (2D MSTE) analysis in patients with chronic severe MR with preserved LV systolic function.
   Subjects and Methods: Forty-three consecutive patients with chronic severe MR with preserved LV systolic function scheduled for mitral valve replacement (MVR) or MV repair were prospectively enrolled. Serial echocardiographic studies were performed before surgery, at 7 days follow-up, and at least 3 months follow-up postoperatively. The conventional echocardiographic parameters were analyzed. Global longitudinal strain (GLS) was obtained quantitatively by 2D MSTE.
   Results: The mean age of patients was 51.7 +/- 14.3 years and 25 (58.1%) were male. In receiver-operating characteristic curve analysis, the most useful cutoff value for discriminating postoperative LV remodeling in severe MR with normal LV systolic function was -20.5% of 2D mid-layer GLS. Patients were divided into two groups by the baseline GLS -20.5%. Preoperative GLS values strongly predicted postoperative LV remodeling or LV dysfunction. The postoperative degree of decrease in LV end-diastolic dimension might be an additive predictive factor.
   Conclusion: STE can be used to predict a decrease in LV function after MVR in patients with chronic severe MR. This promising method could be of use in the clinic when trying to decide upon the optimum time to schedule surgery for such patients.
C1 [Cho, Eun Jeong; Park, Sung-Ji; Yun, Hye Rim; Lee, Sang-Chol; Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Cardiovasc Imaging Ctr,Div Card, Seoul, South Korea.
   [Jeong, Dong Seop; Park, Pyo Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorax Surg,Heart Vasc Stroke Inst, Seoul, South Korea.
   [Cho, Eun Jeong] Natl Canc Ctr, Cardiol Clin, Dept Internal Med, Div Cardiol, Goyang, South Korea.
RP Park, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr,Cardiovasc Imaging Ctr, Div Cardiol,Dept Internal Med,Heart Vasc Stroke I, 81 Irwon Ro, Seoul 06351, South Korea.
EM tyche.park@gmail.com
RI Jeong, Dong Seop/F-4601-2014
OI Jeong, Dong Seop/0000-0002-6947-8403
FU Korean Society of Cardiology [2009-05]
FX This study was supported by a research grant from the Korean Society of
   Cardiology (2009-05).
CR Adamu U, 2009, EUR J ECHOCARDIOGR, V10, P303, DOI 10.1093/ejechocard/jen238
   Ahmed MI, 2010, J AM COLL CARDIOL, V55, P671, DOI 10.1016/j.jacc.2009.08.074
   Banovic M, 2013, BIOMARK MED, V7, P221, DOI [10.2217/BMM.12.100, 10.2217/bmm.12.100]
   CHEN CG, 1991, CIRCULATION, V84, P712, DOI 10.1161/01.CIR.84.2.712
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451
   Enriquez-Sarano M, 2010, CIRCULATION, V121, P804, DOI 10.1161/CIRCULATIONAHA.109.868083
   GREENBAUM RA, 1981, BRIT HEART J, V45, P248
   Grigioni F, 2008, JACC-CARDIOVASC IMAG, V1, P133, DOI 10.1016/j.jcmg.2007.12.005
   Kim MS, 2009, AM HEART J, V157, P345, DOI 10.1016/j.ahj.2008.10.004
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004
   Luchner A, 2013, EUR J HEART FAIL, V15, P859, DOI 10.1093/eurjhf/hft048
   Manaka Maki, 2005, J Cardiol, V45, P53
   Mascle S, 2012, J AM SOC ECHOCARDIOG, V25, P766, DOI 10.1016/j.echo.2012.04.009
   Matsumura T, 2003, J AM COLL CARDIOL, V42, P458, DOI 10.1016/S0735-1097(03)00649-1
   Mizuguchi Y, 2008, J AM SOC ECHOCARDIOG, V21, P1138, DOI 10.1016/j.echo.2008.07.016
   Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537
   de Isla LP, 2009, J AM SOC ECHOCARDIOG, V22, P831, DOI 10.1016/j.echo.2009.04.016
   Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175
   Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013
   Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0
   STARLING MR, 1993, J AM COLL CARDIOL, V22, P239, DOI 10.1016/0735-1097(93)90840-W
   Suri RM, 2009, J THORAC CARDIOV SUR, V137, P1071, DOI 10.1016/j.jtcvs.2008.10.026
   Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109
   Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001
   Witkowski TG, 2013, EUR HEART J-CARD IMG, V14, P69, DOI 10.1093/ehjci/jes155
   Witkowski TG, 2012, ANN THORAC SURG, V93, P754, DOI 10.1016/j.athoracsur.2011.11.034
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 29
TC 15
Z9 18
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 213
EP 221
DI 10.4070/kcj.2016.46.2.213
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300012
PM 27014352
OA Green Published
DA 2021-04-22
ER

PT J
AU Dehghani, MR
   Rezaei, Y
   Fakour, S
   Arjmand, N
AF Dehghani, Mohammad Reza
   Rezaei, Yousef
   Fakour, Sanam
   Arjmand, Nasim
TI White Blood Cell Count to Mean Platelet Volume Ratio Is a Prognostic
   Factor in Patients with Non-ST Elevation Acute Coronary Syndrome with or
   without Metabolic Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE White blood cell count; Mean platelet volume; Acute coronary syndrome;
   Metabolic syndrome; Inflammation
ID C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS;
   ASSOCIATION; OUTCOMES; WOMEN; INFLAMMATION; METAANALYSIS; MECHANISMS;
   THROMBOSIS
AB Background and Objectives: Leukocyte and platelet have been found to be associated with metabolic syndrome (MetS). We aimed to determine the usefulness of a novel marker named white blood cell count to mean platelet volume ratio (WMR) for predicting outcomes of non-ST elevation acute coronary syndrome (NSTE-ACS) with or without MetS.
   Subjects and Methods: A total of 331 NSTE-ACS individuals (60 +/- 12.5 years, 57.4% male) were enrolled and followed for a median of 24 months. MetS was identified using the National Cholesterol Education Program Adult Treatment Panel III criteria.
   Results: Patients were divided into two groups: high WMR (VVMR >= 720) and low WMR (VVMR<720). Major adverse cardiovascular events (MACE) and MetS rates were significantly greater in the higher WMR group compared to those in the low WMR group (MACE: 14.3% vs. 25%, p=0.014; MetS: 50.9% vs. 75%, p<0.001). MetS was diagnosed in 62.2% of patients. MACE incidence in patients with or without MetS was comparable (p=0.737). Among MetS individuals, patients in the high WMR group had more MACE than the low WMR group (11.2% vs. 26.5%, p=0.007). However, MACE was comparable among non-MetS individuals (p=0.681). In multivariable Cox regression analysis, hazard ratios (HR) of MACE incidence for high-WMR in MetS individuals was 2.616 (95% confidence interval: 1.282-5.339, p=0.008). However, HR of MACE incidence for high WMR in non-MetS individuals was not significant.
   Conclusion: Among NSTE-ACS patients without revascularization therapy, elevated admission WMR was associated with an increased risk of developing composite MACE in MetS individuals but not in non-MetS patients.
C1 [Dehghani, Mohammad Reza] Urmia Univ Med Sci, Dept Cardiol, Orumiyeh, Iran.
   [Rezaei, Yousef] Urmia Univ Med Sci, Seyyed al Shohada Heart Ctr, Orumiyeh 5718749441, Iran.
   [Fakour, Sanam; Arjmand, Nasim] Urmia Univ Med Sci, Sch Med, Orumiyeh, Iran.
RP Rezaei, Y (corresponding author), Urmia Univ Med Sci, Seyyed al Shohada Heart Ctr, Orumiyeh 5718749441, Iran.
EM yousefrezaei1986@gmail.com
RI Dehghani, Mohammad Reza/T-1088-2018; Dehghani, Mohammad Reza/H-3500-2018
OI Rezaei, Yousef/0000-0002-6804-4232
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alessi MC, 2008, THROMB HAEMOSTASIS, V99, P995, DOI 10.1160/TH07-11-0682
   Chen YL, 2015, PLATELETS, V26, P31, DOI 10.3109/09537104.2014.880415
   Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x
   Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014
   Dehghani MR, 2015, CARDIOL J, V22, P437, DOI 10.5603/CJ.a2015.0015
   Dehghani MR, 2014, BIOMARKERS, V19, P378, DOI 10.3109/1354750X.2014.915429
   Dohi T, 2009, CIRC J, V73, P1454, DOI 10.1253/circj.CJ-08-1122
   Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47
   Gharipour M, 2013, J RES MED SCI, V18, P467
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Jesri A, 2005, J CLIN HYPERTENS, V7, P712
   Jesri Ammar, 2005, J Clin Hypertens (Greenwich), V7, P705, DOI 10.1111/j.1524-6175.2005.04809.x
   Kajimoto K, 2008, CIRC J, V72, P1481, DOI 10.1253/circj.CJ-07-0928
   Kutlucan A, 2012, BLOOD COAGUL FIBRIN, V23, P388, DOI 10.1097/MBC.0b013e328352e8fa
   Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063
   Liu HX, 2014, PLATELETS, V25, P97, DOI 10.3109/09537104.2013.780017
   Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500
   Mehta RH, 2014, AM HEART J, V168, P182, DOI 10.1016/j.ahj.2014.04.009
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Park BJ, 2012, PLATELETS, V23, P45, DOI 10.3109/09537104.2011.589014
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Rechcinski T, 2013, CARDIOL J, V20, P491, DOI 10.5603/CJ.2013.0134
   RINDER HM, 1991, BLOOD, V78, P1760
   Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E
   Suslova TE, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00501
   Tavil Y, 2007, THROMB RES, V120, P245, DOI 10.1016/j.thromres.2006.10.005
   Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528
   Zaccardi F, 2015, DIABETES-METAB RES, V31, P402, DOI 10.1002/dmrr.2625
NR 29
TC 12
Z9 12
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 229
EP 238
DI 10.4070/kcj.2016.46.2.229
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300014
PM 27014354
OA Green Published
DA 2021-04-22
ER

PT J
AU Bayar, N
   Cekin, AH
   Arslan, S
   Cagirci, G
   Kucukseymen, S
   Cay, S
   Harmandar, FA
   Yesil, B
AF Bayar, Nermin
   Cekin, Ayhan Hilmi
   Arslan, Sakir
   Cagirci, Goksel
   Kucukseymen, Selcuk
   Cay, Serkan
   Harmandar, Ferda Akbay
   Yesil, Bayram
TI Assessment of Aortic Elasticity in Patients with Celiac Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Celiac disease; Elastic modulus; Aortic stiffness; Inflammation
ID ARTERIAL STIFFNESS; INCREASED RISK; ASSOCIATION; ECHOCARDIOGRAPHY;
   RECOMMENDATIONS; CORONARY
AB Background and Objectives: Celiac disease (CD) is a chronic autoimmune disorder induced by dietary gluten intake by individuals who are genetically sensitive. Many studies report an increased risk of cardiovascular diseases in such patients. The aim of this study is to assess aortic elasticity properties in patients with CD that may be associated with an increased risk of cardiovascular disease.
   Subjects and Methods: Eighty-one patients diagnosed with CD by antibody test and biopsy and 63 healthy volunteers were included in this prospective study. Electrocardiographic and echocardiographic examinations were performed.
   Results: The CD group did not have any differences in the conventional echocardiographic parameters compared to the healthy individuals. However, patients in the CD group had an increased aortic stiffness beta index (4.3 +/- 2.3 vs. 3.6 +/- 1.6, p=0.010), increased pressure strain elastic modulus (33.6 +/- 17.0 kPa vs. 28.5 +/- 16.7 kPa, p=0.037), decreased aortic distensibility (7.0 +/- 3.0x10(-6) cm(2)/dyn vs. 8.2 +/- 3.6x10(-6) cm(2)/dyn, p=0.037), and similar aortic strain (17.9 +/- 7.7 vs. 16.0 +/- 5.5, p=0.070) compared to the control group. Patients with CD were found to have an "elevated neutrophil/lymphocyte ratio compared to the control group (2.54 +/- 0.63 vs. 2.24 +/- 0.63, p=0.012). However, gluten-free diet and neutrophil/lymphocyte ratio were not found to be associated with aortic elasticity.
   Conclusion: Patients with CD had increased aortic stiffness and decreased aortic distensibility. Gluten-free diet enabled the patients with CD to have a reduction in the inflammatory parameters whereas the absence of a significant difference in the elastic properties of the aorta may suggest that the risk of cardiovascular disease persists in this patient group despite a gluten-free diet.
C1 [Bayar, Nermin; Arslan, Sakir; Cagirci, Goksel; Kucukseymen, Selcuk] Antalya Educ & Res Hosp, Dept Cardiol, Antalya, Turkey.
   [Cekin, Ayhan Hilmi; Harmandar, Ferda Akbay] Antalya Educ & Res Hosp, Dept Gastroenterol, Antalya, Turkey.
   [Cay, Serkan] Yuksek Ihtisas Educ & Res Hosp, Dept Cardiol, Ankara, Turkey.
   [Yesil, Bayram] Antalya Educ & Res Hosp, Dept Internal Med, Antalya, Turkey.
RP Bayar, N (corresponding author), Antalya Educ & Res Hosp, Dept Cardiol, Kardiyol Klin, TR-07010 Antalya, Turkey.
EM dr.nermin@mynet.com
RI Kucukseymen, Selcuk/Q-4135-2018; cekin, ayhan hilmi/AAL-4341-2020;
   arslan, sakir/A-3933-2017; Harmandar, Ferda/AAD-3862-2019
OI Kucukseymen, Selcuk/0000-0002-9757-3088; cekin, ayhan
   hilmi/0000-0001-7464-8297; 
CR Barbulescu A L, 2012, Curr Health Sci J, V38, P61
   Cekin AH, 2012, TURK J GASTROENTEROL, V23, P490, DOI 10.4318/tjg.2012.0467
   De Marchi S, 2013, ALIMENT PHARM THER, V38, P162, DOI 10.1111/apt.12360
   Ehsani-Ardakani MJ, 2013, ARCH IRAN MED, V16, P78, DOI 013162/AIM.006
   El Gamal YM, 2013, ISRN PEDIAT
   Emilsson L, 2013, ALIMENT PHARM THER, V37, P905, DOI 10.1111/apt.12271
   Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167
   Fasano A, 2006, CURR OPIN GASTROEN, V22, P674, DOI 10.1097/01.mog.0000245543.72537.9e
   Gefel D, 2002, ISRAEL MED ASSOC J, V4, P222
   Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600
   Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5
   Hallert C, 2002, ALIMENT PHARM THERAP, V16, P1333, DOI 10.1046/j.1365-2036.2002.01283.x
   LACOMBE F, 1992, EUR HEART J, V13, P1040, DOI 10.1093/oxfordjournals.eurheartj.a060311
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220
   Lim PO, 2002, J HUM HYPERTENS, V16, P411, DOI 10.1038/sj.jhh.1001404
   Ludvigsson JF, 2007, HEART, V93, P1111, DOI 10.1136/hrt.2006.097097
   Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346
   Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624
   Nestel PJ, 2003, ATHEROSCLEROSIS, V171, P83, DOI 10.1016/j.atherosclerosis.2003.08.003
   Norsa L, 2012, NUTR THER METAB, V30, P1
   Park SW, 2013, J RHEUMATOL, V40, P1619, DOI 10.3899/jrheum.130426
   Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037
   Van den Driessche A, 2009, NETH J MED, V67, P376
   Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009
   Wei L, 2008, ALIMENT PHARM THERAP, V27, P514, DOI 10.1111/j.1365-2036.2007.03594.x
   Yingchoncharoen T, 2012, HEART ASIA, V4, P77, DOI 10.1136/heartasia-2011-010079
NR 29
TC 9
Z9 10
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 239
EP 245
DI 10.4070/kcj.2016.46.2.239
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300015
PM 27014355
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, KE
   Seo, YJ
   Kim, GB
   An, HS
   Song, YH
   Kwon, BS
   Bae, EJ
   Noh, CI
AF Lee, Ko Eun
   Seo, Yeon Jeong
   Kim, Gi Beom
   An, Hyo Soon
   Song, Young Hwan
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
TI Complications of Cardiac Catheterization in Structural Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catheterization; Complications; Risk factors; Heart diseases; Catheters
ID CONFIDENTIAL INQUIRY; RISK-FACTORS; CURRENT ERA; CHILDREN; PREVALENCE
AB Background and Objectives: Cardiac catheterization is used to diagnose structural heart disease (SHD) and perform transcatheter treatment. This study aimed to evaluate complications of cardiac catheterization and the associated risk factors in a tertiary center over 10 years.
   Subjects and Methods: Total 2071 cardiac catheterizations performed at the Seoul National University Children's Hospital from January 2004 to December 2013 were included in this retrospective study.
   Results: The overall complication, severe complication, and mortality rates were 16.2%, 1.15%, and 0.19%, respectively. The factors that significantly increased the risk of overall and severe complications were anticoagulant use before procedure (odds ratio [OR] 1.83, p=0.012 and OR 6.45, p<0.001, respectively), prothrombin time (OR 2.30, p<0.001 and OR 5.99, p<0.001, respectively), general anesthesia use during procedure (OR 1.84, p=0.014 and OR 5.31, p=0.015, respectively), and total procedure time (OR 1.01, p<0.001 and OR 1.02, p<0.001, respectively). Low body weight (OR 0.99, p=0.003), severe SHD (OR 1.37, p=0.012), repetitive procedures (OR 1.7, p=0.009), and total fluoroscopy time (OR 1.01, p=0.005) significantly increased the overall complication risk. High activated partial thromboplastin time (OR 1.04, p=0.001), intensive care unit admission state (OR 14.03, p<0.001), and concomitant electrophysiological study during procedure (OR 3.41, p=0.016) significantly increased severe complication risk.
   Conclusion: Currently, the use of cardiac catheterization in SHD is increasing and becoming more complex; this could cause complications despite the preventive efforts. Careful patient selection for therapeutic catheterization and improved technique and management during the peri-procedural period are required to reduce complications.
C1 [Lee, Ko Eun; Seo, Yeon Jeong; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
   [An, Hyo Soon] Seoul Natl Univ Boramae Hosp, Dept Pediat, Seoul, South Korea.
   [Song, Young Hwan] Bundang Seoul Natl Univ Hosp, Dept Pediat, Songnam, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM ped9526@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; An, Hyo Soon/0000-0001-6513-0592
CR Bobhate P, 2015, PEDIATR CARDIOL, V36, P873, DOI 10.1007/s00246-015-1100-1
   BOOTH P, 1991, BRIT HEART J, V65, P109
   Brotschi B, 2015, HEART, V101, P948, DOI 10.1136/heartjnl-2014-306713
   Busing KA, 2005, RADIOLOGY, V235, P177, DOI 10.1148/radiol.2351040117
   CASSIDY SC, 1992, J AM COLL CARDIOL, V19, P1285, DOI 10.1016/0735-1097(92)90336-L
   DEBONO D, 1993, BRIT HEART J, V70, P297
   Glatz AC, 2013, CATHETER CARDIO INTE, V82, P454, DOI 10.1002/ccd.24737
   Kim Gi Beom, 2014, Korean J Pediatr, V57, P257, DOI 10.3345/kjp.2014.57.6.257
   Krasemann T, 2015, HEART, V101, P915, DOI 10.1136/heartjnl-2015-307453
   Lin CH, 2015, PEDIATR CARDIOL, V36, P1363, DOI 10.1007/s00246-015-1167-8
   Luceri MJ, 2015, PEDIATR BLOOD CANCER, V62, P1222, DOI 10.1002/pbc.25438
   Mehta R, 2008, CATHETER CARDIO INTE, V72, P278, DOI 10.1002/ccd.21580
   Mori Y, 2010, J CARDIOL, V56, P183, DOI 10.1016/j.jjcc.2010.05.001
   PORTER CJ, 1978, J PEDIATR-US, V93, P97, DOI 10.1016/S0022-3476(78)80614-3
   Rhodes JF, 2000, AM J CARDIOL, V86, P1275, DOI 10.1016/S0002-9149(00)01221-2
   Stone PA, 2014, J VASC SURG, V60, P1359, DOI 10.1016/j.jvs.2014.07.035
   Vitiello R, 1998, J AM COLL CARDIOL, V32, P1433, DOI 10.1016/S0735-1097(98)00396-9
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
   West R, 2006, HEART, V92, P810, DOI 10.1136/hrt.2005.073890
   Yetman AT, 1997, J AM COLL CARDIOL, V30, P811, DOI 10.1016/S0735-1097(97)00228-3
   Zeevi B, 1999, CARDIOL YOUNG, V9, P266, DOI 10.1017/S1047951100004923
   Zuckerman WA, 2013, PULM CIRC, V3, P831, DOI 10.1086/674752
NR 22
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 246
EP 255
DI 10.4070/kcj.2016.46.2.246
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300016
PM 27014356
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SE
   Jo, HB
   Moon, HH
   Oh, DJ
   Kwon, KH
   Kwon, JH
   Kim, YK
   Kim, YS
AF Lee, Seung-Eun
   Jo, Hee-Bum
   Moon, Hyoung-Ho
   Oh, Dong-Jun
   Kwon, Ki-Hwan
   Kwon, Jae-Hyun
   Kim, Young-Kwon
   Kim, Yong-Seok
TI Spontaneous Bleeding from Internal Pudendal Artery associated with
   Abciximab after Primary Percutaneous Coronary Intervention: Successful
   Treatment with Percutaneous Gel-Foam Embolization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bleeding; Percutaneous coronary intervention; Abciximab
ID ELEVATION MYOCARDIAL-INFARCTION; MANAGEMENT
AB We describe a case of spontaneous bleeding from a branch of the right internal pudendal artery that resulted in massive scrotal swelling in a patient who had underwent primary percutaneous coronary intervention with the use of abciximab concurrent with conventional anticoagulation and dual antiplatelet therapies for the treatment of acute ST-segment elevation myocardial infarction. This unusual complication was promptly identified by percutaneous peripheral arteriography and successfully treated with gel-foam embolization.
C1 [Lee, Seung-Eun; Jo, Hee-Bum; Moon, Hyoung-Ho; Oh, Dong-Jun; Kwon, Ki-Hwan; Kim, Young-Kwon; Kim, Yong-Seok] Dongguk Univ, Ilsan Hosp, Dept Internal Med, 27 Dongguk Ro, Goyang 10326, South Korea.
   [Kwon, Jae-Hyun] Dongguk Univ, Ilsan Hosp, Dept Radiol, Goyang, South Korea.
   [Kwon, Jae-Hyun; Kim, Young-Kwon; Kim, Yong-Seok] Dongguk Univ, Grad Sch, Dept Med, Seoul, South Korea.
RP Kim, YS (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Internal Med, 27 Dongguk Ro, Goyang 10326, South Korea.
EM harrison72@dumc.or.kr
RI Kwon, Jae Hyun/M-5505-2017
OI Kwon, Jae Hyun/0000-0001-7303-770X
CR Cherukuri Madhavagopal, 2002, J Invasive Cardiol, V14, P692
   Cote AV, 2001, MAYO CLIN PROC, V76, P890
   De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759
   Dorval JF, 2007, CATHETER CARDIO INTE, V69, P995, DOI 10.1002/ccd.21046
   Dziewierz A, 2014, THER CLIN RISK MANAG, V10, P567, DOI 10.2147/TCRM.S50002
   Iqbal Z, 2013, AM J CARDIOL, V111, P1727, DOI 10.1016/j.amjcard.2013.02.020
   Khanlou H, 1998, NEW ENGL J MED, V339, P1861
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Parodi G, 2010, J THROMB THROMBOLYS, V30, P446, DOI 10.1007/s11239-010-0481-5
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 256
EP 259
DI 10.4070/kcj.2016.46.2.256
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300017
PM 27014357
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YM
   Shin, JO
   Kim, M
   Kang, WC
   Moon, J
   Chung, WJ
   Sung, YM
AF Park, Yae Min
   Shin, Jae Ouk
   Kim, Minsu
   Kang, Woong Chol
   Moon, Jeonggeun
   Chung, Wook-Jin
   Sung, Yon Mi
TI Cardiac Metastasis of Leiomyosarcoma Complicated with Complete
   Atrio-Ventricular Block and Ventricular Tachycardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Leiomyosarcoma; Neoplasm, metastasis; Heart; Atrioventicular block;
   Tachycardia, ventricular
ID HEART; LUNG
AB We described a case of a 54-year-old male who presented with dizziness and dyspnea due to cardiac metastasis of leiomyosarcoma. Cardiac metastasis of leiomyosarcoma caused both bradyarrhythmia and tachyarrhythmia in the patient. He was treated with implantation of a permanent pacemaker for management of complete atrio-ventricular block and anti-arrhythmic drug that suppressed ventricular tachycardia successfully.
C1 [Park, Yae Min; Shin, Jae Ouk; Kim, Minsu; Kang, Woong Chol; Moon, Jeonggeun; Chung, Wook-Jin] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
   [Sung, Yon Mi] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea.
RP Park, YM (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, 21 Namdong Daero 774 Beon Gil, Inchon 21565, South Korea.
EM ypruimin@gmail.com
RI Chung, Wook-Jin/AAJ-5613-2021
OI Chung, Wook-Jin/0000-0002-9767-7098
CR Agarwal Vijay, 2003, Indian Heart J, V55, P632
   BALASUNDARAM S, 1992, EUR HEART J, V13, P718, DOI 10.1093/oxfordjournals.eurheartj.a060242
   Gehrmann J, 2001, PACE, V24, P1161, DOI 10.1046/j.1460-9592.2001.01161.x
   Huang Chien-Lung, 2008, Circ Cardiovasc Imaging, V1, pe1, DOI 10.1161/CIRCIMAGING.107.763383
   Jaster M, 2006, J CLIN ONCOL, V24, P3502, DOI 10.1200/JCO.2005.04.9171
   Kasai T, 2007, CHEST, V131, P1569, DOI 10.1378/chest.06-1904
   Lopez FF, 2000, HEART LUNG, V29, P47, DOI 10.1016/S0147-9563(00)90036-0
   Ozyuncu N, 2006, EUROPACE, V8, P545, DOI 10.1093/europace/eul058
   PORTER GA, 1961, AM J MED, V31, P820, DOI 10.1016/0002-9343(61)90167-X
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 260
EP 263
DI 10.4070/kcj.2016.46.2.260
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300018
PM 27014358
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, J
   Song, J
   Huh, J
   Kang, IS
   Yang, JH
   Jun, TG
AF Choi, Jaeyoung
   Song, Jinyoung
   Huh, June
   Kang, I-Seok
   Yang, Ji-Hyuk
   Jun, Tae-Gook
TI Complicated Azygos Vein Aneurysm in an Infant Presenting with Acute
   Pulmonary Thromboembolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Azygos vein; Aneurysm; Pulmonary embolism; Infant; Mediastinal disease
ID FOLLOW-UP; RESECTION; PATIENT; TUMOR
AB Azygos vein aneurysm is a rare cause of mediastinal mass. Most cases present as an incidental finding on imaging modalities, but in few cases the thrombosis in the aneurysm leads to pulmonary thromboembolism, which may require surgical resection. We present a case where, for the first time, a case of a complicated azygos vein aneurysm was diagnosed in infancy, which required surgical resection.
C1 [Choi, Jaeyoung; Song, Jinyoung; Huh, June; Kang, I-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
   [Yang, Ji-Hyuk; Jun, Tae-Gook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg,Heart Vasc Stroke I, Seoul, South Korea.
RP Huh, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
EM herzhuh@skku.edu
OI Huh, June/0000-0003-4523-9632
CR Chiu SSH, 2006, J THORAC IMAG, V21, P66, DOI 10.1097/01.rti.0000187434.14385.a2
   D'Souza ES, 2006, CARDIOVASC INTER RAD, V29, P915, DOI 10.1007/s00270-004-4189-9
   Gnanamuthu BRD, 2008, HEART LUNG CIRC, V17, P62, DOI 10.1016/j.hlc.2006.12.012
   He J, 2012, J THORAC IMAG, V27, pW91, DOI 10.1097/RTI.0b013e318217272d
   Icard P, 1999, EUR J CARDIO-THORAC, V15, P870, DOI 10.1016/S1010-7940(99)00127-X
   Irurzun J, 2008, J VASC INTERV RADIOL, V19, P1251, DOI 10.1016/j.jvir.2008.04.011
   JAIN A, 1994, J COMPUT ASSIST TOMO, V18, P647, DOI 10.1097/00004728-199407000-00026
   Ko SF, 2014, ANN THORAC SURG, V97, P873, DOI 10.1016/j.athoracsur.2013.10.029
   Kurihara C, 2012, ANN THORAC SURG, V94, P1008, DOI 10.1016/j.athoracsur.2012.01.086
   KURIHARA Y, 1993, CLIN RADIOL, V48, P427, DOI 10.1016/S0009-9260(05)81114-6
   STERN WZ, 1961, RADIOLOGY, V77, P622, DOI 10.1148/77.4.622
   Ueda Y, 2014, INTERACT CARDIOV TH, V18, P135, DOI 10.1093/icvts/ivt436
   Weber HS, 2011, CATHETER CARDIO INTE, V77, P99, DOI 10.1002/ccd.22598
NR 13
TC 3
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 264
EP 267
DI 10.4070/kcj.2016.46.2.264
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300019
PM 27014359
OA Green Published
DA 2021-04-22
ER

PT J
AU Balta, S
   Yildirim, AO
   Ozturk, C
AF Balta, Sevket
   Yildirim, Ali Osman
   Ozturk, Cengiz
TI Red Cell Distribution Width and Coronary Artery Calcification
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID CARDIAC SYNDROME-X; LYMPHOCYTE RATIO; ASSOCIATION; NEUTROPHIL;
   MORTALITY; PREDICT
C1 [Balta, Sevket; Yildirim, Ali Osman; Ozturk, Cengiz] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey.
RP Balta, S (corresponding author), Gulhane Mil Med Acad, Dept Cardiol, Tevfik Saglam St, TR-06018 Etlik, Turkey.
EM drsevketb@gmail.com
OI Balta, Sevket/0000-0002-6657-7334
CR Balta S, 2013, BRIT J CANCER, V109, P3125, DOI 10.1038/bjc.2013.598
   Balta S, 2015, MED PRIN PRACT, V24, P584, DOI 10.1159/000437355
   Balta S, 2013, AM J EMERG MED, V31, P989, DOI 10.1016/j.ajem.2013.02.031
   Demirkol S, 2014, CLIN APPL THROMB-HEM, V20, P250, DOI 10.1177/1076029612467227
   Demirkol S, 2013, KARDIOL POL, V71, P480, DOI 10.5603/KP.2013.0094
   Demirkol S, 2012, CLINICS, V67, P1019, DOI 10.6061/clinics/2012(09)06
   Fici F, 2013, J CARDIOVASC PHARM, V62, P388, DOI 10.1097/FJC.0b013e31829f716a
   Gurel OM, 2015, KOREAN CIRC J, V45, P372, DOI 10.4070/kcj.2015.45.5.372
   Uslu AU, 2015, ANN SAUDI MED, V35, P151, DOI 10.5144/0256-4947.2015.151
   Yalcin M, 2015, CLIN APPL THROMB-HEM, V21, P166, DOI 10.1177/1076029613503398
NR 10
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 270
EP 271
DI 10.4070/kcj.2016.46.2.270
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300021
PM 27014361
OA Green Published
DA 2021-04-22
ER

PT J
AU Gurel, OM
   Demircelik, MB
   Eryonucu, B
AF Gurel, Ozgul Malcok
   Demircelik, Muhammed Bora
   Eryonucu, Beyhan
TI Red Cell Distribution Width and Coronary Artery Calcification Reply
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID MORTALITY; DISEASE
C1 [Gurel, Ozgul Malcok; Demircelik, Muhammed Bora; Eryonucu, Beyhan] Turgut Ozal Univ, Dept Cardiol, Ankara, Turkey.
RP Gurel, OM (corresponding author), Turgut Ozal Univ, Dept Cardiol, Ankara, Turkey.
CR Balta S, 2013, AM J EMERG MED, V31, P989, DOI 10.1016/j.ajem.2013.02.031
   Chaikriangkrai K, 2014, N AM J MED SCI, V6, P433, DOI 10.4103/1947-2714.141625
   Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633
   Demirkol S, 2013, KARDIOL POL, V71, P480, DOI 10.5603/KP.2013.0094
   Ding LM, 2010, CIRC J, V74, P523, DOI 10.1253/circj.CJ-09-0485
   Kurtul A, 2015, ANGIOLOGY, V66, P433, DOI 10.1177/0003319714535238
   Kurtul A, 2014, AM J CARDIOL, V114, P972, DOI 10.1016/j.amjcard.2014.07.005
   McCullough PA, 2011, REV CARDIOVASC MED, V12, P200, DOI 10.3909/ricm0624
   Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 272
EP 272
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300022
DA 2021-04-22
ER

PT J
AU Finsterer, J
   Stollberger, C
AF Finsterer, Josef
   Stoellberger, Claudia
TI Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and
   the Nerves
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Muscular diseases; Neuromuscular disease; Cardiomyopathies; Cardiac
   arrhythmias
ID GIRDLE MUSCULAR-DYSTROPHY; GLYCOGEN-STORAGE-DISEASE; LEFT-VENTRICULAR
   NONCOMPACTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR
   MAGNETIC-RESONANCE; COMPLETE ATRIOVENTRICULAR-BLOCK; SPLICE-SITE
   MUTATION; MYOTONIC-DYSTROPHY; HYPERTROPHIC CARDIOMYOPATHY; DILATED
   CARDIOMYOPATHY
AB Little is known regarding cardiac involvement (CI) by neuromuscular disorders (NMDs). The purpose of this review is to summarise and discuss the major findings concerning the types, frequency, and severity of cardiac disorders in NMDs as well as their diagnosis, treatment, and overall outcome. CI in NMDs is characterized by pathologic involvement of the myocardium or cardiac conduction system. Less commonly, additional critical anatomic structures, such as the valves, coronary arteries, endocardium, pericardium, and even the aortic root may be involved. Involvement of the myocardium manifests most frequently as hypertrophic or dilated cardiomyopathy and less frequently as restrictive cardiomyopathy, non-compaction, arrhythmogenic right-ventricular dysplasia, or Takotsubo-syndrome. Cardiac conduction defects and supraventricular and ventricular arrhythmias are common cardiac manifestations of NMDs. Arrhythmias may evolve into life-threatening ventricular tachycardias, asystole, or even sudden cardiac death. CI is common and carries great prognostic significance on the outcome of dystrophinopathies, laminopathies, desminopathies, nemaline myopathy, myotonias, metabolic myopathies, Danon disease, and Barth-syndrome. The diagnosis and treatment of CI in NMDs follows established guidelines for the management of cardiac disease, but cardiotoxic medications should be avoided. CI in NMDs is relatively common and requires complete work-up following the establishment of a neurological diagnosis. Appropriate cardiac treatment significantly improves the overall long-term outcome of NMDs.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Stoellberger, Claudia] Krankenanstalt Rudolfstiftung Wien, Med Dept Cardiol & Intens Care Med 2, Vienna, Austria.
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
OI finsterer, josef/0000-0003-2839-7305
CR Aimo A, 2014, INT J CARDIOL, V176, P1396, DOI 10.1016/j.ijcard.2014.08.022
   Al-Ruwaishid A, 2003, BRAIN DEV-JPN, V25, P62, DOI 10.1016/S0387-7604(02)00151-1
   Al-Thihli K, 2012, GENE, V497, P320, DOI 10.1016/j.gene.2012.01.056
   AMIT R, 1992, MUSCLE NERVE, V15, P455, DOI 10.1002/mus.880150406
   Andrikopoulos G, 2013, HELL J CARDIOL, V54, P227
   Araki A, 2014, NEUROLOGY, V82, P1813, DOI 10.1212/WNL.0000000000000434
   Austin SL, 2012, JIMD REP, V6, P65, DOI 10.1007/8904_2011_118
   Bansal V, 2011, MUSCLE NERVE, V44, P990, DOI 10.1002/mus.22220
   Barisic N, 2002, CROAT MED J, V43, P37
   Barragan-Campos Hector Manuel, 1999, Archivos del Instituto de Cardiologia de Mexico, V69, P559
   Baruteau J, 2013, J INHERIT METAB DIS, V36, P795, DOI 10.1007/s10545-012-9542-6
   Benhayon D, 2015, J CARDIOVASC ELECTR, V26, P305, DOI 10.1111/jce.12604
   Beydoun Said R, 2010, J Med Case Rep, V4, P393, DOI 10.1186/1752-1947-4-393
   Birnkrant DJ, 2015, PEDIAT PULMONOL
   Brea-Calvo G, 2015, AM J HUM GENET, V96, P309, DOI 10.1016/j.ajhg.2014.12.023
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Brembilla-Perrot B, 2014, PACE, V37, P329, DOI 10.1111/pace.12260
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Brunetti-Pierri N, 2011, MOL GENET METAB, V103, P167, DOI 10.1016/j.ymgme.2011.02.007
   Brunklaus A, 2015, EUR J PAEDIATR NEURO, V19, P395, DOI 10.1016/j.ejpn.2015.03.008
   Bu'Lock FA, 1999, ARCH DIS CHILD, V80, P267, DOI 10.1136/adc.80.3.267
   But W. M., 2009, Hong Kong Medical Journal, V15, P474
   Calvo F, 2000, NEUROMUSCULAR DISORD, V10, P560, DOI 10.1016/S0960-8966(00)00147-4
   Carboni N, 2011, MUSCLE NERVE, V44, P826, DOI 10.1002/mus.22228
   Carr AS, 2015, NEUROMUSCULAR DISORD, V25, P511, DOI 10.1016/j.nmd.2015.02.001
   Ceviz N, 2003, INT J CARDIOL, V87, P129, DOI 10.1016/S0167-5273(02)00320-0
   Chauveau C, 2014, HUM MOL GENET, V23, P980, DOI 10.1093/hmg/ddt494
   COELHO E, 1963, Z KREISLAUFFORSCH, V52, P1066
   Corrado G, 2006, CARDIOLOGY, V105, P142, DOI 10.1159/000091152
   Coutance G, 2013, CONGENIT HEART DIS, V8, pE127, DOI 10.1111/j.1747-0803.2012.00695.x
   Cullup T, 2012, NEUROMUSCULAR DISORD, V22, P1096, DOI 10.1016/j.nmd.2012.06.007
   D'Amico A, 2008, NEUROMUSCULAR DISORD, V18, P153, DOI 10.1016/j.nmd.2007.09.013
   D'Arcy C, 2015, J CHILD NEUROL, V30, P1211, DOI 10.1177/0883073814549807
   Dec GW, 2013, J AM COLL CARDIOL, V61, P955, DOI 10.1016/j.jacc.2012.12.011
   Della Marca G, 2010, FUNCT NEUROL, V25, P211
   Dincer P, 2000, NEUROMUSCULAR DISORD, V10, P247, DOI 10.1016/S0960-8966(00)00100-0
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Dittrich S, 2015, KLIN PADIATR, V227, P225, DOI 10.1055/s-0034-1398689
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   El-Menyar AA, 2004, SAUDI MED J, V25, P1723
   Elkohen M, 1996, ARCH MAL COEUR VAISS, V89, P611
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Eminoglu TF, 2011, FORENSIC SCI INT, V210, pE1, DOI 10.1016/j.forsciint.2011.04.003
   Ergl Y, 2011, SAUDI J ANAESTH, V5, P93, DOI 10.4103/1658-354X.76486
   Fanin M, 2003, NEUROMUSCULAR DISORD, V13, P303, DOI 10.1016/S0960-8966(02)00280-8
   Faustmann PM, 1996, J NEUROL SCI, V144, P59, DOI 10.1016/S0022-510X(96)00145-1
   Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229
   Finsterer J, 2005, ACTA CARDIOL, V60, P445, DOI 10.2143/AC.60.4.2004996
   Finsterer J, 2005, CARDIOLOGY, V103, P167, DOI 10.1159/000084588
   Finsterer J, 2015, FORTSCHR NEUROL PSYC, V83, P9, DOI 10.1055/s-0034-1385734
   Finsterer J, 2015, REV PORT CARDIOL, V34
   Finsterer J, 2007, J CARDIOVASC MED, V8, P859, DOI 10.2459/JCM.0b013e3280103d1b
   Finsterer J, 2015, CARDIOLOGY, V130, P48, DOI 10.1159/000368222
   Finsterer J, 2014, KOREAN CIRC J, V44, P348, DOI 10.4070/kcj.2014.44.5.348
   Finsterer J, 2014, INT J CARDIOL, V173, P532, DOI 10.1016/j.ijcard.2014.03.025
   Finsterer J, 2014, NAT REV CARDIOL, V11, P168, DOI 10.1038/nrcardio.2013.213
   Flock A, 2014, OBSTET GYNECOL, V123, P436, DOI 10.1097/AOG.0000000000000101
   Florian A, 2015, EUR HEART J CARDIOVA
   Florian A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0145-x
   Fujita Kengo, 2005, Rinsho Shinkeigaku, V45, P380
   Gal A, 2015, CLIN NEUROPATHOL, V34, P89, DOI 10.5414/NP300789
   Gatayama R, 2013, PEDIATRICS, V131, pE1986, DOI 10.1542/peds.2012-1139
   Gaul C, 2006, J NEUROL, V253, P1317, DOI 10.1007/s00415-006-0213-0
   Gdynia HJ, 2006, J NEUROL NEUROSUR PS, V77, P671, DOI 10.1136/jnnp.2005.078600
   Gossios TD, 2013, EUR J MED GENET, V56, P251, DOI 10.1016/j.ejmg.2013.03.001
   Green DS, 1997, ANN NEUROL, V42, P253, DOI 10.1002/ana.410420219
   Groh WJ, 2012, HEART RHYTHM, V9, P1890, DOI 10.1016/j.hrthm.2012.06.038
   Guo X., 2014, CAN J CARDIOL, V30, pe1
   Hachenberg T, 1992, J Cardiothorac Vasc Anesth, V6, P386, DOI 10.1016/1053-0770(92)90183-8
   Haliloglu G, 2015, J INHERIT METAB DIS, V38, P1099, DOI 10.1007/s10545-015-9856-2
   Hattori T, 1995, Rinsho Shinkeigaku, V35, P1246
   HERTZMAN PA, 1992, JAMA-J AM MED ASSOC, V267, P2932, DOI 10.1001/jama.267.21.2932
   Hikita T, 2008, PEDIATR INT, V50, P698, DOI 10.1111/j.1442-200X.2008.02719.x
   HOFSTAD H, 1984, ACTA NEUROL SCAND, V70, P176
   Hollingsworth KG, 2013, EUR J HEART FAIL, V15, P986, DOI 10.1093/eurjhf/hft057
   Homan David J, 2011, Congest Heart Fail, V17, P102, DOI 10.1111/j.1751-7133.2011.00211.x
   Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085
   ISHIWATA S, 1993, JPN CIRC J, V57, P928, DOI 10.1253/jcj.57.928
   Iwahara N, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0269-5
   Jefferies JL, 2015, J CARD FAIL, V21, P877, DOI 10.1016/j.cardfail.2015.06.381
   Caballero PEJ, 2011, NEUROLOGIST, V17, P38, DOI 10.1097/NRL.0b013e3181d35c93
   Kajino S, 2014, J NEUROL SCI, V340, P94, DOI 10.1016/j.jns.2014.02.036
   Kaneko K, 2014, NEUROMUSCULAR DISORD, V24, P634, DOI 10.1016/j.nmd.2014.04.001
   Kayman-Kurekci G, 2014, NEUROMUSCULAR DISORD, V24, P624, DOI 10.1016/j.nmd.2014.04.007
   Kilic T, 2007, PACE, V30, P916, DOI 10.1111/j.1540-8159.2007.00782.x
   Kim HN, 2014, J KOREAN MED SCI, V29, P879, DOI 10.3346/jkms.2014.29.6.879
   Kimpara T, 1993, Rinsho Shinkeigaku, V33, P886
   Klein CJ, 2014, NEUROLOGY, V82, P873, DOI 10.1212/WNL.0000000000000206
   Konersman CG, 2015, NEUROMUSCULAR DISORD, V25, P418, DOI 10.1016/j.nmd.2015.01.009
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   KRENDEL DA, 1988, ARCH NEUROL-CHICAGO, V45, P698, DOI 10.1001/archneur.1988.00520300118032
   Kuru Satoshi, 2004, Rinsho Shinkeigaku, V44, P375
   LaBarbera Matthew, 2010, J Invasive Cardiol, V22, pE156
   Lang SM, 2015, PEDIATR CARDIOL, V36, P1495, DOI 10.1007/s00246-015-1192-7
   Lee HC, 2012, CLIN GENET, V81, P394, DOI 10.1111/j.1399-0004.2011.01659.x
   Lee Teresa M, 2012, Congest Heart Fail, V18, P183, DOI 10.1111/j.1751-7133.2011.00265.x
   Lefter S, 2015, NEUROMUSCULAR DISORD, V25, P155, DOI 10.1016/j.nmd.2014.09.007
   Liewluck Teerin, 2009, Journal of the Medical Association of Thailand, V92, P290
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Longhi S, 2015, AMYLOID, V22, P147, DOI 10.3109/13506129.2015.1028616
   Losito L, 2009, EUR J PAEDIATR NEURO, V13, P459, DOI 10.1016/j.ejpn.2008.07.011
   Maffe S, 2009, J CARDIOVASC MED, V10, P68, DOI 10.2459/JCM.0b013e3283189564
   Maggi L, 2014, NEUROLOGY, V83, P1634, DOI 10.1212/WNL.0000000000000934
   Magoulas P L, 2013, GENEREVIEWS
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Marques J, 2014, NEUROMUSCULAR DISORD, V24, P419, DOI 10.1016/j.nmd.2014.01.004
   Martinez HR, 2014, EUR J HUM GENET, V22, P486, DOI 10.1038/ejhg.2013.165
   Massari FM, 2011, G ITAL CARDIOL, V12, P388, DOI 10.1714/643.7506
   Matsuda Hiromi, 2014, Masui, V63, P650
   Matsui M, 2015, RINSHO SHINKEIGAKU
   Mayor-Gomez S, 2012, REV NEUROLOGIA, V55, P725, DOI 10.33588/rn.5512.2012465
   Menotti Francesca, 2004, Ital Heart J, V5, P460
   Merlini L, 2000, NEUROLOGY, V54, P1075, DOI 10.1212/WNL.54.5.1075
   Miani D, 2012, AM J CARDIOL, V109, P406, DOI 10.1016/j.amjcard.2011.09.024
   MILLAIRE A, 1990, ANN CARDIOL ANGEIOL, V39, P173
   Mir A, 2012, CONGENIT HEART DIS, V7, pE37, DOI 10.1111/j.1747-0803.2011.00588.x
   Missaglia S, 2015, MOL GENET METAB, V115, P110, DOI 10.1016/j.ymgme.2015.05.001
   Mogahed EA, 2015, EUR J PEDIATR, V174, P1545, DOI 10.1007/s00431-015-2546-0
   Moustafa S, 2013, HEART LUNG CIRC, V22, P769, DOI 10.1016/j.hlc.2012.12.004
   Muller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255
   Naddaf Elie, 2015, J Clin Neuromuscul Dis, V16, P164, DOI 10.1097/CND.0000000000000069
   Nakagawa H, 2014, INTERNAL MED, V53, P315, DOI 10.2169/internalmedicine.53.1386
   Nakayama T, 1999, Rinsho Shinkeigaku, V39, P610
   Nalini A, 2013, NEUROL INDIA, V61, P622, DOI 10.4103/0028-3886.125269
   Namazi MH, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/986139
   Nishikawa A, 2015, MUSCLE NERVE
   Nishino Ichizo, 2005, Rinsho Shinkeigaku, V45, P943
   Nussinovitch U, 2010, PEDIATR CARDIOL, V31, P80, DOI 10.1007/s00246-009-9575-2
   Ojala T, 2015, EUR J PEDIATR, V174, P1689, DOI 10.1007/s00431-015-2574-9
   Okere A, 2013, CIRC-HEART FAIL, V6, pE12, DOI 10.1161/CIRCHEARTFAILURE.112.971424
   Oliveira J, 2015, J HUM GENET, V60, P305, DOI 10.1038/jhg.2015.20
   Palecek T, 2012, INT HEART J, V53, P383, DOI 10.1536/ihj.53.383
   Palladino A, 2011, NEUROMUSCULAR DISORD, V21, P684, DOI 10.1016/j.nmd.2011.06.902
   Pambrun T, 2015, ANN NONINVAS ELECTRO, V20, P28, DOI 10.1111/anec.12168
   Pane M, 2012, NEUROMUSCULAR DISORD, V22, P685, DOI 10.1016/j.nmd.2012.05.006
   Pasqualin LMA, 2014, PEDIATR NEUROL, V50, P400, DOI 10.1016/j.pediatrneurol.2013.11.010
   Pen AE, 2015, EUR J MED GENET, V58, P222, DOI 10.1016/j.ejmg.2015.02.003
   Petri H, 2015, INT J CARDIOL, V182, P403, DOI 10.1016/j.ijcard.2014.12.090
   Petri H, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0059-z
   Petri H, 2014, INT J CARDIOL, V174, P31, DOI 10.1016/j.ijcard.2014.03.088
   Pinol-Ripoll G, 2009, NEUROMUSCULAR DISORD, V19, P418, DOI 10.1016/j.nmd.2009.04.004
   Plonka C, 2013, AM J TRANSPLANT, V13, P1915, DOI 10.1111/ajt.12246
   Prater SN, 2012, GENET MED, V14, P800, DOI 10.1038/gim.2012.44
   Quick S, 2015, MUSCLE NERVE, V52, P661, DOI 10.1002/mus.24717
   Rakocevic-Stojanovic V, 1999, PANMINERVA MED, V41, P27
   Redondo-Verge L, 2011, MUSCLE NERVE, V44, P587, DOI 10.1002/mus.22179
   Ronvelia D, 2012, MOL GENET METAB, V107, P428, DOI 10.1016/j.ymgme.2012.09.013
   Rosales XQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-39
   RUBIN H J, 1947, Proc Staff Meet Tulsa Okla Hillcrest Meml Hosp, V4, P141
   Rudnik-Schoneborn S, 2011, EUR J NEUROL, V18, P191, DOI 10.1111/j.1468-1331.2010.03077.x
   Russo V, 2015, EUR REV MED PHARMACO, V19, P1241
   Sacconi S, 2014, NEUROMUSCULAR DISORD, V24, P648, DOI 10.1016/j.nmd.2014.04.005
   Sakpichaisakul Kullasate, 2010, Journal of the Medical Association of Thailand, V93, P1088
   Sarullo FM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-5
   Schoser B, 2008, MOL GENET METAB, V95, P52, DOI 10.1016/j.ymgme.2008.07.005
   Schottlaender LV, 2015, J NEUROL SCI, V348, P266, DOI 10.1016/j.jns.2014.12.008
   Semplicini C, 2015, NEUROLOGY, V84, P1772, DOI 10.1212/WNL.0000000000001519
   Sentner CP, 2012, JIMD REP, V5, P13, DOI 10.1007/8904_2011_111
   Shemisa Kamal, 2014, J Med Case Rep, V8, P224, DOI 10.1186/1752-1947-8-224
   Simsek Z, 2012, J CARDIOVASC MED, V13, P660, DOI 10.2459/JCM.0b013e32833cdcd0
   Stollberger C, 2014, J CARDIOVASC ELECTR, V25, P905, DOI 10.1111/jce.12436
   Stunnenberg BC, 2014, MUSCLE NERVE, V50, P327, DOI 10.1002/mus.24225
   Sveen ML, 2008, ARCH NEUROL-CHICAGO, V65, P1196, DOI 10.1001/archneur.65.9.1196
   Takahashi T, 2013, J NEUROL NEUROSUR PS, V84, P433, DOI 10.1136/jnnp-2011-301339
   Tanahashi Norio, 2004, Keio J Med, V53, P30
   Tanaka Y, 2013, J NEUROL, V260, P2380, DOI 10.1007/s00415-013-7005-0
   Tandon A, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001338
   Thanaviratananich Sikawat, 2014, J Clin Neuromuscul Dis, V15, P90, DOI 10.1097/CND.0000000000000022
   Tiffin HR, 2013, NEUROGENETICS, V14, P113, DOI 10.1007/s10048-013-0359-8
   Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224
   Tsuda T, 2015, J HUM GENET, V60, P151, DOI 10.1038/jhg.2014.112
   Uechi Y, 2008, INTERNAL MED, V47, P1609, DOI 10.2169/internalmedicine.47.1186
   van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P92, DOI 10.1136/jnnp-2012-304729
   Van der Starre P, 2013, MUSCLE NERVE, V47, P135, DOI 10.1002/mus.23517
   van Westering TLE, 2015, MOLECULES, V20, P8823, DOI 10.3390/molecules20058823
   van Westrum SMS, 2014, MUSCLE NERVE, V50, P909, DOI 10.1002/mus.24233
   Vattemi G, 2011, Acta Myol, V30, P121
   Vidal-Perez R, 2013, EUR HEART J-CARD IMG, V14, P1038, DOI 10.1093/ehjci/jet118
   VIITASALO MT, 1983, J NEUROL SCI, V62, P181, DOI 10.1016/0022-510X(83)90198-3
   Volpi L, 2010, NEUROMUSCULAR DISORD, V20, P512, DOI 10.1016/j.nmd.2010.03.016
   Wahbi K, 2008, NEUROMUSCULAR DISORD, V18, P650, DOI 10.1016/j.nmd.2008.06.365
   Wahbi K, 2008, NEUROMUSCULAR DISORD, V18, P331, DOI 10.1016/j.nmd.2007.11.012
   Wang Shi-Bing, 2008, Pediatrics and Neonatology, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   Watanabe Yuka, 2009, Brain and Nerve (Tokyo), V61, P309
   Wessely R, 2005, CLIN GENET, V67, P220, DOI 10.1111/j.1399-0004.2004.00395.x
   WOCHNA K, 2013, ARCH MED SADOWEJ KRY, V63, P7
   Wochna Katarzyna, 2013, Arch Med Sadowej Kryminol, V63, P11
   Wortmann SB, 2012, EUR J MED GENET, V55, P552, DOI 10.1016/j.ejmg.2012.06.002
   Yajima N, 2009, J NUCL CARDIOL, V16, P989, DOI 10.1007/s12350-009-9149-y
   Yasuma F, 2004, INTERNAL MED, V43, P951, DOI 10.2169/internalmedicine.43.951
   Yilmaz BS, 2015, J PEDIATR ENDOCR MET, V28, P1179, DOI 10.1515/jpem-2014-0528
   Yoda M, 2011, EUR J CARDIO-THORAC, V40, P514, DOI 10.1016/j.ejcts.2010.12.018
   Zhang RN, 2014, WORLD J PEDIATR, V10, P119, DOI 10.1007/s12519-014-0480-2
   Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400
NR 194
TC 14
Z9 14
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 117
EP 134
DI 10.4070/kcj.2016.46.2.117
PG 18
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300001
PM 27014341
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, S
AF Shin, Sehyun
TI Unsolved Favorable Effect of Statin on Blood Viscosity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Shin, Sehyun] Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea.
RP Shin, S (corresponding author), Korea Univ, Coll Engn, Sch Mech Engn, Seoul, South Korea.
EM lexerdshin@korea.ac.kr
RI Shin, Sehyun/C-3128-2011
OI Shin, Sehyun/0000-0002-2611-5610
CR Golebiewska EM, 2014, BRIT J HAEMATOL, V165, P204, DOI 10.1111/bjh.12682
   Ho Chao-Hung, 2004, J Chin Med Assoc, V67, P394
   Jung LY, 2016, KOREAN CIRC J, V46, P147, DOI 10.4070/kcj.2016.46.2.147
   Karthikeyan VJ, 2006, J HUM HYPERTENS, V20, P310, DOI 10.1038/sj.jhh.1001980
   Kim JH, 2015, CLIN HEMORHEOL MICRO
   SHARMA K, 1992, PHYSIOL CHEM PHYS M, V24, P159
   Shin S, 2005, CYTOM PART B-CLIN CY, V65B, P6, DOI 10.1002/cyto.b.20048
   STEINBERG MH, 1971, BLOOD-J HEMATOL, V38, P299, DOI 10.1182/blood.V38.3.299.299
NR 8
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 145
EP 146
DI 10.4070/kcj.2016.46.2.145
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300003
PM 27014343
OA Green Published
DA 2021-04-22
ER

PT J
AU Sung, J
   Jeong, JO
   Kwon, SU
   Won, KH
   Kim, BJ
   Cho, BR
   Kim, MK
   Lee, S
   Kim, HJ
   Lim, SH
   Park, SW
   Park, JE
AF Sung, Jidong
   Jeong, Jin-Ok
   Kwon, Sung Uk
   Won, Kyung Heon
   Kim, Byung Jin
   Cho, Byung Ryul
   Kim, Myeong-Kon
   Lee, Sahng
   Kim, Hak Jin
   Lim, Seong-Hoon
   Park, Seung Woo
   Park, Jeong Euy
TI Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine
   10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5
   mg Monotherapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Amlodipine-valsartan drug combination; Hypertension; Valsartan;
   Amlodipine
ID BLOOD-PRESSURE; EFFICACY; TOLERABILITY; SAFETY; EDEMA
AB Background and Objectives: When monotherapy is inadequate for blood pressure control, the next step is either to continue monotherapy in increased doses or to add another antihypertensive agent. However, direct comparison of double-dose monotherapy versus combination therapy has rarely been done. The objective of this study is to compare 10 mg of amlodipine with an amlodipine/valsartan 5/160 mg combination in patients whose blood pressure control is inadequate with amlodipine 5 mg.
   Subjects and Methods: This study was conducted as a multicenter, open-label, randomized controlled trial. Men and women aged 20-80 who were diagnosed as having hypertension, who had been on amlodipine 5 mg monotherapy for at least 4 weeks, and whose daytime mean systolic blood pressure (SBP) >= 135 mmHg or diastolic blood pressure (DBP)>= 85 mmHg on 24-hour ambulatory blood pressure monitoring (ABPM) were randomized to amlodipine (A) 10 mg or amlodipine/valsartan (AV) 5/160 mg group. Follow-up 24-hour ABPM was done at 8 weeks after randomization.
   Results: Baseline clinical characteristics did not differ between the 2 groups. Ambulatory blood pressure reduction was significantly greater in the AV group compared with the A group (daytime mean SBP change: -14 +/- 11 vs. -9 +/- 9 mmHg, p<0.001, 24-hour mean SBP change: -13 +/- 10 vs. -8 +/- 8 mmHg, p<0.0001). Drug-related adverse events also did not differ significantly (A:AV, 6.5 vs. 4.5 %, p=0.56).
   Conclusion: Amlodipine/valsartan 5/160 mg combination was more efficacious than amlodipine 10 mg in hypertensive patients in whom monotherapy of amlodipine 5 mg had failed.
C1 [Sung, Jidong; Park, Seung Woo; Park, Jeong Euy] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc & Stroke Inst, Seoul, South Korea.
   [Jeong, Jin-Ok] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, Daejeon, South Korea.
   [Kwon, Sung Uk] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med,Vis Cardiac & Vasc Ctr 21, Goyang, South Korea.
   [Won, Kyung Heon] Seoul Med Ctr, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea.
   [Kim, Byung Jin] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Cho, Byung Ryul] Kangwon Natl Univ Hosp, Dept Internal Med, Div Intervent Cardiol, Chunchon, South Korea.
   [Kim, Myeong-Kon] Kyung Hee Univ, Med Ctr, Dept Cardiovasc Med, Seoul, South Korea.
   [Lee, Sahng] Eulji Univ Hosp, Internal Med, Div Cardiol, Daejeon, South Korea.
   [Kim, Hak Jin] Natl Canc Ctr, Ctr Clin Specialty, Dept Cardiol, Goyang, South Korea.
   [Lim, Seong-Hoon] Dankook Univ Hosp, Dept Internal Med, Div Cardiol, Cheonan, South Korea.
RP Park, JE (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM jepark39@gmail.com
RI sung, jd/O-5936-2014
OI Jeong, Jin-Ok/0000-0003-0763-4754; Seong, In-Whan/0000-0003-4628-0258
FU NovartisNovartis
FX This work was supported by a grant from Novartis. Study design,
   acquisition, analysis and interpretation of the data and drafting and
   revising of the article were done solely by investigators, independently
   of the study grant provider.
CR Allemann Y, 2008, J CLIN HYPERTENS, V10, P185, DOI 10.1111/j.1751-7176.2008.07516.x
   Brachmann J, 2008, ADV THER, V25, P399, DOI 10.1007/s12325-008-0054-6
   Flack JM, 2009, J HUM HYPERTENS, V23, P479, DOI 10.1038/jhh.2008.153
   Fogari R, 2007, J HUM HYPERTENS, V21, P220, DOI 10.1038/sj.jhh.1002140
   Ke Yuan-Nan, 2009, Zhonghua Xin Xue Guan Bing Za Zhi, V37, P794
   Ke YN, 2010, CURR MED RES OPIN, V26, P1705, DOI 10.1185/03007995.2010.487391
   Messerli FH, 2000, AM J CARDIOL, V86, P1182, DOI 10.1016/S0002-9149(00)01199-1
   Ogawa H, 2012, AM J MED, V125, P981, DOI 10.1016/j.amjmed.2011.12.010
   Philipp T, 2007, CLIN THER, V29, P563, DOI 10.1016/j.clinthera.2007.03.018
   Philipp T, 2011, J AM SOC HYPERTENS, V5, P417, DOI 10.1016/j.jash.2011.02.008
   Schrader J, 2009, INT J CLIN PRACT, V63, P217, DOI 10.1111/j.1742-1241.2008.01977.x
   Schunkert H, 2009, CURR MED RES OPIN, V25, P2655, DOI 10.1185/03007990903251193
   Sinkiewicz W, 2009, CURR MED RES OPIN, V25, P315, DOI [10.1185/03007990802630588, 10.1185/03007990802630588 ]
   Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038
   White WB, 2008, J CLIN HYPERTENS, V10, P450, DOI 10.1111/j.1751-7176.2008.08259.x
   Zhu DL, 2013, INT J CARDIOL, V167, P2024, DOI 10.1016/j.ijcard.2012.05.039
   박창규, 2008, Korean Circulation Journal, V38, P237
NR 17
TC 5
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 222
EP 228
DI 10.4070/kcj.2016.46.2.222
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300013
PM 27014353
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, S
   Lee, JY
   Park, JK
   Oh, S
   Jeon, DW
   Yang, JY
   Yoon, SJ
AF Shin, Sanghoon
   Lee, Ja Young
   Park, Jong-Kwan
   Oh, Seungjin
   Jeon, Dong Woon
   Yang, Joo Young
   Yoon, Se-Jung
TI The Characteristic Doppler Pattern of the Left Ventricular Outflow Tract
   in a Patient with Orthostatic Hypotension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Shin, Sanghoon; Lee, Ja Young; Park, Jong-Kwan; Oh, Seungjin; Jeon, Dong Woon; Yang, Joo Young; Yoon, Se-Jung] Natl Hlth Insurance Serv Ilsan Hosp, Div Cardiol, 100 Ilsan Ro, Goyang 10444, South Korea.
RP Yoon, SJ (corresponding author), Natl Hlth Insurance Serv Ilsan Hosp, Div Cardiol, 100 Ilsan Ro, Goyang 10444, South Korea.
EM drpuooh@hanmail.net
OI Shin, Sanghoon/0000-0002-2348-2570; Park, Jong Kwan/0000-0002-5506-1412
CR Arnold AC, 2013, CURR HYPERTENS REP, V15, P304, DOI 10.1007/s11906-013-0362-3
   Chou RH, 2015, INT J CARDIOL, V195, P40, DOI 10.1016/j.ijcard.2015.05.060
   Zamani B, 2011, CLIN NEUROL NEUROSUR, V113, P368, DOI 10.1016/j.clineuro.2010.12.014
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 268
EP 269
DI 10.4070/kcj.2016.46.2.268
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300020
PM 27014360
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Kusunose, K
   Kwon, DH
   Park, MM
   Thomas, JD
   Grimm, RA
   Griffin, BP
   Marwick, TH
   Popovic, ZB
AF Park, Jae-Hyeong
   Kusunose, Kenya
   Kwon, Deborah H.
   Park, Margaret M.
   Thomas, James D.
   Grimm, Richard A.
   Griffin, Brian P.
   Marwick, Thomas H.
   Popovic, Zoran B.
TI Relationship between Right Ventricular Longitudinal Strain, Invasive
   Hemodynamics, and Functional Assessment in Pulmonary Arterial
   Hypertension (vol 45, pg 398, 2015)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Park, Jae-Hyeong; Kusunose, Kenya; Kwon, Deborah H.; Park, Margaret M.; Thomas, James D.; Grimm, Richard A.; Griffin, Brian P.; Marwick, Thomas H.; Popovic, Zoran B.] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA.
   [Park, Jae-Hyeong] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Cardiol Div Internal Med, Daejeon, South Korea.
   [Kusunose, Kenya] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima, Japan.
   [Park, Margaret M.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.
   [Marwick, Thomas H.] Menzies Res Inst, Hobart, Australia.
RP Park, JH (corresponding author), Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA.; Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Cardiol Div Internal Med, Daejeon, South Korea.
RI Kusunose, Kenya/AAC-9978-2021; Park, Jae-Hyeong/AAD-9015-2021
OI Kusunose, Kenya/0000-0002-4909-754X; 
CR Park JH, 2015, KOREAN CIRC J, V45, P398, DOI 10.4070/kcj.2015.45.5.398
NR 1
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2016
VL 46
IS 2
BP 273
EP 273
DI 10.4070/kcj.2016.46.2.273
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DH8GU
UT WOS:000373032300023
PM 27014362
OA Green Published
DA 2021-04-22
ER

PT J
AU Marquez, J
   Lee, SR
   Kim, N
   Han, J
AF Marquez, Jubert
   Lee, Sung Ryul
   Kim, Nari
   Han, Jin
TI Post-Translational Modifications of Cardiac Mitochondrial Proteins in
   Cardiovascular Disease: Not Lost in Translation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiovascular diseases; Heart failure; Mitochondria; Post-translational
   modifications
ID CYTOCHROME-C-OXIDASE; PYRUVATE-DEHYDROGENASE COMPLEX; PERMEABILITY
   TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; FATTY-ACID OXIDATION;
   HUMAN HEART-FAILURE; PROTEOMIC ANALYSIS; CREATINE-KINASE; NITRIC-OXIDE;
   TYROSINE PHOSPHORYLATION
AB Protein post-translational modifications (PTMs) are crucial in regulating cellular biology by playing key roles in processes such as the rapid on and off switching of signaling network and the regulation of enzymatic activities without affecting gene expressions. PTMs lead to conformational changes in the tertiary structure of protein and resultant regulation of protein function such as activation, inhibition, or signaling roles. PTMs such as phosphorylation, acetylation, and S-nitrosylation of specific sites in proteins have key roles in regulation of mitochondrial functions, thereby contributing to the progression to heart failure. Despite the extensive study of PTMs in mitochondria! proteins much remains unclear. Further research is yet to be undertaken to elucidate how changes in the proteins may lead to cardiovascular and metabolic disease progression in particular. We aimed to summarize the various types of PTMs that occur in mitochondrial proteins, which might be associated with heart failure. This study will increase the understanding of cardiovascular diseases through PTM.
C1 [Marquez, Jubert; Lee, Sung Ryul; Kim, Nari; Han, Jin] Inje Univ, Grad Sch, Dept Hlth Sci & Technol, Busan, South Korea.
   [Lee, Sung Ryul; Kim, Nari; Han, Jin] Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Natl Res Lab Mitochondrial Signaling,Dept Physiol, 75 Bokji Ro, Busan 47392, South Korea.
RP Han, J (corresponding author), Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Natl Res Lab Mitochondrial Signaling,Dept Physiol, 75 Bokji Ro, Busan 47392, South Korea.
EM phyhanj@inje.ac.kr
FU National Research Foundation of Korea (NRF) - Ministry of Education,
   Science, and TechnologyMinistry of Education, Science and Technology,
   Republic of KoreaNational Research Foundation of Korea [2010-0020224,
   2011-0028925, 2012R1A2A1A03007595]
FX This work was supported by the Priority Research Centers Program
   (2010-0020224) and the Basic Science Research Program (2011-0028925 and
   2012R1A2A1A03007595) through the National Research Foundation of Korea
   (NRF), funded by the Ministry of Education, Science, and Technology.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Akhmedov D, 2012, BBA-MOL CELL RES, V1823, P1815, DOI 10.1016/j.bbamcr.2012.07.005
   Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]
   Arstall MA, 1998, J MOL CELL CARDIOL, V30, P979, DOI 10.1006/jmcc.1998.0662
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199
   Barford D, 1995, CURR OPIN STRUC BIOL, V5, P728, DOI 10.1016/0959-440X(95)80004-2
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200
   Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265
   Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014
   Boudina S, 2002, AM J PHYSIOL-HEART C, V282, pH821, DOI 10.1152/ajpheart.00471.2001
   Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191
   Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018
   Chavez JD, 2013, MOL CELL PROTEOMICS, V12, P1451, DOI 10.1074/mcp.M112.024497
   Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474
   Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200
   Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200
   박진주, 2015, [The Korean Journal of Medicine, 대한내과학회지], V88, P127, DOI 10.3904/kjm.2015.88.2.127
   Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019
   Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371
   Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013
   Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e
   Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   De Sousa E, 1999, CIRC RES, V85, P68
   Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117
   Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042
   Feng JH, 2010, AM J PHYSIOL-CELL PH, V298, pC740, DOI 10.1152/ajpcell.00310.2009
   Foster DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067513
   Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032
   Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293
   Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204
   Grillon JM, 2012, BBA-MOL BASIS DIS, V1822, P607, DOI 10.1016/j.bbadis.2011.11.016
   Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004
   Grotenbreg G, 2007, NATURE, V446, P993, DOI 10.1038/446993a
   Gucek M, 2010, CARDIOVASC RES, V88, P211, DOI 10.1093/cvr/cvq277
   GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989
   Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001
   HANKS SK, 1995, FASEB J, V9, P576
   Haq S, 2001, CIRCULATION, V103, P670
   Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511
   Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hofer A, 2014, EXP GERONTOL, V56, P202, DOI 10.1016/j.exger.2014.03.006
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hollander John M, 2011, Congest Heart Fail, V17, P262, DOI 10.1111/j.1751-7133.2011.00254.x
   HUGHES WA, 1981, BIOCHEM J, V196, P459, DOI 10.1042/bj1960459
   Hurd TR, 2005, BIOCHEM SOC T, V33, P1390, DOI 10.1042/BST0331390
   Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999
   Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001
   Iliodromitis EK, 2007, VASC HEALTH RISK MAN, V3, P629
   Ito K, 2007, BIOCHEM SOC T, V35, P281, DOI 10.1042/BST0350281
   Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213
   Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172
   Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627
   Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006
   Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002
   Kemper JK, 2011, BBA-MOL BASIS DIS, V1812, P842, DOI 10.1016/j.bbadis.2010.11.011
   Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996
   Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497
   Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026
   Koc EC, 2012, BBA-GENE REGUL MECH, V1819, P1055, DOI 10.1016/j.bbagrm.2012.03.003
   Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069
   Kurdi Mazen, 2011, Congest Heart Fail, V17, P255, DOI 10.1111/j.1751-7133.2011.00269.x
   Lee Hye Ah, 2012, J Prev Med Public Health, V45, P323, DOI 10.3961/jpmph.2012.45.5.323
   Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200
   Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011
   Lee S, 2013, TOX RESEARCH, V29, P81, DOI 10.5487/TR.2013.29.2.081
   Li HY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-366
   Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640
   Li X, 2013, PROTEIN SCI, V22, P287, DOI 10.1002/pro.2210
   Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012
   Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121
   Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046
   Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026
   MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170
   Moon KH, 2005, FEBS LETT, V579, P6115, DOI 10.1016/j.febslet.2005.09.082
   Moreno-Gonzalo O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00383
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Morrison RS, 2002, MOL CELL PROTEOMICS, V1, P553, DOI 10.1074/mcp.R200004-MCP200
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700
   Nguyen TTM, 2013, CIRC RES, V113, P1308, DOI 10.1161/CIRCRESAHA.113.301867
   O'Rourke Brian, 2011, Congest Heart Fail, V17, P269, DOI 10.1111/j.1751-7133.2011.00266.x
   Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4
   Onishi A, 2012, EUR J PHARMACOL, V675, P40, DOI 10.1016/j.ejphar.2011.11.040
   Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005
   Palmisano G, 2007, PROTEOMICS, V7, P1575, DOI 10.1002/pmic.200600801
   Papa S, 2008, BBA-BIOENERGETICS, V1777, P719, DOI 10.1016/j.bbabio.2008.04.005
   Papanicolaou KN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00301
   Parang P, 2005, J CARDIOVASC PHARM T, V10, P217, DOI 10.1177/107424840501000402
   Park KJ, 2012, KOREAN CIRC J, V42, P23, DOI 10.4070/kcj.2012.42.1.23
   Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217
   Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32
   Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494
   Peng M, 2014, J PROTEOME RES, V13, P249, DOI 10.1021/pr4005579
   Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011
   POPOV KM, 1993, J BIOL CHEM, V268, P26602
   Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185
   Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Raha S, 2002, FREE RADICAL BIO MED, V32, P421, DOI 10.1016/S0891-5849(01)00816-4
   Ramirez-Correa GA, 2015, DIABETES, V64, P3573, DOI 10.2337/db14-1107
   Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013
   Ren RJ, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-23
   Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x
   Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003
   Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0
   Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806
   Sack M.N., 2012, COLD SPRING HARB PER, V4
   Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837
   Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, pH474
   Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x
   Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401
   Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036
   Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097
   Slade DJ, 2014, BIOPOLYMERS, V101, P133, DOI 10.1002/bip.22256
   Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962
   Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9
   Strumilo S, 2005, ACTA BIOCHIM POL, V52, P759
   Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002
   Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5
   Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875
   Wang SY, 2010, J CHROMATOGR A, V1217, P6496, DOI 10.1016/j.chroma.2010.08.044
   Warnecke A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0370-6
   Wende AR, 2015, PROTEOMICS CLIN APPL
   White MY, 2008, PROTEOM CLIN APPL, V2, P845, DOI 10.1002/prca.200780135
   WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761
   Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214
   Wolanin PM, 2002, GENOME BIOL, V3
   Wolosker H, 1996, FEBS LETT, V392, P274, DOI 10.1016/0014-5793(96)00829-0
   Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819
   Xu M, 2001, BIOCHEM BIOPH RES CO, V287, P752, DOI 10.1006/bbrc.2001.5647
   Xue L, 2012, FEBS LETT, V586, P137, DOI 10.1016/j.febslet.2011.11.031
   Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848
   ZHANG B, 1991, MOL BIOL MED, V8, P39
   Zhang JL, 2005, AM J PHYSIOL-CELL PH, V288, pC840, DOI 10.1152/ajpcell.00325.2004
   Zhang J, 2012, J GEN PHYSIOL, V139, P395, DOI 10.1085/jgp.201210797
   Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016
   Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
   Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299
NR 156
TC 11
Z9 11
U1 0
U2 16
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 1
EP 12
DI 10.4070/kcj.2016.46.1.1
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400001
PM 26798379
OA Green Published
DA 2021-04-22
ER

PT J
AU Borekci, A
   Gur, M
   Turkoglu, C
   Baykan, AO
   Seker, T
   Sahin, DY
   Harbalioglu, H
   Elbasan, Z
   Topuz, M
   Cayli, M
AF Borekci, Abdurrezzak
   Gur, Mustafa
   Turkoglu, Caner
   Baykan, Ahmet Oytun
   Seker, Taner
   Sahin, Durmus Yildiray
   Harbalioglu, Hazar
   Elbasan, Zafer
   Topuz, Mustafa
   Cayli, Murat
TI Neutrophil to Lymphocyte Ratio Predicts Left Ventricular Remodeling in
   Patients with ST Elevation Myocardial Infarction after Primary
   Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Remodeling; Neutrophils; lymphocytes; BNP;
   No-reflow
ID NATRIURETIC PEPTIDE; ARTERY-DISEASE; HEART; REPERFUSION; MECHANISMS;
   ISCHEMIA; OUTCOMES; INJURY; BNP
AB Background and Objectives: It has been demonstrated that the neutrophil/lymphocyte ratio (NLR) might be a useful marker to predict cardiovascular risk and events. We aimed to investigate the role of the NLR to predict ventricular remodeling (VR) in patients with anterior ST-elevation myocardial infarction (STEMI) who were treated with primary percutaneous coronary intervention.
   Subjects and Methods: We prospectively included 274 consecutive anterior STEMI patients. Echocardiography was performed during admission and at six months after myocardial infarction. VR was defined as at least 200/0 increase from baseline in left ventricular end diastolic volume. Patients were divided into two groups according to their VR status: VR (n=67) and non-VR (n=207). Total and differential leukocyte count, N -terminal pro -brain natriuretic peptide (NT-proBNP) and other biochemical markers were measured at admission and 24 hours later.
   Results: Compared with the non-VR group, peak creatine kinase MB (CK-MB), NT-proBNP (24 h), neutrophil/lymphocyte ratio, presence of diabetes, no-reflow frequency and wall motion score index were significantly higher in patients with VR (p<0.05 for all). On multivariate logistic regression analysis, NLR (beta=2.000, 950/o confidence interval=1.577-2.537, p<0.001) as well as peak CK-MB, NT-proBNP (24 h), WMSI and diabetes incidence were associated with VR. The cutoff value of the neutrophil/lymphocyte ratio obtained by receiver operator characteristic curve analysis was 4.25 for the prediction of VR (sensitivity: 79%, specificity: 74%).
   Conclusion: In patients with anterior STEMI, initial NLR and NT-proBNP measured 24 hours after admission may be useful for predicting adverse cardiovascular events including left VR.
C1 [Borekci, Abdurrezzak; Gur, Mustafa] Kafkas Univ, Sch Med, Dept Cardiol, Kars, Turkey.
   [Turkoglu, Caner] Yenimahalle State Hosp, Dept Cardiol, Ankara, Turkey.
   [Baykan, Ahmet Oytun; Seker, Taner; Sahin, Durmus Yildiray; Harbalioglu, Hazar; Elbasan, Zafer; Topuz, Mustafa] Adana Numune Training & Res Hosp, Dept Cardiol, Adana, Turkey.
   [Cayli, Murat] Dicle Univ, Sch Med, Dept Cardiol, Diyarbakir, Turkey.
RP Seker, T (corresponding author), Adana Numune Training & Res Hosp, Dept Cardiol, Adana, Turkey.
EM atanerseker@hotmail.com
RI ELBASAN, ZAFER/W-3376-2018
OI ELBASAN, ZAFER/0000-0001-9422-1995
CR Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA
   Cochet A, 2004, EUR J HEART FAIL, V6, P555, DOI 10.1016/j.ejheart.2003.11.012
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1
   Ducloux D, 2003, J AM SOC NEPHROL, V14, P767, DOI 10.1097/01.ASN.0000048718.43419.44
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   Frangogiannis NG, 1998, J MOL CELL CARDIOL, V30, P2567, DOI 10.1006/jmcc.1998.0829
   Frangogiannis NG, 2014, J CARDIOVASC PHARM, V63, P185, DOI 10.1097/FJC.0000000000000003
   Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7
   Haeck JDE, 2010, AM J CARDIOL, V105, P1065, DOI 10.1016/j.amjcard.2009.12.003
   Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93
   Hermann HP, 2002, CARDIOVASC RES, V53, P116, DOI 10.1016/S0008-6363(01)00437-0
   Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0
   Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647
   Kleczynski P, 2013, DIS MARKERS, V34, P199, DOI 10.3233/DMA-120955
   Lax A, 2015, JACC-HEART FAIL, V3, P50, DOI 10.1016/j.jchf.2014.07.015
   Maxwell SRJ, 1997, INT J CARDIOL, V58, P95, DOI 10.1016/S0167-5273(96)02854-9
   Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108
   Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890
   Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603
   Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239
   Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364
   Sahin DY, 2013, ANGIOLOGY, V64, P423, DOI 10.1177/0003319712453305
   Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Staub D, 2006, AM HEART J, V151, P1223, DOI 10.1016/j.ahj.2005.06.045
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   Tanindi A, 2014, TURK KARDIYOL DERN A, V42, P125, DOI 10.5543/tkda.2014.18949
   Yoon HJ, 2013, KOREAN CIRC J, V43, P731, DOI 10.4070/kcj.2013.43.11.731
NR 30
TC 9
Z9 12
U1 0
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 15
EP 22
DI 10.4070/kcj.2016.46.1.15
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400003
PM 26798381
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YH
   Kim, YK
   Seo, DJ
   Seo, YN
   Lee, CS
   Song, IG
   Yang, DJ
   Kim, KH
   Park, HW
   Kim, WH
   Bae, JH
AF Park, Yo-Han
   Kim, Yong-Kyun
   Seo, Duck-Jun
   Seo, Young-Noon
   Lee, Chung-Seop
   Song, In-Geol
   Yang, Dong-Ju
   Kim, Ki-Hong
   Park, Hyun-Woong
   Kim, Wan-Ho
   Bae, Jang-Ho
TI Analysis of Plaque Composition in Coronary Chronic Total Occlusion
   Lesion Using Virtual Histology-Intravascular Ultrasound
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angina pectoris; Atherosclerotic plaque; Intravascular ultrasonography
ID CONSENSUS DOCUMENT; RECANALIZATION; MULTICENTER; INTERVENTIONS; REGISTRY
AB Background and Objectives: Success rates of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have recently been reported to range from 800/0 to 900%. A better understanding of the pathologic characteristics of the CTO lesion may helpful to improving CTO PCI success rates. We evaluated the CTO lesion in patients with stable angina (SA) by virtual histology-intravascular ultrasound (VH-IVUS).
   Subjects and Methods: The study population consisted of 149 consecutive patients with SA underwent VH-IVUS examination. We analyzed demographic and VH-IVUS findings in 22 CTO patients (17 males; mean, 62.3 years old) compared with 127 non-CTO patients (82 males; mean, 61.3 years old).
   Results: A significantly lower ejection fraction (57.6 +/- 13.00/0 vs. 65.4 +/- 8.80/0, p=0.007) was detected in the CTO group compared with the non-CTO group. Reference vessel lumen area of the proximal and distal segment was significantly less in CTO group than in non-CTO-group. The lesion length of the CTO group was significantly longer than those of the non-CTO group (24.4 +/- 9.6 mm vs. 17.2 +/- 7.4 mm, p<0.001). Total atheroma volume (224 +/- 159 mm(3) vs. 143 +/- 86 mm(3), p=0.006) and percent atheroma volume (63.2 +/- 9.6% vs. 55.8 +/- 8.5%, p=0.011) of the CTO group were also significantly greater than those of non-CTO group. However, the lesion length adjusted plaque composition of the CTO group was not significantly different compared with that of the non-CTO group.
   Conclusion: CTO lesions had a longer lesion length and greater plaque burden than the non-CTO lesion in patients with SA. However, lesion length adjusted plaque composition showed similar between the two groups. These results support that plaque characteristics of CTO lesions are similar to non-CTO lesions in patients with SA.
C1 [Park, Yo-Han; Kim, Yong-Kyun; Seo, Duck-Jun; Seo, Young-Noon; Lee, Chung-Seop; Song, In-Geol; Yang, Dong-Ju; Kim, Ki-Hong; Park, Hyun-Woong; Bae, Jang-Ho] Konyang Univ Hosp, Ctr Heart, Cardiol, 158 Gwanjeodong Ro, Daejeon 35365, South Korea.
   [Kim, Wan-Ho] Andong Sungso Hosp, Cardiol, Andong, South Korea.
RP Bae, JH (corresponding author), Konyang Univ Hosp, Ctr Heart, Cardiol, 158 Gwanjeodong Ro, Daejeon 35365, South Korea.
EM janghobae@yahoo.co.kr
OI Park, Yohan/0000-0001-7416-1841; Seo, Young Hoon/0000-0002-7357-2785
CR Brilakis ES, 2014, J CARDIOVASC TRANSL, V7, P426, DOI 10.1007/s12265-014-9556-6
   Christofferson RD, 2005, AM J CARDIOL, V95, P1088, DOI 10.1016/j.amjcard.2004.12.065
   Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007
   Grantham JA, 2010, CIRC-CARDIOVASC QUAL, V3, P284, DOI 10.1161/CIRCOUTCOMES.108.825760
   Guo J, 2013, INT J CARDIOVAS IMAG, V29, P1249, DOI 10.1007/s10554-013-0222-x
   Guo J, 2013, CATHETER CARDIO INTE, V81, P464, DOI 10.1002/ccd.24356
   Hong YJ, 2013, KOREAN CIRC J, V43, P607, DOI 10.4070/kcj.2013.43.9.607
   Jeroudi OM, 2014, CATHETER CARDIO INTE, V84, P637, DOI 10.1002/ccd.25264
   Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015
   Lee CS, 2012, KOREAN CIRC J, V42, P747, DOI 10.4070/kcj.2012.42.11.747
   MELCHIOR JP, 1987, J AM COLL CARDIOL, V9, P763, DOI 10.1016/S0735-1097(87)80230-9
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Missel E, 2008, EUR HEART J, V29, P2141, DOI 10.1093/eurheartj/ehn293
   Missel E, 2008, AM J CARDIOL, V101, P573, DOI 10.1016/j.amjcard.2007.10.018
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Sakakura K, 2014, EUR HEART J, V35, P1683, DOI 10.1093/eurheartj/eht422
   Srivatsa SS, 1997, J AM COLL CARDIOL, V29, P955, DOI 10.1016/S0735-1097(97)00035-1
   Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283
   Werner GS, 2009, CLIN RES CARDIOL, V98, P435, DOI 10.1007/s00392-009-0013-5
NR 19
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 33
EP 40
DI 10.4070/kcj.2016.46.1.33
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400005
PM 26798383
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, EK
   Chang, SA
   Choi, JO
   Glockner, J
   Shapiro, B
   Choe, YH
   Fine, N
   Jang, SY
   Kim, SM
   Miller, W
   Lee, SC
   Oh, JK
AF Kim, Eun Kyoung
   Chang, Sung-A
   Choi, Jin-Oh
   Glockner, James
   Shapiro, Brian
   Choe, Yeon Hyeon
   Fine, Nowell
   Jang, Shin Yi
   Kim, Sung-Mok
   Miller, Wayne
   Lee, Sang-Chol
   Oh, Jae K.
TI Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed
   Hyperenhancement Patterns in Patients with lschemic and Non-lschemic
   Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathies; Magnetic resonance imaging; Cardiac imaging technique
ID ISCHEMIC CARDIOMYOPATHY; STANDARDIZED DEFINITION; ENHANCEMENT;
   DYSFUNCTION; GUIDELINES; DIAGNOSIS; TIME
AB Background and Objectives: The diagnosis of ischemic (ICM) and non-ischemic cardiomyopathy (NICM) is conventionally determined by the presence or absence of coronary artery disease (CAD) in the setting of a reduced left systolic function. However the presence of CAD may not always indicate that the actual left ventricular (LV) dysfunction mechanism is ischemia, as other non-ischemic etiologies can be responsible. We investigated patterns of myocardial fibrosis using delayed hyperenhancement (DHE) on cardiac magnetic resonance (CMR) in ICM and NICM.
   Subjects and Methods: Patients with systolic heart failure who underwent a CMR were prospectively analyzed. The heart failure diagnosis was based on the modified Framingham criteria and LVEF <350/0. LV dysfunction was classified as ICM or NICM based on coronary anatomy.
   Results: A total of 101 subjects were analyzed; 34 were classified as ICM and 67 as NICM. The DHE pattern was concordant with the conventional diagnosis in 27 (79.404 of the patients with ICM and 62 (92.50/0) of the patients with NCIM. A discordant NICM DHE pattern was present in 8.8% of patients with ICM, and an ICM pattern was detected 6.0% of the patients with NICM. Furthermore, 11.8% of the patients with ICM and 1.5% of those with NICM demonstrated a mixed pattern.
   Conclusion: A subset of patients conventionally diagnosed with ICM or NICM based on coronary anatomy demonstrated a discordant or mixed DHE pattern. CMR-DHE imaging can be helpful to determine the etiology of heart failure in patients with persistent LV systolic dysfunction.
C1 [Kim, Eun Kyoung; Chang, Sung-A; Choi, Jin-Oh; Jang, Shin Yi; Lee, Sang-Chol; Oh, Jae K.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.
   [Choe, Yeon Hyeon; Kim, Sung-Mok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr,Dept Radiol, Cardiovasc & Stroke Imaging Ctr,Heart Vasc & Stro, Seoul, South Korea.
   [Glockner, James; Fine, Nowell; Miller, Wayne; Lee, Sang-Chol; Oh, Jae K.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA.
   [Shapiro, Brian] Mayo Clin, Coll Med, Div Cardiovasc Dis, Jacksonville, FL 32224 USA.
   [Chang, Sung-A] Sungkyunkwan Univ, Sch Med, Dept Med,Heart Vasc & Stroke Inst,Samsung Med Ctr, Div Cardiol,Cardiovasc & Stroke Imaging Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
RP Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Med,Heart Vasc & Stroke Inst,Samsung Med Ctr, Div Cardiol,Cardiovasc & Stroke Imaging Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM sunga.chang@samsung.com
RI Choe, Yeon Hyeon/F-1422-2010; choi, jo/O-5940-2014; kim,
   sungmok/D-6143-2017
OI Choe, Yeon Hyeon/0000-0002-9983-048X; Chang, Sung-A/0000-0001-5124-605X;
   Kim, Sung Mok/0000-0001-5190-2328
FU Samsung Medical Center [SM01131501]
FX This study was supported by Samsung Medical Center grant [#SM01131501]
   (2013).
CR Bax JJ, 2001, CIRCULATION, V104, pI314
   BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4
   Calore C, 2007, J CARDIOVASC MED, V8, P821, DOI 10.2459/JCM.0b013e3280101e3c
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Cummings KW, 2009, RADIOGRAPHICS, V29, P89, DOI 10.1148/rg.291085052
   Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Jackson E, 2007, CLIN RADIOL, V62, P395, DOI 10.1016/j.crad.2006.11.013
   Janik M, 2008, J HYPERTENS, V26, P1677, DOI 10.1097/HJH.0b013e328302ca14
   Kim HW, 2009, J AM COLL CARDIOL, V55, P1, DOI 10.1016/j.jacc.2009.06.059
   Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035
   Nieminen MS, 2005, EUR HEART J, V26, P384
   Senthilkumar Annamalai, 2009, Heart Fail Clin, V5, P349, DOI 10.1016/j.hfc.2009.02.009
   Soriano CJ, 2007, INT J CARDIOL, V116, P167, DOI 10.1016/j.ijcard.2006.03.040
   Soriano CJ, 2005, J AM COLL CARDIOL, V45, P743, DOI 10.1016/j.jacc.2004.11.037
   Wagner A, 2006, J AM COLL CARDIOL, V47, P2027, DOI 10.1016/j.jacc.2006.01.059
   Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4
   Yoon YE, 2014, KOREAN CIRC J, V44, P359, DOI 10.4070/kcj.2014.44.6.359
NR 22
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 41
EP 47
DI 10.4070/kcj.2016.46.1.41
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400006
PM 26798384
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YS
   Olaopa, MA
   Jung, BC
   Lee, SH
   Shin, DG
   Park, HS
   Cho, Y
   Han, SM
   Lee, MH
   Kim, YN
AF Lee, Young Soo
   Olaopa, Michael A.
   Jung, Byung Chun
   Lee, Sang Hee
   Shin, Dong Gu
   Park, Hyoung Seob
   Cho, Yongkeun
   Han, Sang Mi
   Lee, Myung Hoon
   Kim, Yoon Nyun
TI Genetic Variation of SCN5A in Korean Patients with Sick Sinus Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE SCN5A protein; human; Polymorphism; single nucleotide; Sick sinus
   syndrome
ID SODIUM-CHANNEL MUTATIONS; BRUGADA-SYNDROME; SWISS-MODEL; ATRIAL
   STANDSTILL; POLYMORPHISMS; BRADYCARDIA
AB Background and Objectives: Due to recent studies that have shown an association between the genetic variation of SCN5A and sick Sinus syndrome (555), we sought to determine if a similar correlation existed in Korean patients with SSS.
   Subjects and Methods: We enrolled 30 patients with SSS who showed a sinus pause (longer than 3.0 s) in Holter monitoring, in addition to 80 controls. All exons including the putative splicing sites of the SCN5A gene were amplified by polymerase chain reaction and sequenced either directly or following subcloning. Wild-type and single nucleotide polymorphisms were expressed in human embryonic kidney cells, and the peak sodium current (I-Na) was analyzed using the whole-cell patch-clamp technique.
   Results: A total of 9 genetic variations were identified: 7 variations (G87A-A29A, IVS9-3C>A, A1673G-H558R, G3823A-D1275N, T5457C-D1819D, T5963G-L1988R, and C5129T-S1710L) had been previously reported, and 2 variants (A3075T-E1025D and T4847A-F1616Y) were novel; the potential structural effects of F1616Y were analyzed in a three-dimensional model of the SCN5A domain. Patch-clamp studies at room temperature demonstrated that the peak I-Na was significantly increased by 140% in HEK cells transfected with F1616Y compared with wild-type (-335.13 pA/pF +/- 24.04, n=8 vs. -139.95 pA/pF +/- 23.76, n=7, respectively). Furthermore, the voltage dependency of the activation and steady-state inactivation of F1616Y were leftward-shifted compared with wild-type (V-h activation=-55.36 mv +/- 0.22, n=8 vs. V-h activation=-44.21 mV +/- 0.17, n=7; respectively; V-h inactivation=-104.47 mV +/- 0.21, n=7 vs. V-h inactivation= -84.89 mV +/- 0.09, n=12, respectively).
   Conclusion: F1616Y may be associated with SSS.
C1 [Lee, Young Soo] Catholic Univ Daegu, Div Cardiol, Daegu, South Korea.
   [Olaopa, Michael A.] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.
   [Jung, Byung Chun] Daegu Fatima Hosp, Daegu, South Korea.
   [Lee, Sang Hee; Shin, Dong Gu] Yeungnam Univ, Daegu, South Korea.
   [Park, Hyoung Seob; Kim, Yoon Nyun] Keimyung Univ, Dept Internal Med, 56 Dalseong Ro, Daegu 41931, South Korea.
   [Cho, Yongkeun] Kyungpook Natl Univ, Daegu, South Korea.
   [Han, Sang Mi; Lee, Myung Hoon] D&P Biotech, Daegu, South Korea.
   [Lee, Myung Hoon] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Daegu, South Korea.
RP Kim, YN (corresponding author), Keimyung Univ, Dept Internal Med, 56 Dalseong Ro, Daegu 41931, South Korea.
EM ynkim@dsmc.or.kr
FU Ministry of Science, ICT and Future Planning [R0101-15-0147]
FX The research was supported by the Ministry of Science, ICT and Future
   Planning Through the Development for ITSW industrial convergence
   original technology (ID:R0101-15-0147, 2012).
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Baruscotti M, 1996, J PHYSIOL-LONDON, V492, P21, DOI 10.1113/jphysiol.1996.sp021285
   Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062
   Cha KW, 2000, P NATL ACAD SCI USA, V97, P3016, DOI 10.1073/pnas.97.7.3016
   Chen JZ, 2004, CHINESE MED J-PEKING, V117, P652
   GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554
   Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7
   Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985
   Gui JH, 2010, J CARDIOVASC ELECTR, V21, P564, DOI 10.1111/j.1540-8167.2010.01762.x
   Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Lehtinen AB, 2009, ANN NONINVAS ELECTRO, V14, P72, DOI 10.1111/j.1542-474X.2008.00276.x
   Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009
   Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032
   Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006
   Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Shin CH, 2003, KOREAN CIRC J, V33, P150
   Shin DJ, 2004, J HUM GENET, V49, P573, DOI 10.1007/s10038-004-0182-z
   Takahata T, 2003, LIFE SCI, V72, P2391, DOI 10.1016/S0024-3205(03)00121-8
   Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9
   Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090
   Turker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070450
   Veldkamp MW, 2003, CIRC RES, V92, P976, DOI 10.1161/01.RES.0000069689.09869.A8
   Xi YT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1017, DOI 10.1161/CIRCEP.111.969220
NR 25
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 63
EP 71
DI 10.4070/kcj.2016.46.1.63
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400009
PM 26798387
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, H
   Jung, YH
   Kim, KH
   Kim, JY
   Yoon, YW
   Lee, BK
   Hong, BK
   Rim, SJ
   Kwon, HM
   Choi, EY
AF Chung, Hyemoon
   Jung, Young Hak
   Kim, Ki-Hyun
   Kim, Jong-Youn
   Yoon, Young Won
   Lee, Byoung Kwon
   Hong, Bum-Kee
   Rim, Se-Joong
   Kwon, Hyuck Moon
   Choi, Eui-Young
TI Carotid Artery End-Diastolic Velocity and Future Cerebro-Cardiovascular
   Events in Asymptomatic High Risk Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carotid arteries; Doppler; Events
ID INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE;
   ULTRASOUND; STENOSIS; DISEASE; SOCIETY
AB Background and Objectives: Prognostic value of additional carotid Doppler evaluations to carotid intima-media thickness (IMT) and plaque has not been completely evaluated.
   Subjects and Methods: A total of 1119 patients with risk factors for, but without, overt coronary artery disease (CAD), who underwent both carotid ultrasound and Doppler examination were included in the present study. Parameters of interest included peak systolic and end-diastolic velocities, resistive indices of the carotid arteries, IMT, and plaque measurements. The primary end-point was all-cause cerebro-cardiovascular events (CVEs) including acute myocardial infarction, coronary revascularization therapy, heart failure admission, stroke, and cardiovascular death. Model 1 covariates comprised age and sex; Model 2 also included hypertension, diabetes and smoking; Model 3 also had use of aspirin and statin; and Model 4 also included IMT and plaque.
   Results: The mean follow-up duration was 1386 461 days and the mean age of the study population was 60 12 years. Amongst 1119 participants, 43% were women, 57% had a history of hypertension, and 23% had diabetes. During follow-up, 6.6% of patients experienced CVEs. Among carotid Doppler parameters, average common carotid artery end-diastolic velocity was the independent predictor for future CVEs after adjustments for all models variables (HR 0.95 per cm/s, 95% confident interval 0.91-0.99, p=0.034 in Model 4) and significantly increased the predictive value of Model 4 (global X-2=59.0 vs. 62.8, p=0.029).
   Conclusion: Carotid Doppler measurements in addition to IMT and plaque evaluation are independently associated with future CVEs in asymptomatic patients at risk for CAD.
C1 [Chung, Hyemoon; Jung, Young Hak; Kim, Ki-Hyun; Kim, Jong-Youn; Yoon, Young Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon; Choi, Eui-Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol,Heart Ctr, 211 Eonju Ro, Seoul 06273, South Korea.
RP Choi, EY (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol,Heart Ctr, 211 Eonju Ro, Seoul 06273, South Korea.
EM choi0928@yuhs.ac
RI Kim, Kihyun/T-4278-2017
OI Kim, Kihyun/0000-0001-9047-4485; Lee, Byoung Kwon/0000-0001-9259-2776;
   Rim, Se Joong/0000-0002-7631-5581; Choi, Eui-Young/0000-0003-3732-0190;
   Kwon, Hyuck Moon/0000-0001-9901-5015; Hong, Bum Kee/0000-0002-6456-0184;
   Min, Pil-Ki/0000-0001-7033-7651; Kim, Jong-Youn/0000-0001-7040-8771
FU Korean Society of Circulation [201203-11]
FX This work was supported with a research grant (2012) from the Korean
   Society of Circulation (201203-11).
CR Bai CH, 2007, J CLIN ULTRASOUND, V35, P322, DOI 10.1002/jcu.20351
   Barutcu I, 2004, CIRC J, V68, P1127, DOI 10.1253/circj.68.1127
   Beach KW, 2012, VASC ENDOVASC SURG, V46, P466, DOI 10.1177/1538574412452159
   Chuang SY, 2011, STROKE, V42, P1338, DOI 10.1161/STROKEAHA.110.605477
   Dijk JM, 2005, EUR HEART J, V26, P1213, DOI 10.1093/eurheartj/ehi254
   Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516
   Janzen J, 2004, ARCH MAL COEUR VAISS, V97, P909
   Manabe S, 2005, J HUM HYPERTENS, V19, P787, DOI 10.1038/sj.jhh.1001898
   O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103
   Pickett CA, 2008, LANCET, V371, P1587, DOI 10.1016/S0140-6736(08)60691-1
   Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592
   Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011
   Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006
   Yuk HB, 2015, KOREAN CIRC J, V45, P28, DOI 10.4070/kcj.2015.45.1.28
NR 14
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 72
EP 78
DI 10.4070/kcj.2016.46.1.72
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400010
PM 26798388
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KC
   Lee, JC
   Lee, H
   Cho, MS
   Choi, SJ
   Hong, YM
AF Kim, Kwan Chang
   Lee, Jae Chul
   Lee, Hyeryon
   Cho, Min-Sun
   Choi, Soo Jin
   Hong, Young Mi
TI Changes in Caspase-3, B Cell Leukemia/Lymphoma-2, Interleukin-6, Tumor
   Necrosis Factor-alpha and Vascular Endothelial Growth Factor Gene
   Expression after Human Umbilical Cord Blood Derived Mesenchymal Stem
   Cells Transfusion in Pulmonary Hypertension Rat Models
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; pulmonary; Stem cell; Vascular remodeling; Inflammation;
   Apoptosis
ID BONE-MARROW; ARTERIAL-HYPERTENSION; APOPTOSIS; PROLIFERATION; INJURY;
   TISSUE; LUNG; DYSFUNCTION
AB Background and Objective: Failure of vascular smooth muscle apoptosis and inflammatory response in pulmonary arterial hypertension (PAH) is a current research focus. The goals of this study were to determine changes in select gene expressions in monocrotaline (MCT)-induced PAH rat models after human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) transfusion. Materials and
   Methods: The rats were separated into 3 groups i.e., control group (C group), M group (MCT 60 mg/kg), and U group (hUCB-MSCs transfusion) a week after MCT injection.
   Results: TUNEL assay showed that the U group had significantly lowered positive apoptotic cells in the lung tissues, as compared with the M group. mRNA of caspase-3, B cell leukemia/lymphoma (Bcl)-2, interleukin (IL) -6, tumor necrosis factor (TNF)-alpha and vascular endothelial growth factor (VEGF) in the lung tissues were greatly reduced at week 4 in the U group. Immunohistochemical staining of the lung tissues also demonstrated a similar pattern, with the exception of IL -6. The protein expression of caspase-3, Bcl-2 VEGF, IL -6, TNF-alpha and brain natriuretic peptide in the heart tissues were significantly lower in the U group, as compared with the M group at week 2. Furthermore, the protein expression of VEGF, IL -6 and BNP in the heart tissues were significantly lower in the U group at week 4. Collagen content in the heart tissues was significantly lower in the U group, as compared with M group at weeks 2 and 4, respectively.
   Conclusion: hUCB-MSCs could prevent inflammation, apoptosis and remodeling in MCT-induced PAH rat models.
C1 [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Lee, Jae Chul; Lee, Hyeryon; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
   [Cho, Min-Sun] Ewha Womans Univ, Sch Med, Dept Pathol, Seoul, South Korea.
   [Choi, Soo Jin] MEDIPOST Co, Biomed Res Inst, Seoul, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM ymhong@ewha.ac.kr
FU Korean Society of Cardiology [201203-13]; Basic Science Research Program
   through the National Research Foundation of Korea - Ministry of
   Education [KRF-2013R1A1A3004619]
FX This research was supported by grants of The Korean Society of
   Cardiology (201203-13) and Basic Science Research Program through the
   National Research Foundation of Korea funded by the Ministry of
   Education (KRF-2013R1A1A3004619).
CR Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492
   Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50
   Cai J, 2006, MICROVASC RES, V71, P20, DOI 10.1016/j.mvr.2005.10.004
   Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189
   Chu PH, 2008, APMIS, V116, P995, DOI 10.1111/j.1600-0463.2008.00971.x
   Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095
   Han I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt443
   Hong YM, 2014, KOREAN CIRC J, V44, P97, DOI 10.4070/kcj.2014.44.2.97
   Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041
   Jurasz P, 2010, PHARMACOL THERAPEUT, V126, P1, DOI 10.1016/j.pharmthera.2009.12.006
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim KC, 2012, J KOREAN MED SCI, V27, P605, DOI 10.3346/jkms.2012.27.6.605
   Kret M, 2007, J CARDIOVASC PHARM T, V12, P5, DOI 10.1177/1074248406298293
   Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114
   Kucuker SA, 2004, J HEART LUNG TRANSPL, V23, P28, DOI 10.1016/S1053-2498(03)00057-3
   Lee H, 2015, J KOREAN MED SCI, V30, P576, DOI 10.3346/jkms.2015.30.5.576
   Lee JC, 2014, ANAT CELL BIOL, V47, P217, DOI 10.5115/acb.2014.47.4.217
   Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049
   Ohnishi S, 2007, J MOL CELL CARDIOL, V42, P88, DOI 10.1016/j.yjmcc.2006.10.003
   Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100
   Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706
   Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793
   Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788
   Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC
   Ryan JJ, 2015, CAN J CARDIOL, V31, P391, DOI 10.1016/j.cjca.2015.01.023
   Sage E, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-19
   Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje
   Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036
   Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009
   Thomas HC, 1998, TOXICOL APPL PHARM, V151, P236, DOI 10.1006/taap.1998.8458
NR 30
TC 14
Z9 16
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 79
EP 92
DI 10.4070/kcj.2016.46.1.79
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400011
PM 26798389
OA Green Published
DA 2021-04-22
ER

PT J
AU Eom, YW
   Jung, HY
   Oh, JE
   Lee, JW
   Ahn, MS
   Youn, YJ
   Ahn, SG
   Kim, JY
   Lee, SH
   Yoon, J
   Yoo, BS
AF Eom, Young Woo
   Jung, Ha Yun
   Oh, Ji-Eun
   Lee, Jun-Won
   Ahn, Min-Soo
   Youn, Young Jin
   Ahn, Sung Gyun
   Kim, Jang Young
   Lee, Seung-Hwan
   Yoon, Junghan
   Yoo, Byung-Su
TI Isoproterenol Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing
   Ligand-Induced Apoptosis in Human Embryonic Kidney Cells through Death
   Receptor 5 up-Regulation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Isoproterenol; TNF-related apoptosis-inducing ligand; Apoptosis; Death
   receptor 5
ID RAT VENTRICULAR MYOCYTES; HEART-FAILURE; TRAIL/APO-2 LIGAND; DECOY
   RECEPTORS; TARGETING DEATH; TRAIL; STIMULATION; INVOLVEMENT;
   NEUTROPHILS; ACTIVATION
AB Background and Objectives: Chronic impairment of beta-adrenergic receptor signaling increases cardiac apoptosis, hypertrophy and fibrosis. The aim of this study was to investigate whether isoproterenol (ISO), an agonist of the adrenergic receptor, can enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human embryonic kidney (HEK) 293 cells.
   Materials and Methods: HEK 293 cells were treated with ISO and/or TRAIL for 24 hours. Cell viability was evaluated by microscopy and an established viability assay, and apoptotic cell death was analyzed by staining with fluorescein isothiocynate-annexin-V/propidium iodide (PI) and caspase activation. To confirm the mechanism of cell death induced by co-treatment with ISO and TRAIL, expression of TRAIL receptor 2 (death receptor 5, DR5) was evaluated by immunoblotting.
   Results: Although ISO or TRAIL treatment decreased HEK 293 cell viability by 13% and 17%, respectively, co-treatment with ISO and TRAIL resulted in a markedly higher death rate of 35% after 24 hours. Increases were evident in early apoptotic cells (i.e., annexin-V positive/PI negative; 19.4%), late apoptotic cells (i.e., annexin-V positive/PI positive; 6.3%) and dead cells (i.e., annexin-V negative/PI positive; 1.1%) when cells were co-treated with ISO and TRAIL, compared to cells treated with either ISO or TRAIL. In addition, marked increases of cleaved cas-3, cleaved poly (adenosine diphosphate-ribose) polymerase and DR5 were observed in HEK 293 cells co-treated with ISO and TRAIL.
   Conclusion: Treatments combining ISO with TRAIL may be responsible for death of HEK 293 cells through DR5 up-regulation. Activation of adrenergic receptors is responsible for the synergistic cell death observed with TRAIL
C1 [Eom, Young Woo; Oh, Ji-Eun] Yonsei Univ, Wonju Coll Med, Cell Therapy & Tissue Engn Ctr, Wonju, South Korea.
   [Jung, Ha Yun; Lee, Jun-Won; Ahn, Min-Soo; Youn, Young Jin; Ahn, Sung Gyun; Kim, Jang Young; Lee, Seung-Hwan; Yoon, Junghan; Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Yoo, BS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
EM yubs@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
FU Korean Society of Cardiology [201001-01]
FX This study was supported by a grant from the Korean Society of
   Cardiology (201001-01).
CR Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9
   Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821
   Cassatella MA, 2006, J LEUKOCYTE BIOL, V79, P123, DOI 10.1189/jlb.0805431
   Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200
   Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329
   Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059
   Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155
   Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262
   Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343
   Groenning BA, 2000, J AM COLL CARDIOL, V36, P2072, DOI 10.1016/S0735-1097(00)01006-8
   Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523
   Kemp TJ, 2004, J IMMUNOL, V173, P892, DOI 10.4049/jimmunol.173.2.892
   Kemp TJ, 2005, BLOOD, V106, P3474, DOI 10.1182/blood-2005-03-1327
   Kim Y, 2003, MOL CELLS, V15, P283
   Koga Y, 2004, CANCER RES, V64, P1037, DOI 10.1158/0008-5472.CAN-03-1808
   Lee MW, 2002, CANCER LETT, V182, P75
   Liao XD, 2005, LIFE SCI, V77, P160, DOI 10.1016/j.lfs.2004.11.029
   Liu JJ, 2011, APOPTOSIS, V16, P94, DOI 10.1007/s10495-010-0549-x
   Murray DR, 2000, CIRCULATION, V101, P2338, DOI 10.1161/01.CIR.101.20.2338
   Naga Prasad SV, 2001, TRENDS GENET, V17, P544
   Park JB, 2015, GENES GENOM, V37, P213, DOI 10.1007/s13258-014-0239-0
   Prasad S, 2014, TRENDS PHARMACOL SCI, V35, P520, DOI 10.1016/j.tips.2014.07.004
   Shetty S, 2002, APOPTOSIS, V7, P413, DOI 10.1023/A:1020031023947
   Simons MP, 2008, J LEUKOCYTE BIOL, V83, P621, DOI 10.1189/jlb.0707452
   Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111
   Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714
   Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200
   Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375
   Zaugg M, 2000, CIRCULATION, V102, P344
   Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002
NR 30
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 93
EP 98
DI 10.4070/kcj.2016.46.1.93
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400012
PM 26798390
OA Green Published
DA 2021-04-22
ER

PT J
AU Ktzilirmak, F
   Gunes, HM
   Guler, E
   Demir, GG
   Karaca, O
   Canpolat, HG
AF Ktzilirmak, Filiz
   Gunes, Haci Murat
   Guler, Ekrem
   Demir, Gultekin Gunhan
   Karaca, Oguz
   Canpolat, Habibe Gamze
TI Hemopericardium and Cardiac Tamponade in a Patient Treated with
   Dabigatran Etexilate
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pericardial effusion; Dabigatran etexilate; Atrial fibrillation
ID THROMBIN INHIBITOR DABIGATRAN; ATRIAL-FIBRILLATION; COAGULATION ASSAYS;
   WARFARIN
AB Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports of hemopericardium are rare. We described a case of a 66 year-old female patient with non-valvular AF receiving dabigatran etexilate 150 mg twice daily for one year who suffered from hemopericardium. Her laboratory tests performed 1 year prior were normal and her admission tests revealed acute renal failure and elevated international normalized ratio (INR) level (4.79). Urgent pericardiocentesis was followed by improved renal functions and normalized INR. Dabigatran etexilate is a new oral anticoagulant that is increasingly used in daily practice. However, life-threatening complications warrant caution. Elevated INR may be related with overdose but the association of bleeding risk of dabigatran and INR requires further confirmation.
C1 [Ktzilirmak, Filiz; Gunes, Haci Murat; Guler, Ekrem; Demir, Gultekin Gunhan; Karaca, Oguz; Canpolat, Habibe Gamze] Medipol Univ Hosp, Dept Cardiol, Istanbul, Turkey.
   [Ktzilirmak, Filiz] Istanbul Medipol Univ, Dept Cardiol, TEM Avrupa Otoyolu Goztepe Cikisi 1, TR-34214 Istanbul, Turkey.
RP Ktzilirmak, F (corresponding author), Istanbul Medipol Univ, Dept Cardiol, TEM Avrupa Otoyolu Goztepe Cikisi 1, TR-34214 Istanbul, Turkey.
EM filizkizilirmak@hotmail.com
CR Barton CA, 2012, PHARMACOTHERAPY, V32, pE103, DOI 10.1002/j.1875-9114.2012.01036.x
   Boehringer Ingelheim Pharmaceuticals Inc, 2011, PRAD DAB ET PACK INS
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Douxfils J, 2012, THROMB HAEMOSTASIS, V107, P985, DOI 10.1160/TH11-11-0804
   Dy Eliza A, 2012, Ann Pharmacother, V46, pe18, DOI 10.1345/aph.1R112
   Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747
   Kernan L, 2012, CLIN TOXICOL, V50, P571, DOI 10.3109/15563650.2012.705290
   Kim J, 2013, CASE REP MED, V2013, DOI 10.1155/2013/131395
   Lal Y, 2013, AM J MED SCI, V346, P190, DOI 10.1097/MAJ.0b013e31826c5a56
   Lindahl TL, 2011, THROMB HAEMOSTASIS, V105, P371, DOI 10.1160/TH10-06-0342
   Nyby S, 2014, UGESKR LAEGER, V176
   Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001
   van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758
   Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E
NR 14
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 99
EP 101
DI 10.4070/kcj.2016.46.1.99
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400013
PM 26798391
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
   Juong, JY
   Park, TH
AF Kim, Soo Jin
   Juong, Ji Young
   Park, Tae-Ho
TI Ventricular Tachycardia Associated Syncope in a Patient of Variant
   Angina without Chest Pain
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prinzmetal's variant angina; Coronary vasospasm; Tachycardia;
   ventricular
ID SPASM
AB A 68-year-old man was admitted for a syncope workup. After routine evaluation, he was diagnosed with syncope of an unknown cause and was discharged from the hospital. He was readmitted due to dizziness. On repeated Holter monitoring, polymorphic ventricular tachycardia was detected during syncope. We performed intracoronary ergonovine provocation test; severe coronary spasm was induced at 70% stenosis of the proximal left anterior descending artery. The patient was treated with percutaneous coronary intervention. We present a rare case of syncope induced by ventricular arrhythmia in a patient with variant angina without chest pain.
C1 [Kim, Soo Jin; Juong, Ji Young; Park, Tae-Ho] Dong A Univ, Med Ctr, Dept Cardiol, Busan, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Coll Med, Dept Cardiol, 26 Daesingongwon Ro, Busan 49201, South Korea.
EM thpark65@dau.ac.kr
CR BERNTSEN RF, 1993, EUR HEART J, V14, P1297, DOI 10.1093/eurheartj/14.10.1297
   Chin A, 2010, INT J CARDIOL, V145, pE47, DOI 10.1016/j.ijcard.2008.12.138
   European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010
   Gaspardone A, 1999, AM J CARDIOL, V84, P96, DOI 10.1016/S0002-9149(99)00201-5
   Kishida H, 1996, JPN HEART J, V37, P317
   Kusama Y, 2011, J NIPPON MED SCH, V78, P4, DOI 10.1272/jnms.78.4
   Lanza GA, 2007, INT J CARDIOL, V118, P41, DOI 10.1016/j.ijcard.2006.06.016
   Matsue Y, 2012, J AM COLL CARDIOL, V60, P908, DOI 10.1016/j.jacc.2012.03.070
   MYERBURG RJ, 1992, NEW ENGL J MED, V326, P1451, DOI 10.1056/NEJM199205283262202
   Postorino C, 2007, EUROPACE, V9, P568, DOI 10.1093/europace/eum087
   PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8
   Tanabe Y, 2002, J AM COLL CARDIOL, V39, P1120, DOI 10.1016/S0735-1097(02)01746-1
   YASUE H, 1988, CIRCULATION, V78, P1, DOI 10.1161/01.CIR.78.1.1
   Yoo Sang-Yong, 2008, Korean Circulation Journal, V38, P651
NR 14
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 102
EP 106
DI 10.4070/kcj.2016.46.1.102
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400014
PM 26798392
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SH
   Kim, WS
AF Cho, Seong Ho
   Kim, Wook Sung
TI Transatrial Approach for the Repair of the Posterior Post-Infarct
   Ventricular Septal Rupture
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Ventricular septal rupture
ID RIGHT ATRIAL APPROACH; DEFECT
AB Ventricular septal rupture (VSR) is a disastrous mechanical complication of myocardial infarction. Although several surgical interventions have been developed, mortality due to surgical management remains high, especially in the case of posterior VSR. We report a successful case of repair of posterior VSR using an alternative transatrial approach to avoid the complications related to ventricular incision.
C1 [Cho, Seong Ho] Kosin Univ, Gospel Hosp, Dept Thorac & Cardiovasc Surg, Busan, South Korea.
   [Kim, Wook Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 50 Irwon Dong, Seoul 06351, South Korea.
RP Kim, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 50 Irwon Dong, Seoul 06351, South Korea.
EM wooksungkim@yahoo.com
CR Coskun KO, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-3
   FILGUEIRA JL, 1986, ANN THORAC SURG, V42, P208, DOI 10.1016/S0003-4975(10)60521-8
   Kirklin JW, 1993, POSTINFARCTION VENTR, P403
   KOMEDA M, 1990, CIRCULATION, V82, P243
   Lee Weon-Yong, 2011, Korean J Thorac Cardiovasc Surg, V44, P186, DOI 10.5090/kjtcs.2011.44.2.186
   Massetti M, 2000, J THORAC CARDIOV SUR, V119, P784, DOI 10.1016/S0022-5223(00)70014-6
   Muehrcke D D, 1995, Adv Card Surg, V6, P69
   Raddford MJ, 1981, CIRCULATION, V64, P545
NR 8
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 107
EP 110
DI 10.4070/kcj.2016.46.1.107
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400015
PM 26798393
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SY
   Cho, S
   Choi, E
   Kim, WH
AF Kim, Sang Yoon
   Cho, Sungkyu
   Choi, Eunseok
   Kim, Woong-Han
TI Pregnancy and Delivery in Functional Single Ventricle Patient;
   Successful Long-Term Outcome after Right Ventricle Exclusion and Fontan
   Operation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fontan procedure; Ebstein anomaly; Pregnancy; Delivery, obstetric; Heart
   failure
ID CONGENITAL HEART-DISEASE; GUIDELINES; MANAGEMENT; FAILURE
AB Twenty-six-year-old Ebstein's anomaly patient, who had failed both biventricular and one-and-a-half repair, underwent right ventricle exclusion and Fontan operation. She completed pregnancy and delivery owing to the excellent long-term clinical course. Although the caesarean section was performed due to symptoms of heart failure on the gestational age of 32+6 weeks, preterm delivery was agreeable with neonatology support. In Korea, there has not yet been a case of pregnancy and delivery of functional single ventricle patient because most patients have been discouraged from getting pregnant. However, functional single ventricle patient can endure pregnancy and delivery, if valve function and ventricular contractility, status of Fontan pathway and absence of arrhythmia predict favorable outcome as presented in this case. Although the patient maintained her pregnancy without anticoagulation owing to laminar flow in the Fontan pathway and absence of thromboembolic event, anticoagulation should be considered, weighing the benefits and risks during the pregnancy.
C1 [Kim, Sang Yoon; Cho, Sungkyu; Kim, Woong-Han] Seoul Natl Univ Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
   [Choi, Eunseok] Sejong Gen Hosp, Cardiovasc Ctr, Dept Thorac & Cardiovasc Surg, Bucheon, South Korea.
RP Kim, WH (corresponding author), Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 101 Daehak Ro, Seoul 03080, South Korea.
EM woonghan@snu.ac.kr
CR Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
   Canobbio MM, 2013, J AM COLL CARDIOL, V61, pE427, DOI 10.1016/S0735-1097(13)60427-1
   Cho S, 2009, J THORAC CARDIOV SUR, V138, P1246, DOI 10.1016/j.jtcvs.2008.09.029
   Chugh Reema, 2013, Curr Treat Options Cardiovasc Med, V15, P646, DOI 10.1007/s11936-013-0263-4
   Inoue S, 2013, J OBSTET GYNAECOL RE, V39, P378, DOI 10.1111/j.1447-0756.2012.01910.x
   Monagle P, 2011, J AM COLL CARDIOL, V58, P645, DOI 10.1016/j.jacc.2011.01.061
   Sano S, 2002, J THORAC CARDIOV SUR, V123, P640, DOI 10.1067/mtc.2002.121160
   Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690
NR 8
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 111
EP 114
DI 10.4070/kcj.2016.46.1.111
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400016
PM 26798394
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JS
   Pak, HN
   Lee, MH
   Kim, SS
   Joung, B
AF Park, Jong Sung
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Kim, Sung Soon
   Joung, Boyoung
TI Implantable Cardioverter-Defibrillator Lead Extraction by Conventional
   Traction and Counter-Traction Technique (vol 41, pg 164, 2011)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Park, Jong Sung; Pak, Hui-Nam; Lee, Moon-Hyoung; Kim, Sung Soon; Joung, Boyoung] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
RP Park, JS (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
CR Park JS, 2011, KOREAN CIRC J, V41, P164, DOI 10.4070/kcj.2011.41.3.164
   Park Jong Sung, 2010, Korean Circ J, V40, P418, DOI 10.4070/kcj.2010.40.8.418
NR 2
TC 0
Z9 0
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 115
EP 115
DI 10.4070/kcj.2016.46.1.115
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400017
PM 26798395
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, EY
AF Choi, Eui-Young
TI A Novel Approach for Identifying Ischemic Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DILATED CARDIOMYOPATHY; HEART-FAILURE; FIBROSIS
C1 [Choi, Eui-Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol,Heart Ctr, Seoul, South Korea.
   [Choi, Eui-Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol, 211 Eonju Ro, Seoul, South Korea.
RP Choi, EY (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol, 211 Eonju Ro, Seoul, South Korea.
EM choi0928@yuhs.ac
OI Choi, Eui-Young/0000-0003-3732-0190
CR Alter P, 2011, EUR J HEART FAIL, V13, P937, DOI 10.1093/eurjhf/hfr082
   Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049
   ATKINSON JB, 1989, HUM PATHOL, V20, P1155, DOI 10.1016/S0046-8177(89)80005-X
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   BURCH GE, 1970, AM HEART J, V79, P291, DOI 10.1016/0002-8703(70)90416-3
   Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7
   Kim EK, 2016, KOREAN CIRC J, V46, P41, DOI 10.4070/kcj.2016.46.1.41
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   Tenenbaum A, 2002, J AM COLL CARDIOL, V40, P205, DOI 10.1016/S0735-1097(02)01918-6
   UNVERFERTH DV, 1986, AM J CARDIOL, V57, P816, DOI 10.1016/0002-9149(86)90620-X
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 13
EP 14
DI 10.4070/kcj.2016.46.1.13
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400002
PM 26798380
OA Green Published
DA 2021-04-22
ER

PT J
AU Che, HL
   Bae, IH
   Lim, KS
   Uthaman, S
   Song, IT
   Lee, H
   Lee, D
   Kim, WJ
   Ahn, Y
   Park, IK
   Jeong, MH
AF Che, Hui-Lian
   Bae, In-Ho
   Lim, Kyung Seob
   Uthaman, Saji
   Song, In Taek
   Lee, Haeshin
   Lee, Duhwan
   Kim, Won Jong
   Ahn, Youngkeun
   Park, In-Kyu
   Jeong, Myung-Ho
TI Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for
   Prevention of Post-Angioplasty Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Gene delivery; MicroRNA; Nanoparticle; Restenosis
ID DRUG-ELUTING STENTS; SMOOTH-MUSCLE-CELLS; GENE DELIVERY; THERAPY;
   PERSPECTIVE; EFFICACY; SAFETY; MODEL; SIRNA
AB Background and Objectives: MicroRNA 145 is known to be responsible for cellular proliferation, and its enhanced expression reportedly inhibits the retardation of vascular smooth muscle cell growth specifically. In this study, we developed a microRNA 145 nanoparticle immobilized, hyaluronic acid (HA)-coated stent.
   Materials and Methods: For the gene therapy, we used disulfide cross-linked low molecular polyethylenimine as the carrier. The microRNA 145 was labeled with YOYO-1 and the fluorescent microscopy images were obtained. The release of microRNA 145 from the stent was measured with an ultra violet spectrophotometer. The downstream targeting of the c-Myc protein and green fluorescent protein was determined by Western blotting. Finally, we deployed microRNA 145/ssPEl nanoparticles immobilized on HA -coated stents in the balloon injured external iliac artery in a rabbit restenosis model.
   Results: Cellular viability of the nanoparticle-immobilized surface tested using A10 vascular smooth muscle cells showed that MSN exhibited negligible cytotoxicity. In addition, microRNA 145 and downstream signaling proteins were identified by western blots with smooth muscle cell.(SMC) lysates from the transfected A10 cell, as the molecular mechanism for decreased SMC proliferation that results in the inhibition of in-stent restenosis. MicroRNA 145 released from the stent suppressed the growth of the smooth muscle at the peristent implantation area, resulting in the prevention of restenosis at the post-implantation. We investigated the qualitative analyses of instent restenosis in the rabbit model using micro-computed tomography imaging and histological staining.
   Conclusion: MicroRNA 145-eluting stent mitigated in-stent restenosis efficiently with no side effects and can be considered a successful substitute to the current drug-eluting stent.
C1 [Che, Hui-Lian; Uthaman, Saji; Park, In-Kyu] Dept Biomed Sci, Gwangju, South Korea.
   [Che, Hui-Lian; Uthaman, Saji; Park, In-Kyu] BK21 PLUS Ctr Creat Biomed Scientists, Gwangju, South Korea.
   [Che, Hui-Lian; Bae, In-Ho; Lim, Kyung Seob; Ahn, Youngkeun; Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea.
   [Song, In Taek; Lee, Haeshin] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea.
   [Song, In Taek; Lee, Haeshin] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea.
   [Lee, Duhwan; Kim, Won Jong] Pohang Univ Sci & Technol, Dept Chem, Ctr Self Assembly & Complex, Pohang, South Korea.
   [Park, In-Kyu] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, 160 Baekseo Ro, Gwangju 61469, South Korea.
RP Park, IK (corresponding author), Chonnam Natl Univ, Sch Med, Dept Biomed Sci, 160 Baekseo Ro, Gwangju 61469, South Korea.
EM pik96@chonnam.ac.kr
RI Lee, Haeshin/C-1720-2011; Uthaman, Saji/T-6068-2017; Park,
   In-Kyu/W-1613-2017
OI Lee, Haeshin/0000-0003-3961-9727; Uthaman, Saji/0000-0001-6387-7510;
   Park, In-Kyu/0000-0002-8522-8236
FU Korean Society of Cardiology [201203-7]; Leading Foreign Research
   Institute Recruitment Program, through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology (MEST)
   [2011-0030034]; Pioneer Research Center Program, through the National
   Research Foundation of Korea - Ministry of Science, ICT & Future
   Planning [2014M3C1A3053035]
FX This study was supported by a research grant from the Korean Society of
   Cardiology (201203-7).; IKP also acknowledges the partial financial
   supports from the Leading Foreign Research Institute Recruitment
   Program, through the National Research Foundation of Korea (NRF), funded
   by the Ministry of Education, Science and Technology (MEST)
   (2011-0030034), and the Pioneer Research Center Program, through the
   National Research Foundation of Korea, funded by the Ministry of
   Science, ICT & Future Planning (2014M3C1A3053035).
CR Al Ali J, 2013, CAN J CARDIOL, V29, pS284, DOI 10.1016/j.cjca.2013.07.472
   Babapulle MN, 2002, CIRCULATION, V106, P2734, DOI 10.1161/01.CIR.0000038982.49640.70
   Brito LA, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-56
   Che HL, 2012, BIOMATERIALS, V33, P8548, DOI 10.1016/j.biomaterials.2012.07.045
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Fishbein I, 2013, ANGIOL OPEN ACCESS, V1
   Forbes SP, 2013, ATHEROSCLEROSIS, V230, P23, DOI 10.1016/j.atherosclerosis.2013.06.002
   GERSHLICK AH, 2005, HEART S3, V91, P24
   Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017
   Hong YJ, 2013, INT J CARDIOL, V163, P1, DOI 10.1016/j.ijcard.2012.02.003
   Hwang DW, 2011, BIOMATERIALS, V32, P4968, DOI 10.1016/j.biomaterials.2011.03.047
   Lemkine GF, 2001, CURR OPIN MOL THER, V3, P178
   Li D, 2014, INT J NANOMED, V9, P3347, DOI 10.2147/IJN.S61463
   Li JM, 2010, GENE THER, V17, P1279, DOI 10.1038/gt.2010.69
   Lompre AM, 2013, GENE THER, V20, P901, DOI 10.1038/gt.2013.13
   Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Muthiah M, 2014, J BIOMED NANOTECHNOL, V10, P571, DOI 10.1166/jbn.2014.1737
   Nikol S, 1997, HEART, V78, P426, DOI 10.1136/hrt.78.5.426
   Park S, 2012, BIOMATERIALS, V33, P5468, DOI 10.1016/j.biomaterials.2012.04.005
   Paul A, 2012, BIOMATERIALS, V33, P7655, DOI 10.1016/j.biomaterials.2012.06.096
   Thomas MK, 2006, NATL MED J INDIA, V19, P195
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   Ye YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078667
   Yin RX, 2014, THERANOSTICS, V4, P175, DOI 10.7150/thno.7210
   Zhu DW, 2010, INT J NANOMED, V5, P1095, DOI 10.2147/IJN.S14358
NR 26
TC 5
Z9 6
U1 0
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 23
EP 32
DI 10.4070/kcj.2016.46.1.23
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400004
PM 26798382
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Park, KH
   Lim, C
   Kim, DJ
   Jung, Y
   Shin, YC
   Choi, SI
   Chun, EJ
   Yoo, JY
AF Kim, Jun Sung
   Park, Kay-Hyun
   Lim, Cheong
   Kim, Dong Jin
   Jung, Yochun
   Shin, Yoon Cheol
   Choi, Sang Il
   Chun, Eun Ju
   Yoo, Jin Young
TI Prediction of Intimal Tear Site by Computed Tomography in Acute Aortic
   Dissection Type A
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta; Aortic dissection; Computerized tomography
ID TRANSESOPHAGEAL ECHOCARDIOGRAPHY; INTRAMURAL HEMATOMA; ENTRY TEAR; CT;
   PLACEMENT; DIAGNOSIS; SURGERY
AB Background and Objectives: Preoperative identification of intimal tear site in acute type A dissection will help procedural planning. The objective of this study was to determine the key findings of computed tomography (CT)-based prediction for tear site and compare the accuracy between radiologists and surgeons.
   Subjects and Methods: Multi-detector CT (MDCT) images from 50 patients who underwent surgical repair of type A aortic dissection were retrospectively reviewed by 4 cardiac surgeons with limited experience or by 3 radiologists specialized in cardiovascular imaging. Surgical findings of intimal tear site were used as references.
   Results: In surgical findings, the locations of intimal tear that were identified in 43 patients included aorta (n=25), ascending with arch (n=7), and arch only (n=11). The rest were retrograde dissections from the tear of descending aorta. Key CT findings that were most frequently found were defect in the intimal flap shadow (30.0 +/- 4.0 patients/reviewer, accuracy 87.0 +/- 11.7%) and differential filling of false lumen by phase and location (9.4 +/- 2.9 patients/reviewer, 84.8 +/- 10.4%). Surgeons predicted tear site (75.0 +/- 7.7% vs. 86.7 +/- 1.2%, p=0.055) and specified flap defect (80.5 +/- 10.3% vs. 95.7 +/- 7.4%, p=0.073) with lower accuracy than radiologists.
   Conclusions: With MDCT imaging, well-educated surgeons could be accurate in three fourths of cases. There was room for improvement through experience. Considering the substantial possibility of inaccuracy, critical decisions on CT images should be made through thorough reviewing by as many experienced radiologists and surgeons as possible.
C1 [Kim, Jun Sung; Park, Kay-Hyun; Lim, Cheong; Kim, Dong Jin; Shin, Yoon Cheol] Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, 82 Gumi Ro 173 Beon Gil, Songnam 13620, South Korea.
   [Jung, Yochun] Hallo Gen Hosp, Dept Thorac & Cardiovasc Surg, Jeju, South Korea.
   [Choi, Sang Il; Chun, Eun Ju; Yoo, Jin Young] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Songnam, South Korea.
RP Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, 82 Gumi Ro 173 Beon Gil, Songnam 13620, South Korea.
EM doc_k@hanmail.net
RI Jung, Yochun/AAF-1866-2019; Yoo, Jin Young/AAG-6414-2019
OI Yoo, Jin Young/0000-0003-0007-1960; Lim, Cheong/0000-0003-0913-7014;
   Park, Kay-Hyun/0000-0002-1111-9627
FU Seoul National University Bundang Hospital [02-2009-036]
FX This work was supported by a grant (02-2009-036) funded by the Seoul
   National University Bundang Hospital.
CR Berger FH, 2010, EUR J RADIOL, V74, P24, DOI 10.1016/j.ejrad.2009.06.023
   Bonser RS, 2011, J AM COLL CARDIOL, V58, P2455, DOI 10.1016/j.jacc.2011.06.067
   Conzelmann LO, 2011, HERZ, V36, P513, DOI 10.1007/s00059-011-3512-x
   Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004
   Easo J, 2012, J THORAC CARDIOV SUR, V144, P617, DOI 10.1016/j.jtcvs.2011.07.066
   Ehrlich MP, 2013, J THORAC CARDIOV SUR, V145, P159, DOI 10.1016/j.jtcvs.2011.10.093
   GODWIN JD, 1982, J COMPUT ASSIST TOMO, V6, P750, DOI 10.1097/00004728-198208000-00015
   HAMADA S, 1992, RADIOLOGY, V183, P155, DOI 10.1148/radiology.183.1.1549663
   Jaussaud N, 2013, J CARDIOVASC SURG, V54, P373
   Kapoor V, 2004, AM J ROENTGENOL, V183, P109, DOI 10.2214/ajr.183.1.1830109
   Kato N, 2001, J VASC SURG, V34, P1023, DOI 10.1067/mva.2001.118808
   Khoynezhad A, 2010, J VASC SURG, V52, P562, DOI 10.1016/j.jvs.2010.04.036
   Krahenbuhl E, 2012, EUR J CARDIO-THORAC, V41, pe110, DOI 10.1093/ejcts/ezs121
   Lyons O, 2011, J ENDOVASC THER, V18, P591, DOI 10.1583/11-3468.1
   McMahon MA, 2010, RADIOGRAPHICS, V30, P445, DOI 10.1148/rg.302095104
   Mishra M, 2005, INNOVATIONS, V1, P40
   NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101
   Quint LE, 2003, J ENDOVASC THER, V10, P505, DOI 10.1583/1545-1550(2003)010<0505:AITDWS>2.0.CO;2
   Sobocinski J, 2011, EUR J VASC ENDOVASC, V42, P442, DOI 10.1016/j.ejvs.2011.04.037
   Sommer T, 1996, RADIOLOGY, V199, P347, DOI 10.1148/radiology.199.2.8668776
   Takami Y, 2012, CLIN CARDIOL, V35, P500, DOI 10.1002/clc.21991
   Unosawa S, 2013, J THORAC CARDIOV SUR, V146, P67, DOI 10.1016/j.jtcvs.2012.05.067
   Ye C, 2011, EUR J VASC ENDOVASC, V42, P787, DOI 10.1016/j.ejvs.2011.08.015
   Yoshida S, 2003, RADIOLOGY, V228, P430, DOI 10.1148/radiol.2282012162
   Zimpfer D, 2006, ANN THORAC SURG, V82, P747, DOI 10.1016/j.athoracsur.2005.11.066
NR 25
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 48
EP 55
DI 10.4070/kcj.2016.46.1.48
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400007
PM 26798385
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Shin, WS
   Kim, TS
   Kim, SH
   Kim, JH
   Jang, SW
   Pak, HN
   Nam, GB
   Lee, MY
   Rho, TH
   Oh, YS
AF Kim, Ju Youn
   Shin, Woo-Seung
   Kim, Tae-Seok
   Kim, Sung-Hwan
   Kim, Ji-Hoon
   Jang, Sung -Won
   Pak, Hui-Nam
   Nam, Gi-Byoung
   Lee, Man Young
   Rho, Tai-Ho
   Oh, Yong Seog
TI Visualization of the Critical Isthmus by Tracking Delayed Potential in
   Edited Windows for Scar-Related Ventricular Tachycardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Electroanatomical mapping; Delayed potential; Scar-related ventricular
   tachycardia
ID CATHETER ABLATION; MYOCARDIAL-INFARCTION; SITES; CARDIOMYOPATHY;
   IDENTIFICATION; ELECTROGRAMS; CHANNELS; CIRCUIT; ZONE
AB Background and Objectives: Identifying the critical isthmus of slow conduction is crucial for successful treatment of scar-related ventricular tachycardia. Current 3D mapping is not designed for tracking the critical isthmus and may lead to a risk of extensive ablation. We edited the algorithm to track the delayed potential in order to visualize the isthmus and compared the edited map with a conventional map.
   Subjects and Methods: We marked every point that showed delayed potential with blue color. After substrate mapping, we edited to reset the annotation from true ventricular potential to delayed potential and then changed the window of interest from the conventional zone (early, 50-600/0; late, 40-500/0 from peak of QRS) to the edited zone (early, 80-90010; late, 10-200/) for every blue point. Finally, we compared the propagation maps before and after editing.
   Results: We analyzed five scar-related ventricular tachycardia cases. In the propagation maps, the resetting map showed the critical isthmus and entrance and exit sites of tachycardia that showed figure 8 reentry. However, conventional maps only showed the earliest ventricular activation sites and searched for focal tachycardia. All of the tachycardia cases were terminated by ablating the area around the isthmus.
   Conclusion: Identifying the channel and direction of the critical isthmus by a new editing method to track delayed potential is essential in scar-related tachycardia.
C1 [Kim, Ju Youn; Shin, Woo-Seung; Kim, Tae-Seok; Kim, Sung-Hwan; Kim, Ji-Hoon; Jang, Sung -Won; Lee, Man Young; Rho, Tai-Ho; Oh, Yong Seog] Catholic Univ Korea, Coll Med, Div Cardiol, Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
   [Pak, Hui-Nam] Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Nam, Gi-Byoung] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Coll Med, Div Cardiol, Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM oys@catholic.ac.kr
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
CR Arenal A, 2003, J AM COLL CARDIOL, V41, P81, DOI 10.1016/S0735-1097(02)02623-2
   de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763
   de Chillou C, 2002, CIRCULATION, V105, P726, DOI 10.1161/hc0602.103675
   De Chillou C, 2014, HEART RHYTHM, V11, P175, DOI 10.1016/j.hrthm.2013.10.042
   de Chillou C, 2012, PACE, V35, P897, DOI 10.1111/j.1540-8159.2012.03429.x
   Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044
   Fahmy TS, 2008, HEART RHYTHM, V5, P1538, DOI 10.1016/j.hrthm.2008.08.020
   Haqqani HM, 2009, HEART RHYTHM, V6, pS70, DOI 10.1016/j.hrthm.2009.04.023
   Issa ZF, 2012, CLIN ARRHYTHMOLOGY E, P537
   Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216
   Kuck KH, 2009, CIRC-ARRHYTHMIA ELEC, V2, P713, DOI 10.1161/CIRCEP.109.896571
   MORADY F, 1988, J AM COLL CARDIOL, V11, P775, DOI 10.1016/0735-1097(88)90211-2
   Mountantonakis SE, 2013, J AM COLL CARDIOL, V61, P2088, DOI 10.1016/j.jacc.2013.02.031
   Nakahara S, 2010, HEART RHYTHM, V7, P1817, DOI 10.1016/j.hrthm.2010.07.032
   Pedersen CT, 2014, HEART RHYTHM, V11, pE166, DOI 10.1016/j.hrthm.2014.07.024
   Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X
   STEVENSON WG, 1993, CIRCULATION, V88, P1647, DOI 10.1161/01.CIR.88.4.1647
   Vergara Pasquale, 2013, Arch. Cardiol. Méx., V83, P104, DOI 10.1016/j.acmx.2013.02.001
   Vergara P, 2012, J CARDIOVASC ELECTR, V23, P621, DOI 10.1111/j.1540-8167.2011.02246.x
   Verma A, 2005, J CARDIOVASC ELECTR, V16, P465, DOI 10.1046/j.1540-8167.2005.40443.x
   Yokokawa M, 2013, J AM COLL CARDIOL, V61, P66, DOI 10.1016/j.jacc.2012.07.059
NR 21
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2016
VL 46
IS 1
BP 56
EP 62
DI 10.4070/kcj.2016.46.1.56
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB5QJ
UT WOS:000368568400008
PM 26798386
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JK
   Hong, YM
   Jang, GY
   Yun, SW
   Yu, JJ
   Yoon, KL
   Lee, KY
   Kil, HR
AF Lee, Jong-Keuk
   Hong, Young Mi
   Jang, Gi Young
   Yun, Sin Weon
   Yu, Jeong Jin
   Yoon, Kyung Lim
   Lee, Kyung-Yil
   Kil, Hong-Rang
CA Korean Kawasaki Dis Genetics
TI Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean
   Kawasaki Disease Genetics Consortium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mucocutaneous lymph node syndrome; Genome-wide association study;
   Polymorphism; single nucleotide
ID GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS
AB In order to perform large-scale genetic studies of Kawasaki disease (KD) in Korea, the Korean Kawasaki Disease Genetics Consortium (KKDGC) was formed in 2008 with 10 hospitals: Since the establishment of KKDGC, there has been a collection of clinical data from a total of 1198 patients, and approximately 5 mL of blood samples per patient (for genomic deoxyribonucleic acid and plasma isolation), using a standard clinical data collection form and a nation-wide networking system for blood sample pick-up. In the clinical risk factor analysis using the collected clinical data of 478 KD patients, it was found that incomplete KD type, intravenous immunoglobulin (IVIG) non-responsiveness, and long febrile days are major risk factors for coronary artery lesions development, whereas low serum albumin concentration is an independent risk factor for IVIG non-responsiveness. In addition, we identified a KD susceptibility locus at 1p31, a coronary artery aneurysm locus (KCNN2 gene), and the causal variant in the C-reactive protein (CRP) promoter region, as determining the increased CRP levels in KD patients, by means of genome-wide association studies. Currently, this consortium is continually collecting more clinical data and genomic samples to identify the clinical and genetic risk factors via a single nucleotide polymorphism chip and exome sequencing, as well as collaborating with several international KD genetics teams. The consortium-based approach for genetic studies of KD in Korea will be a very effective way to understand the unknown etiology and causal mechanism of KD, which may be affected by multiple genes and environmental factors.
C1 [Lee, Jong-Keuk] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 05505, South Korea.
   [Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Jang, Gi Young] Univ Korea Hosp, Dept Pediat, Seoul, South Korea.
   [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Yu, Jeong Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, Seoul 05505, South Korea.
   [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Lee, Kyung-Yil] Catholic Univ Korea, Dept Pediat, Daejeon St Marys Hosp, Taejon, South Korea.
   [Kil, Hong-Rang] Chungnam Natl Univ Hosp, Dept Pediat, Taejon, South Korea.
RP Lee, JK (corresponding author), Univ Ulsan, Coll Med, Asan Inst Life Sci, 88 Olymp Ro 43-Gil, Seoul 05505, South Korea.
EM cookie_jklee@hotmail.com
FU Korea Ministry of Health and WelfareMinistry of Health & Welfare,
   Republic of Korea [A010384, A111517]; Korea Centers for Disease Control
   and Prevention [2014-ER740200]; Asan Institute for Life Sciences, Seoul,
   Korea [2011-419, 2012-419]
FX We thank all the patients with KD and their families for participating
   in this study. This study was supported by grants (A010384, A111517)
   from the Korea Ministry of Health and Welfare, grant (2014-ER740200)
   from the Korea Centers for Disease Control and Prevention and grant
   (2011-419 & 2012-419) from the Asan Institute for Life Sciences, Seoul,
   Korea.
CR Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   Chang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072037
   Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kim HE, 2012, PEDIATR CARDIOL, V33, P1259, DOI 10.1007/s00246-012-0289-5
   Kim JJ, 2015, PEDIATR CARDIOL, V36, P438, DOI 10.1007/s00246-014-1032-1
   Kim JJ, 2013, J HUM GENET, V58, P521, DOI 10.1038/jhg.2013.43
   Kim JJ, 2012, PEDIATR CARDIOL, V33, P513, DOI 10.1007/s00246-011-0143-1
   Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
NR 10
TC 6
Z9 6
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 443
EP 448
DI 10.4070/kcj.2015.45.6.443
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800001
PM 26617644
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, J
   Lee, SY
   Chon, MK
   Lee, SH
   Hwang, KW
   Kim, JS
   Park, YH
   Kim, JH
   Chun, KJ
AF Hwang, Jongmin
   Lee, Soo Yong
   Chon, Min Ku
   Lee, Sang Hyun
   Hwang, Ki Won
   Kim, Jeong Su
   Park, Yong Hyun
   Kim, June Hong
   Chun, Kook Jin
TI Radiation Exposure in Coronary Angiography: A Comparison of
   Cineangiography and Fluorography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Angiography; Radiation; Cineangiography;
   Fluoroscopy
AB Background and Objectives: Coronary angiography (CAG) is the gold standard for diagnosing coronary artery disease. However, exposure to ionizing radiation delivered during CAG has various negative biological effects on humans. In this study, there was an evaluation of whether fluorography resulted in decreased radiation exposure, as compared with cineangiography.
   Subjects and Methods: Fifty-five patients were prospectively enrolled and divided into two CAG groups, in accordance with the operator's professional discretion: a conventional cineangiography group versus a fluorography group. Fluorography refers to the photography of fluoroscopic images that are retrospectively stored, e.g., using the "Store fluoro" function of the Siemens cardiac angiography system. The primary outcomes included the air kinetic energy released per unit mass {air kerma (AK) mGy} and the dose (kerma)-area product (DAP; mu Gy.m(2)), both measured using built-in software in the Siemens system. The secondary outcomes included the total procedure time and amount of contrast agent used with each CAG method.
   Results: The total AK and DAP were significantly lower in the fluorography group (159.3 +/- 64.9 mGy and 1337.9 +/- 629.6 mu Gy.m(2), respectively) than in the cineangiography group (326.9 +/- 107.5 mGy and 2341.1 +/- 849.9 mu Gy.m(2), respectively; p=0.000 for both). The total procedure time (cineangiography vs. fluorography, 12.8 +/- 4.7 vs. 12.5 +/- 2.9 min; p=0.779) and contrast agent amount (136.1 +/- 28.3 vs. 1.26.3 +/- 25.7, p=0.214) were comparable between the two groups.
   Conclusion: Fluorography is a useful method to decrease the radiation exposure in selected patients requiring CAG.
C1 [Hwang, Jongmin; Lee, Soo Yong; Chon, Min Ku; Lee, Sang Hyun; Hwang, Ki Won; Kim, Jeong Su; Park, Yong Hyun; Kim, June Hong; Chun, Kook Jin] Pusan Natl Univ, Yangsan Hosp, Cardiovasc Ctr, Div Cardiol,Dept Internal Med,Sch Med, Yangsan 50612, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Cardiovasc Ctr, Div Cardiol,Dept Internal Med,Sch Med, 20 Geumo Ro,Mulgeum Eup, Yangsan 50612, South Korea.
EM ptca82@gmail.com
FU Pusan National University Research GrantPusan National University
FX This work was supported for 2 years by a Pusan National University
   Research Grant.
CR Cousins C., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.09.001
   Delewi R, 2013, CIRC-CARDIOVASC INTE, V6, P501, DOI 10.1161/CIRCINTERVENTIONS.113.000220
   Nickoloff EL, 2007, CARDIOVASC INTER RAD, V30, P169, DOI 10.1007/s00270-006-0096-6
   Olcay A, 2014, INT J CARDIOL, V177, P595, DOI 10.1016/j.ijcard.2014.08.144
   Poll LW, 2002, ROFO-FORTSCHR RONTG, V174, P1500, DOI 10.1055/s-2002-35945
   Roguin A, 2013, AM J CARDIOL, V111, P1368, DOI 10.1016/j.amjcard.2012.12.060
   Shah B, 2014, AM J CARDIOL, V113, P1093, DOI 10.1016/j.amjcard.2013.12.013
   Smith-Bindman R, 2010, JAMA-J AM MED ASSOC, V307, P2400, DOI DOI 10.1001/JAMA.2012.5960
NR 8
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 451
EP 456
DI 10.4070/kcj.2015.45.6.451
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800003
PM 26617646
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, CH
   Kim, J
   Kim, MS
   Roh, JH
   Choi, JH
   Jo, U
   Lee, WS
   Kim, YR
   Nam, GB
   Choi, KJ
   Kim, YH
AF Kwon, Chang Hee
   Kim, Jun
   Kim, Min Su
   Roh, Jae-Hyung
   Choi, Jin Hee
   Jo, Uk
   Lee, Woo Seok
   Kim, Yoo Ri
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Impact of Impaired Renal Function on the Incidence of Atrial
   Fibrillation following Radiofrequency Ablation of Cavotricuspid
   Isthmus-Dependent Atrial Flutter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Atrial flutter; Renal insufficiency; Catheter
   ablation
ID GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CATHETER ABLATION;
   RECURRENCE; LONE
AB Background and Objectives: Atrial fibrillation (AF) occurs frequently after successful radiofrequency ablation (RFA) of cavotricuspid isthmus-dependent atrial flutter (CTI-AFL). Renal impairment has been implicated in the development of AF. The purpose of this study is to clarify the impact of impaired renal function on the incidence of AF after RFA of CTI-AFL
   Subjects and Methods: Between January 2001 and December 2013, 240 non-dialysis patients with no prior history of AF {mean age 55.9 +/- 15.2 years old; male, 192 (80.0%)} who had undergone successful CTI-AFL ablation were included in the present study. The baseline estimated glomerular filtration rate was calculated, and patients were divided into those with impaired renal function (<60 mL/min/1.73 m(2)) and those with preserved renal function (>= 60 mL/min/1.73 m(2)). The incidence of AF was retrospectively analyzed.
   Results: 69 (28.8%) patients experienced new onset AF during a median follow-up duration of 26 months (inter-quartile, 7-53). The incidence of AF was significantly higher in patients with impaired renal function than in those with preserved renal function {13/25 (52.0%) versus 56/215 (26.0%), log rank p=0.019}. Age, CHADS(2) score, impaired renal function, and left atrial diameter were significantly associated with the incidence of AF in univariate Cox regression analysis. Multivariate analysis showed that age was the only significant predictor of AF incidence (hazard ratio, 1.024; 95% confidence interval, 1.004-1.044, p=0.020).
   Conclusion: Patients with impaired renal function may require careful attention for the incidence of new onset AF following successful RFA of CTI-AFL
C1 [Kwon, Chang Hee] Konkuk Univ, Sch Med, Med Ctr, Div Cardiol, Seoul, South Korea.
   [Kim, Jun; Kim, Min Su; Roh, Jae-Hyung; Choi, Jin Hee; Jo, Uk; Lee, Woo Seok; Kim, Yoo Ri; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul 05505, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
OI Kim, Jun/0000-0002-3573-638X; Roh, Jae-Hyung/0000-0003-3675-3541
CR Ananthapanyasut W, 2010, CLIN J AM SOC NEPHRO, V5, P173, DOI 10.2215/CJN.03170509
   Anne W, 2004, HEART, V90, P1025, DOI 10.1136/hrt.2003.023069
   Berkowitsch A, 2012, PACE, V35, P532, DOI 10.1111/j.1540-8159.2012.03350.x
   Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheartj/ehi020
   Calkins H, 2004, AM J CARDIOL, V94, P437, DOI 10.1016/j.amjcard.2004.04.058
   Chinitz JS, 2007, HEART RHYTHM, V4, P1029, DOI 10.1016/j.hrthm.2007.04.002
   Deo R, 2010, J CARD FAIL, V16, P55, DOI 10.1016/j.cardfail.2009.07.002
   Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668
   Ellis K, 2007, J CARDIOVASC ELECTR, V18, P799, DOI 10.1111/j.1540-8167.2007.00885.x
   Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180
   Gilligan DM, 2003, PACE, V26, P53, DOI 10.1046/j.1460-9592.2003.00150.x
   Goicoechea M, 2006, J AM SOC NEPHROL, V17, pS231, DOI 10.1681/ASN.2006080938
   Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim JJ, 1996, KOREAN CIRC J, V26, P605
   Laurent V, 2009, J INTERV CARD ELECTR, V24, P119, DOI 10.1007/s10840-008-9323-1
   Lee SH, 2013, J KOREAN MED SCI, V28, P1174, DOI 10.3346/jkms.2013.28.8.1174
   Lee YS, 2010, J CARDIOL, V56, P348, DOI 10.1016/j.jjcc.2010.07.006
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Moubarak G, 2009, ARCH CARDIOVASC DIS, V102, P525, DOI 10.1016/j.acvd.2009.04.002
   Schmidt M, 2011, J CARDIOVASC ELECTR, V22, P1092, DOI 10.1111/j.1540-8167.2011.02069.x
   Schmidt M, 2010, AM J CARDIOL, V105, P368, DOI 10.1016/j.amjcard.2009.09.037
   Shah D, 2000, CIRCULATION, V102, P1517, DOI 10.1161/01.CIR.102.13.1517
   Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066
   Wu TJ, 2001, J AM COLL CARDIOL, V38, P1757, DOI 10.1016/S0735-1097(01)01606-0
NR 25
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 473
EP 478
DI 10.4070/kcj.2015.45.6.473
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800006
PM 26617649
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Choi, SY
   Park, JS
   Seo, JM
   Choi, JH
   Cho, YR
   Park, K
   Kim, MH
   Kim, YD
AF Lee, Dong Hyun
   Choi, Sun Young
   Park, Jong Sung
   Seo, Jeong-Min
   Choi, Jae-Hyuk
   Cho, Young-Rak
   Park, Kyungil
   Kim, Moo Hyun
   Kim, Young-Dae
TI Comparison of Prolonged Atrial Electromechanical Delays with Different
   Definitions in the Discrimination of Patients with Non-Valvular
   Paroxysmal Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Electrocardiography; Echocardiography
ID DOPPLER-ECHOCARDIOGRAPHY; CONDUCTION ABNORMALITIES; MECHANICAL
   FUNCTIONS; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; CATHETER ABLATION;
   INTERVAL; RECOMMENDATIONS; QUANTIFICATION; PREDICTION
AB Background and Objectives: Previous studies have evaluated atrial electromechanical delays (AEMDs) with a number of different definitions to discriminate patients with paroxysmal atrial fibrillation (PAF) from controls without PAF. However, their discriminative values for PAF have not previously been directly compared.
   Subjects and Methods: A total of 65 PAF patients and 130 control subjects matched for age, sex, history of hypertension, and diabetes mellitus were selected. The AEMDi and AEMDp were defined as the time intervals from the initiation of the P wave on the surface electrocardiogram to the initiation and peak of the late diastolic transmitral inflow on pulsed wave Doppler images, respectively. The AEMDim and AEMDpm. were defined as the time intervals from the initiation of the P wave on the surface electrocardiogram to the initiation and peak of the late diastolic lateral mitral annular motion on tissue Doppler images, respectively.
   Results: There were no significant differences in the clinical characteristics between the two groups. All 4 AEMDs were consistently longer in the PAF group, and proven effective to differentiate the PAF patients from the controls. The AEMDi measurement had a larger area under the curve (AUC) than the other AEMDs, left atrial volume index, and P wave amplitude. However, the AEMDp, AEMDim, and AEMDpm measurements had AUCs similar to those of the left atrial volume index and P wave amplitude.
   Conclusion: The findings suggest that the AEMDi is better than the other AEMDs for the discrimination of PAF patients from the controls.
C1 [Lee, Dong Hyun; Choi, Sun Young; Park, Jong Sung; Seo, Jeong-Min; Choi, Jae-Hyuk; Cho, Young-Rak; Park, Kyungil; Kim, Moo Hyun; Kim, Young-Dae] Dong A Univ, Med Ctr, Dept Cardiol, Busan 49201, South Korea.
RP Park, JS (corresponding author), Dong A Univ, Med Ctr, Dept Cardiol, 32 Daesingongwon Ro, Busan 49201, South Korea.
EM thinkmed@dau.ac.kr
OI Lee, Dong Hyun/0000-0001-6253-3396
FU Dong-A University Research Fund
FX This study was supported by the Dong-A University Research Fund in 2015.
   The authors thank Lee Farrand for English proofreading of the
   manuscript.
CR Acar G, 2009, J AM SOC ECHOCARDIOG, V22, P732, DOI 10.1016/j.echo.2009.03.028
   BARBIER P, 1994, J AM COLL CARDIOL, V24, P165, DOI 10.1016/0735-1097(94)90558-4
   Chao TF, 2011, J CARDIOVASC ELECTR, V22, P1325, DOI 10.1111/j.1540-8167.2011.02115.x
   Chao TF, 2011, HEART, V97, P225, DOI 10.1136/hrt.2010.212373
   Cui QQ, 2008, CLIN CARDIOL, V31, P74, DOI 10.1002/clc.20162
   Cui QQ, 2008, ACTA CARDIOL, V63, P701, DOI 10.2143/AC.63.6.2033386
   De Vos CB, 2009, HEART, V95, P835, DOI 10.1136/hrt.2008.148528
   den Uijl DW, 2011, EUROPACE, V13, P1533, DOI 10.1093/europace/eur186
   Erturk M, 2013, ECHOCARDIOGR-J CARD, V30, P699, DOI 10.1111/echo.12101
   FUKUNAMI M, 1991, CIRCULATION, V83, P162, DOI 10.1161/01.CIR.83.1.162
   Karabag T, 2012, EUR HEART J-CARD IMG, V13, P251, DOI 10.1093/ejechocard/jer227
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lim HE, 2009, CIRC J, V73, P249, DOI 10.1253/circj.CJ-08-0813
   Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075
   Mizuno R, 1997, EUR HEART J, V18, P1995
   Omi W, 2005, J AM SOC ECHOCARDIOG, V18, P39, DOI 10.1016/j.echo.2004.08.029
   Ozturk S, 2012, CARDIOL J, V19, P287, DOI 10.5603/CJ.2012.0051
   Pala S, 2010, J ELECTROCARDIOL, V43, P344, DOI 10.1016/j.jelectrocard.2009.11.004
   Park SM, 2010, J AM SOC ECHOCARDIOG, V23, P309, DOI 10.1016/j.echo.2009.12.019
   Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202
   Roshanali F, 2007, CIRCULATION, V116, P2012, DOI 10.1161/CIRCULATIONAHA.107.727081
   Sengul C, 2011, CARDIOL J, V18, P682, DOI 10.5603/CJ.2011.0033
   VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724
   Weijs B, 2012, INT J CARDIOL, V156, P121, DOI 10.1016/j.ijcard.2012.01.024
   Weijs B, 2011, EUROPACE, V13, P1681, DOI 10.1093/europace/eur261
NR 25
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 479
EP 485
DI 10.4070/kcj.2015.45.6.479
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800007
PM 26617650
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, HJ
   Sohn, IS
   Kim, WS
   Hong, GR
   Choi, EY
   Rim, SJ
   Lee, SC
   Chung, WJ
   Choi, JH
   Seo, HS
   Yoon, SJ
   Cho, KI
   Kim, HS
   Yoon, HJ
AF Hwang, Hui-Jeong
   Sohn, Il Suk
   Kim, Woo-Shik
   Hong, Geu-Ru
   Choi, Eui-Young
   Rim, Se-Joong
   Lee, Sang-Chol
   Chung, Wook-Jin
   Choi, Jung-Hyun
   Seo, Hye-Sun
   Yoon, Se Jung
   Cho, Kyoung Im
   Kim, Hyung Seop
   Yoon, Hyun Ju
TI The Clinical Impact of Bedside Contrast Echocardiography in Intensive
   Care Settings: A Korean Multicenter Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Echocardiography; Intensive care
ID EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; RECOMMENDATIONS; IMPROVES
AB Background and Objectives: We assessed the ability of portable echocardiography (with contrasts) to clearly delineate the cardiac structure, and evaluated the impact of its use on the diagnosis and management of critically ill patients in Korea.
   Subjects and Methods: We prospectively enrolled 123 patients (mean age 66 +/- 16 years), who underwent portable transthoracic echocardiography (with contrast) for image enhancement at 12 medical centers. The quality of the global left ventricular (LV) images, the number of the regional LV segments visualized, the ability to visualize the LV apex and the right ventricle (RV), and any changes in the diagnostic procedure and treatment strategy were compared before and after the contrast.
   Results: Of the 123 patients, 52 (42%) were using mechanical ventilators. The amount of poor or uninterpretable images decreased from 48% to 5% (p<0.001), after the contrast. Before the contrast, 15.6 +/- 1.1 of 16 LV segments were seen, which improved to 15.9 +/- 0.6 segments (p=0.001) after the contrast. The ability to visualize the LV apex increased from 47% to 94% (p<0.001), while the inability to clearly visualize the RV decreased from 46% to 19% (p<0.001). Changes in the diagnostic procedure (for example, not requiring other types of imaging studies) were observed in 18% of the patients, and the treatment plan (medication) was altered in 26% of patients after the contrast echocardiography.
   Conclusion: The use of a contrast agent during the portable echocardiography, in intensive care settings, can improve the image quality and impact the diagnostic procedures and treatment for Korean patients.
C1 [Hwang, Hui-Jeong; Sohn, Il Suk; Kim, Woo-Shik] Kyung Hee Univ, Sch Med, Dept Cardiol, Seoul, South Korea.
   [Hong, Geu-Ru; Choi, Eui-Young; Rim, Se-Joong] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Sang-Chol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Chung, Wook-Jin] Gachon Univ, Sch Med, Gil Hosp, Div Cardiol,Heart Ctr, Inchon, South Korea.
   [Choi, Jung-Hyun] Pusan Natl Univ, Dept Internal Med, Div Cardiol, Sch Med, Busan, South Korea.
   [Seo, Hye-Sun] Soonchunhyang Univ Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea.
   [Yoon, Se Jung] NHIS Ilsan Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Cho, Kyoung Im] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Kim, Hyung Seop] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Taegu, South Korea.
   [Yoon, Hyun Ju] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Kwangju, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Cardiol, 892 Dongnam Ro, Seoul 05278, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020; Chung, Wook-Jin/AAJ-5613-2021
OI SOHN, ILSUK/0000-0001-8004-5185; Chung, Wook-Jin/0000-0002-9767-7098
FU Korean Society of Cardiology
FX This study was supported by a grant from the Korean Society of
   Cardiology.
CR Beaulieu Y, 2007, CRIT CARE MED, V35, pS235, DOI 10.1097/01.CCM.0000260673.66681.AF
   Cook CH, 2002, J TRAUMA, V52, P280, DOI 10.1097/00005373-200202000-00013
   Hundley WG, 1998, J AM COLL CARDIOL, V32, P1426, DOI 10.1016/S0735-1097(98)00409-4
   Hundley WG, 1999, AM J CARDIOL, V84, P1365, DOI 10.1016/S0002-9149(99)00577-9
   HWANG JJ, 1993, CHEST, V104, P861, DOI 10.1378/chest.104.3.861
   Jung HO, 2012, KOREAN CIRC J, V42, P725, DOI 10.4070/kcj.2012.42.11.725
   Kurt M, 2009, J AM COLL CARDIOL, V53, P802, DOI 10.1016/j.jacc.2009.01.005
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Makaryus AN, 2005, J AM SOC ECHOCARDIOG, V18, P475, DOI 10.1016/j.echo.2004.10.004
   Mulvagh SL, 2008, J AM SOC ECHOCARDIOG, V21, P1179, DOI 10.1016/j.echo.2008.09.009
   Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462
   Reilly JP, 2000, J AM COLL CARDIOL, V35, P485, DOI 10.1016/S0735-1097(99)00558-6
   Senior R, 2005, EUR J ECHOCARDIOG S2, V6, pS6
   Senior R, 2009, EUR J ECHOCARDIOGR, V10, P194, DOI 10.1093/ejechocard/jep005
   Yong YQ, 2002, AM J CARDIOL, V89, P711, DOI 10.1016/S0002-9149(01)02344-X
NR 15
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 486
EP 491
DI 10.4070/kcj.2015.45.6.486
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800008
PM 26617651
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, NR
   Kim, HC
AF Kim, Na Rae
   Kim, Hyeon Chang
TI Prevalence and Trends of Isolated Systolic Hypertension among Korean
   Adults: the Korea National Health and Nutrition Examination Survey,
   1998-2012
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Prevalence; Trends; Isolated systolic hypertension;
   Isolated diastolic hypertension
ID CORONARY-HEART-DISEASE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE;
   MORTALITY; RISK; AGE; POPULATION; SUBTYPES; MEN
AB Background and Objectives: Systolic and diastolic blood pressure may have different effects on cardiovascular disease, but limited data is available for hypertension subtypes in the Korean population. Thus, the prevalence, and absolute number of hypertension subtypes among Korean adults was estimated.
   Subjects and Methods: The Korea National Health and Nutrition Examination Survey 1998-2012 was used to estimate the prevalence and absolute number of each hypertension subtype among Korean adults aged >= 20 years. Hypertension was classified into four subtypes: treated hypertension (TH), isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), and combined systolic and diastolic hypertension (SDH).
   Results: In 2012, approximately 9.5 million adults were estimated to have hypertension, which consists of 5675671 TH (60.0%), 954253 ISH (10.1%), 1649486 IDH (17.4%), and 1175506 SDH (12.4%). Between 2010 and 2012, the proportion of IDH steadily decreased with age, but ISH increased especially in older ages (>= 40). Between 1998 and 2012, TH markedly increased from 1.4 million to 5.7 million while the number of untreated hypertension remained relatively constant. During the same time, the number of hypertensive elderlies increased from 507000 to 2822000 along with rapid ageing of the Korean population. Despite of significant improvement in treatment rate, there are still around 583000 elderlies with untreated hypertension (423000 ISH; 42000 IDH; 118000 SDH) as of 2012.
   Conclusion: Although the prevalence of hypertension has been constant over the last decades, absolute number of people with hypertension has been increasing. Along with the rapid population ageing, the number of elderly hypertension is increasing and the ISH is also becoming more prevalent.
C1 [Kim, Na Rae] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 03722, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240
FU Korean Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [HI13C0715]
FX This study was supported by a grant from the Korean Health Technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea
   (HI13C0715).
CR Antikainen R, 1998, J HYPERTENS, V16, P577, DOI 10.1097/00004872-199816050-00004
   Asmar R, 2003, J HYPERTENS, V21, pS25, DOI 10.1097/00004872-200307006-00005
   BLACK HR, 1994, HYPERTENSION, V23, P275
   BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305
   Choi SW, 2014, J AM SOC HYPERTENS, V8, P246, DOI 10.1016/j.jash.2014.01.004
   Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650
   Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869
   Franklin SS, 1997, CIRCULATION, V96, P308
   GARLAND C, 1983, AM J EPIDEMIOL, V118, P365, DOI 10.1093/oxfordjournals.aje.a113644
   Huang JF, 2004, AM J HYPERTENS, V17, P955, DOI 10.1016/j.amjhyper.2004.06.007
   Jennrich R, 2003, LANCET, V361, P1390, DOI 10.1016/S0140-6736(03)13062-0
   Joffres MR, 2001, AM J HYPERTENS, V14, P1099, DOI 10.1016/S0895-7061(01)02211-7
   KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0
   Kim BG, 2005, J HUM HYPERTENS, V19, P877, DOI 10.1038/sj.jhh.1001904
   Kim JA, 2007, J HUM HYPERTENS, V21, P107, DOI 10.1038/sj.jhh.1002119
   Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lewington S, 2002, LANCET, V360, P1903
   Martins D, 2001, J Gend Specif Med, V4, P10
   Medical Service Usage Statistics by Region, 2012, MED SERV US STAT REG
   Ministry of Health and Welfare, KOR NAT HLTH NUTR EX
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   Sekikawa A, 1999, INT J EPIDEMIOL, V28, P1044, DOI 10.1093/ije/28.6.1044
   Statistics Korea, 2012 STAT CAUS DEATH
   Tran CL, 2012, HYPERTENSION, V60, P296, DOI 10.1161/HYPERTENSIONAHA.111.188813
   Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774
   WILKING SV, 1988, JAMA-J AM MED ASSOC, V260, P3451
NR 30
TC 9
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 492
EP 499
DI 10.4070/kcj.2015.45.6.492
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800009
PM 26617652
OA Green Published
DA 2021-04-22
ER

PT J
AU Akdag, S
   Akyol, A
   Cakmak, HA
   Gunbatar, H
   Asker, M
   Babat, N
   Tosu, AR
   Yaman, M
   Gumrukcuoglu, HA
AF Akdag, Serkan
   Akyol, Aytac
   Cakmak, Huseyin Altug
   Gunbatar, Hulya
   Asker, Muntecep
   Babat, Naci
   Tosu, Aydin Rodi
   Yaman, Mehmet
   Gumrukcuoglu, Hasan Ali
TI A Novel Echocardiographic Method for Assessing Arterial Stiffness in
   Obstructive Sleep Apnea Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic velocity/propagation; Obstructive sleep apnea; Vascular
   stiffness; Pulse wave analysis; Echocardiography
ID MODE PROPAGATION VELOCITY; INTIMA-MEDIA THICKNESS; AORTIC STIFFNESS;
   ENDOTHELIAL FUNCTION; ATHEROSCLEROSIS; CORONARY; HYPERTENSION;
   PREDICTION; DISEASE; WALL
AB Background and Objectives: Obstructive sleep apnea syndrome (OSAS) is associated with increased arterial stiffness and cardiovascular complications. The objective of this study was to assess whether the color M-mode-derived propagation velocity of the descending thoracic aorta (aortic velocity propagation, AVP) was an echocardiographic marker for arterial stiffness in OSAS.
   Subjects and Methods: : The study population included 116 patients with OSAS and 90 age and gender-matched control subjects. The patients with OSAS were categorized according to their apnea hypopnea index (AHI) as follows: mild to moderate degree (AHI 5-30) and severe degree (AHI >= 30). Aortofemoral pulse wave velocity (PWV), carotid intima-media thickness (CIMT), brachial artery flow-mediated dilatation (FMD), and AVP were measured to assess arterial stiffness.
   Results: AVP and FMD were significantly decreased in patients with OSAS compared to controls (p<0.001). PWV and CIMT were increased in the OSAS group compared to controls (p<0.001). Moreover, AVP and FMD were significantly decreased in the severe OSAS group compared to the mild to moderate OSAS group (p<0.001). PWV and CIMT were significantly increased in the severe group compared to the mild to moderate group (p<0.001). AVP was significantly positively correlated with FMD (r=0.564, p<0.001). However, it was found to be significantly inversely related to PWV (r=-0.580, p<0.001) and CIMT (r=-0.251, p<0.001).
   Conclusion: The measurement of AVP is a novel and practical echocardiographic method, which may be used to identify arterial stiffness in OSAS.
C1 [Akdag, Serkan; Akyol, Aytac; Asker, Muntecep; Babat, Naci; Gumrukcuoglu, Hasan Ali] Yuzuncu Yil Univ, Fac Med, Dept Cardiol, TR-65100 Van, Turkey.
   [Cakmak, Huseyin Altug] Rize Kackar Govt Hosp, Dept Cardiol, Rize, Turkey.
   [Gunbatar, Hulya] Yuzuncu Yil Univ, Fac Med, Dept Pulm Dis, TR-65100 Van, Turkey.
   [Tosu, Aydin Rodi] Mehmet Akif Ersoy Thorac & Cardiovasc Surg Educ &, Dept Cardiol, Istanbul, Turkey.
   [Yaman, Mehmet] Samsun Educ & Training Hosp, Dept Cardiol, Samsun, Turkey.
RP Akdag, S (corresponding author), Yuzuncu Yil Univ, Fac Med, Dept Cardiol, TR-65100 Van, Turkey.
EM altugcakmak@hotmail.com
CR Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017
   Cortuk M, 2014, CLIN RESP J
   Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC
   Drager LF, 2007, CHEST, V131, P1379, DOI 10.1378/chest.06-2703
   Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667
   Gullu H, 2006, ECHOCARDIOGR-J CARD, V23, P835, DOI 10.1111/j.1540-8175.2006.00342.x
   Gunes Y, 2008, MED SCI MONITOR, V14, pMT42
   Gunes Y, 2010, TURK KARDIYOL DERN A, V38, P551
   Gunes Y, 2010, ECHOCARDIOGR-J CARD, V27, P300, DOI 10.1111/j.1540-8175.2009.01019.x
   Guntekin U, 2010, ECHOCARDIOGR-J CARD, V27, P155, DOI 10.1111/j.1540-8175.2009.00987.x
   Hirata K, 2006, CIRC J, V70, P1231, DOI 10.1253/circj.70.1231
   Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC
   Kals J, 2014, EUR J VASC ENDOVASC, V48, P308, DOI 10.1016/j.ejvs.2014.05.018
   Lattimore JDL, 2003, J AM COLL CARDIOL, V41, P1429, DOI 10.1016/S0735-1097(03)00184-0
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009
   PAULE WJ, 1976, ATHEROSCLEROSIS, V25, P111, DOI 10.1016/0021-9150(76)90053-8
   PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399
   Sahin M, 2014, HERZ, V39, P749, DOI 10.1007/s00059-013-3898-8
   Schulz R, 2005, EUR RESPIR J, V25, P69, DOI 10.1183/09031936.04.00030004
   Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008
   Shandas R, 2001, CIRCULATION, V104, P908, DOI 10.1161/hc3301.094926
   Silvestrini M, 2002, STROKE, V33, P1782, DOI 10.1161/01.STR.0000019123.47840.2D
   Simsek H, 2013, EUR REV MED PHARMACO, V17, P689
   Simsek H, 2013, ECHOCARDIOGR-J CARD, V30, P644, DOI 10.1111/echo.12125
   Tavil Y, 2007, J AM SOC ECHOCARDIOG, V20, P366, DOI 10.1016/j.echo.2006.09.005
   Wilkinson IB, 2004, CLIN EXP PHARMACOL P, V31, P795, DOI 10.1111/j.1440-1681.2004.04074.x
   Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4
NR 30
TC 6
Z9 7
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 500
EP 509
DI 10.4070/kcj.2015.45.6.500
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800010
PM 26617653
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, JH
   Hong, SJ
   Seo, IA
   Kwak, MH
   Cho, SM
   Kim, DK
   Choi, SM
   Lee, DS
AF Kang, Ji Hae
   Hong, Seung Ji
   Seo, In Ae
   Kwak, Min Ha
   Cho, Seung Man
   Kim, Doo Kwon
   Choi, Sung Min
   Lee, Dong Seok
TI Early Detection of Kawasaki Disease in Infants
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Early detection of disease; Infants; Kawasaki disease
ID BRAIN NATRIURETIC PEPTIDE; REACTIVATION; INFLAMMATION; DIAGNOSIS; RISK;
   SIGN; SITE; AGE
AB Background and Objectives: This study aimed to investigate the clinical characteristics of infantile Kawasaki disease (KD), and to evaluate early diagnostic features of KD in febrile infants.
   Subjects and Methods: We retrospectively reviewed the medical records of 64 KD patients from January 2010 to October 2014. There was an analysis of the clinical, laboratory data of the infants Versus children groups. Furthermore, the clinical and laboratory data of infantile KD patients were compared with 16 infants who were admitted for other acute febrile diseases.
   Results: A total of 64 patients with KD were identified; 20 (31.3%) were infants; 44 (68.8%) were >1 year old children. Incomplete KD was much more common in infants (n=13,.65.0%) than in children group (n=14, 31.8%) (p=0.013). The infants were characterized by significantly higher rates of inflammatory changes at the Bacille Calmett-Guerin (BCG) inoculation site (p<0.001), but lower rates of changes in the extremities (p=0.029) and cervical lymphadenopathy (p=0.006). The serum levels of platelet after 1 week (p=0.005), C-reactive protein (p=0.038), and N-terminal pro-brain natriuretic peptide (NT-proBNP) (p=0.026) were all significantly higher in the infants group. Comparing the infants with KD versus the other acute febrile diseases, there were significantly higher serum levels of erythrocyte sedimentation rate (p=0.002), C-reactive protein (p=0.046) and NT-proBNP (p=0.001) for the infants with KD group.
   Conclusion: BCGitis and higher levels of NT-proBNP can be helpful for early diagnosis of the incomplete KD in infants, and may be a good predictor of KD in acute febrile infants, when combined with other acute phase reactants.
C1 [Kang, Ji Hae; Hong, Seung Ji; Seo, In Ae; Kwak, Min Ha; Cho, Seung Man; Kim, Doo Kwon; Choi, Sung Min; Lee, Dong Seok] Dongguk Univ, Sch Med, Dept Pediat, Gyeongju 38067, South Korea.
RP Lee, DS (corresponding author), Dongguk Univ, Sch Med, Dept Pediat, 87 Dongdae Ro, Gyeongju 38067, South Korea.
EM lds117@dongguk.ac.kr
OI cho, seung-man/0000-0003-3496-5874
CR Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x
   Chalmers D, 2008, J PAEDIATR CHILD H, V44, P525, DOI 10.1111/j.1440-1754.2008.01364.x
   Chang FY, 2006, PEDIATR INFECT DIS J, V25, P241, DOI 10.1097/01.inf.0000202067.50975.90
   Chuang Chih-Hsien, 2006, Journal of Microbiology Immunology and Infection, V39, P387
   Council Cardiovascular Dis Young, 2001, CIRCULATION, V103, P335
   DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776
   Honkanen VEA, 2003, PEDIATR CARDIOL, V24, P122, DOI 10.1007/s00246-002-0063-1
   Hsieh Yu-Chia, 2002, Journal of Microbiology Immunology and Infection, V35, P57
   HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410
   Japan Kawasaki Disease Research Committee, 1984, REP SUBC STAND DIAGN
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   Kawasaki T, 1967, Arerugi, V16, P178
   Lai CC, 2013, PEDIATR NEONATOL, V54, P43, DOI 10.1016/j.pedneo.2012.10.003
   Manlhiot C, 2009, PEDIATRICS, V124, pE410, DOI 10.1542/peds.2009-0099
   MUKOYAMA M, 1990, LANCET, V335, P801, DOI 10.1016/0140-6736(90)90925-U
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Olivieri L, 2009, J AM SOC ECHOCARDIOG, V22, P159, DOI 10.1016/j.echo.2008.11.003
   Perrin L, 2009, JOINT BONE SPINE, V76, P481, DOI 10.1016/j.jbspin.2008.11.015
   Plantin P, 1998, PRESSE MED, V27, P716
   Seo JH, 2012, KOREAN CIRC J, V42, P823, DOI 10.4070/kcj.2012.42.12.823
   Sinha R, 2005, ARCH DIS CHILD, V90, P891, DOI 10.1136/adc.2004.071332
   Uehara R, 2010, PEDIATR INFECT DIS J, V29, P430, DOI 10.1097/INF.0b013e3181cacede
   Yoshimura K, 2013, J PEDIATR-US, V162, P1205, DOI 10.1016/j.jpeds.2012.11.026
NR 23
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 510
EP 515
DI 10.4070/kcj.2015.45.6.510
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800011
PM 26617654
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SB
   Kim, YH
   Hyun, MC
   Kim, YH
   Kim, HS
   Lee, YH
AF Lee, Sang Bum
   Kim, Young Hyun
   Hyun, Myung Chul
   Kim, Yeo Hyang
   Kim, Hee Sun
   Lee, Young Hwan
TI T-Helper Cytokine Profiles in Patients with Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Cytokine; Th1-Th2 cytokine balance
ID CORONARY-ARTERY LESIONS; ALLERGIC DISEASES; ASSOCIATION; HYGIENE;
   UPDATE; FEVER; CELLS
AB Background and Objectives: Kawasaki disease is an acute systemic vasculitis of which pathogenesis suspected is caused by immune dysregulation. The goal of this study is to evaluate the activation pattern of T helper cell type 1 (Th1) and T helper cell type 2 (Th2) in patients with Kawasaki disease.
   Subjects and Methods: Prospective study of 60 patients (male 36, female 24) with diagnosis of Kawasaki disease were enrolled. One hundred and eighty blood samples from these patients were collected according to the different clinical stages {before initial intravenous immunoglobulin (IVIG), 5 days after initial IVIG, 2 months after initial IVIG}. The plasma level of Th1 cytokines; interferon-gamma (IFN-gamma) & interleukin (IL)-2 and Th2 cytokines; IL-4& IL-10 were measured by enzyme-liked immunosorbent assay.
   Results: In all patients, the plasma level of Th1 cytokines (IFN-gamma, IL-2) and Th2 cytokines (IL-4 and IL-10) were markedly elevated during the acute stage of Kawasaki disease. Since then, the plasma level of all these cytokines decreased significantly along with the process of clinical stages. Regardless of the existence of coronary artery lesion or no response to initial IVIG treatment, there were no significant differences between them.
   Conclusion: These data suggest that both Th1 and Th2 cells may be activated simultaneously during the acute stage of Kawasaki disease. Further studies are therefore required to establish the difference of activation pattern of T helper cells between Kawasaki disease and other inflammatory diseases.
C1 [Lee, Sang Bum; Hyun, Myung Chul; Kim, Yeo Hyang] Kyungbook Natl Univ, Sch Med, Dept Pediat, Taegu, South Korea.
   [Kim, Young Hyun; Lee, Young Hwan] Yeungnam Univ, Coll Med, Dept Pediat, Taegu 42415, South Korea.
   [Kim, Hee Sun] Yeungnam Univ, Coll Med, Dept Microbiol, Taegu 42415, South Korea.
RP Lee, YH (corresponding author), Yeungnam Univ, Coll Med, Dept Pediat, 170 Hyeonchung Ro, Taegu 42415, South Korea.
EM yhlee3535@ynu.ac.kr
FU Biomedical Research Institute grant, Kyungpook National University
   Hospital
FX This study was supported by Biomedical Research Institute grant,
   Kyungpook National University Hospital (2011).
CR Bertotto A, 1997, PEDIATR RES, V41, P560, DOI 10.1203/00006450-199704000-00017
   Brogan PA, 2008, CLIN EXP IMMUNOL, V151, P267, DOI 10.1111/j.1365-2249.2007.03567.x
   BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863
   deInocencio J, 1995, CRIT REV IMMUNOL, V15, P349, DOI 10.1615/CritRevImmunol.v15.i3-4.80
   Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004
   Japan Kawasaki Disease Research Committee, 1984, REP SUBC STAND DIAGN
   Jason J, 1997, CLIN IMMUNOL IMMUNOP, V84, P296, DOI 10.1006/clin.1997.4376
   Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x
   Kawasaki T, 1967, Arerugi, V16, P178
   Kimura J, 2004, CLIN EXP IMMUNOL, V137, P444, DOI 10.1111/j.1365-2249.2004.02506.x
   Kuo HC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-38
   Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x
   LEUNG DYM, 1990, J RHEUMATOL, V17, P15
   Liew WK, 2011, PEDIAT ALLERG IMM-UK, V22, P488, DOI 10.1111/j.1399-3038.2011.01149.x
   Matsubara T, 1999, CLIN EXP IMMUNOL, V116, P554
   Matsuoka S, 1997, EUR J PEDIATR, V156, P30
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x
   Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77
   Sinha R, 2005, ARCH DIS CHILD, V90, P891, DOI 10.1136/adc.2004.071332
   STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259
   Takahashi K, 2014, CURR OPIN RHEUMATOL, V26, P31, DOI 10.1097/BOR.0000000000000010
   Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815
NR 24
TC 14
Z9 15
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 516
EP 521
DI 10.4070/kcj.2015.45.6.516
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800012
PM 26617655
OA Green Published
DA 2021-04-22
ER

PT J
AU Lin, CY
   Chung, FP
   Lin, YJ
   Chen, SA
AF Lin, Chin-Yu
   Chung, Fa-Po
   Lin, Yenn-Jiang
   Chen, Shih-Ann
TI Intramural Reentrant Ventricular Tachycardia in a Patient with Severe
   Hypertensive Left Ventricular Hypertrophy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catheter ablation; Hypertension; Hypertrophy, left ventricular;
   Tachycardia, ventricular
ID SYSTEMIC HYPERTENSION; SUDDEN-DEATH; ARRHYTHMIAS; HEART
AB We describe the case of a patient with severe hypertensive left ventricular hypertrophy and sustained hemodynamically unstable ventricular tachycardia (VT). Entrainment was demonstrated in the electrophysiological study. Activation mapping and pacemapping identified the location of the intramural reentrant VT with the exit site close to the epicardium. However, VT persisted after ablation at the epicardial exit site. Successful ablation was performed endocardially at the corresponding position.
C1 [Lin, Chin-Yu; Chung, Fa-Po; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei 11217, Taiwan.
   [Lin, Chin-Yu; Chung, Fa-Po; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.
   [Lin, Chin-Yu; Chung, Fa-Po; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan.
RP Chen, SA (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM epsachen@ms41.hinet.net
OI Lin, Chin-Yu/0000-0003-3282-7523
CR Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290
   Dunn FG, 1987, AM J CARDIOL, V60, P191
   FROHLICH ED, 1992, NEW ENGL J MED, V327, P998, DOI 10.1056/NEJM199210013271406
   Galinier M, 1997, J HYPERTENS, V15, P1779, DOI 10.1097/00004872-199715120-00089
   GHALI JK, 1991, J AM COLL CARDIOL, V17, P1277, DOI 10.1016/S0735-1097(10)80135-4
   Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957
   Kannel W B, 1972, N Engl J Med, V287, P781, DOI 10.1056/NEJM197210192871601
   KANNEL WB, 1975, CIRCULATION, V51, P606, DOI 10.1161/01.CIR.51.4.606
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Lorell BH, 2000, CIRCULATION, V102, P470
   MCLENACHAN JM, 1987, NEW ENGL J MED, V317, P787, DOI 10.1056/NEJM198709243171302
   MESSERLI FH, 1984, AM J MED, V77, P18, DOI 10.1016/0002-9343(84)90430-3
   PRINGLE SD, 1992, AM J CARDIOL, V69, P913, DOI 10.1016/0002-9149(92)90792-W
   Valles E, 2010, CIRC-ARRHYTHMIA ELEC, V3, P63, DOI 10.1161/CIRCEP.109.859942
NR 14
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 526
EP 530
DI 10.4070/kcj.2015.45.6.526
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800014
PM 26617657
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JH
   Park, TH
   Kim, MH
   Kim, YD
   Rhyou, HI
   Rha, SH
   Park, KJ
   Woo, JS
AF Choi, Jae-Hyuk
   Park, Tae-Ho
   Kim, Moo-Hyun
   Kim, Young-Dae
   Rhyou, Hyo In
   Rha, Seo Hee
   Park, Kwon Jae
   Woo, Jong Soo
TI A Rare Cause of Secondary Hypertension in A Young Adult
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Kidney neoplasms; Nephrectomy
ID JUXTAGLOMERULAR CELL TUMOR; RENIN; DIAGNOSIS
AB Reninoma is a rare, renin-secreting, benign renal neoplasm that can cause secondary hypertension. We report a case of a 21-year-old man who suffered from progressively worsening headache for 2 months with a history of hypertension for 7 years. Laboratory studies showed normal potassium level, increased basal plasma renin activity, and normal serum aldosterone level. Abdominal computed tomography and magnetic resonance imaging revealed a small mass in the middle region of the right kidney. Partial nephrectomy was performed; immunohistochemical results demonstrated typical features of reninoma. Postoperatively, blood pressure and potassium level were normal at the 2-month follow-up.
C1 [Choi, Jae-Hyuk; Park, Tae-Ho; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, Busan 49201, South Korea.
   [Rhyou, Hyo In] Dong A Univ, Coll Med, Dept Internal Med, Busan 49201, South Korea.
   [Rha, Seo Hee] Dong A Univ, Coll Med, Dept Pathol, Busan 49201, South Korea.
   [Park, Kwon Jae; Woo, Jong Soo] Dong A Univ, Coll Med, Dept Cardiovasc Surg, Busan 49201, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, 26 Daesingongwon Ro, Busan 49201, South Korea.
EM thpark65@dau.ac.kr
CR CONN JW, 1972, ARCH INTERN MED, V130, P682, DOI 10.1001/archinte.130.5.682
   Dong DX, 2010, UROL ONCOL-SEMIN ORI, V28, P34, DOI 10.1016/j.urolonc.2009.08.003
   Dong DX, 2010, J HYPERTENS, V28, P628, DOI 10.1097/HJH.0b013e328333b056
   EDDY RL, 1971, ANN INTERN MED, V75, P725, DOI 10.7326/0003-4819-75-5-725
   HAAB F, 1995, J UROLOGY, V153, P1781, DOI 10.1016/S0022-5347(01)67304-X
   Kim HJ, 2006, ARCH PATHOL LAB MED, V130, P707
   Lin SY, 2010, J FORMOS MED ASSOC, V109, P237, DOI 10.1016/S0929-6646(10)60047-2
   LINDOP GBM, 1983, HISTOPATHOLOGY, V7, P421, DOI 10.1111/j.1365-2559.1983.tb02255.x
   Mete UK, 2003, UROLOGY, V61, DOI 10.1016/S0090-4295(03)00104-3
   ROBERTSON PW, 1967, AM J MED, V43, P963, DOI 10.1016/0002-9343(67)90256-2
   Wonga L, 2008, J HYPERTENS, V26, P368, DOI 10.1097/HJH.0b013e3282f283f3
NR 11
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 531
EP 534
DI 10.4070/kcj.2015.45.6.531
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800015
PM 26617658
OA Green Published
DA 2021-04-22
ER

PT J
AU Champion, S
AF Champion, Sebastien
TI Takotsubo Cardiomyopathy related to Pheochromocytoma or Other Etiology
   Should Be Considered as Similar
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Champion, Sebastien] Ctr Hosp Univ Reunion, F-78000 Versailles, France.
RP Champion, S (corresponding author), Ctr Hosp Univ Reunion, 27 Rue Lafayette, F-78000 Versailles, France.
EM champion.seb@wanadoo.fr
CR Kohan AA, 2014, CARDIOVASC DIAGN THE, V4, P138, DOI 10.3978/j.issn.2223-3652.2013.10.03
   Champion S, 2015, EUR HEART J-ACUTE CA, V4, P189, DOI 10.1177/2048872614547686
   Choi SY, 2014, KOREAN CIRC J, V44, P89, DOI 10.4070/kcj.2014.44.2.89
NR 3
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 535
EP 535
DI 10.4070/kcj.2015.45.6.535
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800016
PM 26617659
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, HS
   Hong, SJ
AF Jeong, Han Saem
   Hong, Soon Jun
TI Current Practices in Korea: Coronary Angiography and Intervention Using
   Radial Access
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FEMORAL ACCESS; METAANALYSIS; SITE
C1 [Jeong, Han Saem; Hong, Soon Jun] Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul 02841, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, 73 Inchon Ro, Seoul 02841, South Korea.
EM psyche94@gmail.com
OI Jeong, Han Saem/0000-0002-6035-4332
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015
   Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016
   Burzotta F, 2012, AM HEART J, V163, P230, DOI 10.1016/j.ahj.2011.10.019
   Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390
   Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220
   RADNER S, 1948, ACTA RADIOL, V29, P178, DOI 10.3109/00016924809132437
   Rao SV, 2012, EUR HEART J, V33, P2521, DOI 10.1093/eurheartj/ehs169
   Sciahbasi A, 2009, AM J CARDIOL, V103, P796, DOI 10.1016/j.amjcard.2008.11.049
   Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6
   Youn YJ, 2015, KOREAN CIRC J, V45, P457, DOI [10.4070/kcj.2015.45.6.457, 10.4070/kcj.2015.45.6.449]
NR 14
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 449
EP 450
DI 10.4070/kcj.2015.45.6.449
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800002
PM 26617645
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Lee, JW
   Ahn, SG
   Lee, SH
   Yoon, J
   Cho, BR
   Cheong, SS
   Kim, HY
   Lee, JH
   Bae, JH
   Lee, JB
   Suh, J
   Park, KS
   Han, KR
   Jeong, MH
   Rha, SW
   Her, SH
   Cho, YH
   Kim, SW
AF Youn, Young Jin
   Lee, Jun-Won
   Ahn, Sung-Gyun
   Lee, Seung-Hwan
   Yoon, Junghan
   Cho, Byung-Ryul
   Cheong, Sang Sig
   Kim, Hee-Yeol
   Lee, Jae-Hwan
   Bae, Jang-Ho
   Lee, Jin-Bae
   Suh, Jon
   Park, Keum-Soo
   Han, Kyoo-Rok
   Jeong, Myung Ho
   Rha, Seung-Woon
   Her, Sung-Ho
   Cho, Yun-Hyeong
   Kim, Sang Wook
TI Current Practice of Transradial Coronary Angiography and Intervention:
   Results from the Korean Transradial Intervention Prospective Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary angiography; Percutaneous coronary intervention; Radial artery;
   Registries
ID RADIAL ARTERY-OCCLUSION; FEMORAL ACCESS; METAANALYSIS; CATHETERIZATION;
   ASSOCIATION; OUTCOMES; SITE; COMPLICATIONS; ANGIOPLASTY; PREVALENCE
AB Background and Objectives: Although increasing evidence has indicated that radial access is a beneficial technique, few studies have focused on Korean
   subjects. The aim of this study was to evaluate current practice of coronary angiography (CAG) and percutaneous coronary intervention (PCI) using radial access in South Korea. Subjects and Methods: A total of 6338 subjects were analyzed from Korean Transradial Intervention prospective registry that was conducted at 20 centers in Korea. After evaluating the initial access, subjects intended for radial access were assessed for their baseline, procedure-related, and complication data. Subjects were categorized into three groups: group of overall subjects (n=5554); group of subjects who underwent PCI (n=1780); and group of subjects who underwent primary percutaneous coronary intervention (PPCI) (n=167).
   Results: The rate of radial artery as an initial access and the rate of access site crossover was 87.6% and 4.40%, respectively, in overall subjects. Those rates were 82.4% and 8.1%, respectively, in subjects who underwent PCI, and 60.1% and 4.8%, respectively, in subjects who underwent PPCI. For subjects who underwent CAG, a 6-F introducer sheath and a 5-F angiographic catheter was the most commonly used. During PCI, a 6-F introducer sheath (90.6%) and a 6-F guiding catheter were standardly used.
   Conclusion: The large prospective registry allowed us to present the current practice of CAG and PCI using radial access. These data provides evidence to achieve consensus on radial access in CAG and PCI in the Korean population.
C1 [Youn, Young Jin; Lee, Jun-Won; Ahn, Sung-Gyun; Lee, Seung-Hwan; Yoon, Junghan] Wonju Severance Christian Hosp, Wonju, South Korea.
   [Cho, Byung-Ryul] Kangwon Natl Univ Hosp, Chunchon, South Korea.
   [Cheong, Sang Sig] Univ Ulsan, Gangneung Asan Hosp, Kangnung, South Korea.
   [Kim, Hee-Yeol] Catholic Univ, St Marys Hosp, Bucheon, South Korea.
   [Lee, Jae-Hwan] Chungnam Natl Univ Hosp, Taejon, South Korea.
   [Bae, Jang-Ho] Konyang Univ Hosp, Taejon, South Korea.
   [Lee, Jin-Bae] Daegu Catholic Univ, Med Ctr, Taegu, South Korea.
   [Suh, Jon] Soonchunhyang Univ Bucheon Hosp, Bucheon, South Korea.
   [Park, Keum-Soo] Inha Univ Hosp, Inchon, South Korea.
   [Han, Kyoo-Rok] Hallym Univ, Kandgong Sacred Heart Hosp, Seoul, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea.
   [Rha, Seung-Woon] Korea Univ, Guro Hosp, Seoul, South Korea.
   [Her, Sung-Ho] Catholic Univ, St Marys Hosp, Taejon, South Korea.
   [Cho, Yun-Hyeong] Kwandong Univ, Myongi Hosp, Goyang, South Korea.
   [Kim, Sang Wook] Chung Ang Univ Hosp, Seoul, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, 162 Ilsan, Wonju 26426, South Korea.
EM jyoon@yonsei.ac.kr
OI Lee, Jun-Won/0000-0001-6206-1704; Lee, Jae-Hwan/0000-0002-6561-7760;
   Ahn, Sung Gyun/0000-0002-1528-2739
FU Korean Society of Interventional Cardiology [2012-1]
FX The KOTRI prospective registry was supported by a grant (2012-1) from
   the Korean Society of Interventional Cardiology. The Korean Society of
   Interventional Cardiology was not involved in the study design, data
   collection, data analysis, or writing of this report. The authors of
   this manuscript and the steering committee are solely responsible for
   the design and conduct of this study, all study analyses, the drafting
   and editing of the manuscript, and its final contents.
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Baklanov DV, 2013, J AM COLL CARDIOL, V61, P420, DOI 10.1016/j.jacc.2012.10.032
   Ball WT, 2011, CIRC-CARDIOVASC INTE, V4, P336, DOI 10.1161/CIRCINTERVENTIONS.110.960864
   Burzotta F, 2012, AM HEART J, V163, P230, DOI 10.1016/j.ahj.2011.10.019
   Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390
   Dahm JB, 2002, CATHETER CARDIO INTE, V57, P172, DOI 10.1002/ccd.10321
   Dehghani P, 2009, JACC-CARDIOVASC INTE, V2, P1057, DOI 10.1016/j.jcin.2009.07.014
   Hamon M, 2013, EUROINTERVENTION, V8, P1242, DOI 10.4244/EIJV8I11A192
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Karrowni W, 2013, JACC-CARDIOVASC INTE, V6, P814, DOI 10.1016/j.jcin.2013.04.010
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Mamas MA, 2012, HEART, V98, P303, DOI 10.1136/heartjnl-2011-300558
   Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
   Mercuri M, 2011, JACC-CARDIOVASC INTE, V4, P347, DOI 10.1016/j.jcin.2010.11.011
   Montalescot G, 2008, INT J CARDIOL, V129, P379, DOI 10.1016/j.ijcard.2007.07.127
   Pristipino C, 2007, AM J CARDIOL, V99, P1216, DOI 10.1016/j.amjcard.2006.12.038
   Pristipino C, 2010, EUROINTERVENTION, V6, P240, DOI 10.4244/
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4
   Sanmartin M, 2007, CATHETER CARDIO INTE, V70, P185, DOI 10.1002/ccd.21058
   Spaulding C, 1996, CATHETER CARDIO DIAG, V39, P365, DOI 10.1002/(SICI)1097-0304(199612)39:4<365::AID-CCD8>3.0.CO;2-B
   Steffenino G, 2011, J CARDIOVASC MED, V12, P116, DOI 10.2459/JCM.0b013e328340392c
   Stella PR, 1997, CATHETER CARDIO DIAG, V40, P156, DOI 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.3.CO;2-E
   Takeshita S, 2014, AM J CARDIOL, V113, P1986, DOI 10.1016/j.amjcard.2014.03.040
   Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011
   Vink MA, 2011, HEART, V97, P1938, DOI 10.1136/heartjnl-2011-300524
NR 28
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 457
EP 468
DI 10.4070/kcj.2015.45.6.457
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800004
PM 26617647
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, SH
   Choi, JY
   Park, EJ
   Lee, JJ
   Lee, S
   Na, JO
   Choi, CU
   Lim, HE
   Kim, JW
   Kim, EJ
   Rha, SW
   Seo, HS
   Oh, DJ
   Park, CG
AF Park, Sung-Hun
   Choi, Ja Yeon
   Park, Eun Jin
   Lee, Jae Joong
   Lee, Sunki
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Kim, Jin Won
   Kim, Eung Ju
   Rha, Seung-Woon
   Seo, Hong Seog
   Oh, Dong Joo
   Park, Chang Gyu
TI Prevalence of Gastrointestinal Diseases and Treatment Status in
   Noncardiac Chest Pain Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Chest pain; Gastroesophageal reflux
ID GASTROESOPHAGEAL-REFLUX DISEASE; RISK-FACTORS; NCCP
AB Background and Objectives: We evaluated the prevalence of gastroesophageal reflux diseases (GERD) in noncardiac chest pain (NCCP) patients, risk factors for GERD, and status of prescriptions for GERD in Korean population.
   Subjects and Methods: This was a retrospective non-interventional observational nation-wide 45-center study. Patients with a normal coronary angiogram (CAG) and upper gastroendoscopy within 2 years after CAG were enrolled. The prevalence of GERD was examined. Other gastrointestinal diseases including peptic ulcer diseases or gastritis were also examined. Risk factors for GERD were compared between the GERD group and non-GERD group. The ratio of patients medicated for gastrointestinal diseases (antacids or proton-pump inhibitor) was also examined.
   Results: Nine hundred four patients were enrolled. Among the NCCP patients, GERD was present in 436 (48.2%), peptic ulcer disease in 154 patients (17.0%), and gastritis in 659 (72.9%). There was no difference in risk factors for GERD between the GERD and non-GERD patients. Medications for GERD and other gastrointestinal diseases were prescribed in 742 (82.1%) patients.
   Conclusion: GERD was common (42.8%) in Korean NCCP patients and most (82.1%) received the prescription of gastrointestinal medications. No differences were evident in risk factors between GERD and non-GERD patients.
C1 [Park, Sung-Hun; Choi, Ja Yeon; Park, Eun Jin; Lee, Jae Joong; Lee, Sunki; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Rha, Seung-Woon; Seo, Hong Seog; Oh, Dong Joo; Park, Chang Gyu] Korea Univ, Guro Hosp, Cardiovasc Ctr, Seoul 08308, South Korea.
RP Park, CG (corresponding author), Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
EM parkcg@kumc.or.kr
FU Chosun University Hospital; Yeungnam University Medical Center; Hallym
   University Medical Center Kangnam Hospital; Korea University Medical
   Center Ansan Hospital; Hallym University Medical Center Hangang
   Hospital; Maryknoll Medical Center; Ulsan University Hospital; Yonsei
   University Severance Hospital; Chungnam National University Hospital;
   Pusan National University Yangsan HospitalPusan National University;
   Wonkwang University Hospital; Changwon Fatima Hospital; Seoul Medical
   Center; Bundang Cha Medical Center; Chonnam National University
   Hospital; Bong Seng Memorial Hospital; Daegu Catholic University Medical
   Center; Soonchunhyang University Cheonan Hospital; Korea University
   Medical Center Kuro Hospital; lnje University Haeundae Paik Hospital;
   Dongguk University Gyeongju Hospital
FX Authors acknowledge following hospitals for supporting this study:
   Chosun University Hospital, Yeungnam University Medical Center, Hallym
   University Medical Center Kangnam Hospital, Korea University Medical
   Center Ansan Hospital, Hallym University Medical Center Hangang
   Hospital, Maryknoll Medical Center, Ulsan University Hospital, Yonsei
   University Severance Hospital, Chungnam National University Hospital,
   Pusan National University Yangsan Hospital, Wonkwang University
   Hospital, Changwon Fatima Hospital, Seoul Medical Center, Bundang Cha
   Medical Center, Chonnam National University Hospital, Bong Seng Memorial
   Hospital, Daegu Catholic University Medical Center, Soonchunhyang
   University Cheonan Hospital, Korea University Medical Center Kuro
   Hospital, lnje University Haeundae Paik Hospital, Dongguk University
   Gyeongju Hospital.
CR Carmin CN, 2008, ARCH WOMEN MENT HLTH, V11, P287, DOI 10.1007/s00737-008-0021-x
   Choi TH, 2010, KOREAN J MED, V79, P16
   Cremonini F, 2005, AM J GASTROENTEROL, V100, P1226, DOI 10.1111/j.1572-0241.2005.41657.x
   Eslick GD, 2003, ALIMENT PHARM THER, V17, P1115, DOI 10.1046/j.1365-2036.2003.01557.x
   Fass R, 2011, J NEUROGASTROENTEROL, V17, P110, DOI 10.5056/jnm.2011.17.2.110
   Faybush EM, 2004, GASTROENTEROL CLIN N, V33, P41, DOI 10.1016/S0889-8553(03)00131-6
   Gill RS, 2012, WOMENS HEALTH, V8, P131, DOI [10.2217/WHE.12.3, 10.2217/whe.12.3]
   Gill RS, 2012, WOMENS HLTH LOND ENG, V8, P144
   Hollerbach S, 2000, NEUROGASTROENT MOTIL, V12, P555, DOI 10.1046/j.1365-2982.2000.00230.x
   Kim N, 2008, ALIMENT PHARM THER, V27, P173, DOI 10.1111/j.1365-2036.2007.03561.x
   Lampe FC, 1998, EUR HEART J, V19, P63, DOI 10.1053/euhj.1997.0729
   Lee SH, 2000, KOREAN J GASTROINTES, V6, P1
   Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x
   Wong WM, 2004, WORLD J GASTROENTERO, V10, P707, DOI 10.3748/wjg.v10.i5.707
   Wong WM, 2005, J GASTROEN HEPATOL, V20, pS14, DOI 10.1111/j.1440-1746.2005.04166.x
   Wong WM, 2002, ALIMENT PHARM THERAP, V16, P465, DOI 10.1046/j.1365-2036.2002.01217.x
NR 16
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 469
EP 472
DI 10.4070/kcj.2015.45.6.469
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800005
PM 26617648
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YJ
   Shin, DH
   Kim, JS
   Kim, BK
   Ko, YG
   Hong, MK
   Jang, Y
   Choi, D
AF Lee, Yong-Joon
   Shin, Dong-Ho
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Ko, Young-Guk
   Hong, Myeong-Ki
   Jang, Yangsoo
   Choi, Donghoon
TI Femoropopliteal Artery Stent Fracture with Recurrent In-Stent
   Reocclusion and Aneurysm Formation: Successful Treatment with
   Self-Expandable Viabahn Endoprosthesis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood vessel prosthesis; Graft occlusion, vascular; Aneurysm, false
ID SUPERFICIAL FEMORAL-ARTERY; EXPANDING NITINOL STENTS; BALLOON
   ANGIOPLASTY; IMPLANTATION; CORONARY; PATENCY; LESIONS
AB Primary stenting in femoropopliteal lesions of intermediate length has recently shown favorable outcomes. However, s'tent fractures are a concern after bare metal stent implantation. The incidence of stent fracture varies widely (ranging from 20% to 65%) depending on factors such as the treated lesions or stent type and may potentially lead to various complications. We reported a case of stent fracture with complete dislocation combined with recurrent in-stent reocclusion and aneurysm formation in a patient with occlusive disease of the femoropopliteal artery, which was successfully treated with self-expandable endovascular stent graft.
C1 [Lee, Yong-Joon; Shin, Dong-Ho; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Hong, Myeong-Ki; Jang, Yangsoo; Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Seoul 03722, South Korea.
RP Choi, D (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cdhlyj@yuhs.ac
CR Babalik E, 2003, CIRC J, V67, P643, DOI 10.1253/circj.67.643
   Iida O, 2009, JACC-CARDIOVASC INTE, V2, P665, DOI 10.1016/j.jcin.2009.04.014
   Krankenberg H, 2007, CIRCULATION, V116, P285, DOI 10.1161/CIRCULATIONAHA.107.689141
   Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468
   Nikanorov A, 2008, J VASC SURG, V48, P435, DOI 10.1016/j.jvs.2008.02.029
   Okamura T, 2008, J CARDIOL, V51, P74, DOI 10.1016/j.jjcc.2007.11.002
   Rits J, 2008, EUR J VASC ENDOVASC, V36, P339, DOI 10.1016/j.ejvs.2008.05.005
   Rivolta N, 2010, CARDIOVASC INTER RAD, V33, P1036, DOI 10.1007/s00270-009-9677-5
   Sabeti S, 2005, J ENDOVASC THER, V12, P6, DOI 10.1583/04-1359.1
   Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026
   Schillinger M, 2007, CIRCULATION, V115, P2745, DOI 10.1161/CIRCULATIONAHA.107.688341
   Solis J, 2006, CATHETER CARDIO INTE, V67, P319, DOI 10.1002/ccd.20600
   Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211
   Tsuji Y, 2011, ANN VASC SURG, V25, DOI 10.1016/j.avsg.2010.12.039
NR 14
TC 3
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2015
VL 45
IS 6
BP 522
EP 525
DI 10.4070/kcj.2015.45.6.522
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CX1OP
UT WOS:000365465800013
PM 26617656
OA Green Published
DA 2021-04-22
ER

PT J
AU Kaul, S
AF Kaul, Sanjiv
TI Assessment of Myocardial Collateral Blood Flow with Contrast
   Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Collateral blood circulation; Contrast echocardiography; Myocardial
   ischemia
ID TWO-DIMENSIONAL ECHOCARDIOGRAPHY; INFARCT SIZE; CORONARY-ARTERY;
   MICROBUBBLES; PERFUSION; ISCHEMIA; EXTENT; ULTRASOUND; DOG
AB Humans have pre-formed collateral vessels that enlarge with ischemia. In addition, new vessels can be formed within ischemic zones from pre-formed endocardial arcades of vessels providing rich collateral flow. Collateral flow under resting conditions (if > 25% of normal) is enough to maintain myocardial viability, but may be insufficient to prevent myocardial ischemia under stress. Coronary angiography is a poor tool for collateral flow assessment. Myocardial contrast echocardiography is arguably the gold standard for experimental and clinical measurement of collateral flow. This review describes several experimental and clinical studies that highlight the importance of the collateral circulation in coronary artery disease.
C1 [Kaul, Sanjiv] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA.
RP Kaul, S (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Cardiovasc Div UHN 62, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM kauls@ohsu.edu
CR Baroldi G., 1967, CORONARY CIRCULATION
   Coggins MP, 2001, CIRCULATION, V104, P2471, DOI 10.1161/hc4501.098954
   Cohen MV, 1985, CORONARY COLLATERALS
   FORCE T, 1986, CIRCULATION, V73, P1360, DOI 10.1161/01.CIR.73.6.1360
   FULTON WFM, 1964, BRIT HEART J, V26, P1
   Gross L, 1933, AM HEART J, V9, P165, DOI 10.1016/S0002-8703(33)90712-7
   JAYAWEERA AR, 1994, CIRC RES, V74, P1157, DOI 10.1161/01.RES.74.6.1157
   Kaul S, 1997, CIRCULATION, V96, P3745
   KAUL S, 1991, J AM COLL CARDIOL, V17, P1403, DOI 10.1016/S0735-1097(10)80154-8
   Kaul S, 1985, J AM COLL CARDIOL, V6, P82530
   Kaul S, 1987, CIRC RES, V61, P7785
   Kaul S, 2008, CIRCULATION, V118, P291, DOI 10.1161/CIRCULATIONAHA.107.747303
   Keller MW, 1989, CIRC RES, V65, P45867
   KERBER RE, 1975, CIRCULATION, V52, P1097, DOI 10.1161/01.CIR.52.6.1097
   Le DE, 2004, HEART, V90, P1199, DOI 10.1136/hrt.2003.020875
   Leong-Poi H, 2005, J AM COLL CARDIOL, V45, P565, DOI 10.1016/j.jacc.2004.11.032
   LIEBERMAN AN, 1981, CIRCULATION, V63, P739, DOI 10.1161/01.CIR.63.4.739
   LIMA JAC, 1985, CIRCULATION, V71, P1048, DOI 10.1161/01.CIR.71.5.1048
   Lindner JR, 2002, J AM SOC ECHOCARDIOG, V15, P396, DOI 10.1067/mje.2002.117290
   Lower R., 1932, EARLY SCI OXFORD, V9, P13
   SABIA PJ, 1992, CIRCULATION, V85, P2080, DOI 10.1161/01.CIR.85.6.2080
   SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601
   Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x
   Vernon SM, 1996, AM J CARDIOL, V78, P958, DOI 10.1016/S0002-9149(96)00478-X
   Wei K, 1998, CIRCULATION, V97, P473
   Wei K, 1997, J AM COLL CARDIOL, V29, P1081, DOI 10.1016/S0735-1097(97)00029-6
   WEYMAN AE, 1984, CIRCULATION, V70, P102, DOI 10.1161/01.CIR.70.1.102
NR 27
TC 1
Z9 2
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 351
EP 356
DI 10.4070/kcj.2015.45.5.351
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400001
PM 26413100
OA Green Published
DA 2021-04-22
ER

PT J
AU Gurel, OM
   Demircelik, MB
   Bilgic, MA
   Yilmaz, H
   Yilmaz, OC
   Cakmak, M
   Eryonucu, B
AF Gurel, Ozgul Malcok
   Demircelik, Muhammed Bora
   Bilgic, Mukadder Ayse
   Yilmaz, Hakki
   Yilmaz, Omer Caglar
   Cakmak, Muzaffer
   Eryonucu, Beyhan
TI Association between Red Blood Cell Distribution Width and Coronary
   Artery Calcification in Patients Undergoing 64-Multidetector Computed
   Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery calcification score; Coronary computerized tomography
   angiography; Red blood cell distribution width
ID C-REACTIVE PROTEIN; DISEASE; CALCIUM; POPULATION; EVENTS; ADULTS; RISK;
   BIOMARKERS; ANEMIA; COUNT
AB Background and Objectives: The red blood cell distribution width (RDW) has been found to be associated with cardiovascular morbidity and mortality. The objective of this study was to determine whether the RDW measures are associated with the coronary artery calcification score (CACS) in patients who did not present with obvious coronary heart disease (CHD).
   Subjects and Methods: A total of 527 consecutive patients with a low to intermediate risk for CHD but without obvious disease were enrolled in this study. The study subjects underwent coronary computerized tomography angiography and CACS was calculated. The patients were divided into two groups based on CACS: Group I (CACS <= 100) and Group II (CACS>100). The two groups were compared in terms of classic CHD risk factors and haematological parameters, particularly the RDW.
   Results: Group I patients were younger than Group II patients. The Framingham risk score (FRS) in patients of Group II was significantly higher than that in patients of Group I. Group II patients had significantly elevated levels of haemoglobin, RDW, neutrophil count, and neutrophil/lymphocyte ratio compared with Group I patients. CACS was correlated with age, RDW, and ejection fraction. In the multivariate analysis, age, RDW, and FRS were independent predictors of CACS. Using the receiver-operating characteristic curve analysis, a RDW value of 13.05% was identified as the best cut-off for predicting the severity of CACS (>100) (area under the curve=0.706).
   Conclusion: We found that the RDW is an independent predictor of the CACS, suggesting that it might be a useful marker for predicting CAD.
C1 [Gurel, Ozgul Malcok; Demircelik, Muhammed Bora; Eryonucu, Beyhan] Turgut Ozal Univ, Sch Med, Dept Cardiol, TR-5706510 Ankara, Turkey.
   [Bilgic, Mukadder Ayse; Yilmaz, Hakki] Turgut Ozal Univ, Sch Med, Dept Internal Med, Nephrol Sect, TR-5706510 Ankara, Turkey.
   [Yilmaz, Omer Caglar] Ankara Occupat Dis Hosp, Dept Cardiol, Ankara, Turkey.
   [Cakmak, Muzaffer] Turgut Ozal Univ, Sch Med, Dept Internal Med, TR-5706510 Ankara, Turkey.
RP Demircelik, MB (corresponding author), Turgut Ozal Univ, Sch Med, Dept Cardiol, TR-5706510 Ankara, Turkey.
EM drdemircelik@yahoo.com
RI Yilmaz, Omer Caglar/ABB-6582-2020
OI Yilmaz, Omer Caglar/0000-0001-5245-5216
CR Afonso L, 2011, NEPHRON CLIN PRACT, V119, pC277, DOI 10.1159/000328918
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024
   Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088
   Aung N, 2013, HEART, V99, P1261, DOI 10.1136/heartjnl-2013-303910
   Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]
   Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079
   Chaikriangkrai K, 2014, N AM J MED SCI, V6, P433, DOI 10.4103/1947-2714.141625
   Chistiakov DA, 2015, ACTA PHYSIOL, V213, P539, DOI 10.1111/apha.12438
   de Gonzalo-Calvo D, 2012, CYTOKINE, V58, P193, DOI 10.1016/j.cyto.2012.01.005
   Demir A, 2002, PEDIATR INT, V44, P612, DOI 10.1046/j.1442-200X.2002.01636.x
   Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
   Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067
   Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010
   Karabulut A, 2012, CORONARY ARTERY DIS, V23, P68, DOI 10.1097/MCA.0b013e32834f1188
   Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55
   Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018
   Lippi G, 2013, EUR J INTERN MED, V24, pE15, DOI 10.1016/j.ejim.2012.09.005
   Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628
   MARGOLIS JR, 1980, RADIOLOGY, V137, P609, DOI 10.1148/radiology.137.3.7444045
   Nunez J, 2011, CURR MED CHEM, V18, P3226, DOI 10.2174/092986711796391633
   Olson JC, 2000, DIABETES, V49, P1571, DOI 10.2337/diabetes.49.9.1571
   Park BJ, 2011, CLIN CHIM ACTA, V412, P925, DOI 10.1016/j.cca.2011.01.021
   Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003
   Sunkara N, 2014, EXPERT REV CARDIOVAS, V12, P87, DOI 10.1586/14779072.2014.868305
   Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9
   Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809
   Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023
NR 30
TC 8
Z9 8
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 372
EP 377
DI 10.4070/kcj.2015.45.5.372
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400005
PM 26413104
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, SJ
   Choi, JH
   Kim, SY
   Kim, KS
   Kim, YR
   Kang, SH
AF Joo, Seung-Jae
   Choi, Joon-Hyouk
   Kim, Song-Yi
   Kim, Ki-Seok
   Kim, Young Ree
   Kang, Sung Ha
TI An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody
   against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking
   Clopidogrel
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood platelets; Glycoprotein IIb/IIIa; Platelet function test; Flow
   cytometry; Clopidogrel
ID PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE; PRACTICE
   GUIDELINES; AMERICAN-COLLEGE; FUNCTION TESTS; MANAGEMENT; THROMBOSIS;
   CARDIOLOGY
AB Background and Objectives: Residual platelet reactivity in patients who are taking clopidogrel is commonly measured with VerifyNow assay, which is based on the principle of light transmission aggregometry. However, to evaluate the residual platelet reactivity, it would be more accurate if the reactivity of platelet glycoprotein (GP) IIb/IIIa is directly monitored. In this study, PAC1, a monoclonal antibody against activated platelet GP IIb/IIIa, was used to measure the residual platelet reactivity.
   Subjects and Methods: Twenty seven patients with coronary artery disease taking clopidogrel were enrolled. Platelets in whole blood were stained with fluorescein isothiocyanate (FITC)-conjugated PAC1. Mean fluorescence intensity (MFI) and % positive platelets (PP) were measured with flow cytometry, and the binding index (BI; MFI x %PP/100) was calculated. P2Y12 reaction unit (PRU) and % inhibition of VerifyNow assay were also measured in the usual manner.
   Results: PRU of VerifyNow assay correlated significantly with MFI, % PP, and BI at 10 mu M (r=0.59, 0.73, and 0.60, respectively, all p<0.005) and 20 mu M of adenosine diphosphate (ADP; r=0.61, 0.75, and 0.63, respectively, all p<0.005). The % inhibition also correlated significantly with MFI, % PP, and BI at 10 mu M (r=-0.60, -0.69, and -0.59, respectively, all p<0.005) and 20 mu M of ADP (r=-0.63, -0.71, and -0.62, respectively, all p<0.005).
   Conclusion: Direct measurements of the reactivity of platelet GP IIb/IIIa were feasible using PAC1 and flow cytometry in patients taking clopidogrel. Further clinical studies are required to determine the cut-off values which would define high residual platelet reactivity in patients on this treatment protocol.
C1 [Joo, Seung-Jae; Choi, Joon-Hyouk; Kim, Song-Yi; Kim, Ki-Seok] Jeju Natl Univ Hosp, Dept Cardiol, Jeju 63241, South Korea.
   [Kim, Young Ree; Kang, Sung Ha] Jeju Natl Univ Hosp, Lab Med, Jeju 63241, South Korea.
RP Joo, SJ (corresponding author), Jeju Natl Univ Hosp, Dept Cardiol, 15 Aran 13 Gil, Jeju 63241, South Korea.
EM sejjoo@jejunu.ac.kr
FU Korean Society of Cardiology
FX This study was supported by a research grant from The Korean Society of
   Cardiology in 2011.
CR ABRAMS CS, 1990, BLOOD, V75, P128
   Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133
   Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059
   Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181
   Cayla G, 2008, ARCH CARDIOVASC DIS, V101, P743, DOI 10.1016/j.acvd.2008.10.004
   Furman Mark I, 2003, Am Heart J, V145, pe6, DOI 10.1067/mhj.2003.116
   Furman MI, 2004, J AM COLL CARDIOL, V43, P2319, DOI 10.1016/j.jacc.2003.12.055
   Geiger J, 2005, CLIN CHEM, V51, P957, DOI 10.1373/clinchem.2004.047050
   Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051
   Harder S, 2001, THROMB RES, V102, P39, DOI 10.1016/S0049-3848(01)00223-7
   Joo SJ, 2012, KOREAN CIRC J, V42, P295, DOI 10.4070/kcj.2012.42.5.295
   Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562
   Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596
   Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732
   Quinn MJ, 2003, ARTERIOSCL THROM VAS, V23, P945, DOI 10.1161/01.ATV.0000066686.46338.F1
   SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107
   SHATTIL SJ, 1987, BLOOD, V70, P307
   Sibbing D, 2011, THROMB HAEMOSTASIS, V106, P191, DOI 10.1160/TH11-01-0040
   Siller-Matula JM, 2010, J THROMB HAEMOST, V8, P351, DOI 10.1111/j.1538-7836.2009.03699.x
   Xiao ZH, 2004, J AM COLL CARDIOL, V43, P1982, DOI 10.1016/j.jacc.2003.10.071
NR 23
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 378
EP 385
DI 10.4070/kcj.2015.45.5.378
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400006
PM 26413105
OA Green Published
DA 2021-04-22
ER

PT J
AU Bilik, MZ
   Kaplan, I
   Yildiz, A
   Akil, MA
   Acet, H
   Yuksel, M
   Polat, N
   Aydin, M
   Oylumlu, M
   Ertas, F
   Kaya, H
   Alan, S
AF Bilik, Mehmet Zihni
   Kaplan, Ibrahim
   Yildiz, Abdulkadir
   Akil, Mehmet Ata
   Acet, Halit
   Yuksel, Murat
   Polat, Nihat
   Aydin, Mesut
   Oylumlu, Mustafa
   Ertas, Faruk
   Kaya, Hasan
   Alan, Sait
TI Apelin Levels In Isolated Coronary Artery Ectasia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Apelin protein; human; Coronary artery disease; Dilatation; pathologic;
   Inflammation
ID SMOOTH-MUSCLE-CELLS; IN-VIVO; DISEASE; INFLAMMATION; EXPRESSION;
   CONTRACTILITY
AB Background and Objectives: The etiopathogenesis of coronary artery ectasia (CAE) is not known completely. In most of the cases, CAE is associated with atherosclerosis; however, isolated CAE has a nonatherosclerotic mechanism. The association between atherosclerotic coronary artery disease and apelin has been examined in previous studies. However, the role of plasma apelin in isolated coronary artery ectasia has not been studied. In this study, we investigated the relationship between plasma apelin levels and isolated coronary artery ectasia.
   Subjects and Methods: The study population included a total of 54 patients. Twenty-six patients had isolated CAE (53.6 +/- 8.1 years); 28 patients with normal coronary arteries (51.6 +/- 8.8 years) and with similar risk factors and demographic characteristics served as the control group. Apelin levels were measured using an enzyme-linked immunoassay kit.
   Results: Apelin level in the CAE group was significantly lower (apelin=0.181 +/- 0.159 ng/mL) than that in the control group (apelin=0.646 +/- 0.578 ng/mL) (p=0.033). Glucose, creatinine, total cholesterol, triglyceride, low density lipoprotein cholesterol, and high density lipoprotein cholesterol levels were not significantly different between the two groups.
   Conclusion: In this study, we showed that patients with isolated CAE have decreased plasma apelin levels compared with the control group. Based on the data, a relationship between plasma apelin and isolated CAE was determined.
C1 [Bilik, Mehmet Zihni; Yildiz, Abdulkadir; Akil, Mehmet Ata; Acet, Halit; Yuksel, Murat; Polat, Nihat; Aydin, Mesut; Oylumlu, Mustafa; Ertas, Faruk; Kaya, Hasan; Alan, Sait] Dicle Univ, Fac Med, Dept Cardiol, TR-21100 Diyarbakir, Turkey.
   [Kaplan, Ibrahim] Dicle Univ, Fac Med, Dept Biochem, TR-21100 Diyarbakir, Turkey.
RP Bilik, MZ (corresponding author), Dicle Univ, Fac Med, Dept Cardiol, TR-21100 Diyarbakir, Turkey.
EM mzbilik@mynet.com
RI Yuksel, Murat/B-7287-2013; Kaya, Hasan/F-8496-2013; YILDIZ,
   Abdulkadir/A-2857-2015
OI Yuksel, Murat/0000-0003-2636-5211; Kaya, Hasan/0000-0003-3923-4026;
   YILDIZ, Abdulkadir/0000-0002-2291-5071
FU Dicle University DUBAPDicle University
FX We are grateful to Dicle University DUBAP for their sponsorship about
   English editing of this manuscript.
CR Arroyo-Espliguero R, 2004, EUR HEART J, V25, P401, DOI 10.1016/j.ehj.2003.12.017
   Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018
   Ayhan S, 2013, TURK KARDIYOL DERN A, V41, P185, DOI 10.5543/tkda.2013.83030
   Chandrasekaran B, 2008, EUR J HEART FAIL, V10, P725, DOI 10.1016/j.ejheart.2008.06.002
   Dagli N, 2009, HEART VESSELS, V24, P84, DOI 10.1007/s00380-008-1087-0
   Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje
   El-Shehaby AM, 2010, SCAND J CLIN LAB INV, V70, P421, DOI 10.3109/00365513.2010.504281
   Ellinor PT, 2006, EUR HEART J, V27, P222, DOI 10.1093/eurheartj/ehi648
   Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017
   Finkelstein A, 2005, ATHEROSCLEROSIS, V179, P353, DOI 10.1016/j.atherosclerosis.2004.10.020
   HARTNELL GG, 1985, BRIT HEART J, V54, P392
   Hashimoto T, 2006, ARTERIOSCL THROM VAS, V26, P1267, DOI 10.1161/01.ATV.0000218841.39828.91
   Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013
   Kadoglou NPE, 2010, TRANSL RES, V155, P238, DOI 10.1016/j.trsl.2010.01.004
   Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001
   Lamblin N, 2002, J AM COLL CARDIOL, V40, P43, DOI 10.1016/S0735-1097(02)01909-5
   Leeper NJ, 2009, AM J PHYSIOL-HEART C, V296, pH1329, DOI 10.1152/ajpheart.01341.2008
   Li LF, 2013, ACTA BIOCH BIOPH SIN, V45, P875, DOI 10.1093/abbs/gmt085
   Li Z, 2008, INTERNAL MED, V47, P1951, DOI 10.2169/internalmedicine.47.1287
   Malyszko J, 2008, TRANSPL P, V40, P3466, DOI 10.1016/j.transproceed.2008.06.059
   RATH S, 1985, AM HEART J, V109, P785, DOI 10.1016/0002-8703(85)90639-8
   Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com
   Simpkin JC, 2007, BASIC RES CARDIOL, V102, P518, DOI 10.1007/s00395-007-0671-2
   Sincer Isa, 2011, Anadolu Kardiyol Derg, V11, P414, DOI 10.5152/akd.2011.108
   Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1
   Tokgozoglu L, 2004, ACTA CARDIOL, V59, P515, DOI 10.2143/AC.59.5.2005226
   Turhan H, 2005, CORONARY ARTERY DIS, V16, P45, DOI 10.1097/00019501-200502000-00009
   Turhan H, 2004, AM J CARDIOL, V94, P1303, DOI 10.1016/j.amjcard.2004.07.120
   Valente S, 2007, J CARDIOVASC MED, V8, P815, DOI 10.2459/JCM.0b013e3280115667
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 30
TC 5
Z9 5
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 386
EP 390
DI 10.4070/kcj.2015.45.5.386
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400007
PM 26413106
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, JK
   Park, SJ
   On, YK
   Kim, JS
   Park, KM
AF Hwang, Jin Kyung
   Park, Seung-Jung
   On, Young Keun
   Kim, June Soo
   Park, Kyoung-Min
TI Clinical Characteristics and Features of Frequent Idiopathic Ventricular
   Premature Complexes in the Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular premature complexes; Cardiomyopathies; Electrocardiography;
   Korean
ID OUTFLOW TRACT TACHYCARDIA; ELECTROCARDIOGRAPHIC PATTERNS;
   ATHEROSCLEROSIS RISK; QRS DURATION; AMERICAN; ECHOCARDIOGRAPHY;
   RECOMMENDATIONS; COMMITTEE; ABLATION; SITE
AB Background and Objectives: Frequent ventricular premature complexes (VPCs) increase the risk of cardiomyopathy (CMP). However, most data regarding VPCs have been obtained from Western population and in-hospital patient-based studies. The objective of this study was to define the clinical characteristics and features of idiopathic VPCs in the Korean population.
   Subjects and Methods: We investigated subjects undergoing transthoracic echocardiography and documented VPC burdens >1% by Holter monitoring in an outpatient clinic at Samsung Medical Center, Korea. We analyzed demographic and clinical features and the nature of the VPCs by electrocardiography (ECG).
   Results: A total of 666 patients were registered. Mean age was 54.7 +/- 16.8 years, and 365 (54.8%) patients were female. Typical VPC-related symptoms, such as palpitation and a dropped beat, were observed in 394 (59.2%) patients. Some patients received beta-blockers (n=95; 14.3%) and anti-arrhythmic agents (n=14; 2.1%). The ECG analysis was performed in 405 patients; 322 (79.5%) exhibited left bundle branch block (LBBB) and 347 (85.8%) exhibited an inferior axis. The precordial R-wave transition was predominantly distributed over V3 in 230 patients (56.6%). Thirty-one patients (4.5%) were diagnosed with VPC-induced CMP.
   Conclusion: The incidence of frequent VPCs was slightly higher in females, and palpitation was the most frequent complaint. The most common ECG features were LBBB, inferior axis, and late precordial R-wave transition.
C1 [Hwang, Jin Kyung; Park, Seung-Jung; On, Young Keun; Kim, June Soo; Park, Kyoung-Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 06351, South Korea.
RP Park, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM kyongmin.park@gmail.com
FU Korean Society of Cardiology
FX This research was supported by a grant from the Korean Society of
   Cardiology (2012).
CR Ataklte F, 2013, AM J CARDIOL, V112, P1263, DOI 10.1016/j.amjcard.2013.05.065
   Baman TS, 2010, HEART RHYTHM, V7, P865, DOI 10.1016/j.hrthm.2010.03.036
   Ban JE, 2013, EUROPACE, V15, P735, DOI 10.1093/europace/eus371
   Betensky BP, 2011, J AM COLL CARDIOL, V57, P2255, DOI 10.1016/j.jacc.2011.01.035
   Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003
   Callans DJ, 1997, J AM COLL CARDIOL, V29, P1023, DOI 10.1016/S0735-1097(97)00004-1
   Cheriyath P, 2011, AM J CARDIOL, V107, P151, DOI 10.1016/j.amjcard.2010.09.002
   Chugh SS, 2000, J CARDIOVASC ELECTR, V11, P328, DOI 10.1111/j.1540-8167.2000.tb01802.x
   Dixit S, 2003, J CARDIOVASC ELECTR, V14, P1, DOI 10.1046/j.1540-8167.2003.02404.x
   Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015
   Kamakura S, 1998, CIRCULATION, V98, P1525, DOI 10.1161/01.CIR.98.15.1525
   Kanagaratnam L, 2001, J AM COLL CARDIOL, V37, P1408, DOI 10.1016/S0735-1097(01)01127-5
   KOSTIS JB, 1987, J AM COLL CARDIOL, V10, P231, DOI 10.1016/S0735-1097(87)80001-3
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lin D, 2008, HEART RHYTHM, V5, P663, DOI 10.1016/j.hrthm.2008.02.009
   Movsowitz C, 1996, AM HEART J, V131, P930, DOI 10.1016/S0002-8703(96)90175-1
   Munoz FD, 2011, J CARDIOVASC ELECTR, V22, P791, DOI 10.1111/j.1540-8167.2011.02021.x
   Ng GA, 2006, HEART, V92, P1707, DOI 10.1136/hrt.2005.067843
   Pol LC, 2014, HEART RHYTHM, V11, P299, DOI 10.1016/j.hrthm.2013.10.055
   Simpson RJ, 2002, AM HEART J, V143, P535, DOI 10.1067/mhj.2002.120298
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776
   Yokokawa M, 2012, HEART RHYTHM, V9, P1460, DOI 10.1016/j.hrthm.2012.04.036
NR 23
TC 4
Z9 5
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 391
EP 397
DI 10.4070/kcj.2015.45.5.391
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400008
PM 26413107
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Kim, SJ
   Son, JS
   Kim, SH
   Lee, CH
AF Lee, Sang-Yun
   Kim, Soo-Jin
   Son, Jae Sung
   Kim, Seong-Ho
   Lee, Chang-Ha
TI Stepwise Approach Using Combined Management in Patients with Congenital
   Heart Disease and Borderline Pulmonary Vascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary hypertension; Congenital heart defect; Vasodilators; Pulmonary
   vascular resistance
ID ATRIAL SEPTAL-DEFECT; ARTERIAL-HYPERTENSION; THERAPY; PROSTACYCLIN;
   REDUCTION; BOSENTAN; ADULTS
AB Background and Objectives: Despite remarkable advances in pediatric cardiology, pulmonary arterial hypertension associated with congenital heart disease remains a major problem. In the past decade new vasodilators have been introduced and appear to be effective in reducing pulmonary vascular resistance (PVR).
   Subjects and Methods: From 2000 to 2011, we retrospectively reviewed the records of 22 patients who had congenital septal defects and borderline pulmonary vascular disease (PVD). The PVR in these patients was from 6 to 16 wood units.m(2), and/or the systolic pulmonary arterial pressure was more than 2/3 of the systemic arterial pressure.
   Results: The median age was 16 years (range, 9 months-46 years). The median duration of follow-up was 7.4 years (range, 1.4-11.7 years). According to hemodynamic data and clinical symptoms, the initial management comprised targeted medical therapy in four (18%), complete closure in four (18%), and partial closure in 14 patients (63.6%). In the four patients who had a high PVR and negative vasoreactivity, the PVR decreased and vasoreactivity increased after targeted medical therapy; three of these patients underwent cardiac surgery later. Finally, 11 (50%) received targeted medical therapy and 21 patients (95.4%) underwent cardiac surgery. Complete closure resulted in six patients and partial closure in 17 patients. Mortality was observed in two patients. The other 19 patients (91%) had New York Heart Association functional class I.
   Conclusion: Targeted medical therapy may be effective in reducing PVR in patients with congenital heart disease and borderline PVD. A stepwise approach may help to achieve improved outcomes in these patients.
C1 [Lee, Sang-Yun; Kim, Seong-Ho; Lee, Chang-Ha] Sejong Cardiovasc Inst, Dept Thorac & Cardiovasc Surg, Dept Pediat, Bucheon, South Korea.
   [Kim, Soo-Jin; Son, Jae Sung] Konkuk Univ, Sch Med, Dept Pediat, Seoul, South Korea.
RP Kim, SJ (corresponding author), Konkuk Univ Hosp, Dept Pediat, Div Pediat Cardiol, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM ksoojn@naver.com
RI ; Kim, Soo-Jin/P-2677-2014
OI Son, Jae Sung/0000-0002-1970-9461; Kim, Soo-Jin/0000-0001-9671-6019
CR Allcock RJ, 2003, HEART, V89, P1344, DOI 10.1136/heart.89.11.1344
   Balzer DT, 2002, CIRCULATION, V106, pI76, DOI 10.1161/01.cir.0000032875.55215.cb
   Diller GP, 2007, HEART, V93, P974, DOI 10.1136/hrt.2006.089185
   Dimopoulos K, 2008, INT J CARDIOL, V129, P163, DOI 10.1016/j.ijcard.2008.02.004
   Eicken Andreas, 2007, Int J Cardiol, V117, pe40, DOI 10.1016/j.ijcard.2006.10.023
   Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488
   Frost AE, 2005, J HEART LUNG TRANSPL, V24, P501, DOI 10.1016/j.healun.2004.02.004
   Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014
   Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715
   Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5
   Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291
   Ivy DD, 2013, J AM COLL CARDIOL, V62, pD117, DOI 10.1016/j.jacc.2013.10.028
   Jin HF, 2012, KOREAN CIRC J, V42, P513, DOI 10.4070/kcj.2012.42.8.513
   Khan Sadaf A, 2006, Congenit Heart Dis, V1, P244, DOI 10.1111/j.1747-0803.2006.00043.x
   LAFARGE CG, 1970, CARDIOVASC RES, V4, P23, DOI 10.1093/cvr/4.1.23
   McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501
   RABINOVITCH M, 1978, CIRCULATION, V58, P1107, DOI 10.1161/01.CIR.58.6.1107
   Rosenzweig EB, 1999, CIRCULATION, V99, P1858, DOI 10.1161/01.CIR.99.14.1858
   Schwerzmann M, 2006, INT J CARDIOL, V110, P104, DOI 10.1016/j.ijcard.2005.05.062
   Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486
   STEELE PM, 1987, CIRCULATION, V76, P1037, DOI 10.1161/01.CIR.76.5.1037
   Valente AM, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.001
   Yamauchi H, 2001, ANN THORAC SURG, V72, P905, DOI 10.1016/S0003-4975(00)02537-6
NR 23
TC 0
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 408
EP 415
DI 10.4070/kcj.2015.45.5.408
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400010
PM 26413109
OA Green Published
DA 2021-04-22
ER

PT J
AU Moon, JR
   Song, J
   Huh, J
   Kang, IS
   Park, SW
   Chang, SA
   Yang, JH
   Jun, TG
AF Moon, Ju Ryoung
   Song, Jinyoung
   Huh, June
   Kang, I-Seok
   Park, Seung Woo
   Chang, Sung-A
   Yang, Ji-Hyuk
   Jun, Tae-Gook
TI Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital heart disease; Risk factors; Metabolic cardiovascular
   syndrome
ID PHYSICAL-ACTIVITY; SCIENTIFIC STATEMENT; METABOLIC SYNDROME;
   ASSOCIATION; OBESITY; NUTRITION; CHILDREN; POPULATION; GLUCOSE; HEALTH
AB Background and Objectives: The objective of this study was to analyze cardiovascular risk factors in adults with congenital heart disease (ACHD).
   Subjects and Methods: The subjects for this study comprised 135 patients, aged 18 years and above, who visited the ACHD clinic at the Samsung Medical Center and 135 adults with a structurally normal heart who were randomly selected from the Center for Health Promotion during the same period. For the analysis, the ACHD group was further divided into an ACHD group that underwent correction by cardiac surgery and a cyanotic group.
   Results: The mean (standard diviation) age (years) of patients in the surgically corrected group was 48.4 (10.9) years, while that of patients in the cyanotic group was 43.1 (9.0) years and that of patients in the control group was 47.1 (10.3) years (p=0.042). The adjusted odds ratios (ORs) for past smoking, hypertension, diabetes mellitus, hypercholesterolemia, obesity, and metabolic syndrome were significantly higher in the surgically corrected patients than in the controls. However, the ORs for all variables excluding past smoking were significantly lower in the cyanotic group compared with the control group. After adjustment for age, gender, smoking, alcohol use, and exercise, the ORs for metabolic syndrome were 0.46 (0.35-0.57, p<0.001) and 1.48 (1.14-1.92, p=0.003) in the cyanotic and surgically corrected groups, respectively.
   Conclusion: Cardiovascular risk factors need to be considered in surgically corrected ACHD patients as well as in adults with a structurally normal heart. A further study with a long-term follow-up is needed for developing guidelines for prevention.
C1 [Moon, Ju Ryoung] Sungkyunkwan Univ, Grown Up Congenital Heart Clin, Heart Vasc Stroke Inst, Samsung Med Ctr,Sch Med, Seoul 06351, South Korea.
   [Song, Jinyoung; Huh, June; Kang, I-Seok] Sungkyunkwan Univ, Grown Up Congenital Heart Clin, Dept Pediat, Heart Vasc Stroke Inst,Samsung Med Ctr,Sch Med, Seoul 06351, South Korea.
   [Park, Seung Woo; Chang, Sung-A] Sungkyunkwan Univ, Grown Up Congenital Heart Clin, Heart Vasc Stroke Inst, Div Cardiol,Samsung Med Ctr,Sch Med, Seoul 06351, South Korea.
   [Yang, Ji-Hyuk; Jun, Tae-Gook] Sungkyunkwan Univ, Grown Up Congenital Heart Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc Stroke Inst,Samsung Med Ctr,Sch Med, Seoul 06351, South Korea.
RP Huh, J (corresponding author), Sungkyunkwan Univ, Grown Up Congenital Heart Clin, Dept Pediat, Heart Vasc Stroke Inst,Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM herzhuh@gmail.com
OI Huh, June/0000-0003-4523-9632; Chang, Sung-A/0000-0001-5124-605X
FU Korean Society of Cardiology [PHO 01105711]
FX This study was supported by a grant (2010) from the Korean Society of
   Cardiology (No. PHO 01105711).
CR Babor T.F., 2001, ALCOHOL USE DISORDER, V2nd ed.
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Fyfe A, 2005, AM J CARDIOL, V96, P283, DOI 10.1016/j.amjcard.2005.03.060
   GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X
   Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98
   Grundy SM, 2004, ENDOCRIN METAB CLIN, V33, P267, DOI 10.1016/j.ecl.2004.03.001
   HAIT G, 1972, CIRCULATION, V46, P333, DOI 10.1161/01.CIR.46.2.333
   Jang SY, 2013, KOREAN CIRC J, V43, P316, DOI 10.4070/kcj.2013.43.5.316
   Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568
   Kim MH, 2004, J KOREAN MED SCI, V19, P195, DOI 10.3346/jkms.2004.19.2.195
   King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176
   Korean Heart Foundation, 2012, STAT CARD SURG CONG
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lundell KH, 1997, ACTA PAEDIATR, V86, P1082, DOI 10.1111/j.1651-2227.1997.tb14812.x
   de Souza MDM, 2012, HEART, V98, P1207, DOI 10.1136/heartjnl-2012-301828
   Martinez-Quintana E, 2010, METABOLISM, V59, P1642, DOI 10.1016/j.metabol.2010.03.014
   Moon JR, 2004, J KOREAN PEDIAT CARD, V8, P135
   Reybrouck T, 2005, EUR J CARDIOV PREV R, V12, P498, DOI 10.1097/01.hjr.0000176510.84165.eb
   Rhee MY, 2014, KOREAN CIRC J, V44, P30, DOI 10.4070/kcj.2014.44.1.30
   Somerville J, 1997, ANNU REV MED, V48, P283
   Statistics Korea, 2012, STAT CAUS DEATH
   Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2
   Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, 2014, 3 NCEP
   Varady KA, 2005, J NUTR, V135, P1829
   de Vasconcelos IQA, 2008, ARQ BRAS CARDIOL, V91, P207
   World Health Organization, 2010, GLOB REC PHYS ACT HL
   World Health Organization Western Pacific Region IASO International Association for the Study of Obesity and International Obesity Task Force, 2000, AS PAC PERSP RED OB
   Yoon YS, 2004, AM J CLIN NUTR, V80, P217
NR 29
TC 10
Z9 10
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 416
EP 423
DI 10.4070/kcj.2015.45.5.416
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400011
PM 26413110
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SY
   Park, JS
   Bang, JH
   Kang, EJ
AF Kim, So Yeon
   Park, Jong Sung
   Bang, Jung Hee
   Kang, Eun Ju
TI Brachial Plexus Injury Caused by Indwelling Axillary Venous Pacing Leads
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac resynchronization therapy; Complications; Peripheral nerve
   injuries; Brachial plexus
ID PACEMAKER IMPLANTATION; PARALYSIS
AB A 64-year-old male patient underwent cardiac resynchronization therapy (CRT) device implantation via the axillary venous approach. Two weeks later, the patient started complaining of "electric shock-like" pain in the left axillary area. During physical examination, typical pain in the left axillary area was reproduced whenever his left shoulder was passively abducted more than 60 degrees. Fluoroscopic examination showed that the left ventricle (LV) and right atrium (RA) leads were positioned at an acute angle directing towards the left brachial plexus whenever the patient's shoulder was passively abducted. Brachial plexus irritation by the angulated CRT leads was strongly suspected. To relieve the acute angulation, we had to adjust the entry site of the LV and RA leads from the distal to the proximal axillary vein using the cut-down method. After successful lead repositioning, the neuropathic pain improved rapidly. Although transvenous pacing lead-induced nerve injury is not a frequent complication, this possibility should be kept in mind by the operators.
C1 [Kim, So Yeon; Park, Jong Sung] Dong A Univ, Med Ctr, Dept Cardiol, Busan 49201, South Korea.
   [Bang, Jung Hee] Dong A Univ, Med Ctr, Dept Cardiovasc Surg, Busan 49201, South Korea.
   [Kang, Eun Ju] Dong A Univ, Med Ctr, Dept Radiol, Busan 49201, South Korea.
RP Park, JS (corresponding author), Dong A Univ, Med Ctr, Dept Cardiol, 26 Daesingongwon Ro, Busan 49201, South Korea.
EM thinkmed@dau.ac.kr
CR Harris K, 2013, HEART LUNG, V42, P65, DOI 10.1016/j.hrtlng.2012.09.002
   Kim KH, 2014, CIRC J, V78, P865, DOI 10.1253/circj.CJ-13-0884
   Pozo E, 2011, EUROPACE, V13, P592, DOI 10.1093/europace/euq397
   Ramza BM, 1997, AM J CARDIOL, V80, P892, DOI 10.1016/S0002-9149(97)00542-0
NR 4
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 428
EP 431
DI 10.4070/kcj.2015.45.5.428
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400013
PM 26413112
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, GH
   Kim, DK
   Song, YJ
   Yang, JI
   Shin, HC
   Ong, S
   Lee, HY
AF Lee, Ga-Hee
   Kim, Dae-Kyeong
   Song, Yeo-Jeong
   Yang, Ju-Il
   Shin, Ho-Cheol
   Ong, Sungmoon
   Lee, Ho Young
TI Stroke in a Young Individual with Left Ventricular Noncompaction and
   Left Atrium Standstill
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Isolated noncompaction of the ventricular myocardium; Atrial standstill;
   Stroke
ID NON-COMPACTION; MYOCARDIUM; CARDIOMYOPATHY; ASSOCIATION; DIAGNOSIS;
   FEATURES
AB Isolated left ventricular noncompaction (LVNC) is a rare cardiomyopathy with morphologic characteristics of two distinct myocardial layers i.e., thin compacted epicardial and thick noncompacted endocardial layers. The noncompacted myocardium consists of prominent ventricular trabeculae and deep intertrabecular recesses. It can lead to arrhythmias, heart failure or systemic embolisms. Electrocardiographic patterns of patients with LVNC are various and non-specific; however, the most common findings are intraventricular conduction delay, left ventricular hypertrophy, and repolarization abnormalities. We reported the first case, to the best of our knowledge, of a 29-year-old man who had recent cerebral infarction and incidental LVNC with spontaneous left atrial standstill.
C1 [Lee, Ga-Hee; Kim, Dae-Kyeong; Song, Yeo-Jeong; Yang, Ju-Il; Shin, Ho-Cheol; Ong, Sungmoon; Lee, Ho Young] Inje Univ, Coll Med, Busan Paik Hosp, Div Cardiol,Dept Internal Med, Busan 47392, South Korea.
RP Kim, DK (corresponding author), Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med, 75 Bokji Ro, Busan 47392, South Korea.
EM epkimdk@paik.ac.kr
OI Ong, Sungmoon/0000-0003-0215-6482
CR Aras D, 2006, J CARD FAIL, V12, P726, DOI 10.1016/j.cardfail.2006.08.002
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Duncan E, 2013, PACE, V36, pe120, DOI 10.1111/j.1540-8159.2010.02957.x
   DUSEK J, 1975, ARCH PATHOL, V99, P312
   Fazelifar AF, 2005, PACE, V28, P1005, DOI 10.1111/j.1540-8159.2005.00198.x
   Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7
   Habib G, 2011, EUR J HEART FAIL, V13, P177, DOI 10.1093/eurjhf/hfq225
   Jacquier A, 2010, EUR HEART J, V31, P1098, DOI 10.1093/eurheartj/ehp595
   Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   Pitta S, 2007, J CLIN ULTRASOUND, V35, P465, DOI 10.1002/jcu.20349
   Stanton C, 2009, AM J CARDIOL, V104, P1135, DOI 10.1016/j.amjcard.2009.05.062
   Steffel J, 2009, AM J CARDIOL, V104, P984, DOI 10.1016/j.amjcard.2009.05.042
   Stollberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6
   Thuny F, 2010, ARCH CARDIOVASC DIS, V103, P150, DOI 10.1016/j.acvd.2010.01.002
   Weiford BC, 2004, CIRCULATION, V109, P2965, DOI 10.1161/01.CIR.0000132478.60674.D0
NR 16
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 432
EP 438
DI 10.4070/kcj.2015.45.5.432
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400014
PM 26413113
OA Green Published
DA 2021-04-22
ER

PT J
AU Saglam, M
   Saygin, H
   Kozan, H
   Ozturk, E
   Mutlu, H
AF Saglam, Muzaffer
   Saygin, Hasan
   Kozan, Huseyin
   Ozturk, Ersin
   Mutlu, Hakan
TI Noncompaction of Ventricular Myocardium Involving the Right Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Multidetector computed tomography; Magnetic resonance imaging; Isolated
   noncompaction of the ventricular myocardium
ID CARDIOMYOPATHY; ADULTS
AB Noncompaction ventricular myocardium is an unusual cause of cardiomyopathy. It is association with congenital heart defects, most often with outflow obstructive lesions or coronary anomalies. However, no factor could explain the arrest of development of myocardial structure (isolated form). The pathogenesis of isolated noncompaction is thought to be an arrest in endomyocardial morphogenesis. It has been reported that myocardial noncompaction could present as acquired disease. The most common site of involvement is the left ventricle, with right ventricular involvement being reported in a few cases. In this report, we present a case with noncompaction of the right ventricle (RV). Cardiac computed tomography angiography and magnetic resonance imaging demonstrated morphological abnormalities of the RV.
C1 [Saglam, Muzaffer; Saygin, Hasan; Kozan, Huseyin; Ozturk, Ersin; Mutlu, Hakan] GATA Haydarpasa Training Hosp, Dept Radiol, TR-34668 Istanbul, Turkey.
RP Saglam, M (corresponding author), GATA Haydarpasa Training Hosp, Dept Radiol, TR-34668 Istanbul, Turkey.
EM mzsaglam@yahoo.com
RI Mutlu, Hakan/B-2440-2016
OI Mutlu, Hakan/0000-0002-5370-8614
CR Acar G, 2013, TURK KARDIYOL DERN A, V41, P267, DOI 10.5543/tkda.2013.27095
   Alehan D, 2005, CARDIOL YOUNG, V15, P434, DOI 10.1017/S1047951105000910
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Hruda J, 2005, PEDIATR CARDIOL, V26, P452, DOI 10.1007/s00246-004-0752-z
   Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   Ritter M, 1997, MAYO CLIN PROC, V72, P26, DOI 10.4065/72.1.26
   Sert A, 2013, PEDIATR CARDIOL, V34, P1896, DOI 10.1007/s00246-012-0435-0
   Song ZZ, 2007, J ULTRAS MED, V26, P547, DOI 10.7863/jum.2007.26.4.547
   Stollberger C, 2006, INT J CARDIOL, V111, P131, DOI 10.1016/j.ijcard.2005.08.009
   Taylor GP, 1992, DEV PATHOLOGY EMBRYO, P467
NR 13
TC 6
Z9 6
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 439
EP 441
DI 10.4070/kcj.2015.45.5.439
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400015
PM 26413114
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, JM
AF Ko, Jung Min
TI Genetic Syndromes associated with Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart defects; congenital; Down syndrome; Turner syndrome; 22q11
   deletion syndrome; Williams syndrome; Noonan syndrome
ID WILLIAMS-BEUREN SYNDROME; NOONAN-SYNDROME; DOWN-SYNDROME;
   TURNER-SYNDROME; FOLLOW-UP; CARDIOVASCULAR-DISEASE; 22Q11.2 DELETION;
   CHILDREN; DEFECTS; PREVALENCE
AB Recent research has demonstrated that genetic alterations or variations contribute considerably to the development of congenital heart disease. Many kinds of genetic tests are commercially available, and more are currently under development. Congenital heart disease is frequently accompanied by genetic syndromes showing both cardiac and extra-cardiac anomalies. Congenital heart disease is the leading cause of birth defects, and is an important cause of morbidity and mortality during infancy and childhood. This review introduces common genetic syndromes showing various types of congenital heart disease, including Down syndrome, Turner syndrome, 22q11 deletion syndrome, Williams syndrome, and Noonan syndrome. Although surgical techniques and perioperative care have improved substantially, patients with genetic syndromes may be at an increased risk of death or major complications associated with surgery. Therefore, risk management based on an accurate genetic diagnosis is necessary in order to effectively plan the surgical and medical management and follow-up for these patients. In addition, multidisciplinary approaches and care for the combined extra-cardiac anomalies may help to reduce mortality and morbidity accompanied with congenital heart disease.
C1 [Ko, Jung Min] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 03080, South Korea.
RP Ko, JM (corresponding author), Seoul Natl Univ, Dept Pediat, Childrens Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM jmko@snu.ac.kr
FU Korean Ministry of Science, ICT and Future Planning
   [NRF-2012R1A1A3001588]
FX This study was supported by a grant, No. NRF-2012R1A1A3001588, from the
   Korean Ministry of Science, ICT and Future Planning.
CR Adams GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002479
   Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748
   Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001
   Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039
   Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374
   Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101
   Bray I, 1998, PRENATAL DIAG, V18, P9, DOI 10.1002/(SICI)1097-0223(199801)18:1<9::AID-PD210>3.0.CO;2-F
   Bull MJ, 2011, PEDIATRICS, V128, P393, DOI 10.1542/peds.2011-1605
   CARMI R, 1992, AM J MED GENET, V43, P569, DOI 10.1002/ajmg.1320430313
   Cleves MA, 2007, BIRTH DEFECTS RES A, V79, P657, DOI 10.1002/bdra.20393
   Collins RT, 2013, CIRCULATION, V127, P2125, DOI 10.1161/CIRCULATIONAHA.112.000064
   Collins RT, 2010, AM J CARDIOL, V105, P874, DOI 10.1016/j.amjcard.2009.10.069
   Cunniff C, 2001, PEDIATRICS, V107, P1192
   Davenport ML, 2010, J CLIN ENDOCR METAB, V95, P1487, DOI 10.1210/jc.2009-0926
   Dulac Y, 2008, ARCH CARDIOVASC DIS, V101, P485, DOI 10.1016/j.acvd.2008.05.007
   Eskedal LT, 2007, CARDIOL YOUNG, V17, P423, DOI 10.1017/S1047951107000881
   Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853
   Formigari R, 2009, EUR J CARDIO-THORAC, V35, P606, DOI 10.1016/j.ejcts.2008.11.005
   Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.3.CO;2-6
   KECECIOGLU D, 1993, EUR HEART J, V14, P1458, DOI 10.1093/eurheartj/14.11.1458
   Ko JM, 2008, J HUM GENET, V53, P999, DOI 10.1007/s10038-008-0343-6
   Lee BH, 2011, J PEDIATR-US, V159, P1029, DOI 10.1016/j.jpeds.2011.05.024
   Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021
   MARINO B, 1989, J PEDIATR-US, V115, P834, DOI 10.1016/S0022-3476(89)80679-1
   Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0
   McDonald-McGinn DM, 1993, GENEREVIEWS R
   Moss EM, 1999, J PEDIATR-US, V134, P193, DOI 10.1016/S0022-3476(99)70415-4
   Oskarsdottir S, 2005, DEV MED CHILD NEUROL, V47, P177, DOI 10.1017/S0012162205000320
   Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056
   Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074
   Prandstraller D, 1999, PEDIATR CARDIOL, V20, P108, DOI 10.1007/s002469900416
   Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X
   Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421
   Shaw AC, 2007, ARCH DIS CHILD, V92, P128, DOI 10.1136/adc.2006.104547
   Stochholm K, 2006, J CLIN ENDOCR METAB, V91, P3897, DOI 10.1210/jc.2006-0558
   Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406
   TUBMAN TRJ, 1991, BMJ-BRIT MED J, V302, P1425, DOI 10.1136/bmj.302.6790.1425
   Tucker EM, 2007, J AM COLL CARDIOL, V50, P1196, DOI 10.1016/j.jacc.2007.06.014
   van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4
   ZALZSTEIN E, 1991, PEDIATR CARDIOL, V12, P219, DOI 10.1007/BF02310569
NR 40
TC 19
Z9 20
U1 0
U2 10
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 357
EP 361
DI 10.4070/kcj.2015.45.5.357
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400002
PM 26413101
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, KI
AF Cho, Kyoung Im
TI Right Ventricular Longitudinal Strain: A Target Indicator in the
   Treatment of Pulmonary Arterial Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ECHOCARDIOGRAPHIC-ASSESSMENT; MAGNETIC-RESONANCE; GUIDELINES
C1 Kosin Univ, Coll Med, Dept Internal Med, Div Cardiol, Busan 49267, South Korea.
RP Cho, KI (corresponding author), Kosin Univ, Coll Med, Dept Internal Med, Div Cardiol, 262 Gamcheon Ro, Busan 49267, South Korea.
EM kyoungim74@gmail.com
CR Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040
   Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC
   Freed BH, 2015, ECHOCARDIOGR-J CARD, V32, P257, DOI 10.1111/echo.12662
   Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297
   Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051
   Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465
   Karas MG, 2012, PROG CARDIOVASC DIS, V55, P144, DOI 10.1016/j.pcad.2012.07.011
   Kossaify A, 2015, CLIN MED INSIGHTS-CA, V9, P65, DOI 10.4137/CMC.S27462
   Park JH, 2015, KOREAN CIRC J, V45, P398, DOI 10.4070/kcj.2015.45.5.398
   Pirat B, 2006, AM J CARDIOL, V98, P699, DOI 10.1016/j.amjcard.2006.03.056
   Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010
   Schiller NB, 2009, JACC-CARDIOVASC IMAG, V2, P150, DOI 10.1016/j.jcmg.2008.11.006
   van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068
NR 13
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 362
EP 363
DI 10.4070/kcj.2015.45.5.362
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400003
PM 26413102
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, SA
   Seo, HJ
   Kim, SK
   Lee, YR
   Choi, S
   Ahn, KT
   Kim, JH
   Park, JH
   Lee, JH
   Choi, SW
   Seong, IW
   Jeon, BH
   Jeong, JO
AF Jin, Seon-Ah
   Seo, Hee Jung
   Kim, Sun Kyeong
   Lee, Yu Ran
   Choi, Sunga
   Ahn, Kye-Taek
   Kim, Jun-Hyung
   Park, Jae-Hyeong
   Lee, Jae-Hwan
   Choi, Si Wan
   Seong, In-Whan
   Jeon, Byeong Hwa
   Jeong, Jin-Ok
TI Elevation of the Serum Apurinic/Apyrimidinic Endonuclease 1/Redox
   Factor-1 in Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE APEX1 protein, human; Ref-1 protein, human; Biological markers; Coronary
   artery disease
ID DNA-DAMAGE; APE1/REF-1; REPAIR; EXPRESSION
AB Background and Objectives: Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein involved in the DNA base excision repair pathway, inflammation, angiogenesis, and survival pathways. We investigated serum APE1/Ref-1 in patients with coronary artery disease (CAD).
   Subjects and Methods: Serum APE1/Ref-1 was measured with a sandwich enzyme-linked immunosorbent assay from 360 patients who received coronary angiograms. They were divided into two groups; a control (n=57) and a CAD group (n=303), the latter included angina (n=128) and myocardial infarction (MI, n=175).
   Results: The levels of APE1/Ref-1 were higher in the CAD than the control (0.63 +/- 0.07 vs. 0.12 +/- 0.07 ng/100 mu L, respectively; p<0.01). They were also higher in MI than angina (0.81 +/- 0.10 vs. 0.38 +/- 0.11 ng/100 mu L, respectively; p<0.01) and different according to the thrombolysis in myocardial infarction (TIMI) flow (0.88 +/- 0.09 for TIMI flow 0, 1, 2 vs. 0.45 +/- 0.13 ng/100 mu L for TIMI flow 3, p<0.01) in acute coronary syndrome. In correlation analysis, the levels of APE1/Ref-1 were positively correlated with Troponin I (r=0.222; p<0.0001) and N-terminal pro-B type natriuretic peptide (NT-proBNP, r=0.217; p<0.0001) but not high sensitivity to C-reactive protein. Also, they revealed a negative correlation with ejection fraction (EF, r=-0.221; p=0.002). However, there were no significant differences among the three groups, were divided by their levels of APE1/Ref-1, for major adverse cardiovascular events (death, recurrent MI, stroke, revascularization) (8.2 vs. 14.0 vs. 12.5%, p=ns).
   Conclusion: The levels of serum APE1/Ref-1 are elevated in CAD, and are higher in MI than in angina. They are correlated with Troponin I, NT-proBNP, and EF.
C1 [Jin, Seon-Ah; Seo, Hee Jung; Kim, Sun Kyeong; Ahn, Kye-Taek; Kim, Jun-Hyung; Park, Jae-Hyeong; Lee, Jae-Hwan; Choi, Si Wan; Seong, In-Whan; Jeong, Jin-Ok] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, Daejeon 35015, South Korea.
   [Lee, Yu Ran; Choi, Sunga; Jeon, Byeong Hwa] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Physiol, Daejeon 35015, South Korea.
RP Jeong, JO (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jojeong@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021; Choi, Sunga/W-7929-2018
OI Choi, Sunga/0000-0002-3358-7923; gim, junhyeong/0000-0002-1185-1543;
   Jeong, Jin-Ok/0000-0003-0763-4754; Jeon, Byeong Hwa/0000-0002-3347-2739;
   Seong, In-Whan/0000-0003-4628-0258; jin, seon-ah/0000-0001-6895-9101;
   Choi, Si Wan/0000-0002-1035-1512; Lee, Jae-Hwan/0000-0002-6561-7760;
   Park, Jae-Hyeong/0000-0001-7035-286X
FU Korean Society of Cardiology; Chungnam National University Hospital
   Research Fund; National Research Foundation of Korea (NRF) - Ministry of
   Education [NRF-2014R1A6A1029617]
FX This study was supported by grants from the Korean Society of Cardiology
   2012, Chungnam National University Hospital Research Fund 2012, and
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF), fund by the Ministry of Education
   (NRF-2014R1A6A1029617). The biospecimens used in this study were
   provided by the Biobank of Chungnam University Hospital, a member of
   Korea Biobank.
CR Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0
   Choi S, 2013, BIOCHEM BIOPH RES CO, V435, P403, DOI 10.1016/j.bbrc.2013.04.101
   Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058001
   Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X
   Jeon BH, 2004, CIRC RES, V95, P902, DOI 10.1161/01.RES.0000146947.84294.4c
   Kim HC, 2012, KOREAN CIRC J, V42, P223, DOI 10.4070/kcj.2012.42.4.223
   Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Naganuma T, 2010, AM J HYPERTENS, V23, P186, DOI 10.1038/ajh.2009.221
   Park MS, 2013, BIOCHEM BIOPH RES CO, V435, P621, DOI 10.1016/j.bbrc.2013.05.030
   Patterson C, 2004, CIRC RES, V95, P849, DOI 10.1161/01.RES.0000147313.80351.92
   Pines A, 2005, NUCLEIC ACIDS RES, V33, P4379, DOI 10.1093/nar/gki751
   송선헌, 2012, Clinical Hypertension, V18, P126, DOI 10.5646/jksh.2012.18.3.126
   Shin JH, 2015, CANC RES TREAT
   Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367
   Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194
   Thakur S, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.42
   Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570
   Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006
   Wang D, 2004, MOL CANCER THER, V3, P679
   Zhang Y, 2009, INT J ONCOL, V35, P1069, DOI 10.3892/ijo_00000422
NR 21
TC 15
Z9 16
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 364
EP 371
DI 10.4070/kcj.2015.45.5.364
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400004
PM 26413103
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Kusunose, K
   Kwon, DH
   Park, MM
   Erzurum, SC
   Thomas, JD
   Grimm, RA
   Griffin, BP
   Marwick, TH
   Popovic, ZB
AF Park, Jae-Hyeong
   Kusunose, Kenya
   Kwon, Deborah H.
   Park, Margaret M.
   Erzurum, Serpil C.
   Thomas, James D.
   Grimm, Richard A.
   Griffin, Brian P.
   Marwick, Thomas H.
   Popovic, Zoran B.
TI Relationship between Right Ventricular Longitudinal Strain, Invasive
   Hemodynamics, and Functional Assessment in Pulmonary Arterial
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Familial primary pulmonary hypertension; Heart ventricles; Ventricular
   function; right
ID RIGHT-HEART; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; THERAPY;
   GUIDELINES; SURVIVAL; ECHOCARDIOGRAPHY; PREDICTION; BRANCH
AB Background and Objectives: Right ventricular longitudinal strain (RVLS) is a new parameter of RV function. We evaluated the relationship of RVLS by speckle-tracking echocardiography with functional and invasive parameters in pulmonary arterial hypertension (PAH) patients. Subjects and
   Methods: Thirty four patients with World Health Organization group 1 PAH (29 females, mean age 45 +/- 13 years old). RVLS were analyzed with velocity vector imaging.
   Results: Patients with advanced symptoms {New York Heart Association (NYHA) functional class III/IV} had impaired RVLS in global RV (RVLSglobal, -17 +/- 5 vs. -12 +/- 3%, p<0.01) and RV free wall (RVLSFW, -19 +/- 5 vs. -14 +/- 4%, p<0.01 to NYHA class I/II). Baseline RVLSglobal and RVLSFW showed significant correlation with 6-minute walking distance (r=-0.54 and r=-0.57, p<0.01 respectively) and logarithmic transformation of brain natriuretic peptide concentration (r=0.65 and r=0.65, p<.01, respectively). These revealed significant correlations with cardiac index (r=-0.50 and r=-0.47, p<0.01, respectively) and pulmonary vascular resistance (PVR, r=0.45 and r=0.45, p=0.01, respectively). During a median follow-up of 33 months, 25 patients (74%) had follow-up examinations. Mean pulmonary arterial pressure (mPAP, 54 +/- 13 to 46 +/- 16 mmHg, p=0.03) and PVR (11 +/- 5 to 6 +/- 2 wood units, p<0.01) were significantly decreased with pulmonary vasodilator treatment. RVLSglobal (-12 +/- 5 to -16 +/- 5%, p<0.01) and RVLSFW (-14 +/- 5 to -18 +/- 5%, p<0.01) were significantly improved. The decrease of mPAP was significantly correlated with improvement of RVLSglobal (r=0.45, p<0.01) and RVLSFW (r=0.43, p<0.01). The PVR change demonstrated significant correlation with improvement of RVLSglobal (r=0.40, p<0.01).
   Conclusion: RVLS correlates with functional and invasive hemodynamic parameters in PAH patients. Decrease of mPAP and PVR as a result of treatment was associated with improvement of RVLS.
C1 [Park, Jae-Hyeong; Kusunose, Kenya; Kwon, Deborah H.; Park, Margaret M.; Thomas, James D.; Grimm, Richard A.; Griffin, Brian P.; Marwick, Thomas H.; Popovic, Zoran B.] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44195 USA.
   [Park, Jae-Hyeong] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Cardiol Div Internal Med, Daejeon, South Korea.
   [Kusunose, Kenya] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima, Japan.
   [Park, Margaret M.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA.
   [Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Pulm & Crit Care Med, Cleveland, OH 44195 USA.
   [Marwick, Thomas H.] Menzies Res Inst, Hobart, Tas, Australia.
RP Popovic, ZB (corresponding author), Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, J1-13,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM popoviz@ccf.org
RI Park, Jae-Hyeong/AAD-9015-2021; Kusunose, Kenya/AAC-9978-2021
OI Kusunose, Kenya/0000-0002-4909-754X; Park,
   Jae-Hyeong/0000-0001-7035-286X
CR Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   Beygui F, 2004, INT J CARDIOVAS IMAG, V20, P509, DOI 10.1007/s10554-004-1097-7
   Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492
   Brown SB, 2011, CHEST, V140, P27, DOI 10.1378/chest.10-1136
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111
   DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343
   Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640
   Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297
   Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022
   Giusca S, 2010, HEART, V96, P281, DOI 10.1136/hrt.2009.171728
   Gomberg-Maitland M, 2011, J AM COLL CARDIOL, V57, P1053, DOI 10.1016/j.jacc.2010.11.020
   Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465
   Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061
   Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291
   Jamal F, 2003, AM J PHYSIOL-HEART C, V285, pH2842, DOI 10.1152/ajpheart.00218.2003
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015
   Noordegraaf AV, 2011, EUR RESPIR REV, V20, P243, DOI 10.1183/09059180.00006511
   Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565
   Pirat B, 2006, AM J CARDIOL, V98, P699, DOI 10.1016/j.amjcard.2006.03.056
   Puwanant S, 2010, CIRCULATION, V121, P259, DOI 10.1161/CIRCULATIONAHA.108.844340
   RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203
   Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010
   Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015
   Torbicki A, 2007, EUR HEART J, V28, P1187, DOI 10.1093/eurheartj/ehm074
   Verhaert D, 2010, CIRC-HEART FAIL, V3, P340, DOI 10.1161/CIRCHEARTFAILURE.109.900134
   Yuan XP, 2004, ACAD RADIOL, V11, P1211, DOI 10.1016/j.acra.2004.07.016
NR 28
TC 14
Z9 16
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 398
EP 407
DI 10.4070/kcj.2015.45.5.398
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400009
PM 26413108
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JY
   Park, EJ
   Kim, HD
   Park, SH
   Song, JY
   Lee, DI
   Shim, J
   Kim, YH
AF Choi, Jah Yeon
   Park, Eun Jin
   Kim, Hee Dong
   Park, Sung Hun
   Song, Ji Young
   Lee, Dae In
   Shim, Jaemin
   Kim, Young-Hoon
TI Ethanol Infusion in the Vein of Marshall in a Patient with Persistent
   Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation
ID ABLATION; ELECTROGRAMS
AB We report the case of a 64-year-old male with persistent atrial fibrillation (AF) terminated by ethanol infusion into vein of Marshall as add-on therapy. Three-dimensional automated complex fractionated atrial electrogram (CFAE) during AF revealed clustering of CFAE at perimitral isthmus (PMI) and its unipolar mapping showed rotor-like activation, which was suggested to be critical in the perpetuation of AF. AF was organized to atrial tachycardia (AT) by 100% ethanol infusion in the vein of Marshall. Adjunctive radiofrequency ablation at PMI successfully terminated AT and led to bidirectional block of PMI.
C1 [Choi, Jah Yeon; Park, Eun Jin; Kim, Hee Dong; Park, Sung Hun; Song, Ji Young; Lee, Dae In; Shim, Jaemin; Kim, Young-Hoon] Korea Univ, Anam Hosp, Dept Cardiol, Coll Med, Seoul 02841, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Coll Med, 73 Inchon Ro, Seoul 02841, South Korea.
EM yhkmd@unitel.co.kr
OI Choi, Jah Yeon/0000-0002-6793-4137
CR Baez-Escudero JL, 2012, HEART RHYTHM, V9, P1207, DOI 10.1016/j.hrthm.2012.03.008
   Gaita F, 2005, CIRCULATION, V111, P136, DOI 10.1161/01.CIR.0000151310.00337.FA
   Hsu LF, 2004, CIRCULATION, V109, P828, DOI 10.1161/01.CIR.0000116753.56467.BC
   Hwang C, 2009, HEART RHYTHM, V6, pS35, DOI 10.1016/j.hrthm.2009.08.034
   Jadidi AS, 2013, J AM COLL CARDIOL, V62, P802, DOI 10.1016/j.jacc.2013.03.081
   Kamanu S, 2006, J CARDIOVASC ELECTR, V17, P839, DOI 10.1111/j.1540-8167.2006.00516.x
   Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D
   Nademanee K, 2011, IEEE ENG MED BIO, P5539, DOI 10.1109/IEMBS.2011.6091413
   Valderrabano M, 2009, HEART RHYTHM, V6, P1552, DOI 10.1016/j.hrthm.2009.07.036
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 424
EP 427
DI 10.4070/kcj.2015.45.5.424
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400012
PM 26413111
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SW
   Kim, HC
   Lee, HS
   Suh, I
AF Lee, Seung Won
   Kim, Hyeon Chang
   Lee, Hye Sun
   Suh, Il
TI Thirty-Year Trends in Mortality from Cardiovascular Diseases in Korea
   (vol 45, pg 202, 2015)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Lee, Seung Won] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea.
   [Lee, Seung Won; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120749, South Korea.
   [Kim, Hyeon Chang; Suh, Il] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea.
   [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul 120749, South Korea.
RP Lee, SW (corresponding author), Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea.
CR Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
NR 1
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2015
VL 45
IS 5
BP 442
EP 442
DI 10.4070/kcj.2015.45.5.442
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CS3JU
UT WOS:000361970400016
PM 26413115
OA Green Published
DA 2021-04-22
ER

PT J
AU Hang, YJ
   Ahn, Y
   Jeong, MH
AF Hang, Young Joon
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Role of Intravascular Ultrasound in Patients with Acute Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocardial infarction; Atherosclerosis; Ultrasonography, interventional
ID PERCUTANEOUS CORONARY INTERVENTION; NO-REFLOW PHENOMENON; C-REACTIVE
   PROTEIN; EARLY STENT THROMBOSIS; PLAQUE RUPTURE; VIRTUAL HISTOLOGY;
   LESION MORPHOLOGY; HARMONIZING OUTCOMES; STATIN THERAPY; IMPACT
AB Rupture of a vulnerable plaque and subsequent thrombus formation are important mechanisms leading to the development of an acute myocardial infarction (AMI). Typical intravascular ultrasound (IVUS) features of AMI include plaque rupture, thrombus, positive remodeling, attenuated plaque, spotty calcification, and thin-cap fibroatheroma. No-reflow phenomenon was attributable to the embolization of thrombus and plaque debris that results from mechanical fragmentation of the vulnerable plaque by percutaneous coronary intervention (PCI). Several grayscale IVUS features including plaque rupture, thrombus, positive remodeling, greater plaque burden, decreased post-PCI plaque volume, and tissue prolapse, and virtual histology-IVUS features such as large necrotic core-containing lesion and thin-cap fibroatheroma were the independent predictors of no-reflow phenomenon in AMI patients. Non-culprit lesions associated with recurrent events were more likely than those not associated with recurrent events to be characterized by a plaque burden of >= 70%, a minimal luminal area of <= 4.0 mm(2), or to be classified as thin-cap fibroatheromas.
C1 [Hang, Young Joon; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Convergence Res Ctr Nominated, Korea Minist Hlth & Welf, Div Cardiol, Gwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Convergence Res Ctr Nominated, Korea Minist Hlth & Welf, Div Cardiol, 42 Jaebong Ro, Gwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Health Technology R&D Project, Ministry of Health Welfare, Korea
   [HI13C1527, HI13C0163]; National Research Foundation of Korea Grant -
   Korean Government [2011-0008875]; Bio & Medical Technology Development
   Program of National Research Foundation (NRF) - Korean government (MEST)
   [2012M3A9C6049744]; Chonnam National University Hospital Research
   Institute of Clinical Medicine, Korea [CRI 11080-21]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Korea (HI13C1527), and a grant of
   the National Research Foundation of Korea Grant funded by the Korean
   Government (2011-0008875), and a grant of the Korean Health Technology
   R&D Project, Ministry of Health & Welfare, Korea (HI13C0163), and the
   Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) funded by the Korean government (MEST)
   (2012M3A9C6049744), and Chonnam National University Hospital Research
   Institute of Clinical Medicine (CRI 11080-21), Korea.
CR Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822
   BOCKSCH W, 1995, EUR HEART J, V16, P46, DOI 10.1093/eurheartj/16.suppl_J.46
   Choi SY, 2011, CIRC-CARDIOVASC INTE, V4, P239, DOI 10.1161/CIRCINTERVENTIONS.110.959791
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801
   De Gregorio J, 1998, J AM COLL CARDIOL, V32, P577, DOI 10.1016/S0735-1097(98)00287-3
   Endo M, 2010, JACC-CARDIOVASC INTE, V3, P540, DOI 10.1016/j.jcin.2010.01.015
   Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354
   Fujii K, 2003, CIRCULATION, V108, P2473, DOI 10.1161/01.CIR.0000097121.95451.39
   Hasegawa T, 2006, AM HEART J, V151, P332, DOI 10.1016/j.ahj.2005.03.041
   Hassam SE, 2006, J AM COLL CARDIOL, V47, P2413, DOI 10.1016/j.jacc.2005.11.091
   Hong MK, 2000, CATHETER CARDIO INTE, V51, P22
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   Hong YJ, 2013, INT J CARDIOL, V168, P1674, DOI 10.1016/j.ijcard.2013.03.089
   Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034
   Hong YJ, 2010, AM J CARDIOL, V106, P1241, DOI 10.1016/j.amjcard.2010.06.046
   Hong YJ, 2010, J CARDIOL, V56, P15, DOI 10.1016/j.jjcc.2010.01.010
   Hong YJ, 2009, J CARDIOL, V54, P36, DOI 10.1016/j.jjcc.2009.03.003
   Hong YJ, 2008, JACC-CARDIOVASC IMAG, V1, P489, DOI 10.1016/j.jcmg.2008.04.004
   Hong YJ, 2009, J CARDIOL, V53, P278, DOI 10.1016/j.jjcc.2008.12.006
   Iijima R, 2006, AM J CARDIOL, V97, P29, DOI 10.1016/j.amjcard.2005.07.104
   Katayama T, 2006, AM J CARDIOL, V97, P301, DOI 10.1016/j.amjcard.2005.08.043
   Kawaguchi R, 2007, J AM COLL CARDIOL, V50, P1641, DOI 10.1016/j.jacc.2007.06.051
   Kawamoto T, 2007, J AM COLL CARDIOL, V50, P1635, DOI 10.1016/j.jacc.2007.05.050
   Kim KH, 2013, KOREAN CIRC J, V43, P377, DOI 10.4070/kcj.2013.43.6.377
   Kim WH, 2012, KOREAN CIRC J, V42, P33, DOI 10.4070/kcj.2012.42.1.33
   Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311
   Kotani J, 2003, AM J CARDIOL, V91, P870, DOI 10.1016/S0002-9149(03)00023-7
   Kusama I, 2007, J AM COLL CARDIOL, V50, P1230, DOI 10.1016/j.jacc.2007.07.004
   Lee SY, 2009, JACC-CARDIOVASC INTE, V2, P65, DOI 10.1016/j.jcin.2008.08.022
   Lehman SJ, 2009, JACC-CARDIOVASC IMAG, V2, P1262, DOI 10.1016/j.jcmg.2009.07.007
   LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844
   Maehara A, 2002, J AM COLL CARDIOL, V40, P904, DOI 10.1016/S0735-1097(02)02047-8
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Nakamura M, 2001, J AM COLL CARDIOL, V37, P63, DOI 10.1016/S0735-1097(00)01097-4
   Nakamura Tomohiro, 2007, J Interv Cardiol, V20, P335, DOI 10.1111/j.1540-8183.2007.00282.x
   Nicholls SJ, 2007, J AM COLL CARDIOL, V49, P263, DOI 10.1016/j.jacc.2006.10.038
   Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   Ohshima K, 2011, J CARDIOL, V57, P36, DOI 10.1016/j.jjcc.2010.08.002
   PETERSON ED, 1994, ANN INTERN MED, V121, P919, DOI 10.7326/0003-4819-121-12-199412150-00003
   Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064
   Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F
   Sato H, 2004, J AM COLL CARDIOL, V44, P300, DOI 10.1016/j.jacc.2004.04.036
   Singh V, 2015, AM J CARDIOL, V115, P1357, DOI 10.1016/j.amjcard.2015.02.037
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Tanaka A, 2002, CIRCULATION, V105, P2148, DOI 10.1161/01.CIR.0000015697.59592.07
   Tanaka A, 2005, J AM COLL CARDIOL, V45, P1594, DOI 10.1016/j.jacc.2005.01.053
   van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003
   van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wu XF, 2011, JACC-CARDIOVASC INTE, V4, P495, DOI 10.1016/j.jcin.2010.12.012
NR 52
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 259
EP 265
DI 10.4070/kcj.2015.45.4.259
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500001
PM 26240578
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KM
   Im, SI
   Chun, KJ
   Hwang, JK
   Park, SJ
   Kim, JS
   On, YK
AF Park, Kyoung-Min
   Im, Sung Ii
   Chun, Kwang Jin
   Hwang, Jin Kyung
   Park, Seung-Jung
   Kim, June Soo
   On, Young Keun
TI Coupling Interval Ratio Is Associated with Ventricular Premature
   Complex-Related Symptoms
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular premature complexes; Arrhythmias, cardiac;
   Electrocardiography
ID CATHETER ABLATION; INDUCED CARDIOMYOPATHY; REVERSAL; BEATS; BURDEN;
   ECTOPY
AB Background and Objectives: Frequent ventricular premature complex (VPC) is one of the most common arrhythmia syndromes. Symptoms observed frequently with this arrhythmia syndrome remain limited. We sought to identify predictors of VPC-related symptoms by analyzing demographic information, VPC burden, and VPC surface electrocardiogram characteristics.
   Subjects and Methods: We prospectively enrolled 109 patients with idiopathic outflow tract VPCs (63 males, 49 +/- 16 years old). They were divided into Group A (n=30, without VPC-related symptoms of palpitations or "dropped beats") and Group B (n=79, with VPC-related symptoms). Measured parameters were sinus and VPC QRS width, coupling interval (CI) between the previous sinus beat and VPC, CI ratio (% CI/sinus cycle length), post-VPC CI and CI ratio, and VPC amplitude.
   Results: Both groups had similar age (p=0.22), daily VPC burden (p=0.15), and VPC site of origin (p=0.36). The VPC CI ratio was higher in Group B (60 +/- 15%) than in Group A (49 +/- 22%) (p=0.01).
   Conclusion:VPC-related symptoms are associated with a higher VPC CI ratio (>50%). The physiologic basis for these results deserves further study.
C1 [Park, Kyoung-Min; Im, Sung Ii; Chun, Kwang Jin; Hwang, Jin Kyung; Park, Seung-Jung; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea.
RP Park, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, 81 Irwon Ro, Seoul 135710, South Korea.
EM kyongmin.park@gmail.com
CR Baman TS, 2010, HEART RHYTHM, V7, P865, DOI 10.1016/j.hrthm.2010.03.036
   Ban JE, 2013, KOREAN CIRC J, V43, P811, DOI 10.4070/kcj.2013.43.12.811
   Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003
   Chen JY, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.033
   Conti CR, 2005, CLIN CARDIOL, V28, P314, DOI 10.1002/clc.4960280702
   EBER LM, 1974, AM J CARDIOL, V33, P378, DOI 10.1016/0002-9149(74)90319-1
   Efremidis M, 2008, EUROPACE, V10, P769, DOI 10.1093/europace/eun060
   Gaita F, 2001, J AM COLL CARDIOL, V38, P364, DOI 10.1016/S0735-1097(01)01403-6
   Ghanbari H, 2010, EXPERT REV CARDIOVAS, V8, P651, DOI [10.1586/erc.10.25, 10.1586/ERC.10.25]
   Huizar JF, 2011, CIRC-ARRHYTHMIA ELEC, V4, P543, DOI 10.1161/CIRCEP.111.962381
   Jakopin J, 1979, Bibl Cardiol, P164
   KOMATSU T, 1993, JPN CIRC J, V57, P781, DOI 10.1253/jcj.57.781
   Migliore F, 2011, J CARDIOVASC MED, V12, P598, DOI 10.2459/JCM.0b013e328337591d
   MILLAR K, 1966, CIRC RES, V19, P481, DOI 10.1161/01.RES.19.3.481
   Mountantonakis SE, 2011, HEART RHYTHM, V8, P1608, DOI 10.1016/j.hrthm.2011.04.026
   OTSUJI Y, 1993, EUR HEART J, V14, P1044, DOI 10.1093/eurheartj/14.8.1044
   ROLFE SJ, 1984, AM J CARDIOL, V53, P1028, DOI 10.1016/0002-9149(84)90631-3
   Sarrazin JF, 2009, HEART RHYTHM, V6, P1543, DOI 10.1016/j.hrthm.2009.08.004
   Sun YP, 2003, INT J CARDIOVAS IMAG, V19, P295, DOI 10.1023/A:1025418531853
   Takemoto M, 2005, J AM COLL CARDIOL, V45, P1259, DOI 10.1016/j.jacc.2004.12.073
   THANAVARO S, 1983, AM HEART J, V106, P484, DOI 10.1016/0002-8703(83)90690-7
   Wilber DJ, 2009, HEART, V95, P1209, DOI 10.1136/hrt.2009.166579
   Yarlagadda RK, 2005, CIRCULATION, V112, P1092, DOI 10.1161/CIRCULATIONAHA.105.546432
   YELLIN EL, 1979, CIRC RES, V44, P712, DOI 10.1161/01.RES.44.5.712
   오혜림, 2003, Korean Circulation Journal, V33, P1118
NR 25
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 294
EP 300
DI 10.4070/kcj.2015.45.4.294
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500006
PM 26240583
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SB
   Choi, HS
   Son, S
   Hong, YM
AF Lee, Seul Bee
   Choi, Han Seul
   Son, Sejung
   Hong, Young Mi
TI Cardiac Function in Kawasaki Disease Patients with Respiratory Symptoms
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Reverse transcriptase polymerase
   chain reaction; Respiratory virus; Natriuretic peptide, brain;
   Echocardiography, Doppler
ID CONGESTIVE-HEART-FAILURE; VIRAL-INFECTIONS; TEI-INDEX; EPIDEMIOLOGIC
   FEATURES; DIAGNOSIS; CHILDREN; ASSOCIATION; ILLNESS; JAPAN; KOREA
AB Background and Objectives: Respiratory symptoms are often observed in children with Kawasaki disease (KD) during the acute phase. The association of respiratory viruses in children with KD was investigated using multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) and tissue Doppler echocardiography.
   Subjects and Methods: 138 KD patients were included from January 2010 to June 2013. We compared 3 groups (group 1: n=94, KD without respiratory symptoms; group 2: n=44, KD with respiratory symptoms; and group 3: n=50, febrile patients with respiratory symptoms). Laboratory data were obtained from each patient including N-terminal pro-brain natriuretic peptide (NT-proBNP). Echocardiographic measurements were compared between group 1 and group 2. RT-PCR was performed using nasopharyngeal secretion to screen for the presence of 14 viruses in groups 2 and 3.
   Results: The incidence of KD with respiratory symptoms was 31.8%. The duration of fever was significantly longer, and coronary artery diameter was larger in group 2 than in group 1. Tei index was significantly higher and coronary artery diameter larger in group 2 than group 1. Coronary artery diameter, C-reactive protein levels, platelet count, alanine aminotransferase levels, and NT-pro BNP levels were significantly higher and albumin levels lower in group 2 compared with group 3.
   Conclusion: NT-pro BNP was a valuable diagnostic tool in differentiating KD from other febrile viral respiratory infections. Some viruses were more frequently observed in KD patients than in febrile controls. Tei index using tissue Doppler imaging was increased in KD patients with respiratory symptoms.
C1 [Lee, Seul Bee; Choi, Han Seul; Son, Sejung; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM ymhong@ewha.ac.kr
CR Ajami G, 2010, CARDIOL YOUNG, V20, P44, DOI 10.1017/S1047951109991910
   Bae Hyun Kyung, 2014, Korean J Pediatr, V57, P357, DOI 10.3345/kjp.2014.57.8.357
   Brogan PA, 2002, ARCH DIS CHILD, V86, P286, DOI 10.1136/adc.86.4.286
   Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246
   Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002
   Burns JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074529
   Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008
   Chang LY, 2004, PEDIATRICS, V114, pE678, DOI 10.1542/peds.2004-0726
   DANDAH N, 2009, PEDIAT CARDIOL, V30, P810
   GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381
   Jaggi P, 2013, CLIN INFECT DIS, V56, P58, DOI 10.1093/cid/cis807
   Jordan-Villegas A, 2010, PEDIATR INFECT DIS J, V29, P770, DOI 10.1097/INF.0b013e3181dba70b
   KAWASAKI T, 1974, PEDIATRICS, V54, P271
   Kim GB, 2014, KOREAN CIRC J, V44, P250, DOI 10.4070/kcj.2014.44.4.250
   Kim Ja Hye, 2012, Korean J Pediatr, V55, P470, DOI 10.3345/kjp.2012.55.12.470
   Mejia AAS, 2014, PEDIATR CARDIOL, V35, P411, DOI 10.1007/s00246-013-0794-1
   Melish M E, 1996, Pediatr Rev, V17, P153, DOI 10.1542/pir.17-5-153
   Nakamura Y, 1987, Prog Clin Biol Res, V250, P19
   Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182
   Park YW, 2011, PEDIATR INT, V53, P36, DOI 10.1111/j.1442-200X.2010.03178.x
   Principi N, 2013, J INFECTION, V67, P1, DOI 10.1016/j.jinf.2013.04.004
   Rowley AH, 1999, PEDIATR CLIN N AM, V46, P313, DOI 10.1016/S0031-3955(05)70120-6
   Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
   Treadwell TA, 2002, PEDIATR INFECT DIS J, V21, P976, DOI 10.1097/00006454-200210000-00018
   Tsai HC, 2015, J FORMOS MED ASSOC, V114, P72, DOI 10.1016/j.jfma.2014.07.005
   Vijayan AP, 2009, INDIAN PEDIATR, V46, P607
   Wood LE, 2009, HEART, V95, P787, DOI 10.1136/hrt.2008.143669
   Yanagawa H, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e65
   Ye Q, 2015, INT J CARDIOL, V178, P5, DOI 10.1016/j.ijcard.2014.10.095
NR 30
TC 3
Z9 3
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 317
EP 324
DI 10.4070/kcj.2015.45.4.317
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500009
PM 26240586
OA Green Published
DA 2021-04-22
ER

PT J
AU Attar, A
   Aghasadeghi, K
   Parsanezhad, ME
   Jahromi, BN
   Habibagahi, M
AF Attar, Armin
   Aghasadeghi, Kamran
   Parsanezhad, Mohammad Ebrahim
   Jahromi, Bahia Namavar
   Habibagahi, Mojtaba
TI Absence of Correlation between Changes in the Number of Endothelial
   Progenitor Cell Subsets
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endothelial progenitor cells; Endothelium
ID NORMAL-PREGNANCY; IDENTITY
AB Background and Objectives: Previously, various methodologies were used to enumerate the endothelial progenitor cells (EPCs). We now know that these methodologies enumerate at least three different EPC subsets: circulating angiogenic cells (CACs), colony-forming unit endothelial cells (CFU-ECs), and endothelial colony-forming cells (ECFCs). It is not clear whether there is a correlation between changes in the number of these subsets. The aim of the current study is to find an answer to this question.
   Materials and Methods: The number of all EPC subsets was quantified in the peripheral blood of nine pregnant women in their first and third trimesters of pregnancy. We enumerated 14 cell populations by quantitative flow-cytometry using various combinations of the markers, CD34, CD133, CD309, and CD45, to cover most of the reported phenotypes of CACs and ECFCs. Culturing technique was used to enumerate the CFU-ECs. Changes in the number of cells were calculated by subtracting the number of cells in the first trimester peripheral blood from the number of cells in the third trimester peripheral blood, and correlations between these changes were analyzed.
   Results: The number of CFU-ECs did not correlate with the number of ECFCs and CACs. Also, CACs and ECFCs showed independent behaviors. However, the number of CACs showed a strong correlation with the number of CD133(+)CD309(+) cells (p=0.001) and a moderate correlation with the number of CD34(+)CD309(+) cells (p=0.042). Also, the number of ECFCs was correlated with the number of CD309(+)CD45(-) cells (p=0.029) and CD34(+)CD45(-) cells (p=0.03).
   Conclusion: Our study showed that the three commonly used methods for quantifying EPC subsets represent different cells with independent behaviors. Also, any study that measured the number of EPCs using the flow cytometry method with a marker combination that lacks CD309 may be inaccurate.
C1 [Attar, Armin; Aghasadeghi, Kamran] Shiraz Univ Med Sci, Sch Med, Dept Cardiovasc Med, Shiraz 713441864, Iran.
   [Attar, Armin] Shiraz Univ Med Sci, Sch Med, Cell & Mol Med Res Club, Shiraz 713441864, Iran.
   [Attar, Armin] Shiraz Univ Med Sci, Sch Med, Student Res Comm, Shiraz 713441864, Iran.
   [Aghasadeghi, Kamran] Shiraz Univ Med Sci, Cardiovasc Res Ctr, Sch Med, Shiraz 713441864, Iran.
   [Parsanezhad, Mohammad Ebrahim] Shiraz Univ Med Sci, Sch Med, Div Infertil & Reprod Med, Dept OB GYN, Shiraz 713441864, Iran.
   [Parsanezhad, Mohammad Ebrahim] Shiraz Univ Med Sci, Sch Med, Infertil & Reprod Med Res Ctr, Shiraz 713441864, Iran.
   [Jahromi, Bahia Namavar] Shiraz Univ Med Sci, Sch Med, Perinatol Res Ctr, Infertil Res Ctr,Dept OB GYN, Shiraz 713441864, Iran.
   [Habibagahi, Mojtaba] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz 713441864, Iran.
RP Aghasadeghi, K (corresponding author), Shiraz Univ Med Sci, Cardiovasc Res Ctr, Dept Cardiovasc Med, Shiraz 713441864, Iran.
EM aghasadk@sums.ac.ir
RI Jahromi, Bahia Namavar/AAA-3982-2021; aghasadeghi, kamran/D-2847-2018;
   Parsanezhad, Mohammad Ebrahim/ABF-6802-2020; Jahromi, Bahia
   Namavar/D-9736-2012; Attar, Armin/E-3891-2018; Kojuri, Javad/D-2830-2018
OI Jahromi, Bahia Namavar/0000-0002-7839-9627; aghasadeghi,
   kamran/0000-0002-8159-6365; Parsanezhad, Mohammad
   Ebrahim/0000-0003-2057-7758; Jahromi, Bahia Namavar/0000-0002-7839-9627;
   Attar, Armin/0000-0002-4133-4870; Kojuri, Javad/0000-0001-8909-897X
FU Shiraz University of Medical Sciences [93-7682]
FX This investigation is the result of a thesis supported by the research
   grant #93-7682 from the Vice Chancellor of research at Shiraz University
   of Medical Sciences. The authors would like to thank Dr. Nasrin
   Shokrpour working at the Center for Development of Clinical Research of
   Nemazee Hospital for the editorial assistance.
CR Allanore Y, 2007, CLIN EXP RHEUMATOL, V25, P60
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Attar Armin, 2013, Iranian Biomedical Journal, V17, P146, DOI 10.6091/ibj.1100.2013
   Buemi M, 2007, AM J OBSTET GYNECOL, V196, P68, DOI 10.1016/j.ajog.2006.08.032
   Davani S, 2010, ATHEROSCLEROSIS, V210, P48, DOI 10.1016/j.atherosclerosis.2009.11.041
   Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93
   George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331
   Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101
   Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040
   Lin C, 2009, AM J HYPERTENS, V22, P1014, DOI 10.1038/ajh.2009.101
   Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007
   Parsanezhad ME, 2015, J CHIN MED ASSOC, V78, P345, DOI 10.1016/j.jcma.2015.03.013
   Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958
   Povsic TJ, 2009, AM HEART J, V157, P335, DOI 10.1016/j.ahj.2008.10.010
   Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4
   Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761
   Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x
   Tura O, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-53
   Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
NR 23
TC 12
Z9 12
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 325
EP 332
DI 10.4070/kcj.2015.45.4.325
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500010
PM 26240587
OA Green Published
DA 2021-04-22
ER

PT J
AU Varetto, G
   Gibello, L
   Trevisan, A
   Castagno, C
   Garneri, P
   Rispoli, P
AF Varetto, Gianfranco
   Gibello, Lorenzo
   Trevisan, Alessandra
   Castagno, Claudio
   Garneri, Paolo
   Rispoli, Pietro
TI Primary Aortoenteric Fistula of a Saccular Aneurysm: Case Study and
   Literature Review
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic aneurysm; abdominal; Complications; Fistula
ID PRIMARY AORTODUODENAL FISTULA; AORTIC GRAFT; REPAIR
AB Primary aortoenteric fistula is a direct communication between the aorta and intestinal lumen and it represents a rare but potentially lethal complication of an abdominal aortic aneurysm. However, it may occur less frequently in a naive non-aneurysmatic aorta. Diagnosis is often difficult and delayed in most cases, unless there is a high level of clinical awareness. Urgent surgery is still the recommended treatment. We describe the case of primary aortoenteric fistula of a saccular aneurysm. A 55-year-old woman was referred to our center with hematemesis, melena, and severe anemia who was dignosed previously with unknown saccular abdominal aneurysm.
C1 [Varetto, Gianfranco; Gibello, Lorenzo; Trevisan, Alessandra; Castagno, Claudio; Garneri, Paolo; Rispoli, Pietro] AOU Citta Salute & Sci, Dept Surg Sci, Div Vasc Surg, I-10126 Turin, Italy.
RP Varetto, G (corresponding author), AOU Citta Salute & Sci, Dept Surg Sci, Div Vasc Surg, Corso Bramante 88, I-10126 Turin, Italy.
EM gianfranco.varetto@unito.it
OI Varetto, Gianfranco/0000-0003-4262-886X; Gibello,
   Lorenzo/0000-0002-9825-031X; RISPOLI, PIETRO/0000-0003-3336-9122
CR Bala M, 2009, WORLD J GASTROENTERO, V15, P3191, DOI 10.3748/wjg.15.3191
   Berger P, 2011, SEMIN VASC SURG, V24, P205, DOI 10.1053/j.semvascsurg.2011.10.011
   Bisdas T, 2010, J VASC SURG, V52, P323, DOI 10.1016/j.jvs.2010.02.277
   Chenu C, 2009, EUR J VASC ENDOVASC, V37, P401, DOI 10.1016/j.ejvs.2008.11.037
   Chung J, 2011, SEMIN VASC SURG, V24, P220, DOI 10.1053/j.semvascsurg.2011.10.012
   Danneels MIL, 2006, EUR J VASC ENDOVASC, V32, P27, DOI 10.1016/j.ejvs.2005.11.031
   Genoves-Gasco B, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.11.030
   Kim Jae Su, 2013, Korean J Gastroenterol, V61, P343
   Lawlor D K, 2004, Vasc Endovascular Surg, V38, P281, DOI 10.1177/153857440403800315
   Lee Chung Won, 2012, Korean J Thorac Cardiovasc Surg, V45, P330, DOI 10.5090/kjtcs.2012.45.5.330
   Lemos DW, 2003, J VASC SURG, V37, P686, DOI 10.1067/mva.2003.101
   Malas MB, 2011, VASC ENDOVASC SURG, V45, P83, DOI 10.1177/1538574410380793
   Philippakis GE, 2013, INT J SURG CASE REP, V4, P477, DOI 10.1016/j.ijscr.2013.01.024
   Ramanujam S, 2004, GASTROINTEST ENDOSC, V59, P300, DOI 10.1016/S0016-5107(03)02357-5
   Ranasinghe W, 2011, ANN VASC SURG, V25, DOI 10.1016/j.avsg.2010.09.021
   Saers SJF, 2005, BRIT J SURG, V92, P143, DOI 10.1002/bjs.4928
   Senadhi V, 2010, CASE REP GASTROENTER, V4, P510
   Setacci C, 2011, SEMIN VASC SURG, V24, P242, DOI 10.1053/j.semvascsurg.2011.10.009
   Shulik O, 2013, AM J CASE REP, V14, P194, DOI 10.12659/AJCR.889277
   Song Y, 2008, SURGERY, V143, P43, DOI 10.1016/j.surg.2007.06.036
NR 20
TC 4
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 337
EP 339
DI 10.4070/kcj.2015.45.4.337
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500012
PM 26240589
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, PS
   Park, JW
   Lee, YJ
   Kim, DJ
   You, SC
   Park, DH
   Uhm, JS
   Kim, NK
AF Yang, Pil-Sung
   Park, Je Wook
   Lee, Yong-Joon
   Kim, Dong-Jun
   You, Seng Chan
   Park, Dong Hyuk
   Uhm, Jae-Sun
   Kim, Nam Kyun
TI Transvascular Implantation of an Implantable Cardioverter-Defibrillator
   in a Patient Who has Undergone One-and-a-Half Ventricle Repair
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter-defibrillator; Heart defects; congenital;
   Arrhythmogenic right ventricular dysplasia; Bidirectional cavopulmonary
   shunt
ID EXPERIENCE
AB Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden cardiac death, which is a major cause of mortality in adult congenital heart disease patients. But ICD implantation by the conventional transvascular approach is not always possible in patients who have undergone palliative surgery due to congenital and structural heart disease. Here, we report a case in which an ICD was transvascularly implanted in an arrhythmogenic right ventricular cardiomyopathy patient who had undergone a one-and-a-half ventricle repair.
C1 [Yang, Pil-Sung; Park, Je Wook; Lee, Yong-Joon; Kim, Dong-Jun; You, Seng Chan; Park, Dong Hyuk; Uhm, Jae-Sun] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Cardiol,Arrhythmia Ctr, Seoul 120749, South Korea.
   [Kim, Nam Kyun] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Pediat Cardiol,Arrhythmia Ctr, Seoul 120749, South Korea.
RP Kim, NK (corresponding author), Severance Cardiovasc Hosp, Arrhythmia Ctr, Dept Pediat Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM pednk@yuhs.ac
OI Yang, Pil-sung/0000-0002-6552-1742
CR Akerstrom F, 2013, WORLD J CARDIOL, V5, P347, DOI 10.4330/wjc.v5.i9.347
   Cannon BC, 2006, PACE, V29, P181, DOI 10.1111/j.1540-8159.2006.00314.x
   Khanna AD, 2011, AM J CARDIOL, V108, P729, DOI 10.1016/j.amjcard.2011.04.020
   Koyak Z, 2012, CIRCULATION, V126, P1944, DOI 10.1161/CIRCULATIONAHA.112.104786
   Kreutzer C, 1999, J THORAC CARDIOV SUR, V117, P662, DOI 10.1016/S0022-5223(99)70285-0
   Lambiase PD, 2014, EUR HEART J, V35, P1657, DOI 10.1093/eurheartj/ehu112
   Mondesert B, 2014, CURR OPIN CARDIOL, V29, P45, DOI 10.1097/HCO.0000000000000019
   Nery PB, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2012.04.020
   Uyeda T, 2012, PEDIATR INT, V54, P379, DOI 10.1111/j.1442-200X.2011.03556.x
   WINKLE RA, 1989, J AM COLL CARDIOL, V13, P1353, DOI 10.1016/0735-1097(89)90310-0
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 344
EP 347
DI 10.4070/kcj.2015.45.4.344
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500014
PM 26240591
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, HK
   Kang, SY
   Yu, JJ
   Jae-Kon, K
   Kim, YH
AF Ko, Hong Ki
   Kang, So Yeon
   Yu, Jeong Jin
   Jae-Kon, Ko
   Kim, Young-Hwue
TI Small Left Atrial Size Complicating Percutaneous Transcatheter Device
   Closure of Secundum Atrial Septal Defect with Conventional Approach (vol
   45, pg 216, 2015)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Ko, Hong Ki] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Pediat, Suwon 441749, South Korea.
   [Kang, So Yeon; Yu, Jeong Jin; Jae-Kon, Ko; Kim, Young-Hwue] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pediat Cardiol,Dept Pediat, Seoul, South Korea.
RP Ko, HK (corresponding author), Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Pediat, Suwon 441749, South Korea.
CR Ko HK, 2015, KOREAN CIRC J, V45, P216, DOI 10.4070/kcj.2015.45.3.216
NR 1
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 348
EP 348
DI 10.4070/kej.2015.45.4.348
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500015
PM 26240592
DA 2021-04-22
ER

PT J
AU Yilmaz, S
   Canpolat, U
   Aydogdu, S
   Abboud, HE
AF Yilmaz, Samet
   Canpolat, Ugur
   Aydogdu, Sinan
   Abboud, Hanna Emily
TI Diabetic Cardiomyopathy; Summary of 41 Years
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Diabetic cardiomyopathies; Heart failure; Diabetes mellitus
ID GLYCATION END-PRODUCTS; HEART-FAILURE; DIASTOLIC DYSFUNCTION; CARDIAC
   STRUCTURE; INSULIN-RESISTANCE; MELLITUS; GLUCOSE; MITOCHONDRIA;
   PREVENTS; IMPACT
AB Patients with diabetes have an increased risk for development of cardiomyopathy, even in the absence of well known risk factors like coronary artery disease and hypertension. Diabetic cardiomyopathy was first recognized approximately four decades ago. To date, several pathophysiological mechanisms thought to be responsible for this new entity have also been recognized. In the presence of hyperglycemia, non-enzymatic glycosylation of several proteins, reactive oxygen species formation, and fibrosis lead to impairment of cardiac contractile functions. Impaired calcium handling, increased fatty acid oxidation, and increased neurohormonal activation also contribute to this process. Demonstration of left ventricular hypertrophy, early diastolic and late systolic dysfunction by sensitive techniques, help us to diagnose diabetic cardiomyopathy. Traditional treatment of heart failure is beneficial in diabetic cardiomyopathy, but specific strategies for prevention or treatment of cardiac dysfunction in diabetic patients has not been clarified yet. In this review we will discuss clinical and experimental studies focused on pathophysiology of diabetic cardiomyopathy, and summarize diagnostic and therapeutic approaches developed towards this entity.
C1 [Yilmaz, Samet; Canpolat, Ugur; Aydogdu, Sinan] Turkey Yuksek Ihtisas Educ & Res Hosp, Cardiol Clin, TR-06100 Ankara, Turkey.
   [Abboud, Hanna Emily] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, San Antonio, DC USA.
RP Yilmaz, S (corresponding author), Turkey Yuksek Ihtisas Educ & Res Hosp, Cardiol Clin, TR-06100 Ankara, Turkey.
EM sametyilmazmd@gmail.com
RI Canpolat, Ugur/S-3482-2018; YILMAZ, SAMET/Q-5077-2016
OI Canpolat, Ugur/0000-0002-4250-1706; YILMAZ, SAMET/0000-0002-8445-1911
CR Adal E, 2006, J PEDIATR ENDOCR MET, V19, P713
   Amin AH, 2015, EUR J PHARMACOL, V747, P166, DOI 10.1016/j.ejphar.2014.12.002
   Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046
   Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570
   Bella JN, 2001, AM J CARDIOL, V87, P1260, DOI 10.1016/S0002-9149(01)01516-8
   Berg TJ, 1999, DIABETES CARE, V22, P1186, DOI 10.2337/diacare.22.7.1186
   Bonito P, 2005, DIABETIC MED, V22, P1720, DOI 10.1111/j.1464-5491.2005.01685.x
   Brooks BA, 2008, DIABETES OBES METAB, V10, P739, DOI 10.1111/j.1463-1326.2007.00803.x
   Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239
   Cai L, 2005, DIABETES, V54, P1829, DOI 10.2337/diabetes.54.6.1829
   Cay S, 2008, BLOOD PRESSURE, V17, P164, DOI 10.1080/08037050802218417
   Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242
   Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271
   Dobrin JS, 2010, EXPERT REV CARDIOVAS, V8, P373, DOI [10.1586/erc.10.17, 10.1586/ERC.10.17]
   Falcao-Pires I, 2011, BASIC RES CARDIOL, V106, P801, DOI 10.1007/s00395-011-0184-x
   Feliers D, 2006, AM J PHYSIOL-RENAL, V290, pF927, DOI 10.1152/ajprenal.00331.2005
   Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008
   From AM, 2006, AM J MED, V119, P591, DOI 10.1016/j.amjmed.2006.05.024
   He YM, 2012, CLIN CARDIOL, V35, P505, DOI 10.1002/clc.21985
   Huisamen B, 2001, MOL CELL BIOCHEM, V223, P15, DOI 10.1023/A:1017528402205
   Jellis CL, 2011, AM J CARDIOL, V107, P615, DOI 10.1016/j.amjcard.2010.10.024
   Jweied EE, 2005, AM J PHYSIOL-HEART C, V289, pH2478, DOI 10.1152/ajpheart.00638.2005
   Kiencke S, 2010, EUR J HEART FAIL, V12, P951, DOI 10.1093/eurjhf/hfq110
   Lapolla A, 2007, DIABETES CARE, V30, P670, DOI 10.2337/dc06-1508
   Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011
   Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4
   Malhotra A, 1997, CARDIOVASC RES, V34, P34, DOI 10.1016/S0008-6363(97)00059-X
   Nielsen JM, 2009, EUR J HEART FAIL, V11, P638, DOI 10.1093/eurjhf/hfp070
   Nozynski J, 2011, J HEART LUNG TRANSPL, V30, P558, DOI 10.1016/j.healun.2010.11.006
   Palmieri V, 2008, DIABETES RES CLIN PR, V79, P262, DOI 10.1016/j.diabres.2007.09.014
   Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037
   Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284
   Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8
   Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062
   Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030
   RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4
   Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98
   Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025
   Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270
   Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002
   Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039
   Shishehbor MH, 2003, AM J CARDIOL, V91, P1514, DOI 10.1016/S0002-9149(03)00414-4
   Shivalkar B, 2006, AM J CARDIOL, V97, P77, DOI 10.1016/j.amjcard.2005.07.111
   Thomas CM, 2014, AM J PHYSIOL-HEART C, V307, pH1036, DOI 10.1152/ajpheart.00340.2014
   Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200
   Velagaleti RS, 2010, CIRC-CARDIOVASC IMAG, V3, P257, DOI 10.1161/CIRCIMAGING.109.911438
   von Bibra H, 2004, HEART, V90, P1483, DOI 10.1136/hrt.2003.020842
   von Bibra H, 2010, DIABETOLOGIA, V53, P1033, DOI 10.1007/s00125-010-1682-3
   Wu MS, 2008, BRIT J PHARMACOL, V154, P758, DOI 10.1038/bjp.2008.119
   Yoshida N, 2005, METABOLISM, V54, P345, DOI 10.1016/j.metabol.2004.09.014
NR 50
TC 38
Z9 43
U1 0
U2 15
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 266
EP 272
DI 10.4070/kcj.2015.45.4.266
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500002
PM 26240579
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, MJ
   Oh, S
AF Cha, Myung-Jin
   Oh, Seil
TI The Theory of Relativity in E (ectopy) and C (coupling): Who Will Prove
   It?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTERVAL
C1 [Cha, Myung-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM seil@snu.ac.kr
RI Oh, Seil/J-5539-2012
OI Oh, Seil/0000-0002-2504-9615
CR Jin SW, 1999, KOREAN CIRC J, V29, P697
   Munoz FD, 2011, J CARDIOVASC ELECTR, V22, P791, DOI 10.1111/j.1540-8167.2011.02021.x
   Park KM, 2015, EUROPACE
   Park KM, 2015, KOREAN CIRC J, V45, P294, DOI 10.4070/kcj.2015.45.4.294
   Sun YP, 2003, INT J CARDIOVAS IMAG, V19, P295, DOI 10.1023/A:1025418531853
   THANAVARO S, 1983, AM HEART J, V106, P484, DOI 10.1016/0002-8703(83)90690-7
   Wilber DJ, 2009, HEART, V95, P1209, DOI 10.1136/hrt.2009.166579
   Yokokawa M, 2012, HEART RHYTHM, V9, P92, DOI 10.1016/j.hrthm.2011.08.015
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 273
EP 274
DI 10.4070/kcj.2015.45.4.273
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500003
PM 26240580
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kim, JH
   Jeong, MH
   Park, H
   Jeong, YA
   Ahn, Y
   Kim, JH
   Chae, SC
   Kim, YJ
   Hur, SH
   Seong, IW
   Hong, TJ
   Choi, D
   Cho, MC
   Kim, CJ
   Seung, KB
   Chung, WS
   Jang, YS
   Cho, JG
   Park, JC
   Park, SJ
AF Lee, Seung Hun
   Kim, Ju Han
   Jeong, Myung Ho
   Park, Hyukjin
   Jeong, Yun Ah
   Ahn, Youngkeun
   Kim, Jong Hyun
   Chae, Shung Chull
   Kim, Young Jo
   Hur, Seung Ho
   Seong, In Whan
   Hong, Taek Jong
   Choi, Donghoon
   Cho, Myeong Chan
   Kim, Chong Jin
   Seung, Ki Bae
   Chung, Wook Sung
   Jang, Yang Soo
   Cho, Jeong Gwan
   Park, Jong Chun
   Park, Seung Jung
CA Other Korea Acute Myocardial Infar
TI Clinical Characteristics and Outcomes of Acute ST-Segment Elevation
   Myocardial Infarction in Younger Korean Adults
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Young adult; Prognosis
ID HEART-DISEASE; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; REGISTRY;
   OBESITY; DEFINITION; COMMITTEE; UPDATE; STROKE
AB Background and Objectives: This study aims to investigate the clinical features, angiographic findings, and outcomes of younger Korean ST-segment elevation myocardial infarction (STEMI) patients.
   Subjects and Methods: We analyzed major adverse cardiac events (MACE) in the Korea Acute Myocardial Infarction Registry from November 2005 to October 2010. The registered patients were divided into two groups; young age group (<65 years) and old age group (>= 65 years).
   Results: The young age group included 5281 patients (age, 53 +/- 7.8 years), and the old age group included 4896 patients (age, 74.3 +/- 6.5 years). Male gender, smoking, family history, dyslipidemia, and metabolic syndrome were more frequently observed in the young age group than in the old age group (89.5% vs. 59.3%, p<0.001; 77.3% vs. 47.2%, p<0.001; 11% vs. 4.6%, p<0.001; 11.2% vs. 7.7%, p<0.001; 67.6% vs. 62.9%, p<0.001). Most of the young Korean adults with STEMI complained of typical chest pain (89.8%), and they had a shorter symptom-to-door time (12 +/- 53.2 hours vs. 17.3 +/- 132 hours, p=0.010). The young age group showed a favorable prognosis, which was represented by the MACE, compared with the old age group at one month (1.8% vs. 2.80/0, p=0.028), six months (6.80/0 vs. 8.2%, p<0.001), and twelve months (10.1% vs. 11.9%, p=0.025). However, there was no significant difference in the adjusted MACE rate at one month {hazard ratio (HR) 0.95, 95% confidence interval (CI) 0.60-1.51, p=0.828} and twelve months (HR 0.86, 95% CI 0.68-1.10, p=0.233).
   Conclusion: Younger Korean adults with STEMI have clinical outcomes similar to old aged patients, and therefore, they should be treated intensively like the elderly patients.
C1 [Lee, Seung Hun; Kim, Ju Han; Jeong, Myung Ho; Park, Hyukjin; Jeong, Yun Ah; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ Hosp, Ctr Heart, Gwangju 501757, South Korea.
   [Kim, Jong Hyun] Hanseo Hosp, Ctr Cardiovasc, Busan, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Daegu, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Daegu, South Korea.
   [Seong, In Whan] Chungnam Natl Univ Hosp, Dept Internal Med, Taejon, South Korea.
   [Hong, Taek Jong] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.
   [Choi, Donghoon; Jang, Yang Soo] Yonsei Univ, Severans Hosp, Dept Internal Med, Seoul 120749, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Seung, Ki Bae; Chung, Wook Sung] Catholic Univ, Korea Hosp, Dept Internal Med, Seoul, South Korea.
   [Park, Seung Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
RP Kim, JH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, 42 Jebong Ro, Gwangju 501757, South Korea.
EM kim@zuhan.com
OI Jeong, Jin-Ok/0000-0003-0763-4754; Seong, In-Whan/0000-0003-4628-0258
CR BARBASH GI, 1995, EUR HEART J, V16, P313
   Bhatia Lovleen C, 2013, J Cardiovasc Dis Res, V4, P107, DOI 10.1016/j.jcdr.2012.07.003
   Choudhury L, 1999, AM J MED, V107, P254, DOI 10.1016/S0002-9343(99)00218-1
   Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86
   FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q
   French JK, 2004, HEART, V90, P99, DOI 10.1136/heart.90.1.99
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2
   Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149
   Jinnouchi H, 2013, INT HEART J, V54, P123, DOI 10.1536/ihj.54.123
   Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Lee SR, 2008, CIRC J, V72, P392, DOI 10.1253/circj.72.392
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Morillas P, 2007, CARDIOLOGY, V107, P217, DOI 10.1159/000095421
   Newby DE, 1999, CIRCULATION, V99, P1411, DOI 10.1161/01.CIR.99.11.1411
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, N ENGL J MED, V312, P932
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   ZIMMERMAN FH, 1995, J AM COLL CARDIOL, V26, P654, DOI 10.1016/0735-1097(95)00254-2
NR 25
TC 13
Z9 14
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 275
EP 284
DI 10.4070/kcj.2015.45.4.275
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500004
PM 26240581
OA Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Ahn, Y
   Kim, YH
   Seon, HJ
   Park, KH
   Yoon, HJ
   Yoon, NS
   Kim, KH
   Hong, YJ
   Park, HW
   Kim, JH
   Jeong, MH
   Cho, JG
   Park, JC
AF Sim, Doo Sun
   Ahn, Youngkeun
   Kim, Yun-Hyeon
   Seon, Hyun Ju
   Park, Keun Ho
   Yoon, Hyun Ju
   Yoon, Nam Sik
   Kim, Kye Hun
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
TI The Relationship among N-Terminal Pro-B-Type Natriuretic Peptide,
   High-Sensitivity C-Reactive Protein and Infarct Size in Patients with
   Acute ST-Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Multidetector computed tomography; C-reactive
   protein; Pro-brain natriuretic peptide (1-76)
ID PERCUTANEOUS CORONARY INTERVENTION; COMPUTED-TOMOGRAPHY; DELAYED
   ENHANCEMENT; PROGNOSTIC VALUE; ANGIOGRAPHIC ASSESSMENT; REPERFUSION;
   MORTALITY; RISK; ASSOCIATION; PREDICTION
AB Background and Objectives: We sought to investigate the relationship between levels of high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and the infarct size and left ventricular (LV) volume after acute myocardial infarction (MI).
   Subjects and Methods: Eighty-six patients with acute ST-elevation MI underwent delayed enhancement multidetector computed tomography immediately after they underwent percutaneous coronary intervention to determine the infarct size. LV function and remodeling were assessed by echocardiography. Hs-CRP and NT-proBNP were measured at admission, 24 hours and two months later.
   Results: Both hs-CRP and NT-proBNP at 24 hours showed a positive correlation with infarct size and a negative correlation with LV ejection fraction at the baseline and two months later. NT-proBNP at two months correlated with infarct size, LV ejection fraction, and LV end diastolic and systolic volume indices at two months. In patients with high NT-proBNP levels at 24 hours and two months, infarct size was larger and LV ejection fraction was lower. NT-proBNP was higher in patients who developed LV remodeling at two months: 929 pg/mL vs. 134 pg/mL, p=0.002. In contrast, hs-CRP at two months showed no relationship to infarct size, LV function, or LV volumes at two months.
   Conclusion: Elevated hs-CRP level 24 hours after the onset of acute MI is associated with infarct size and LV dysfunction, whereas elevated levels of NT-proBNP 24 hours and two months after the onset of acute MI are both correlated with infarct size, LV dysfunction, and LV remodeling.
C1 [Sim, Doo Sun; Ahn, Youngkeun; Park, Keun Ho; Yoon, Hyun Ju; Yoon, Nam Sik; Kim, Kye Hun; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Ctr Cardiovasc, Dept Cardiol,Res Inst Med Sci, Gwangju 501757, South Korea.
   [Kim, Yun-Hyeon; Seon, Hyun Ju] Chonnam Natl Univ Hosp, Dept Radiol, Gwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Ctr Cardiovasc, Dept Cardiol, 671 Jebong Ro, Gwangju 501757, South Korea.
EM cecilyk@hanmail.net
FU National Research Foundation of Korea - Korean Government (MEST)Ministry
   of Education, Science and Technology, Republic of KoreaNational Research
   Foundation of KoreaKorean Government [2010-0020261]; Korean Health
   Technology R&D Project, and Korea's Ministry of Health Welfare
   [HI12C0199, HI13C1527]
FX This study was supported by a grant from the National Research
   Foundation of Korea, which is funded by the Korean Government (MEST)
   (No. 2010-0020261), and the Korean Health Technology R&D Project, and
   Korea's Ministry of Health & Welfare (HI12C0199, HI13C1527).
CR Anzai T, 1997, CIRCULATION, V96, P778
   Bolognese L, 1997, CIRCULATION, V96, P3353
   Boussel L, 2008, AM J ROENTGENOL, V191, P441, DOI 10.2214/AJR.07.3404
   Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB
   Harb TS, 2002, AM J CARDIOL, V89, P216, DOI 10.1016/S0002-9149(01)02204-4
   Hu XZ, 2006, J CLIN LAB ANAL, V20, P19, DOI 10.1002/jcla.20094
   Ibrahim T, 2010, RADIOLOGY, V254, P88, DOI 10.1148/radiol.09090660
   James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC
   Khan SQ, 2008, HEART, V94, P40, DOI 10.1136/hrt.2006.108985
   Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663
   Kwon TG, 2009, INT J CARDIOL, V133, P173, DOI 10.1016/j.ijcard.2007.12.022
   Mayr A, 2011, INT J CARDIOL, V147, P118, DOI 10.1016/j.ijcard.2009.09.537
   Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033
   MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82
   Nagaya N, 1998, AM HEART J, V135, P21, DOI 10.1016/S0002-8703(98)70338-2
   Ohlmann P, 2006, AM HEART J, V152, P1161, DOI 10.1016/j.ahj.2006.07.016
   Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
   Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9
   Rodriguez-Granillo GA, 2009, JACC-CARDIOVASC IMAG, V2, P1072, DOI 10.1016/j.jcmg.2009.03.023
   Sadanandan S, 2004, J AM COLL CARDIOL, V44, P564, DOI 10.1016/j.jacc.2004.03.072
   Sato A, 2012, J AM COLL CARDIOL, V59, P730, DOI 10.1016/j.jacc.2011.10.890
   Sim DS, 2013, INT J CARDIOL, V168, P4328, DOI 10.1016/j.ijcard.2013.05.088
   Suleiman M, 2006, J AM COLL CARDIOL, V47, P962, DOI 10.1016/j.jacc.2005.10.055
   Suleiman M, 2003, AM J MED, V115, P695, DOI 10.1016/j.amjmed.2003.06.008
   Suzuki S, 2004, CIRCULATION, V110, P1387, DOI 10.1161/01.CIR.0000141295.60857.30
   Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244
   Uehara K, 2003, HEART VESSELS, V18, P67, DOI 10.1007/s10380-003-0692-2
   van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302
   vantHof AWJ, 1997, LANCET, V350, P615, DOI 10.1016/S0140-6736(96)07120-6
NR 30
TC 8
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 285
EP 293
DI 10.4070/kcj.2015.45.4.285
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500005
PM 26240582
OA Green Published
DA 2021-04-22
ER

PT J
AU Moon, J
   Lee, HJ
   Kim, JY
   Pak, HN
   Lee, MH
   Kim, YJ
   Joung, B
AF Moon, Jeonggeun
   Lee, Hye-Jeong
   Kim, Jong-Youn
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Kim, Young Jin
   Joung, Boyoung
TI Prognostic Implications of Right and Left Atrial Enlargement after
   Radiofrequency Catheter Ablation in Patients with Nonvalvular Atrial
   Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Right atrium; Left atrium; Atrial fibrillation; Catheter ablation;
   Prognosis
ID PULMONARY VEIN ISOLATION; EARLY RECURRENCE; ANTRUM ISOLATION; DELAYED
   CURE; PREDICTORS; TACHYARRHYTHMIAS
AB Background and Objectives: The prognostic role of the right atrium (RA) compared with that of the left atrium (LA) is unclear in patients with atrial fibrillation (AF). We assessed structural changes in both atria and determined their association with recurrence of AF after radiofrequency catheter ablation (RFCA).
   Subjects and Methods: All 111 patients with nonvalvular AF (87 men; mean age, 57 +/- 11 years; 68 with paroxysmal AF) who underwent RFCA were enrolled consecutively. Three-dimensional volumes of both atria measured from computed tomography images were compared between subjects with and without recurrence of AF during the follow-up.
   Results: Early (<3 months), 6-month, and 1-year recurrence was documented in 26 (24%), 30 (27%), and 36 (32%) patients, respectively. Significantly larger RA and LA volume indices (RAVI and LAVI) were observed in the early, 6-month, and 1-year recurrence groups (p<0.05 for all). In multivariate analysis, Early recurrence was independently associated with RAVI (for each 10 mL/m2 increase; odds ratio [OR], 1.31; 95% confidence interval [CI], 1.03-1.66, p = 0.03), but not with LAVI. However, both RAVI and LAVI failed to predict 6-month outcomes independently. LAVI was the only independent predictor of 1-year recurrence (for each 10 mL/m2 increase; OR, 1.36; 95% CI, 1.08-1.71, p=0.009).
   Conclusion: RA enlargement was more closely related to early recurrence of AF after RFCA than LA size. However, LA size, rather than RA volume, was a determinant of long-term AF prognosis after RFCA. These findings suggest a temporal pattern in the prognostic implication of enlargement in each atrium that switches over time after RFCA for AF.
C1 [Moon, Jeonggeun] Gachon Univ Med & Sci, Dept Internal Med, Div Cardiol, Inchon, South Korea.
   [Lee, Hye-Jeong; Kim, Young Jin] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul 120752, South Korea.
   [Kim, Jong-Youn; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 120752, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM cby6908@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620; Lee, Hye-Jeong/0000-0003-4349-9174;
   Lee, Moon-Hyoung/0000-0002-7268-0741; Kim, Young
   Jin/0000-0002-6235-6550; Joung, Boyoung/0000-0001-9036-7225; Kim,
   Jong-Youn/0000-0001-7040-8771
FU Korea Society of Cardiology
FX This study was supported by a grant from the Korea Society of Cardiology
   (2012).
CR Akutsu Y, 2011, CIRC-CARDIOVASC IMAG, V4, P524, DOI 10.1161/CIRCIMAGING.110.962761
   Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4
   Andrade JG, 2012, PACE, V35, P106, DOI 10.1111/j.1540-8159.2011.03256.x
   Arya A, 2010, EUROPACE, V12, P173, DOI 10.1093/europace/eup331
   Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157
   Avitall B, 2008, HEART RHYTHM, V5, P839, DOI 10.1016/j.hrthm.2008.02.042
   Bauer A, 2004, CARDIOVASC RES, V61, P764, DOI 10.1016/j.cardiores.2003.12.013
   Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014
   Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005
   Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825
   Hof IE, 2011, EUROPACE, V13, P371, DOI 10.1093/europace/euq464
   Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2
   Jiang H, 2006, J INTERV CARD ELECTR, V15, P157, DOI 10.1007/s10840-006-9003-y
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lee SH, 2004, J INTERV CARD ELECTR, V10, P221, DOI 10.1023/B:JICE.0000026915.02503.92
   Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87
   Luong C, 2015, CAN J CARDIOL, V31, P29, DOI 10.1016/j.cjca.2014.10.009
   Moon J, 2012, CIRC J, V76, P860, DOI 10.1253/circj.CJ-11-1232
   O'Donnell D, 2003, AM J CARDIOL, V91, P83, DOI 10.1016/S0002-9149(02)03005-9
   O'Neill MD, 2006, J INTERV CARD ELECTR, V16, P153, DOI 10.1007/s10840-006-9045-1
   Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7
   SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792
   Schoonderwoerd BA, 2004, J CARDIOVASC ELECTR, V15, P1167, DOI 10.1046/j.1540-8167.2004.03693.x
   Schotten U, 2001, CIRCULATION, V103, P691
   Themistoclakis S, 2008, HEART RHYTHM, V5, P679, DOI 10.1016/j.hrthm.2008.01.031
   Verma A, 2005, J AM COLL CARDIOL, V45, P285, DOI 10.1016/j.jacc.2004.10.035
   Wann LS, 2011, CIRCULATION, V123, P104, DOI 10.1161/CIR.0b013e3181fa3cf4
   WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954
NR 28
TC 8
Z9 8
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 301
EP 309
DI 10.4070/kcj.2015.45.4.301
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500007
PM 26240584
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Hwang, SY
   Shim, JL
   Jeong, MH
AF Kim, Jin Shil
   Hwang, Seon Young
   Shim, Jae Lan
   Jeong, Myung Ho
TI Cognitive Function and Self-Care in Patients with Chronic Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Cognition; Self care; Outpatients
ID DISEASE; UPDATE; IMPAIRMENT; DEFICITS
AB Background and Objectives: This study examined the association of cognitive function with self-care and major adverse cardiac events (MACE) among heart failure (HF) patients.
   Subjects and Methods: In this prospective study, 86 outpatients with HF completed face-to-face interviews including neuropsychological testing to evaluate cognitive function and the use of the Self-Care of Heart Failure Index to measure self-care. Functional status was assessed with the New York Heart Association (NYHA) classification. Follow-up data on MACE were obtained at 24 months after enrollment.
   Results: Compared with the Korean norm values, more than half of the HF patients had cognitive deficits in global function (33.0%), immediate recall (65.1%), delayed recall memory (65.1%), and executive function (60.5%). Patients with symptomatic HF (>= NYHA class II) had the higher risk for substantially poor cognitive function in all areas of cognitive function than asymptomatic HF patients (NYHA class I, p<0.05). Most patients demonstrated poor self-care adequacy in maintenance (84.9%), management of symptoms (100%), and confidence (86.0%). After adjustment for age and gender, memory function was significantly associated with self-care confidence (odds ratio 1.41, 95% confidence interval 1.03-1.92, p=0.033). No relationship was found between cognition and self-care maintenance. There were 19 MACE's during the 24-month follow-up. Patients without MACE had a significantly higher global cognitive function (p=0.024), while no cognitive domains were significant predictors of MACE when adjusted for age and gender.
   Conclusion: HF patients with memory loss have poorer self-care confidence. Studies are warranted to examine the functional implication of cognitive deficits and adverse outcomes in a larger sample.
C1 [Kim, Jin Shil] Gachon Univ, Coll Nursing, Inchon, South Korea.
   [Hwang, Seon Young; Shim, Jae Lan] Hanyang Univ, Coll Nursing, Seoul 133791, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ, Dept Cardiol, Gwangju, South Korea.
RP Hwang, SY (corresponding author), Hanyang Univ, Coll Nursing, 222 Wangsimni Ro, Seoul 133791, South Korea.
EM seon9772@hanyang.ac.kr
FU Korean Society of Cardiology
FX This study was supported by a grant from the Korean Society of
   Cardiology (2012).
CR Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071
   Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467
   Cameron J, 2009, HEART LUNG, V38, P410, DOI 10.1016/j.hrtlng.2008.11.004
   Chen J, 2013, J AM COLL CARDIOL, V61, P1078, DOI 10.1016/j.jacc.2012.11.057
   Dardiotis E, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/595821
   Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682
   Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Health Insurance Review Et Assessment Service, CHRON DIS SUMM STAT
   Heckman GA, 2008, GERIATR AGING, V11, P15
   Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586
   Kang Y., 2003, SEOUL NEUROPSYCHOLOG
   Kang Y, 1997, J KOREAN NEUROL ASS, V15, P300
   Kim JS, 2012, PERSPECT NURS SCI, V9, P45
   Lee CS, 2011, HEART LUNG, V40, P12, DOI 10.1016/j.hrtlng.2009.12.003
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Pressler SJ, 2010, J CARD FAIL, V16, P750, DOI 10.1016/j.cardfail.2010.04.007
   Pressler SJ, 2010, J CARDIOVASC NURS, V25, P189, DOI 10.1097/JCN.0b013e3181ca36fe
   Pressler SJ, 2010, NURS RES, V59, P127, DOI 10.1097/NNR.0b013e3181d1a747
   Riegel B, 2008, J CARDIOVASC NURS, V23, P190, DOI 10.1097/01.JCN.0000305091.35259.85
   Riegel B, 2011, NAT REV CARDIOL, V8, P644, DOI 10.1038/nrcardio.2011.95
   Riegel B, 2009, J CARDIOVASC NURS, V24, P485, DOI 10.1097/JCN.0b013e3181b4baa0
   Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628
   van den Hurk K, 2011, EUR J HEART FAIL, V13, P1362, DOI 10.1093/eurjhf/hfr138
   Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001
   Youn-Jung Son，, 2011, [Korean Journal of Adult Nursing, 성인간호학회지], V23, P244
   Zuccala G, 2001, J NEUROL NEUROSUR PS, V70, P109, DOI 10.1136/jnnp.70.1.109
NR 27
TC 13
Z9 14
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 310
EP 316
DI 10.4070/kcj.2015.45.4.310
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500008
PM 26240585
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JH
   Uhm, JS
   Lee, SE
   Chun, KH
   Lee, HJ
   Lee, SH
   Hong, GR
   Lee, MH
AF Choi, Jung-Ho
   Uhm, Jae-Sun
   Lee, Sang-Eun
   Chun, Kyung-Hyeon
   Lee, Hye-Jeong
   Lee, Seung Hyun
   Hong, Geu-Ru
   Lee, Moon-Hyoung
TI Constrictive Pericarditis Long after a Gunshot Wound
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Foreign body reaction; Pericarditis; constrictive; Atrial flutter
ID BULLET
AB Constrictive pericarditis is an uncommon post-inflammatory disorder characterized by a variably thickened, fibrotic, and frequently calcified, pericardium. Etiology of the constriction can occur for many reasons. Although foreign bodies are not the common cause of constrictive pericarditis, the long-term presence of foreign bodies, like bullets, is presumed to cause chronic constrictive pericarditis even after a very long asymptomatic period. A 69-year-old patient with atrial flutter was admitted to the hospital. A cardiac computed tomography showed a bullet located adjacent to the right atrium. The transthoracic echocardiography showed a thickened pericardium and septal bouncing motion, which were compatible with constrictive pericarditis. The history of the patient revealed an injury by gunshot during the Korean War in 1950. Radiofrequency ablation of the atrial flutter was performed, and after ablation, the bullet was removed surgically. The patient was discharged home after surgery without complications.
C1 [Choi, Jung-Ho; Uhm, Jae-Sun; Lee, Sang-Eun; Chun, Kyung-Hyeon; Hong, Geu-Ru; Lee, Moon-Hyoung] Yonsei Univ, Dept Cardiol, Severance Hosp, Coll Med, Seoul 120752, South Korea.
   [Lee, Hye-Jeong] Yonsei Univ, Dept Radiol, Severance Hosp, Coll Med, Seoul 120752, South Korea.
   [Lee, Seung Hyun] Yonsei Univ, Dept Cardiovasc Surg, Severance Hosp, Coll Med, Seoul 120752, South Korea.
RP Lee, MH (corresponding author), Yonsei Univ, Dept Cardiol, Severance Hosp, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM mhlee@yuhs.ac
OI Uhm, Jae-Sun/0000-0002-1611-8172; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Lee, Sang-Eun/0000-0001-6645-4038; CHUN,
   KYEONG-HYEON/0000-0002-7798-658X; Lee, Hye-Jeong/0000-0003-4349-9174;
   lee, seung hyun/0000-0002-0311-6565
CR Burkhart HM, 1998, AM SURGEON, V64, P341
   Davis RE, 2005, J TRAUMA, V58, P378, DOI 10.1097/01.TA.0000066126.25269.B7
   DRESSLER W, 1959, ARCH INTERN MED, V103, P28, DOI 10.1001/archinte.1959.00270010034006
   LeMaire SA, 1998, ANN THORAC SURG, V65, P1786, DOI 10.1016/S0003-4975(98)00246-X
   LIMANDRI G, 1994, AM J EMERG MED, V12, P105, DOI 10.1016/0735-6757(94)90214-3
   Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380
   MEYNS BP, 1994, ANN THORAC SURG, V57, P489, DOI 10.1016/0003-4975(94)91031-6
   MONSUEZ JJ, 1992, J THORAC CARDIOV SUR, V104, P846
   Myers RBH, 1999, AM HEART J, V138, P219, DOI 10.1016/S0002-8703(99)70105-5
   Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD
   WOOD P, 1961, AM J CARDIOL, V7, P48, DOI 10.1016/0002-9149(61)90422-2
NR 11
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 333
EP 336
DI 10.4070/kcj.2015.45.4.333
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500011
PM 26240588
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, JK
   Kim, HR
   Kwon, HW
   Kwon, BS
   Kim, GB
   Bae, EJ
   Noh, CI
   Kim, WH
AF Yoon, Ja Kyoung
   Kim, Hye Rim
   Kwon, Hye Won
   Kwon, Bo Sang
   Kim, Gi Beom
   Bae, Eun Jung
   Noh, Chung Ii
   Kim, Woong Han
TI Ruptured Tricuspid Valve Papillary Muscle in a Neonate with Intractable
   Persistent Fetal Circulation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cyanosis; Neonate; Tricuspid regurgitation; Papillary muscles; Cardiac
   surgery
ID SECONDARY; REPAIR
AB Unguarded tricuspid regurgitation (TR) due to a flail tricuspid leaflet is a rare condition of newborn cyanosis. A high perinatal mortality has been associated with this fatal condition. But, there are feasible surgical repairs to improve survival. We report the case of a male fullterm neonate with intractable hypoxia. He had profound tricuspid insufficiency and leaflet prolapse caused by a ruptured papillary muscle supporting the anterior leaflet of the tricuspid valve. He presented with severe cyanosis and respiratory distress immediately after birth. Despite medical management, the pulmonary vascular resistance was not decreased and a low cardiac output persisted. Initial stabilization was accomplished with nitric oxide and extracorporeal membrane oxygenation. The tricuspid valve repair surgery was successfully performed subsequently. TR resulting from papillary muscle rupture is a potentially lethal condition. Timely diagnosis and proper surgical treatment can be lifesaving.
C1 [Yoon, Ja Kyoung; Kim, Hye Rim; Kwon, Hye Won; Kwon, Bo Sang; Kim, Gi Beom; Bae, Eun Jung; Noh, Chung Ii] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Kim, Woong Han] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
RP Bae, EJ (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM eunjbaek@snu.ac.kr
RI 권, 혜원/Q-1141-2019; Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
CR ALKALAY AL, 1988, AM J DIS CHILD, V142, P753, DOI 10.1001/archpedi.1988.02150070067027
   Anagnostopoulos PV, 2007, ANN THORAC SURG, V83, P1458, DOI 10.1016/j.athoracsur.2006.10.077
   Arrington CB, 2005, CARDIOL YOUNG, V15, P660, DOI 10.1017/S1047951105001885
   Benvenuti L A, 1992, Am J Cardiovasc Pathol, V4, P79
   DEBUSK RF, 1969, NEW ENGL J MED, V281, P1458, DOI 10.1056/NEJM196912252812607
   Fleming GA, 2008, PEDIATR CARDIOL, V29, P442, DOI 10.1007/s00246-007-9109-8
   Lim KA, 2004, CARDIOL YOUNG, V14, P450, DOI 10.1017/S1047951104004172
   Sachdeva R, 2007, ANN THORAC SURG, V83, P680, DOI 10.1016/j.athoracsur.2006.06.054
   Yemul MA, 2014, ECHOCARDIOGR-J CARD, V31, pE151, DOI 10.1111/echo.12522
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 340
EP 343
DI 10.4070/kcj.2015.45.4.340
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500013
PM 26240590
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JY
   Lee, SH
   Kim, BS
   Seo, HS
   Kim, WS
   Ahn, Y
   Lee, NH
   Koh, KK
   Kang, TS
   Jo, SH
   Hong, BK
   Bae, JH
   Yang, HM
   Cha, KS
   Kim, BS
   Kwak, CH
   Cho, DK
   Kim, U
   Zo, JH
   Kang, DH
   Pyun, WB
   Chun, KJ
   Namgung, J
   Cha, TJ
   Juhn, JH
   Jung, YL
   Jang, YS
AF Jang, Ji-Yong
   Lee, Sang-Hak
   Kim, Byung Soo
   Seo, Hong Seog
   Kim, Woo-Shik
   Ahn, Youngkeun
   Lee, Nae-Hee
   Koh, Kwang Kon
   Kang, Tae-Soo
   Jo, Sang-Ho
   Hong, Bum-Kee
   Bae, Jang-Ho
   Yang, Hyoung-Mo
   Cha, Kwang Soo
   Kim, Bum Soo
   Kwak, Choong Hwan
   Cho, Deok-Kyu
   Kim, Ung
   Zo, Joo-Hee
   Kang, Duk-Hyun
   Pyun, Wook Bum
   Chun, Kook Jin
   Namgung, June
   Cha, Tae-Joon
   Juhn, Jae-Hyeon
   Jung, Yeili
   Jang, Yangsoo
TI Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in
   the Treatment of Hypercholesterolemic Hypertensive Patients (vol 45, pg
   225, 2015)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Jang, Ji-Yong; Lee, Sang-Hak; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol,Dept Internal Med, Seoul 120749, South Korea.
   [Jang, Ji-Yong; Lee, Sang-Hak; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Hosp, Cardiovasc Res Inst,Dept Internal Med, Seoul 120749, South Korea.
   [Kim, Byung Soo] Daedong Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Seo, Hong Seog] Korea Univ, Coll Med, Guro Hosp, Div Cardiol,Cardiovasc Ctr, Seoul 136705, South Korea.
   [Kim, Woo-Shik] Kyung Hee Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ Hosp, Heart Res Ctr, Dept Cardiol, Gwangju, South Korea.
   [Lee, Nae-Hee] Soon Chun Hyang Univ, Bucheon Hosp, Dept Cardiol, Bucheon, South Korea.
   [Koh, Kwang Kon] Gachon Univ, Gil Med Ctr, Dept Cardiol, Inchon, South Korea.
   [Kang, Tae-Soo] Dankook Univ, Coll Med, Div Cardiol, Cheonan, South Korea.
   [Jo, Sang-Ho] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Anyang, South Korea.
   [Hong, Bum-Kee] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Gangnam Severance Hosp, Seoul 120749, South Korea.
   [Bae, Jang-Ho] Konyang Univ Hosp, Dept Internal Med, Div Cardiol, Taejon, South Korea.
   [Yang, Hyoung-Mo] Ajou Univ, Med Ctr, Dept Cardiol, Suwon 441749, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ Hosp, Div Cardiol, Busan, South Korea.
   [Kim, Bum Soo] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Cardiol,Kangbuk Samsung Hosp, Seoul, South Korea.
   [Kwak, Choong Hwan] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jinju, South Korea.
   [Kwak, Choong Hwan] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea.
   [Cho, Deok-Kyu] Myongji Hosp, Cardiovasc Ctr, Dept Cardiol, Goyang, South Korea.
   [Kim, Ung] Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Zo, Joo-Hee] Seoul Natl Univ, Coll Med, SMG SNU Boramae Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Kang, Duk-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea.
   [Pyun, Wook Bum] Ewha Womans Univ, Dept Internal Med, Mokdong Hosp, Div Cardiol, Seoul, South Korea.
   [Chun, Kook Jin] Pusan Natl Univ, Yangsan Hosp, Dept Cardiol, Yangsan, South Korea.
   [Namgung, June] Inje Univ Ilsan, Polk Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Cha, Tae-Joon] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Juhn, Jae-Hyeon; Jung, Yeili] LG Life Sci Ltd, Clin Dev Dept, Seoul, South Korea.
RP Jang, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol,Dept Internal Med, Seoul 120749, South Korea.
OI Yang, Hyoung-Mo/0000-0003-3602-9772
CR Jang JY, 2015, KOREAN CIRC J, V45, P225, DOI 10.4070/kcj.2015.45.3.225
NR 1
TC 0
Z9 0
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2015
VL 45
IS 4
BP 349
EP 349
DI 10.4070/kcj.2015.45.4.349
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CO0EI
UT WOS:000358822500016
PM 26240593
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, MY
AF Rhee, Moo-Yong
TI High Sodium Intake: Review of Recent Issues on Its Association with
   Cardiovascular Events and Measurement Methods
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Sodium; dietary; Hypertension; Cardiovascular diseases; Urine specimen
   collection
ID 24-H URINARY SODIUM; PLASMA-RENIN ACTIVITY; DIETARY RISK-FACTORS;
   BLOOD-PRESSURE; SALT INTAKE; POTASSIUM EXCRETION;
   ESSENTIAL-HYPERTENSION; NONPHARMACOLOGIC INTERVENTIONS;
   MYOCARDIAL-INFARCTION; ELECTROLYTE EXCRETION
AB There has been a long-known association between high dietary sodium intake and hypertension, as well as the increased risk of cardiovascular disease. Reduction of sodium intake is a major challenge for public health. Recently, there have been several controversial large population-based studies regarding the current recommendation for dietary sodium intake. Although these studies were performed in a large population, they aroused controversies because they had a flaw in the study design and methods. In addition, knowledge of the advantages and disadvantages of the methods is essential in order to obtain an accurate estimation of sodium intake. I have reviewed the current literatures on the association between sodium intake and cardiovascular events, as well as the methods for the estimation of sodium intake.
C1 Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, Clin Trial Ctr, Goyang 410773, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, Clin Trial Ctr, 27 Dongguk Ro, Goyang 410773, South Korea.
EM mooyong_rhee@dumc.or.kr
FU Korea Ministry of Food and Drug SafetyMinistry of Food & Drug Safety
   (MFDS) [13162MFDS106]
FX This research was supported by grants (13162MFDS106) from the Korea
   Ministry of Food and Drug Safety in 2013.
CR ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144
   ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605
   Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69
   [Anonymous], 1988, BMJ, V297, P319
   [Anonymous], 2012, SURV NATR INT AN REL
   BINGHAM S, 1983, CLIN SCI, V64, P629, DOI 10.1042/cs0640629
   BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066
   Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139
   BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901
   Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55
   de Boer RA, 2012, EUR HEART J, V33, P2351, DOI 10.1093/eurheartj/ehs198
   Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249
   Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996
   FORBES GB, 1976, AM J CLIN NUTR, V29, P1359
   Franco V, 2006, J AM COLL NUTR, V25, p247S, DOI 10.1080/07315724.2006.10719574
   Grassi G, 2002, CIRCULATION, V106, P1957, DOI 10.1161/01.CIR.0000033519.45615.C7
   Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210
   Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3
   Hawkes C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046727
   He FJ, 2007, CURR OPIN CARDIOL, V22, P298, DOI 10.1097/HCO.0b013e32814f1d8c
   He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325
   He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4
   Henderson L, 2003, NATL DIET NUTR SURVE, V3
   HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786
   JAMES WPT, 1987, LANCET, V1, P426
   Ji C, 2014, NUTR METAB CARDIOVAS, V24, P140, DOI 10.1016/j.numecd.2013.06.011
   Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA
   Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001
   Kawamura M, 2014, CLIN EXP HYPERTENS
   KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x
   Khaw KT, 2004, AM J CLIN NUTR, V80, P1397
   KIRBY CR, 1986, J APPL PHYSIOL, V61, P967
   KNUIMAN JT, 1986, HUM NUTR-CLIN NUTR, V40C, P229
   Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606
   Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406
   Leiba A, 2005, NUTRITION, V21, P462, DOI 10.1016/j.nut.2004.08.021
   LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806
   LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805
   LYKKEN GI, 1980, AM J CLIN NUTR, V33, P2674
   MACGREGOR GA, 1982, LANCET, V1, P351, DOI 10.1016/S0140-6736(82)91389-7
   Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x
   MATTES RD, 1991, J AM COLL NUTR, V10, P383
   Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122
   Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f
   Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1
   Murakami K, 2008, NUTRITION, V24, P16, DOI 10.1016/j.nut.2007.09.001
   National Centre for Social Research, 2008, ASS DIET SOD LEV AD
   O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889
   O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729
   Ortega RM, 2011, BRIT J NUTR, V105, P787, DOI 10.1017/S000711451000423X
   Park S, 2011, J HYPERTENS, V29, P1502, DOI 10.1097/HJH.0b013e3283486311
   권용주, 2010, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V39, P535
   Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193
   Polonia Jorge, 2006, Rev Port Cardiol, V25, P801
   Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431
   Rhee MY, 2013, EUR HEART J, V34, P1117
   Rhee MY, 2013, EUR J CLIN NUTR, V67, P875, DOI 10.1038/ejcn.2013.87
   Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360
   Rhee MY, 2013, J KOREAN MED SCI, V28, P555, DOI 10.3346/jkms.2013.28.4.555
   Ribic CH, 2010, PUBLIC HEALTH NUTR, V13, P1803, DOI 10.1017/S136898001000025X
   ROSE G, 1986, J HYPERTENS, V4, P781
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Scottish Centre for Social Research, 2011, SURV 24 HOUR UR SOD
   Shin SJ, 2011, J KOREAN MED SCI, V26, P1061, DOI 10.3346/jkms.2011.26.8.1061
   Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608
   STANBURY SW, 1951, CLIN SCI, V10, P267
   Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574
   Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567
   Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307
   Taylor Rod S, 2013, Cochrane Database Syst Rev, pCD009217, DOI 10.1002/14651858.CD009217.pub2
   Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115
   Tikellis C, 2012, HYPERTENSION, V60, P98, DOI 10.1161/HYPERTENSIONAHA.112.191767
   Verma S, 2011, EUR HEART J, V32, P2135, DOI 10.1093/eurheartj/ehr066
   Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429
   WESSON LG, 1964, MEDICINE, V43, P547, DOI 10.1097/00005792-196409000-00002
   WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028
   Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839
   Whelton PK, 1997, ARCH INTERN MED, V157, P657
   WHO, 2007, RED SALT INT POP REP
   World Health Organization, 2012, GUID SOD INT AD CHIL
   YAMORI Y, 1982, JPN CIRC J, V46, P939, DOI 10.1253/jcj.46.939
   YAMORI Y, 1982, JPN CIRC J, V46, P933, DOI 10.1253/jcj.46.933
   Yoshita Katsushi, 2005, Environmental Health and Preventive Medicine, V10, P150, DOI 10.1007/BF02900808
NR 85
TC 8
Z9 8
U1 0
U2 11
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 175
EP 183
DI 10.4070/kcj.2015.45.3.175
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600001
PM 26023304
OA Green Published
DA 2021-04-22
ER

PT J
AU Joung, B
   Chen, PS
AF Joung, Boyoung
   Chen, Peng-Sheng
TI Function and Dysfunction of Human Sinoatrial Node
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Calcium; Sinoatrial node; Adrenergic beta-agonists; Sick sinus syndrome;
   Biological pacemaker
ID ATRIAL-FIBRILLATION; INTRACELLULAR CA2+; HEART-RATE;
   SYMPATHETIC-STIMULATION; OXIDIZED CAMKII; VOLTAGE CLOCKS; PACEMAKER;
   INITIATION; CALCIUM; CHANNEL
AB Sinoatrial node (SAN) automaticity is jointly regulated by a voltage (cyclic activation and deactivation of membrane ion channels) and Ca2+ clocks (rhythmic spontaneous sarcoplasmic reticulum Ca2+. release). Using optical mapping in Langendorff-perfused canine right atrium, we previously demonstrated that the P-adrenergic stimulation pushes the leading pacemaker to the superior SAN, which has the fastest activation rate and the most robust late diastolic intracellular calcium (Ca,) elevation. Dysfunction of the superior SAN is commonly observed in animal models of heart failure and atrial fibrillation (AF), which are known to be associated with abnormal SAN automaticity. Using the 3D electroanatomic mapping techniques, we demonstrated that superior SAN served as the earliest atrial activation site (EAS) during sympathetic stimulation in healthy humans. In contrast, unresponsiveness of superior SAN to sympathetic stimulation was a characteristic finding in patients with AF and SAN dysfunction, and the 3D electroanatomic mapping technique had better diagnostic sensitivity than corrected SAN recovery time testing. However, both tests have significant limitations in detecting patients with symptomatic sick sinus syndrome. Recently, we reported that the location of the EAS can be predicted by the amplitudes of P-wave in the inferior leads. The inferior P-wave amplitudes can also be used to assess the superior SAN responsiveness to sympathetic stimulation. Inverted or isoelectric P-waves at baseline that fail to normalize during isoproterenol infusion suggest SAN dysfunction. P-wave morphology analyses may be helpful in determining the SAN function in patients at risk of symptomatic sick sinus syndrome.
C1 [Joung, Boyoung] Yonsei Univ, Coll Med, Dept Med, Div Cardiol, Seoul 120749, South Korea.
   [Chen, Peng-Sheng] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.
   [Chen, Peng-Sheng] Indiana Univ Sch Med, Dept Med, Div Cardiol, Indianapolis, IN 46202 USA.
RP Chen, PS (corresponding author), 1801 N Capitol Ave,Room 475, Indianapolis, IN 46202 USA.
EM chenpp@iupui.edu
OI Joung, Boyoung/0000-0001-9036-7225
FU Basic Science Research Program through the National Research Foundation
   of Korea - Korean Heart Rhythm Society [2011-3]; Ministry of Education,
   Science and Technology a grant of the Korean Healthcare technology R&D
   project - Ministry of Health Welfare [NRF-2010-0021993,
   NRF-2012R1A2A2A02045367, HI12C1552]; United States National Institutions
   of Health [R01 HL71140, P01 HL78931]; Indiana University Health/Indiana
   University School of Medicine Strategic Research Initiative;
   Medtronic-Zipes Endowment of the Indiana University
FX This study was supported in part by research grants from the Basic
   Science Research Program through the National Research Foundation of
   Korea funded by the Korean Heart Rhythm Society (2011-3), the Ministry
   of Education, Science and Technology (NRF-2010-0021993,
   NRF-2012R1A2A2A02045367), a grant of the Korean Healthcare technology
   R&D project funded by Ministry of Health & Welfare (HI12C1552), United
   States National Institutions of Health grants R01 HL71140 and P01
   HL78931, the Indiana University Health/Indiana University School of
   Medicine Strategic Research Initiative and a Medtronic-Zipes Endowment
   of the Indiana University.
CR Adan V, 2003, AM FAM PHYSICIAN, V67, P1725
   Aronow WS, 1999, J AM GERIATR SOC, V47, P740, DOI 10.1111/j.1532-5415.1999.tb01602.x
   BOINEAU JP, 1984, CIRC RES, V54, P332, DOI 10.1161/01.RES.54.3.332
   BOINEAU JP, 1978, CIRCULATION, V58, P1036, DOI 10.1161/01.CIR.58.6.1036
   Chen PS, 2010, CIRC J, V74, P221, DOI 10.1253/circj.CJ-09-0712
   Chen WT, 2013, EUR J CLIN INVEST, V43, P957, DOI 10.1111/eci.12125
   Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4
   DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041
   Efimov IR, 2010, CIRC RES, V106, P255, DOI 10.1161/CIRCRESAHA.109.209841
   Elvan A, 1996, CIRCULATION, V94, P2953, DOI 10.1161/01.CIR.94.11.2953
   Essebag V, 2003, J AM COLL CARDIOL, V41, P249, DOI 10.1016/S0735-1097(02)02709-2
   Fedorov VV, 2009, CIRC RES, V104, P915, DOI 10.1161/CIRCRESAHA.108.193193
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   GOMES JAC, 1981, CIRCULATION, V63, P80, DOI 10.1161/01.CIR.63.1.80
   Hocini M, 2003, CIRCULATION, V108, P1172, DOI 10.1161/01.CIR.0000090685.13169.07
   Huke S, 2011, J CLIN INVEST, V121, P2975, DOI 10.1172/JCI58389
   Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x
   Joung B, 2011, CIRC-ARRHYTHMIA ELEC, V4, P799, DOI 10.1161/CIRCEP.111.965897
   Joung B, 2011, J CARDIOVASC ELECTR, V22, P448, DOI 10.1111/j.1540-8167.2010.01905.x
   Joung B, 2011, YONSEI MED J, V52, P211, DOI 10.3349/ymj.2011.52.2.211
   Joung B, 2010, AM J PHYSIOL-HEART C, V299, pH634, DOI 10.1152/ajpheart.00347.2010
   Joung Boyoung, 2009, Korean Circ J, V39, P217, DOI 10.4070/kcj.2009.39.6.217
   Joung B, 2010, HEART RHYTHM, V7, P88, DOI 10.1016/j.hrthm.2009.09.018
   Joung B, 2009, CIRCULATION, V119, P788, DOI 10.1161/CIRCULATIONAHA.108.817379
   Ju YK, 1998, J PHYSIOL-LONDON, V508, P153, DOI 10.1111/j.1469-7793.1998.153br.x
   Kim D, 2010, J AM COLL CARDIOL, V56, P805, DOI 10.1016/j.jacc.2010.03.070
   Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058
   Kodama I, 1997, CARDIOVASC RES, V35, P13, DOI 10.1016/S0008-6363(97)00114-4
   Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078
   Lancaster MK, 2004, J PHYSIOL-LONDON, V556, P481, DOI 10.1113/jphysiol.2003.057372
   Li J, 1997, AM J PHYSIOL-HEART C, V273, pH2481
   Lou Q, 2014, CIRCULATION, V130, P315, DOI 10.1161/CIRCULATIONAHA.113.007086
   Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268
   Maltsev VA, 2008, CARDIOVASC RES, V77, P274, DOI 10.1093/cvr/cvm058
   Maltsev VA, 2006, J PHARMACOL SCI, V100, P338, DOI 10.1254/jphs.CR0060018
   Marrouche NF, 2002, J AM COLL CARDIOL, V39, P1046, DOI 10.1016/S0735-1097(02)01703-5
   Moon J, 2012, CIRC J, V76, P860, DOI 10.1253/circj.CJ-11-1232
   Mun HS, 2013, CIRC J, V77, P2255, DOI 10.1253/circj.CJ-12-1615
   Park S, 2011, KOREAN CIRC J, V41, P658, DOI 10.4070/kcj.2011.41.11.658
   Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB
   SCHUESSLER RB, 1986, AM J PHYSIOL, V250, pH630
   Shinohara T, 2010, AM J PHYSIOL-HEART C, V299, pH1805, DOI 10.1152/ajpheart.00723.2010
   Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833
   Tellez JO, 2006, CIRC RES, V99, P1384, DOI 10.1161/01.RES.0000251717.98379.69
   Turker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070450
   Uhm JS, 2014, EUROPACE, V16, P1061, DOI 10.1093/europace/eut393
   van den Berg MP, 2001, J AM COLL CARDIOL, V38, P1585, DOI 10.1016/S0735-1097(01)01546-7
   Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9
   Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1
   Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271
   Wolf RM, 2013, AM J PHYSIOL-HEART C, V304, pH1253, DOI 10.1152/ajpheart.00734.2012
   Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081
   Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106
   Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778
NR 54
TC 7
Z9 8
U1 0
U2 14
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 184
EP 191
DI 10.4070/kcj.2015.45.3.184
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600002
PM 26023305
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, XJ
   Yoon, MH
   Sea, KW
   Tahk, SJ
   Lim, HS
   Yang, HM
   Choi, BJ
   Choi, SY
   Hwang, GS
   Shin, JH
   Park, JS
AF Jin, Xiong Jie
   Yoon, Myeong-Ho
   Sea, Kyoung-Woo
   Tahk, Seung-Jea
   Lim, Hong-Seok
   Yang, Hyoung-Mo
   Choi, Byoung-Joo
   Choi, So-Yeon
   Hwang, Gyo-Seung
   Shin, Joon-Han
   Park, Jin-Sun
TI Usefulness of Hyperemic Microvascular Resistance Index as a Predictor of
   Clinical Outcomes in Patients with ST-Segment Elevation Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Microcirculation; Percutaneous coronary
   intervention
ID PERCUTANEOUS CORONARY INTERVENTION; MICROCIRCULATORY RESISTANCE; FLOW
   RESERVE; ANGIOPLASTY; ANGIOGRAPHY; RECOVERY
AB Background and Objectives: Microvascular function is a useful predictor of left ventricular functional changes in patients with ST-segment elevation myocardial infarction (STEM. We evaluated the usefulness of the hyperemic microvascular resistance index (hMVRI) for predicting long-term major adverse cardiovascular events (MACEs) in patients with STEMI assessed immediately after primary percutaneous coronary intervention (PCI).
   Subjects and Methods: hMVRI were evaluated in 145 patients with first acute STEMI treated with primary PCI using an intracoronary Doppler wire. hMVRI was defined as the ratio of mean aortic pressure over hyperemic averaged peak velocity of infarct-related artery. Major adverse cardiovascular events (MACEs) included cardiac death and re-hospitalization for congestive heart failure.
   Results: During the mean follow-up of 85 +/- 43 months, MACEs occurred in 17.2% of patients. Using a receiver-operating characteristics analysis, hMVRI >2.82 mm Hg.cm-1.sec (sensitivity: 87%; specificity: 69%; and area under curve: 0.818) was the best cut-off values for predicting future cardiac events. The Cox proportional hazard analysis showed that hMVRI was an independent predictor for long-term MACEs (hazard ratio 1.741, 95% confidence interval 1.348-2.264, p<0.001). The Kaplan-Meier survival analysis showed a higher incidence of MACEs in patients with hMVRI >2.82 mm Hg.cm-1.sec (p<0.001).
   Conclusion: hMVRI was a strong predictor of long-term MACEs in patients with STEMI treated with primary PCI.
C1 [Jin, Xiong Jie; Yoon, Myeong-Ho; Sea, Kyoung-Woo; Tahk, Seung-Jea; Lim, Hong-Seok; Yang, Hyoung-Mo; Choi, Byoung-Joo; Choi, So-Yeon; Hwang, Gyo-Seung; Shin, Joon-Han; Park, Jin-Sun] Ajou Univ, Sch Med, Dept Cardiol, Suwon 443721, South Korea.
RP Yoon, MH (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 Worldcup Ro, Suwon 443721, South Korea.
EM yoonmh65@hanmail.net
OI Yang, Hyoung-Mo/0000-0003-3602-9772
CR Aarnoudse W, 2004, CIRCULATION, V110, P2137, DOI 10.1161/01.CIR.0000143893.18451.0E
   Angeja BG, 2001, AM HEART J, V141, P329, DOI 10.1067/mhj.2001.113075
   Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062
   Furber AP, 2004, CIRCULATION, V110, P3527, DOI 10.1161/01.CIR.0000148686.95696.1E
   Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125
   Gibson CM, 2002, CIRCULATION, V105, P1909, DOI 10.1161/01.CIR.0000014683.52177.B5
   Kawamoto T, 1999, CIRCULATION, V100, P339, DOI 10.1161/01.CIR.100.4.339
   Kitabata H, 2009, JACC-CARDIOVASC IMAG, V2, P263, DOI 10.1016/j.jcmg.2008.11.013
   Klauss V, 1997, CIRCULATION, V96, P159
   Lepper W, 2000, CIRCULATION, V101, P2368, DOI 10.1161/01.CIR.101.20.2368
   Leung DY, 2011, HEART, V97, P587, DOI 10.1136/hrt.2009.183327
   Lim HS, 2009, EUR HEART J, V30, P2854, DOI 10.1093/eurheartj/ehp313
   MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Takahashi T, 2004, AM J CARDIOL, V94, P1033, DOI 10.1016/j.amjcard.2004.06.061
   van Liebergen RAM, 1998, CIRCULATION, V98, P2133, DOI 10.1161/01.CIR.98.20.2133
   Yamamoto K, 2001, J AM COLL CARDIOL, V38, P1383, DOI 10.1016/S0735-1097(01)01585-6
   Yoon MH, 2008, AM J CARDIOL, V102, P129, DOI 10.1016/j.amjcard.2008.03.024
NR 21
TC 8
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 194
EP 201
DI 10.4070/kcj.2015.45.3.194
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600004
PM 26023307
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, HK
   Kang, SY
   Yu, JJ
   Ko, JK
   Kim, YH
AF Ko, Hong Ki
   Kang, So Yeon
   Yu, Jeong Jin
   Ko, Jae-Kon
   Kim, Young-Hwue
TI Small Left Atrial Size Complicating Percutaneous Transcatheter Device
   Closure of Secundum Atrial Septal Defect with Conventional Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defect; congenital; Heart septal defects; atrial; Cardiac
   catheterization; Septal occluder device
ID BALLOON SIZING TECHNIQUE; OCCLUDER; FEASIBILITY; DEFICIENT; SAFETY
AB Background and Objectives: Transcatheter device closure becomes the first option for treating secundum atrial septal defect (ASD), but the conventional method is sometimes unsuccessful even when the defect size indicates the closure to be feasible. To increase the success rate, modified methods have been introduced and used. This study aimed to find predictors for using the modified methods in the device closure of secundum ASDs.
   Subjects and Methods: Between October 2010 and December 2012, 92 patients with ASDs underwent the transcatheter device closure. We analyzed the sizes of the defect, the surrounding rims, and the ratios of the left atrium (LA) dimensions to the device size in the patients who underwent the procedure either using the conventional or modified methods.
   Results: Among the 88 successful cases (95.7%), 22 patients (25%) required modified methods (12 using pulmonary vein and 10 using balloon). The modified method group had the larger size of ASDs and smaller posterosuperior rim. The mean ratios of the LA anteroposterior diameter, width, and length to the device size were all significantly smaller in the modified methods group than in the conventional group (1.20 vs. 1.56, 1.32 vs. 1.71, and 1.61 vs. 2.07, respectively). We found that the risk factors for the modified methods were smaller retroaortic rim, larger ASD, and smaller LA dimension/device size.
   Conclusion: In addition to larger defects and smaller retroaortic rim, the smaller ratios of the LA dimensions to the device size influenced the need for the application of modified methods in the transcatheter device closure of ASDs.
C1 [Ko, Hong Ki] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Pediat, Suwon 441749, South Korea.
   [Kang, So Yeon; Yu, Jeong Jin; Ko, Jae-Kon; Kim, Young-Hwue] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pediat Cardiol,Dept Pediat, Seoul 138736, South Korea.
RP Kim, YH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Pediat Cardiol,Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.
EM yhkim@amc.seoul.kr
CR Abaci A, 2013, CATHETER CARDIO INTE, V82, P1123, DOI 10.1002/ccd.24875
   Butera G, 2008, AM HEART J, V156, P706, DOI 10.1016/j.ahj.2008.06.008
   Carlson KM, 2005, CATHETER CARDIO INTE, V66, P390, DOI 10.1002/ccd.20443
   Chessa M, 2002, J AM COLL CARDIOL, V39, P1061, DOI 10.1016/S0735-1097(02)01711-4
   Crawford GB, 2012, CATHETER CARDIO INTE, V80, P157, DOI 10.1002/ccd.24347
   Dalvi BV, 2005, CATHETER CARDIO INTE, V64, P102, DOI 10.1002/ccd.20248
   Du ZD, 2002, AM J CARDIOL, V90, P865, DOI 10.1016/S0002-9149(02)02709-1
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI DOI 10.1016/S0735-1097(02)01862-4
   Hijazi ZM, 2011, ANN PEDIAT CARDIOL, V4, P34
   Huang CF, 2007, J FORMOS MED ASSOC, V106, P986, DOI 10.1016/S0929-6646(08)60073-X
   Kammache I, 2011, CATHETER CARDIO INTE, V78, P665, DOI 10.1002/ccd.23077
   Papa M, 2013, CATHETER CARDIO INTE, V81, P1180, DOI 10.1002/ccd.24633
   Park S, 2010, J KOREAN ACAD NURS, V40, P191, DOI 10.4040/jkan.2010.40.2.191
   Raghuram Arani R, 2008, Interact Cardiovasc Thorac Surg, V7, P167, DOI 10.1510/icvts.2007.165647
   Rigatelli G, 2012, J INTERV CARDIOL, V25, P628, DOI 10.1111/j.1540-8183.2012.00755.x
   Rosas Martin, 2007, Congenit Heart Dis, V2, P148, DOI 10.1111/j.1747-0803.2007.00091.x
   Wahab HA, 2011, CATHETER CARDIO INTE, V78, P1041, DOI 10.1002/ccd.23182
   Wiley JM, 2002, CATHETER CARDIO INTE, V57, P257, DOI 10.1002/ccd.10307
NR 18
TC 1
Z9 1
U1 3
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 216
EP 224
DI 10.4070/kcj.2015.45.3.216
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600007
PM 26023310
OA Green Published
DA 2021-04-22
ER

PT J
AU Chun, WJ
   Nah, DY
   Bae, JH
   Chung, JW
   Lee, H
   Moon, IS
AF Chun, Woo-Jung
   Nah, Deuk-Young
   Bae, Jun-Ho
   Chung, Jin-Wook
   Lee, HyunSook
   Moon, Il Soo
TI Glucose-Insulin-Potassium Solution Protects Ventricular Myocytes of
   Neonatal Rat in an In Vitro Covers lip Ischemia/Reperfusion Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocytes; cardiac; Glucose-insulin-potassium cardioplegic solution;
   GIcNAc; O-GIcNac transferase
ID ELEVATION MYOCARDIAL-INFARCTION; REPERFUSION INJURY; O-GLCNAC; ISCHEMIA;
   INFUSION; HEART; TRIAL; PROTEINS; THERAPY; STRESS
AB Background and Objectives: The benefit of high glucose-insulin-potassium (GIK) solution in clinical applications is controversial. We. established a neonatal rat ventricular myocyte (NRVM) in vitro coverslip ischemia/reperfusion (I/R) model and investigated the effects of GIK solution on suppressing reactive oxygen species (ROS) and upregulating O-GIcNacylation, which protects cells from ischemic injury.
   Materials and Methods: NRVMs were isolated from postnatal day 3-4 Sprague-Dawley rat pups and grown in Dulbecco's modified Eagle's medium containing high glucose (4.5 g/L), fetal bovine serum, and penicillin/streptomycin. The effects of the GIK solution on ROS production, apoptosis, and expression of O-GIcNAc and O-GIcNAc transferase (OGT) were investigated in the coverslip I/R model.
   Results: Covering the 24-well culture plates for 3 hr with 12 mm diameter coverslips resulted in the appropriate ischemic shock. Glucose and insulin synergistically reduced ROS production, protected NRVM dose-dependently from apoptosis, and altered O-GIcNAc and OGT expression.
   Conclusion: The high GIK solution protected NRVM from I/R injury in vitro by reducing ROS and altering 0-GIcNacylation.
C1 [Chun, Woo-Jung] Sungkyunkwan Univ, Coll Med, Samsung Changwon Hosp, Div Cardiol,Dept Internal Med, Chang Won, South Korea.
   [Nah, Deuk-Young; Bae, Jun-Ho; Chung, Jin-Wook] Dongguk Univ, Dept Internal Med, Div Cardiol, Gyeongju 780350, South Korea.
   [Lee, HyunSook; Moon, Il Soo] Dongguk Univ, Coll Med, Dongguk Med Inst, Dept Anat, Gyeongju 780350, South Korea.
RP Nah, DY (corresponding author), Dongguk Univ, Coll Med, Dept Internal Med, Div Cardiol, 87 Dongdae Ro, Gyeongju 780350, South Korea.
EM ptca@dongguk.ac.kr
FU Research Foundation of The Korean Society of Cardiology
FX This study was supported by grants from the Research Foundation of The
   Korean Society of Cardiology (2011), and part of this study was
   presented as an abstract at The Annual Scientific meeting of The Korean
   Society of Cardiology in 2012. We thank Eun-Jung Jung for excellent
   technical support.
CR Apstein CS, 1997, CIRCULATION, V96, P1074, DOI 10.1161/01.CIR.96.4.1074
   BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303
   Carbo R, 2003, CLIN EXP PHARMACOL P, V30, P64, DOI 10.1046/j.1440-1681.2003.03792.x
   Cave AC, 2000, CIRCULATION, V101, P2090, DOI 10.1161/01.CIR.101.17.2090
   Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006
   Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009
   Diaz R, 2007, JAMA-J AM MED ASSOC, V298, P2399, DOI 10.1001/jama.298.20.2399
   Grossman AN, 2013, CIRCULATION, V127, P1040, DOI 10.1161/CIRCULATIONAHA.112.130625
   Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711
   Howell NJ, 2011, CIRCULATION, V123, P170, DOI 10.1161/CIRCULATIONAHA.110.945170
   Ji LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE871, DOI 10.1152/ajpendo.00623.2009
   Jovic M, 2009, GEN PHYSIOL BIOPHYS, V28, P262
   Krljanac G, 2005, AM J CARDIOL, V96, P1053, DOI 10.1016/j.amjcard.2005.05.068
   Laybutt DR, 1997, AM J PHYSIOL-HEART C, V273, pH1309
   Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437
   Moon IS, 2007, MOL CELLS, V24, P76
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009
   Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431
   OBEID AI, 1978, CIRC RES, V43, P601, DOI 10.1161/01.RES.43.4.601
   Oliver EMF, 1994, LANCET, V343, P155
   OLIVER MF, 1968, LANCET, V1, P710
   Pitts KR, 2004, AM J PHYSIOL-HEART C, V287, pH1801, DOI 10.1152/ajpheart.00232.2004
   Rasoul S, 2007, INT J CARDIOL, V122, P52, DOI 10.1016/j.ijcard.2006.11.037
   ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114
   SODIPALLARES D, 1962, AM J CARDIOL, V9, P166, DOI 10.1016/0002-9149(62)90035-8
   Thibault H, 2007, HEART METAB, V37, P19
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   Yusuf S, 2004, AM HEART J, V148, P1068, DOI 10.1016/j.ahj.2004.08.033
   Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200
NR 30
TC 11
Z9 11
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 234
EP 241
DI 10.4070/kcj.2015.45.3.234
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600009
PM 26023312
OA Green Published
DA 2021-04-22
ER

PT J
AU Bayar, N
   Cagirci, G
   Ureyen, CM
   Kus, G
   Kucukseymen, S
   Arslan, S
AF Bayar, Nermin
   Cagirci, Goksel
   Ureyen, Cagin Mustafa
   Kus, Gorkem
   Kucukseymen, Selcuk
   Arslan, Sakir
TI The Relationship between Spontaneous Multi-Vessel Coronary Artery
   Dissection and Celiac Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Celiac disease; Homocysteine; Dissection
AB Celiac disease (CD) is an immune-mediated enteropathy involving the small intestines. Genetic and environmental risk factors as well as autoimmunity have been linked to its etiology. Studies have shown that coronary artery disease, autoimmune myocarditis, arrhythmias and premature atherosclerosis are more prevalent in individuals with CD compared to individuals without the disease. In this case report a young male patient with CD presented with acute myocardial infarction with spontaneous coronary artery dissections of two vessels. To the best of our knowledge, this is the first case report of spontaneous multi-vessel coronary artery dissection in a patient with CD.
C1 [Bayar, Nermin; Cagirci, Goksel; Ureyen, Cagin Mustafa; Kus, Gorkem; Kucukseymen, Selcuk; Arslan, Sakir] Antalya Educ & Res Hosp, Dept Cardiol, TR-07100 Antalya, Turkey.
RP Bayar, N (corresponding author), Antalya Educ & Res Hosp, Dept Cardiol, TR-07100 Antalya, Turkey.
EM dr.nermin@mynet.com
RI arslan, sakir/A-3933-2017; Kucukseymen, Selcuk/Q-4135-2018
OI Kucukseymen, Selcuk/0000-0002-9757-3088
CR COLLIN P, 1989, SCAND J GASTROENTERO, V24, P81, DOI 10.3109/00365528909092243
   De Marchi S, 2013, ALIMENT PHARM THER, V38, P162, DOI 10.1111/apt.12360
   Frustaci A, 2002, CIRCULATION, V105, P2611, DOI 10.1161/01.CIR.0000017880.86166.87
   Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600
   Hering D, 1998, Z KARDIOL, V87, P961, DOI 10.1007/s003920050253
   Kamran M, 2008, J INVASIVE CARDIOL, V20, P553
   Lim PO, 2002, J HUM HYPERTENS, V16, P411, DOI 10.1038/sj.jhh.1001404
   Ludvigsson JF, 2007, HEART, V93, P1111, DOI 10.1136/hrt.2006.097097
   Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346
   Mathur M, 2014, JACC-CARDIOVASC INTE, V7, pE9, DOI 10.1016/j.jcin.2013.05.029
   Najaf Syed Muhammad, 2005, J Coll Physicians Surg Pak, V15, P108
   Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019
   RUSTGI AK, 1988, ARCH INTERN MED, V148, P1583, DOI 10.1001/archinte.148.7.1583
   Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521
   Srinivas M, 2005, POSTGRAD MED J, V81, P68, DOI 10.1136/pgmj.2004.018952
   Vrints CJM, 2010, HEART, V96, P801, DOI 10.1136/hrt.2008.162073
   WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909
   Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507
NR 18
TC 9
Z9 9
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 242
EP 244
DI 10.4070/kcj.2015.45.3.242
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600010
PM 26023313
OA Green Published
DA 2021-04-22
ER

PT J
AU Piao, ZH
   Jeong, MH
   Jeong, HC
   Park, KH
   Sim, DS
   Hong, YJ
   Kim, JH
   Ahn, Y
AF Piao, Zhe Hao
   Jeong, Myung Ho
   Jeong, Hae Chang
   Park, Keun Ho
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
TI Coronary Artery Fistula with Giant Aneurysm and Coronary Stenosis
   Treated by Transcatheter Embolization and Stent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arteriovenous fistula; Coronary aneurysm; Embolization; therapeutic;
   Therapeutics; Stents
ID COIL EMBOLIZATION
AB Coronary artery fistula (CAF) with giant aneurysm and accompanied by coronary artery stenosis is a very rare disease. Herein, we report a case of a 76-year-old woman having a complex coronary-to-pulmonary artery fistula associated with a giant aneurysm and accompanied by coronary artery stenosis. The patient was successfully treated using transcatheter coil embolization and coronary stent implantation. Eight years later, we performed a follow-up coronary angiogram, which revealed the CAF and the aneurysm were completely occluded and previous stent patency.
C1 [Piao, Zhe Hao; Jeong, Myung Ho; Jeong, Hae Chang; Park, Keun Ho; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiovasc Med, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiovasc Med, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR Ahn CM, 2010, AM HEART J, V160, P987, DOI 10.1016/j.ahj.2010.07.013
   Balanescu S, 2001, Ital Heart J, V2, P669
   Cebi N, 2008, INT J CARDIOVAS IMAG, V24, P349, DOI 10.1007/s10554-007-9277-x
   Flores-Rios X, 2011, REV ESP CARDIOL, V64, P164, DOI 10.1016/j.recesp.2010.08.003
   Ito M, 2000, JPN HEART J, V41, P659, DOI 10.1536/jhj.41.659
   Jo SH, 2006, CIRCULATION, V114, pE631, DOI 10.1161/CIRCULATIONAHA.106.635276
   Jung KT, 2011, TEX HEART I J, V38, P730
   Liu LG, 2011, INTERACT CARDIOV TH, V12, P639, DOI 10.1510/icvts.2010.257659
   Mavroudis C, 1997, ANN THORAC SURG, V63, P1235, DOI 10.1016/S0003-4975(97)00251-8
   Pala S, 2011, TURK KARDIYOL DERN A, V39, P88
   Radwan K, 2011, CARDIOL J, V18, P434
   REIDY JF, 1983, BRIT HEART J, V49, P284
   Tekbas G, 2011, TEX HEART I J, V38, P314
   URRUTIA CO, 1983, ANN THORAC SURG, V35, P300, DOI 10.1016/S0003-4975(10)61563-9
NR 14
TC 3
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 245
EP 247
DI 10.4070/kcj.2015.45.3.245
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600011
PM 26023314
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DK
   Ko, SH
   Seo, GW
   Song, PS
   Kim, KH
   Seol, SH
   Song, JW
   Kim, DI
AF Kim, Dong-Kie
   Ko, Sung-Hyun
   Seo, Guang-Won
   Song, Pil-Sang
   Kim, Ki-Hun
   Seol, Sang-Hoon
   Song, Jong-Woon
   Kim, Doo-Il
TI Mechanical Extraction of a Massive Intracoronary Thrombus from the
   Super-Dominant Right Coronary Artery in Thrombogenic Lung Cancer Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary thrombosis; Coronary vessel anomalies; Inferior wall myocardial
   infarction
ID INFERIOR MYOCARDIAL-INFARCTION; CONGENITAL ABSENCE
AB The congenital absence of the left circumflex artery and a compensatory super-dominant right coronary artery (RCA) is a very rare benign coronary anomaly in the clinic. The presence of a massive thrombus in the super-dominant RCA can lead to fatal results in cases of acute myocardial infarction, unless the thrombus is mechanically removed. Aspiration of the thrombus using a 6 Fr right Judkins guide catheter is useful to extract a massive thrombus and is both safe and effective. We report a case of complete revascularization of the super-dominant RCA after thrombus aspiration using a 6 Fr Judkins right catheter in a patient with acute inferior and inferolateral wall myocardial infarction.
C1 [Kim, Dong-Kie; Ko, Sung-Hyun; Seo, Guang-Won; Song, Pil-Sang; Kim, Ki-Hun; Seol, Sang-Hoon; Kim, Doo-Il] Inje Univ, Coll Med, Div Cardiol, Haeundae Paik Hosp, Busan 612896, South Korea.
   [Song, Jong-Woon] Inje Univ, Coll Med, Dept Radiol, Haeundae Paik Hosp, Busan 612896, South Korea.
RP Kim, DI (corresponding author), Inje Univ, Coll Med, Div Cardiol, Haeundae Paik Hosp, 875 Haeun Daero, Busan 612896, South Korea.
EM jo1216@inje.ac.kr
CR BESTETTI RB, 1985, INT J CARDIOL, V8, P331, DOI 10.1016/0167-5273(85)90225-6
   Farto e Abreu P, 1993, Rev Port Cardiol, V12, P305
   Fujii T, 2002, CIRCULATION S, V66, P1
   GENTZLER RD, 1975, CIRCULATION, V52, P490, DOI 10.1161/01.CIR.52.3.490
   Guo JC, 2012, INTERNAL MED, V51, P71, DOI 10.2169/internalmedicine.51.6141
   Hara M, 2005, J ATHEROSCLER THROMB, V12, P315, DOI 10.5551/jat.12.315
   Hong PS, 2014, HERZ, V39, P957, DOI 10.1007/s00059-013-3893-0
   Onoda S, 2004, JPN HEART J, V45, P673, DOI 10.1536/jhj.45.673
   Ooijen PMA, 2004, EUR RADIOL, V14, P2163, DOI 10.1007/s00330-004-2493-z
   RATH S, 1985, AM HEART J, V109, P785, DOI 10.1016/0002-8703(85)90639-8
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Yip HK, 2001, AM J CARDIOL, V87, P1184, DOI 10.1016/S0002-9149(01)01491-6
NR 12
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 248
EP 252
DI 10.4070/kcj.2015.45.3.248
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600012
PM 26023315
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HK
   Ahn, Y
AF Kim, Hyun Kuk
   Ahn, Youngkeun
TI Mortality Trends of Cardiovascular Disease in Korea; Big Challenges in
   Ischemic Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ACUTE MYOCARDIAL-INFARCTION; REGISTRY
C1 [Kim, Hyun Kuk; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Ctr Cardiovasc, Dept Cardiol, Gwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Ctr Cardiovasc, Dept Cardiol, 671 Jebong Ro, Gwangju 501757, South Korea.
EM cecilyk@hanmail.net
CR Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467
   Kim HK, 2014, KOREAN J INTERN MED, V29, P703, DOI 10.3904/kjim.2014.29.6.703
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Lee KS, 2014, J PUBLIC HEALTH-UK, V36, P225, DOI 10.1093/pubmed/fdt056
   Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
   Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301
   Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619
   Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423
NR 8
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 192
EP 193
DI 10.4070/kcj.2015.45.3.192
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600003
PM 26023306
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SW
   Kim, HC
   Lee, HS
   Suh, I
AF Lee, Seung Won
   Kim, Hyeon Chang
   Lee, Hye Sun
   Suh, Il
TI Thirty-Year Trends in Mortality from Cardiovascular Diseases in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular diseases; Myocardial ischemia; Mortality; Trends; Korea
ID CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; GLOBAL BURDEN;
   RISK-FACTORS; REGISTRY; DECLINE; DEATHS; HEALTH; JAPAN; RATES
AB Background and Objectives: An understanding of cardiovascular diseases (CVD) mortality is important for the development of strategies aimed at reducing the burden of CVD. Thus, we examined the changing pattern of CVD mortality in Korea over 30 years (1983-2012) by analyzing the Cause of Death Statistics.
   Materials and Methods: Deaths from diseases of the circulatory system and those of five CVD categories were analyzed: total heart diseases, acute rheumatic fever/chronic rheumatic heart disease, hypertensive heart disease, ischemic heart disease (IHD) and atherosclerosis. To assess the effects of population ageing on CVD mortality, crude and age-adjusted mortality rates were calculated. Age-adjusted mortality rates were calculated by using the direct standardization method.
   Results: Over the 30-year period analyzed in this study, circulatory system disease mortality markedly declined. The age-adjusted mortality rate decreased by 78.5% in men and by 76.3% in women. Consistent decreasing trends were observed for mortalities from rheumatic heart disease, hypertensive heart disease, and atherosclerosis. However, IHD mortality rapidly increased during the 30 years. Crude IHD mortality showed a steady increase until 2007, after which there were fluctuations. But the penalized regression splines showed that crude IHD mortality continued to increase. Age-adjusted IHD mortality peaked in the early 2000s, and started to decrease during the last few years.
   Conclusion: In summary, total CVD mortality rate has significantly decreased over the 30-year period analyzed in this study but the IHD mortality rate has continuously increased until recently. The prevention and management of cardiovascular diseases amongst the Korean population, especially IHD, still represents a great challenge.
C1 [Lee, Seung Won] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea.
   [Lee, Seung Won; Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120752, South Korea.
   [Kim, Hyeon Chang; Suh, Il] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea.
   [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul 120752, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019; Lee, Hye Sun/J-2154-2015
OI Kim, Hyeon Chang/0000-0001-7867-1240; Suh, Il/0000-0002-9689-7849; Lee,
   Hye Sun/0000-0001-6328-6948
FU Korean Health Technology R&D Project, Ministry of Health Welfare, Korea
   [HI13C0715]
FX This work was supported by the Korean Health Technology R&D Project,
   Ministry of Health & Welfare, Korea (HI13C0715).
CR Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380
   Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511
   CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5
   Clarke R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3513
   Costa MJ, 2008, PENALIZED SPLINE MOD
   Deaton C, 2011, EUR J CARDIOVASC NUR, V10, pS5, DOI 10.1016/S1474-5151(11)00111-3
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
   Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467
   Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165
   Kang SH, 2012, AM J CARDIOL, V109, P787, DOI 10.1016/j.amjcard.2011.11.006
   Kesteloot H E, 2001, J Cardiol, V37 Suppl 1, P1
   Kim Hyeon Chang, 2013, J Prev Med Public Health, V46, P165, DOI 10.3961/jpmph.2013.46.4.165
   Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163
   Kim HK, 2014, KOREAN J INTERN MED, V29, P703, DOI 10.3904/kjim.2014.29.6.703
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Korea National Statistical Office, CAUS DEATH STAT STAT
   Kramer KM, 2008, CARDIAC NURSING, P753
   Lee KS, 2014, J PUBLIC HEALTH-UK, V36, P225, DOI 10.1093/pubmed/fdt056
   Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x
   Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042
   Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301
   Sekikawa A, 1999, INT J EPIDEMIOL, V28, P1044, DOI 10.1093/ije/28.6.1044
   Suh I, 2001, ACTA CARDIOL, V56, P75, DOI 10.2143/AC.56.2.2005621
   Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619
   TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583
   Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2
   Yang SM, 2012, SOC SCI MED, V75, P1280, DOI 10.1016/j.socscimed.2012.04.026
   원태영, 2007, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V18, P256
NR 28
TC 42
Z9 43
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 202
EP 209
DI 10.4070/kcj.2015.45.3.202
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600005
PM 26023308
OA Green Published
DA 2021-04-22
ER

PT J
AU Belen, E
   Degirmencioglu, A
   Zencirci, E
   Tipi, FF
   Altun, O
   Karakus, G
   Helvaci, A
   Zencirci, AE
   Kalaycioglu, E
AF Belen, Erdal
   Degirmencioglu, Aleks
   Zencirci, Ertugrul
   Tipi, Fatih Fahri
   Altun, Ozgur
   Karakus, Gultekin
   Helvaci, Aysen
   Zencirci, Aycan Esen
   Kalaycioglu, Ezgi
TI The Association between Subclinical Hypothyroidism and Epicardial
   Adipose Tissue Thickness
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular diseases; Echocardiography; Epicardium; Hypothyroidism;
   Visceral adipose tissue
ID CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE;
   WAIST CIRCUMFERENCE; THYROID-FUNCTION; BLOOD-PRESSURE; RISK-FACTORS;
   FAT; HORMONE; PARAMETERS
AB Background and Objectives: Subclinical hypothyroidism (SH) is considered to be a potential risk factor for cardiovascular disease. Epicardial adipose tissue (EAT) thickness is also closely related to cardiovascular disorders. The aim of this study was to evaluate whether SH is associated with higher EAT thickness.
   Subjects and Methods: Fifty-one consecutive patients with SH and 51 healthy control subjects were prospectively enrolled into this trial. Thyroid hormone levels, lipid parameters, body mass index, waist and neck circumference, and EAT thickness measured by echocardiography were recorded in all subjects.
   Results: Mean EAT thickness was increased in the SH group compared to the control group (6.7 +/- 1.4 mm vs. 4.7 +/- 1.2 mm, p<0.001). EAT thickness was shown to be correlated with thyroid stimulating hormone level (r=0.303, p=0.002). Multivariate logistic regression analysis revealed that EAT thickness was independently associated with SH {odds ratio (OR): 3.87, 95% confidence interval (Cl): 1.92-7.78, p<0.001; OR: 3.80, 95% Cl: 2.18-6.62, p<0.001}.
   Conclusion: Epicardial adipose tissue thickness is increased in patients with SH compared to control subjects, and this increase in EAT thickness may be associated with the potential cardiovascular adverse effects of SH.
C1 [Belen, Erdal; Tipi, Fatih Fahri; Altun, Ozgur; Helvaci, Aysen] Istanbul Okmeydani Training & Res Hosp, Istanbul, Turkey.
   [Degirmencioglu, Aleks] Acibadem Univ, Sch Med, Istanbul, Turkey.
   [Zencirci, Ertugrul; Karakus, Gultekin] Acibadem Maslak Hosp, Istanbul, Turkey.
   [Zencirci, Aycan Esen] Dr Siyami Ersek Cardiovasc Surg Training & Res Ho, Istanbul, Turkey.
   [Kalaycioglu, Ezgi] Ahi Evren Chest & Cardiovasc Surg Educ & Res Hosp, Trabzon, Turkey.
RP Degirmencioglu, A (corresponding author), Acibadem Maslak Hosp, Buyukdere St 40, TR-34457 Istanbul, Turkey.
EM alexdegirmencioglu@hotmail.com
RI Zencirci, Ertugrul/X-6487-2018; KALAYCIOGLU, EZGI/ABG-6777-2020;
   Degirmencioglu, Aleks/X-1039-2018
OI KALAYCIOGLU, EZGI/0000-0003-2122-1817; 
CR Ashizawa K, 2010, CLIN ENDOCRINOL, V72, P689, DOI 10.1111/j.1365-2265.2009.03697.x
   Asik M, 2013, CLIN ENDOCRINOL, V79, P571, DOI 10.1111/cen.12176
   Ben-Noun L, 2001, OBES RES, V9, P470, DOI 10.1038/oby.2001.61
   Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011
   Biondi B, 2007, THYROID, V17, P625, DOI 10.1089/thy.2007.0158
   Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398
   Castro JP, 2003, CURR HYPERTENS REP, V5, P393, DOI 10.1007/s11906-003-0085-y
   Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6
   De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x
   Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405
   Fommei E, 2002, J CLIN ENDOCR METAB, V87, P1996, DOI 10.1210/jc.87.5.1996
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698
   Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45
   Jones DD, 2010, AM J MED, V123, P502, DOI 10.1016/j.amjmed.2009.12.023
   Jung Chan Hee, 2003, Korean J Intern Med, V18, P146
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707
   lacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536
   Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E
   Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002
   Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005
   Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361
   Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718
   Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062
   Santos OC, 2014, J ENDOCRINOL INVEST
   Unubol M, 2014, MINERVA ENDOCRINOL, V39, P135
   Uzunlulu M, 2007, ENDOCR J, V54, P71, DOI 10.1507/endocrj.K06-124
   Waring AC, 2012, CLIN ENDOCRINOL, V76, P911, DOI 10.1111/j.1365-2265.2011.04328.x
   Waterhouse DF, 2007, THYROID, V17, P243, DOI 10.1089/thy.2006.0208
NR 30
TC 5
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 210
EP 215
DI 10.4070/kcj.2015.45.3.210
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600006
PM 26023309
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JY
   Lee, SH
   Kim, BS
   Seo, HS
   Kim, WS
   Ahn, Y
   Lee, NH
   Koh, KK
   Kang, TS
   Jo, SH
   Hong, BK
   Bae, JH
   Yang, HM
   Cha, KS
   Kim, BS
   Kwak, CH
   Cho, DK
   Kim, U
   Zo, JH
   Kang, DH
   Pyun, WB
   Chun, KJ
   Namgung, J
   Cha, TJ
   Juhn, JH
   Jung, Y
   Jang, Y
AF Jang, Ji-Yong
   Lee, Sang-Hak
   Kim, Byung Soo
   Seo, Hong Seog
   Kim, Woo-Shik
   Ahn, Youngkeun
   Lee, Nae-Hee
   Koh, Kwang Kon
   Kang, Tae-Soo
   Jo, Sang-Ho
   Hong, Bum-Kee
   Bae, Jang-Ho
   Yang, Hyoung-Mo
   Cha, Kwang Soo
   Kim, Bum Soo
   Kwak, Choong Hwan
   Cho, Deok-Kyu
   Kim, Ung
   Zo, Joo-Hee
   Kang, Duk-Hyun
   Pyun, Wook Bum
   Chun, Kook Jin
   Namgung, June
   Cha, Tae-Joon
   Juhn, Jae-Hyeon
   Jung, YeiLi
   Jang, Yangsoo
TI Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in
   the Treatment of Hypercholesterolemic Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Valsartan; Rosuvastatin; Drug therapy; combination; Controlled clinical
   trials; randomized; Blood pressure
ID BLOOD-PRESSURE CONTROL; CHOLESTEROL; COMBINATION; PRAVASTATIN; EFFICACY;
   AMLODIPINE; LOVASTATIN; INHIBITORS; RECEPTOR; STATINS
AB Background and Objectives: We compared the efficacy and safety of valsartan and rosuvastatin combination therapy with each treatment alone in hypercholesterolemic hypertensive patients.
   Subjects and Methods: Patients who met inclusion criteria were randomized to receive 1 of the following 2-month drug regimens: valsartan 160 mg plus rosuvastatin 20 mg, valsartan 160 mg plus placebo, or rosuvastatin 20 mg plus placebo. The primary efficacy variables were change in sitting diastolic blood pressure (sitDBP) and sitting systolic blood pressure (sitSBP), and percentage change in low-density lipoprotein-cholesterol (LDL-C) in the combination, valsartan, and rosuvastatin groups. Adverse events (AEs) during the study were analyzed.
   Results: A total of 354 patients were screened and 123 of them were finally randomized. Changes of sitDBP by least squares mean (LSM) were -11.1, -7.2, and -3.6 mm Hg, respectively, and was greater in the combination, as compared to both valsartan (p=0.02) and rosuvastatin (p<0.001). Changes of sitSBP by LSM were -13.2, -10.8, and -4.9 mm Hg, and was greater in the combination, as compared to rosuvastatin (p=0.006) and not valsartan (p=0.42). Percentage changes of LDL-C by LSM were -52, -4, and -47% in each group, and was greater in the combination, as compared to valsartan (p<0.001), similar to rosuvastatin (p=0.16). Most AEs were mild and resolved by the end of the study.
   Conclusion: Combination treatment with valsartan and rosuvastatin exhibited an additive blood pressure-lowering effect with acceptable tolerability, as compared to valsartan monotherapy. Its lipid lowering effect was similar to rosuvatatin monotherapy.
C1 [Jang, Ji-Yong; Lee, Sang-Hak; Jang, Yangsoo] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea.
   [Jang, Ji-Yong; Lee, Sang-Hak; Jang, Yangsoo] Yonsei Univ, Coll Med, Dept Internal Med, Cardiovasc Res Inst,Severance Hosp, Seoul, South Korea.
   [Kim, Byung Soo] Daedong Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Seo, Hong Seog] Korea Univ, Coll Med, Div Cardiol, Cardiovasc Ctr,Guro Hosp, Seoul 136705, South Korea.
   [Kim, Woo-Shik] Kyung Hee Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ Hosp, Heart Res Ctr, Dept Cardiol, Gwangju, South Korea.
   [Lee, Nae-Hee] Soon Chun Hyang Univ, Bucheon Hosp, Dept Cardiol, Bucheon, South Korea.
   [Koh, Kwang Kon] Gachon Univ, Gil Med Ctr, Dept Cardiol, Inchon, South Korea.
   [Kang, Tae-Soo] Dankook Univ, Coll Med, Div Cardiol, Cheonan, South Korea.
   [Jo, Sang-Ho] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Anyang, South Korea.
   [Hong, Bum-Kee] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Gangnam Severance Hosp, Seoul, South Korea.
   [Bae, Jang-Ho] Konyang Univ Hosp, Dept Internal Med, Div Cardiol, Taejon, South Korea.
   [Yang, Hyoung-Mo] Ajou Univ, Dept Cardiol, Med Ctr, Suwon 441749, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ Hosp, Div Cardiol, Busan, South Korea.
   [Kim, Bum Soo] Sungkyunkwan Univ, Dept Internal Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Kwak, Choong Hwan] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jinju, South Korea.
   [Kwak, Choong Hwan] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea.
   [Cho, Deok-Kyu] Myongji Hosp, Cardiovasc Ctr, Dept Cardiol, Goyang, South Korea.
   [Kim, Ung] Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Zo, Joo-Hee] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Kang, Duk-Hyun] Univ Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, Seoul, South Korea.
   [Pyun, Wook Bum] Ewha Womans Univ, Dept Internal Med, Mokdong Hosp, Div Cardiol, Seoul, South Korea.
   [Chun, Kook Jin] Pusan Natl Univ, Yangsan Hosp, Dept Cardiol, Yangsan, South Korea.
   [Namgung, June] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Cha, Tae-Joon] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Juhn, Jae-Hyeon; Jung, YeiLi] LG Life Sci Ltd, Clin Dev Dept, Seoul, South Korea.
RP Jang, YS (corresponding author), Severance Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM jangys1212@yuhs.ac
OI Yang, Hyoung-Mo/0000-0003-3602-9772; Kwak, Choong
   Hwan/0000-0001-6035-4415; Hong, Bum Kee/0000-0002-6456-0184; Jang,
   Yangsoo/0000-0002-2169-3112
FU LG Life Science
FX This study was supported by LG Life Science. The sponsor provided
   investigational products including the active and placebo pills used in
   this study. J.H.J and Y.L.J are full-time employees of LG Life. Yangsoo
   Jang and Sang-Hak Lee contributed to the study design, interpretation of
   the data, and writing of the manuscript. Jae-Hyeon Juhn and YeiLe Jung
   contributed to the statistical analyses. Ji-Yong Jang contributed to the
   interpretation of the data and writing of the manuscript. All authors
   contributed to the design of the article and revised the manuscript. We
   thank all study participants, investigators, and coordinators.
CR Avis HJ, 2010, J AM COLL CARDIOL, V55, P1121, DOI 10.1016/j.jacc.2009.10.042
   Borghi C, 2004, J HYPERTENS, V22, P1707, DOI 10.1097/00004872-200409000-00014
   Borghi C, 2000, J CARDIOVASC PHARM, V35, P549, DOI 10.1097/00005344-200004000-00006
   Cifkova R, 2003, J Hypertens, V21, P1779
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Egede R, 2012, INT J CARDIOL, V158, P376, DOI 10.1016/j.ijcard.2011.01.071
   Glorioso N, 1999, HYPERTENSION, V34, P1281, DOI 10.1161/01.HYP.34.6.1281
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Jiang J, 1997, HYPERTENSION, V30, P968, DOI 10.1161/01.HYP.30.4.968
   Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9
   Kaesemeyer WH, 1999, J AM COLL CARDIOL, V33, P234, DOI 10.1016/S0735-1097(98)00514-2
   Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571
   KEIDAR S, 1994, ATHEROSCLEROSIS, V107, P71, DOI 10.1016/0021-9150(94)90143-0
   Koh KK, 2004, CIRCULATION, V110, P3687, DOI 10.1161/01.CIR.0000143085.86697.13
   Lewis TV, 1998, BRIT J PHARMACOL, V124, P222, DOI 10.1038/sj.bjp.0701800
   Nazzaro P, 1999, HYPERTENSION, V33, P719, DOI 10.1161/01.HYP.33.2.719
   Nickenig G, 2002, CIRCULATION, V105, P530, DOI 10.1161/hc0402.102619
   ODriscoll GP, 1997, CONTEMP ECON POLICY, V15, P1, DOI 10.1111/j.1465-7287.1997.tb00451.x
   Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292
   Philipp T, 2007, CLIN THER, V29, P563, DOI 10.1016/j.clinthera.2007.03.018
   Pool JL, 1999, J HUM HYPERTENS, V13, P275, DOI 10.1038/sj.jhh.1000788
   Rajagopalan S, 2007, AM J CARDIOL, V100, P222, DOI 10.1016/j.amjcard.2007.02.085
   Roberts C, 1999, BRIT MED J, V319, P185, DOI 10.1136/bmj.319.7203.185
   Savic V, 2013, DIABETES VASC DIS RE, V10, P420, DOI 10.1177/1479164113485102
   Sposito AC, 1999, AM J CARDIOL, V83, P1497, DOI 10.1016/S0002-9149(99)00132-0
   Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002
   STRAZNICKY NE, 1995, AM J CARDIOL, V75, P582, DOI 10.1016/S0002-9149(99)80621-3
   Thomas F, 2002, EUR HEART J, V23, P528, DOI 10.1053/euhj.2001.2888
   White CM, 2002, J CLIN PHARMACOL, V42, P963
   Wilson TW, 1998, HYPERTENSION, V31, P225, DOI 10.1161/01.HYP.31.1.225
NR 30
TC 13
Z9 15
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 225
EP 233
DI 10.4070/kcj.2015.45.3.225
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600008
PM 26023311
OA Green Published
DA 2021-04-22
ER

PT J
AU Ban, JE
   Park, SW
   Lee, HS
   Choi, JI
   Kim, YH
AF Ban, Ji-Eun
   Park, Sang-Weon
   Lee, Hyun-Soo
   Choi, Jong-Il
   Kim, Young-Hoon
TI Swallowing-Induced Atrial Tachyarrhythmias Successfully Ablated at the
   Left Posterior Interatrial Septum in Patient with Wolff-Parkinson-White
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Deglutition; Atrial tachycardia; Catheter ablation
ID RADIOFREQUENCY CATHETER ABLATION; INDUCED TACHYCARDIA; THERAPY
AB We reported a case of a 55-year-old patient who presented with palpitation after swallowing. Initial surface electrocardiogram revealed ventricular preexcitation utilizing a left lateral bypass tract. The orthodromic atrioventricular reentrant tachycardia (AVRT) was induced during electrophysiologic studies. After successful ablation of the AVRT utilizing a left lateral free wall bypass tract, 2 different atrial tachycardias (ATs) were induced under isoproterenol infusion. When the patient swallowed saliva or drank water, 2 consecutive beats of atrial premature complexes (APCs) preceded another non-sustained AT repeatedly, which was coincident with the patient's symptom. The preceding APC couplet had the same activation sequence with one induced AT, and the subsequent non-sustained AT had the same activation sequence with the other induced AT respectively. We first targeted the preceding 2 consecutive APCs at the left posterior interatrial septum. The following non-sustained AT was also eliminated following ablation of the APCs. After ablation, the patient remained free from the swallowing-induced atrial tachyarrhythmias during the one year follow-up.
C1 [Ban, Ji-Eun; Park, Sang-Weon; Lee, Hyun-Soo; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea.
RP Park, SW (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 136705, South Korea.
EM swparkmd@gmail.com
CR Ardell JL, 2011, HEART RHYTHM, V8, P590, DOI 10.1016/j.hrthm.2010.12.019
   Baman NS, 2004, PACE, V27, P555, DOI 10.1111/j.1540-8159.2004.00482.x
   GREENSPON AJ, 1988, PACE, V11, P1566, DOI 10.1111/j.1540-8159.1988.tb06275.x
   MATSUBARA K, 1988, CLIN CARDIOL, V11, P798, DOI 10.1002/clc.4960111114
   MORADY F, 1987, PACE, V10, P133, DOI 10.1111/j.1540-8159.1987.tb05933.x
   Nakahara S, 2014, HEART RHYTHM, V11, P169, DOI 10.1016/j.hrthm.2012.12.028
   Satish OS, 2005, PACE, V28, P594, DOI 10.1111/j.1540-8159.2005.09536.x
   Tada H, 2007, PACE, V30, P1224, DOI 10.1111/j.1540-8159.2007.00844.x
   Undavia M, 2006, HEART RHYTHM, V3, P971, DOI 10.1016/j.hrthm.2006.04.010
   Yamauchi Y, 2005, J CARDIOVASC ELECTR, V16, P1370, DOI 10.1111/j.1540-8167.2005.00249.x
   YEH SJ, 1986, J ELECTROCARDIOL, V19, P193, DOI 10.1016/S0022-0736(86)80028-0
   Yokoshiki H, 2011, J ELECTROCARDIOL, V44
NR 12
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2015
VL 45
IS 3
BP 253
EP 258
DI 10.4070/kcj.2015.45.3.253
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CJ5AK
UT WOS:000355499600013
PM 26023316
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, YK
   Hur, SH
AF Cho, Yun-Kyeong
   Hur, Seung-Ho
TI Practical Application of Coronary Imaging Devices in Cardiovascular
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Diagnostic imaging; Percutaneous coronary
   intervention
ID OPTICAL COHERENCE TOMOGRAPHY; DRUG-ELUTING STENT; INTRAVASCULAR
   ULTRASOUND GUIDANCE; NEAR-INFRARED SPECTROSCOPY; QUANTITATIVE TISSUE
   CHARACTERIZATION; FRACTIONAL FLOW RESERVE; TERM CLINICAL-OUTCOMES;
   ANGIOGRAPHIC GUIDANCE; RANDOMIZED-TRIAL; INTEGRATED BACKSCATTER
AB The significant morbidity and mortality associated with coronary artery disease has spurred the development of intravascular imaging devices to optimize the detection and assessment of coronary lesions and percutaneous coronary interventions. lntravascular ultrasound (IVUS) uses reflected ultrasound waves to quantitatively and qualitatively assess lesions; integrated backscatter and virtual histology IVUS more precisely characterizes plaque composition; angioscopy directly visualize thrombus and plaque; optical coherence tomography using near-infrared (NIR) light with very high spatial resolution provides more accurate images; and the recently introduced NIR spectroscopy identifies chemical components in coronary artery plaques based on differential light absorption in the NIR spectrum. This article reviews usefulness of these devices and hybrids thereof.
C1 [Cho, Yun-Kyeong; Hur, Seung-Ho] Keimyung Univ, Dongsan Hosp, Dept Internal Med, Taegu 700712, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Dongsan Hosp, Dept Internal Med, 56 Dalseong Ro, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
CR Ahn JM, 2014, AM J CARDIOL, V113, P1338, DOI 10.1016/j.amjcard.2013.12.043
   Ahn JM, 2013, AM J CARDIOL, V111, P829, DOI 10.1016/j.amjcard.2012.11.054
   Ahn SG, 2013, KOREAN CIRC J, V43, P231, DOI 10.4070/kcj.2013.43.4.231
   Alfonso F, 2008, J AM COLL CARDIOL, V51, P2403, DOI 10.1016/j.jacc.2008.03.029
   ARNETT EN, 1979, ANN INTERN MED, V91, P350, DOI 10.7326/0003-4819-91-3-350
   Bourantas CV, 2005, COMPUT MED IMAG GRAP, V29, P597, DOI 10.1016/j.compmedimag.2005.07.001
   Cervinka P, 2014, CAN J CARDIOL, V30, P420, DOI 10.1016/j.cjca.2013.12.016
   Chen SL, 2013, CATHETER CARDIO INTE, V81, P456, DOI 10.1002/ccd.24601
   Chieffo A, 2013, AM HEART J, V165, P65, DOI 10.1016/j.ahj.2012.09.017
   Choi BJ, 2013, EUR HEART J, V34, P2047, DOI 10.1093/eurheartj/eht132
   Claessen BE, 2012, JACC-CARDIOVASC IMAG, V5, pS111, DOI 10.1016/j.jcmg.2011.11.018
   Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P974, DOI 10.1016/j.jcin.2011.07.005
   de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012
   Dixon SR, 2012, AM J CARDIOL, V109, P60, DOI 10.1016/j.amjcard.2011.07.068
   Frey AW, 2000, CIRCULATION, V102, P2497, DOI 10.1161/01.CIR.102.20.2497
   Gaster AL, 2003, HEART, V89, P1043, DOI 10.1136/heart.89.9.1043
   Gil RJ, 2007, AM HEART J, V154, P669, DOI 10.1016/j.ahj.2007.06.017
   Gonzalo N, 2012, J AM COLL CARDIOL, V59, P1080, DOI 10.1016/j.jacc.2011.09.078
   Gutierrez-Chico JL, 2012, CIRC-CARDIOVASC INTE, V5, P20, DOI 10.1161/CIRCINTERVENTIONS.111.965301
   Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111
   Hodgson J M, 1989, Int J Card Imaging, V4, P187, DOI 10.1007/BF01745149
   Hur SH, 2013, CATHETER CARDIO INTE, V81, P407, DOI 10.1002/ccd.23279
   Im E, 2014, CIRC-CARDIOVASC INTE, V7, P88, DOI 10.1161/CIRCINTERVENTIONS.113.000797
   Ino Y, 2013, CORONARY ARTERY DIS, V24, P95, DOI 10.1097/MCA.0b013e32835c872b
   Jakabcin J, 2010, CATHETER CARDIO INTE, V75, P578, DOI 10.1002/ccd.22244
   Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013
   Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436
   Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1161/01.CIR.0000017200.47342.10
   Kawasaki M, 2001, J AM COLL CARDIOL, V38, P486, DOI 10.1016/S0735-1097(01)01393-6
   Kim IC, 2014, EUR HEART J SUPPL, V35, P1141
   Kim JS, 2013, JACC-CARDIOVASC INTE, V6, P369, DOI 10.1016/j.jcin.2012.11.009
   Kim JS, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.002
   Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092
   Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
   Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014
   Kubo T, 2008, JACC-CARDIOVASC IMAG, V1, P475, DOI 10.1016/j.jcmg.2008.03.012
   Lee SY, 2009, JACC-CARDIOVASC INTE, V2, P65, DOI 10.1016/j.jcin.2008.08.022
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Madder RD, 2013, JACC-CARDIOVASC INTE, V6, P838, DOI 10.1016/j.jcin.2013.04.012
   Madder RD, 2012, CIRC-CARDIOVASC INTE, V5, P55, DOI 10.1161/CIRCINTERVENTIONS.111.963934
   MINTZ GS, 1993, AM J CARDIOL, V71, P799, DOI 10.1016/0002-9149(93)90827-Y
   Moreno PR, 2002, CIRCULATION, V105, P923, DOI 10.1161/hc0802.104291
   Mudra H, 2001, CIRCULATION, V104, P1343, DOI 10.1161/hc3701.096064
   Nasu K, 2008, AM J CARDIOL, V101, P1079, DOI 10.1016/j.amjcard.2007.11.064
   Oemrawsingh PV, 2003, CIRCULATION, V107, P62, DOI 10.1161/01.CIR.0000043240.87526.3F
   Parise H, 2011, AM J CARDIOL, V107, P374, DOI 10.1016/j.amjcard.2010.09.030
   Park KW, 2013, INT J CARDIOL, V167, P721, DOI 10.1016/j.ijcard.2012.03.059
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Pawlowski T, 2013, INT J CARDIOVAS IMAG, V29, P1685, DOI 10.1007/s10554-013-0283-x
   POTKIN BN, 1992, J AM COLL CARDIOL, V20, P942, DOI 10.1016/0735-1097(92)90197-U
   Prati F, 2012, EUROINTERVENTION, V8, P823, DOI 10.4244/EIJV8I7A125
   Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387
   Pyxaras SA, 2013, AM HEART J, V166, P1010, DOI 10.1016/j.ahj.2013.08.016
   Rath Pratap Chandra, 2014, Indian Heart J, V66, P31, DOI 10.1016/j.ihj.2013.12.048
   Reith S, 2013, HEART, V99, P700, DOI 10.1136/heartjnl-2013-303616
   Rodriguez-Granillo GA, 2005, CATHETER CARDIO INTE, V66, P514, DOI 10.1002/ccd.20447
   Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064
   Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249
   Russo RJ, 2009, CIRC-CARDIOVASC INTE, V2, P113, DOI 10.1161/CIRCINTERVENTIONS.108.778647
   Schiele F, 2000, INT J CARDIOVASC INT, V3, P207
   Shiono Y, 2012, CIRC J, V76, P2218, DOI 10.1253/circj.CJ-12-0195
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Takano M, 2010, CIRC J, V74, P240, DOI 10.1253/circj.CJ-09-0769
   Takarada S, 2010, CATHETER CARDIO INTE, V75, P202, DOI 10.1002/ccd.22273
   Tang Z, 2014, J GERIATR CARDIOL, V11, P44, DOI 10.3969/j.issn.1671-5411.2014.01.012
   Uchida Y, 2011, J CARDIOL, V57, P18, DOI 10.1016/j.jjcc.2010.11.001
   Vergallo R, 2013, AM J CARDIOL, V112, P1315, DOI 10.1016/j.amjcard.2013.05.076
   Waxman S, 2009, JACC-CARDIOVASC IMAG, V2, P858, DOI 10.1016/j.jcmg.2009.05.001
   WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304
   Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942
   Wu XF, 2010, AM J CARDIOL, V105, P48, DOI 10.1016/j.amjcard.2009.08.649
   Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6
   Youn YJ, 2011, CLIN CARDIOL, V34, P706, DOI 10.1002/clc.20966
   Zhang YJ, 2012, EUROINTERVENTION, V8, P855, DOI 10.4244/EIJV8I7A129
NR 74
TC 5
Z9 5
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 87
EP 95
DI 10.4070/kcj.2015.45.2.87
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100001
PM 25810728
OA Green Published
DA 2021-04-22
ER

PT J
AU Gurzun, MM
   Popescu, AC
   Ginghina, C
   Popescu, BA
AF Gurzun, Maria-Magdalena
   Popescu, Andreea C.
   Ginghina, Carmen
   Popescu, Bogdan A.
TI Management of Organic Mitral Regurgitation: Guideline Recommendations
   and Controversies
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mitral regurgitation; Mitral annuloplasty; Echocardiography
ID GLOBAL LONGITUDINAL STRAIN; BRAIN NATRIURETIC PEPTIDE; 3-DIMENSIONAL
   TRANSESOPHAGEAL ECHOCARDIOGRAPHY; EXERCISE PULMONARY-HYPERTENSION;
   LEFT-VENTRICULAR DYSFUNCTION; VALVE REPAIR; CONVENTIONAL TREATMENT;
   PROGNOSTIC IMPORTANCE; PERCUTANEOUS REPAIR; ATRIAL FUNCTION
AB Mitral regurgitation (MR) represents the second most frequent valvular heart disease. The appropriate management of organic MR remains unclear in many aspects, especially in several specific clinical scenarios. This review aims to discuss the current guideline recommendations regarding the management of organic MR, while highlighting the controversial aspects encountered in daily clinical practice. The role of imaging is essential in establishing the most appropriate type of surgical treatment (repair or replace), which is based on morphological mitral valve (MV) characteristics (reparability of the valve) and local surgical expertise in valve repair. The potential advantages of 3-dimensional echocardiography in assessing the MV are discussed. Other modern imaging techniques (tissue Doppler and speckle tracking) may provide additional useful information in borderline cases. Exercise echocardiography (evaluating MR severity, pulmonary pressure, or right ventricular function) may have an important role in the management of difficult cases. Finally, the moment when surgery is no longer an option and alternative solutions should be sought is also discussed. Although in everyday clinical practice the timing of surgery is not always straightforward, some newer clinical and echocardiographic indicators can guide this decision and help improve the outcome of these patients.
C1 [Gurzun, Maria-Magdalena; Popescu, Andreea C.; Ginghina, Carmen; Popescu, Bogdan A.] Univ Med & Pharm Carol Davila, Dept Cardiol, Bucharest 022328, Romania.
   [Gurzun, Maria-Magdalena; Ginghina, Carmen; Popescu, Bogdan A.] Emergency Inst Cadiovasc Dis Prof Dr CC Iliescu, Dept Cardiol, Bucharest, Romania.
   [Popescu, Andreea C.] Emergency Univ Hosp Elias, Dept Cardiol, Bucharest, Romania.
RP Popescu, BA (corresponding author), Univ Med & Pharm Carol Davila, Emergency Inst Cadiovasc Dis Prof Dr CC Iliescu, Dept Cardiol, Euroecolab, Sos Fundeni 258,Sect 2, Bucharest 022328, Romania.
EM bogdan.a.popescu@gmail.com
RI Popescu, Bogdan A/A-4528-2011
OI Popescu, Bogdan A/0000-0001-6122-8533
FU General Electric HealthcareGE Healthcare; Romanian Ministry of National
   Education, CNCS-UEFISCDI [PN-II-ID-PCE-2012-4-0560, 21/2013]; Sectorial
   Operational Programme Human Resources Development (SOP HRD); European
   Social FundEuropean Social Fund (ESF); Romanian Government
   [POSDRU/159/1.5/S/132395]
FX Popescu BA has received research support and lecture honoraria from
   General Electric Healthcare.; This work was supported by a grant of the
   Romanian Ministry of National Education, CNCS-UEFISCDI, project number
   PN-II-ID-PCE-2012-4-0560 (contract 21/2013), and by the Sectorial
   Operational Programme Human Resources Development (SOP HRD), financed by
   the European Social Fund and by the Romanian Government under the
   contract number POSDRU/159/1.5/S/132395.
CR Alfieri O, 2001, J THORAC CARDIOV SUR, V122, P674, DOI 10.1067/mtc.2001.117277
   Barbieri A, 2011, EUR HEART J, V32, P751, DOI 10.1093/eurheartj/ehq294
   Beladan CC, 2014, HEART, V100, P731, DOI 10.1136/heartjnl-2012-302064
   Bolling SF, 2010, ANN THORAC SURG, V90, P1904, DOI 10.1016/j.athoracsur.2010.07.062
   Bonow RO, 2014, JACC-CARDIOVASC IMAG, V7, P233, DOI 10.1016/j.jcmg.2014.01.009
   Borg AN, 2008, HEART, V94, P597, DOI 10.1136/hrt.2007.126284
   Cameli M, 2013, AM J CARDIOL, V111, P595, DOI 10.1016/j.amjcard.2012.10.049
   Castillo JG, 2014, EUR J CARDIO-THORAC, V45, P139, DOI 10.1093/ejcts/ezt196
   Castillo JG, 2012, J THORAC CARDIOV SUR, V144, P308, DOI 10.1016/j.jtcvs.2011.12.054
   Crawford FA, 2005, J AM COLL CARDIOL, V45, P1041, DOI 10.1016/j.jacc.2004.12.059
   De Bonis M, 2013, EUR HEART J, V34, P13, DOI 10.1093/eurheartj/ehs248
   De Bonis M, 2012, NAT REV CARDIOL, V9, P133, DOI 10.1038/nrcardio.2011.169
   DELAHAYE JP, 1991, EUR HEART J, V12, P5, DOI 10.1093/eurheartj/12.suppl_B.5
   Detaint D, 2005, CIRCULATION, V111, P2391, DOI 10.1161/01.CIR.0000164269.80908.9D
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022
   Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065
   Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355
   Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436
   Gammie JS, 2009, ANN THORAC SURG, V87, P1431, DOI 10.1016/j.athoracsur.2009.01.064
   Ghoreishi M, 2011, J THORAC CARDIOV SUR, V142, P1439, DOI 10.1016/j.jtcvs.2011.08.030
   Guarracino F, 2014, ANESTH ANALG, V118, P1188, DOI 10.1213/ANE.0000000000000215
   Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584
   Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X
   Kang DH, 2014, J AM COLL CARDIOL, V63, P2398, DOI 10.1016/j.jacc.2014.02.577
   Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314
   Klaar U, 2011, EUR J HEART FAIL, V13, P163, DOI 10.1093/eurjhf/hfq189
   Kusunose K, 2013, CIRC-CARDIOVASC IMAG, V6, P167, DOI 10.1161/CIRCIMAGING.112.000162
   Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105
   Le Tourneau T, 2010, J AM COLL CARDIOL, V56, P570, DOI 10.1016/j.jacc.2010.02.059
   Li MZ, 2005, J AM COLL CARDIOL, V45, P1034, DOI 10.1016/j.jacc.2004.10.073
   Magne J, 2012, EUR J HEART FAIL, V14, P1293, DOI 10.1093/eurjhf/hfs114
   Magne J, 2012, HEART, V98, P584, DOI 10.1136/heartjnl-2011-301128
   Magne J, 2011, J AM SOC ECHOCARDIOG, V24, P1004, DOI 10.1016/j.echo.2011.04.003
   Magne J, 2010, CIRCULATION, V122, P33, DOI 10.1161/CIRCULATIONAHA.110.938241
   Mascle S, 2012, J AM SOC ECHOCARDIOG, V25, P766, DOI 10.1016/j.echo.2012.04.009
   Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030
   Messika-Zeitoun D, 2013, HEART, V99, P975, DOI 10.1136/Heartjnl-2013-303792
   Moustafa SE, 2011, EUR J ECHOCARDIOGR, V12, P291, DOI 10.1093/ejechocard/jer003
   Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Omran AS, 2002, J AM SOC ECHOCARDIOG, V15, P950, DOI 10.1067/mje.2002.121534
   Pandis D, 2014, J AM SOC ECHOCARDIOG, V27, P627, DOI 10.1016/j.echo.2014.02.008
   Pepi M, 2006, J AM COLL CARDIOL, V48, P2524, DOI 10.1016/j.jacc.2006.02.079
   Pizarro R, 2009, J AM COLL CARDIOL, V54, P1099, DOI 10.1016/j.jacc.2009.06.013
   Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011
   Ring L, 2014, JACC-CARDIOVASC IMAG, V7, P225, DOI 10.1016/j.jcmg.2013.12.009
   Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175
   Rusinaru D, 2011, CIRC-CARDIOVASC IMAG, V4, P473, DOI 10.1161/CIRCIMAGING.110.961011
   Shanks M, 2010, CIRC-CARDIOVASC IMAG, V3, P694, DOI 10.1161/CIRCIMAGING.110.947176
   Shiran A, 2009, J AM COLL CARDIOL, V53, P401, DOI 10.1016/j.jacc.2008.09.048
   Surder D, 2013, HEART, V99, P1034, DOI 10.1136/heartjnl-2012-303105
   Suri RM, 2013, JAMA-J AM MED ASSOC, V310, P609, DOI 10.1001/jama.2013.8643
   Tietge WJ, 2012, NETH HEART J, V20, P94, DOI 10.1007/s12471-012-0249-y
   Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400
   Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455
   Vegas A, 2010, ANESTH ANALG, V110, P1548, DOI 10.1213/ANE.0b013e3181d41be7
   Walls MC, 2008, J HEART VALVE DIS, V17, P1
   Witkowski TG, 2013, EUR HEART J-CARD IMG, V14, P69, DOI 10.1093/ehjci/jes155
NR 58
TC 1
Z9 2
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 96
EP 105
DI 10.4070/kcj.2015.45.2.96
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100002
PM 25810729
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, J
   Lee, Y
   Kang, S
   Chun, H
   Pyun, WB
   Park, SH
   Chung, KM
   Chung, IM
AF Seo, Jihyeon
   Lee, Yoonpyo
   Kang, Seokhyung
   Chun, Hyejin
   Pyun, Wook Bum
   Park, Seong-Hoon
   Chung, Kyong-Mee
   Chung, Ick-Mo
TI Poor Health-Related Quality of Life and Proactive Primary Control
   Strategy May Act as Risk Factors for Acute Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Quality of life; Psychological stress
ID SECONDARY-CONTROL STRATEGIES; ISCHEMIC-HEART-DISEASE; ANXIETY;
   METAANALYSIS; MORTALITY; STRESS; DEPRESSION; HOSTILITY; WORK
AB Background and Objectives: Increasing evidence supports that psychological factors may be related to development of coronary artery disease (CAD). Although psychological well-being, ill-being, and control strategy factors may play a significant role in CAD, rarely have these factors been simultaneously examined previously. We assessed comprehensive psychological factors in patients with acute coronary syndrome (ACS).
   Subjects and Methods: A total of 85 ACS patients (56 unstable angina, 29 acute myocardial infarction; 52.6 +/- 10.2 years; M/F=68/17) and 63 healthy controls (48.7 +/- 6.7 years, M/F=43/20) were included. Socio-demographic information, levels of psychological maladjustment, such as anxiety, hostility, and job stress, health-related quality of life (HRQoL.), and primary and secondary control strategy use were collected through self-report questionnaires.
   Results: There was no significant difference between the ACS group and control group in levels of anxiety, hostility, and job stress. However, ACS patients had significantly lower scores on the general health perception and bodily pain subscales of HRQoL than the control group. The ACS group, as compared with the controls, tended to use primary control strategies more, although not reaching statistical significance by univariate analysis. Multivariate logistic regression analysis after adjusting age and gender identified the physical domain of HRQoL {odds ratio (OR)=0.40}, primary control strategy (OR=1.92), and secondary control strategy (OR=0.53) as independent predictors of ACS.
   Conclusion: Poor HRQoL and primary control strategy, proactive behaviors in achieving ones' goal, may act as risk factors for ACS, while secondary control strategy to conform to current situation may act as a protective factor for ACS.
C1 [Seo, Jihyeon; Chung, Kyong-Mee] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea.
   [Lee, Yoonpyo; Kang, Seokhyung; Pyun, Wook Bum; Park, Seong-Hoon; Chung, Ick-Mo] Ewha Womans Univ, Mokdong Hosp, Sch Med, Div Cardiol, Seoul 158710, South Korea.
   [Chun, Hyejin] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Hlth Promot Ctr, Seoul 158710, South Korea.
   [Chung, Ick-Mo] Ewha Womans Univ, Mokdong Hosp, Sch Med, Ewha Global Top Project 5, Seoul 158710, South Korea.
RP Chung, IM (corresponding author), Ewha Womans Univ, Mokdong Hosp, Sch Med, Div Cardiol, 1071 Anyang Cheon Ro, Seoul 158710, South Korea.
EM kmchung@yonsei.ac.kr; ickmo@ewha.ac.kr
OI Chun, Hyejin/0000-0001-6241-5453
FU Korean Society of Cardiology; CardioVascular Research Foundation (CVRF),
   Seoul, Korea
FX This study has been supported by a grant (2010) from the Korean Society
   of Cardiology and by a grant (2012) from the CardioVascular Research
   Foundation (CVRF), Seoul, Korea. We deeply appreciate for the data
   collection by Hohee Nam R.N., Sejeong Kim R.N., and Wonpyung Whangbo
   R.N. (all, Ewha Womans University Mokdong Hospital).
CR An K, 2004, HEART LUNG, V33, P75, DOI 10.1016/j.hrtlng.2003.12.007
   Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6
   Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   Chida Y, 2009, J AM COLL CARDIOL, V53, P936, DOI 10.1016/j.jacc.2008.11.044
   Chipperfield JG, 2006, HEALTH PSYCHOL, V25, P226, DOI 10.1037/0278-6133.25.2.226
   Chipperfield JG, 1999, J AGING HEALTH, V11, P517, DOI 10.1177/089826439901100403
   DEROGATIS LR, 1977, SCL 90 R VERSION MAN
   Gwak JH, 2006, J KOREAN GERONTOL SO, V26, P565
   Huppert FA, 2003, BRIT J HEALTH PSYCH, V8, P107, DOI 10.1348/135910703762879246
   Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
   KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225
   Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049
   Lavie CJ, 2004, AM J CARDIOL, V93, P336, DOI 10.1016/j.amjcard.2003.10.015
   Lehto S, 2000, SCAND CARDIOVASC J, V34, P580
   Mendis S., 2011, GLOBAL ATLAS CARDIOV
   Na RH, 2000, KOREAN J ART THER, V7, P87
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298
   Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892
   Siegman AW, 2000, PSYCHOSOM MED, V62, P248, DOI 10.1097/00006842-200003000-00017
   Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548
   Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   WEISZ JR, 1984, AM PSYCHOL, V39, P955, DOI 10.1037/0003-066X.39.9.955
   Westin L, 2005, SCAND CARDIOVASC J, V39, P50, DOI 10.1080/14017430410003903
   Westin L, 1997, J INTERN MED, V242, P239, DOI 10.1046/j.1365-2796.1997.00203.x
   Wrosch C, 2000, PSYCHOL AGING, V15, P387, DOI 10.1037//0882-7974.15.3.387
   Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006
NR 30
TC 5
Z9 5
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 117
EP 124
DI 10.4070/kcj.2015.45.2.117
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100006
PM 25810733
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SW
   Cho, KI
   Kim, HS
   Heo, JH
   Cha, TJ
AF Lee, Sea-Won
   Cho, Kyoung-Im
   Kim, Hyun-Su
   Heo, Jung-Ho
   Cha, Tae-Joon
TI The Impact of Subclinical Hypothyroidism or Thyroid Autoimmunity on
   Coronary Vasospasm in Patients without Associated Cardiovascular Risk
   Factors
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypothyroidism; Autoimmunity; Coronary vasopasm
ID ENDOTHELIUM-DEPENDENT VASODILATATION; HASHIMOTOS-THYROIDITIS; SPASTIC
   ANGINA; ARTERIAL STIFFNESS; DYSFUNCTION; DISEASE; PATHOGENESIS; SYSTEM;
   WOMEN
AB Background and Objectives: Subclinical hypothyroidism is associated with endothelial dysfunction and impaired coronary flow reserve. However, the effect of subclinical hypothyroidism or thyroid autoimmunity on variant angina has yet to be determined.
   Subjects and Methods: Among 385 consecutive patients without associated cardiovascular risk factors who underwent coronary angiography with the ergonovine provocation test (EPT), 165 had a positive EPT {EPT(+)} and 220 had a negative EPT {EPT(-)}. The relationship between coronary artery spasm and the presence of subclinical thyroid dysfunction as well as serum thyroid peroxidase autoantibody (TPO Ab) was evaluated.
   Results: The proportion of patients with subclinical hypothyroidism among those who were EPT(+) was significantly higher than that in those who were EPT(-) (18% vs. 11%, p=0.001). However, there was no significant difference in the proportion of patients with subclinical hyperthyroidism between the groups. Moreover, EPT(+) patients showed significantly more positive TPO Ab (33% vs. 14%, p<0.001) than those with EPT(-). There was a positive correlation between EPT(+) and TPO positivity (r=0.226, p<0.001), subclinical hypothyroidism (r=0.112, p=0.033), and body mass index (r=0.123, p=0.018). Binary logistic regression analysis revealed that the significant predictors of EPT(+) were body mass index {adjusted odds ratio (OR)=1.042, 95% confidence interval (CI)=1.005-1.080}, presence of subclinical hypothyroidism (OR=3.047, 95% CI=1.083-8.572), TPO Ab titer (OR=1.028, 95% CI=1.015-1.041), and the presence of TPO Ab (OR=4.904, 95% CI=1.544-15.567).
   Conclusion: Subclinical hypothyroidism and the presence of TPO Ab are significantly associated with coronary vasospasm in patients without cardiovascular risk factors.
C1 [Lee, Sea-Won] Busan Vet Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Cho, Kyoung-Im; Kim, Hyun-Su; Heo, Jung-Ho; Cha, Tae-Joon] Kosin Univ, Coll Med, Dept Internal Med, Div Cardiol, Busan 602702, South Korea.
RP Cho, KI (corresponding author), Kosin Univ, Coll Med, Dept Internal Med, Div Cardiol, 262 Gamcheon Ro, Busan 602702, South Korea.
EM kyoungim74@gmail.com
CR Akasaka T, 1997, AM J CARDIOL, V80, P705, DOI 10.1016/S0002-9149(97)00499-2
   Al Suwaidi J, 2001, J AM COLL CARDIOL, V37, P1523, DOI 10.1016/S0735-1097(01)01212-8
   Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011
   BORY M, 1993, LANCET, V342, P436, DOI 10.1016/0140-6736(93)92850-S
   Cai YF, 2011, HYPERTENS RES, V34, P1098, DOI 10.1038/hr.2011.91
   Canturk Z, 2003, THYROID, V13, P971, DOI 10.1089/105072503322511382
   Cho KI, 2014, INT J RHEUM DIS
   Ciccone MM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-22
   Cikim AS, 2004, THYROID, V14, P605, DOI 10.1089/1050725041692891
   Cooper DS, 2001, NEW ENGL J MED, V345, P260, DOI 10.1056/NEJM200107263450406
   Kahaly GJ, 2000, THYROID, V10, P665, DOI 10.1089/10507250050137743
   Kashiwagi Y, 2013, CORONARY ARTERY DIS, V24, P559, DOI 10.1097/MCA.0000000000000024
   Kugiyama K, 1997, J AM COLL CARDIOL, V30, P920, DOI 10.1016/S0735-1097(97)00236-2
   Lekakis J, 1997, THYROID, V7, P411, DOI 10.1089/thy.1997.7.411
   Mizuma H, 2001, CIRC RES, V88, P313, DOI 10.1161/01.RES.88.3.313
   Nagasaki T, 2006, J CLIN ENDOCR METAB, V91, P154, DOI 10.1210/jc.2005-1342
   Obuobie K, 2002, J CLIN ENDOCR METAB, V87, P4662, DOI 10.1210/jc.2002-020493
   Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802
   Owen PJD, 2007, THYROID, V17, P519, DOI 10.1089/thy.2007.0051
   Pirich C, 2000, J CLIN EPIDEMIOL, V53, P623, DOI 10.1016/S0895-4356(99)00187-0
   Schultz M, 2011, HORM METAB RES, V43, P653, DOI 10.1055/s-0031-1283162
   Selwyn AP, 1997, AM J CARDIOL, V79, P17, DOI 10.1016/S0002-9149(97)00125-2
   Sharma R, 2011, CLIN LAB, V57, P719
   Stamatelopoulos KS, 2009, THYROID, V19, P857, DOI 10.1089/thy.2008.0326
   Taddei S, 2003, J CLIN ENDOCR METAB, V88, P3731, DOI 10.1210/jc.2003-030039
   Taddei S, 2006, J CLIN ENDOCR METAB, V91, P5076, DOI 10.1210/jc.2006-1075
   WEI JY, 1979, AM J CARDIOL, V43, P335, DOI 10.1016/S0002-9149(79)80023-5
   Yasue H, 1997, INTERNAL MED, V36, P760, DOI 10.2169/internalmedicine.36.760
   YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955
   Zaya M, 2014, J AM COLL CARDIOL, V63, P103, DOI 10.1016/j.jacc.2013.10.038
NR 30
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 125
EP 130
DI 10.4070/kcj.2015.45.2.125
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100007
PM 25810734
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Lee, MH
   Shim, JS
   Choi, DP
   Song, BM
   Lee, SW
   Choi, H
   Kim, HC
AF Park, Ji Hye
   Lee, Myung Ha
   Shim, Jee-Seon
   Choi, Dong Phil
   Song, Bo Mi
   Lee, Seung Won
   Choi, Hansol
   Kim, Hyeon Chang
TI Effects of Age, Sex, and Menopausal Status on Blood Cholesterol Profile
   in the Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cholesterol; Triglycerides; High density lipoprotein-cholesterol; Low
   density lipoprotein-cholesterol; Epidemiology
ID DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; NUTRITION
   EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; METABOLIC
   SYNDROME; LOW-FAT; RISK; PLASMA; ADULTS
AB Background and Objectives: To investigate age-specific and sex-specific distributions of blood cholesterol in the general Korean population.
   Subjects and Methods: We analyzed data for 8284 men and 9246 women aged >= 10 years who participated in the fifth (2010-2012) Korea National Health and Nutrition Examination Survey. Age-specific means, medians, and selected percentiles were calculated for men, premenopausal women, and postmenopausal women.
   Results: Median total cholesterol (TC) level increased with age across all age groups, from 147 to 196 mg/dL in males and from 159 to 210 mg/dL in females. Triglyceride (TG) levels increased with age in females; however, in males, TO levels rapidly increased during young adulthood, peaked at 50-54 years, and then decreased. High density lipoprotein-cholesterol (HDL-C) levels were higher in females than in males and decreased with increasing age in both males and females. Low density lipoprotein-cholesterol (LDL-C) levels increased with age across all age groups, from 89 to 127 mg/dL in males and from 82 to 113 mg/dL in females. Lipoprotein-cholesterol fraction (TC/HDL-C, LDL-C/HDL-C, TG/HDL-C, non-HDL-C) levels increased with age in females, but increased more rapidly in males during young adulthood and decreased after middle age.
   Conclusion: Blood cholesterol levels and lipoprotein-cholesterol fractions present different distributions by age, sex, and menopausal status.
C1 [Park, Ji Hye; Choi, Dong Phil; Song, Bo Mi; Lee, Seung Won; Choi, Hansol] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120752, South Korea.
   [Lee, Myung Ha; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea.
   [Shim, Jee-Seon; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120752, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240; Shim, Jee-Seon/0000-0002-8671-3153
FU Korean Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [HI13C0715]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).
CR ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356
   Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2
   Assmann G, 1998, EUR HEART J, V19, pA2
   Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260
   CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   GRANFONE A, 1992, METABOLISM, V41, P1193, DOI 10.1016/0026-0495(92)90008-X
   Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014
   Hwang YC, 2012, J KOREAN MED SCI, V27, P1530, DOI 10.3346/jkms.2012.27.12.1530
   Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438
   KINOSIAN B, 1995, J INVEST MED, V43, P443
   Kosmas CE, 2014, AM J MED SCI, V347, P504, DOI 10.1097/MAJ.0000000000000231
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee MH, 2012, DIABETES METAB J, V36, P43, DOI 10.4093/dmj.2012.36.1.43
   Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E
   Nam GE, 2014, J PUBLIC HLTH OXF
   Natarajan S, 2003, AM J PREV MED, V25, P50, DOI 10.1016/S0749-3797(03)00092-8
   Packard Chris J, 2004, J Atheroscler Thromb, V11, P6
   Roh E, 2013, DIABETES METAB J, V37, P433, DOI 10.4093/dmj.2013.37.6.433
   SANDERS K, 1994, LIPIDS, V29, P129, DOI 10.1007/BF02537152
   SCHAEFER EJ, 1981, AM J CLIN NUTR, V34, P1758
   SCHAEFER EJ, 1994, J LIPID RES, V35, P779
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634
   Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644
   YANO Y, 1980, ATHEROSCLEROSIS, V36, P173, DOI 10.1016/0021-9150(80)90226-9
NR 30
TC 12
Z9 12
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 141
EP 148
DI 10.4070/kcj.2015.45.2.141
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100009
PM 25810736
OA Green Published
DA 2021-04-22
ER

PT J
AU Khaheshi, I
   Mahjoob, MP
   Esmaeeli, S
   Eslami, V
   Haybar, H
AF Khaheshi, Isa
   Mahjoob, Mohammad Parsa
   Esmaeeli, Shook
   Eslami, Vahid
   Haybar, Habib
TI Simultaneous Thrombosis of the Left Anterior Descending Artery and the
   Right Coronary Artery in a 34-Year-Old Crystal Methamphetamine Abuser
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Methamphetamine; Coronary thrombosis; Angiography
AB This case report underscores that crystal methamphetamine abuse is an important cause of multivessel coronary thrombosis and raises doubts about the therapeutic options. The patient was a 34-year-old smoker and crystal methamphetamine abuser with no significant medical history, who presented with retrosternal chest pain associated with cold sweats. Twelve-lead electrocardiogram revealed diffuse ST-segment elevation in I, II, AVL, AVF, and V 2-6 leads. He underwent urgent coronary angiography and it showed Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow in coronary arteries and presence of a thrombus in the left anterior descending artery (LAD) and the right coronary artery (RCA). The patient underwent medical therapy with antiplatelet agents and anticoagulants. Repeat coronary angiography after three months of dual therapy with warfarin and aspirin did not show any thrombus or any significant lesion in the RCA and the LAD having TIMI grade 3 flow.
C1 [Khaheshi, Isa; Mahjoob, Mohammad Parsa; Eslami, Vahid] Shahid Beheshti Univ Med Sci, Modarres Hosp, Cardiovasc Dept, Cardiovasc Res Ctr, Tehran, Iran.
   [Esmaeeli, Shook] Univ Tehran Med Sci, SSRC, Iranian Inst Reduct High Risk Behav, Iranian Res Ctr HIV AIDS IRCHA, Tehran, Iran.
   [Haybar, Habib] Ahvaz Jundishapur Univ Med Sci, Cardiovasc Dept, Cardiovasc Res Ctr, Ahwaz, Iran.
RP Mahjoob, MP (corresponding author), Shahid Beheshti Univ Med Sci, Modarres Hosp, Cardiovasc Dept, Cardiovasc Res Ctr, Kaj Sq, Tehran, Iran.
EM parsa3903@yahoo.com
RI Eslami, Vahid/O-1626-2018; Heybar, Habib/U-3984-2017; mahjoob, mohammad
   parsa/AAG-6390-2020; Khaheshi, Isa/K-9315-2018
OI Heybar, Habib/0000-0002-9204-8698; Eslami, Vahid/0000-0002-4304-3997;
   /0000-0003-1269-3134
CR Benzaquen BS, 2001, AM HEART J, V142, P402, DOI 10.1067/mhj.2001.117607
   Chen Jack P, 2007, J Invasive Cardiol, V19, pE89
   Costa G M, 2001, Ital Heart J, V2, P478
   Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x
   Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P1847, DOI 10.1038/sj.npp.1301578
   Hung MJ, 2003, INT J CLIN PRACT, V57, P62
   Meltser Henry, 2004, Int J Cardiovasc Intervent, V6, P39
   Wijetunga M, 2003, J TOXICOL-CLIN TOXIC, V41, P981, DOI 10.1081/CLT-120026521
   Wijetunga M, 2004, HAWAII MED J, V63, P25
   Wijetunga Mevan, 2004, Hawaii Med J, V63, P8
NR 10
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 158
EP 160
DI 10.4070/kcj.2015.45.2.158
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100011
PM 25810738
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, SY
   Kim, NK
   Eun, LY
   Jung, JW
   Choi, JY
AF Jung, Se Yong
   Kim, Nam Kyun
   Eun, Lucy Youngmin
   Jung, Jo Won
   Choi, Jae Young
TI Transcatheter Treatment of Atrial Septal Defect Presenting with
   Platypnea-Orthodeoxia Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Platypnea-orthodeoxia syndromes; Atrial septal defect; Amplatzer Septal
   Occluder
ID MANAGEMENT; MIGRAINE; CLOSURE
AB A 29-year-old woman was referred to our institute for symptomatic hypoxemia. Her dyspnea was aggravated while sitting or standing and relieved while in supine position. She did not have any pulmonary disease. Transthoracic echocardiography and heart computed tomography revealed an underestimated small atrial septal defect (ASD) with a left-to-right shunt. A cardiac catheterization was performed to evaluate pulmonary hypertension. It revealed a normal pulmonary artery pressure and a large ASD with bidirectional shunt during Valsalva maneuver by intracardiac echocardiogram. Her arterial oxygen saturation decreased from 93% while supine to 79% while at a 15 degrees sitting position. Thus, the patient was diagnosed with platypnea-orthodeoxia syndrome. The ASD was successfully closed with Amplatzer (St. Jude Medical) septal occluder and both platypnea and orthodeoxia were resolved immediately after the procedure.
C1 [Jung, Se Yong; Kim, Nam Kyun; Jung, Jo Won; Choi, Jae Young] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Pediat Cardiol,Congenital Heart Dis Ctr,Dept, Seoul 120749, South Korea.
   [Eun, Lucy Youngmin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pediat, Seoul 120749, South Korea.
RP Choi, JY (corresponding author), Severance Cardiovasc Hosp, Congenital Heart Dis Ctr, Div Pediat Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM cjy0122@yuhs.ac
RI Jung, Yong/AAR-3286-2020
OI Jung, Yong/0000-0003-1337-563X; Choi, Jae Young/0000-0002-1247-6669;
   Eun, Lucy/0000-0002-4577-3168
CR ADOLPH EA, 1992, ANN INTERN MED, V116, P138, DOI 10.7326/0003-4819-116-2-138
   BURCHELL HB, 1949, AM J PHYSIOL, V159, P563
   Cheng TO, 1999, CATHETER CARDIO INTE, V47, P64, DOI 10.1002/(SICI)1522-726X(199905)47:1<64::AID-CCD15>3.3.CO;2-Y
   Delgado Gabriel, 2004, J Invasive Cardiol, V16, P578
   Hashimoto M, 2006, J THORAC CARDIOV SUR, V132, P1225, DOI 10.1016/j.jtcvs.2006.07.021
   Hirai N, 2003, CIRC J, V67, P172, DOI 10.1253/circj.67.172
   Luermans JGLM, 2009, CATHETER CARDIO INTE, V74, P1078, DOI 10.1002/ccd.22226
   Mortelmans K, 2005, EUR HEART J, V26, P1533, DOI 10.1093/eurheartj/ehi170
   Natalie AA, 2010, AM J MED SCI, V339, P78, DOI 10.1097/MAJ.0b013e3181b7f190
   Rao PS, 2001, CATHETER CARDIO INTE, V54, P77, DOI 10.1002/ccd.1243
   ROBIN ED, 1976, NEW ENGL J MED, V294, P941, DOI 10.1056/NEJM197604222941711
   Robin ED, 1997, CHEST, V112, P1449, DOI 10.1378/chest.112.6.1449
   Rodrigues P, 2012, CARDIOLOGY, V123, P15, DOI 10.1159/000339872
   SEWARD JB, 1984, MAYO CLIN PROC, V59, P221, DOI 10.1016/S0025-6196(12)61253-1
   Tobis JM, 2005, TEX HEART I J, V32, P362
   van Gaal William J, 2005, Cardiovasc Ultrasound, V3, P28
NR 16
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 169
EP 173
DI 10.4070/kcj.2015.45.2.169
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100014
PM 25810741
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, IS
   Pyun, WB
AF Kang, In Sook
   Pyun, Wook Bum
TI Subclinical Hypothyroidism or Thyroid Autoimmunity and Variant Angina:
   By Chance? or with a Chance?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CORONARY-ARTERY SPASM; THYROTOXICOSIS; HORMONE
C1 [Kang, In Sook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea.
   [Pyun, Wook Bum] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM pwb423@ewha.ac.kr
CR Choi YH, 2005, CORONARY ARTERY DIS, V16, P135, DOI 10.1097/00019501-200505000-00001
   Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31
   FEATHERSTONE HJ, 1983, ARCH INTERN MED, V143, P554, DOI 10.1001/archinte.143.3.554
   Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033
   Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283
   Lee SW, 2015, KOREAN CIRC J, V45, P125, DOI 10.4070/kcj.2015.45.2.125
   Napoli R, 2010, CLIN ENDOCRINOL, V72, P107, DOI 10.1111/j.1365-2265.2009.03609.x
   Nishikawa M, 1998, INTERNAL MED, V37, P398, DOI 10.2169/internalmedicine.37.398
   Saravanan P, 2001, ENDOCRIN METAB CLIN, V30, P315, DOI 10.1016/S0889-8529(05)70189-4
   Saravanan P, 2001, ENDOCRIN METAB CLIN, V30, pviii
   SCHOOLMEESTER WL, 1979, SOUTHERN MED J, V72, P776, DOI 10.1097/00007611-197907000-00004
   Turemen EE, 2011, ENDOCR J, V58, P349
   WEI JY, 1979, AM J CARDIOL, V43, P335, DOI 10.1016/S0002-9149(79)80023-5
NR 13
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 106
EP 107
DI 10.4070/kcj.2015.45.2.106
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100003
PM 25810730
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KI
AF Kim, Kwang-il
TI Distribution of Blood Cholesterol Profile in Untreated Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DENSITY-LIPOPROTEIN CHOLESTEROL; RISK; AGE
C1 Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Songnam 463707, South Korea.
RP Kim, KI (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, 166 Gumi Ro, Songnam 463707, South Korea.
EM kikim907@snu.ac.kr
RI Kim, Kwang-il/D-8024-2012
OI Kim, Kwang-il/0000-0002-6658-047X
CR Bittner V, 2009, J AM COLL CARDIOL, V54, P2374, DOI 10.1016/j.jacc.2009.10.008
   Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112
   Kannel W B, 1992, Ann Epidemiol, V2, P5
   Park JH, 2015, KOREAN CIRC J, V45, P141, DOI 10.4070/kcj.2015.45.2.141
   Raffel C, 2006, NAT CLIN PRACT CARD, V3, P318, DOI 10.1038/ncpcardio0558
   SCHAEFER EJ, 1994, J LIPID RES, V35, P779
NR 6
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 108
EP 109
DI 10.4070/kcj.2015.45.2.108
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100004
PM 25810731
OA Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Jeong, MH
   Park, DS
   Kim, JH
   Lim, KS
   Kim, HK
   Kim, SS
   Cho, JY
   Jeong, HC
   Park, KH
   Hong, YJ
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
AF Sim, Doo Sun
   Jeong, Myung Ho
   Park, Dae Sung
   Kim, Jung Ha
   Lim, Kyung Seob
   Kim, Hyun Kuk
   Kim, Sung Soo
   Cho, Jae Yeong
   Jeong, Hae Chang
   Park, Keun Ho
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
TI Effect of Pretreatment of Ezetimibe/Simvastatin on Arterial Healing and
   Endothelialization after Drug-Eluting Stent Implantation in a Porcine
   Coronary Restenosis Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary restenosis; Drug-eluting stents; Ezetimibe;
   Hydroxymethylglutaryl-CoA reductase inhibitors
ID C-REACTIVE PROTEIN; PRIMARY HYPERCHOLESTEROLEMIA; CHOLESTEROL
   ABSORPTION; RANDOMIZED-TRIAL; RABBIT MODEL; EZETIMIBE; ATHEROSCLEROSIS;
   INFLAMMATION; REDUCTION; ATORVASTATIN
AB Background and Objectives: We sought to evaluate the effect of the early use of ezetimibe/simvastatin (Vytorin (R)) on arterial healing and endothelialization after the implantation of a drug-eluting stent (DES) in a porcine model of coronary restenosis.
   Materials and Methods: A total of 20 pigs (40 coronary arteries) were randomly allocated to a pretreatment or no treatment group. The pretreatment group (n=20) received oral ezetimibe/simvastatin (10/20 mg) daily for 7 days before stenting and the no pretreatment group (n=20) did not All pigs were treated with ezetimibe/simvastatin (10/20 mg) daily after stenting for 4 weeks. Stenting was performed using a bare-metal stent (BMS, n=10) and three types of DES: biolimus A9-eluting stent (BES, n=10), zotarolimus-eluting stent (ZES, n=10), and everolimus-eluting stents (EES, n=10). Four weeks later, pigs underwent a follow-up coronary angiography and were sacrificed for histopathologic analysis.
   Results: There were no significant differences between the pretreatment and no pretreatment groups in the internal elastic lamina area, lumen area, neointima area, stenotic area, injury score, fibrin score, and inflammation score. In both groups, the fibrin score was higher in pigs with DES than in BMS, particularly in ZES and EES. The inflammatory score was not different between DES and BMS.
   Conclusion: In a porcine model of coronary restenosis, pretreatment with ezetimibe/simvastatin before DES implantation failed to improve arterial healing and endothelialization compared to treatment after stenting.
C1 [Sim, Doo Sun; Jeong, Myung Ho; Park, Dae Sung; Kim, Jung Ha; Lim, Kyung Seob; Kim, Hyun Kuk; Kim, Sung Soo; Cho, Jae Yeong; Jeong, Hae Chang; Park, Keun Ho; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ, Hosp Designated, Heart Res Ctr, Welf & Family Affairs,Minist Hlth, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Hosp Designated, Heart Res Ctr, Welf & Family Affairs,Minist Hlth, 671 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
RI SungSoo, Kim/Q-3672-2016
OI Kim, Sung Soo/0000-0002-5190-227X
FU Korea Society of Cardiology [201303-11]
FX This study was supported by a grant (No. 201303-11) from the Korea
   Society of Cardiology (2011).
CR Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64
   Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8
   Briand F, 2009, CTS-CLIN TRANSL SCI, V2, P127, DOI 10.1111/j.1752-8062.2009.00098.x
   Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2
   Cho JS, 2010, J KOREAN MED SCI, V25, P716, DOI 10.3346/jkms.2010.25.5.716
   Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4
   Davis HR, 2011, ATHEROSCLEROSIS, V215, P266, DOI 10.1016/j.atherosclerosis.2011.02.010
   Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260
   Dietrich T, 2009, INT J CARDIOVAS IMAG, V25, P827, DOI 10.1007/s10554-009-9487-5
   Drachman DE, 2000, J AM COLL CARDIOL, V36, P2325, DOI 10.1016/S0735-1097(00)01020-2
   Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227
   Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937
   Gomez-Garre D, 2009, BRIT J PHARMACOL, V156, P1218, DOI 10.1111/j.1476-5381.2008.00091.x
   Graf K, 2008, MOL IMAGING, V7, P68, DOI 10.2310/7290.2008.0009
   Hong YJ, 2007, J KOREAN MED SCI, V22, P802, DOI 10.3346/jkms.2007.22.5.802
   Kerzner B, 2003, AM J CARDIOL, V91, P418, DOI 10.1016/S0002-9149(02)03236-8
   Kolodgie FD, 2002, CIRCULATION, V106, P1195, DOI 10.1161/01.CIR.0000032141.31476.15
   LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172
   Lim KS, 2013, KOREAN CIRC J, V43, P744, DOI 10.4070/kcj.2013.43.11.744
   Maekawa T, 2012, J VASC SURG, V56, P1689, DOI 10.1016/j.jvs.2012.05.071
   Nakagami H, 2009, ATHEROSCLEROSIS, V203, P51, DOI 10.1016/j.atherosclerosis.2008.05.026
   Park KH, 2013, INT J CARDIOL, V168, P1853, DOI 10.1016/j.ijcard.2012.12.070
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Ridker PM, 2001, CIRCULATION, V103, P1191
   Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839
   Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   van Heek M, 2001, BRIT J PHARMACOL, V134, P409, DOI 10.1038/sj.bjp.0704260
   VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36
NR 30
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 110
EP 116
DI 10.4070/kcj.2015.45.2.110
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100005
PM 25810732
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HJ
   Yoon, JH
   Lee, EJ
   Oh, JH
   Lee, JY
   Lee, SJ
   Han, JW
AF Kim, Hye Jin
   Yoon, Ji-Hong
   Lee, Eun-Jung
   Oh, Jin Hee
   Lee, Jae Young
   Lee, Soon Ju
   Han, Ji Whan
TI Normal Left Ventricular Torsion Mechanics in Healthy Children: Age
   Related Changes of Torsion Parameters Are Closely Related to Changes in
   Heart Rate
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular function; Speckle tracking echocardiography; Torsion;
   Rotation; Child
ID SPECKLE-TRACKING ECHOCARDIOGRAPHY; MAGNETIC-RESONANCE; TWIST MECHANICS;
   STRAIN; DEFORMATION; ROTATION; BIOMECHANICS; VALIDATION; PRINCIPLES;
   PHASE
AB Background and Objectives: This study was aimed at assessing left ventricular torsion (LVtor) mechanics using speckle, tracking echocardiography (STE), establishing normal reference values of principal LVtor parameters, and analyzing the age-related changes in normal children.
   Subjects and Methods: Eighty children (aged 3 months to 15 years) with normal cardiac function and rhythm were recruited. LVtor parameters including rotations, twist and untwist, torsion, and their rate indices were measured using STE. Age and heart rate related changes of the parameters were analyzed.
   Results: Speckle tracking echocardiography analyses for LVtor parameters had excellent reliability in 64 of 80 subjects (80%) (intraclass correlation coefficients; 0.93-0.97). Early systolic twist (EST) motions (-8.4--0.1 degrees) were observed in all subjects during an early 20 +/- 7% of systolic time intervals. The peak systolic twist and torsion were 17.0 +/- 6.5 degrees and 2.9 +/- 1.3 degrees/cm, respectively. The peak twist velocity was recorded at 51 +/- 13% of systolic time and the peak untwist velocity at 13.8 +/- 11.5% of diastolic time intervals. Multivariate analysis showed that heart rate change was an independent predictor of changes in torsion parameters; significantly decreasing LV length-normalized apical and basal rotation, torsion, and twist and untwist rate with increasing age. Isovolumetric recoil rate was independent of change in age and heart rate.
   Conclusion: Left ventricle showed unique torsion mechanics in children with EST, torsion, and untwists. Heart rate was an independent predictor of the change in torsion parameters with aging.
C1 [Kim, Hye Jin; Yoon, Ji-Hong; Lee, Eun-Jung; Oh, Jin Hee; Lee, Jae Young; Lee, Soon Ju; Han, Ji Whan] Catholic Univ Korea, Coll Med, Dept Pediat, Seoul 137701, South Korea.
RP Lee, JY (corresponding author), Catholic Univ Korea, Coll Med, Dept Pediat, 222 Banpo Daero, Seoul 137701, South Korea.
EM jaeyounglee@catholic.ac.kr
OI Yoon, Ji Hong/0000-0001-8498-2352
CR Al-Naami GH, 2010, EUR J ECHOCARDIOGR, V11, P853, DOI 10.1093/ejechocard/jeq078
   Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040
   Ashikaga H, 2007, J AM COLL CARDIOL, V49, P909, DOI 10.1016/j.jacc.2006.07.074
   BEYAR R, 1989, AM J PHYSIOL, V257, pH1119
   Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002
   Cheung YF, 2011, ECHOCARDIOGR-J CARD, V28, P738, DOI 10.1111/j.1540-8175.2011.01429.x
   Dong SJ, 2001, AM J PHYSIOL-HEART C, V281, pH2002
   Forsey J, 2014, J AM SOC ECHOCARDIOG, V27, P215, DOI 10.1016/j.echo.2013.10.012
   Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558
   Kaku K, 2014, J AM SOC ECHOCARDIOG, V27, P55, DOI 10.1016/j.echo.2013.10.002
   Khoo NS, 2012, J AM SOC ECHOCARDIOG, V25, P294, DOI 10.1016/j.echo.2011.10.010
   Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007
   Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019
   Moral JAU, 2011, AM J CARDIOL, V108, P1788, DOI 10.1016/j.amjcard.2011.07.047
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365
   Notomi Y, 2005, CIRCULATION, V111, P1141, DOI 10.1161/01.CIR.0000157151.10971.98
   Notomi Y, 2006, CIRCULATION, V113, P2534, DOI 10.1161/CIRCULATIONAHA.105.537639
   Parisi V, 2013, CLIN PHYSIOL FUNCT I, V33, P117, DOI 10.1111/cpf.12002
   Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030
   Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006
   Sengupta PP, 2005, J APPL PHYSIOL, V99, P1104, DOI 10.1152/japplphysiol.00191.2005
   Taber LA, 1996, J BIOMECH, V29, P745, DOI 10.1016/0021-9290(95)00129-8
   Takahashi K, 2010, J AM SOC ECHOCARDIOG, V23, P286, DOI 10.1016/j.echo.2009.11.018
   Takeuchi M, 2006, J AM SOC ECHOCARDIOG, V19, P1077, DOI 10.1016/j.echo.2006.04.011
   van Dalen BM, 2008, AM J PHYSIOL-HEART C, V295, pH1705, DOI 10.1152/ajpheart.00513.2008
   Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001
   Young AA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-49
   Zhang Y, 2010, ECHOCARDIOGR-J CARD, V27, P1205, DOI 10.1111/j.1540-8175.2010.01226.x
NR 28
TC 8
Z9 9
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 131
EP 140
DI 10.4070/kcj.2015.45.2.131
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100008
PM 25810735
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, KS
   Hsueh, CH
   Hellyer, JA
   Park, HW
   Lee, YS
   Garlie, J
   Onkka, P
   Doytchinova, AT
   Garner, JB
   Patel, J
   Chen, LS
   Fishbein, MC
   Everett, T
   Lin, SF
   Chen, PS
AF Rhee, Kyoung-Suk
   Hsueh, Chia-Hsiang
   Hellyer, Jessica A.
   Park, Hyung Wook
   Lee, Young Soo
   Garlie, Jason
   Onkka, Patrick
   Doytchinova, Anisiia T.
   Garner, John B.
   Patel, Jheel
   Chen, Lan S.
   Fishbein, Michael C.
   Everett, Thomas
   Lin, Shien-Fong
   Chen, Peng-Sheng
TI Cervical Vagal Nerve Stimulation Activates the Stellate Ganglion in
   Ambulatory Dogs
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Autonomic nervous system; Vagus nerve stimulation; Stellate ganglion
ID AUTONOMIC REGULATION THERAPY; CHRONIC HEART-FAILURE; VAGUS NERVE;
   ATRIAL-FIBRILLATION; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; ANTHEM-HF;
   FIBERS; ARRHYTHMIAS; CANINES
AB Background and Objectives: Recent studies showed that, in addition to parasympathetic nerves, cervical vagal nerves contained significant sympathetic nerves. We hypothesized that cervical vagal nerve stimulation (VNS) may capture the sympathetic nerves within the vagal nerve and activate the stellate ganglion.
   Materials and Methods: We recorded left stellate ganglion nerve activity (SGNA), left thoracic vagal nerve activity (VNA), and subcutaneous electrocardiogram in seven dogs during left cervical VNS with 30 seconds on-time and 30 seconds off time. We then compared the SGNA between VNS on and off times.
   Results: Cervical VNS at moderate (0.75 mA) output induced large SGNA, elevated heart rate (HR), and reduced HR variability, suggesting sympathetic activation. Further increase of the VNS output to >1.5 mA increased SGNA but did not significantly increase the HR, suggesting simultaneous sympathetic and parasympathetic activation. The differences of integrated SGNA and integrated VNA between VNS on and off times (Delta SGNA) increased progressively from 5.2 mV-s {95% confidence interval (CI): 1.25-9.06, p=0.018, n=7} at 1.0 mA to 13.7 mV-s (CI: 5.97-21.43, p=0.005, n=7) at 1.5 mA. The difference in HR (Delta HR, bpm) between on and off times was 5.8 bpm (CI: 0.28-11.29, p=0.042, n=7) at 1.0 mA and 5.3 bpm (CI 1.92 to 12.61, p=0.122, n=7) at 1.5 mA.
   Conclusion: Intermittent cervical VNS may selectively capture the sympathetic components of the vagal nerve and excite the stellate ganglion at moderate output. Increasing the output may result in simultaneously sympathetic and parasympathetic capture.
C1 [Rhee, Kyoung-Suk; Hsueh, Chia-Hsiang; Hellyer, Jessica A.; Park, Hyung Wook; Lee, Young Soo; Garlie, Jason; Onkka, Patrick; Doytchinova, Anisiia T.; Garner, John B.; Patel, Jheel; Everett, Thomas; Lin, Shien-Fong; Chen, Peng-Sheng] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.
   [Rhee, Kyoung-Suk; Hsueh, Chia-Hsiang; Hellyer, Jessica A.; Park, Hyung Wook; Lee, Young Soo; Garlie, Jason; Onkka, Patrick; Doytchinova, Anisiia T.; Garner, John B.; Patel, Jheel; Everett, Thomas; Lin, Shien-Fong; Chen, Peng-Sheng] Indiana Univ Sch Med, Dept Med, Div Cardiol, Indianapolis, IN 46202 USA.
   [Chen, Lan S.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA.
   [Fishbein, Michael C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [Rhee, Kyoung-Suk] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju 561756, South Korea.
   [Park, Hyung Wook] Chonnam Natl Univ, Sch Med, Dept Cardiovasc Med, Kwangju, South Korea.
   [Lee, Young Soo] Catholic Univ Daegu, Coll Med, Div Cardiol, Taegu, South Korea.
RP Chen, PS (corresponding author), Indiana Univ Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave,E475, Indianapolis, IN 46202 USA.
EM chenpp@iupui.edu
RI Lin, Shien-fong/AAQ-1608-2020
OI Lin, Shien-fong/0000-0003-1270-3961
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01 HL78931, R01
   71140, R21 HL106554, R41HL124741]; Piansky Endowment; Medtronic-Zipes
   Endowment; Indiana University Health-Indiana University School of
   Medicine Strategic Research Initiative; Chonbuk National University,
   Jeonju, Korea; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001108, UL1TR001108, UL1TR002529,
   UL1TR001108, UL1TR001108, UL1TR001108, UL1TR001108, UL1TR001108] Funding
   Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, R41HL124741, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, R21HL106554, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, R21HL106554,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931,
   P01HL078931, P01HL078931, P01HL078931, P01HL078931, P01HL078931] Funding
   Source: NIH RePORTER
FX This study was supported in part by National Institutes of Health grants
   P01 HL78931, R01 71140, R21 HL106554, R41HL124741, a Piansky Endowment
   (M.C.F.), a Medtronic-Zipes Endowment (P.S.C.), the Indiana University
   Health-Indiana University School of Medicine Strategic Research
   Initiative and Chonbuk National University, Jeonju, Korea. The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336
   ARMOUR JA, 1972, AM J PHYSIOL, V223, P1068
   Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C
   De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391
   del Negro CA, 1999, J NEUROPHYSIOL, V81, P1478
   Dicarlo L, 2013, J CARD FAIL, V19, P655, DOI 10.1016/j.cardfail.2013.07.002
   ELLISON JP, 1969, AM J ANAT, V124, P149, DOI 10.1002/aja.1001240203
   GOLDBERGER AL, 1986, INT J CARDIOL, V13, P47, DOI 10.1016/0167-5273(86)90078-1
   Kawagishi K, 2008, J CLIN NEUROSCI, V15, P1023, DOI 10.1016/j.jocn.2007.08.032
   Klein HU, 2010, CARDIOL J, V17, P638
   Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709
   MIZERES NJ, 1955, AM J ANAT, V96, P285, DOI 10.1002/aja.1000960205
   Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045
   Onkka P, 2013, HEART RHYTHM, V10, P585, DOI 10.1016/j.hrthm.2012.12.015
   Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012
   Premchand RK, 2014, J CARD FAIL, V20, P808, DOI 10.1016/j.cardfail.2014.08.009
   Robinson EA, 2015, J CARDIOVASC ELECTR, V26, P70, DOI 10.1111/jce.12508
   Sabbah Hani N, 2011, Cleve Clin J Med, V78 Suppl 1, pS24, DOI 10.3949/ccjm.78.s1.04
   SCHWARTZ PJ, 1973, CIRC RES, V32, P215, DOI 10.1161/01.RES.32.2.215
   Seki A, 2014, HEART RHYTHM, V11, P1411, DOI 10.1016/j.hrthm.2014.04.032
   Shen MJ, 2013, HEART RHYTHM, V10, P910, DOI 10.1016/j.hrthm.2013.01.029
   Shen MJ, 2011, CIRCULATION, V123, P2204, DOI 10.1161/CIRCULATIONAHA.111.018028
   Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203
   Terry R, 2009, IEEE ENG MED BIO, P4631, DOI 10.1109/IEMBS.2009.5332676
   Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345
NR 25
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 149
EP 157
DI 10.4070/kcj.2015.45.2.149
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100010
PM 25810737
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, J
   Song, IJ
   Lee, S
   Jeong, HJ
   Kim, HM
   Koh, BS
   Park, SH
AF Seo, Jiwon
   Song, In Ji
   Lee, Sak
   Jeong, Hyeon Joo
   Kim, Hye Min
   Koh, Beom Seok
   Park, Sung Ha
TI A Case of Constrictive Pericarditis due to lmmunoglobulin G4-Related
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE lmmunoglobulin G; Inflammation; Pericarditis; constrictive
ID IGG4-RELATED SYSTEMIC-DISEASE
AB Immunoglobulin G4-related disease (IgG4-RD) can involve any organ. The majority of reported cases involve IgG4-RD of the biliary tract or pancreas, while only two cases of pericarditis have been reported. A 58-year-old man visited the outpatient clinic of our institution with a seven-day history of progressive dyspnea. Based on his transthoracic echocardiogram and transesophageal echocardiogram, he was diagnosed with constrictive pericarditis. The histopathology of his pericardiectomy revealed the cause of constrictive pericarditis to be IgG4-RD. Prednisolone (40 mg) was initiated after the pericardiectomy. As the patient's symptoms resolved, he was discharged and followed-up on an outpatient basis. This is the first case report of constrictive pericarditis caused by IgG4-RD in Korea.
C1 [Seo, Jiwon; Song, In Ji; Koh, Beom Seok; Park, Sung Ha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Lee, Sak] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea.
   [Jeong, Hyeon Joo; Kim, Hye Min] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea.
RP Park, SH (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM shpark0530@yuhs.ac
OI Lee, Sak/0000-0001-6130-2342; Kim, Hye Min/0000-0002-2899-9480; Park,
   Sungha/0000-0001-5362-478X; Jeong, Hyeon Joo/0000-0002-9695-1227
CR Cheuk W, 2010, ADV ANAT PATHOL, V17, P303, DOI 10.1097/PAP.0b013e3181ee63ce
   Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72
   Imazio M, 2011, CIRCULATION, V124, P1270, DOI 10.1161/CIRCULATIONAHA.111.018580
   Kamisawa T, 2005, PANCREAS, V31, P28, DOI 10.1097/01.mpa.0000167000.11889.3a
   Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P67, DOI 10.1097/BOR.0b013e328341a240
   Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057
   Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123
   Sekiguchi H, 2012, CHEST, V142, P781, DOI 10.1378/chest.11-2608
   Sekiguchi H, 2012, CIRC-HEART FAIL, V5, pE30, DOI 10.1161/CIRCHEARTFAILURE.111.966408
   SPODICK DH, 1987, AM HEART J, V114, P1529, DOI 10.1016/0002-8703(87)90569-2
NR 10
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 161
EP 164
DI 10.4070/kcj.2015.45.2.161
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100012
PM 25810739
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KI
   Kim, MJ
   Oh, JK
   Lee, JH
   Park, JH
   Choi, SW
   Jeong, JO
   Seong, IW
AF Park, Kwang-In
   Kim, Mi Joo
   Oh, Jin Kyung
   Lee, Jae-Hwan
   Park, Jae-Hyeong
   Choi, Si Wan
   Jeong, Jin-Ok
   Seong, In-Whan
TI Intracardiac Echocardiography to Guide Biopsy for Two Cases of
   Intracardiac Masses
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac tumor; Echocardiography; Biopsy
ID TUMORS; TRANSESOPHAGEAL; HEART
AB Pathologic diagnosis of a cardiac mass is vital in determining the proper treatment modality. Open heart surgery or transesophageal echocardiography guided biopsy can be feasible methods to confirm the pathology. However, the former is highly invasive and both methods require general anesthesia. The introduction of intracardiac echocardiography (ICE) can provide good anatomic information of heart and does not require general anesthesia. In this report, we present two cases of cardiac tumors which were confirmed by percutaneous biopsy under the guidance of an ICE. The patients underwent cardiac biopsy without any complications.
C1 [Park, Kwang-In; Kim, Mi Joo; Oh, Jin Kyung; Lee, Jae-Hwan; Park, Jae-Hyeong; Choi, Si Wan; Jeong, Jin-Ok; Seong, In-Whan] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, Taejon 301721, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 33 Munhwa Ro, Taejon 301721, South Korea.
EM myheart@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Seong, In-Whan/0000-0003-4628-0258; Lee, Jae-Hwan/0000-0002-6561-7760;
   Choi, Si Wan/0000-0002-1035-1512; Park, Jae-Hyeong/0000-0001-7035-286X;
   Jeong, Jin-Ok/0000-0003-0763-4754
CR Abramowitz Yigal, 2007, Int J Cardiol, V118, pe39, DOI 10.1016/j.ijcard.2006.12.039
   Awad Sawsan M, 2009, Curr Cardiol Rep, V11, P210
   Hijazi ZM, 2009, CIRCULATION, V119, P587, DOI 10.1161/CIRCULATIONAHA.107.753046
   LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027
   LEIBOWITZ G, 1995, AM HEART J, V130, P1224, DOI 10.1016/0002-8703(95)90146-9
   Mitchell ARJ, 2007, EUR J ECHOCARDIOGR, V8, P505, DOI 10.1016/j.euje.2006.08.005
   Poommipanit Paul, 2011, J Invasive Cardiol, V23, pE99
   Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7
   Scholte AJHA, 2004, ECHOCARDIOGR-J CARD, V21, P721, DOI 10.1111/j.0742-2822.2004.03124.x
   Sze DY, 2008, J VASC INTERV RADIOL, V19, P1662, DOI 10.1016/j.jvir.2008.08.001
   TROCCOLI R, 1964, Ann Sanita Pubblica, V25, P1467
NR 11
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2015
VL 45
IS 2
BP 165
EP 168
DI 10.4070/kcj.2015.45.2.165
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CE6VK
UT WOS:000351976100013
PM 25810740
OA Green Published
DA 2021-04-22
ER

PT J
AU Rossano, JW
   Jang, GY
AF Rossano, Joseph W.
   Jang, Gi Young
TI Pediatric Heart Failure: Current State and Future Possibilities
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pediatrics; Heart failure; Ventricular assist device
ID VENTRICULAR ASSIST DEVICE; MECHANICAL CIRCULATORY SUPPORT; CONVERTING
   ENZYME-INHIBITORS; DILATED CARDIOMYOPATHY; BERLIN HEART; INTERNATIONAL
   SOCIETY; UNITED-STATES; CHILDREN; MORTALITY; TRANSPLANTATION
AB Heart failure is a complex pathophysiological syndrome that can occur in children from a variety of diseases, including cardiomyopathies, myocarditis, and congenital heart disease. The condition is associated with a high rate of morbidity and mortality and places a significant burden on families of affected children and to society as a whole. Current medical therapy is taken largely from the management of heart failure in adults, though clear survival benefit of these medications are lacking. Ventricular assist devices (VADs) have taken an increasingly important role in the management of advanced heart failure in children. The predominant role of these devices has been as a bridge to heart transplantation, and excellent results are currently achieved for most children with cardiomyopathies. There is an ongoing investigation to improve outcomes in high-risk populations, such as small infants and those with complex congenital heart disease, including patients with functionally univentricular hearts. Additionally, there is an active investigation and interest in expansion of VADs beyond the predominant utilization as a bridge to a heart transplant into ventricular recovery, device explant without a heart transplantation (bridge to recovery), and placement of devices without the expectation of recovery or transplantation (destination therapy).
C1 [Rossano, Joseph W.] Univ Penn, Perelman Sch Med, Cardiac Ctr, Dept Pediat,Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   [Jang, Gi Young] Korea Univ Hosp, Dept Pediat, Ansan, South Korea.
RP Rossano, JW (corresponding author), Univ Penn, Perelman Sch Med, Cardiac Ctr, Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM rossanoj@email.chop.edu
CR Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051
   Albers S, 2008, BRIT J CLIN PHARMACO, V65, P511, DOI 10.1111/j.1365-2125.2007.03046.x
   Alexander PMA, 2013, CIRCULATION, V128, P2039, DOI 10.1161/CIRCULATIONAHA.113.002767
   Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712
   Amodeo A, 2012, INT J CARDIOL, V161, pE43, DOI 10.1016/j.ijcard.2012.04.009
   Andrews RE, 2008, CIRCULATION, V117, P79, DOI 10.1161/CIRCULATIONAHA.106.671735
   Baldwin JT, 2011, CIRCULATION, V123, P1233, DOI 10.1161/CIRCULATIONAHA.110.978023
   Benden C, 2013, J HEART LUNG TRANSPL, V32, P989, DOI 10.1016/j.healun.2013.08.008
   Bernstein D, 2011, PROG PEDIATR CARDIOL, V31, P35, DOI 10.1016/j.ppedcard.2010.11.007
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Cabrera AG, 2013, J HEART LUNG TRANSPL, V32, P1107, DOI 10.1016/j.healun.2013.07.012
   Cha MJ, 2013, CIRC J, V77, P2056, DOI 10.1253/circj.CJ-12-1269
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541
   Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738
   Daubeney PEF, 2006, CIRCULATION, V114, P2671, DOI 10.1161/CIRCULATIONAHA.106.635128
   Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470
   Drakos SG, 2012, CIRCULATION, V126, P230, DOI 10.1161/CIRCULATIONAHA.111.040261
   Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078
   Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014
   Everitt MD, 2014, J AM COLL CARDIOL, V63, P1405, DOI 10.1016/j.jacc.2013.11.059
   Fraser CD, 2012, NEW ENGL J MED, V367, P532, DOI 10.1056/NEJMoa1014164
   Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363
   Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad
   Hechter SJ, 2001, AM J CARDIOL, V87, P660, DOI 10.1016/S0002-9149(00)01452-1
   Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a
   Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006
   Hetzer Roland, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P99
   Hsu DT, 2010, CIRCULATION, V122, P333, DOI 10.1161/CIRCULATIONAHA.109.927988
   Imamura M, 2009, ANN THORAC SURG, V87, P1894, DOI 10.1016/j.athoracsur.2009.03.049
   Irving CA, 2014, J HEART LUNG TRANSPL, V33, P211, DOI 10.1016/j.healun.2013.10.001
   Jefferies JL, 2005, CIRCULATION, V112, P2799, DOI 10.1161/CIRCULATIONAHA.104.528281
   Kantor PF, 2013, CAN J CARDIOL, V29, P1535, DOI 10.1016/j.cjca.2013.08.008
   Kantor PF, 2010, J AM COLL CARDIOL, V55, P1377, DOI 10.1016/j.jacc.2009.11.059
   Kirk R, 2014, J HEART LUNG TRANSPL, V33, P888, DOI 10.1016/j.healun.2014.06.002
   Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004
   Kwon HW, 2012, KOREAN CIRC J, V42, P184, DOI 10.4070/kcj.2012.42.3.184
   Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715
   Macicek SM, 2009, PEDIATRICS, V124, pE898, DOI 10.1542/peds.2008-2198
   Massin MM, 2008, CLIN CARDIOL, V31, P388, DOI 10.1002/clc.20262
   McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596
   Miera O, 2011, ANN THORAC SURG, V91, P1256, DOI 10.1016/j.athoracsur.2010.12.013
   Miyamoto SD, 2014, EUR HEART J, V35, P33, DOI 10.1093/eurheartj/ehs229
   Morales DLS, 2007, ASAIO J, V53, P701, DOI 10.1097/MAT.0b013e31815d68bf
   Morales DLS, 2011, J HEART LUNG TRANSPL, V30, P1, DOI 10.1016/j.healun.2010.08.033
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Nandi D, 2014, J AM COLL CARDIOL, V33, pS84
   Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737
   O'Sullivan JJ, 2008, TRANSPLANTATION, V85, P975, DOI 10.1097/TP.0b013e318168fe3c
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103
   Padalino MA, 2014, ARTIF ORGANS, V38, P418, DOI 10.1111/aor.12185
   Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7
   Price JF, 2008, PEDIATR CRIT CARE ME, V9, P279, DOI 10.1097/PCC.0b013e31816c6ed1
   Price JF, 2006, CIRCULATION, V114, P1063, DOI 10.1161/CIRCULATIONAHA.105.608869
   Reddy S, 2012, PHYSIOL GENOMICS, V44, P562, DOI 10.1152/physiolgenomics.00163.2011
   Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rossano JW, 2014, ANN THORAC SURG, V97, P1438, DOI 10.1016/j.athoracsur.2013.06.120
   Rossano JW, 2014, CIRCULATION, V129, P607, DOI 10.1161/CIRCULATIONAHA.113.003615
   Rossano JW, 2013, CIRC-HEART FAIL, V6, P1223, DOI 10.1161/CIRCHEARTFAILURE.112.000029
   Rossano JW, 2012, J CARD FAIL, V18, P459, DOI 10.1016/j.cardfail.2012.03.001
   Rossano JW, 2012, CIRCULATION, V126
   Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171
   Shamszad P, 2013, J CARD FAIL, V19, P672, DOI 10.1016/j.cardfail.2013.08.006
   Shiba N, 2008, VASC HEALTH RISK MAN, V4, P103, DOI 10.2147/vhrm.2008.04.01.103
   Stauffer BL, 2013, J MOL CELL CARDIOL, V57, P43, DOI 10.1016/j.yjmcc.2013.01.005
   Tavazzi L, 2013, CIRC-HEART FAIL, V6, P473, DOI 10.1161/CIRCHEARTFAILURE.112.000161
   Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867
   van der Bom T, 2013, CIRCULATION, V127, P322, DOI 10.1161/CIRCULATIONAHA.112.135392
   VanderPluym CJ, 2011, J THORAC CARDIOV SUR, V141, P588, DOI 10.1016/j.jtcvs.2010.06.038
   Vatta M, 2004, J AM COLL CARDIOL, V43, P811, DOI 10.1016/j.jacc.2003.09.052
   Viollet L, 2012, AM J CARDIOL, V110, P98, DOI 10.1016/j.amjcard.2012.02.064
   Wilmot I, 2011, J CARD FAIL, V17, P487, DOI 10.1016/j.cardfail.2011.02.008
   Wittlieb-Weber CA, 2013, CIRCULATION, V128
   Wong DTH, 2011, AM J CARDIOL, V107, P573, DOI 10.1016/j.amjcard.2010.10.015
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
NR 79
TC 12
Z9 13
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 1
EP 8
DI 10.4070/kcj.2015.45.1.1
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500001
PM 25653697
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, YA
   Jeong, MH
   Jeong, HC
   Ahn, Y
   Kim, YJ
   Kim, CJ
   Cho, MC
AF Jeong, Yun Ah
   Jeong, Myung Ho
   Jeong, Hae Chang
   Ahn, Youngkeun
   Kim, Young Jo
   Kim, Chong Jin
   Cho, Myeong Chan
CA Korea Acute Myocardial Infarction
TI Impact of Smoking on Clinical Outcomes in Female Patients with Acute
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hospital mortality; Myocardial infarction; Female; Smoking
ID FOLLOW-UP; MORTALITY; WOMEN; MEN; DISEASE; RISK
AB Background and Objectives: Cigarette smoking has been recognized as a prominent threat to women's health. We investigated the impact of smoking on clinical outcomes in Korean female patients after acute myocardial infarction (AMI).
   Subjects and Methods: Out of the AMI patients who enrolled in the Korea AMI Registry, 4444 female patients were included in this study. Patients were divided into two groups-non-smoker and smoker-according to their current smoking status. We compared in-hospital mortality and major adverse cardiac events (MACE), including cardiac death, myocardial infarction, repeated percutaneous coronary intervention (PCI), or coronary artery bypass grafting during the one-year clinical follow-up period between two groups.
   Results: The non-smoker group had more hypertension (HTN) and diabetes mellitus. The levels of total cholesterol, triglyceride, and low-density lipoprotein cholesterol were higher in the non-smoker group. However, in-hospital mortality was significantly higher in the smoker group (1.0% vs. 2.4%, p=0.002), and cardiac death during the 12-month clinical follow-up was significantly more frequent in the smoker group (2.2% vs. 4.5%, p=0.003). Total MACEs during the 12 months were higher in the smoker group (4.9% vs. 6.8%, p=0.014). Smoking and HTN were independent predictors of MACE {odds ratio (OR): 1.742, 95% confidence interval (CI): 1.010-3.000, p=0.046; OR: 1.573, 95% CI: 1.003-2.466, p=0.049, respectively}.
   Conclusion: Female smokers with AMI showed significantly higher in-hospital mortality and MACE rates during the one-year clinical follow-up period.
C1 [Jeong, Yun Ah; Jeong, Myung Ho; Jeong, Hae Chang; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Kwangju 501757, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Cardiovasc Med, Taegu, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ Hosp, Dept Cardiovasc Med, Seoul, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Cardiovasc Med, Cheongju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Society of Cardiology, The Korea Centers for Disease Control and
   Prevention [2013-E63005-01]; Korean Health Technology R&D Project,
   Ministry of Health & Welfare, Republic of Korea [HI13C1527]
FX This study was supported by grants of The Korean Society of Cardiology,
   The Korea Centers for Disease Control and Prevention (2013-E63005-01),
   and The Korean Health Technology R&D Project (HI13C1527), Ministry of
   Health & Welfare, Republic of Korea.
CR Choi YJ, 2013, J GERIATR CARDIOL, V10, P146, DOI 10.3969/j.issn.1671-5411.2013.02.006
   ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193
   Grundtvig M, 2013, INT J CARDIOL, V167, P2792, DOI 10.1016/j.ijcard.2012.07.010
   Jang SY, 2013, KOREAN CIRC J, V43, P316, DOI 10.4070/kcj.2013.43.5.316
   최명자, 2013, [The Korean Journal of Medicine, 대한내과학회지], V84, P522, DOI 10.3904/kjm.2013.84.4.522
   설수영, 2011, [The Korean Journal of Medicine, 대한내과학회지], V80, P562
   Lee Ju Hwan, 2009, Korean Circ J, V39, P423, DOI 10.4070/kcj.2009.39.10.423
   Nauta ST, 2012, CIRCULATION, V126, P2184, DOI 10.1161/CIRCULATIONAHA.112.113811
   Njolstad I, 1996, CIRCULATION, V93, P450
   NYBOE J, 1991, AM HEART J, V122, P438, DOI 10.1016/0002-8703(91)90997-V
   Park Jong Seon, 2007, Korean Journal of Internal Medicine, V22, P87
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
   Prescott E, 1998, INT J EPIDEMIOL, V27, P27, DOI 10.1093/ije/27.1.27
   ROSENBERG L, 1981, AM J OBSTET GYNECOL, V139, P47, DOI 10.1016/0002-9378(81)90410-5
   Shiraki T, 2011, ACTA MED OKAYAMA, V65, P307
   Sim DS, 2013, KOREAN CIRC J, V43, P100, DOI 10.4070/kcj.2013.43.2.100
   김민석, 2010, [The Korean Journal of Medicine, 대한내과학회지], V79, P661
   Statistics Korea, 2012, 2012 DEATH STAT
   TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V
   Wijnbergen I, 2013, CATHETER CARDIO INTE, V82, P379, DOI 10.1002/ccd.24800
   최명자, 2011, Korean Journal of Health Promotion, V11, P34
NR 21
TC 9
Z9 9
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 22
EP 27
DI 10.4070/kcj.2015.45.1.22
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500004
PM 25653700
OA Green Published
DA 2021-04-22
ER

PT J
AU Yuk, HB
   Park, HW
   Jung, IJ
   Kim, WH
   Kim, KH
   Yang, DJ
   Park, YH
   Kim, YK
   Song, IG
   Bae, JH
AF Yuk, Hyung Bin
   Park, Hyun Woong
   Jung, Ik Ju
   Kim, Wan Ho
   Kim, Ki-Hong
   Yang, Dong-Ju
   Park, Yo Han
   Kim, Yong Kyun
   Song, In Geol
   Bae, Jang-Ho
TI Analysis of Carotid Ultrasound Findings on Cardiovascular Events in
   Patients with Coronary Artery Disease during Seven-Year Follow-Up
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carotid artery plaque; Carotid intima-media thickness; Coronary artery
   disease; Death
ID INTIMA-MEDIA THICKNESS; ATHEROSCLEROSIS RISK; PREDICTIVE-VALUE; WALL
   THICKNESS; PLAQUE; STROKE; PROGRESSION; MORTALITY; SCORE; MEN
AB Background and Objectives: Both carotid intima-media thickness (CIMT) and carotid plaque are important factors in the primary prevention of cardiac disease. However, it is unclear which one is more important for prognosis, especially in patients with coronary artery disease (CAD).
   Subjects and Methods: In total, 1426 consecutive CAD patients, proven by angiography, were followed-up for a mean of 85 months. The study population was divided into four groups depending on the CIMT (>= 0.83 mm, >95 percentile in Korea) and the presence or absence of carotid plaque.
   Results: Patients with carotid plaque and thick CIMT (n=237, 16.6%) had a higher prevalence of hypertension, diabetes mellitus, and dyslipidemia than those had plaque and thin CIMT (n=213, 14.9%), those without plaque and thick CIMT (n=265, 18.6%) and those without plaque and thin CIMT (n=711, 49.9%). The patients with carotid plaque and thick CIMT group had a higher cardiac mortality rate (20.7% vs. 13.1%, 9.4% and 3.9%, respectively, p<0.001) and higher major adverse cardiovascular events (MACE) including death, acute myocardial infarction, and stroke (27.8% vs. 18.8%, 15.5% and 9.3%, respectively, p<0.001) than any other groups. Multivariate Cox regression analysis showed that the presence of carotid plaque with thick CIMT had the highest hazard ratio (HR) compared to other groups (HR 2.23 vs. 1.81, 2.01) for cardiac mortality. Also, carotid plaque had a higher HR than CIMT for mortality (HR 1.56 vs. 1.37) and MACE (HR 1.54 vs. 1.36) in the total study population.
   Conclusion: Carotid plaque is a more important prognostic factor than CIMT in patients with CAD, and adding a thick CIMT to carotid plaque increases the prognostic power for cardiac events.
C1 [Yuk, Hyung Bin; Park, Hyun Woong; Jung, Ik Ju; Kim, Wan Ho; Kim, Ki-Hong; Yang, Dong-Ju; Park, Yo Han; Kim, Yong Kyun; Song, In Geol; Bae, Jang-Ho] Konyang Univ Hosp, Ctr Heart, Div Cardiol, Taejon 302718, South Korea.
RP Bae, JH (corresponding author), Konyang Univ Hosp, Ctr Heart, Div Cardiol, 158 Gwanjeodong Ro, Taejon 302718, South Korea.
EM janghobae@yahoo.co.kr
OI Park, Yohan/0000-0001-7416-1841
CR Bae JH, 2006, ARTERIOSCL THROM VAS, V26, P2380, DOI 10.1161/01.ATV.0000240420.36229.f9
   Battes L, 2013, AM J CARDIOL, V112, P27, DOI 10.1016/j.amjcard.2013.02.049
   Brook RD, 2006, ARTERIOSCL THROM VAS, V26, P656, DOI 10.1161/01.ATV.0000200079.18690.60
   Chambless LE, 2000, AM J EPIDEMIOL, V151, P478
   Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841
   Fathi R, 2004, J AM COLL CARDIOL, V43, P616, DOI 10.1016/j.jacc.2003.09.042
   Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609
   Held C, 2001, EUR HEART J, V22, P62, DOI 10.1053/euhj.1999.2006
   Hirano M, 2010, ATHEROSCLEROSIS, V211, P451, DOI 10.1016/j.atherosclerosis.2010.03.003
   Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044
   조대경, 2005, Korean Circulation Journal, V35, P834
   KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8
   Kawai T, 2013, HYPERTENS RES, V36, P902, DOI 10.1038/hr.2013.61
   Komorovsky R, 2005, AM J CARDIOL, V95, P116, DOI 10.1016/j.amjcard.2004.08.075
   Lee SK, 1999, KOREAN CIRC J, V29, P1201
   Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea
   Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002
   Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075
   O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103
   Park HW, 2013, INT J CARDIOL, V166, P658, DOI 10.1016/j.ijcard.2011.11.084
   Petersen Christina, 2006, Cardiovasc Ultrasound, V4, P16, DOI 10.1186/1476-7120-4-16
   PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705
   Simon A, 2010, ARTERIOSCL THROM VAS, V30, P182, DOI 10.1161/ATVBAHA.109.196980
   Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011
   Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253
   Wannarong T, 2013, STROKE, V44, P1859, DOI 10.1161/STROKEAHA.113.001461
   Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256
NR 30
TC 8
Z9 10
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 28
EP 37
DI 10.4070/kcj.2015.45.1.28
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500005
PM 25653701
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, DG
   Son, JW
   Park, JY
   Choi, JW
   Ryu, SK
AF Shin, Dong Geum
   Son, Jung-Woo
   Park, Ji Young
   Choi, Jae Woong
   Ryu, Sung Kee
TI Impact of Coronary Artery Anatomy on Clinical Course and Prognosis in
   Apical Hypertrophic Cardiomyopathy: Analysis of Coronary Angiography and
   Computed Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathy; hypertrophic; Coronary artery disease; Coronary
   angiography; Multidetector Computed Tomography
ID PREVALENCE; DISEASE
AB Background and Objectives: Apical hypertrophic cardiomyopathy (AHCM) is an uncommon variant of hypertrophic cardiomyopathy with a relatively benign course. However, the prognostic factors of AHCM-particularly those associated with coronary artery disease (CAD) and its anatomical subtypes-are not well known.
   Subjects and Methods: We enrolled 98 consecutive patients with AHCM who underwent coronary angiography or coronary computed tomography scanning at two general hospitals in Korea from January 2002 to March 2012. Patient charts were reviewed for information regarding cardiovascular (CV) risk factors, symptoms, and occurrence of CV events and/or mortality. We also reviewed echocardiographic data and angiography records.
   Results: The mean age at the time of enrollment was 61.45 +/- 9.78 years, with female patients comprising 38.6%. The proportions of mixed and pure types of AHCM were 34.4% and 65.6%, respectively. CAD was found in 31 (31.6%) patients. The mean follow-up period was 53.1 +/- 60.7 months. CV events occurred in 22.4% of patients, and the mortality rate was 5.1%. The mixed-type was more frequent in CV event group although this difference was not statistically significant (50% vs. 30%, p=0.097). The presence of CAD emerged as an independent risk factor for CV events in univariate and multivariate Cox regression analysis after adjusting for other CV risk factors.
   Conclusion: Coronary artery disease is an independent risk factor for CV events in AHCM patients. However, AHCM without CAD has a benign natural course, comparable with the general population.
C1 [Shin, Dong Geum] Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Div Cardiol, Seoul 120749, South Korea.
   [Son, Jung-Woo] Hallym Univ, Chuncheon Sacred Heart Hosp, Div Cardiol, Chunchon, South Korea.
   [Park, Ji Young; Choi, Jae Woong; Ryu, Sung Kee] Eulji Univ, Sch Med, Dept Internal Med, Div Cardiol,Seoul Eulji Hosp, Seoul 139711, South Korea.
RP Ryu, SK (corresponding author), Eulji Univ, Sch Med, Dept Internal Med, Div Cardiol,Seoul Eulji Hosp, 68 Hangeulbiseok Ro, Seoul 139711, South Korea.
EM ysk1140@eulji.ac.kr
OI Son, Jung-Woo/0000-0002-1790-3228
CR BRAUNWALD E, 1964, CIRCULATION, V30, P3
   CUBUKCU AA, 1993, INT J CARDIOL, V38, P329, DOI 10.1016/0167-5273(93)90254-E
   Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2
   Eriksson MJ, 2002, J AM COLL CARDIOL, V39, P638, DOI 10.1016/S0735-1097(01)01778-8
   GAVALIATSIS IP, 1992, JPN HEART J, V33, P499
   Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602
   Kitaoka H, 2003, AM J CARDIOL, V92, P1183, DOI 10.1016/j.amjcard.2003.07.027
   KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8
   Maron BJ, 2013, CIRCULATION, V127, P585, DOI 10.1161/CIRCULATIONAHA.112.136085
   Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3
   Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401
   Mitchell MA, 1997, PACE, V20, P1866, DOI 10.1111/j.1540-8159.1997.tb03578.x
   Okishige K, 2001, INTERNAL MED, V40, P396, DOI 10.2169/internalmedicine.40.396
   PARTANEN J, 1991, CLIN CARDIOL, V14, P936, DOI 10.1002/clc.4960141115
   PASTERNAC A, 1982, CIRCULATION, V65, P778, DOI 10.1161/01.CIR.65.4.778
   Sakamoto T, 2001, J Cardiol, V37 Suppl 1, P161
   Sorajja P, 2003, CIRCULATION, V108, P2342, DOI 10.1161/01.CIR.0000097110.55312.BF
   Sorajja P, 2003, J AM COLL CARDIOL, V42, P889, DOI 10.1016/S0735-1097(03)00854-4
   Suganuma Y, 1997, Nihon Ronen Igakkai Zasshi, V34, P474
   Yang Hyun Suk, 2005, Korean Journal of Internal Medicine, V20, P111
NR 20
TC 4
Z9 7
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 38
EP 43
DI 10.4070/kcj.2015.45.1.38
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500006
PM 25653702
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SK
   Cho, SK
   Kim, H
   Cho, JY
   Yoon, HJ
   Yoon, NS
   Hong, YJ
   Park, HW
   Kim, JH
   Ahn, Y
   Jeong, MH
   Cho, JG
   Park, JC
AF Cho, Soo Kyung
   Cho, Sang Ki
   Kim, Kye Hun
   Cho, Jae Yeong
   Yoon, Hyun Ju
   Yoon, Nam Sik
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
TI Effects of Age on Arterial Stiffness and Blood Pressure Variables in
   Patients with Newly Diagnosed Untreated Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Vascular stiffness; Aging
ID PULSE-WAVE VELOCITY; WHITE-COAT HYPERTENSION; STAGE RENAL-DISEASE;
   CARDIOVASCULAR EVENTS; AORTIC STIFFNESS; RISK; DETERMINANTS; PREDICTOR;
   MORTALITY; STROKE
AB Background and Objectives: To investigate the impact of age on arterial stiffness and blood pressure (BP) variables in newly diagnosed untreated hypertension (HT).
   Subjects and Methods: A total of 144 patients with newly diagnosed untreated HT were divided into two groups: young group (age =50 years, n=71), and old group (age >50 years, n=73). BP variables were measured on office or 24 hours ambulatory BP monitoring (ABPM). Parameters of arterial stiffness were measured on pulse wave velocity (PWV). Pulse wave analysis (PWA) was compared.
   Results: Although office BP and pulse pressure (PP) were significantly (p<0.05) higher in the young group than in the old group, BP and PP on ABPM were not significantly different. Central systolic BP and PP, augmentation pressure, augmentation index on PWA, and PWV were significantly higher or faster in the old group compared to that in the young group. Age showed significant positive correlation with both PWV and PWA variables in the young group with HT. However, age only showed significant positive correlation with PWV in the old group with HT. In the young group with HT, PWA variable showed better correlation with age than PWV.
   Conclusion: Considering BP levels on ABPM, office BP is prone to be overestimated in young patients with HT. Parameters of arterial stiffness measured by PWV and PWA were more affected by age rather than by BP level in patients with HT. Therefore, PWA variable might be a more sensitive marker of arterial stiffness in young patients with HT. However, PWV might be a better marker for old patients with HT.
C1 [Cho, Soo Kyung; Cho, Sang Ki] Christian Hosp, Dept Internal Med, Kwangju, South Korea.
   [Kim, Kye Hun; Cho, Jae Yeong; Yoon, Hyun Ju; Yoon, Nam Sik; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Ahn, Youngkeun; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ Hosp, Translat Res Ctr Aging, Dept Cardiol, Kwangju 501757, South Korea.
RP Kim, H (corresponding author), Chonnam Natl Univ Hosp, Translat Res Ctr Aging, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM christiankyehun@hanmail.net
CR Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068
   Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   Dolan E, 2004, BLOOD PRESS MONIT, V9, P307, DOI 10.1097/00126097-200412000-00007
   Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342
   Khattar RS, 1999, J HUM HYPERTENS, V13, P111, DOI 10.1038/sj.jhh.1000729
   Lee SJ, 2013, KOREAN CIRC J, V43, P73, DOI 10.4070/kcj.2013.43.2.73
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037
   McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181
   Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226
   Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3
   Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106
   Phillips RA, 2001, AM J HYPERTENS, V14, P649, DOI 10.1016/S0895-7061(01)01308-5
   PICKERING T, 1992, CLIN CARDIOL, V15, P3, DOI 10.1002/clc.4960151403
   PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225
   Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078
   RUTAN GH, 1988, CIRCULATION, V77, P504, DOI 10.1161/01.CIR.77.3.504
   Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B
   STAESSEN JA, 1993, J HYPERTENS, V11, P1289
   Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30
   Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628
   Tsai PS, 2003, CLIN EXP HYPERTENS, V25, P443, DOI 10.1081/CEH-120024987
   Turnbull F, 2003, LANCET, V362, P1527
   Verdecchia P, 1998, HYPERTENSION, V32, P983, DOI 10.1161/01.HYP.32.6.983
   Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496
   ZWEIKER R, 1994, ACTA MED AUST, V21, P86
   박승훈, 2007, [The Korean Journal of Medicine, 대한내과학회지], V72, P181
NR 28
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 44
EP 50
DI 10.4070/kcj.2015.45.1.44
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500007
PM 25653703
OA Green Published
DA 2021-04-22
ER

PT J
AU Negishi, J
   Ohuchi, H
   Yasuda, K
   Miyazaki, A
   Norifumi, N
   Yamada, O
AF Negishi, Jun
   Ohuchi, Hideo
   Yasuda, Kenji
   Miyazaki, Aya
   Norifumi, Nakanishi
   Yamada, Osamu
TI Unscheduled Hospitalization in Adults with Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defects, congenital; Hospitalization; Aging
ID PREVALENCE; MANAGEMENT; MORTALITY; SURGERY
AB Background and Objectives: Little information is available regarding adult patients with congenital heart disease (CHD) who needed unscheduled hospitalization (USH). This paper aims to elucidate the clinical features of adult patients with CHD requiring USH.
   Subjects and Methods: Study subjects included patients with CHD aged 18 years or older who were hospitalized at our facility during a 5-year study period. Medical records were retrospectively reviewed and data regarding USH were collected. Patient's background, underlying heart disease, cause of hospitalization, and prognosis (second USH regardless of cause or death) were examined.
   Results: Overall, 959 CHD patients underwent a total of 1761 hospitalizations, including 145 patients who were unexpectedly hospitalized 239 times. The median age at USH was 27 years old. Of the 959 patients, 54% were male. Underlying heart diseases included repaired tetralogy of Fallot (21%), single ventricular physiology after Fontan operation (17%), and Eisenmenger syndrome (12%). The causes of USH included arrhythmia (40%), heart failure (20%), infectious disease (13%), and hemorrhage or thrombus (13%). A total of 48 patients required readmission. In total, 13 patients died, including four hospital deaths. The USH-free survival rate was 77% for 1 year and 58% for 3 years.
   Conclusion: The rate of USH was high for adults with complicated CHD. Common causes of USH included arrhythmia, heart failure, hemorrhage- related or thrombus-related conditions and infection. These data provide the current status of medical care for adult CHD patients in Japan and their therapeutic needs.
C1 [Negishi, Jun; Ohuchi, Hideo; Yasuda, Kenji; Miyazaki, Aya; Norifumi, Nakanishi; Yamada, Osamu] Natl Cerebral Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan.
RP Negishi, J (corresponding author), Natl Cerebral Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.
EM j-negishi@umin.ac.jp
CR DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0
   Engelfriet P, 2005, EUR HEART J, V26, P2325, DOI 10.1093/eurheartj/ehi396
   Ghai A, 2001, J AM COLL CARDIOL, V37, P585, DOI 10.1016/S0735-1097(00)01141-4
   Gurvitz MZ, 2007, J AM COLL CARDIOL, V49, P875, DOI 10.1016/j.jacc.2006.09.051
   Hiramatsu T, 2011, EUR J CARDIO-THORAC, V40, P1007, DOI 10.1016/j.ejcts.2011.01.022
   Kaemmerer H, 2003, J THORAC CARDIOV SUR, V126, P1048, DOI 10.1016/S0022-5223(03)00737-2
   Kaemmerer H, 2008, AM J CARDIOL, V101, P521, DOI 10.1016/j.amjcard.2007.09.110
   Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224
   Miyazaki A, 2012, CIRC J, V76, P2855, DOI 10.1253/circj.CJ-12-0208
   Niwa K, 2004, INT J CARDIOL, V96, P211, DOI 10.1016/j.ijcard.2003.06.019
   Ohuchi H, 2012, CIRC J, V76, P195, DOI 10.1253/circj.CJ-11-0540
   Opotowsky AR, 2009, J AM COLL CARDIOL, V54, P460, DOI 10.1016/j.jacc.2009.04.037
   Perloff JK, 2001, CIRCULATION, V103, P2637
   Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019
   Seddio F, 2013, EUR J CARDIO-THORAC, V43, P605, DOI 10.1093/ejcts/ezs350
   Shaddy Robert E, 2008, Expert Rev Cardiovasc Ther, V6, P165, DOI 10.1586/14779072.6.2.165
   Shiina Y, 2011, INT J CARDIOL, V146, P13, DOI 10.1016/j.ijcard.2009.05.032
   Trojnarska Olga, 2007, Cardiol J, V14, P127
   Verheugt CL, 2010, HEART, V96, P872, DOI 10.1136/hrt.2009.185595
   Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032
   Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
NR 22
TC 14
Z9 14
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 59
EP 66
DI 10.4070/kcj.2015.45.1.59
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500009
PM 25653705
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, PH
   Lee, SW
   Lee, JY
   Kim, YH
   Lee, CW
   Park, DW
   Park, SW
   Park, SJ
AF Lee, Pil Hyung
   Lee, Seung-Whan
   Lee, Jong-Young
   Kim, Young-Hak
   Lee, Cheol Whan
   Park, Duk-Woo
   Park, Seong-Wook
   Park, Seung-Jung
TI Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent
   Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Percutaneous coronary intervention; Complications
ID CLINICAL CHARACTERISTICS; IMPACT
AB Drug-eluting stent (DES) implantation is currently the standard treatment for various types of coronary artery disease. However, previous reports indicate that stent fractures, which usually occur after a period of time from the initial DES implantation, have increased during the DES era; stent fractures can contribute to unfavorable events such as in-stent restenosis and stent thrombosis. In our present report, we describe two cases of zotarolimus-eluting stent fracture: one that was detected six hours after implementation, and the other case that was detected immediately after deployment. Both anatomical and technical risk factors contributed to these unusual cases of immediate stent fracture.
C1 [Lee, Pil Hyung; Lee, Seung-Whan; Lee, Jong-Young; Kim, Young-Hak; Lee, Cheol Whan; Park, Duk-Woo; Park, Seong-Wook; Park, Seung-Jung] Univ Ulsan, Dept Cardiol, Coll Med, Asan Med Ctr, Seoul 138736, South Korea.
RP Park, SJ (corresponding author), Univ Ulsan, Dept Cardiol, Coll Med, Asan Med Ctr, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM sjpark@amc.seoul.kr
CR Alexopoulos D, 2011, HELL J CARDIOL, V52, P1
   Amico F, 2013, CATHETER CARDIO INTE, V81, P52, DOI 10.1002/ccd.24414
   Aoki J, 2007, CATHETER CARDIO INTE, V69, P380, DOI 10.1002/ccd.20950
   Chakravarty T, 2010, AM J CARDIOL, V106, P1075, DOI 10.1016/j.amjcard.2010.06.010
   Chhatriwalla AK, 2010, CLIN CARDIOL, V33, pE70, DOI 10.1002/clc.20739
   Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051
   Halwani DO, 2012, J BIOMED MATER RES B, V100B, P292, DOI 10.1002/jbm.b.31911
   Holmes DR, 2013, NEW ENGL J MED, V368, P1558, DOI 10.1056/NEJMc1301999
   Kim HS, 2009, INT J CARDIOL, V133, P354, DOI 10.1016/j.ijcard.2008.01.005
   Kuramitsu S, 2012, CIRC-CARDIOVASC INTE, V5, P663, DOI 10.1161/CIRCINTERVENTIONS.112.969238
   Lee MS, 2007, CATHETER CARDIO INTE, V69, P387, DOI 10.1002/ccd.20942
   Mohsen Mohammed Khalil, 2013, Heart Views, V14, P72, DOI 10.4103/1995-705X.115501
   Popma JJ, 2009, AM J CARDIOL, V103, P923, DOI 10.1016/j.amjcard.2008.12.022
   Sianos G, 2004, CATHETER CARDIO INTE, V61, P111, DOI 10.1002/ccd.10709
   Smaldone Costantino, 2010, J Invasive Cardiol, V22, pE186
NR 15
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 67
EP 70
DI 10.4070/kcj.2015.45.1.67
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500010
PM 25653706
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YH
   Yang, HM
   Tahk, SJ
   Hong, YS
   Park, JS
   Seo, KW
   Choi, YW
   Noh, CK
AF Lee, You-Hong
   Yang, Hyoung-Mo
   Tahk, Seung-Jea
   Hong, You-Sun
   Park, Jin-Sun
   Seo, Kyoung-Woo
   Choi, Yong-Woo
   Noh, Choong-Kyun
TI Recurrent Stent Thrombosis in a Patient with Antiphospholipid Syndrome
   and Dual Anti-Platelet Therapy Non-Responsiveness
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Antiphospholipid syndrome; Percutaneous coronary intervention; Stents;
   Thrombosis
ID INTERNATIONAL CONSENSUS STATEMENT; ACUTE MYOCARDIAL-INFARCTION;
   CLASSIFICATION CRITERIA; ANTIBODY SYNDROME; RESTENOSIS; DISEASE; RISK
AB Antiphospholipid syndrome (APS), the most common acquired hypercoagulable condition, is diagnosed by persistent presence of antiphospholipid antibodies and episodes of vascular thrombosis. It may be an important predisposing factor for stent thrombosis, resulting in poor outcomes. Also, anti-platelet therapy non-responsiveness is associated with stent thrombosis. We report a case of a 39-year-old man who after undergoing successful percutaneous coronary intervention for significant coronary artery disease suffered repeated stent thrombosis events leading to ST-segment elevation myocardial infarction. Eventually, he underwent coronary artery bypass surgery because of uncontrolled thrombosis and was diagnosed as having APS and dual antiplatelet therapy non-responsiveness.
C1 [Lee, You-Hong; Yang, Hyoung-Mo; Tahk, Seung-Jea; Park, Jin-Sun; Seo, Kyoung-Woo; Choi, Yong-Woo; Noh, Choong-Kyun] Ajou Univ, Sch Med, Dept Cardiol, Suwon 443721, South Korea.
   [Hong, You-Sun] Ajou Univ, Sch Med, Dept Cardiovasc Thorac Surg, Suwon 443721, South Korea.
RP Yang, HM (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 Worldcup Ro, Suwon 443721, South Korea.
EM yhhm20@hanmail.net
OI Yang, Hyoung-Mo/0000-0003-3602-9772
CR Burzotta F, 2008, EUR HEART J, V29, P3011, DOI 10.1093/eurheartj/ehn479
   Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187
   Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311
   Klomp M, 2011, JACC-CARDIOVASC INTE, V4, P896, DOI 10.1016/j.jcin.2011.05.011
   Levine SR, 2004, JAMA-J AM MED ASSOC, V291, P576
   Lim W, 2006, JAMA-J AM MED ASSOC, V295, P1050, DOI 10.1001/jama.295.9.1050
   Lockshin M, 2003, LUPUS, V12, P518, DOI 10.1191/0961203303lu391oa
   Ludia C, 1998, AUTOIMMUNITY, V27, P141, DOI 10.3109/08916939809003861
   Middlebrooks EH, 2010, CASE REP MED, V2010, DOI 10.1155/2010/974149
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Muir D F, 2003, Int J Cardiovasc Intervent, V5, P44
   Musuraca G, 2004, BLOOD COAGUL FIBRIN, V15, P95, DOI 10.1097/00001721-200401000-00015
   Perl L, 2012, CARDIOLOGY, V122, P76, DOI 10.1159/000338347
   Takeuchi S, 1998, HEART, V79, P96, DOI 10.1136/hrt.79.1.96
   Tripodi A, 2001, BRIT J HAEMATOL, V115, P672, DOI 10.1046/j.1365-2141.2001.03178.x
   van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055
   Weissman A, 2006, REV CARDIOVASC MED, V7, P244
   Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
NR 18
TC 1
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 71
EP 76
DI 10.4070/kcj.2015.45.1.71
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500011
PM 25653707
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, S
   Lee, K
   Chang, SA
   Kim, DK
AF Chung, Seungmin
   Lee, Kyungho
   Chang, Sung-A
   Kim, Duk-Kyung
TI Aggravation of Hepatopulmonary Syndrome after Sildenafil Treatment in a
   Patient with Coexisting Portopulmonary Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hepatopulmonary syndrome; Pulmonary arterial hypertension; Sildenafil
ID PULMONARY ARTERIAL-HYPERTENSION; ENDOTHELIN-B RECEPTOR; HEMODYNAMICS;
   PATHOGENESIS
AB Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are complications of portal hypertension and cirrhosis. Their pathophysiological mechanisms clearly differ. HPS is characterized by a defect in arterial oxygenation induced by pulmonary vascular dilatation. In contrast, PPHTN is predominantly due to excessive pulmonary vasoconstriction and vascular remodeling, but is rarely associated with hypoxia. We report a case of a patient who had both HPS and PPHTN at the time of presentation. HPS was aggravated after sildenafil administration for the treatment of PPHTN. We demonstrated increased amount of intrapulmonay shunt after sildenafil challenge by using agitated saline contrast transthoracic echocardiography.
C1 [Chung, Seungmin; Chang, Sung-A; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Div Cardiol, Heart Vasc & Stroke Inst, Seoul 135710, South Korea.
   [Lee, Kyungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Heart Vasc & Stroke Inst, 81 Irwon Ro, Seoul 135710, South Korea.
EM dukkyung.kim@samsung.com
RI Kim, Duk Kyung/F-4613-2014
OI Lee, Kyungho/0000-0003-2627-0220; Chang, Sung-A/0000-0001-5124-605X
CR Castro PF, 2011, THORAX, V66, P1097, DOI 10.1136/thx.2010.156711
   Fallon MB, 2005, J CLIN GASTROENTEROL, V39, pS138, DOI 10.1097/01.mcg.0000155570.19340.61
   Gough MS, 2009, LIVER TRANSPLANT, V15, P30, DOI 10.1002/lt.21533
   Gudavalli A, 2002, J AM SOC ECHOCARDIOG, V15, P1012, DOI 10.1067/mje.2002.121435
   Hoeper MM, 2004, LANCET, V363, P1461, DOI 10.1016/S0140-6736(04)16107-2
   Kleinsasser A, 2001, AM J RESP CRIT CARE, V163, P339, DOI 10.1164/ajrccm.163.2.2003021
   Ling YQ, 2004, HEPATOLOGY, V39, P1593, DOI 10.1002/hep.20244
   Olschewski H, 2004, PHARMACOL THERAPEUT, V102, P139, DOI 10.1016/j.pharmthera.2004.01.003
   Pham DM, 2010, J CLIN GASTROENTEROL, V44, pE136, DOI 10.1097/MCG.0b013e3181da76fc
   Reichenberger F, 2006, EUR RESPIR J, V28, P563, DOI 10.1183/09031936.06.00030206
   Rodriguez-Roisin R, 2004, EUR RESPIR J, V24, P861, DOI 10.1183/09031936.04.00010904
   Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185
   Schwartz BG, 2012, J AM COLL CARDIOL, V59, P9, DOI 10.1016/j.jacc.2011.07.051
   Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003
   Zhang JL, 2009, AM J PHYSIOL-GASTR L, V296, pG704, DOI 10.1152/ajpgi.90627.2008
   Zopey Radhika, 2013, Case Rep Pulmonol, V2013, P561870, DOI 10.1155/2013/561870
NR 16
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 77
EP 80
DI 10.4070/kcj.2015.45.1.77
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500012
PM 25653708
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, CY
   Bae, MH
   Kim, NK
   Yang, YA
   Kim, KY
   Lee, JH
   Eun, JS
   Cho, Y
AF Kim, Chang-Yeon
   Bae, Myung Hwan
   Kim, Nam Kyun
   Yang, Young Ae
   Kim, Kyu Yeun
   Lee, Jang Hoon
   Eun, Jung Su
   Cho, Yongkeun
TI Case of Recurrent Ventricular Fibrillations with Osborn Wave Developed
   during Therapeutic Hypothermia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypothermia; Electrocardiography; Ventricular fibrillation
ID CARDIAC-ARREST; ELECTROCARDIOGRAM; ELEVATION; SURVIVORS
AB Therapeutic hypothermia (TH) has been used to protect neurological functions in cardiac arrest patient. Although Osborn wave is not pathognomonic of hypothermia, it is a well-known electrocardiogram finding of hypothermic patients. The cellular and ionic mechanisms of the Osborn wave have been suggested, and its relationship to tachyarrhythmias, such as ventricular tachycardia and ventricular fibrillation, is being explored. This case highlights the arrhythmogenic potential of Osborn wave and individual difference in response of TH.
C1 [Kim, Chang-Yeon; Bae, Myung Hwan; Kim, Nam Kyun; Yang, Young Ae; Kim, Kyu Yeun; Lee, Jang Hoon; Eun, Jung Su; Cho, Yongkeun] Kyungpook Natl Univ Hosp, Dept Internal Med, Taegu 700721, South Korea.
RP Bae, MH (corresponding author), Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM bmh0325@knu.ac.kr
CR Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006
   Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289
   Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P305, DOI 10.1161/CIRCEP.110.945824
   EMSLIESMITH D, 1959, BRIT HEART J, V21, P343
   Graham CA, 2001, WILD ENVIRON MED, V12, P232, DOI 10.1580/1080-6032(2001)012[0232:TEIH]2.0.CO;2
   Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968
   Holzer M, 2002, NEW ENGL J MED, V346, P549
   Janata A, 2009, PROG CARDIOVASC DIS, V52, P168, DOI 10.1016/j.pcad.2009.07.001
   Maruyama Mitsunori, 2004, Indian Pacing Electrophysiol J, V4, P33
   Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027
   Mustafa S, 2005, CARDIOLOGY, V103, P118, DOI 10.1159/000083434
   OKADA M, 1984, J ELECTROCARDIOL, V17, P123, DOI 10.1016/S0022-0736(84)81085-7
   Piktel JS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P79, DOI 10.1161/CIRCEP.110.958355
   Rolfast CL, 2012, CRIT CARE, V16, DOI 10.1186/cc11369
   Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010
   Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811
   Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589
   Vassallo SU, 1999, ACAD EMERG MED, V6, P1121, DOI 10.1111/j.1553-2712.1999.tb00114.x
   Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372
NR 19
TC 8
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 81
EP 84
DI 10.4070/kcj.2015.45.1.81
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500013
PM 25653709
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, BC
   Kim, NH
   Nam, GB
   Park, HW
   On, YK
   Lee, YS
   Lim, HE
   Joung, B
   Cha, TJ
   Hwang, GS
   Oh, S
   Kim, JS
AF Jung, Byung Chun
   Kim, Nam Ho
   Nam, Gi Byung
   Park, Hyung Wook
   On, Young Keun
   Lee, Young Soo
   Lim, Hong Euy
   Joung, Boyoung
   Cha, Tae Joon
   Hwang, Gyo Seung
   Oh, Seil
   Kim, June Soo
TI The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic
   Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart
   Rhythm Society
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Antithrombotic agent; Anticoagulant
ID STROKE PREVENTION; ORAL ANTICOAGULANTS; WARFARIN; ASPIRIN; RISK;
   RIVAROXABAN; CLOPIDOGREL; GUIDELINES; DABIGATRAN
AB In patients with nonvalvular atrial fibrillation (AF), the risk of stroke varies considerably according to individual clinical status. The CHA(2)DS(2)-VASc score is better than the CHADS(2) score for identifying truly lower risk patients with AF. With the advent of novel oral anticoagulants (NOACs), the strategy for antithrombotic therapy has undergone significant changes due to its superior efficacy, safety and convenience compared with warfarin. Furthermore, new aspects of antithrombotic therapy and risk assessment of stroke have been revealed: the efficacy of stroke prevention with aspirin is weak, while the risk of major bleeding is not significantly different from that of oral anticoagulant (OAC) therapy, especially in the elderly. Reflecting these pivotal aspects, previous guidelines have been updated in recent years by overseas societies and associations. The Korean Heart Rhythm Society has summarized the new evidence and updated recommendations for stroke prevention of patients with nonvalvular AF. First of all, antithrombotic therapy must be considered carefully and incorporate the clinical characteristics and circumstances of each individual patient, especially with regards to balancing the benefits of stroke prevention with the risk of bleeding, recommending the CHA(2)DS(2)-VASc score rather than the CHADS(2) score for assessing the risk of stroke, and employing the HAS-BLED score to validate bleeding risk. In patients with truly low risk (lone AF, CHA(2)DS(2)-VASc score of 0), no antithrombotic therapy is recommended, whereas OAC therapy, including warfarin (international normalized ratio 2-3) or NOACs, is recommended for patients with a CHA(2)DS(2)-VASc score >= 2 unless contraindicated. In patients with a CHA(2)DS(2)-VASc score of 1, OAC therapy should be preferentially considered, but depending on bleeding risk or patient preferences, antiplatelet therapy or no therapy could be permitted.
C1 [Jung, Byung Chun] Daegu Fatima Hosp, Dept Med, Div Cardiol, Taegu 701724, South Korea.
   [Kim, Nam Ho] Wonkwang Univ Hosp, Dept Internal Med, Div Cardiol, Iksan, South Korea.
   [Nam, Gi Byung] Univ Ulsan, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Park, Hyung Wook] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Kwangju, South Korea.
   [On, Young Keun; Kim, June Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.
   [Lee, Young Soo] Catholic Univ Daegu, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Lim, Hong Euy] Korea Univ, Guro Hosp, Dept Med, Div Cardiol, Seoul, South Korea.
   [Joung, Boyoung] Yonsei Univ, Severance Hosp, Dept Med, Div Cardiol, Seoul 120749, South Korea.
   [Cha, Tae Joon] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Pusan, South Korea.
   [Hwang, Gyo Seung] Ajou Univ Hosp, Dept Med, Div Cardiol, Suwon, South Korea.
   [Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
RP Jung, BC (corresponding author), Daegu Fatima Hosp, Dept Med, Div Cardiol, 99 Ayang Ro, Taegu 701724, South Korea.
EM augusteorn@naver.com
RI Oh, Seil/J-5539-2012
OI Oh, Seil/0000-0002-2504-9615; Joung, Boyoung/0000-0001-9036-7225
CR Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
   Bang OY, 2014, J STROKE, V16, P73, DOI 10.5853/jos.2014.16.2.73
   Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253
   Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   [Clinical Research Center for Stroke Writing group of clinical practice guideline for stroke], 2009, CLIN PRACTICE GUIDEL, P34
   Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4
   Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301
   Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003
   박종무, 2012, [Korean Journal of Stroke, 대한뇌졸중학회지], V14, P106, DOI 10.5853/kjs.2012.14.3.106
   Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Ogawa S, 2013, J ARRYTHM, V29, P190, DOI 10.1016/j.joa.2013.03.002
   Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021
   van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441
   Wong KSL, 2014, STROKE, V45, P1739, DOI 10.1161/STROKEAHA.113.002968
NR 25
TC 29
Z9 29
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 9
EP 19
DI 10.4070/kcj.2015.45.1.9
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500002
PM 25653698
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, HJ
   Jung, JW
AF Shin, Hong Ju
   Jung, Jo Won
TI Increasing Demand for Hospitalization in Adults with Congenital Heart
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Shin, Hong Ju] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Div Cardiovasc Surg,Congenital Heart Dis Ctr,Seve, Seoul 120752, South Korea.
   [Jung, Jo Won] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Pediat Cardiol,Dept Pediat,Congenital Heart D, Seoul 120752, South Korea.
RP Jung, JW (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Pediat Cardiol,Dept Pediat,Congenital Heart D, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM jwjung@yuhs.ac
CR Negishi J, 2015, KOREAN CIRC J, V45, P59, DOI 10.4070/kcj.2015.45.1.59
   Seddio F, 2013, EUR J CARDIO-THORAC, V43, P605, DOI 10.1093/ejcts/ezs350
   Verheugt CL, 2010, HEART, V96, P872, DOI 10.1136/hrt.2009.185595
   Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 20
EP 21
DI 10.4070/kcj.2015.45.1.20
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500003
PM 25653699
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, JH
   Kim, HJ
   Lee, EJ
   Moon, S
   Lee, JY
   Lee, JW
   Chung, NG
   Cho, B
   Kim, HK
AF Yoon, Ji-Hong
   Kim, Hye Jin
   Lee, Eun-Jung
   Moon, Sena
   Lee, Jae Young
   Lee, Jae Wook
   Chung, Nack Gyun
   Cho, Bin
   Kim, Hack Ki
TI Early Left Ventricular Dysfunction in Children after Hematopoietic Stem
   Cell Transplantation for Acute Leukemia: A Case Control Study Using
   Speckle Tracking Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Childhood leukemia; Stem cell transplantation; Heart function; Speckle
   tracking; Echocardiography; Strain rate
ID BONE-MARROW-TRANSPLANTATION; CAUSE-SPECIFIC MORTALITY; CLINICAL
   HEART-FAILURE; 5-YEAR SURVIVORS; DIASTOLIC FUNCTION; CARDIAC-FUNCTIONS;
   CHILDHOOD-CANCER; ANTHRACYCLINE; FRACTION; THERAPY
AB Background and Objectives: Cardiovascular complications are the leading cause of morbidity and mortality in childhood cancer survivors. Hematopoietic stem cell transplantation (HSCT) is a curable therapy for pediatric cancer. However, changes in cardiac function in children after HSCT are not well known. We assessed left ventricular (LV) function in children after HSCT using speckle tracking echocardiography (STE).
   Subjects and Methods: Forty consecutive patients with median age of 11.9 years (range, 1.5-16 years) who received HSCT for acute leukemia and had comprehensive echocardiography before and after (median 9.2 month) HSCT were included in this study. The LV function parameters including conventional tissue Doppler imaging (TDI) and STE data were collected from pre-and post-HSCT echocardiography. These data were compared to those of 39 age-matched normal controls.
   Results: Compared to normal controls, post HSCT patients had similar (p=0.06) LV ejection fraction. However, the following three LV function parameters were significantly decreased in post HSCT patients: rate-corrected velocity of circumferential fiber shortening (p=0.04), mitral inflow E velocity (p<0.001), and mitral septal annular E' velocity (p=0.03). The following four STE parameters were also significantly decreased in post HSCT patients: LV global circumferential systolic strain (p<0.01), strain rate (SR, p=0.01), circumferential diastolic SR (p<0.01), and longitudinal diastolic SR (p<0.001). There was no significant change in TDI or STE parameters after HSCT compared to preHSCT. Patients with anthracycline cumulative dose >400 mg/m(2) showed significantly (p<0.05) lower circumferential systolic strain and circumferential diastolic SR.
   Conclusion: Subclinical cardiac dysfunction is evident in children after HSCT. It might be associated with pre-HSCT anthracycline exposure with little effect of conditioning regimens. Serial monitoring of cardiac function is mandatory for all children following HSCT.
C1 [Yoon, Ji-Hong; Kim, Hye Jin; Lee, Eun-Jung; Moon, Sena; Lee, Jae Young; Lee, Jae Wook; Chung, Nack Gyun; Cho, Bin; Kim, Hack Ki] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, Seoul 137701, South Korea.
RP Lee, JY (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, 222 Banpo Daero, Seoul 137701, South Korea.
EM jaeyounglee@catholic.ac.kr
OI Yoon, Ji Hong/0000-0001-8498-2352
CR Alehan D, 2012, PEDIATR BLOOD CANCER, V58, P250, DOI 10.1002/pbc.23281
   Armenian SH, 2011, BLOOD, V118, P1413, DOI 10.1182/blood-2011-01-331835
   Armenian SH, 2010, BIOL BLOOD MARROW TR, V16, P1138, DOI 10.1016/j.bbmt.2010.02.021
   Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P2, DOI 10.1016/j.bbmt.2008.05.017
   Baysal T, 2010, PEDIATR HEMAT ONCOL, V27, P13, DOI 10.3109/08880010903352299
   Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079
   BRAVERMAN AC, 1991, J CLIN ONCOL, V9, P1215, DOI 10.1200/JCO.1991.9.7.1215
   BULOCK FA, 1995, BRIT HEART J, V73, P340
   Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028
   Cheung YF, 2010, HEART, V96, P1137, DOI 10.1136/hrt.2010.194118
   Children's Oncology Group, 2013, LONG TERM FOLL GUID
   Chow EJ, 2011, ANN INTERN MED, V155, P21, DOI 10.7326/0003-4819-155-1-201107050-00004
   Chow PC, 2008, HEART, V94, P855, DOI 10.1136/hrt.2007.131862
   Daly KP, 2011, BONE MARROW TRANSPL, V46, P1532, DOI 10.1038/bmt.2010.345
   Kremer LCM, 2002, ANN ONCOL, V13, P503, DOI 10.1093/annonc/mdf118
   Lahteenmaki PM, 2004, ACTA ONCOL, V43, P196, DOI 10.1080/02841860310023471
   Lipshultz SE, 2001, CIRCULATION, V104, P310
   MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922
   Mavinkurve-Groothuis AMC, 2009, ULTRASOUND MED BIOL, V35, P697, DOI 10.1016/j.ultrasmedbio.2008.09.026
   Mertens AC, 2007, PEDIATR BLOOD CANCER, V48, P723, DOI 10.1002/pbc.21114
   Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133
   Nieder ML, 2011, BIOL BLOOD MARROW TR, V17, P1573, DOI 10.1016/j.bbmt.2011.09.013
   Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185
   Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943
   Rathe M, 2007, PEDIATR BLOOD CANCER, V48, P663, DOI 10.1002/pbc.20313
   Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923
   Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575
   Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407
   van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005
NR 29
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 51
EP 58
DI 10.4070/kcj.2015.45.1.51
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500008
PM 25653704
OA Green Published
DA 2021-04-22
ER

PT J
AU Koo, BK
AF Koo, Bon-Kwon
TI Coronary Circulation; Macro or Micro, That Is the Question (vol 44, pg
   139, 2014)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 Seoul Natl Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea.
CR 2015, KOREAN, V45
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2015
VL 45
IS 1
BP 85
EP 85
DI 10.4070/kcj.2015.45.1.85
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CA8JI
UT WOS:000349164500014
PM 25654276
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Kim, MH
   Guo, LZ
   Park, MK
   Yi, SJ
AF Lee, Dong Hyun
   Kim, Moo Hyun
   Guo, Long Zhe
   Park, Min Kyu
   Yi, So Jeong
TI Lower Loading Dose of Prasugrel Compared with Conventional Loading Doses
   of Clopidogrel and Prasugrel in Korean Patients Undergoing Elective
   Coronary Angiography: A Randomized Controlled Study Evaluating
   Pharmacodynamic Efficacy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prasugrel; Clopidogrel; Platelet function tests; Population
   heterogeneity; Coronary artery disease
ID ELEVATION MYOCARDIAL-INFARCTION; TREATMENT PLATELET REACTIVITY; DUAL
   ANTIPLATELET THERAPY; ASSOCIATION TASK-FORCE; ST-SEGMENT ELEVATION;
   CLINICAL-OUTCOMES; FUNCTION TESTS; BLEEDING COMPLICATIONS; PRACTICE
   GUIDELINES; PREDICTIVE VALUES
AB Background and Objectives: Although prasugrel allows for rapid and potent platelet inhibition, the efficacy and safety of lower doses of prasugrel for patients of East Asian ethnicity has not yet been investigated. We compared the effect of a lower loading dose (LD) of prasugrel with conventional LDs of clopidogrel and prasugrel in Korean patients.
   Subjects and Methods: Forty-three Korean patients undergoing coronary angiography were enrolled in the study. Participants were randomly administered LDs of clopidogrel 600 mg, prasugrel 30 mg or prasugrel 60 mg prior to coronary angiography. Platelet reactivity was assessed at baseline and at the time of peak platelet inhibition using light transmission aggregometry (LTA), the VerifyNow assay, and multiple electrode aggregometry.
   Results: Although baseline platelet reactivity between the groups showed no significant differences, at the time of peak platelet inhibition, the prasugrel 30 mg (18.9 +/- 10.0%) and 60 mg groups (13.8 +/- 10.8%) showed significantly more potent platelet inhibition than the clopidogrel 600 mg group (52.9 15.8%; p<0.001) by LTA. However, there were no significant differences between the prasugrel 30 mg and 60 mg groups (p=0.549).
   Conclusion: The loading effect of prasugrel 30 mg was more potent than clopidogrel 600 mg and was not significantly different from prasugrel 60 mg.
C1 [Lee, Dong Hyun; Kim, Moo Hyun] Dong A Univ Hosp, Dept Cardiol, Pusan 602715, South Korea.
   [Kim, Moo Hyun; Guo, Long Zhe; Park, Min Kyu; Yi, So Jeong] Dong A Univ Hosp, Reg Clin Trial Ctr, Pusan 602715, South Korea.
RP Kim, MH (corresponding author), Dong A Univ Hosp, Dept Cardiol, 26 Daeshingongwon Ro, Pusan 602715, South Korea.
EM kimmh@dau.ac.kr
OI Lee, Dong Hyun/0000-0001-6253-3396
FU Korea Health Industry Development Institute (KHIDI) - Ministry of Health
   & Welfare, Republic of Korea [HI14C1063]; Ministry of Education, Science
   and Technology, Republic of KoreaMinistry of Education, Science and
   Technology, Republic of Korea [2012R1A1A1A20 05932]
FX This research was supported by a grant of the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
   (grant number: HI14C1063) and funded by the Ministry of Education,
   Science and Technology (No. 2012R1A1A1A20 05932), Republic of Korea.
CR Angiolillo DJ, 2004, EUR HEART J, V25, P1903, DOI 10.1016/j.ehj.2004.07.036
   Bonello L, 2012, J THROMB HAEMOST, V10, P1999, DOI 10.1111/j.1538-7836.2012.04875.x
   Cayla G, 2013, AM J CARDIOL, V111, P38, DOI 10.1016/j.amjcard.2012.08.043
   Cuisset T, 2009, EUROINTERVENTION, V5, P325, DOI 10.4244/51
   Grosdidier C, 2013, AM J CARDIOL, V111, P985, DOI 10.1016/j.amjcard.2012.12.013
   Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83
   Jin HY, 2014, KOREAN CIRC J, V44, P82, DOI 10.4070/kcj.2014.44.2.82
   Jin HY, 2013, INT J CARDIOL, V167, P1877, DOI 10.1016/j.ijcard.2012.04.154
   Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0
   Kim MH, 2013, CIRC J, V77, P1253, DOI 10.1253/circj.CJ-12-0783
   Ko YG, 2011, AM HEART J, V161, P383, DOI 10.1016/j.ahj.2010.10.036
   Marcucci R, 2010, THROMB HAEMOSTASIS, V104, P279, DOI 10.1160/TH10-01-0007
   O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6
   Park KW, 2011, AM J CARDIOL, V108, P1556, DOI 10.1016/j.amjcard.2011.07.012
   Parodi G, 2012, AM J CARDIOL, V109, P214, DOI 10.1016/j.amjcard.2011.08.034
   Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512
   Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482
   Serebruany V, 2010, EUR HEART J, V31, P227, DOI 10.1093/eurheartj/ehp434
   Siller-Matula JM, 2010, J THROMB HAEMOST, V8, P351, DOI 10.1111/j.1538-7836.2009.03699.x
   Small DS, 2010, EUR J CLIN PHARMACOL, V66, P127, DOI 10.1007/s00228-009-0737-1
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Sugidachi A, 2007, J THROMB HAEMOST, V5, P1545, DOI 10.1111/j.1538-7836.2007.02598.x
   Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101
   Tsukahara K, 2010, CIRC J, V74, P679, DOI 10.1253/circj.CJ-09-0601
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Yokoi H, 2012, THROMB RES, V129, P623, DOI 10.1016/j.thromres.2011.11.023
   Zhang HZ, 2014, PLATELETS, V25, P292, DOI 10.3109/09537104.2013.815341
   Zhang HZ, 2014, PLATELETS, V25, P285, DOI 10.3109/09537104.2013.815340
NR 28
TC 8
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 386
EP 393
DI 10.4070/kcj.2014.44.6.386
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400002
PM 25469140
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, HO
   Nam, CW
   Cho, YK
   Yoon, HJ
   Park, HS
   Kim, H
   Chung, IS
   Doh, JH
   Koo, BK
   Hyun, DW
   Hur, SH
   Kim, YN
   Kim, KB
AF Cho, Hyun-Ok
   Nam, Chang-Wook
   Cho, Yun-Kyeong
   Yoon, Hyuck-Jun
   Park, Hyoung-Seob
   Kim, Hyungseop
   Chung, In-Sung
   Doh, Joon-Hyung
   Koo, Bon-Kwon
   Hyun, Dae-Woo
   Hur, Seung-Ho
   Kim, Yoon-Nyun
   Kim, Kwon-Bae
TI Characteristics of Function-Anatomy Mismatch in Patients with Coronary
   Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fractional flow reserve; myocardial; Coronary angiography; Coronary
   artery disease
ID FRACTIONAL FLOW RESERVE; INTRAVASCULAR ULTRASOUND; PRESSURE
   MEASUREMENTS; PROGNOSTIC VALUE; SEX-DIFFERENCES; BLOOD-FLOW;
   ANGIOGRAPHY; STENOSIS; SEVERITY; ACCURACY
AB Background and Objectives: Coronary lesions with mismatched functional and anatomical significance are not uncommon. We assessed the accuracy and predictors of mismatch between fractional flow reserve (FFR) and quantitative coronary angiography (DCA) analyses in patients with coronary lesions.
   Subjects and Methods: A total of 643 lesions with pre-interventional FFR and QCA measurements were consecutively enrolled and divided into four groups using FFR <= 0.80 and percent diameter stenosis (%DS) >= 50% as cutoffs for functional and anatomical significance, respectively. Accordingly, FFR >0.80 and DS >= 50%, and FFR <= 0.80 and DS <50% defined false-positive (FP) and false-negative (FN) lesions, respectively.
   Results: Overall, 40.4% (260/643) of the lesions were mismatched, and 51.7% (218/414) and 18.3% (42/229) were FP and FN lesions, respectively. In a multivariate analysis, independent predictors of FP were non-left anterior descending artery location {odds ratio (OR), 0.36; 95% confidence interval (CI), 0.28-0.56; p<0.001}, shorter lesion length (OR, 0.96; 95% CI, 0.95-0.98; p<0.001), multi-vessel disease (OR, 0.47; 95% CI, 0.30-0.75; p=0.001), and larger minimal lumen diameter by QCA (OR, 2.88; 95% CI, 1.65-5.00; p<0.001). Independent predictors of FN were multi-vessel disease (OR, 1.82; 95% CI, 1.24-5.27; p=0.048), aging (OR, 0.96; 95% CI, 0.93-0.99; p=0.034), smoking (OR, 0.36; 95% CI, 0.14-0.93; p=0.034), and smaller reference vessel diameter by QCA (OR, 0.30; 95% CI, 0.10-0.87; p=0.026).
   Conclusion: A mismatch between FFR and angiographic lesion severity is not rare in patients with coronary artery disease; therefore, an angiography-guided evaluation could under- or over-estimate lesion severity in specific lesion subsets.
C1 [Cho, Hyun-Ok; Nam, Chang-Wook; Cho, Yun-Kyeong; Yoon, Hyuck-Jun; Park, Hyoung-Seob; Kim, Hyungseop; Hur, Seung-Ho; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Taegu 700712, South Korea.
   [Cho, Hyun-Ok; Hyun, Dae-Woo] Cardiovasc Ctr, Andong Med Grp, Andong, South Korea.
   [Chung, In-Sung] Keimyung Univ, Dongsan Med Ctr, Dept Occupat & Environm Med, Taegu, South Korea.
   [Doh, Joon-Hyung] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
RP Nam, CW (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, 56 Dalseong Ro, Taegu 700712, South Korea.
EM ncwcv@dsmc.or.kr
FU Korean Society of Cardiology; Scholar Research Grant of Keimyung
   University
FX This study was supported by a grant from The Korean Society of
   Cardiology in 2013 and by a grant from the Scholar Research Grant of
   Keimyung University in 2012.
CR DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013
   Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6
   Kang SJ, 2013, JACC-CARDIOVASC INTE, V6, P562, DOI 10.1016/j.jcin.2013.02.016
   Kim HS, 2012, JACC-CARDIOVASC INTE, V5, P1037, DOI 10.1016/j.jcin.2012.06.016
   Kim JE, 2012, KOREAN CIRC J, V42, P441, DOI 10.4070/kcj.2012.42.7.441
   Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013
   Leone AM, 2013, CIRC-CARDIOVASC INTE, V6, P29, DOI 10.1161/CIRCINTERVENTIONS.112.971101
   Melikian N, 2010, JACC-CARDIOVASC INTE, V3, P307, DOI 10.1016/j.jcin.2009.12.010
   Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jacc.2006.08.048
   Nam CW, 2011, KOREAN CIRC J, V41, P304, DOI 10.4070/kcj.2011.41.6.304
   Park SJ, 2012, JACC-CARDIOVASC INTE, V5, P1029, DOI 10.1016/j.jcin.2012.07.007
   PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183
   PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077
   REIBER JHC, 1993, CATHETER CARDIO DIAG, V28, P187, DOI 10.1002/ccd.1810280301
   Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004
   TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333
NR 18
TC 13
Z9 14
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 394
EP 399
DI 10.4070/kcj.2014.44.6.394
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400003
PM 25469141
OA Green Published
DA 2021-04-22
ER

PT J
AU Seyyed-Mohammadzad, MH
   Khademvatani, K
   Kerachian, A
   Eskandari, R
   Rezaei, Y
AF Seyyed-Mohammadzad, Mir Hossein
   Khademvatani, Kamal
   Kerachian, Abdollah
   Eskandari, Ramin
   Rezaei, Yousef
TI Slow Coronary Flow Phenomenon and Increased Platelet Volume Indices
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary circulation; Mean platelet volume
ID ANGINA-PECTORIS; ACTIVATION; ARTERIES; DISEASE
AB Background and Objectives: We sought to determine the relationship between mean platelet volume (MPV), platelet distribution width (PD1N), and platelet larger cell ratio (P-LCR) with slow coronary.flow (SCF).
   Subjects and Methods: Eighty participants who underwent coronary angiography were divided into two groups, 50 participants with SCF as case group, and 30 with normal coronary flow (NCF) as control group. Baseline characteristics and laboratory data were collected before angiography.
   Results: Platelet volume indices MPV (10.8 +/- 1.2 fL), PD1N (14.5 +/- 2.2 fL), and P-LCR (30.5 +/- 8.1%) in the SCF group were significantly (p<0.05) higher than those (10.1 +/- 0.9 fL, 13.2 +/- 1.8 fL, and 26.8 +/- 6.8%, respectively) in the NCF group. The patients with three SCF arteries had significantly higher platelet volume indices compared to those with NCF arteries; however, the patients with one SCF artery did not. Based on linear regression model, MPV, PDVV, and P-LCR were independent predictors of mean infarction frame counting (TFC). In multivariate analysis, MPV {odds ratio (OR)=32.393, 95% confidence interval (CI)=1.189-882.606, p=0.0391 and P-LCR (OR=0.566, 950/s CI=0.330-0.937, p=0.028) were independent predictors of SCF.
   Conclusion: Platelet volume indices MPV, PDW, and P-LCR were associated with both the presence and extent of SCF.
C1 [Seyyed-Mohammadzad, Mir Hossein; Khademvatani, Kamal; Kerachian, Abdollah] Urmia Univ Med Sci, Dept Cardiol, Seyyed al Shohada Heart Ctr, Orumiyeh, Iran.
   [Eskandari, Ramin] Iran Univ Med Sci, Firoozgar Hosp, Dept Cardiol, Tehran, Iran.
   [Rezaei, Yousef] Urmia Univ Med Sci, Seyyed al Shohada Heart Ctr, Orumiyeh, Iran.
RP Khademvatani, K (corresponding author), Urmia Univ Med Sci, Dept Cardiol, Seyyed al Shohada Heart Ctr, Orumiyeh, Iran.
EM khademvatan2002@yahoo.com
RI kerachian, abdollah/W-6006-2019; Khademvatani, Kamal/S-9239-2017;
   Seyed-Mohammadzad, MirHossein/V-7699-2017
OI kerachian, abdollah/0000-0002-7263-4315; Khademvatani,
   Kamal/0000-0003-3927-2954; Rezaei, Yousef/0000-0002-6804-4232
CR Albayrak S, 2009, INT HEART J, V50, P545, DOI 10.1536/ihj.50.545
   Cakmak M, 2008, CARDIOLOGY, V110, P39, DOI 10.1159/000109405
   Celik T, 2010, J THROMB THROMBOLYS, V29, P310, DOI 10.1007/s11239-009-0353-z
   Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x
   Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014
   Elsherbiny IA, 2012, J CARDIOL, V59, P176, DOI 10.1016/j.jjcc.2011.11.009
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Goel PK, 2001, ANGIOLOGY, V52, P507, DOI 10.1177/000331970105200801
   Gokce M, 2005, CLIN CARDIOL, V28, P145, DOI 10.1002/clc.4960280310
   Grotto HZW, 2004, CLIN LAB HAEMATOL, V26, P347, DOI 10.1111/j.1365-2257.2004.00634.x
   Isik T, 2012, CARDIOL J, V19, P355, DOI 10.5603/CJ.2012.0065
   Li JJ, 2007, CLIN CHIM ACTA, V385, P43, DOI 10.1016/j.cca.2007.05.024
   MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964
   Nurkalem Z, 2008, TURK KARDIYOL DERN A, V36, P363
   Sen N, 2009, PLATELETS, V20, P23, DOI 10.1080/09537100802458969
   Seyyed-Mohammadzad MH, 2015, ANATOL J CARDIOL, V15, P25, DOI 10.5152/akd.2014.5169
   TAMBE AA, 1972, AM HEART J, V84, P66, DOI 10.1016/0002-8703(72)90307-9
   Turhan H, 2006, INT J CARDIOL, V108, P224, DOI 10.1016/j.ijcard.2005.05.008
   Vagdatli E, 2010, HIPPOKRATIA, V14, P28
   van der Loo B, 1999, ARTERIOSCL THROM VAS, V19, P672, DOI 10.1161/01.ATV.19.3.672
NR 20
TC 4
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 400
EP 405
DI 10.4070/kcj.2014.44.6.400
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400004
PM 25469142
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, SP
   Park, YN
   Lee, CN
   Park, JW
   Bae, KR
   Jun, SV
   Lee, YS
   Lee, JB
   Ryu, JK
   Choi, JY
   Chang, SG
   Kim, KS
AF Hong, Seung Pyo
   Park, Yon Noong
   Lee, Chan Nook
   Park, Joung Won
   Bae, Kyung Ryun
   Jun, Seung Vvoon
   Lee, Young Soo
   Lee, Jin Bae
   Ryu, Jae Kean
   Choi, Ji Yong
   Chang, Sung Guk
   Kim, Kee Sik
TI Usefulness of the Doppler Flow of the Ophthalmic Artery in the
   Evaluation of Carotid and Coronary Atherosclerosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Carotid arteries; Coronary vessels; Ophthalmic artery;
   Ultrasound
ID INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; RISK; REPRODUCIBILITY;
   PREVENTION; PREDICTION; EXPERIENCE; REDUCTION; STATEMENT; SEVERITY
AB Background and Objectives: There is little information about the relationship between the Doppler flow of the ophthalmic artery (OA) and carotid and coronary atherosclerosis. The aim of the investigation was to assess the clinical usefulness of the Doppler flow of the OA to estimate the severity of carotid and coronary atherosclerosis.
   \Subjects and Methods: The study was a retrospective analysis of the findings in 140 patients (mean age: 60 years, male: 64%) who underwent coronary angiography (CA) for the evaluation of typical angina between July 2010 and October 2011 in our single center. The severity of coronary artery stenosis was based on the Gensini score (GS). Significant coronary artery disease (CAD) was defined as the obstruction of over 750/s of the major coronary arteries confirmed with CA. The pulsed Doppler flow of the OA and carotid ultrasound were performed before CA.
   Results: The mean systolic velocity/mean diastolic velocity (MSV/MDV), pulsatile index and resistance index in the Doppler flow of the OA were identified as significant and independent correlations with carotid intima-media thickness, and MSV/MDV was identified to have a significant and independent correlation with the GS. MSV/MDV >2.1 was the independent predictor for significant CAD {odds ratio (OR) 3.8, 95% confidence interval (CI) 1.5-9.7, p=0.005} and carotid plaque (OR 2.8, 95% CI 1.1-7.0, p=0.028), after adjustment for CAD-associated factors.
   Conclusion: The Doppler flow of the OA might be a useful predictor of the severity of carotid and coronary atherosclerosis.
C1 [Hong, Seung Pyo; Park, Yon Noong; Lee, Chan Nook; Park, Joung Won; Bae, Kyung Ryun; Jun, Seung Vvoon; Lee, Young Soo; Lee, Jin Bae; Ryu, Jae Kean; Choi, Ji Yong; Chang, Sung Guk; Kim, Kee Sik] Daegu Catholic Univ, Med Ctr, Dept Cardiol, 33 Duryugongwon Ro 17 Gil, Taegu 718800, South Korea.
RP Kim, KS (corresponding author), Daegu Catholic Univ, Med Ctr, Dept Cardiol, 33 Duryugongwon Ro 17 Gil, Taegu 718800, South Korea.
EM kks7379@cu.ac.kr
CR Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI 10.2337/dc13-S067
   Burger-Kentischer A, 2006, ATHEROSCLEROSIS, V184, P28, DOI 10.1016/j.atherosclerosis.2005.03.028
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688
   Fukuda M, 1999, FOLIA OPHTHALMOL JPN, V50, P218
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   GILLUM RF, 1991, AM HEART J, V122, P262, DOI 10.1016/0002-8703(91)90796-K
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   HU HH, 1993, STROKE, V24, P1196, DOI 10.1161/01.STR.24.8.1196
   LIEB WE, 1991, ARCH OPHTHALMOL-CHIC, V109, P527, DOI 10.1001/archopht.1991.01080040095036
   Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875
   Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32
   Maruyoshi H, 2010, CIRC J, V74, P1251, DOI 10.1253/circj.CJ-09-0866
   Matthiessen ET, 2004, EYE, V18, P400, DOI 10.1038/sj.eye.6700651
   Metz CE, 1998, STAT MED, V17, P1033, DOI 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z
   MICHELSON EL, 1979, ARCH INTERN MED, V139, P1139, DOI 10.1001/archinte.139.10.1139
   Nemeth J, 2002, J CLIN ULTRASOUND, V30, P332, DOI 10.1002/jcu.10079
   Paivansalo M, 2004, ACTA RADIOL, V45, P404, DOI 10.1080/02841850410005246
   Paivansalo M, 1999, ACTA RADIOL, V40, P270
   Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75
   RALPH RA, 1974, ANN OPHTHALMOL, V6, P323
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011
   Tedeschi-Reiner E, 2005, AM J CARDIOL, V96, P1107, DOI 10.1016/j.amjcard.2005.05.070
   Tranquart F, 2003, J CLIN ULTRASOUND, V31, P258, DOI 10.1002/jcu.10169
   Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X
   Yatsuka YI, 1996, JPN J OPHTHALMOL, V40, P103
   Zielinski T, 2007, AM J HYPERTENS, V20, P1058, DOI 10.1016/j.amjhyper.2007.05.011
NR 30
TC 4
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 406
EP 414
DI 10.4070/kcj.2014.44.6.406
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400005
PM 25469143
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SM
   Lee, JB
   Go, YB
   Song, HY
   Lee, BJ
   Kwak, JH
AF Lee, Sang Min
   Lee, Jeong Bong
   Go, Young Bin
   Song, Ho Young
   Lee, Byung Jin
   Kwak, Ji Hee
TI Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy
   in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Immunoglobulins; intravenous; Risk factors
ID AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY LESIONS; RISK-FACTORS;
   CLINICAL-FEATURES; NATIONWIDE SURVEY; DIAGNOSIS; INFECTION; CHILDREN;
   JAPAN
AB Background and Objectives: Ten to twenty percent of children with Kawasaki disease (KD) do not respond to initial intravenous immunoglobulin (IVIG) treatment. If untreated, approximately 15% to 25% of KD patients have complications. The aim of this study was to find useful predictors of responsiveness to initial IVIG treatment in KD.
   Subjects and Methods: We retrospectively reviewed medical records of 91 children diagnosed with KD at Myong Ji Hospital from March 2012 to April 2014. Before and after (24 hours to 36 hours) IVIG treatment, the following laboratory data were obtained: hemoglobin (Fib) level, white blood cell count, proportion of neutrophil, lymphocyte and eosinophil, platelet count, erythrocyte sedimentation rate (ERS), C-reactive protein (CRP), creatine kinase (CK), creatine kinase MB (CK-MB), and N-terminal pro-brain natriuretic peptide (NT-proBNP). Subjects were then divided into two groups: IVIG-responsive or IVIG-resistant.
   Results: Of 91 patients, 11 (12%) required retreatment. By univariate analysis, before-IVIG laboratory parameters of white blood cell count, % neutrophil, ERS, CRP, sodium, CK, CK-MB, and NT-proBNP were significantly different between IVIG-responsive and IVIG-resistant patient groups. In the after-IVIG laboratory parameters, Hb level, white blood cell count, % neutrophil, % lymphocyte, CRP, CK, CK-MB, and NT-proBNP were significantly different between the two groups. While the mean-differences were not statistically significant, fractional change (FC)-CRP and FC-% neutrophil showed significant difference. By multivariate analysis, FC-CRP was confirmed to be an independent predictor for initial IVIG resistance.
   Conclusion: Fractional change-C-reactive protein might be a useful and important value for predicting initial IVIG resistance in KD patients.
C1 [Lee, Sang Min; Lee, Jeong Bong; Go, Young Bin; Song, Ho Young; Lee, Byung Jin; Kwak, Ji Hee] Myongji Hosp, Dept Pediat, Goyang 412270, South Korea.
RP Kwak, JH (corresponding author), Myongji Hosp, Dept Pediat, 55 Hwasu Ro 14Beon Gil, Goyang 412270, South Korea.
EM hihikwak@hanmail.net
CR Anderson MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1824
   Ashouri N, 2008, J PEDIATR-US, V153, P365, DOI 10.1016/j.jpeds.2008.03.014
   Barone SR, 2000, ARCH PEDIAT ADOL MED, V154, P453, DOI 10.1001/archpedi.154.5.453
   Belay ED, 2006, PEDIATR INFECT DIS J, V25, P245, DOI 10.1097/01.inf.0000202068.30956.16
   Brogan PA, 2002, ARCH DIS CHILD, V86, P286, DOI 10.1136/adc.86.4.286
   Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2
   Davis GK, 2006, CLIN BIOCHEM, V39, P600, DOI 10.1016/j.clinbiochem.2005.12.004
   Do Young-Sun, 2010, Korean Circ J, V40, P239, DOI 10.4070/kcj.2010.40.5.239
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   FUKUSHIGE J, 1994, ACTA PAEDIATR, V83, P1057, DOI 10.1111/j.1651-2227.1994.tb12985.x
   Hwang JY, 2011, ARCH DIS CHILD, V96, P1088, DOI 10.1136/adc.2010.184101
   Japan Kawasaki Disease Research Committee, 1984, REP SUBC STAND DIAGN
   Kim HK, 2011, KOREAN CIRC J, V41, P379, DOI 10.4070/kcj.2011.41.7.379
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Maconochie IK, 2004, ARCH DIS CHILD-FETAL, V89, pEP3, DOI 10.1136/adc.2004.053728
   Manlhiot C, 2012, EUR J PEDIATR, V171, P657, DOI 10.1007/s00431-011-1631-2
   Minich LL, 2007, PEDIATRICS, V120, pE1434, DOI 10.1542/peds.2007-0815
   Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890
   Nakamura Y, 2008, J EPIDEMIOL, V18, P167, DOI 10.2188/jea.JE2008001
   Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182
   Newton PJ, 2009, AUST CRIT CARE, V22, P117, DOI 10.1016/j.aucc.2009.06.001
   Oates-Whitehead R. M., 2003, COCHRANE DATABASE SY
   Perrin L, 2009, JOINT BONE SPINE, V76, P481, DOI 10.1016/j.jbspin.2008.11.015
   RELLER M, 1984, PEDIATR CARDIOL, V5, P205, DOI 10.1007/BF02427046
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Sonobe T, 2007, PEDIATR INT, V49, P421, DOI 10.1111/j.1442-200X.2007.02396.x
   Sudo D, 2012, EUR J PEDIATR, V171, P651, DOI 10.1007/s00431-011-1630-3
   Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021
   Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10
   Young JHM, 2013, HONG KONG J PAEDIATR, V18, P204
NR 30
TC 13
Z9 18
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 415
EP 422
DI 10.4070/kcj.2014.44.6.415
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400006
PM 25469144
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Jang, YH
   Lee, MY
   Hwang, J
   Lee, SH
   Chon, MK
   Hwang, SA
   Kim, JS
   Park, YH
   Chun, KJ
   Kim, JH
AF Lee, Soo Yong
   Jang, Young Ho
   Lee, Mi Young
   Hwang, Jongmin
   Lee, Sang Hyun
   Chon, Min Ku
   Hwang, Sun Ae
   Kim, Jeong Su
   Park, Yong Hyun
   Chun, Kook Jin
   Kim, June Hong
TI The Effect of Radiographic Contrast Media on Reperfusion Injury in the
   Isolated Rat Heart
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contrast media; Heart; Myocardial infarction; Myocardial reperfusion
ID ELEVATION MYOCARDIAL-INFARCTION; OSMOLAR; METAANALYSIS; IODIXANOL;
   VISCOSITY; STRESS; SIZE
AB Background and Objectives: We investigated the effects of commonly used contrast media (CM) on myocardial ischemia-reperfusion injury in isolated rat hearts.
   Subjects and Methods: Isolated rat hearts were subjected to 30 minutes of regional ischemia and 2 hours of reperfusion. The following CM (1 mL/1 L Krebs-Henseleit buffer) were randomly perfused for 15 minutes beginning 5 minutes before reperfusion and ending 10 minutes after reperfusion: iohexol (n=8), iopromide (n=8), ioversol (n=8), iomeprol (n=8), iopamidol (n=7), ioxaglate (n=8), and iodixanol (n=7). The effects of a direct bolus injection of undiluted iohexol, iopromide, or ioxaglate (each n=6) via the aortic root immediately prior to reperfusion were also evaluated. The area of necrosis, expressed as the percentage of the area at risk (AN/AR), and cardiodynamic variables were measured.
   Results: The AN/AR of the control and experimental groups in the order described in methods was 33.7 +/- 6.4%, 30.3 +/- 7.4%, 34.7 +/- 12.6%, 29.2 +/- 10.2%, 20.9 +/- 7.6%, 22.6 +/- 8.7%, 18.8 +/- 7.9%, and 19.9 +/- 11.4%, respectively. Groups that received iomeprol and ioxaglate exhibited significantly decreased AN/AR values compared to those of control hearts (p=0.042 and p=0.013). No significant differences in the AN/AR were observed between control hearts and the groups injected with a single bolus of CM. No significant hemodynamic changes were noted after reperfusion among the groups.
   Conclusion: The overall effects of the CM on coronary reperfusion were not deleterious, and better effects were noted in two CM groups. However, it is unclear whether this result was attributed to a specific physiochemical property of the CM.
C1 [Lee, Soo Yong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 626770, South Korea.
   [Jang, Young Ho] Yoonsung Hosp, Inst Canc Rehabil & Convalescence, Cheongdo, South Korea.
   [Lee, Mi Young] Keimyung Univ, Sch Med, Dept Prevent Med, Taegu, South Korea.
   [Hwang, Jongmin; Lee, Sang Hyun; Chon, Min Ku; Kim, Jeong Su; Park, Yong Hyun; Chun, Kook Jin; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Internal Med,Div Cardiol, Yangsan 626770, South Korea.
   [Hwang, Jongmin; Lee, Sang Hyun; Chon, Min Ku; Kim, Jeong Su; Park, Yong Hyun; Chun, Kook Jin; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Sch Med, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, South Korea.
   [Hwang, Sun Ae] Pusan Natl Univ, Yangsan Hosp, Cardiovasc Res Lab, Yangsan, South Korea.
RP Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Internal Med, 20 Geumo Ro, Yangsan 626770, South Korea.
EM junehongk@gmail.com
FU Pusan National University Research GrantPusan National University
FX This study was supported by a Pusan National University Research Grant
   2014.
CR Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833
   Cecchi E, 2009, INT J CARDIOL, V134, P189, DOI 10.1016/j.ijcard.2008.01.039
   Falck G, 1999, PHYSIOL RES, V48, P331
   Falck G, 2000, CARDIOVASC INTER RAD, V23, P466, DOI 10.1007/s002700010106
   From AM, 2010, CIRC-CARDIOVASC INTE, V3, P351, DOI 10.1161/CIRCINTERVENTIONS.109.917070
   Gonzalez-Castillo C, 2003, AM J PHYSIOL-HEART C, V284, pH1348, DOI 10.1152/ajpheart.00323.2002
   Heinrich MC, 2009, RADIOLOGY, V250, P68, DOI 10.1148/radiol.2501080833
   Heinrich MC, 2005, RADIOLOGY, V235, P843, DOI 10.1148/radiol.2353040726
   Oriyanhan W, 2005, HEART VESSELS, V20, P278, DOI 10.1007/s00380-005-0841-9
   Pastukh V, 2005, MOL CELL BIOCHEM, V269, P59, DOI 10.1007/s11010-005-2536-z
   Piper HM, 1999, ANN THORAC SURG, V68, P1913, DOI 10.1016/S0003-4975(99)01025-5
   Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002
   Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197
   Schmid I, 2007, INT J CARDIOL, V118, P389, DOI 10.1016/j.ijcard.2006.12.011
   SCHMIEDEL E, 1994, EUR J RADIOL, V18, pS104, DOI 10.1016/0720-048X(94)90103-1
   Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494
   Seeliger E, 2010, RADIOLOGY, V256, P406, DOI 10.1148/radiol.10091485
   Sendeski MM, 2011, CLIN EXP PHARMACOL P, V38, P292, DOI 10.1111/j.1440-1681.2011.05503.x
   Wasilewski J, 2007, KARDIOL POL, V65, P778
   Wessely R, 2009, CIRC-CARDIOVASC INTE, V2, P430, DOI 10.1161/CIRCINTERVENTIONS.109.874933
   Yalcin O, 2008, AM J PHYSIOL-HEART C, V294, pH2098, DOI 10.1152/ajpheart.00015.2008
NR 21
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 423
EP 428
DI 10.4070/kcj.2014.44.6.423
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400007
PM 25469145
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, TH
   Oh, YS
   Eom, MY
   Jung, YL
   Cho, HA
   Choi, W
   Shim, WH
AF Kim, Tae-Hoon
   Oh, Young-Soo
   Eom, Moon-Yong
   Jung, Young-Lee
   Cho, Hyun-A
   Choi, Woong
   Shim, Won-Heum
TI Acute ST Elevated Myocardial Injury due to Coronary Thrombosis during
   Thoracic Endovascular Aortic Repair in Patient with Protein S Deficiency
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Protein S deficiency; Endovascular procedures; Coronary thrombosis;
   Aortic aneurysm; thoracic
ID YOUNG-ADULTS; OPEN SURGERY; DISEASE; ARTERY
AB A 71-year-old woman who had suffered from pulmonary thromboembolism with deep vein thrombosis for 12 years presented the hospital with a huge thoracic aortic aneurysm. During thoracic endovascular therapy, she had a sudden coronary artery occlusion without having organized stenosis or plaque rupture even under the dual antiplatelet treatment and heparinization. She turned out to be having a protein S deficiency. A procedure related thrombotic adverse event in patient with protein S deficiency is very rare, so we report a case with literature review.
C1 [Kim, Tae-Hoon; Oh, Young-Soo; Eom, Moon-Yong; Jung, Young-Lee; Cho, Hyun-A; Choi, Woong; Shim, Won-Heum] Sejong Gen Hosp, Div Cardiol, Dept Internal Med, Puchon 422711, South Korea.
RP Shim, WH (corresponding author), Sejong Gen Hosp, Div Cardiol, 28 Hohyeon Ro 489Beon Gil, Puchon 422711, South Korea.
EM whshim@yuhs.ac
RI Kim, Tae-Hoon/AAG-3292-2021
OI Kim, Tae-Hoon/0000-0002-4032-1285
CR ALLAART CF, 1990, THROMB HAEMOSTASIS, V64, P206
   Beattie S, 1997, HEART LUNG, V26, P76, DOI 10.1016/S0147-9563(97)90012-1
   Bub GL, 2011, J VASC SURG, V53, P21, DOI 10.1016/j.jvs.2010.07.053
   CARRIE D, 1993, ARCH MAL COEUR VAISS, V86, P921
   Desai ND, 2012, J THORAC CARDIOV SUR, V144, P604, DOI 10.1016/j.jtcvs.2012.05.049
   Douay X, 1998, ACTA NEUROL SCAND, V98, P124
   ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677
   Lee WA, 2007, J VASC SURG, V45, P1095, DOI 10.1016/j.jvs.2007.01.050
   Manzar KJ, 1997, AM J MED SCI, V314, P342, DOI 10.1097/00000441-199711000-00013
   Mateo J, 1997, THROMB HAEMOSTASIS, V77, P444
   Munts AG, 1998, J NEUROL, V245, P21
   SCHWARZ HP, 1984, BLOOD, V64, P1297
   Sukhija R, 2004, AM J CARDIOL, V94, P1358, DOI 10.1016/j.amjcard.2004.07.136
   Walsh SR, 2008, J VASC SURG, V47, P1094, DOI 10.1016/j.jvs.2007.09.062
   Wang GJ, 2009, J VASC SURG, V49, P42, DOI 10.1016/j.jvs.2008.07.070
NR 15
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 429
EP 433
DI 10.4070/kcj.2014.44.6.429
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400008
PM 25469146
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, SJ
   Kim, SM
   Won, JH
   Lim, HS
AF Park, Se-Jun
   Kim, Sun-Mi
   Won, Je-Hwan
   Lim, Hong-Seok
TI A Case of Secondary Hypertension Associated with the Nutcracker
   Phenomenon
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Renal nutcracker phenomenon; Hypertension
ID HEMATURIA; DIAGNOSIS; PRESSURE
AB A 25-year-old Korean woman was referred for uncontrolled hypertension. Laboratory examination revealed increased plasma renin activity and microscopic hematuria. Computed tomography demonstrated compression of the left renal vein (LRV) between the aorta and superior mesenteric artery; however, both renal arteries were intact and there was no adrenal mass. Renal vein catheterization showed external compression with a pressure gradient of up to 8 mm Hg between the LRV and the inferior vena cava. Plasma renin activity in the LRV was almost five times higher than that in the right renal vein. In this patient, renin-dependent hypertension was caused by renal congestion due to LRV obstruction.
C1 [Park, Se-Jun; Kim, Sun-Mi; Lim, Hong-Seok] Ajou Univ, Sch Med, Dept Cardiol, Suwon 441749, South Korea.
   [Won, Je-Hwan] Ajou Univ, Sch Med, Dept Radiol, Suwon 441749, South Korea.
RP Lim, HS (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 Worldcup Ro, Suwon 441749, South Korea.
EM hslimmd@gmail.com
OI Park, Se-Jun/0000-0002-3408-6776
CR Ahmed K, 2006, EUR J VASC ENDOVASC, V31, P410, DOI 10.1016/j.ejvs.2005.05.045
   ARMANINI D, 1982, BRIT J UROL, V54, P348, DOI 10.1111/j.1464-410X.1982.tb08940.x
   BURNETT JC, 1980, AM J PHYSIOL, V238, pF279
   CHAIT A, 1971, AMER J ROENTGENOL RA, V111, P729, DOI 10.2214/ajr.111.4.729
   Chen SW, 2011, J UROLOGY, V186, P570, DOI 10.1016/j.juro.2011.03.135
   Doty JM, 1999, J TRAUMA, V47, P1000, DOI 10.1097/00005373-199912000-00002
   EL-SADR A R, 1950, Urol Cutaneous Rev, V54, P257
   HOHENFELLNER M, 1991, J UROLOGY, V146, P685, DOI 10.1016/S0022-5347(17)37893-X
   Hosotani Y, 2003, AM J MED, V114, P617, DOI 10.1016/S0002-9343(03)00091-3
   Neste MG, 1996, J VASC INTERV RADIOL, V7, P859, DOI 10.1016/S1051-0443(96)70861-8
   SHAPER KRL, 1994, BRIT J UROL, V74, P144, DOI 10.1111/j.1464-410X.1994.tb16575.x
   Textor SC, 2010, AM J HYPERTENS, V23, P1159, DOI 10.1038/ajh.2010.174
   Venkatachalam S, 2011, ANN VASC SURG, V25, P1154, DOI 10.1016/j.avsg.2011.01.002
   WENDEL RG, 1980, J UROLOGY, V123, P761, DOI 10.1016/S0022-5347(17)56121-2
NR 14
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 434
EP 436
DI 10.4070/kcj.2014.44.6.434
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400009
PM 25469147
OA Green Published
DA 2021-04-22
ER

PT J
AU Yamazoe, M
   Mizuno, A
   Suyama, Y
   Nishi, Y
   Suzuki, K
   Niwa, K
   Okada, M
AF Yamazoe, Masahiro
   Mizuno, Atsushi
   Suyama, Yasuhiro
   Nishi, Yutaro
   Suzuki, Koyu
   Niwa, Koichiro
   Okada, Masato
TI Endomyocardial Biopsy and Magnetic Resonance Imaging of Acute
   Myocarditis with Adult-Onset Still's Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocarditis; Still disease; adult-onset; Magnetic resonance imaging;
   Heart failure
ID ETANERCEPT
AB A 36-year-old female with a high-grade fever and epigastric abdominal pain was prescribed antibiotics, but developed hypoxia and dyspnea. An echocardiography revealed diffuse hypokinesis and massive pericardial effusion, after which diagnostic cardiac catheterization and an endomyocardial biopsy (EMB) were peformed to reveal fibrosis and infiltration of inflammation cells composed primarily of neutrophils. Clinical manifestation of a spiking fever, leukocytosis, elevated ferritin levels, skin rash and EMB findings led to a diagnosis of adultonset Still's disease (AOSD) with acute myocarditis. Pulse therapy of intravenous methylprednisolone was performed for three days, followed by a daily dose of prednisone (60 mg). After a course of steroid therapy for fever and pericardial effusion, and conducting a left ventricular ejection fraction, the patient showed improvement and was discharged asymptomatic within 32 days of admission. This study is the first to report on a case of myocarditis in AOSD diagnosed by neutrophil infiltration in the myocardium.
C1 [Yamazoe, Masahiro; Mizuno, Atsushi; Nishi, Yutaro; Niwa, Koichiro] St Lukes Int Hosp, Div Cardiol, Tokyo 1048560, Japan.
   [Suyama, Yasuhiro; Okada, Masato] St Lukes Int Hosp, Immuno Rheumatol Ctr, Tokyo 1048560, Japan.
   [Suzuki, Koyu] St Lukes Int Hosp, Div Pathol, Tokyo 1048560, Japan.
RP Yamazoe, M (corresponding author), St Lukes Int Hosp, Div Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
EM masahiro.yamazoe@gmail.com
RI Suyama, Yasuhiro/J-8298-2019
OI Suyama, Yasuhiro/0000-0002-9298-9121
CR BANK I, 1985, ARTHRITIS RHEUM, V28, P452, DOI 10.1002/art.1780280415
   Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908
   Geluk CA, 2002, NETH J MED, V60, P223
   Jadhav P, 2009, INT J RHEUM DIS, V12, P272, DOI 10.1111/j.1756-185X.2009.01423.x
   Kuek A, 2007, RHEUMATOLOGY, V46, P1043, DOI 10.1093/rheumatology/kem066
   Raffeiner B, 2011, JOINT BONE SPINE, V78, P100, DOI 10.1016/j.jbspin.2010.09.014
   Shauer A, 2013, ISR MED ASSOC J, V15, P180
   YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424
   Yang DH, 2008, RHEUMATOL INT, V29, P95, DOI 10.1007/s00296-008-0619-3
NR 9
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 437
EP 440
DI 10.4070/kcj.2014.44.6.437
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400010
PM 25469148
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, YE
   Hong, YJ
   Kim, HK
   Kim, JA
   Na, JO
   Yang, DH
   Kim, YJ
   Choi, EY
AF Yoon, Yeonyee E.
   Hong, Yoo Jin
   Kim, Hyung-Kwan
   Kim, Jeong A.
   Na, Jin Oh
   Yang, Dong Hyun
   Kim, Young Jin
   Choi, Eui-Young
TI 2014 Korean Guidelines for Appropriate Utilization of Cardiovascular
   Magnetic Resonance Imaging: A Joint Report of the Korean Society of
   Cardiology and the Korean Society of Radiology
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Guideline; Appropriateness criteria; Magnetic resonance imaging; Heart;
   Evidence-based medicine
ID CORONARY-ARTERY-DISEASE; LATE GADOLINIUM-ENHANCEMENT;
   EMISSION-COMPUTED-TOMOGRAPHY; RIGHT-VENTRICULAR FUNCTION; PULMONARY
   VALVE-REPLACEMENT; ACUTE MYOCARDIAL-INFARCTION; WALL-MOTION
   ABNORMALITIES; CONGENITAL HEART-DISEASE; FRACTIONAL FLOW RESERVE; AORTIC
   ELASTIC PROPERTIES
AB Cardiac magnetic resonance (CMR) imaging is now widely used in several fields of cardiovascular disease assessment due to recent technical developments. CMR can give physicians information that cannot be found with other imaging modalities. However, there is no guideline which is suitable for Korean people for the use of CMR. Therefore, we have prepared a Korean guideline for the appropriate utilization of CMR to guide Korean physicians, imaging specialists, medical associates and patients to improve the overall medical system performances. By addressing CMR usage and creating these guidelines we hope to contribute towards the promotion of public health. This guideline is a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.
C1 [Yoon, Yeonyee E.] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Cardiol, Songnam, South Korea.
   [Hong, Yoo Jin; Kim, Young Jin] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul 120752, South Korea.
   [Kim, Hyung-Kwan] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Cardiovasc Ctr,Dept Internal Med,Div Cardiol, Seoul, South Korea.
   [Kim, Jeong A.] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Radiol, Goyang, South Korea.
   [Na, Jin Oh] Korea Univ, Coll Med, Korea Univ Guro Hosp, Cardiovasc Ctr, Seoul 136705, South Korea.
   [Yang, Dong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.
   [Choi, Eui-Young] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol, Seoul 120752, South Korea.
RP Kim, YJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM dryj@yuhs.ac; choi0928@yuhs.ac
FU Guideline Development Fund of the Korean Society of Cardiology; Korean
   Society of Radiology; Korean Society of Cardiovascular Imaging
FX This work was supported by the Guideline Development Fund of the Korean
   Society of Cardiology, the Korean Society of Radiology, and Korean
   Society of Cardiovascular Imaging.
CR Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071
   Alfakih K, 2004, EUR RADIOL, V14, P1813, DOI 10.1007/s00330-004-2387-0
   American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021
   Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7
   Assomull RG, 2011, CIRCULATION, V124, P1351, DOI 10.1161/CIRCULATIONAHA.110.011346
   Axel L, 2004, J MAGN RESON IMAGING, V19, P816, DOI 10.1002/jmri.20076
   Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727
   BARNER HB, 1985, J THORAC CARDIOV SUR, V90, P668
   Baumgartner D, 2005, J THORAC CARDIOV SUR, V129, P730, DOI 10.1016/j.jtcvs.2004.07.019
   Beanlands RSB, 2007, CAN J CARDIOL, V23, P107, DOI 10.1016/S0828-282X(07)70730-4
   Beerbaum P, 2003, CIRCULATION, V108, P1355, DOI 10.1161/01.CIR.0000087603.97036.C2
   Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P271, DOI 10.3109/10976640009148691
   Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011
   Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014
   Bogaert J, 2000, EUR RADIOL, V10, P1847, DOI 10.1007/s003300000611
   Botnar R, 2000, MAGN RESON MATER PHY, V10, P18
   Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807
   Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007
   BRYAN AJ, 1994, CURR OPIN CARDIOL, V9, P641, DOI 10.1097/00001573-199411000-00002
   Bunce NH, 2003, RADIOLOGY, V227, P201, DOI 10.1148/radiol.2271020316
   CAMERON AAC, 1995, J AM COLL CARDIOL, V26, P895, DOI 10.1016/0735-1097(95)00280-4
   Capomolla S, 2000, AM HEART J, V139, P596, DOI 10.1016/S0002-8703(00)90036-X
   Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1
   Casolo G, 2005, INT J CARDIOL, V103, P317, DOI 10.1016/j.ijcard.2004.09.007
   Cawley PJ, 2013, CIRC-CARDIOVASC IMAG, V6, P48, DOI 10.1161/CIRCIMAGING.112.975623
   Cawley PJ, 2009, CIRCULATION, V119, P468, DOI 10.1161/CIRCULATIONAHA.107.742486
   CHEITLIN MD, 1974, CIRCULATION, V50, P780, DOI 10.1161/01.CIR.50.4.780
   Chessa M, 2005, EUR HEART J, V26, P2728, DOI 10.1093/eurheartj/ehi491
   Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798
   Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5
   Clemente A, 2010, CLIN IMAG, V34, P337, DOI 10.1016/j.clinimag.2009.08.030
   Costa MA, 2007, J AM COLL CARDIOL, V50, P514, DOI 10.1016/j.jacc.2007.04.053
   Crean A, 2009, CLIN MED INSIGHTS-CA, V3, P69
   Cury RC, 2008, CIRCULATION, V118, P837, DOI 10.1161/CIRCULATIONAHA.107.740597
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   De Cobelli F, 1998, Radiol Med, V95, P54
   De Cobelli Francesco, 1999, Rays (Rome), V24, P140
   Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345
   Dickfeld T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P172, DOI 10.1161/CIRCEP.110.958744
   DIDIER D, 1986, AM J CARDIOL, V57, P1363, DOI 10.1016/0002-9149(86)90219-5
   Djavidani B, 2005, J AM COLL CARDIOL, V45, P2048, DOI 10.1016/j.jacc.2005.03.036
   Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94
   DUERINCKX AJ, 1995, AM J ROENTGENOL, V165, P662, DOI 10.2214/ajr.165.3.7645491
   Duerinckx AJ, 1998, JMRI-J MAGN RESON IM, V8, P896, DOI 10.1002/jmri.1880080420
   Durongpisitkul Kritvikrom, 2002, Journal of the Medical Association of Thailand, V85, pS658
   Eitel I, 2011, HEART, V97, P2038, DOI 10.1136/heartjnl-2011-300098
   Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049
   Fallah-Rad N, 2011, J AM COLL CARDIOL, V57, P2263, DOI 10.1016/j.jacc.2010.11.063
   Fathala A, 2011, ANN CARD ANAESTH, V14, P134, DOI 10.4103/0971-9784.81570
   Fattori R, 2000, J CARDIOV MAGN RESON, V2, P251, DOI 10.3109/10976640009148688
   Ferket BS, 2011, J AM COLL CARDIOL, V57, P1591, DOI 10.1016/j.jacc.2010.10.055
   Fieno DS, 2006, J CARDIOVASC MAGN R, V8, P839, DOI 10.1080/10976640600777975
   Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700
   Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001
   Fleisher Lee A, 2009, Cleve Clin J Med, V76 Suppl 4, pS9, DOI 10.3949/ccjm.76.s4.02
   Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015
   Fluechter S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-30
   Fogel MA, 1996, J AM COLL CARDIOL, V28, P212, DOI 10.1016/0735-1097(96)00111-8
   Follath F, 1998, J AM COLL CARDIOL, V32, P1167, DOI 10.1016/S0735-1097(98)00400-8
   Fonseca C, 2006, HEART FAIL REV, V11, P95, DOI 10.1007/s10741-006-9481-0
   Francone M, 2006, EUR RADIOL, V16, P944, DOI 10.1007/s00330-005-0009-0
   Freeman WK, 2009, MAYO CLIN PROC, V84, P79, DOI 10.1016/S0025-6196(11)60812-4
   Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802
   Galjee MA, 1996, CIRCULATION, V93, P660
   Gao P, 2012, CIRC-CARDIOVASC IMAG, V5, P448, DOI 10.1161/CIRCIMAGING.111.971549
   Garg R, 2005, AM J CARDIOL, V95, P688, DOI 10.1016/j.amjcard.2004.10.053
   Gargiulo P, 2013, CIRC-CARDIOVASC IMAG, V6, P574, DOI 10.1161/CIRCIMAGING.113.000035
   Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036
   Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230
   Geva T, 2002, CIRCULATION, V106, P473, DOI 10.1161/01.CIR.0000023624.33478.18
   GEVA T, 1994, CIRCULATION, V90, P348, DOI 10.1161/01.CIR.90.1.348
   Gharib AM, 2008, RADIOLOGY, V247, P220, DOI 10.1148/radiol.2471070274
   Giang TH, 2004, EUR HEART J, V25, P1657, DOI 10.1016/j.ehj.2004.06.037
   Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021
   Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4
   Greil GF, 2007, PEDIATR RADIOL, V37, P666, DOI 10.1007/s00247-007-0498-x
   Greil GF, 2002, CIRCULATION, V105, P908, DOI 10.1161/hc0802.105563
   Groothuis JGJ, 2013, EUR HEART J, V34, P1990, DOI 10.1093/eurheartj/eht077
   Grosse-Wortmann L, 2009, CIRC-CARDIOVASC IMAG, V2, P219, DOI 10.1161/CIRCIMAGING.108.834192
   Grothoff M, 2008, PEDIATR RADIOL, V38, P186, DOI 10.1007/s00247-007-0691-y
   Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0
   Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005
   Gulati G, 2004, CARDIOVASC INTER RAD, V27, P459, DOI 10.1007/s00270-004-0123-4
   Haghi D, 2007, INT J CARDIOL, V120, P205, DOI 10.1016/j.ijcard.2006.09.019
   Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007
   Hamilton-Craig C, 2012, INT J CARDIOVAS IMAG, V28, P1111, DOI 10.1007/s10554-011-9926-y
   Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29
   Hassan W, 2007, CATHETER CARDIO INTE, V70, P881, DOI 10.1002/ccd.21287
   Heijenbrok-Kal MH, 2007, AM HEART J, V154, P415, DOI 10.1016/j.ahj.2007.04.061
   Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003
   Holman ER, 1997, CIRCULATION, V95, P924
   Holt NF, 2012, AM FAM PHYSICIAN, V85, P239
   HONDA N, 1993, RADIOLOGY, V186, P189, DOI 10.1148/radiology.186.1.8416562
   Hong YJ, 2011, INT J CARDIOVAS IMAG, V27, P89, DOI 10.1007/s10554-011-9961-8
   Hosch W, 2008, AMYLOID, V15, P196, DOI 10.1080/13506120802193233
   Hundley WG, 1999, CIRCULATION, V100, P1697, DOI 10.1161/01.CIR.100.16.1697
   Hundley WG, 2002, CIRCULATION, V106, P2328, DOI 10.1161/01.CIR.0000036017.46437.02
   HUNDLEY WG, 1995, CIRCULATION, V91, P2955, DOI 10.1161/01.CIR.91.12.2955
   Ismail TF, 2012, HEART, V98, P438, DOI 10.1136/heartjnl-2011-300814
   Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040
   Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016
   Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484
   Jeserich M, 2013, INT J CARDIOVAS IMAG, V29, P121, DOI 10.1007/s10554-012-0052-2
   Joshi SB, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-69
   Jost CHA, 2012, INT J CARDIOVAS IMAG, V28, P1147, DOI 10.1007/s10554-011-9923-1
   Junttila MJ, 2011, HEART, V97, P1852, DOI 10.1136/heartjnl-2011-300153
   Kato R, 2003, CIRCULATION, V107, P2004, DOI 10.1161/01.CIR.0000061951.81767.4E
   Kato S, 2010, J AM COLL CARDIOL, V56, P983, DOI 10.1016/j.jacc.2010.01.071
   Kelder JC, 2011, CIRCULATION, V124, P2865, DOI 10.1161/CIRCULATIONAHA.111.019216
   Keller DI, 2003, INT J CARDIOVAS IMAG, V19, P537, DOI 10.1023/B:CAIM.0000004351.40409.ee
   Kern MJ, 2006, CIRCULATION, V114, P1321, DOI 10.1161/CIRCULATIONAHA.106.177276
   Kim KH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-52
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866
   Kim Yong-Jin, 2011, Curr Cardiol Rep, V13, P185, DOI 10.1007/s11886-011-0179-0
   Kitagawa K, 2010, INT J CARDIOVAS IMAG, V26, P173, DOI 10.1007/s10554-010-9687-z
   Klem I, 2012, J AM COLL CARDIOL, V60, P408, DOI 10.1016/j.jacc.2012.02.070
   Klem I, 2011, CIRC-CARDIOVASC IMAG, V4, P610, DOI 10.1161/CIRCIMAGING.111.964965
   Koca B, 2014, CARDIOL YOUNG, V24, P422, DOI 10.1017/S1047951113000504
   Kon MWS, 2004, J HEART VALVE DIS, V13, P600
   Korosoglou G, 2010, JACC-CARDIOVASC IMAG, V3, P361, DOI 10.1016/j.jcmg.2009.11.015
   Korperich H, 2004, CIRCULATION, V109, P1987, DOI 10.1161/01.CIR.0000126494.66859.A2
   Kozerke S, 2001, RADIOLOGY, V218, P548, DOI 10.1148/radiology.218.2.r01ja07548
   Kuijpers D, 2003, CIRCULATION, V107, P1592, DOI 10.1161/01.CIR.0000060544.41744.7C
   Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29
   La Manna A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-82
   Lacomis JM, 2006, J INTERV CARD ELECTR, V16, P7, DOI 10.1007/s10840-006-9016-6
   Langerak SE, 2002, CIRCULATION, V105, P328, DOI 10.1161/hc0302.102598
   Lee C, 2012, J AM COLL CARDIOL, V60, P1005, DOI 10.1016/j.jacc.2012.03.077
   Lemmer J, 2011, CLIN RES CARDIOL, V100, P289, DOI 10.1007/s00392-010-0241-8
   Ley S, 2007, PEDIATR RADIOL, V37, P426, DOI 10.1007/s00247-007-0414-4
   Leyva F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-29
   Leyva F, 2011, HEART FAIL REV, V16, P251, DOI 10.1007/s10741-010-9213-3
   Lipinski MJ, 2013, J AM COLL CARDIOL, V62, P826, DOI 10.1016/j.jacc.2013.03.080
   Lockie T, 2011, J AM COLL CARDIOL, V57, P70, DOI 10.1016/j.jacc.2010.09.019
   Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D
   Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81
   Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258
   Mansour M, 2006, J CARDIOVASC ELECTR, V17, P719, DOI 10.1111/j.1540-8167.2006.00491.x
   Marcus FI, 2010, EUR HEART J, V31, P806, DOI 10.1093/eurheartj/ehq025
   Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340
   Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061
   Maron MS, 2012, CIRC-CARDIOVASC IMAG, V5, P441, DOI 10.1161/CIRCIMAGING.112.972760
   Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812
   Maron MS, 2010, AM J CARDIOL, V105, P1842, DOI 10.1016/j.amjcard.2010.01.367
   Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119
   Maron MS, 2009, J AM COLL CARDIOL, V54, P220, DOI 10.1016/j.jacc.2009.05.006
   Mastouri R, 2010, EXPERT REV CARDIOVAS, V8, P1335, DOI 10.1586/ERC.10.77
   Mavrogeni S, 2004, J AM COLL CARDIOL, V43, P649, DOI 10.1016/j.jacc.2003.08.052
   Mavrogeni S, 2008, INT J CARDIOL, V124, P27, DOI 10.1016/j.ijcard.2007.02.035
   Mavrogeni S, 2006, J CARDIOVASC MAGN R, V8, P493, DOI 10.1080/10976640600604773
   MCCONNELL MV, 1995, CIRCULATION, V92, P3158, DOI 10.1161/01.CIR.92.11.3158
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024
   Mercer-Rosa L, 2012, CIRC-CARDIOVASC IMAG, V5, P637, DOI 10.1161/CIRCIMAGING.112.972588
   Miller CD, 2013, JACC-CARDIOVASC IMAG, V6, P785, DOI 10.1016/j.jcmg.2012.11.022
   Miller CD, 2011, JACC-CARDIOVASC IMAG, V4, P862, DOI 10.1016/j.jcmg.2011.04.016
   Minami Y, 2011, J AM COLL CARDIOL, V57, P2346, DOI 10.1016/j.jacc.2011.02.033
   Mitchell JH, 2007, AM J CARDIOL, V100, P296, DOI 10.1016/j.amjcard.2007.02.091
   Mollet NR, 2002, CIRCULATION, V106, P2873, DOI 10.1161/01.CIR.0000044389.51236.91
   Monney PA, 2011, HEART, V97, P1312, DOI 10.1136/hrt.2010.204818
   Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035
   Moon JCC, 2004, HEART, V90, P645, DOI 10.1136/hrt.2003.014969
   Moon JCC, 2003, EUR HEART J, V24, P2151, DOI 10.1016/j.ehj.2003.09.017
   Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X
   Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018
   Motwani M, 2013, RADIOLOGY, V268, P26, DOI 10.1148/radiol.13121239
   Nagata M, 2011, RADIOLOGY, V259, P384, DOI 10.1148/radiol.11101323
   Nagel E, 1999, CIRCULATION, V99, P763, DOI 10.1161/01.CIR.99.6.763
   Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030
   NELSON CL, 1991, AM J CARDIOL, V68, P973, DOI 10.1016/0002-9149(91)90423-I
   O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010
   Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5
   Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047
   Oosterhof T, 2006, AM HEART J, V151, P265, DOI 10.1016/j.ahj.2005.03.058
   Oosterhof T, 2005, RADIOLOGY, V237, P868, DOI 10.1148/radiol.2373041324
   Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664
   Paetsch I, 2004, CIRCULATION, V110, P835, DOI 10.1161/01.CIR.0000138927.00357.FB
   Paetsch I, 2006, EUR HEART J, V27, P1459, DOI 10.1093/eurheartj/ehi883
   Patel MR, 2013, J AM COLL CARDIOL, V61, P2207, DOI 10.1016/j.jacc.2013.02.005
   Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352
   Pennell DJ, 2004, J CARDIOVASC MAGN R, V6, P727, DOI 10.1081/JCMR-200038581
   Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040
   PENNELL DJ, 1992, AM J CARDIOL, V70, P34, DOI 10.1016/0002-9149(92)91386-I
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pilz G, 2006, CLIN RES CARDIOL, V95, P531, DOI 10.1007/s00392-006-0422-7
   Plein S, 2004, J AM COLL CARDIOL, V44, P2173, DOI 10.1016/j.jacc.2004.08.056
   Prasad SK, 2004, CIRCULATION, V109, P207, DOI 10.1161/01.CIR.0000107842.29467.C5
   Rayatzadeh H, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-31
   REBERGEN SA, 1993, CIRCULATION, V88, P2257, DOI 10.1161/01.CIR.88.5.2257
   Rerkpattanapipat P, 2003, AM J CARDIOL, V92, P603, DOI 10.1016/S0002-9149(03)00734-3
   Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723
   Rieber J, 2006, EUR HEART J, V27, P1465, DOI 10.1093/eurheartj/ehl039
   Roes SD, 2009, EUR J NUCL MED MOL I, V36, P594, DOI 10.1007/s00259-008-1001-0
   Roest AAW, 2002, RADIOLOGY, V223, P204, DOI 10.1148/radiol.2231010924
   Romero J, 2013, EUR HEART J-CARD IMG, V14, P1080, DOI 10.1093/ehjci/jet040
   Romero J, 2012, JACC-CARDIOVASC IMAG, V5, P494, DOI 10.1016/j.jcmg.2012.02.009
   Rowin EJ, 2012, JACC-CARDIOVASC IMAG, V5, P119, DOI 10.1016/j.jcmg.2011.08.020
   Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026
   Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064
   Rutledge JM, 2002, PEDIATR CARDIOL, V23, P137, DOI 10.1007/s00246-001-0037-8
   Sakuma H, 2006, J AM COLL CARDIOL, V48, P1946, DOI 10.1016/j.jacc.2006.07.055
   Salehian O, 2004, CIRCULATION, V110, P3229, DOI 10.1161/01.CIR.0000147284.54140.73
   Sardanelli F, 2002, EUR RADIOL, V12, P193, DOI 10.1007/s003300101017
   Sarikouch S, 2011, CIRC-CARDIOVASC IMAG, V4, P703, DOI 10.1161/CIRCIMAGING.111.963637
   Schalla S, 2002, RADIOLOGY, V224, P845, DOI [10.1148/radiol.2243010945, 10.1148/radiol.22430T0945]
   Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008
   Schwitter J, 2001, CIRCULATION, V103, P2230
   Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617
   Schwitter J, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-61
   Schwitter J, 2013, EUR HEART J, V34, P775, DOI 10.1093/eurheartj/ehs022
   Selvanayagam JB, 2005, CIRCULATION, V111, P1027, DOI 10.1161/01.CIR.0000156328.28485.AD
   Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74
   Sen-Chowdhry S, 2003, INT J CARDIOVAS IMAG, V19, P545
   Sen-Chowdhry S, 2006, J AM COLL CARDIOL, V48, P2132, DOI 10.1016/j.jacc.2006.07.045
   Shah Dipan J, 2009, Heart Fail Clin, V5, P315, DOI 10.1016/j.hfc.2009.02.001
   Shah DJ, 2009, HEART FAIL CLIN, V5, pV
   Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB
   Shiga T, 2006, ARCH INTERN MED, V166, P1350, DOI 10.1001/archinte.166.13.1350
   Shimada T, 2001, AM J MED, V110, P520, DOI 10.1016/S0002-9343(01)00677-5
   Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220
   Smith Sidney C Jr, 2006, J Am Coll Cardiol, V47, pe1, DOI 10.1016/j.jacc.2005.12.001
   SONDERGAARD L, 1993, AM HEART J, V126, P1156, DOI 10.1016/0002-8703(93)90669-Z
   Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023
   Tandri H, 2005, J AM COLL CARDIOL, V45, P98, DOI 10.1016/j.jacc.2004.09.053
   Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005
   Taylor AM, 2005, RADIOLOGY, V234, P542, DOI 10.1148/radiol.2342032059
   Taylor AM, 2000, CIRCULATION, V101, P1670
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Thomson LEJ, 2008, CIRC-CARDIOVASC IMAG, V1, P31, DOI 10.1161/CIRCIMAGING.108.769786
   To ACY, 2011, JACC-CARDIOVASC IMAG, V4, P1123, DOI 10.1016/j.jcmg.2011.06.022
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Trent RJ, 2000, HEART, V83, P40, DOI 10.1136/heart.83.1.40
   Valle-Munoz A, 2009, EUR J ECHOCARDIOGR, V10, P968, DOI 10.1093/ejechocard/jep115
   Vogelsberg H, 2008, J AM COLL CARDIOL, V51, P1022, DOI 10.1016/j.jacc.2007.10.049
   von Knobelsdorff-Brenkenhoff F, 2009, CIRC-CARDIOVASC IMAG, V2, P397, DOI 10.1161/CIRCIMAGING.108.840967
   Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6
   Wahl A, 2004, EUR HEART J, V25, P1230, DOI 10.1016/j.ehj.2003.11.018
   Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352
   Watkins S, 2009, CIRCULATION, V120, pA2T0, DOI 10.1161/CIRCULATIONAHA.109.872358
   Weber C, 2008, EUR RADIOL, V18, P2406, DOI 10.1007/s00330-008-1033-7
   Weinsaft JW, 2011, JACC-CARDIOVASC IMAG, V4, P702, DOI 10.1016/j.jcmg.2011.03.017
   Weinsaft JW, 2009, JACC-CARDIOVASC IMAG, V2, P969, DOI 10.1016/j.jcmg.2009.03.017
   Wilke N, 1997, RADIOLOGY, V204, P373, DOI 10.1148/radiology.204.2.9240523
   Yalonetsky S, 2011, AM J CARDIOL, V107, P767, DOI 10.1016/j.amjcard.2010.10.058
   Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016
   Yoon YE, 2012, J AM COLL CARDIOL, V60, P2316, DOI 10.1016/j.jacc.2012.07.060
   Zurick AO, 2011, JACC-CARDIOVASC IMAG, V4, P1180, DOI 10.1016/j.jcmg.2011.08.011
NR 249
TC 7
Z9 9
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 359
EP 385
DI 10.4070/kcj.2014.44.6.359
PG 27
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400001
PM 25469139
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SA
   Kim, KH
   Shin, HS
   Lee, HS
   Choi, HM
   Kim, HK
AF Lee, Seung-Ah
   Kim, Kyung-Hee
   Shin, Hyo-Sun
   Lee, Hee-Sun
   Choi, Hong-Mi
   Kim, Hyung-Kwan
TI Successful Medical Treatment of Prosthetic Mitral Valve Endocarditis
   Caused by Brucella abortus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Infective endocarditis; Cardiac valve prosthesis; Brucella abortus
ID SURGICAL-TREATMENT; DISEASE
AB Although Brucella endocarditis is a rare complication of human brucellosis, it is the main cause of the mortality in this disease. Traditionally, the therapeutic approach to endocarditis caused by Brucella species requires a combination of antimicrobial therapy and valve replacement surgery In the literature, only a few cases of mitral prosthetic valve endocarditis caused by Brucella species have been successfully treated without reoperation. We present a case of a 42-year-old man with a prosthetic mitral valve infected by Brucella abortus who was cured solely by medical treatment.
C1 [Lee, Seung-Ah; Kim, Kyung-Hee; Shin, Hyo-Sun; Lee, Hee-Sun; Choi, Hong-Mi; Kim, Hyung-Kwan] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Div Cardiol,Dept Internal Med, Seoul 110744, South Korea.
RP Kim, KH (corresponding author), Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM learnbyliving9@gmail.com
RI Kim, Hyung-Kwan/R-8375-2019
OI Kim, Kyung-Hee/0000-0003-0214-0296
CR Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
   Botta L, 2009, J CARDIOVASC MED, V10, P257, DOI 10.2459/JCM.0b013e32831ec369
   Cohen N, 1997, CLIN CARDIOL, V20, P291, DOI 10.1002/clc.4960200319
   FERNANDEZGUERRERO ML, 1993, INFECT DIS CLIN N AM, V7, P135
   Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4
   JACOBS F, 1990, REV INFECT DIS, V12, P740
   Karaoglan I, 2009, ANKEM DERGISI, V23, P46
   Keshtkar-Jahromi M, 2012, ANN THORAC SURG, V94, P2141, DOI 10.1016/j.athoracsur.2012.07.006
   Mert Ali, 2002, Ann Thorac Cardiovasc Surg, V8, P381
   Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570
   PEERY TM, 1960, AM J PATHOL, V36, P673
   Reguera JM, 2003, EUR J CLIN MICROBIOL, V22, P647, DOI 10.1007/s10096-003-1026-z
   Roushan MRH, 2006, CLIN INFECT DIS, V42, P1075, DOI 10.1086/501359
   Sasmazel A, 2010, ANN THORAC SURG, V89, P1432, DOI 10.1016/j.athoracsur.2010.01.048
NR 14
TC 2
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 441
EP 443
DI 10.4070/kcj.2014.44.6.441
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400011
PM 25469149
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Kao, WY
   Wert, SH
   Liu, IF
AF Lee, Ching-Wei
   Kao, Wei-Yu
   Wert, Shih-Hsien
   Liu, I-Fan
TI Esophageal Submucosal Tumor-A Red Flag in Patients Receiving Thoracic
   Aortic Aneurysmal Stent-Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID AORTOESOPHAGEAL FISTULA; REPAIR
C1 [Lee, Ching-Wei; Liu, I-Fan] Taipei Vet Gen Hosp, Div Cardiol, Tao Yuan Branch, Dept Med, Taoyuan, Taiwan.
   [Kao, Wei-Yu] Taipei Vet Gen Hosp, Div Gastroenterol, Tao Yuan Branch, Dept Med, Taoyuan, Taiwan.
   [Wert, Shih-Hsien] Taipei Vet Gen Hosp, Div Cardiovasc Surg, Tao Yuan Branch, Dept Surg, Taoyuan, Taiwan.
RP Liu, IF (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Tao Yuan Branch, Dept Med, 201 Sec 2,Shih Pai Rd, Taoyuan, Taiwan.
EM wes0208@yahoo.com.tw
CR Chiba D, 2013, INTERNAL MED, V52, P451, DOI 10.2169/internalmedicine.52.9139
   Eggebrecht H, 2009, JACC-CARDIOVASC INTE, V2, P570, DOI 10.1016/j.jcin.2009.03.010
   Muradi A, 2013, DIAGN INTERV RADIOL, V19, P81, DOI 10.4261/1305-3825.DIR.5912-12.1
NR 3
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 444
EP 445
DI 10.4070/kcj.2014.44.6.444
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400012
PM 25469150
OA Green Published
DA 2021-04-22
ER

PT J
AU Madias, JE
AF Madias, John E.
TI A Comparison of Pheochromocytoma and Takotsubo Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Madias, John E.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Madias, John E.] Elmhurst Hosp Ctr, Div Cardiol, Elmhurst, NY 11373 USA.
RP Madias, JE (corresponding author), Elmhurst Hosp Ctr, Div Cardiol, 79-01 Broadway, Elmhurst, NY 11373 USA.
EM madiasj@nychhc.org
CR Choi SY, 2014, KOREAN CIRC J, V44, P89, DOI 10.4070/kcj.2014.44.2.89
   Madias JE, 2014, EUR HEART J-ACUTE CA, V3, P28, DOI 10.1177/2048872613504311
NR 2
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2014
VL 44
IS 6
BP 446
EP 446
DI 10.4070/kcj.2014.44.6.446
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU5XH
UT WOS:000345676400013
PM 25469151
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, S
   Hwang, C
AF Han, Seongwook
   Hwang, Chun
TI How to Achieve Complete and Permanent Pulmonary Vein Isolation without
   Complications
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Catheter ablation; radiofrequency; Pulmonary veins;
   Isolation
ID HEART RHYTHM ASSOCIATION; ATRIAL-FIBRILLATION; CATHETER ABLATION;
   RADIOFREQUENCY ABLATION; FREQUENCY; HUMANS; SITES; ESC
AB The efficacy and safety of catheter ablation for the management of atrial fibrillation (AF) has been improved in recent years. Radiofrequency (RF) catheter ablation for maintaining sinus rhythm is superior to the current antiarrhythmic drug therapy in selected patients. Pulmonary vein isolation (PVI) is the cornerstone of various catheter ablation strategies. It is well recognized that pulmonary vein (PV) antrum contributes to the AF initiation and/or perpetuation. Since PV stenosis is a complication of ablation within a PV, the ablation site for PVI has shifted to the junction between the left atrium and the PV rather than the ostium of the PV. However, PV reconnection after ablation is the major cause of recurrence of AF. The recovery of PV conduction could be caused by anatomical variations such as the failure to produce complete transmural lesion or gaps at the ablation line due to the transient electrophysiologic effects from the RE ablation. In this review, we discussed several factors to be considered for the achievement of the best PVI, including clinical aspects and technical aspects.
C1 [Han, Seongwook; Hwang, Chun] Utah Valley Reg Med Ctr, Cent Utah Clin Cardiol, Provo, UT 84604 USA.
   [Han, Seongwook] Keimyung Univ, Dongsan Med Ctr, Dept Cardiol, Taegu, South Korea.
RP Hwang, C (corresponding author), Utah Valley Reg Med Ctr, Cent Utah Med Clin Cardiol, 1055 North 500 West, Provo, UT 84604 USA.
EM chunhwang17@gmail.com
CR Andrade JG, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1103, DOI 10.1161/CIRCEP.113.000454
   Arbelo E, 2012, EUROPACE, V14, P1094, DOI 10.1093/europace/eus153
   Cabrera JA, 2009, HEART RHYTHM, V6, P1192, DOI 10.1016/j.hrthm.2009.04.016
   Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789
   Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116
   Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Hassink RJ, 2003, J AM COLL CARDIOL, V42, P1108, DOI 10.1016/S0735-1097(03)00918-5
   Jain MK, 1999, IEEE T BIO-MED ENG, V46, P1405, DOI 10.1109/10.804568
   Kalifa J, 2003, CIRCULATION, V108, P668, DOI 10.1161/01.CIR.0000086979.39843.7B
   Kautzner J, 2012, HEART RHYTHM, V9, pS28
   Kowalski M, 2012, J AM COLL CARDIOL, V59, P930, DOI 10.1016/j.jacc.2011.09.076
   Kumagai K, 2004, J AM COLL CARDIOL, V43, P2281, DOI 10.1016/j.jacc.2004.01.051
   Lin YJ, 2010, HEART RHYTHM, V7, P1255, DOI 10.1016/j.hrthm.2010.06.019
   McGann CJ, 2008, J AM COLL CARDIOL, V52, P1263, DOI 10.1016/j.jacc.2008.05.062
   Parkash R, 2011, J CARDIOVASC ELECTR, V22, P729, DOI 10.1111/j.1540-8167.2011.02010.x
   Piccini JP, 2009, CIRC-ARRHYTHMIA ELEC, V2, P626, DOI 10.1161/CIRCEP.109.856633
   Ranjan R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P279, DOI 10.1161/CIRCEP.110.960567
   Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x
   Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011
   Sotomi Y, 2013, AM J CARDIOL, V111, P552, DOI 10.1016/j.amjcard.2012.10.040
   Tan AY, 2006, J AM COLL CARDIOL, V48, P132, DOI 10.1016/j.jacc.2006.02.054
   WITTKAMPF FHM, 1989, CIRCULATION, V80, P962, DOI 10.1161/01.CIR.80.4.962
NR 24
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 291
EP 300
DI 10.4070/kcj.2014.44.5.291
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400002
PM 25278981
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
   Lim, JH
   Hwang, KB
   Woo, SH
   Jeong, JW
   Kim, YC
   Joe, DY
   Ko, JS
   Rhee, SJ
   Lee, EM
   Oh, SK
AF Yun, Kyeong Ho
   Lim, Jae Hong
   Hwang, Kyo Burn
   Woo, Sun Ho
   Jeong, Jin Woo
   Kim, Yong Cheol
   Joe, Dai-Yeol
   Ko, Jum Suk
   Rhee, Sang Jae
   Lee, Eun Mi
   Oh, Seok Kyu
TI Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary
   Intervention on Contrast-Induced Nephropathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contrast media; Kidney; Statins
ID CHRONIC KIDNEY-DISEASE; STATIN THERAPY; INJURY; IMPACT
AB Background and Objectives: Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality. This observational, non-randomized study evaluated the effect of rosuvastatin loading before percutaneous coronary intervention (PCI) on the incidence of CIN in patients with acute coronary syndrome (ACS).
   Subjects and Methods: A total of 824 patients who underwent PCI for ACS were studied (408 patients in the statin group=40 mg rosuvastatin loading before PCI; 416 patients of control group=no statin pretreatment). Serum creatinine concentrations were measured before and 24 and 48 hours after PCI. The primary endpoint was development of CIN defined as an increase in serum creatinine concentration of >= 0.5 mg/dL or >= 25% above baseline within 72 hours after PCI.
   Results: The incidence of CIN was significantly lower in the statin group than that in the control group (18.8% vs. 13.5%, p=0.040). The maximum percent changes in serum creatinine and estimated glomerular filtration rate in the statin group within 48 hours were significantly lower than those in the control group (5.84 +/- 22.59% vs. 2.43 +/- 24.49%, p=0.038; -11.44 +/- 14.00 vs. -9.51 +/- 13.89, p=0.048, respectively). The effect of rosuvastatin on preventing CIN was greater in the subgroups of patients with diabetes, high-dose contrast medium, multi-vessel stents, high baseline C-reactive protein, and myocardial infarction. A multivariate analysis revealed that rosuvastatin loading was independently associated with a decreased risk for CIN (odds ratio, 0.64; 95% confidence interval, 0.43-0.95, p=0.026).
   Conclusion: High-dose rosuvastatin loading before PCI was associated with a significantly lower incidence of CIN in patients with ACS.
C1 [Yun, Kyeong Ho; Lim, Jae Hong; Hwang, Kyo Burn; Woo, Sun Ho; Jeong, Jin Woo; Kim, Yong Cheol; Joe, Dai-Yeol; Ko, Jum Suk; Rhee, Sang Jae; Lee, Eun Mi; Oh, Seok Kyu] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan 570711, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan 570711, South Korea.
EM dryunkh@gmail.com
OI Kim, Yongcheol/0000-0001-5568-4161
CR Agarwal R, 2004, J AM SOC NEPHROL, V15, P2502, DOI 10.1097/01.ASN.0000143720.71748.79
   Budano C, 2011, AM HEART J, V161, P963, DOI 10.1016/j.ahj.2011.02.004
   Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056
   Giusti-Paiva A, 2004, SHOCK, V21, P271, DOI 10.1097/10.shk.0000115756.74059.ce
   Gotoh K, 2013, OBES RES CLIN PRACT, V7, pE342, DOI 10.1016/j.orcp.2013.04.001
   Han YL, 2014, J AM COLL CARDIOL, V63, P62, DOI 10.1016/j.jacc.2013.09.017
   Jia XW, 2009, AM J CARDIOL, V104, P519, DOI 10.1016/j.amjcard.2009.04.014
   Jo SH, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.042
   Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76
   Leoncini M, 2014, J AM COLL CARDIOL, V63, P71, DOI 10.1016/j.jacc.2013.04.105
   Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013
   Liuni A, 2010, J AM COLL CARDIOL, V55, P1002, DOI 10.1016/j.jacc.2009.11.046
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   Pappy R, 2011, INT J CARDIOL, V151, P348, DOI 10.1016/j.ijcard.2011.05.045
   Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317
   Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020
   Sposito AC, 2002, ARTERIOSCL THROM VAS, V22, P1524, DOI 10.1161/01.ATV.0000032033.39301.6A
   Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486
   Toso A, 2010, AM J CARDIOL, V105, P288, DOI 10.1016/j.amjcard.2009.09.026
   Vidt DG, 2006, AM J CARDIOL, V97, P1602, DOI 10.1016/j.amjcard.2005.12.052
   Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115
   Yun KH, 2011, KOREAN CIRC J, V41, P458, DOI 10.4070/kcj.2011.41.8.458
   Yun KH, 2011, INT J CARDIOL, V146, P68, DOI 10.1016/j.ijcard.2010.04.052
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
NR 24
TC 15
Z9 15
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 301
EP 306
DI 10.4070/kcj.2014.44.5.301
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400003
PM 25278982
OA Green Published
DA 2021-04-22
ER

PT J
AU Sen, F
   Yilmaz, S
   Kuyumcu, MS
   Ozeke, O
   Balci, MM
   Aydogdu, S
AF Sen, Fatih
   Yilmaz, Samet
   Kuyumcu, Mevlut Serdar
   Ozeke, Ozcan
   Balci, Mustafa Mucahit
   Aydogdu, Sinan
TI The Presence of Fragmented QRS on 12-Lead Electrocardiography in
   Patients with Coronary Artery Ectasia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ectasia; Angiography; Coronary artery disease
ID DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; BRUGADA SYNDROME;
   ANEURYSMS; DISEASE; ARRHYTHMIAS; PROGNOSIS; MORTALITY; ISCHEMIA; MARKERS
AB Background and Objectives: Coronary artery ectasia (CAE) is an angiographic finding characterized by dilation of an arterial segment with a diameter at least 1.5 times that of its adjacent normal coronary artery. Fragmented QRS (fQRS) complexes are electrocardiographic signals which reflect altered ventricular conduction around regions of a myocardial scar and/or ischaemia. In the present study, we aimed to evaluate the presence of fQRS in patients with CAE.
   Subjects and Methods: The study population included 100 patients with isolated CAE without coronary artery disease (CAD) and 80 angiographically normal controls. fQRS was defined as the presence of an additional R wave or notching of R or S wave or the presence of fragmentation in two contiguous leads corresponding to a major coronary artery territory.
   Results: The two groups were similar in terms of age, sex, hypertension, dyslipidemia, and family history of CAD. The presence of fQRS was significantly (p<0.05) higher in the CAE group than that in the normal coronary artery group (29% vs. 6.2%, p=0.008). Isolated CAE were detected most commonly in the right coronary artery (61%), followed by left anterior descending artery (52%), left circumflex artery (36%), and left main artery (9%). Multivariate stepwise logistic regression analysis showed that CAE {odd S ratio (OR) 1.412; 95% confidence interval (Cl) 1.085-1.541; p=0.003} and diabetes (OR 1.310; 95% CI 1.025-1.482; p=0.041) were independently associated with fQRS.
   Conclusion: The presence of fragmented QRS associated with increased risk for arrhythmias and cardiovascular mortality was significantly higher in patients with CAE than in patient with normal coronary artery. Further studies are needed to determine whether the presence of fragmented ORS is a possible new risk factor for patients with CAE.
C1 [Sen, Fatih; Yilmaz, Samet; Kuyumcu, Mevlut Serdar; Ozeke, Ozcan; Balci, Mustafa Mucahit; Aydogdu, Sinan] Turkey Yuksek Ihtisas Educ & Res Hosp, Cardiol Clin, TR-06100 Ankara, Turkey.
RP Yilmaz, S (corresponding author), Turkey Yuksek Ihtisas Educ & Res Hosp, Cardiol Clin, Kizilay Sok 6, TR-06100 Ankara, Turkey.
EM sametyilmazmd@gmail.com
RI Ozeke, Ozcan/N-1871-2015; YILMAZ, SAMET/Q-5077-2016; Ozeke,
   Ozcan/AAS-8730-2020
OI Ozeke, Ozcan/0000-0002-4770-8159; YILMAZ, SAMET/0000-0002-8445-1911;
   Ozeke, Ozcan/0000-0002-4770-8159
CR Aboeata Ahmed S, 2012, Front Biosci (Elite Ed), V4, P300
   Akyurek O, 2003, AM HEART J, V145, P66, DOI 10.1067/mhj.2003.48
   Aydin M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/106145
   Baranchuk A, 2012, INT J CARDIOL, V160, P151, DOI 10.1016/j.ijcard.2012.05.072
   BEFELER B, 1977, AM J MED, V62, P597, DOI 10.1016/0002-9343(77)90423-5
   Boles U, 2010, CORONARY ARTERY DIS, V21, P318, DOI 10.1097/MCA.0b013e32833b20da
   Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892
   Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284
   Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019
   Das MK, 2010, HEART RHYTHM, V7, P74, DOI 10.1016/j.hrthm.2009.09.065
   Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024
   Dogan A, 2008, CORONARY ARTERY DIS, V19, P559, DOI 10.1097/MCA.0b013e3283109079
   FALSETTI HL, 1976, CHEST, V69, P630, DOI 10.1378/chest.69.5.630
   Farto e Abreu P, 1993, Rev Port Cardiol, V12, P305
   Femenia Francisco, 2012, J Cardiovasc Dis Res, V3, P32, DOI 10.4103/0975-3583.91602
   Finkelstein A, 2005, ATHEROSCLEROSIS, V179, P353, DOI 10.1016/j.atherosclerosis.2004.10.020
   Haraoka K, 2010, HEART RHYTHM, V7, P1808, DOI 10.1016/j.hrthm.2010.09.008
   Huang QJ, 2014, ANATOL J CARDIOL, V14, P322, DOI 10.5152/akd.2014.5327
   Kruger D, 1999, J AM COLL CARDIOL, V34, P1461, DOI 10.1016/S0735-1097(99)00375-7
   Li JJ, 2008, INT J CARDIOL, V130, pE69, DOI 10.1016/j.ijcard.2007.11.078
   MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5
   MATTERN AL, 1972, AM J CARDIOL, V30, P906, DOI 10.1016/0002-9149(72)90019-7
   Michael MA, 2007, PROG CARDIOVASC DIS, V50, P198, DOI 10.1016/j.pcad.2007.05.003
   Nagata K, 2001, JPN HEART J, V42, P249, DOI 10.1536/jhj.42.249
   Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064
   Satran A, 2005, CIRCULATION, V111, P2424, DOI 10.1161/01.CIR.0000165121.50527.DE
   Sha J, 2011, ANN NONINVAS ELECTRO, V16, P270, DOI 10.1111/j.1542-474X.2011.00442.x
   Take Y, 2012, HEART RHYTHM, V9, P752, DOI 10.1016/j.hrthm.2011.11.045
   Tigen K, 2009, CAN J CARDIOL, V25, P517, DOI 10.1016/S0828-282X(09)70137-0
NR 29
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 307
EP 311
DI 10.4070/kcj.2014.44.5.307
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400004
PM 25278983
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, J
   Chang, HJ
   Choi, JH
   Yang, PS
   Lee, SE
   Heo, R
   Shin, S
   Cho, IJ
   Kim, YJ
   Shim, CY
   Hong, GR
   Chung, N
AF Park, Junbeom
   Chang, Hyuk-Jae
   Choi, Jung-Ho
   Yang, Pil-Sung
   Lee, Sang-Eun
   Heo, Ran
   Shin, Sanghoon
   Cho, In-Jeong
   Kim, Young-Jin
   Shim, Chi Young
   Hong, Geu-Ru
   Chung, Namsik
TI Late Gadolinium Enhancement in Cardiac MRI in Patients with Severe
   Aortic Stenosis and Preserved Left Ventricular Systolic Function Is
   Related to Attenuated Improvement of Left Ventricular Geometry and
   Filling Pressure after Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac magnetic resonance imaging; Echocardiography; Aortic stenosis;
   Late gadolinium enhancement
ID CARDIOVASCULAR MAGNETIC-RESONANCE; MYOCARDIAL-INFARCTION; DELAYED
   ENHANCEMENT; DISEASE; DYSFUNCTION; ECHOCARDIOGRAPHY; HEART;
   RECOMMENDATIONS; QUANTIFICATION; VISUALIZATION
AB Background and Objectives: We investigated echocardiographic predictors: left ventricular (LV) geometric changes following aortic valve replacement (AVR) according to the late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) in patients with severe aortic stenosis (AS) and preserved LV systolic function.
   Subjects and Methods: We analyzed 41 patients (24 males, 63.1 +/- 8.7 years) with preserved LV systolic function who were scheduled to undergo AVR for severe AS. All patients were examined with transthoracic echocardiography (TIE), CMR before and after AVR (in the hospital) and serial TTEs (at 6 and 12 months) were repeated.
   Results: The group with LGE (LGE+) showed greater wall thickness (septum, 14.3 +/- 2.6 mm vs. 11.5 +/- 2.0 mm, p=0.001, posterior; 14.3 +/- 2.5 mm vs. 11.4 +/- 1.6 mm, p<0.001), lower tissue Doppler image (TDIS', 4.4 +/- 1.4 cm/s vs. 5.5 +/- 1.2 cm/s, p=0.021; TDI E', 3.2 +/- 0.9 cm/s vs. 4.8 +/- 1.4 cm/s, p=0.002), and greater E/e' (21.8 +/- 10.3 vs. 15.4 +/- 6.3, p=0.066) than those without LGE (LGE-). Multivariate analysis show that TDI e' (odds ratio=0.078, 95% confidence interval=0.007-0.888, p=0.040) was an independent determinant of LGE+. In an analysis of the 6- and 12-month follow-up compared with pre-AVR, LGE- showed decreased LV end-diastolic diameter (48.3 +/- 5.0 mm vs. 45.8 +/- 3.6 mm, p=0.027; 48.3 +/- 5.0 mm vs. 46.5 +/- 3.4 mm, p=0.019). Moreover, E/e' (at 12 months) showed further improved LV filling pressure (16.0 +/- 6.6 vs. 12.3 +/- 4.3, p=0.001) compared with pre-AVR. However, LGE+ showed no significant improvement.
   Conclusion: The absence of LGE is associated with favorable improvements in LV geometry and filling pressure. TDI E' is an independent determinant of LGE in patients with severe AS and preserved LV systolic function.
C1 [Park, Junbeom; Chang, Hyuk-Jae; Choi, Jung-Ho; Yang, Pil-Sung; Lee, Sang-Eun; Heo, Ran; Shin, Sanghoon; Cho, In-Jeong; Kim, Young-Jin; Shim, Chi Young; Hong, Geu-Ru; Chung, Namsik] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol & Radiol, Seoul 120752, South Korea.
   [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Yonsei Univ Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol & Radiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM hjchang@yuhs.ac
RI Heo, Ran/AAJ-8471-2021; Shim, Chi Young/AAK-1057-2021
OI Heo, Ran/0000-0002-2675-3612; Shim, Chi Young/0000-0002-6136-0136;
   Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304;
   Lee, Sang-Eun/0000-0001-6645-4038; Shin, Sanghoon/0000-0002-2348-2570;
   Kim, Young Jin/0000-0002-6235-6550
FU IT R&D program of MSIP/KEIT [10044910]
FX This work was supported by the IT R&D program of MSIP/KEIT (10044910,
   Development of Multi-modality Imaging and 3D Simulation-Based
   Integrative Diagnosis-Treatment Support Software System for
   Cardiovascular Diseases).
CR Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074
   Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623
   Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748
   Clavel MA, 2008, CIRCULATION, V118, pS234, DOI 10.1161/CIRCULATIONAHA.107.757427
   Connolly HM, 1997, CIRCULATION, V95, P2395, DOI 10.1161/01.CIR.95.10.2395
   CZER LSC, 1988, J THORAC CARDIOV SUR, V95, P390
   Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011
   Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7
   HESS OM, 1984, CIRCULATION, V69, P855, DOI 10.1161/01.CIR.69.5.855
   Hovda S, 2008, COMPUT METH PROG BIO, V92, P279, DOI 10.1016/j.cmpb.2008.03.002
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   KRAYENBUEHL HP, 1989, CIRCULATION, V79, P744, DOI 10.1161/01.CIR.79.4.744
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Levy F, 2008, J AM COLL CARDIOL, V51, P1466, DOI 10.1016/j.jacc.2007.10.067
   Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258
   MARON BJ, 1975, AM J CARDIOL, V35, P725, DOI 10.1016/0002-9149(75)90065-X
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035
   Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
   Powell DE, 2000, ARCH INTERN MED, V160, P1337, DOI 10.1001/archinte.160.9.1337
   Rochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067
   Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215
   SMITH N, 1978, CIRCULATION, V58, P255, DOI 10.1161/01.CIR.58.2.255
   Tarantini G, 2003, EUR J CARDIO-THORAC, V24, P879, DOI 10.1016/S1010-7940(03)00575-X
   Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455
   VILLARI B, 1995, CIRCULATION, V91, P2353, DOI 10.1161/01.CIR.91.9.2353
   Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772
   Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4
NR 28
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 312
EP 319
DI 10.4070/kcj.2014.44.5.312
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400005
PM 25278984
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, KH
   Kang, SJ
AF Cho, Kee Hyun
   Kang, Soo Jung
TI Clinically Useful Predictors of Resistance to Intravenous Immunoglobulin
   and Prognosis of Coronary Artery Lesions in Patients with Incomplete
   Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; lmmunoglobulins; Coronary arteries
ID AMERICAN-HEART-ASSOCIATION; GAMMA-GLOBULIN THERAPY; RISK-FACTORS;
   CHILDREN; NONRESPONSIVENESS; ABNORMALITIES
AB Background and Objectives; The prevalence of incomplete Kawasaki disease (iKD) is progressively increasing. We aimed to retrospectively investigate the predictors of intravenous immunoglobulin (IVIG) resistance in iKD patients and compare them with those of IVIG resistance in complete Kawasaki disease (cKD) patients. We also compared the prognosis of coronary artery lesions (CALs) between the IVIG non-responders and responders in both iKD and cKD groups.
   Subjects and Methods: A total of 234 cKD and 77 iKD patients were treated with IVIG between February 2009 and April 2012. Among these 311 patients, we reviewed the data of 77 iKD patients and 75 age-matched cKD patients.
   Results: Patients with iKD having an elevated neutrophil count {percentage of segmented neutrophils (SEG%) >= 79.0} were at risk of IVIG resistance, while patients with cKD having SEG% >= 79.25 and serum total bilirubin (TB) >= 0.56 mg/dL were at risk of IVIG resistance as shown by multivariable logistic regression analysis. Fractional changes of laboratory data before and after IVIG treatment showed that C-reactive protein (CRP) and N-terminal B type natriuretic peptide (NT-proBNP) levels were significantly elevated in IVIG non-responders of the iKD group, whereas erythrocyte sedimentation rate was significantly elevated in IVIG non-responders of the cKD group. Among the patients who had CALs at 10 months after the start of illness, the z scores of coronary arteries were higher in IVIG non-responders of the iKD group, when compared with IVIG non-responders of the cKD group.
   Conclusion: Elevated SEG%, changes in CRP and NT-proBNP levels may help in early detection of IVIG resistance in patients of the iKD group, which may aid in predicting the prognosis of CALs in these patients. Further studies with a larger number of patients are warranted.
C1 [Cho, Kee Hyun; Kang, Soo Jung] CHA Univ, Dept Pediat, CHA Bundang Med Ctr, Songnam 463712, South Korea.
RP Kang, SJ (corresponding author), CHA Univ, Dept Pediat, CHA Bundang Med Ctr, 59 Yatap Ro, Songnam 463712, South Korea.
EM kittysooni@medimail.co.kr
OI Kang, Soo Jung/0000-0003-1482-3086
CR Ashouri N, 2008, J PEDIATR-US, V153, P365, DOI 10.1016/j.jpeds.2008.03.014
   Durongpisitkul K, 2003, PEDIATR CARDIOL, V24, P145, DOI 10.1007/s00246-002-0216-2
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815
   Ghelani SJ, 2012, PEDIATR CARDIOL, V33, P1097, DOI 10.1007/s00246-012-0232-9
   Giannouli G, 2013, PEDIATR CARDIOL, V34, P1476, DOI 10.1007/s00246-013-0673-9
   Ha KS, 2013, EUR J PEDIATR, V172, P343, DOI 10.1007/s00431-012-1891-5
   Honkanen VEA, 2003, PEDIATR CARDIOL, V24, P122, DOI 10.1007/s00246-002-0063-1
   Kim HK, 2011, KOREAN CIRC J, V41, P379, DOI 10.4070/kcj.2011.41.7.379
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Manlhiot C, 2012, EUR J PEDIATR, V171, P657, DOI 10.1007/s00431-011-1631-2
   McCrindle BW, 2007, CIRCULATION, V116, P174, DOI 10.1161/CIRCULATIONAHA.107.690875
   McNeal-Davidson A, 2012, PEDIATR INT, V54, P627, DOI 10.1111/j.1442-200X.2012.03609.x
   Millar K, 2012, INT J CARDIOL, V154, P9, DOI 10.1016/j.ijcard.2010.08.070
   Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x
   Sonobe T, 2007, PEDIATR INT, V49, P421, DOI 10.1111/j.1442-200X.2007.02396.x
   Sudo D, 2012, EUR J PEDIATR, V171, P651, DOI 10.1007/s00431-011-1630-3
   Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021
   Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10
   Yeo Y, 2009, EUR J PEDIATR, V168, P157, DOI 10.1007/s00431-008-0722-1
NR 23
TC 12
Z9 15
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 328
EP 335
DI 10.4070/kcj.2014.44.5.328
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400007
PM 25278986
OA Green Published
DA 2021-04-22
ER

PT J
AU Ayaz, T
   Durakoglugil, ME
   Kocaman, SA
   Durakoglugil, T
   Erdogan, T
   Sahin, OZ
   Sahin, SB
   Cicek, Y
   Satiroglu, O
AF Ayaz, Teslime
   Durakoglugil, Murtaza Emre
   Kocaman, Sinan Altan
   Durakoglugil, Tugba
   Erdogan, Turan
   Sahin, Osman Zikrullah
   Sahin, Serap Baydur
   Cicek, Yuksel
   Satiroglu, Omer
TI Bilirubin Level is Associated with Left Ventricular Hypertrophy
   Independent of Blood Pressure in Previously Untreated Hypertensive
   Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Left ventricular hypertrophy; Uric acid; Bilirubin; Waist
   circumference
ID SERUM URIC-ACID; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE;
   MOLECULAR-MECHANISMS; RISK; MASS; POPULATION; REGRESSION; EVENTS; IMPACT
AB Background and Objectives: Left ventricular hypertrophy (LVH), a sign of subclinical cardiovascular disease, is an important predictor of cardiovascular morbidity and mortality. The aim of our study was to determine the association of left ventricular mass (LVM) with possible causative anthropometric and biochemical parameters as well as carotid intima-media thickness (CIMT) and brachial flow-mediated dilation (FMD) as surrogates of atherosclerosis and endothelial dysfunction, respectively, in previously untreated hypertensive patients.
   Subjects and Methods: Our study included 114 consecutive previously untreated hypertensive patients who underwent echocardiography and ultrasonography to evaluate their vascular status and function via brachial artery CIMT and FMD.
   Results: Among all study parameters, age, systolic blood pressure (BP), diastolic BP, pulse pressure, plasma glucose, uric acid, total bilirubin, direct bilirubin, hemoglobin, and CIMT were positively correlated with the LVM index. Multiple logistic regression analysis revealed that office systolic BP, age, male gender, and total bilirubin were independent predictors of LVH.
   Conclusion: Bilirubin seems to be related to LVM and LVH. The positive association of bilirubin with these parameters is novel and requires further research.
C1 [Ayaz, Teslime; Sahin, Osman Zikrullah; Sahin, Serap Baydur] Recep Tayyip Erdogan Univ, Educ & Res Hosp, Dept Internal Med, Rize, Turkey.
   [Durakoglugil, Murtaza Emre; Kocaman, Sinan Altan; Erdogan, Turan; Cicek, Yuksel; Satiroglu, Omer] Recep Tayyip Erdogan Univ, Educ & Res Hosp, Dept Cardiol, Rize, Turkey.
   [Durakoglugil, Tugba] Recep Tayyip Erdogan Univ, Educ & Res Hosp, Dept Radiol, Rize, Turkey.
RP Durakoglugil, ME (corresponding author), Recep Tayyip Erdogan Univ, Sch Med, Dept Cardiol, TR-53100 Islampasa Mah, Rize, Turkey.
EM emredur@hotmail.com
RI Durakoglugil, Emre/Q-3547-2019
OI Durakoglugil, Emre/0000-0001-5268-4262
CR Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104
   Artham SM, 2009, PROG CARDIOVASC DIS, V52, P153, DOI 10.1016/j.pcad.2009.05.002
   Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006
   Conde MV, 2011, AM J PHYSIOL-HEART C, V301, pH1153, DOI 10.1152/ajpheart.00886.2010
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Cuspidi C, 2007, AM J HYPERTENS, V20, P678, DOI 10.1016/j.amjhyper.2007.01.013
   de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026
   DIAZGIL JJ, 1989, MOL BIOL MED, V6, P197
   Gardin JM, 2004, JAMA-J AM MED ASSOC, V292, P2396, DOI 10.1001/jama.292.19.2396
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250
   Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066
   Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23
   Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14
   Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8
   Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223
   LEVY D, 1992, CLIN EXP HYPERTENS A, V14, P85, DOI 10.3109/10641969209036173
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Mancini GB, 2004, CIRCULATION, V109, P22, DOI 10.1161/01.CIR.0000133443.77237.2f
   Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003
   Okin PM, 2004, JAMA-J AM MED ASSOC, V292, P2343, DOI 10.1001/jama.292.19.2343
   Onat A, 2007, ANATOL J CARDIOL, V7, P29
   Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014
   Osgood K, 2013, METAB SYNDR RELAT D, V11, P157, DOI 10.1089/met.2012.0151
   Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013
   Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x
   SAVAGE DD, 1990, AM J CARDIOL, V65, P371, DOI 10.1016/0002-9149(90)90304-J
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011
   Tsioufis C, 2005, J HUM HYPERTENS, V19, P211, DOI 10.1038/sj.jhh.1001810
NR 30
TC 2
Z9 2
U1 1
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 336
EP 343
DI 10.4070/kcj.2014.44.5.336
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400008
PM 25278987
OA Green Published
DA 2021-04-22
ER

PT J
AU Moon, SW
   Ko, YG
   Hong, GR
   Lee, S
   Chang, BC
   Shim, JK
   Kwak, YR
   Hong, MK
AF Moon, Sung Woo
   Ko, Young-Guk
   Hong, Geu-Ru
   Lee, Sak
   Chang, Byung-Chul
   Shim, Jae-Kwang
   Kwak, Young-Ran
   Hong, Myeong-Ki
TI Transcatheter Aortic Valve Implantation in a Patient with Previous
   Mitral Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Catheters; Heart valve prosthesis; Prosthesis
   implantation; Mitral valve
ID COREVALVE REVALVING SYSTEM; PROSTHESIS; STENOSIS
AB Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or are unsuitable candidates for open heart surgery. However, concerns exist over treating patients who have previously undergone mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement who was successfully treated with TAVI using a CoreValve.
C1 [Moon, Sung Woo; Ko, Young-Guk; Hong, Geu-Ru; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Lee, Sak; Chang, Byung-Chul] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea.
   [Shim, Jae-Kwang; Kwak, Young-Ran] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Anesthesiol & Pain Med, Seoul 120752, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Div Cardiol,Severance Cardiovasc Hosp, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
RI Chang, Byung/AAP-9674-2020
OI Chang, Byung Chul/0000-0001-5005-8217; Hong,
   Myeong-Ki/0000-0002-2090-2031
CR Antman EM, 2012, CIRCULATION, V125, P3054, DOI 10.1161/CIRCULATIONAHA.112.121251
   Bruschi G, 2013, INTERACT CARDIOV TH, V17, P90, DOI 10.1093/icvts/ivt086
   Bruschi G, 2009, ANN THORAC SURG, V88, pE50, DOI 10.1016/j.athoracsur.2009.07.028
   Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049
   Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839
   Jamieson WRE, 2003, EUR J CARDIO-THORAC, V24, P873, DOI 10.1016/S1010-7940(03)00566-9
   Kim IS, 2012, KOREAN CIRC J, V42, P788, DOI 10.4070/kcj.2012.42.11.788
   Petronio AS, 2010, CIRC-CARDIOVASC INTE, V3, P359, DOI 10.1161/CIRCINTERVENTIONS.109.930453
   Rodes-Cabau J, 2008, CIRC-CARDIOVASC INTE, V1, P233, DOI 10.1161/CIRCINTERVENTIONS.108.813592
   Soon JL, 2011, J AM COLL CARDIOL, V58, P715, DOI 10.1016/j.jacc.2011.04.023
NR 10
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 344
EP 347
DI 10.4070/kcj.2014.44.5.344
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400009
PM 25278988
OA Green Published
DA 2021-04-22
ER

PT J
AU Finsterer, J
   Stollberger, C
   Gatterer, E
   Jakubiczka, S
AF Finsterer, Josef
   Stoellberger, Claudia
   Gatterer, Edmund
   Jakubiczka, Sibylle
TI Intermittent Pre-Excitation-Syndrome in Facio-Scapulo-Humeral Muscular
   Dystrophy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart; Muscular dystrophy; Fasuoscapulohumerales; Arrhythmia;
   Pre-excitation syndromes; Cardiomyopathies
ID CARDIAC INVOLVEMENT; HEART
AB Pre-excitation-syndrome has not been reported as a phenotypic feature of facio-scapulo-humeral muscular dystrophy (FSH-MD). In a 39-year-old male with FSH-MD due to a reduced tandem repeat size in the D4Z4-locus on chromosome 4q35, cardiac involvement, manifesting as an incomplete right bundle-branch-block, tall T-waves in V 3-5, ST-elevation in V 2-4, and mild thickening of the left ventricular myocardium, was first recognised 10 years earlier. Follow-up at age 39 years revealed mild myocardial thickening, two intra-ventricular aberrant bands, and, surprisingly, intermittent pre-excitation on a routine electrocardiography. Cardiac involvement in FSH-MD may manifest as hypertrophic cardiomyopathy or various arrhythmias, of which one maybe pre-excitation-syndrome.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
   [Stoellberger, Claudia; Gatterer, Edmund] Krankenanstalt Rudolfstiftung Wien, Dept Med 2, A-1180 Vienna, Austria.
   [Jakubiczka, Sibylle] Univ Hosp Magdeburg, Inst Human Genet, Magdeburg, Germany.
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR BERLIT P, 1991, EUR ARCH PSY CLIN N, V241, P177, DOI 10.1007/BF02219718
   Faustmann PM, 1996, J NEUROL SCI, V144, P59, DOI 10.1016/S0022-510X(96)00145-1
   Finsterer J, 2008, SCAND CARDIOVASC J, V42, P9, DOI 10.1080/14017430701854953
   Galetta F, 2005, NEUROMUSCULAR DISORD, V15, P403, DOI 10.1016/j.nmd.2005.02.006
   KILMER DD, 1995, AM J PHYS MED REHAB, V74, pS131, DOI 10.1097/00002060-199509001-00007
   Laforet P, 1998, NEUROLOGY, V51, P1454, DOI 10.1212/WNL.51.5.1454
   Shigeto Hiroshi, 2002, Rinsho Shinkeigaku, V42, P881
   STEVENSON WG, 1990, J AM COLL CARDIOL, V15, P292, DOI 10.1016/S0735-1097(10)80052-X
   TOPALOGLU H, 1990, POSTGRAD MED J, V66, P1088, DOI 10.1136/pgmj.66.782.1088
   Trevisan CP, 2006, EUR NEUROL, V56, P1, DOI 10.1159/000094248
NR 10
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 348
EP 350
DI 10.4070/kcj.2014.44.5.348
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400010
PM 25278989
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Park, SD
   Baek, YS
   Lee, SY
   Shin, SH
   Woo, SI
   Kim, DH
   Kwan, J
AF Kim, Soo-Han
   Park, Sang-Don
   Baek, Yong-Soo
   Lee, Seon-Young
   Shin, Sung-Hee
   Woo, Sung-Il
   Kim, Dae-Hyeok
   Kwan, Jun
TI Prasugrel-Induced Hypersensitivity Skin Reaction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prasugrel; Clopidogrel; Thienopyridine; Hypersensitivity; Exanthema
ID CLOPIDOGREL; TICLOPIDINE; ASPIRIN; THERAPY
AB We report a case of hypersensitivity skin reaction to prasugrel. The patient exhibited a generalized skin rash after treatment with prasugrel, which was resolved after discontinuation of prasugrel and substitution to clopidogrel. Clopidogrel was successfully administered as an alternative to prasugrel without any signs of further hypersensitivity.
C1 [Kim, Soo-Han; Park, Sang-Don; Baek, Yong-Soo; Lee, Seon-Young; Shin, Sung-Hee; Woo, Sung-Il; Kim, Dae-Hyeok; Kwan, Jun] Inha Univ, Coll Med, Dept Internal Med, Div Cardiol, Inchon, South Korea.
RP Kim, SH (corresponding author), Inha Univ Hosp, Dept Internal Med, Div Cardiol, 27 Inhang Ro, Inchon 400711, South Korea.
EM naeaidi@hanmail.net
CR Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597
   Cheema AN, 2011, J AM COLL CARDIOL, V58, P1445, DOI 10.1016/j.jacc.2011.06.040
   Deshmukh AJ, 2012, ANN PHARMACOTHER, V46, P1123, DOI 10.1345/aph.1R062
   Lokhandwala J, 2011, CURR ALLERGY ASTHM R, V11, P52, DOI 10.1007/s11882-010-0152-9
   Lokhandwala JO, 2009, CIRC-CARDIOVASC INTE, V2, P348, DOI 10.1161/CIRCINTERVENTIONS.108.832964.108.832964
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Mutnick JLM, 2012, ANN ALLERG ASTHMA IM, V108, P124, DOI 10.1016/j.anai.2011.11.005
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
NR 8
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 355
EP 357
DI 10.4070/kcj.2014.44.5.355
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400012
PM 25278991
OA Green Published
DA 2021-04-22
ER

PT J
AU Madias, JE
AF Madias, John E.
TI Inverse Takotsubo Syndrome Resulting from a Fall, Malleolar Fracture,
   Anesthesia, Surgery, or Complicating Pulmonary Embolism?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Madias, John E.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Madias, John E.] Elmhurst Hosp Ctr, Div Cardiol, Elmhurst, NY 11373 USA.
RP Madias, JE (corresponding author), Elmhurst Hosp Ctr, Div Cardiol, 79-01 Broadway, Elmhurst, NY 11373 USA.
EM madiasj@nychhc.org
CR Lee SH, 2013, KOREAN CIRC J, V43, P834, DOI 10.4070/kcj.2013.43.12.834
   Madias JE, 2013, INT J UROL
   Madias JE, 2014, EUR HEART J-ACUTE CA, V3, P28, DOI 10.1177/2048872613504311
   Madias JE, 2012, J ELECTROCARDIOL, V45, P795, DOI 10.1016/j.jelectrocard.2012.09.005
   Reynolds HR, 2011, CIRCULATION, V124, P1414, DOI 10.1161/CIRCULATIONAHA.111.026542
   Song BG, 2011, CLIN CARDIOL, V34, P693, DOI 10.1002/clc.20953
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 358
EP 358
DI 10.4070/kcj.2014.44.5.358
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400013
PM 25278992
OA Green Published
DA 2021-04-22
ER

PT J
AU Senoo, K
   Lane, D
   Lip, GYH
AF Senoo, Keitaro
   Lane, Deirdre
   Lip, Gregory Y. H.
TI Stroke and Bleeding Risk in Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Stroke; Hemorrhage; Risk assessment
ID NET CLINICAL BENEFIT; STRATIFICATION SCHEMES; ORAL ANTICOAGULANTS;
   APPENDAGE CLOSURE; ANTITHROMBOTIC TREATMENT; PREDICTING STROKE;
   HEART-DISEASE; FOLLOW-UP; WARFARIN; PREVENTION
AB Non-valvular atrial fibrillation (AF) is the most common cardiac arrhythmia in the clinical setting. AF increases both the risk and severity of strokes, and is associated with substantial morbidity and mortality. Despite the clear net clinical benefit of oral anticoagulants (OACs) in patients with AF at risk for stroke, major bleeding events, especially intracranial bleeds, may be devastating. In the last decade, four new OACs have been approved for stroke prevention in patients with AF and are at least as effective as warfarin with better bleeding profiles. These new agents have changed and simplified our approach to stroke prevention because the threshold for initiation of OACs is lowered. An important clinical practice shift is the initial identification of "low-risk" patients who do not need antithrombotic therapy, with low-risk comprising CHA(2)DS(2)-VASc {Congestive heart failure, Hypertension, Age >= 75 years (double), Diabetes mellitus, previous Stroke/transient ischemic attack/thromboembolism (double), Vascular disease, Age 65-74 years, and female gender (score of 0 for males and 1 for female)}. Subsequent to this step, effective stroke prevention consisting of OACs can be offered to patients with one or more stroke risk factors. Apart from stroke risk, another consideration is bleeding risk assessment, with a focus on the use of the validated HAS-BLED {Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile international normalized ratio (INR), Elderly (age >65 years), drugs or alcohol concomitantly} score. A high HAS-BLED score can flag patients potentially at risk for bleeding, and alert clinicians to the need for careful review and follow up, and the need to consider potentially correctable bleeding risk factors that include uncontrolled hypertension, labile INRs, concomitant aspirin use, and alcohol excess.
C1 [Senoo, Keitaro; Lane, Deirdre; Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.
RP Lip, GYH (corresponding author), Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, 13187QH, Birmingham, W Midlands, England.
EM g.y.h.lip@bham.ac.uk
RI Lane, Deirdre/AAX-1866-2020
OI Lane, Deirdre/0000-0002-5604-9378
FU Boehringer IngelheimBoehringer Ingelheim; Bayer HealthcareBayer AGBayer
   Healthcare Pharmaceuticals; BMSBristol-Myers Squibb; PfizerPfizer; BMJ
   Clinical Evidence
FX Deirdre Lane: Dr. Lane reports investigator-initated grants from
   Boehringer Ingelheim and Bayer Healthcare, personal fees from BMS,
   Pfizer, Boehringer Ingelheim and Bayer for educational lectures,
   non-financial support from Boehringer Inge Iheim for conference travel,
   and royalties from BMJ Clinical Evidence.
CR Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054
   Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019
   Azoulay L, 2013, EUR HEART J
   Banerjee A, 2012, THROMB HAEMOSTASIS, V107, P584, DOI 10.1160/TH11-11-0784
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Camm AJ, 2012, EUROPACE, V14, P1385, DOI 10.1093/europace/eus305
   Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443
   Dulli DA, 2003, NEUROEPIDEMIOLOGY, V22, P118, DOI 10.1159/000068743
   Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316
   EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002
   Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065
   Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031
   Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
   Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079
   FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8
   Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864
   Gallego P, 2014, AM J MED, V127, P1083, DOI 10.1016/j.amjmed.2014.05.023
   Gallego P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P312, DOI 10.1161/CIRCEP.111.967000
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Goto S, 2013, EUR HEART J, V34, P1039
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018
   Hart RG, 2007, NEUROLOGY, V69, P546
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990
   Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508
   Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Japanese Circulation Society, 2013, GUID PHARM ATR FIBR
   Kerr CR, 2005, J AM COLL CARDIOL, V46, P1307, DOI 10.1016/j.jacc.2005.07.007
   Landmesser U, 2012, EUR HEART J, V33, P698, DOI 10.1093/eurheartj/ehr393
   Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061
   Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425
   Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760
   Lip GYH, 2014, CHEST, V146, P719, DOI 10.1378/chest.13-2976
   Lip GYH, 2012, CIRC-ARRHYTHMIA ELEC, V5, P941, DOI 10.1161/CIRCEP.112.972869
   Lip GYH, 2011, THROMB HAEMOSTASIS, V106, P997, DOI 10.1160/TH11-10-0690
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527
   Nieuwlaat R, 2006, EUR HEART J, V27, P3018, DOI 10.1093/eurheartj/ehl015
   Ogawa S, 2013, J ARRYTHM, V29, P190, DOI 10.1016/j.joa.2013.03.002
   Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025
   Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x
   Olesen JB, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.11.024
   Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175
   Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364
   Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124
   Paciaroni M, 2005, J THROMB HAEMOST, V3, P1218, DOI 10.1111/j.1538-7836.2005.01344.x
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Poli D, 2014, INTERN EMERG MED, V9, P443, DOI 10.1007/s11739-014-1065-8
   Potpara TS, 2012, HEART, V98, P1341, DOI 10.1136/heartjnl-2012-301841
   Potpara TS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P319, DOI 10.1161/CIRCEP.111.966713
   Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097
   Reddy VY, 2013, J AM COLL CARDIOL, V61, P2551, DOI 10.1016/j.jacc.2013.03.035
   Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389
   Roldan V, 2013, CHEST, V143, P179, DOI 10.1378/chest.12-0608
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003
   Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021
   Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
   Taillandier S, 2012, J CARDIOVASC ELECTR, V23, P708, DOI 10.1111/j.1540-8167.2011.02257.x
   Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057
   van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0
   van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x
   You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304
NR 71
TC 29
Z9 31
U1 0
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 281
EP 290
DI 10.4070/kcj.2014.44.5.281
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400001
PM 25278980
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, J
   Kim, GB
   Kwon, HW
   Kwon, BS
   Bae, EJ
   Il Noh, C
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
AF Lee, Joowon
   Kim, Gi Beom
   Kwon, Hye Won
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
   Lim, Hong Gook
   Kim, Woong Han
   Lee, Jeong Ryul
   Kim, Yong Jin
TI Safety and Efficacy of the Off-Label Use of Milrinone in Pediatric
   Patients with Heart Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Milrinone; Heart disease; Child; Safety
ID JUNCTIONAL ECTOPIC TACHYCARDIA; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS;
   INTRAVENOUS MILRINONE; RISK-FACTORS; CHILDREN; FAILURE; ARRHYTHMIAS;
   INFANTS; PHARMACOKINETICS
AB Background and Objectives: Milrinone is often used in children to treat acute heart failure and prevent low cardiac output syndrome after cardiac surgery. Due to the lack of studies on the long-term milrinone use in children, the objective of this study was to assess the safety and efficacy of the current patterns of milrinone use for >= 3 days in infants and children with heart diseases.
   Subjects and Methods: We retrospectively reviewed the medical records of patients aged <13 years who received milrinone for >= 3 days from January 2005 to December 2012. Patients' characteristics including age, sex, height, weight, and body surface area were recorded. The following parameters were analyzed to identify the clinical application of milrinone: initial infusion rate, maintenance continuous infusion rate, total duration of milrinone therapy, and concomitantly infused inotropes. The safety of milrinone was determined based on the occurrence of adverse events such as hypotension, arrhythmia, chest pain, headache, hypokalemia, and thrombocytopenia.
   Results: We assessed 730 admissions (684 patients) during this period. Ventricular septal defects were the most common diagnosis (42.4%) in these patients. Milrinone was primarily used after cardiac surgery in 715 admissions (97.9%). The duration of milrinone treatment varied from 3 to 64.4 days (>= 7 days in 149 admissions). Ejection fraction and fractional shortening of the left ventricle improved in patients receiving milrinone after cardiac surgery. Dose reduction of milrinone due to hypotension occurred in only 4 admissions (0.5%). Although diverse arrhythmias occurred in 75 admissions (10.3%), modification of milrinone infusion to manage arrhythmia occurred in only 3 admissions (0.4%). Multivariate analysis indicated that the development of arrhythmia was not influenced by the pattern of milrinone use.
   Conclusion: Milrinone was generally administered for >= 3 days in children with heart diseases. The use of milrinone for >= 3 days was effective in preventing low cardiac output after cardiac surgery when combined with other inotropes, suggesting that milrinone could be safely employed in pediatric patients with heart diseases.
C1 [Lee, Joowon; Kim, Gi Beom; Kwon, Hye Won; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Lim, Hong Gook; Kim, Woong Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM ped9526@snu.ac.kr
RI 권, 혜원/Q-1141-2019; Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; Lee, Joowon/0000-0001-5089-6093
FU Ministry of Food and Drug safetyMinistry of Food & Drug Safety (MFDS)
   [12172MFDS231]
FX This study was supported by a 2012 grant (12172MFDS231) from Ministry of
   Food and Drug safety.
CR Assad-Kottner C, 2008, J CARD FAIL, V14, P839, DOI 10.1016/j.cardfail.2008.08.004
   Bishara Teresa, 2010, Can J Hosp Pharm, V63, P420
   CHANG AC, 1995, CRIT CARE MED, V23, P1907, DOI 10.1097/00003246-199511000-00018
   COLUCCI WS, 1991, AM HEART J, V121, P1945, DOI 10.1016/0002-8703(91)90829-7
   Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541
   Delaney JW, 2006, J THORAC CARDIOV SUR, V131, P1296, DOI 10.1016/j.jtcvs.2006.02.010
   Duggal B, 2005, PEDIATR CARDIOL, V26, P642, DOI 10.1007/s00246-005-0881-z
   Fleming GA, 2008, CIRCULATION, V118, P1619, DOI 10.1161/CIRCULATIONAHA.108.790162
   FRIEDMAN RA, 1991, J AM COLL CARDIOL, V18, P152, DOI 10.1016/S0735-1097(10)80233-5
   Grosse-Wortmann L, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-85
   Hoffman TM, 2003, CIRCULATION, V107, P996, DOI 10.1161/01.CIR.0000051365.81920.28
   Hoffman TM, 2002, ANN THORAC SURG, V74, P1607, DOI 10.1016/S0003-4975(02)04014-6
   Ichikawa R, 2011, CIRC J, V75, P932, DOI 10.1253/circj.CJ-10-0918
   KIKURA M, 1995, ANESTH ANALG, V81, P44, DOI 10.1097/00000539-199507000-00009
   Klugman D, 2010, PEDIATR CARDIOL, V31, P222, DOI 10.1007/s00246-009-9589-9
   Lindsay CA, 1998, J PEDIATR-US, V132, P329, DOI 10.1016/S0022-3476(98)70454-8
   Makhoul M, 2013, PEDIATR CARDIOL, V34, P370, DOI 10.1007/s00246-012-0465-7
   McMahon CJ, 2007, PEDIATR CARDIOL, V28, P317, DOI 10.1007/s00246-007-0020-0
   Miyake CY, 2014, AM J CARDIOL, V113, P535, DOI 10.1016/j.amjcard.2013.10.021
   MONRAD ES, 1985, CIRCULATION, V71, P972, DOI 10.1161/01.CIR.71.5.972
   MONRAD ES, 1984, CIRCULATION, V70, P1030, DOI 10.1161/01.CIR.70.6.1030
   PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103
   Pasquali SK, 2008, CIRC-CARDIOVASC QUAL, V1, P74, DOI 10.1161/CIRCOUTCOMES.108.787176
   Price JF, 2006, J CARD FAIL, V12, P139, DOI 10.1016/j.cardfail.2005.11.001
   Ramamoorthy C, 1998, ANESTH ANALG, V86, P283, DOI 10.1097/00000539-199802000-00011
   Seino Y, 1996, CRIT CARE MED, V24, P1490, DOI 10.1097/00003246-199609000-00010
   Smith AH, 2011, AM J CARDIOL, V108, P1620, DOI 10.1016/j.amjcard.2011.07.023
   Vogt W, 2011, INTENS CARE MED, V37, P1390, DOI 10.1007/s00134-011-2266-5
   Weerasinghe A, 1998, ANN THORAC SURG, V66, P2145, DOI 10.1016/S0003-4975(98)00749-8
   Zampi JD, 2012, PEDIATR CARDIOL, V33, P1362, DOI 10.1007/s00246-012-0348-y
NR 30
TC 6
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 320
EP 327
DI 10.4070/kcj.2014.44.5.320
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400006
PM 25278985
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, S
   Jeong, MH
   Jung, HK
   Lee, KJ
   Kim, KH
   Hong, YJ
   Kim, JH
   Ahn, Y
AF Jang, Suyoung
   Jeong, Myung Ho
   Jung, Hyung Ki
   Lee, Kyung Jin
   Kim, Kye Hun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
TI Successful Stent Implantation for Aortoiliac Bifurcation Stenosis in a
   Young Patient with Behcet's Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Behcet disease; Iliac artery; Stents
ID VASCULAR INVOLVEMENT; ANEURYSM
AB Behcet's disease (BD) is a multisystem vascular inflammatory disease. BD can affect blood vessels of nearly all sizes and types. Arterial involvement is a rare but serious condition in the course of BD. Here, we report a case of stenosis at the iliac artery bifurcation which was treated with percutaneous balloon angioplasty and stent implantation in a 37-year-old patient with BD.
C1 [Jang, Suyoung; Jeong, Myung Ho; Jung, Hyung Ki; Lee, Kyung Jin; Kim, Kye Hun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun] Chonnam Natl Univ, Sch Med, Dept Cardiovasc Med, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR BEHCET H, 1940, DERMATOLOGICA, V81, P73
   Cakir O, 2002, ANN VASC SURG, V16, P516, DOI 10.1007/s10016-001-0179-4
   Criteria for diagnosis of Behcet's disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-6736(90)92643-V
   DROBINSKI G, 1987, EUR HEART J, V8, P1133, DOI 10.1093/oxfordjournals.eurheartj.a062179
   Duzgun N, 2006, SCAND J RHEUMATOL, V35, P65, DOI 10.1080/03009740500255761
   Ideguchi H, 2011, CLIN EXP RHEUMATOL, V29, pS47
   Kaouel Karim, 2013, Tunis Med, V91, P423
   Ko GY, 2000, BRIT J RADIOL, V73, P1270, DOI 10.1259/bjr.73.876.11205670
   Melikoglu M, 2008, CLIN REV ALLERG IMMU, V35, P40, DOI 10.1007/s12016-007-8064-8
   Nakamura H, 2001, Mod Rheumatol, V11, P332, DOI 10.3109/s10165-001-8065-z
   ODUFFY JD, 1990, RHEUM DIS CLIN N AM, V16, P423
   Park TK, 2013, KOREAN CIRC J, V43, P277, DOI 10.4070/kcj.2013.43.4.277
   Sarica-Kucukoglu R, 2006, INT J DERMATOL, V45, P919, DOI 10.1111/j.1365-4632.2006.02832.x
   Sonia H, 2008, OPEN CARDIOVASC MED, V2, P118, DOI 10.2174/1874192400802010118
   Tekbas G, 2012, CARDIOVASC INTER RAD, V35, P826, DOI 10.1007/s00270-011-0322-8
   Toprak O, 2007, AM J MED SCI, V334, P396, DOI 10.1097/MAJ.0b013e318068d7c3
   Ugurlucan M, 2006, J CARDIAC SURG, V21, P589, DOI 10.1111/j.1540-8191.2006.00310.x
   Uher P, 2002, J ENDOVASC THER, V9, P67, DOI 10.1583/1545-1550(2002)009<0067:LTROSF>2.0.CO;2
   Ulusan Z, 2011, CARDIOVASC J AFR, V22, pE4, DOI 10.5830/CVJA-2010-077
NR 19
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2014
VL 44
IS 5
BP 351
EP 354
DI 10.4070/kcj.2014.44.5.351
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9IV
UT WOS:000342394400011
PM 25278990
OA Green Published
DA 2021-04-22
ER

PT J
AU Hung, CY
   Hsieh, YC
   Huang, JL
   Lin, CH
   Wu, TJ
AF Hung, Chen-Ying
   Hsieh, Yu-Cheng
   Huang, Jin-Long
   Lin, Ching-Heng
   Wu, Tsu-Juey
TI Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by
   CHADS(2)/CHA(2)DS(2)VASc Score
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hydroxymethylglutaryl-CoA reductase inhibitors; Atrial fibrillation;
   Primary prevention
ID C-REACTIVE PROTEIN; RISK-FACTORS; NEW-ONSET; GENDER-DIFFERENCES;
   OXIDATIVE STRESS; CHADS(2) SCORE; DRUG-THERAPY; FOLLOW-UP; ATORVASTATIN;
   METAANALYSIS
AB Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased cardiovascular morbidity and mortality. The antiarrhythmic effect of statins on AF prevention appears to be highly significant in most clinical studies. However, some discrepancies do exist among different clinical studies. Different clinical settings and types of stains used may explain these differences between trials. The CHADS(2) and CHA(2)DS(2)VASc scoring systems have been used for stroke risk stratification in AF patients. The recent study suggested that these scores can also be used to guide statin therapy for AF prevention. Patients with higher scores had a higher risk of developing AF and gained more benefits from statins therapy than those with lower scores. This review article focused on the ability of these scores to predict AF prevention by statins.
C1 [Hung, Chen-Ying; Hsieh, Yu-Cheng; Huang, Jin-Long; Wu, Tsu-Juey] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung 40705, Taiwan.
   [Hsieh, Yu-Cheng; Huang, Jin-Long; Wu, Tsu-Juey] Natl Yang Ming Univ, Fac Med, Sch Med, Cardiovasc Res Ctr,Inst Clin Med,Dept Internal Me, Taipei 112, Taiwan.
   [Huang, Jin-Long; Wu, Tsu-Juey] Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung 40705, Taiwan.
RP Wu, TJ (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, 1650 Taiwan Blvd,Sect 4, Taichung 40705, Taiwan.
EM tjwu@vghtc.gov.tw
CR Amer MS, 2011, J AM SOC HYPERTENS, V5, P395, DOI 10.1016/j.jash.2011.03.004
   Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F
   Bang CN, 2014, EUR J PREV CARDIOL, V21, P330, DOI 10.1177/2047487312462804
   Bang CN, 2013, INT J CARDIOL, V167, P624, DOI 10.1016/j.ijcard.2012.08.056
   Calo L, 2011, PACE, V34, P111, DOI 10.1111/j.1540-8159.2010.02942.x
   Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Caorsi C, 2008, EUR CYTOKINE NETW, V19, P99, DOI 10.1684/ecn.2008.0124
   Chao TF, 2013, INT J CARDIOL, V168, P1360, DOI 10.1016/j.ijcard.2012.12.011
   Chao TF, 2011, HEART RHYTHM, V8, P1155, DOI 10.1016/j.hrthm.2011.03.016
   Chello M, 2006, CRIT CARE MED, V34, P660, DOI 10.1097/01.CCM.0000201407.89977.EA
   Chen PS, 1999, AM J CARDIOL, V84, p125R
   Crandall MA, 2009, PACE, V32, P648, DOI 10.1111/j.1540-8159.2009.02339.x
   Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010
   Dernellis J, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.032
   Djindjic B, 2009, VOJNOSANIT PREGL, V66, P966, DOI 10.2298/VSP0912966D
   Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350
   Fang WT, 2012, BRIT J CLIN PHARMACO, V74, P744, DOI 10.1111/j.1365-2125.2012.04258.x
   Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063
   Fauchier L, 2013, CURR OPIN CARDIOL, V28, P7, DOI 10.1097/HCO.0b013e32835b0956
   Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292
   Goonasekara CL, 2010, EXPERT REV CARDIOVAS, V8, P965, DOI 10.1586/ERC.10.79
   Haywood LJ, 2009, J AM COLL CARDIOL, V54, P2023, DOI 10.1016/j.jacc.2009.08.020
   Huang SS, 2013, PLOS ONE, V8
   Hung CY, 2013, INT J CARDIOL, V168, P1131, DOI 10.1016/j.ijcard.2012.11.087
   Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027
   Hung CY, 2012, LIFE SCI J, V9, P30
   Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062
   Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054
   Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9
   Komatsu T, 2011, INT HEART J, V52, P359, DOI 10.1536/ihj.52.359
   Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225
   Kostapanos MS, 2007, CARDIOVASC RES, V75, P10, DOI 10.1016/j.cardiores.2007.02.029
   KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9
   Kumagai K, 2004, CARDIOVASC RES, V62, P105, DOI 10.1016/j.cardiores.2004.01.018
   Lee CW, 2012, AM J CARDIOL, V109, P1700, DOI 10.1016/j.amjcard.2012.01.399
   Li J, 2010, CLIN CARDIOL, V33, P222, DOI 10.1002/clc.20724
   Liang YJ, 2008, CARDIOLOGY, V110, P182, DOI 10.1159/000111928
   Liu T, 2008, INT J CARDIOL, V126, P160, DOI 10.1016/j.ijcard.2007.07.137
   Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042
   Macfarlane PW, 2011, EUROPACE, V13, P634, DOI 10.1093/europace/eur016
   Maehama T, 2010, AM J CARDIOL, V106, P535, DOI 10.1016/j.amjcard.2010.03.067
   Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Murray KT, 2007, HEART RHYTHM, V4, pS88, DOI 10.1016/j.hrthm.2006.12.027
   Naji Franjo, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P9
   Nakhjavani M, 2011, CELL STRESS CHAPERON, V16, P195, DOI 10.1007/s12192-010-0232-8
   Ozaydin M, 2006, AM J CARDIOL, V97, P1490, DOI 10.1016/j.amjcard.2005.11.082
   Page RL, 2005, NAT REV DRUG DISCOV, V4, P899, DOI 10.1038/nrd1876
   Park JH, 2011, EUROPACE, V13, P1541, DOI 10.1093/europace/eur135
   Pellegrini CN, 2009, HEART, V95, P704, DOI 10.1136/hrt.2008.154054
   Pena JM, 2012, EUR HEART J, V33, P531, DOI 10.1093/eurheartj/ehr460
   Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31
   Rahimi K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1250
   Romano M, 2000, J INVEST MED, V48, P183
   Romano M, 2000, LAB INVEST, V80, P1095, DOI 10.1038/labinvest.3780115
   Sandhu RK, 2012, AM J CARDIOL, V109, P538, DOI 10.1016/j.amjcard.2011.10.006
   Savelieva I, 2011, EUROPACE, V13, P308, DOI 10.1093/europace/eur002
   Savelieva I, 2010, N-S ARCH PHARMACOL, V381, P207, DOI 10.1007/s00210-009-0468-y
   Shiroshita-Takeshita A, 2005, J INTERV CARD ELECTR, V13, P181, DOI 10.1007/s10840-005-2362-y
   Sironi L, 2005, ARTERIOSCL THROM VAS, V25, P598, DOI 10.1161/01.ATV.0000157145.98200.55
   Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7
   Su Y, 2010, J CARDIOVASC PHARM, V55, P21, DOI 10.1097/FJC.0b013e3181bfb1df
   Tonstad S., 2007, Metabolic Syndrome and Related Disorders, V5, P174, DOI 10.1089/met.2006.0037
   Wang TJ, 2002, CIRCULATION, V106, P1189, DOI 10.1161/01.CIR.0000032135.98011.C4
   Wang ZS, 2011, PHARMACOTHERAPY, V31, P1051, DOI 10.1592/phco.31.11.1051
   Wann LS, 2011, CIRCULATION, V123, P1144, DOI 10.1161/CIR.0b013e31820f14c0
   Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229
NR 67
TC 4
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 205
EP 209
DI 10.4070/kcj.2014.44.4.205
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900001
PM 25089130
OA Green Published
DA 2021-04-22
ER

PT J
AU Nazer, B
   Gerstenfeld, EP
AF Nazer, Babak
   Gerstenfeld, Edward P.
TI Catheter Ablation of Ventricular Tachycardia in Patients with
   Post-Infarction Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Tachycardia; ventricular; Catheter ablation; Myocardial infarction;
   Cardiomyopathy
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; ANTIARRHYTHMIC-DRUG THERAPY;
   STRUCTURAL HEART-DISEASE; MYOCARDIAL-INFARCTION; RADIOFREQUENCY
   ABLATION; ISCHEMIC CARDIOMYOPATHY; RANDOMIZED-TRIAL; SLOW CONDUCTION;
   ASSIST DEVICES; SUDDEN-DEATH
AB Monomorphic ventricular tachycardia (VT) in patients with post-infarction cardiomyopathy (CMP) is caused by reentry through slowly conducting tissue with in areas of myocardial scar. The use of implantable cardioverter-defibrillators (ICDs) has helped to decrease the risk of arrhythmic death in patients with post-infarction CMP, but the symptomatic and psychological burden of ICD shocks remains significant. Experience with catheter ablation has progressed substantially in the past 20 years, and is now routinely used to treat patients with post-infarction CMP who experience VT or receive ICD therapy. Depending on the hemodynamic tolerance of VT, a variety of mapping techniques may be used to identify sites for catheter ablation, including activation and entrainment mapping for mappable VTs, or substrate mapping for unmappable VTs. In this review, we discuss the pathophysiology of VT in post-infarction CMP patients, and the contemporary practice of catheter ablation.
C1 [Nazer, Babak; Gerstenfeld, Edward P.] Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophys Sect, San Francisco, CA 94118 USA.
RP Gerstenfeld, EP (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, Electrophys Sect, MU East 4th Floor,500 Parnassus Ave, San Francisco, CA 94118 USA.
EM egerstenfeld@medicine.ucsf.edu
CR Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098
   Andersen M, 2009, J HEART LUNG TRANSPL, V28, P733, DOI 10.1016/j.healun.2009.03.011
   ANDERSON KP, 1978, CIRCULATION, V57, P890, DOI 10.1161/01.CIR.57.5.890
   Arenal A, 2003, J AM COLL CARDIOL, V41, P81, DOI 10.1016/S0735-1097(02)02623-2
   Aryana A, 2007, CIRCULATION, V115, P1191, DOI 10.1161/CIRCULATIONAHA.106.672162
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Bogun F, 2006, J AM COLL CARDIOL, V47, P2013, DOI 10.1016/j.jacc.2005.12.062
   Bogun F, 2005, J AM COLL CARDIOL, V46, P667, DOI 10.1016/j.jacc.2005.01.064
   Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503
   Calkins H, 2000, J AM COLL CARDIOL, V35, P1905, DOI 10.1016/S0735-1097(00)00615-X
   Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534
   Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297
   Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165
   Dandamudi G, 2007, HEART RHYTHM, V4, P1165, DOI 10.1016/j.hrthm.2007.05.029
   DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589
   Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044
   Frankel DS, 2012, J AM COLL CARDIOL, V59, P1529, DOI 10.1016/j.jacc.2012.01.026
   Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038
   Haqqani HM, 2009, J AM COLL CARDIOL, V54, P166, DOI 10.1016/j.jacc.2009.04.024
   Harikrishnan P, 2014, J AM COLL CARDIOL, V63, pA294, DOI 10.1016/S0735-1097(14)60294-1
   Hegel MT, 1997, INT J PSYCHIAT MED, V27, P57, DOI 10.2190/1G9V-EQMD-MTLQ-E0BW
   Hsia HH, 2009, J INTERV CARD ELECTR, V26, P21, DOI 10.1007/s10840-009-9421-8
   Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216
   Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001
   Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4
   Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748
   MORADY F, 1988, J AM COLL CARDIOL, V11, P775, DOI 10.1016/0735-1097(88)90211-2
   Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7
   Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Mountantonakis SE, 2013, J AM COLL CARDIOL, V61, P2088, DOI 10.1016/j.jacc.2013.02.031
   MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6
   Narang R, 1996, EUR HEART J, V17, P1390
   OKUMURA K, 1987, CIRCULATION, V75, P369, DOI 10.1161/01.CIR.75.2.369
   Osaki S, 2008, J HEART LUNG TRANSPL, V27, P353, DOI 10.1016/j.healun.2007.11.572
   OZ MC, 1994, J AM COLL CARDIOL, V24, P1688, DOI 10.1016/0735-1097(94)90175-9
   Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457
   Ruffy R, 1995, J CARDIOVASC ELECTR, V6, P1089, DOI 10.1111/j.1540-8167.1995.tb00386.x
   Sacher F, 2008, HEART RHYTHM, V5, P62, DOI 10.1016/j.hrthm.2007.09.012
   Sapp JL, 2013, CIRCULATION, V128, P2289, DOI 10.1161/CIRCULATIONAHA.113.003423
   Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633
   Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330
   STEVENSON WG, 1993, CIRCULATION, V88, P1647, DOI 10.1161/01.CIR.88.4.1647
   Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604
   Sweeney MO, 2010, HEART RHYTHM, V7, P353, DOI 10.1016/j.hrthm.2009.11.027
   Tanner H, 2010, J CARDIOVASC ELECTR, V21, P47, DOI 10.1111/j.1540-8167.2009.01563.x
   Verma A, 2005, J CARDIOVASC ELECTR, V16, P465, DOI 10.1046/j.1540-8167.2005.40443.x
   1997, N ENGL J MED, V337, P1576
NR 48
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 210
EP 217
DI 10.4070/kcj.2014.44.4.210
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900002
PM 25089131
OA Green Published
DA 2021-04-22
ER

PT J
AU Namazi, MH
   Saadat, H
   Safi, M
   Vakili, H
   Alipourparsa, S
   Bozorgmanesh, M
   Haybar, H
AF Namazi, Mohammad Hasan
   Saadat, Habibollah
   Safi, Morteza
   Vakili, Hossein
   Alipourparsa, Saeed
   Bozorgmanesh, Mohammadreza
   Haybar, Habib
TI Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of
   Coronary Artery Stenosis as Determined by the Synergy between
   Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE PTX3 protein; Coronary artery disease; Percutaneous coronary
   intervention; Coronary artery bypass grafting; Angiography
ID ASSOCIATION TASK-FORCE; ELEVATION MYOCARDIAL-INFARCTION; PRACTICE
   GUIDELINES COMMITTEE; CLINICAL SYNTAX SCORE; AMERICAN-COLLEGE; STABLE
   ANGINA; ROC CURVE; DISEASE; RISK; OUTCOMES
AB Background and Objectives: The aim of this study was to examine the hypothesis that pentraxin 3 (PTX3) can have a diagnostic value for predicting anatomical complexity of coronary artery stenosis as measured by the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score.
   Subjects and Methods: We investigated the association of systemic arterial PTX3 with SYNTAX score among 500 patients with ischemic heart disease assigned to medical treatment (251), percutaneous coronary intervention (PCI) (197), or coronary artery bypass graft (CABG) (52).
   Results: The clinical judgment of the cardiologists was near-perfectly concordant with the SYNTAX score. Mean {99% confidence intervals (CIs)} SYNTAX scores were 5.8 (5.1-6.6), 18.4 (17.1-19.8), and 33.2 (32.8-33.6) in patients assigned to medical therapy, PCI, and CABG, respectively. The AROC (95% CIs) for discriminating between patients with and without a high SYNTAX score (> 23) was 0.920 (0.895-0.946) for systemic arterial levels of PTX3. As the systemic arterial level of PTX3 increased, the SYNTAX scores also increased almost in a curvilinear fashion, with the value corresponding to the SYNTAX score of 23 being 0.29 ng . dL(-1). This cutpoint achieved a sensitivity of 0.66 (0.57-0.74), a specificity of 0.94 (0.91-0.96), a positive predictive value of 0.79 (0.70-0.87), and a negative predictive value of 0.89 (0.85-0.92).
   Conclusion: We observed that systemic arterial levels of PTX3 were associated with the SYNTAX score in a curvilinear fashion. The discriminatory power of systemic arterial levels of PTX3 for a high SYNTAX score was excellent. The interesting finding of this study was the near perfect concordance between the decisions made by the cardiologists based on their clinical judgment and the SYNTAX score. The systemic arterial PTX3 level of 0.29 ng . dL(-1) was highly specific for diagnosing complex coronary artery stenosis.
C1 [Namazi, Mohammad Hasan; Saadat, Habibollah; Safi, Morteza; Vakili, Hossein; Alipourparsa, Saeed] Shahid Beheshti Univ Med Sci, Cardiovasc Res Ctr, Tehran, Iran.
   [Bozorgmanesh, Mohammadreza] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.
   [Haybar, Habib] Ahvaz Jundishapur Univ Med Sci, Cardiovasc Res Ctr, Ahwaz, Iran.
RP Haybar, H (corresponding author), Ahvaz Jundishapur Univ Med Sci, Cardiovasc Res Ctr, Ahwaz, Iran.
EM takamoolsk@yahoo.com
RI vakili, hossein/P-4016-2018; Parsa, Saeed Alipour/J-1428-2016; Saadat,
   Habibollah/K-9221-2018; namazi, Mohammad Hasan/K-8925-2018; safi,
   morteza/P-2932-2018; Heybar, Habib/U-3984-2017
OI Parsa, Saeed Alipour/0000-0002-3305-2451; namazi, Mohammad
   Hasan/0000-0001-5801-9925; Heybar, Habib/0000-0002-9204-8698; vakili,
   hossien/0000-0003-3611-5670; parsa, saeed/0000-0003-4381-2773
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   [Anonymous], 2005, HUM PENTR 3 PTX3 EL
   Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53
   Brown AJ, 2014, ANGIOLOGY, V65, P408, DOI 10.1177/0003319713483542
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   Capodanno D, 2011, AM HEART J, V161, P462, DOI 10.1016/j.ahj.2010.11.018
   Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14
   Farooq V, 2014, HEART, V100, P276, DOI 10.1136/heartjnl-2013-304273
   Farooq V, 2011, HEART, V97, P1902, DOI 10.1136/heartjnl-2011-300718
   Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051
   Genereux P, 2011, CIRC-CARDIOVASC INTE, V4, P553, DOI 10.1161/CIRCINTERVENTIONS.111.961862
   Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829
   Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Haybar H, 2013, HEART, V99, P640, DOI 10.1136/heartjnl-2012-303560
   Hosmer DW., 2000, APPL LOGISTIC REGRES, V2nd ed
   Jou YL, 2012, CATHETER CARDIO INTE, V80, P222, DOI 10.1002/ccd.23450
   Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
   Kappetein P, 2010, GEN SWITZ EUR ASS CA
   Karakas MF, 2013, J INVEST MED, V61, P278, DOI 10.2310/JIM.0b013e31827c2971
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Lemesle G, 2009, CATHETER CARDIO INTE, V73, P612, DOI 10.1002/ccd.21883
   Magro M, 2012, AM J CARDIOL, V109, P601, DOI 10.1016/j.amjcard.2011.10.013
   Mc Fadden D., 1974, J PUBLIC ECON, V3, P303, DOI DOI 10.1016/0047-2727(74)90003-6
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Pearson TA, 2004, CIRCULATION, V110, pE543, DOI 10.1161/01.CIR.0000148979.11121.6B
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Pencina MJ, 2008, STAT MED, V27, P207, DOI 10.1002/sim.3106
   Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103
   Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049
   Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062
NR 38
TC 3
Z9 4
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 220
EP U80
DI 10.4070/kcj.2014.44.4.220
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900004
PM 25089133
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, YH
   Kim, Y
   Hyeon, CW
   Hyun, S
   Kwon, JE
   Won, H
   Shin, SY
   Lee, WS
   Lee, KJ
   Kim, SW
   Kim, TH
   Kim, CJ
AF Choi, Young Hwan
   Kim, Young
   Hyeon, Cheol Won
   Hyun, Seonghyup
   Kwon, Jee Eun
   Won, Hoyoun
   Shin, Seung Yong
   Lee, Wang-Soo
   Lee, Kwang Je
   Kim, Sang-Wook
   Kim, Tae Ho
   Kim, Chee Jeong
TI Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of
   Ezetimibe
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ezetimibe; Hydroxymethylglutaryl-CoA reductase inhibitors; Lipids;
   Lipoproteins
ID INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; PRIMARY
   HYPERCHOLESTEROLEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; ABSORPTION
   INHIBITOR; ENDOTHELIAL FUNCTION; AND/OR SIMVASTATIN; RANDOMIZED-TRIAL;
   ATORVASTATIN; LOVASTATIN
AB Background and Objectives: The inhibition of cholesterol absorption by ezetimibe increases cholesterol synthesis. The effect of inhibition of cholesterol synthesis on cholesterol absorption is controversial. The influence of these interactions on cholesterol levels is unknown. We investigated on the extent to which cholesterol levels were affected by the reaction of one pathway to the inhibition of the other pathway.
   Subjects and Methods: This case-controlled study enrolled 198 patients who needed cholesterol-lowering drugs. Ezetimibe (10 mg) was administered to the patients with (n=58) and without on-going statin therapy (n=58). Simvastatin (20 mg) was administered to the patients treated with (n=41) and without ezetimibe (n=41).
   Results: Ezetimibe without statin lowered the total cholesterol by 13.3 +/- 8.8% (p<0.001) and the low density lipoprotein-cholesterol (LDL-C) by 18.7 +/- 15.3% (p<0.001). Ezetimibe added to statin decreased the total cholesterol by 21.1 +/- 7.7% (p<0.001) and the LDL-C by 29.9 +/- 12.6% (p<0.001). The total cholesterol and LDL-C were reduced more by ezetimibe in patients with statin therapy than in those without statin therapy (p<0.001 and p<0.001, respectively). The differences in the effect of simvastatin on total cholesterol and LDL-C between the patients with and without ezetimibe showed borderline significance (p=0.10 and p=0.055, respectively).
   Conclusion: A prior inhibition of cholesterol synthesis by statin enhanced the effect of ezetimibe on total cholesterol and LDL-C by 7.8% and 11.2%, respectively. This finding suggests that ezetimibe increased cholesterol synthesis, resulting in a significant elevation of cholesterol levels.
C1 [Choi, Young Hwan; Kim, Young; Hyeon, Cheol Won; Hyun, Seonghyup; Kwon, Jee Eun; Won, Hoyoun; Shin, Seung Yong; Lee, Wang-Soo; Lee, Kwang Je; Kim, Sang-Wook; Kim, Tae Ho; Kim, Chee Jeong] Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 156070, South Korea.
RP Kim, CJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, 102 Heukseok Ro, Seoul 156070, South Korea.
EM cjkim@cau.ac.kr
RI Shin, Seung Yong/AAF-7226-2019
OI Shin, Seung Yong/0000-0002-3408-6899; Won, Hoyoun/0000-0001-7880-3477
CR Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8
   Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a
   Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4
   Fichtlscherer S, 2006, EUR HEART J, V27, P1182, DOI 10.1093/eurheartj/ehi881
   Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031
   Gagne C, 2002, AM J CARDIOL, V90, P1084, DOI 10.1016/S0002-9149(02)02774-1
   Gouni-Berthold I, 2008, ATHEROSCLEROSIS, V198, P198, DOI 10.1016/j.atherosclerosis.2007.09.034
   Hidaka H, 1995, J Atheroscler Thromb, V2, P60
   Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742
   Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2
   Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311
   Meaney A, 2009, J CLIN PHARMACOL, V49, P838, DOI 10.1177/0091270009337011
   Pearson TA, 2005, MAYO CLIN PROC, V80, P587, DOI 10.4065/80.5.587
   Pearson TA, 2009, AM J CARDIOL, V103, P369, DOI 10.1016/j.amjcard.2008.09.090
   Piorkowski M, 2007, J AM COLL CARDIOL, V49, P1035, DOI 10.1016/j.jacc.2006.10.064
   Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602
   Sager PT, 2003, AM J CARDIOL, V92, P1414, DOI 10.1016/j.amjcard.2003.08.048
   Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC
   Sudhop T, 2009, J LIPID RES, V50, P2117, DOI 10.1194/jlr.P900004-JLR200
   Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569
   UUSITUPA MIJ, 1992, ARTERIOSCLER THROMB, V12, P807, DOI 10.1161/01.ATV.12.7.807
   VANHANEN H, 1992, EUR J CLIN PHARMACOL, V42, P127, DOI 10.1007/BF00278470
NR 22
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 227
EP 232
DI 10.4070/kcj.2014.44.4.227
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900005
PM 25089134
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, GB
   Park, S
   Kwon, BS
   Han, JW
   Park, YW
   Hong, YM
AF Kim, Gi Beom
   Park, Sohee
   Kwon, Bo Sang
   Han, Ji Whan
   Park, Yong Won
   Hong, Young Mi
TI Evaluation of the Temporal Association between Kawasaki Disease and
   Viral Infections in South Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Infection; Association
ID EPIDEMIOLOGIC FEATURES; MANAGEMENT; CHILDREN
AB Background and Objectives: This study is aimed at elucidating potential temporal associations between the occurrence of Kawasaki disease (KD) and various viral infections.
   Subjects and Methods: We obtained monthly patterns of KD from the seventh nationwide survey and viral detection data from the Korea Centers for Disease Control and Prevention from 2009 to 2011 and evaluated temporal correlations between them for each month. The respiratory viruses detected using a multiplex real-time-polymerase chain reaction kit were influenza virus (A/H1N1, A/H3N2, A/H5N1, and B), adenovirus, parainfluenza virus (type 1, 2, 3), respiratory syncytial virus (type A, B), human rhinovirus, human coronavirus (OC43/229E, NL63), human bocavirus, and enterovirus.
   Results: We obtained data from a total of 13031 patients who were treated for acute KD from 87 hospitals with pediatric residence programs. During this survey, KD showed highest overall incidence in summer and winter seasons and lowest incidence in February and October. We received viral detection data for a total of 14267 patients. Viral detection was highest during winter and spring seasons. The most commonly detected virus was human rhinovirus (32.6%), followed by influenza virus (26.8%). The monthly incidence of KD showed significant correlation with the monthly overall viral detection (p=0.022, r=0.382). In particular, human bocavirus and enterovirus have significant correlations with monthly patterns of KD occurrence (p=0.032 and p=0.007, respectively) and influenza virus correlated with KD occurrence with borderline significance (p=0.063).
   Conclusion: The temporal association between monthly occurrence of KD and viral detection suggests the etiologic importance of precedent infection in the development of KD.
C1 [Kim, Gi Beom; Kwon, Bo Sang] Seoul Natl Univ Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Park, Sohee] Yonsei Univ, Dept Biostat, Seoul 120749, South Korea.
   [Han, Ji Whan] Uijeongbu St Marys Hosp, Dept Pediat, Uijongbu, South Korea.
   [Park, Yong Won] Inje Univ, Seoul Paik Hosp, Dept Pediat, Seoul, South Korea.
   [Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea.
RP Kwon, BS (corresponding author), Seoul Natl Univ Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM cielcel0@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
FU Korean Society of Cardiology [0620113320]
FX The authors thank all the pediatricians and hospitals that participated
   in the seventh nationwide KD survey and especially thank the Laboratory
   of Respiratory Viruses at the Korea Centers for Disease Control and
   Prevention for supplying national viral detection data. This study is
   supported by a grant (No. 0620113320) from the Korean Society of
   Cardiology (2011).
CR Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002
   Catalano-Pons C, 2007, CLIN MICROBIOL INFEC, V13, P1220, DOI 10.1111/j.1469-0691.2007.01827.x
   Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008
   Cheong HM, 2013, PREVALENCE RESPIRATO, V6, P589
   Esper F, 2005, J INFECT DIS, V191, P499, DOI 10.1086/428291
   조은영, 2009, Clinical and Experimental Pediatrics, V52, P1241
   Frazer J, 2012, NATURE, V484, P21, DOI 10.1038/484021a
   Jordan-Villegas A, 2010, PEDIATR INFECT DIS J, V29, P770, DOI 10.1097/INF.0b013e3181dba70b
   Kawasaki T, 1967, Arerugi, V16, P178
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kim Ja Hye, 2012, Korean J Pediatr, V55, P470, DOI 10.3345/kjp.2012.55.12.470
   Luca NJC, 2012, DRUGS, V72, P1029, DOI 10.2165/11631440-000000000-00000
   Nakamura Y, 2008, J EPIDEMIOL, V18, P273, DOI 10.2188/jea.JE2008030
   Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126
   Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182
   Park YW, 2011, PEDIATR INT, V53, P36, DOI 10.1111/j.1442-200X.2010.03178.x
   Principi N, 2013, J INFECTION, V67, P1, DOI 10.1016/j.jinf.2013.04.004
   Rigante D, 2012, RHEUMATOL INT, V32, P4037, DOI 10.1007/s00296-010-1613-0
   Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152
   Santos RA, 2011, J MICROBIOL IMMUNOL, V44, P235, DOI 10.1016/j.jmii.2011.01.016
   Takahashi K, 2011, CLIN EXP IMMUNOL, V164, P20, DOI 10.1111/j.1365-2249.2011.04361.x
   Wood LE, 2009, HEART, V95, P787, DOI 10.1136/hrt.2008.143669
NR 22
TC 15
Z9 16
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 250
EP 254
DI 10.4070/kcj.2014.44.4.250
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900008
PM 25089137
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CH
   Kim, U
AF Lee, Chan-Hee
   Kim, Ung
TI Revascularization for Patients with Idiopathic Thrombocytopenic Purpura
   and Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Idiopathic thrombocytopenic purpura; Coronary artery disease; Myocardial
   revascularization
ID ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS IMMUNOGLOBULIN; STEROID-THERAPY
AB Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder with a low platelet count characterized by premature platelet destruction and suppression of platelet production mediated by autoantibodies, which may predispose to bleeding. Although the prevalence of coronary artery disease (CAD) in ITP seems to be rare, their co-occurrence is not unusual. Patients with ITP have increased risks for thrombosis and atherosclerosis associated with hemostatic factors, endothelial damage, and the negative effects of steroid and immunoglobulin therapies. Thus, the coexistence of ITP and CAD presents complex problems requiring a balance between hemorrhagic risk and prevention of thrombosis. Here, the authors present two patients with ITP, who were revascularized in different ways for CAD. Although the optimal management of thrombocytopenic patients with CAD is uncertain, individualized treatment modalities can be useful in patients with ITP and CAD.
C1 [Lee, Chan-Hee; Kim, Ung] Yeungnam Univ, Med Ctr, Div Cardiol, Taegu 705717, South Korea.
RP Kim, U (corresponding author), Yeungnam Univ, Med Ctr, Div Cardiol, 170 Hyeonchung Ro, Taegu 705717, South Korea.
EM woongwa@hanmail.net
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Caputo RP, 2000, J INVASIVE CARDIOL, V12, P365
   Chevalier B, 2003, CATHETER CARDIO INTE, V58, P285, DOI 10.1002/ccd.10431
   Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501
   Cines DB, 2009, BLOOD, V113, P6511, DOI 10.1182/blood-2009-01-129155
   Elkayam O, 2000, ANN RHEUM DIS, V59, P77, DOI 10.1136/ard.59.1.77
   Fisman DN, 1997, CAN J CARDIOL, V13, P775
   Fong Man-Cai, 2006, J Chin Med Assoc, V69, P436
   Fruchter O, 2002, AM J MED SCI, V323, P279, DOI 10.1097/00000441-200205000-00010
   Inoue Y, 2004, ANN THORAC SURG, V77, P1819, DOI 10.1016/S0003-4975(03)01247-5
   Khandekar MM, 2006, J CLIN PATHOL, V59, P146, DOI 10.1136/jcp.2004.025387
   Mathew TC, 1997, ANN THORAC SURG, V64, P1059, DOI 10.1016/S0003-4975(97)00763-7
   Moretti C, 2008, INT J CARDIOL, V130, pE96, DOI 10.1016/j.ijcard.2007.06.141
   Neskovic AN, 2010, HERZ, V35, P43, DOI 10.1007/s00059-010-3262-1
   Paolini R, 1999, BLOOD COAGUL FIBRIN, V10, P439, DOI 10.1097/00001721-199910000-00007
   Patrassi GM, 1995, CLIN APPL THROMB-HEM, V1, P277, DOI 10.1177/107602969500100406
   Russo A, 2011, INTERACT CARDIOV TH, V13, P153, DOI 10.1510/icvts.2011.271296
   Stangel M, 1997, CLIN NEUROPHARMACOL, V20, P385, DOI 10.1097/00002826-199710000-00002
   Yellin A, 2003, J THORAC CARDIOV SUR, V125, P554, DOI 10.1067/mtc.2003.31
NR 20
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 264
EP 267
DI 10.4070/kcj.2014.44.4.264
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900010
PM 25089139
OA Green Published
DA 2021-04-22
ER

PT J
AU Kalcik, M
   Gursoy, MO
   Karakoyun, S
   Yesin, M
   Astarcioglu, MA
   Ozkan, M
AF Kalcik, Macit
   Gursoy, M. Ozan
   Karakoyun, Suleyman
   Yesin, Mahmut
   Astarcioglu, Mehmet Ali
   Ozkan, Mehmet
TI Potential Inherited Causes of Recurrent Prosthetic Mitral Valve
   Thrombosis in a Pregnant Patient Suffering from Recurrent Miscarriage
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pregnancy; Heart valves; Thrombophilia; Abortion; spontaneous;
   Thrombosis
ID ARTERY-DISEASE; POLYMORPHISM; ASSOCIATION; GENE
AB An effective anticoagulation is critical in pregnant patients with prosthetic heart valves. Inherited disorders may interfere with the coagulation cascade and may be associated with obstetrical complications as well as with prosthetic valve-derived complications. The patient in the present case had a history of recurrent prosthetic heart valve thrombosis (PHVT) despite an effective anticoagulation. She underwent a thrombolysis with low-dose prolonged infusion of tissue-type plasminogen activator for the management of her recurrrent prosthetic valve thrombosis. The genetic testing showed homozygous mutations of methylenetetrahydrofolate reductase (MTHFR) A 1298 C and heterozygous mutations of B-fibrinogen 455 G-A. Inherited disorders such as MTHFR A 1298 C and fibrinogen 455G/A polymorphisms may be involved in the pathogenesis of recurrent PHVT and/or pregnancy loss.
C1 [Kalcik, Macit; Gursoy, M. Ozan; Karakoyun, Suleyman; Yesin, Mahmut; Astarcioglu, Mehmet Ali] Kosuyolu Kartal Heart & Res Hosp, Dept Cardiol, TR-34480 Istanbul, Turkey.
   [Ozkan, Mehmet] Kars Kafkas Univ, Fac Med, Dept Cardiol, Kars, Turkey.
RP Kalcik, M (corresponding author), Kosuyolu Kartal Heart & Res Hosp, Dept Cardiol, Milangaz Caddesi Unluer Sitesi B Blok 22 Kartal, TR-34480 Istanbul, Turkey.
EM macitkalcik@yahoo.com
RI Astarcioglu, Mehmet/AAA-8047-2021; karakoyun, suleyman/C-4460-2017
OI karakoyun, suleyman/0000-0003-0916-9059; ASTARCIOGLU, MEHMET
   ALI/0000-0001-8577-9890
CR Bozdemir V, 2010, ANATOL J CARDIOL, V10, P209, DOI 10.5152/akd.2010.059
   Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004
   Chan WS, 2000, ARCH INTERN MED, V160, P191, DOI 10.1001/archinte.160.2.191
   D'Uva Maristella, 2010, J Clin Med Res, V2, P18, DOI 10.4021/jocmr2010.02.260w
   James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008
   Kim SY, 2011, AM J REPROD IMMUNOL, V66, P252, DOI 10.1111/j.1600-0897.2011.00996.x
   Ozkan M, 2013, CIRCULATION, V128, P532, DOI 10.1161/CIRCULATIONAHA.113.001145
   Ozkan M, 2013, JACC-CARDIOVASC IMAG, V6, P206, DOI 10.1016/j.jcmg.2012.10.016
   Ozkan M, 2009, CIRCULATION, V120, pE151, DOI 10.1161/CIRCULATIONAHA.109.873786
   Spiroski I, 2008, ACTA BIOCHIM POL, V55, P587, DOI 10.18388/abp.2008_3065
   Weng XD, 1999, THROMB HAEMOSTASIS, V82, P1406
NR 11
TC 9
Z9 9
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 268
EP 270
DI 10.4070/kcj.2014.44.4.268
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900011
PM 25089140
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, S
   Miller, JM
   Das, MK
AF Han, Seongwook
   Miller, John M.
   Das, Mithilesh Kumar
TI Supraventricular Tachycardia and Sinus Rhythm with Contralateral Bundle
   Branch Block Patterns
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bundle-branch block; Tachycardia; supraventricular; Bundle of His;
   Purkinje fibers
AB A contralateral bundle branch block (BBB) aberration during tachycardia with a preexisting BBB strongly suggests the presence of ventricular tachycardia. We report on a middle-aged, female patient presented with wide QRS tachycardia. The patient had orthodromic atrioventricular tachycardia with a left BBB aberration in the presence of a preexisting right BBB due to an abnormal His-Purkinje system. We learned that the contralateral BBB aberration with supraventricular tachycardia could be seen when the His-Purkinje system was abnormal.
C1 [Han, Seongwook; Miller, John M.; Das, Mithilesh Kumar] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.
RP Das, MK (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 North Capitol Ave, Indianapolis, IN 46202 USA.
EM midas@iupui.edu
CR de Pdua F, 2011, COMPREHENSIVE ELECTR, P554
   DEMOULIN JC, 1972, BRIT HEART J, V34, P807
   Issa Z, 2009, CLIN ARRHYTHMOLOGY E, P398
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 271
EP 273
DI 10.4070/kcj.2014.44.4.271
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900012
PM 25089141
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, E
   Baek, JY
   Chung, HH
   Park, SI
   Jang, JH
   Yu, HA
   Woo, GH
   Youn, HJ
AF Chung, Eun
   Baek, Ju Yeol
   Chung, Han Hee
   Park, Seong Il
   Jang, Ji Hye
   Yu, Hyun A.
   Woo, Gi Hyeon
   Youn, Ho Joong
TI A Case of Unruptured Aneurysm of the Right Sinus of Valsalva with Right
   Ventricular Outflow Obstruction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sinus of Valsalva; Aneurysm; Ventricular outflow obstruction
ID ECHOCARDIOGRAPHIC DIAGNOSIS
AB A 66-year-old man presented with exertional dyspnea. He was found to have an unruptured aneurysm of the right sinus of Valsalva causing significant right ventricular outflow obstruction. This aneurysm was diagnosed by transthoracic two-dimensional echocardiography, transthoracic three-dimensional echocardiography, transesophageal echocardiography, contrast echocardiography and 64-slice multidetector cardiac computed tomography. Because unruptured aneurysms of the sinus of Valsalva are rarely symptomatic, they can be difficult to detect. However, the unruptured aneurysm of the right sinus of Valsalva in this case caused significant right ventricular outflow tract obstruction, resulting in exertional dyspnea.
C1 [Chung, Eun; Chung, Han Hee; Park, Seong Il; Jang, Ji Hye; Yu, Hyun A.; Woo, Gi Hyeon; Youn, Ho Joong] Catholic Univ, Korea Coll Med, Dept Internal Med, Seoul, South Korea.
   [Baek, Ju Yeol] Cheongju St Marys Hosp, Dept Internal Med, 173-19 Juseong Ro, Cheongju 360568, South Korea.
RP Baek, JY (corresponding author), Cheongju St Marys Hosp, Dept Internal Med, 173-19 Juseong Ro, Cheongju 360568, South Korea.
EM megaroad1000@gmail.com
CR DEV V, 1993, AM HEART J, V126, P930, DOI 10.1016/0002-8703(93)90709-I
   Feldman DN, 2006, CARDIOLOGY, V106, P73, DOI 10.1159/000092635
   KIEFABER RW, 1986, J AM COLL CARDIOL, V7, P438, DOI 10.1016/S0735-1097(86)80519-8
   Moustafa S, 2007, AM J CARDIOL, V99, P1159, DOI 10.1016/j.amjcard.2006.11.047
   Ott David A, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P165
   TERDJMAN M, 1984, J AM COLL CARDIOL, V3, P1227, DOI 10.1016/S0735-1097(84)80181-3
   Thankachen R, 2003, TEX HEART I J, V30, P152
   Yang YH, 2008, J CARDIAC SURG, V23, P782, DOI 10.1111/j.1540-8191.2008.00662.x
NR 8
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 274
EP 277
DI 10.4070/kcj.2014.44.4.274
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900013
PM 25089142
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, KC
AF Hwang, Ki-Chul
TI The Role of MicroRNAs in Vascular Diseases; Smooth Muscle Cell
   Differentiation and De-Differentiation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GENE-EXPRESSION; MYOCARDIN; PLASTICITY; SRF
C1 Yonsei Univ, Coll Med, Inst Cardiovasc Res, Severance Biomed Sci Inst, Seoul 120752, South Korea.
RP Hwang, KC (corresponding author), Yonsei Univ, Coll Med, Inst Cardiovasc Res, Severance Biomed Sci Inst, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM kchwang@yuhs.ac
CR Albinsson S, 2013, PHARMACOL RES, V75, P28, DOI 10.1016/j.phrs.2013.04.003
   Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688
   Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005
   Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517
   CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172, DOI 10.1161/01.ATV.17.1.172
   Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195
   Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007
   Kee HJ, 2014, KOREAN CIRC J, V44, P255, DOI 10.4070/kcj.2014.44.4.255
   Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306
   Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200
   McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505
   McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005
   Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003
   Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382
   Xie CQ, 2011, VITAM HORM, V87, P321, DOI 10.1016/B978-0-12-386015-6.00034-2
   Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006
NR 18
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 218
EP 219
DI 10.4070/kcj.2014.44.4.218
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900003
PM 25089132
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Lee, JS
   Ko, YG
   Lee, SH
   Lee, BS
   Kang, SM
   Chang, BC
   Pak, HN
AF Park, Jae Hyung
   Lee, Jihei Sara
   Ko, Young-Guk
   Lee, Seung Hyun
   Lee, Beom Seob
   Kang, Seok-Min
   Chang, Byung Cheol
   Pak, Hui-Nam
TI Histological and Biochemical Comparisons between Right Atrium and Left
   Atrium in Patients with Mitral Valvular Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Mitral valve disease; Fibrosis; Subendocardium
ID VALVE DISEASE; EXPRESSION; CELLS; HEART; BEHAVIORS; APPENDAGE; ANATOMY
AB Background and Objectives: It has been known that the dominant driver of atrial fibrillation (AF) exists in the left atrium (LA) and the incidence of systemic thromboembolism is higher than that of pulmonary thromboembolism in patients with AF. Therefore, we hypothesized that histological and biochemical characteristics of the LA and the right atrium (RA) are different in patients with mitral valvular AF.
   Subjects and Methods: We analyzed the histology and messenger ribonucleic acid (mRNA) or protein expression associated with endothelial function and thrombogenesis in 33 human atrial appendage tissues (20 LA tissues, 13 RA tissues) taken from 25 patients {57.7 +/- 11.3 years old, 44% males, AF: sinus rhythm (SR)=17:8} with mitral valve disease. We also performed whole mRNA quantification in 8 tissues (both LA and RA tissues from 4 patients) by using next generation sequencing (NGS).
   Results: 1) The degree of fibrosis (p=0.001) and subendocardial smooth muscle thickness (p=0.004) were significantly greater in the LA than in the RA. 2) More advanced matrix fibrosis was found in the LA of patients with AF than in the LA of patients with SR (p=0.046), but not in the RA. 3) There was no LA-RA difference in protein (Western blot) and mRNA {quantitative real-time polymerase chain reaction (qRT-PCR)} expressions of NF-kappa B, 3-NT, CD31, E-selectin, inducible NO synthase, stromal cell-derived factor-1 alpha, Endothelin-1, platelet-derived growth factor, myeloperoxidase, or NCX, except for higher mRNA expression of HCN4 in the RA (qRT-PCR, p=0.026) and that of KCNN1 in the LA (NGS, p=0.016).
   Conclusion: More advanced matrix and subendocardial remodeling were noticed in the LA than in the RA in patients with mitral valvular AF. However, the expressions of tissue factors associated with thrombogenesis were not significantly different between the RA and the LA.
C1 [Park, Jae Hyung; Lee, Jihei Sara; Ko, Young-Guk; Lee, Seung Hyun; Lee, Beom Seob; Kang, Seok-Min; Chang, Byung Cheol; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Seoul 120752, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM ygko@yuhs.ac; hnpak@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015; Chang, Byung/AAP-9674-2020
OI Pak, Hui-Nam/0000-0002-3256-3620; Ko, Young-Guk/0000-0001-7748-5788;
   Kang, Seok-Min/0000-0001-9856-9227; lee, seung hyun/0000-0002-0311-6565
FU Korean Society of Cardiology; Korea Health 21 R&D Project, Ministry of
   Health and Welfare in Republic of Korea [A120478]
FX This research was supported by a grant from the Korean Society of
   Cardiology (2011) and the Korea Health 21 R&D Project (A120478),
   Ministry of Health and Welfare in Republic of Korea.
CR Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131
   [Anonymous], AM J CARDIOL
   Burstein B, 2008, CIRCULATION, V117, P1630, DOI 10.1161/CIRCULATIONAHA.107.748053
   Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16
   Chen CN, 2006, BLOOD, V107, P1933, DOI 10.1182/blood-2005-08-3137
   Corradi D, 2011, J CARDIOVASC ELECTR, V22, P223, DOI 10.1111/j.1540-8167.2010.01887.x
   DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074
   Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108
   Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2
   Freestone B, 2008, Hamostaseologie, V28, P207
   Frenette PS, 1998, BLOOD, V91, P1318, DOI 10.1182/blood.V91.4.1318
   Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X
   Goldsmith I, 2000, AM HEART J, V140, P777, DOI 10.1067/mhj.2000.110284
   Ho SY, 2010, PACE, V33, P620, DOI 10.1111/j.1540-8159.2009.02659.x
   King T, 2002, DEV DYNAM, V225, P212, DOI 10.1002/dvdy.10142
   Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942
   Malmstrom RE, 2010, ACTA PHYSIOL, V198, P441, DOI 10.1111/j.1748-1716.2009.02062.x
   Modrego J, 2010, J CARDIOVASC ELECTR, V21, P859, DOI 10.1111/j.1540-8167.2010.01718.x
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Ohkita M, 2002, CLIN SCI, V103, p68S, DOI 10.1042/CS103S068S
   Park JH, 2013, CARDIOVASC PATHOL, V22, P58, DOI 10.1016/j.carpath.2012.05.001
   ROSENBLUM WI, 1994, AM J PATHOL, V145, P33
   Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124
   Sohara H, 1997, J AM COLL CARDIOL, V29, P106, DOI 10.1016/S0735-1097(96)00427-5
   Subramaniam B, 2006, J AM SOC ECHOCARDIOG, V19, P429, DOI 10.1016/j.echo.2005.10.013
   Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524
   Turu MM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-47
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
NR 28
TC 6
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 233
EP 242
DI 10.4070/kcj.2014.44.4.233
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900006
PM 25089135
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, Y
   Cha, MJ
   Choi, EK
   Oh, IY
   Oh, S
AF Cho, Youngjin
   Cha, Myung-Jin
   Choi, Eue-Keun
   Oh, Il-Young
   Oh, Seil
TI Effects of Low-Intensity Autonomic Nerve Stimulation on Atrial
   Electrophysiology
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Autonomic nervous system; Atrial fibrillation; Atrial remodeling
ID GANGLIONATED PLEXI; FIBRILLATION INDUCIBILITY; PREVENTION; ABLATION;
   HYPERINNERVATION; PATHOPHYSIOLOGY; GAP-43; VAGUS
AB Background and Objectives: The cardiac autonomic nervous system is an emerging target for therapeutic control of atrial fibrillation (AF). We evaluated the effects of low-intensity autonomic nerve stimulation (LI-ANS) on atrial electrophysiology, AF vulnerability, and neural remodeling.
   Materials and Methods: Fourteen dogs were subjected to 3 hours rapid atrial pacing (RAP, 5 Hz) and concomitant high frequency LI-ANS (20 Hz, at voltages 40% below the threshold) as follows: no autonomic stimulation (control, n=3); or right cervical vagus nerve (RVN, n=6), anterior right ganglionated plexi (ARGP, n=3), and superior left ganglionated plexi (SLGP, n=2) stimulation. Programmed and burst atrial pacing were performed at baseline and at the end of each hour to determine atrial effective refractory period (ERP), window of vulnerability (WOV), and inducibility of sustained AF.
   Results: Atrial ERP was significantly shortened by 3 hours RAP (in control group, Delta ERP=-47.9 +/- 8.9%, p=0.032), and RAP-induced ERP shortening was attenuated by LI-ANS (in LI-ANS group,.ERP=-15.4 +/- 5.9%, p=0.019; vs. control, p=0.035). Neither WOV for AF nor AF inducibility changed significantly during 3 hours RAP with simultaneous LI-ANS. There was no significant difference between the control and LI-ANS group in nerve density and sprouting evaluated by anti-tyrosine hydroxylase and anti-growth associated protein-43 staining. Among the various sites for LI-ANS, the ARGP-stimulation group showed marginally lower Delta WOV (p=0.077) and lower nerve sprouting (p=0.065) compared to the RVN-stimulation group.
   Conclusion: Low-intensity autonomic nerve stimulation significantly attenuated the shortening of atrial ERP caused by RAP. ARGP may be a better target for LI-ANS than RVN for the purpose of suppressing atrial remodeling in AF.
C1 [Cho, Youngjin; Cha, Myung-Jin; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Oh, Il-Young] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM seil@snu.ac.kr
RI Choi, Eue-Keun/K-3752-2019; Choi, Eue-Keun/J-5968-2014; Oh,
   Seil/J-5539-2012
OI Choi, Eue-Keun/0000-0002-0411-6372; Oh, Seil/0000-0002-2504-9615
FU National Research Foundation - Ministry of Education [NRF-2012R1A1A
   2006353]; Seoul National University Hospital Research Fund [0420120350]
FX This study was supported by grants from the National Research Foundation
   funded by the Ministry of Education (NRF-2012R1A1A 2006353), and grants
   from the Seoul National University Hospital Research Fund (0420120350).
CR Allessie MA, 2001, CIRCULATION, V103, P769
   Bettoni M, 2002, CIRCULATION, V105, P2753, DOI 10.1161/01.CIR.0000018443.44005.D8
   Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960
   Chang CM, 2001, CIRCULATION, V103, P22
   Choi EK, 2010, CIRCULATION, V121, P2615, DOI 10.1161/CIRCULATIONAHA.109.919829
   Coumel P, 1996, J CARDIOVASC ELECTR, V7, P999, DOI 10.1111/j.1540-8167.1996.tb00474.x
   Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013
   Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014
   GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319
   Hoover DB, 2009, NEUROSCIENCE, V164, P1170, DOI 10.1016/j.neuroscience.2009.09.001
   Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066
   JACOBSON RD, 1986, J NEUROSCI, V6, P1843
   Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047
   Ogawa M, 2009, HEART RHYTHM, V6, P1772, DOI 10.1016/j.hrthm.2009.08.011
   Oh S, 2006, HEART RHYTHM, V3, P701, DOI 10.1016/j.hrthm.2006.02.020
   Oh S, 2012, HEART RHYTHM, V9, P810, DOI 10.1016/j.hrthm.2012.01.016
   Pokushalov E, 2009, HEART RHYTHM, V6, P1257, DOI 10.1016/j.hrthm.2009.05.018
   PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101
   Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302
   Sakamoto S, 2010, J THORAC CARDIOV SUR, V139, P444, DOI 10.1016/j.jtcvs.2009.04.056
   Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774
   Shen MJ, 2011, CIRCULATION, V123, P2204, DOI 10.1161/CIRCULATIONAHA.111.018028
   Sheng X, 2011, J AM COLL CARDIOL, V57, P563, DOI 10.1016/j.jacc.2010.09.034
   Tai CT, 2002, J CARDIOVASC ELECTR, V13, P83, DOI 10.1046/j.1540-8167.2002.00083.x
   Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203
   Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315
   Wijffels MCEF, 1997, CIRCULATION, V96, P3710
   YUAN BX, 1994, ANAT REC, V239, P75, DOI 10.1002/ar.1092390109
   Zhang YH, 2005, CIRCULATION, V112, P2904, DOI 10.1161/CIRCULATIONAHA.105.568832
   Zhang YH, 2009, HEART RHYTHM, V6, P244, DOI 10.1016/j.hrthm.2008.10.043
NR 30
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 243
EP 249
DI 10.4070/kcj.2014.44.4.243
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900007
PM 25089136
OA Green Published
DA 2021-04-22
ER

PT J
AU Kee, HJ
   Kim, GR
   Cho, SN
   Kwon, JS
   Ahn, Y
   Kook, H
   Jeong, MH
AF Kee, Hae Jin
   Kim, Gwi Ran
   Cho, Soo-Na
   Kwon, Jin-Sook
   Ahn, Youngkeun
   Kook, Hyun
   Jeong, Myung Ho
TI miR-18a-5p MicroRNA Increases Vascular Smooth Muscle Cell
   Differentiation by Downregulating Syndecan4
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE miR-8a; Cell differentiation; Vascular smooth muscle; Syndecan4; Smad2
   protein
ID PHENOTYPIC SWITCH; PROLIFERATION
AB Background and Objectives: Differentiation and de-differentiation of vascular smooth muscle cells (VSMCs) are important events in atherosclerosis and restenosis after angioplasty. MicroRNAs are considered a key regulator in cellular processes such as differentiation, proliferation, and apoptosis. Here, we report the role of new miR-18a-5p microRNA and its downstream target genes in VSMCs and in a carotid balloon injury model.
   Materials and Methods: Expression of miR-18a-5p and its candidate genes was examined in VSMCs and in a carotid artery injury model by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and microRNA microarray analysis. VSMC differentiation marker genes including smooth muscle (SM) alpha-actin and SM22 alpha were determined by Western blot, qRT-PCR, and a SM22 alpha promoter study. Gene overexpression or knockdown was performed in VSMCs.
   Results: miR-18a-5p was upregulated in the rat carotid artery at the early time after balloon injury. Transfection of the miR-18a-5p mimic promoted the VSMC differentiation markers SM alpha-actin and SM22 alpha. In addition, miR-18a-5p expression was induced in differentiated VSMCs, whereas it decreased in de-differentiated VSMCs. We identified syndecan4 as a downstream target of miR-18-5p in VSMCs. Overexpression of syndecan4 decreased Smad2 expression, whereas knockdown of syndecan4 increased Smad2 expression in VSMCs. Finally, we showed that Smad2 induced the expression of VSMC differentiation marker genes in VSMCs.
   Conclusion: These results indicate that miR-18a-5p is involved in VSMC differentiation by targeting syndecan4.
C1 [Kee, Hae Jin; Kim, Gwi Ran; Cho, Soo-Na; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju 501757, South Korea.
   [Kwon, Jin-Sook] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Cheongju, South Korea.
   [Kook, Hyun] Chonnam Natl Univ, Dept Pharmacol, Kwangju, South Korea.
   [Kook, Hyun] Chonnam Natl Univ, Med Res Ctr Gene Regulat, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Society of Cardiology
FX This study was supported by a research grant from the Korean Society of
   Cardiology in 2011.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517
   Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009
   Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195
   Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200
   Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327
   Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106
   Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006
   Ikesue M, 2011, ARTERIOSCL THROM VAS, V31, P1066, DOI 10.1161/ATVBAHA.110.217703
   Kee HJ, 2011, VASC PHARMACOL, V55, P127, DOI 10.1016/j.vph.2011.07.001
   Kwon JS, 2012, ATHEROSCLEROSIS, V225, P41, DOI 10.1016/j.atherosclerosis.2012.07.040
   Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422
   Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306
   Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689
   Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150
   Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921
NR 20
TC 28
Z9 30
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 255
EP 263
DI 10.4070/kcj.2014.44.4.255
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900009
PM 25089138
OA Green Published
DA 2021-04-22
ER

PT J
AU Mizuno, A
   Niwa, K
AF Mizuno, Atsushi
   Niwa, Koichiro
TI The Usefulness of a Three Dimensional Roadmap and Pressure-Wire Assisted
   Angioplasty in Chronic Thromboembolic Pulmonary Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Mizuno, Atsushi; Niwa, Koichiro] St Lukes Int Hosp, Ctr Cardiovasc, Dept Cardiol, Tokyo 1408560, Japan.
RP Mizuno, A (corresponding author), St Lukes Int Hosp, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1408560, Japan.
EM atmizu@luke.or.jp
CR Glockler M, 2013, CATHETER CARDIO INTE, V82, P436, DOI 10.1002/ccd.24646
   Inami T, 2013, JACC-CARDIOVASC INTE, V6, P725, DOI 10.1016/j.jcin.2013.03.009
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2014
VL 44
IS 4
BP 278
EP 279
DI 10.4070/kcj.2014.44.4.278
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PO
UT WOS:000342411900014
PM 25089143
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MC
   Jeong, MH
   Kim, SH
   Hong, YJ
   Kim, JH
   Ahn, Y
AF Kim, Min Chul
   Jeong, Myung Ho
   Kim, Sang Hyung
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
TI Current Status of Coronary Intervention in Patients with ST-Segment
   Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocardial infarction; Coronary artery disease; Percutaneous coronary
   intervention
ID FRACTIONAL FLOW RESERVE; CARDIOGENIC-SHOCK; CLINICAL-OUTCOMES;
   RANDOMIZED-TRIAL; CULPRIT VESSEL; REVASCULARIZATION; MANAGEMENT;
   REPERFUSION; ANGIOGRAPHY; OCCLUSION
AB Primary percutaneous coronary intervention (PCI) is a standard interventional treatment modality for ST-segment elevation myocardial infarction (STEMI). Diagnostic coronary angiogram during PCI reveals multivessel coronary artery disease in about half of patients with STEMI, and it is difficult to make decision on the extent of intervention in these patients. Although revascularization for the infarct-related artery only is still effective for STEMI patients, several studies have reported the efficacy of multivessel revascularization during primary PCI, as well as in a staged PCI procedure. Clinicians should consider clinical aspects such as initial cardiogenic shock and myocardial viability when performing primary multivessel intervention, including the risks and benefits of multivessel revascularization in patients undergoing primary PCI. This review describes the current status of performing multivessel PCI in patients with STEMI and proposes an optimal revascularization strategy based on the previous literature.
C1 [Kim, Min Chul; Jeong, Myung Ho; Kim, Sang Hyung; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Ctr Heart, Dept Cardiovasc Med, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, Dept Cardiovasc Med, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU National Research Foundation of Korea - Korean Government (MEST),
   Republic of Korea [2010-0020261]; Research of the Korea Centers for
   Disease Control and Prevention [2013-E63005-00]; The Korean Health
   Technology RD Project [HI13C1527]
FX This study was supported by a grant from the National Research
   Foundation of Korea funded by the Korean Government (MEST), Republic of
   Korea (2010-0020261), and a grant (2013-E63005-00) for Research of the
   Korea Centers for Disease Control and Prevention, and The Korean Health
   Technology R&D Project (HI13C1527).
CR Abe D, 2013, HEART VESSELS
   Aggarwal V, 2012, EUROINTERVENTION, V7, P1095, DOI 10.4244/EIJV7I9A174
   Bagai A, 2013, AM HEART J, V166, P684, DOI 10.1016/j.ahj.2013.07.027
   Bangalore S, 2011, AM J CARDIOL, V107, P1300, DOI 10.1016/j.amjcard.2010.12.039
   Bauer T, 2012, AM J CARDIOL, V109, P941, DOI 10.1016/j.amjcard.2011.11.020
   BENGTSON JR, 1992, J AM COLL CARDIOL, V20, P1482, DOI 10.1016/0735-1097(92)90440-X
   Biondi-Zoccai G, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.013
   Brener SJ, 2008, AM HEART J, V155, P140, DOI 10.1016/j.ahj.2007.09.007
   Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016
   Chung JW, 2012, CIRC J, V76, P1624, DOI 10.1253/circj.CJ-11-1285
   Claessen BE, 2012, EUR HEART J, V33, P768, DOI 10.1093/eurheartj/ehr471
   Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051
   Dangas GD, 2010, JACC-CARDIOVASC INTE, V3, P1096, DOI 10.1016/j.jcin.2010.09.005
   Dziewierz A, 2010, AM J CARDIOL, V106, P342, DOI 10.1016/j.amjcard.2010.03.029
   Esposito G, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.009
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Fokkema ML, 2009, EUR HEART J, V30, P908, DOI 10.1093/eurheartj/ehp033
   Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1937, DOI 10.1016/j.jacc.2004.08.050
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139
   Jensen LO, 2012, EUROINTERVENTION, V8, P456, DOI 10.4244/EIJV8I4A72
   Jo HS, 2011, KOREAN CIRC J, V41, P718, DOI 10.4070/kcj.2011.41.12.718
   Kelly DJ, 2013, EUROINTERVENTION, V8, P1190, DOI 10.4244/EIJV8I10A183
   Kirschbaum SW, 2010, JACC-CARDIOVASC INTE, V3, P392, DOI 10.1016/j.jcin.2010.01.011
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Lee HW, 2012, CARDIOL J, V19, P256, DOI 10.5603/CJ.2012.0047
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Mylotte D, 2013, JACC-CARDIOVASC INTE, V6, P115, DOI 10.1016/j.jcin.2012.10.006
   Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025
   Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P821, DOI 10.1016/j.jcin.2010.06.006
   Parodi G, 2005, HEART, V91, P1541, DOI 10.1136/hrt.2004.054692
   PERRONEFILARDI P, 1995, CIRCULATION, V91, P2556, DOI 10.1161/01.CIR.91.10.2556
   Petersen SE, 2003, INT J CARDIOVAS IMAG, V19, P409, DOI 10.1023/A:1025856816168
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Qarawani D, 2008, INT J CARDIOL, V123, P288, DOI 10.1016/j.ijcard.2006.12.013
   Rigattieri S, 2008, J INTERV CARDIOL, V21, P1, DOI 10.1111/j.1540-8183.2007.00317.x
   Roe MT, 2001, AM J CARDIOL, V88, P170, DOI 10.1016/S0002-9149(01)01615-0
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184
   Taggart DP, 2011, HEART, V97, P445, DOI 10.1136/hrt.2010.216135
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722
   Vieira RD, 2012, CIRCULATION, V126, pS158, DOI 10.1161/CIRCULATIONAHA.111.084236
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
   Yang JH, 2014, CRIT CARE MED, V42, P17, DOI 10.1097/CCM.0b013e3182a2701d
NR 50
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 131
EP 138
DI 10.4070/kcj.2014.44.3.131
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700001
PM 24876852
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, K
   Kim, M
   Cho, YR
   Park, JS
   Park, TH
   Kim, MH
   Kim, YD
AF Park, Kyungil
   Kim, Minkwan
   Cho, Young-Rak
   Park, Jong-Sung
   Park, Tea-Ho
   Kim, Moo Hyun
   Kim, Young-Dae
TI Association between Cardiac Troponin Level and Coronary Flow Reserve in
   Patients without Coronary Artery Disease: Insight from a Thermodilution
   Technique Using an Intracoronary Pressure Wire
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardiol coronary flow reserve; Troponin; Vascular resistance;
   Microvessels
ID MICROCIRCULATORY RESISTANCE; MYOCARDIAL VIABILITY; INDEX; ELEVATION
AB Background and Objectives: Cardiac troponins are associated with increased mortality, even among patients with no coronary artery disease. Elevated cardiac troponin levels are frequently observed in patients without significant coronary lesions, although the mechanism underlying this finding is unclear. The aim of our study was to evaluate the association between the levels of cardiac troponin and coronary flow reserve (CFR).
   Subjects and Methods: We evaluated serum cardiac troponin-I in 19 patients (9 female; age 61.9 +/- 10.9 year-old). All patients had an ejection fraction >40% and angiographically normal coronary arteries. Simultaneous measurements of fractional flow reserve (FFR), the index of microcirculatory resistance (IMR), and CFR measurements using an intracoronary temperature- and pressure-sensing guidewire under basal conditions and during maximal hyperemia were performed in three vessels: the left anterior descending artery (LAD), left circumflex artery (LCX) and right coronary artery (RCA).
   Results: All patients were followed for a median of 13 months. FFR, IMR, and CFR measurements were performed successfully in all subjects. Mean CFRs of LAD, LCX, and RCA were 1.98 +/- 1.20, 2.75 +/- 2.11, and 4.44 +/- 2.51, respectively. Mean IMRs of LAD, LCX and RCA were 33.28 +/- 18.78, 29.11 +/- 26.70, and 30.55 +/- 23.65, respectively. There was a poor correlation between CFR and troponin-I values in each vessel. In selecting the lowest value of CFR in each patient as the corresponding value, the lowest CFR was not associated with troponin-I levels (r=-0.219, p=0.367).
   Conclusion: In patients without significant coronary lesions, the correlation between CFR and troponin-I level was not significant using a thermodilution technique. Further study of a larger population with longer-term follow-up may be needed to more fully understand microvascular dysfunction.
C1 [Park, Kyungil; Cho, Young-Rak; Park, Jong-Sung; Park, Tea-Ho; Kim, Moo Hyun; Kim, Young-Dae] Dong A Univ Hosp, Reg Cardiocerebrovasc Ctr, Pusan, South Korea.
   [Park, Kyungil; Kim, Minkwan; Cho, Young-Rak; Park, Jong-Sung; Park, Tea-Ho; Kim, Moo Hyun; Kim, Young-Dae] Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, Pusan 602714, South Korea.
RP Kim, YD (corresponding author), Dong A Univ, Dong A Univ Hosp, Coll Med, Reg Cardiovasc Ctr,Dept Internal Med,Div Cardiol, 26 Daesingongwon Ro, Pusan 602714, South Korea.
EM kimyd@dau.ac.kr
FU Korean Society of Cardiology, Republic of Korea
FX This study was supported by a grant from the Korean Society of
   Cardiology (2011), Republic of Korea.
CR Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456
   Barbato E, 2004, EUR HEART J, V25, P219, DOI 10.1016/j.ehj.2003.11.009
   Beleslin B, 2008, EUR HEART J, V29, P2617, DOI 10.1093/eurheartj/ehn418
   Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143
   Cortigiani L, 2012, JACC-CARDIOVASC IMAG, V5, P1079, DOI 10.1016/j.jcmg.2012.08.007
   De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223
   Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327
   Eggers KM, 2007, CIRCULATION, V116, P1907, DOI 10.1161/CIRCULATIONAHA.107.708529
   Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062
   Kern MJ, 2006, CIRCULATION, V114, P1321, DOI 10.1161/CIRCULATIONAHA.106.177276
   Layland JJ, 2012, HEART, V98, P1492, DOI 10.1136/heartjnl-2012-302252
   Leonardi S, 2012, J AM COLL CARDIOL, V60, P2296, DOI 10.1016/j.jacc.2012.09.005
   Leung DY, 2011, HEART, V97, P587, DOI 10.1136/hrt.2009.183327
   Lim HS, 2009, EUR HEART J, V30, P2854, DOI 10.1093/eurheartj/ehp313
   Logstrup BB, 2010, EUR J ECHOCARDIOGR, V11, P665, DOI 10.1093/ejechocard/jeq037
   Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359
   Nakanishi K, 2013, AM J CARDIOL, V112, P928, DOI 10.1016/j.amjcard.2013.05.025
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Oh JH, 2013, KOREAN CIRC J, V43, P534, DOI 10.4070/kcj.2013.43.8.534
   Sicari R, 2009, AM J CARDIOL, V103, P626, DOI 10.1016/j.amjcard.2008.10.033
   Takashio S, 2013, J AM COLL CARDIOL, V62, P632, DOI 10.1016/j.jacc.2013.03.065
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   van den Bos EJ, 2011, EUR HEART J, V32, P611, DOI 10.1093/eurheartj/ehq491
NR 24
TC 5
Z9 5
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 141
EP 147
DI 10.4070/kcj.2014.44.3.141
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700003
PM 24876854
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, ES
   O'Brien, TM
   Menon, S
   Bartone, C
   Mazur, W
   Kereiakes, DJ
AF Chung, Eugene S.
   O'Brien, Thomas M.
   Menon, Santosh
   Bartone, Cheryl
   Mazur, Wojciech
   Kereiakes, Dean J.
TI A Pilot Study of Target Weight Guided Treatment in Acute Heart Failure
   Using Ultrafiltration or Usual Care: Effect on Sodium Removal
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ultrafiltration; Heart failure; Diuretics; Sodium
ID DIURETIC RESISTANCE; FUROSEMIDE; ASSOCIATION; GUIDELINES; MANAGEMENT;
   DIAGNOSIS; MORTALITY; OUTCOMES
AB Background and Objectives: In the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure trial, ultrafiltration (UF) removed volume more effectively than usual care (UC). Hypothetically, UF may be superior to UC due to increased sodium (Na) removal and less neurohormonal activation. We compared UF and UC in a randomized pilot trial of target weight guided therapy for acute decompensated heart failure (ADHF).
   Subjects and Methods: Sixteen patients with ADHF were enrolled and target weights established prospectively, prior to randomization to UC or UF. UF patients did not receive diuretics and UC patients were all treated with a continuous furosemide drip. All urine and ultrafiltrate were collected and Na concentrations measured.
   Results: Similar volumes were removed in UC and UF groups (110105 mL and 107415 mL, respectively) and the UF group also produced 45325 mL of urine. Na concentration was 138 +/- 6 meq/L in the ultrafiltrate, 85 +/- 73 meq/L in the UC group's urine, and 26 +/- 23 meq/L in the UF group's urine. Given the relevant associated volumes, total meq of the Na removed was similar (1168 in UC vs. 1216 in UF). The UF group produced isotonic ultrafiltrate and a higher volume of dilute urine than anticipated.
   Conclusion: In a randomized pilot study of target weight guided therapy with UC or UF for ADHF, there were no differences in total volumes or Na removed, and lengths of hospital stays were similar. Isotonic fluid loss by UF was accompanied by the production of very dilute urine.
C1 [Chung, Eugene S.; O'Brien, Thomas M.; Menon, Santosh; Bartone, Cheryl; Mazur, Wojciech; Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA.
RP Chung, ES (corresponding author), Christ Hosp, Heart & Vasc Ctr, 2123 Auburn Ave,Ste 100, Cincinnati, OH 45219 USA.
EM chunge@ohioheart.org
FU CHF Solutions, Inc.
FX This study was supported by a grant from CHF Solutions, Inc.
CR Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   AGOSTONI P, 1994, AM J MED, V96, P191, DOI 10.1016/0002-9343(94)90142-2
   Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073
   Costanzo MR, 2005, J AM COLL CARDIOL, V46, P2047, DOI 10.1016/j.jacc.2005.05.099
   FAUCHALD P, 1986, ACTA MED SCAND, V219, P47
   Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61
   Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091
   Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065
   McCurley JM, 2004, J AM COLL CARDIOL, V44, P1301, DOI 10.1016/j.jacc.2004.04.059
   Neuberg GW, 2002, AM HEART J, V144, P31, DOI 10.1067/mhj.2002.123144
   Nieminen MS, 2005, EUR HEART J, V26, P384
   Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628
   O'Brien Thomas M, 2012, Congest Heart Fail, V18, P43, DOI 10.1111/j.1751-7133.2011.00251.x
   RIMONDINI A, 1987, AM J MED, V83, P43, DOI 10.1016/0002-9343(87)90495-5
   Rogers HL, 2008, J CARD FAIL, V14, P1, DOI 10.1016/j.cardfail.2007.09.007
   Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067
NR 16
TC 17
Z9 19
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 156
EP 161
DI 10.4070/kcj.2014.44.3.156
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700005
PM 24876856
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, IJ
   Jang, SY
   Chang, HJ
   Shin, S
   Shim, CY
   Hong, GR
   Chung, N
AF Cho, In-Jeong
   Jang, Sung-Yeol
   Chang, Hyuk-Jae
   Shin, Sanghoon
   Shim, Chi Young
   Hong, Geu-Ru
   Chung, Namsik
TI Aortic Aneurysm Screening in a High-Risk Population: A Non-Contrast
   Computed Tomography Study in Korean Males with Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta; Aneurysm; Prevalence; Computed tomography
ID CARDIOVASCULAR-ANGIOGRAPHY; TASK-FORCE; PREVALENCE; DISSECTION;
   INTERVENTIONS; ASSOCIATION; RADIOLOGY; SOCIETY; DISEASE; SURGERY
AB Background and Objectives: Screening strategies for aortic aneurysm (AA) according to risk factors and ethnicity are controversial. This study explored the prevalence of AA and determined whether screening is necessary in a population of multiple risk factors.
   Subjects and Methods: From June, 2012 to April, 2013, 542 consecutive elderly (>= 65 years) male hypertensive patients without a history of AA were prospectively enrolled. After excluding 15 patients (2.8%) with aortic valve surgery, 30 patients (5.5%) with suboptimal computed tomography (CT) images, the remaining 496 patients (age 73 +/- 5 years) comprised the study population. Maximal diameters of the thoracic and abdominal aorta were measured using non-contrast CT.
   Results: The prevalence of thoracic AA (TAA, diameter >= 40 mm) and abdominal AA (AAA, diameter >= 30 mm) was 36.5% (181/496) and 6.0% (30/496), respectively. In the multivariate logistic regression analysis, determinants for TAA were age {odds ratio (OR) 1.059, 95% confidence interval (CI) 1.018-1.101, p=0.005}, dyslipidemia (OR 0.621, 95% CI 0.418-0.923, p=0.018), body surface area (OR 11.92, 95% CI 2.787-50.97, p=0.001), diastolic blood pressure (OR 1.029, 95% CI 1.009-1.049, p=0.004) and AAA (OR 3.070, 95% CI 1.398-6.754, p=0.005). In contrast, AAA was independently associated with dysplipidemia (OR 2.792, 95% CI 1.091-7.143, p=0.032), current/past smokers (OR 4.074, 95% CI 1.160-14.31, p=0.028), and TAA (OR 3.367, 95% CI 1.550-7.313, p=0.002).
   Conclusion: The prevalence of AA was significant and TAA was more prevalent than AAA in elderly Korean males with hypertension. Future research should establish distinct screening strategies for TAA and AAA according to risk factors and ethnicity.
C1 [Cho, In-Jeong; Jang, Sung-Yeol; Chang, Hyuk-Jae; Shin, Sanghoon; Shim, Chi Young; Hong, Geu-Ru; Chung, Namsik] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Chang, Hyuk-Jae; Shim, Chi Young] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM hjchang@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304;
   Chang, Hyuk-Jae/0000-0002-6139-7545; Shin, Sanghoon/0000-0002-2348-2570
FU Leading Foreign Research Institute Recruitment Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning (MSIP) [2012027176]
FX This research was supported by Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP)
   (No. 2012027176).
CR Acosta S, 2006, J VASC SURG, V44, P237, DOI 10.1016/j.jvs.2006.04.037
   Adachi K, 2000, SURG TODAY, V30, P594, DOI 10.1007/s005950070098
   Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176
   Davies RR, 2002, ANN THORAC SURG, V73, P17, DOI 10.1016/S0003-4975(01)03236-2
   Elefteriades JA, 2002, ANN THORAC SURG, V74, pS1877, DOI 10.1016/S0003-4975(02)04147-4
   Elefteriades JA, 2010, J AM COLL CARDIOL, V55, P841, DOI 10.1016/j.jacc.2009.08.084
   Hiratzka Loren F, 2010, Catheter Cardiovasc Interv, V76, pE43
   Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526
   Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A
   Jamrozik K, 2000, MED J AUSTRALIA, V173, P345, DOI 10.5694/j.1326-5377.2000.tb125684.x
   Lindholt JS, 1997, BRIT J SURG, V84, P40
   Mao SS, 2008, ACAD RADIOL, V15, P827, DOI 10.1016/j.acra.2008.02.001
   Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400
   Poon JTC, 2010, ANZ J SURG, V80, P630, DOI 10.1111/j.1445-2197.2010.05345.x
   Rizzo JA, 1998, J CLIN EPIDEMIOL, V51, P747, DOI 10.1016/S0895-4356(98)00050-X
   Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236
   TAKEI H, 1995, SURG TODAY, V25, P608, DOI 10.1007/BF00311434
   Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005
   Wolak A, 2008, JACC-CARDIOVASC IMAG, V1, P200, DOI 10.1016/j.jcmg.2007.11.005
NR 19
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 162
EP 169
DI 10.4070/kcj.2014.44.3.162
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700006
PM 24876857
OA Green Published
DA 2021-04-22
ER

PT J
AU Chang, SA
   Kim, SM
   Choi, SH
   Choe, YH
   Kim, YW
   Kim, DK
AF Chang, Sung-A
   Kim, Sung Mok
   Choi, Seung-Hyuk
   Choe, Yeon Hyeon
   Kim, Young-Wook
   Kim, Duk-Kyung
TI Clinical Utility of Coronary CT Angiography with Stress Perfusion CT in
   Preoperative Cardiac Risk Evaluation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Vascular surgical procedure; Coronary artery disease; Multidetector
   computed tomography; Myocardial perfusion imaging
ID DUAL-SOURCE CT; ABDOMINAL AORTIC-ANEURYSM; MAJOR VASCULAR-SURGERY;
   COMPUTED-TOMOGRAPHY; NONCARDIAC SURGERY; REVASCULARIZATION; REPAIR;
   HEART
AB Background and Objectives: Vascular surgery carries high operative risk. Recently developed cardiac computed tomography (CT) provides excellent imaging of coronary artery disease (CAD), as well as myocardial perfusions. We investigated the role of stress perfusion CT with coronary computed tomography angiography (CCTA) using 128-slice dual source CT (DSCT) in preoperative cardiac risk evaluation.
   Subjects and Methods: Patients scheduled for vascular surgery were admitted and underwent the adenosine stress perfusion CT with CCTA using DSCT. Patients who presented with unstable angina, recent myocardial infarction, decompensated heart failure, or renal failure were excluded. Stress perfusion CT was first acquired using sequential mode during adenosine infusion, after which, scanning for CT angiography was followed by helical mode. Perioperative events were followed up for 1 month.
   Results: Ninety-one patients completed the study. Most patients (94.5%) had coronary atherosclerosis, with 36 (39.6%) patients had more than 50% coronary artery stenosis. Perfusion defects with significant stenosis were found in 12 cases (13.2%). Revascularization after DSCT was rarely performed. Four patients (4.4%) experienced cardiac events in the perioperative period: two experienced heart failure and two had non-fatal myocardial infarction.
   Conclusion: We cannot conclude that the stress perfusion CT, with CCTA using DSCT, plays a significant role in preoperative risk evaluation from this study. However, the coronary atherosclerosis and the significant CAD were commonly found. The perfusion defects with significant lesions were found in only small fraction of the patients, and did not contribute to perioperative myocardial infarction or heart failure.
C1 [Chang, Sung-A; Choi, Seung-Hyuk; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Dept Med, Div Cardiol, Seoul 135710, South Korea.
   [Kim, Sung Mok; Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul 135710, South Korea.
   [Kim, Young-Wook] Sungkyunkwan Univ, Sch Med, Dept Vasc Surg, Seoul 135710, South Korea.
   [Chang, Sung-A; Kim, Sung Mok; Choe, Yeon Hyeon; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
   [Chang, Sung-A; Kim, Sung Mok; Choe, Yeon Hyeon; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul 135710, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Cardiovasc Imaging Ctr, Dept Med,Div Cardiol,Samsung Med Ctr, 81 Irwon Ro, Seoul 135710, South Korea.
EM dkkim@skku.edu
RI Kim, Duk Kyung/F-4613-2014; Choe, Yeon Hyeon/F-1422-2010
OI Choe, Yeon Hyeon/0000-0002-9983-048X; Kim, Sung Mok/0000-0001-5190-2328;
   Chang, Sung-A/0000-0001-5124-605X
FU Korean Society of Cardiology [2009-02]
FX This study was supported by a grant from the Korean Society of
   Cardiology (2009-02).
CR Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004
   BARON JF, 1994, NEW ENGL J MED, V330, P663, DOI 10.1056/NEJM199403103301002
   Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014
   BOUCHER CA, 1985, NEW ENGL J MED, V312, P389, DOI 10.1056/NEJM198502143120701
   Budde RPJ, 2010, EUR J VASC ENDOVASC, V40, P196, DOI 10.1016/j.ejvs.2010.03.032
   Catalan P, 2011, RADIOLOGY, V258, P426, DOI 10.1148/radiol.10100384
   Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
   Chang SA, 2008, AM HEART J, V156, P375, DOI 10.1016/j.ahj.2008.03.016
   De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499
   de Virgilio C, 1999, ARCH SURG-CHICAGO, V134, P947, DOI 10.1001/archsurg.134.9.947
   DEVIRGILIO C, 1999, ARCH SURG-CHICAGO, V134, P950
   Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0
   Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101
   Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250
   Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028
   HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016
   Kim SM, 2014, J COMPUT ASSIST TOMO, V38, P44, DOI 10.1097/RCT.0b013e3182a77626
   Kim SM, 2013, INT J CARDIOVAS IMAG, V29, P875, DOI 10.1007/s10554-012-0138-x
   Kurata A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083950
   Mahnken AH, 2010, INVEST RADIOL, V45, P298, DOI 10.1097/RLI.0b013e3181dfa3cf
   MASON JJ, 1995, JAMA-J AM MED ASSOC, V273, P1919, DOI 10.1001/jama.273.24.1919
   McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905
   POLDERMANS D, 1993, CIRCULATION, V87, P1506, DOI 10.1161/01.CIR.87.5.1506
   Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014
   Russo V, 2007, HEART, V93, P1591, DOI 10.1136/hrt.2006.105023
   Seki M, 2005, ANESTH ANALG, V100, P1236, DOI 10.1213/01.ANE.0000152009.49024.F1
NR 26
TC 2
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 170
EP 176
DI 10.4070/kcj.2014.44.3.170
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700007
PM 24876858
OA Green Published
DA 2021-04-22
ER

PT J
AU Iyisoy, A
   Celik, T
   Celik, M
   Sag, C
AF Iyisoy, Atila
   Celik, Turgay
   Celik, Murat
   Sag, Cemal
TI Aorta-Right Atrial Tunnel: An Interesting Type of a Congenital Coronary
   Artery Anomaly
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Fistula; Aneurysm
AB An 18-year-old girl with an aortico-right atrial tunnel originating from the left sinus of Valsalva, in which the left anterior descending and circumflex coronary arteries arose independently from the different parts of the tunnel, was reported. In the differential diagnosis of continuous murmur, this type of tunnel should be taken into consideration. Surgical approach should be offered.
C1 [Iyisoy, Atila; Celik, Turgay; Celik, Murat; Sag, Cemal] Gulhane Mil Med Acad, Sch Med, Dept Cardiol, Etlik, Turkey.
RP Celik, M (corresponding author), Gulhane Mil Med Acad, Dept Cardiol, TR-06018 Etlik, Turkey.
EM drcelik00@hotmail.com
RI Celik, Turgay/I-2981-2019
OI Celik, Turgay/0000-0001-8418-0130
CR Baykan A, 2013, CARDIOL YOUNG, V23, P457, DOI 10.1017/S1047951112001151
   Gajjar T, 2005, J THORAC CARDIOV SUR, V130, P1287, DOI 10.1016/j.jtcvs.2005.07.021
   Kalangos A, 2000, ANN THORAC SURG, V69, P635, DOI 10.1016/S0003-4975(99)01346-6
   Kursaklioglu H, 2005, INT J CARDIOVAS IMAG, V21, P383, DOI 10.1007/s10554-004-7252-3
   OTEROCOTO E, 1980, J THORAC CARDIOV SUR, V80, P941
   ROSENBERG H, 1986, J THORAC CARDIOV SUR, V91, P841
   Sreedharan M, 2006, INT J CARDIOL, V107, P410, DOI 10.1016/j.ijcard.2005.01.056
   Turkay C, 2003, J THORAC CARDIOV SUR, V125, P1058, DOI 10.1067/mtc.2003.87
NR 8
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 193
EP 195
DI 10.4070/kcj.2014.44.3.193
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700011
PM 24876862
OA Green Published
DA 2021-04-22
ER

PT J
AU Champion, S
AF Champion, Sebastien
TI Statins for Patients with Cardiogenic Shock
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID ACUTE MYOCARDIAL-INFARCTION
C1 Univ Reunion, Ctr Hosp, F-97400 St Denis, France.
RP Champion, S (corresponding author), Univ Reunion, Ctr Hosp, Route Bellepierre, F-97400 St Denis, France.
EM champion.seb@wanadoo.fr
CR Champion S, 2012, ARCH INTERN MED, V172, P1613, DOI 10.1001/archinternmed.2012.4418
   Champion S, 2012, J CRIT CARE, V27, P511, DOI 10.1016/j.jcrc.2012.07.018
   Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947
   Koreny M, 2002, AM J MED, V112, P115, DOI 10.1016/S0002-9343(01)01070-1
   Sakaeda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028124
   Sim DS, 2013, KOREAN CIRC J, V43, P100, DOI 10.4070/kcj.2013.43.2.100
   Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 200
EP 201
DI 10.4070/kcj.2014.44.3.200
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700013
PM 24876864
OA Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Jeong, MH
AF Sim, Doo Sun
   Jeong, Myung Ho
TI Statins for Patients with Cardiogenic Shock Reply
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID MYOCARDIAL-INFARCTION; THERAPY
C1 [Sim, Doo Sun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea.
RP Sim, DS (corresponding author), Chonnam Natl Univ Hosp, Kwangju, South Korea.
CR Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029
   Garot P, 2010, EUROINTERVENTION, V6, P350, DOI 10.4244/EIJV6I3A58
   Sim DS, 2013, KOREAN CIRC J, V43, P100, DOI 10.4070/kcj.2013.43.2.100
   Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006
NR 4
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 202
EP 202
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700014
DA 2021-04-22
ER

PT J
AU Kim, JW
   Yun, KH
   Kim, EK
   Kim, YC
   Joe, DY
   Ko, JS
   Rhee, SJ
   Lee, EM
   Yoo, NJ
   Kim, NH
   Oh, SK
   Jeong, JW
AF Kim, Ji Won
   Yun, Kyeong Ho
   Kim, Eun Kyoung
   Kim, Yong Cheol
   Joe, Dai-Yeol
   Ko, Jum Suk
   Rhee, Sang Jae
   Lee, Eun Mi
   Yoo, Nam Jin
   Kim, Nam-Ho
   Oh, Seok Kyu
   Jeong, Jin-Won
TI Effect of High Dose Rosuvastatin Loading before Primary Percutaneous
   Coronary Intervention on Infarct Size in Patients with ST-Segment
   Elevation Myocardial Infarction (vol 44, pg 76, 2014)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Kim, Ji Won; Yun, Kyeong Ho; Kim, Eun Kyoung; Kim, Yong Cheol; Joe, Dai-Yeol; Ko, Jum Suk; Rhee, Sang Jae; Lee, Eun Mi; Yoo, Nam Jin; Kim, Nam-Ho; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan, South Korea.
RP Kim, JW (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan, South Korea.
CR Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76
NR 1
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 203
EP 203
DI 10.4070/kcj.2014.44.3.203
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700015
OA Green Published, Green Accepted
DA 2021-04-22
ER

PT J
AU Koo, BK
AF Koo, Bon-Kwon
TI Coronary Circulation; Macro or Micro, That It the Question
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MICROCIRCULATION
C1 Seoul Natl Univ Hosp, Ctr Cardiovasc, Dept Internal Med, Seoul 110744, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Ctr Cardiovasc, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM bkkoo@snu.ac.kr
CR Aarnoudse W, 2004, CIRCULATION, V110, P2137, DOI 10.1161/01.CIR.0000143893.18451.0E
   Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331
   Layland J, 2013, CIRC-CARDIOVASC INTE, V6, P231, DOI 10.1161/CIRCINTERVENTIONS.112.000180
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Park K, 2014, KOREAN CIRC J, V44, P141, DOI 10.4070/kcj.2014.44.3.141
   Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054
   Pijls NHJ, 2002, CIRCULATION, V105, P2482, DOI 10.1161/01.CIR.0000017199.09457.3D
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 139
EP 140
DI 10.4070/kcj.2014.44.3.139
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700002
PM 24876853
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YJ
   Choi, YH
   Park, SY
   Nam, CW
   Cho, JH
   Kang, WY
   Lee, SR
   Lee, SY
   Kim, SW
   Lim, SY
   Yun, KH
   Kim, JS
   Kim, JW
   Kang, WC
   Kim, KS
   Choi, JH
   Chung, JW
   Kim, SJ
   Ahn, Y
   Jeong, MH
AF Hong, Young Joon
   Choi, Yun Ha
   Park, Soo Young
   Nam, Chang Wook
   Cho, Jang Hyun
   Kang, Won Yu
   Lee, Sang Rok
   Lee, Sung Yun
   Kim, Sang Wook
   Lim, Sang Yeob
   Yun, Kyung Ho
   Kim, Jung Sun
   Kim, Jin Won
   Kang, Woong Chol
   Kim, Ki Seok
   Choi, Jin Ho
   Chung, Joong Wha
   Kim, Soo Joong
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Clinical Outcomes in Patients with Intermediate Coronary Stenoses:
   MINIATURE Investigators (Korea MultIceNter TrIal on Long-Term Clinical
   Outcome According to the Plaque Burden and Treatment Strategy in Lesions
   with MinimUm Lumen ARea lEss Than 4 mm(2) Using Intravascular
   Ultrasound)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Atherosclerotic plaque; Intravascular
   ultrasonography
ID FRACTIONAL FLOW RESERVE; C-REACTIVE PROTEIN; FUNCTIONAL-SIGNIFICANCE;
   DIABETES-MELLITUS; LDL-CHOLESTEROL; ARTERY STENOSES; STATIN THERAPY;
   ATHEROSCLEROSIS; DISEASE; SEVERITY
AB Background and Objectives: We evaluated the two-year clinical outcomes in patients with angiographically intermediate lesions according to the plaque burden and treatment strategy.
   Subjects and Methods: We prospectively enrolled patients with angiographically intermediate lesions (diameter stenosis 30-70%) with an intravascular ultrasound (IVUS) minimum lumen area (MLA) <4 mm(2) with 50-70% plaque burden of 16 Korean percutaneous coronary intervention centers. Patients were divided into medical therapy group (n=85) and zotarolimus-eluting stent group (ZES; Resolute) group (n=74). We evaluated the incidences of two-year major adverse cardiovascular events (MACE).
   Results: A two-year clinical follow-up was completed in 143 patients and MACE occurred in 12 patients. There were no significant differences in the incidences of death (1.3% vs. 3.0%, p=0.471), target vessel-related non-fatal myocardial infarction (0.0% vs. 0.0%, p=1.000) and target vessel revascularizations (7.8% vs. 4.5%, p=0.425) between medical and ZES groups. Independent predictors of two-year MACE included acute myocardial infarction {odds ratio (OR)=2.87; 95% confidence interval (CI) 1.43-6.12, p=0.014}, diabetes mellitus (OR=2.46; 95% CI 1.24-5.56, p=0.028) and non-statin therapy (OR=2.32; 95% CI 1.18-5.24, p=0.034).
   Conclusion: Medical therapy shows comparable results with ZES, and myocardial infarction, diabetes mellitus and non-statin therapy were associated with the occurrence of two-year MACE in patients with intermediate lesion with IVUS MLA <4 mm(2) with 50-70% of plaque burden.
C1 [Hong, Young Joon; Choi, Yun Ha; Park, Soo Young; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Sch Med, Div Cardiol, Kwangju, South Korea.
   [Nam, Chang Wook] Keimyung Univ, Coll Med, Dongsan Med Ctr, Div Cardiol, Taegu, South Korea.
   [Cho, Jang Hyun] St Carollo Hosp, Div Cardiol, Sunchon, South Korea.
   [Kang, Won Yu] Gwangju Vet Hosp, Div Cardiol, Kwangju, South Korea.
   [Lee, Sang Rok] Chonbuk Natl Univ, Coll Med, Div Cardiol, Jeonju, South Korea.
   [Lee, Sung Yun] Inje Univ, Ilsan Paik Hosp, Coll Med, Div Cardiol, Goyang, South Korea.
   [Kim, Sang Wook] Chung Ang Univ, Coll Med, Div Cardiol, Seoul 156756, South Korea.
   [Lim, Sang Yeob] Korea Univ, Ansan Hosp, Coll Med, Div Cardiol, Ansan, South Korea.
   [Yun, Kyung Ho] Wonkwang Univ, Coll Med, Div Cardiol, Iksan, South Korea.
   [Kim, Jung Sun] Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol, Seoul 120749, South Korea.
   [Kim, Jin Won] Korea Univ, Guro Hosp, Div Cardiol, Seoul, South Korea.
   [Kang, Woong Chol] Gachon Univ, Gil Med Ctr, Div Cardiol, Inchon, South Korea.
   [Kim, Ki Seok] Jeju Natl Univ, Coll Med, Div Cardiol, Cheju, South Korea.
   [Choi, Jin Ho] Samsung Med Ctr, Div Cardiol, Seoul, South Korea.
   [Chung, Joong Wha] Chosun Univ, Coll Med, Div Cardiol, Kwangju, South Korea.
   [Kim, Soo Joong] Kyung Hee Univ, Med Ctr, Div Cardiol, Seoul, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Cardiovasc Convergence Res Ctr, Korea Acute Myocardial Infarct Registry, 671 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Society of Interventional Cardiology; Korean Health Technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0163,
   HI13C1527]; The Korean Society of Cardiology; The Korea Centers for
   Disease Control and Prevention [2013-E63005-00]; National Research
   Foundation (NRF) - Korean government (MEST)Ministry of Education,
   Science and Technology, Republic of KoreaKorean Government
   [2012M3A9C6049744]; National Research Foundation of Korea - Korean
   GovernmentNational Research Foundation of KoreaKorean Government
   [2011-0008875]; Korea Healthcare technology R& D Project, Ministry for
   Health, Welfare and Family Affairs [HI12C0275]; Chonnam National
   University Hospital Research Institute of Clinical Medicine, Republic of
   Korea [CRI 11080-21]
FX This study was supported by a grant of the Korean Society of
   Interventional Cardiology, and a grant of the Korean Health Technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea
   (HI13C0163), and a grant of The Korean Society of Cardiology, The Korea
   Centers for Disease Control and Prevention (2013-E63005-00), and The
   Korean Health Technology R&D Project (HI13C1527), Ministry of Health &
   Welfare, and the Bio & Medical Technology Development Program of the
   National Research Foundation (NRF) funded by the Korean government
   (MEST) (2012M3A9C6049744), and the National Research Foundation of Korea
   Grant funded by the Korean Government (2011-0008875), and the Korea
   Healthcare technology R&D Project, Ministry for Health, Welfare and
   Family Affairs (HI12C0275), and Chonnam National University Hospital
   Research Institute of Clinical Medicine (CRI 11080-21), Republic of
   Korea.
CR Abizaid A, 1998, AM J CARDIOL, V82, P423, DOI 10.1016/S0002-9149(98)00355-5
   Ahn JM, 2011, JACC-CARDIOVASC INTE, V4, P665, DOI 10.1016/j.jcin.2011.02.013
   Baumgart D, 1998, CIRCULATION, V98, P40, DOI 10.1161/01.CIR.98.1.40
   Boyle PJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.07.003
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   DHAWAN J, 1995, INT J CARDIOL, V49, P267, DOI 10.1016/0167-5273(95)02315-N
   Hong YJ, 2012, J CARDIOL, V60, P277, DOI 10.1016/j.jjcc.2012.04.003
   Kang SJ, 2011, JACC-CARDIOVASC INTE, V4, P1168, DOI 10.1016/j.jcin.2011.08.009
   Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013
   Lip GYH, 1999, POSTGRAD MED J, V75, P463, DOI 10.1136/pgmj.75.886.463
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051
   Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499
   Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Stancoven A, 2007, AM J CARDIOL, V99, p5H, DOI 10.1016/j.amjcard.2007.04.005
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Takayama T, 2013, J CARDIOL, V61, P381, DOI 10.1016/j.jjcc.2013.01.010
   Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055
   1994, CIRCULATION, V89, P1545
NR 22
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 148
EP 155
DI 10.4070/kcj.2014.44.3.148
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700004
PM 24876855
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YS
   Kang, HJ
   Hong, MH
   Kang, WS
   Choe, N
   Kook, H
   Jeong, MH
   Ahn, Y
AF Kim, Yong Sook
   Kang, Hea Jin
   Hong, Moon Hwa
   Kang, Wan Seok
   Choe, Nakwon
   Kook, Hyun
   Jeong, Myung Ho
   Ahn, Youngkeun
TI Angiopoietin-Like 4 Is Involved in the Poor Angiogenic Potential of High
   Glucose-Insulted Bone Marrow Stem Cells
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stem cells; Diabetes mellitus; ANGPTL4 protein; rat; MicroRNAs
ID ENDOTHELIAL PROGENITOR CELLS; CARDIOVASCULAR RISK; INHIBITION;
   PROTEIN-4; DISEASE; HEART
AB Background and Objectives: Diabetes is reported to reduce the function or number of progenitor cells. We compared the gene expression patterns of bone marrow-derived mesenchymal stem cells from diabetic (DM-BMCs) and healthy (non-DM-BMCs) rats and suggested Angiopoietin-like 4 (Angptl4) could be a responsible factor for impaired angiogenesis of DM-BMCs.
   Subjects and Methods: BMCs were isolated from DM or non-DM rat, and in vitro angiogenesis activity was compared by tube formation assay on Matrigel and complementary deoxyribonucleic acid expression was analyzed by microarray with or without oxytocin treatment. Human BMCs (hBMCs) were treated with high glucose, and were performed polymerase chain reaction, Western blot, and enzyme-linked immunosorbent assay. Angptl4 plasmid DNA and micro ribonucleic acid-132 (miR-132) were transfected to immortalized hBMCs.
   Results: In vitro angiogenesis assay showed the impaired tube formation in DM-BMCs, and slightly recovery by oxytocin treatment. Angptl4, an adipokine, was upregulated in DM-BMCs compared to non-DM-BMCs. Oxytocin treatment reduced Angptl4 in DM-BMCs. In hBMCs, overexpression of Angptl4 attenuated the tube formation. In addition to Angptl4, miR-132 was increased by high glucose treatment. Collectively, high glucose resulted in impaired tube formation through miR-132 induction and Angptl4 upregulation in BMCs.
   Conclusion: Our results show that the angiogenic activity of BMCs is impaired by high glucose stress, which would be mediated by Angptl4 and miR-132.
C1 [Kim, Yong Sook; Kang, Hea Jin; Hong, Moon Hwa; Kang, Wan Seok; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Res Lab Cardiovasc Regenerat, Kwangju 501757, South Korea.
   [Kim, Yong Sook; Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Cardiovasc Convergence Res Ctr, Kwangju 501757, South Korea.
   [Kang, Hea Jin; Kang, Wan Seok] Chonnam Natl Univ, Grad Sch, Ctr Mol Med, Kwangju, South Korea.
   [Choe, Nakwon; Kook, Hyun] Chonnam Natl Univ, Sch Med, Ctr Gene Regulat, Dept Pharmacol & Med Res, Kwangju, South Korea.
   [Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM cecilyk@hanmail.net
FU Korean Society of Cardiology
FX This work was supported by a research grant from the Korean Society of
   Cardiology in 2011.
CR Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186
   Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009
   Cull CA, 2007, CIRCULATION, V116, P2119, DOI 10.1161/CIRCULATIONAHA.107.733428
   Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z
   Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527
   Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6
   Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Ito Y, 2003, CANCER RES, V63, P6651
   Kim YS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-38
   Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195
   Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Okochi-Takada E, 2013, ONCOGENE
   Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161
   Porrello ER, 2010, CIRC RES, V107, P1292, DOI 10.1161/CIRCRESAHA.110.235168
   Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Westenskow PD, 2013, J CLIN INVEST, V123, P4900, DOI 10.1172/JCI70230
   Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776
NR 20
TC 10
Z9 10
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 177
EP 183
DI 10.4070/kcj.2014.44.3.177
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700008
PM 24876859
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, S
   Kim, S
   Ko, YG
   Hong, MK
   Jang, Y
   Choi, D
AF Shin, Sanghoon
   Kim, Seunghwan
   Ko, Young-Guk
   Hong, Myeung-Ki
   Jang, Yangsoo
   Choi, Donghoon
TI Retrograde Distal Superficial Femoral Artery Approach in the Supine
   Position for Chronic Superficial Femoral Artery Occlusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral arterial disease; Femoral artery; Angioplasty
ID SUBINTIMAL RECANALIZATION; POPLITEAL APPROACH; ANGIOPLASTY; CATHETER;
   PUNCTURE; DEVICE
AB Subintimal angioplasty is an effective method for the treatment of long superficial femoral artery (SFA) occlusions. One of the major limiting factors for the success of this procedure is the failure to re-enter the true lumen. The recently introduced luminal re-entry devices provide a high technical success rate, but failures can occur. In such cases, a retrograde popliteal approach can serve as a potential backup option. However, the need to reposition the patient remains a drawback. Here, we report a case of an 81-year-old male with a long SFA occlusion treated using a retrograde distal SFA approach in the supine position after the initial failure of antegrade angioplasty.
C1 [Shin, Sanghoon; Kim, Seunghwan; Ko, Young-Guk; Hong, Myeung-Ki; Jang, Yangsoo; Choi, Donghoon] Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp,Div Cardiol, Seoul 120752, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp,Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM cdhlyj@yuhs.ac
OI Shin, Sanghoon/0000-0002-2348-2570; Hong, Myeong-Ki/0000-0002-2090-2031
CR Bolia A, 1998, EUR J RADIOL, V28, P199, DOI 10.1016/S0720-048X(98)00115-6
   Casserly IP, 2004, CATHETER CARDIO INTE, V62, P237, DOI 10.1002/ccd.20051
   Grimm J, 2001, J VASC INTERV RADIOL, V12, P935, DOI 10.1016/S1051-0443(07)61572-3
   Hausegger KA, 2004, CARDIOVASC INTER RAD, V27, P26, DOI 10.1007/s00270-003-0025-x
   HEENAN SD, 1994, CLIN RADIOL, V49, P824, DOI 10.1016/S0009-9260(05)81976-2
   Heenan SD, 1994, CLIN RADIOL, V49, P827
   Ko YG, 2007, J ENDOVASC THER, V14, P374, DOI 10.1583/06-1983.1
   Noory E, 2008, J ENDOVASC THER, V15, P310, DOI 10.1583/07-2324.1
   Spinosa DJ, 2003, J VASC INTERV RADIOL, V14, P1449, DOI 10.1097/01.RVI.0000096764.74047.21
   TONNESEN KH, 1988, CARDIOVASC INTER RAD, V11, P127, DOI 10.1007/BF02577101
   TRIGAUX JP, 1991, AM J ROENTGENOL, V157, P1259, DOI 10.2214/ajr.157.6.1950877
   Yilmaz S, 2001, CARDIOVASC INTER RAD, V24, P154, DOI 10.1007/s002700001751
   ZAITOUN R, 1990, CATHETER CARDIO DIAG, V21, P154, DOI 10.1002/ccd.1810210306
NR 13
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 184
EP 188
DI 10.4070/kcj.2014.44.3.184
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700009
PM 24876860
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HM
   Kim, HL
   Lee, HS
   Jung, JH
   Kim, CH
   Oh, S
   Kim, JH
   Zo, JH
AF Kim, Hyue Mee
   Kim, Hack-Lyoung
   Lee, Hak Seung
   Jung, Ji-Hyun
   Kim, Chee Hae
   Oh, Sooyeon
   Kim, Jung Ho
   Zo, Joo-Hee
TI Nonbacterial Thrombotic Endocarditis in a Patient with Bowel Infarction
   due to Mesenteric Vein Thrombosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endocarditis; non-infective; Echocardiography; Venous thrombosis
ID CANCER
AB Ante mortem cases of venous thrombosis in patients with nonbacterial thrombotic endocarditis (NBTE) have not yet been reported. We describe a rare case of NBTE in a patient with mesenteric vein thrombosis. A healthy 37-year-old man with abdominal pain and fever underwent emergency small bowel resection due to bowel ischemia resulting from mesenteric vein thrombosis. Transthoracic echocardiography revealed multiple mobile masses attached to the anterior leaflet of the mitral valves and their chordae tendineae. On suspicion of infective endocarditis, the cardiac masses were excised through open-heart surgery. However, pathologic reviews were compatible with NBTE. The patient was stable after the cardiac surgery and was treated with warfarin. Laboratory and imaging findings regarding his hypercoagulable condition were all negative.
C1 [Kim, Hyue Mee; Kim, Hack-Lyoung; Lee, Hak Seung; Jung, Ji-Hyun; Kim, Chee Hae; Oh, Sooyeon; Zo, Joo-Hee] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med, Seoul 156707, South Korea.
   [Kim, Jung Ho] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Pathol, Seoul 156707, South Korea.
RP Kim, HL (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med, 20 Boramae Ro 5 Gil, Seoul 156707, South Korea.
EM khl2876@gmail.com
RI Kim, Hack-Lyoung/AAL-5038-2020
OI Kim, Hack-Lyoung/0000-0002-6703-1472; Kim, Jung Ho/0000-0002-6031-3629;
   Lee, Hak Seung/0000-0002-2200-6601
CR Aryana A, 2006, J GEN INTERN MED, V21, pC12, DOI 10.1111/j.1525-1497.2006.00614.x
   Asopa S, 2007, EUR J CARDIO-THORAC, V32, P696, DOI 10.1016/j.ejcts.2007.07.029
   DEPPISCH LM, 1976, AM HEART J, V92, P723, DOI 10.1016/S0002-8703(76)80008-7
   el-Shami K, 2007, ONCOLOGIST, V12, P518, DOI 10.1634/theoncologist.12-5-518
   Habib G, 2010, EUR J ECHOCARDIOGR, V11, P202, DOI 10.1093/ejechocard/jeq004
   Lee V, 2012, J FORENSIC LEG MED, V19, P312, DOI 10.1016/j.jflm.2012.02.021
   Llenas-Garcia J, 2007, REV ESP CARDIOL, V60, P493, DOI 10.1016/S0300-8932(07)75066-2
   LOPEZ JA, 1987, AM HEART J, V113, P773, DOI 10.1016/0002-8703(87)90719-8
   Norisada K, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-8
   Otto CM, 2013, TXB CLIN ECHOCARDIOG, P202
   Rabinstein AA, 2005, J NEUROL, V252, P352, DOI 10.1007/s00415-005-0660-z
   Sivasankaran S, 2002, Indian Heart J, V54, P196
   STODDARD MF, 1989, AM HEART J, V117, P966, DOI 10.1016/0002-8703(89)90638-8
   Vinales KL, 2010, CIRCULATION, V122, pE459, DOI 10.1161/CIRCULATIONAHA.110.954032
NR 14
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 189
EP 192
DI 10.4070/kcj.2014.44.3.189
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700010
PM 24876861
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JJ
   Cho, JY
   Lee, YH
   Lee, BH
   Park, CG
   Seo, HS
   Oh, DJ
   Na, JO
AF Lee, Jae Joong
   Cho, Jae Young
   Lee, Yun Ho
   Lee, Byung Hyun
   Park, Chang Gyu
   Seo, Hong Seog
   Oh, Dong Joo
   Na, Jin Oh
TI An Adult Case of Tetralogy of Fallot Accompanied by Multiple Anomalies
   Including Multidirectional Coronary Artery Fistulas
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tetralogy of Fallot; Arteriovenous fistula; Coronary artery
ID EXPERIENCE; CLOSURE
AB Multidirectional coronary artery fistulas (CAFs) are rare in patients with tetralogy of Fallot (TOF). We report an adult patient who underwent open-heart surgery for TOF 24 years before the discussed presentation. Coronary angiogram and cardiac computed tomography revealed multidirectional CAFs originating from the left main coronary artery and draining to the left atrium, pulmonary artery and subphrenic artery. The patient also showed additional congenital anomalies, such as persistent left superior vena cava and right-sided aortic arch.
C1 [Lee, Jae Joong; Cho, Jae Young; Lee, Yun Ho; Lee, Byung Hyun; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo; Na, Jin Oh] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Na, JO (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM jinona@medimail.co.kr
RI Cho, Jae Young/AAW-7137-2020
OI Cho, Jae Young/0000-0001-7972-6223
CR ARANI DT, 1978, AM HEART J, V96, P438, DOI 10.1016/0002-8703(78)90152-7
   Balanescu S, 2001, Ital Heart J, V2, P669
   Canga Y, 2012, CARDIOL J, V19, P278, DOI 10.5603/CJ.2012.0050
   Cheung DLC, 2001, ANN THORAC SURG, V71, P190, DOI 10.1016/S0003-4975(00)01862-2
   DABIZZI RP, 1980, CIRCULATION, V61, P95, DOI 10.1161/01.CIR.61.1.95
   FELL EH, 1958, ARCH SURG-CHICAGO, V77, P331
   FERNANDES ED, 1992, ANN THORAC SURG, V54, P732, DOI 10.1016/0003-4975(92)91019-6
   Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067
   HACKETT D, 1984, BRIT HEART J, V52, P477
   Mittal CM, 2011, ANN PEDIAT CARDIOL, V4, P202, DOI 10.4103/0974-2069.84673
   Monmeneu J V, 1995, Rev Esp Cardiol, V48, P768
   Mullasari AS, 2002, HEART, V87, P60, DOI 10.1136/heart.87.1.60-a
   Qureshi S A, 2001, J Interv Cardiol, V14, P299, DOI 10.1111/j.1540-8183.2001.tb00336.x
   SAPIN P, 1990, MEDICINE, V69, P101, DOI 10.1097/00005792-199069020-00004
   Sreedharan M, 2004, INT J CARDIOL, V94, P323, DOI 10.1016/j.ijcard.2003.04.031
   Umana E, 2002, ANGIOLOGY, V53, P353, DOI 10.1177/000331970205300315
NR 16
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2014
VL 44
IS 3
BP 196
EP 199
DI 10.4070/kcj.2014.44.3.196
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PM
UT WOS:000342411700012
PM 24876863
OA Green Published
DA 2021-04-22
ER

PT J
AU Cheung, YF
AF Cheung, Yiu-fai
TI Functional Assessment for Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Congenital heart disease; Ventricular function; Tissue Doppler imaging;
   Speckle tracking echocardiography; Echocardiography, three-dimensional
ID RIGHT-VENTRICULAR FUNCTION; SYSTEMIC RIGHT VENTRICLE; SPECKLE-TRACKING
   ECHOCARDIOGRAPHY; TISSUE DOPPLER-ECHOCARDIOGRAPHY; CARDIAC
   MAGNETIC-RESONANCE; MYOCARDIAL PERFORMANCE INDEX; ARTERIAL SWITCH
   OPERATION; 2-DIMENSIONAL STRAIN ECHOCARDIOGRAPHY; SURGICALLY REPAIRED
   TETRALOGY; LATE GADOLINIUM ENHANCEMENT
AB Significant improvement in survival of children with congenital cardiac malformations has resulted in an increasing population of adolescent and adult patients with congenital heart disease. Of the long-term cardiac problems, ventricular dysfunction remains an important issue of concern. Despite corrective or palliative repair of congenital heart lesions, the right ventricle, which may be the subpulmonary or systemic ventricular chamber, and the functional single ventricle are particularly vulnerable to functional impairment. Regular assessment of cardiac function constitutes an important aspect in the long-term follow up of patients with congenital heart disease. Echocardiography remains the most useful imaging modality for longitudinal monitoring of cardiac function. Conventional echocardiographic assessment has focused primarily on quantification of changes in ventricular size and blood flow velocities during the cardiac cycles. Advances in echocardiographic technologies including tissue Doppler imaging and speckle tracking echocardiography have enabled direct interrogation of myocardial deformation. In this review, the issues of ventricular dysfunction in congenital heart disease, conventional echocardiographic and novel myocardial deformation imaging techniques, and clinical applications of these techniques in the functional assessment of congenital heart disease are discussed.
C1 Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China.
RP Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM xfcheung@hku.hk
RI Cheung, Yiu Fai/C-4240-2009
OI Cheung, Yiu Fai/0000-0002-7279-4992
CR Abbas A, 2004, J AM SOC ECHOCARDIOG, V17, P1155, DOI 10.1016/j.echo.2004.06.005
   Abd el Rahman MY, 2002, PEDIATR CARDIOL, V23, P502, DOI 10.1007/s00246-002-1469-5
   Abraham TP, 2001, J AM COLL CARDIOL, V37, P731, DOI 10.1016/S0735-1097(00)01173-6
   AKAGI T, 1993, J AM COLL CARDIOL, V22, P1182, DOI 10.1016/0735-1097(93)90435-4
   Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040
   [Anonymous], J AM SOC ECHOCARDIOG
   Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B
   Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
   Bos JM, 2006, J AM SOC ECHOCARDIOG, V19, P1033, DOI 10.1016/j.echo.2006.03.007
   Bouzas B, 2005, EUR HEART J, V26, P433, DOI 10.1093/eurheartj/ehi091
   Burns AT, 2009, JACC-CARDIOVASC IMAG, V2, P709, DOI 10.1016/j.jcmg.2009.01.015
   Chen RHS, 2013, EUR HEART J-CARD IMG, V14, P480, DOI 10.1093/ehjci/jes204
   Cheng A, 2009, EUROPACE, V11, P10, DOI 10.1093/europace/eup272
   Cheung EWY, 2008, HEART VESSELS, V23, P112, DOI 10.1007/s00380-007-1016-7
   Cheung EWY, 2009, AM J CARDIOL, V104, P1264, DOI 10.1016/j.amjcard.2009.06.043
   Cheung MMH, 2005, HEART, V91, P1338, DOI 10.1136/hrt.2004.048207
   Cheung YF, 2000, HEART, V83, P420, DOI 10.1136/heart.83.4.420
   Cheung YF, 2012, NAT REV CARDIOL, V9, P644, DOI 10.1038/nrcardio.2012.128
   Cheung YF, 2011, CIRC J, V75, P1735, DOI 10.1253/circj.CJ-10-1253
   Chow PC, 2008, HEART, V94, P855, DOI 10.1136/hrt.2007.131862
   Chow PC, 2008, INT J CARDIOL, V127, P192, DOI 10.1016/j.ijcard.2007.06.004
   Chow PC, 2008, AM J CARDIOL, V101, P874, DOI 10.1016/j.amjcard.2007.11.033
   Chow PC, 2011, INT J CARDIOL, V152, P28, DOI 10.1016/j.ijcard.2010.05.078
   Colan SD, 2005, CONGENITAL HEART DIS, P217
   CULLEN S, 1995, CIRCULATION, V91, P1782, DOI 10.1161/01.CIR.91.6.1782
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   De Caro E, 2013, CONGENIT HEART DIS
   de Veire NRV, 2008, HEART, V94, P1065, DOI [10.1136/hrt.2007.120758, 10.1136/hrt.2006.099424corr1]
   Derrick GP, 2000, CIRCULATION, V102, P154
   Diller GP, 2012, CIRCULATION, V125, P2440, DOI 10.1161/CIRCULATIONAHA.111.086983
   Diller GP, 2012, AM HEART J, V163, P859, DOI 10.1016/j.ahj.2012.01.038
   Dos L, 2005, HEART, V91, P652, DOI 10.1136/hrt.2003.029769
   Eyskens B, 2004, CARDIOL YOUNG, V14, P255, DOI 10.1017/S1047951104003038
   FOGEL MA, 1995, AM J PHYSIOL-HEART C, V269, pH1132
   Friedberg MK, 2007, J AM SOC ECHOCARDIOG, V20, P1073, DOI 10.1016/j.echo.2007.02.015
   Friedberg MK, 2013, AM HEART J, V165, P551, DOI 10.1016/j.ahj.2012.06.029
   Friedberg MK, 2012, EUR HEART J-CARD IMG, V13, P905, DOI 10.1093/ehjci/jes067
   Frigiola A, 2004, CIRCULATION, V110, pII153, DOI 10.1161/01.CIR.0000138397.60956.c2
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V91, P1775, DOI 10.1161/01.CIR.91.6.1775
   Gayat E, 2011, J AM SOC ECHOCARDIOG, V24, P878, DOI 10.1016/j.echo.2011.04.016
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Gewillig M, 2005, HEART, V91, P839, DOI 10.1136/hrt.2004.051789
   Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3
   Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396
   Harrild DM, 2013, CIRC-CARDIOVASC INTE, V6, P680, DOI 10.1161/CIRCINTERVENTIONS.113.000690
   Heimdal A, 1998, J AM SOC ECHOCARDIOG, V11, P1013, DOI 10.1016/S0894-7317(98)70151-8
   Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827, DOI 10.1016/S0735-1097(96)00387-7
   Hillis GS, 2004, J AM COLL CARDIOL, V43, P360, DOI 10.1016/j.jacc.2003.07.044
   Ho PK, 2012, J AM SOC ECHOCARDIOG, V25, P393, DOI 10.1016/j.echo.2012.01.003
   Ho SY, 1996, CIRCULATION, V94, P1642, DOI 10.1161/01.CIR.94.7.1642
   Hui L, 2005, HEART, V91, P68, DOI 10.1136/hrt.2003.027524
   Hung J, 2007, J AM SOC ECHOCARDIOG, V20, P213, DOI 10.1016/j.echo.2007.01.010
   Janousek J, 2009, HEART, V95, P940, DOI 10.1136/hrt.2008.151266
   Jiang L, 1994, PRINCIPLES PRACTICE, P901
   Kalogeropoulos AP, 2012, J AM SOC ECHOCARDIOG, V25, P304, DOI 10.1016/j.echo.2011.12.003
   Kaneko S, 2012, J AM SOC ECHOCARDIOG, V25, P1222, DOI 10.1016/j.echo.2012.08.005
   Kapetanakis S, 2005, CIRCULATION, V112, P992, DOI 10.1161/CIRCULATIONAHA.104.474445
   KELLY DT, 1971, CIRCULATION, V44, P403, DOI 10.1161/01.CIR.44.3.403
   Khoo NS, 2011, JACC-CARDIOVASC IMAG, V4, P128, DOI 10.1016/j.jcmg.2010.09.022
   Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745
   Koestenberger M, 2011, J AM SOC ECHOCARDIOG, V24, P45, DOI 10.1016/j.echo.2010.10.001
   Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026
   Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019
   Li SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078826
   Li SN, 2011, J AM SOC ECHOCARDIOG, V24, P819, DOI 10.1016/j.echo.2011.03.020
   Liang XC, 2010, CLIN CARDIOL, V33, P104, DOI 10.1002/clc.20711
   Lorch SM, 2008, J AM SOC ECHOCARDIOG, V21, P1207, DOI 10.1016/j.echo.2008.08.011
   Lorenz CH, 2000, J CARDIOV MAGN RESON, V2, P97, DOI 10.3109/10976640009148678
   Losay J, 2001, CIRCULATION, V104, pI121
   Lubiszewska B, 2000, J AM COLL CARDIOL, V36, P1365, DOI 10.1016/S0735-1097(00)00864-0
   Manovel A, 2010, EUR J ECHOCARDIOGR, V11, P417, DOI 10.1093/ejechocard/jep226
   Marcus KA, 2012, AM J PHYSIOL-HEART C, V302, pH196, DOI 10.1152/ajpheart.00740.2011
   Marcus KA, 2011, J AM SOC ECHOCARDIOG, V24, P625, DOI 10.1016/j.echo.2011.01.021
   Mercer-Rosa L, 2013, J AM SOC ECHOCARDIOG, V26, P1322, DOI 10.1016/j.echo.2013.06.022
   Mercer-Rosa L, 2012, CIRC-CARDIOVASC IMAG, V5, P637, DOI 10.1161/CIRCIMAGING.112.972588
   Metton O, 2010, EUR J CARDIO-THORAC, V38, P728, DOI 10.1016/j.ejcts.2010.03.065
   Mi YP, 2006, INT J CARDIOL, V109, P329, DOI 10.1016/j.ijcard.2005.06.036
   Moiduddin N, 2009, AM J CARDIOL, V104, P862, DOI 10.1016/j.amjcard.2009.05.018
   Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067
   Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
   Nesser HJ, 2009, ECHOCARDIOGR-J CARD, V26, P324, DOI 10.1111/j.1540-8175.2008.00866.x
   Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082
   Onishi T, 2012, CIRCULATION, V126
   PENNY DJ, 1992, AM J CARDIOL, V69, P974, DOI 10.1016/0002-9149(92)90808-C
   Pettersen E, 2007, J AM COLL CARDIOL, V49, P2450, DOI 10.1016/j.jacc.2007.02.062
   Pettersen E, 2009, AM J CARDIOL, V104, P583, DOI 10.1016/j.amjcard.2009.04.029
   Plymen CM, 2013, EUR HEART J-CARD IMG, V14, P963, DOI 10.1093/ehjci/jet014
   Prieto LR, 1998, CIRCULATION, V98, P997, DOI 10.1161/01.CIR.98.10.997
   Rathod RH, 2010, J AM COLL CARDIOL, V55, P1720, DOI 10.1016/j.jacc.2009.12.036
   Redington AN, 2006, CARDIOL CLIN, V24, P631, DOI 10.1016/j.ccl.2006.08.007
   Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011
   Rentzsch A, 2005, Z KARDIOL, V94, P524, DOI 10.1007/s00392-005-0258-6
   Roche SL, 2010, HEART, V96, P2010, DOI 10.1136/hrt.2010.206169
   Roos-Hesselink JW, 2004, EUR HEART J, V25, P1264, DOI 10.1016/j.ehj.2004.03.009
   Russel IK, 2009, JACC-CARDIOVASC IMAG, V2, P648, DOI 10.1016/j.jcmg.2009.03.001
   Sanchez-Quintana D, 1999, HEART, V81, P182, DOI 10.1136/hrt.81.2.182
   Senzaki H, 2002, CIRCULATION, V105, P2885, DOI 10.1161/01.CIR.0000018621.96210.72
   Seo Y, 2011, JACC-CARDIOVASC IMAG, V4, P358, DOI 10.1016/j.jcmg.2010.12.007
   Silversides CK, 2010, CAN J CARDIOL, V26, pE98, DOI 10.1016/S0828-282X(10)70356-1
   Singh TP, 2001, J AM COLL CARDIOL, V37, P2120, DOI 10.1016/S0735-1097(01)01283-9
   Smiseth OA, 2012, EUR HEART J-CARD IMG, V13, P61, DOI 10.1093/ejechocard/jer243
   Soriano BD, 2008, CIRCULATION, V117, P1842, DOI 10.1161/CIRCULATIONAHA.107.715854
   Sun HY, 2013, J AM SOC ECHOCARDIOG, V26, P765, DOI 10.1016/j.echo.2013.03.017
   Sutherland G R, 1994, J Am Soc Echocardiogr, V7, P441
   Takayasu H, 2011, ECHOCARDIOGR-J CARD, V28, P720, DOI 10.1111/j.1540-8175.2011.01417.x
   Tei C, 1995, J Cardiol, V26, P357
   Tekten T, 2003, ECHOCARDIOGR-J CARD, V20, P503, DOI 10.1046/j.1540-8175.2003.03086.x
   Truong UT, 2010, AM J CARDIOL, V105, P1465, DOI 10.1016/j.amjcard.2009.12.074
   Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158
   van der Hulst AE, 2011, EUR HEART J, V32, P2236, DOI 10.1093/eurheartj/ehr093
   Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001
   Vogel M, 2004, J AM COLL CARDIOL, V43, P100, DOI 10.1016/j.jacc.2003.06.018
   Vogel M, 2002, CIRCULATION, V105, P1693, DOI 10.1161/01.CIR.0000013773.67850.BA
   Vogt M, 2009, EUR J ECHOCARDIOGR, V10, P691, DOI 10.1093/ejechocard/jep047
   Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352
   Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001
   Weidemann F, 2002, AM J CARDIOL, V90, P133, DOI 10.1016/S0002-9149(02)02435-9
   WERNOVSKY G, 1988, CIRCULATION, V77, P1333, DOI 10.1161/01.CIR.77.6.1333
   WESSEL HU, 1980, J THORAC CARDIOV SUR, V80, P582
   Wilson NJ, 1998, J AM COLL CARDIOL, V32, P758, DOI 10.1016/S0735-1097(98)00309-X
   Winlaw DS, 2005, CIRCULATION, V111, P405, DOI 10.1161/01.CIR.0000153355.92687.FA
   Yodwut C, 2012, J AM SOC ECHOCARDIOG, V25, P978, DOI 10.1016/j.echo.2012.06.001
   Young AA, 2012, JACC-CARDIOVASC IMAG, V5, P282, DOI 10.1016/j.jcmg.2011.11.016
   Yuda S, 2013, ECHOCARDIOGRAPHY
NR 125
TC 7
Z9 8
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 59
EP 73
DI 10.4070/kcj.2014.44.2.59
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300001
PM 24653734
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JW
   Yun, KH
   Kim, EK
   Kim, YC
   Joe, DY
   Ko, JS
   Rhee, SJ
   Lee, EM
   Yoo, NJ
   Kim, NH
   Oh, SK
   Jeong, JW
AF Kim, Ji Won
   Yun, Kyeong Ho
   Kim, Eun Kyoung
   Kim, Yong Cheol
   Joe, Dai-Yeol
   Ko, Jum Suk
   Rhee, Sang Jae
   Lee, Eun Mi
   Yoo, Nam Jin
   Kim, Nam-Ho
   Oh, Seok Kyu
   Jeong, Jin-Won
TI Effect of High Dose Rosuvastatin Loading before Primary Percutaneous
   Coronary Intervention on Infarct Size in Patients with ST-Segment
   Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty; Myocardial infarction; Stents; Hydroxymethylglutaryl-CoA
   Reductase inhibitors
ID RANDOMIZED-TRIAL; ATORVASTATIN PRETREATMENT; STATIN THERAPY;
   HEART-DISEASE; ANGIOPLASTY; PRAVASTATIN; EFFICACY; EVENTS
AB Background and Objectives: High dose rosuvastatin loading before percutaneous coronary interventions (PCI) reduces the myocardial damage and the incidence of adverse cardiac events in patients with stable angina and acute coronary syndrome. However, no studies are present yet about rosuvastatin loading in patients with ST-segment elevation myocardial infarction (STEMI) in a primary PCI setting.
   Subjects and Methods: A total of 475 patients who underwent primary PCI for STEMI were studied. The study population was divided into two groups with 208 patients in the statin group=40 mg rosuvastatin loading before primary PCI and 267 patients in the control group=no statin pretreatment. At median 3 days after PCI a single-photon emission computed tomography (SPECT) was performed with technetium 99m tetrofosmin For this study were compared infarct size, corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and the myocardial blush grade (MBG) between the both groups.
   Results: Baseline clinical and procedural characteristics were similar between the groups. Infarct size, as assessed by SPECT, was significantly smaller (19.0 +/- 15.9% vs. 22.9 +/- 16.5%, p=0.009) in the statin group than in the control group. Patients of the statin group showed a lower corrected TIMI frame count (28.2 +/- 19.3 vs. 32.6 +/- 21.4, p=0.020), and higher MBG (2.49 +/- 0.76 vs. 2.23 +/- 0.96, p=0.001) than the patients of the control group. The multivariate analysis revealed that rosuvastatin loading {odds ratio (OR) 0.61}, pain to balloon time (OR 2.05), anterior myocardial infarction (OR 3.89) and final the MBG (OR 2.93) were independent predictors of a large infarct size.
   Conclusion: A high dose rosuvastatin loading before the primary PCI reduced the infarct size by microvascular myocardial perfusion improvement.
C1 [Kim, Ji Won; Yun, Kyeong Ho; Kim, Eun Kyoung; Kim, Yong Cheol; Joe, Dai-Yeol; Ko, Jum Suk; Rhee, Sang Jae; Lee, Eun Mi; Yoo, Nam Jin; Kim, Nam-Ho; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan 570711, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 570711, South Korea.
EM dryunkh@gmail.com
OI Kim, Yongcheol/0000-0001-5568-4161
CR Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Hahn JY, 2011, AM HEART J, V162, P1026, DOI 10.1016/j.ahj.2011.08.011
   홍영준, 2003, Korean Circulation Journal, V33, P891
   Kim JS, 2010, JACC-CARDIOVASC INTE, V3, P332, DOI 10.1016/j.jcin.2009.11.021
   Lee CW, 2011, HEART, V97, P715, DOI 10.1136/hrt.2009.190934
   Lev EI, 2009, AM J CARDIOL, V103, P165, DOI 10.1016/j.amjcard.2008.08.052
   Liu HL, 2013, CLIN THER, V35, P261, DOI 10.1016/j.clinthera.2013.01.009
   McTaggart F, 2003, ATHEROSCLEROSIS SUPP, V4, P9, DOI 10.1016/S1567-5688(03)00004-7
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   PEDERSEN TR, 1994, LANCET, V344, P1383
   Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Sposito AC, 2002, ARTERIOSCL THROM VAS, V22, P1524, DOI 10.1161/01.ATV.0000032033.39301.6A
   van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302
   Yun KH, 2011, KOREAN CIRC J, V41, P458, DOI 10.4070/kcj.2011.41.8.458
   Yun KH, 2011, INT J CARDIOL, V146, P68, DOI 10.1016/j.ijcard.2010.04.052
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
NR 20
TC 22
Z9 25
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 76
EP 81
DI 10.4070/kcj.2014.44.2.76
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300003
PM 24653736
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, SY
   Cho, KI
   Han, YJ
   You, GI
   Kim, JH
   Heo, JH
   Kim, HS
   Cha, TJ
   Lee, JW
AF Choi, Seon Yoon
   Cho, Kyoung Im
   Han, You Jin
   You, Ga In
   Kim, Je Hun
   Heo, Jeong Ho
   Kim, Hyun Soo
   Cha, Tae Joon
   Lee, Jae Woo
TI Impact of Pheochromocytoma on Left Ventricular Hypertrophy and QTc
   Prolongation: Comparison with Takotsubo Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Long QT syndrome; Hypertrophy; left ventricular; Catecholamines
ID CARDIOVASCULAR COMPLICATIONS; STRESS; DIAGNOSIS
AB Background and Objectives: Excessive catecholamine causes the alteration of cardiac structure and function. This study evaluated if there is any difference in left ventricular hypertrophy (LVH) and QTc prolongation in conditions with pheochromocytoma and Takotsubo cardiomyopathy (TC).
   Subjects and Methods: We reviewed the medical records of 20 pheochromocytoma patients for cardiovascular events prior to diagnosis. The patient's clinical history and electrocardiographic and echocardiographic findings were compared to those of 20 patients diagnosed with TC.
   Results: Left ventricular (LV) mass index (133.3 +/- 37.8 vs. 113.3 +/- 17.3, p=0.031), relative wall thickness (0.55 +/- 0.15 vs. 0.47 +/- 0.07, p=032) and elevated blood pressure (BP) were more prominent in pheochromocytoma compared to TC. The mean creatinine kinase-MB elevation, reduced LV systolic function and ST segment changes were more prominent in the TC group compared to the pheochromocytoma groups (all p<0.05). The prevalence of QTc prolongation was high in patients with pheochromocytoma (45%) and TC (55%), and TC male patients appeared to have a more prolonged QTc interval. Urine epinephrine (r=0.844, p=0.004) and norepinephrine level (r=0.782, p=0.013) were significantly correlated with LV mass index, and the predictors for the QTc prolongation were male gender and the presence of LVH.
   Conclusion: A prolonged QTc was prominent in pheochromocytoma and TC regardless of BP and systolic LV function, and LVH was more prominent in pheochromocytoma than TC.
C1 [Choi, Seon Yoon; Cho, Kyoung Im; Han, You Jin; You, Ga In; Kim, Je Hun; Heo, Jeong Ho; Kim, Hyun Soo; Cha, Tae Joon; Lee, Jae Woo] Kosin Univ, Sch Med, Cardiovasc Res Inst, Pusan 602702, South Korea.
RP Cho, KI (corresponding author), Kosin Univ, Sch Med, Cardiovasc Res Inst, 262 Gamcheon Ro, Pusan 602702, South Korea.
EM kyoungim74@gmail.com
CR Agarwal V, 2011, INT J CARDIOL, V153, P241, DOI 10.1016/j.ijcard.2011.03.027
   Ahn JH, 2011, J KOREAN MED SCI, V26, P959, DOI 10.3346/jkms.2011.26.7.959
   Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398
   Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625
   Chakraborty Praloy, 2010, Indian Heart J, V62, P447
   CHENG TO, 1976, CHEST, V70, P397, DOI 10.1378/chest.70.3.397
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   Eisenhofer G, 2007, DRUG SAFETY, V30, P1031, DOI 10.2165/00002018-200730110-00004
   FOUADTARAZI FM, 1992, AM J HYPERTENS, V5, P134, DOI 10.1093/ajh/5.3.134
   GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V
   Giavarini A, 2013, HEART, V99, P1438, DOI 10.1136/heartjnl-2013-304073
   GIFFORD RW, 1985, CARDIOLOGY, V72, P126
   GOLDBAUM TS, 1986, AM J MED, V81, P921
   Hannan PJ, 1997, CIRCULATION, V96, P3799
   Insulander P, 2005, J CARDIOVASC ELECTR, V16, P59, DOI 10.1046/j.1540-8167.2005.04117.x
   Kaese S, 2013, INTENS CARE MED, V39, P1473, DOI 10.1007/s00134-013-2942-8
   Kelm M, 1996, J HYPERTENS, V14, P1357, DOI 10.1097/00004872-199611000-00015
   Leite LR, 2010, CASE REP MED, V2010, DOI 10.1155/2010/976120
   Matsuoka K, 2003, AM J CARDIOL, V92, P230, DOI 10.1016/S0002-9149(03)00547-2
   Panikkath R, 2013, ANN NONINVAS ELECTRO, V18, P225, DOI 10.1111/anec.12003
   Prejbisz A, 2011, J HYPERTENS, V29, P2049, DOI 10.1097/HJH.0b013e32834a4ce9
   RADTKE WE, 1975, AM J CARDIOL, V35, P701, DOI 10.1016/0002-9149(75)90060-0
   Sacha J, 2013, HERZ, V38, P790, DOI 10.1007/s00059-013-3756-8
   SHUB C, 1986, AM J CARDIOL, V57, P971, DOI 10.1016/0002-9149(86)90741-1
   SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023
   Takizawa M, 2007, INT J CARDIOL, V114, pE15, DOI 10.1016/j.ijcard.2006.07.125
   van der Heide Kinge, 2011, J Med Case Rep, V5, P368, DOI 10.1186/1752-1947-5-368
   WHALEN RK, 1992, J UROLOGY, V147, P1, DOI 10.1016/S0022-5347(17)37119-7
   Yu R, 2012, ENDOCR PRACT, V18, P483, DOI 10.4158/EP11327.OR
   Zelinka T, 2012, HORM METAB RES, V44, P379, DOI 10.1055/s-0032-1306294
NR 30
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 89
EP 96
DI 10.4070/kcj.2014.44.2.89
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300005
PM 24653738
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YM
   Kwon, JH
   Choi, S
   Kim, KC
AF Hong, Young Mi
   Kwon, Jung Hyun
   Choi, Shinkyu
   Kim, Kwan Chang
TI Apoptosis and Inflammation Associated Gene Expressions in
   Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan
   Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension, pulmonary; Monocrotaline; Apoptosis; Gene expression;
   Bosentan
ID ENDOTHELIAL-CELLS; ARTERIAL-HYPERTENSION; CLINICAL-TRIALS;
   MESSENGER-RNA; SMOOTH-MUSCLE; NEONATAL-RAT; PROLIFERATION; RECEPTOR;
   PYRROLE; LUNGS
AB Background and Objectives: Vascular wall remodeling in pulmonary hypertension can be caused by an aberration in the normal balance between proliferation and apoptosis of endothelial cell in the pulmonary artery. The objective of this study was to evaluate the effect of bosentan on apoptosis in monocrotaline (MCT)-induced pulmonary hypertension.
   Materials and Methods: Sprague-Dawley rats were divided into three groups: control (C) group, M group (MCT 60 mg/kg) and B group (MCT 60 mg/kg plus bosentan 20 mg/day orally). Gene expressions of Bcl (B cell leukemia/lymphoma)-2, caspase-3, complement component (C)-6, vascular endothelial growth factor (VEGF), interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-alpha) were analyzed by real time polymerase chain reaction and western blot analysis.
   Results: The messenger ribonucleic acid (mRNA) expressions of caspase-3 and VEGF were significantly increased in the M group compared with the C group, and significantly decreased in the B group compared with the M group in week 4. mRNA expression of IL-6 was significantly decreased in weeks 1, 2, and 4 in the B group compared with the M group. mRNA expression of TNF-alpha was significantly decreased on day 5 and in weeks 1 and 2 in the B group compared with the M group.
   Conclusion: Bosentan may have potential for preventing apoptosis and inflammation.
C1 [Hong, Young Mi; Kwon, Jung Hyun] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Choi, Shinkyu] Ewha Womans Univ, Sch Med, Dept Physiol, Seoul 158710, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul 158710, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Global Top Res Program 5, Seoul 158710, South Korea.
RP Kim, KC (corresponding author), Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM mdkkchang@ewha.ac.kr
FU National Research Foundation of Korea GrantNational Research Foundation
   of Korea [KRF-2009-0064784]
FX This work was supported by a National Research Foundation of Korea Grant
   (KRF-2009-0064784).
CR Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015
   Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50
   D'Amico DJ, 2006, OPHTHALMOLOGY, V113, P992, DOI 10.1016/j.ophtha.2006.02.027
   Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863
   Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160
   GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402
   HAHN AWA, 1990, CELL REGUL, V1, P649
   HILLIKER KS, 1985, AM REV RESPIR DIS, V131, P46
   Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2
   Jankov RP, 2006, PEDIATR RES, V60, P245, DOI 10.1203/01.pdr.0000233056.37254.0b
   Jankov RP, 2001, PEDIATR RES, V50, P172, DOI 10.1203/00006450-200108000-00003
   Jasmin JF, 2001, CIRCULATION, V103, P314
   Jurasz P, 2010, PHARMACOL THERAPEUT, V126, P1, DOI 10.1016/j.pharmthera.2009.12.006
   KIDO M, 1981, JPN J MED, V20, P170
   Koo HS, 2011, KOREAN CIRC J, V41, P83, DOI 10.4070/kcj.2011.41.2.83
   Kuwano K, 2000, AM J RESP CELL MOL, V22, P147, DOI 10.1165/ajrcmb.22.2.f178
   Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049
   Lim Kyoung Ah, 2010, Korean Circ J, V40, P459, DOI 10.4070/kcj.2010.40.9.459
   Matter CM, 2006, CIRCULATION, V113, P1879, DOI 10.1161/CIRCULATIONAHA.106.611731
   Partovian C, 1998, AM J PHYSIOL-HEART C, V275, pH1948
   Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793
   Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452
   ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484
   Sage E, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-19
   Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje
   Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762
   Stier S, 2005, J BIOCHEM MOL BIOL, V38, P447
   SUGITA T, 1983, EXP LUNG RES, V5, P201, DOI 10.3109/01902148309061515
   Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005
   Wilson DW, 2000, TOXICOL APPL PHARM, V166, P69, DOI 10.1006/taap.2000.8966
NR 30
TC 9
Z9 10
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 97
EP 104
DI 10.4070/kcj.2014.44.2.97
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300006
PM 24653739
OA Green Published
DA 2021-04-22
ER

PT J
AU Chatpun, S
   Cabrales, P
AF Chatpun, Surapong
   Cabrales, Pedro
TI Nitric Oxide Synthase Inhibition Attenuates Cardiac Response to
   Hemodilution with Viscogenic Plasma Expander
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Nitric oxide; Endothelial nitric oxide synthase; Blood viscosity;
   Hemodilution; Ventricular function
ID L-ARGININE; MICROVASCULAR PERFUSION; OXYGEN-CONSUMPTION;
   HEMORRHAGIC-SHOCK; VASCULAR-TONE; METHYL-ESTER; IN-VIVO; VISCOSITY;
   RATS; INCREASES
AB Background and Objectives: Increased vascular wall shear stress by elevated plasma viscosity significantly enhances the endothelial nitric oxide synthase (eNOS) activity during an acute isovolemic hemodilution. Also the modulation of plasma viscosity has effects on the cardiac function that were revealed if a left ventricular (LV) pressure-volume (PV) measurement was used. The aim of this study was to assess cardiac function responses to nitric oxide synthase (NOS) inhibitors with the presence of an elevated plasma viscosity but a low hematocrit level. Furthermore, systemic parameters were monitored in a murine model.
   Materials and Methods: As test group five anesthetized hamsters were administered with N(G)-nitro-L-arginine methyl ester (L-NAME), NOS inhibitor, whereas five other hamsters were used as control group without L-NAME infusion. The dosage of L-NAME was 10 mg/kg. An isovolemic hemodilution was performed by 40% of estimated blood volume with 6% w/v dextran 2000 kDa, high viscosity plasma expanders (PEs) with viscosity 6.34 cP. LV function was measured and assessed using a 1.4 Fr PV conductance catheter.
   Results: The study results demonstrated that NOS inhibition prevented the normal cardiac adaptive response after hemodilution. The endsystolic pressure increased 14% after L-NAME infusion and maintained higher than at the baseline after hemodilution, whereas it gradually decreased in the animals without L-NAME infusion. The admission of L-NAME significantly decreased the maximum rate of ventricular pressure rise (+dP/dt(max)), stroke volume and cardiac output after hemodilution if compared to the control group (p<0.05).
   Conclusion: This finding supports the presumption that nitric oxide induced by an increased plasma viscosity with the use of a high viscosity PE plays a major role in the cardiac function during an acute isovolemic hemodilution.
C1 [Chatpun, Surapong] Prince Songkla Univ, Fac Med, Inst Biomed Engn, Hat Yai 90110, Thailand.
   [Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, San Diego, CA USA.
RP Chatpun, S (corresponding author), Prince Songkla Univ, Fac Med, Inst Biomed Engn, Hat Yai 90110, Thailand.
EM surapong.c@psu.ac.th
RI Cabrales, Pedro/A-1930-2014
OI Cabrales, Pedro/0000-0002-8794-2839
FU Bioengineering Research Partnership grant [R24-HL64395]; Faculty of
   Medicine, Prince of Songkla University [54-221-25-2-3];  [P01-HL071064];
   [R01-HL62354];  [R01-HL62318]; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900, P01HL110900,
   P01HL110900, P01HL110900, P01HL110900, P01HL110900] Funding Source: NIH
   RePORTER
FX The authors greatly thank Cynthia Walser for the surgical preparation of
   the animals. This work was supported by the Bioengineering Research
   Partnership grant R24-HL64395, program project P01-HL071064, grant
   R01-HL62354 and R01-HL62318 and by the Faculty of Medicine, Prince of
   Songkla University grant 54-221-25-2-3.
CR AMEZCUA JL, 1989, BRIT J PHARMACOL, V97, P1119, DOI 10.1111/j.1476-5381.1989.tb12569.x
   Biwer LA, 2013, ACTA PHYSIOL, V207, P156, DOI 10.1111/j.1748-1716.2012.02474.x
   Boo YC, 2006, EXP MOL MED, V38, P453, DOI 10.1038/emm.2006.53
   BRYAN S, 2011, OPEN ACCESS ANIM PHY, V3, P1, DOI DOI 10.2147/OAAP.S14997
   Cabrales P, 2005, SHOCK, V23, P549, DOI 10.1097/01.shk.0000164187.38741.19
   Cabrales P, 2008, RESUSCITATION, V77, P379, DOI 10.1016/j.resuscitation.2008.01.008
   Cabrales P, 2006, AM J PHYSIOL-HEART C, V291, pH2445, DOI 10.1152/ajpheart.00394.2006
   Chatpun S, 2012, LIFE SCI, V90, P39, DOI 10.1016/j.lfs.2011.10.013
   Chatpun S, 2010, BIORHEOLOGY, V47, P225, DOI 10.3233/BIR-2010-0574
   Chatpun Surapong, 2010, Asian J Transfus Sci, V4, P102, DOI 10.4103/0973-6247.67034
   Chen YJ, 2002, CIRCULATION, V106, P273, DOI 10.1161/01.CIR.0000021120.90970.B9
   Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984
   Crystal GJ, 1999, J APPL PHYSIOL, V86, P1944
   Crystal GJ, 1999, CARDIOVASC RES, V42, P232, DOI 10.1016/S0008-6363(98)00325-3
   deWit C, 1997, PFLUG ARCH EUR J PHY, V434, P354, DOI 10.1007/s004240050408
   Fitch RM, 2001, CARDIOVASC RES, V51, P351, DOI 10.1016/S0008-6363(01)00299-1
   FOZARD JR, 1991, BRIT J PHARMACOL, V102, P823, DOI 10.1111/j.1476-5381.1991.tb12259.x
   Herring N, 2002, CIRCULATION, V106, pE5, DOI 10.1161/01.CIR.0000019901.15743.73
   Hsieh NK, 2008, VASC PHARMACOL, V48, P122, DOI 10.1016/j.vph.2008.01.006
   PABLA R, 1995, CIRC RES, V77, P984, DOI 10.1161/01.RES.77.5.984
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7
   Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x
   Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019
   REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x
   Sakai H, 2000, MICROVASC RES, V60, P21, DOI 10.1006/mvre.2000.2240
   Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176
   Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004
   WARD JE, 1993, J CARDIOVASC PHARM, V21, P804, DOI 10.1097/00005344-199305000-00018
   WIDDOP RE, 1992, BRIT J PHARMACOL, V105, P653, DOI 10.1111/j.1476-5381.1992.tb09034.x
NR 30
TC 1
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 105
EP 112
DI 10.4070/kcj.2014.44.2.105
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300007
PM 24653740
OA Green Published
DA 2021-04-22
ER

PT J
AU Yuksel, IO
   Arslan, S
   Bayar, N
   Kucukseymen, S
   Koklu, E
   Erol, B
AF Yuksel, Isa Oner
   Arslan, Sakir
   Bayar, Nermin
   Kucukseymen, Selcuk
   Koklu, Erkan
   Erol, Bekir
TI An Unusual Pattern of All Three Coronary Arteries Originating from a
   Single Coronary Artery Arising from the Right Sinus of Valsalva
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Coronary angiography; Tomography
ID ANOMALIES
AB Anomalous origin of coronary arteries is generally asymptomatic and a rare disease. However, some cases can cause severe life-threatening events such as myocardial ischemia, arrhythmia, and acute myocardial infarction. We describe a case of a single coronary artery arising from the right sinus of Valsalva in a 48-year-old female patient with a complaint of stable angina pectoris and palpitations. Coronary angiography revealed that all three coronary arteries arose from the right sinus. Coronary CT angiography confirmed that there was an anomalous origin of the left coronary artery arising from the right sinus of Valsalva. The patient was managed with conservative treatment.
C1 [Yuksel, Isa Oner; Arslan, Sakir; Bayar, Nermin; Kucukseymen, Selcuk; Koklu, Erkan; Erol, Bekir] Antalya Educ & Res Hosp, TR-07030 Antalya, Turkey.
RP Yuksel, IO (corresponding author), Antalya Educ & Res Hosp, TR-07030 Antalya, Turkey.
EM drisayuksel2@hotmail.com
RI arslan, sakir/A-3933-2017; koklu, erkan/AAE-8595-2020; Kucukseymen,
   Selcuk/Q-4135-2018; koklu, erkan/AAD-1697-2019
OI Kucukseymen, Selcuk/0000-0002-9757-3088; 
CR CLICK RL, 1989, J AM COLL CARDIOL, V13, P531, DOI 10.1016/0735-1097(89)90588-3
   LIPTON MJ, 1979, RADIOLOGY, V130, P39, DOI 10.1148/130.1.39
   Makaryus Amgad N, 2005, J Invasive Cardiol, V17, P56
   Song SH, 2013, KOREAN CIRC J, V43, P123, DOI 10.4070/kcj.2013.43.2.123
   Villa RB, 2001, REV ESP CARDIOL, V54, P269
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 6
TC 0
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 125
EP 127
DI 10.4070/kcj.2014.44.2.125
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300011
PM 24653744
OA Green Published
DA 2021-04-22
ER

PT J
AU Chang, SA
AF Chang, Sung-A
TI Beyond Vasodilator: Anti-Apoptotic Effect of Endothelin Receptor
   Antagonist
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PULMONARY ARTERIAL-HYPERTENSION; BOSENTAN
C1 [Chang, Sung-A] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul 135710, South Korea.
   Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul 135710, South Korea.
RP Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, 81 Irwon Ro, Seoul 135710, South Korea.
EM sunga.chang@samsung.com
OI Chang, Sung-A/0000-0001-5124-605X
CR Bien S, 2007, CANCER RES, V67, P10428, DOI 10.1158/0008-5472.CAN-07-1344
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Eberl LP, 2003, BRIT J CANCER, V88, P788, DOI 10.1038/sj.bjc.6600810
   Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8
   Gong S, 2013, SPINAL CORD
   Hong YM, 2014, KOREAN CIRC J, V44, P97, DOI 10.4070/kcj.2014.44.2.97
   Malenfant S, 2013, PULM CIRC, V3, P278, DOI 10.4103/2045-8932.114752
   Rubin LJ, 2012, LIFE SCI, V91, P517, DOI 10.1016/j.lfs.2012.07.033
   Sitbon O, 2012, EUR RESPIR REV, V21, P321, DOI 10.1183/09059180.00004812
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 74
EP 75
DI 10.4070/kcj.2014.44.2.74
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300002
PM 24653735
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, HY
   Yang, TH
   Choi, KN
   Seo, JS
   Jang, JS
   Kim, DK
   Kim, DS
AF Jin, Han-Young
   Yang, Tae-Hyun
   Choi, Kyu-Nam
   Seo, Jeong-Sook
   Jang, Jae-Sik
   Kim, Dae-Kyeong
   Kim, Dong-Soo
TI Randomized Comparison of the Platelet Inhibitory Efficacy between Low
   Dose Prasugrel and Standard Dose Clopidogrel in Patients Who Underwent
   Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Purinergic P2Y receptor antagonists; Platelet function tests;
   Percutaneous coronary intervention
ID TRITON-TIMI 38; OF-CARE ASSAY; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES;
   10 MG; REACTIVITY; AGGREGATION; THERAPY; EVENTS; IMPACT
AB Background and Objectives: Increased bleeding rates with standard dose prasugrel have led to increased questions about the effectiveness and safety of the lower maintenance dose. We compared platelet inhibitory efficacy between low dose prasugrel and standard dose clopidogrel in patients on maintenance dose dual antiplatelet therapy.
   Subjects and Methods: Forty-three patients who underwent percutaneous coronary intervention were randomized to receive 75 mg clopidogrel (n=23) or 5 mg prasugrel (n=20). Another 20 patients were allocated to 10 mg prasugrel as a reference comparison group. All patients (weight, >= 60 kg; age, <75 years) had been receiving 100 mg aspirin and 75 mg clopidogrel daily. The platelet function test was performed at baseline and 30 days after randomization. The primary endpoint was P2Y(12) reaction unit (PRU) at 30 days between 5 mg prasugrel and 75 mg clopidogrel.
   Results: No differences in baseline PRU values were observed among the three groups. The prasugrel (5 mg) group had a significantly lower PRU value compared with that of 75 mg clopidogrel (174.6 +/- 60.2 vs. 223.4 +/- 72.9, p=0.022) group at 30 days, whereas the 10 mg prasugrel group showed a lower PRU value (71.9 +/- 34.4) compared with that of the 5 mg prasugrel (p<0.001). The rate of high on-treatment platelet reactivity (PRU >235) was significant lower in the 5 mg prasugrel group than that in the 75 mg clopidogrel group (15.0% vs. 56.5%, p=0.010).
   Conclusion: Prasugrel (5 mg) is more potent antiplatelet therapy than 75 mg clopidogrel in non-low body weight and non-elderly patients on a maintenance dose dual antiplatelet therapy.
C1 [Jin, Han-Young; Yang, Tae-Hyun; Choi, Kyu-Nam; Seo, Jeong-Sook; Jang, Jae-Sik; Kim, Dae-Kyeong; Kim, Dong-Soo] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med,Div Cardiol, Pusan 614735, South Korea.
RP Yang, TH (corresponding author), Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med,Div Cardiol, 75 Bokji Ro, Pusan 614735, South Korea.
EM yangthmd@naver.com
RI Jang, Jae-Sik/B-4379-2015
OI Jang, Jae-Sik/0000-0001-7865-124X
CR Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047
   Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010
   Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181
   Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094
   Cuisset T, 2009, AM J CARDIOL, V104, P1078, DOI 10.1016/j.amjcard.2009.06.007
   Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812
   Erlinge D, 2013, J AM COLL CARDIOL, V62, P577, DOI 10.1016/j.jacc.2013.05.023
   Erlinge D, 2012, J AM COLL CARDIOL, V60, P2032, DOI 10.1016/j.jacc.2012.08.964
   Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312
   Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236
   Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877
   Jin HY, 2013, INT J CARDIOL, V167, P1877, DOI 10.1016/j.ijcard.2012.04.154
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Li YG, 2009, PLATELETS, V20, P316, DOI 10.1080/09537100903046317
   Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171
   Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110
   Michelson AD, 2009, EUR HEART J, V30, P1753, DOI 10.1093/eurheartj/ehp159
   Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332
   Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046
   Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512
   Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067
   Small DS, 2010, CLIN PHARMACOKINET, V49, P777, DOI 10.2165/11537820-000000000-00000
   Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8
   Unger EF, 2009, NEW ENGL J MED, V361, P942, DOI 10.1056/NEJMp0907122
   Varenhorst C, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.021
   Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wiviott SD, 2011, AM J CARDIOL, V108, P905, DOI 10.1016/j.amjcard.2011.05.020
   Wiviott SD, 2010, CIRCULATION, V122, P394, DOI 10.1161/CIRCULATIONAHA.109.921502
   Yusuf S, 2006, NEW ENGL J MED, V354, P1464
NR 30
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 82
EP 88
DI 10.4070/kcj.2014.44.2.82
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300004
PM 24653737
OA Green Published
DA 2021-04-22
ER

PT J
AU Rahman, A
   Islam, AKMM
AF Rahman, Afzalur
   Islam, A. K. M. Monwarul
TI Unprotected Left Main Percutaneous Coronary Intervention in a
   108-Year-Old Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angina, unstable; Percutaneous coronary intervention; Elderly
ID CARDIOVASCULAR DATA REGISTRY; BYPASS GRAFT-SURGERY; ARTERY-DISEASE;
   METAANALYSIS; STENTS; REVASCULARIZATION; MORTALITY; AGE
AB With the increase in life expectancy, the proportion of very elderly people is increasing. Coronary artery disease (CAD) is an important cause of mortality and morbidity in this age group, for which myocardial revascularization is often indicated. Percutaneous coronary intervention (PCI) in the very elderly bears the inherent risks of complications and mortality, but the potential benefits may outweigh these risks. A number of observational studies, registries, and few randomized controlled trials have shown the safety and feasibility of PCI in octogenarians and nonagenarians. However, PCI is only rarely done in centenarians; so, the outcome of percutaneous coronary revascularization in this age group is largely unknown. PCI in a centenarian with complex CAD is described here; the patient presented with unstable angina despite optimum medical therapy, and surgery was declined. Good angiographic success was followed by non-cardiac complications, which were managed with a multidisciplinary approach.
C1 [Rahman, Afzalur; Islam, A. K. M. Monwarul] Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
RP Islam, AKMM (corresponding author), Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
EM drmonwarbd@yahoo.com
CR Alam M, 2013, AM J CARDIOL, V112, P615, DOI 10.1016/j.amjcard.2013.04.034
   [Anonymous], ANN THORAC SURG
   Bauer T, 2011, INT J CARDIOL, V151, P164, DOI 10.1016/j.ijcard.2010.05.006
   Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005
   Dash D, 2013, HEART ASIA, V5, P18, DOI 10.1136/heartasia-2012-010218
   Douglas PS, 2009, J AM COLL CARDIOL, V53, P1629, DOI 10.1016/j.jacc.2009.03.005
   Fajadet J, 2012, EUR HEART J, V33, P36, DOI 10.1093/eurheartj/ehr426
   Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381
   Groeneveld PW, 2008, J AM COLL CARDIOL, V51, P2017, DOI 10.1016/j.jacc.2008.01.057
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Kaehler J, 2006, HEART, V92, P1167, DOI 10.1136/hrt.2005.071266
   King SB, 2010, ANNU REV MED, V61, P199, DOI 10.1146/annurev.med.032309.063039
   McKellar SH, 2008, NAT CLIN PRACT CARD, V5, P738, DOI 10.1038/ncpcardio1348
   Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5
   Office for National Statistics, 2002, STAT B EST VER OLD I
   Rana O, 2013, BR J CARDIOL, V20, P27
   Rathod K, 2013, BR J CARDIOL, V20, P6
   Singh M, 2009, CIRC-CARDIOVASC INTE, V2, P20, DOI 10.1161/CIRCINTERVENTIONS.108.826172
   United State's Census Bureau, 2012 STAT ABSTR POP
   Wang TY, 2011, NAT REV CARDIOL, V8, P79, DOI 10.1038/nrcardio.2010.184
NR 20
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 113
EP 117
DI 10.4070/kcj.2014.44.2.113
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300008
PM 24653741
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, H
   Kim, M
   Uhm, JS
   Pak, HN
   Lee, MH
   Joung, B
AF Cho, Hyunsoo
   Kim, Mihyun
   Uhm, Jae-Sun
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Joung, Boyoung
TI Transvenous Pacemaker Lead Removal in Pacemaker Lead Endocarditis with
   Large Vegetations: A Report of Two Cases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac pacemaker, artificial; Endocarditis
ID CARDIOVERTER-DEFIBRILLATORS; INFECTIONS; MANAGEMENT
AB Pacemaker lead endocarditis is treated with total removal of the infected device and proper antibiotics. The outcomes of patients undergoing percutaneous lead extraction for large vegetations (>2 cm) have not yet been shown. In this case report, we present two patients with pacemaker lead endocarditis with large vegetations of maximum diameter 2.4 cm and 3.2 cm. The first patient had multiple vegetations attached to the tricuspid and mitral valves and developed septic emboli to the brain, lung, and liver. The second patient had a large, persistent vegetation on the tricuspid valve, even two weeks after complete removal of the leads. Both patients were successfully treated with transvenous pacemaker lead removal and antibiotics.
C1 [Cho, Hyunsoo; Kim, Mihyun; Uhm, Jae-Sun; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM cby6908@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Joung, Boyoung/0000-0001-9036-7225; Cho, Hyunsoo/0000-0003-2651-6403;
   Uhm, Jae-Sun/0000-0002-1611-8172
FU Korean Heart Rhythm Society [2011-3]; Basic Science Research Program
   through the National Research Foundation of Korea - Ministry of
   Education, Science and Technology [2012-0007604, 2012-045367]; Korean
   Healthcare Technology R&D Project - Ministry of Health Welfare [A121668]
FX This study was supported in part by research grants from the Korean
   Heart Rhythm Society (2011-3), the Basic Science Research Program
   through the National Research Foundation of Korea funded by the Ministry
   of Education, Science and Technology (2012-0007604, 2012-045367), and a
   grant of the Korean Healthcare Technology R&D Project funded by the
   Ministry of Health & Welfare (A121668).
CR CAMUS C, 1993, CLIN INFECT DIS, V17, P46, DOI 10.1093/clinids/17.1.46
   Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011
   Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098
   Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664
   Meier-Ewert HK, 2003, AM HEART J, V146, P339, DOI 10.1016/S0002-8703(03)00188-1
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Ruttmann E, 2006, PACE, V29, P231, DOI 10.1111/j.1540-8159.2006.00328.x
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
NR 8
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 118
EP 121
DI 10.4070/kcj.2014.44.2.118
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300009
PM 24653742
OA Green Published
DA 2021-04-22
ER

PT J
AU Nakatani, S
   Taniike, M
   Makino, N
   Egami, Y
   Shutta, R
   Tanouchi, J
   Nishino, M
AF Nakatani, Shimpei
   Taniike, Masayuki
   Makino, Nobuhiko
   Egami, Yasuyuki
   Shutta, Ryu
   Tanouchi, Jun
   Nishino, Masami
TI A Case of Sudden Cardiac Death due to Pilsicainide-Induced Torsades de
   Pointes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pilsicainide; Torsades de pointes; Sudden cardiac death
ID ONSET ATRIAL-FIBRILLATION
AB An 84-year-old male received oral pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert his paroxysmal atrial fibrillation to a sinus rhythm; the patient developed sudden cardiac death two days later. The Holter electrocardiogram, which was worn by chance, revealed torsade de pointes with gradually prolonged QT intervals. This drug is rapidly absorbed from the gastrointestinal tract, and most of it is excreted from the kidney. Although the patient's renal function was not highly impaired and the dose of pilsicainide was low, the plasma concentration of pilsicainide may have been high, which can produce torsades de pointes in the octogenarian. Although the oral administration of class IC drugs, including pilsicainide, is effective to terminate atrial fibrillation, careful consideration must be taken before giving these drugs to octogenarians.
C1 [Nakatani, Shimpei; Taniike, Masayuki; Makino, Nobuhiko; Egami, Yasuyuki; Shutta, Ryu; Tanouchi, Jun; Nishino, Masami] Osaka Rosai Hosp, Div Cardiol, Sakai, Osaka 5918025, Japan.
RP Nishino, M (corresponding author), Osaka Rosai Hosp, Div Cardiol, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.
EM mnishino@orh.go.jp
CR Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233
   [Anonymous], 1989, NEW ENGL J MED, V321, P406
   Atarashi H, 1996, AM J CARDIOL, V78, P694, DOI 10.1016/S0002-9149(96)00401-8
   Kaneko Y, 2012, INTERNAL MED, V51, P443, DOI 10.2169/internalmedicine.51.6828
NR 4
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 122
EP 124
DI 10.4070/kcj.2014.44.2.122
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300010
PM 24653743
OA Green Published
DA 2021-04-22
ER

PT J
AU Petrou, E
   Vartela, V
   Girasis, C
   Boutsikou, M
   Iakovou, I
   Pavlides, G
AF Petrou, Emmanouil
   Vartela, Vasiliki
   Girasis, Chrysafios
   Boutsikou, Maria
   Iakovou, Ioannis
   Pavlides, Gregory
TI Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Petrou, Emmanouil; Vartela, Vasiliki; Girasis, Chrysafios; Boutsikou, Maria; Iakovou, Ioannis; Pavlides, Gregory] Onassis Cardiac Surg Ctr, Dept Cardiol, GR-17674 Kallithea Athens, Greece.
RP Petrou, E (corresponding author), Onassis Cardiac Surg Ctr, Dept Cardiol, 356 Sygrou Ave, GR-17674 Kallithea Athens, Greece.
EM emmgpetrou@hotmail.com
RI Boutsikou, Maria/AAX-7289-2020
OI Boutsikou, Maria/0000-0002-5457-2472
CR Egred M, 2006, CIRCULATION, V113, pE745, DOI 10.1161/CIRCULATIONAHA.105.568238
   Yunoki K, 2006, CIRCULATION, V114, pE558, DOI 10.1161/CIRCULATIONAHA.106.618611
NR 2
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2014
VL 44
IS 2
BP 128
EP 129
DI 10.4070/kcj.2014.44.2.128
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PI
UT WOS:000342411300012
PM 24653745
OA Green Published
DA 2021-04-22
ER

PT J
AU Shim, CY
   Lindner, JR
AF Shim, Chi Young
   Lindner, Jonathan R.
TI Cardiovascular Molecular Imaging with Contrast Ultrasound: Principles
   and Applications
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Molecular imaging; Contrast ultrasound; Microbubbles
ID CELL-ADHESION MOLECULE-1; VON-WILLEBRAND-FACTOR; TARGETED MICROBUBBLES;
   ACTIVATED LEUKOCYTES; ENDOTHELIAL-CELLS; IN-VIVO; ATHEROSCLEROSIS;
   INFLAMMATION; ANGIOGENESIS; THERAPY
AB Methods for imaging the molecular or cellular profile of tissue are being developed for all forms of non-invasive cardiovascular imaging. It is thought that these technologies will potentially improve patient outcomes by allowing diagnosis of disease at an early-stage, monitoring disease progression, providing important information on patient risk, and for tailoring therapy to the molecular basis of disease. Molecular imaging is also already assuming an important role in science by providing a better understanding of the molecular basis of cardiovascular pathology, for assessing response to new therapies, and for rapidly optimizing new or established therapies. Ultrasound-based molecular imaging is one of these new approaches. Contrast-enhanced ultrasound molecular imaging relies on the detection of novel site-targeted microbubbles (MB) or other acoustically active particles which are administered by intravenous injection, circulate throughout the vascular compartment, and are then retained and imaged within regions of disease by ligand-directed binding. The technique is thought to be advantageous in practical terms of cost, time, and ease of use. The aim of this review is to discuss the molecular participants of cardiovascular disease that have been targeted for ultrasound imaging, general features of site-targeted MB, imaging protocols, and potential roles of ultrasound molecular imaging in cardiovascular research and clinical medicine.
C1 [Shim, Chi Young; Lindner, Jonathan R.] Oregon Hlth & Sci Univ, Knight Cardiovasc Ctr, Portland, OR 97239 USA.
RP Lindner, JR (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Ctr, UHN 62, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM lindnerj@ohsu.edu
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136
FU National Institutes of Health, Bethesda, MarylandUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-HL-078610, R01-HL-111969]
FX Dr. Lindner is supported by grants R01-HL-078610 and R01-HL-111969 from
   the National Institutes of Health, Bethesda, Maryland.
CR Alonso A, 2007, STROKE, V38, P1508, DOI 10.1161/STROKEAHA.106.471391
   Anderson DR, 2007, CARDIOVASC RES, V73, P597, DOI 10.1016/j.cardiores.2006.11.029
   BASSENGE E, 1991, EUR HEART J, V12, P12, DOI 10.1093/eurheartj/12.suppl_E.12
   Behm CZ, 2008, CIRCULATION, V117, P2902, DOI 10.1161/CIRCULATIONAHA.107.744037
   Behm Carolyn Z, 2006, Ultrasound Q, V22, P67
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   Chadderdon SM, 2013, CIRCULATION
   Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1
   Cines DB, 1998, BLOOD, V91, P3527
   Davidson BP, 2012, J AM COLL CARDIOL, V60, P1690, DOI 10.1016/j.jacc.2012.07.027
   Davidson BP, 2012, HEART, V98, P246, DOI 10.1136/heartjnl-2011-300737
   Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8
   Dayton PA, 2004, MOL IMAGING, V3, P125, DOI 10.1162/1535350041464883
   Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022
   Hamilton AJ, 2004, J AM COLL CARDIOL, V43, P453, DOI 10.1016/j.jacc.2003.07.048
   Inaba Y, 2012, TRANSL RES, V159, P140, DOI 10.1016/j.trsl.2011.12.001
   Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738
   Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386
   Lanza GM, 1996, CIRCULATION, V94, P3334, DOI 10.1161/01.CIR.94.12.3334
   Lanza GM, 2000, J AM SOC ECHOCARDIOG, V13, P608, DOI 10.1067/mje.2000.105840
   Leong-Poi H, 2005, CIRCULATION, V111, P3248, DOI 10.1161/CIRCULATIONAHA.104.481515
   Leong-Poi H, 2003, CIRCULATION, V107, P455, DOI 10.1161/01.CIR.0000044916.05919.8B
   Leong-Poi H, 2009, CARDIOVASC RES, V84, P190, DOI 10.1093/cvr/cvp248
   Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6
   Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1
   Lindner JR, 2000, CIRCULATION, V102, P531
   Lindner JR, 2004, NAT REV DRUG DISCOV, V3, P527, DOI 10.1038/nrd1417
   Lindner JR, 2002, J AM SOC ECHOCARDIOG, V15, P396, DOI 10.1067/mje.2002.117290
   Lindner JR, 2000, CIRCULATION, V101, P668, DOI 10.1161/01.CIR.101.6.668
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Liu YN, 2013, CIRC-CARDIOVASC IMAG, V6, P74, DOI 10.1161/CIRCIMAGING.112.975193
   McCarty OJT, 2010, JACC-CARDIOVASC IMAG, V3, P947, DOI 10.1016/j.jcmg.2010.06.013
   Palmowski M, 2008, MOL CANCER THER, V7, P101, DOI 10.1158/1535-7163.MCT-07-0409
   Pysz MA, 2012, QUANT IMAGING MED SU, V2, P68, DOI 10.3978/j.issn.2223-4292.2012.06.05
   Quillard T, 2012, CIRC RES, V111, P231, DOI 10.1161/CIRCRESAHA.112.268144
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x
   Ryu JC, 2013, CIRCULATION, V127, P710, DOI 10.1161/CIRCULATIONAHA.112.116103
   SANG O, 1998, CELL RES, V8, P171
   Sinusas AJ, 2008, CIRC-CARDIOVASC IMAG, V1, P244, DOI 10.1161/CIRCIMAGING.108.824359
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Villanueva FS, 2007, CIRCULATION, V115, P345, DOI 10.1161/CIRCULATIONAHA.106.633917
   Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1
   Wang XW, 2012, CIRCULATION, V125, P3117, DOI 10.1161/CIRCULATIONAHA.111.030312
   Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95
   Xie F, 2009, CIRCULATION, V119, P1378, DOI 10.1161/CIRCULATIONAHA.108.825067
NR 46
TC 4
Z9 6
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 1
EP 9
DI 10.4070/kcj.2014.44.1.1
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100001
PM 24497883
OA Green Published
DA 2021-04-22
ER

PT J
AU Schuhmann, CG
   Hacker, M
   Jung, P
   Kortz, F
   Sohn, HY
AF Schuhmann, Christoph G.
   Hacker, Marcus
   Jung, Philip
   Kroetz, Florian
   Sohn, Hae-Young
TI Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial
   Ischemia but May Be Indicative of the Severity of Coronary Artery
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myeloperoxidase; Coronary artery disease; Myocardial ischemia;
   Myocardial perfusion imaging; Acute coronary syndrome
ID UNSTABLE ANGINA; CHEST-PAIN; PLASMA MYELOPEROXIDASE; PLAQUE EROSION;
   INFARCTION; RISK; REPERFUSION; NEUTROPHILS; EXPRESSION; OXIDANT
AB Background and Objectives: Elevated levels of myeloperoxidase (MPO) have been found in patients in different stages of coronary artery disease (CAD). The aim of this study was to assess whether the MPO liberation is increased by stress inducible myocardial ischemia and could be used to improve the diagnostic accuracy of non-invasive evaluation for myocardial ischemia.
   Subjects and Methods: Seventy-six patients with suspected myocardial ischemia who underwent stress myocardial perfusion scintigraphy (MPS) were enrolled. 59 patients with an acute coronary syndrome (ACS) who received a percutaneous coronary intervention along with 12 healthy volunteers were also included in the study. In every subject the MPO plasma levels were assessed by enzyme linked immunosorbent assay. In patients undergoing MPS, the MPO levels were measured serially before and after the stress testing.
   Results: Of the 76 patients undergoing MPS, 38 were diagnosed with a stress inducible myocardial ischemia. The patients with a stress induced ischemia had significantly higher basal MPO levels than those without it (32 +/- 3 ng/mL vs. 24 +/- 4 ng/mL, p=0.03). However, there was no relevant change in the MPO levels after the stress test compared to the baseline. The patients with ACS showed significantly higher MPO levels than the patients undergoing MPS (131 +/- 14 ng/mL vs. 28 +/- 2 ng/mL, p<0.01) and the healthy subjects (131 +/- 14 ng/mL vs. 26 +/- 2 ng/mL, p<0.01).
   Conclusion: Since the MPO plasma levels did not increase after the stress MPS, MPO appears not to be a useful biomarker for detecting a stress inducible myocardial ischemia. Yet, the MPO levels correlate with the different stages of CAD and may hold significance as an indicator for its clinical severity.
C1 [Schuhmann, Christoph G.; Jung, Philip; Kroetz, Florian; Sohn, Hae-Young] Univ Munich, Univ Hosp, Dept Cardiol, Med Klin 1, Munich, Germany.
   [Hacker, Marcus] Univ Munich, Univ Hosp, Dept Nucl Med, Munich, Germany.
RP Sohn, HY (corresponding author), Klinikum Univ Munchen, Dept Cardiol, Med Klin 1, Campus Innenstadt,Ziemssenstr 1, D-80336 Munich, Germany.
EM haeyoung.sohn@med.uni-muenchen.de
FU University of Munich (Friedrich-Baur-Stiftung)
FX This work was supported by a grant from the University of Munich
   (Friedrich-Baur-Stiftung).
CR Aminian A, 2009, EUR J INTERN MED, V20, P527, DOI 10.1016/j.ejim.2009.05.008
   Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51
   Biasucci LM, 1996, J AM COLL CARDIOL, V27, P611, DOI 10.1016/0735-1097(95)00524-2
   Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003
   Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/00041433-200308000-00003
   Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295
   DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342
   Eggers KM, 2010, CLIN BIOCHEM, V43, P240, DOI 10.1016/j.clinbiochem.2009.09.026
   Ferrante G, 2010, CIRCULATION, V122, P2505, DOI 10.1161/CIRCULATIONAHA.110.955302
   HANSEN PR, 1995, CIRCULATION, V91, P1872, DOI 10.1161/01.CIR.91.6.1872
   Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X
   Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697
   Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/j.jacc.2003.08.011
   Marshall CJ, 2010, AM J CARDIOL, V106, P316, DOI 10.1016/j.amjcard.2010.03.028
   Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033
   Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040
   Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20
   Naruko T, 2010, HEART, V96, P1716, DOI 10.1136/hrt.2009.187609
   Ndrepepa G, 2008, EUR J CLIN INVEST, V38, P90, DOI 10.1111/j.1365-2362.2007.01908.x
   Rebeiz AG, 2011, CORONARY ARTERY DIS, V22, P553, DOI 10.1097/MCA.0b013e32834c5e98
   Rudolph V, 2007, FREE RADICAL BIO MED, V42, P460, DOI 10.1016/j.freeradbiomed.2006.11.004
   Sawicki M, 2011, EUR J CLIN INVEST, V41, P667, DOI 10.1111/j.1365-2362.2010.02457.x
   SLOMKA PJ, 1995, J NUCL MED, V36, P1115
   Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f
   Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9
   Wiersma JJ, 2011, CLIN CHIM ACTA, V412, P86, DOI 10.1016/j.cca.2010.09.019
   Yunoki K, 2010, AM J CARDIOL, V105, P922, DOI 10.1016/j.amjcard.2009.11.013
   Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136
NR 28
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 10
EP 15
DI 10.4070/kcj.2014.44.1.10
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100002
PM 24497884
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, MY
   Kim, JH
   Kim, YS
   Chung, JW
   Bae, JH
   Nah, DY
   Kim, YK
   Lee, MM
   Lim, CY
   Byun, JE
   Park, HK
   Kang, BW
   Kim, JW
   Kim, SW
AF Rhee, Moo-Yong
   Kim, Ji-Hyun
   Kim, Yong-Seok
   Chung, Jin-Wook
   Bae, Jun-Ho
   Nah, Deuk-Young
   Kim, Young-Kwon
   Lee, Myoung-Mook
   Lim, Chi-Yeon
   Byun, Jae-Eon
   Park, Hye-Kyung
   Kang, Baeg-Won
   Kim, Jong-Wook
   Kim, Sun-Woong
TI High Sodium Intake in Women with Metabolic Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sodium, dietary; Metabolic syndrome; Hypertension
ID NUTRITION EXAMINATION SURVEY; KOREAN NATIONAL-HEALTH; BLOOD-PRESSURE;
   SALT SENSITIVITY; URINE COLLECTION; HYPERTENSION; MORTALITY; MEN
AB Background and Objectives: Metabolic syndrome and high sodium intake are associated with frequent cardiovascular events. Few studies have estimated sodium intake in subjects with metabolic syndrome by 24-hour urine sodium excretion. We evaluated sodium intake in individuals with metabolic syndrome.
   Subjects and Methods: Participants were recruited by random selection and through advertisement. Twenty four-hour urine collection, ambulatory blood pressure measurements, and blood test were performed. Sodium intake was estimated by 24-hour urine sodium excretion. Participants receiving antihypertensive medications were excluded from analysis.
   Results: Among the 463 participants recruited, subjects with metabolic syndrome had higher levels of 24-hour urine sodium excretion than subjects without metabolic syndrome (p=0.0001). There was a significant relationship between the number of metabolic syndrome factors and 24-hour urine sodium excretion (p=0.001). The proportion of subjects with metabolic syndrome was increased across the tertile groups of 24-hour urine sodium excretion (p<0.0001). The association of high sodium intake and metabolic syndrome was significant only among women. Among the factors related to metabolic syndrome, body mass index had an independent association with 24-hour urine sodium excretion (p<0.0001).
   Conclusion: Women with metabolic syndrome exhibited significantly higher sodium intake, suggesting that dietary education to reduce sodium consumption should be emphasized for women with metabolic syndrome.
C1 [Rhee, Moo-Yong; Kim, Ji-Hyun; Kim, Yong-Seok; Kim, Young-Kwon; Lee, Myoung-Mook] Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, Goyang 410773, South Korea.
   [Lim, Chi-Yeon] Dongguk Univ, Ilsan Hosp, Clin Trial Ctr, Goyang 410773, South Korea.
   [Chung, Jin-Wook; Bae, Jun-Ho; Nah, Deuk-Young] Dongguk Univ, Coll Med, Dept Internal Med, Div Cardiol, Goyang 410773, South Korea.
   [Byun, Jae-Eon; Park, Hye-Kyung; Kang, Baeg-Won; Kim, Jong-Wook] Minist Food & Drug, Food Nutr & Dietary Safety Bur, Nutr Safety Policy Div, Osong, South Korea.
   [Kim, Sun-Woong] Dongguk Univ, Survey Res Ctr, Dept Stat, Seoul, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, 27 Dongguk Ro, Goyang 410773, South Korea.
EM mooyong_rhee@dumc.or.kr
FU Korea Food and Drug Administration [11162KFDA162]; Korean Society of
   Cardiology [2010-2]
FX This research was supported by grants from the Korea Food and Drug
   Administration in 2011 (11162KFDA162) and Korean Society of Cardiology
   (2010-2).
CR Ando K, 2012, ANN MED, V44, pS119, DOI 10.3109/07853890.2012.671538
   [Anonymous], 1988, BMJ, V297, P319
   Baudrand R., 2013, CLIN ENDOCRINOL OXF
   Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6
   김동희, 2008, Korean Circulation Journal, V38, P29
   Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55
   He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990
   Hoffmann IS, 2009, NUTR METAB CARDIOVAS, V19, P123, DOI 10.1016/j.numecd.2008.02.011
   Jee SH, 2012, KOREAN CIRC J, V42, P371, DOI 10.4070/kcj.2012.42.6.371
   Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001
   Khaw KT, 2004, AM J CLIN NUTR, V80, P1397
   Kim BK, 2012, BLOOD PRESS MONIT, V17, P120, DOI 10.1097/MBP.0b013e328354079b
   KNUIMAN JT, 1986, HUM NUTR-CLIN NUTR, V40C, P229
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Lee JS, 2011, NUTR RES PRACT, V5, P60, DOI 10.4162/nrp.2011.5.1.60
   Lim Ji Hyon, 2010, Korean Circ J, V40, P314, DOI 10.4070/kcj.2010.40.7.314
   LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806
   MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7
   권용주, 2010, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V39, P535
   Rabi DM, 2011, CAN J CARDIOL, V27, P415, DOI 10.1016/j.cjca.2011.03.015
   Rhee MY, 2013, EUR J CLIN NUTR, V67, P875, DOI 10.1038/ejcn.2013.87
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Shin SJ, 2011, J KOREAN MED SCI, V26, P1061, DOI 10.3346/jkms.2011.26.8.1061
   Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608
   Sung Joong Kyung, 2010, Korean Circ J, V40, P55, DOI 10.4070/kcj.2010.40.2.55
   Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4
   Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429
   WHO, 2007, RED SALT INT POP REP
   Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257
   Yoshita Katsushi, 2005, Environmental Health and Preventive Medicine, V10, P150, DOI 10.1007/BF02900808
NR 30
TC 17
Z9 17
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 30
EP 36
DI 10.4070/kcj.2014.44.1.30
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100005
PM 24497887
OA Green Published
DA 2021-04-22
ER

PT J
AU Baek, JE
   Park, SJ
   Woo, SB
   Choi, JY
   Jung, JW
   Kim, NK
AF Baek, Jae Eun
   Park, Su Jin
   Woo, Saet Byul
   Choi, Jae Young
   Jung, Jo Won
   Kim, Nam Kyun
TI Changes in Patient Characteristics of Infective Endocarditis with
   Congenital Heart Disease: 25 Years Experience in a Single Institution
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Infective endocarditis; Heart disease; congenital
ID PROFILE
AB Background and Objectives: The profile of infective endocarditis (IE) has changed and is now showing an increasing prevalence of IE among congenital heart disease (CHD) patients. We studied the change of clinical profiles of IE over the past 25 years in patients with CHD at a single institution.
   Subjects and Methods: We reviewed medical records retrospectively for 325 patients diagnosed with IE between January 1, 1987, and March 31, 2012. We analyzed and compared the differences in patient characteristics and outcomes between 1987-2000 (group A) and 2001-2012 (group B).
   Results: Over the 25-year period, 93 cases of IE in CHD patients were diagnosed (59 cases in group A and 34 cases in group B). Ventricular septal defect was the most common underlying cardiac disease observed during the entire period. The most common causative pathogen was Streptococcus in both groups. Group A contained 16 cases (27.1%) that had undergone cardiac surgery, whereas this number was 19 (55.8%) in group B. The number of patients who had undergone palliative care or surgery using prosthetic materials was higher among group B patients (p<0.001). Surgical procedures due to uncontrolled infection were performed in three cases in group A and 10 cases in group B.
   Conclusion: Infective endocarditis and CHD show a close correlation, and the profile of IE patients can change in line with an increase in the survival rate of patients with complex CHD and the improvement of surgical techniques. Ongoing reassessment and the systematic management of these patients is crucial in the prevention and treatment of IE.
C1 [Baek, Jae Eun; Woo, Saet Byul; Choi, Jae Young; Jung, Jo Won; Kim, Nam Kyun] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Congenital Heart Dis Ctr,Dept Pediat,Div Pediat C, Seoul 120752, South Korea.
   [Park, Su Jin] Sejong Gen Hosp, Dept Pediat Cardiol, Bucheon, South Korea.
RP Kim, NK (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Congenital Heart Dis Ctr,Dept Pediat,Div Pediat C, 50 Yonsei Ro, Seoul 120752, South Korea.
EM pednk@yuhs.ac
OI Choi, Jae Young/0000-0002-1247-6669
CR AHN S, 2000, KOREAN CIRC J, V30, P166
   Barnes PD, 1997, J INFECTION, V35, P209, DOI 10.1016/S0163-4453(97)92662-1
   백재숙, 2007, Korean Circulation Journal, V37, P635
   DEGEVIGNEY G, 1995, EUR HEART J, V16, P7, DOI 10.1093/eurheartj/16.suppl_B.7
   Di Filippo S, 2006, HEART, V92, P1490, DOI 10.1136/hrt.2005.085332
   Elbey MA, 2013, ANATOL J CARDIOL, V13, P523, DOI 10.5152/akd.2013.172
   Fortun J, 2013, INFECTION, V41, P167, DOI 10.1007/s15010-012-0326-6
   Garg N, 2005, INT J CARDIOL, V98, P253, DOI 10.1016/j.ijcard.2003.10.043
   Gewitz Michael H., 1997, Current Opinion in Pediatrics, V9, P518, DOI 10.1097/00008480-199710000-00015
   Harris P. Scott, 1996, Cardiology Clinics, V14, P437, DOI 10.1016/S0733-8651(05)70294-0
   Ikama MS, 2013, MED SANTE TROP, V23, P89, DOI 10.1684/mst.2013.0151
   김성혜, 2006, Korean Circulation Journal, V36, P318
   박창범, 2005, Korean Circulation Journal, V35, P633
   Knirsch W, 2005, INT J CARDIOL, V101, P285, DOI 10.1016/j.ijcard.2004.03.035
   Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753
   Micheletti A, 2010, Pediatr Med Chir, V32, P270
   Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599
   Nakatani S, 2003, CIRC J, V67, P901, DOI 10.1253/circj.67.901
   Niwa K, 2005, HEART, V91, P795, DOI 10.1136/hrt.2004.043323
   Petti CA, 2003, CARDIOL CLIN, V21, pvii
   Petti Cathy A., 2003, Cardiology Clinics, V21, P219, DOI 10.1016/S0733-8651(03)00030-4
   RUBINSTEIN E, 1995, EUR HEART J, V16, P84, DOI 10.1093/eurheartj/16.suppl_B.84
   Ternhag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067519
   Wilson W, 2008, J AM DENT ASSOC, V139, p3S, DOI 10.14219/jada.archive.2008.0346
   YOON KA, 1989, J KOREAN PEDIAT SOC, V32, P11
NR 25
TC 6
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 37
EP 41
DI 10.4070/kcj.2014.44.1.37
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100006
PM 24497888
OA Green Published
DA 2021-04-22
ER

PT J
AU Cybula-Walczak, A
   Szymanski, FM
   Platek, AE
   Karpinski, G
AF Cybula-Walczak, Aneta
   Szymanski, Filip M.
   Platek, Anna E.
   Karpinski, Grzegorz
TI Myocardial Infarction Type 4b in Human Immunodeficiency Virus-Infected
   Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Human immunodeficiency virus; Myocardial infarction; Antiretroviral
   therapy
ID ANTIRETROVIRAL DRUGS; HIV; RISK; DISEASE
AB We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, enoxaparin) and discharged. After 1.5 months, another STEMI related with in-stent thrombosis took place. The cART scheme was altered, resulting in no further cardiac events in the follow-up period, with undetectable levels of HIV ribonucleic acid. This case highlights the association between HIV infection and the specific drugs of cART, and the risk of cardiovascular disease development.
C1 [Cybula-Walczak, Aneta] Med Univ Warsaw, Dept Hepatol & Acquired Immunodeficiencies, PL-01201 Warsaw, Poland.
   [Szymanski, Filip M.; Platek, Anna E.; Karpinski, Grzegorz] Med Univ Warsaw, Dept Cardiol, PL-01201 Warsaw, Poland.
RP Cybula-Walczak, A (corresponding author), Med Univ Warsaw, Dept Hepatol & Acquired Immunodeficiencies, 37 Wolska St, PL-01201 Warsaw, Poland.
EM anetacybula@gmail.com
RI Platek, Anna E./AAU-9950-2020; Cybula, Aneta/U-4130-2018
OI Platek, Anna E./0000-0002-7286-2318; Cybula, Aneta/0000-0001-8071-7455;
   Karpinski, Grzegorz/0000-0002-0094-0102; Szymanski, Filip
   M./0000-0002-2638-7894
CR Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483
   Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063
   Deeks SG, 2012, NEW ENGL J MED, V367, P1246, DOI 10.1056/NEJMcpc1200090
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723
   Hrynkiewicz-Szymanska A, 2011, SLEEP BREATH, V15, P607, DOI 10.1007/s11325-010-0361-4
   Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x
   Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197
   Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4
   Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb
   Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184
NR 10
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 42
EP 44
DI 10.4070/kcj.2014.44.1.42
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100007
PM 24497889
OA Green Published
DA 2021-04-22
ER

PT J
AU Ryu, IH
   Kim, WH
   Ryu, AJ
   Kim, MG
   Jeon, JW
   Kim, JS
   Lee, JJ
   Choi, JH
AF Ryu, Il Hwan
   Kim, Won Ho
   Ryu, Ah Jeong
   Kim, Min Gyu
   Jeon, Jae Woong
   Kim, Joo Seok
   Lee, Jae Joon
   Choi, Jin Ho
TI Percutaneous Closure of an Iatrogenic Ventricular Septal Defect
   Following Concomitant Septal Myectomy at the Time of Aortic Valve
   Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defects; Septal occluder device
ID TRANSCATHETER CLOSURE; HYPERTROPHY; STENOSIS
AB A 77-year-old female patient underwent aortic valve replacement (AVR) with concomitant septal myectomy and tricuspid annuloplasty. Her symptoms did not improve after a successful operation. Echocardiogram demonstrated the presence of an iatrogenic ventricular septal defect (VSD). It was muscular in location and not the usual AVR with membraneous type of VSD, suggesting a complication from the myectomy. Percutaneous closure of the VSD remained the only feasible option due to her poor overall medical status. A 14-mm Amplazter VSD occluder was deployed successfully, by means of the trans-septal technique. She has improved very well postoperatively.
C1 [Ryu, Il Hwan; Kim, Won Ho; Ryu, Ah Jeong; Kim, Min Gyu; Jeon, Jae Woong; Kim, Joo Seok; Lee, Jae Joon] Eulji Univ, Eulji Univ Hosp, Sch Med, Dept Internal Med, Taejon 302799, South Korea.
   [Choi, Jin Ho] Eulji Univ, Eulji Univ Hosp, Sch Med, Div Thorac & Cardiovasc Surg, Taejon 302799, South Korea.
RP Choi, JH (corresponding author), Eulji Univ, Eulji Univ Hosp, Sch Med, Div Thorac & Cardiovasc Surg, 95 Dunsanseo Ro, Taejon 302799, South Korea.
EM jinho@eulji.ac.kr
CR Carminati M, 2007, EUR HEART J, V28, P2361, DOI 10.1093/eurheartj/ehm314
   HESS OM, 1983, J AM COLL CARDIOL, V1, P783, DOI 10.1016/S0735-1097(83)80191-0
   Holzer R, 2006, CATHETER CARDIO INTE, V68, P620, DOI 10.1002/ccd.20659
   Kayalar N, 2010, ANN THORAC SURG, V89, P459, DOI 10.1016/j.athoracsur.2009.10.065
   Kilicgedik A, 2012, PERFUSION-UK, V27, P253, DOI 10.1177/0267659112439597
   Minakata K, 2005, ANN THORAC SURG, V80, P1424, DOI 10.1016/j.athoracsur.2005.03.109
   PANZA JA, 1988, EUR HEART J, V9, P71, DOI 10.1093/eurheartj/9.suppl_E.71
   Spies C, 2009, CARDIOLOGY, V112, P31, DOI 10.1159/000137695
   Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 45
EP 48
DI 10.4070/kcj.2014.44.1.45
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100008
PM 24497890
OA Green Published
DA 2021-04-22
ER

PT J
AU Om, SY
   Park, GM
   Kim, JY
   Yoon, YH
   Lee, S
   Kim, YH
   Song, JK
AF Om, Sang Yong
   Park, Gyung Min
   Kim, Jin Yong
   Yoon, Yong Hoon
   Lee, Sinwon
   Kim, Young-Hak
   Song, Jae-Kwan
TI Transcatheter Closures for Fistula Tract and Paravalvular Leak after
   Mitral Valve Replacement and Tricuspid Annuloplasty
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Paravalvular leaks; Transcatheter closure; Mitral valve replacement
ID AMPLATZER DUCT OCCLUDER; PERCUTANEOUS CLOSURE; REGURGITATION
AB Paravalvular leaks (PVLs) often occur after surgical valve replacement. Surgical reoperation has been the gold standard of therapy for PVLs, but it carries a higher operative risk and an increased incidence of re-leaks compared to the initial surgery. In high surgical risk patients with appropriate geometries, transcatheter closure of PVLs could be an alternative to redo-surgery. Here, we report a case of successful staged transcatheter closures of a fistula tract between the aorta and right atrium, and mitral PVLs after mitral valve replacement and tricuspid annuloplasty.
C1 [Om, Sang Yong; Kim, Jin Yong; Yoon, Yong Hoon; Lee, Sinwon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea.
   [Kim, Young-Hak; Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul 138736, South Korea.
   [Park, Gyung Min] Cathol Univ Korea, Daejeon St Marys Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
RP Song, JK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88 Olympic Ro 43-Gil, Seoul 138736, South Korea.
EM jksong@amc.seoul.kr
CR Binder RK, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0342-2
   Cortes M, 2008, AM J CARDIOL, V101, P382, DOI 10.1016/j.amjcard.2007.08.052
   Eisenhauer AC, 2001, CATHETER CARDIO INTE, V54, P234, DOI 10.1002/ccd.1274
   HOURIHAN M, 1992, J AM COLL CARDIOL, V20, P1371, DOI 10.1016/0735-1097(92)90250-Q
   Kort HW, 2004, CATHETER CARDIO INTE, V61, P548, DOI 10.1002/ccd.10785
   Kuehl M, 2009, CATHETER CARDIO INTE, V73, P838, DOI 10.1002/ccd.21926
   Kursaklioglu H, 2010, TEX HEART I J, V37, P461
   Nietlispach F, 2010, JACC-CARDIOVASC INTE, V3, P759, DOI 10.1016/j.jcin.2010.04.013
   Pate GE, 2006, CATHETER CARDIO INTE, V67, P158, DOI 10.1002/ccd.20560
   Pate GE, 2006, CATHETER CARDIO INTE, V68, P528, DOI 10.1002/ccd.20795
   Shapira Y, 2007, J HEART VALVE DIS, V16, P305
   Webb JG, 2005, CATHETER CARDIO INTE, V65, P69, DOI 10.1002/ccd.20337
NR 12
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 49
EP 53
DI 10.4070/kcj.2014.44.1.49
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100009
PM 24497891
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, J
   Kim, GB
   Kwon, BS
   Bae, EJ
   Noh, CI
AF Lee, Joowon
   Kim, Gi Beom
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
TI Two Cases of Super-Giant Coronary Aneurysms after Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Coronary aneurysm; Coronary thrombosis; Coronary
   artery disease
ID ARTERY ABNORMALITIES; THERAPY; RUPTURE
AB Acute giant coronary aneurysm after Kawasaki disease (KD) is a catastrophic complication that can be fatal and very difficult to manage. However, no fixed consensus has been reached for the management of super-giant coronary aneurysms in the acute setting. Here, we report the successful management of young children with super-giant coronary aneurysms after KD. Based on our experience, hemodynamic stabilization to prevent further coronary dilation or rupture and strict anticoagulation to avoid thrombus formation are mandatory in the management of this condition.
C1 [Lee, Joowon; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM ped9526@snu.ac.kr
OI Lee, Joowon/0000-0001-5089-6093
CR Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   Burns JC, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e27
   Chen SJ, 2013, HEART, V99, P76, DOI 10.1136/heartjnl-2012-302126
   Imai Y, 2006, EUR J PEDIATR, V165, P130, DOI 10.1007/s00431-005-0016-9
   Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x
   KATO H, 1991, Acta Paediatrica Japonica, V33, P27
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   KATO H, 1979, PEDIATRICS, V63, P175
   Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2
   Kuramochi Y, 2000, PEDIATR INT, V42, P470, DOI 10.1046/j.1442-200x.2000.01270.x
   McNeal-Davidson A, 2013, PEDIATR CARDIOL, V34, P170, DOI 10.1007/s00246-012-0409-2
   Ohkubo T, 2007, PEDIATR INT, V49, P1, DOI 10.1111/j.1442-200X.2007.02312.x
   Panzer J, 2008, CARDIOL YOUNG, V18, P189, DOI 10.1017/S1047951108001911
   Suda K, 2009, CIRC J, V73, P1319, DOI 10.1253/circj.CJ-08-0931
   Sunagawa K, 2008, PEDIATR CARDIOL, V29, P1115, DOI 10.1007/s00246-008-9236-x
   Suzuki N, 1999, PEDIATR INT, V41, P318, DOI 10.1046/j.1442-200x.1999.01058.x
   Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131
NR 17
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 54
EP 58
DI 10.4070/kcj.2014.44.1.54
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100010
PM 24497892
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, BW
   Hwang, HJ
   Seung, M
   Lee, MH
AF Song, Byeong-Wook
   Hwang, Hye Jin
   Seung, Minji
   Lee, Moon-Hyoung
TI Effect of Hypoxic Paracrine Media on Calcium-Regulatory Proteins in
   Infarcted Rat Myocardium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Stem cells; Paracrine communication; Calcium
   homeostasis endoplasmic reticulum protein
ID MESENCHYMAL STEM-CELLS; IMPROVES CARDIAC-FUNCTION; CONDUCTION BLOCK;
   NA/CA EXCHANGE; EXPRESSION; REPAIR; TRANSPLANTATION
AB Background and Objectives: An increase in intracellular calcium concentration due to loss of Ca2+ homeostasis triggers arrhythmia or cardiac cell death in the heart. Paracrine factors released from stem cells have beneficial cardioprotective effects. However, the mechanism of modulation of Ca2+ homeostasis by paracrine factors in ischemic myocardium remains unclear.
   Materials and Methods: We isolated rat bone marrow-derived mesenchymal stem cells (MSCs), and prepared paracrine media (PM) from MSCs under hypoxic or normoxic conditions (hypoxic PM and normoxic PM). We induced rat myocardial infarction by left anterior descending ligation for 1 hour, and treated PM into the border region of infarcted myocardium (n=6/group) to identify the alteration in calcium-regulated proteins. We isolated and stained the heart tissue with specific calcium-related antibodies after 11 days.
   Results: The hypoxic PM treatment increased Ca2+-related proteins such as L-type Ca2+ channel, sarcoplasmic reticulum Ca2+ ATPase, Na+/K+ ATPase, and calmodulin, whereas the normoxic PM treatment increased those proteins only slightly. The sodium-calcium exchanger was significantly reduced by hypoxic PM treatment, compared to moderate suppression by the normoxic PM treatment.
   Conclusion: Our results suggest that hypoxic PM was significantly associated with the positive regulation of Ca2+ homeostasis in infarcted myocardium.
C1 [Song, Byeong-Wook] Catholic Univ, Korea Coll Med, Incheon St Marys Hosp, Inst Cathol Integrat Med, Inchon, South Korea.
   [Hwang, Hye Jin; Seung, Minji; Lee, Moon-Hyoung] Yonsei Univ, Coll Med, Severance Cardiovascular Res Ctr, Div Cardiol, Seoul 120752, South Korea.
RP Lee, MH (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mhlee@yuhs.ac
RI Song, Byeong-Wook/R-1077-2019
OI Song, Byeong-Wook/0000-0002-9962-0941; Lee,
   Moon-Hyoung/0000-0002-7268-0741; Seung, Minji/0000-0002-4759-4331
FU Korean Society of Cardiology; National Research Foundation of Korea -
   Ministry of Education, Science, Republic of Korea [2011-0014595]
FX This research was supported by a grant from the Korean Society of
   Cardiology (2007) and the Basic Science Research Program through the
   National Research Foundation of Korea (2011-0014595) funded by the
   Ministry of Education, Science, Republic of Korea.
CR Beeres SLMA, 2005, J AM COLL CARDIOL, V46, P1943, DOI 10.1016/j.jacc.2005.07.055
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455
   Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038
   Couzin J, 2004, SCIENCE, V304, P192, DOI 10.1126/science.304.5668.192
   Decker KF, 2010, AM J PHYSIOL-HEART C, V299, pH1588, DOI 10.1152/ajpheart.00362.2010
   EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Hwang HJ, 2012, J AM COLL CARDIOL, V60, P1698, DOI 10.1016/j.jacc.2012.04.056
   JECK CD, 1994, J MOL CELL CARDIOL, V26, P99, DOI 10.1006/jmcc.1994.1011
   Leszek P, 2007, EUR J HEART FAIL, V9, P579, DOI 10.1016/j.ejheart.2007.01.011
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mathur A, 2004, LANCET, V364, P183, DOI 10.1016/S0140-6736(04)16632-4
   Min JY, 2002, ANN THORAC SURG, V74, P1568, DOI 10.1016/S0003-4975(02)03952-8
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1
   Ostadal P, 2003, BIOCHEM BIOPH RES CO, V306, P457, DOI 10.1016/S0006-291X(03)00986-0
   Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066
   Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938
   Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467
   Talukder MAH, 2008, AM J PHYSIOL-HEART C, V294, pH1426, DOI 10.1152/ajpheart.01016.2007
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033
   Webster KA, 2006, ANTIOXID REDOX SIGN, V8, P1667, DOI 10.1089/ars.2006.8.1667
NR 27
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 16
EP 21
DI 10.4070/kcj.2014.44.1.16
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100003
PM 24497885
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SR
   Choi, EK
   Kang, DY
   Cha, MJ
   Cho, Y
   Oh, IY
   Oh, S
AF Lee, So-Ryoung
   Choi, Eue-Keun
   Kang, Do-Yoon
   Cha, Myung-Jin
   Cho, Youngjin
   Oh, Il-Young
   Oh, Seil
TI Prognostic Implication of QRS Variability during Hospitalization in
   Patients with Acute Decompensated Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Heart decompensation; Electrocardiography; variation;
   Prognosis
ID VENTRICULAR SYSTOLIC DYSFUNCTION; BUNDLE-BRANCH BLOCK; CARDIAC
   RESYNCHRONIZATION; DILATED CARDIOMYOPATHY; DURATION; MORTALITY;
   PROLONGATION; PREVALENCE; SURVIVAL; RISK
AB Background and Objectives: Heart failure (HF) patients display more varied QRS duration. We investigated whether QRS variability during hospitalization for acute decompensated HF is associated with poor clinical outcomes after discharge.
   Subjects and Methods: One hundred seventy three patients (64% males; age 60 +/- 13 years) admitted for acute decompensated HF with severe left ventricular (LV) dysfunction (LV ejection fraction <= 35%) were consecutively enrolled. QRS variability was calculated by the difference between maximum and minimum QRS duration acquired during hospitalization. The prognostic implications on composite endpoints of death or urgent heart transplantation were analyzed.
   Results: Forty-two patients (24.3%) died and three patients (1.7%) underwent urgent heart transplantation during the follow-up of 51 +/- 18 months. Patients who reached composite endpoints (n=45) showed greater QRS variability than those who did not (n=128) (20 +/- 23 ms vs. 14 +/- 14 ms, p=0.046). Patients who had high QRS variability (more than 22 ms; n=36) tended to have a higher event rate than those with QRS variability <22 ms {39% vs. 23%, hazard ratio (HR), 1.88; 95% confidence interval (CI) 1.001-3.539, p=0.05}. Adjusting with other variables, high QRS variability was an independent predictor for composite outcome (HR 1.94; 95% CI 1.023-3.683, p=0.042).
   Conclusion: QRS variability measured during hospitalization for acute decompensated HF has a prognostic impact in HF patients with severe LV dysfunction.
C1 [Lee, So-Ryoung; Choi, Eue-Keun; Kang, Do-Yoon; Cha, Myung-Jin; Cho, Youngjin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Oh, Il-Young] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM choiek17@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/K-3752-2019; Choi,
   Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372
FU Seoul National University Hospital [03-2011-0370, 04-2010-0260,
   04-2010-1140]
FX This study was supported by grant number 03-2011-0370,
   04-2010-0260,04-2010-1140 from the Seoul National University Hospital
   research fund.
CR Aranda JM, 2002, AM J CARDIOL, V90, P335, DOI 10.1016/S0002-9149(02)02479-7
   Baldasseroni Samuele, 2003, Ital Heart J, V4, P607
   Barsheshet A, 2011, AM J CARDIOL, V107, P540, DOI 10.1016/j.amjcard.2010.10.007
   Bleeker GB, 2004, J CARDIOVASC ELECTR, V15, P544, DOI 10.1046/j.1540-8167.2004.03604.x
   Brilakis ES, 2002, AM J CARDIOL, V89, P1013, DOI 10.1016/S0002-9149(02)02267-1
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Cleland JGF, 1999, EUR J HEART FAIL, V1, P229, DOI 10.1016/S1388-9842(99)00032-X
   Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041
   Gulati A, 2013, CIRCULATION, V128, P1623, DOI 10.1161/CIRCULATIONAHA.113.002518
   Horwich T, 2003, AM J CARDIOL, V92, P804, DOI 10.1016/S0002-9149(03)00887-7
   Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586
   Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516
   Kalra PR, 2002, INT J CARDIOL, V86, P225, DOI 10.1016/S0167-5273(02)00270-X
   Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071
   Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6
   Lee CW, 2001, CIRCULATION, V103, P2784
   McCullough PA, 2005, INT J CARDIOL, V102, P303, DOI 10.1016/j.ijcard.2004.10.008
   Murkofsky RL, 1998, J AM COLL CARDIOL, V32, P476, DOI 10.1016/S0735-1097(98)00242-3
   PARAMESHWAR J, 1992, AM HEART J, V123, P421, DOI 10.1016/0002-8703(92)90656-G
   Sandhu R, 2004, AM J CARDIOL, V93, P244, DOI 10.1016/j.amjcard.2003.09.053
   Shamim W, 2002, HEART, V88, P47, DOI 10.1136/heart.88.1.47
   Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528
   Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247
   Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656
   Xiao HB, 1996, INT J CARDIOL, V53, P163, DOI 10.1016/0167-5273(95)02502-2
NR 25
TC 1
Z9 1
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2014
VL 44
IS 1
BP 22
EP 29
DI 10.4070/kcj.2014.44.1.22
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PG
UT WOS:000342411100004
PM 24497886
OA Green Published
DA 2021-04-22
ER

PT J
AU Fu, LJ
   Huan, MR
   Chen, SB
AF Fu, Lijun
   Huan, Meirong
   Chen, Shubao
TI Primary Carnitine Deficiency and Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiomyopathies; Carnitine deficiency, primary
ID GENOTYPE-PHENOTYPE CORRELATION; TRANSPORTER OCTN2;
   VENTRICULAR-FIBRILLATION; DILATED CARDIOMYOPATHY; QT SYNDROME;
   FOLLOW-UP; MUTATIONS; CHILDREN; DISEASE; DEFECT
AB Carnitine is essential for the transfer of long-chain fatty acids from the cytosol into mitochondria for subsequent beta-oxidation. A lack of carnitine results in impaired energy production from long-chain fatty acids, especially during periods of fasting or stress. Primary carnitine deficiency (PCD) is an autosomal recessive disorder of mitochondrial beta-oxidation resulting from defective carnitine transport and is one of the rare treatable etiologies of metabolic cardiomyopathies. Patients affected with the disease may present with acute metabolic decompensation during infancy or with severe cardiomyopathy in childhood. Early recognition of the disease and treatment with L-carnitine may be life-saving. In this review article, the pathophysiology, clinical presentation, diagnosis, treatment and prognosis of PCD are discussed, with a focus on cardiac involvements.
C1 [Fu, Lijun; Huan, Meirong; Chen, Shubao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiol, Shanghai 200127, Peoples R China.
RP Chen, SB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiol, Shanghai 200127, Peoples R China.
EM chensb@sh163.net
FU Innovation Program of Shanghai Municipal Education CommissionInnovation
   Program of Shanghai Municipal Education Commission [12YZ035]
FX The research was supported by grants from the Innovation Program of
   Shanghai Municipal Education Commission (no. 12YZ035).
CR Agnetti A, 2013, INT J CARDIOL, V162, pE34, DOI 10.1016/j.ijcard.2012.05.038
   Cederbaum SD, 2002, MOL GENET METAB, V77, P195, DOI 10.1016/S1096-7192(02)00169-5
   CHAPOY PR, 1980, NEW ENGL J MED, V303, P1389, DOI 10.1056/NEJM198012113032403
   Cox GF, 2006, PEDIATRICS, V118, P1519, DOI 10.1542/peds.2006-0163
   Cox GF, 2007, PROG PEDIATR CARDIOL, V24, P15, DOI 10.1016/j.ppedcard.2007.08.013
   De Biase I, 2012, JIMD REP, V2, P87, DOI 10.1007/8904_2011_52
   E XF, 2002, J GERONTOL A-BIOL, V57, pB270, DOI 10.1093/gerona/57.7.B270
   El-Hattab AW, 2010, GENET MED, V12, P19, DOI 10.1097/GIM.0b013e3181c5e6f7
   Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041686
   Filippo CADS, 2008, MOL GENET METAB, V94, P162, DOI 10.1016/j.ymgme.2008.02.002
   Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30
   Fu Li-jun, 2012, Zhonghua Er Ke Za Zhi, V50, P929
   GARAVAGLIA B, 1991, NEUROLOGY, V41, P1691, DOI 10.1212/WNL.41.10.1691
   Glube N, 2007, MOL PHARMACEUT, V4, P160, DOI 10.1021/mp060073a
   Helton E, 2000, PEDIATRICS, V105, P1260
   Kilic M, 2012, JIMD REP, V3, P17, DOI 10.1007/8904_2011_36
   Koizumi A, 1999, HUM MOL GENET, V8, P2247, DOI 10.1093/hmg/8.12.2247
   Kothari S S, 1998, Indian Heart J, V50, P59
   Labarthe F, 2009, MOL GENET METAB, V98, P55
   Lee NC, 2010, MOL GENET METAB, V100, P46, DOI 10.1016/j.ymgme.2009.12.015
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lund AM, 2007, J INHERIT METAB DIS, V30, P341, DOI 10.1007/s10545-007-0527-9
   Magoulas PL, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-68
   MATSUISHI T, 1985, NEUROPEDIATRICS, V16, P6, DOI 10.1055/s-2008-1052536
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   Paulson DJ, 1998, MOL CELL BIOCHEM, V180, P33, DOI 10.1023/A:1006826620218
   Pierpont MEM, 2000, AM HEART J, V139, pS96, DOI 10.1067/mhj.2000.103921
   Rasmussen J, 2013, J INHERIT METAB DIS
   Rasmussen J, 2013, J INHERIT METAB DIS, V36, P35, DOI 10.1007/s10545-012-9488-8
   REBOUCHE CJ, 1992, FASEB J, V6, P3379
   Rijlaarsdam RS, 2004, PACE, V27, P675, DOI 10.1111/j.1540-8159.2004.00507.x
   Rinaldo P, 1997, J PEDIATR-US, V131, P304, DOI 10.1016/S0022-3476(97)70171-9
   Rizos I, 2000, AM HEART J, V139, pS120, DOI 10.1067/mhj.2000.103917
   Rose EC, 2012, HUM MUTAT, V33, P118, DOI 10.1002/humu.21607
   Sarafoglou K, 2010, CLIN GENET, V78, P191, DOI 10.1111/j.1399-0004.2009.01368.x
   Scaglia F, 1998, GENET MED, V1, P34
   Shibbani K, 2013, CLIN GENET
   Spiekerkoetter U, 2003, J INHERIT METAB DIS, V26, P613, DOI 10.1023/A:1025968502527
   Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004
   STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512
   Stanley CA, 2011, NELSON TXB PEDIAT, P460
   Takahashi R, 2007, HYPERTENSION, V50, P497, DOI 10.1161/HYPERTENSIONAHA.107.088609
   Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378
   TEIN I, 1990, PEDIATR RES, V28, P247, DOI 10.1203/00006450-199009000-00020
   TRIPP ME, 1981, NEW ENGL J MED, V305, P385, DOI 10.1056/NEJM198108133050707
   WABER LJ, 1982, J PEDIATR-US, V101, P700, DOI 10.1016/S0022-3476(82)80294-1
   Wang YH, 2000, HUM MUTAT, V16, P401, DOI 10.1002/1098-1004(200011)16:5<401::AID-HUMU4>3.0.CO;2-J
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356
   Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669
   Yamak AA, 2007, CLIN GENET, V72, P59, DOI 10.1111/j.1399-0004.2007.00814.x
NR 50
TC 25
Z9 28
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 785
EP 792
DI 10.4070/kcj.2013.43.12.785
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700001
PM 24385988
OA Green Published
DA 2021-04-22
ER

PT J
AU Ock, SY
   Cho, KI
   Kim, HJ
   Lee, NY
   Kim, EJ
   Kim, NK
   Lee, WH
   Yeo, GE
   Heo, JJ
   Han, YJ
   Cha, TJ
AF Ock, So Young
   Cho, Kyoung Im
   Kim, Hyung Joon
   Lee, Nae Young
   Kim, Eun Jeong
   Kim, Nam Kyu
   Lee, Weon Hyoung
   Yeo, Go Eun
   Heo, Jae Joon
   Han, You Jin
   Cha, Tae-Joon
TI The Impacts of C-Reactive Protein and Atrial Fibrillation on Carotid
   Atherosclerosis and Ischemic Stroke in Patients with Suspected Ischemic
   Cerebrovascular Disease: A Single-Center Retrospective Observational
   Cohort Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; C-reactive protein; Carotid atherosclerosis
ID MEDIA THICKNESS; RISK-FACTORS; INFLAMMATION; PLAQUE; ASSOCIATION;
   MECHANISMS; PREDICTION; CORONARY; INTIMA; GERMANY
AB Background and Objectives: Carotid intima-media thickness (IMT) is associated with chronic inflammation, and C-reactive protein (CRP) level is elevated in patients with atrial fibrillation (AF). We investigated the impacts of CRP and AF on carotid atherosclerosis and ischemic stroke in patients with suspected ischemic cerebrovascular disease.
   Subjects and Methods: One-hundred forty patients (78 males) with suspected ischemic cerebrovascular disease underwent carotid ultrasonography. The mean common carotid artery IMT, mean internal carotid artery (ICA) IMT, and plaque score were measured. Patients were divided into four groups according to the presence of AF and elevated CRP level {n = 46 for AF(-)CRP(-), n = 38 for AF(-)CRP(+), n = 43 for AF(+) CRP(-), and n = 13 for AF(+) CRP(+)}.
   Results: Common carotid artery IMT was significantly higher in the AF(-) CRP(+) (0.98 +/- 0.51 mm) and AF(+)CRP(+) (0.96 +/- 0.27 mm) groups compared to the AF(-)CRP(-) (0.80 +/- 0.32 mm) and AF(+)CRP(-) (0.77 +/- 0.19 mm) groups (p = 0.027). Although there was no significant difference in mean ICA IMT among the groups, plaque score was the highest in the AF(+)CRP(+) (4.18 +/- 3.84 mm) group, followed by AF(-)CRP(+) (3.87 +/- 2.78 mm), AF(+)CRP(-) (1.34 +/- 2.61 mm), and AF(-) CRP(-) (1.17 +/- 2.02 mm) (p<0.001). The AF(+)CRP(+) group showed significantly higher incidence of ischemic stroke than the other groups (all p<0.05). Binary logistic regression analysis showed that age {odds ratio (OR) = 1.033, p = 0.001}, elevated CRP (OR = 3.884, p = 0.001), and the presence of AF (OR = 1.375, p = 0.018) were significantly correlated with incidence of ischemic stroke.
   Conclusion: Elevated plasma CRP concentration may be a reliable surrogate marker for predicting carotid atherosclerosis in patients with AF, which may be related to increased risk of ischemic stroke.
C1 [Ock, So Young; Cho, Kyoung Im; Kim, Hyung Joon; Lee, Nae Young; Kim, Eun Jeong; Kim, Nam Kyu; Lee, Weon Hyoung; Yeo, Go Eun; Heo, Jae Joon; Han, You Jin; Cha, Tae-Joon] Kosin Univ, Coll Med, Cardiovasc Res Inst, Dept Internal Med,Div Cardiol, Pusan 602702, South Korea.
RP Cha, TJ (corresponding author), Kosin Univ, Coll Med, Cardiovasc Res Inst, Dept Internal Med,Div Cardiol, 262 Gamcheon Ro, Pusan 602702, South Korea.
EM chatjn@gmail.com
CR Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433
   Bruins P, 1997, CIRCULATION, V96, P3542
   Burke AP, 2002, CIRCULATION, V105, P2019, DOI 10.1161/01.CIR.0000015507.29953.38
   Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16
   CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513
   Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-4
   Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180
   Garcia BA, 2003, J VASC SURG, V38, P1018, DOI 10.1016/S0741-5214(03)00709-2
   Hadjiev DI, 2007, MED SCI MONITOR, V13, pRA50
   JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131
   KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703
   Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56
   Nagai Y, 2002, ULTRASOUND MED BIOL, V28, P1239, DOI 10.1016/S0301-5629(02)00573-2
   O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Shah Prediman K., 1999, Cardiology Clinics, V17, P271, DOI 10.1016/S0733-8651(05)70074-6
   Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145
   Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167
   Winbeck K, 2002, CEREBROVASC DIS, V13, P57, DOI 10.1159/000047747
NR 27
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 796
EP 803
DI 10.4070/kcj.2013.43.12.796
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700003
PM 24385990
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KM
   Yoo, BS
   Ko, A
   Kim, JM
   Kim, HS
   Lee, JW
   Kim, JY
   Youn, YJ
   Ahn, SG
   Lee, SH
   Yoon, J
AF Kim, Kyung Min
   Yoo, Byung-Su
   Ko, Anna
   Kim, Jeong Min
   Kim, Hyun Sik
   Lee, Jun-Won
   Kim, Jang-Young
   Youn, Young Jin
   Ahn, Sung Gyun
   Lee, Seung-Hwan
   Yoon, Junghan
TI Do Different Arterial Stiffness Parameters Provide Similar Information
   in High-Risk Patients for Coronary Artery Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulse wave velocity; Coronary artery disease; Arterial stiffness
ID PULSE-WAVE VELOCITY; AUGMENTATION INDEX; AORTIC STIFFNESS;
   HEART-DISEASE; INDEPENDENT PREDICTOR; HYPERTENSIVE PATIENTS;
   CARDIOVASCULAR RISK; MORTALITY; PRESSURE
AB Background and Objectives: The aim of our study was to compare the values of brachial-ankle pulse wave velocity (baPWV) measured with two different non-invasive methods as predictors of coronary artery disease (CAD) in patients who had undergone coronary angiography.
   Subjects and Methods: From 6373 patients who visited our laboratory for non-invasive procedures, we enrolled 965 consecutive patients undergoing coronary angiography. Data for baPWV and peripheral augmentation index (pAI) were recorded. CAD was defined as greater than 50% stenosis of a major epicardial artery in a coronary angiogram. In addition, the severity of CAD was classified as: none/minimal or 1-, 2-, or 3-vessel disease, based on previous or current angiographic findings.
   Results: Among 965 subjects, the mean age was 63.7 +/- 11.6 years, and 58.2% were male. Compared with subjects without CAD disease, those with CAD showed higher values of baPWV (16.6 +/- 3.5 m/sec vs. 15.9 +/- 3.4 m/sec, p<0.001), and lower values of pAI (73.5 +/- 15.9% vs. 76.0 +/- 15.7%, p = 0.01). When the severity of CAD was expressed as none/minimal or 1-, 2-, or 3-vessel disease, there was a significant association between the extent of CAD and baPWV (p < 0.001). In univariate analysis, high PWV and low pAI were associated with an increased prevalence of CAD (p < 0.001).
   Conclusion: Increased baPWV and decreased pAI were associated with the presence of CAD in the elderly.
C1 [Kim, Kyung Min; Yoo, Byung-Su; Ko, Anna; Kim, Jeong Min; Kim, Hyun Sik; Lee, Jun-Won; Kim, Jang-Young; Youn, Young Jin; Ahn, Sung Gyun; Lee, Seung-Hwan; Yoon, Junghan] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Wonju 220701, South Korea.
RP Yoo, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 162 Ilsan Dong, Wonju 220701, South Korea.
EM yubs@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
CR Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305
   Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7
   Fantin F, 2007, AGE AGEING, V36, P43, DOI 10.1093/ageing/afl115
   Franklin SS, 2001, CIRCULATION, V103, P1245
   Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342
   Hlimonenko I, 2007, P ANN INT IEEE EMBS, P1703, DOI 10.1109/IEMBS.2007.4352637
   Hope SA, 2007, J HYPERTENS, V25, P2105, DOI 10.1097/HJH.0b013e3282a9be41
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   김석환, 2006, Korean Circulation Journal, V36, P221
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Munir S, 2008, HYPERTENSION, V51, P112, DOI 10.1161/HYPERTENSIONAHA.107.096016
   Nurnberger J, 2002, J HYPERTENS, V20, P2407, DOI 10.1097/00004872-200212000-00020
   Seo Won-Woo, 2010, Korean Circ J, V40, P224, DOI 10.4070/kcj.2010.40.5.224
   Song HG, 2010, INT J CARDIOL, V139, P263, DOI 10.1016/j.ijcard.2008.10.032
   한승환, 2004, Korean Circulation Journal, V34, P468
NR 18
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 819
EP 824
DI 10.4070/kcj.2013.43.12.819
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700006
PM 24385993
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, CW
   Woo, SB
   Choi, JY
   Jung, JW
   Park, YH
   Park, HK
   Shin, HJ
   Kim, NK
AF Han, Chang Woo
   Woo, Saet Byul
   Choi, Jae Young
   Jung, Jo Won
   Park, Yong Hwan
   Park, Han Ki
   Shin, Hong Ju
   Kim, Nam Kyun
TI QTc Prolongation after Ventricular Septal Defect Repair in Infants
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular septal defect; Electrocardiography; Infant
ID CARDIOPULMONARY BYPASS; INTERVAL PROLONGATION; SURGERY; ARRHYTHMIAS;
   RISK
AB Background and Objectives: Prolonging of the corrected QT interval (QTc) has been reported after cardiac surgery in some studies. However, there have not been many studies on infant open cardiac surgery for ventricular septal defect (VSD) repair. This study was performed to define the changes in QTc and to find related post-surgery factors in this patient group.
   Subjects and Methods: From 2008 to 2012, 154 infants underwent VSD repair at the Severance Cardiovascular Hospital. This study includes 105 of these cases. QTc was measured in these patients retrospectively. Demographic data and peri-procedural data, such as Aristotle score, cross-clamp time and bypass time, were analyzed. The exclusion criteria included multiple and small VSDs that underwent direct closure.
   Results: Mean post-operative QTc was increased compared to the pre-operative measurements (from 413.6 +/- 2.3 to 444.9 +/- 2.5, p<0.001). In multiple linear regression, the comprehensive Aristotle score was associated with increasing QTc (p=0.047). The incidence of transient arrhythmia, such as atrial tachycardia, junctional ectopic tachycardia, premature atrial contraction, or premature ventricular contraction, was associated with QTc prolongation (p=0.005). Prolonged QTc was also associated with cross-clamp time (p=0.008) and low weight (p=0.042). Total length of stay at the intensive care unit and intubation time after surgery were not associated with QTc prolongation.
   Conclusion: Prolonged QTc could be seen after VSD repair in infants. This phenomenon was associated with peri-procedural factors such as the Aristotle score and cross-clamp time. Patients with QTc prolongation after cardiac surgery had an increased tendency towards arrhythmogenicity in the post-operative period.
C1 [Han, Chang Woo; Woo, Saet Byul; Choi, Jae Young; Jung, Jo Won; Kim, Nam Kyun] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med,Dept Pediat, Div Pediat Cardiol,Congenital Heart Dis Ctr, Seoul 120752, South Korea.
   [Park, Yong Hwan; Park, Han Ki; Shin, Hong Ju] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiovasc Surg, Congenital Heart Dis Ctr,Coll Med, Seoul 120752, South Korea.
RP Kim, NK (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Pediat Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM pednk@yuhs.ac
OI Park, Han Ki/0000-0002-7472-7822; park, young hwan/0000-0001-9802-8017;
   Choi, Jae Young/0000-0002-1247-6669
CR Aburawi EH, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-67
   Ali N, 2010, JCPSP-J COLL PHYSICI, V20, P427, DOI 07.2010/JCPSP.427431
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Bae MH, 2013, KOREAN CIRC J, V43, P370, DOI 10.4070/kcj.2013.43.6.370
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N
   Davey P, 2002, J PHARMACOL TOXICOL, V48, P3, DOI 10.1016/S1056-8719(03)00008-X
   Delaney JW, 2006, J THORAC CARDIOV SUR, V131, P1296, DOI 10.1016/j.jtcvs.2006.02.010
   Elming Hanne, 2002, Card Electrophysiol Rev, V6, P289, DOI 10.1023/A:1016345412555
   JAIN U, 1994, ANESTH ANALG, V78, P638
   Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035
   MacLeod RS, 2005, J ELECTROCARDIOL, V38, P8, DOI 10.1016/j.jelectrocard.2005.06.095
   Manrique AM, 2010, J THORAC CARDIOV SUR, V139, P162, DOI 10.1016/j.jtcvs.2009.07.064
   Nagele P, 2012, ANESTHESIOLOGY, V117, P321, DOI 10.1097/ALN.0b013e31825e6eb3
   Punn R, 2011, CARDIOL YOUNG, V21, P400, DOI 10.1017/S1047951111000175
   Reingardiene D, 2007, MEDICINA-LITHUANIA, V43, P347, DOI 10.3390/medicina43040043
   Rekawek J, 2007, J THORAC CARDIOV SUR, V133, P900, DOI 10.1016/j.jtcvs.2006.12.011
   Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426
   Trinkley KE, 2013, CURR MED RES OPIN
   VETTER VL, 1982, AM J CARDIOL, V50, P588, DOI 10.1016/0002-9149(82)90328-9
   Vrtovec B, 2006, TEX HEART I J, V33, P3
   김여향, 2009, Clinical and Experimental Pediatrics, V52, P1364
NR 21
TC 0
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 825
EP 829
DI 10.4070/kcj.2013.43.12.825
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700007
PM 24385994
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YM
   Kim, SJ
   Park, CH
   Kang, WC
   Shin, MS
   Koh, KK
   Choi, IS
AF Park, Yae Min
   Kim, Su Ji
   Park, Chul-Hyun
   Kang, Woong Chol
   Shin, Mi-Seung
   Koh, Kwang Kon
   Choi, In Suck
TI Repeated Aborted Sudden Cardiac Death with Long QT Syndrome in a Patient
   with Anomalous Origin of the Right Coronary Artery from the Left
   Coronary Cusp
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Long QT syndrome; Tachycardia, ventricular; Coronary vessel anomalies
ID TORSADE-DE-POINTES; MYOCARDIAL-INFARCTION; DISPERSION; INTERVAL
AB A 15-year-old female with a prior history of aborted cardiac death and surgical correction of anomalous origin of the right coronary artery (RCA) presented with polymorphic ventricular tachycardia. Her electrocardiogram after defibrillation was suggestive of congenital long QT syndrome (LQTS). The patient was treated with a beta-blocker and remained free from ventricular arrhythmia during the follow-up of more than 6 months. Here, we present the case of a young female with repeated aborted cardiac death accompanied by anomalous origin of the RCA and congenital LQTS for the first time.
C1 [Park, Yae Min; Kim, Su Ji; Kang, Woong Chol; Shin, Mi-Seung; Koh, Kwang Kon; Choi, In Suck] Gachon Univ, Gil Hosp, Div Cardiol, Inchon 405760, South Korea.
   [Park, Chul-Hyun] Gachon Univ, Gil Hosp, Thorac & Cardiovasc Surg Div, Inchon 405760, South Korea.
RP Choi, IS (corresponding author), Gachon Univ, Gil Hosp, Div Cardiol, 21 Namdong Daero 774beon Gil, Inchon 405760, South Korea.
EM cis@gilhospital.com
CR Angelini P, 2002, TEX HEART I J, V29, P271
   Chauhan VS, 2001, J ELECTROCARDIOL, V34, P109, DOI 10.1054/jelc.2001.23116
   ElSherif N, 1997, CIRCULATION, V96, P4392
   Kawabata M, 2008, J ELECTROCARDIOL, V41, P117, DOI 10.1016/j.jelectrocard.2007.09.009
   MORENO FL, 1994, CIRCULATION, V90, P94, DOI 10.1161/01.CIR.90.1.94
   Shimizu W, 1997, CIRCULATION, V96, P2038, DOI 10.1161/01.CIR.96.6.2038
   Tester DJ, 2006, J AM COLL CARDIOL, V47, P764, DOI 10.1016/j.jacc.2005.09.056
NR 7
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 830
EP 833
DI 10.4070/kcj.2013.43.12.830
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700008
PM 24385995
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Kim, J
   Lee, SH
   Choi, JH
   Park, YH
   Kim, JH
   Chun, KJ
AF Lee, Soo Yong
   Kim, Jun
   Lee, Sang Hyun
   Choi, Jin Hee
   Park, Yong Hyun
   Kim, June Hong
   Chun, Kook Jin
TI Ventricular Fibrillation in a Patient with Tachycardia-Induced
   Cardiomyopathy after Liver Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Ventricular fibrillation; Liver transplantation;
   Heart failure
ID CONGESTIVE-HEART-FAILURE; ATRIAL-FIBRILLATION; VENOVENOUS BYPASS;
   COMPLICATIONS; ABLATION
AB We report a case of atrial fibrillation-related tachycardia induced cardiomyopathy and ventricular fibrillation after liver transplantation in a 41-year-old man with end-stage liver failure. Atrial fibrillation and congestive heart failure occurred postoperatively. Cardiac arrests due to ventricular fibrillation occurred 6 months after the operation with subsequent implantations of an implantable cardioverter-defibrillator. Ventricular arrhythmias did not recur during the 18 months after normalization of heart functions with guideline-directed medical treatments.
C1 [Lee, Soo Yong; Kim, Jun; Lee, Sang Hyun; Choi, Jin Hee; Park, Yong Hyun; Kim, June Hong; Chun, Kook Jin] Pusan Natl Univ, Yangsan Hosp, Dept Cardiol, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Cardiol, Geum O St 20, Yangsan 626770, South Korea.
EM mdjunkim@gmail.com
OI Kim, Jun/0000-0002-3573-638X
FU Pusan National University Yangsan HospitalPusan National University
FX This work was supported by a 2013 research grant from Pusan National
   University Yangsan Hospital.
CR Christians KK, 2001, AM J SURG, V182, P713, DOI 10.1016/S0002-9610(01)00799-1
   Chung M, 2011, J CLIN ANESTH, V23, P428, DOI 10.1016/j.jclinane.2010.08.017
   DEE GW, 1995, CLIN TRANSPLANT, V9, P463
   Fouad TR, 2009, TRANSPLANTATION, V87, P763, DOI 10.1097/TP.0b013e318198d734
   Fujino T, 2007, CIRC J, V71, P936, DOI 10.1253/circj.71.936
   Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018
   Huffman C, 2010, TRANSPL P, V42, P3673, DOI 10.1016/j.transproceed.2010.08.034
   Joghetaei N, 2011, CIRC-ARRHYTHMIA ELEC, V4, P592, DOI 10.1161/CIRCEP.111.963447
   Kanji S, 2008, CRIT CARE MED, V36, P1620, DOI 10.1097/CCM.0b013e3181709e43
   Lee HR, 2007, LIVER TRANSPLANT, V13, P1343, DOI 10.1002/lt.21169
   Lishmanov Anton, 2010, Congest Heart Fail, V16, P122, DOI 10.1111/j.1751-7133.2010.00147.x
   Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC
   Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790
   Sakai T, 2007, LIVER TRANSPLANT, V13, P961, DOI 10.1002/lt.21072
   Pires LJT, 2012, TRANSPL P, V44, P2497, DOI 10.1016/j.transproceed.2012.07.037
   von Vital JM, 2011, TRANSPLANTATION, V91, pE62, DOI 10.1097/TP.0b013e3182115bc1
NR 16
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 839
EP 841
DI 10.4070/kcj.2013.43.12.839
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700010
PM 24385997
OA Green Published
DA 2021-04-22
ER

PT J
AU Disli, OM
   Erdil, N
   Akca, B
   Otlu, YO
   Battaloglu, B
AF Disli, Olcay Murat
   Erdil, Nevzat
   Akca, Baris
   Otlu, Yilmaz Omur
   Battaloglu, Bektas
TI Large Thrombus Formation from Right Atrial Incision Site after Closure
   of Atrial Septal Defect
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defects; Thrombosis; Heart surgery; Heart atrium
ID PULMONARY-EMBOLISM; MANAGEMENT; MYXOMA; REPAIR; HEART
AB Atrial septal defect (ASD) is the common congenital anomaly which requires surgical interventions. Right atrial thrombus formations after primary suture repairs of the ASD and evidences of thromboembolic complications are extremely rare. Specifically, the cases of thromboembolic complications have high mortality and morbidity risks. Two cases of giant intra-atrial thrombus formation detected in the late stage after primary repairs of ASDs are being discussed.
C1 [Disli, Olcay Murat; Erdil, Nevzat; Akca, Baris; Battaloglu, Bektas] Inonu Univ, Fac Med, Dept Cardiovasc Surg, TR-44280 Malatya, Turkey.
   [Otlu, Yilmaz Omur] Inonu Univ, Fac Med, Dept Cardiol, TR-44280 Malatya, Turkey.
RP Disli, OM (corresponding author), Inonu Univ, Fac Med, Dept Cardiovasc Surg, Elazig Rd, TR-44280 Malatya, Turkey.
EM olcay.disli@inonu.edu.tr
RI disli, olcay murat/ABI-3289-2020; AKCA, BARIS/ABG-7339-2020; Battaloglu,
   Bektas/ABI-6211-2020; Erdil, Nevzat/K-8079-2019
OI disli, olcay murat/0000-0002-9699-4817; AKCA, BARIS/0000-0001-9154-4764;
   Erdil, Nevzat/0000-0002-8275-840X
CR Alpert JS, 1988, MANUAL CARDIOVASCULA, P235
   ARMSTONG WF, 2010, FEIGENBAUMS ECHOCARD
   BACKER CL, 1988, ANN THORAC SURG, V45, P561, DOI 10.1016/S0003-4975(10)64535-3
   Chartier L, 1999, CIRCULATION, V99, P2779, DOI 10.1161/01.CIR.99.21.2779
   Chessa M, 2002, J AM COLL CARDIOL, V39, P1061, DOI 10.1016/S0735-1097(02)01711-4
   Cianciulli TF, 2008, TEX HEART I J, V35, P454
   Dinckal MH, 2003, ECHOCARDIOGR-J CARD, V20, P535, DOI 10.1046/j.1540-8175.2003.03091.x
   Ferencz C, 1993, EPIDEMIOLOGY CONGENI, V4, P33
   HARO M, 1995, THORAX, V50, P911, DOI 10.1136/thx.50.8.911
   HAWE A, 1969, CIRCULATION, V39, pI185
   Kirklin JW, 1986, CARDIAC SURGERY, P488
   Rodriguez CJ, 2001, J AM SOC ECHOCARDIOG, V14, P63, DOI 10.1067/mje.2001.108539
   Sheikh AY, 2007, ANN THORAC SURG, V84, P1742, DOI 10.1016/j.athoracsur.2007.05.065
   SUZUKI I, 1994, SURG TODAY, V24, P176, DOI 10.1007/BF02473405
   Thompson CA, 1999, SOUTH MED J, V92, P826, DOI 10.1097/00007611-199908000-00018
   Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690
   황여주, 2004, The Korean Journal of Thoracic and Cardiovascular Surgery, V37, P448
NR 17
TC 2
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 842
EP 844
DI 10.4070/kcj.2013.43.12.842
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700011
PM 24385998
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, JH
   Choi, RK
   Oh, SS
   Kim, TS
   Lee, SJ
   Ahn, DS
AF Chung, Jae Hoon
   Choi, Rak Kyeong
   Oh, Sam Se
   Kim, Tae Sik
   Lee, Suk Jin
   Ahn, Dae Sung
TI A Case of Partial Congenital Pericardial Defect Presenting as Acute
   Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defects; congenital; Pericardium; Coronary artery disease
ID ARTERY DISEASE
AB Congenital pericardial defects are rare and asymptomatic for both partial and complete defects. However, some patients can experience syncope, arrhythmia, and chest pain. When a patient experiences a symptom, it may be caused by herniation and dynamic compression or torsion of a heart structure including the coronary arteries. Diagnosis of a congenital pericardial defect may be difficult, especially in old patients with concomitant coronary artery disease. The clinical importance of congenital pericardial defect has not been stressed and congenital pericardial defects are regarded as benign, but in this case, pericardial defect was responsible for myocardial ischemia. The authors report a case of partial congenital pericardial defect causing herniation and dynamic compression of the coronary arteries, presenting as an acute coronary syndrome in an old man, with an emphasis on the unique features of the coronary angiogram that support the diagnosis of partial pericardial defects.
C1 [Chung, Jae Hoon; Choi, Rak Kyeong; Oh, Sam Se; Kim, Tae Sik; Lee, Suk Jin; Ahn, Dae Sung] Sejong Gen Hosp, Div Internal Med, Puchon 422711, South Korea.
RP Choi, RK (corresponding author), Sejong Gen Hosp, Div Internal Med, 28 Hohyeon Ro 489beon Gil, Puchon 422711, South Korea.
EM yoorimbin@sejongh.co.kr
CR AMIRI A, 1989, THORAC CARDIOV SURG, V37, P379, DOI 10.1055/s-2007-1020358
   Connolly H M, 1995, J Am Soc Echocardiogr, V8, P87, DOI 10.1016/S0894-7317(05)80362-1
   FISHER FD, 1964, JAMA-J AM MED ASSOC, V188, P78
   Nguyen DQ, 2001, ANN THORAC SURG, V72, P1371, DOI 10.1016/S0003-4975(00)02705-3
   Rusk RA, 1999, HEART, V81, P327, DOI 10.1136/hrt.81.3.327
   SPODICK DH, 2001, HEART DIS TXB CARDIO, P1823
   Spodik D., 1997, PERICARDIUM COMPREHE, P65
   Sunao K, 2004, ANGIOLOGY, V55, P445
NR 8
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 845
EP 848
DI 10.4070/kcj.2013.43.12.845
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700012
PM 24385999
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, DG
AF Shin, Dong-Gu
TI Papillary Muscle Ventricular Tachycardia: Another Zigsaw Puzzle to Be
   Solved
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CATHETER ABLATION; ARRHYTHMIAS; FIBRILLATION; PURKINJE; SWINE
C1 Yeungnam Univ Hosp, Dept Internal Med, Cardiovasc Div, Taegu 705717, South Korea.
RP Shin, DG (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Cardiovasc Div, 170 Hyeonchung Ro, Taegu 705717, South Korea.
EM dgshin@med.yu.ac.kr
CR Ban JE, 2013, KOREAN CIRC J, V43, P811, DOI 10.4070/kcj.2013.43.12.811
   Bogun F, 2008, J AM COLL CARDIOL, V51, P1794, DOI 10.1016/j.jacc.2008.01.046
   Doppalapudi H, 2008, CIRC-ARRHYTHMIA ELEC, V1, P23, DOI 10.1161/CIRCEP.107.742940
   Good E, 2008, HEART RHYTHM, V5, P1530, DOI 10.1016/j.hrthm.2008.08.032
   Kim YH, 1999, CIRCULATION, V100, P1450, DOI 10.1161/01.CIR.100.13.1450
   Pak HN, 2006, J CARDIOVASC ELECTR, V17, P777, DOI 10.1111/j.1540-8167.2006.00511.x
   RAWLING DA, 1985, CIRC RES, V57, P252, DOI 10.1161/01.RES.57.2.252
   Yamada T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P324, DOI 10.1161/CIRCEP.109.922310
   Yamada T, 2010, J CARDIOVASC ELECTR, V21, P62, DOI 10.1111/j.1540-8167.2009.01594.x
   Yokokawa M, 2010, HEART RHYTHM, V7, P1654, DOI 10.1016/j.hrthm.2010.07.013
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 793
EP 795
DI 10.4070/kcj.2013.43.12.793
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700002
PM 24385989
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, DH
   Jung, S
   Lee, EJ
   Lee, JY
   Moon, S
   Lee, JW
   Chung, NG
   Cho, B
   Kim, HK
AF Kwon, Dae Hyun
   Jung, Seungwon
   Lee, Eun-Jung
   Lee, Jae Young
   Moon, Sena
   Lee, Jae Wook
   Chung, Nack Gyun
   Cho, Bin
   Kim, Hack Ki
TI Incidence and Risk Factors for Early-Onset Hypertension after Allogeneic
   Hematopoietic Stem Cell Transplantation in Children
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hematopoletic stem cell transplantation; Child; Incidence; Blood
   pressure; Hypertension
ID PEDIATRIC HEART-TRANSPLANTATION; MARROW-TRANSPLANTATION; CARDIOVASCULAR
   EVENTS; LUNG-TRANSPLANTATION; UNITED-STATES; SURVIVORS; PREHYPERTENSION;
   PREVALENCE; ADOLESCENTS; DISEASE
AB Background and Objectives: Survivors of pediatric hematopoietic stem cell transplantation (HSCT) are at risk for developing hypertension. The objectives of this study are to evaluate the prevalence and risk factors of early onset hypertension during the engraftment period after HSCT.
   Subjects and Methods: This is a retrospective study of 157 consecutive patients (mean age at HSCT: 9.1 +/- 5.1 years) who underwent HSCT for acute myeloid leukemia (n=47), acute lymphoblastic leukemia (n=43), severe aplastic anemia (n=41), and other reasons (n=26). Blood pressure data were collected at five time points: 0, 7, 14, 21, and 28 days after HSCT. Hypertension was defined as having systolic and/or diastolic blood pressure >= 95th percentile according to age, gender, and height. To analyze the risk factors related to hypertension, data, including patients' demographic and transplant characteristics, were reviewed.
   Results: Hypertension developed in 59 patients (38%), among whom 12 (7.6%) required long term therapy. Thirty-two (54%) patients had systolic and diastolic, 8 (14%) had only systolic, and 19 (32%) had only diastolic hypertension. Younger age, acute graft-versus-host disease, sinusoidal obstruction syndrome, treatment with antifungal agent, and greater increase in serum creatinine (Cr) levels were associated with hypertension. Multivariate analysis showed that younger age at HSCT and greater increase in serum Cr level were independent risk factors for hypertension.
   Conclusion: Prevalence of hypertension during immediate post-HSCT period is high, especially in younger children. A greater increase in Cr after HSCT was significantly associated with hypertension. Further study is needed to elucidate long-term cardiovascular complications in pediatric HSCT survivors.
C1 [Kwon, Dae Hyun; Jung, Seungwon; Lee, Eun-Jung; Lee, Jae Young; Moon, Sena; Lee, Jae Wook; Chung, Nack Gyun; Cho, Bin; Kim, Hack Ki] Catholic Univ Korea, Dept Pediat, Coll Med, Seoul 137701, South Korea.
RP Lee, EJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, 222 Banpo Daero, Seoul 137701, South Korea.
EM yo-ej@hanmail.net
CR Armenian SH, 2012, BLOOD, V120, P4505, DOI 10.1182/blood-2012-06-437178
   Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335
   Boucek MM, 2006, J HEART LUNG TRANSPL, V25, P893, DOI 10.1016/j.healun.2006.05.014
   Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329
   Esiashvili N, 2009, RADIOTHER ONCOL, V90, P242, DOI 10.1016/j.radonc.2008.09.017
   Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x
   Hoffmeister PA, 2010, BIOL BLOOD MARROW TR, V16, P515, DOI 10.1016/j.bbmt.2009.11.018
   Holthe JEK, 1998, BONE MARROW TRANSPL, V22, P559, DOI 10.1038/sj.bmt.1701388
   Izumi N, 2007, BONE MARROW TRANSPL, V40, P875, DOI 10.1038/sj.bmt.1705834
   Kist-van Holthe JE, 2005, BONE MARROW TRANSPL, V36, P605, DOI 10.1038/sj.bmt.1705110
   Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292
   Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P1100, DOI 10.1016/j.bbmt.2009.05.010
   McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052
   Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18
   Onusko E, 2003, AM FAM PHYSICIAN, V67, P67
   Panoulas VF, 2008, RHEUMATOLOGY, V47, P72, DOI 10.1093/rheumatology/kem311
   Redwine KM, 2012, J PEDIATR-US, V160, P98, DOI 10.1016/j.jpeds.2011.07.010
   Roche SL, 2008, J HEART LUNG TRANSPL, V27, P501, DOI 10.1016/j.healun.2008.01.018
   Shapiro DJ, 2012, PEDIATRICS, V130, P604, DOI 10.1542/peds.2011-3888
   Singer DRJ, 1996, J HUM HYPERTENS, V10, P395
   Sinha MD, 2012, NEPHROL DIAL TRANSPL, V27, P3359, DOI 10.1093/ndt/gfr804
   Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949
   Ventura HO, 1997, MED CLIN N AM, V81, P1347, DOI 10.1016/S0025-7125(05)70587-3
   Wehbe E, 2013, CLIN J AM SOC NEPHRO, V8, P19, DOI 10.2215/CJN.04800512
NR 26
TC 6
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 804
EP 810
DI 10.4070/kcj.2013.43.12.804
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700004
PM 24385991
OA Green Published
DA 2021-04-22
ER

PT J
AU Ban, JE
   Lee, HS
   Lee, DI
   Park, HC
   Park, JS
   Nagamoto, Y
   Choi, JI
   Lim, HE
   Park, SW
   Kim, YH
AF Ban, Ji-Eun
   Lee, Hyun-Soo
   Lee, Dae-In
   Park, Hwan-Cheol
   Park, Jae-Seok
   Nagamoto, Yasutsugu
   Choi, Jong-Il
   Lim, Hong-Euy
   Park, Sang-Weon
   Kim, Young-Hoon
TI Electrophysiological Characteristics Related to Outcome after Catheter
   Ablation of Idiopathic Ventricular Arrhythmia Originating from the
   Papillary Muscle in the Left Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Papillary muscles; Left ventricle; Arrhythmia; Catheter ablation
ID PURKINJE POTENTIALS; REENTRANT CIRCUIT; TACHYCARDIA; MACROREENTRY;
   FIBRILLATION; INFARCTION; SWINE
AB Background and Objectives: The electrophysiological properties associated with favorable outcome of radiofrequency catheter ablation (RFCA) for idiopathic ventricular arrhythmia (VA) originating from the papillary muscle (PM) remain unclear. The purpose of this study was to investigate the relationships of electrophysiological characteristics and predictors with the outcome of RFCA in patients with VAs originating from PM in the left ventricle (LV).
   Subjects and Methods: Twelve (4.2%) of 284 consecutive patients with idiopathic VAs originating from LV PM were assessed. The electrophysiological data were compared between the patients in the successful group and patients in the recurrence group after RFCA.
   Results: In 12 patients with PM VAs, non-sustained ventricular tachycardias (VTs, n = 6), sustained VTs (n=4) and premature ventricular complexes (n=2) were identified as the presenting arrhythmias. Seven of eight patients showing high-amplitude discrete potentials at the ablation site had a successful outcome (85.7%), while the remaining four patients who showed low-amplitude fractionated potentials at the ablation site experienced VA recurrence. The mean duration from onset to peak downstroke (Delta t) on the unipolar electrogram was significantly longer in the successful group than in the recurrence group (58 +/- 8 ms vs. 37 +/- 9 ms, p=0.04). A slow downstroke >50 ms of the initial Q wave on the unipolar electrogram at ablation sites was also significantly associated with successful outcome (85.7% vs. 25.0%, p=0.03).
   Conclusion: In PM VAs, the high-amplitude discrete potentials before QRS and slow downstroke of the initial Q wave on the unipolar electrogram at ablation sites were related to favorable outcome after RFCA.
C1 [Ban, Ji-Eun; Lee, Hyun-Soo; Lee, Dae-In; Park, Jae-Seok; Nagamoto, Yasutsugu; Choi, Jong-Il; Lim, Hong-Euy; Park, Sang-Weon; Kim, Young-Hoon] Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea.
   [Park, Hwan-Cheol] Hanyang Univ, Guri Hosp, Dept Internal Med, Div Cardiol, Guri, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 136705, South Korea.
EM yhkmd@unitel.co.kr
CR Aiba T, 2001, PACE, V24, P333, DOI 10.1046/j.1460-9592.2001.00333.x
   Bogun F, 2008, J AM COLL CARDIOL, V51, P1794, DOI 10.1016/j.jacc.2008.01.046
   Chen PS, 2001, J AM COLL CARDIOL, V37, P1475, DOI 10.1016/S0735-1097(01)01152-4
   Crawford T, 2010, HEART RHYTHM, V7, P725, DOI 10.1016/j.hrthm.2010.01.040
   Doppalapudi H, 2008, CIRC-ARRHYTHMIA ELEC, V1, P23, DOI 10.1161/CIRCEP.107.742940
   Good E, 2008, HEART RHYTHM, V5, P1530, DOI 10.1016/j.hrthm.2008.08.032
   Kim YH, 1999, CIRCULATION, V100, P1450, DOI 10.1161/01.CIR.100.13.1450
   Liu XK, 2008, HEART RHYTHM, V5, P479, DOI 10.1016/j.hrthm.2007.11.013
   Maruyama M, 2001, J CARDIOVASC ELECTR, V12, P968, DOI 10.1046/j.1540-8167.2001.00968.x
   Nogami A, 2000, J AM COLL CARDIOL, V36, P811, DOI 10.1016/S0735-1097(00)00780-4
   Pak HN, 2006, J CARDIOVASC ELECTR, V17, P777, DOI 10.1111/j.1540-8167.2006.00511.x
   Yamada T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P324, DOI 10.1161/CIRCEP.109.922310
   Yamada T, 2010, J CARDIOVASC ELECTR, V21, P62, DOI 10.1111/j.1540-8167.2009.01594.x
   Yamada T, 2009, J INTERV CARD ELECTR, V24, P143, DOI 10.1007/s10840-008-9327-x
   Yamada T, 2009, J CARDIOVASC ELECTR, V20, P866, DOI 10.1111/j.1540-8167.2009.01448.x
   Yokokawa M, 2010, HEART RHYTHM, V7, P1654, DOI 10.1016/j.hrthm.2010.07.013
   Zipes DP, 2003, J CARDIOVASC ELECTR, V14, P902, DOI 10.1046/j.1540-8167.2003.03228.x
NR 17
TC 23
Z9 23
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 811
EP 818
DI 10.4070/kcj.2013.43.12.811
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700005
PM 24385992
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kim, DH
   Jung, MS
   Lee, JW
   Nam, KM
   Cho, YS
   Jeong, JH
AF Lee, Seung-Hyun
   Kim, Dong-Hyun
   Jung, Min-Suk
   Lee, Jang-Won
   Nam, Kyung-Min
   Cho, Young-Sun
   Jeong, Joon-Hoon
TI Inverted-Takotsubo Cardiomyopathy in a Patient with Pulmonary Embolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stress cardiomyopathy; Takotsubo cardiomyopathy; Pulmonary embolism
ID APICAL BALLOONING SYNDROME; ACUTE MYOCARDIAL-INFARCTION
AB As the use of early coronary angiography and echocardiography become widely available in the setting of acute coronary syndrome, the gradual increase for variant forms of transient left ventricular (LV) apical ballooning syndrome have been recognized. This syndrome usually occurs in women and is frequently elicited by an intense emotional, psychological, and physical event. While the patients' characteristics between typical and non-typical LV ballooning syndrome seem to differ, the presentation, clinical features, and reversibility of LV wall motion abnormalities are similar. We present a middle-aged woman who experienced inverted takotsubo cardiomyopathy triggered by pulmonary embolism. To the best of our knowledge, this case is particularly unique and is rarely reported in the disease entity.
C1 [Lee, Seung-Hyun; Kim, Dong-Hyun; Jung, Min-Suk; Lee, Jang-Won; Nam, Kyung-Min; Cho, Young-Sun; Jeong, Joon-Hoon] Wallace Mem Baptist Hosp, Dept Internal Med, Div Cardiol, Pusan 609728, South Korea.
RP Jeong, JH (corresponding author), Wallace Mem Baptist Hosp, Dept Internal Med, Div Cardiol, 200 Geumdan Ro, Pusan 609728, South Korea.
EM jjhoonmd@hanmail.net
CR Challa S, 2011, EUR J ECHOCARDIOGR, V12, pE39, DOI 10.1093/ejechocard/jer151
   박효은, 2008, Korean Circulation Journal, V38, P677
   Hahn JY, 2007, AM HEART J, V154, P1166, DOI 10.1016/j.ahj.2007.08.003
   Hurst RT, 2006, J AM COLL CARDIOL, V48, P579, DOI 10.1016/j.jacc.2006.06.015
   Nef HM, 2010, NAT REV CARDIOL, V7, P187, DOI 10.1038/nrcardio.2010.16
   Patankar Gautam R, 2013, J Med Case Rep, V7, P84, DOI 10.1186/1752-1947-7-84
   Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008
   Prasad A, 2007, CIRCULATION, V115, pE56, DOI 10.1161/CIRCULATIONAHA.106.669341
   Ramaraj Radhakrishnan, 2010, Congest Heart Fail, V16, P284, DOI 10.1111/j.1751-7133.2010.00188.x
   Sarin S, 2005, J ELECTROCARDIOL, V38, P361, DOI 10.1016/j.jelectrocard.2005.05.008
   Smedra-Kazmirska Anna, 2010, Anestezjol Intens Ter, V42, P85
   Todd Keith, 2009, Indian Pacing Electrophysiol J, V9, P268
   Ueyama T, 2008, ANN NY ACAD SCI, V1148, P479, DOI 10.1196/annals.1410.079
   Van de Walle SOA, 2006, MAYO CLIN PROC, V81, P1499, DOI 10.4065/81.11.1499
NR 14
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2013
VL 43
IS 12
BP 834
EP 838
DI 10.4070/kcj.2013.43.12.834
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PC
UT WOS:000342410700009
PM 24385996
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Lee, J
   Jeong, H
   Choe, WS
   Seo, WW
   Lim, WH
   Kim, YC
   Hur, J
   Lee, SE
   Yang, HM
   Cho, HJ
   Kim, HS
AF Lee, Joo Myung
   Lee, Jaewon
   Jeong, Heewon
   Choe, Won Seok
   Seo, Won-Woo
   Lim, Woo-Hyun
   Kim, Young-Chan
   Hur, Jin
   Lee, Sang Eun
   Yang, Han-Mo
   Cho, Hyun-Jai
   Kim, Hyo-Soo
TI Development of a Rabbit Model for a Preclinical Comparison of Coronary
   Stent Types In-Vivo
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Prosthesis and implants; Stents; Model, animal; NZW rabbits
ID DRUG-ELUTING STENTS; VASCULAR ENDOTHELIAL-CADHERIN;
   RE-ENDOTHELIALIZATION; NEOINTIMAL FORMATION; BALLOON ANGIOPLASTY;
   RESTENOSIS MODELS; PROGENITOR CELLS; ARTERY-DISEASE; TIME-COURSE;
   THROMBOSIS
AB Along with the development of innovative stent designs, preclinical trials in animal models are essential. Many animal models have been used and appear to yield comparable results to clinical trials despite substantial criticisms about their validity. Among the animal models, porcine coronary artery models have been the standard models for the preclinical evaluation of endovascular devices. However, rapid growth rate, high body weight potential, and the propensity to develop granulomatous inflammatory reactions are major limitations of the porcine coronary artery model. Compared with porcine coronary artery models, the comparative rabbit iliac artery model has the advantages of being small and easy to handle and relatively inexpensive. Furthermore, the rabbit model has been known to reliably reflect human restenosis histopathologically and have major advantages such as pairwise comparison, which makes each animal serve as its own control subject, therefore, maximizing its statistical power for comparative testing. However, despite the widespread use of this model, a systematic description of the procedure and harvest protocols has never been published. This article describes the surgical procedure, stent implantation procedure, method for tissue harvesting, and how measurements are performed. Although the results of animal models may not perfectly extrapolate to humans, the comparative rabbit iliac artery model may be a useful tool for assessing and comparing the efficacy of new coronary stents with conventional stent systems. This thorough description of the techniques required for vascular access, stent implantation, tissue preparation, and measurement, should aid investigators wishing to begin using the comparative rabbit iliac artery model.
C1 [Lee, Joo Myung; Lee, Jaewon; Jeong, Heewon; Choe, Won Seok; Seo, Won-Woo; Lim, Woo-Hyun; Kim, Young-Chan; Hur, Jin; Lee, Sang Eun; Yang, Han-Mo; Cho, Hyun-Jai] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea.
   [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Mol Med & Biopharmaceut Sci, World Class Univ Program, Seoul 110744, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
EM usahyosoo@gmail.com
OI Lee, Joo Myung/0000-0002-2178-4014; Lim, Woo-Hyun/0000-0001-9298-8500
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean government [2010-0020258]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by the Korean
   government (2010-0020258).
CR Akin I, 2011, HERZ, V36, P190, DOI 10.1007/s00059-011-3458-z
   Asada Y, 1996, ATHEROSCLEROSIS, V121, P45, DOI 10.1016/0021-9150(95)05682-3
   Bayes-Genis, 2000, Curr Interv Cardiol Rep, V2, P303
   Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029
   Che HL, 2012, BIOMATERIALS, V33, P8548, DOI 10.1016/j.biomaterials.2012.07.045
   Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78
   Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398
   DOERNING BJ, 1992, LAB ANIM SCI, V42, P267
   Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Lee JM, 2012, BIOMATERIALS, V33, P8917, DOI 10.1016/j.biomaterials.2012.08.066
   Lim WH, 2011, ARTERIOSCL THROM VAS, V31, P2798, DOI 10.1161/ATVBAHA.111.226134
   Lowe HC, 2003, CATHETER CARDIO INTE, V60, P515, DOI 10.1002/ccd.10705
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Nakamura T, 2012, EUROINTERVENTION, V8, P493, DOI 10.4244/EIJV8I4A77
   Nakazawa G, 2011, CIRC-CARDIOVASC INTE, V4, P38, DOI 10.1161/CIRCINTERVENTIONS.110.957654
   Perkins LEL, 2010, VET PATHOL, V47, P58, DOI 10.1177/0300985809352978
   Robert R, 2004, J BIOMED MATER RES B, V70B, P303, DOI 10.1002/jbm.b.30040
   ROBERTSON SA, 1994, LAB ANIM SCI, V44, P159
   ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995
   Schwartz RS, 2004, J AM COLL CARDIOL, V44, P1373, DOI 10.1016/j.jacc.2004.04.060
   Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091
   Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X
   Simsek C, 2011, PANMINERVA MED, V53, P19
   Sommer CM, 2010, CARDIOVASC INTER RAD, V33, P565, DOI 10.1007/s00270-009-9757-6
   Touchard AG, 2006, TOXICOL PATHOL, V34, P11, DOI 10.1080/01926230500499407
   Van Dyck CJ, 2013, CATHETER CARDIO INTE, V81, pE259, DOI 10.1002/ccd.24595
   VanBelle E, 1997, CIRCULATION, V95, P438
NR 29
TC 2
Z9 3
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 713
EP 722
DI 10.4070/kcj.2013.43.11.713
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600001
PM 24363745
OA Green Published
DA 2021-04-22
ER

PT J
AU Tekin, K
   Cagliyan, CE
   Tanboga, IH
   Balli, M
   Uysal, OK
   Ozkan, B
   Arik, OZ
   Cayli, M
AF Tekin, Kamuran
   Cagliyan, Caglar Emre
   Tanboga, Ibrahim Halil
   Balli, Mehmet
   Uysal, Onur Kadir
   Ozkan, Bugra
   Arik, Osman Ziya
   Cayli, Murat
TI Influence of the Timing of Percutaneous Coronary Intervention on
   Clinical Outcomes in Non-ST-Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Myocardial infarction; Prognosis
ID INVASIVE MANAGEMENT; RANDOMIZED-TRIALS; METAANALYSIS; ANGIOPLASTY;
   IMMEDIATE; STRATEGY; RATES
AB Background and Objectives: We have intended to investigate the influence of the timing of invasive procedures on all-cause mortality, recurrent myocardial infarction (MI), re-hospitalization due to cardiac causes and left ventricular function over a 3-month period among patients with Non-ST-elevation myocardial infarction (NSTEMI).
   Subjects and Methods: A total of 131 NSTEMI patients with moderate-high Thrombolysis in Myocardial Infarction risk scores, who had been admitted to our department between July 2011-December 2011 were included in our study. They had been randomized into 2 groups according to the timing of the percutaneous coronary intervention (PCI). Patient undergoing PCI in the first 24 hours of hospitalization were named the "Early Invasive Group" and those undergoing PCI between 24-72 hours of hospitalization were named the "Delayed Invasive Group". All patients were followed up for 3 months.
   Results: Third month left ventricular ejection fraction (LVEF) values were higher in the early invasive group (59.9 +/- 6.0% vs. 54.1 +/- 8.7%; p<0.001). Recurrent MI rates were lower in the early invasive group (2.9% vs. 14.5%; p=0.016). Similarly, hospitalization rates due to cardiac events were lower in the early invasive group (8.7% vs. 30.6%; p=0.001). All cause mortality appeared to be lower in the early invasive group, although not to a statistically significant degree (0% vs. 4.8%; p=0.065).
   Conclusion: The early invasive strategy appears to be more effective for the reduction of recurrent MI, re-hospitalization due to cardiac events, and the preservation of 3rd month LVEF in patients with moderate-high risk NSTEMI when compared to a delayed invasive strategy.
C1 [Tekin, Kamuran] Batman State Hosp, Dept Cardiol, TR-72010 Batman, Turkey.
   [Cagliyan, Caglar Emre; Tanboga, Ibrahim Halil; Balli, Mehmet; Uysal, Onur Kadir; Ozkan, Bugra; Arik, Osman Ziya; Cayli, Murat] Adanana Numune Educ & Res Hosp, Dept Cardiol, Istanbul, Turkey.
RP Tekin, K (corresponding author), Batman State Hosp, Dept Cardiol, TR-72010 Batman, Turkey.
EM kamurantekin@gmail.com
RI cagliyan, caglar/U-3741-2018; Ozkan, Bugra/L-3053-2018; Tanboga, Ibrahim
   H/E-8886-2010
OI cagliyan, caglar/0000-0002-2529-4995; 
CR Bigi R, 2003, HEART, V89, P1009, DOI 10.1136/heart.89.9.1009
   de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259
   Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236
   Katritsis DG, 2011, EUR HEART J, V32, P32, DOI 10.1093/eurheartj/ehq276
   Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986
   Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908
   Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267
   Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593
   Patel TN, 2006, AM J CARDIOL, V97, P1685, DOI 10.1016/j.amjcard.2006.01.028
   Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815
   Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707
   Sorajja P, 2010, J AM COLL CARDIOL, V55, P1416, DOI 10.1016/j.jacc.2009.11.063
   Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002
   Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40
NR 14
TC 13
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 725
EP 730
DI 10.4070/kcj.2013.43.11.725
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600003
PM 24363747
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JH
   Chun, KJ
   Lee, SH
   Chon, MK
   Lee, SG
   Kim, JS
   Kim, J
   Park, YH
   Kim, JH
AF Choi, Jin Hee
   Chun, Kook-Jin
   Lee, Sang Hyun
   Chon, Min Ku
   Lee, Sang-Gwon
   Kim, Jeong Su
   Kim, Jun
   Park, Yong-Hyun
   Kim, June Hong
TI Usefulness of Intracoronary Epinephrine in Severe Hypotension during
   Percutaneous Coronary Interventions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessels; Epinephrine; Hypotension; Percutaneous coronary
   intervention
ID CARDIOPULMONARY-RESUSCITATION; NO-REFLOW; VASOPRESSIN
AB Background and Objectives: Life-threatening hypotension during percutaneous coronary interventions (PCI) is devastating for the patient and is associated with fatal adverse outcomes. The aim of our study was to assess the usefulness of intracoronary epinephrine in severe hypotension unresponsive to other measures during PCI.
   Subjects and Methods: We analyzed the Pusan National University Yangsan hospital cardiac catheterization laboratory database to identify patients who underwent PCI from December 2008 to July 2012. The outcomes were changes of blood pressure (BP) and heart rate (HR) before and after intracoronary epinephrine and in-hospital mortality.
   Results: A total of 30 patients who were initially stable and received intracoronary epinephrine for severe hypotension during PCI were included. Following administration of intracoronary epinephrine (dose 181 +/- 24.8 microgram), systolic and diastolic BP (from 53.8 +/- 13.0 mm Hg up to 112.8 +/- 21.2 mm Hg, from 35 +/- 7.6 mm Hg up to 70.6 +/- 12.7 mm Hg, respectively) and HR (from 39.4 +/- 5.1 beats/min up to 96.8 +/- 29.3 beats/min) were increased. Additionally, 21 patients (70%) showed hemodynamically acceptable responses to intracoronary epinephrine without the intraaortic balloon pump and temporary pacemaker during the PCI. In-hospital mortality was 17% (n=5).
   Conclusion: Although our study was small, intracoronary epinephrine was found to be well tolerated and resulted in prompt and successful recovery from severe hypotension in most patients when other measures were ineffective. Intracoronary epinephrine could be a safe and useful measure in patients developing severe hypotension during PCI.
C1 [Choi, Jin Hee; Chun, Kook-Jin; Lee, Sang Hyun; Chon, Min Ku; Kim, Jeong Su; Kim, Jun; Park, Yong-Hyun; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, Yangsan 626770, South Korea.
   [Lee, Sang-Gwon] Pusan Natl Univ, Yangsan Hosp, Dept Thorac & Cardiovasc Surg, Yangsan 626770, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Cardiovasc Ctr, 20 Geumo Ro, Yangsan 626770, South Korea.
EM ptca82@gmail.com
OI Kim, Jun/0000-0002-3573-638X
FU Pusan National University Research GrantPusan National University
FX This work was supported for two years by a Pusan National University
   Research Grant.
CR Aral A, 1997, ANN THORAC SURG, V64, P1046, DOI 10.1016/S0003-4975(97)00798-4
   Baim DS, 2002, CATHETER CARDIO INTE, V57, P310, DOI 10.1002/ccd.10320
   Brunton L, 2010, GOODMAN GILMANS PHAR, P282
   Comroe JH, 1974, NONRESPIRATORY FUNCT, P285
   Grmec S, 2006, CRIT CARE, V10, DOI 10.1186/cc3967
   KAHN JK, 1993, AM HEART J, V126, P463, DOI 10.1016/0002-8703(93)91073-N
   Kiss G, 2009, HEART LUNG, V38, P228, DOI 10.1016/j.hrtlng.2008.04.005
   Kitsou V, 2009, J EMERG MED, V37, P369, DOI 10.1016/j.jemermed.2008.07.003
   Lucreziotti S, 2005, CARDIOLOGY, V103, P196, DOI 10.1159/000085127
   OTTO CW, 1984, ANN EMERG MED, V13, P840, DOI 10.1016/S0196-0644(84)80455-2
   ROBERTSON RM, 1982, CIRCULATION, V65, P281, DOI 10.1161/01.CIR.65.2.281
   Skelding KA, 2002, CATHETER CARDIO INTE, V57, P305, DOI 10.1002/ccd.10303
   Zhong JQ, 2005, RESUSCITATION, V66, P263, DOI 10.1016/j.resuscitation.2005.02.014
NR 13
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 739
EP 743
DI 10.4070/kcj.2013.43.11.739
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600005
PM 24363749
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, KS
   Jeong, MH
   Bae, IH
   Park, DS
   Kim, JM
   Kim, JH
   Cho, DL
   Sim, DS
   Park, KH
   Hong, YJ
   Ahn, Y
AF Lim, Kyung Seob
   Jeong, Myung Ho
   Bae, In Ho
   Park, Dae Sung
   Kim, Jong Min
   Kim, Jung Ha
   Cho, Dong Lyun
   Sim, Doo Sun
   Park, Keun-Ho
   Hong, Young Joon
   Ahn, Youngkeun
TI Histopathological Comparison among Biolimus, Zotarolimus and
   Everolimus-Eluting Stents in Porcine Coronary Restenosis Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Percutaneous coronary intervention; Coronary
   restenosis; Inflammation
ID BARE-METAL STENTS; MYOCARDIAL-INFARCTION; BIODEGRADABLE POLYMER;
   ARTERY-DISEASE; FOLLOW-UP; RANDOMIZED-TRIALS; OUTCOMES; INTERVENTION;
   METAANALYSIS; THROMBOSIS
AB Background and Objectives: The aim of this study was to examine the histolopathogical effects among the biolimus, zotarolimus, and everolimus eluting stent (EES) in the porcine coronary restenosis model.
   Subjects and Methods: Pigs were randomized into three groups in which the coronary arteries (15 pigs, 10 coronaries in each group) had either a biolimus A9 eluting stent (BES, n= 10), zotarolimus eluting stent (ZES, n= 10) or an EES (n= 10). Histopathologic analysis was performed at 28 days after stenting.
   Results: There were no significant differences in the injury score among the three groups. There was a significant difference in the internal elastic lamina, lumen area, neointima area, percent area stenosis, and the fibrin and inflammation score among the three groups (4.3 +/- 0.53 mm(2), 2.5 +/- 0.93 mm(2), 1.8 +/- 1.03 mm(2), 40.7 +/- 20.80%, 1.7 +/- 0.41, 1.4 +/- 0.72 in the BES group vs. 5.1 +/- 0.55 mm(2), 2.3 +/- 1.14 mm(2), 2.8 +/- 1.00 mm(2), 55.4 +/- 21.23%, 2.0 +/- 0.39, 1.6 +/- 0.76 in the ZES group vs. 4.4 +/- 0.53 mm(2), 1.7 +/- 1.22 mm(2), 2.8 +/- 1.23 mm(2), 64.0 +/- 26.00%, 1.8 +/- 0.76, 2.1 +/- 0.90 in the EES group, respectively). BES is more effective in inhibiting neointimal hyperplasia compared to ZES and EES (p<0.0001). According to the fibrin and inflammation score, BES and EES are more effective in decreasing the fibrin deposition compared to ZES (p<0.001). Moreover, BES and ZES are more effective in reducing the inflammatory reaction compared to EES (p<0.001).
   Conclusion: The result demonstrates that BES shows better histopathological characteristics than ZES and EES at one month after stenting in the porcine coronary restenosis model.
C1 [Lim, Kyung Seob; Jeong, Myung Ho; Bae, In Ho] Korea Cardiovasc Stent Inst, Jangseong, South Korea.
   [Lim, Kyung Seob; Jeong, Myung Ho; Bae, In Ho; Park, Dae Sung; Kim, Jong Min; Kim, Jung Ha; Cho, Dong Lyun; Sim, Doo Sun; Park, Keun-Ho; Hong, Young Joon; Ahn, Youngkeun] Korea Minist Hlth & Welf, Heart Res Ctr, Kwangju, South Korea.
   [Lim, Kyung Seob; Jeong, Myung Ho; Park, Dae Sung; Kim, Jong Min; Kim, Jung Ha; Cho, Dong Lyun; Sim, Doo Sun; Park, Keun-Ho; Hong, Young Joon; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Cardiovasc Res Ctr, Kwangju, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Regener Res Ctr, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, Korea Cardiovasc Stent Res Inst, Dept Educ & Res,Korea Minist hlth, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korea Healthcare Technology R&D Project, Ministry of Health and Welfare,
   Republic of Korea [A084869]; Cardiovascular Research Center, Chonnam
   National University Hospital; Regeneromics Research Center, Chonnam
   National University
FX This study was supported by a grant of the Korea Healthcare Technology
   R&D Project (A084869), Ministry of Health and Welfare, Republic of
   Korea, Cardiovascular Research Center, Chonnam National University
   Hospital and Regeneromics Research Center, Chonnam National University.
CR Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014
   Byrne R A, 2009, Minerva Cardioangiol, V57, P567
   De Luca G, 2013, AM J CARDIOL, V111, P1295, DOI 10.1016/j.amjcard.2013.01.281
   de Souza CF, 2013, EINSTEIN-SAO PAULO, V11, P350, DOI 10.1590/S1679-45082013000300015
   Grube E, 2006, EXPERT REV MED DEVIC, V3, P731, DOI 10.1586/17434440.3.6.731
   Hannan EL, 2013, CATHETER CARDIO INTE, V81, P1097, DOI 10.1002/ccd.24512
   Jimenez-Quevedo P, 2013, EUROINTERVENTION, V9, P328, DOI 10.4244/EIJV9I3A54
   Jonas M, 2005, CIRC RES, V97, P725, DOI 10.1161/01.RES.0000183730.52908.C6
   Kandzari DE, 2013, JACC-CARDIOVASC INTE, V6, P504, DOI 10.1016/j.jcin.2012.12.125
   Kim SJ, 2013, CORONARY ARTERY DIS, V24, P431, DOI 10.1097/MCA.0b013e328362b2e7
   Kolodgie FD, 2002, CIRCULATION, V106, P1195, DOI 10.1161/01.CIR.0000032141.31476.15
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Malik N, 1998, HEART, V80, P509, DOI 10.1136/hrt.80.5.509
   Min GS, 2012, KOREAN CIRC J, V42, P266, DOI 10.4070/kcj.2012.42.4.266
   Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045
   Onuma Y, 2013, EUROINTERVENTION, V8, P1047, DOI 10.4244/EIJV8I9A161
   Ostojic M, 2008, CATHETER CARDIO INTE, V72, P901, DOI 10.1002/ccd.21775
   Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022
   Park KH, 2013, INT J CARDIOL, V168, P1853, DOI 10.1016/j.ijcard.2012.12.070
   Park KW, 2013, J AM COLL CARDIOL, V61, P536, DOI 10.1016/j.jacc.2012.11.015
   Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065
   Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9
   Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2
   Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086
   Tada N, 2010, CIRC-CARDIOVASC INTE, V3, P174, DOI 10.1161/CIRCINTERVENTIONS.109.877522
   Vardi M, 2013, CATHETER CARDIOVASC
   Vorpahl M, 2010, CURR PHARM DESIGN, V16, P4064, DOI 10.2174/138161210794454879
   Yamasaki M, 2012, EUROINTERVENTION, V8, P724, DOI 10.4244/EIJV8I6A112
NR 30
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 744
EP 751
DI 10.4070/kcj.2013.43.11.744
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600006
PM 24363750
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MH
   Lee, SP
   Kim, YJ
   Sohn, DW
AF Lee, Min-Ho
   Lee, Seung-Pyo
   Kim, Yong-Jin
   Sohn, Dae-Won
TI Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Amyloidosis; Monoclonal gammopathy
ID PRIMARY SYSTEMIC AMYLOIDOSIS; STEM-CELL TRANSPLANTATION; VENTRICULAR
   DIASTOLIC FUNCTION; LIGHT-CHAIN AMYLOIDOSIS; HIGH-DOSE MELPHALAN; AL
   AMYLOIDOSIS; MAGNETIC-RESONANCE; ELECTROCARDIOGRAPHIC FINDINGS;
   DOPPLER-ECHOCARDIOGRAPHY; SURVIVAL
AB Background and Objectives: Cardiac involvement is frequent in systemic amyloidosis and is the most important determinant of the clinical outcome. The aims of this study were to assess the incidence and prognosis of cardiac amyloidosis and discuss the diagnostic issues related to cardiac amyloidosis.
   Subjects and Methods: We retrospectively studied all patients diagnosed with systemic amyloidosis who presented to our institution from January 1999 to December 2011.
   Results: Of the 129 patients with systemic amyloidosis, cardiac amyloidosis was diagnosed in 62 patients. At the 3 years' follow-up of the patients with systemic amyloidosis, there was a statistically significant difference in mortality between patients with cardiac amyloidosis and the rest of the patients (58.1% vs. 37.3%, p=0.008). In the Cox proportional hazard model, old age {hazard ratio (HR) 18.336, p= 0.006},elevation of cardiac troponin I (cTNI) (HR 13.246, p=0.020), left ventricular (LV) systolic dysfunction (HR 5.137, p=0.041) and diastolic dysfunction (HR 64.595, p=0.022) were independently associated with survival in cardiac amyloidosis. In the diagnosis of monoclonal gammopathy, serum or urine protein electrophoresis was not sensitive enough to be used clinically compared to serum free light chain assay (35.8% vs. 96.4%).
   Conclusion: In systemic amyloidosis, cardiac involvement was the most important determinant of the prognosis, and old age, elevation of cTNI, LV systolic dysfunction and diastolic dysfunction were independently associated with survival in cardiac amyloidosis.
C1 [Lee, Min-Ho; Lee, Seung-Pyo; Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Sohn, DW (corresponding author), Seoul Natl Univ Hosp, Ctr Cardiovasc, 101 Daehak Ro, Seoul 110744, South Korea.
EM dwsohn@snu.ac.kr
RI Lee, Minho/AAJ-6477-2020
OI Lee, Minho/0000-0003-0748-7766
CR Arbustini E, 2002, AMYLOID, V9, P108, DOI 10.3109/13506120208995243
   CARROLL JD, 1982, AM J CARDIOL, V49, P9, DOI 10.1016/0002-9149(82)90270-3
   CUETOGARCIA L, 1984, MAYO CLIN PROC, V59, P589, DOI 10.1016/S0025-6196(12)62409-4
   Dispenzieri A, 2001, J CLIN ONCOL, V19, P3350, DOI 10.1200/JCO.2001.19.14.3350
   Dispenzieri A, 2003, LANCET, V361, P1787, DOI 10.1016/S0140-6736(03)13396-X
   Dubrey SW, 1998, QJM-MON J ASSOC PHYS, V91, P141, DOI 10.1093/qjmed/91.2.141
   Duston M A, 1987, Am J Med, V82, P412, DOI 10.1016/0002-9343(87)90439-6
   Falk R H, 2000, Adv Intern Med, V45, P107
   Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381
   HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225
   KLEIN AL, 1991, CIRCULATION, V83, P808, DOI 10.1161/01.CIR.83.3.808
   KLEIN AL, 1989, J AM COLL CARDIOL, V13, P1017, DOI 10.1016/0735-1097(89)90254-4
   KLEIN AL, 1990, J AM COLL CARDIOL, V16, P1135, DOI 10.1016/0735-1097(90)90545-Z
   Kristen AV, 2007, EUR J HEART FAIL, V9, P617, DOI 10.1016/j.ejheart.2007.01.012
   KYLE RA, 1983, MAYO CLIN PROC, V58, P665
   KYLE RA, 1986, BLOOD, V68, P220
   Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x
   Merlini G, 2004, J INTERN MED, V255, P159, DOI 10.1046/j.1365-2796.2003.01262.x
   Morris KL, 2007, INTERN MED J, V37, P456, DOI 10.1111/j.1445-5994.2007.01368.x
   Murtagh B, 2005, AM J CARDIOL, V95, P535, DOI 10.1016/j.amjcard.2004.10.028
   Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7
   Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385
   Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614
   Perugini E, 2006, HEART, V92, P343, DOI 10.1136/hrt.2005.061911
   Rahman JE, 2004, J AM COLL CARDIOL, V43, P410, DOI 10.1016/j.jacc.2003.08.043
   Seldin DC, 2004, BLOOD, V104, P1888, DOI 10.1182/blood-2004-01-0089
   Skinner M, 2004, ANN INTERN MED, V140, P85, DOI 10.7326/0003-4819-140-2-200401200-00008
   Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023
   Vogelsberg H, 2008, J AM COLL CARDIOL, V51, P1022, DOI 10.1016/j.jacc.2007.10.049
   Westermark P, 2002, AMYLOID, V9, P197
NR 30
TC 14
Z9 15
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 752
EP 760
DI 10.4070/kcj.2013.43.11.752
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600007
PM 24363751
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, TJ
   Kim, JK
   Park, BM
   Song, PS
   Kim, DK
   Kim, KH
   Seol, SH
   Kim, DI
AF Kim, Tae-Jin
   Kim, Jae-Kyun
   Park, Bo-Min
   Song, Pil-Sang
   Kim, Dong-Kie
   Kim, Ki-Hun
   Seol, Sang-Hoon
   Kim, Doo-Il
TI Fatal Subacute Stent Thrombosis Induced by Guidewire Fracture with
   Retained Filaments in the Coronary Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous; Stents; Thrombosis; Complications
ID ANGIOPLASTY; RETRIEVAL; CATHETER; FRAGMENT; MANAGEMENT
AB During percutaneous coronary intervention, guidewire fractures are very exceptionally encountered in medical practice, but can cause fatal complications such as intracoronary thrombus formation, embolization and perforation. Removal of the remnant segments of guidewire is important for the prognosis. There are several methods being recommended for the treatment of fractured guidewire remnants. However, the best treatment of remnant guidewire filament is still unclear. Herein, we present a case where we did not completely remove remnant guidewire filaments that caused fatal coronary thrombosis.
C1 [Kim, Tae-Jin; Kim, Jae-Kyun; Park, Bo-Min; Song, Pil-Sang; Kim, Dong-Kie; Kim, Ki-Hun; Seol, Sang-Hoon; Kim, Doo-Il] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, Pusan 612030, South Korea.
RP Kim, DI (corresponding author), Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, 1435 Jwa Dong, Pusan 612030, South Korea.
EM jo1216@inje.ac.kr
CR Al-Amri HS, 2012, J CARDIAC SURG, V27, P307, DOI 10.1111/j.1540-8191.2011.01352.x
   Alexiou K, 2006, TEX HEART I J, V33, P139
   Cho YH, 2007, CIRC J, V71, P1326, DOI 10.1253/circj.71.1326
   Collins Nicholas, 2007, J Invasive Cardiol, V19, pE230
   Darwazah AK, 2007, J CARDIAC SURG, V22, P526, DOI 10.1111/j.1540-8191.2007.00462.x
   HARTZLER GO, 1987, AM J CARDIOL, V60, P1260, DOI 10.1016/0002-9149(87)90604-7
   Hong Young-Min, 2010, Korean Circ J, V40, P475, DOI 10.4070/kcj.2010.40.9.475
   Kang JH, 2012, KOREAN CIRC J, V42, P201, DOI 10.4070/kcj.2012.42.3.201
   Karabulut A, 2010, CARDIOL J, V17, P104
   KHONSARI S, 1986, AM J CARDIOL, V58, P855, DOI 10.1016/0002-9149(86)90370-X
   Kim JH, 2012, J INVASIVE CARDIOL, V24, P74
   Kim JY, 2005, YONSEI MED J, V46, P166, DOI 10.3349/ymj.2005.46.1.166
   van Gaal William J, 2006, Int J Cardiol, V112, pe9, DOI 10.1016/j.ijcard.2006.01.040
   Woodfield SL, 1998, CATHETER CARDIO DIAG, V44, P220, DOI 10.1002/(SICI)1097-0304(199806)44:2<220::AID-CCD20>3.0.CO;2-P
NR 14
TC 8
Z9 8
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 761
EP 765
DI 10.4070/kcj.2013.43.11.761
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600008
PM 24363752
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Kang, EJ
   Park, TH
   Woo, JS
   Hong, SH
   Kim, YD
AF Lee, Dong Hyun
   Kang, Eun-Ju
   Park, Tae-Ho
   Woo, Jong Soo
   Hong, Sook Hee
   Kim, Young-Dae
TI A Case of Right Sinus of Valsalva Rupture with Dissection into
   Interventricular Septum Causing Left Ventricular Outflow Tract
   Obstruction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sinus of Valsalva; Aneurysm; Ventricular outflow obstruction; Aortic
   valve insufficiency
ID ANEURYSM
AB Sinus of Valsalva aneurysm (SVA) is an uncommon anomaly of the aorta. Rupture of SVA often precipitates dramatic clinical complications, including heart failures. Right SVAs are the most common type, and when they rupture, they usually rupture into the right ventricle or right atrium. Rupture into left ventricle or interventricular septum is rare. Herein, we report a case of right SVA rupture with dissection into interventricular septum, which produced significant left ventricular outflow tract obstruction and aortic regurgitation. The case was successfully treated by surgical operation.
C1 [Lee, Dong Hyun; Park, Tae-Ho; Kim, Young-Dae] Dong A Univ, Coll Med, Dept Cardiol, Pusan 602715, South Korea.
   [Kang, Eun-Ju] Dong A Univ, Coll Med, Dept Radiol, Pusan 602715, South Korea.
   [Woo, Jong Soo] Dong A Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Pusan 602715, South Korea.
   [Hong, Sook Hee] Dong A Univ, Coll Med, Dept Pathol, Pusan 602715, South Korea.
RP Kim, YD (corresponding author), Dong A Univ, Coll Med, Dept Cardiol, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM kimyd@dau.ac.kr
OI Lee, Dong Hyun/0000-0001-6253-3396
CR Avci A, 2010, ECHOCARDIOGR-J CARD, V27, P341, DOI 10.1111/j.1540-8175.2009.01088.x
   Bricker AO, 2010, RADIOGRAPHICS, V30, P99, DOI 10.1148/rg.301095719
   Das KM, 2006, INT J CARDIOVAS IMAG, V22, P797, DOI 10.1007/s10554-006-9090-y
   Feldman DN, 2006, CARDIOLOGY, V106, P73, DOI 10.1159/000092635
   Nunes MDP, 2008, ECHOCARDIOGR-J CARD, V25, P102, DOI 10.1111/j.1540-8175.2007.00547.x
   Park KH, 2011, KOREAN CIRC J, V41, P464, DOI 10.4070/kcj.2011.41.8.464
   Pepper C, 1998, HEART, V80, P190, DOI 10.1136/hrt.80.2.190
   Taher T, 2005, CIRCULATION, V111, pE101, DOI 10.1161/01.CIR.0000157044.63554.02
NR 8
TC 7
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 770
EP 773
DI 10.4070/kcj.2013.43.11.770
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600010
PM 24363754
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, GY
   Jeon, ES
AF Lee, Ga Yeon
   Jeon, Eun-Seok
TI Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis;
   Roles and Responsibilities of Cardiologist
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BRAIN NATRIURETIC PEPTIDE; STAGING SYSTEM; AL AMYLOIDOSIS; BIOMARKERS
C1 [Lee, Ga Yeon; Jeon, Eun-Seok] Sungkyunkwan Univ, Sch Med, Cardiac & Vasc Ctr, Dept Med,Div Cardiol, Seoul 135710, South Korea.
   Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul 135710, South Korea.
RP Jeon, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Cardiac & Vasc Ctr, Dept Med,Div Cardiol, 81 Irwon Ro, Seoul 135710, South Korea.
EM esjeon@skku.edu
RI lee, ga yeon/I-9382-2017
CR Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029
   Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001
   Falk RH, 2011, CIRCULATION, V124, P1079, DOI 10.1161/CIRCULATIONAHA.110.010447
   Kapoor P, 2011, AM J MED, V124, P1006, DOI 10.1016/j.amjmed.2011.04.013
   Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724
   Lee MH, 2013, KOREAN CIRC J, V43, P752, DOI 10.4070/kcj.2013.43.11.752
   Lehrke S, 2009, AMYLOID, V16, P187, DOI 10.3109/13506120903421538
   Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2
   Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614
   Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 723
EP 724
DI 10.4070/kcj.2013.43.11.723
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600002
PM 24363746
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Jeong, MH
   Jeong, Y
   Kim, KH
   Song, JE
   Cho, JY
   Jang, SY
   Jeong, HC
   Lee, KH
   Park, KH
   Sim, DS
   Yoon, NS
   Hong, YJ
   Park, HW
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Yoon, Hyun Ju
   Jeong, Myung Ho
   Jeong, Yuna
   Kim, Kye Hun
   Song, Ji Eun
   Cho, Jae Yeong
   Jang, Su Young
   Jeong, Hae Chang
   Lee, Ki Hong
   Park, Keun Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Progressive Dilation of the Left Atrium and Ventricle after Acute
   Myocardial Infarction Is Associated with High Mortality
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Ventricular remodeling; Heart failure; Prognosis
ID ASYMPTOMATIC PATIENTS; HEART; SIZE; COMMITTEE; PATTERNS; VOLUME; TIME
AB Background and Objectives: The purpose of this study is to identify the prevalence of progressive dilation in patients with acute myocardial infarction (AMI) combined with heart failure (HF) and determine the prognostic significance and associated factors with a geometric change of an infarcted heart.
   Subjects and Methods: A total of 1310 AMI patients with HF (63.9 +/- 12.5 years, 70% male) between November 2005 and April 2011 underwent echocardiography at admission and one year later. Left ventricular (LV) remodeling is defined as 20% progression, and left atria (LA) remodeling is 10% compared with the initial volume index.
   Results: The prevalence of both LA and LV remodeling was 13.9%; LV only was 9.3%, LA only 22.8% and non-remodeling was 55.1%, respectively. In the non-remodeling group, Killip class II was more frequent (83.9%, p<0.001) whereas in other remodeling groups, Killip class III was more frequent. Initial wall motion score index, ejection fraction, maximal cardiac enzyme, high sensitive C-reactive protein, B type natriuretic peptide, and triglyceride serum levels were significantly associated with heart remodeling. All causes of death occurred in 168 cases (12.8%) during the follow-up period. Mortality was the highest in the LV and LA remodeling group (20.9%) and the lowest in the non-remodeling group (11.4%). During the period of follow-up, the cumulative survival rate was significantly lower in the groups of LA and LV remodeling than in others (log rank p=0.006).
   Conclusion: Total mortality was significantly increased in patients AMI with geometrically progressive LA and LV dilatation.
C1 [Yoon, Hyun Ju; Jeong, Myung Ho; Jeong, Yuna; Kim, Kye Hun; Song, Ji Eun; Cho, Jae Yeong; Jang, Su Young; Jeong, Hae Chang; Lee, Ki Hong; Park, Keun Ho; Sim, Doo Sun; Yoon, Nam Sik; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Korea Cardiovasc Stent Res Inst, Ctr Heart, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU The Korean Society of Cardiology
FX This study was supported by a new investigator grant from The Korean
   Society of Cardiology (2012).
CR Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA
   APPLETON CP, 1993, J AM COLL CARDIOL, V22, P1972, DOI 10.1016/0735-1097(93)90787-2
   Basnight M A, 1991, J Am Soc Echocardiogr, V4, P547
   BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835
   Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA
   Brzezinska B, 2007, KARDIOL POL, V65, P1190
   Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Eefting F D, 2006, Neth Heart J, V14, P95
   GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755
   Gaudron P, 2001, J AM COLL CARDIOL, V38, P33, DOI 10.1016/S0735-1097(01)01319-5
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426
   Giannuzzi P, 1996, J AM COLL CARDIOL, V28, P383, DOI 10.1016/0735-1097(96)00163-5
   Giannuzzi P, 2001, AM HEART J, V141, P131, DOI 10.1067/mhj.2001.111260
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Hatzitolios AI, 2009, INT J CARDIOL, V134, P322, DOI 10.1016/j.ijcard.2009.02.001
   Hong YJ, 2005, AM J CARDIOL, V95, P619, DOI 10.1016/j.amjcard.2004.10.039
   KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9
   Ko Jum Suk, 2009, Korean Circ J, V39, P236, DOI 10.4070/kcj.2009.39.6.236
   Kuppahally SS, 2010, AM HEART J, V160, P877, DOI 10.1016/j.ahj.2010.07.003
   Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43
   Rouleau JL, 1993, J AM COLL CARDIOL, V22, P390, DOI 10.1016/0735-1097(93)90042-Y
   Simonson J S, 1989, J Am Soc Echocardiogr, V2, P25
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tiyyagura SR, 2006, MT SINAI J MED, V73, P840
   Yoon HJ, 2011, KOREAN CIRC J, V41, P124, DOI 10.4070/kcj.2011.41.3.124
   Yun KH, 2011, KOREAN CIRC J, V41, P458, DOI 10.4070/kcj.2011.41.8.458
   ZIMMER HG, 1990, J MOL CELL CARDIOL, V22, P1231, DOI 10.1016/0022-2828(90)90060-F
NR 30
TC 12
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 731
EP 738
DI 10.4070/kcj.2013.43.11.731
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600004
PM 24363748
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HL
   Seo, JB
   Chung, WY
   Zo, JH
   Kim, MA
   Kim, SH
AF Kim, Hack-Lyoung
   Seo, Jae-Bin
   Chung, Woo-Young
   Zo, Joo-Hee
   Kim, Myung-A
   Kim, Sang-Hyun
TI Simultaneously Presented Acute Ischemic Stroke and Non-ST Elevation
   Myocardial Infarction in a Patient with Paroxysmal Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Cerebral infarct; Embolism; Myocardial infarction;
   Percutaneous transluminal coronary angioplasty
ID CORONARY EMBOLISM
AB Although atrial fibrillation is the most frequent cause of embolic stroke, coronary embolism from atrial fibrillation is a very rare cause of acute myocardial infarction. Therefore, simultaneously presented acute ischemic stroke and acute myocardial infarction due to atrial fibrillation in the same patient has not been documented. The present report describes the case of a 58-year-old man with paroxysmal atrial fibrillation who initially presented with a large cerebral infarction due to embolic occlusion of the left middle cerebral artery. Four hours after the diagnosis of cerebral embolism, he was subsequently diagnosed with acute myocardial infarction due to concurrent coronary embolism. He underwent successful coronary revascularization with a drug-eluting stent. The possibility of combined coronary embolism as a rare etiology should be kept in mind when a patient with acute embolic stroke presents, especially when there is evidence of acute myocardial infarction.
C1 [Kim, Hack-Lyoung; Seo, Jae-Bin; Chung, Woo-Young; Zo, Joo-Hee; Kim, Myung-A; Kim, Sang-Hyun] Seoul Natl Univ, Boramae Med Ctr, Ctr Cardiovasc, Seoul, South Korea.
RP Kim, SH (corresponding author), Seoul Natl Univ, Coll Med, Med Ctr, Dept Internal Med, 20 Boramae Ro 5-Gil, Seoul 156707, South Korea.
EM shkimmd@snu.ac.kr
RI Kim, Hack-Lyoung/AAL-5038-2020
OI Kim, Hack-Lyoung/0000-0002-6703-1472; Kim, Sang-Hyun/0000-0001-8026-1582
CR Acikel S, 2011, INT J CARDIOL, V149, pE33, DOI 10.1016/j.ijcard.2009.03.077
   Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730
   Burzotta F, 2008, INT J CARDIOL, V123, P313, DOI 10.1016/j.ijcard.2006.12.018
   Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253
   Chlapoutakis GN, 2010, INT J CARDIOL, V139, pE1, DOI 10.1016/j.ijcard.2008.06.085
   HART RG, 1992, LANCET, V339, P589, DOI 10.1016/0140-6736(92)90873-2
   Jensen JK, 2007, AM J CARDIOL, V99, P867, DOI 10.1016/j.amjcard.2006.10.052
   Motreff P, 2010, HEART, V96, P809, DOI 10.1136/hrt.2009.183285
   Saraiva F, 2011, REV PORT CARDIOL, V30, P543
   Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
NR 11
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 766
EP 769
DI 10.4070/kcj.2013.43.11.766
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600009
PM 24363753
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, EY
   Li, MH
   Choi, CW
   Park, KH
   Choi, JY
AF Choi, Eun Young
   Li, Meihua
   Choi, Chang Won
   Park, Kyo Hoon
   Choi, Jung Yun
TI A Case of Progressive Ductal Constriction in a Fetus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ductus arteriosus; Constriction, patholoic; Ultrasonography, prenatal;
   Echocardiography; Prenatal diagnosis
ID IDIOPATHIC CONSTRICTION; INTRAUTERINE CLOSURE; ARTERIOSUS; FETAL;
   ECHOCARDIOGRAPHY; DIAGNOSIS
AB The ductus arteriosus is a normal and essential structure in fetal circulation. Since the introduction of fetal echocardiography, there have been reports of ductal constriction, many of which were related to maternal use of some medications. However, there have been some reports of idiopathic ductal constriction, which usually present in later gestation. Recently we experienced a case, which initially showed an S-shaped ductus with mild narrowing at 23 weeks and 27 weeks gestation and developed severe ductal constriction at 33 weeks. Soon after birth, ductus was searched for but no ductus was found in 2-D and color images. The neonate required mechanical ventilation with supplemental oxygen for 3 days. All echocardiographic abnormalities were normalized in 7 months. We report progressive ductal constriction in an S-shaped ductus and emphasize the importance of continuous follow up extending to the third trimester and even immediately after birth.
C1 [Choi, Eun Young; Choi, Chang Won; Choi, Jung Yun] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam 463707, South Korea.
   [Park, Kyo Hoon] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Ginecol, Songnam 463707, South Korea.
   [Li, Meihua] Harbin Childrens Hosp, Dept Pediat Cardiol, Harbin, Peoples R China.
RP Choi, JY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pediat, 82 Gumi Ro 173Beon Gil, Songnam 463707, South Korea.
EM choi3628@snuh.ac.kr
CR [Anonymous], ARQ BRAS CARDIOL
   BENSON CB, 1995, ULTRASOUND OBST GYN, V5, P95, DOI 10.1046/j.1469-0705.1995.05020095.x
   CHAO RC, 1993, PRENATAL DIAG, V13, P989, DOI 10.1002/pd.1970131014
   Enzensberger C, 2012, J ULTRAS MED, V31, P1285
   Gewillig M, 2009, EUR HEART J, V30, P1530, DOI 10.1093/eurheartj/ehp128
   Harada K, 1997, ULTRASOUND OBST GYN, V10, P247, DOI 10.1046/j.1469-0705.1997.10040247.x
   Hofstadler G, 1996, AM J OBSTET GYNECOL, V174, P879, DOI 10.1016/S0002-9378(96)70317-4
   Ishida H, 2011, CONGENIT HEART DIS, V6, P51, DOI 10.1111/j.1747-0803.2010.00411.x
   Leal SD, 1997, AM J PERINAT, V14, P205, DOI 10.1055/s-2007-994128
   MIELKE G, 1995, ULTRASOUND OBST GYN, V5, P338, DOI 10.1046/j.1469-0705.1995.05050338.x
   Mielke G, 1998, PRENATAL DIAG, V18, P139, DOI 10.1002/(SICI)1097-0223(199802)18:2<139::AID-PD230>3.0.CO;2-#
   Mielke G, 2000, ULTRASOUND OBST GYN, V15, P213, DOI 10.1046/j.1469-0705.2000.00082.x
   Nygaard SI, 2009, PEDIATR CARDIOL, V30, P176, DOI 10.1007/s00246-008-9269-1
   Shima Y, 2011, EUR J PEDIATR, V170, P237, DOI 10.1007/s00431-010-1295-3
   Soslow JH, 2008, ECHOCARDIOGR-J CARD, V25, P650, DOI 10.1111/j.1540-8175.2008.00667.x
   Trevett TN, 2004, ULTRASOUND OBST GYN, V23, P517, DOI 10.1002/uog.980
   TULZER G, 1991, J AM COLL CARDIOL, V18, P532, DOI 10.1016/0735-1097(91)90611-C
   Wei S, 2011, ECHOCARDIOGR-J CARD, V28, pE85, DOI 10.1111/j.1540-8175.2010.01333.x
   Weichert J, 2010, CONGENIT HEART DIS, V5, P398, DOI 10.1111/j.1747-0803.2010.00424.x
   Zielinsky P, 2010, J PERINATOL, V30, P17, DOI 10.1038/jp.2009.101
NR 20
TC 4
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 774
EP 781
DI 10.4070/kcj.2013.43.11.774
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600011
PM 24363755
OA Green Published
DA 2021-04-22
ER

PT J
AU Alizade, E
   Bulut, M
   Aar, G
   Gol, G
   Koyuncu, A
   Esen, AM
AF Alizade, Elnur
   Bulut, Mustafa
   Aar, Goksel
   Gol, Gokhan
   Koyuncu, Atilla
   Esen, Ali Metin
TI Multimodality Cardiac Imaging of a Noninfectious Pseudoaneursym of the
   Mitral-Aortic Intervalvular Fibrosa
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ANEURYSM
C1 [Alizade, Elnur; Bulut, Mustafa; Aar, Goksel; Gol, Gokhan; Koyuncu, Atilla; Esen, Ali Metin] Kartal Kosuyolu Heart & Res Hosp, Cardiol Clin, TR-34846 Istanbul, Turkey.
RP Alizade, E (corresponding author), Kartal Kosuyolu Heart & Res Hosp, Cardiol Clin, TR-34846 Istanbul, Turkey.
EM elnur17@yahoo.com
CR BANSAL RC, 1983, CIRCULATION, V67, P930, DOI 10.1161/01.CIR.67.4.930
   BARBETSEAS J, 1992, CIRCULATION, V85, P212, DOI 10.1161/01.CIR.85.1.212
   Kassim TA, 2010, EUR J ECHOCARDIOGR, V11, DOI 10.1093/ejechocard/jep189
   Robles P, 2007, INTERNAL MED, V46, P1825, DOI 10.2169/internalmedicine.46.6189
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2013
VL 43
IS 11
BP 782
EP 783
DI 10.4070/kcj.2013.43.11.782
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9PB
UT WOS:000342410600012
PM 24363756
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, JY
   Ahn, Y
   Jeong, MH
AF Cho, Jae Yeong
   Ahn, Youngkeun
   Jeong, Myung Ho
TI A Bumpy and Winding but Right Path to Domestic Drug-Eluting Coronary
   Stents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Acute myocardial infarction; Coronary artery disease; Drug-eluting
   stents
ID ALPHA-LIPOIC ACID; ACUTE MYOCARDIAL-INFARCTION; ABCIXIMAB-COATED STENT;
   MUSCLE-CELL-PROLIFERATION; BARE-METAL STENTS; BIODEGRADABLE POLYMER;
   GLYCOPROTEIN IIB/IIIA; ARTERY-DISEASE; FOLLOW-UP; ANTIPLATELET THERAPY
AB Restenosis and stent thrombosis remain major concerns after percutaneous coronary intervention for the treatment of coronary artery disease. The present review was undertaken in order to highlight the various coronary stents that have been investigated in our Heart Research Center, and how far we have come from the first heparin-coated stent first used in the late 1990s. Thereafter, from the abciximab-coated stent to the current gene-delivery stent and other newer agents, our group has applied a range of techniques in this field. However, in groups similar to ours, the restenosis rates of such stents are still high for second-generation drug-eluting stents (DESs). Moreover, our nation imports almost all of these types of stents from other countries. Thus, we need to develop domestic coronary stents. Research into newer DESs are warranted in Korea so as to achieve improved safety and efficacy outcomes.
C1 [Cho, Jae Yeong; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Korea Cardiovasc Stent Res Inst, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Cardiovasc Stent Res Inst, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Regeneromics Research Center, Chonnam National University
FX This study was supported by a grant of the Regeneromics Research Center,
   Chonnam National University.
CR Ahn YK, 1999, CATHETER CARDIO INTE, V48, P324, DOI 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K
   AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1
   Bae IH, 2012, J MATER SCI-MATER M, V23, P1259, DOI 10.1007/s10856-012-4587-5
   Bae Y, 1998, KOREAN CIRC J, V28, P89
   Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014
   Bazzino O, 1998, NEW ENGL J MED, V338, P1488
   Bonow RO, 2012, BRAUNWALDS HEART DIS
   CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402
   Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Che HL, 2012, BIOMATERIALS, V33, P8548, DOI 10.1016/j.biomaterials.2012.07.045
   Chen H, 2005, BIOMATERIALS, V26, P7418, DOI 10.1016/j.biomaterials.2005.05.053
   Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791
   Cote G, 1999, CIRCULATION, V99, P30, DOI 10.1161/01.CIR.99.1.30
   Duguay D, 2007, BRIT J PHARMACOL, V151, P1315, DOI 10.1038/sj.bjp.0707334
   Fattori R, LANCET
   FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   GIRALDO AA, 1985, ARCH PATHOL LAB MED, V109, P173
   HIROOKA Y, 1992, HYPERTENSION, V20, P175, DOI 10.1161/01.HYP.20.2.175
   Hong YJ, 2007, INT J CARDIOL, V123, P23, DOI 10.1016/j.ijcard.2006.11.101
   Hong YJ, 2007, J KOREAN MED SCI, V22, P802, DOI 10.3346/jkms.2007.22.5.802
   Hong YJ, 2011, KOREAN CIRC J, V41, P535, DOI 10.4070/kcj.2011.41.9.535
   Hong YJ, 2013, INT J CARDIOL, V163, P1, DOI 10.1016/j.ijcard.2012.02.003
   Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644
   Jere D, 2010, J NANOSCI NANOTECHNO, V10, P3366, DOI 10.1166/jnn.2010.2228
   Jere D, 2009, INT J PHARMACEUT, V378, P194, DOI 10.1016/j.ijpharm.2009.05.046
   Jiang HL, 2011, INT J PHARMACEUT, V420, P256, DOI 10.1016/j.ijpharm.2011.08.045
   Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017
   Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9
   Kim JM, 2011, KOREAN CIRC J, V41, pII
   Kim JM, 2012, KOREAN CIRC J, V42, pII
   Kim SS, 2010, CIRC J, V74, P442, DOI 10.1253/circj.CJ-09-0674
   Kim W, 2006, J AM COLL CARDIOL, V47, P933, DOI 10.1016/j.jacc.2005.10.054
   Kim Weon, 2004, Korean Journal of Internal Medicine, V19, P220
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059
   Kwon JC, 2013, INT J CARDIOL
   Lake DF, 2012, BASIC CLIN PHARM, P985
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee KM, 2006, ATHEROSCLEROSIS, V189, P106, DOI 10.1016/j.atherosclerosis.2005.12.003
   Lefkovits J, 1996, EUR HEART J, V17, P9
   Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008
   Lim KS, 2011, KOREAN CIRC J, V41, P241, DOI 10.4070/kcj.2011.41.5.241
   Lim SY, 2009, J CARDIOL, V54, P375, DOI 10.1016/j.jjcc.2009.06.005
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Logeart D, 1997, EUR J CELL BIOL, V74, P376
   Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Mickelson JK, 1999, J AM COLL CARDIOL, V33, P97, DOI 10.1016/S0735-1097(98)00532-4
   NAKAMURA M, 1994, J AM COLL CARDIOL, V24, P1321, DOI 10.1016/0735-1097(94)90115-5
   OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189
   Packer L, 1997, Adv Pharmacol, V38, P79
   PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R
   Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086
   Park KH, 2011, J CARDIOL, V57, P53, DOI 10.1016/j.jjcc.2010.10.002
   Pfuetze K D, 2000, Curr Atheroscler Rep, V2, P47, DOI 10.1007/s11883-000-0094-0
   Pratt RE, 1996, CIRCULATION, V93, P848, DOI 10.1161/01.CIR.93.5.848
   Puskas JE, 2009, WIRES NANOMED NANOBI, V1, P451, DOI 10.1002/wnan.38
   Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065
   Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560
   Reverter JC, 1996, J CLIN INVEST, V98, P863, DOI 10.1172/JCI118859
   Rich D.H., 1979, PEPTIDES, V1, P241
   SCHNEIDER JE, 1993, CIRCULATION, V88, P628, DOI 10.1161/01.CIR.88.2.628
   SHAPPELL SB, 1990, J IMMUNOL, V144, P2702
   Sim DS, 2009, TISSUE ENG REGEN MED, V6, P555
   Simon DI, 1997, ARTERIOSCL THROM VAS, V17, P528, DOI 10.1161/01.ATV.17.3.528
   Simoons ML, 1997, LANCET, V349, P1429
   Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2
   Song SJ, 2011, J MATER CHEM, V21, P8169, DOI 10.1039/c0jm03994b
   Song SJ, 2010, J MATER CHEM, V20, P4792, DOI 10.1039/b925409a
   Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086
   Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   SUNG CP, 1993, J CARDIOVASC PHARM, V21, P221, DOI 10.1097/00005344-199302000-00006
   Sung CP, 1997, J PHARMACOL EXP THER, V283, P910
   Sung MJ, 2005, CIRC RES, V97, P880, DOI 10.1161/01.RES.0000186522.89544.4D
   Tam SH, 1998, CIRCULATION, V98, P1085, DOI 10.1161/01.CIR.98.11.1085
   Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C
   Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   Tsyganov I, 2005, SURF COAT TECH, V200, P1041, DOI 10.1016/j.surfcoat.2005.02.093
   Vrolix MCM, 2000, AM J CARDIOL, V86, P385, DOI 10.1016/S0002-9149(00)00951-6
   Wakeyama T, 2003, CIRC J, V67, P519
   Wasserman MA, 2003, AM J CARDIOL, V91, p34A
   Watanabe K, 1996, AM HEART J, V132, P23, DOI 10.1016/S0002-8703(96)90386-5
   Windecker S, 2001, CIRCULATION, V104, P928, DOI 10.1161/hc3401.093146
   Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296
NR 90
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 645
EP 654
DI 10.4070/kcj.2013.43.10.645
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500001
PM 24255648
OA Green Published
DA 2021-04-22
ER

PT J
AU Akyuz, A
   Alpsoy, S
   Akkoyun, DC
   Degirmenci, H
   Guler, N
AF Akyuz, Aydin
   Alpsoy, Seref
   Akkoyun, Dursun Cayan
   Degirmenci, Hasan
   Guler, Niyazi
TI Maximal Exercise-Corrected QT as a Predictor of Coronary Artery Disease:
   Comparison of Simpler Heart Rate Corrections
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Corrected QT; Exercise test
ID MYOCARDIAL-ISCHEMIA; ST-SEGMENT; INTERVAL; ELECTROCARDIOGRAMS;
   DETERMINANTS; ARRHYTHMIAS; DEPRESSION; DISPERSION; FORMULAS; SYSTEM
AB Background and Objectives: The relationship between QT prolongation and myocardial ischemia is widely known. Due to the limited value of ST depression, we aimed to evaluate, by using four simpler heart rate corrections (Bazett, Framingham, Fridericia and Hodges), the value of maximal exercise-QTc prolongation in the diagnosis of coronary artery disease (CAD) presence and severity.
   Subjects and Methods: We enrolled 234 subjects (mean age 57.3 +/- 9 years, 143 men) who had undergone exercise testing and coronary angiography due to a suspicion of CAD in the study. Evaluating CAD severity with Gensini scoring, the CAD group (n=122) and controls with non-CAD were compared in terms of corrected QT duration at maximal exercise.
   Results: Age, gender, hypertension, dyslipidemia, smoking, exercise duration, resting, and peak heart rate were similar between the two groups (all p>0.05). The CAD group had higher raw QT values than the controls {268 (169-438) vs. 240 (168-348), p<0.001}. Although Framingham QTc of >= 350 ms and Fridericia QTc of >= 340 ms were seen to be useful for the diagnosis of CAD, there was no additive diagnostic value of exercise QTc in addition to ST depression. Maximal exercise-QTc Bazett (r=0.163, p=0.01), Framingham (r=0.239, p=0.001), and Fridericia (r=0.206, p=0.001) equations were weakly positively correlated with Gensini scoring.
   Conclusion: The patients with CAD have longer QTc intervals at peak heart rates during exercise. This finding provides insufficient evidence to support routine incorporation of QTc at peak heart rates into exercise test interpretation.
C1 [Akyuz, Aydin; Alpsoy, Seref; Akkoyun, Dursun Cayan; Degirmenci, Hasan; Guler, Niyazi] Namik Kemal Univ, Sch Med, Dept Cardiol, Tekirdag, Turkey.
RP Akyuz, A (corresponding author), Namik Kemal Univ, Sch Med, Dept Cardiol, Tekirdag, Turkey.
EM ayakyuzq5@gmail.com
RI Alpsoy, Seref/Z-1808-2018
CR ARROWOOD JA, 1993, J APPL PHYSIOL, V75, P2217
   Aytemir K, 1999, PACE, V22, P1397, DOI 10.1111/j.1540-8159.1999.tb00635.x
   Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
   Chauhan VS, 2004, PACE, V27, P1415, DOI 10.1111/j.1540-8159.2004.00647.x
   Chugh SS, 2009, CIRCULATION, V119, P663, DOI 10.1161/CIRCULATIONAHA.108.797035
   Crow RS, 2003, CIRCULATION, V108, P1985, DOI 10.1161/01.CIR.0000095027.28753.9D
   Davey P, 1999, CLIN CARDIOL, V22, P513, DOI 10.1002/clc.4960220805
   Fridericia LS, 1920, ACTA MED SCAND, V53, P469, DOI [10.1111/j.0954-6820.1920.tb18266.x, DOI 10.1111/J.0954-6820.1920.TB18266.X]
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87
   Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x
   Hirao H, 1996, J AM COLL CARDIOL, V28, P1269, DOI 10.1016/S0735-1097(96)00313-0
   HODGES M, 1983, J AM COLL CARDIOL, V1, P694
   Kannankeril PJ, 2002, AM J PHYSIOL-HEART C, V282, pH2091, DOI 10.1152/ajpheart.00825.2001
   Lauer MS, 2006, J ELECTROCARDIOL, V39, P315, DOI 10.1016/j.jelectrocard.2005.12.005
   Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030
   Magnano AR, 2002, J AM COLL CARDIOL, V39, P1820, DOI 10.1016/S0735-1097(02)01852-1
   Malik M, 2001, J CARDIOVASC ELECTR, V12, P411, DOI 10.1046/j.1540-8167.2001.00411.x
   MIRANDA CP, 1992, AM J CARDIOL, V69, P303, DOI 10.1016/0002-9149(92)90224-M
   Mittleman Murray A., 1996, Cardiology Clinics, V14, P263
   Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014
   Rautaharju PM, 2002, J CARDIOVASC ELECTR, V13, P1211, DOI 10.1046/j.1540-8167.2002.01211.x
   RICKARDS AF, 1981, BRIT HEART J, V45, P56
   SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D
   Schijvenaars BJA, 2008, J ELECTROCARDIOL, V41, P190, DOI 10.1016/j.jelectrocard.2008.01.012
   Schwartz PJ, 2001, CIRCULATION, V103, P89
   Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X
   Sohaib SMA, 2008, J ELECTROCARDIOL, V41, P704, DOI 10.1016/j.jelectrocard.2008.01.010
   Takase B, 2009, ANATOL J CARDIOL, V9, P189
   Ulgen MS, 2000, ACTA CARDIOL, V55, P335, DOI 10.2143/AC.55.6.2005764
NR 30
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 655
EP 663
DI 10.4070/kcj.2013.43.10.655
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500002
PM 24255649
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, W
   Kang, WY
   Hwang, SH
   Cho, SC
   Kim, W
   Jeong, MH
AF Kim, Kyung Hwan
   Kim, Wan
   Kang, Won Yu
   Hwang, Sun Ho
   Cho, Sang Cheol
   Kim, Weon
   Jeong, Myung Ho
CA Korean Working Grp Myocardial Infr
TI The Impact of Ischemic Time on the Predictive Value of High-Sensitivity
   C-Reactive Protein in ST-Segment Elevation Myocardial Infarction
   Patients Treated by Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE C-reactive protein; Myocardial infarction; Myocardial reperfusion
ID HEART-ASSOCIATION; PROGNOSTIC VALUE; UNSTABLE ANGINA; ARTERY-DISEASE;
   CARDIOVASCULAR-DISEASE; RISK; EVENTS; COMPLEMENT; MORTALITY; ADMISSION
AB Background and Objectives: The high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, has been known to be elevated in patients with coronary artery disease. However, there is controversy about the predictive value of hs-CRP after acute myocardial infarction (MI). Therefore, we evaluated the impact of ischemic time on the predictive value of hs-CRP in ST-segment elevation myocardial infarction (STEMI) patients who were treated by primary percutaneous coronary intervention (PCI).
   Subjects and Methods: We enrolled 5123 STEMI patients treated by primary PCI from the Korean Working Group in Myocardial Infarction and divided enrolled patients into four groups by symptom-to-balloon time (SBT) and level of hs-CRP (Group I: SBT <6 hours and hs-CRP <3 mg/L, Group II: SBT <6 hours and hs-CRP >= 3 mg/L, Group III: SBT <6 hours and hs-CRP <3 mg/L, and Group IV: SBT >= 6 hours and hs-CRP >= 3 mg/L). To evaluate the impact of ischemic time on the predictive value of hs-CRP in STEMI patients, we compared the cumulative cardiac event-free survival rate between these four groups.
   Results: The sum of the cumulative incidence of all-cause mortality and recurrence of MI was higher in Group IV than in the other groups. However, there was no significant difference among Group I, Group II, and Group III. The Cox-regression analyses showed that an elevated level of hs-CRP (>= 3 mg/L) was an independent predictor of long-term cardiovascular outcomes only among late-presenting STEMI patients (p=0.017, hazard ratio=2.462).
   Conclusion: For STEMI patients with a long ischemic time (>= 6 hours), an elevated level of hs-CRP is a poor prognostic factor of long-term cardiovascular outcomes.
C1 [Kim, Kyung Hwan; Kim, Wan; Kang, Won Yu; Hwang, Sun Ho; Cho, Sang Cheol] Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, Kwangju 506705, South Korea.
   [Kim, Weon] Kyung Hee Univ, Coll Med, Dept Cardiovasc Med, Seoul, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Coll Med, Dept Cardiovasc Med, Kwangju, South Korea.
RP Kim, W (corresponding author), Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, 99 Cheomdanwolbong Ro, Kwangju 506705, South Korea.
EM kvhwkim@chol.com
CR Ahmed K, 2012, KOREAN CIRC J, V42, P164, DOI 10.4070/kcj.2012.42.3.164
   BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G
   Bogaty P, 2001, CIRCULATION, V103, P3062, DOI 10.1161/01.CIR.103.25.3062
   Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab
   Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733
   Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
   Hong YJ, 2011, KOREAN CIRC J, V41, P440, DOI 10.4070/kcj.2011.41.8.440
   Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97
   LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701
   Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5
   Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033
   Mouridsen MR, 2012, J ELECTROCARDIOL, V45, P260, DOI 10.1016/j.jelectrocard.2011.11.004
   Nikfardjam M, 2000, J INTERN MED, V247, P341, DOI 10.1046/j.1365-2796.2000.00670.x
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672
   Raposeiras-Roubin S, 2012, ANGIOLOGY, V63, P30, DOI 10.1177/0003319711406502
   Roberts WL, 2001, CLIN CHEM, V47, P418
   Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939
   Schoos MM, 2011, AM J CARDIOL, V107, P1597, DOI 10.1016/j.amjcard.2011.01.042
   THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003
   Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244
   Vrsalovic M, 2012, CLIN BIOCHEM, V45, P1506, DOI 10.1016/j.clinbiochem.2012.05.026
   Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402
   Zebrack JS, 2002, J AM COLL CARDIOL, V39, P632, DOI 10.1016/S0735-1097(01)01804-6
NR 24
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 664
EP 673
DI 10.4070/kcj.2013.43.10.664
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500003
PM 24255650
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JO
   Chang, SA
   Park, SJ
   Lee, SC
   Park, SW
AF Choi, Jin-Oh
   Chang, Sung-A
   Park, Sung Ji
   Lee, Sang-Chol
   Park, Seung Woo
TI Improved Detection of Ischemic Heart Disease by Combining High-Frequency
   Electrocardiogram Analysis with Exercise Stress Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Treadmill test; Echocardiography, stress: Electrocardiography; Coronary
   artery disease
ID CORONARY-ARTERY-DISEASE; MYOCARDIAL-ISCHEMIA; ST-SEGMENT; QRS
   POTENTIALS; PERFORMANCE; DEPRESSION; OCCLUSION; UPDATE; DOGS
AB Background and Objectives: Because the exercise treadmill test (ETT) based on ST/segment analysis is limited due to low sensitivity and specificity, there has been an interest in the additional analysis of high-frequency components of QRS (HFQRS) for the detection of coronary artery disease (CAD). We sought to evaluate the feasibility and clinical usefulness of HFQRS analysis during exercise stress echocardiography (ESE).
   Subjects and Methods: We evaluated 175 patients (age 57 +/- 9, 118 men) who performed ESE and either coronary computed tomographic angiography or coronary angiography. ETT was performed using the HyperQ stress system for both conventional ST-segment analysis and HFQRS intensity analysis.
   Results: Thirty-two patients (31%) had significant CAD. The sensitivity and specificity of HFQRS analysis were 68.8% and 74.8%, respectively. The combined model, including HFQRS analysis and ESE, provided the best diagnostic accuracy, with the area under the receiver-operating characteristics curve (AUC) of 0.948 {95% confidence interval (CI)=0.913-0.984} compared with ST-segment analysis (AUC 0.679, 95% CI=0.592-0.766).
   Conclusion: HFQRS analysis during ESE is feasible and may provide additional diagnostic information for the detection of significant CAD.
C1 [Choi, Jin-Oh; Chang, Sung-A; Park, Sung Ji; Lee, Sang-Chol; Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr,Dept Med, 81 Irwon Ro, Seoul 135710, South Korea.
EM choijean5@gmail.com
OI Chang, Sung-A/0000-0001-5124-605X
FU Korean Society of Cardiology [2008-10]
FX The study was supported by a grant (No. 2008-10) from the Korean Society
   of Cardiology.
CR ABBOUD S, 1990, INT J CARDIOL, V26, P285, DOI 10.1016/0167-5273(90)90084-I
   ABBOUD S, 1987, CIRCULATION, V76, P585, DOI 10.1161/01.CIR.76.3.585
   ABBOUD S, 1991, CIRC RES, V68, P1751, DOI 10.1161/01.RES.68.6.1751
   ABBOUD S, 1987, COMPUT BIOMED RES, V20, P384, DOI 10.1016/0010-4809(87)90052-8
   Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001
   Geleijnse ML, 1997, J AM COLL CARDIOL, V30, P595, DOI 10.1016/S0735-1097(97)00206-4
   GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Higgins JP, 2007, INT J CARDIOL, V116, P285, DOI 10.1016/j.ijcard.2006.04.047
   Kligfield P, 2006, CIRCULATION, V114, P2070, DOI 10.1161/CIRCULATIONAHA.105.561944
   Lauer M, 2005, CIRCULATION, V112, P771, DOI 10.1161/CIRCULATIONAHA.105.166543
   Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433
   MORAVI V, 1987, CIRCULATION, V76, P237, DOI 10.1161/01.CIR.76.1.237
   Nedeljkovic Ivana, 2006, Cardiovasc Ultrasound, V4, P22
   OKIN PM, 1995, J AM COLL CARDIOL, V25, P1726, DOI 10.1016/0735-1097(95)00085-I
   Pettersson J, 2000, J AM COLL CARDIOL, V36, P1827, DOI 10.1016/S0735-1097(00)00936-0
   Schlegel TT, 2004, MAYO CLIN PROC, V79, P339, DOI 10.4065/79.3.339
   Sharir T, 2012, AM J CARDIOL, V109, P642, DOI 10.1016/j.amjcard.2011.10.022
   Toledo E, 2009, J ELECTROCARDIOL, V42, P240, DOI 10.1016/j.jelectrocard.2008.12.023
NR 19
TC 2
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 674
EP 680
DI 10.4070/kcj.2013.43.10.674
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500004
PM 24255651
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Song, J
   Kang, IS
   Chang, SA
   Huh, J
   Park, SW
AF Kim, Kwang Hoon
   Song, Jinyoung
   Kang, I-Seok
   Chang, Sung-A
   Huh, June
   Park, Seung Woo
TI Balloon Occlusive Diameter of Non-Circular Atrial Septal Defects in
   Transcatheter Closure with Amplatzer Septal Occluder
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Amplatzer septal occluder; Balloon occlusion
ID 3-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PERCUTANEOUS CLOSURE;
   DEVICE; SIZE
AB Background and Objectives: The aim of this study was to investigate the balloon occlusive diameter (BOD) of non-circular defects in the transcatheter closure of atrial septal defect (ASD).
   Subjects and Methods: A total of 67 patients who had undergone transcatheter closure of an ASD were reviewed retrospectively. A non-circular defect was defined as the ratio of the short diameter to the long diameter of the defect on the en-face image less than 0.75. The BOD was compared with the long diameter of the defect and then compared between the two groups.
   Results: There were 22 patients with circular defects and 45 patients with non-circular defects. The difference in BOD measuring from the long diameter of the defect was quite different between the two groups and significantly smaller in non-circular morphology (0.1 +/- 4.0 vs. 2.3 +/- 2.1, p=0.006). The difference in BOD measurement from the long diameter of ASD showed a positive correlation with the ratio of the short diameter to the long diameter of ASD (b/a) (r(2)=0.102, p=0.008). In the non-circular morphology of ASD, the difference in BOD measured from the long diameter had a significant negative correlation with the long diameter of ASD (r(2)=0.230, p=0.001), whereas in circular ASD, no significant correlation was found between the difference in BOD and the long diameter of ASD (p=0.201).
   Conclusion: The BOD compared with the long diameter measured from three-dimensional transesophageal echocardiography was smaller in non-circular ASD than in circular ASD. This difference was much smaller in non-circular ASD with a large long diameter.
C1 [Kim, Kwang Hoon; Song, Jinyoung; Kang, I-Seok; Huh, June] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 135710, South Korea.
   [Chang, Sung-A; Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea.
RP Song, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Cardiac & Vasc Ctr, 81 Irwon Ro, Seoul 135710, South Korea.
EM amyjys@naver.com
OI Huh, June/0000-0003-4523-9632; Chang, Sung-A/0000-0001-5124-605X
CR Acar P, 2000, CARDIOL YOUNG, V10, P484
   Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211
   Bhaya M, 2013, ECHOCARDIOGR-J CARD, V30, P345, DOI 10.1111/echo.12106
   Chan KC, 1999, HEART, V82, P300, DOI 10.1136/hrt.82.3.300
   Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072
   FERREIRA SMAG, 1992, BRIT HEART J, V67, P316
   Huang XS, 2010, J AM SOC ECHOCARDIOG, V23, P714, DOI 10.1016/j.echo.2010.04.016
   Johri AM, 2011, J AM SOC ECHOCARDIOG, V24, P431, DOI 10.1016/j.echo.2010.12.011
   Kim NK, 2011, KOREAN CIRC J, V41, P633, DOI 10.4070/kcj.2011.41.11.633
   Ko SF, 2009, AM J ROENTGENOL, V193, P1522, DOI 10.2214/AJR.09.2854
   Majunke N, 2009, AM J CARDIOL, V103, P550, DOI 10.1016/j.amjcard.2008.10.018
   MARX GR, 1995, J AM COLL CARDIOL, V25, P482, DOI 10.1016/0735-1097(94)00372-W
   Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   Nasis A, 2011, HEART LUNG CIRC, V20, P343, DOI 10.1016/j.hlc.2011.01.005
   Roberson DA, 2011, J AM SOC ECHOCARDIOG, V24, P600, DOI 10.1016/j.echo.2011.02.008
   Seo JS, 2012, J AM SOC ECHOCARDIOG, V25, P1031, DOI 10.1016/j.echo.2012.07.017
   van den Bosch AE, 2006, J AM SOC ECHOCARDIOG, V19, P815, DOI 10.1016/j.echo.2006.01.016
   Yew G, 2005, CATHETER CARDIO INTE, V64, P193, DOI 10.1002/ccd.20268
   Zanchetta N, 2004, INT J CARDIOL, V95, P61, DOI 10.1016/j.ijcard.2003.04.022
NR 19
TC 3
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 681
EP 685
DI 10.4070/kcj.2013.43.10.681
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500005
PM 24255652
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, N
   Kim, KH
   Park, KH
   Sim, DS
   Youn, HJ
   Hong, YJ
   Park, HW
   Kim, JH
   Ahn, Y
   Jeong, MH
   Cho, JG
   Park, JC
AF Yoon, Namsik
   Kim, Kye Hun
   Park, Keun Ho
   Sim, Doo Sun
   Youn, Hyun Ju
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
TI Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial
   Remodeling in an Ischemic Heart Failure Model of Rats
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angiotensin-II receptor blocker; Atrial remodeling; Atrial fibrillation
ID VENTRICULAR MYOCARDIAL-INFARCTION; FIBRILLATION; CONNEXINS; ANTAGONIST;
   EXPRESSION; GUIDELINES; MANAGEMENT; SYSTEM; ESC
AB Background and Objectives: It is widely known that angiotensin-II receptor blockers (ARBs) have reverse remodeling effects in atrium. Although atrial fibrillation is frequent in ischemic heart failure clinically, experiments to demonstrate ARB's effects on atrial remodeling in a heart failure model are rare.
   Materials and Methods: A heart failure model and a sham-operated group were formed in 25 Sprague-Dawley male rats of roughly 260 g in weight. Ischemic heart failure models were obtained via ligation of the left anterior descending coronary artery. In the ARB group, 30 mg/kg of losartan was administrated over a day for 4 weeks. Echocardiography was performed to measure left ventricle ejection fraction and left atrial diameter (LAD) at the baseline and 4 weeks after the operation. 4 weeks later, histologic and immunohistochemical evaluation were performed.
   Results: Groups were divided into the sham group, heart failure group, and heart failure-ARB group. We maintained 5 rats in each group for 4 weeks after operation. The decrease of left ventricular ejection fraction in the heart failure-ARB group was less than that in the heart failure group (p=0.023). The increase of LAD in the heart failure-ARB group was less than that in the heart failure group (p=0.025). Masson's trichrome stain revealed less fibrosis in the heart failure-ARB group. Immunohistochemical stain and western blot for connexin 43 showed less expression in the heart failure-ARB group.
   Conclusion: In the ischemic heart failure model of rats, structurally and histologically, the ARB, losartan, has atrial reverse-remodeling effects. However, electrically, its role as an electrical stabilizer should be studied further.
C1 [Yoon, Namsik; Kim, Kye Hun; Park, Keun Ho; Sim, Doo Sun; Youn, Hyun Ju; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Ahn, Youngkeun; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju 501757, South Korea.
RP Cho, JG (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM jgcho@unitel.co.kr
FU Korean Society of Cardiology
FX This study was supported by a grant from the Korean Society of
   Cardiology in 2009.
CR Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157
   Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3
   Camm AJ, 2012, EUROPACE, V14, P1385, DOI 10.1093/europace/eus305
   Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Daniels MCG, 2001, AM J PHYSIOL-HEART C, V281, pH2150
   Dhein S, 2006, ADV CARDIOL, V42, P161, DOI 10.1159/000092568
   Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2
   Gollob MH, 2006, CURR OPIN CARDIOL, V21, P155, DOI 10.1097/01.hco.0000221574.95383.6f
   Hoyano Makoto, 2010, Cardiovasc Pathol, V19, pe149, DOI 10.1016/j.carpath.2009.07.002
   Jalife J, 2003, J INTERV CARD ELECTR, V9, P85, DOI 10.1023/A:1026251517004
   JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006
   Kato T, 2012, CIRCULATION, V125, P203, DOI 10.1161/CIRCULATIONAHA.111.075432
   Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9
   Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87
   MITCHELL GF, 1992, J AM COLL CARDIOL, V19, P1136, DOI 10.1016/0735-1097(92)90314-D
   Miyauchi Y, 2003, CIRCULATION, V108, P360, DOI 10.1161/01.CIR.0000080327.32573.7C
   Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612
   Novo G, 2008, BRIT J CLIN PHARMACO, V66, P345, DOI 10.1111/j.1365-2125.2008.03234.x
   Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266
   Rucker-Martin C, 2006, CARDIOVASC RES, V72, P69, DOI 10.1016/j.cardiores.2006.06.016
   Takeuchi S, 2006, CIRC J, V70, P575, DOI 10.1253/circj.70.575
   Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686
   Wollert KC, 1997, AM J CARDIOL, V80, pA158, DOI 10.1016/S0002-9149(97)00473-6
NR 23
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 686
EP 693
DI 10.4070/kcj.2013.43.10.686
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500006
PM 24255653
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, H
   Her, SH
   Park, MW
   Cho, JS
   Kim, CJ
   Kwon, JB
   Ro, SM
   Park, YK
AF Yang, Hyun
   Her, Sung-Ho
   Park, Mahn Won
   Cho, Jung Sun
   Kim, Chan Joon
   Kwon, Jong-Bum
   Ro, Sang Mi
   Park, Yun Kyung
TI A Case of Three Consecutive Events of Acute Myocardial Infarctions in
   Three Different Vessels
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Coronary vessels; Thrombosis
ID CLOPIDOGREL RESISTANCE; ASPIRIN; DEATH
AB A 51-year-old man was being admitted to the emergency department with chest pains. He had a history of acute myocardial infarction (MI) on two prior occasions and was successfully treated with drug eluting stents. He was diagnosed with 3 consecutive events of acute MI in 3 different vessels. The consecutive events of acute MI in different vessels are a very rare case. He did not have risk factors, such as coagulation abnormality, clopidogrel resistance, patient's compliance and vessel abnormality, except for his cigarette smoking. We reported the first case with 3 consecutive events of acute MI in each 3 vessels during a long-term interval.
C1 [Her, Sung-Ho; Park, Mahn Won; Cho, Jung Sun; Kim, Chan Joon; Ro, Sang Mi; Park, Yun Kyung] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Cardiol,Dept Internal Med, Taejon 301723, South Korea.
   [Kwon, Jong-Bum] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Thorac & Cardiovasc Surg, Taejon 301723, South Korea.
RP Her, SH (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Cardiol,Dept Internal Med, 64 Daeheung Ro, Taejon 301723, South Korea.
EM hhhsungho@naver.com
CR Brito JD, 2012, ARQ BRAS CARDIOL, V98, pE7, DOI 10.1590/S0066-782X2012000100018
   Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921
   Falk E, 2000, Ital Heart J, V1, P835
   Gan Feng, 2012, BMC Res Notes, V5, P523, DOI 10.1186/1756-0500-5-523
   Godino C, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-4
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016
   Kanei Yumiko, 2009, J Invasive Cardiol, V21, P66
   Kim Sung Soo, 2009, Korean Circ J, V39, P434, DOI 10.4070/kcj.2009.39.10.434
   장명희, 2007, [Journal of Rheumatic Diseases, 대한류마티스학회지], V14, P96
   Michos ED, 2006, MAYO CLIN PROC, V81, P518, DOI 10.4065/81.4.518
   Peovska Irena, 2008, Cardiol J, V15, P463
   Sweeny JM, 2009, NAT REV CARDIOL, V6, P273, DOI 10.1038/nrcardio.2009.10
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684
NR 14
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 694
EP 698
DI 10.4070/kcj.2013.43.10.694
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500007
PM 24255654
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, W
   Ryu, DR
   Han, SS
   Ryu, SW
   Cho, BR
   Kwon, H
   Kim, BR
AF Lee, Wonho
   Ryu, Dong Rueol
   Han, Seon-Sook
   Ryu, Sook-Won
   Cho, Byung Ryul
   Kwon, Hyucki
   Kim, Bo Ra
TI Very Early Onset of Amiodarone-Induced Pulmonary Toxicity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Amiodarone; Drug toxicity; Myocardial infarctions; Arrhythmias; cardiac
ID RECOGNITION
AB Amiodarone is a widely used antiarrhythmic agent. Among its various adverse effects, amiodarone-induced pulmonary toxicity ( APT) is the most life threatening complication, which has been described mostly in patients who have been in treatment with high accumulative doses for a long duration of time. However, amiodarone therapy in short-term duration induced APT was rarely reported. We describe a case of a 54-year-old man who is presented with symptoms of APT after a few days of therapy for post-myocardial infarction ventricular tachycardia. For early diagnosis and successful treatment, awareness and high suspicion of this rare type of early onset APT is crucial in patients with amiodarone therapy.
C1 [Lee, Wonho; Ryu, Dong Rueol; Han, Seon-Sook; Cho, Byung Ryul; Kwon, Hyucki; Kim, Bo Ra] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon 200722, South Korea.
   [Ryu, Sook-Won] Kangwon Natl Univ Hosp, Dept Lab Med, Chunchon 200722, South Korea.
RP Ryu, DR (corresponding author), Kangwon Natl Univ Hosp, Dept Internal Med, Div Cardiol, 156 Baengnyeong Ro, Chunchon 200722, South Korea.
EM rdr0203@gmail.com
CR DUSMAN RE, 1990, CIRCULATION, V82, P51, DOI 10.1161/01.CIR.82.1.51
   Ernawati DK, 2008, BRIT J CLIN PHARMACO, V66, P82, DOI 10.1111/j.1365-2125.2008.03177.x
   MARTIN WJ, 1988, CHEST, V93, P1242, DOI 10.1378/chest.93.6.1242
   MARTIN WJ, 1988, CHEST, V93, P1067, DOI 10.1378/chest.93.5.1067
   Papiris SA, 2010, DRUG SAFETY, V33, P539, DOI 10.2165/11532320-000000000-00000
   Tanawuttiwat T, 2010, HEART LUNG CIRC, V19, P435, DOI 10.1016/j.hlc.2010.01.008
   김정혁, 2011, Acute and Critical Care, V26, P117
NR 7
TC 5
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 699
EP 701
DI 10.4070/kcj.2013.43.10.699
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500008
PM 24255655
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, HS
   Kim, HK
   Park, EA
   Lee, W
   Park, JH
   Sohn, DW
AF Ahn, Hyo-Suk
   Kim, Hyung-Kwan
   Park, Eun-Ah
   Lee, Whal
   Park, Jae-Hyung
   Sohn, Dae-Won
TI Isolated, Broad-Based Apical Diverticulum: Cardiac Magnetic Resonance Is
   a "Terminator" of Cardiac Imaging Modality for the Evaluation of Cardiac
   Apex
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diverticulum; Heart aneurysm; magnetic resonance imaging
ID ENHANCEMENT
AB In spite of the frequent involvement of many cardiac diseases, it is difficult to evaluate the left ventricular apex in detail with transthoracic echocardiography, a first-line imaging modality in cardiovascular diseases, because the apex is very closely located at the echocardiographic probe. Cardiac magnetic resonance enables us to evaluate the cardiac apex without any limitation to the image acquisition. We here present a case regarding a broad-based apical diverticulum, which was initially confused with apical aneurysm.
C1 [Ahn, Hyo-Suk; Kim, Hyung-Kwan; Sohn, Dae-Won] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
   [Ahn, Hyo-Suk; Kim, Hyung-Kwan; Sohn, Dae-Won] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
   [Park, Eun-Ah; Lee, Whal; Park, Jae-Hyung] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul 110744, South Korea.
RP Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 110744, South Korea.
EM cardiman73@gmail.com
RI Kim, Hyung-Kwan/R-8375-2019
CR Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992
   Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035
   OBRYAN, 1866, MALFORMATIONS HUMAN
   Ohlow MA, 2006, CARDIOLOGY, V106, P63, DOI 10.1159/000092634
   Paz Y, 2004, J THORAC CARDIOV SUR, V128, P313, DOI 10.1016/j.jtcvs.2003.12.029
   Weinsaft JW, 2011, JACC-CARDIOVASC IMAG, V4, P702, DOI 10.1016/j.jcmg.2011.03.017
NR 6
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 702
EP 704
DI 10.4070/kcj.2013.43.10.702
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500009
PM 24255656
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, DS
   Jung, SS
   Joo, CU
AF Jo, Dae Sun
   Jung, Sung Su
   Joo, Chan Uhng
TI A Case of Unusual Visceral Heterotaxy Syndrome with Isolated Levocardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Levocardia; Heterotaxy syndrome
ID POLYSPLENIA SYNDROME; DIAGNOSIS; ASPLENIA
AB Situs inversus of the abdominal organs in the presence of normally placed heart on the left side of the thorax is known as situs inversus with isolated levocardia. This rare condition is commonly associated with severe congenital defects of the heart. We report a case of situs inversus with levocardia in a 19-year-old asymptomatic male patient with completely normal heart on the left chest. Spiral computed tomography of the thorax and abdomen and echocardiographic studies revealed situs inversus of abdominal organs, normal heart (levocardia), mirrored left lungs, a midline liver, a left-sided inferior vena cava connecting to the right atrium, multiple splenic masses in the abdominal right upper quadrant, and aneurysmal dilatation of a splenic artery.
C1 [Jo, Dae Sun; Jung, Sung Su; Joo, Chan Uhng] Chonbuk Natl Univ, Sch Med, Dept Pediat, Jeonju, South Korea.
RP Joo, CU (corresponding author), Chonbuk Natl Univ Hosp, Dept Pediat, 20 Geonji Ro, Jeonju 561712, South Korea.
EM joocu@chonbuk.ac.kr
RI Jo, Dae Sun/S-2762-2019
OI Jo, Dae Sun/0000-0002-3141-9539
CR Budhiraja S, 2000, J PEDIATR SURG, V35, P1115, DOI 10.1053/jpsu.2000.7839
   De La Villeon B, 2011, J VISC SURG, V148, pE395, DOI 10.1016/j.jviscsurg.2011.09.013
   Ditchfield MR, 1998, PEDIATR RADIOL, V28, P303, DOI 10.1007/s002470050358
   Gayer G, 1999, ABDOM IMAGING, V24, P178, DOI 10.1007/s002619900471
   Gindes L, 2007, J ULTRAS MED, V26, P361, DOI 10.7863/jum.2007.26.3.361
   Imamura T, 2011, CONGENIT ANOM, V51, P187, DOI 10.1111/j.1741-4520.2011.00321.x
   LIBERTHS.RR, 1973, AM HEART J, V85, P40, DOI 10.1016/0002-8703(73)90524-3
   MOLLER JH, 1967, CIRCULATION, V36, P789, DOI 10.1161/01.CIR.36.5.789
   O'Leary PW, 2013, MOSS ADAMS HEART DIS, P1207
   PEOPLES WM, 1983, PEDIATR CARDIOL, V4, P129, DOI 10.1007/BF02076338
   Pickhardt PJ, 2002, AM J ROENTGENOL, V179, P1429, DOI 10.2214/ajr.179.6.1791429
   ROSE V, 1975, BRIT HEART J, V37, P840
   Van Praagh R, 1989, MOSS HEART DIS INFAN, P530
   VIJAYAKUMAR V, 1991, CLEV CLIN J MED, V58, P243, DOI 10.3949/ccjm.58.3.243
NR 14
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 705
EP 709
DI 10.4070/kcj.2013.43.10.705
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500010
PM 24255657
OA Green Published
DA 2021-04-22
ER

PT J
AU Islam, S
   Hayton, J
   Kim, DY
AF Islam, Saidul
   Hayton, James
   Kim, Dong-Yeon
TI Hampton's Hump in a Patient with Severe Left Ventricular Dysfunction and
   Biventricular Thrombosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PULMONARY
C1 [Islam, Saidul; Hayton, James; Kim, Dong-Yeon] LAMB Hosp, Dept Internal Med, Parbatipur 5250, Dinajpur, Bangladesh.
RP Kim, DY (corresponding author), LAMB Hosp, Dept Internal Med, Parbatipur 5250, Dinajpur, Bangladesh.
EM dongyeonk@lambproject.org
CR Haine SE, 2008, CAN J CARDIOL, V24, pE92, DOI 10.1016/S0828-282X(08)70205-8
   Hampton AO, 1940, AM J ROENTGENOL RADI, V43, P305
   MINOR RL, 1991, AM HEART J, V122, P1477, DOI 10.1016/0002-8703(91)90598-C
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 710
EP 711
DI 10.4070/kcj.2013.43.10.710
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500011
PM 24255658
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, JC
   Seol, MD
   Yoon, JW
   Lee, YS
   Kim, DK
   Choi, YH
   Ahn, HS
   Cho, WH
AF Joo, Jung-Chul
   Seol, Myung Do
   Yoon, Jin Won
   Lee, Young Soo
   Kim, Dong-Keun
   Choi, Yong Hoon
   Ahn, Hyo Seong
   Cho, Wook Hyun
TI A Case of Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like
   Episodes (MELAS) Syndrome with Intracardiac Thrombus (vol 43, pg 204,
   2013)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Joo, Jung-Chul; Seol, Myung Do; Yoon, Jin Won; Lee, Young Soo; Kim, Dong-Keun; Choi, Yong Hoon; Ahn, Hyo Seong; Cho, Wook Hyun] Seoul Hosp, Sahmyook Med Ctr, Seoul, South Korea.
RP Joo, JC (corresponding author), Seoul Hosp, Sahmyook Med Ctr, Seoul, South Korea.
CR Joo JC, 2013, KOREAN CIRC J, V43, P204, DOI 10.4070/kcj.2013.43.3.204
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2013
VL 43
IS 10
BP 712
EP 712
DI 10.4070/kcj.2013.43.10.712
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HL
UT WOS:000342389500012
OA Green Published
DA 2021-04-22
ER

PT J
AU Yeter, D
   Deth, R
   Kuo, HC
AF Yeter, Deniz
   Deth, Richard
   Kuo, Ho-Chang
TI Mercury Promotes Catecholamines Which Potentiate Mercurial Autoimmunity
   and Vasodilation: Implications for Inositol 1,4,5-Triphosphate 3-Kinase
   C Susceptibility in Kawasaki Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Kawasaki syndrome; Catecholamines; Mercury; Autoimmunity
ID ANGIOTENSIN-CONVERTING ENZYME; BRAIN NATRIURETIC PEPTIDE; FACTOR
   CIRCULATING LEVELS; RELAXING FACTOR EDRF; LYMPH-NODE SYNDROME;
   PROTEIN-KINASE-C; CORONARY-ARTERY; INSERTION/DELETION POLYMORPHISM;
   EPIDEMIOLOGIC FEATURES; CHINESE POPULATION
AB Previously, we reviewed biological evidence that mercury could induce autoimmunity and coronary arterial wall relaxation as observed in Kawasaki syndrome (KS) through its effects on calcium signaling, and that inositol 1,4,5-triphosphate 3-kinase C (ITPKC) susceptibility in KS would predispose patients to mercury by increasing Ca2+ release. Hg2+ sensitizes inositol 1,4,5-triphosphate (IP3) receptors at low doses, which release Ca2+ from intracellular stores in the sarcoplasmic reticulum, resulting in delayed, repetitive calcium influx. ITPKC prevents IP3 from triggering IP3 receptors to release calcium by converting IP3 to inositol 1,3,4,5-tetrakisphosphate. Defective IP3 phosphorylation resulting from reduced genetic expressions of ITPKC in KS would promote IP3, which increases Ca2+ release. Hg2+ increases catecholamine levels through the inhibition of S-adenosylmethionine and subsequently catechol-O-methyltransferase (COMT), while a single nucleotide polymorphism of the COMT gene (rs769224) was recently found to be significantly associated with the development of coronary artery lesions in KS. Accumulation of norepinephrine or epinephrine would potentiate Hg2+-induced calcium influx by increasing IP3 production and increasing the permeability of cardiac sarcolemma to Ca2+. Norepinephrine and epinephrine also promote the secretion of atrial natriuretic peptide, a potent vasodilator that suppresses the release of vasoconstrictors. Elevated catecholamine levels can induce hypertension and tachycardia, while increased arterial pressure and a rapid heart rate would promote arterial vasodilation and subsequent fatal thromboses, particularly in tandem. Genetic risk factors may explain why only a susceptible subset of children develops KS although mercury exposure from methylmercury in fish or thimerosal in pediatric vaccines is nearly ubiquitous. During the infantile acrodynia epidemic, only 1 in 500 children developed acrodynia whereas mercury exposure was very common due to the use of teething powders. This hypothesis mirrors the leading theory for KS in which a widespread infection only induces KS in susceptible children. Acrodynia can mimic the clinical picture of KS, leading to its inclusion in the differential diagnosis for KS. Catecholamine levels are often elevated in acrodynia and may also play a role in KS. We conclude that KS may be the acute febrile form of acrodynia.
C1 [Deth, Richard] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.
   [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan.
   [Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
RP Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, 123 Dapei Rd, Kaohsiung, Taiwan.
EM erickuo48@yahoo.com.tw
RI Kuo, Ho-Chang/AAQ-6644-2020
OI Kuo, Ho-Chang/0000-0002-3295-2984
CR ADLER R, 1982, J PEDIATR-US, V101, P967, DOI 10.1016/S0022-3476(82)80023-1
   ASCHNER M, 1989, AM J DIS CHILD, V143, P1133
   Bang Sunhee, 2011, Korean J Pediatr, V54, P340, DOI 10.3345/kjp.2011.54.8.340
   Beck C, 2004, PEDIATR DERMATOL, V21, P254, DOI 10.1111/j.0736-8046.2004.21314.x
   BENY JL, 1990, EUR J PHARMACOL, V185, P235, DOI 10.1016/0014-2999(90)90647-O
   Brannan EH, 2012, PEDIATR EMERG CARE, V28, P812, DOI 10.1097/PEC.0b013e3182628a05
   Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611
   Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072
   Mora FJC, 2009, AN PEDIATR, V71, P371, DOI 10.1016/j.anpedi.2009.06.027
   Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P179, DOI 10.1097/01.inf.0000250686.70233.8e
   Chakrabartty S, 2009, INDIAN PEDIATR, V46, P648
   CHEEK D B, 1951, Med J Aust, V2, P6
   CHEEK DB, 1953, J PEDIATR-US, V42, P239, DOI 10.1016/S0022-3476(53)80220-9
   Chi H, 2010, HUM MOL GENET, V19, P1147, DOI 10.1093/hmg/ddp586
   Cho SY, 2011, ANN CLIN LAB SCI, V41, P360
   CRACK P, 1992, BRIT J PHARMACOL, V107, P566, DOI 10.1111/j.1476-5381.1992.tb12784.x
   Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2
   Denny MF, 1996, NEUROTOXICOLOGY, V17, P47
   Dixit M, 2013, J BIOL CHEM, V288, P4194, DOI 10.1074/jbc.M112.423293
   Edwards DH, 2008, ARTERIOSCL THROM VAS, V28, P1774, DOI 10.1161/ATVBAHA.108.172692
   Falcini F, 1999, ENDOTHELIUM-NEW YORK, V6, P209, DOI 10.3109/10623329909053411
   Falcini F, 1996, J RHEUMATOL, V23, P1798
   Forstermann U, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17B, P1108
   FORSTERMANN U, 1986, N-S ARCH PHARMACOL, V334, P501, DOI 10.1007/BF00569393
   FUJIWARA T, 1990, AM HEART J, V120, P612, DOI 10.1016/0002-8703(90)90019-T
   Fukazawa R, 2004, PEDIATR RES, V56, P597, DOI 10.1203/01.PDR.0000139426.16381.C8
   Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881
   HARE MF, 1995, J PHARMACOL EXP THER, V272, P1016
   Hisatome I, 2000, BIOPHYS J, V79, P1336, DOI 10.1016/S0006-3495(00)76386-7
   이효진, 2009, Clinical and Experimental Pediatrics, V52, P87
   Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187
   Huang YC, 2010, INT J IMMUNOGENET, V37, P439, DOI 10.1111/j.1744-313X.2010.00943.x
   Inoue N, 2010, CLIN CHIM ACTA, V411, P267, DOI 10.1016/j.cca.2009.11.020
   Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889
   Kawamura T, 2000, PEDIATR INT, V42, P241, DOI 10.1046/j.1442-200x.2000.01225.x
   KAWASAKI T, 1975, PEDIATRICS, V56, P336
   Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996
   Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981
   Kishimoto S, 2011, PEDIATR INT, V53, P736, DOI 10.1111/j.1442-200X.2011.03351.x
   Kudoh A, 2003, JPN HEART J, V44, P547, DOI 10.1536/jhj.44.547
   Kuo HC, 2011, J CLIN IMMUNOL, V31, P650, DOI 10.1007/s10875-011-9524-8
   Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370
   Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154
   Kurotobi S, 2005, PEDIATR CARDIOL, V26, P425, DOI 10.1007/s00246-004-0812-4
   Lim Goh-Woon, 2010, Korean Circ J, V40, P507, DOI 10.4070/kcj.2010.40.10.507
   Lim YJ, 2012, INDIAN J PEDIAT
   Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e
   Lou J, 2012, MOL BIOL REP, V39, P11137, DOI 10.1007/s11033-012-2022-0
   Martindale W, 1982, EXTRA PHARMACOPOEIA, V2
   Mason WH, 1999, CLIN INFECT DIS, V28, P169, DOI 10.1086/515133
   MATUCCICERINIC M, 1992, J LAB CLIN MED, V120, P428
   McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796
   Michaeli-Yossef Y, 2007, PEDIATR NEPHROL, V22, P903, DOI 10.1007/s00467-007-0430-5
   Mori J, 2011, PEDIATR INT, V53, P354, DOI 10.1111/j.1442-200X.2010.03264.x
   Mutter J, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-2
   Nakamura Y, 2004, PEDIATR INT, V46, P33, DOI 10.1111/j.1442-200X.2004.01840.x
   Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126
   No SJ, 2013, PEDIATR CARDIOL, V34, P286, DOI 10.1007/s00246-012-0440-3
   Ohta M, 1999, Rinsho Byori, V47, P408
   Ohta S, 2002, EUR J PEDIATR, V161, P631, DOI 10.1007/s00431-002-1050-5
   Okada Y, 2004, J INFECTION, V48, P199, DOI 10.1016/j.jinf.2003.08.002
   Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45
   Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59
   Onouchi Y, 2012, CIRC J, V76, P1581, DOI 10.1253/circj.CJ-12-0568
   Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176
   ORLOWSKI JP, 1980, PEDIATRICS, V66, P633
   Park YW, 2011, PEDIATR INT, V53, P36, DOI 10.1111/j.1442-200X.2010.03178.x
   Peng Q, 2012, PEDIATR CARDIOL, V33, P1046, DOI 10.1007/s00246-012-0223-x
   Peng Qian, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P644, DOI 10.3760/cma.j.issn.1003-9406.2011.06.010
   ROSENBLUM WI, 1992, J CEREBR BLOOD F MET, V12, P703, DOI 10.1038/jcbfm.1992.96
   Shim YH, 2006, J KOREAN MED SCI, V21, P208, DOI 10.3346/jkms.2006.21.2.208
   Sokolow S, 2011, CELL CALCIUM, V49, P208, DOI 10.1016/j.ceca.2010.12.008
   Staiano RI, 2013, ADV EXP MED BIOL, V961, P317, DOI 10.1007/978-1-4614-4756-6_27
   Stoiber T, 2004, MUTAT RES-GEN TOX EN, V563, P97, DOI 10.1016/j.mrgentox.2004.06.009
   Sun Yu-Ping, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P169
   Takeuchi D, 2007, CIRC J, V71, P357, DOI 10.1253/circj.71.357
   Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597
   Thier R, 2003, TOXICOL LETT, V140, P75, DOI 10.1016/S0378-4274(02)00502-7
   Torres AD, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e34
   Tremoulet AH, 2012, J PEDIATR-US, V161, P506, DOI 10.1016/j.jpeds.2012.02.048
   United Nations Environmental Programme, 2002, GLOB MERC ASS REP
   Toru W, 2006, PEDIATR NEPHROL, V21, P778, DOI 10.1007/s00467-006-0086-6
   Wu SF, 2004, PEDIATR CARDIOL, V25, P529, DOI 10.1007/s00246-003-0662-5
   Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006
   Yoshikawa H, 2012, PEDIATR INFECT DIS J, V31, P523, DOI 10.1097/INF.0b013e3182463879
   Zhang Qing-you, 2006, Zhonghua Er Ke Za Zhi, V44, P886
NR 86
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 581
EP 591
DI 10.4070/kcj.2013.43.9.581
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900001
PM 24174958
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KS
   Kim, SY
   Choi, JH
   Joo, SJ
   Kim, DW
   Cho, MC
AF Kim, Ki-Seok
   Kim, Song Yi
   Choi, Joon Hyeok
   Joo, Seung Jae
   Kim, Dong Woon
   Cho, Myeong Chan
TI Bortezomib Reduces Neointimal Hyperplasia in a Rat Carotid Artery Injury
   Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary restenosis; Angioplasty; Proteasome; Nuclear factor kappa B
ID PROTEASOME INHIBITOR BORTEZOMIB; KAPPA-B; INTIMAL HYPERPLASIA; BALLOON
   ANGIOPLASTY; OXIDATIVE STRESS; PROLIFERATION; RESTENOSIS; TARGET
AB Background and Objectives: The ubiquitin-proteasome system is the major intracellular protein degradation pathway in the eukaryotic cells. Bortezomib inhibits 26S proteasome-induced I-kappa B alpha degradation and suppresses nuclear factor-kappa B (NF-kappa B) activation. We examined the effect of bortezomib on neointima formation after of a rat carotid artery balloon injury.
   Materials and Methods: After carotid artery balloon denudation, bortezomib was immediately administered by tail vein injection (systemic treatment) and by using an F-127 pluronic gel (perivascular treatment). Two weeks after the injury, we compared the degree of neointima formation in the carotid artery and the tissue expression patterns of NF-kappa B and I-kappa B alpha.
   Results: The systemic treatment group exhibited a 29% reduction in neointima volume at two weeks after the balloon injury. On the western blot analysis, the bortezomib group exhibited an increased I-kappa B alpha expression, which suggested the inhibition of I-kappa B alpha degradation. On immunofluorescence analysis, the nuclear import of NF-kappa B was clearly decreased in the systemic bortezomib group. The perivascular bortezomib treatment group exhibited a significant reduction in the neointimal area (0.21 +/- 0.06 mm(2) vs. 0.06 +/- 0.01 mm(2), p<0.05), the neointima/media area ratio (1.43 +/- 0.72 vs. 0.47 +/- 0.16, p<0.05) and the % area stenosis (45.5 +/- 0.72% vs. 14.5 +/- 0.05%, p<0.05) compared with the control group. In situ vascular smooth muscle cell proliferation at 2 days after the injury was significantly inhibited (24.7 +/- 10.9% vs. 10.7 +/- 4.7%, p<0.05).
   Conclusion: Bortezomib suppressed NF-kappa B activation through the inhibition of I-kappa B alpha degradation, and significantly reduced neointima formation in a rat carotid artery injury model. These data suggested that bortezomib represented a new potent therapeutic agent for the prevention of restenosis.
C1 [Kim, Ki-Seok; Kim, Song Yi; Choi, Joon Hyeok; Joo, Seung Jae] Jeju Natl Univ, Coll Med, Dept Med, Cheju 690716, South Korea.
   [Kim, Dong Woon; Cho, Myeong Chan] Chungbuk Natl Univ, Coll Med, Dept Med, Cheongju, South Korea.
RP Kim, KS (corresponding author), Jeju Natl Univ, Coll Med, Dept Med, 15 Aran 13 Gil, Cheju 690716, South Korea.
EM kiseok@jejunu.ac.kr
FU Korean Society of Circulation
FX This study was supported by a grant from the Korean Society of
   Circulation (2004).
CR AUTIERI MV, 1995, BIOCHEM BIOPH RES CO, V213, P827, DOI 10.1006/bbrc.1995.2204
   Azevedo LCP, 2000, CARDIOVASC RES, V47, P436, DOI 10.1016/S0008-6363(00)00091-2
   Bohorquez M, 1999, J COLLOID INTERF SCI, V216, P34, DOI 10.1006/jcis.1999.6273
   Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje
   CLOWES AW, 1985, LAB INVEST, V52, P611
   Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2
   Elliott PJ, 2001, AM J CLIN PATHOL, V116, P637
   Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200
   GLAGOV S, 1994, CIRCULATION, V89, P2888, DOI 10.1161/01.CIR.89.6.2888
   He XP, 2008, TRANSPL P, V40, P1722, DOI 10.1016/j.transproceed.2008.01.063
   Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015
   Hussein MA, 2006, EXPERT OPIN PHARMACO, V7, P767, DOI 10.1517/14656566.7.6.767
   ITOH H, 1995, SURG TODAY, V25, P293, DOI 10.1007/BF00311249
   Jackson G, 2005, CANCER TREAT REV, V31, P591, DOI 10.1016/j.ctrv.2005.10.001
   Kim DW, 2004, CIRCULATION, V109, P1558, DOI 10.1161/01.CIR.0000124063.74526.BE
   Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119
   Pekol T, 2005, DRUG METAB DISPOS, V33, P771, DOI 10.1124/dmd.104.002956
   Pollman MJ, 1999, CIRC RES, V84, P113
   Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445
   Schwartz Rowena, 2004, Oncology (Williston Park), V18, P14
   Sinn DI, 2007, NEUROSCI RES, V58, P12, DOI 10.1016/j.neures.2007.01.006
   STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105
   Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585
   Yeh ETH, 2002, CIRCULATION, V105, P408, DOI 10.1161/circ.105.4.408
   Zahradka P, 2002, J MOL CELL CARDIOL, V34, P1609, DOI 10.1006/jmcc.2002.2111
   Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015
NR 26
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 592
EP U72
DI 10.4070/kcj.2013.43.9.592
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900002
PM 24174959
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, JJ
   Kim, JY
   Choi, EY
   Min, PK
   Cho, M
   Lee, DL
   Hong, SY
   Yoon, YW
   Lee, BK
   Hong, BK
   Rim, SJ
   Kwon, HM
AF Cha, Jung-Joon
   Kim, Jong-Youn
   Choi, Eui-Young
   Min, Pil-Ki
   Cho, Minhee
   Lee, Da-Lyung
   Hong, Sung-Yu
   Yoon, Young-Won
   Lee, Byoung Kwon
   Hong, Bum-Kee
   Rim, Se-Joong
   Kwon, Hyuck Moon
TI Effect of Abciximab on the Levels of Circulating Microparticles in
   Patients with Acute Myocardial Infarction Treated by Primary Angioplasty
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cell-derived microparticles; Myocardial infarction; Platelet aggregation
   inhibitors
ID ACUTE CORONARY SYNDROMES; ENDOTHELIAL MICROPARTICLES; ELEVATED LEVELS;
   ANTAGONISTS; ACTIVATION; ADHESION; ARTERY
AB Background and Objectives: We investigated the effect of the additional use of abciximab during percutaneous coronary intervention (PCI) on the level of procoagulant microparticles (MPs) in patients with ST-segment elevation myocardial infarction (STEMI) who had undergone primary PCI.
   Subjects and Methods: In this study, we studied 86 patients with STEMI (72 men, age 58 +/- 13) who had undergone primary PCI. The decision to administer abciximab immediately prior to PCI was left to the discretion of the operator. Blood samples for analysis of MPs were obtained from the femoral artery before and after PCI. MPs with procoagulant potential were measured using a commercial kit. The cellular origins of MPs were determined by antigenic capture with specific antibodies.
   Results: Procoagulant MPs captured onto annexin V were not changed significantly after PCI {13.4 +/- 13.2 nM vs. 13.2 +/- 16.1 nM phosphatidylserine equivalent (PS eq), p=0.479}. Abciximab was used in 30 of 86 patients (35%) immediately prior to PCI. In patients who had undergone PCI without abciximab, no significant change in the level of MPs was observed after PCI. However, in the abciximab group, the level of circulating MPs was significantly decreased after PCI (12.0 +/- 10.7 nM vs. 7.8 +/- 11.7 nM PS eq, p=0.018). Levels of endothelial- and platelet- derived MPs also showed a significant reduction after PCI in the abciximab group.
   Conclusion: Primary PCI with additional abciximab significantly reduced the level of procoagulant MPs regardless of their cellular origins in patients with STEMI.
C1 [Cha, Jung-Joon; Kim, Jong-Youn; Choi, Eui-Young; Min, Pil-Ki; Cho, Minhee; Yoon, Young-Won; Lee, Byoung Kwon; Hong, Bum-Kee; Rim, Se-Joong; Kwon, Hyuck Moon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, Seoul 135720, South Korea.
   [Min, Pil-Ki; Yoon, Young-Won] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 135720, South Korea.
   [Lee, Da-Lyung; Hong, Sung-Yu] Yonsei Univ Hlth Syst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea.
RP Min, PK (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cardiol Div,Dept Internal Med, 211 Eonju Ro, Seoul 135720, South Korea.
EM cardioblues@yuhs.ac
OI Cha, Jung-Joon/0000-0002-8299-1877
FU Korean Society of Cardiology (Industrial-Educational Cooperation)
FX This study was supported by grants from the Korean Society of Cardiology
   (Industrial-Educational Cooperation, 2010).
CR Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   Amabile N, 2009, J HEART LUNG TRANSPL, V28, P1081, DOI 10.1016/j.healun.2009.06.005
   Aymong ED, 2002, CIRCULATION, V105, P2981, DOI 10.1161/01.CIR.0000019905.18467.07
   Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0
   Bernal-Mizrachi L, 2004, INT J CARDIOL, V97, P439, DOI 10.1016/j.ijcard.2003.10.029
   Gawaz M, 1997, CIRCULATION, V96, P1809, DOI 10.1161/01.CIR.96.6.1809
   Jeske WP, 1997, THROMB RES, V88, P271, DOI 10.1016/S0049-3848(97)00254-5
   Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x
   Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047
   Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053
   Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841
   Min PK, 2013, ATHEROSCLEROSIS, V227, P323, DOI 10.1016/j.atherosclerosis.2013.01.032
   Morel O, 2004, J THROMB HAEMOST, V2, P1118, DOI 10.1111/j.1538-7836.2004.00805.x
   Morel O, 2009, ATHEROSCLEROSIS, V204, P636, DOI 10.1016/j.atherosclerosis.2008.10.039
   Nozaki T, 2010, EUR J HEART FAIL, V12, P1223, DOI 10.1093/eurjhf/hfq145
   Puddu Paolo, 2010, Can J Cardiol, V26, P140
   Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x
   Simon DI, 1997, ARTERIOSCL THROM VAS, V17, P528, DOI 10.1161/01.ATV.17.3.528
   VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5
   Yeh CH, 1998, BLOOD, V92, P3268, DOI 10.1182/blood.V92.9.3268.421k41_3268_3276
NR 20
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 600
EP 606
DI 10.4070/kcj.2013.43.9.600
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900003
PM 24174960
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YJ
   Jeong, MH
   Choi, YH
   Park, SY
   Rhew, SH
   Jeong, HC
   Cho, JY
   Jang, SY
   Lee, KH
   Park, KH
   Sim, DS
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Park, HW
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Hong, Young Joon
   Jeong, Myung Ho
   Choi, Yun Ha
   Park, Soo Young
   Rhew, Si Hyun
   Jeong, Hae Chang
   Cho, Jae Yeong
   Jang, Su Young
   Lee, Ki Hong
   Park, Keun Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Comparison of Coronary Plaque Components between Non-Culprit Lesions in
   Patients with Acute Coronary Syndrome and Target Lesions in Patients
   with Stable Angina: Virtual Histology-Intravascular Ultrasound Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Angina, stable; Atherosclerotic plaque;
   Ultrasonography, intravascular
ID OPTICAL COHERENCE TOMOGRAPHY; ELEVATION MYOCARDIAL-INFARCTION;
   RADIOFREQUENCY DATA-ANALYSIS; ASSOCIATION TASK-FORCE; INFLAMMATORY
   MARKERS; PRACTICE GUIDELINES; DEATH; ATHEROSCLEROSIS; CLASSIFICATION;
   MANAGEMENT
AB Background and Objectives: The differences in plaque characteristics between non-culprit lesions (NCL) in acute coronary syndrome (ACS) patients (ACS-NCL) and target lesions (TL) in stable angina (SA) patients (SA-TL) are not well understood. We used a virtual histology- intravascular ultrasound (VH-IVUS) to compare the plaque components between ACS-NCL and SA-TL.
   Subjects and Methods: We compared VH-IVUS findings between 290 ACS-NCL and 276 SA-TL. VH-IVUS classified the color-coded tissue into four major components: green (fibrotic); yellow-green (fibro-fatty); white {dense calcium (DC)}; and red {necrotic core (NC)}. Thin-cap fibroatheroma (TCFA) was defined as a NC >= 10% of the plaque area in at least 3 consecutive frames without overlying fibrous tissue in the presence of >= 40% plaque burden.
   Results: Although the plaque burden was significantly smaller (52 +/- 13% vs. 54 +/- 14%, p=0.044), ACS-NCL had a greater %NC area (17.9 +/- 11.6% vs. 14.3 +/- 8.7%, p<0.001) and %DC area (9.7 +/- 9.8% vs. 8.1 +/- 8.0%, p=0.032) compared with SA-TL at the minimum lumen site. By volumetric analysis, ACS-NCL had a greater %NC volume (15.8 +/- 9.2% vs. 13.9 +/- 7.4%, p=0.006) compared with SA-TL. TCFA was observed more frequently in ACS-NCL compared with SA-TL (27.6% vs. 18.1%, p=0.032). Independent predictors of TCFA by multivariate analysis were ACS {odds ratio (OR): 2.204, 95% CI: 1.321-3.434, p=0.021} and high-sensitivity C-reactive protein (OR: 1.101; 95% CI 1.058-1.204, p=0.035).
   Conclusion: Although the plaque burden was significantly smaller, ACL-NCL had more vulnerable plaque components compared with SATL, and ACS and high-sensitivity C-reactive protein were the independent predictors of TCFA.
C1 Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   Chonnam Natl Univ Hosp, Korea Cardiovasc Stent Inst, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Acute Myocardial Infarct Registry, 671 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Society of Interventional Cardiology; Bio & Medical Technology
   Development Program of the National Research Foundation (NRF) - Korean
   government (MEST) [2012M3A9C6049744]; National Research Foundation of
   Korea Grant - Korean Government [2011-0008875]; Chonnam National
   University Hospital Research Institute of Clinical Medicine, Republic of
   Korea [CRI 11080-21]
FX This study was supported by a grant of the Korean Society of
   Interventional Cardiology, and the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF), funded by the Korean
   government (MEST) (2012M3A9C6049744), the National Research Foundation
   of Korea Grant, funded by the Korean Government (2011-0008875), and the
   Chonnam National University Hospital Research Institute of Clinical
   Medicine (CRI 11080-21), Republic of Korea.
CR Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b
   Bouki KP, 2012, INT J CARDIOL, V154, P287, DOI 10.1016/j.ijcard.2010.09.059
   Burke AP, 2002, CIRCULATION, V105, P2019, DOI 10.1161/01.CIR.0000015507.29953.38
   DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801
   FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657
   Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   Hong YJ, 2011, KOREAN CIRC J, V41, P440, DOI 10.4070/kcj.2011.41.8.440
   Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P339, DOI 10.1016/j.jcmg.2008.10.017
   Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69
   Kato K, 2012, CIRC-CARDIOVASC IMAG, V5, P433, DOI 10.1161/CIRCIMAGING.112.973701
   Kubo T, 2010, AM J CARDIOL, V105, P318, DOI 10.1016/j.amjcard.2009.09.032
   Kunimasa T, 2005, CIRC J, V69, P1346, DOI 10.1253/circj.69.1346
   Li QX, 2010, HEART, V96, P196, DOI 10.1136/hrt.2009.175455
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Missel E, 2008, AM J CARDIOL, V101, P573, DOI 10.1016/j.amjcard.2007.10.018
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nakachi T, 2008, CIRC J, V72, P1953, DOI 10.1253/circj.CJ-08-0185
   O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6
   Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936
   Park JP, 2010, CIRC J, V74, P332, DOI 10.1253/circj.CJ-09-0570
   Roberts WL, 2001, CLIN CHEM, V47, P418
   Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Yamamoto M, 2009, CIRC J, V73, P497, DOI 10.1253/circj.CJ-08-0762
   1994, CIRCULATION, V89, P1545
NR 27
TC 7
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 607
EP 614
DI 10.4070/kcj.2013.43.9.607
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900004
PM 24174961
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, SH
   Park, SD
   Woo, SI
   Kim, DH
   Park, KS
   Kwan, J
AF Shin, Sung-Hee
   Park, Sang-Don
   Woo, Seong-Il
   Kim, Dae-Hyeok
   Park, Keum-Soo
   Kwan, Jun
TI Utility of Global Strain by Two-Dimensional and Three-Dimensional
   Speckle Tracking for Assessing Left Ventricular Diastolic Function:
   Comparison with Pressure Wire Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diastole; Echocardiography; Ventricular pressure
ID PRESERVED EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; LEFT ATRIAL
   VOLUME; FILLING PRESSURES; HEART-FAILURE; POWERFUL PREDICTOR;
   ECHOCARDIOGRAPHY; SURVIVAL; RELAXATION
AB Background and Objectives: We evaluated the utility of two-dimensional (2D) and three-dimensional (3D) left ventricular (LV) global myocardial deformity parameters for assessing LV diastolic function by comparing invasive measures of LV performance.
   Subjects and Methods: Echocardiography and LV pressure were assessed in 39 patients. Myocardial LV longitudinal, circumferential, and radial deformations, as well as area strain, were evaluated utilizing 2D and 3D speckle tracking software. The 2D early diastolic strain rate (2D-SRe) was measured from the 3 apical and 3 short axis views. The 3D diastolic index (3D-DI) was calculated by the % change of global strain during the first one-third of the diastolic period. LV end diastolic pressure (LVEDP) and the rate of LV pressure change (dP/dt) were collected using a pressure-conducted catheter and tau was calculated.
   Results: dP/dt(min) were related to early mitral annular velocity (e'), 2D-SRelong, 2D-SReradial, as well as 3D-DIlong, and 3D-DIas. Additionally, LVEDP was associated with the ratio of mitral early diastolic velocity (E) to 2D-SRelong, 2D-SRecirc, 2D-SReradial, 3D-DIlong, 3D-DIcirc, and 3D-DIas. E/2D-SRelong, E/2D-SReradial, E/3D-DIlong, and E/3D-DIas were comparable with E/e' in predicting patients with elevated LVEDP. Among those patients with E/e' of 8 to 15, E/3D-DIlong provided incremental value in identifying those with LVEDP >= 15 mm Hg.
   Conclusion: 2D-SRelong, 2D-SReradial, 3D-DIlong, and 3D-DIas were related to LV relaxation, and the ratios of E to those parameters were associated with LVEDP. In addition, among patients with indeterminate E/e', E/3D-DIlong offered incremental value in predicting elevated LVEDP, suggesting it may provide supplementary information in the evaluation of LV diastolic function.
C1 [Shin, Sung-Hee; Park, Sang-Don; Woo, Seong-Il; Kim, Dae-Hyeok; Park, Keum-Soo; Kwan, Jun] Inha Univ, Coll Med, Div Cardiol, Inchon 400711, South Korea.
RP Shin, SH (corresponding author), Inha Univ, Coll Med, Div Cardiol, 27 Inhang Ro, Inchon 400711, South Korea.
EM sshin@inha.ac.kr
FU Korean Society of Cardiology; Inha University Research Grant
   [INHA40899-01]
FX This study was supported by a grant (2010) from the Korean Society of
   Cardiology and an Inha University Research Grant (INHA40899-01).
CR Anavekar NS, 2006, J AM SOC ECHOCARDIOG, V19, P28, DOI 10.1016/j.echo.2005.07.011
   Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Hillis GS, 2004, J AM COLL CARDIOL, V43, P360, DOI 10.1016/j.jacc.2003.07.044
   Ishii K, 2009, J AM COLL CARDIOL, V54, P1589, DOI 10.1016/j.jacc.2009.06.030
   Marwick TH, 2006, J AM COLL CARDIOL, V47, P1313, DOI 10.1016/j.jacc.2005.11.063
   Moller JE, 2008, CIRCULATION, V117, P2591, DOI 10.1161/CIRCULATIONAHA.107.738625
   Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43
   Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015
   Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6
   Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
   Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623
   Ommen SR, 2000, CIRCULATION, V102, P1788
   Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256
   Park TH, 2006, AM J PHYSIOL-HEART C, V290, pH724, DOI 10.1152/ajpheart.00714.2005
   Penicka M, 2010, J AM COLL CARDIOL, V55, P1700, DOI 10.1016/j.jacc.2009.11.076
   Pislaru C, 2004, CIRCULATION, V109, P2905, DOI 10.1161/01.CIR.0000129311.73402.EF
   Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054
   Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480
   Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0
   STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4
   Urbano-Moral JA, 2013, EUR HEART J CARDIOVA
   Urbano-Moral JA, 2012, ECHOCARDIOGR-J CARD, V29, P997, DOI 10.1111/j.1540-8175.2012.01773.x
   Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882
NR 23
TC 5
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 615
EP 621
DI 10.4070/kcj.2013.43.9.615
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900005
PM 24174962
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Kim, H
   Lee, JP
   Choi, SW
   Cho, HO
   Shin, HW
   Park, HS
   Cho, YK
   Nam, CW
   Hur, SH
   Kim, YN
   Kim, KB
AF Yoon, Hyuck-Jun
   Kim, Hyungseop
   Lee, Jae-Pil
   Choi, Sang-Woong
   Cho, Hyun-Ok
   Shin, Hong-Won
   Park, Hyoung-Seob
   Cho, Yun-Kyeong
   Nam, Chang-Wook
   Hur, Seung-Ho
   Kim, Yoon-Nyun
   Kim, Kwon-Bae
TI The Efficacy of the Cystatin C Based Glomerular Filtration Rate in the
   Estimation of Safe Contrast Media Volume
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contrast media; Cystatin C; Glomerular filtration rate; Acute kidney
   injury
ID PERCUTANEOUS CORONARY INTERVENTION; CREATININE CLEARANCE RATIO;
   ACUTE-RENAL-FAILURE; INDUCED NEPHROPATHY; SERUM CREATININE; CANADIAN
   ASSOCIATION; RISK-FACTORS; PREDICTION; MARKER; PREVENTION
AB Background and Objectives: The risk of contrast-induced nephropathy (CIN) is significantly influenced by baseline renal function and the amount of contrast media (CM). We evaluated the usefulness of the cystatin C (CyC) based estimated glomerular filtration rate (eGFR(CyC)) in the prediction of CIN and to determine the safe CM dosage.
   Subjects and Methods: We prospectively enrolled a total of 723 patients who received percutaneous coronary intervention (PCI) and investigated the clinical factors associated with the development of CIN. Renal function was calculated as eGFRCyC and a modified diet in the renal disease (MDRD) equation, respectively. Systemic exposure of CM was calculated as CM volume to eGFR ratio. We conducted a regression analysis to evaluate the predictive role of CM volume to eGFR(CyC) for the risk of CIN.
   Results: The incidence of CIN was 4.0% (29/723). The patients with CIN had a lower hemoglobin level, decreased renal function, and a higher CyC value, and had greater CM exposure. Through multivariate regression analyses, hemoglobin {odds ratio (OR) 0.743, p= 0.032}, CM volume/eGFR(CyC) (OR 1.697, p= 0.006) and CM volume/MDRD (OR 2.275, p<0.001) were found to be independent predictors for CIN. In the receiver operating characteristic curve analysis, fair discrimination for CIN was found at a CM volume/eGFR(CyC) level of 4.493 (C-statics=0.814), and at this value, the sensitivity and specificity were 79.3% and 80.0%, respectively.
   Conclusion: Both the CM volume/MDRD and CM volume/eGFR(CyC) method would be simple, useful indicators for determining the safe CM-dose based on eGFR value before PCI. However, there was no significantly different predictive value between creatinine and CyC based GFR estimations.
C1 [Yoon, Hyuck-Jun; Kim, Hyungseop; Lee, Jae-Pil; Choi, Sang-Woong; Shin, Hong-Won; Park, Hyoung-Seob; Cho, Yun-Kyeong; Nam, Chang-Wook; Hur, Seung-Ho; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Taegu 700712, South Korea.
   [Cho, Hyun-Ok] Andong Med Grp, Dept Cardiol, Andong, South Korea.
RP Kim, H (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, 56 Dalseong Ro, Taegu 700712, South Korea.
EM khyungseop@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
FU Korean Society of Cardiology
FX This study was supported by a research grant from the Korean Society of
   Cardiology (2009).
CR Altmann DB, 1997, J INTERV CARDIOL, V10, P113, DOI 10.1111/j.1540-8183.1997.tb00018.x
   Benko A, 2007, CAN ASSOC RADIOL J, V58, P79
   Chong E, 2010, ANN ACAD MED SINGAP, V39, P374
   CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056
   Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487
   Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6
   Hatano M, 1991, Nihon Jinzo Gakkai Shi, V33, P1097
   Kim U, 2008, KOREAN CIRC J, V38, P301
   KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921
   Laskey WK, 2007, J AM COLL CARDIOL, V50, P584, DOI 10.1016/j.jacc.2007.03.058
   Lee Kang Hyu, 2010, Korean Circ J, V40, P68, DOI 10.4070/kcj.2010.40.2.68
   Lepanto L, 2011, CAN ASSOC RADIOL J, V62, P238, DOI 10.1016/j.carj.2010.07.008
   LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019
   Mehran R, 2006, KIDNEY INT, V69, pS11, DOI 10.1038/sj.ki.5000368
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Murphy SW, 2000, J AM SOC NEPHROL, V11, P177
   NEWMAN DJ, 1995, KIDNEY INT, V47, P312, DOI 10.1038/ki.1995.40
   Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854
   Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33
   Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073
   Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0
   Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431
   Weisbord SD, 2008, ARCH INTERN MED, V168, P1325, DOI 10.1001/archinte.168.12.1325
   Yoon HJ, 2011, KOREAN CIRC J, V41, P265, DOI 10.4070/kcj.2011.41.5.265
NR 30
TC 3
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 622
EP 627
DI 10.4070/kcj.2013.43.9.622
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900006
PM 24174963
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Ko, YG
   Lee, DY
   Choi, D
AF Kim, Jung-Ho
   Ko, Young-Guk
   Lee, Do-Yun
   Choi, Donghoon
TI Endovascular Repair of Aortoiliac Aneurysm Using Bifurcated Stent Grafts
   with Sandwich Technique for Preserving the Internal Iliac Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endovascular procedures; Stents; Aortic aneurysm; Iliac; Aneurysm
ID EMBOLIZATION; OCCLUSION
AB In this case, we describe a case of a 76-year-old male with extensive aortoiliac aneurysms treated by endovascular aneurysm repair using the sandwich technique in order to preserve left internal iliac artery perfusion. The sandwich technique refers to the deployment of multiple paralleled stent grafts into main distal and side branches in overlapping with a single proximal stent graft. The procedure was successfully performed without complications. Post-procedural CT angiography demonstrated patent stent grafts without any endoleak. The strengths and limitations of the sandwich technique need to be investigated in large-scale, long-term clinical trials.
C1 [Kim, Jung-Ho; Ko, Young-Guk; Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Lee, Do-Yun] Yonsei Univ Hlth Syst, Severance Hosp, Dept Radiol, Seoul 120752, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM ygko@yuhc.ac
OI Ko, Young-Guk/0000-0001-7748-5788; Choi, Donghoon/0000-0002-2009-9760;
   Ha, Jong-Won/0000-0002-8260-2958; Kim, Jung Ho/0000-0002-5033-3482
CR Armon MP, 1998, EUR J VASC ENDOVASC, V15, P255, DOI 10.1016/S1078-5884(98)80186-X
   Cheng SWK, 2004, J ENDOVASC THER, V11, P605, DOI 10.1583/04-1268R.1
   Coppi G, 2010, J VASC INTERV RADIOL, V21, P1579, DOI 10.1016/j.jvir.2010.05.027
   Falkensammer J, 2007, J ENDOVASC THER, V14, P619, DOI 10.1583/1545-1550(2007)14[619:NHOTIA]2.0.CO;2
   Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5
   Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7
   Karch LA, 2000, J VASC SURG, V32, P676, DOI 10.1067/mva.2000.109750
   Lobato AC, 2013, J VASC SURG, V57, p26S, DOI 10.1016/j.jvs.2012.09.081
   Lobato AC, 2012, J ENDOVASC THER, V19, P691, DOI 10.1583/JEVT-12-4023R.1
   Lobato AC, 2011, J ENDOVASC THER, V18, P106, DOI 10.1583/10-3320.1
   Rayt HS, 2008, CARDIOVASC INTER RAD, V31, P728, DOI 10.1007/s00270-008-9319-3
   Razavi MK, 2000, J VASC INTERV RADIOL, V11, P561, DOI 10.1016/S1051-0443(07)61606-6
   Ricci C, 2012, CARDIOVASC INTER RAD, V35, P1195, DOI 10.1007/s00270-012-0378-0
   Riesenman PJ, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.10.004
   van Groenendael L, 2009, CATHETER CARDIO INTE, V73, P156, DOI 10.1002/ccd.21763
   Yano OJ, 2001, J VASC SURG, V34, P204, DOI 10.1067/mva.2001.115380
   Yoshida Rde A, 2012, ANN VASC SURG, V26
NR 17
TC 1
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 628
EP 631
DI 10.4070/kcj.2013.43.9.628
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900007
PM 24174964
OA Green Published
DA 2021-04-22
ER

PT J
AU Heo, SH
   Kang, MH
AF Heo, Seung Hye
   Kang, Min-Ho
TI A Case of Dilated Cardiomyopathy with Massive Left Ventricular Thrombus
   after Use of a Sibutramine-Containing Slimming Product
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sibutramine; Cardiomyopathy, dilated; Anti-obesity agents
ID ACUTE MYOCARDIAL-INFARCTION; QT INTERVAL PROLONGATION; CASE SERIES;
   OBESITY
AB Sibutramine, which acts as an anti-obesity drug by inhibiting reuptake of serotonin and norepinephrine, has now been banned due to cardiovascular adverse effects. However, despite being banned, it is not uncommon for people to purchase products with sibutramine or its analogues used as adulterants in non-prescription slimming products or health foods available on the internet. Sibutramine has been associated with rare but serious adverse reactions such as cardiac arrhythmia including QT interval prolongation, myocardial infarction, and cardiomyopathy, as well as increases in blood pressure and pulse rate. Here, we report a case of a 32-year-old male who presented with dilated cardiomyopathy with massive left ventricular thrombus after taking unauthorized sibutramine-containing slimming pills sold over the internet.
C1 [Heo, Seung Hye; Kang, Min-Ho] Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, Seoul 100032, South Korea.
RP Kang, MH (corresponding author), Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, 9 Mareunnae Ro, Seoul 100032, South Korea.
EM eukmh@naver.com
CR Cheung BMY, 2011, DRUG SAFETY, V34, P641, DOI 10.2165/11592040-000000000-00000
   Colman E, 2012, CIRCULATION, V125, P2156, DOI 10.1161/CIRCULATIONAHA.111.028381
   Ernest D, 2008, ANN PHARMACOTHER, V42, P1514, DOI 10.1345/aph.1L129
   Eroglu E, 2009, INT J CARDIOL, V137, pE43, DOI 10.1016/j.ijcard.2008.06.017
   Fernandez WG, 2010, MIL MED, V175, P622, DOI 10.7205/MILMED-D-10-00011
   Gomez-Barrado JJ, 2010, REV ESP CARDIOL, V63, P243, DOI 10.1016/S0300-8932(10)70047-6
   Harrison-Woolrych M, 2006, BRIT J CLIN PHARMACO, V61, P464, DOI 10.1111/j.1365-2125.2006.02574.x
   James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114
   Muller D, 2009, DTSCH ARZTEBL INT, V106, P218, DOI 10.3238/arztebl.2009.0218
   Poss J, 2010, DEUT MED WOCHENSCHR, V135, P965, DOI 10.1055/s-0030-1253684
   Sayin T, 2005, INT J CARDIOL, V99, P481, DOI 10.1016/j.ijcard.2003.11.060
   Scheen AJ, 2011, DIABETES CARE, V34, pS114, DOI 10.2337/dc11-s205
   Tang MHY, 2011, BRIT J CLIN PHARMACO, V71, P250, DOI 10.1111/j.1365-2125.2010.03822.x
   von Haehling S, 2007, EUR HEART J, V28, P2830, DOI 10.1093/eurheartj/ehm493
   Williams G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c824
   Yim KMA, 2008, CLIN TOXICOL, V46, P877, DOI 10.1080/15563650802136258
   Yuen Y. P., 2007, Hong Kong Medical Journal, V13, P216
NR 17
TC 5
Z9 5
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 632
EP 635
DI 10.4070/kcj.2013.43.9.632
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900008
PM 24174965
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YJ
   Kim, YJ
   Kim, SH
   Youn, YN
   Park, S
AF Kim, Young Ju
   Kim, Young Jin
   Kim, Se Hoon
   Youn, Young-Nam
   Park, Sungha
TI Primary Cardiac Angiofibroma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac tumor; Magnetic resonance imaging
ID TUMORS
AB Cardiac Angiofibroma is an uncommon intracardiac tumor. Thus far, only 4 cases of the rare intracardiac tumor have been reported. The present case-report describes an intracardiac angiofibroma in a 57-year-old healthy female. The patient was incidentally diagnosed with a left ventricle mass during echocardiography. We performed cardiac imaging, surgical excision and histological evaluation of the mass. The angiofibroma demonstrated features different from the relatively common cardiac tumors such as fibroma, myxoma and angiosarcoma. The cardiac MRI showed slightly high signal intensity on both T1 and T2, with the central core of lower signal intensity. The resected tumor was a whitish and rubbery mass. Histologically, the tumor showed the benign vascular proliferations associated with the surrounding collagen deposition.
C1 [Kim, Young Ju; Park, Sungha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Kim, Young Jin] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Radiol, Seoul 120752, South Korea.
   [Kim, Se Hoon] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Pathol, Seoul 120752, South Korea.
   [Youn, Young-Nam] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Cardiovasc Surg, Seoul 120752, South Korea.
RP Park, S (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM shpark0530@yuhs.ac
OI Kim, Se Hoon/0000-0001-7516-7372
CR Brechtel K, 1999, J CARDIOV MAGN RESON, V1, P159, DOI 10.3109/10976649909080845
   Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0
   Cao DB, 2012, EUR J CARDIO-THORAC, V41, P962, DOI 10.1093/ejcts/ezr077
   FUNARI M, 1991, J COMPUT ASSIST TOMO, V15, P953, DOI 10.1097/00004728-199111000-00009
   Jutley RS, 2006, J CARDIOVASC SURG, V47, P481
   KIRILLOV MM, 1986, KLIN MED MOSCOW+, V64, P120
   Satge D, 2005, FETAL DIAGN THER, V20, P44, DOI 10.1159/000081368
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 636
EP 639
DI 10.4070/kcj.2013.43.9.636
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900009
PM 24174966
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KN
   Cho, KI
   Kim, JJ
   Kang, JH
   Goo, JJ
   Lee, JY
   Kim, SM
AF Kim, Kyoung-Nyoun
   Cho, Kyoung-Im
   Kim, Jae-Joon
   Kang, Ji-Hoon
   Goo, Ja-Jun
   Lee, Ja-Young
   Kim, Seong-Man
TI A Case of Aorta-Right Atrial Tunnel Presented with an Asymptomatic
   Murmur
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta; Right atrium; Coronary vessel anomalies; Coronary angiography
AB Aorta-right atrial tunnel is a rare and distinct congenital anomaly. It is a vascular channel that originates from one of the sinuses of Valsalva with a tortuous course anterior or posterior to the ascending aorta, and terminates either in the superior vena cava or in the right atrium (RA). We report a 42-year-old female briefly with aorta-right atrial tunnel in which the left coronary artery arose from the tunnel and terminated into the RA.
C1 [Kim, Kyoung-Nyoun; Kim, Jae-Joon; Kang, Ji-Hoon; Goo, Ja-Jun; Lee, Ja-Young; Kim, Seong-Man] Maryknoll Med Ctr, Dept Internal Med, Div Cardiol, Pusan, South Korea.
   [Cho, Kyoung-Im] Kosin Univ, Sch Med, Dept Internal Med, Div Cardiol, Pusan 602702, South Korea.
RP Cho, KI (corresponding author), Kosin Univ, Sch Med, Dept Internal Med, Div Cardiol, 262 Gamcheon Ro, Pusan 602702, South Korea.
EM kyoungim74@gmail.com
CR Angelini P, 2007, CIRCULATION, V115, P1296, DOI 10.1161/CIRCULATIONAHA.106.618082
   Gajjar T, 2005, J THORAC CARDIOV SUR, V130, P1287, DOI 10.1016/j.jtcvs.2005.07.021
   Kalangos A, 2000, ANN THORAC SURG, V69, P635, DOI 10.1016/S0003-4975(99)01346-6
   Krishna CS, 2010, TEX HEART I J, V37, P480
   OTEROCOTO E, 1980, J THORAC CARDIOV SUR, V80, P941
   ROSENBERG H, 1986, J THORAC CARDIOV SUR, V91, P841
   Sung YM, 2011, ANN THORAC SURG, V92, P743, DOI 10.1016/j.athoracsur.2011.01.002
   Turkay C, 2003, J THORAC CARDIOV SUR, V125, P1058, DOI 10.1067/mtc.2003.87
NR 8
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2013
VL 43
IS 9
BP 640
EP 643
DI 10.4070/kcj.2013.43.9.640
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HF
UT WOS:000342388900010
PM 24174967
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, SU
   Yeung, AC
   Ikeno, F
AF Kwon, Sung Uk
   Yeung, Alan C.
   Ikeno, Fumiaki
TI The Role of Large Animal Studies in Cardiac Regenerative Therapy Concise
   Review of Translational Stem Cell Research
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Translational research; Clinical trial; Stem cells; Heart diseases;
   Regenerative medicine
ID ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION;
   BONE-MARROW-CELLS; CHRONIC HEART-FAILURE; ISCHEMIC CARDIOMYOPATHY;
   INTRAMYOCARDIAL INJECTION; INTRACORONARY INJECTION; MONONUCLEAR-CELLS;
   TRANSENDOCARDIAL DELIVERY; DOUBLE-BLIND
AB Animal models have long been developed for cardiovascular research. These animal models have been helpful in understanding disease, discovering potential therapeutics, and predicting efficacy. Despite many efforts, however, translational study has been underestimated. Recently, investigations have identified stem cell treatment as a potentially promising cell therapy for regenerative medicine, largely because of the stem cell's ability to differentiate into many functional cell types. Stem cells promise a new era of cell-based therapy for salvaging the heart. However, stem cells have the potential risk of tumor formation. These properties of stem cells are considered a major concern over the efficacy of cell therapy. The translational/preclinical study of stem cells is essential but only at the beginning stages. What types of heart disease are indicated for stem cell therapy, what type of stem cell, what type of animal model, how do we deliver stem cells, and how do we improve heart function? These may be the key issues that the settlement of which would facilitate the transition of stem cell research from bench to bedside. In this review article, we discuss state-of-the-art technology in stem cell therapies for cardiovascular diseases.
C1 [Kwon, Sung Uk; Yeung, Alan C.; Ikeno, Fumiaki] Stanford Univ, Med Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Kwon, Sung Uk] Inje Univ, Ilsan Paik Hosp, Vis Cardiac & Vasc Ctr 21, Goyang, South Korea.
RP Ikeno, F (corresponding author), Stanford Univ, Med Ctr, Div Cardiovasc Med, 300 Pasteur Dr,Falk CVRB007, Stanford, CA 94305 USA.
EM fikeno@stanford.edu
CR Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Ang KL, 2008, NAT CLIN PRACT CARD, V5, P663, DOI 10.1038/ncpcardio1321
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF
   Bubela T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-133
   Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317
   Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1
   Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436
   Ishikawa K, 2011, AM J PHYSIOL-HEART C, V301, pH530, DOI 10.1152/ajpheart.01103.2010
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   McCall FC, 2012, NAT PROTOC, V7, P1479, DOI 10.1038/nprot.2012.075
   Mewton N, 2011, BASIC RES CARDIOL, V106, P1247, DOI 10.1007/s00395-011-0214-8
   Moos Malcolm Jr, 2008, Trends Pharmacol Sci, V29, P591, DOI 10.1016/j.tips.2008.09.003
   Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pompilio G, 2008, THORAC CARDIOV SURG, V56, P71, DOI 10.1055/s-2007-989351
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Schuleri KH, 2008, COMPARATIVE MED, V58, P568
   Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421
   Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1
   Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073
   Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024
   Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670
   Verdouw PD, 1998, CARDIOVASC RES, V39, P121, DOI 10.1016/S0008-6363(98)00069-8
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Zhang H, 2013, HEART FAIL REV
   Zhang JY, 1996, CIRCULATION, V94, P1089, DOI 10.1161/01.CIR.94.5.1089
   Zhao Q, 2008, ANN THORAC SURG, V86, P1833, DOI 10.1016/j.athoracsur.2008.08.068
NR 43
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 511
EP 518
DI 10.4070/kcj.2013.43.8.511
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400001
PM 24044009
OA Green Published
DA 2021-04-22
ER

PT J
AU Ji, MS
   Jeong, MH
   Ahn, Y
   Kim, YJ
   Chae, SC
   Hong, TJ
   Seong, IW
   Chae, JK
   Kim, CJ
   Cho, MC
   Rha, SW
   Bae, JH
   Seung, KB
   Park, SJ
AF Ji, Mi Seon
   Jeong, Myung Ho
   Ahn, Youngkeun
   Kim, Young Jo
   Chae, Shung Chull
   Hong, Taek Jong
   Seong, In Whan
   Chae, Jei Keon
   Kim, Chong Jin
   Cho, Myeong Chan
   Rha, Seung-Woon
   Bae, Jang Ho
   Seung, Ki Bae
   Park, Seung Jung
CA Korea Acute Myocardial Infarction
TI One-Year Clinical Outcomes among Patients with Metabolic Syndrome and
   Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Metabolic syndrome; Myocardial infarction; Low density
   lipoprotein-cholesterol
ID LOW-DENSITY-LIPOPROTEIN; ELUTING STENTS; IMPACT; SIMVASTATIN;
   ATORVASTATIN; EVENTS; RISK; LDL; ATHEROSCLEROSIS; DYSLIPIDEMIA
AB Background and Objectives: Metabolic syndrome (MetS) is an important risk factor for cardiovascular disease. However, the clinical outcome of acute myocardial infarction (AMI) with MetS has not been well examined. The purpose of this study was to evaluate the clinical outcomes of AMI patients with MetS.
   Subjects and Methods: We evaluated a total of 6352 AMI patients who had successful percutaneous coronary interventions and could be identified for MetS between 2005 and 2008 at 51 hospitals participating in the Korea Acute Myocardial Infarction Registry. They were divided into 2 groups according to the presence of MetS: the MetS group (n=2493, 39.2%) versus the Non-MetS group (n=3859, 60.8%). In addition, 4049 AMI patients with high levels of low density lipoprotein-cholesterol (LDL-C) (>= 100 mg/dL) among them, were divided into the MetS group (n=1561, 38.6%) versus the Non-MetS group (n=2488, 61.4%).
   Results: In the overall population, there was no significant difference in 12-month the major adverse cardiac events (MACE) rate between the 2 groups. However, the MetS group showed a significantly higher 12-month MACE rate in the high LDL-C population. Multivariate analysis showed that MetS was an independent prognostic factor for 12-month MACE {hazard ratio (HR) 1.607, 95% confidence interval (CI) 1.027 to 2.513, adjusted p=0.038} and for 12-month target vessel revascularization (HR 1.564, 95% CI 1.092 to 2.240, adjusted p=0.015) in the high LDL-C population.
   Conclusion: MetS patients with AMI in the overall population showed no significant difference in 12-month clinical outcomes. However, in patients with higher LDL-C >= 100 mg/dL, they showed significantly worse clinical outcome than Non-MetS patients. Therefore, it is important to ascertain the presence of MetS in AMI patients, and more aggressive therapy should be strongly considered for AMI patient with MetS.
C1 [Ji, Mi Seon; Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Kwangju, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Taegu, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Taegu, South Korea.
   [Hong, Taek Jong] Pusan Natl Univ Hosp, Pusan, South Korea.
   [Seong, In Whan] Chungnam Natl Univ Hosp, Taejon, South Korea.
   [Chae, Jei Keon] Chunbuk Natl Univ Hosp, Jeonju, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ Hosp, Seoul, South Korea.
   [Cho, Myeong Chan] Chungbuk National University Hosp, Cheongju, South Korea.
   [Rha, Seung-Woon] Korea Univ, Guro Hosp, Seoul, South Korea.
   [Bae, Jang Ho] Konyang Univ, Taejon, South Korea.
   [Seung, Ki Bae] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea.
   [Park, Seung Jung] Asan Med Ctr, Seoul, South Korea.
   [Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ, Korea Cardiovasc Stent Res Inst, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Korea Acute Myocardial Infarct Registry, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI Jeong, Jin-Ok/0000-0003-0763-4754; Seong, In-Whan/0000-0003-4628-0258
FU Korean Circulation Society
FX This study was conducted with the support of the Korean Circulation
   Society in commemoration of its 50th Anniversary.
CR Ascaso J, 2007, AM J CARDIOVASC DRUG, V7, P39, DOI 10.2165/00129784-200707010-00004
   Bahadir MA, 2009, J ATHEROSCLER THROMB, V16, P684, DOI 10.5551/jat.1123
   Baldassarre S, 2005, INT J CARDIOL, V104, P338, DOI 10.1016/j.ijcard.2005.01.006
   Deedwania PC, 2005, AM J CARDIOL, V95, P360, DOI 10.1016/j.amjcard.2004.09.034
   Devaraj S, 2006, J CLIN ENDOCR METAB, V91, P4489, DOI 10.1210/jc.2006-0299
   Filardi PP, 2010, G ITAL CARDIOL, V11, p10S, DOI 10.1714/664.7725
   Fukushima Y, 2011, CLIN CHIM ACTA, V412, P1423, DOI 10.1016/j.cca.2011.04.021
   Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028
   Goswami B, 2010, CARDIOVASC J AFR, V21, P41
   Goyal SN, 2012, DIABETES VASC DIS RE, V9, P177, DOI 10.1177/1479164111430336
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hoffmann R, 2007, AM J CARDIOL, V100, P1347, DOI 10.1016/j.amjcard.2007.06.021
   Karthikeyan G, 2009, J AM COLL CARDIOL, V53, P244, DOI 10.1016/j.jacc.2008.09.041
   Kim Jeong Su, 2010, Diabetes Res Clin Pract, V88, pe38, DOI 10.1016/j.diabres.2010.03.024
   Koba Shinji, 2008, J Atheroscler Thromb, V15, P250
   Lee MG, 2010, J KOREAN MED SCI, V25, P1456, DOI 10.3346/jkms.2010.25.10.1456
   Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153
   Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s
   Moon JY, 2007, CARDIOLOGY, V108, P282, DOI 10.1159/000099097
   Murrow JR, 2012, J CLIN LIPIDOL, V6, P42, DOI 10.1016/j.jacl.2011.08.006
   Ray KK, 2004, CURR OPIN LIPIDOL, V15, P637, DOI 10.1097/00041433-200412000-00003
   Selcuk H, 2009, CORONARY ARTERY DIS, V20, P370, DOI 10.1097/MCA.0b013e32832ed31e
   Sim DS, 2010, J CARDIOL, V56, P1, DOI 10.1016/j.jjcc.2010.04.002
   Skilton MR, 2007, ATHEROSCLEROSIS, V190, P416, DOI 10.1016/j.atherosclerosis.2006.02.019
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Ulus T, 2012, EUR REV MED PHARMACO, V16, P328
   Wouterjukema J, 2005, DIABETES CARE, V28, P873, DOI 10.2337/diacare.28.4.873
   Xu D, 2012, ATHEROSCLEROSIS, V221, P416, DOI 10.1016/j.atherosclerosis.2011.12.016
   Yazdandoust S, 2012, LIPIDS, V47, P963, DOI 10.1007/s11745-012-3706-x
   Zeller M, 2005, ARCH INTERN MED, V165, P1192, DOI 10.1001/archinte.165.10.1192
NR 30
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 519
EP 526
DI 10.4070/kcj.2013.43.8.519
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400002
PM 24044010
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, PC
   Choi, IS
   Ahn, T
   Moon, J
   Park, Y
   Seo, JG
   Suh, SY
   Ahn, Y
   Jeong, MH
AF Oh, Pyung Chun
   Choi, In Suck
   Ahn, Taehoon
   Moon, Jeonggeun
   Park, Yeonjeong
   Seo, Jong Goo
   Suh, Soon Yong
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Predictors of Recovery of Left Ventricular Systolic Dysfunction after
   Acute Myocardial Infarction: From the Korean Acute Myocardial Infarction
   Registry and Korean Myocardial Infarction Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute myocardial infarction; Ventricular ejection fraction; Prognosis
ID POSITRON-EMISSION-TOMOGRAPHY; NONISCHEMIC HEART-FAILURE; VIABILITY;
   SURVIVAL; THERAPY; SIZE; ECHOCARDIOGRAPHY; QUANTIFICATION; ANGIOPLASTY
AB Background and Objectives: We investigated the predictors of the recovery of depressed left ventricular ejection fraction (LVEF) in patients with moderate or severe left ventricular (LV) systolic dysfunction after acute myocardial infarction (MI).
   Subjects and Methods: We analyzed 1307 patients, who had moderately or severely depressed LVEF (<45%) on echocardiography soon after acute MI and who underwent a follow-up echocardiography, among 27369 patients from the Korea Working Group on the Myocardial Infarction Registry. Patients were categorized into two groups according to recovery of LVEF: group I with consistently depressed LVEF (<45%) at the follow-up echocardiography and group II with a recovery of LVEF (>= 45%).
   Results: Recovery of LV systolic dysfunction was observed in 51% of the subjects (group II, n=663; Delta LVEF, 16.2 +/- 9.3%), whereas there was no recovery in the remaining subjects (group I, n=644; Delta LVEF, 0.6 +/- 7.1%). In the multivariate analysis, independent predictors of recovery of depressed LVEF were as follows {odds ratio (OR) [95% confidence interval (CI)]}: moderate systolic dysfunction {LVEF >= 30% and <45%; 1.73 (1.12-2.67)}, Killip class I-II {1.52 (1.06-2.18)}, no need for diuretics {1.59 (1.19-2.12)}, non-ST-segment elevation MI {1.55 (1.12-2.16)}, lower peak troponin I level {<24 ng/mL, median value; 1.55 (1.16-2.07)}, single-vessel disease {1.53 (1.13-2.06)}, and non-left anterior descending (LAD) culprit lesion {1.50 (1.09-2.06)}. In addition, the use of statin was independently associated with a recovery of LV systolic dysfunction {OR (95% CI), 1.46 (1.07-2.00)}.
   Conclusion: Future contractile recovery of LV systolic dysfunction following acute MI was significantly related with less severe heart failure at the time of presentation, a smaller extent of myonecrosis, or non-LAD culprit lesions rather than LAD lesions.
C1 [Oh, Pyung Chun; Choi, In Suck; Ahn, Taehoon; Moon, Jeonggeun; Park, Yeonjeong; Seo, Jong Goo; Suh, Soon Yong] Gachon Univ, Gil Hosp, Dept Internal Med, Div Cardiol, Inchon 405760, South Korea.
   [Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Dept Internal Med, Div Cardiol, Kwangju, South Korea.
RP Ahn, T (corresponding author), Gachon Univ, Gil Hosp, Dept Internal Med, Div Cardiol, 21 Namdong Daero 774beon Gil, Inchon 405760, South Korea.
EM encore@gilhospital.com
CR Abdel-Salam Z, 2010, CARDIOVASC REVASCULA, V11, P2, DOI 10.1016/j.carrev.2009.01.003
   Aronow WS, 2002, AM J CARDIOL, V90, P147, DOI 10.1016/S0002-9149(02)02438-4
   Auerbach MA, 1999, CIRCULATION, V99, P2921, DOI 10.1161/01.CIR.99.22.2921
   Bauters C, 2010, ARCH CARDIOVASC DIS, V103, P538, DOI 10.1016/j.acvd.2010.10.001
   Bolognese L, 1997, CIRCULATION, V96, P3353
   CHRISTIAN TF, 1990, J AM COLL CARDIOL, V16, P1632, DOI 10.1016/0735-1097(90)90313-E
   EITZMAN D, 1992, J AM COLL CARDIOL, V20, P559, DOI 10.1016/0735-1097(92)90008-B
   GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755
   Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071
   Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049
   John SM, 1994, CIRCULATION, V89, P68, DOI DOI 10.1161/01.CIR.89.1.68
   Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Leclercq F, 1997, AM J CARDIOL, V80, P6, DOI 10.1016/S0002-9149(97)00275-0
   Ottervanger JP, 2001, EUR HEART J, V22, P785, DOI 10.1053/euhj.2000.2316
   Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088
   Solomon SD, 2001, ANN INTERN MED, V134, P451, DOI 10.7326/0003-4819-134-6-200103200-00009
   Steen H, 2007, J CARDIOVASC MAGN R, V9, P749, DOI 10.1080/10976640701544589
   Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Wijns W, 1998, NEW ENGL J MED, V339, P173, DOI 10.1056/NEJM199807163390307
   1983, N ENGL J MED, V309, P331
NR 22
TC 17
Z9 17
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 527
EP 533
DI 10.4070/kcj.2013.43.8.527
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400003
PM 24044011
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, JH
   Kim, C
   Ahn, J
   Kim, JH
   Yang, MJ
   Lee, HW
   Choi, JH
   Lee, HC
   Cha, KS
   Hong, TJ
AF Oh, Jun-Hyok
   Kim, Changhoon
   Ahn, Jinhee
   Kim, Jin Hee
   Yang, Mi Jin
   Lee, Hye Won
   Choi, Jung Hyun
   Lee, Han Cheol
   Cha, Kwang Soo
   Hong, Taek Jong
TI The Relationship between Microcirculatory Resistance and Fractional Flow
   Reserve in Patients with Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Fractional flow reserve; myocardial;
   Microcirculation; Percutaneous coronary intervention
ID MICROVASCULAR RESISTANCE; EXPERIMENTAL VALIDATION; STENOSIS SEVERITY;
   INDEX; ANGIOPLASTY; EXTENT
AB Background and Objectives: It was demonstrated that the fractional flow reserve (FFR) with partial balloon obstruction may have implications for assessing viable myocardium. In a different way, the index of microcirculatory resistance (IMR) was introduced as a useful indicator for assessing microvascular function. We evaluated the relationship between the FFR0.8 and the IMR.
   Subjects and Methods: We studied 48 consecutive patients who had undergone coronary intervention for acute myocardial infarction (AMI). After revascularization using stent(s), an undersized short balloon was positioned inside the stent and inflated to create a specific normalized pressure drop of FFR (distal coronary/aortic pressure=0.80) at rest. The FFR0.8 was obtained during hyperemia with the fixed state balloon-induced partial obstruction. IMR was measured by three injections of saline. The association between the FFR0.8 and the IMR was investigated.
   Results: The mean age of the patients was 60 +/- 12 years and 36 (75%) overall presented with ST-segment elevation myocardial infarction. The mean FFR0.8 was 0.68 +/- 0.06. A statistically significant correlation between the FFR0.8 and the log-transformed IMRtrue (LnIMR(true)) was found through a multivariable linear regression analysis (beta=0.056, p<0.001). Both the FFR0.8 and the LnIMR(true) had a positive correlation with the log-transformed peak troponin I (TnI) with statistical significance (r(2)=0.119, p=0.017; r(2)=0.225, p=0.006, respectively).
   Conclusion: There was a positive correlation between the LnIMR(true) and the FFR0.8. Both of the values were associated with peak TnI. Those values may be used as appropriate surrogate measures of microvascular function after AMI.
C1 [Oh, Jun-Hyok; Ahn, Jinhee; Kim, Jin Hee; Yang, Mi Jin; Lee, Hye Won; Choi, Jung Hyun; Lee, Han Cheol; Cha, Kwang Soo; Hong, Taek Jong] Pusan Natl Univ Hosp, Dept Cardiol, Med Res Inst, Pusan 602739, South Korea.
   [Kim, Changhoon] Pusan Natl Univ Hosp, Dept Prevent Med, Med Res Inst, Pusan 602739, South Korea.
RP Cha, KS (corresponding author), Pusan Natl Univ Hosp, Dept Cardiol, Med Res Inst, 179 Gudeok Ro, Pusan 602739, South Korea.
EM cks@pusan.ac.kr
FU Korean Society of Cardiology
FX This study was supported by a grant from the Korean Society of
   Cardiology (2011).
CR Aarnoudse W, 2004, CIRCULATION, V110, P2137, DOI 10.1161/01.CIR.0000143893.18451.0E
   Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7
   De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223
   De Bruyne B, 2001, CIRCULATION, V104, P157, DOI 10.1161/01.CIR.104.2.157
   Fearon WF, 2004, CIRCULATION, V109, P2269, DOI 10.1161/01.CIR.0000128669.99355.CB
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Fearon WF, 2008, J AM COLL CARDIOL, V51, P560, DOI 10.1016/j.jacc.2007.08.062
   Kim JH, 2012, CATHETER CARDIO INTE, V80, P581, DOI 10.1002/ccd.23277
   Kitabata H, 2009, JACC-CARDIOVASC IMAG, V2, P263, DOI 10.1016/j.jcmg.2008.11.013
   Kocaman SA, 2009, ATHEROSCLEROSIS, V203, P178, DOI 10.1016/j.atherosclerosis.2008.06.009
   Lim HS, 2009, EUR HEART J, V30, P2854, DOI 10.1093/eurheartj/ehp313
   McGeoch R, 2010, JACC-CARDIOVASC INTE, V3, P715, DOI 10.1016/j.jcin.2010.04.009
   Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054
   Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184
   Zhang Z, 2011, AM J PHYSIOL-HEART C, V300, pH2096, DOI 10.1152/ajpheart.01123.2010
NR 15
TC 2
Z9 3
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 534
EP 540
DI 10.4070/kcj.2013.43.8.534
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400004
PM 24044012
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, SG
   Yoon, J
   Kim, J
   Uh, Y
   Kim, KM
   Lee, JH
   Lee, JW
   Youn, YJ
   Ahn, MS
   Kim, JY
   Yoo, BS
   Lee, SH
   Tahk, SJ
   Choe, KH
AF Ahn, Sung Gyun
   Yoon, Junghan
   Kim, Juwon
   Uh, Young
   Kim, Kyung Min
   Lee, Ji Hyun
   Lee, Jun-Won
   Youn, Young Jin
   Ahn, Min-Soo
   Kim, Jang-Young
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Tahk, Seung-Jea
   Choe, Kyung-Hoon
TI Genotype- and Phenotype-Directed Personalization of Antiplatelet
   Treatment in Patients with Non-ST Elevation Acute Coronary Syndromes
   Undergoing Coronary Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Antiplatelet agents; Genetic testing; Platelet function tests;
   Point-of-care systems
ID TREATMENT PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL;
   NANOPARTICLE PROBES; SEGMENT ELEVATION; DOSE CLOPIDOGREL; INTERVENTION;
   THERAPY; ASSAY; STANDARD
AB Background and Objectives: We evaluated the effectiveness of genotype-and phenotype-directed individualization of P2Y12 inhibitors to decrease high on-treatment platelet reactivity (HOPR).
   Subjects and Methods: Sixty-five patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes were randomly assigned to genotype-or phenotype-directed treatment. All patients were screened for CYP2C19*2, *3, or *17 alleles by using the Verigene CLO assay (Nanosphere, Northbrook, IL, USA). The P2Y(12) reaction unit (PRU) was measured using the VerifyNow P2Y12 assay (Accumetrics, San Diego, CA, USA). 21 CYP2C19 *2 or *3 carriers (65.6%) and 11 patients with HOPR (33.3%), defined as a PRU value >= 230, were given 90 mg ticagrelor twice daily; non-carriers and patients without HOPR were given 75 mg clopidogrel daily. The primary endpoint was the percentage of patients with HOPR after 30 days of treatment.
   Results: PRU decreased following both genotype-and phenotype-directed therapies (242 +/- 83 vs. 109 +/- 90, p<0.001 in the genotype-directed group; 216 +/- 74 vs. 109 +/- 90, p=0.001 in the phenotype-directed group). Five subjects (16.2%) in the genotype-directed group and one (3.3%) in the phenotype-directed group had HOPR at day 30 (p=0.086). All patients with HOPR at the baseline who received ticagrelor had a PRU value of <230 after 30 days of treatment. Conversely, clopidogrel did not lower the number of patients with HOPR at the baseline.
   Conclusion: Tailored antiplatelet therapy according to point-of-care genetic and phenotypic testing may be effective in decreasing HOPR after 30 days.
C1 [Ahn, Sung Gyun; Yoon, Junghan; Kim, Kyung Min; Lee, Ji Hyun; Lee, Jun-Won; Youn, Young Jin; Ahn, Min-Soo; Kim, Jang-Young; Yoo, Byung-Su; Lee, Seung-Hwan; Choe, Kyung-Hoon] Yonsei Univ, Wonju Coll Med, Div Cardiol, Wonju 220701, South Korea.
   [Kim, Juwon; Uh, Young] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju 220701, South Korea.
   [Tahk, Seung-Jea] Ajou Univ, Med Ctr, Dept Cardiol, Suwon 441749, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, 20 Ilsan Ro, Wonju 220701, South Korea.
EM jyoon@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
FU Korean Society of Circulation
FX This work was supported by a research grant from the Korean Society of
   Circulation (2011-12).
CR Ahn SG, 2012, JACC-CARDIOVASC INTE, V5, P259, DOI 10.1016/j.jcin.2011.12.009
   Ahn SG, 2011, PLATELETS, V22, P305, DOI 10.3109/09537104.2010.525268
   Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047
   Buchan BW, 2011, AM J CLIN PATHOL, V136, P604, DOI 10.1309/AJCPCPU9Q2IRNYXC
   Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047
   Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791
   Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979
   Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812
   Jannetto PJ, 2010, J CLIN MICROBIOL, V48, P3997, DOI 10.1128/JCM.01118-10
   Ko YG, 2011, AM HEART J, V161, P383, DOI 10.1016/j.ahj.2010.10.036
   Lee Kyounghoon, 2009, Korean Circ J, V39, P512, DOI 10.4070/kcj.2009.39.12.512
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636
   Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703
   Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
   Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4
   Park KW, 2012, CARDIOVASC THER, V30, P5, DOI 10.1111/j.1755-5922.2010.00249.x
   Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732
   Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5
   Saracini C, 2012, GENET TEST MOL BIOMA, V16, P500, DOI 10.1089/gtmb.2011.0259
   Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232
   Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631
   Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004
   Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
NR 29
TC 12
Z9 12
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 541
EP 549
DI 10.4070/kcj.2013.43.8.541
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400005
PM 24044013
OA Green Published
DA 2021-04-22
ER

PT J
AU Vranes, M
   Davidovic, L
   Vasic, D
   Radmili, O
AF Vranes, Milica
   Davidovic, Lazer
   Vasic, Dragan
   Radmili, Oliver
TI Coexistence of Internal Carotid Artery Stenosis in Patients with
   Abdominal Aortic Aneurysm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prevalence; Signs and Symptoms; Internal carotid artery stenosis; Aortic
   aneurysm; abdominal
ID CARDIOVASCULAR HEALTH; HIGHER PREVALENCE; RISK-FACTORS; DISEASE;
   POPULATION; ENDARTERECTOMY; MANAGEMENT
AB Background and Objectives: Abdominal Aortic Aneurysm (AAA) and carotid disease have medical and social significance, considering their morbidity, disability, and economic consequences. The study objectives were to determine the prevalence of asymptomatic internal carotid artery (ICA) lesions >= 70% in patients with AAA, the correlation of AAA diameter with the degree of ICA stenosis and symptoms, and the importance of preventive ultrasound checkups.
   Subjects and Methods: A prospective non-randomized controlled study including 740 patients, aged from 18-85 years, who were suitable for the inclusion and exclusion criteria and reported at the vascular laboratory of the Institute for Vascular and Endovascular Surgery, Clinical Center of Serbia from 1st of December 2011 to the 1st of November 2012.
   Results: The prevalence of asymptomatic ICA stenosis >= 70% in patients with AAA is 10.8%. Male representatives have more symptomatic ICA stenosis >= 70%. Patients with small aneurysms more often have asymptomatic ICA stenosis >= 70%. The occurrence of symptoms of carotid disease was more prevalent among patients with ICA stenosis >= 70% compared to the group with stenosis < 70%. There was no correlation found between the grade of ICA stenosis with the size of AAA.
   Conclusion: The prevalence of asymptomatic ICA stenosis >= 70% in patients with AAA is found to be 10.8%. Male patients with ICA stenosis >= 70% more often had symptoms of carotid disease. In the smaller aneurysms, ICA stenosis >= 70% occurs frequently, but without the symptoms of carotid disease, and there was no correlation between the size of AAA and the grade of ICA stenosis. Clinical implications of ICA imaging in patients with previously diagnosed AAA is necessary.
C1 [Vranes, Milica; Davidovic, Lazer; Vasic, Dragan; Radmili, Oliver] Clin Ctr Serbia, Clin Vasc & Endovasc Surg, Belgrade 11000, Serbia.
   [Davidovic, Lazer] Univ Belgrade, Fac Med, Belgrade, Serbia.
RP Vranes, M (corresponding author), Clin Ctr Serbia, Clin Vasc & Endovasc Surg, 8 Dr K Todorov St, Belgrade 11000, Serbia.
EM vranesmilica@gmail.com
CR Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963
   [Anonymous], 1994, STROKE, V25, P2523
   Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135
   Brown PM, 1996, J VASC SURG, V23, P213, DOI 10.1016/S0741-5214(96)70265-3
   Brown PM, 1996, J VASC SURG, V23, P221
   CHAMBERS BR, 1984, STROKE, V15, P964, DOI 10.1161/01.STR.15.6.964
   DEBAKEY ME, 1953, SURG GYNECOL OBSTET, V97, P257
   DEBAKEY ME, 1959, ANN SURG, V149, P690, DOI 10.1097/00000658-195905000-00010
   DUBOST C, 1952, AMA ARCH SURG, V64, P405, DOI 10.1001/archsurg.1952.01260010419018
   Fayad P, 2007, STROKE, V38, P707, DOI 10.1161/01.STR.0000250047.01624.fd
   FISHER M, 1951, AMA ARCH NEUROL PSY, V65, P346, DOI 10.1001/archneurpsyc.1951.02320030083009
   Goessens BMB, 2007, STROKE, V38, P1470, DOI 10.1161/STROKEAHA.106.477091
   Kang SS, 1999, SURGERY, V126, P687, DOI 10.1016/S0039-6060(99)70123-6
   Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275
   Lee TT, 1997, ANN INTERN MED, V126, P337, DOI 10.7326/0003-4819-126-5-199703010-00001
   LEONARDO RA, 1943, HIST SURG
   Liapis CD, 2003, J VASC SURG, V38, P1220, DOI 10.1016/S0741-5214(03)00716-X
   NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485
   OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752
   Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271
   PUJIA A, 1992, STROKE, V23, P818, DOI 10.1161/01.STR.23.6.818
   ROTHWELL PM, 1995, LANCET, V345, P209
   Salem MK, 2009, EUR J VASC ENDOVASC, V38, P748, DOI 10.1016/j.ejvs.2009.07.012
   Sicard GA, 1999, SURGERY, V126, P691
   Sila CA, 2008, NEW ENGL J MED, V358, P1617, DOI 10.1056/NEJMclde0800741
   STRULLY KJ, 1953, J NEUROSURG, V10, P474, DOI 10.3171/jns.1953.10.5.0474
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035
   WIEBERS DO, 1990, STROKE, V21, P984, DOI 10.1161/01.STR.21.7.984
   WILLEIT J, 1993, ARTERIOSCLER THROMB, V13, P661, DOI 10.1161/01.ATV.13.5.661
   Wilmink TBM, 1999, J VASC SURG, V30, P1099, DOI 10.1016/S0741-5214(99)70049-2
   Zureik M, 2002, J HYPERTENS, V20, P85, DOI 10.1097/00004872-200201000-00013
   Zwibel WJ, 2004, INTRO VASCULAR ULTRA, P272
NR 32
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 550
EP 556
DI 10.4070/kcj.2013.43.8.550
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400006
PM 24044014
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, S
   Lee, J
   Lee, SY
   Bae, JW
   Hwang, KK
   Kim, DW
   Cho, MC
   Kim, SM
AF Park, Soonyoung
   Lee, Jooyoung
   Lee, Sang Yeub
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Kim, Dong-Woon
   Cho, Myeong-Chan
   Kim, Sang Min
TI Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow
   during Primary Percutaneous Coronary Intervention for ST-Segment
   Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Thrombocytopenia; Abciximab; No-reflow phenomenon
ID GLYCOPROTEIN IIB/IIIA RECEPTOR; MANAGEMENT; BLOCKADE; HEPARIN;
   ANGIOPLASTY; TRIAL
AB Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed successfully for the rare complication of acute profound thrombocytopenia after using abciximab and an intra-aortic balloon pump for the treatment of a no-reflow phenomenon and consecutive cardiogenic shock during primary percutaneous coronary intervention.
C1 [Park, Soonyoung; Lee, Jooyoung; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan; Kim, Sang Min] Chungbuk Natl Univ Hosp, Dept Internal Med, Reg Cardiovasc Ctr, Div Cardiol, Cheongju 361711, South Korea.
RP Kim, SM (corresponding author), Chungbuk Natl Univ Hosp, Dept Internal Med, Reg Cardiovasc Ctr, Div Cardiol, 776 1sunhwan Ro, Cheongju 361711, South Korea.
EM sangmin3410@gmail.com
CR ABBO KM, 1995, AM J CARDIOL, V75, P778, DOI 10.1016/S0002-9149(99)80410-X
   Butler MJ, 2011, PHARMACOL THERAPEUT, V132, P72, DOI 10.1016/j.pharmthera.2011.05.010
   Claeys LGY, 2003, EUR J VASC ENDOVASC, V25, P85, DOI 10.1053/ejvs.2002.1757
   COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373
   Klein LW, 2003, CATHETER CARDIO INTE, V60, P194, DOI 10.1002/ccd.10620
   Lincoff AM, 2000, CIRCULATION, V102, P2923
   Makoni S N, 2001, Heart, V86, pE18, DOI 10.1136/heart.86.6.e18
   Merlini PA, 2004, CIRCULATION, V109, P2203, DOI 10.1161/01.CIR.0000127867.41621.85
   Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1
   Warkentin TE, 2003, BRIT J HAEMATOL, V121, P535, DOI 10.1046/j.1365-2141.2003.04334.x
   1994, N ENGL J MED, V330, P956
NR 11
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 557
EP 560
DI 10.4070/kcj.2013.43.8.557
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400007
PM 24044015
OA Green Published
DA 2021-04-22
ER

PT J
AU Min, JH
   Kang, MH
AF Min, Jung Hwa
   Kang, Min-Ho
TI Kounis Syndrome Presenting as Very Late Stent Thrombosis in an
   Everolimus-Eluting Stent Following Wasp Stings
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypersensitivity; Drug-eluting stent; Thrombosis; Acute coronary
   syndrome
ID MYOCARDIAL-INFARCTION; ALLERGIC REACTION; HYPERSENSITIVITY; ANGINA
AB Kounis syndrome is the concurrence of acute coronary syndromes with conditions associated with mast cell activation following an allergic insult. We report a 56-year-old man who experienced a ST-segment elevation myocardial infarction after wasp stings. The patient presented without signs of anaphylaxis or shock. Coronary angiography showed an everolimus-eluting stent thrombosis (ST) of the left anterior descending artery occluding the vessel completely which was deployed for stable angina 3 years ago. The patient had been compliant with anti-platelet therapy, and no relevant cardiovascular events occurred until the day of admission. We interpreted our patient's condition as a manifestation of Kounis syndrome. To our knowledge, this is the first case of Kounis syndrome showing very late ST in a second-generation drug-eluting stent caused by wasp stings.
C1 [Min, Jung Hwa; Kang, Min-Ho] Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, Seoul 100032, South Korea.
RP Kang, MH (corresponding author), Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, 9 Mareunnae Ro, Seoul 100032, South Korea.
EM eukmh@naver.com
CR Biteker M, 2010, EXPERT REV CLIN IMMU, V6, P777, DOI [10.1586/eci.10.47, 10.1586/ECI.10.47]
   Chen JP, 2009, JACC-CARDIOVASC INTE, V2, P583, DOI 10.1016/j.jcin.2009.04.017
   Greif Martin, 2009, Cases J, V2, P7800, DOI 10.4076/1757-1626-2-7800
   Horjeti B, 2011, INT J CARDIOL, V150, pE70, DOI 10.1016/j.ijcard.2009.10.050
   Jackson CE, 2009, CIRC-CARDIOVASC INTE, V2, P79, DOI 10.1161/CIRCINTERVENTIONS.108.820266
   Joner M, J AM COLL CARDIOL
   Karasu E, 2011, INT J CARDIOL, V148, P382, DOI 10.1016/j.ijcard.2010.10.099
   Kasim S, 2012, CASE REP CARDIOL, V2012, DOI 10.1155/2012/701753
   King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002
   Kogias JS, 2007, INT J CARDIOL, V114, P252, DOI 10.1016/j.ijcard.2005.11.059
   Kogias JS, 2010, INT J CARDIOL, V139, P206, DOI 10.1016/j.ijcard.2008.08.026
   Kounis NG, 1999, CIRCULATION, V100, pE156
   Kounis NG, 2006, INT J CARDIOL, V110, P7, DOI 10.1016/j.ijcard.2005.08.007
   Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008
   Siddiqi OK, 2012, CURR OPIN CARDIOL, V27, P634, DOI 10.1097/HCO.0b013e3283587c7e
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   Tsigkas G, 2011, INT J CARDIOL, V149, P281, DOI 10.1016/j.ijcard.2011.02.060
   Valla M, 2011, INT J CARDIOL, V148, pE63, DOI 10.1016/j.ijcard.2009.03.065
   Venturini E, 2011, INT J CARDIOL, V146, pE16, DOI 10.1016/j.ijcard.2008.12.190
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
NR 20
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 561
EP 564
DI 10.4070/kcj.2013.43.8.561
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400008
PM 24044016
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Seo, SM
   Seo, MJ
   Min, HK
   Cho, MJ
   Kim, YS
   Kim, YS
   Baek, SH
AF Lee, Jong Min
   Seo, Suk Min
   Seo, Min Ji
   Min, Hong Ki
   Cho, Min Jung
   Kim, Yu Seung
   Kim, Young Shin
   Baek, Sang Hong
TI A Case of Reversible Very Low Voltage Electrocardiogram in Fulminant
   Myocarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocarditis; Arrhythmia; Extracorporeal membrane oxygenation
ID SUPPORT
AB Clinical features of acute myocarditis range from a subclinical state to a fulminant state. Fulminant myocarditis with ventricular arrhythmia or atrioventricular block is associated with a high mortality rate. In cases in which aggressive medical therapy for fulminant myocarditis is not likely to be successful, intensive and emergency mechanical circulatory support, such as extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon pump, should be considered. We report life salvage of acute fulminant myocarditis in a 53-year-old woman presented with malignant arrhythmia and cardiogenic shock supported by ECMO.
C1 [Lee, Jong Min; Seo, Suk Min; Seo, Min Ji; Min, Hong Ki; Cho, Min Jung; Kim, Yu Seung; Kim, Young Shin; Baek, Sang Hong] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 137701, South Korea.
   [Seo, Suk Min] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Ctr Cardiovasc, Inchon, South Korea.
   [Seo, Suk Min] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Div Cardiol, Inchon, South Korea.
   [Baek, Sang Hong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Ctr Cardiovasc, Seoul 137701, South Korea.
   [Baek, Sang Hong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol, Seoul 137701, South Korea.
RP Baek, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Ctr Cardiovasc, 222 Banpo Daero, Seoul 137701, South Korea.
EM whitesh@catholic.ac.kr
RI Seo, Suk Min/AAB-8238-2021
CR Aoyama N, 2002, CIRC J, V66, P133, DOI 10.1253/circj.66.133
   Bruch C, 2001, J AM COLL CARDIOL, V38, P219, DOI 10.1016/S0735-1097(01)01313-4
   Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908
   Hare JM, 2001, EUR HEART J, V22, P269, DOI 10.1053/euhj.2000.2272
   Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009
   McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003
   MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z
   Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938
NR 8
TC 1
Z9 1
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 565
EP 568
DI 10.4070/kcj.2013.43.8.565
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400009
PM 24044017
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HS
   Lee, SA
   Shin, HS
   Choi, HM
   Kim, SJ
   Kim, HK
   Park, YB
AF Lee, Hee-Sun
   Lee, Seung-Ah
   Shin, Hyo-Sun
   Choi, Hong-Mi
   Kim, Soo-Jung
   Kim, Hyung-Kwan
   Park, Young-Bae
TI A Case of Cardiac Beriberi: A Forgotten but Memorable Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Beriberi; heart failure; Thiamine deficiency
ID HEART-DISEASE; THIAMINE; DIAGNOSIS
AB Thiamine (vitamin B-1) serves as an important cofactor in body metabolism and energy production. It is related with the biosynthesis of neurotransmitters and the production of substances used in defense against oxidant stress. Thus, a lack of thiamine affects several organ systems, in particular the cardiovascular and nervous system. The cardiac insufficiency caused by thiamine deficiency is known as cardiac beriberi, with this condition resulting from unbalanced nutrition and chronic excessive alcohol intake. Given that the disease is now very rare in developed nations such as Korea, it is frequently missed by cardiologists, with potentially fatal consequences. Herein, we present a case study in order to draw attention to cardiac beriberi. We believe that this case will be helpful for young cardiologists, reminding them of the importance of this forgotten but memorable disease.
C1 [Lee, Hee-Sun; Lee, Seung-Ah; Shin, Hyo-Sun; Choi, Hong-Mi; Kim, Soo-Jung; Kim, Hyung-Kwan; Park, Young-Bae] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Park, YB (corresponding author), Seoul Natl Univ, Coll Med, Ctr Cardiovasc, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM parkyb@snu.ac.kr
RI Kim, Hyung-Kwan/R-8375-2019
CR Astudillo L, 2003, AM J MED, V115, P157, DOI 10.1016/S0002-9343(03)00283-3
   CAPPELLI V, 1990, J MOL CELL CARDIOL, V22, P1095, DOI 10.1016/0022-2828(90)90073-B
   Essa E, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-41
   JONES RH, 1959, CIRCULATION, V19, P275, DOI 10.1161/01.CIR.19.2.275
   LAHEY WJ, 1953, AM J MED, V14, P248, DOI 10.1016/0002-9343(53)90023-0
   Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077
   NAIDOO DP, 1987, S AFR MED J, V72, P241
   NAIDOO DP, 1990, S AFR MED J, V77, P125
   Rao SN, 2010, J TROP PEDIATRICS, V56, P284, DOI 10.1093/tropej/fmp108
   Sriram K, 2012, NUTR CLIN PRACT, V27, P41, DOI 10.1177/0884533611426149
   Towbin A, 2004, J PEDIATR-US, V145, P263, DOI 10.1016/j.jpeds.2004.04.051
   Voigt A, 2011, EUR RADIOL, V21, P925, DOI 10.1007/s00330-010-1985-2
   Wooley JA, 2008, NUTR CLIN PRACT, V23, P487, DOI 10.1177/0884533608323430
   Yang JD, 2012, AM J MED, V125, pE5, DOI 10.1016/j.amjmed.2011.12.019
NR 14
TC 10
Z9 10
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 569
EP 572
DI 10.4070/kcj.2013.43.8.569
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400010
PM 24044018
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, HS
   Lee, SW
   Jung, YK
   Jeon, U
   Park, SH
   Lee, SJ
   Sin, WY
   Jin, DK
AF Rhee, Ho Sung
   Lee, Se-Whan
   Jung, Young Kyu
   Jeon, Ung
   Park, Sang-Ho
   Lee, Seung-Jin
   Sin, Won-Yong
   Jin, Dong-Kyu
TI Takotsubo Cardiomyopathy Associated with Severe Hypocalcemia Secondary
   to Idiopathic Hypoparathyroidism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Takotsubo cardiomyopathy; Hypocalcemia; Hypoparathyroidism
ID ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; DYSFUNCTION; FEATURES
AB The etiology and pathophysiology of takotsubo cardiomyopathy have not yet been fully clarified. We report a case of takotsubo cardiomyopathy associated with severe hypocalcemia secondary to hypoparathyroidism. A 69-year-old woman presented with acute pulmonary edema caused by severe left ventricular dysfunction with apical ballooning compatible with takotsubo cardiomyopathy. Laboratory tests revealed severe hypocalcemia secondary to idiopathic hypoparathyroidism. Coronary angiography showed normal coronary artery function. Her symptoms and signs of heart failure improved dramatically with the correction of hypocalcemia through calcium and calcitriol replacement.
C1 [Rhee, Ho Sung; Lee, Se-Whan; Jung, Young Kyu; Jeon, Ung; Park, Sang-Ho; Lee, Seung-Jin; Sin, Won-Yong; Jin, Dong-Kyu] Soonchunhyang Univ, Cheonan Hosp, Sch Med, Dept Internal Med, Cheonan 330721, South Korea.
RP Lee, SW (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Sch Med, Dept Internal Med, 31 Suncheonhyang 6 Gil, Cheonan 330721, South Korea.
EM lovelee93@hanmail.net
CR Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X
   BASHOUR T, 1980, CHEST, V78, P663, DOI 10.1378/chest.78.4.663
   BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137
   Chraibi S, 2001, ANN MED INTERNE, V152, P483
   CSANADY M, 1990, BRIT HEART J, V63, P58
   HUDDLE KRL, 1988, S AFR MED J, V73, P242
   Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403
   LEVINE SN, 1985, AM J MED, V78, P1033, DOI 10.1016/0002-9343(85)90228-1
   Opie LH, 2007, HEART DIS, P509
   Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002
   Rallidis LS, 1997, INT J CARDIOL, V61, P89, DOI 10.1016/S0167-5273(97)00124-1
   Suzuki T, 1998, CLIN CARDIOL, V21, P227, DOI 10.1002/clc.4960210319
   Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X
   Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046
NR 14
TC 5
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 573
EP 577
DI 10.4070/kcj.2013.43.8.573
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400011
PM 24044019
OA Green Published
DA 2021-04-22
ER

PT J
AU Tas, MH
   Simsek, Z
   Degirmenci, H
   Ogul, H
   Aksu, U
   Kantarci, A
AF Tas, Muhammed Hakan
   Simsek, Ziya
   Degirmenci, Husnu
   Ogul, Hayri
   Aksu, Ugur
   Kantarci, Abdulmecit
TI A Rare Congenital Anomaly: Interrupted Aortic Arch and Giant Ascending
   Aortic Aneurysm in a Young Male
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Tas, Muhammed Hakan; Simsek, Ziya; Degirmenci, Husnu; Ogul, Hayri; Aksu, Ugur; Kantarci, Abdulmecit] Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
RP Tas, MH (corresponding author), Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
EM mhakantas@gmail.com
NR 0
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 578
EP 579
DI 10.4070/kcj.2013.43.8.578
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400012
PM 24044020
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, MH
   Cheon, SS
   Song, JH
   Jang, SY
   Choi, WS
   Kim, KH
   Park, SH
   Lee, JH
   Yang, DH
   Park, HS
   Cho, Y
   Chae, SC
AF Bae, Myung Hwan
   Cheon, Sang Soo
   Song, Joon Hyuk
   Jang, Se Yong
   Choi, Won Suk
   Kim, Kyun Hee
   Park, Sun Hee
   Lee, Jang Hoon
   Yang, Dong Heon
   Park, Hun Sik
   Cho, Yongkeun
   Chae, Shung Chull
TI Etiologies and Predictors of False-Positive Diagnosis of ST-Segment
   Elevation Myocardial Infarction (vol 43, pg 370, 2013)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Bae, Myung Hwan; Cheon, Sang Soo; Song, Joon Hyuk; Jang, Se Yong; Choi, Won Suk; Kim, Kyun Hee; Park, Sun Hee; Lee, Jang Hoon; Yang, Dong Heon; Park, Hun Sik; Cho, Yongkeun; Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, Taegu, South Korea.
RP Bae, MH (corresponding author), Kyungpook Natl Univ Hosp, Dept Internal Med, Taegu, South Korea.
CR Bae MH, 2013, KOREAN CIRC J, V43, P370, DOI 10.4070/kcj.2013.43.6.370
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2013
VL 43
IS 8
BP 580
EP 580
DI 10.4070/kcj.2013.43.8.580
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9HA
UT WOS:000342388400013
OA Green Published, Green Accepted
DA 2021-04-22
ER

PT J
AU Kochar, M
   Min, JK
AF Kochar, Minisha
   Min, James K.
TI Physiologic Assessment of Coronary Artery Disease by Cardiac Computed
   Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Prognosis; Coronary artery disease; Multiditector computed tomography
ID FRACTIONAL FLOW RESERVE; MYOCARDIAL CT PERFUSION; DIAGNOSTIC-ACCURACY;
   BLOOD-FLOW; PRESSURE MEASUREMENTS; ANGIOGRAPHY; INTERVENTION;
   PERFORMANCE; STENOSIS; 64-ROW
AB Coronary artery disease (CAD) remains the leading cause of death and morbidity worldwide. To date, diagnostic evaluation of patients with suspected CAD has relied upon the use of physiologic non-invasive testing by stress electrocardiography, echocardiography, myocardial perfusion imaging (MPI) and magnetic resonance imaging. Indeed, the importance of physiologic evaluation of CAD has been highlighted by large-scale randomized trials that demonstrate the propitious benefit of an integrated anatomic-physiologic evaluation method by performing lesion-specific ischemia assessment by fractional flow reserve (FFR)-widely considered the "gold" standard for ischemia assessment-at the time of invasive angiography. Coronary CT angiography (CCTA) has emerged as an attractive non-invasive test for anatomic illustration of the coronary arteries and atherosclerotic plaque. In a series of prospective multicenter trials, CCTA has been proven as having high diagnostic performance for stenosis detection as compared to invasive angiography. Nevertheless, CCTA evaluation of obstructive stenoses is prone to overestimation of severity and further, detection of stenoses by CCTA does not reliably determine the hemodynamic significance of the visualized lesions. Recently, a series of technological innovations have advanced the possibility of CCTA to enable physiologic evaluation of CAD, thereby creating the potential of this test to provide an integrated anatomic-physiologic assessment of CAD. These advances include rest-stress MPI by CCTA as well as the use of computational fluid dynamics to non-invasively calculate FFR from a typically acquired CCTA. The purpose of this review is to summarize the most recent data addressing these 2 physiologic methods of CAD evaluation by CCTA.
C1 [Kochar, Minisha] Kaiser Permanente, Div Cardiol, Panorama City, CA USA.
   [Min, James K.] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.
   [Min, James K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
RP Min, JK (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Dept Med Imaging & Biomed Sci, 8700 Beverly Blvd,S Mark Taper Bldg,Room 1253, Los Angeles, CA 90048 USA.
EM james.min@cshs.org
CR Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041
   Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
   DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013
   Ehara M, 2006, CIRC J, V70, P564, DOI 10.1253/circj.70.564
   Elhendy A, 2006, J NUCL CARDIOL, V13, P629, DOI 10.1016/j.nuclcard.2006.06.128
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250
   Feuchtner GM, 2012, HEART, V98, P1510, DOI 10.1136/heartjnl-2012-302531
   Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6
   George RT, 2009, CIRC-CARDIOVASC IMAG, V2, P174, DOI 10.1161/CIRCIMAGING.108.813766
   Glagov S, 1997, ATHEROSCLEROSIS, V131, pS13, DOI 10.1016/S0021-9150(97)06117-0
   GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204
   Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6
   Kim HJ, 2010, ANN BIOMED ENG, V38, P2314, DOI 10.1007/s10439-010-9992-7
   Kim HJ, 2009, ANN BIOMED ENG, V37, P2153, DOI 10.1007/s10439-009-9760-8
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058
   Melikian N, 2010, JACC-CARDIOVASC INTE, V3, P307, DOI 10.1016/j.jcin.2009.12.010
   Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576
   Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274
   Min JK, 2010, J AM COLL CARDIOL, V55, P957, DOI 10.1016/j.jacc.2009.08.087
   Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, P1
   Nikolaou K, 2006, AM J ROENTGENOL, V187, P111, DOI 10.2214/AJR.05.1697
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354
   Pijls NHJ, 1998, HEART, V80, P539, DOI 10.1136/hrt.80.6.539
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0
   Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056
   Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050
   Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092
   So A, 2012, J CARDIOVASC COMPUT, V6, P308, DOI 10.1016/j.jcct.2012.07.002
   So A, 2011, J CARDIOVASC COMPUT, V5, P467, DOI 10.1016/j.jcct.2011.11.002
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333
   Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565
   Williams MC, 2012, HEART, V98, P521, DOI 10.1136/heartjnl-2012-301677
   WOLFKIEL CJ, 1987, CIRCULATION, V76, P1262, DOI 10.1161/01.CIR.76.6.1262
NR 45
TC 5
Z9 6
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 435
EP 442
DI 10.4070/kcj.2013.43.7.435
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900001
PM 23964289
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MS
   Flammer, AJ
   Lerman, A
AF Lee, Moo-Sik
   Flammer, Andreas J.
   Lerman, Amir
TI The Decline Effect in Cardiovascular Medicine: Is the Effect of
   Cardiovascular Medicine and Stent on Cardiovascular Events Decline Over
   the Years?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiovascular drug; Stents; Percataneous coronary intervention
ID ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; LOW-DOSE ASPIRIN;
   ESTROGEN PLUS PROGESTIN; PROTON-PUMP INHIBITORS; VITAMIN-E CONSUMPTION;
   DRUG-ELUTING STENTS; TRUNK DISEASE BMS; BARE-METAL STENTS; BETA-BLOCKERS
AB The term decline effect is referred to a diminution of scientifically discovered effects over time. Reasons for the decline effect are multifaceted and include publication bias, selective reporting, outcomes reporting bias, regression to the mean, scientific paradigm shift, overshadowing and habituation, among others. Such effects can be found in cardiovascular medicines through medications (e. g., aspirin, antithrombotics, proton pump inhibitor, beta-blockers, statins, estrogen/progestin, angiotensin converting enzyme inhibitor etc.), as well as with interventional devices (e. g., angioplasty, percutaneous coronary intervention, stents). The scientific community should understand the various dimensions of the decline effects, and effective steps should be undertaken to prevent or recognize such decline effects in cardiovascular medicines.
C1 [Lee, Moo-Sik; Flammer, Andreas J.; Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.
   [Lee, Moo-Sik] Konyang Univ, Dept Prevent Med, Coll Med, Taejon, South Korea.
RP Lerman, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.
EM Lerman.Amir@mayo.edu
RI Flammer, Andreas/AAJ-1328-2021
OI Flammer, Andreas/0000-0002-1373-0630
CR Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701
   Aikawa M, 2001, CIRCULATION, V103, P276
   Al Suwaidi J, 2000, JAMA-J AM MED ASSOC, V284, P1828, DOI 10.1001/jama.284.14.1828
   [Anonymous], ASP PREV CARD DIS
   [Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI DOI 10.1056/NEJM198907203210301
   Barbash IM, 2011, FUTUR CARDIOL, V7, P765, DOI [10.2217/fca.11.56, 10.2217/FCA.11.56]
   Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325
   Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015
   Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624
   Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002
   Bielecka-Dabrowa A, 2010, CURR VASC PHARMACOL, V8, P733, DOI 10.2174/157016110793563861
   Bonaca MP, 2009, J AM COLL CARDIOL, V54, P969, DOI 10.1016/j.jacc.2009.03.083
   Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046
   Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005
   Calonge N, 2009, ANN INTERN MED, V150, P396
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Cohen M, 2002, AM HEART J, V144, P470, DOI 10.1067/mhj.2002.126115
   Corteville B, 2010, TIJDSCHR GENEESKD, V66, P213
   Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670
   Cucherat M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001560.pub2
   Dabhadkar KC, 2011, ANNU REV PUBL HEALTH, V32, P23, DOI 10.1146/annurev-publhealth-031210-101214
   Dangas G, 1999, J AM COLL CARDIOL, V33, P1294, DOI 10.1016/S0735-1097(99)00018-2
   De Caterina AR, 2011, CURR ATHEROSCLER REP, V13, P147, DOI 10.1007/s11883-010-0157-9
   Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165
   DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374
   DICKERSIN K, 1993, ONLINE J CURR CLIN T
   Douketis JD, 2011, THROMB RES, V127, P513, DOI 10.1016/j.thromres.2011.02.010
   Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081
   Earnshaw SR, 2011, ARCH INTERN MED, V171, P218, DOI 10.1001/archinternmed.2010.525
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Egger M, 2001, SYSTEMATIC REV HLTH
   Ejiri K, 2012, CIRC J, V76, P65, DOI 10.1253/circj.CJ-11-0300
   European Medicines Agency, 2009, PUBL STAT POSS INT C
   Faxon DP, 2009, AM HEART J, V157, P412, DOI 10.1016/j.ahj.2008.11.019
   Ferguson JJ, 2003, AM HEART J, V146, P628, DOI 10.1016/S0002-8703(03)00165-0
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Frishman WH, 2011, J CLIN HYPERTENS, V13, P649, DOI 10.1111/j.1751-7176.2011.00515.x
   Frohlich Edward D, 2009, Ther Adv Cardiovasc Dis, V3, P455, DOI 10.1177/1753944709346519
   Goodman SG, 2003, CIRCULATION, V107, P238, DOI 10.1161/01.CIR.0000050144.67910.13
   GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001
   Gurbel PA, 2010, DRUG HEALTHC PATIENT, V2, P233, DOI 10.2147/DHPS.S7297
   Gurbel PA, 2011, NAT REV CARDIOL, V8, P7, DOI 10.1038/nrcardio.2010.185
   Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018
   HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U
   Hilliard AA, 2010, JACC-CARDIOVASC INTE, V3, P172, DOI 10.1016/j.jcin.2009.11.013
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197
   Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624
   Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410
   Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218
   Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281
   Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998
   Joviliano EE, 2011, ANN VASC SURG, V25, P846, DOI 10.1016/j.avsg.2011.02.026
   Kadota K, 2011, CIRC J, V75, P1250, DOI 10.1253/circj.CJ-11-0307
   Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016
   Kaneko H, 2011, CIRC J, V75, P1243, DOI 10.1253/circj.CJ-11-0234
   Kopecky SL, 2010, MAYO CLIN CARDIOVASC, V8, P6
   Lamotte M, 2006, PHARMACOECONOMICS, V24, P155, DOI 10.2165/00019053-200624020-00005
   Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129
   Lehrer J, 2010, TRUTH WEARS OFF IS T
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Li JJ, 2010, TEX HEART I J, V37, P49
   Li YH, 2007, INT HEART J, V48, P677, DOI 10.1536/ihj.48.677
   Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3
   Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4
   Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475
   MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028
   Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2
   Morrissey RP, 2009, J AM COLL CARDIOL, V54, P1425, DOI 10.1016/j.jacc.2009.04.093
   Newby LK, 2002, JAMA-J AM MED ASSOC, V287, P3087, DOI 10.1001/jama.287.23.3087
   Nirnjee SM, 2005, TRENDS CARDIOVAS MED, V15, P41
   Palmer AR, 2000, ANNU REV ECOL SYST, V31, P441, DOI 10.1146/annurev.ecolsys.31.1.441
   Park SJ, 2011, CIRC J, V75, P749, DOI 10.1253/circj.CJ-11-0217
   Raber L, 2011, CARDIOVASC THER, V29, P176, DOI 10.1111/j.1755-5922.2010.00144.x
   Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744
   RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004
   Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321
   Rutishauser J, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13310
   Saini SD, 2008, ARCH INTERN MED, V168, P1684, DOI 10.1001/archinte.168.15.1684
   Saito S, 1999, CATHETER CARDIO INTE, V48, P262, DOI 10.1002/(SICI)1522-726X(199911)48:3<262::AID-CCD5>3.0.CO;2-4
   Sakhuja R, 2010, ANNU REV MED, V61, P215, DOI 10.1146/annurev.med.051508.221014
   Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x
   Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Spoladore Roberto, 2010, Recenti Progressi in Medicina, V101, P429
   Sposito AC, 2011, ARTERIOSCL THROM VAS, V31, P1240, DOI 10.1161/ATVBAHA.110.218685
   STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102
   STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003
   Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1
   Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640
   Suryapranata H, 2001, HEART, V85, P667, DOI 10.1136/heart.85.6.667
   TAKARO T, 1982, CIRCULATION, V66, P14, DOI 10.1161/01.CIR.66.1.14
   Tonelli M, 2011, CAN MED ASSOC J, V183, pE1189, DOI 10.1503/cmaj.101280
   Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018
   US Department of Health & Human services; FDA, 2009, INF HEALTHC PROF UPD
   US Preventive Services Task Force, 1996, GUID CLIN PREV SERV
   von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027
   Weir MR, 2009, POSTGRAD MED, V121, P90, DOI 10.3810/pgm.2009.05.2007
   Widimsky P, 2010, EUR HEART J, V31, P634, DOI 10.1093/eurheartj/ehp535
   Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa
   Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009
   Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629
   Yousuf O, 2011, NAT REV CARDIOL, V8, P547, DOI 10.1038/nrcardio.2011.96
   Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302
   Zhou Z, 2006, AM J CARDIOL, V97, P155, DOI 10.1016/j.amjcard.2005.07.135
NR 106
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 443
EP 452
DI 10.4070/kcj.2013.43.7.443
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900002
PM 23964290
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Youn, HJ
   Yi, JE
   Chin, JY
   Kim, TS
   Jung, HO
   Chang, K
   Choi, YS
   Jung, JI
AF Lee, Dong-Hyeon
   Youn, Ho-Joong
   Yi, Jeong Eun
   Chin, Jung Yeon
   Kim, Tae-Seok
   Jung, Hae-Ok
   Chang, Kiyuk
   Choi, Yun-Seok
   Jung, Jung-Im
TI Gender Difference in Bone Loss and Vascular Calcification Associated
   with Age
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Gender; Osteoporosis; Coronary vessels; Calcium; Bone density
ID CORONARY-ARTERY CALCIFICATION; MINERAL DENSITY; POSTMENOPAUSAL WOMEN;
   CARDIOVASCULAR-DISEASE; RISK-ASSESSMENT; FRACTURE RISK; OLDER-ADULTS;
   OSTEOPOROSIS; CALCIUM; PREVALENCE
AB Background and Objectives: It is widely known that both bone loss and vascular calcification are age-related processes. The purpose of this study was to investigate the relationship between coronary artery calcium (CAC) score or bone mineral density (BMD) with age and whether there is a gender difference factoring in the two conditions among healthy subjects.
   Subjects and Methods: Between March 2009 and August 2011, participants included 1727 subjects (mean age: 55+/-10 years, M : F=914 : 813) with routine health check-ups. After being categorized into three groups (normal, osteopenia, and osteoporosis) according to the World Health Organization (WHO) diagnostic classification, we estimated BMD by dual energy X-ray absorptiometry (DEXA) and CAC score by dual-source CT (DSCT).
   Results: There was a significant gender difference among the risk factors, including total-lumbar spine (1.213+/-0.176 g/cm(2) : 1.087+/-0.168 g/cm(2), p< 0.001) and femur (1.024+/-0.131 g/cm(2) : 0.910+/-0.127 g/cm(2), p< 0.001) in BMD by DEXA, and CAC score (68+/-227 : 27+/-116, p< 0.001) in coronary artery calcification by DSCT. Age in male [odds ratio (OR): 1.138 {95% confidence interval (CI): 1.088-1.190}, p< 0.001] and menopause in female subjects {OR: 12.370 (95% CI: 3.120-49.047), p< 0.001} were, respectively, independently associated with osteopenia.
   Conclusion: Although our results do not demonstrate a direct association between CAC score and BMD in both genders, there is a gender difference of CAC score in normal and osteopenia groups according to the WHO diagnostic classification. Additionally, we suggest that more specific therapeutic strategies be considered during any early bone loss period, especially in female subjects.
C1 [Lee, Dong-Hyeon; Youn, Ho-Joong; Yi, Jeong Eun; Chin, Jung Yeon; Kim, Tae-Seok; Jung, Hae-Ok; Chang, Kiyuk; Choi, Yun-Seok] Catholic Univ Korea, Coll Medicne, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, Seoul 137701, South Korea.
   [Jung, Jung-Im] Catholic Univ Korea, Coll Medicne, Seoul St Marys Hosp, Dept Radiol, Seoul 137701, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Coll Medicne, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 137701, South Korea.
EM younhj@catholic.ac.kr
OI Jung, Jung Im/0000-0001-8264-9388
CR AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Bakhireva LN, 2005, MENOPAUSE, V12, P691, DOI 10.1097/01.gme.0000184422.50696.ef
   Choi SH, 2009, CLIN ENDOCRINOL, V71, P644, DOI 10.1111/j.1365-2265.2009.03535.x
   Christian RC, 2002, J CLIN ENDOCR METAB, V87, P1062, DOI 10.1210/jc.87.3.1062
   Compston JE, 1998, OSTEOPOROSIS INT, V8, P531, DOI 10.1007/s001980050094
   Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5
   Farhat GN, 2007, OSTEOPOROSIS INT, V18, P999, DOI 10.1007/s00198-007-0338-8
   Frost ML, 2008, CALCIFIED TISSUE INT, V83, P112, DOI 10.1007/s00223-008-9153-2
   Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8
   Jorgensen L, 2004, AM J EPIDEMIOL, V160, P549, DOI 10.1093/aje/kwh252
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P1395, DOI 10.1007/s00198-008-0712-1
   KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200
   KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802
   Kim KI, 2011, J BONE MINER METAB, V29, P369, DOI 10.1007/s00774-010-0229-5
   Lee HT, 2011, KOREAN CIRC J, V41, P76, DOI 10.4070/kcj.2011.41.2.76
   Lin T, 2011, OSTEOPOROSIS INT, V22, P627, DOI 10.1007/s00198-010-1303-5
   LOOKER AC, 1995, J BONE MINER RES, V10, P796
   Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464
   Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680
   Samelson EJ, 2007, J BONE MINER RES, V22, P1449, DOI 10.1359/JBMR.070519
   Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815
   Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711
   Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755
   Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191
NR 24
TC 6
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 453
EP 461
DI 10.4070/kcj.2013.43.7.453
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900003
PM 23964291
OA Green Published
DA 2021-04-22
ER

PT J
AU Demirelli, S
   Karakelleoglu, S
   Gundogdu, F
   Tas, MH
   Kaya, A
   Duman, H
   Degirmenci, H
   Hamur, H
   Simsek, Z
AF Demirelli, Selami
   Karakelleoglu, Sule
   Gundogdu, Fuat
   Tas, Muhammed Hakan
   Kaya, Ahmet
   Duman, Hakan
   Degirmenci, Husnu
   Hamur, Hikmet
   Simsek, Ziya
TI The Impact of Trimetazidine Treatment on Left Ventricular Functions and
   Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment
   Elevation Myocardial Infarction Undergoing Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Natriuretic peptide, brain; Percutaneous coronary intervention;
   Trimetazidine
ID FATTY-ACID OXIDATION; HEART-FAILURE; ARTERY-DISEASE; TRIMPOL-II; ANGINA;
   ISCHEMIA
AB Background and Objectives: The aim of this study was to investigate the impact of treatment with oral trimetazidine (TMZ) applied before and after percutaneous coronary interventions (PCI) on short-term left ventricular functions and plasma brain natriuretic peptide (BNP) levels in patients with non-ST segment elevation myocardial infarction (NSTEMI) undergoing PCI.
   Subjects and Methods: The study included 45 patients who were undergoing PCI with the diagnosis of NSTEMI. The patients were randomized into two groups. The first group (n= 22) of the patients hospitalized with the diagnosis of NSTEMI was given conventional therapy plus 60 mg TMZ just prior to PCI. Treatment with TMZ was continued for one month after the procedure. TMZ treatment was not given to the second group (n= 23). Echocardiography images were recorded and plasma BNP levels were measured just prior to the PCI and on the 1st and 30th days after PCI.
   Results: The myocardial performance index (MPI) was greater in the second group (p= 0.02). In the comparison of BNP levels, they significantly decreased in both of the groups during the 30-day follow-up period (29.0+/-8 and 50.6+/-33, p< 0.01 respectively). However, decreasing of BNP levels was higher in the group administered with TMZ. The decrease of left ventriclular end-diastolic volume was observed in all groups at 30 days after intervention, but was higher in the group administered with TMZ (p= 0.01).
   Conclusion: Trimetazidine treatment commencing prior to PCI and continued after PCI in patients with NSTEMI provides improvements in MPI, left ventricular end diastolic volume and a decrease in BNP levels.
C1 [Demirelli, Selami] Erzurum Reg Training & Res Hosp, Dept Cardiol, Erzurum, Turkey.
   [Karakelleoglu, Sule; Gundogdu, Fuat; Tas, Muhammed Hakan; Simsek, Ziya] Ataturk Univ, Fac Med, Dept Cardiol, Erzurum, Turkey.
   [Kaya, Ahmet] Ordu Univ, Fac Med, Dept Cardiol, Ordu, Turkey.
   [Duman, Hakan] Rize State Hosp, Dept Cardiol, Rize, Turkey.
   [Degirmenci, Husnu] Erzurum Palandoken State Hosp, Dept Cardiol, Erzurum, Turkey.
   [Hamur, Hikmet] Mengucek Gazi Reg Training & Res Hosp, Dept Cardiol, Erzincan, Turkey.
RP Demirelli, S (corresponding author), Erzurum Reg Training & Res Hosp, Dept Cardiol, Erzurum, Turkey.
EM demirelli23@yahoo.com
OI duman, hakan/0000-0002-1441-7320
CR *AM HEART ASS, 1999, 1999 HEART STROK STA
   AUSSEDAT J, 1993, J CARDIOVASC PHARM, V21, P128, DOI 10.1097/00005344-199301000-00019
   Banach M, 2006, ROLE TRIMETAZIDINE T, P52
   Fragasso G, 2006, J AM COLL CARDIOL, V48, P992, DOI 10.1016/j.jacc.2006.03.060
   Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1
   Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580
   Labrou A, 2007, AM J CARDIOVASC DRUG, V7, P143, DOI 10.2165/00129784-200707020-00006
   Lopaschuk Gary D., 1998, Journal of Molecular and Cellular Cardiology, V30, pA112
   Lopez N, 2007, CARDIOVASC RES, V75, P536, DOI 10.1016/j.cardiores.2007.04.025
   Marazzi G, 2007, INT J CARDIOL, V120, P79, DOI 10.1016/j.ijcard.2006.08.082
   NAKAMURA S, 1991, AM J HYPERTENS, V4, P909, DOI 10.1093/ajh/4.11.909
   Patrizia B, 2002, PHARMACOL RES, V45, P69, DOI 10.1006/phrs.2001.0905
   Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603
   Rosano GMC, 2006, AM J CARDIOL, V98, p14J, DOI 10.1016/j.amjcard.2006.07.004
   Ruzyllo W, 2004, CURR MED RES OPIN, V20, P1447, DOI 10.1185/030079904X2637
   Stanley WC, 2002, EXPERT OPIN INV DRUG, V11, P615, DOI 10.1517/13543784.11.5.615
   Szwed H, 2001, EUR HEART J, V22, P2267, DOI 10.1053/euhj.2001.2896
   White HD, 2003, J AM COLL CARDIOL, V42, P1917, DOI 10.1016/j.jacc.2003.09.006
   YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464
NR 19
TC 11
Z9 11
U1 0
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 462
EP 467
DI 10.4070/kcj.2013.43.7.462
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900004
PM 23964292
OA Green Published
DA 2021-04-22
ER

PT J
AU Il Im, S
   Choi, WG
   Rha, SW
   Choi, BG
   Choi, SY
   Kim, SW
   Na, JO
   Choi, CU
   Lim, HE
   Kim, JW
   Kim, EJ
   Park, CG
   Seo, HS
   Oh, DJ
AF Il Im, Sung
   Choi, Woong Gil
   Rha, Seung-Woon
   Choi, Byoung Geol
   Choi, Se Yeon
   Kim, Sun Won
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Kim, Jin Won
   Kim, Eung Ju
   Park, Chang Gyu
   Seo, Hong Seog
   Oh, Dong Joo
TI Significant Response to Lower Acetylcholine Dose Is Associated with
   Worse Clinical and Angiographic Characteristics in Patients with
   Vasospastic Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angina pectoris, variant; Acetylcholine
ID CORONARY-ARTERY SPASM; VARIANT ANGINA; INTRACORONARY INJECTION;
   MYOCARDIAL BRIDGE; HYPERREACTIVITY; ERGONOVINE; INDUCTION; TONE
AB Background and Objectives: The intracoronary injection of acetylcholine (Ach) has been shown to induce coronary spasms in patients with variant angina. Clinical significance and angiographic characteristics of patients with a significant response to lower Ach dosages are as-yet non-clarified compared with patients responding to higher Ach doses.
   Subjects and Methods: A total of 3034 consecutive patients underwent coronary angiography with Ach provocation tests from January 2004 to August 2010. Ach was injected in incremental doses of 20, 50, 100 mu g into the left coronary artery. Significant coronary artery spasm was defined as focal or diffuse severe transient luminal narrowing (> 70%) with/without chest pain or ST-T change on the electrocardiogram (ECG). We compared the clinical and angiographic characteristics of patients who responded to a lower Ach dose (20 or 50 mu g, n= 556) to those that responded to a higher Ach dose (100 mu g, n= 860).
   Results: The baseline clinical and procedural characteristics are well balanced between the two groups, except diabetes was higher in the lower Ach dose group and there were differences in medication history. After adjusting for confounding factors, the lower Ach dose group showed more frequent temporary ST elevation and atrioventricular block on the ECG. Furthermore, the group of patients who responded to the lower Ach dose was associated with a higher incidence of baseline and severe spasm than those who responded to a higher Ach dose.
   Conclusion: Patients with a significant response to a lower Ach dose were associated with more frequent ST elevation, baseline spasm, and more severe spasm compared with those who responded to a higher Ach dose, suggesting more intensive medical therapy with close clinical follow-up is required for those patients.
C1 [Il Im, Sung; Choi, Woong Gil; Rha, Seung-Woon; Choi, Byoung Geol; Choi, Se Yeon; Kim, Sun Won; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo] Korea Univ, Ctr Cardiovasc, Guro Hosp, Seoul 152703, South Korea.
   [Choi, Woong Gil] Konkuk Univ, Dept Cardiol, Chungju Hosp, Chungju, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Ctr Cardiovasc, Guro Hosp, 148 Gurodong Ro, Seoul 152703, South Korea.
EM swrha617@yahoo.co.kr
OI Choi, Byoung Geol/0000-0002-6090-869X
CR Chen KY, 2010, J HUM HYPERTENS, V24, P77, DOI 10.1038/jhh.2009.40
   ELTAMIMI H, 1993, J AM COLL CARDIOL, V21, P1152, DOI 10.1016/0735-1097(93)90239-W
   HORIO Y, 1986, AM J CARDIOL, V57, P984, DOI 10.1016/0002-9149(86)90743-5
   Im SI, 2013, CARDIOLOGY, V125, P250, DOI 10.1159/000351181
   KASKI JC, 1986, CIRCULATION, V74, P1255, DOI 10.1161/01.CIR.74.6.1255
   KASKI JC, 1989, J AM COLL CARDIOL, V14, P1456, DOI 10.1016/0735-1097(89)90382-3
   Kawano H, 2005, INTERNAL MED, V44, P91, DOI 10.2169/internalmedicine.44.91
   KUGA T, 1993, J AM COLL CARDIOL, V22, P144, DOI 10.1016/0735-1097(93)90828-O
   Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283
   Lee SJK, 1996, INT J CARDIOL, V55, P117
   LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702
   Nardi F, 2011, INTERNAL MED, V50, P2601, DOI 10.2169/internalmedicine.50.6086
   NEWMAN CM, 1990, AM J CARDIOL, V66, P1070, DOI 10.1016/0002-9149(90)90507-W
   Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802
   Okumura K, 1996, J AM COLL CARDIOL, V27, P45, DOI 10.1016/0735-1097(95)00432-7
   OKUMURA K, 1988, J AM COLL CARDIOL, V12, P883, DOI 10.1016/0735-1097(88)90449-4
   OKUMURA K, 1988, CIRCULATION, V77, P535, DOI 10.1161/01.CIR.77.3.535
   Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050
   Sakata K, 1997, AM HEART J, V133, P484, DOI 10.1016/S0002-8703(97)70199-6
   Sueda S, 2002, CORONARY ARTERY DIS, V13, P231, DOI 10.1097/00019501-200206000-00005
   YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955
   YASUE H, 1979, CIRCULATION, V59, P938, DOI 10.1161/01.CIR.59.5.938
NR 22
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 468
EP 473
DI 10.4070/kcj.2013.43.7.468
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900005
PM 23964293
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YM
   Lee, HS
   Lim, RS
   Choi, JI
   Lim, HE
   Park, SW
   Choi, IS
   Kim, YH
AF Park, Yae Min
   Lee, Hyun Soo
   Lim, Ra Seung
   Choi, Jong-Il
   Lim, Hong Euy
   Park, Sang Weon
   Choi, In Suck
   Kim, Young-Hoon
TI Inadvertently Developed Ventricular Fibrillation during
   Electrophysiologic Study and Catheter Ablation: Incidence, Cause, and
   Prognosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular fibrillation; Electrophysiologic study, cardiac; Catheter
   ablation
ID DEFIBRILLATION THRESHOLD; ANTIARRHYTHMIC DRUGS; ATRIAL-FIBRILLATION;
   CARDIOVERSION; EFFICACY; HUMANS
AB Background and Objectives: Ventricular fibrillation (VF) can inadvertently occur during electrophysiologic study (EPS) or catheter ablation. We investigated the incidence, cause, and progress of inadvertently developed VF during EPS and catheter ablation.
   Subjects and Methods: We reviewed patients who had developed inadvertent VF during EPS or catheter ablation. Patients who developed VF during programmed ventricular stimulation to induce ventricular tachycardia or VF were excluded.
   Results: Inadvertent VF developed in 11 patients (46.7 +/- 9.3 years old) among 2624 patients (0.42%); during catheter ablation for atrial fibrillation (AF) in nine patients, frequent ventricular premature beats (VPBs) in one, and Wolff-Parkinson-White (WPW) syndrome were observed in one. VF was induced after internal cardioversion in six AF patients due to incorrect R-wave synchronization of a direct current shock. Two AF patients showed spontaneous VF induction during isoproterenol infusion while looking for AF triggering foci. The remaining AF patient developed VF after rapid atrial pacing to induce AF, but the catheter was accidentally moved to the right ventricular (RV) apex. A patient with VPB ablation spontaneously developed VF during isoproterenol infusion. The focus of VPB was in the RV outflow tract and successfully ablated. A patient with WPW syndrome developed VF after rapid RV pacing with a cycle length of 240 ms. Single high energy (biphasic 150-200 J) external defibrillation was successful in all patients, except in two, who spontaneously terminated VF. The procedure was uneventfully completed in all patients. At a mean follow-up period of 17.4 +/- 15.5 months, no patient presented with ventricular arrhythmia.
   Conclusion: Although rare, inadvertent VF can develop during EPS or catheter ablation. Special caution is required to avoid incidental VF during internal cardioversion, especially under isoproterenol infusion.
C1 [Park, Yae Min; Lee, Hyun Soo; Lim, Ra Seung; Choi, Jong-Il; Lim, Hong Euy; Park, Sang Weon; Kim, Young-Hoon] Korea Univ, Div Cardiol, Coll Med, Seoul 136705, South Korea.
   [Choi, In Suck] Gachon Univ, Dept Internal Med, Div Cardiol, Inchon, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Div Cardiol, Med Ctr, 73 Inchon Ro, Seoul 136705, South Korea.
EM yhkmd@unitel.co.kr
CR BABBS CF, 1983, MED INSTRUM, V17, P18
   Barold HS, 1997, J CARDIOVASC ELECTR, V8, P436, DOI 10.1111/j.1540-8167.1997.tb00809.x
   COHEN TJ, 1991, J AM COLL CARDIOL, V18, P1280, DOI 10.1016/0735-1097(91)90547-M
   COOPER RAS, 1993, CIRCULATION, V87, P1673, DOI 10.1161/01.CIR.87.5.1673
   DENES P, 1983, J AM COLL CARDIOL, V1, P292, DOI 10.1016/S0735-1097(83)80030-8
   GUARNIERI T, 1987, AM J CARDIOL, V60, P1061, DOI 10.1016/0002-9149(87)90352-3
   HOROWITZ LN, 1987, J AM COLL CARDIOL, V9, P1261, DOI 10.1016/S0735-1097(87)80465-5
   Kanda M, 2002, J AM COLL CARDIOL, V39, P1799, DOI 10.1016/S0735-1097(02)01867-3
   Kettering K, 2000, Z KARDIOL, V89, P269, DOI 10.1007/s003920050484
   LERMAN BB, 1987, J CLIN INVEST, V80, P797, DOI 10.1172/JCI113136
   MARINCHAK RA, 1988, PACE, V11, P7, DOI 10.1111/j.1540-8159.1988.tb03925.x
   MURGATROYD FD, 1995, J AM COLL CARDIOL, V25, P1347, DOI 10.1016/0735-1097(94)00555-5
   OPIE LH, 1979, AM J CARDIOL, V43, P131, DOI 10.1016/0002-9149(79)90055-9
   ROSENTHAL RE, 1986, AM J EMERG MED, V4, P248, DOI 10.1016/0735-6757(86)90079-3
   SCHEINMAN MM, 1983, CIRCULATION, V67, P1169, DOI 10.1161/01.CIR.67.6.1169
   SHARMA AD, 1983, J PHARMACOL EXP THER, V227, P716
   SURAWICZ B, 1982, CIRCULATION, V65, P428, DOI 10.1161/01.CIR.65.3.428
   WINKLE RA, 1990, CIRCULATION, V81, P1477, DOI 10.1161/01.CIR.81.5.1477
NR 18
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 474
EP 480
DI 10.4070/kcj.2013.43.7.474
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900006
PM 23964294
OA Green Published
DA 2021-04-22
ER

PT J
AU Fukuda, T
   Kurano, M
   Fukumura, K
   Yasuda, T
   Iida, H
   Morita, T
   Yamamoto, Y
   Takano, N
   Komuro, I
   Nakajima, T
AF Fukuda, Taira
   Kurano, Miwa
   Fukumura, Kazuya
   Yasuda, Tomohiro
   Iida, Haruko
   Morita, Toshihiro
   Yamamoto, Yumiko
   Takano, Nami
   Komuro, Issei
   Nakajima, Toshiaki
TI Cardiac Rehabilitation Increases Exercise Capacity with a Reduction of
   Oxidative Stress
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Reactive oxygen species; Antioxidants; Exercise therapy; Oxygen
   consumption; Cardiovascular diseases
ID PHYSICAL-ACTIVITY
AB Background and Objectives: Reactive oxygen species (ROS) mediate various signaling pathways that underlie vascular inflammation in atherogenesis and cardiovascular diseases. Cardiac rehabilitation (CR) has a variety of multiple beneficial effects, including anti-inflammatory effects. The purpose of the present study was to investigate the effects of CR on ROS in patients with cardiovascular diseases.
   Subjects and Methods: The serum level of derivatives of reactive oxidative metabolites, an index of oxidative stress, was measured in 100 patients with cardiovascular diseases before, and, subsequently, 3 and 6 months after, CR. A biological antioxidant potential (BAP) test was applied to assess the antioxidant power of the serum.
   Results: The resting reactive oxidative metabolite levels decreased 3-6 months after CR {pre: 351+/- 97 Carratelli unit (CARR U), 3 months: 329+/-77 CARR U, 6 months: 325+/-63 CARR U, all p< 0.01} with the increase of the percentage of the predicted values of VO2peak and the percentage of the predicted values of VO2 at the anaerobic threshold (VO2 AT) and the decrease of the B-type natriuretic peptide (BNP). The BAP test and antioxidative/oxidative stress ratio increased 6 months after CR. The % changes of the antioxidative/oxidative stress ratio was positively correlated with the % changes of VO2 AT, and negatively correlated with the % changes of the BNP.
   Conclusion: These results suggest that intensive supervised CR significantly improved exercise capacity, which may be attributable to an adaptive response involving more efficient oxidative metabolites or the increased capacity of endogenous anti-oxidative systems in patients with cardiovascular diseases.
C1 [Fukuda, Taira] Hitotsubashi Univ, Ctr Hlth, Tokyo 1868601, Japan.
   [Fukuda, Taira; Kurano, Miwa; Fukumura, Kazuya; Yasuda, Tomohiro; Iida, Haruko; Morita, Toshihiro; Nakajima, Toshiaki] Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan.
   [Yamamoto, Yumiko; Takano, Nami; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan.
RP Fukuda, T (corresponding author), Hitotsubashi Univ, Ctr Hlth, 2-1 Naka, Tokyo 1868601, Japan.
EM t.fukuda@r.hit-u.ac.jp
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [25750288] Funding Source: KAKEN
CR Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E
   Cesarone MR, 1999, INT ANGIOL, V18, P127
   Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532
   Fukui T, 2011, HYPERTENS RES, V34, P1041, DOI 10.1038/hr.2011.76
   Gerardi G, 2002, CLIN CHEM LAB MED, V40, P104, DOI 10.1515/CCLM.2002.019
   Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408
   Harrison D, 2003, AM J CARDIOL, V91, p7A
   Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005
   LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005
   Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5
   Lubrano V, 2002, IMMUNO-ANAL BIOL SPE, V17, P172, DOI DOI 10.1016/S0923-2532(02)01188-2
   Mercken EM, 2005, AM J RESP CRIT CARE, V172, P994, DOI 10.1164/rccm.200411-1580OC
   PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804
   Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270
   Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103
   Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011
NR 18
TC 10
Z9 10
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 481
EP 487
DI 10.4070/kcj.2013.43.7.481
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900007
PM 23964295
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Kim, DH
   Choi, WG
   Il Woo, S
   Choi, IS
   Kwan, J
   Park, KS
   Shin, SH
AF Kim, Soo Hyun
   Kim, Dae-Hyeok
   Choi, Woong Gil
   Il Woo, Seoung
   Choi, In Suk
   Kwan, Jun
   Park, Keum Soo
   Shin, Sung-Hee
TI Intercoronary Communication between the Circumflex and Right Coronary
   Arteries Coexisted with Coronary Vasospasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Coronary vasospasm
AB Intercoronary arterial connection between normal coronary arteries is a rare variant of coronary anatomy in which there is open-ended circulation. It is distinguished from collaterals seen in the occlusive coronary artery disease. We report a case of bidirectional intercoronary communication between the left circumflex artery and the right coronary artery without occlusive coronary artery disease, but with left anterior descending artery spasm.
C1 [Kim, Soo Hyun; Choi, Woong Gil] Konkuk Univ, Coll Med, Div Cardiol, Dept Internal Med, Chungju, South Korea.
   [Kim, Dae-Hyeok; Il Woo, Seoung; Kwan, Jun; Park, Keum Soo; Shin, Sung-Hee] Inha Univ, Coll Med, Div Cardiol, Dept Internal Med, Inchon 400711, South Korea.
   [Choi, In Suk] Gachon Univ, Dept Internal Med, Div Cardiol, Inchon, South Korea.
RP Shin, SH (corresponding author), Inha Univ, Coll Med, Div Cardiol, Dept Internal Med, 27 Inhang Ro, Inchon 400711, South Korea.
EM sshin@inha.ac.kr
CR Atak R, 2002, HEART, V88, P29, DOI 10.1136/heart.88.1.29
   Chung Seung-Kyu, 2010, Korean Circ J, V40, P465, DOI 10.4070/kcj.2010.40.9.465
   Fournier JA, 2003, REV ESP CARDIOL, V56, P1026, DOI 10.1157/13052394
   Gavrielatos Gerasimos, 2006, Int J Cardiol, V112, pe63, DOI 10.1016/j.ijcard.2006.02.034
   Gur M, 2006, INT J CARDIOVAS IMAG, V22, P339, DOI 10.1007/s10554-005-9042-y
   Ozlu MF, 2010, TURK KARDIYOL DERN A, V38, P416
   REIG J, 1995, ANGIOLOGY, V46, P235, DOI 10.1177/000331979504600307
   Sengul C, 2011, TURK KARDIYOL DERN A, V39, P344, DOI 10.5543/tkda.2011.01380
   TAKATSU F, 1989, CATHETER CARDIO DIAG, V16, P103, DOI 10.1002/ccd.1810160207
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 10
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 488
EP 490
DI 10.4070/kcj.2013.43.7.488
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900008
PM 23964296
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, H
   Lee, SJ
   Park, JK
   Choi, IS
   Won, HY
   Kim, S
   Cha, JJ
   Lee, BK
AF Chung, Hyemoon
   Lee, Sung-Joo
   Park, Jong-Kwan
   Choi, In Suk
   Won, Ho Yeon
   Kim, Sohee
   Cha, Jung-Joon
   Lee, Byoung Kwon
TI Spontaneous Coronary Artery Dissection Mimicking Coronary Spasm
   Diagnosed by Intravascular Ultrasonography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery dissection, spanteneous; Ultrasonography,
   interventional; Coronary vasospasm
ID MANAGEMENT; ULTRASOUND; PROGNOSIS; THERAPY
AB Spontaneous coronary artery dissection (SCAD) is a rare and occasionally life-threatening cause of acute coronary syndrome. Patients may present with clinical scenarios ranging from angina pectoris to cardiogenic shock to sudden cardiac death, and it may be a potentially life-threatening condition if not recognized. However, its etiology, pathophysiology and optimal therapeutic strategies have not been well understood. SCAD is diagnosed on the basis of coronary angiography, but complementary techniques as such intravascular ultrasound (IVUS) and optical coherence tomography should be considered for diagnostic clarification where appropriate. Likewise, the selection of treatment strategy depends upon the clinical manifestation, location and the extent of dissection and amount of ischemic myocardium at risk. Herein, we present the case of a 35-year-old woman who presented with acute myocardial infarction. She was diagnosed by IVUS with spontaneous diffuse dissection of the left anterior descending artery without atheroma, treated with percutaneous coronary stenting, and had a favorable clinical course and was discharged on medical therapy.
C1 [Chung, Hyemoon; Kim, Sohee; Cha, Jung-Joon; Lee, Byoung Kwon] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Gangnam Severance Hosp, Seoul 135720, South Korea.
   [Lee, Sung-Joo] Chungju Med Ctr, Div Cardiol, Dept Internal Med, Chungju, South Korea.
   [Park, Jong-Kwan] NHIC Ilsan Hosp, Div Cardiol, Dept Internal Med, Goyang, South Korea.
   [Choi, In Suk] Gachon Univ, Div Cardiol, Dept Internal Med, Inchon, South Korea.
   [Won, Ho Yeon] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Severance Hosp, Seoul 135720, South Korea.
RP Lee, BK (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Gangnam Severance Hosp, 211 Eonju Ro, Seoul 135720, South Korea.
EM cardiobk@yuhs.ac
OI Park, Jong Kwan/0000-0002-5506-1412; Lee, Byoung
   Kwon/0000-0001-9259-2776; Cha, Jung-Joon/0000-0002-8299-1877
CR Adlam D, 2010, J INVASIVE CARDIOL, V22, P549
   Almafragi A, 2010, CARDIOL J, V17, P92
   Almeda FQ, 2004, CLIN CARDIOL, V27, P377, DOI 10.1002/clc.4960270702
   Arnold JR, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-24
   Borczuk AC, 1997, CARDIOVASC RES, V33, P527, DOI 10.1016/S0008-6363(96)00257-X
   Desai S, 2012, AM J FOREN MED PATH, V33, P26, DOI 10.1097/PAF.0b013e3181e29598
   GONZALEZ JI, 1989, AM J CARDIOL, V63, P885, DOI 10.1016/0002-9149(89)90068-4
   Hering D, 1998, Z KARDIOL, V87, P961, DOI 10.1007/s003920050253
   JORGENSEN MB, 1994, AM HEART J, V127, P1382, DOI 10.1016/0002-8703(94)90060-4
   Lerakis S, 2001, J AM SOC ECHOCARDIOG, V14, P1132, DOI 10.1067/mje.2001.115654
   Maehara A, 2002, AM J CARDIOL, V89, P466, DOI 10.1016/S0002-9149(01)02272-X
   Manghat NE, 2005, CLIN RADIOL, V60, P1120, DOI 10.1016/j.crad.2005.05.009
   Mortensen KH, 2009, CATHETER CARDIO INTE, V74, P710, DOI 10.1002/ccd.22115
   Paraskevaidis S, 2010, OPEN CARDIOVASC MED, V4, P178, DOI 10.2174/1874192401004010178
   Pretty HC, 1931, BMJ-BRIT MED J, V1, P341, DOI [10.1136/bmj.1.3667.667, DOI 10.1136/BMJ.1.3667.667]
   Regar E, 2011, HERZ, V36, P417, DOI 10.1007/s00059-011-3487-7
   ROBINOWITZ M, 1982, AM J MED, V72, P923, DOI 10.1016/0002-9343(82)90853-1
   Shamloo BK, 2010, J INVASIVE CARDIOL, V22, P222
   Tweet MS, 2012, CIRCULATION, V126, P579, DOI 10.1161/CIRCULATIONAHA.112.105718
   Vanzetto G, 2009, EUR J CARDIO-THORAC, V35, P250, DOI 10.1016/j.ejcts.2008.10.023
NR 20
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 491
EP 496
DI 10.4070/kcj.2013.43.7.491
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900009
PM 23964297
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, Y
   Lim, J
   Lim, J
   Kim, S
   Jung, T
   Choi, W
AF Kim, Youngjoong
   Lim, Joohan
   Lim, Jonggu
   Kim, Soohyun
   Jung, Taeyoung
   Choi, Woonggil
TI Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hemoptysis; Antiplatelet drugs; Myocardial infarction
ID ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA; EVENTS CURE; ASPIRIN;
   INTERVENTION; COMBINATION; THERAPY; TRIAL
AB Combination treatment of antiplatelet drugs containing aspirin and clopidogrel reduces systemic ischemic events after percutaneous coronary intervention (PCI) in high risk patients. However, this combination treatment of antiplatelet drugs is associated with increased risk of nonfatal and fatal bleeding. Diffuse alveolar hemorrhage after PCI is a rare complication that has been mostly reported in association with glycoprotein IIb/IIIa inhibitors. We report the case of a 62-year-old man who presented with ST elevation myocardial infarction and suffered a diffuse alveolar hemorrhage after clopidogrel use following primary PCI.
C1 [Kim, Youngjoong; Lim, Jonggu; Kim, Soohyun; Jung, Taeyoung; Choi, Woonggil] Konkuk Univ, Coll Med, Div Cardiol, Dept Internal Med, Chungju 380704, South Korea.
   [Lim, Joohan] Inha Univ, Coll Med, Dept Internal Med, Div Hematooncol, Inchon, South Korea.
RP Choi, W (corresponding author), Konkuk Univ, Coll Med, Div Cardiol, Dept Internal Med, 82 Gugwon Daero, Chungju 380704, South Korea.
EM gilll7@kku.ac.kr
CR Chae，Sung-Chul, 2004, Korean Circulation Journal, V34, P23
   Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812
   Ener Rasih Atilla, 2006, J Invasive Cardiol, V18, P254
   Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B
   Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271
   Ikeda M, 2011, CARDIOVASC REVASCULA, V12, P407, DOI 10.1016/j.carrev.2011.03.003
   Kilaru P K, 2001, J Invasive Cardiol, V13, P535
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4
   Payne DA, 2002, J VASC SURG, V35, P1204, DOI 10.1067/mva.2002.122027
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
NR 11
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 497
EP 499
DI 10.4070/kcj.2013.43.7.497
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900010
PM 23964298
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, MH
   Nah, JC
AF Kang, Min-Ho
   Nah, Jong-Chun
TI A Delayed, Unusual Non-Cardiogenic Pulmonary Edema after Intravascular
   Administration of Non-Ionic, Low Osmolar Radiocontrast Media for
   Coronary Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary edema; Hypersensitivity; Contrast media
ID RADIOGRAPHIC CONTRAST-MEDIA; AGENTS
AB Non-cardiogenic pulmonary edema (NCPE) is a rare adverse reaction to iodinated radiocontrast media (RCM), in which all previous cases were immediate reactions. A 56-year-old male was given iopamidol, a non-ionic, low osmolar RCM, during coronary artery angiography. He developed pulmonary edema and fever a day after the procedure. Despite diuretic therapy, the patient's pulmonary edema worsened and his high fever persisted. The patient's pulmonary edema was eventually resolved with intravenous steroid treatment. We interpreted the patient's condition as NCPE manifesting as a delayed reaction to RCM. To our knowledge, our case is the first to show NCPE as a delayed hypersensitivity reaction.
C1 [Kang, Min-Ho; Nah, Jong-Chun] Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, Seoul 100032, South Korea.
RP Nah, JC (corresponding author), Inje Univ, Sch Med, Seoul Paik Hosp, Div Cardiol,Dept Med, 9 Mareunnae Ro, Seoul 100032, South Korea.
EM drjcna@nate.com
CR Bellin MF, 2011, EUR RADIOL, V21, P2305, DOI 10.1007/s00330-011-2200-9
   Bristedt P, 1998, ACTA RADIOL, V39, P81
   Brockow K, 2005, ALLERGY, V60, P150, DOI 10.1111/j.1398-9995.2005.00745.x
   Brockow K, 2009, IMMUNOL ALLERGY CLIN, V29, P453, DOI 10.1016/j.iac.2009.04.001
   Christiansen C, 2000, EUR RADIOL, V10, P1965, DOI 10.1007/s003300000543
   Christiansen C, 2002, CURR OPIN ALLERGY CL, V2, P333, DOI 10.1097/00130832-200208000-00007
   GOLDSMITH SR, 1995, J ALLERGY CLIN IMMUN, V96, P698, DOI 10.1016/S0091-6749(95)70272-5
   Hauggaard A, 1996, ACTA RADIOL, V37, P823
   Nakajima T, 2005, NEUROL SURG TOKYO, V33, P703
   Namasivayam S, 2006, EMERG RADIOL, V12, P210, DOI 10.1007/s10140-006-0488-6
   Nayak KR, 2009, J INVASIVE CARDIOL, V21, P548
   Newman B, 2001, PEDIATR RADIOL, V31, P597, DOI 10.1007/s002470100483
   Paul RE, 2002, LANCET, V359, P1037, DOI 10.1016/S0140-6736(02)08068-6
   RAMESH S, 1995, ANN ALLERG ASTHMA IM, V75, P308
   Webb JAW, 2003, EUR RADIOL, V13, P181, DOI 10.1007/s00330-002-1650-5
NR 15
TC 2
Z9 2
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 500
EP 503
DI 10.4070/kcj.2013.43.7.500
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900011
PM 23964299
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, JA
   Yang, TH
   Lee, JY
   Koo, DW
   Choi, IS
   Cho, SY
   Kim, MS
AF Hwang, Ji-An
   Yang, Tae-Hyun
   Lee, Ji-Young
   Koo, Dong-Wan
   Choi, In Suk
   Cho, Sun-Young
   Kim, Min-Sung
TI Severe Pulmonary Hypertension in Primary Sjogren's Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension, pulmonary; Sjogren's syndrome
ID CONNECTIVE-TISSUE DISEASES; PROGRESSIVE SYSTEMIC-SCLEROSIS;
   ARTERIAL-HYPERTENSION; LUPUS-ERYTHEMATOSUS; THERAPY; ASSOCIATION;
   INVOLVEMENT; DIAGNOSIS
AB A 65 year-old female with a history of xerostomia and xerophthalmia was presented with dyspnea on exertion (New York Heart Association class III). Echocardiography and cardiac catheterization demonstrated severe pulmonary hypertension (PH). Laboratory examinations showed positive anti-nuclear and anti-Ro/SS-A antibodies. Schirmer's test was positive and salivary gland scintigraphy revealed severely decreased tracer uptakes in both parotid and submandibular glands. By excluding other possible causes of PH during further examinations, she was diagnosed with severe PH associated with primary Sjogren's syndrome. Her dyspnea symptom was much improved with endothelin receptor antagonist and azathioprine.
C1 [Hwang, Ji-An; Yang, Tae-Hyun; Lee, Ji-Young; Koo, Dong-Wan; Cho, Sun-Young; Kim, Min-Sung] Inje Univ, Coll Med, Busan Paik Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Res Inst, Pusan 614735, South Korea.
   [Choi, In Suk] Gachon Univ, Dept Internal Med, Div Cardiol, Inchon, South Korea.
RP Yang, TH (corresponding author), Inje Univ, Coll Med, Busan Paik Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Res Inst, 75 Bokji Ro, Pusan 614735, South Korea.
EM yangthmd@naver.com
CR Distler O, 2006, RHEUMATOLOGY, V45, P22, DOI 10.1093/rheumatology/kel314
   FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580
   Gonzalez-Lopez L, 2004, LUPUS, V13, P105, DOI 10.1191/0961203304lu509oa
   Kamata Y, 2005, ANN RHEUM DIS, V64, P1236, DOI 10.1136/ard.2004.029074
   Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275
   Kim KH, 2000, KOREAN CIRC J, V30, P605
   Kokosi M, 2010, CLIN CHEST MED, V31, P489, DOI 10.1016/j.ccm.2010.05.007
   Launay D, 2007, MEDICINE, V86, P299, DOI 10.1097/MD.0b013e3181579781
   Nakagawa N, 2003, INTERNAL MED, V42, P1248, DOI 10.2169/internalmedicine.42.1248
   QUISMORIO FP, 1984, SEMIN ARTHRITIS RHEU, V13, P349, DOI 10.1016/0049-0172(84)90015-5
   SALERNI R, 1977, ANN INTERN MED, V86, P394, DOI 10.7326/0003-4819-86-4-394
   Sanchez O, 2002, REV MED INTERNE, V23, P41, DOI 10.1016/S0248-8663(01)00514-8
   Sanchez O, 1999, THORAX, V54, P273, DOI 10.1136/thx.54.3.273
   Sanchez O, 2006, CHEST, V130, P182, DOI 10.1378/chest.130.1.182
   SATO T, 1993, HUM PATHOL, V24, P199, DOI 10.1016/0046-8177(93)90301-V
   SOWA JM, 1993, HUM PATHOL, V24, P1035, DOI 10.1016/0046-8177(93)90122-W
   UNGERER RG, 1983, AM J MED, V75, P65, DOI 10.1016/0002-9343(83)91169-5
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   WIENERKRONISH JP, 1981, AM REV RESPIR DIS, V124, P499
NR 19
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 504
EP 507
DI 10.4070/kcj.2013.43.7.504
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900012
PM 23964300
OA Green Published
DA 2021-04-22
ER

PT J
AU Suzuki, S
   Ozawa, S
AF Suzuki, Satoru
   Ozawa, Seiji
TI Bicuspid Aortic Valve and Coronary Artery Stenosis in the Cardiac CT
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID COMPUTED-TOMOGRAPHY; ANGIOGRAPHY
C1 [Suzuki, Satoru; Ozawa, Seiji] Ozawa Clin, Kumamoto 8600812, Japan.
RP Suzuki, S (corresponding author), Ozawa Clin, Chuoh Ku, 4-3-20 Minami Kumamoto, Kumamoto 8600812, Japan.
EM s-satoru@kumamoto-u.ac.jp
CR Fayad ZA, 2002, CIRCULATION, V106, P2026, DOI 10.1161/01.CIR.0000034392.34211.FC
   Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2013
VL 43
IS 7
BP 508
EP 509
DI 10.4070/kcj.2013.43.7.508
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GV
UT WOS:000342387900013
PM 23964301
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YR
   Han, KH
AF Kim, Yoo Ri
   Han, Ki Hoon
TI Familial Hypercholesterolemia and the Atherosclerotic Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypercholesterolemia, familial; Low density lipoprotein-cholesterol;
   Hydroxymethyglutanyl-CoA Reductase Inhibitors; Ezetimibe
ID CORONARY-HEART-DISEASE; LDL CHOLESTEROL; GENETIC CAUSES; DIAGNOSIS
AB Familial hypercholesterolemia (FH) is associated with premature atherosclerotic cardiovascular diseases, and is inherited as an autosomal dominant trait. The prevalence of heterozygous FH is one in five hundred people. Owing to dysfunctional low density lipoprotein (LDL) receptors due to genetic mutations, serum low density lipoprotein-cholesterol (LDL-C) levels are considerably increased from birth. FH is clinically diagnosed by confirmation of family history and characteristic findings such as tendon xanthoma or xanthelasma. Thus, clinical concern and suspicion are important for early diagnosis of the disease. Current guidelines recommend lowering LDL-C concentration to at least 50% from baseline. Statins are shown to lower LDL-C levels with high safety, and thus, have been the drug of choice. However, it is difficult to achieve an ideal level of LDL-C with a single statin therapy in the majority of FH patients. Alternatively, lipid lowering combination therapy with the recently-introduced ezetimibe has shown more encouraging results.
C1 [Kim, Yoo Ri; Han, Ki Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea.
RP Han, KH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olympic Ro 43 Gil, Seoul 138736, South Korea.
EM steadyhan@amc.seoul.kr
CR Akram ON, 2010, ARTERIOSCL THROM VAS, V30, P1279, DOI 10.1161/ATVBAHA.110.209007
   Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567
   Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356
   Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1
   Scientific Steering Committee on behalf of the Simon Broome Register Group, 1991, BMJ, V303, P893
   Sibley C, 2006, CLEV CLIN J MED, V73, P57, DOI 10.3949/ccjm.73.1.57
   Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836
   Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X
   WHO Human Genetics Programme, 1999, FAM HYP FH REP 2 WHO
   Wierzbicki AS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1095
   WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6
   Yuan G, 2006, CAN MED ASSOC J, V174, P1124, DOI 10.1503/cmaj.051313
   1999, ATHEROSCLEROSIS, V142, P105
NR 15
TC 8
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 363
EP 367
DI 10.4070/kcj.2013.43.6.363
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300001
PM 23882283
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, HC
   Ahn, Y
AF Jeong, Hae Chang
   Ahn, Youngkeun
TI False Positive ST-Segment Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PREVALENCE
C1 [Jeong, Hae Chang; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiovasc, 671 Jebong Ro, Kwangju 501757, South Korea.
EM cecilyk@hanmail.net
CR Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA
   Bae MH, 2013, KOREAN CIRC J, V43, P370, DOI 10.4070/kcj.2013.43.6.370
   Chung SL, 2013, AM J EMERG MED, V31, P825, DOI 10.1016/j.ajem.2013.02.009
   Kang WY, 2011, INT J CARDIOL, V146, P207, DOI 10.1016/j.ijcard.2009.07.001
   Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754
   McCabe JM, 2012, ARCH INTERN MED, V172, P864, DOI 10.1001/archinternmed.2012.945
   McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072
   Nfor T, 2012, J EMERG MED, V43, P561, DOI 10.1016/j.jemermed.2011.09.027
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580
   Widimsky P, 2006, CAN J CARDIOL, V22, P1147, DOI 10.1016/S0828-282X(06)70952-7
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 368
EP 369
DI 10.4070/kcj.2013.43.6.368
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300002
PM 23882284
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, MH
   Cheon, SS
   Song, JH
   Jang, SY
   Choi, WS
   Kim, KH
   Park, SH
   Lee, JH
   Yang, DH
   Park, HS
   Cho, Y
   Chae, SC
AF Bae, Myung Hwan
   Cheon, Sang Soo
   Song, Joon Hyuk
   Jang, Se Yong
   Choi, Won Suk
   Kim, Kyun Hee
   Park, Sun Hee
   Lee, Jang Hoon
   Yang, Dong Heon
   Park, Hun Sik
   Cho, Yongkeun
   Chae, Shung Chull
TI Etiologies and Predictors of ST-Segment Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; False positive reactions
ID PERCUTANEOUS CORONARY INTERVENTION; BUNDLE-BRANCH BLOCK; CLINICAL
   CHARACTERISTICS; ARTERY-DISEASE; Q-WAVE; ELECTROCARDIOGRAM;
   REPOLARIZATION; ANGIOGRAPHY; PREVALENCE; DIAGNOSIS
AB Background and Objectives: Rapid diagnosis of ST-segment elevation myocardial infarction (STEMI) is essential for the appropriate management of patients. We investigated the prevalence, etiologies and predictors of false-positive diagnosis of STEMI and subsequent inappropriate catheterization laboratory activation in patients with presumptive diagnosis of STEMI.
   Subjects and Methods: Four hundred fifty-five consecutive patients (62 +/- 13 years, 345 males) with presumptive diagnosis of STEMI between August 2008 and November 2010 were included.
   Results: A false-positive diagnosis of STEMI was made in 34 patients (7.5%) with no indication of coronary artery lesion. Common causes for the false-positive diagnosis were coronary spasm in 10 patients, left ventricular hypertrophy in 5 patients, myocarditis in 4 patients, early repolarization in 3 patients, and previous myocardial infarction and stress-induced cardiomyopathy in 2 patients each. In multivariate logistic regression analysis, symptom-to-door time >12 hours {odds ratio (OR) 4.995, 95% confidence interval (CI) 1.384-18.030, p=0.014}, presenting symptom other than chest pain (OR 7.709, 95% CI 1.255-39.922, p=0.027), absence of Q wave (OR 9.082, CI 2.631-31.351, p<0.001) and absence of reciprocal changes on electrocardiography (ECG) (OR 17.987, CI 5.295-61.106, p<0.001) were independent predictors of false-positive diagnosis of STEMI.
   Conclusion: In patients whom STEMI was planned for primary coronary intervention, the false-positive diagnosis of STEMI was not rare. Correct interpretation of ECGs and consideration of ST-segment elevation in conditions other than STEMI may reduce inappropriate catheterization laboratory activation.
C1 [Bae, Myung Hwan; Cheon, Sang Soo; Song, Joon Hyuk; Jang, Se Yong; Choi, Won Suk; Kim, Kyun Hee; Park, Sun Hee; Lee, Jang Hoon; Yang, Dong Heon; Park, Hun Sik; Cho, Yongkeun; Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, Taegu 700721, South Korea.
RP Cho, Y (corresponding author), Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM choyk@mail.knu.ac.kr
CR Ahmar W, 2008, INT J CARDIOL, V128, P131, DOI 10.1016/j.ijcard.2007.05.053
   Al-Faleh H, 2006, AM HEART J, V151, P10, DOI 10.1016/j.ahj.2005.02.043
   Antikainen RL, 2006, J HUM HYPERTENS, V20, P451, DOI 10.1038/sj.jhh.1002006
   Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065
   Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892
   Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908
   Gu YL, 2008, NETH HEART J, V16, P325, DOI 10.1007/BF03086173
   Hung MJ, 2007, INT J CARDIOL, V117, P37, DOI 10.1016/j.ijcard.2006.03.055
   Kang WY, 2011, INT J CARDIOL, V146, P207, DOI 10.1016/j.ijcard.2009.07.001
   Kim PJ, 2007, CIRC J, V71, P1383, DOI 10.1253/circj.71.1383
   Klinceva M, 2007, INT J CARDIOL, V120, P411, DOI 10.1016/j.ijcard.2006.07.228
   Lange RA, 2004, NEW ENGL J MED, V351, P2195, DOI 10.1056/NEJMcp041997
   Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754
   Lee Jun-Won, 2010, Korean Circ J, V40, P277, DOI 10.4070/kcj.2010.40.6.277
   MILLER DH, 1987, ARCH INTERN MED, V147, P257, DOI 10.1001/archinte.147.2.257
   Nakayama N, 2009, CIRC J, V73, P484, DOI 10.1253/circj.CJ-08-0554
   Peterson ED, 1996, J AM COLL CARDIOL, V28, P305, DOI 10.1016/0735-1097(96)00133-7
   Prasad A, 2007, CIRCULATION, V115, pE56, DOI 10.1161/CIRCULATIONAHA.106.669341
   Prasad SB, 2008, AM J CARDIOL, V102, P155, DOI 10.1016/j.amjcard.2008.03.031
   Sasaki K, 2001, AM J CARDIOL, V87, P1340, DOI 10.1016/S0002-9149(01)01549-1
   Sgarbossa EB, 1996, NEW ENGL J MED, V334, P481, DOI 10.1056/NEJM199602223340801
   Surawicz B, 2002, J AM COLL CARDIOL, V40, P1870, DOI 10.1016/S0735-1097(02)02492-0
   Takagi M, 2007, J CARDIOVASC ELECTR, V18, P1244, DOI 10.1111/j.1540-8167.2007.00971.x
   Tsuka Y, 1999, CORONARY ARTERY DIS, V10, P465, DOI 10.1097/00019501-199910000-00006
   Turnipseed SD, 2006, ACAD EMERG MED, V13, P961, DOI 10.1197/j.aem.2006.04.014
   Watanabe K, 2004, CIRC J, V68, P280, DOI 10.1253/circj.68.280
   Yan RT, 2007, AM J CARDIOL, V100, P169, DOI 10.1016/j.amjcard.2007.02.074
NR 27
TC 9
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 370
EP 376
DI 10.4070/kcj.2013.43.6.370
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300003
PM 23882285
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, WH
   Park, HW
   Song, IG
   Yang, DJ
   Seo, YH
   Bin Yuk, H
   Park, YH
   Kwon, TG
   Rihal, CS
   Lerman, A
   Lee, MS
   Bae, JH
AF Kim, Ki Hong
   Kim, Wan Ho
   Park, Hyun Woong
   Song, In Girl
   Yang, Dong Ju
   Seo, Young Hoon
   Bin Yuk, Hyung
   Park, Yo Han
   Kwon, Taek Geun
   Rihal, Charanjit S.
   Lerman, Amir
   Lee, Moo-Sik
   Bae, Jang-Ho
TI Impact of Plaque Composition on Long-Term Clinical Outcomes in Patients
   with Coronary Artery Occlusive Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Intravascular ultrasonography; Plaque, atherosclerotic; Coronary artery
   disease
ID HISTOLOGY-INTRAVASCULAR ULTRASOUND; VIRTUAL HISTOLOGY;
   MYOCARDIAL-INFARCTION; VULNERABLE PLAQUE; RISK-FACTORS; ATHEROSCLEROSIS;
   CLASSIFICATION; ASSOCIATION; PREDICTORS; DISRUPTION
AB Background and Objectives: It is unclear which plaque component is related with long-term clinical outcomes in patients with coronary artery occlusive disease (CAOD). We assessed the relationship between plaque compositions and long-term clinical outcomes in those patients.
   Subjects and Methods: The study subjects consisted of 339 consecutive patients (mean 61.7 +/- 12.2 years old, 239 males) who underwent coronary angiogram and a virtual histology-intravascular ultrasound examination. Major adverse cardiac and cerebrovascular events (MACCE), including all-cause death, non-fatal myocardial infarction, cerebrovascular events, and target vessel revascularization were evaluated during a mean 28-month follow-up period.
   Results: Patients with high fibrofatty volume (FFV, >8.90 mm(3), n=169) had a higher incidence of MACCE (25.4% vs. 14.7%, p=0.015), male sex (75.7% vs. 65.3%, p=0.043), acute coronary syndrome (53.3% vs. 35.9%, p=0.002), multivessel disease (62.7% vs. 41.8%, p<0.001) and post-stent slow flow (10.7% vs. 2.4%, p=0.002) than those with low FFV (FFV=8.90 mm(3), n=170). Other plaque composition factors such as fibrous area/volume, dense calcified area/volume, and necrotic core area/volume did not show any impact on MACCE. Cardiogenic shock {hazard ratio (HR)=8.44; 95% confidence interval (CI)=3.00-23.79; p<0.001} and FFV (HR=1.85; 95% CI=1.12-3.07; p=0.016) were the independent predictors of MACCE by Cox regression analysis. Thin-cap fibroatheroma, necrotic core area, and necrotic core volume were not associated with MACCE.
   Conclusion: FFV of a culprit lesion was associated with unfavorable long-term clinical outcomes in patients with CAOD.
C1 [Kim, Ki Hong; Park, Hyun Woong; Song, In Girl; Yang, Dong Ju; Seo, Young Hoon; Bin Yuk, Hyung; Park, Yo Han; Kwon, Taek Geun; Bae, Jang-Ho] Konyang Univ Hosp, Div Cardiol, Taejon 302718, South Korea.
   [Kim, Wan Ho] Andong Sungso Hosp, Andong, South Korea.
   [Rihal, Charanjit S.; Lerman, Amir] Mayo Clin, Rochester, MN USA.
   [Lee, Moo-Sik] Konyang Univ, Div Epidemiol, Taejon, South Korea.
RP Bae, JH (corresponding author), Konyang Univ Hosp, Div Cardiol, 158 Gwanjeodong Ro, Taejon 302718, South Korea.
EM janghobae@yahoo.co.kr
OI Seo, Young Hoon/0000-0002-7357-2785; Park, Yohan/0000-0001-7416-1841
CR Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822
   BUJA LM, 1994, CIRCULATION, V89, P503, DOI 10.1161/01.CIR.89.1.503
   Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610
   Carlier SG, 2006, J NUCL CARDIOL, V13, P831, DOI 10.1016/j.nuclcard.2006.10.013
   DAVIES MJ, 1993, BRIT HEART J, V69, P377
   DeMaria AN, 2006, J AM COLL CARDIOL, V47, pC32, DOI 10.1016/j.jacc.2005.11.047
   Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9
   FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657
   Frutkin AD, 2007, EUR HEART J, V28, P1783, DOI 10.1093/eurheartj/ehm145
   Fuessl RT, 2001, CORONARY ARTERY DIS, V12, P91, DOI 10.1097/00019501-200103000-00002
   Fujii K, 2005, AM J CARDIOL, V96, P1476, DOI 10.1016/j.amjcard.2005.07.054
   Kim WH, 2012, KOREAN CIRC J, V42, P33, DOI 10.4070/kcj.2012.42.1.33
   LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844
   Marso SP, 2012, JACC-CARDIOVASC IMAG, V5, pS42, DOI 10.1016/j.jcmg.2012.01.008
   Missel E, 2008, EUR HEART J, V29, P2141, DOI 10.1093/eurheartj/ehn293
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nair Anuja, 2007, EuroIntervention, V3, P113
   Nakamura Tomohiro, 2007, J Interv Cardiol, V20, P335, DOI 10.1111/j.1540-8183.2007.00282.x
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Philipp S, 2010, EUR HEART J, V31, P196, DOI 10.1093/eurheartj/ehp428
   Rodriguez-Granillo GA, 2006, HEART, V92, P388, DOI 10.1136/hrt.2004.057810
   Rodriguez-Granillo GA, 2006, AM HEART J, V151, P1020, DOI 10.1016/j.ahj.2005.06.040
   Sabate M, 1999, AM J CARDIOL, V84, P135, DOI 10.1016/S0002-9149(99)00222-2
   Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6
   SILVA JA, 1995, CIRCULATION, V92, P1731, DOI 10.1161/01.CIR.92.7.1731
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Surmely JF, 2007, HEART, V93, P928, DOI 10.1136/hrt.2006.102111
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
NR 29
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 377
EP 383
DI 10.4070/kcj.2013.43.6.377
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300004
PM 23882286
OA Green Published
DA 2021-04-22
ER

PT J
AU Tas, MH
   Aksakal, E
   Gurlertop, Y
   Simsek, Z
   Gundogdu, F
   Sevimli, S
   Bakirci, EM
   Karakelleoglu, S
AF Tas, Muhammed Hakan
   Aksakal, Enbiya
   Gurlertop, Yekta
   Simsek, Ziya
   Gundogdu, Fuat
   Sevimli, Serdar
   Bakirci, Eftal Murat
   Karakelleoglu, Sule
TI Assesment of Myocardial Ischemia by Combination of Tissue
   Synchronisation Imaging and Dobutamine Stress Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dobutamine stress echocardiography; Ischemia; Tissue Synchronisation
   Imaging
ID CARDIAC RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR FUNCTION; MECHANICAL
   DYSSYNCHRONY; HEART-FAILURE; CARDIOMYOPATHY
AB Background and Objectives: Dobutamine stress echocardiography (DSE) is an important non-invasive imaging method for evaluating ischemia. However, wall motion interpretation can be impaired by the experience level of the interpreter and the subjectivity of the visual assessment. In our study we aimed to combine DSE and tissue syncronisation imaging to increase sensitivity for detecting ischemia.
   Subjects and Methods: 50 patients with indications for DSE were included in the study. In 25 patients we found DSE positive for ischemia and in the other 25 patients we found it to be negative. The negative group was accepted as the control group. There was no significant difference in terms of risk factors and echocardiographic parameters between the two groups, except for wall motion scores. In both groups, left ventricular dyssychrony was accepted as the difference between time to peak systolic velocity (Ts) in the reciprocal four couple of non-apical segments at rest and during peak stress. Timings were corrected for heart rate. We compared the differences of the dyssynchronisation value at rest and during peak stress to determine the distinctions within the groups and between the groups of DSE positive and negative patients.
   Results: We found that stress and ischemia did not create any significant difference over the left intraventricular dyssynchrony with DSE, although at the segmenter level it prolonged the time to peak systolic velocity (p<0.05). These alterations did not show any significant difference between positive and negative DSE groups.
   Conclusion: As a result, this segmenter dyssynchrony and the time to peak systolic velocity, which is corrected for heart rate, did not enhance any new value over DSE for detecting ischemia.
C1 [Tas, Muhammed Hakan; Aksakal, Enbiya; Gurlertop, Yekta; Simsek, Ziya; Gundogdu, Fuat; Sevimli, Serdar; Bakirci, Eftal Murat; Karakelleoglu, Sule] Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
RP Tas, MH (corresponding author), Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
EM mhakantas@gmail.com
RI GURLERTOP, Hanefi Yekta/AAG-3036-2021
CR CORDAY E, 1988, EUR HEART J, V9, P29, DOI 10.1093/eurheartj/9.suppl_F.29
   Da Costa A, 2006, HEART RHYTHM, V3, P406, DOI 10.1016/j.hrthm.2005.12.017
   De Sutter J, 2005, AM J CARDIOL, V96, P1543, DOI 10.1016/j.amjcard.2005.07.062
   Dohi K, 2005, J AM COLL CARDIOL, V45, p289A
   Gorcsan J, 2004, AM J CARDIOL, V93, P1178, DOI 10.1016/j.amjcard.2004.01.054
   Gottdiener JS, 2003, CURR PROB CARDIOLOGY, V28, P485, DOI 10.1016/j.cpcardiol.2003.10.001
   Hummel JP, 2005, HEART RHYTHM, V2, P1211, DOI 10.1016/j.hrthm.2005.07.027
   Kang SJ, 2008, J AM SOC ECHOCARDIOG, V21, P948, DOI 10.1016/j.echo.2008.01.009
   Kyriakides ZS, 2007, INT J CARDIOL, V119, P3, DOI 10.1016/j.ijcard.2006.03.091
   Lafitte S, 2006, J AM COLL CARDIOL, V47, P2253, DOI 10.1016/j.jacc.2005.11.087
   LEIER CV, 1983, ANN INTERN MED, V99, P490, DOI 10.7326/0003-4819-99-4-490
   Marwick TH, 2003, HEART, V89, P113, DOI 10.1136/heart.89.1.113
   PICANO E, 2003, STRESS ECHOCARDIOGRA
   Sade LE, 2005, AM J CARDIOL, V96, P141, DOI 10.1016/j.amjcard.2005.03.036
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Tian IW, 2007, J ULTRAS MED, V26, P893, DOI 10.7863/jum.2007.26.7.893
   Valzania C, 2007, EUR J HEART FAIL, V9, P644, DOI 10.1016/j.ejheart.2007.01.009
NR 17
TC 0
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 384
EP 390
DI 10.4070/kcj.2013.43.6.384
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300005
PM 23882287
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, YH
   Enkhdorj, R
   Kim, BK
   Kim, SG
   Kim, JH
   Shin, J
AF Lim, Young-Hyo
   Enkhdorj, Rentsendorj
   Kim, Bae Keun
   Kim, Soon Gil
   Kim, Jeong Hyun
   Shin, Jinho
TI Correlation between Proximal Abdominal Aortic Stiffness Measured by
   Ultrasound and Brachial-Ankle Pulse Wave Velocity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Abdominal aorta; Arteriosclerosis; Blood pressure; Elastic modulus;
   Pulse wave velocity
ID AGE-RELATED-CHANGES; INDEPENDENT PREDICTOR; CARDIOVASCULAR RISK;
   ARTERIAL COMPLIANCE; DISTENSIBILITY; PRESSURE; ATHEROSCLEROSIS; FEMALE;
   INDEX
AB Background and Objectives: The proximal portion of the abdominal aorta (AA) is characterized by minimal arteriosclerosis compared with other aortic segments. To assess the clinical usefulness of this characteristic, the correlation between ultrasonographically measured proximal AA stiffness and brachial-ankle pulse wave velocity (baPWV) was examined.
   Subjects and Methods: 285 subjects were analyzed, half with hypertension and half with normal blood pressure. Proximal AA was examined using ultrasonography; strain, distensibility, elastic modulus, and the stiffness index were determined. After adjustment for age, gender, body mass index (BMI), systolic blood pressure (SBP), and heart rate, the relationships between baPWV and all these parameters were tested.
   Results: The mean age of the study subjects was 58.1 +/- 12.8 years and the mean BMI was 24.3 +/- 3.8 kg/cm(2). 58.9% of the subjects were female. 42.8% were hypertensive subjects. Among the hypertensive subjects, 56.0% were taking antihypertensive medication. Adjusted partial correlation coefficients for the relationship between baPWV with strain, distensibility, elastic modulus, and the stiffness index of the proximal AA were -0.203 (p=0.01), -0.121 (p=0.129), 0.304 (p=0.0001), and 0.299 (p=0.0001), respectively, in normotensive subjects. In the multivariate analyses, such correlations were observed mainly in the normotensive group, whereas there was no association among hypertensive subjects regardless of antihypertensive medication status.
   Conclusion: baPWV is moderately correlated with the stiffness parameters for the proximal AA, mainly in normotensive subjects.
C1 [Lim, Young-Hyo; Kim, Bae Keun; Kim, Soon Gil; Kim, Jeong Hyun; Shin, Jinho] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133792, South Korea.
   [Enkhdorj, Rentsendorj] Shatin Cent Hosp, Dept Gen Surg, Ulaanbaatar, Mongolia.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 17 Heangdang Dong, Seoul 133792, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR Ahlgren AR, 1997, ULTRASOUND MED BIOL, V23, P983, DOI 10.1016/S0301-5629(97)00082-3
   Dart AM, 2008, HYPERTENSION, V51, P1129, DOI 10.1161/HYPERTENSIONAHA.107.106310
   Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93
   Erdogan D, 2006, INT J CARDIOVAS IMAG, V22, P157, DOI 10.1007/s10554-005-9007-1
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Giannattasio C, 2002, J AM COLL CARDIOL, V39, P1275, DOI 10.1016/S0735-1097(02)01755-2
   Giannattasio C, 2007, J HYPERTENS, V25, P593, DOI 10.1097/HJH.0b013e3280119012
   Gosling RG, 2003, HYPERTENSION, V41, P1180, DOI 10.1161/01.HYP.0000072271.36866.2A
   Gur M, 2008, INT J CLIN PRACT, V62, P138, DOI 10.1111/j.1742-1241.2006.01202.x
   Haskett D, 2010, BIOMECH MODEL MECHAN, V9, P725, DOI 10.1007/s10237-010-0209-7
   Hung CS, 2009, NUTR METAB CARDIOVAS, V19, P241, DOI 10.1016/j.numecd.2008.07.006
   Ito N, 2006, HYPERTENS RES, V29, P989, DOI 10.1291/hypres.29.989
   Kaibe M, 2002, GERIATR GERONTOL INT, V2, P199, DOI DOI 10.1046/J.1444-1586.2002.00045.X
   KAWASAKI T, 1987, CARDIOVASC RES, V21, P678, DOI 10.1093/cvr/21.9.678
   Kim MJ, 2008, KOREAN J PEDIAT, V51, P1012
   Kolipaka A, 2012, J MAGN RESON IMAGING, V35, P582, DOI 10.1002/jmri.22866
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Lee Young Soo, 2004, Korean Circulation Journal, V34, P865
   LEHMANN ED, 1993, BRIT J RADIOL, V66, P126, DOI 10.1259/0007-1285-66-782-126
   Li BY, 2006, HYPERTENS RES, V29, P309, DOI 10.1291/hypres.29.309
   신진호, 2005, Korean Circulation Journal, V35, P683
   Mokhtari A, 2008, BLOOD PRESSURE, V17, P291, DOI 10.1080/08037050802584313
   Nakamura U, 2003, HYPERTENS RES, V26, P163, DOI 10.1291/hypres.26.163
   Okubo M, 2001, PEDIATR CARDIOL, V22, P198, DOI 10.1007/s002460010203
   Pannier BM, 2002, AM J HYPERTENS, V15, P743, DOI 10.1016/S0895-7061(02)02962-X
   Pitsavos C, 1998, AM HEART J, V135, P604, DOI 10.1016/S0002-8703(98)70274-1
   Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275
   Regnault V, 2012, J AM COLL CARDIOL, V59, P1771, DOI 10.1016/j.jacc.2012.01.044
   Seo JS, 2007, J KOREAN MED SCI, V22, P536, DOI 10.3346/jkms.2007.22.3.536
   STEFANADIS C, 1990, EUR HEART J, V11, P990, DOI 10.1093/oxfordjournals.eurheartj.a059639
   Tsamis A, 2011, AM J PHYSIOL-HEART C, V301, pH1286, DOI 10.1152/ajpheart.00570.2010
   Zakai NA, 2007, J THROMB HAEMOST, V5, P1128, DOI 10.1111/j.1538-7836.2007.02528.x
NR 32
TC 5
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 391
EP 399
DI 10.4070/kcj.2013.43.6.391
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300006
PM 23882288
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, BS
   Kim, SH
   Jin, T
   Choi, EY
   Oh, J
   Park, S
   Lee, SH
   Chung, JH
   Kang, SM
AF Lee, Beom Seob
   Kim, Soo Hyuk
   Jin, Taewon
   Choi, Eun Young
   Oh, Jaewon
   Park, Sungha
   Lee, Sang Hak
   Chung, Ji Hyung
   Kang, Seok-Min
TI Protective Effect of Survivin in Doxorubicin-Induced Cell Death in H9c2
   Cardiac Myocytes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Apoptosis; Doxorubicin; Myocytes; cardiac
ID P38 MAPK; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; DOWN-REGULATION;
   CREB; ACTIVATION; EXPRESSION; PHOSPHORYLATION; PATHWAY; BCL-2
AB Background and Objectives: Apoptosis has been known to be an important mechanism of doxorubicin-induced cardiotoxicity. Survivin, which belongs to the inhibitor of apoptosis protein family, is associated with apoptosis and alteration of the cardiac myocyte molecular pathways. Therefore, we investigated the anti-apoptotic effect and cellular mechanisms of survivin using a protein delivery system in a doxorubicin-induced cardiac myocyte injury model.
   Materials and Methods: We constructed a recombinant survivin which was fused to the protein transduction domain derived from HIV-TAT protein. In cultured H9c2 cardiac myocytes, TAT-survivin (1 mu M) was added for 1 hour prior to doxorubicin (1 mu M) treatment for 24 hours. Cell viability and apoptosis were evaluated by 2-(4,5-dimethyltriazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, caspase-3 activity, and terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling assay. We measured the expression levels of several apoptosis-related signal proteins.
   Results: The survivin level was significantly reduced in a dose dependent manner up to 1 mu M of doxorubicin in concentration. Purified recombinant TAT-survivin protein was efficiently delivered to H9c2 cardiac myocytes, and its transduction showed an anti-apoptotic effect, demonstrated by reduced caspase-3 activity and the apoptotic index, concomitantly with increased cell viability against doxorubicin injury. The phosphorylation of p38 mitogen-activated protein (MAP) kinase and the release of Smac from mitochondria were suppressed and the expression levels of Bcl-2 and cAMP response element-binding protein (CREB), the transcription factor of Bcl-2, were recovered following TAT-survivin transduction, indicating that survivin had an anti-apoptotic effect against doxorubicin injury.
   Conclusion: Our results suggest that survivin has a potentially cytoprotective effect against doxorubicin-induced cardiac myocyte apoptosis through mechanisms that involve a decrease in the phosphorylation of p38 MAP kinase, mitochondrial Smac release, and increased expression of Bcl-2 and CREB.
C1 [Lee, Beom Seob; Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young] Yonsei Univ, Grad Program Sci Aging, Seoul 120752, South Korea.
   [Lee, Beom Seob; Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young; Oh, Jaewon; Park, Sungha; Lee, Sang Hak; Chung, Ji Hyung; Kang, Seok-Min] Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Lee, Beom Seob; Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young; Oh, Jaewon; Park, Sungha; Lee, Sang Hak; Chung, Ji Hyung; Kang, Seok-Min] Cardiovasc Res Inst, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
RP Kang, SM (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM smkang@yuhs.ac
OI Oh, Jaewon/0000-0002-4585-1488; Park, Sungha/0000-0001-5362-478X; Kang,
   Seok-Min/0000-0001-9856-9227
FU Korean Society of Cardiology
FX This study was supported by a grant from the Korean Society of
   Cardiology (2008).
CR Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.E02-10-0653
   Gaitanaki C, 2008, J EXP BIOL, V211, P2524, DOI 10.1242/jeb.018960
   Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007
   Ha JH, 2012, CELL BIOL TOXICOL, V28, P19, DOI 10.1007/s10565-011-9202-x
   Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100
   Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599
   Kanwar JR, 2010, EXPERT OPIN THER PAT, V20, P1723, DOI 10.1517/13543776.2010.533657
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Kwon JH, 2007, BIOCHEM BIOPH RES CO, V363, P399, DOI 10.1016/j.bbrc.2007.09.001
   Leibowitz Brian, 2010, Cancer biology & therapy, V9, P417, DOI 10.4161/cbt.9.6.11392
   Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160
   Levkau B, 2011, J MOL CELL CARDIOL, V50, P6, DOI 10.1016/j.yjmcc.2010.10.013
   Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024
   Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024
   Rosa J, 2006, MOL BIOL CELL, V17, P1483
   Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137
   See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038
   Sen P, 2007, BBA-MOL CELL RES, V1773, P367, DOI 10.1016/j.bbamcr.2006.11.012
   Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200
   Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002
   Van Laethem A, 2004, FASEB J, V18, P1946, DOI 10.1096/fj.04-2285fje
   Venkatakrishnan CD, 2006, AM J PHYSIOL-HEART C, V291, pH2680, DOI 10.1152/ajpheart.00395.2006
   Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005
   Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306
   Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571
   Wong JC, 2012, J CELL BIOCHEM, V113, P3587, DOI 10.1002/jcb.24237
   Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544
   Zhang JY, 2006, MOL CELL BIOL, V26, P1223, DOI 10.1128/MCB.26.4.1223-1234.2006
NR 30
TC 14
Z9 15
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 400
EP 407
DI 10.4070/kcj.2013.43.6.400
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300007
PM 23882289
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, MY
   Shin, DH
   Kwon, JH
   Chang, WS
   Choi, KU
   Song, YA
   Oh, KH
   Lee, JH
AF Hong, Man Yong
   Shin, Dae-Hee
   Kwon, Jang Hoon
   Chang, Woo-Sung
   Choi, Kyu Un
   Song, Yun A.
   Oh, Kwang Hoon
   Lee, Je Hoon
TI Anomalous Separate Origin of Left Anterior Descending Coronary Artery:
   Presented as Acute Anterior Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Acute anterior wall myocardial infarction
AB Coronary artery anomalies are rare presentations in primary percutaneous coronary interventions of acute myocardial infarction. Herein, we report the case of a 59-year-old man with acute anterior myocardial infarction who had anomalous separate origin of left anterior descending artery (LAD) and left circumflex artery (LCX) from the left coronary aortic sinus. Coronary angiography showed a normal right coronary artery and LCX, but no visualization of the LAD. After several unsuccessful attempts to cannulate the LAD, we found the LAD ostium located by the side of the LCX ostium. There was total occlusion at proxymal LAD. Coronary computed tomography angiography demonstrated the precise, separate origin of LAD and LCX from the left coronary aortic sinus.
C1 [Hong, Man Yong; Shin, Dae-Hee; Kwon, Jang Hoon; Chang, Woo-Sung; Choi, Kyu Un; Song, Yun A.; Oh, Kwang Hoon; Lee, Je Hoon] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Internal Med, Kangnung 210711, South Korea.
RP Shin, DH (corresponding author), Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Internal Med, 38 Bang Dong Gil Sacheon Myon, Kangnung 210711, South Korea.
EM drshin@ulsan.ac.kr
CR Cademartiri F, 2008, EUR RADIOL, V18, P781, DOI 10.1007/s00330-007-0821-9
   Kim JH, 2011, KOREAN CIRC J, V41, P612, DOI 10.4070/kcj.2011.41.10.612
   Malago R, 2010, RADIOL MED, V115, P679, DOI 10.1007/s11547-010-0522-3
   Papadopoulos D P, 2007, Int J Cardiol, V114, pe105, DOI 10.1016/j.ijcard.2006.08.014
   Rohit Manojkumar, 2008, J Invasive Cardiol, V20, pE37
   SEROTA H, 1990, AM J CARDIOL, V65, P891, DOI 10.1016/0002-9149(90)91432-6
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640, DOI 10.1016/0735-1097(92)90019-J
NR 7
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 408
EP 410
DI 10.4070/kcj.2013.43.6.408
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300008
PM 23882290
OA Green Published
DA 2021-04-22
ER

PT J
AU Akyuz, A
   Alpsoy, S
   Akkoyun, DC
AF Akyuz, Aydin
   Alpsoy, Seref
   Akkoyun, Dursun Cayan
TI Spontaneous Coronary Artery Dissection and Woven Coronary Artery: Three
   Cases and a Review of the Literature
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Coronary heart disease; Coronary angiography
ID PREGNANCY
AB Spontaneous coronary artery dissection (SCAD) and woven coronary artery anomaly (WCAA) are relatively rare. A few of the previously reported woven coronary artery cases have involved in a single coronary artery. We present an unusual woven case involving all coronary arteries and two patient with SCAD. We have also reviewed the literature related to these disease, as they resemble one another.
C1 [Akyuz, Aydin; Alpsoy, Seref; Akkoyun, Dursun Cayan] Namik Kemal Univ, Sch Med, Dept Cardiol, Tekirdag, Turkey.
RP Akyuz, A (corresponding author), Namik Kemal Univ, Sch Med, Dept Cardiol, Tekirdag, Turkey.
EM ayakyuzq5@gmail.com
RI Alpsoy, Seref/Z-1808-2018
CR [Anonymous], 1985, NHLBI PTCA REGISTRY, P9
   ASUNCION CM, 1972, OBSTET GYNECOL, V40, P202
   Celik T, 2010, CLIN CARDIOL, V33, pE86, DOI [10.1002/clc.20415, 10.1002/clc.20292]
   Cohen DE, 2000, CATHETER CARDIO INTE, V49, P318, DOI 10.1002/(SICI)1522-726X(200003)49:3<318::AID-CCD19>3.0.CO;2-C
   DEMAIO SJ, 1989, AM J CARDIOL, V64, P471, DOI 10.1016/0002-9149(89)90423-2
   Dhawan R, 2002, ANGIOLOGY, V53, P89, DOI 10.1177/000331970205300112
   Hering D, 1998, Z KARDIOL, V87, P961, DOI 10.1007/s003920050253
   James AH, 2006, CIRCULATION, V113, P1564, DOI 10.1161/CIRCULATIONAHA.105.576751
   JORGENSEN MB, 1994, AM HEART J, V127, P1382, DOI 10.1016/0002-8703(94)90060-4
   Kamineni Raghunandan, 2002, Cardiol Rev, V10, P279, DOI 10.1097/00045415-200209000-00004
   Koga T, 1998, ANGIOLOGY, V49, P83, DOI 10.1177/000331979804900112
   Kursaklioglu H, 2006, INT J CARDIOL, V113, P121, DOI 10.1016/j.ijcard.2005.08.019
   Maeder M, 2005, INT J CARDIOL, V101, P363, DOI 10.1016/j.ijcard.2004.03.045
   Martuscelli E, 2000, Ital Heart J, V1, P306
   ROBINOWITZ M, 1982, AM J MED, V72, P923, DOI 10.1016/0002-9343(82)90853-1
   SANE DC, 1988, AM J CARDIOL, V61, P1158, DOI 10.1016/0002-9149(88)90159-2
   SIEGEL RJ, 1994, ARCH PATHOL LAB MED, V118, P196
   Soylu K, 2012, J CARDIAC SURG, V27, P345, DOI 10.1111/j.1540-8191.2012.01453.x
   Thompson Ellen A, 2005, J Invasive Cardiol, V17, P59
   Vrints CJM, 2010, HEART, V96, P801, DOI 10.1136/hrt.2008.162073
NR 20
TC 8
Z9 8
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 411
EP 415
DI 10.4070/kcj.2013.43.6.411
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300009
PM 23882291
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, S
   Ko, YG
   Choi, D
   Lee, DY
AF Lee, Sangeun
   Ko, Young-Guk
   Choi, Donghoon
   Lee, Do-yun
TI A Case of Abdominal Aortic Aneurysm with Short Angulated Proximal Neck
   Treated with the Chimney Graft Technique
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic aneurysm, abdominal; Endovascular techniques
ID FOR-VASCULAR-SURGERY; STENT-GRAFT; REPAIR; GUIDELINES; VESSELS
AB Endovascular aneurysm repair (EVAR) using stent grafts has shown to be an effective alternative to surgical repair in treating an abdominal aortic aneurysm (AAA). EVAR is associated with shorter hospital stays, less blood loss, shorter operating times, and lower early morbidity and mortality compared to open surgical repair, although EVAR required a higher reintervention rate during a longer follow-up period. However, short or severely an angulated infrarenal proximal aortic neck is considered unsuitable for EVAR. The chimney graft technique is a modified procedure based on the deployment of a covered or bare-metal stent parallel to the main aortic endograft within the aneurysm, thereby creating a conduit that runs outside the aortic main endograft to preserve flow to the aortic branches. In this case report, we present a 78-year-old patient with an AAA with a short and severely angulated proximal neck who was successfully treated by EVAR using the chimney graft technique.
C1 [Lee, Sangeun; Ko, Young-Guk; Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Lee, Do-yun] Yonsei Univ Hlth Syst, Severance Hosp, Dept Radiol, Seoul 120752, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM ygko@yuhs.ac
CR Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363
   Donas KP, 2012, J VASC SURG, V55, P659, DOI 10.1016/j.jvs.2011.09.052
   ERNST CB, 1993, NEW ENGL J MED, V328, P1167
   Greenberg R, 2000, CARDIOVASC SURG, V8, P350, DOI 10.1016/S0967-2109(00)00035-1
   Greenberg RK, 2003, J VASC SURG, V38, P990, DOI 10.1016/S0741-5214(03)00896-6
   Greenberg RK, 2009, J VASC SURG, V50, P730, DOI 10.1016/j.jvs.2009.05.051
   Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7
   Hertzer NR, 2002, J VASC SURG, V35, P1145, DOI 10.1067/mva.2002.123686
   Hiramoto JS, 2009, J VASC SURG, V49, P1100, DOI 10.1016/j.jvs.2008.11.060
   Leurs LJ, 2006, J ENDOVASC THER, V13, P640, DOI 10.1583/06-1882.1
   Lindsay TF, 2005, CAN MED ASSOC J, V172, P867, DOI 10.1503/cmaj.1041584
   Moulakakis KG, 2012, J VASC SURG, V55, P1497, DOI 10.1016/j.jvs.2011.10.009
   Ohrlander T, 2008, J ENDOVASC THER, V15, P427, DOI 10.1583/07-2315.1
   Panuccio G, 2011, J VASC SURG, V53
   Panuccio G, 2011, J VASC SURG, V53, P885, DOI 10.1016/j.jvs.2010.10.106
   Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348
   Stanley BM, 2001, J ENDOVASC THER, V8, P457, DOI 10.1583/1545-1550(2001)008<0457:EOPSGF>2.0.CO;2
NR 17
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 416
EP 421
DI 10.4070/kcj.2013.43.6.416
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300010
PM 23882292
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, DS
   Jeong, JH
   Park, PW
   Lee, YT
   Park, SJ
   Kim, JS
   On, YK
AF Jeong, Dong Seop
   Jeong, Jae-Han
   Park, Pyo Won
   Lee, Young Tak
   Park, Seung-Jung
   Kim, June Soo
   On, Young Keun
TI A Hybrid Procedure for Atrial Fibrillation Using Total Thoracoscopic
   Ablation and Post-Procedural Electrophysiological Confirmation of
   Ablation Lines
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Ablation techniques
ID PULMONARY VEIN ISOLATION; PARTIAL AUTONOMIC DENERVATION;
   SURGICAL-TREATMENT; STROKE
AB Atrial fibrillation (AF) is the most common chronic arrhythmia in the world, and it is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality. To overcome the limitations of transvenous radiofrequency (RF) ablation for AF, total thoracoscopic ablation (TTA) has evolved as a new technique. TTA has several advantages over transvenous RF ablation and is known to produce better outcomes, especially in patients with persistent AF. Herein, we report 2 cases of successful TTA followed by an electrophysiological study confirming satisfactory ablation lines; the first such procedure reported in Korea.
C1 [Jeong, Dong Seop; Jeong, Jae-Han; Park, Pyo Won; Lee, Young Tak] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 135710, South Korea.
   [Park, Seung-Jung; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, Seoul 135710, South Korea.
RP On, YK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, 81 Irwon Ro, Seoul 135710, South Korea.
EM yk.on@samsung.com
CR Edgerton JR, 2008, ANN THORAC SURG, V86, P35, DOI 10.1016/j.athoracsur.2008.03.071
   Edgerton JR, 2007, J INTERV CARD ELECTR, V20, P89, DOI 10.1007/s10840-007-9177-y
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   HALPERIN JL, 1988, STROKE, V19, P937, DOI 10.1161/01.STR.19.8.937
   Jansen WPJ, 2009, EUR HEART J, V30, P813
   McClelland JH, 2007, J CARDIOVASC ELECTR, V18, P1289, DOI 10.1111/j.1540-8167.2007.00977.x
   Oh S, 2006, HEART RHYTHM, V3, P701, DOI 10.1016/j.hrthm.2006.02.020
   Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7
   Sagbas E, 2007, ANN THORAC SURG, V83, P1724, DOI 10.1016/j.athoracsur.2006.12.009
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
   Wolf RK, 2005, J THORAC CARDIOV SUR, V130, P797, DOI 10.1016/j.jtcvs.2005.03.041
NR 11
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 422
EP 425
DI 10.4070/kcj.2013.43.6.422
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300011
PM 23882293
OA Green Published
DA 2021-04-22
ER

PT J
AU Ercan, S
   Oylumlu, M
   Altunbas, G
   Davutoglu, V
AF Ercan, Suleyman
   Oylumlu, Muhammed
   Altunbas, Gokhan
   Davutoglu, Vedat
TI An Iatrogenically Unmasked Life Threatening Disease: Brugada Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Brugada syndrome; Propafenone; Atrial fibrillation; Acute myocardial
   infarction
ID ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; DEATH
AB Brugada syndrome is a life threatening disease that is usually overlooked during emergency service admissions. It is characterized by typical electrocardiography resembling right bundle branch block, static or dynamic ST-segment elevation in leads V 1-3. There is familial tendency in some cases. A majority of patients have a structurally normal heart and are likely to remain asymptomatic, however they may present to emergency departments with syncope and various serious arrhythmias. Therefore it is crucially important for emergency medicine physicians not to omit this potential diagnosis. Herein we report a case with Brugada syndrome which was iatrogenically unmasked after propafenone administration for atrial fibrillation.
C1 [Ercan, Suleyman; Davutoglu, Vedat] Gaziantep Univ, Sch Med, Dept Cardiol, TR-27310 Gaziantep, Turkey.
   [Oylumlu, Muhammed] Sehitkamil State Hosp, Dept Cardiol, Gaziantep, Turkey.
   [Altunbas, Gokhan] Kilis State Hosp, Dept Cardiol, Kilis, Turkey.
RP Ercan, S (corresponding author), Gaziantep Univ, Sch Med, Dept Cardiol, TR-27310 Gaziantep, Turkey.
EM sleymanercan@yahoo.com
CR Antzelevitch C, 1998, J CARDIOVASC ELECTR, V9, P513, DOI 10.1111/j.1540-8167.1998.tb01844.x
   Brugada J, 1998, CIRCULATION, V97, P457
   BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J
   Chutani S, 2008, EMERG MED J, V25, P117, DOI 10.1136/emj.2007.052829
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 426
EP 428
DI 10.4070/kcj.2013.43.6.426
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300012
PM 23882294
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Song, JY
   Baek, JS
AF Lee, Sang Yun
   Song, Jin Young
   Baek, Jae Suk
TI Percutaneous Closure of the Acquired Gerbode Shunt Using the Amplatzer
   Duct Occluder in a 3-Month Old Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defect; Septal occluder device
ID RIGHT ATRIAL SHUNT; DEFECT
AB The Gerbode shunt, known as the left ventricle to the right atrial communication, is a rather rare finding, following surgical closure of septal defects. Even though the surgical closure is accepted as a treatment of choice, we report a successful percutaneous transcatheter closure of the Gerbode shunt in a 3-months old baby who weighed 3 kilograms.
C1 [Lee, Sang Yun; Baek, Jae Suk] Sejong Cardiovasc Inst, Dept Pediat, Puchon, South Korea.
   [Song, Jin Young] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul 135710, South Korea.
RP Song, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM amyjys@naver.com
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
CR Choi Deok Young, 2010, Korean Circ J, V40, P230, DOI 10.4070/kcj.2010.40.5.230
   GERBODE F, 1958, ANN SURG, V148, P433, DOI 10.1097/00000658-195809000-00012
   Kelle AM, 2009, CARDIOL YOUNG, V19, P96, DOI 10.1017/S1047951109991685
   Newman J N Jr, 1996, J Am Soc Echocardiogr, V9, P716
   Rothman Abraham, 2008, J Invasive Cardiol, V20, pE273
   Spence MS, 2006, CATHETER CARDIO INTE, V67, P663, DOI 10.1002/ccd.20629
   Trehan V, 2006, CATHETER CARDIO INTE, V68, P942, DOI 10.1002/ccd.20896
NR 7
TC 9
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 429
EP 431
DI 10.4070/kcj.2013.43.6.429
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300013
PM 23882295
OA Green Published
DA 2021-04-22
ER

PT J
AU Tas, MH
   Simsek, Z
   Degirmenci, H
   Ogul, H
   Colak, A
   Senocak, H
AF Tas, Muhammed Hakan
   Simsek, Ziya
   Degirmenci, Husnu
   Ogul, Hayri
   Colak, Abdurrahim
   Senocak, Huseyin
TI Left Atrial Thrombus in a Patient with Mitral Bioprosthetic Valve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Tas, Muhammed Hakan; Simsek, Ziya; Degirmenci, Husnu; Ogul, Hayri; Colak, Abdurrahim; Senocak, Huseyin] Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
RP Tas, MH (corresponding author), Ataturk Univ, Dept Cardiol, Erzurum, Turkey.
EM mhakantas@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 432
EP 433
DI 10.4070/kcj.2013.43.6.432
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300014
PM 23882296
OA Green Published
DA 2021-04-22
ER

PT J
AU Dahdouh, Z
   Roule, V
   Lognone, T
   Sabatier, R
   Bignon, M
   Malcor, G
   Lemaitre, A
   Blanchart, K
   Wain-Hobson, J
   Saplacan, V
   Cutone, F
   Buklas, D
   Ivascau, C
   Massetti, M
   Grollier, G
AF Dahdouh, Ziad
   Roule, Vincent
   Lognone, Therese
   Sabatier, Remi
   Bignon, Mathieu
   Malcor, Guillaume
   Lemaitre, Adrien
   Blanchart, Katrien
   Wain-Hobson, Julien
   Saplacan, Vladimir
   Cutone, Fabio
   Buklas, Dimitrios
   Ivascau, Calin
   Massetti, Massimo
   Grollier, Gilles
TI Iatrogenic Bidirectional Dissection of the Right Coronary Artery and the
   Ascending Aorta: The Worst Nightmare for an Interventional Cardiologist
   (vol 42, pg 504, 2012)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Dahdouh, Ziad; Roule, Vincent; Lognone, Therese; Sabatier, Remi; Bignon, Mathieu; Malcor, Guillaume; Lemaitre, Adrien; Blanchart, Katrien; Wain-Hobson, Julien; Grollier, Gilles] CHU Caen, Dept Cardiol, F-14000 Caen, France.
   [Saplacan, Vladimir; Cutone, Fabio; Buklas, Dimitrios; Ivascau, Calin; Massetti, Massimo] CHU Caen, Dept Thorac & Cardiovasc Surg, F-14000 Caen, France.
RP Dahdouh, Z (corresponding author), CHU Caen, Dept Cardiol, F-14000 Caen, France.
CR Dahdouh Z, 2012, KOREAN CIRC J, V42, P504, DOI 10.4070/kcj.2012.42.7.504
NR 1
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2013
VL 43
IS 6
BP 434
EP 434
DI 10.4070/kcj.2013.43.6.434
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GP
UT WOS:000342387300015
OA Green Accepted, Green Published
DA 2021-04-22
ER

PT J
AU Chiong, JR
   Cheung, RJ
AF Chiong, Jun R.
   Cheung, Rebecca J.
TI Long-Term Anticoagulation in the Extreme Elderly with the Newer
   Antithrombotics: Safe or Sorry?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Anticoagulants; Aging; Atrial fibrillation; Stroke; Aged
ID NONVALVULAR ATRIAL-FIBRILLATION; RANDOMIZED CONTROLLED-TRIAL; RE-LY
   TRIAL; STROKE PREVENTION; RISK-FACTORS; INTRACRANIAL HEMORRHAGE;
   BLEEDING RISK; WARFARIN; DABIGATRAN; THERAPY
AB Background and Objectives: The prevalence of atrial fibrillation (AF) doubles in the extreme elderly and is higher than in the rest of the population. Warfarin therapy to prevent thromboembolic events secondary to AF is often underutilized and under-prescribed in this subgroup, due to the fear of bleeding and other complications. Newer oral anticoagulants such as rivaroxaban and dabigatran offer alternative therapeutic options for the extreme elderly. We review the clinical trial data of these newer agents in the extreme elderly population.
   Subjects and Methods: The primary literature was identified through PubMed, using the following search terms: anticoagulation, rivaroxaban, dabigatran, warfarin, elderly, AF, bleeding, stroke, and aging. Additional references were identified through the review of references from the articles obtained. We included clinical studies evaluating anticoagulation therapies in AF. Selection emphasis was placed on those evaluating anticoagulation in the elderly population.
   Results: Dabigatran and rivaroxaban have predictable, dose-proportional pharmacokinetic and pharmacodynamic properties, which make them favorable options for the elderly. Fewer monitoring parameters and drug interactions allow for the greater ease of use. A landmark trial shows that the rate of intracranial hemorrhage with dabigatran is lower in this population compared to warfarin. However, the data is based on a small number of subjects enrolled in the clinical trials. As such, the real-world use of these agents may not replicate the published rates of bleeding and thrombosis in the study populations.
   Conclusion: More research is needed in this area, specifically in this population, before newer agents such as rivaroxaban and dabigatran are widely recommended for use in the extreme elderly patients.
C1 [Chiong, Jun R.; Cheung, Rebecca J.] Loma Linda Univ, Sch Pharm, Loma Linda, CA 92350 USA.
   [Chiong, Jun R.] Cebu Inst Med, Cebu, Philippines.
RP Cheung, RJ (corresponding author), Loma Linda Univ, Sch Pharm, 11262 Campus St, Loma Linda, CA 92350 USA.
EM rcheung@llu.edu
CR Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
   Albers GW, 2003, LANCET, V362, P1691
   [Anonymous], 2011, COUM PACK INS
   [Anonymous], 2011, XAR PACK INS
   [Anonymous], 2012, PRAD PACK INS
   Chen WT, 2011, MAYO CLIN PROC, V86, P509, DOI 10.4065/mcp.2010.0755
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747
   Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034
   Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Goto S, 2011, CAN WE AVOID STROKE
   Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614
   Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048
   Hylek EM, 2006, STROKE, V37, P1075, DOI 10.1161/01.STR.0000209239.71702.ce
   Jacobs JM, 2011, ARCH INTERN MED, V171, P1287, DOI 10.1001/archinternmed.2011.308
   Jeong JH, 2005, J KOREAN MED SCI, V20, P26, DOI 10.3346/jkms.2005.20.1.26
   Kowey PR, 2012, AM J MED, V125, P732, DOI 10.1016/j.amjmed.2011.10.035
   Lakshminarayan K, 2006, STROKE, V37, P1969, DOI 10.1161/01.STR.0000230607.07928.17
   Lam MPS, 2012, BRIT J CLIN PHARMACO, V73, P340, DOI 10.1111/j.1365-2125.2011.04097.x
   Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864
   Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003
   Sinnaeve PR, 2012, J INTERN MED, V271, P15, DOI 10.1111/j.1365-2796.2011.02464.x
   Tincania E, 2009, BLOOD COAGUL FIBRIN, V20, P47, DOI 10.1097/MBC.0b013e32831be9da
   Torn M, 2005, ARCH INTERN MED, V165, P1527, DOI 10.1001/archinte.165.13.1527
   WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   Zimetbaum PJ, 2010, AM J MED, V123, P446, DOI 10.1016/j.amjmed.2009.11.015
NR 30
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 287
EP 292
DI 10.4070/kcj.2013.43.5.287
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200001
PM 23755073
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SW
AF Kim, Sang-Wook
TI Comparison of Two Different Strategies of Intravascular Ultrasound
   Guidance during Percutaneous Coronary Intervention; Routine versus
   Selective
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID STENT THROMBOSIS; IMPACT
C1 Chung Ang Univ Hosp, Heart Res Inst, Coll Med, Ctr Cardiovasc, Seoul 156755, South Korea.
RP Kim, SW (corresponding author), Chung Ang Univ Hosp, Heart Res Inst, Coll Med, Ctr Cardiovasc, 102 Heukseok Ro, Seoul 156755, South Korea.
EM swivus@gmail.com
CR Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P974, DOI 10.1016/j.jcin.2011.07.005
   Di Mario C, 1998, EUR HEART J, V19, P207, DOI 10.1053/euhj.1996.0433
   Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882
   Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020
   Kim Sang-Wook, 2007, J Invasive Cardiol, V19, P506
   Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P428, DOI 10.1016/j.jcin.2009.01.011
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Okabe T, 2007, AM J CARDIOL, V100, P615, DOI 10.1016/j.amjcard.2007.03.072
   Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249
   Seo JB, 2013, KOREAN CIRC J, V43, P303, DOI 10.4070/kcj.2013.43.5.303
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 293
EP 294
DI 10.4070/kcj.2013.43.5.293
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200002
PM 23755074
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HS
   Cho, KI
AF Kim, Hyun Soo
   Cho, Kyoung Im
TI Impact of Chronic Emotional Stress on Myocardial Function in
   Postmenopausal Women and Its Relationship with Endothelial Dysfunction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Emotional stress; Echocardiography; Endothelium
ID DEPENDENT DILATION; UNITED-STATES; RISK-FACTORS; ARTERY; DEPRESSION;
   DISEASE
AB Background and Objectives: An association between chronic stress and cardiovascular diseases has been described, but the underlying mechanisms have not been fully elucidated. We investigate the impact of perceived stress on the left ventricular (LV) and endothelial functions in postmenopausal women.
   Subjects and Methods: We investigated 64 consecutive postmenopausal women (mean age 56.7 +/- 9.7 years) with atypical chest pain and chronic stress. Patients with coronary heart disease were excluded. Global and segmental longitudinal deformation parameters of LV were used as parameters to assess myocardial function and brachial flow-mediated dilatation (FMD) was used to assess the endothelial function, and patients were analyzed by the Symptom Checklist 90 Revised (SCL-90-R) to determine emotional stress. The study participants were divided into two groups, based on global severity index (GSI): >= 50 (group A, n=27) or < 50 (group B, n=37).
   Results: Although there were no significant differences in LV geometry or myocardial performance indices between the groups, global LV strain was significantly reduced in group A compared to group B (-16.6 +/- 2.7% vs. -19.1 +/- 1.9%, p=0.001). There were also significant differences in the value of reactive FMD (6.6 +/- 2.2% vs. 9.5 +/- 2.9%, p<0.001), and same result was observed for nitroglycerine-induced dilatation (14.6 +/- 4.7% vs. 18.0 +/- 5.8%, p=0.016). Multivariate linear regression analysis showed that GSI was the only significant attributor to global LV strain (beta=0.149, p=0.008) and reactive FMD (beta=-0.200, p=0.041).
   Conclusion: Chronic emotional stress may exert negative effects on the LV and endothelial functions, which may be associated with the severity of stress. This study provides a possible mechanism by which stress is associated with an increased risk of cardiovascular dysfunction.
C1 [Kim, Hyun Soo; Cho, Kyoung Im] Kosin Univ, Div Cardiol, Dept Internal Med, Sch Med, Pusan 602702, South Korea.
RP Cho, KI (corresponding author), Kosin Univ, Div Cardiol, Dept Internal Med, Sch Med, 34 Amnam Dong, Pusan 602702, South Korea.
EM kyoungim74@gmail.com
FU Korean Society of Circulation (Industrial-educational cooperation)
FX This study was supported by a grant from the Korean Society of
   Circulation (Industrial-educational cooperation 2011).
CR Adams MR, 1998, J AM COLL CARDIOL, V32, P123, DOI 10.1016/S0735-1097(98)00206-X
   Ako J, 2002, J AM COLL CARDIOL, V39, P741, DOI 10.1016/S0735-1097(01)01808-3
   BAUM A, 1990, HEALTH PSYCHOL, V9, P653, DOI 10.1037/0278-6133.9.6.653
   Becker M, 2006, HEART, V92, P1102, DOI 10.1136/hrt.2005.077107
   Boudrez H, 2001, QUAL LIFE RES, V10, P37, DOI 10.1023/A:1016697719078
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4
   Chan J, 2006, J AM COLL CARDIOL, V48, P2026, DOI 10.1016/j.jacc.2006.07.050
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473
   Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281
   Hardt J, 2000, EUR J PAIN-LONDON, V4, P137, DOI 10.1053/eujp.2000.0162
   Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F
   HENRY JP, 1971, ATHEROSCLEROSIS, V14, P203, DOI 10.1016/0021-9150(71)90050-5
   Hwang JW, 2008, AUST NZ J PSYCHIAT, V42, P301, DOI 10.1080/00048670701881546
   Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V
   Mohri M, 1998, LANCET, V351, P1165, DOI 10.1016/S0140-6736(97)07329-7
   PANG KYC, 1990, CULT MED PSYCHIAT, V14, P495
   Park Young-Joo, 2002, Health Care Women Int, V23, P389, DOI 10.1080/0739933029008955
   Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005
   Selye H., 1956, STRESS LIFE
   Skydsbjerg M, 2001, SCAND J PSYCHOL, V42, P327, DOI 10.1111/1467-9450.00244
   Spieker LE, 2002, CIRCULATION, V105, P2817, DOI 10.1161/01.CIR.0000021598.15895.34
   STRAWN WB, 1991, CIRC RES, V68, P1270, DOI 10.1161/01.RES.68.5.1270
   Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189
   VITA JA, 1992, CIRCULATION, V85, P1390, DOI 10.1161/01.CIR.85.4.1390
   Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046
   Zaroff JG, 2000, STROKE, V31, P1136, DOI 10.1161/01.STR.31.5.1136
NR 27
TC 9
Z9 9
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 295
EP 302
DI 10.4070/kcj.2013.43.5.295
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200003
PM 23755075
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, JB
   Park, KW
   Lee, HY
   Kang, HJ
   Koo, BK
   Kim, SH
   Kim, HS
AF Seo, Jae-Bin
   Park, Kyung Woo
   Lee, Hae-Young
   Kang, Hyun-Jae
   Koo, Bon-Kwon
   Kim, Sang-Hyun
   Kim, Hyo-Soo
TI Comparison of Two Different Strategies of Intravascular Ultrasound
   Guidance during Percutaneous Coronary Intervention; Routine versus
   Selective
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ultrasonography, interventional; Drug-eluting stents; Dilatation,
   percutaneous coronary intervention
ID ELUTING STENT IMPLANTATION; CLINICAL-OUTCOMES; RESTENOSIS; INVITRO;
   ANGIOPLASTY; ANGIOGRAPHY; ARTERIES; INVIVO
AB Background and Objectives: Intravascular ultrasound (IVUS) is helpful during percutaneous coronary intervention (PCI), because it can be used to confirm good apposition or optimal expansion of stents. In this study, we compared angiographic result as well as clinical outcomes between two different strategies of IVUS-guidance, the selective vs. the routine.
   Subjects and Methods: The study population consisted of 279 patients undergoing electric and emergency intracoronary implatation of TAXUS stent from August 2003 through September 2006. For this study, we divided physicians into two groups; doctors to perform PCI under 'routine' IVUS-guidance vs. PCI under 'selective' IVUS-guidance. Among a total of 279 patients (384 lesions) who underwent PCI with TAXUS stent, 87 patients underwent the procedure under the strategy of 'routine' IVUS-guidance, whereas 192 patients under 'selective' IVUS-guidance.
   Results: The baseline clinical features of the patients are similar between the two groups. The actual rate of IVUS usage was 89.2% in the routine group and 68.2% in the selective group (p<0.01). A high rate of adjunctive ballooning was determined as a remarkable procedure-related parameter which was comparable between the two groups (72.5% vs. 76.1% in routine vs. selective, p=0.57). The minimal lumen diameter at immediate post-PCI was significantly larger in the routine IVUS group than that in the selective group (2.58 mm vs. 2.48 mm, p=0.03). However, the difference disappeared during the follow-up period (1.98 mm vs. 1.98 mm, p=0.94). Clinical outcomes at 1 year were not different between the two groups.
   Conclusion: PCI under the strategy of 'selective' IVUS-guidance was comparable to PCI under 'routine' IVUS-guidance in terms of angiographic and clinical outcomes in circumstances with frequent use of adjunctive ballooning after stenting.
C1 [Seo, Jae-Bin; Park, Kyung Woo; Lee, Hae-Young; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Sang-Hyun; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 110 Daehak Ro, Seoul 110744, South Korea.
EM hyosoo@snu.ac.kr
RI Kang, Hyun-Jae/D-6121-2012; Park, Kyung Woo/AAX-3046-2020
OI Kang, Hyun-Jae/0000-0002-3500-1746; Lee, Hae-Young/0000-0002-9521-4102;
   Kim, Sang-Hyun/0000-0001-8026-1582
FU Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of
   Korea [0412-CR02-0704-0001]; Innovative Research Institute for Cell
   Therapy, Seoul National University Hospital - Ministry of Health,
   Welfare & Family, Republic of Korea [A062260]
FX This study was supported by a grant from the Clinical Research Center
   for Ischemic Heart Disease, Seoul, Republic of Korea
   (0412-CR02-0704-0001) and a grant from the Innovative Research Institute
   for Cell Therapy, Seoul National University Hospital (A062260),
   sponsored by the Ministry of Health, Welfare & Family, Republic of
   Korea.
CR BAPTISTA J, 1995, AM HEART J, V129, P177, DOI 10.1016/0002-8703(95)90057-8
   CARROZZA JP, 1992, J AM COLL CARDIOL, V20, P328, DOI 10.1016/0735-1097(92)90098-8
   CAVAYE DM, 1993, INT ANGIOL, V12, P245
   Choi JW, 2001, AM HEART J, V142, P112, DOI 10.1067/mhj.2001.115793
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Fitzgerald PJ, 2000, CIRCULATION, V102, P523
   Fujii K, 2004, CIRCULATION, V109, P1085, DOI 10.1161/01.CIR.0000121327.67756.19
   GUSSENHOVEN EJ, 1989, J AM COLL CARDIOL, V14, P947, DOI 10.1016/0735-1097(89)90471-3
   Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882
   Kastrati A, 2006, CIRCULATION, V113, P2293, DOI 10.1161/CIRCULATIONAHA.105.601823
   Mudra H, 2001, CIRCULATION
   NAKAMURA S, 1995, J AM COLL CARDIOL, V25, P633, DOI 10.1016/0735-1097(94)00453-W
   Oemrawsingh PV, 2003, CIRCULATION, V107, P62, DOI 10.1161/01.CIR.0000043240.87526.3F
   Orford JL, 2004, AM HEART J, V148, P501, DOI 10.1016/j.ahj.2004.03.033
   Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026
   Rogacka R, 2009, CURR CARDIOL REV, V5, P78, DOI 10.2174/157340309788166697
   Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249
   Russo RJ, 2009, CIRC-CARDIOVASC INTE, V2, P113, DOI 10.1161/CIRCINTERVENTIONS.108.778647
   Schiele F, 2000, INT J CARDIOVASC INT, V3, P207
   STGOAR FG, 1991, J AM COLL CARDIOL, V18, P952
   TOBIS JM, 1989, CIRCULATION, V80, P873, DOI 10.1161/01.CIR.80.4.873
   TOBIS JM, 1991, CIRCULATION, V83, P913, DOI 10.1161/01.CIR.83.3.913
NR 22
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 303
EP 308
DI 10.4070/kcj.2013.43.5.303
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200004
PM 23755076
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Lee, HD
   Suh, YK
   Kim, JH
   Chun, KJ
   Park, YH
   Kim, J
   Han, DC
   Sohn, CB
AF Kim, Jeong Su
   Lee, Heon Deok
   Suh, Yong Kweon
   Kim, June Hong
   Chun, Kook Jin
   Park, Yong Hyun
   Kim, Jun
   Han, Dong Cheul
   Sohn, Chang Bae
TI Prediction of Fractional Flow Reserve without Hyperemic Induction Based
   on Resting Baseline Pd/Pa
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular physiological phenomana; Fractional flow reserve,
   myocardial
ID STENOSIS SEVERITY; CORONARY; ADENOSINE; INTRACORONARY; ANGIOGRAPHY
AB Background and Objectives: The purposes of this study are 1) to investigate the relationship between resting baseline Pd/Pa, determined by the ratio of the pressures proximal (Pa) and distal (Pd) to the target lesion before, inducing hyperemia and fractional flow reserve (FFR) and 2) to identify a resting baseline Pd/Pa range that might reliably preclude the need for hyperemic induction.
   Subjects and Methods: A total of 622 pressure wire data sets obtained from intermediate stenotic lesions were analyzed.
   Results: There was a good linear relationship between resting baseline Pd/Pa and FFR (r=0.746, p<0.001). Receiver-operating characteristic curves of the resting baseline Pd/Pa with FFR <= 0.80 as the reference variable showed an area under the curve of 0.89 (95% confidence intervals 0.863-0.914, p<0.001) with a diagnostic accuracy of 82.3% when the resting baseline Pd/Pa was <= 0.92. These results showed that certain cutoff values can reliably predict FFR, whether positive or negative. The resting baseline Pd/Pa <= 0.95 (n=257, 41.3%) had a negative predictive value (NPV) of 98.1% and a sensitivity of 97.3%. the resting baseline Pd/Pa <= 0.88 (n=65, 10.5%) had a positive predictive value (PPV) of 96.2% and a specificity of 99.8%. These were consistent regardless of coronary vessel, lesion location, lesion length, or degree of stenosis.
   Conclusion: In intermediate lesions, the resting baseline Pd/Pa was linearly related to FFR. A certain range of the resting baseline Pd/Pa values had an excellent NPV with high sensitivity or excellent PPV with high specificity for determining the lesion significance.
C1 [Kim, Jeong Su; Kim, June Hong; Chun, Kook Jin; Park, Yong Hyun; Kim, Jun; Han, Dong Cheul; Sohn, Chang Bae] Pusan Natl Univ, Sch Med, Yangsan Hosp, Div Cardiol,Dept Internal Med, Yangsan 626770, South Korea.
   [Lee, Heon Deok; Suh, Yong Kweon] Pusan Natl Univ, Sch Med, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, South Korea.
   Dong A Univ, Dept Mech Engn, Pusan, South Korea.
RP Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Yangsan Hosp, Div Cardiol,Dept Internal Med, 20 Geumo Ro, Yangsan 626770, South Korea.
EM junehongk@gmail.com
OI Kim, Jun/0000-0002-3573-638X
FU Medical Research Institute Grant, Pusan National University Yangsan
   Hospital
FX This study was supported by a Medical Research Institute Grant (2012),
   Pusan National University Yangsan Hospital.
CR Berry C, 2013, J AM COLL CARDIOL, V61, P1421, DOI 10.1016/j.jacc.2012.09.065
   De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88
   De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
   Jang HJ, 2013, EUR HEART J
   Kim JH, 2012, CATHETER CARDIO INTE, V80, P581, DOI 10.1002/ccd.23277
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Lindstaedt M, 2009, CLIN RES CARDIOL, V98, P717, DOI 10.1007/s00392-009-0056-7
   Mamas MA, 2010, J INVASIVE CARDIOL, V22, P260
   PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354
   Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003
   Seo MK, 2012, CIRC-CARDIOVASC INTE, V5, P401, DOI 10.1161/CIRCINTERVENTIONS.111.965392
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   정해억, 2002, Korean Circulation Journal, V32, P391
NR 15
TC 14
Z9 14
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 309
EP 315
DI 10.4070/kcj.2013.43.5.309
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200005
PM 23755077
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SY
   Ju, EY
   Cho, SI
   Lee, SW
   Kim, DK
AF Jang, Shin Yi
   Ju, Eun Young
   Cho, Sung-Il
   Lee, Seung Wook
   Kim, Duk-Kyung
TI Comparison of Cardiovascular Risk Factors for Peripheral Artery Disease
   and Coronary Artery Disease in the Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral artery disease; Coronary artery disease; Risk factors
ID URBAN JAPANESE POPULATION; METABOLIC SYNDROME; HEART-DISEASE;
   VASCULAR-DISEASE; BLOOD-PRESSURE; BODY-MASS; SMOKING; ASSOCIATION;
   PREVALENCE; HYPERTENSION
AB Background and Objectives: The objective of this study was to analyze and compare risk factors for peripheral artery disease (PAD) and coronary artery disease (CAD).
   Subjects and Methods: The sample included 7936 Korean patients aged >= 20 years who were hospitalized from 1994 to 2004. Of the 7936 subjects, PAD (n=415), CAD (n=3686), and normal controls (Control) (n=3835) were examined at the Health Promotion Center, Samsung Medical Center.
   Results: The mean age (years) of PAD subjects was 64.4 (+/- 9.3), while CAD subjects was 61.2 (+/- 9.9), and Control subjects was 59.9 (+/- 9.1) (p<0.01). The proportion of males was 90.6% for PAD, 71.4% for CAD, and 75.5% for Control subjects (p<0.01). The adjusted odds ratios (ORs) for hypertension, diabetes mellitus, hypercholesterolemia, smoking, metabolic syndrome and chronic kidney disease were significantly higher in subjects with PAD or CAD compared to those in Control. However, the ORs for high density lipoprotein, being overweight, and being obese were significantly lower in PAD subjects compared to those in Control.
   Conclusion: We found that cardiovascular risk factors were in fact risk factors for both PAD and CAD.
C1 [Jang, Shin Yi; Kim, Duk-Kyung] Sungkyunkwan Univ, Div Cardiol, Cardiac & Vasc Ctr, Samsung Med Ctr,Sch Med,Dept Med,Cardiovasc Imagi, Seoul 135710, South Korea.
   [Ju, Eun Young; Cho, Sung-Il; Lee, Seung Wook] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 135710, South Korea.
EM dukkyung.kim@samsung.com
CR Aboyans V, 2006, CIRCULATION, V113, P2623, DOI 10.1161/CIRCULATIONAHA.105.608679
   Barba R, 2009, EUR J CARDIOV PREV R, V16, P457, DOI 10.1097/HJR.0b013e32832b1818
   Bennett PC, 2009, J HUM HYPERTENS, V23, P213, DOI 10.1038/jhh.2008.126
   Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720
   Brevetti G, 2001, J AM GERIATR SOC, V49, P1261, DOI 10.1046/j.1532-5415.2001.49248.x
   Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773
   Clark N, 2003, DIABETES CARE, V26, P3333
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   CRIQUI MH, 1989, AM J EPIDEMIOL, V129, P1110, DOI 10.1093/oxfordjournals.aje.a115233
   Diehm N, 2006, EUR J VASC ENDOVASC, V31, P59, DOI 10.1016/j.ejvs.2005.09.006
   Eckel RH, 2002, CIRCULATION, V105, P2923, DOI 10.1161/01.CIR.0000017823.53114.4C
   Gornik Heather L, 2006, Cleve Clin J Med, V73 Suppl 4, pS30
   Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033
   Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481
   Haltmayer M, 2001, INT ANGIOL, V20, P200
   Hatmi ZN, 2011, INT J CARDIOL, V151, P328, DOI 10.1016/j.ijcard.2010.06.007
   Heuser RR, 2008, EXPERT REV MED DEVIC, V5, P279, DOI 10.1586/17434440.5.3.279
   Higashiyama A, 2009, CIRC J, V73, P2258, DOI 10.1253/circj.CJ-09-0264
   Hozawa A, 2007, HYPERTENS RES, V30, P1169, DOI 10.1291/hypres.30.1169
   Hwang YC, 2009, INT J CARDIOL, V134, P313, DOI 10.1016/j.ijcard.2008.12.025
   Kim S, 2006, INT J EPIDEMIOL, V35, P60, DOI 10.1093/ije/dyi255
   Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707
   Kon V, 2011, NAT REV NEPHROL, V7, P45, DOI 10.1038/nrneph.2010.157
   Ness J, 2005, J GERONTOL A-BIOL, V60, P255, DOI 10.1093/gerona/60.2.255
   Ozkan U, 2009, J VASC INTERV RADIOL, V20, P437, DOI 10.1016/j.jvir.2009.01.010
   Pasternak RC, 2004, CIRCULATION, V109, P2605, DOI 10.1161/01.CIR.0000128518.26834.93
   Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194
   Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019
   Tamura U, 2010, J ATHEROSCLER THROMB, V17, P12, DOI 10.5551/jat.1800
   Willigendael EM, 2004, J VASC SURG, V40, P1158, DOI 10.1016/j.jvs.2004.08.049
NR 30
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 316
EP 328
DI 10.4070/kcj.2013.43.5.316
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200006
PM 23755078
OA Green Published
DA 2021-04-22
ER

PT J
AU Oladipo, I
   Adedokun, A
AF Oladipo, Idris
   Adedokun, Ayoade
TI Comparison of the Average of Five Readings with Averages from Fewer
   Readings for Automated Oscillometric Blood Pressure Measurement in an
   Outpatient Clinic
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bloop pressure; Outpatients; Populations; Mean arterial pressure
ID HYPERTENSION; DEVICE; VALIDATION; SOCIETY
AB Background and Objectives: The optimal number of consecutive measurements for obtaining an average blood pressure (BP) reading in clinical practice is yet undefined by research. This study aimed to compare readings obtained from an average of 5 with averages of 2, 3, and 4, sequential measurements.
   Subjects and Methods: Using an automated oscillometric device (BpTRU), BP measurement was conducted on 410 consenting adults attending a general outpatients clinic. Comparison of an average of 5 readings with averages of 2, 3, and 4 readings involved evaluation of correlations, Bland-Altman analysis, comparison of means and distribution of readings, and determination of the proportion of differences between compared readings which were clinically non-significant.
   Results: 397 (96.8%) sets of complete BP readings were suitable for analysis. Clinically non-significant differences (<= 5 mm Hg) were found between at least 79.3% (n=315) and 96.5% (n=383) of compared systolic and diastolic readings, respectively. Bland-Altman's analysis revealed that the 95% limits of agreement for the differences between compared readings were approximately 2-4, 3-7, and 4-11 mm Hg for 2, 3 and 4 readings' systolic comparisons while those for diastolic comparisons were 2-3, 3-5, and 4-7 mm Hg, respectively. Statistically non-significant differences were observed in all comparisons of the distributions of readings that were classified as <140 mm Hg or >= 140 mm Hg and <90 mm Hg or >= 90 mm Hg for systolic and diastolic readings, respectively. Strong positive correlations were found between 5 average readings and each of 2, 3, and 4 average readings, respectively.
   Conclusion: An average of 5 readings may be excessive for routine BP measurement using this device at outpatient clinics.
C1 [Oladipo, Idris; Adedokun, Ayoade] Lagos State Univ Teaching Hosp LASUTH, Dept Family Med, Lagos, Nigeria.
RP Oladipo, I (corresponding author), Lagos State Univ Teaching Hosp LASUTH, Dept Family Med, Lagos, Nigeria.
EM holladipo@yahoo.com
FU NIH GrantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R03TW007452-04]
FX This study was made possible through the research capacity developed
   from the NIH Grant R03TW007452-04. The authors are thankful to all the
   patients who participated in this study.
CR Crippa G, 2003, AM J HYPERTENS, V16, p46A, DOI 10.1016/S0895-7061(03)00185-7
   Crippa G, 2005, AM J HYPERTENS, V18, p28A
   Culleton BF, 2006, BLOOD PRESS MONIT, V11, P37, DOI 10.1097/01.mbp.0000189794.36230.a7
   Ghuman Nimrta, 2009, Curr Cardiol Rep, V11, P414
   Kim Soon-Gil, 2010, Korean Circ J, V40, P423, DOI 10.4070/kcj.2010.40.9.423
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   Myers MG, 2008, BLOOD PRESS MONIT, V13, P333, DOI 10.1097/MBP.0b013e3283104247
   Myers MG, 2003, AM J HYPERTENS, V16, P494, DOI 10.1016/S0895-7061(03)00058-X
   O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002
   O'Brien E., 1993, J HYPERTENS, V11, pS43
   Pickering TG, 2005, CIRCULATION, V111, P697, DOI [10.1161/01.CIR.0000154900.76284.F6, 10.1161/01.HYP.0000150859.47929.8e]
   Powers BJ, 2011, ANN INTERN MED, V154, P781, DOI 10.7326/0003-4819-154-12-201106210-00005
   Scherpbier-de Haan N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593875
   van der Wel MC, 2011, ANN FAM MED, V9, P128, DOI 10.1370/afm.1211
   Verdecchia P, 2007, HYPERTENSION, V49, P777, DOI 10.1161/01.HYP.0000258215.26755.20
   Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683
   Wright JM, 2001, BLOOD PRESS MONIT, V6, P161, DOI 10.1097/00126097-200106000-00008
NR 17
TC 3
Z9 3
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 329
EP 335
DI 10.4070/kcj.2013.43.5.329
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200007
PM 23755079
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, K
   Kim, JH
   Kim, HJ
   Lee, SO
   Jang, EY
   Kim, JS
AF Choi, Kyu
   Kim, Jung Hee
   Kim, Hyo Jin
   Lee, Se-ok
   Jang, Eun-young
   Kim, June Soo
TI A Case of Riata (R) Dual Coil Defibrillator Lead Failure in a Patient
   with Ventricular Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter-defibrillators; Noise; Equipment failure
AB A 50-year-old man, who underwent a procedure for an implantable cardioverter defibrillator (ICD), visited the outpatient department of our clinic after suffering multiple ICD shocks. The ICD interrogation revealed recurrent shock due to a high frequency of noise that is sensed by the device as ventricular fibrillation. Chest radiography revealed a significant split in the insulation of the lead allowing the inner wire to protrude. We considered the removal of the failed lead, but the removal of ICD lead is potentially a high risk procedure, so we cut and capped a proximal part of the failed lead and inserted a new lead. This is the first report of a St. Jude Riata (R) dual coil defibrillator lead failure with clinical and radiologic evidence of a defect in lead insulation in Korea.
C1 [Choi, Kyu; Kim, Jung Hee; Kim, Hyo Jin; Lee, Se-ok; Jang, Eun-young] Sungkyunkwan Univ, Dept Internal Med, Samsung Med Ctr, Cardiac & Vasc Ct,Sch Med, Seoul 135710, South Korea.
   [Kim, June Soo] Sungkyunkwan Univ, Dept Internal Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Div Cardiol,Sch Med, Seoul 135710, South Korea.
RP Kim, JS (corresponding author), Sungkyunkwan Univ, Dept Internal Med, Samsung Med Ctr, Div Cardiol,Sch Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM juneskim@skku.edu
CR Chan CW, 2012, PACE, V35, pe261, DOI 10.1111/j.1540-8159.2011.03164.x
   Erkapic D, 2011, J CARDIOVASC ELECTR, V22, P1018, DOI 10.1111/j.1540-8167.2011.02055.x
   Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7
   Kodoth V, 2011, EUR HEART J, V32, P310
   Krebsbach A, 2011, J CARDIOVASC ELECTR, V22, P1070, DOI 10.1111/j.1540-8167.2011.02042.x
   Liu J, 2012, CIRC-ARRHYTHMIA ELEC, V5, P809, DOI 10.1161/CIRCEP.112.973081
   McAnulty J, 1997, NEW ENGL J MED, V337, P1576
   Schmutz M, 2012, INT J CARDIOL
   Shen S, 2012, J CARDIOVASC ELECTR, V23, P1207, DOI 10.1111/j.1540-8167.2012.02378.x
   Sung RK, 2012, HEART RHYTHM, V9, P1954, DOI 10.1016/j.hrthm.2012.08.006
   Valk S, 2010, PACE, V33, P770, DOI 10.1111/j.1540-8159.2009.02664.x
   Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334
NR 12
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 336
EP 339
DI 10.4070/kcj.2013.43.5.336
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200008
PM 23755080
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, DG
   Kim, SE
   Park, MS
   Kim, EJ
   Lee, JH
   Park, DG
   Han, KR
   Oh, DJ
AF Kang, Dae Gil
   Kim, Sung Eun
   Park, Myoung Soo
   Kim, Eun Jung
   Lee, Jun Hee
   Park, Dae Gyun
   Han, Kyoo Rok
   Oh, Dong Jin
TI Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a
   Patient with Panhypopituitarism due to Radiotherapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tachycardia, ventricular; Torsades de pointes; Hypopituitarism;
   Radiotherapy
ID HYPOTHYROIDISM
AB We describe a 64-year-old male patient with panhypopituitarism who experienced polymorphic ventricular tachycardia (VT) associated with long QT intervals. The panhypopituitarism developed as a sequelae of radiation therapy administered 20 years prior to his current presentation and was recently aggravated by urinary tract infection with sepsis. In this case, polymorphic VT was resistant to conventional therapy (including magnesium infusion), and QT prolongation and T wave inversion were normalized after the administration of steroid and thyroid hormones. Thyroid hormone is generally known to be associated with torsades de pointes (TdP), but steroid or other hormones may also provoke TdP. Hormonal disorders should be considered as a cause of polymorphic VT with long QT intervals. Some arrhythmias can be life-threatening, and they can be prevented with supplementation of the insufficient hormone.
C1 [Kang, Dae Gil; Kim, Sung Eun; Park, Myoung Soo; Kim, Eun Jung; Lee, Jun Hee; Park, Dae Gyun; Han, Kyoo Rok; Oh, Dong Jin] Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiol,Kangdong Sacred Heart Hosp, Seoul 134701, South Korea.
RP Kim, SE (corresponding author), Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiol,Kangdong Sacred Heart Hosp, 150 Seongan Ro, Seoul 134701, South Korea.
EM drhyangii@hallym.or.kr
CR HARTOG M, 1968, BRIT MED J, V2, P275, DOI 10.1136/bmj.2.5600.275
   Hume-Smith HV, 2008, ANESTH ANALG, V107, P806, DOI 10.1213/ane.0b013e3181815ce3
   IGA K, 1992, Heart and Vessels, V7, P107, DOI 10.1007/BF01744458
   Izumi C, 1998, JPN CIRC J, V62, P543, DOI 10.1253/jcj.62.543
   Kim NH, 2001, J KOREAN MED SCI, V16, P355, DOI 10.3346/jkms.2001.16.3.355
   Molokhia M, 2008, BRIT J CLIN PHARMACO, V66, P386, DOI 10.1111/j.1365-2125.2008.03229.x
   NISHIZAWA S, 2009, AM J EMERG MED, V27
   Odening KE, 2012, HEART RHYTHM, V9, P1150, DOI 10.1016/j.hrthm.2012.02.028
   Roden DM, 1997, CLIN CARDIOL, V20, P285, DOI 10.1002/clc.4960200318
   Sanaei-Zadeh H, 2011, CLIN TOXICOL, V49, P379, DOI 10.3109/15563650.2011.587125
   Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057
   Schenck JB, 2006, AM J MED SCI, V331, P154, DOI 10.1097/00000441-200603000-00008
   Shojaie Mohammad, 2008, Cases J, V1, P298, DOI 10.1186/1757-1626-1-298
   TAKIMOTO K, 1994, CIRC RES, V75, P1006, DOI 10.1161/01.RES.75.6.1006
NR 14
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 340
EP 342
DI 10.4070/kcj.2013.43.5.340
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200009
PM 23755081
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Kim, BK
   Oh, J
   Park, JS
   Lee, DJ
   Lee, HC
   Kim, JH
   Hong, MK
AF Lee, Seung-Hyun
   Kim, Byeong-Keuk
   Oh, Jaewon
   Park, Jin Su
   Lee, Dong-Jun
   Lee, Han-Cheol
   Kim, Jin Ho
   Hong, Myeong-Ki
TI Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients
   Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of
   Prasugrel in Clopidogrel Nonresponders
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Thrombosis; Clopidogrel; Prasugrel
ID PERCUTANEOUS CORONARY INTERVENTION
AB Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.
C1 [Lee, Seung-Hyun; Kim, Byeong-Keuk; Oh, Jaewon; Park, Jin Su; Lee, Dong-Jun; Lee, Han-Cheol; Kim, Jin Ho; Hong, Myeong-Ki] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 120752, South Korea.
   [Hong, Myeong-Ki] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 120752, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
OI Oh, Jaewon/0000-0002-4585-1488; Lee, Seung-Hyun/0000-0001-7549-9430;
   Hong, Myeong-Ki/0000-0002-2090-2031; Kim,
   Byeong-Keuk/0000-0003-2493-066X
CR Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011
   Angiolillo DJ, 2005, THROMB RES, V115, P101, DOI 10.1016/j.thromres.2004.07.007
   Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Douglas JS, 2005, CIRCULATION, V112, P2826, DOI 10.1161/CIRCULATIONAHA.104.530097
   Gurbel PA, 2006, NAT CLIN PRACT CARD, V3, P387, DOI 10.1038/ncpcardio0602
   Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8
   Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877
   Lee SW, 2005, J AM COLL CARDIOL, V46, P1833, DOI 10.1016/j.jacc.2005.07.048
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989
   Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
NR 13
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 343
EP 346
DI 10.4070/kcj.2013.43.5.343
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200010
PM 23755082
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, J
   Suh, J
   Seo, HS
   Cho, YH
   Lee, NH
AF Choi, Jaehuk
   Suh, Jon
   Seo, Hye-Sun
   Cho, Yoon Haeng
   Lee, Nae Hee
TI A Case of Sheathless Transradial Coronary Intervention for Complex
   Coronary Lesions with a Standard Guiding Catheter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Radial artery
ID HYDROPHILIC SHEATHS; RANDOMIZED-TRIALS; RADIAL ARTERY; ACCESS;
   METAANALYSIS; DIAMETER
AB One of the major limitations of transradial coronary intervention is the inability to use large guiding system, which leads to the development of dedicated sheathless guide catheter system. However, these devices are not available in the Republic of Korea. We present a case in which conventional guiding catheter was used for sheathless transradial coronary intervention in the treatment of complex coronary anatomy.
C1 [Choi, Jaehuk; Suh, Jon; Seo, Hye-Sun; Cho, Yoon Haeng; Lee, Nae Hee] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Div Cardiol,Dept Internal Med, Puchon 420767, South Korea.
RP Lee, NH (corresponding author), Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Div Cardiol,Dept Internal Med, 170 Jomaru Ro, Puchon 420767, South Korea.
EM naeheelee@naver.com
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Cogliano MA, 2004, CATHETER CARDIO INTE, V63, P104, DOI 10.1002/ccd.20142
   Dahm JB, 2002, CATHETER CARDIO INTE, V57, P172, DOI 10.1002/ccd.10321
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269, DOI 10.1016/S0735-1097(97)00064-8
   Kozak M, 2003, CATHETER CARDIO INTE, V59, P207, DOI 10.1002/ccd.10522
   Liang M, 2010, CATHETER CARDIO INTE, V75, P222, DOI 10.1002/ccd.22236
   Mamas MA, 2008, CATHETER CARDIO INTE, V72, P357, DOI 10.1002/ccd.21637
   Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4
   Sakai H, 2001, CATHETER CARDIO INTE, V54, P204, DOI 10.1002/ccd.1268
   Yoo BS, 2005, INT J CARDIOL, V101, P421, DOI 10.1016/j.ijcard.2004.03.061
   Youn YJ, 2011, KOREAN CIRC J, V41, P143, DOI 10.4070/kcj.2011.41.3.143
NR 12
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 347
EP 350
DI 10.4070/kcj.2013.43.5.347
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200011
PM 23755083
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, S
   Rha, SW
   Kook, H
   Kim, DH
   Oh, SK
   Cho, DH
   Kim, W
   Oh, DJ
AF Lee, Sunki
   Rha, Seung-Woon
   Kook, Hyungdon
   Kim, Dong Hyeok
   Oh, Suk-kyu
   Cho, Dong Hyuk
   Kim, Woohyeun
   Oh, Dong Joo
TI Spontaneous Partial Regression of Coronary Artery Fistula Following
   Optimal Medical Therapy in a Patient Who Had Combined Significant
   Coronary Artery Spasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Arteriovenous fistula; Coronary artery
   vasospasm
ID LONG-TERM OBSERVATIONS
AB Coronary artery fistulas (CAFs) are one of the most rare cardiac anomalies. Some patients with CAF may suffer from ischemic chest pain that originates from combined significant coronary artery spasm (CAS). Spontaneous regression of CAF has been reported in a few cases, almost all of which were infants. We report an adult patient who presented with ischemic chest pain due to multiple coronary arteries to pulmonary artery fistulas and combined significant CAS induced by intracoronary acetylcholine provocation test. Spontaneous regression of one of the fistulas was observed at 2-year angiography follow-up.
C1 [Lee, Sunki; Rha, Seung-Woon; Kook, Hyungdon; Kim, Dong Hyeok; Oh, Suk-kyu; Cho, Dong Hyuk; Kim, Woohyeun; Oh, Dong Joo] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM swrha617@yahoo.co.kr
CR BANDO S, 1989, Tokushima Journal of Experimental Medicine, V36, P59
   Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067
   Harle T, 2012, CLIN RES CARDIOL, V101, P313, DOI 10.1007/s00392-011-0405-1
   JAFFE RB, 1973, CIRCULATION, V47, P133, DOI 10.1161/01.CIR.47.1.133
   Kugiyama K, 1996, CIRCULATION, V94, P266, DOI 10.1161/01.CIR.94.3.266
   LEU HJ, 1990, INT ANGIOL, V9, P147
   LEVIN DC, 1978, CIRCULATION, V58, P25, DOI 10.1161/01.CIR.58.1.25
   Malcic Ivan, 2009, Lijec Vjesn, V131, P65
   Monmeneu J V, 1995, Rev Esp Cardiol, V48, P768
   NAKATANI S, 1991, CHEST, V99, P1288, DOI 10.1378/chest.99.5.1288
   Popoiu A, 2010, PEDIATR CARDIOL, V31, P144, DOI 10.1007/s00246-009-9559-2
   Sunder KRS, 1997, INT J CARDIOL, V58, P47
   Taleb MM, 2012, CARDIOVASC INTERV TH, V27, P127, DOI 10.1007/s12928-012-0096-1
   Umana E, 2002, ANGIOLOGY, V53, P353, DOI 10.1177/000331970205300315
   Yasuma K, 1998, JPN CIRC J, V62, P783, DOI 10.1253/jcj.62.783
NR 15
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 351
EP 355
DI 10.4070/kcj.2013.43.5.351
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200012
PM 23755084
OA Green Published
DA 2021-04-22
ER

PT J
AU Yeon, MH
   Choi, YR
   Lee, SY
   Bae, JW
   Hwang, KK
   Kim, DW
   Cho, MC
   Kim, SM
AF Yeon, Myeong Ho
   Choi, Young Rak
   Lee, Sang Yeub
   Bae, Jang Whan
   Hwang, Kyung Kuk
   Kim, Dong Woon
   Cho, Myeong Chan
   Kim, Sang Min
TI A Rare Combination of the Left Circumflex Coronary Artery Fistula
   Connecting a Dilated Coronary Sinus with Persistent Left Superior Vena
   Cava and Multiple Arteriovenous Fistulae
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Arteriovenous fistula; Coronary sinus
ID TRANSCATHETER CLOSURE; MANAGEMENT; ANEURYSM; PATIENT
AB Coronary artery fistula (CAF) is an abnormal communication between an epicardial coronary artery and a cardiac chamber, major vessel or other vascular structures. This report presents a rare case of CAF in which a dilated left main trunk and proximal circumflex coronary artery are connected to a dilated coronary sinus. There were also two other fistulae and persistent left superior vena cava. The coronary fistula was managed conservatively.
C1 [Yeon, Myeong Ho; Choi, Young Rak; Lee, Sang Yeub; Bae, Jang Whan; Hwang, Kyung Kuk; Kim, Dong Woon; Cho, Myeong Chan; Kim, Sang Min] Chungbuk Natl Univ Hosp, Ctr Cardiovasc, Cheongju 361711, South Korea.
RP Kim, SM (corresponding author), Chungbuk Natl Univ Hosp, Ctr Cardiovasc, 776 1sunhwan Ro, Cheongju 361711, South Korea.
EM sangmin3410@gmail.com
CR Abe T, 1996, ANN THORAC SURG, V61, P1520, DOI 10.1016/0003-4975(96)80001-R
   Abusaid Ghassan H, 2011, J Cardiol Cases, V4, pe43, DOI 10.1016/j.jccase.2011.05.008
   Armsby LR, 2002, J AM COLL CARDIOL, V39, P1026, DOI 10.1016/S0735-1097(02)01742-4
   Ata Y, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-62
   Chowdhury UK, 2009, HELL J CARDIOL, V50, P73
   Darwazah AK, 2011, J CARDIAC SURG, V26, P608, DOI 10.1111/j.1540-8191.2011.01283.x
   Early SA, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-41
   Gandy KL, 2004, ANN THORAC SURG, V77, P1081, DOI 10.1016/j.athoracsur.2003.05.006
   Gufler H, 2008, CLIN RES CARDIOL, V97, P272, DOI 10.1007/s00392-007-0620-y
   Kabbani Z, 2008, CARDIOVASC REVASCULA, V9, P14, DOI 10.1016/j.carrev.2007.06.001
   Makaryus Amgad N, 2003, J Invasive Cardiol, V15, P270
   Raju MG, 2009, J CARDIOL, V53, P467, DOI 10.1016/j.jjcc.2008.09.009
   Said SAM, 2010, WORLD J CARDIOL, V2, P6, DOI 10.4330/wjc.v2.i1.6
   Zhu XY, 2009, CLIN CARDIOL, V32, P506, DOI 10.1002/clc.20650
   ZUBERBUHLER JR, 1974, AM HEART J, V88, P41, DOI 10.1016/0002-8703(74)90347-0
NR 15
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 356
EP 359
DI 10.4070/kcj.2013.43.5.356
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200013
PM 23755085
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, JS
AF Kim, Jun
   Kim, Jeong-Su
TI Incidental Visualization of the Septal Vein of the Left Atrium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Jun; Kim, Jeong-Su] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, 20 Geumo Ro, Yangsan 626770, South Korea.
EM mdjunkim@gmail.com
OI Kim, Jun/0000-0002-3573-638X
CR Corcoran SJ, 1999, J CARDIOVASC ELECTR, V10, P804, DOI 10.1111/j.1540-8167.1999.tb00260.x
   Hwang C, 2000, CIRCULATION, V101, P1503, DOI 10.1161/01.CIR.101.13.1503
   von Ludinghausen M, 1995, Clin Anat, V8, P169, DOI 10.1002/ca.980080302
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2013
VL 43
IS 5
BP 360
EP 361
DI 10.4070/kcj.2013.43.5.360
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9GE
UT WOS:000342386200014
PM 23755086
OA Green Published
DA 2021-04-22
ER

PT J
AU Niwa, K
AF Niwa, Koichiro
TI Aortopathy in Congenital Heart Disease in Adults: Aortic Dilatation with
   Decreased Aortic Elasticity that Impacts Negatively on Left Ventricular
   Function
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Aortic disease; Congenital heart defects; Cystic medial necrosis of
   aorta; Tetralogy of fallot
ID CYSTIC MEDIAL NECROSIS; ROOT DILATION; ASCENDING AORTA; VALVE
   REGURGITATION; LEAFLET MORPHOLOGY; RISK-FACTORS; TETRALOGY; FALLOT;
   REPAIR; ABNORMALITIES
AB Bicuspid aortic valve and/or coarctation of the aorta are consistently associated with ascending aortic and para-coarctation medial abnormalities. Medial abnormalities in the ascending aorta are prevalent in other types of patients with a variety of forms congenital heart disease (CHD), such as single ventricle, persistent truncus arteriosus, transposition of the great arteries, hypoplastic left heart syndrome, tetralogy of Fallot. These abnormalities encompass a wide age range, and may predispose to dilatation, aneurysm, and rupture that necessitates aortic valve and root surgery. This dilatation can develop in CHD patients without stenotic region. These CHDs exhibit ongoing dilatation of the aortic root and reduced aortic elasticity and increased aortic stiffness that may relate to intrinsic properties of the aortic root. The concept of aortic dilatation is shifting a paradigm of aortic dilatation, as so called post stenotic dilatation, to primary intrinsic aortopahy. These aortic dilatation and increased stiffness can induce aortic aneurysm, rupture of the aorta and aortic regurgitation, but also provoke left ventricular hypertrophy, reduced coronary artery flow and left ventricular failure. We can recognize this association of aortic pathophysiological abnormality, aortic dilation and aorto-left ventricular interaction as a new clinical entity: "aortopathy".
C1 [Niwa, Koichiro] St Lukes Int Hosp, Ctr Cardiovasc, Dept Cardiol & Adult CHD Program, Tokyo 1048560, Japan.
RP Niwa, K (corresponding author), St Lukes Int Hosp, Ctr Cardiovasc, Dept Cardiol & Adult CHD Program, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
EM koniwa@luke.or.jp
CR BAHNSON HT, 1962, J THORAC CARDIOV SUR, V44, P419, DOI 10.1016/S0022-5223(19)32936-8
   Bhat AH, 2004, PEDIATR CARDIOL, V25, P654, DOI 10.1007/s00246-003-0665-2
   Bonderman D, 1999, CIRCULATION, V99, P2138, DOI 10.1161/01.CIR.99.16.2138
   CAPELLI H, 1982, AM J CARDIOL, V49, P1979, DOI 10.1016/0002-9149(82)90218-1
   Carlo WF, 2011, CONGENIT HEART DIS, V6, P228, DOI 10.1111/j.1747-0803.2011.00520.x
   CARLSON RG, 1970, AM J CARDIOL, V25, P411, DOI 10.1016/0002-9149(70)90006-8
   Cheung YF, 2006, HEART, V92, P1827, DOI 10.1136/hrt.2006.091199
   Chong WY, 2006, AM J CARDIOL, V97, P905, DOI 10.1016/j.amjcard.2005.09.141
   Chowdhury UK, 2008, J THORAC CARDIOV SUR, V136, P757, DOI 10.1016/j.jtcvs.2007.12.044
   Cohen MS, 2003, J AM COLL CARDIOL, V42, P533, DOI 10.1016/S0735-1097(03)00715-0
   David TE, 2000, J THORAC CARDIOV SUR, V119, P210, DOI 10.1016/S0022-5223(00)70175-9
   de Sa M, 1999, J THORAC CARDIOV SUR, V118, P588, DOI 10.1016/S0022-5223(99)70002-4
   DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799
   EDWARDS WD, 1978, CIRCULATION, V57, P1022, DOI 10.1161/01.CIR.57.5.1022
   Egan M, 2009, PEDIATR CARDIOL, V30, P562, DOI 10.1007/s00246-009-9435-0
   Elkins RC, 2008, J THORAC CARDIOV SUR, V136, P623, DOI 10.1016/j.jtcvs.2008.02.080
   Erdheim J, 1930, VIRCHOWS ARCH A, V276, P187, DOI 10.1007/BF02275142
   Grotenhuis HB, 2009, HEART, V95, P1931, DOI 10.1136/hrt.2009.175877
   Gurvitz M, 2004, AM J CARDIOL, V94, P1337, DOI 10.1016/j.amjcard.2004.07.130
   HAHN RT, 1992, J AM COLL CARDIOL, V19, P283, DOI 10.1016/0735-1097(92)90479-7
   Ihling C, 1999, HEART, V82, P286, DOI 10.1136/hrt.82.3.286
   ISNER JM, 1987, CIRCULATION, V75, P689, DOI 10.1161/01.CIR.75.4.689
   Jackson V, 2011, EUR J CARDIO-THORAC, V40, pE118, DOI 10.1016/j.ejcts.2011.04.014
   John AS, 2009, AM J MED GENET A, V149A, P939, DOI 10.1002/ajmg.a.32770
   Klein A L, 1990, J Am Soc Echocardiogr, V3, P54
   LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1
   Losay J, 2006, J AM COLL CARDIOL, V47, P2057, DOI 10.1016/j.jacc.2005.12.061
   MANALOESTRELLA P, 1967, ARCH PATHOL, V83, P336
   Marino BS, 2006, CARDIOL YOUNG, V16, P481, DOI 10.1017/S1047951106000953
   MCKUSICK VA, 1972, LANCET, V1, P1026
   Murakami T, 2000, ANN THORAC SURG, V70, P1907, DOI 10.1016/S0003-4975(00)01837-3
   Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19
   Niwa K, 2005, INT J CARDIOL, V103, P117, DOI 10.1016/j.ijcard.2004.07.002
   Niwa K, 2002, CIRCULATION, V106, P1374, DOI 10.1161/01.CIR.0000028462.88597.AD
   Niwa K, 2001, CIRCULATION, V103, P393
   Perloff JK, 2012, CLIN RECOGNITION CON, P74
   RAO BNS, 1971, AM HEART J, V81, P361
   REID R T W, 1952, Med J Aust, V2, P628
   RIEKER RP, 1975, ANN THORAC SURG, V19, P17, DOI 10.1016/S0003-4975(10)65727-X
   ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712, DOI 10.1016/S0735-1097(10)80188-3
   Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092
   Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118
   SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P13, DOI 10.1016/S0002-9149(77)80004-0
   Schwartz ML, 2004, CIRCULATION, V110, pII128, DOI 10.1161/01.CIR.0000138392.68841.d3
   Segura AM, 1998, CIRCULATION, V98, pII331
   Seki M, 2012, EUR J CARDIO-THORAC, V41, P277, DOI 10.1016/j.ejcts.2011.05.024
   Senzaki H, 2008, HEART, V94, P70, DOI 10.1136/hrt.2006.114306
   SIEVERS HH, 1984, CIRCULATION, V70, P202, DOI 10.1161/01.CIR.70.2.202
   Takeuchi T, 1996, ACT PED CARDIOL JPN, V12, P506
   Tan JL, 2005, CIRCULATION, V112, P961, DOI 10.1161/CIRCULATIONAHA.105.537928
   Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51
   YOSHIDA K, 1988, CIRCULATION, V78, P840, DOI 10.1161/01.CIR.78.4.840
NR 52
TC 21
Z9 21
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 215
EP 220
DI 10.4070/kcj.2013.43.4.215
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300001
PM 23682279
OA Green Published
DA 2021-04-22
ER

PT J
AU Kounis, NG
   Soufras, GD
   Almpanis, G
   Tsigkas, G
   Mazarakis, A
AF Kounis, Nicholas G.
   Soufras, George D.
   Almpanis, George
   Tsigkas, Grigorios
   Mazarakis, Andreas
TI Acute Stent Thrombosis and Heparin Induced Thrombocytopenia: Another
   Manifestation of Kounis Syndrome?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kounis, Nicholas G.] Patras Highest Inst Educ & Technol, Dept Med Sci, Patras, Greece.
   St Andrews State Gen Hosp, Dept Cardiol, Patras, Greece.
RP Kounis, NG (corresponding author), Patras Highest Inst Educ & Technol, Dept Med Sci, Patras, Greece.
EM ngkounis@otenet.gr
RI Tsigkas, Grigorios/AAU-5684-2020
OI Tsigkas, Grigorios/0000-0002-2779-0765
CR Arepally GM, 2001, BLOOD, V98, P1252, DOI 10.1182/blood.V98.4.1252
   CHONG BH, 1995, BRIT J HAEMATOL, V89, P431, DOI 10.1111/j.1365-2141.1995.tb08346.x
   DAWES J, 1982, THROMB RES, V27, P65, DOI 10.1016/0049-3848(82)90279-1
   Howell WH, 1918, AM J PHYSIOL, V47, P328
   Kounis NG, 2012, INT J CARDIOL, V156, P125, DOI 10.1016/j.ijcard.2011.05.052
   Kounis NG, 2011, FUTUR CARDIOL, V7, P805, DOI [10.2217/fca.11.63, 10.2217/FCA.11.63]
   Kounis NG, 2011, J AM COLL CARDIOL, V58, P885, DOI 10.1016/j.jacc.2010.11.082
   Shin HW, 2012, KOREAN CIRC J, V42, P646, DOI 10.4070/kcj.2012.42.9.646
   Vakil Niyati H, 2012, J Pediatr Pharmacol Ther, V17, P12, DOI 10.5863/1551-6776-17.1.12
NR 9
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 221
EP 222
DI 10.4070/kcj.2013.43.4.221
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300002
PM 23682280
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YJ
   Koh, YS
   Park, HE
   Lee, HJ
   Hwang, BH
   Kang, MK
   Lee, SY
   Kim, PJ
   Ihm, SH
   Seung, KB
   Chang, K
AF Lee, Yong-Jin
   Koh, Yoon-Seok
   Park, Hyo Eun
   Lee, Hee Jung
   Hwang, Byung-Hee
   Kang, Min-Kyu
   Lee, So-Young
   Kim, Pum-Joon
   Ihm, Sang-Hyun
   Seung, Ki-Bae
   Chang, Kiyuk
TI Spatial and Temporal Expression, and Statin Responsiveness of Galectin-1
   and Galectin-3 in Murine Atherosclerosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Galectin 1; Galectin 3; Atherosclerosis; Macrophages
ID SMOOTH-MUSCLE-CELLS; INFLAMMATORY RESPONSE; LESIONS; PROLIFERATION;
   ATHEROGENESIS; ACTIVATION; SECRETION; MICE
AB Background and Objectives: Existing data on the spatiotemporal expression patterns of a variety of galectins in murine atherosclerosis are limited. We investigated the expression levels of galectins, and their in vivo spatiotemporal expression patterns and statin responsiveness in the inflamed atherosclerotic plaques of apolipoprotein E (apoE)(-/-) mice.
   Materials and Methods: Galectins expression patterns in aortic atherosclerotic plaques and serum galectin-3 levels were investigated in 26-week-old apoE(-/-) (n=6) and C57BL/6 mice (n=9). To investigate the spatial and temporal patterns of galectin-1 and galectin-3 in plaques, high-cholesterol diet-fed 26-week-old (n=12) and 36-week-old apoE(-/-) mice (n=6) were sacrificed and their aortas were examined for galectins' expression using immunoblot analysis and immunohistochemical stain. 36-week-old apoE(-/-) mice were treated with atorvastatin (n=3, 0.57 mg/kg/day) for the evaluation of its effect on aortic galectins' expression.
   Results: Immunoblot analyses showed that galectin-1 and galectin-3 were the predominant galectins expressed in murine atherosclerosis. The serum galectin-3 level was significantly higher in apoE(-/-) mice (p<0.001). While galectin-1 was weakly expressed in both intimal plaques and the media of atherosclerotic aortas, galectin-3 was heavily and exclusively accumulated in intimal plaques. Galectin-3 distribution was colocalized with plaque macrophages' distribution (r=0.66). As the degree of plaque extent and inflammation increased, the intraplaque galectin-3 expression levels proportionally elevated (p<0.01 vs. baseline), whereas galectin-1 expression had not elevated (p=0.14 vs. baseline). Atorvastatin treatment markedly reduced intraplaque galectin-3 and macrophage signals (p<0.001 vs. baseline), whereas it failed to reduce galectin-1 expression in the aortas.
   Conclusion: Galectin-3 is the predominant gal and is colocalized with macrophages within atherosclerotic plaques. Intraplaque galectin-3 expression reflects the degree of plaque inflammation.
C1 Seoul St Marys Hosp, Cardiovasc Res Ctr, Seoul, South Korea.
   Catholic Univ Korea, Coll Med, Dept Cardiovasc Med, Seoul 137701, South Korea.
RP Chang, K (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Ctr Cardiovasc, 222 Banpodaero, Seoul 137701, South Korea.
EM kiyuk@catholic.ac.kr
RI Koh, Yoon-Seok/AAE-1749-2019
OI Ihm, Sang Hyun/0000-0001-5017-5421
FU National Research Foundation of Korea - Korea GovernmentNational
   Research Foundation of KoreaKorean Government [NRF-2012R1A1A 2042674]
FX This journal was supported by National Research Foundation of Korea
   Grant funded by the Korea Government (NRF-2012R1A1A 2042674).
CR Romaniuk MA, 2010, BIOCHEM J, V432, P535, DOI 10.1042/BJ20100538
   Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0
   Arar C, 1998, FEBS LETT, V430, P307, DOI 10.1016/S0014-5793(98)00683-8
   Chellan B, 2007, EXP MOL PATHOL, V83, P399, DOI 10.1016/j.yexmp.2007.04.004
   Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106
   Falcone C, 2011, INT J IMMUNOPATH PH, V24, P905, DOI 10.1177/039463201102400409
   Forsman H, 2011, ARTHRITIS RHEUM-US, V63, P445, DOI 10.1002/art.30118
   Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4
   Iacobini C, 2009, ARTERIOSCL THROM VAS, V29, P831, DOI 10.1161/ATVBAHA.109.186791
   Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154
   Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852
   Kircher MF, 2008, CIRCULATION, V117, P388, DOI 10.1161/CIRCULATIONAHA.107.719765
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009
   LIU FT, 1995, AM J PATHOL, V147, P1016
   Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x
   Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x
   MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650
   Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6
   Moiseeva EP, 2000, CARDIOVASC RES, V45, P493, DOI 10.1016/S0008-6363(99)00276-X
   Nachtigal M, 1998, AM J PATHOL, V152, P1199
   Nachtigal M, 2008, AM J PATHOL, V172, P247, DOI 10.2353/ajpath.2008.070348
   Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502
   Puato M, 2010, STROKE, V41, P1163, DOI 10.1161/STROKEAHA.110.580811
   Rabinovich GA, 2002, GLYCOCONJUGATE J, V19, P565, DOI 10.1023/B:GLYC.0000014087.41914.72
   Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9
   Rubinstein N, 2004, TISSUE ANTIGENS, V64, P1, DOI 10.1111/j.0001-2815.2004.00278.x
   Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156
   ZANETTA JP, 1994, HISTOL HISTOPATHOL, V9, P385
NR 28
TC 19
Z9 21
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 223
EP 230
DI 10.4070/kcj.2013.43.4.223
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300003
PM 23682281
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, SG
   Yoon, J
   Sung, JK
   Lee, JH
   Lee, JW
   Youn, YJ
   Ahn, MS
   Kim, JY
   Yoo, BS
   Lee, SH
   Choe, KH
AF Ahn, Sung Gyun
   Yoon, Junghan
   Sung, Joong Kyung
   Lee, Ji-Hyun
   Lee, Jun-Won
   Youn, Young-Jin
   Ahn, Min-Soo
   Kim, Jang-Young
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Choe, Kyung-Hoon
TI Intravascular Ultrasound-Guided Percutaneous Coronary Intervention
   Improves the Clinical Outcome in Patients Undergoing Multiple
   Overlapping Drug-Eluting Stents Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Intravascular ultrasonography; Coronary stenosis; Drug-eluting stents;
   Percutaneous coronary intervention; Thrombosis
ID ACUTE MYOCARDIAL-INFARCTION; TASK-FORCE; GUIDANCE; IMPACT; DEFINITIONS;
   PREDICTORS; RESTENOSIS; THROMBOSIS
AB Background and Objectives: Stented segment length is a predictive factor for restenosis and stent thrombosis still in the drug-eluting stent (DES) era, and the benefit of routine intravascular ultrasound (IVUS) is still unclear. The aim of the present study was to investigate whether IVUS-guided percutaneous coronary intervention (PCI) improved the vascular outcomes as compared with conventional PCI in the treatment of diffuse coronary artery disease.
   Subjects and Methods: From our registry database from January 2006 to May 2009, we identified 85 consecutive patients with de novo coronary lesions treated with at least 64 mm of multiple, overlapping DES. The 2-year rate of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, non-fatal myocardial infarction, target lesion revascularization (TLR), or stent thrombosis, was compared according to the use of IVUS.
   Results: The 2-year MACE rate was lower in the IVUS-guided group than that of the angiography-guided group (8% vs. 33.3%, p=0.005). The incidence of TLR was lower in patients with IVUS use than in those without IVUS use (0% vs. 27.8%, p<0.001). On Cox proportional hazard analysis, no IVUS use {hazard ratio (HR) 5.917, 95% confidence interval (CI) 1.037-33.770, p=0.045} and age (HR 1.097, 95% CI 1.006-1.138, p=0.032) were unfavorable predictors for the 2-year MACE.
   Conclusion: The use of IVUS may improve the effectiveness and safety of multiple overlapping drug-eluting stenting for long, diffuse coronary lesions.
C1 [Ahn, Sung Gyun; Yoon, Junghan; Sung, Joong Kyung; Lee, Ji-Hyun; Lee, Jun-Won; Youn, Young-Jin; Ahn, Min-Soo; Kim, Jang-Young; Yoo, Byung-Su; Lee, Seung-Hwan; Choe, Kyung-Hoon] Yonsei Univ, Wonju Coll Med, Div Cardiol, Wonju 220701, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, 20 Ilsan Ro, Wonju 220701, South Korea.
EM jyoon@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
CR Ahmed K, 2011, AM J CARDIOL, V108, P8, DOI 10.1016/j.amjcard.2011.02.339
   Aoki J, 2005, AM HEART J, V150, P994, DOI 10.1016/j.ahj.2005.01.050
   Brugaletta S, 2011, INT J CARDIOVAS IMAG, V27, P239, DOI 10.1007/s10554-010-9788-8
   Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8
   Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P974, DOI 10.1016/j.jcin.2011.07.005
   Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Hannan EL, 2008, CIRCULATION, V117, P2071, DOI 10.1161/CIRCULATIONAHA.107.725531
   Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882
   Hur SH, 2011, CATHETER CARDIOVASC
   홍순준, 2007, Korean Circulation Journal, V37, P530
   Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI 10.1016/j.jacc.2012.09.001
   Kim JS, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.002
   Kim SH, 2010, AM J CARDIOL, V106, P612, DOI 10.1016/j.amjcard.2010.04.016
   Lee CW, 2006, AM J CARDIOL, V98, P918, DOI 10.1016/j.amjcard.2006.05.011
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Maluenda G, 2010, CATHETER CARDIO INTE, V75, P86, DOI 10.1002/ccd.22198
   Okabe T, 2007, AM J CARDIOL, V100, P615, DOI 10.1016/j.amjcard.2007.03.072
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Tin-Hay EL, 2010, INT J CARDIOL, V145, P422, DOI 10.1016/j.ijcard.2009.05.038
   Youn YJ, 2011, CLIN CARDIOL, V34, P706, DOI 10.1002/clc.20966
NR 24
TC 13
Z9 13
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 231
EP 238
DI 10.4070/kcj.2013.43.4.231
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300004
PM 23682282
OA Green Published
DA 2021-04-22
ER

PT J
AU Chae, MJ
   Jung, IH
   Jang, DH
   Lee, SY
   Hyun, JY
   Jung, JH
   Ahn, DS
   Lim, DS
   Lee, SJ
AF Chae, Myung-Joon
   Jung, In-Hyun
   Jang, Duck-Hyun
   Lee, Soo-Yeon
   Hyun, Joo-Yong
   Jung, Jae-Hoon
   Ahn, Dae-Sung
   Lim, Dal-Soo
   Lee, Sook-Jin
TI The Brachial Ankle Pulse Wave Velocity is Associated with the Presence
   of Significant Coronary Artery Disease but Not the Extent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arterial stiffness; Coronary artery disease; Atherosclerosis
ID INDEPENDENT PREDICTOR; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS;
   AORTIC STIFFNESS; ALL-CAUSE; RISK; ATHEROSCLEROSIS; MORTALITY; FAILURE;
   MARKER
AB Background and Objectives: Arterial stiffness is well known as an important risk factor for cardiovascular disease. At our institution, we assessed the association between arterial stiffness, as determined by brachial ankle pulse wave velocity (baPWV), and the extent of coronary artery disease (CAD), as detected by conventional coronary angiography (CAG) in patients who visited the outpatient clinic for angina without any previous history of heart disease. In addition, we evaluated if the level of baPWV could predict the revascularization as a clinical outcome.
   Subjects and Methods: On a retrospective basis, we analyzed the data of 651 consecutive patients who had undergone baPWV and elective CAG for suspected CAD between June 2010 and July 2011, at a single cardiovascular center.
   Results: The baPWV was one of the statistically meaningful predictors of significant CAD (diameter of stenosis >50%) in addition to male gender, age, the level of high density lipoprotein-cholesterol, and hemoglobin A(1)c in multivariate analysis. However, baPWV was not the significant predictor of revascularization. When the extent of CAD was classified into following 4 groups; no significant CAD, 1-, 2- and 3-vessel disease, there was significant difference of baPWV between the significant and non-significant CAD group, but there was no difference of baPWV among the 3 significant CAD groups, although there was a trend toward the positive correlation.
   Conclusion: Although baPWV was an independent predictor of significant CAD, it was neither associated significantly with the extent of CAD nor with the risk of revascularization. Therefore, baPWV has a limited value for portending the severity of CAD in patients with chest pain.
C1 [Chae, Myung-Joon; Jung, In-Hyun; Jang, Duck-Hyun; Lee, Soo-Yeon; Hyun, Joo-Yong; Jung, Jae-Hoon; Ahn, Dae-Sung; Lim, Dal-Soo; Lee, Sook-Jin] Sejong Gen Hosp, Dept Cardiol, Puchon 422711, South Korea.
RP Jung, IH (corresponding author), Sejong Gen Hosp, Dept Cardiol, 91-121 Sosabon Dong, Puchon 422711, South Korea.
EM drjih@naver.com
CR Amar J, 2001, J HYPERTENS, V19, P381, DOI 10.1097/00004872-200103000-00005
   Asmar R, 2001, J HYPERTENS, V19, P813, DOI 10.1097/00004872-200104000-00019
   ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   DEMER LL, 1991, CIRCULATION, V83, P2083, DOI 10.1161/01.CIR.83.6.2083
   Igarashi Y, 2005, CIRC J, V69, P237, DOI 10.1253/circj.69.237
   Imanishi R, 2004, HYPERTENS RES, V27, P71, DOI 10.1291/hypres.27.71
   Kim HJ, 2009, DIABETES RES CLIN PR, V85, P30, DOI 10.1016/j.diabres.2009.03.013
   Kingwell BA, 2002, J AM COLL CARDIOL, V40, P773, DOI 10.1016/S0735-1097(02)02009-0
   Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   LEHMANN ED, 1992, DIABETIC MED, V9, P114, DOI 10.1111/j.1464-5491.1992.tb01746.x
   Liu CS, 2011, J ATHEROSCLER THROMB, V18, P652, DOI 10.5551/jat.7021
   LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655
   Nam HJ, 2012, INT J CARDIOL, V157, P227, DOI 10.1016/j.ijcard.2011.01.045
   Safar Michel E, 2002, Am J Geriatr Cardiol, V11, P295, DOI 10.1111/j.1076-7460.2002.00695.x
   Seo Won-Woo, 2010, Korean Circ J, V40, P224, DOI 10.4070/kcj.2010.40.5.224
   Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815
   Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5
   Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616
   Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061
   Xu YX, 2008, HYPERTENS RES, V31, P1079, DOI 10.1291/hypres.31.1079
   Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615
   Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359
   Yambe M, 2004, HYPERTENS RES, V27, P625, DOI 10.1291/hypres.27.625
NR 28
TC 7
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 239
EP 245
DI 10.4070/kcj.2013.43.4.239
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300005
PM 23682283
OA Green Published
DA 2021-04-22
ER

EF